Companies:
10,660
total market cap:
HK$1092.228 T
Sign In
๐บ๐ธ
EN
English
$ HKD
$
USD
๐บ๐ธ
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
๐ป๐ณ Vietnam
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
ETFs
๐ All ETFs
๐๏ธ Bond ETFs
๏ผ Dividend ETFs
โฟ Bitcoin ETFs
โข Ethereum ETFs
๐ช Crypto Currency ETFs
๐ฅ Gold ETFs & ETCs
๐ฅ Silver ETFs & ETCs
๐ข๏ธ Oil ETFs & ETCs
๐ฝ Commodities ETFs & ETNs
๐ Emerging Markets ETFs
๐ Small-Cap ETFs
๐ Low volatility ETFs
๐ Inverse/Bear ETFs
โฌ๏ธ Leveraged ETFs
๐ Global/World ETFs
๐บ๐ธ USA ETFs
๐บ๐ธ S&P 500 ETFs
๐บ๐ธ Dow Jones ETFs
๐ช๐บ Europe ETFs
๐จ๐ณ China ETFs
๐ฏ๐ต Japan ETFs
๐ฎ๐ณ India ETFs
๐ฌ๐ง UK ETFs
๐ฉ๐ช Germany ETFs
๐ซ๐ท France ETFs
โ๏ธ Mining ETFs
โ๏ธ Gold Mining ETFs
โ๏ธ Silver Mining ETFs
๐งฌ Biotech ETFs
๐ฉโ๐ป Tech ETFs
๐ Real Estate ETFs
โ๏ธ Healthcare ETFs
โก Energy ETFs
๐ Renewable Energy ETFs
๐ก๏ธ Insurance ETFs
๐ฐ Water ETFs
๐ด Food & Beverage ETFs
๐ฑ Socially Responsible ETFs
๐ฃ๏ธ Infrastructure ETFs
๐ก Innovation ETFs
๐ Semiconductors ETFs
๐ Aerospace & Defense ETFs
๐ Cybersecurity ETFs
๐ฆพ Artificial Intelligence ETFs
Watchlist
Account
UBS
UBS
#147
Rank
HK$1.106 T
Marketcap
๐จ๐ญ
Switzerland
Country
HK$350.34
Share price
-5.92%
Change (1 day)
43.33%
Change (1 year)
๐ฆ Banks
๐ณ Financial services
Categories
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
Annual Reports (20-F)
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
EPS
Stock Splits
Dividends
Dividend yield
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports
ESG Reports
Sustainability Reports
UBS
Annual Reports (20-F)
Submitted on 2022-03-07
UBS - 20-F annual report
Text size:
Small
Medium
Large
0001610520
0001114446
--12-31
--12-31
FY
FY
FALSE
FALSE
2021
2021
FALSE
FALSE
TRUE
FALSE
FALSE
FALSE
FALSE
24/02/2022
24/02/2022
Switzerland
David Kelly
International Financial Reporting Standards
203
719 3000
0001610520
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
2021-12-31
0001610520
ubs:UBSAGMember
2020-12-31
0001610520
2020-12-31
0001610520
ubs:SegmentNonSwissMember
2020-01-01
2020-12-31
0001610520
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentSwissMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentPCBMember
2021-01-01
2021-12-31
0001610520
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:LaterThanTenYearsAndNotLaterThanTwentyYearsMember
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentIBMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentPCBMember
2019-01-01
2019-12-31
0001610520
ubs:SegmentAMMember
2020-12-31
0001610520
ubs:SegmentIBMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentPCBMember
2020-01-01
2020-12-31
0001610520
ubs:GlobalMember
2020-12-31
0001610520
ubs:IncludedInOtherComprehensiveIncomeMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2019-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ubs:ClientVehiclesMember
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:SecuritisationVehiclesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:InvestmentFundsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:AssumptionOfLifeExpectancyMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:DomesticRealEstateAndPropertyMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
2021-01-01
2021-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentSwissMember
2019-01-01
2019-12-31
0001610520
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
2020-12-31
0001610520
ubs:SegmentIBMember
2021-01-01
2021-12-31
0001610520
ubs:SegmentPCBMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentPCBMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:TemporaryDifferenceRelatedToOtherMember
2021-12-31
0001610520
ubs:SegmentNonSwissMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentNonSwissMember
2021-01-01
2021-12-31
0001610520
ubs:SegmentIBMember
2020-01-01
2020-12-31
0001610520
ubs:SegmentGWMMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentIBMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentIBMember
2019-01-01
2019-12-31
0001610520
ubs:GlobalMember
2019-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:SecuritisationVehiclesMember
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:SecuritisationVehiclesMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:SecuritisationVehiclesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ubs:IncludedInOtherComprehensiveIncomeMember
2019-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromCustomersMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2019-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
2021-12-31
0001610520
ifrs-full:UnusedTaxLossesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGWMMember
2021-01-01
2021-12-31
0001610520
ifrs-full:UnusedTaxLossesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:NotTimeSpecificMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentAMMember
2021-01-01
2021-12-31
0001610520
ubs:SegmentGWMMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGWMMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:GlobalMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentNonSwissMember
2020-01-01
2020-12-31
0001610520
ubs:SegmentAMMember
2019-01-01
2019-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2019-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:LaterThanTenYearsAndNotLaterThanTwentyYearsMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ClientVehiclesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromBanksMember
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromCustomersMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:PensionPlansMember
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:SecuritisationVehiclesMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:UBSAGMember
ubs:DerivativeFinancialAssetsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
2021-12-31
0001610520
ubs:SegmentPCBMember
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ifrs-full:RestructuringProvisionMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentAMMember
2020-01-01
2020-12-31
0001610520
2019-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:RestructuringProvisionMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:SegmentAMMember
2021-12-31
0001610520
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentAMMember
2019-01-01
2019-12-31
0001610520
ifrs-full:RestructuringProvisionMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentAMMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ubs:ClientVehiclesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ubs:ClientVehiclesMember
2021-12-31
0001610520
ubs:DerivativeFinancialLiabilitiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanUBSGroupAGSharesMember
2021-12-31
0001610520
ubs:EquityOwnershipPlanMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:VariableCompensationOtherMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:DeferredContingentCapitalPlanMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:SegmentNonSwissMember
2019-01-01
2019-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentGWMMember
2021-01-01
2021-12-31
0001610520
ubs:IncludedInOtherComprehensiveIncomeMember
2019-01-01
2019-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationAndCommitmentsMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationAndCommitmentsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:CashPerformanceAwardsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:VariableCompensationOtherMember
2019-01-01
2019-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:SegmentGWMMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherMember
2021-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:PensionPlansMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromCustomersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ClientVehiclesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:InvestmentFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:DerivativeFinancialAssetsMember
ubs:ClientVehiclesMember
2020-12-31
0001610520
ubs:SegmentSwissMember
2021-01-01
2021-12-31
0001610520
ubs:SegmentPCBMember
2021-01-01
2021-12-31
0001610520
ubs:IncludedInOtherComprehensiveIncomeMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ubs:DerivativeFinancialLiabilitiesMember
ubs:ClientVehiclesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2019-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DerivativeFinancialLiabilitiesMember
2021-12-31
0001610520
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:DomesticRealEstateAndPropertyMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:UnusedTaxLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentSwissMember
2021-01-01
2021-12-31
0001610520
ubs:GlobalMember
2019-01-01
2019-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:PensionPlansMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromCustomersMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ubs:SegmentAMMember
2020-01-01
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:PensionPlansMember
2019-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2021-12-31
0001610520
ubs:DerivativeFinancialAssetsMember
ubs:ClientVehiclesMember
2020-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:DerivativeFinancialAssetsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:GlobalMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromCustomersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGWMMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2019-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:DerivativeFinancialLiabilitiesMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:SecuritisationVehiclesMember
ubs:DerivativeFinancialLiabilitiesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticRealEstateAndPropertyMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:SegmentAMMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:AssumptionOfLifeExpectancyMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticRealEstateAndPropertyMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanUBSAGDebtInstrumentsMember
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationCommitmentsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:DeferredContingentCapitalPlanMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:DeferredContingentCapitalPlanMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:PerformanceAwardsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CashPerformanceAwardsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:PerformanceAwardsMember
2019-01-01
2019-12-31
0001610520
ubs:FinancialAdvisorCompensationMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:VariableCompensationOtherMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
ubs:DeferredCompensationAwardsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ubs:ClientVehiclesMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:SegmentAMMember
2021-12-31
0001610520
ubs:SegmentAMMember
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DerivativeFinancialLiabilitiesMember
ubs:ClientVehiclesMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:AssumptionOfLifeExpectancyMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:CompensationPriorYearsMember
ubs:DeferredCompensationAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationCommitmentsMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationAndCommitmentsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
2019-01-01
2019-12-31
0001610520
ubs:FinancialAdvisorCompensationAndCommitmentsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:DeferredCompensationAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCashPaymentsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:EquityOwnershipPlanMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationCommitmentsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:DeferredContingentCapitalPlanMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:PerformanceAwardsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:FinancialAssetsAtFairValueHeldforTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueRelatedToOtherTransfersMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:TopOfRangeMember
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:GlobalMember
2019-01-01
2019-12-31
0001610520
ubs:SegmentIBMember
2019-01-01
2019-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:DerivativeFinancialAssetsMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticRealEstateAndPropertyMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:DomesticRealEstateAndPropertyMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ubs:CompensationPerformanceYearMember
ubs:AssetManagementEOPMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
ubs:DeferredCompensationAwardsMember
2019-01-01
2019-12-31
0001610520
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ubs:FinancialAdvisorCompensationCashPaymentsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:AssetManagementEOPMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ubs:DeferredContingentCapitalPlanMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCashPaymentsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:EquityOwnershipPlanMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationAndCommitmentsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromBanksMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanSecuritiesLentToUBSAGMember
2021-12-31
0001610520
ubs:PerformanceAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:CompensationPriorYearsMember
ubs:AssetManagementEOPMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CashPerformanceAwardsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCommitmentsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCommitmentsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:DeferredCompensationAwardsMember
2019-01-01
2019-12-31
0001610520
ubs:FinancialAdvisorCompensationCashPaymentsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationAndCommitmentsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:EquityOwnershipPlanMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ubs:ClientVehiclesMember
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:NotLaterThanOneYearMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCommitmentsMember
2019-01-01
2019-12-31
0001610520
ubs:DeferredContingentCapitalPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:PensionPlansMember
2019-12-31
0001610520
ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationCashPaymentsMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationCashPaymentsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
ubs:DeferredCompensationAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CashPerformanceAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:VariableCompensationOtherMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:AssumptionOfLifeExpectancyMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationAndCommitmentsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:WeightedAverageMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ubs:CompensationPerformanceYearMember
ubs:DeferredCompensationAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationAndCommitmentsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationAndCommitmentsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ubs:FinancialAdvisorCompensationCashPaymentsMember
2021-01-01
2021-12-31
0001610520
ubs:EquityOwnershipPlanMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:CashPerformanceAwardsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:DeferredContingentCapitalPlanMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PerformanceAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:VariableCompensationOtherMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:CompensationPriorYearsMember
ubs:DeferredCompensationAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
ubs:DeferredCompensationAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ubs:UBSAGMember
ubs:ClientVehiclesMember
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ubs:FinancialAssetsAtFairValueHeldforTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueRelatedToOtherTransfersMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationCashPaymentsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:EquityOwnershipPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
2021-12-31
0001610520
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:DomesticRealEstateAndPropertyMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValueBankAccountsAtUBSAGMember
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationCommitmentsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:AssumptionOfLifeExpectancyMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:PerformanceAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:EquityOwnershipPlanMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanDerivativeInstrumentsUbsAgCounterpartyMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PerformanceAwardsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ubs:CashPerformanceAwardsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:CompensationPerformanceYearMember
ubs:DeferredCompensationAwardsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValueBankAccountsAtUBSAGMember
2020-12-31
0001610520
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValueBankAccountsAtUBSAGMember
2021-12-31
0001610520
ubs:EquityOwnershipPlanMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:VariableCompensationOtherMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:EquityOwnershipPlanMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PerformanceAwardsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:CashPerformanceAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:DeferredContingentCapitalPlanMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCashPaymentsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanTenYearsMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:SegmentSwissMember
2019-01-01
2019-12-31
0001610520
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanUBSAGDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:LaterThanTenYearsMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
2021-12-31
0001610520
ifrs-full:UnusedTaxLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentIBMember
2019-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromBanksMember
2021-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:PensionPlansMember
2021-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:DerivativeFinancialAssetsMember
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:RestructuringProvisionMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCommitmentsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:IntragroupFundingMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UKPensionPlanMember
2019-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ubs:DerivativeFinancialAssetsMember
2020-12-31
0001610520
ubs:SegmentSwissMember
2020-01-01
2020-12-31
0001610520
ubs:SegmentGWMMember
2020-12-31
0001610520
ubs:IncludedInOtherComprehensiveIncomeMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentNonSwissMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:LaterThanTenYearsAndNotLaterThanTwentyYearsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ubs:IncludedInOtherComprehensiveIncomeMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentAMMember
2020-12-31
0001610520
ubs:SegmentAMMember
2019-12-31
0001610520
ubs:UBSAGMember
ubs:DerivativeFinancialAssetsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
2021-12-31
0001610520
ubs:SegmentPCBMember
2019-01-01
2019-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:DomesticRealEstateAndPropertyMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:PensionPlansMember
2019-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
2021-12-31
0001610520
ubs:DerivativeFinancialLiabilitiesMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2020-12-31
0001610520
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentIBMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ubs:ClientVehiclesMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DerivativeFinancialLiabilitiesMember
ubs:ClientVehiclesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanSecuritiesLentToUBSAGMember
2020-12-31
0001610520
ubs:PerformanceAwardsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:PerformanceAwardsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationAndCommitmentsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:DeferredCompensationAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DeferredCompensationAwardsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:NotLaterThanOneYearMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanTenYearsMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromBanksMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
2020-12-31
0001610520
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:IntragroupFundingMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromBanksMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:SwissPensionPlanMember
2019-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:GoodsOrServicesTransferredOnRecurringBasisMember
2021-01-01
2021-12-31
0001610520
ifrs-full:RestructuringProvisionMember
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:PerformanceAwardsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:EquityOwnershipPlanMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:EquityOwnershipPlanMember
2019-01-01
2019-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:PensionPlansMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
2020-01-01
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:DerivativeFinancialAssetsMember
ubs:ClientVehiclesMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:AssumptionOfLifeExpectancyMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:SecuritisationVehiclesMember
ubs:DerivativeFinancialLiabilitiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:SecuritisationVehiclesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanUBSGroupAGSharesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:VariableCompensationOtherMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:DeferredCompensationAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ubs:FinancialAssetsAtFairValueHeldforTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueRelatedToThoseInExchangeForSecuritiesReceivedMember
2021-12-31
0001610520
ubs:SegmentAMMember
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:VariableCompensationOtherMember
2020-01-01
2020-12-31
0001610520
ubs:VariableCompensationOtherMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationAndCommitmentsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanDerivativeInstrumentsUbsAgCounterpartyMember
2020-12-31
0001610520
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:CashPerformanceAwardsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:CashPerformanceAwardsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:VariableCompensationOtherMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:VariableCompensationOtherMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCommitmentsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DeferredContingentCapitalPlanMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
2021-12-31
0001610520
ubs:CreditSpreadRiskMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:SecuritisationVehiclesMember
ubs:DerivativeFinancialAssetsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DeferredContingentCapitalPlanMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ubs:CashPerformanceAwardsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCashPaymentsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:TopOfRangeMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PerformanceAwardsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:WeightedAverageMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticRealEstateAndPropertyMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromCustomersMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanPropertiesOccupiedByUBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCommitmentsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
ubs:AssetManagementEOPMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationAndCommitmentsMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationCashPaymentsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationCommitmentsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:VariableCompensationOtherMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCashPaymentsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValueBankAccountsAtUBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:EquityOwnershipPlanMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationAndCommitmentsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ubs:SegmentIBMember
2019-12-31
0001610520
ubs:GlobalMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:GlobalMember
2019-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DeferredContingentCapitalPlanMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:EquityOwnershipPlanMember
2019-01-01
2019-12-31
0001610520
ubs:FinancialAdvisorCompensationMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:CashPerformanceAwardsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:EquityOwnershipPlanMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CashPerformanceAwardsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:NotLaterThanOneYearMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:SegmentAMMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DerivativeFinancialAssetsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTenYearsMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ubs:SegmentPCBMember
2019-12-31
0001610520
ubs:GlobalMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromBanksMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:IntragroupFundingMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:SecuritisationVehiclesMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:UBSAGMember
ubs:DerivativeFinancialLiabilitiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:AssumptionOfLifeExpectancyMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanDerivativeInstrumentsUbsAgCounterpartyMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticRealEstateAndPropertyMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanUBSAGDebtInstrumentsMember
2020-12-31
0001610520
ubs:DeferredContingentCapitalPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:IntragroupFundingMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:PensionPlansMember
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCashPaymentsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCommitmentsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationCommitmentsMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationCashPaymentsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationCommitmentsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCashPaymentsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ubs:UBSAGMember
ubs:ClientVehiclesMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:UBSAGMember
ubs:DerivativeFinancialAssetsMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:IntragroupFundingMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:VariableCompensationOtherMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:PensionPlansMember
2019-12-31
0001610520
ubs:AssetManagementEOPMember
2020-01-01
2020-12-31
0001610520
ubs:CompensationPerformanceYearMember
ubs:DeferredCompensationAwardsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCashPaymentsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:IntragroupFundingMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:USAndGermanPensionPlansMember
2019-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanPropertiesOccupiedByUBSAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
ubs:DeferredCompensationAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:VariableCompensationOtherMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationCashPaymentsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:NotTimeSpecificMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherMember
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LaterThanTenYearsAndNotLaterThanTwentyYearsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CashPerformanceAwardsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:SecuritisationVehiclesMember
ubs:UBSAGMember
ubs:DerivativeFinancialAssetsMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanPropertiesOccupiedByUBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
ubs:DeferredCompensationAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:PerformanceAwardsMember
2019-01-01
2019-12-31
0001610520
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:CompensationPriorYearsMember
ubs:DeferredCompensationAwardsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromBanksMember
2021-12-31
0001610520
ubs:VariableCompensationOtherMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationCommitmentsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2020-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentAMMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:PensionPlansMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UBSAGMember
ubs:PensionPlansMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:PensionPlansMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromBanksMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:PensionPlansMember
2019-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DeferredContingentCapitalPlanMember
2019-01-01
2019-12-31
0001610520
ubs:FinancialAdvisorCompensationCommitmentsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:SwissPensionPlanMember
2019-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:WeightedAverageMember
2020-12-31
0001610520
ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ubs:FinancialAssetsAtFairValueHeldforTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueRelatedToThoseInExchangeForCashReceivedMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:GlobalMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:GlobalMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:EquityOwnershipPlanMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:PerformanceAwardsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:GoodsOrServicesTransferredOnRecurringBasisMember
2021-01-01
2021-12-31
0001610520
ifrs-full:RestructuringProvisionMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CashPerformanceAwardsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneMonthMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentIBMember
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ubs:SegmentGWMMember
2019-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ubs:UBSAGMember
ubs:ClientVehiclesMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:SegmentIBMember
2021-12-31
0001610520
ubs:SegmentPCBMember
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:LaterThanFiveYearsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanSecuritiesLentToUBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromBanksMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:USAndGermanPensionPlansMember
2019-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:SecuritisationVehiclesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:AssumptionOfLifeExpectancyMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:SegmentPCBMember
2020-12-31
0001610520
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:VariableCompensationOtherMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCashPaymentsMember
2019-01-01
2019-12-31
0001610520
ubs:CashPerformanceAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticRealEstateAndPropertyMember
2020-12-31
0001610520
ubs:EquityOwnershipPlanMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2020-12-31
0001610520
ubs:SegmentIBMember
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:EquityPriceRiskMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UKPensionPlanMember
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationAndCommitmentsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromCustomersMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:PensionPlansMember
2020-12-31
0001610520
ubs:DerivativeFinancialAssetsMember
ubs:ClientVehiclesMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentPCBMember
2019-12-31
0001610520
ubs:DeferredContingentCapitalPlanMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:SegmentAMMember
2020-12-31
0001610520
ubs:ClientVehiclesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:PerformanceAwardsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CashPerformanceAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAssetsAtFairValueHeldforTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueRelatedToThoseInExchangeForCashReceivedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ubs:CreditSpreadRiskMember
2020-01-01
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CommodityPriceRiskMember
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ubs:VariableCompensationOtherMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:GlobalMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:TopOfRangeMember
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:LaterThanTenYearsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:USAndGermanPensionPlansMember
2019-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:DerivativeFinancialLiabilitiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:CashPerformanceAwardsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:TopOfRangeMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:SecuritisationVehiclesMember
ubs:UBSAGMember
ubs:DerivativeFinancialLiabilitiesMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:ClientVehiclesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:SecuritisationVehiclesMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:SecuritisationVehiclesMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:InterestRateRiskMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:FinancialAssetsMeasuredAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:FinancialAssetsOffBalanceSheetMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialAssetsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryDebtInstrumentsMemberMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
ubs:FinancialAssetsMeasuredAtFairValueMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
ubs:AssetManagementEOPMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
2021-01-01
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:TopOfRangeMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTenYearsMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentIBMember
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:SegmentAMMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialAssetsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:FinancialAssetsMeasuredAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialGuaranteeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:FinancialAssetsMeasuredAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:FinancialAssetsOffBalanceSheetMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:FinancialAssetsAtFairValueMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades6To8Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
2021-12-31
0001610520
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ubs:DerivativeFinancialLiabilitiesMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
2020-12-31
0001610520
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PerformanceAwardsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:LoanCommitmentsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:LoanCommitmentsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:FinancialAssetsMeasuredAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ifrs-full:FinancialGuaranteeContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueHeldForTradingDebtInstrumentsMemberMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades9To13Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:WeightedAverageMember
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialGuaranteeContractsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanDerivativeInstrumentsUbsAgCounterpartyMember
2021-12-31
0001610520
ubs:DeferredCompensationAwardsMember
2021-01-01
2021-12-31
0001610520
ubs:DeferredContingentCapitalPlanMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanUBSGroupAGSharesMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CurrencyRiskMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromBanksMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:TopOfRangeMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationAndCommitmentsMember
ubs:CompensationPerformanceYearMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:EquityOwnershipPlanMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialAssetsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:DeferredContingentCapitalPlanMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:SecuritisationVehiclesMember
ubs:DerivativeFinancialAssetsMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:TemporaryDifferenceRelatedToOtherMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGWMMember
2019-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialAssetsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
ubs:FinancialAssetsMeasuredAtFairValueMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGradesDefaultedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades4To5Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:UBSBusinessSolutionsAGSubsidiariesMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:FinancialAssetsMeasuredAtFairValueMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:SegmentIBMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ClientVehiclesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
2020-12-31
0001610520
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentPCBMember
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ubs:DeferredContingentCapitalPlanMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:SecuritisationVehiclesMember
ubs:UBSAGMember
ubs:DerivativeFinancialAssetsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationAndCommitmentsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:EquityOwnershipPlanMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2019-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:AssumptionOfLifeExpectancyMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanUBSAGDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:UBSAGMember
ubs:TemporaryDifferenceRelatedToCompensationMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:ParentIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CurrencyRiskMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:FinancialAssetsOffBalanceSheetMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:FinancialAssetsOffBalanceSheetMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:FinancialAssetsMeasuredAtFairValueMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:EquityPriceRiskMember
2020-12-31
0001610520
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:CreditSpreadRiskMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:PensionPlansMember
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades4To5Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryDebtInstrumentsMemberMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:FinancialAssetsAtFairValueMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades4To5Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCommitmentsMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:TopOfRangeMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:PensionPlansMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:PerformanceAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:CreditSpreadRiskMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationDeferredCashbasedAwardsMember
ubs:CompensationPriorYearsMember
2020-01-01
2020-12-31
0001610520
ubs:NotTimeSpecificMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:LaterThanFiveYearsMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:ReverseRepurchaseAgreementAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ShortTermNotesAndDebenturesIssuedMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ubs:NotesAndDebenturesIssuedMember
2020-01-01
2020-12-31
0001610520
ubs:ShortTermNotesAndDebenturesIssuedMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:TemporaryDifferenceRelatedToRealEstateCapitalizedForUSTaxPurposesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:LaterThanFiveYearsMember
2020-12-31
0001610520
ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
2021-12-31
0001610520
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:NotLaterThanOneMonthMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LongTermNotesAndDebenturesIssuedMember
2021-12-31
0001610520
ubs:SegmentGWMAmericasCashGeneratingUnitMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:TemporaryDifferenceRelatedToCompensationMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneMonthMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ubs:LongTermNotesAndDebenturesIssuedMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromBanksMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LongTermNotesAndDebenturesIssuedMember
2019-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ClientVehiclesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanPropertiesOccupiedByUBSAGMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CashPerformanceAwardsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ifrs-full:FinancialGuaranteeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryDebtInstrumentsMemberMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:IntragroupFundingMember
2021-01-01
2021-12-31
0001610520
ubs:SegmentGWMExAmericasCashGeneratingUnitMember
2021-12-31
0001610520
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:LaterThanFiveYearsMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OverTheCounterDerivativeLiabilitiesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueHeldForTradingDebtInstrumentsMemberMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades9To13Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:LaterThanTenYearsMember
ubs:ParentIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ubs:OverTheCounterDerivativeLiabilitiesMember
2020-12-31
0001610520
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ubs:FinancialAssetsAtFairValueNotHeldForTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanSecuritiesLentToUBSAGMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LongTermNotesAndDebenturesIssuedMember
2020-12-31
0001610520
ifrs-full:LaterThanTenYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ubs:ShortTermNotesAndDebenturesIssuedMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:UBSAGMember
ubs:TemporaryDifferenceRelatedToCompensationMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:LoansAndAdvancesToCustomersMember
2020-01-01
2020-12-31
0001610520
ubs:ShorttermDownInterestRateShockScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SteepenerInterestRateShockScenarioMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignRealEstateAndPropertyMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:AuctionRateSecuritiesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:NotesAndDebenturesIssuedMember
2019-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:TemporaryDifferenceRelatedToCompensationMember
2021-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:UBSAGMember
ubs:TemporaryDifferenceRelatedToRealEstateCapitalizedForUSTaxPurposesMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:EMEAMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-01-01
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:InterestRateContractsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ubs:SegmentPCBMember
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentAMMember
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ubs:PlusOneBasisPointsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
2020-01-01
2020-12-31
0001610520
ubs:UBSBusinessSolutionsAGSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:OverTheCounterDerivativeLiabilitiesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ubs:OverTheCounterDerivativeLiabilitiesMember
2021-12-31
0001610520
ubs:DerivativeFinancialLiabilitiesMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ubs:UbsAGIssuerMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:UBSAGMember
ubs:TemporaryDifferenceRelatedToOtherMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:NotesAndDebenturesIssuedMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneMonthMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:NotesAndDebenturesIssuedMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:EMEAMember
2019-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ShortTermNotesAndDebenturesIssuedMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:ParentIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignRealEstateAndPropertyMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryDebtInstrumentsMemberMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:ParentIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades6To8Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ubs:ShortTermNotesAndDebenturesIssuedMember
2020-01-01
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ubs:LongTermNotesAndDebenturesIssuedMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignRealEstateAndPropertyMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ShortTermNotesAndDebenturesIssuedMember
2020-01-01
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades9To13Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignRealEstateAndPropertyMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades6To8Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ubs:UBSAGSubsidiariesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignRealEstateAndPropertyMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades6To8Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades2To3Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:UBSAGMember
ubs:TemporaryDifferenceRelatedToRealEstateCapitalizedForUSTaxPurposesMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ShortTermNotesAndDebenturesIssuedMember
2021-12-31
0001610520
ubs:SegmentGWMExAmericasCashGeneratingUnitMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades0To1Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:LaterThanTenYearsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ubs:EMEAMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DerivativeFinancialLiabilitiesMember
2020-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:UBSAGMember
ubs:DerivativeFinancialLiabilitiesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:DeferredContingentCapitalPlanMember
ubs:CompensationPriorYearsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:ShorttermUpInterestRateShockScenarioMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:NotesAndDebenturesIssuedMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LongTermNotesAndDebenturesIssuedMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentAMMember
2019-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:SwissPensionPlanMember
2019-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromBanksMember
2021-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:WeightedAverageMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentPCBMember
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:PerformanceAwardsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationAndCommitmentsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:NotLaterThanOneYearMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CommodityPriceRiskMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:TopOfRangeMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:JPYCurrencyExchangeRateMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:SecuritisationVehiclesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ubs:ParentIssuerMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:IntragroupFundingMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ubs:ParentIssuerMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ubs:ClientVehiclesMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromBanksMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2019-12-31
0001610520
ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:FinancialAssetsAtFairValueHeldForTradingDebtInstrumentsMemberMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NonrecurringFairValueMeasurementMember
ifrs-full:OtherAssetsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ubs:FinancialAssetsAtFairValueHeldForTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:FinancialAdvisorCompensationDeferredSharebasedAwardsMember
ubs:CompensationPriorYearsMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:SegmentIBMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ubs:NotesAndDebenturesIssuedMember
2019-12-31
0001610520
ubs:UBSAGMember
ubs:IntragroupFundingMember
2020-01-01
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ParallelUpInterestRateShockScenarioMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades9To13Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OverTheCounterDerivativeLiabilitiesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTenYearsMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LongTermNotesAndDebenturesIssuedMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:GBPCurrencyExchangeRateMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherMember
2021-12-31
0001610520
ubs:NotTimeSpecificMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:PensionPlansMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromCustomersMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:PensionPlansMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2019-12-31
0001610520
ubs:FinancialAdvisorCompensationMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ubs:UBSAGMember
ubs:ClientVehiclesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:AssumptionOfLifeExpectancyMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:VariableCompensationOtherMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationAndCommitmentsMember
ubs:CompensationPerformanceYearMember
2019-01-01
2019-12-31
0001610520
ubs:SubsidiariesIssuerMember
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:SecuritisationVehiclesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:LaterThanTenYearsMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:ParentIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades0To1Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:DomesticRealEstateAndPropertyMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:ParentIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:FinancialAssetsAtFairValueHeldForTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ubs:SegmentIBMember
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromCustomersMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAdvisorCompensationCommitmentsMember
ubs:CompensationPerformanceYearMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:ParentIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ubs:DerivativeFinancialLiabilitiesMember
ubs:ClientVehiclesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentIBMember
2021-12-31
0001610520
2018-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:PensionPlansMember
2019-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromCustomersMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2019-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ShortTermNotesAndDebenturesIssuedMember
2019-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:UBSAGMember
ubs:TemporaryDifferenceRelatedToOtherMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ubs:ParallelUpInterestRateShockScenarioMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignRealEstateAndPropertyMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:GBPCurrencyExchangeRateMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CorporateAndMunicipalBondsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:EquityIndexContractsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromCustomersMember
2020-12-31
0001610520
ubs:GoodsOrServicesTransferredOnRecurringBasisMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:EMEAMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-01-01
2020-12-31
0001610520
ubs:SteepenerInterestRateShockScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ParallelDownInterestRateShockScenarioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGradesDefaultedMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:EMEAMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:SecuritisationVehiclesMember
ubs:UBSAGMember
ubs:DerivativeFinancialLiabilitiesMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:FinancialAssetsAtFairValueNotHeldForTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:GBPCurrencyExchangeRateMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:DerivativeFinancialLiabilitiesMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2021-12-31
0001610520
ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PlusOneBasisPointsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FlattenerInterestRateShockScenarioMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGradesDefaultedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:RepurchaseAgreementLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FlattenerInterestRateShockScenarioMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:OptionContractMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:OptionContractMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:JPYCurrencyExchangeRateMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:LoansAndAdvancesToCustomersMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ubs:JPYCurrencyExchangeRateMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
ubs:LongTermIncentivePlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ubs:EMEAMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGradesDefaultedMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ubs:LongTermNotesAndDebenturesIssuedMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTenYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2020-12-31
0001610520
ubs:EURCurrencyExchangeRateMember
2020-01-01
2020-12-31
0001610520
ifrs-full:TemporaryDifferenceMember
ubs:TemporaryDifferenceRelatedToRealEstateCapitalizedForUSTaxPurposesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SIXGroupAGMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OverTheCounterDerivativeLiabilitiesMember
2021-12-31
0001610520
ubs:SegmentGWMAmericasCashGeneratingUnitMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTenYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToBanksMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ubs:LongTermIncentivePlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ubs:FlattenerInterestRateShockScenarioMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ubs:EMEAMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ubs:DebtInstrumentsHeldMeasuredAtFairValueThroughOtherComprehensiveIncomePledgedAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:SegmentGFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:OptionContractMember
ubs:UBSAGMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades2To3Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LongTermIncentivePlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:FinancialAssetsAtFairValueHeldForTradingDebtInstrumentsMemberMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ubs:EMEAMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:FinancialAssetsAtFairValueHeldforTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueRelatedToThoseInExchangeForSecuritiesReceivedMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentAMMember
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades4To5Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ubs:NotesAndDebenturesIssuedMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OverTheCounterDerivativeLiabilitiesMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades0To1Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ubs:LongTermNotesAndDebenturesIssuedMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:IntragroupFundingMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ubs:EMEAMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ubs:SegmentGFMember
2019-01-01
2019-12-31
0001610520
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ParallelDownInterestRateShockScenarioMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:FuturesContractMember
ifrs-full:InterestRateRiskMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ubs:ParallelUpInterestRateShockScenarioMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:CreditRiskMember
ubs:CreditDefaultSwapMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:OptionContractMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ubs:UnsettledPurchaseOfNonDerivativeFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:UBSAGSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ubs:UBSAGMember
ubs:AssetManagementEOPMember
2021-01-01
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ForeignRealEstateAndPropertyMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades0To1Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SIXGroupAGMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:ForwardContractMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
2021-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromCustomersMember
2020-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UKPensionPlanMember
2019-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ubs:ReverseRepurchaseAgreementAssetsAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionMember
2020-12-31
0001610520
ubs:ParallelDownInterestRateShockScenarioMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ShorttermDownInterestRateShockScenarioMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:WeightedAverageMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:OptionContractMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:OptionContractMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanTenYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:DebtInstrumentsHeldMeasuredAtFairValueThroughOtherComprehensiveIncomePledgedAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ubs:EURCurrencyExchangeRateMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:JPYCurrencyExchangeRateMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ubs:CompensationPerformanceYearMember
ubs:AssetManagementEOPMember
2021-01-01
2021-12-31
0001610520
ubs:ShorttermDownInterestRateShockScenarioMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:WeightedAverageMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:CreditRiskMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:OptionContractMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:LoanCommitmentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ParallelDownInterestRateShockScenarioMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ShorttermUpInterestRateShockScenarioMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:SwapContractMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OverTheCounterDerivativeLiabilitiesMember
2019-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ubs:TimeBandFromYear2018TillYear2021Member
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2021-12-31
0001610520
ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SteepenerInterestRateShockScenarioMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ifrs-full:MiscellaneousOtherProvisionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:ForwardContractMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:ForwardContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:ForwardContractMember
ubs:UBSAGMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ubs:GoodsOrServicesTransferredOnPerformancebasedBasisMember
2021-01-01
2021-12-31
0001610520
ubs:RepurchaseAgreementLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:ForwardContractMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ubs:ParallelUpInterestRateShockScenarioMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:SegmentGFMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:PlusOneBasisPointsMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ubs:RepurchaseAgreementLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromCustomersMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ubs:ShorttermDownInterestRateShockScenarioMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ParallelUpInterestRateShockScenarioMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:CreditRiskMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:SwapContractMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ubs:UBSAGMember
ubs:ClientVehiclesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DerivativeFinancialLiabilitiesMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:AssumptionOfLifeExpectancyMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CHFCurrencyExchangeRateMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ubs:CHFCurrencyExchangeRateMember
2019-01-01
2019-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:IntragroupFundingMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:NotesAndDebenturesIssuedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades0To1Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:SwissPensionPlanMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ubs:SteepenerInterestRateShockScenarioMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTenYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ubs:FlattenerInterestRateShockScenarioMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:ForwardContractMember
ubs:UBSAGMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentGFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:MiscellaneousOtherProvisionsMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
ubs:LongTermIncentivePlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromCustomersMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ubs:GBPCurrencyExchangeRateMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:SwapContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:MiscellaneousOtherProvisionsMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:OptionContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ubs:OverTheCounterDerivativeLiabilitiesMember
2019-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGradesDefaultedMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CHFCurrencyExchangeRateMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:PreciousMetalsAndOtherPhysicalCommoditiesMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:AssumptionOfLifeExpectancyMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ubs:SegmentGFMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UnsettledSalesOfNonDerivativeFinancialInstrumentsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:OptionContractMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ubs:UBSSwitzerlandAGSubsidiariesMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ubs:ShorttermUpInterestRateShockScenarioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromCustomersMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTenYearsMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromBanksMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:OptionContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:OptionContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ubs:UBSBankUSASubsidiariesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentGFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:OptionContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:SwapContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ubs:UBSEuropeSESubsidiariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:GBPCurrencyExchangeRateMember
2019-01-01
2019-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:OptionContractMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FlattenerInterestRateShockScenarioMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ubs:PlusOneBasisPointsMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ubs:ShorttermDownInterestRateShockScenarioMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ShorttermUpInterestRateShockScenarioMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CreditSpreadRiskMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:FuturesContractMember
ubs:UBSAGMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:OptionContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UnsettledPurchaseOfNonDerivativeFinancialInstrumentsMember
2020-12-31
0001610520
ubs:DebtInstrumentsHeldMeasuredAtAmortizedCostPledgedAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ubs:CHFCurrencyExchangeRateMember
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:GBPCurrencyExchangeRateMember
2021-12-31
0001610520
ubs:ShorttermUpInterestRateShockScenarioMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ShorttermUpInterestRateShockScenarioMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:OptionContractMember
ubs:UBSAGMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:OptionContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:JPYCurrencyExchangeRateMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:GBPCurrencyExchangeRateMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTenYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToCustomersMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ubs:CompensationPriorYearsMember
ubs:LongTermIncentivePlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanTenYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ubs:UBSAGMember
ubs:GoodsOrServicesTransferredOnRecurringBasisMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
ubs:AssetManagementEOPMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:PlanAssetsAtFairValuePlanUBSGroupAGSharesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentGWMMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromCustomersMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ubs:SegmentGFMember
2019-12-31
0001610520
ubs:CHFCurrencyExchangeRateMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:EURCurrencyExchangeRateMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:IntragroupFundingMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
ubs:AgencyTransactionsMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UbsAGIssuerMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ParallelUpInterestRateShockScenarioMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ubs:GoodsOrServicesTransferredOnPerformancebasedBasisMember
2020-01-01
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:SegmentGFMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:RepurchaseAgreementLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:ForwardContractMember
ifrs-full:InterestRateRiskMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:ForwardContractMember
ifrs-full:InterestRateRiskMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:SwapContractMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:AgencyTransactionsMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ubs:UnsettledSalesOfNonDerivativeFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentIBMember
2021-01-01
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:SwapContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:WeightedAverageMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2021-12-31
0001610520
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGFMember
2020-01-01
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:OptionContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ubs:UBSSecuritiesLLCSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:FlattenerInterestRateShockScenarioMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SteepenerInterestRateShockScenarioMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2020-12-31
0001610520
ubs:AssetManagementEOPMember
2021-01-01
2021-12-31
0001610520
ubs:CompensationPerformanceYearMember
ubs:LongTermIncentivePlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ubs:UBSFinancialServicesIncSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAssetManagementAGSubsidiariesMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
2020-12-31
0001610520
ubs:UBSSwitzerlandAGSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSEuropeSESubsidiariesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ubs:ParallelDownInterestRateShockScenarioMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:OptionContractMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2020-12-31
0001610520
ubs:PlusOneBasisPointsMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ParallelDownInterestRateShockScenarioMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:CreditRiskMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:SwapContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CHFCurrencyExchangeRateMember
2019-01-01
2019-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:IntragroupFundingMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:IntragroupFundingMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
ubs:AgencyTransactionsMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ForeignRealEstateAndPropertyMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades9To13Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ubs:SteepenerInterestRateShockScenarioMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ParallelDownInterestRateShockScenarioMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:PlanAssetsMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CHFCurrencyExchangeRateMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:JPYCurrencyExchangeRateMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:EURCurrencyExchangeRateMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:SwapContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ubs:ShorttermUpInterestRateShockScenarioMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ifrs-full:CreditRiskMember
ubs:TotalReturnSwapMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ShorttermDownInterestRateShockScenarioMember
2021-12-31
0001610520
ubs:CompensationPriorYearsMember
ubs:AssetManagementEOPMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PlusOneBasisPointsMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:EMEAMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
2020-12-31
0001610520
ifrs-full:EffectOfAssetCeilingMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:FuturesContractMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ifrs-full:FuturesContractMember
ifrs-full:InterestRateRiskMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:SwapContractMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentGFMember
2020-12-31
0001610520
ubs:UBSAmericasIncSubsidiariesMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:SegmentGFMember
2021-12-31
0001610520
ubs:UnsettledSalesOfNonDerivativeFinancialInstrumentsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGFMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:CreditSpreadRiskMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:InterestRateRiskMember
2020-12-31
0001610520
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:ParallelDownInterestRateShockScenarioMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades2To3Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ubs:EMEAMember
2019-01-01
2019-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignRealEstateAndPropertyMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:NotLaterThanOneYearMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ifrs-full:OptionContractMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ubs:UBSBankUSASubsidiariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGradesDefaultedMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2021-12-31
0001610520
ubs:NotesAndDebenturesIssuedMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGFMember
2019-12-31
0001610520
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromBanksMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ubs:GBPCurrencyExchangeRateMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ForeignRealEstateAndPropertyMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PlusOneBasisPointsMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ubs:ShorttermUpInterestRateShockScenarioMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashCollateralPayablesOnDerivativeInstrumentsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CHFCurrencyExchangeRateMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ubs:NotesAndDebenturesIssuedMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:EMEAMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:CreditSpreadRiskMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToBanksMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:NonSubordinatedDebtMember
2020-12-31
0001610520
ubs:PlusOneBasisPointsMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ubs:UnsettledPurchaseOfNonDerivativeFinancialInstrumentsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ParallelUpInterestRateShockScenarioMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:ForwardContractMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:FuturesContractMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:ForwardContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:OptionContractMember
ubs:UBSAGMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:SwapContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
2021-12-31
0001610520
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:JPYCurrencyExchangeRateMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:EURCurrencyExchangeRateMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:EURCurrencyExchangeRateMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ubs:ShorttermUpInterestRateShockScenarioMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ubs:EURCurrencyExchangeRateMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:JPYCurrencyExchangeRateMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ubs:SegmentGFMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UnsettledSalesOfNonDerivativeFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:CreditRiskMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:OptionContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
2021-12-31
0001610520
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:FairValueHedgesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:EquityIndexContractsNetMember
ubs:EquityDividendYieldsMeasurementInputMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ubs:GBPCurrencyExchangeRateMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
ubs:AssetManagementEOPMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignRealEstateAndPropertyMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades2To3Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
ubs:LongTermIncentivePlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentGWMMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ubs:ShortTermNotesAndDebenturesIssuedMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:CreditRiskMember
ubs:TotalReturnSwapMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:ParentIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2020-12-31
0001610520
ubs:UBSAmericasIncSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:MiscellaneousOtherProvisionsMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades6To8Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades0To1Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:CreditRiskMember
ubs:CreditDefaultSwapMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:NotLaterThanOneYearMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:InterestRateContractsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2019-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:FairValueHedgesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
ubs:LongTermIncentivePlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromBanksMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ubs:JPYCurrencyExchangeRateMember
2020-12-31
0001610520
ubs:FlattenerInterestRateShockScenarioMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2019-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2019-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:SwapContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:TopOfRangeMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
ubs:LoanPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:InterestRateContractsNetMember
ubs:HistoricalVolatilityForInterestRatesMeasurementInputMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanTenYearsMember
ubs:ParentIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ubs:InternalCreditGradesDefaultedMember
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CashFlowHedgesMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:DiscountRateMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:EURCurrencyExchangeRateMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
2021-12-31
0001610520
ifrs-full:FairValueHedgesMember
ifrs-full:InterestRateRiskMember
ubs:InterestRateBenchmarkReformExceptionsEffectOnCashFlowHedgesMember
2021-12-31
0001610520
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ubs:ParallelDownInterestRateShockScenarioMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ParallelUpInterestRateShockScenarioMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ubs:CreditSpreadRiskMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:AgencyTransactionsMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:MiscellaneousOtherProvisionsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:MortgagesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ubs:SteepenerInterestRateShockScenarioMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ubs:DebtInstrumentsHeldMeasuredAtAmortizedCostPledgedAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades2To3Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:FlattenerInterestRateShockScenarioMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:OptionContractMember
ubs:UBSAGMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ubs:ParallelUpInterestRateShockScenarioMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PlusOneBasisPointsMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:SegmentGFMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FuturesContractMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ubs:CompensationPerformanceYearMember
ubs:LongTermIncentivePlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:UBSAssetManagementAGSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ShorttermUpInterestRateShockScenarioMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentAMMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:InterestRateContractsMember
2019-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:SwapContractMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ubs:CHFCurrencyExchangeRateMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:EURCurrencyExchangeRateMember
2020-12-31
0001610520
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:SwissPensionPlanMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2020-12-31
0001610520
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ubs:CreditSpreadRiskMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ubs:ShortTermNotesAndDebenturesIssuedMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2020-01-01
2020-12-31
0001610520
ubs:GoodsOrServicesTransferredOnRecurringBasisMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2019-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2019-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:SwapContractMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ubs:CompensationPerformanceYearMember
ubs:VariableCompensationMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:FundingSpreadMeasurementInputMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
ubs:EquityDividendYieldsMeasurementInputMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:EquityIndexContractsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-01-01
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:PlusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades0To1Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
ubs:LoanPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ubs:InternalCreditGrades0To1Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:CashFlowHedgesMember
ifrs-full:InterestRateRiskMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:EquityIndexContractsNetMember
ubs:EquityDividendYieldsMeasurementInputMember
2020-12-31
0001610520
ifrs-full:CashFlowHedgesMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsNetMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
ubs:EquityToFXCorrelationMeasurementInputMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:CashFlowHedgesMember
ifrs-full:InterestRateRiskMember
ubs:InterestRateBenchmarkReformExceptionsEffectOnCashFlowHedgesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ubs:InternalCreditGrades0To1Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2021-01-01
2021-12-31
0001610520
ubs:ShorttermDownInterestRateShockScenarioMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SteepenerInterestRateShockScenarioMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ubs:SteepenerInterestRateShockScenarioMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FlattenerInterestRateShockScenarioMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ubs:UBSAmericasHoldingLLCSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ubs:InternalCreditGrades9To13Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2019-12-31
0001610520
ifrs-full:FairValueHedgesMember
ifrs-full:InterestRateRiskMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2019-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:CreditDerivativeContractsNetMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentIBMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UnsettledPurchaseOfNonDerivativeFinancialInstrumentsMember
2021-12-31
0001610520
ubs:OverTheCounterDerivativeLiabilitiesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
2021-01-01
2021-12-31
0001610520
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
2021-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades2To3Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentAMMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SteepenerInterestRateShockScenarioMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:SegmentGFMember
2021-12-31
0001610520
ubs:InternalCreditGrades6To8Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ubs:InternalCreditGrades4To5Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ParallelUpInterestRateShockScenarioMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:ParentIssuerMember
ubs:SubordinatedDebtMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:SteepenerInterestRateShockScenarioMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FlattenerInterestRateShockScenarioMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:WeightedAverageMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsNetMember
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:MarketComparableAndSecuritizationModelMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2019-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:ParentIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToCustomersMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:FuturesContractMember
ubs:UBSAGMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromCustomersMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromBanksMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:SwissPensionPlanMember
ubs:ForeignRealEstateAndPropertyMember
2020-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades4To5Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AssetBackedSecuritiesMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CashAndBankBalancesAtCentralBanksMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:ParentIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ubs:InternalCreditGradesDefaultedMember
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ubs:PlusOneBasisPointsMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ShorttermDownInterestRateShockScenarioMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ubs:VariableCompensationMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ifrs-full:FairValueHedgesMember
ifrs-full:InterestRateRiskMember
ubs:InterestRateBenchmarkReformExceptionsEffectOnCashFlowHedgesMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:LoanCommitmentsMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ubs:InternalCreditGradesDefaultedMember
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:LongTermNotesAndDebenturesIssuedMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ubs:RealEstateLoanMember
ubs:LifetimeWeightedAverageMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:SwapContractMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentIBMember
2019-01-01
2019-12-31
0001610520
ifrs-full:MiscellaneousOtherProvisionsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ShorttermUpInterestRateShockScenarioMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ubs:ParallelDownInterestRateShockScenarioMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:EquityIndexContractsNetMember
ubs:EquityToFXCorrelationMeasurementInputMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:FundingSpreadMeasurementInputMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
2019-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:WeightedAverageMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
ubs:LoanPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:EquityIndexContractsNetMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:NotLaterThanOneMonthMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentGFMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:FuturesContractMember
ubs:UBSAGMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LongTermIncentivePlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UnemploymentRateMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:MinusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:InterestRateRiskMember
2020-12-31
0001610520
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:SevereDownsideScenarioMember
ubs:PlusFivePercentMember
2021-01-01
2021-12-31
0001610520
ubs:InternalCreditGrades4To5Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:ParentIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsMember
2019-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentGFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FairValueHedgesMember
ifrs-full:InterestRateRiskMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ubs:InternalCreditGrades6To8Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:LoansAndAdvancesToCustomersMember
2019-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2019-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ubs:SmallMediumEnterpriseMember
ubs:LifetimeWeightedAverageMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ubs:ParallelUpInterestRateShockScenarioMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades9To13Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ubs:FlattenerInterestRateShockScenarioMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ShorttermDownInterestRateShockScenarioMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:ParentIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ubs:UBSFinancialServicesIncSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:NotLaterThanOneYearMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ubs:EURCurrencyExchangeRateMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:IntragroupFundingMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:UBSAGMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:HousePriceIndexMember
ubs:PlusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromBanksMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ubs:JPYCurrencyExchangeRateMember
2019-01-01
2019-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
ubs:LoanPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:EquityIndexContractsNetMember
ubs:EquityDividendYieldsMeasurementInputMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades4To5Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:DepositsFromBanksMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades4To5Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:CashFlowHedgesMember
ifrs-full:InterestRateRiskMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2019-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember
2021-12-31
0001610520
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
ubs:LoanPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsNetMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
ubs:EquityToEquityCorrelationMeasurementInputMember
2021-12-31
0001610520
ubs:GoodsOrServicesTransferredOnPerformancebasedBasisMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:PlusOneBasisPointsMember
ubs:InterestCurrencyEURMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2019-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanTenYearsMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:NotLaterThanOneYearMember
ubs:ParentIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:LoansAndAdvancesToBanksMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:DepositsFromBanksMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokerageReceivablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember
ubs:ParentIssuerMember
ubs:SubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:PresentValueOfDefinedBenefitObligationMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeForDebtInstrumentsMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CreditCardMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentIBMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ubs:LongTermIncentivePlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:InternalCreditGrades6To8Member
ubs:OnBalanceSheetFinancialInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ubs:TimeBandFromYear2021Member
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ubs:InternalCreditGrades2To3Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:InterestRateContractsNetMember
ubs:HistoricalVolatilityForInterestRatesMeasurementInputMember
2020-12-31
0001610520
ubs:InternalCreditGrades9To13Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:EquityIndexContractsNetMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsNetMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtAmortisedCostMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ubs:UBSAmericasHoldingLLCSubsidiariesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:InterestRateContractsNetMember
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentAMMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentPCBMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2019-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:GBPCurrencyExchangeRateMember
2020-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ubs:InternalCreditGrades0To1Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsMember
2019-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2019-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentGFMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CashFlowHedgesMember
ifrs-full:InterestRateRiskMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentGFMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2020-01-01
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:GoodsOrServicesTransferredOnRecurringBasisMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CreditCardMember
2021-12-31
0001610520
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsNetMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:BaselineScenarioMember
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:OptionContractMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:CreditRiskMember
ubs:UBSAGMember
ubs:CreditDefaultSwapMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:DiscountRateMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:GrossDomesticProductMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentIBMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:OptionContractMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2019-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanFiveYearsMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
2020-12-31
0001610520
ubs:ParallelUpInterestRateShockScenarioMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ubs:ShorttermUpInterestRateShockScenarioMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:SegmentGFMember
2021-12-31
0001610520
ubs:InternalCreditGradesDefaultedMember
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ubs:InternalCreditGrades9To13Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:AuctionRateSecuritiesMember
2019-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:MarketComparableAndSecuritizationModelMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:EquityIndexContractsNetMember
ubs:EquityToFXCorrelationMeasurementInputMember
2021-12-31
0001610520
ifrs-full:FairValueHedgesMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DiscountRateMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:FundingSpreadMeasurementInputMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:HousePriceIndexMember
ubs:PlusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember
ubs:ParentIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:EquityIndexContractsMember
2019-12-31
0001610520
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:FundingSpreadMeasurementInputMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:InterestRateContractsNetMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:MarketComparableAndSecuritizationModelMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
ubs:VariableCompensationMember
2019-01-01
2019-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ubs:CHFCurrencyExchangeRateMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:EquityIndexContractsNetMember
ubs:EquityToFXCorrelationMeasurementInputMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsNetMember
2020-12-31
0001610520
ifrs-full:EquityPriceRiskMember
ifrs-full:FuturesContractMember
ubs:UBSAGMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentAMMember
2020-01-01
2020-12-31
0001610520
ubs:LifetimeWeightedAverageMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:EquityIndexContractsNetMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:EquityIndexContractsNetMember
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ubs:InternalCreditGrades2To3Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2020-01-01
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
2020-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:MarketComparableAndSecuritizationModelMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2019-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:EquityMember
ifrs-full:WeightedAverageMember
ubs:PlusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FloatingInterestRateMember
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
ubs:SubsidiariesIssuerMember
ubs:NonSubordinatedDebtMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CashFlowHedgesMember
ifrs-full:InterestRateRiskMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ShorttermDownInterestRateShockScenarioMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentPCBMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentPCBMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ParallelDownInterestRateShockScenarioMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ubs:CompensationPriorYearsMember
ubs:VariableCompensationMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:EquityIndexContractsNetMember
ubs:EquityToEquityCorrelationMeasurementInputMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:NotLaterThanOneMonthMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentAMMember
2019-01-01
2019-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CreditCardMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherLoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ModelAndMethodologyChangesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherLoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherLoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:RealEstateLoanMember
2021-12-31
0001610520
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember
2020-12-31
0001610520
ifrs-full:CashFlowHedgesMember
ifrs-full:InterestRateRiskMember
ubs:InterestRateBenchmarkReformExceptionsEffectOnCashFlowHedgesMember
2021-12-31
0001610520
ifrs-full:FairValueHedgesMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:UBSAGMember
ubs:InterestRateContractsNetMember
ubs:HistoricalVolatilityForInterestRatesMeasurementInputMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:EquityIndexContractsMember
2019-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentGFMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:SwapContractMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:SegmentGFMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ShorttermDownInterestRateShockScenarioMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:WeightedAverageMember
ubs:MarketComparableAndSecuritizationModelMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
ubs:LoanPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
ubs:EquityToFXCorrelationMeasurementInputMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2019-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:FairValueHedgesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentIBMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ubs:CompensationPerformanceYearMember
ubs:VariableCompensationMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2020-01-01
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:InterestRateContractsNetMember
ubs:HistoricalVolatilityForInterestRatesMeasurementInputMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
ubs:EquityDividendYieldsMeasurementInputMember
2020-12-31
0001610520
ubs:VariableCompensationMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentGFMember
2019-01-01
2019-12-31
0001610520
ifrs-full:MortgagesMember
ifrs-full:WeightedAverageMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:SevereDownsideScenarioMember
ubs:MinusTenPercentMember
2021-01-01
2021-12-31
0001610520
ubs:CompensationPerformanceYearMember
ubs:VariableCompensationMember
2019-01-01
2019-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:MinusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:CompensationPriorYearsMember
ubs:LongTermIncentivePlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:FairValueHedgesMember
ifrs-full:InterestRateRiskMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:TopOfRangeMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:GoodsOrServicesTransferredOnPerformancebasedBasisMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherLoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanFiveYearsMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2019-01-01
2019-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanFiveYearsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentGFMember
2019-01-01
2019-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:OtherClientCounterpartiesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
ubs:VariableCompensationMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
2021-12-31
0001610520
ubs:InternalCreditGrades9To13Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:OtherClientCounterpartiesMember
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentPCBMember
2019-01-01
2019-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ubs:InternalCreditGrades2To3Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:SevereDownsideScenarioMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:WeightedAverageMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentIBMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
2019-01-01
2019-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:CreditRiskMember
ubs:UBSAGMember
ubs:CreditDefaultSwapMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FairValueHedgesMember
ifrs-full:InterestRateRiskMember
2020-01-01
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:InterestRateContractsNetMember
ubs:HistoricalVolatilityForInterestRatesMeasurementInputMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsNetMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentAMMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:MortgagesMember
ubs:LifetimeWeightedAverageMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2019-01-01
2019-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CreditCardMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:HousePriceIndexMember
ubs:MinusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CreditCardMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DiscountRateMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:BaselineScenarioMember
ubs:PlusTenPercentMember
2021-01-01
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UnemploymentRateMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:GrossDomesticProductMember
ubs:PlusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:OtherClientCounterpartiesMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:VariableCompensationMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:FundingSpreadMeasurementInputMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentIBMember
2019-01-01
2019-12-31
0001610520
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:CreditDerivativeContractsNetMember
ubs:BondPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ModelAndMethodologyChangesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:LoansAndAdvancesToCustomersMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
ubs:EquityDividendYieldsMeasurementInputMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:LoansAndAdvancesToBanksMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ubs:PlusOneBasisPointsMember
ubs:InterestCurrencyCHFMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SteepenerInterestRateShockScenarioMember
ubs:InterestCurrencyGBPMember
2021-12-31
0001610520
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:SegmentGFMember
2021-12-31
0001610520
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ubs:InternalCreditGrades0To1Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ubs:InternalCreditGrades2To3Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:OtherLoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OffbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherLoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:WeightedAverageMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:SevereDownsideScenarioMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:GrossDomesticProductMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:BaselineScenarioMember
ubs:MinusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherLoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherLoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherOffbalanceSheetCommitmentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherOffbalanceSheetCommitmentsMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:TopOfRangeMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
ubs:LoanPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:EquityIndexContractsNetMember
2021-12-31
0001610520
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:FundingSpreadMeasurementInputMember
2021-12-31
0001610520
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
ubs:EquityDividendYieldsMeasurementInputMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2019-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:BaselineScenarioMember
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:PlusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:VariableCompensationMember
2019-01-01
2019-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ubs:RealEstateLoanMember
ubs:SevereDownsideScenarioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:MarketComparableAndSecuritizationModelMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsNetMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
ubs:LoanPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:ForwardContractMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:OtherLoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherLoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:LifetimeWeightedAverageMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:MarketComparableAndSecuritizationModelMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:InterestRateContractsNetMember
ubs:HistoricalVolatilityForInterestRatesMeasurementInputMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:InterestRateContractsNetMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2019-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentIBMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:SwapContractMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:CreditDerivativeContractsNetMember
ubs:BondPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2019-12-31
0001610520
ubs:ParallelDownInterestRateShockScenarioMember
ubs:OtherInterestCurrencyMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FlattenerInterestRateShockScenarioMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:VariableCompensationMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:OtherOffbalanceSheetCommitmentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentAMMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentIBMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember
ubs:NotSpecifiedLevelOfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2019-12-31
0001610520
ifrs-full:FuturesContractMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UnemploymentRateMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:SevereDownsideScenarioMember
ubs:MinusFivePercentMember
2021-01-01
2021-12-31
0001610520
ubs:CompensationPriorYearsMember
ubs:VariableCompensationMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSSecuritiesLLCSubsidiariesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentGFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ubs:InternalCreditGrades6To8Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
ubs:VariableCompensationMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ubs:ShorttermDownInterestRateShockScenarioMember
ubs:InterestCurrencyUSDMember
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:MinusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CreditCardMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:GrossDomesticProductMember
ubs:MinusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:BaselineScenarioMember
ubs:PlusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2019-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2019-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:TopOfRangeMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:EquityIndexContractsNetMember
ubs:EquityToEquityCorrelationMeasurementInputMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentAMMember
2019-01-01
2019-12-31
0001610520
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:ForwardContractMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
ubs:VariableCompensationMember
2021-01-01
2021-12-31
0001610520
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentPCBMember
2020-01-01
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:EquityIndexContractsNetMember
ubs:EquityToEquityCorrelationMeasurementInputMember
2021-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ubs:InternalCreditGrades4To5Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ubs:InternalCreditGrades4To5Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ubs:OtherClientCounterpartiesMember
ubs:LifetimeWeightedAverageMember
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:PlusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CorporateAndMunicipalBondsMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ubs:InternalCreditGrades6To8Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2021-12-31
0001610520
ubs:InternalCreditGrades6To8Member
ubs:OtherCreditLinesSubjectToExpectedCreditLossMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:InternalCreditGrades4To5Member
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanFiveYearsMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommittedRevocableCreditLinesMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2019-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades0To1Member
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades2To3Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades9To13Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGradesDefaultedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:OtherLoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
ubs:VariableCompensationMember
2019-01-01
2019-12-31
0001610520
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:UBSAGMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades0To1Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:CommittedRevocableCreditLinesMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
2019-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:OffBalanceSheetFinancialInstrumentsWithoutOtherCreditLinesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades2To3Member
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember
ubs:InternalCreditGrades0To1Member
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
ubs:LoanPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:InternalCreditGrades6To8Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:LoanCommitmentsMember
ubs:InternalCreditGradesDefaultedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:InternalCreditGrades2To3Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades4To5Member
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
ubs:CommittedRevocableCreditLinesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades6To8Member
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ubs:CompensationPriorYearsMember
ubs:VariableCompensationMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OffbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:OnbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:MortgagesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherOffbalanceSheetCommitmentsMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:EquityIndexContractsNetMember
ubs:EquityDividendYieldsMeasurementInputMember
2021-12-31
0001610520
ifrs-full:CurrencySwapContractMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:FairValueHedgesMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsNetMember
ubs:BondPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:CreditRiskMember
ubs:UBSAGMember
ubs:TotalReturnSwapMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:CreditRiskMember
ubs:UBSAGMember
ubs:TotalReturnSwapMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherLoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CreditCardMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
ubs:VariableCompensationMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherOffbalanceSheetCommitmentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LoanCommitmentsMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:InterestRateContractsNetMember
ubs:HistoricalVolatilityForInterestRatesMeasurementInputMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentIBMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherLoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:MortgagesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:InterestRateBasisPointSensitivityMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherOffbalanceSheetCommitmentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OffbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OffbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:WeightedAverageMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
ubs:LoanPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
ubs:EquityToFXCorrelationMeasurementInputMember
2020-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:CreditDerivativeContractsNetMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:EquityIndexContractsNetMember
ubs:EquityToFXCorrelationMeasurementInputMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherOffbalanceSheetCommitmentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentGWMMember
2019-01-01
2019-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:FuturesContractMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentAMMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:NotLaterThanOneMonthMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherOffbalanceSheetCommitmentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OnbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherOffbalanceSheetCommitmentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentGWMMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:WeightedAverageMember
ubs:MarketComparableAndSecuritizationModelMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
ubs:EquityToEquityCorrelationMeasurementInputMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ubs:OtherOffbalanceSheetCommitmentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherOffbalanceSheetCommitmentsMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsNetMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:OtherLoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:SmallMediumEnterpriseMember
ubs:SevereDownsideScenarioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherOffbalanceSheetCommitmentsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ubs:OtherOffbalanceSheetCommitmentsMember
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:OnbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OffbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:BaselineScenarioMember
ubs:MinusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ifrs-full:WeightedAverageMember
ubs:MinusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentGWMMember
2019-01-01
2019-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OffbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CreditCardMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentGWMMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:GoodsOrServicesTransferredOnPerformancebasedBasisMember
2020-01-01
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
ubs:EquityToFXCorrelationMeasurementInputMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ModelAndMethodologyChangesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OffbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
ubs:EquityToEquityCorrelationMeasurementInputMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentGFMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentAMMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:EquityIndexContractsNetMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OffbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:MarketComparableAndSecuritizationModelMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
ubs:LoanPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:UBSAGMember
ubs:InterestRateContractsNetMember
ubs:HistoricalVolatilityForInterestRatesMeasurementInputMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:CashAndBankBalancesAtCentralBanksMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:FundingSpreadMeasurementInputMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsNetMember
ubs:BondPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:EquityIndexContractsNetMember
ubs:EquityToEquityCorrelationMeasurementInputMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanFiveYearsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2019-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsNetMember
ubs:BondPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherOffbalanceSheetCommitmentsMember
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OffbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherLoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
2019-01-01
2019-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
ubs:LoanPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsNetMember
2021-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:NotLaterThanOneMonthMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:InterestRateContractsNetMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsNetMember
ubs:BondPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ifrs-full:FuturesContractMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:OffbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentAMMember
2019-01-01
2019-12-31
0001610520
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:FundingSpreadMeasurementInputMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:BaselineScenarioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ubs:CreditCardMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanFiveYearsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LombardLoanMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CreditCardMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:VariableCompensationMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:GoodsOrServicesTransferredOnPerformancebasedBasisMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentGFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:SegmentPCBMember
2019-01-01
2019-12-31
0001610520
ubs:SmallMediumEnterpriseMember
ubs:BaselineScenarioMember
2021-12-31
0001610520
ifrs-full:EquityMember
ifrs-full:WeightedAverageMember
ubs:MinusTenPercentMember
2021-01-01
2021-12-31
0001610520
ubs:RealEstateLoanMember
ubs:BaselineScenarioMember
2021-12-31
0001610520
ifrs-full:DebtSecuritiesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OffbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherOffbalanceSheetCommitmentsMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsNetMember
ubs:BondPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:MarketComparableAndSecuritizationModelMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:MarketComparableAndSecuritizationModelMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UnemploymentRateMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:HousePriceIndexMember
ubs:MinusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:FinancialIntermediariesAndHedgeFundsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:FinancialIntermediariesAndHedgeFundsMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherOffbalanceSheetCommitmentsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:SICRWatchListMember
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CreditCardMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGrades9To13Member
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2020-12-31
0001610520
ubs:SevereDownsideScenarioMember
ubs:HousePriceIndexMember
ubs:PlusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ifrs-full:WeightedAverageMember
ubs:PlusFivePercentMember
2021-01-01
2021-12-31
0001610520
ubs:BaselineScenarioMember
ubs:HousePriceIndexMember
ubs:MinusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:SICRPDLayerMember
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:SevereDownsideScenarioMember
ubs:PlusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialGuaranteeContractsMember
ubs:InternalCreditGrades6To8Member
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:InterestRateContractsMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentAMMember
2019-01-01
2019-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:MarketComparableAndSecuritizationModelMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:SICR30DaysPastDueCriterionMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherLoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OffbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ubs:ModelAndMethodologyChangesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:InternalCreditGradesDefaultedMember
ubs:IrrevocableCommittedProlongationOfLoansMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:SegmentGFMember
2019-01-01
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ubs:SegmentIBMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:MarketComparablePricesMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
ubs:BondPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsNetMember
ubs:BondPriceEquivalentMeasurementInputMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:OptionPricingModelMember
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
ubs:EquityToEquityCorrelationMeasurementInputMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGWMAmericasCashGeneratingUnitMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGWMAmericasCashGeneratingUnitMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGWMExAmericasCashGeneratingUnitMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGWMExAmericasCashGeneratingUnitMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentAMMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:NotLaterThanOneYearMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:NotLaterThanOneYearMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanFiveYearsMember
ubs:OverTheCounterMember
2021-12-31
0001610520
2019-01-01
0001610520
2020-01-01
0001610520
2021-01-01
0001610520
ubs:UBSAGMember
2018-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CorporateAndMunicipalBondsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:LoansAndAdvancesToCustomersMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:InterestRateContractsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:EquityIndexContractsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:LoansAndAdvancesToCustomersMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:AuctionRateSecuritiesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:InterestRateContractsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:EquityIndexContractsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CreditDerivativeContractsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialInstrumentsNetMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-01-01
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:FixedInterestRateMember
ubs:UbsAGIssuerMember
ubs:SubordinatedDebtMember
2020-12-31
0001610520
ifrs-full:GoodwillMember
ifrs-full:GrossCarryingAmountMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueHeldForTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueHeldforTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueRelatedToThoseInExchangeForCashReceivedMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueHeldforTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueRelatedToThoseInExchangeForSecuritiesReceivedMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueHeldforTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueRelatedToOtherTransfersMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueNotHeldForTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DebtInstrumentsHeldMeasuredAtAmortizedCostPledgedAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DebtInstrumentsHeldMeasuredAtFairValueThroughOtherComprehensiveIncomePledgedAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2021-12-31
0001610520
ubs:SegmentGWMMember
ubs:ClearstreamFundCentreAGMember
2020-01-01
2020-12-31
0001610520
ubs:SegmentAMMember
ubs:ClearstreamFundCentreAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
2019-01-01
2019-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticRealEstateInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignRealEstateInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:AssetBackedSecuritiesMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:DomesticBondsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ForeignBondsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:DomesticRealEstateInvestmentFundsMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ForeignRealEstateInvestmentFundsMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:InsuranceContractsMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ubs:AssetBackedSecuritiesMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticRealEstateInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticRealEstateInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignRealEstateInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignRealEstateInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:AssetBackedSecuritiesMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:AssetBackedSecuritiesMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:DomesticBondsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ForeignBondsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:DomesticRealEstateInvestmentFundsMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ForeignRealEstateInvestmentFundsMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:InsuranceContractsMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ubs:AssetBackedSecuritiesMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:DomesticRealEstateInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignRealEstateInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:AssetBackedSecuritiesMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticRealEstateInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticRealEstateInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsBelowBBBMinusMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsBelowBBBMinusMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticRealEstateInvestmentFundsMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:InsuranceContractsMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticRealEstateInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticRealEstateInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsBelowBBBMinusMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsBelowBBBMinusMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticRealEstateInvestmentFundsMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:InsuranceContractsMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticRealEstateInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticRealEstateInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignRealEstateInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignRealEstateInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticRealEstateInvestmentFundsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignRealEstateInvestmentFundsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:InsuranceContractsMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticRealEstateInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticRealEstateInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignRealEstateInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignRealEstateInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:DomesticRealEstateInvestmentFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignRealEstateInvestmentFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:InsuranceContractsMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticRealEstateInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticRealEstateInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:CashAndCashEquivalentsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsBelowBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsBelowBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquityInvestmentFundsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquityInvestmentFundsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticRealEstateInvestmentFundsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentFundsMember
2021-12-31
0001610520
ifrs-full:InsuranceContractsMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticRealEstateInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticRealEstateInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:InsuranceContractsMember
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:CashAndCashEquivalentsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsBelowBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsBelowBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquityInvestmentFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquityInvestmentFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsAAAToBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignBondsInvestmentFundsBelowBBBMinusMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticRealEstateInvestmentFundsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentFundsMember
2020-12-31
0001610520
ifrs-full:InsuranceContractsMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-12-31
0001610520
ubs:IncreaseDecreaseDueToModificationOfDeferredCompensationAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:ForwardStartingReverseRepurchaseAgreementsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:ForwardStartingReverseRepurchaseAgreementsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ifrs-full:LoanCommitmentsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ifrs-full:LoanCommitmentsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
2020-01-01
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
2019-12-31
0001610520
ifrs-full:GoodwillMember
ifrs-full:GrossCarryingAmountMember
2021-12-31
0001610520
ifrs-full:GoodwillMember
ifrs-full:GrossCarryingAmountMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
2020-01-01
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
2019-12-31
0001610520
ifrs-full:GoodwillMember
2021-12-31
0001610520
ifrs-full:GoodwillMember
ubs:SegmentGWMAmericasCashGeneratingUnitMember
2021-12-31
0001610520
ifrs-full:GoodwillMember
ubs:SegmentGWMExAmericasCashGeneratingUnitMember
2021-12-31
0001610520
ifrs-full:GoodwillMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
2021-12-31
0001610520
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
ubs:SegmentGWMAmericasCashGeneratingUnitMember
2021-12-31
0001610520
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
ubs:SegmentGWMExAmericasCashGeneratingUnitMember
2021-12-31
0001610520
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
ubs:SegmentIBMember
2021-12-31
0001610520
ubs:SegmentIBMember
2021-12-31
0001610520
ubs:SegmentGFMember
2021-12-31
0001610520
ubs:SegmentIBMember
2020-12-31
0001610520
ubs:SegmentGFMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentIBMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGFMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentIBMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:GoodwillMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:GoodwillMember
ubs:UBSAGMember
ubs:SegmentGWMAmericasCashGeneratingUnitMember
2021-12-31
0001610520
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
ubs:UBSAGMember
ubs:SegmentGWMAmericasCashGeneratingUnitMember
2021-12-31
0001610520
ifrs-full:GoodwillMember
ubs:UBSAGMember
ubs:SegmentGWMExAmericasCashGeneratingUnitMember
2021-12-31
0001610520
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
ubs:UBSAGMember
ubs:SegmentGWMExAmericasCashGeneratingUnitMember
2021-12-31
0001610520
ifrs-full:GoodwillMember
ubs:UBSAGMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
ubs:UBSAGMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:GoodwillMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GoodwillMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:GoodwillMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:IntangibleAssetsOtherThanGoodwillMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:UBSAGMember
2019-12-31
0001610520
ubs:ClearstreamFundCentreAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:IssuedCapitalMember
2018-12-31
0001610520
ifrs-full:SharePremiumMember
2018-12-31
0001610520
ifrs-full:SharePremiumMember
2019-01-01
2019-12-31
0001610520
ifrs-full:TreasurySharesMember
2018-12-31
0001610520
ifrs-full:TreasurySharesMember
2019-01-01
2019-12-31
0001610520
ifrs-full:RetainedEarningsMember
2018-12-31
0001610520
ifrs-full:RetainedEarningsMember
2019-01-01
2019-01-01
0001610520
ifrs-full:RetainedEarningsMember
2019-01-01
2019-12-31
0001610520
ifrs-full:IssuedCapitalMember
2019-12-31
0001610520
ifrs-full:SharePremiumMember
2019-12-31
0001610520
ifrs-full:SharePremiumMember
2020-01-01
2020-12-31
0001610520
ifrs-full:TreasurySharesMember
2019-12-31
0001610520
ifrs-full:TreasurySharesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:RetainedEarningsMember
2019-12-31
0001610520
ifrs-full:RetainedEarningsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:IssuedCapitalMember
2020-12-31
0001610520
ifrs-full:SharePremiumMember
2020-12-31
0001610520
ifrs-full:SharePremiumMember
2021-01-01
2021-12-31
0001610520
ifrs-full:TreasurySharesMember
2020-12-31
0001610520
ifrs-full:TreasurySharesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:RetainedEarningsMember
2020-12-31
0001610520
ifrs-full:RetainedEarningsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:IssuedCapitalMember
2021-12-31
0001610520
ifrs-full:SharePremiumMember
2021-12-31
0001610520
ifrs-full:TreasurySharesMember
2021-12-31
0001610520
ifrs-full:RetainedEarningsMember
2021-12-31
0001610520
ifrs-full:IssuedCapitalMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:SharePremiumMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:RetainedEarningsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:IssuedCapitalMember
ubs:UBSAGMember
2018-12-31
0001610520
ifrs-full:SharePremiumMember
ubs:UBSAGMember
2018-12-31
0001610520
ifrs-full:RetainedEarningsMember
ubs:UBSAGMember
2018-12-31
0001610520
ifrs-full:RetainedEarningsMember
ubs:UBSAGMember
2019-01-01
2019-01-01
0001610520
ifrs-full:IssuedCapitalMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:SharePremiumMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:SharePremiumMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:RetainedEarningsMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:RetainedEarningsMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:IssuedCapitalMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:SharePremiumMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:SharePremiumMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:RetainedEarningsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:RetainedEarningsMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FairValueHedgesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CashFlowHedgesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FairValueHedgesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CashFlowHedgesMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAmericasHoldingLLCSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAmericasIncSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAssetManagementAGSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSBankUSASubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSEuropeSESubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSFinancialServicesIncSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSSecuritiesLLCSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSSwitzerlandAGSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAmericasHoldingLLCSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAmericasIncSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAssetManagementAGSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSBankUSASubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSEuropeSESubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSFinancialServicesIncSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSSecuritiesLLCSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSSwitzerlandAGSubsidiariesMember
2021-12-31
0001610520
ifrs-full:OtherReservesMember
ubs:UBSAGMember
2018-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
ubs:UBSAGMember
2018-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
ubs:UBSAGMember
2018-12-31
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
ubs:UBSAGMember
2018-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
ubs:UBSAGMember
2018-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
ubs:UBSAGMember
2018-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
ubs:UBSAGMember
2019-01-01
2019-01-01
0001610520
ubs:UBSAGMember
2019-01-01
2019-01-01
0001610520
ifrs-full:OtherReservesMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:OtherReservesMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:OtherReservesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:OtherReservesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:OtherReservesMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:OtherReservesMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LandAndBuildingsAndEquipmentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:RightofuseAssetsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ComputerSoftwareMember
ifrs-full:GrossCarryingAmountMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:ProjectsInProgressMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LandAndBuildingsAndEquipmentMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:RightofuseAssetsMember
2021-12-31
0001610520
ifrs-full:ComputerSoftwareMember
ifrs-full:GrossCarryingAmountMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:ProjectsInProgressMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LandAndBuildingsAndEquipmentMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:RightofuseAssetsMember
2020-12-31
0001610520
ifrs-full:ComputerSoftwareMember
ifrs-full:GrossCarryingAmountMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:ProjectsInProgressMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:LandAndBuildingsAndEquipmentMember
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:RightofuseAssetsMember
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:ComputerSoftwareMember
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:ProjectsInProgressMember
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:LandAndBuildingsAndEquipmentMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:RightofuseAssetsMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:ComputerSoftwareMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:ProjectsInProgressMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:LandAndBuildingsAndEquipmentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:RightofuseAssetsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:ComputerSoftwareMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:ProjectsInProgressMember
2021-01-01
2021-12-31
0001610520
ubs:LandAndBuildingsAndEquipmentMember
2021-12-31
0001610520
ifrs-full:RightofuseAssetsMember
2021-12-31
0001610520
ifrs-full:ComputerSoftwareMember
2021-12-31
0001610520
ubs:ProjectsInProgressMember
2021-12-31
0001610520
ubs:LandAndBuildingsAndEquipmentMember
2020-12-31
0001610520
ifrs-full:RightofuseAssetsMember
2020-12-31
0001610520
ifrs-full:ComputerSoftwareMember
2020-12-31
0001610520
ubs:ProjectsInProgressMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ClearstreamFundCentreAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:OtherInvestmentsMember
2020-12-31
0001610520
ubs:LIBORBenchmarkRateCHFMember
ubs:InterstRateBenchmarkReformMember
2021-12-31
0001610520
ubs:LIBORBenchmarkRateUSDMember
ubs:InterstRateBenchmarkReformMember
2021-12-31
0001610520
ubs:LIBORBenchmarkRateGBPMember
ubs:InterstRateBenchmarkReformMember
2021-12-31
0001610520
ubs:LIBORBenchmarkRateEURMember
ubs:InterstRateBenchmarkReformMember
2021-12-31
0001610520
ubs:LIBORBenchmarkRateJPYMember
ubs:InterstRateBenchmarkReformMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LIBORBenchmarkRateCHFMember
ubs:InterstRateBenchmarkReformMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LIBORBenchmarkRateUSDMember
ubs:InterstRateBenchmarkReformMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LIBORBenchmarkRateGBPMember
ubs:InterstRateBenchmarkReformMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LIBORBenchmarkRateEURMember
ubs:InterstRateBenchmarkReformMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LIBORBenchmarkRateJPYMember
ubs:InterstRateBenchmarkReformMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:IncreaseDecreaseDueToModificationOfDeferredCompensationAwardsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueHeldForTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueHeldforTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueRelatedToThoseInExchangeForCashReceivedMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueHeldforTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueRelatedToThoseInExchangeForSecuritiesReceivedMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueHeldforTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueRelatedToOtherTransfersMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:FinancialAssetsAtFairValueNotHeldForTradingHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:DebtInstrumentsHeldMeasuredAtAmortizedCostPledgedAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:DebtInstrumentsHeldMeasuredAtFairValueThroughOtherComprehensiveIncomePledgedAsCollateralPermittedToBeSoldOrRepledgedAtFairValueMember
2020-12-31
0001610520
ubs:LongTermIncentivePlanMember
2019-01-01
2019-12-31
0001610520
ubs:AssetManagementEOPMember
2019-01-01
2019-12-31
0001610520
ubs:CompensationPerformanceYearMember
ubs:LongTermIncentivePlanMember
2019-01-01
2019-12-31
0001610520
ubs:CompensationPriorYearsMember
ubs:LongTermIncentivePlanMember
2019-01-01
2019-12-31
0001610520
ubs:CompensationPerformanceYearMember
ubs:AssetManagementEOPMember
2019-01-01
2019-12-31
0001610520
ubs:CompensationPriorYearsMember
ubs:AssetManagementEOPMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:LongTermIncentivePlanMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:AssetManagementEOPMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
ubs:LongTermIncentivePlanMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
ubs:LongTermIncentivePlanMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPerformanceYearMember
ubs:AssetManagementEOPMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:CompensationPriorYearsMember
ubs:AssetManagementEOPMember
2019-01-01
2019-12-31
0001610520
ubs:OtherDefinedBenefitPlansMember
2021-12-31
0001610520
ubs:OtherDefinedBenefitPlansMember
2020-12-31
0001610520
ubs:PensionPlansMember
2021-12-31
0001610520
ubs:PensionPlansMember
2020-12-31
0001610520
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:OtherDefinedBenefitPlansMember
2021-01-01
2021-12-31
0001610520
ubs:OtherDefinedBenefitPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2020-01-01
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2021-01-01
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2021-01-01
2021-12-31
0001610520
ubs:SwissPensionPlanMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2020-01-01
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2021-01-01
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2021-01-01
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2021-01-01
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:PensionPlansMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2021-01-01
2021-12-31
0001610520
ubs:PensionPlansMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:PensionPlansMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2021-01-01
2021-12-31
0001610520
ubs:PensionPlansMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:FairValueHedgesMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:FairValueHedgesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:OnbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OnbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ubs:OnbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OnbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:AllowanceForCreditLossesMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ubs:OffbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OffbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OffbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OffbalanceSheetLoanPortfolioMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:GrossCarryingAmountMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OnbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:OnbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ubs:OnbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OnbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OnbalanceSheetLoanPortfolioMember
2020-12-31
0001610520
ifrs-full:LoanCommitmentsMember
2021-12-31
0001610520
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:NotLaterThanOneMonthMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:NotLaterThanOneMonthMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanFiveYearsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:NotLaterThanOneMonthMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:NotLaterThanOneMonthMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
2020-12-31
0001610520
ifrs-full:CurrencySwapContractMember
ifrs-full:LaterThanFiveYearsMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LoansAndAdvancesToCustomersMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ClearstreamFundCentreAGMember
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2020-01-01
2020-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UpsideScenarioMember
2021-12-31
0001610520
ubs:RealEstateLoanMember
ubs:UpsideScenarioMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UpsideScenarioMember
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:MildDownsideScenarioMember
2021-12-31
0001610520
ubs:RealEstateLoanMember
ubs:MildDownsideScenarioMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:MildDownsideScenarioMember
2021-12-31
0001610520
ubs:SmallMediumEnterpriseMember
ubs:MildDownsideScenarioMember
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:OtherClientCounterpartiesMember
2021-12-31
0001610520
ubs:SmallMediumEnterpriseMember
ubs:UpsideScenarioMember
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:OtherClientCounterpartiesMember
2021-12-31
0001610520
ubs:UpsideScenarioMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LifetimeWeightedAverageMember
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2021-01-01
2021-12-31
0001610520
ifrs-full:MortgagesMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:LifetimeWeightedAverageMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:BaselineScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:UpsideScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:MildDownsideScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:SevereDownsideScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:LifetimeWeightedAverageMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:LifetimeWeightedAverageMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:BaselineScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:UpsideScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:MildDownsideScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:SevereDownsideScenarioMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:LifetimeWeightedAverageMember
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:OtherClientCounterpartiesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:OtherClientCounterpartiesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:OtherClientCounterpartiesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:OtherClientCounterpartiesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:OtherClientCounterpartiesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherClientCounterpartiesMember
ubs:LifetimeWeightedAverageMember
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyUSDMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyEURMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:BondCurrencyCHFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:EquityIndicesVariancesMember
ubs:SP500Member
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:Eurostoxx50Member
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:SPIMember
ubs:EquityIndicesVariancesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:SwissRealEstateMember
ubs:SingleFamiliyHomesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:UnitedStatesSPCaseShillerMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:OtherRealEstateMember
ubs:EurozoneHousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
2020-01-01
2020-12-31
0001610520
ubs:BaselineScenarioMember
2021-01-01
2021-12-31
0001610520
ubs:BaselineScenarioMember
2020-01-01
2020-12-31
0001610520
ubs:MildDownsideScenarioMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
2020-01-01
2020-12-31
0001610520
ubs:SevereDownsideScenarioMember
2021-01-01
2021-12-31
0001610520
ubs:SevereDownsideScenarioMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:InterestRateBasisPointSensitivityMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:UnemploymentRateMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:UnemploymentRateMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:UnemploymentRateMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:UnemploymentRateMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:GrossDomesticProductMember
ubs:MinusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:GrossDomesticProductMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:GrossDomesticProductMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:GrossDomesticProductMember
ubs:PlusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:MinusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:MinusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:MinusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:MinusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:MinusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:HousePriceIndexMember
ubs:MinusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:HousePriceIndexMember
ubs:MinusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:HousePriceIndexMember
ubs:MinusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:HousePriceIndexMember
ubs:MinusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:HousePriceIndexMember
ubs:MinusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:HousePriceIndexMember
ubs:PlusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:HousePriceIndexMember
ubs:PlusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:HousePriceIndexMember
ubs:PlusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:HousePriceIndexMember
ubs:PlusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:HousePriceIndexMember
ubs:PlusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:PlusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:PlusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:PlusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:PlusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:PlusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:MinusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:MinusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:MinusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:MinusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:MinusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:MinusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:MinusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:MinusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:MinusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:MinusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:PlusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:PlusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:PlusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:PlusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:PlusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:PlusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:PlusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:PlusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:PlusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:PlusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UpsideScenarioMember
ubs:MinusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:MildDownsideScenarioMember
ubs:MinusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UpsideScenarioMember
ubs:MinusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:MildDownsideScenarioMember
ubs:MinusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UpsideScenarioMember
ubs:PlusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:MildDownsideScenarioMember
ubs:PlusFivePercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:UpsideScenarioMember
ubs:PlusTenPercentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityMember
ubs:MildDownsideScenarioMember
ubs:PlusTenPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:MinusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:MinusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:HousePriceIndexMember
ubs:MinusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:HousePriceIndexMember
ubs:MinusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:HousePriceIndexMember
ubs:PlusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:HousePriceIndexMember
ubs:PlusTwoAndAHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:PlusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:PlusFivePercentMember
ubs:HousePriceIndexMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
ubs:PlusTwoPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:MinusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:MinusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusHalfPercentMember
2021-01-01
2021-12-31
0001610520
ubs:UpsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:MildDownsideScenarioMember
ubs:InterestRateBasisPointSensitivityMember
ubs:PlusOnePercentMember
2021-01-01
2021-12-31
0001610520
ubs:TimeBandFromYear2018TillYear2021Member
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:GovernmentBillsBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:InvestmentFundsMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossThatMeetDefinitionOfHeldForTradingCategoryMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:ForeignExchangeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:InterestRateContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:EquityIndexContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CreditDerivativeContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2021-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:DerivativesMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:CommodityContractsMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:BrokeragePayablesMeasuredAtFairValueThroughProfitOrLossMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
ubs:AmountDueUnderUnitLinkedInvestmentContractsMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:RecurringFairValueMeasurementMember
ubs:UBSAGMember
ubs:OverTheCounterDebtInstrumentsMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ubs:OtherLocationsMember
2021-12-31
0001610520
ubs:OtherLocationsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OtherLocationsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherLocationsMember
2020-12-31
0001610520
ubs:UBSGroupEntitiesExcludingUBSAGMember
2021-12-31
0001610520
ubs:UBSGroupEntitiesExcludingUBSAGMember
2021-01-01
2021-12-31
0001610520
ubs:SIXGroupAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AssociatesMember
2021-12-31
0001610520
ifrs-full:AssociatesMember
2020-12-31
0001610520
ubs:SIXGroupAGMember
2021-12-31
0001610520
ubs:SIXGroupAGMember
2020-12-31
0001610520
ubs:ClearstreamFundCentreAGMember
2020-12-31
0001610520
ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember
2021-12-31
0001610520
ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OtherDefinedBenefitPlansMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherDefinedBenefitPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UBSAGMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UBSAGMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:PensionPlansMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PensionPlansMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:UBSAGMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:UBSAGMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:UBSAGMember
ubs:PensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:UBSAGMember
ubs:PensionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:PensionPlansMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PensionPlansMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2020-01-01
2020-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SwissPensionPlanMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfDiscountRatesMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ActuarialAssumptionOfInterestCreditRateMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:OtherMaterialActuarialAssumptionsMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAssetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:OtherReservesMember
2018-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
2018-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
2018-12-31
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
2018-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
2018-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
2018-12-31
0001610520
2019-01-01
2019-01-01
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
2019-01-01
2019-01-01
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
2019-01-01
2019-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
2019-01-01
2019-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
2019-01-01
2019-12-31
0001610520
ifrs-full:OtherReservesMember
2019-01-01
2019-12-31
0001610520
ifrs-full:OtherReservesMember
2019-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
2019-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
2019-12-31
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
2019-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
2019-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
2019-12-31
0001610520
ifrs-full:OtherReservesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:OtherReservesMember
2020-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
2020-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
2020-12-31
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
2020-12-31
0001610520
ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember
2020-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
2020-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
2020-12-31
0001610520
ifrs-full:OtherReservesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
2021-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
2021-12-31
0001610520
ifrs-full:OtherReservesMember
2021-12-31
0001610520
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember
2021-12-31
0001610520
ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember
2021-12-31
0001610520
ifrs-full:ReserveOfCashFlowHedgesMember
2021-12-31
0001610520
ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:SubparticipatedLoanCommitmentsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:SubparticipatedLoanCommitmentsMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentAMMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentIBMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentGFMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentAMMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentIBMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentGFMember
2021-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentGWMMember
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentPCBMember
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentAMMember
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentIBMember
2020-12-31
0001610520
ifrs-full:LegalProceedingsProvisionMember
ubs:UBSAGMember
ubs:SegmentGFMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
ubs:ForwardStartingReverseRepurchaseAgreementsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
ubs:ForwardStartingReverseRepurchaseAgreementsMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
ubs:SubparticipatedLoanCommitmentsMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ifrs-full:LoanCommitmentsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueMember
ubs:UBSAGMember
ubs:SubparticipatedLoanCommitmentsMember
2020-12-31
0001610520
ubs:ClearstreamFundCentreAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ClearstreamFundCentreAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ClearstreamFundCentreAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:DiscountRateMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:DiscountRateMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:DiscountRateMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:DiscountRateMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:CorporateAndMunicipalBondsMember
2020-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:WeightedAverageMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:WeightedAverageMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:WeightedAverageMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:WeightedAverageMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ifrs-full:CreditSpreadMeasurementInputMember
ifrs-full:DiscountedCashFlowMember
ifrs-full:Level3OfFairValueHierarchyMember
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentAMMember
ubs:ClearstreamFundCentreAGMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentGWMMember
ubs:ClearstreamFundCentreAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:AssociatesMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AssociatesMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SIXGroupAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:FairValueHedgesMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:FairValueHedgesMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ifrs-full:HedgesOfNetInvestmentInForeignOperationsMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FairValueHedgesMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CashFlowHedgesMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FairValueHedgesMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CashFlowHedgesMember
ifrs-full:InterestRateRiskMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:StructuredSecuritiesFinancingTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:AuctionRateSecuritiesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:AssetBackedSecuritiesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InterestRateContractsNetMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InterestRateContractsNetMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CreditDerivativeContractsNetMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CreditDerivativeContractsNetMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ForeignExchangeContractsNetMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ForeignExchangeContractsNetMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:EquityIndexContractsNetMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherFinancialInstrumentsNetMember
2020-01-01
2020-12-31
0001610520
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2021-01-01
2021-12-31
0001610520
ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember
2020-01-01
2020-12-31
0001610520
ubs:StructuredSecuritiesFinancingTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:StructuredSecuritiesFinancingTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:AuctionRateSecuritiesMember
2021-01-01
2021-12-31
0001610520
ubs:AuctionRateSecuritiesMember
2020-01-01
2020-12-31
0001610520
ubs:AssetBackedSecuritiesMember
2021-01-01
2021-12-31
0001610520
ubs:AssetBackedSecuritiesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityInvestmentsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityInvestmentsMember
2020-01-01
2020-12-31
0001610520
ubs:InterestRateContractsNetMember
2021-01-01
2021-12-31
0001610520
ubs:InterestRateContractsNetMember
2020-01-01
2020-12-31
0001610520
ubs:CreditDerivativeContractsNetMember
2021-01-01
2021-12-31
0001610520
ubs:CreditDerivativeContractsNetMember
2020-01-01
2020-12-31
0001610520
ubs:ForeignExchangeContractsNetMember
2021-01-01
2021-12-31
0001610520
ubs:ForeignExchangeContractsNetMember
2020-01-01
2020-12-31
0001610520
ubs:EquityIndexContractsNetMember
2021-01-01
2021-12-31
0001610520
ubs:EquityIndexContractsNetMember
2020-01-01
2020-12-31
0001610520
ubs:OtherFinancialInstrumentsNetMember
2021-01-01
2021-12-31
0001610520
ubs:OtherFinancialInstrumentsNetMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialAssetsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:AgencyTransactionsMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:AgencyTransactionsMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
ubs:AgencyTransactionsMember
ubs:ExchangeTradedMember
2021-12-31
0001610520
ifrs-full:CommodityPriceRiskMember
ubs:UBSAGMember
ubs:AgencyTransactionsMember
ubs:ExchangeTradedMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAssetManagementAmericasIncSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAssetManagementHongKongLimitedSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UbsAssetManagementLifeLtdSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAssetManagementSwitzerlandAGSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSBusinessSolutionsUSLLCSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSCreditCorpSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSFranceSASubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSFundManagementLuxembourgSASubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSFundManagementSwitzerlandAGSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSMonacoSASubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UbsOConnorLlcMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSRealtyInvestorsLLCSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSSecuritiesAustraliaLtdSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSSecuritiesHongKongLimitedSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSSecuritiesJapanCoLtdSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UbsSumiTrustWealthManagementCoLtdMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAssetManagementAmericasIncSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAssetManagementHongKongLimitedSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UbsAssetManagementLifeLtdSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAssetManagementSwitzerlandAGSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSBusinessSolutionsUSLLCSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSCreditCorpSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSFranceSASubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSFundManagementLuxembourgSASubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSFundManagementSwitzerlandAGSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSMonacoSASubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UbsOConnorLlcMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSRealtyInvestorsLLCSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSSecuritiesAustraliaLtdSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSSecuritiesHongKongLimitedSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSSecuritiesJapanCoLtdSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UbsSumiTrustWealthManagementCoLtdMember
2021-12-31
0001610520
ubs:UBSAssetManagementAmericasIncSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAssetManagementHongKongLimitedSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UbsAssetManagementLifeLtdSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAssetManagementSwitzerlandAGSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSBusinessSolutionsUSLLCSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSCreditCorpSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSFranceSASubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSFundManagementLuxembourgSASubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSFundManagementSwitzerlandAGSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSMonacoSASubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UbsOConnorLlcMember
2021-01-01
2021-12-31
0001610520
ubs:UBSRealtyInvestorsLLCSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSSecuritiesAustraliaLtdSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSSecuritiesHongKongLimitedSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSSecuritiesJapanCoLtdSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:UbsSumiTrustWealthManagementCoLtdMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAssetManagementAmericasIncSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAssetManagementHongKongLimitedSubsidiariesMember
2021-12-31
0001610520
ubs:UbsAssetManagementLifeLtdSubsidiariesMember
2021-12-31
0001610520
ubs:UBSAssetManagementSwitzerlandAGSubsidiariesMember
2021-12-31
0001610520
ubs:UBSBusinessSolutionsUSLLCSubsidiariesMember
2021-12-31
0001610520
ubs:UBSCreditCorpSubsidiariesMember
2021-12-31
0001610520
ubs:UBSFranceSASubsidiariesMember
2021-12-31
0001610520
ubs:UBSFundManagementLuxembourgSASubsidiariesMember
2021-12-31
0001610520
ubs:UBSFundManagementSwitzerlandAGSubsidiariesMember
2021-12-31
0001610520
ubs:UBSMonacoSASubsidiariesMember
2021-12-31
0001610520
ubs:UbsOConnorLlcMember
2021-12-31
0001610520
ubs:UBSRealtyInvestorsLLCSubsidiariesMember
2021-12-31
0001610520
ubs:UBSSecuritiesAustraliaLtdSubsidiariesMember
2021-12-31
0001610520
ubs:UBSSecuritiesHongKongLimitedSubsidiariesMember
2021-12-31
0001610520
ubs:UBSSecuritiesJapanCoLtdSubsidiariesMember
2021-12-31
0001610520
ubs:UbsSumiTrustWealthManagementCoLtdMember
2021-12-31
0001610520
ifrs-full:IssuedCapitalMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
2020-12-31
0001610520
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:USDefinedContributionPlanMember
2021-01-01
2021-12-31
0001610520
ubs:USDefinedContributionPlanMember
2020-01-01
2020-12-31
0001610520
ubs:USDefinedContributionPlanMember
2019-01-01
2019-12-31
0001610520
ubs:UkDefinedContributionPlanMember
2021-01-01
2021-12-31
0001610520
ubs:UkDefinedContributionPlanMember
2020-01-01
2020-12-31
0001610520
ubs:UkDefinedContributionPlanMember
2019-01-01
2019-12-31
0001610520
ubs:OtherDefinedContributionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:OtherDefinedContributionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:OtherDefinedContributionPlansMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:USDefinedContributionPlanMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USDefinedContributionPlanMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USDefinedContributionPlanMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:UkDefinedContributionPlanMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UkDefinedContributionPlanMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UkDefinedContributionPlanMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:OtherDefinedContributionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherDefinedContributionPlansMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OtherDefinedContributionPlansMember
2019-01-01
2019-12-31
0001610520
ubs:UBSBrasilServicosMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
ubs:UBSBrasilServicosMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:UBSBrasilServicosMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
ubs:UBSAGMember
ubs:UBSBrasilServicosMember
2020-01-01
2020-12-31
0001610520
ubs:LIBORBenchmarkRateCHFMember
ubs:InterstRateBenchmarkReformMember
2021-01-01
2021-12-31
0001610520
ubs:LIBORBenchmarkRateUSDMember
ubs:InterstRateBenchmarkReformMember
2021-01-01
2021-12-31
0001610520
ubs:LIBORBenchmarkRateGBPMember
ubs:InterstRateBenchmarkReformMember
2021-01-01
2021-12-31
0001610520
ubs:LIBORBenchmarkRateEURMember
ubs:InterstRateBenchmarkReformMember
2021-01-01
2021-12-31
0001610520
ubs:LIBORBenchmarkRateJPYMember
ubs:InterstRateBenchmarkReformMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LIBORBenchmarkRateCHFMember
ubs:InterstRateBenchmarkReformMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LIBORBenchmarkRateUSDMember
ubs:InterstRateBenchmarkReformMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LIBORBenchmarkRateGBPMember
ubs:InterstRateBenchmarkReformMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LIBORBenchmarkRateEURMember
ubs:InterstRateBenchmarkReformMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LIBORBenchmarkRateJPYMember
ubs:InterstRateBenchmarkReformMember
2021-01-01
2021-12-31
0001610520
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:MortgagesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:LombardLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2020-01-01
2020-12-31
0001610520
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:MortgagesMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:ChangesDueToSICRStageMovesMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:LombardLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:CommodityTradeFinanceMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CommodityTradeFinanceMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:MortgagesMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:LombardLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:CreditCardMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:CreditCardMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LombardLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CreditCardMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:CreditCardMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:ModelAndMethodologyChangesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ModelAndMethodologyChangesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ModelAndMethodologyChangesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ModelAndMethodologyChangesMember
2020-01-01
2020-12-31
0001610520
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2020-01-01
2020-12-31
0001610520
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
2019-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LandAndBuildingsAndEquipmentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:RightofuseAssetsMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:ComputerSoftwareMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:ProjectsInProgressMember
2021-01-01
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LandAndBuildingsAndEquipmentMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:RightofuseAssetsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:ComputerSoftwareMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:ProjectsInProgressMember
2021-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:LandAndBuildingsAndEquipmentMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ifrs-full:RightofuseAssetsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:ComputerSoftwareMember
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:GrossCarryingAmountMember
ubs:UBSAGMember
ubs:ProjectsInProgressMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:UBSAGMember
ubs:LandAndBuildingsAndEquipmentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:RightofuseAssetsMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:ComputerSoftwareMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:UBSAGMember
ubs:ProjectsInProgressMember
2021-01-01
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:UBSAGMember
ubs:LandAndBuildingsAndEquipmentMember
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:RightofuseAssetsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:ComputerSoftwareMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:UBSAGMember
ubs:ProjectsInProgressMember
2021-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:UBSAGMember
ubs:LandAndBuildingsAndEquipmentMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:RightofuseAssetsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ifrs-full:ComputerSoftwareMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember
ubs:UBSAGMember
ubs:ProjectsInProgressMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LandAndBuildingsAndEquipmentMember
2021-12-31
0001610520
ifrs-full:RightofuseAssetsMember
ubs:UBSAGMember
2021-12-31
0001610520
ifrs-full:ComputerSoftwareMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ProjectsInProgressMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LandAndBuildingsAndEquipmentMember
2020-12-31
0001610520
ifrs-full:RightofuseAssetsMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:ComputerSoftwareMember
ubs:UBSAGMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ProjectsInProgressMember
2020-12-31
0001610520
ifrs-full:RightofuseAssetsMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:RightofuseAssetsMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ubs:ChangesDueToSICRStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:ChangesDueToSICRStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ubs:RemeasurementsWithoutStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:RemeasurementsWithoutStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
ubs:FinancialIntermediariesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ModelAndMethodologyChangesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ModelAndMethodologyChangesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ModelAndMethodologyChangesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ModelAndMethodologyChangesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToNewAndDerecognizedTransactionsMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ChangesDueToSICRStageMovesMember
ubs:SecuritiesFinancingTransactionsREITMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CommodityTradeFinanceMember
ubs:ChangesDueToSICRStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:CreditCardMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:MortgagesMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CreditCardMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ifrs-full:MortgagesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RealEstateLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:CorporateLoansMember
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:SmallMediumEnterpriseMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:OtherMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LoansToFinancialAdvisorsMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:LombardLoanMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CreditCardMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:CreditCardMember
ubs:RemeasurementsWithoutStageMovesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ModelAndMethodologyChangesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ModelAndMethodologyChangesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ModelAndMethodologyChangesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:ModelAndMethodologyChangesMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:TwelvemonthExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2020-01-01
2020-12-31
0001610520
ifrs-full:FinancialInstrumentsCreditimpairedMember
ifrs-full:LifetimeExpectedCreditLossesMember
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesDueToOtherAllowanceAndProvisionMovementMember
2020-01-01
2020-12-31
0001610520
ubs:WealthManagementBusinessInAustriaMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:WealthManagementBusinessInAustriaMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherDefinedBenefitPlansMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherDefinedBenefitPlansMember
2020-12-31
0001610520
ifrs-full:CurrencyRiskMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsBelowBBBMinusMember
2021-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ForeignBondsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UKPensionPlanMember
ubs:ForeignBondsBelowBBBMinusMember
2020-12-31
0001610520
ubs:UKPensionPlanMember
ubs:ForeignBondsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsBelowBBBMinusMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsBelowBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsBelowBBBMinusMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
ubs:ForeignBondsBelowBBBMinusMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquitySecuritiesMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquitySecuritiesMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquitySecuritiesMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquitySecuritiesMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquitySecuritiesMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquitySecuritiesMember
2021-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquitySecuritiesMember
2020-12-31
0001610520
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquitySecuritiesMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquitySecuritiesMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquitySecuritiesMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquitySecuritiesMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquitySecuritiesMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquitySecuritiesMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquitySecuritiesMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquitySecuritiesMember
2021-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquitySecuritiesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquitySecuritiesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquitySecuritiesMember
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquitySecuritiesMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquitySecuritiesMember
2020-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquitySecuritiesMember
2020-12-31
0001610520
ifrs-full:Level2And3OfFairValueHierarchyMember
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquitySecuritiesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:DomesticEquitySecuritiesMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:USAndGermanPensionPlansMember
ubs:ForeignEquitySecuritiesMember
2020-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:SecuritisationVehiclesMember
2021-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember
ifrs-full:SecuritisationVehiclesMember
ubs:UBSAGMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:IncludedInOtherComprehensiveIncomeMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:IncludedInOtherComprehensiveIncomeMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:IncludedInOtherComprehensiveIncomeMember
2019-01-01
2019-12-31
0001610520
ubs:UBSAGMember
ubs:IncludedInOtherComprehensiveIncomeMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:IncludedInOtherComprehensiveIncomeMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:IncludedInOtherComprehensiveIncomeMember
2019-12-31
0001610520
ubs:InterstRateBenchmarkReformMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InterstRateBenchmarkReformMember
2021-12-31
0001610520
ubs:InterstRateBenchmarkReformMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InterstRateBenchmarkReformMember
2021-01-01
2021-12-31
0001610520
srt:AmericasMember
2021-12-31
0001610520
country:US
2021-12-31
0001610520
srt:AsiaPacificMember
2021-12-31
0001610520
country:CH
2021-12-31
0001610520
srt:AmericasMember
2020-12-31
0001610520
country:US
2020-12-31
0001610520
srt:AsiaPacificMember
2020-12-31
0001610520
country:CH
2020-12-31
0001610520
srt:AmericasMember
2019-12-31
0001610520
country:US
2019-12-31
0001610520
srt:AsiaPacificMember
2019-12-31
0001610520
country:CH
2019-12-31
0001610520
srt:AmericasMember
2021-01-01
2021-12-31
0001610520
country:US
2021-01-01
2021-12-31
0001610520
srt:AsiaPacificMember
2021-01-01
2021-12-31
0001610520
country:CH
2021-01-01
2021-12-31
0001610520
srt:AmericasMember
2020-01-01
2020-12-31
0001610520
country:US
2020-01-01
2020-12-31
0001610520
srt:AsiaPacificMember
2020-01-01
2020-12-31
0001610520
country:CH
2020-01-01
2020-12-31
0001610520
srt:AmericasMember
2019-01-01
2019-12-31
0001610520
country:US
2019-01-01
2019-12-31
0001610520
srt:AsiaPacificMember
2019-01-01
2019-12-31
0001610520
country:CH
2019-01-01
2019-12-31
0001610520
srt:AmericasMember
ubs:UBSAGMember
2021-12-31
0001610520
country:US
ubs:UBSAGMember
2021-12-31
0001610520
srt:AsiaPacificMember
ubs:UBSAGMember
2021-12-31
0001610520
country:CH
ubs:UBSAGMember
2021-12-31
0001610520
srt:AmericasMember
ubs:UBSAGMember
2020-12-31
0001610520
country:US
ubs:UBSAGMember
2020-12-31
0001610520
srt:AsiaPacificMember
ubs:UBSAGMember
2020-12-31
0001610520
country:CH
ubs:UBSAGMember
2020-12-31
0001610520
srt:AmericasMember
ubs:UBSAGMember
2019-12-31
0001610520
country:US
ubs:UBSAGMember
2019-12-31
0001610520
srt:AsiaPacificMember
ubs:UBSAGMember
2019-12-31
0001610520
country:CH
ubs:UBSAGMember
2019-12-31
0001610520
srt:AmericasMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
country:US
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
srt:AsiaPacificMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
country:CH
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
srt:AmericasMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
country:US
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
srt:AsiaPacificMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
country:CH
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
srt:AmericasMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
country:US
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
srt:AsiaPacificMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
country:CH
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ubs:MortgageLoanPortfolioRegionAmericasMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MortgageLoanPortfolioRegionAmericasMember
2021-01-01
2021-12-31
0001610520
ubs:MortgageLoanPortfolioRegionsEmeaAndAsiaPacificMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MortgageLoanPortfolioRegionsEmeaAndAsiaPacificMember
2021-01-01
2021-12-31
0001610520
ubs:PlusOneBasisPointsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PlusOneBasisPointsMember
2021-01-01
2021-12-31
0001610520
ubs:ParallelUpInterestRateShockScenarioMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ParallelUpInterestRateShockScenarioMember
2021-01-01
2021-12-31
0001610520
ubs:PlusOneBasisPointsMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:PlusOneBasisPointsMember
2020-12-31
0001610520
dei:BusinessContactMember
2021-01-01
2021-12-31
0001610520
dei:BusinessContactMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:Level1OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2021-12-31
0001610520
ifrs-full:Level2OfFairValueHierarchyMember
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2021-12-31
0001610520
ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember
ubs:UBSAGMember
ubs:RepurchaseAgreementsAndCashCollateralOnSecuritiesLentMember
2021-12-31
0001610520
ifrs-full:SharePremiumMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:RetainedEarningsMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanFiveYearsMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanFiveYearsMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2021-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ifrs-full:InterestRateSwapContractMember
ifrs-full:LaterThanFiveYearsMember
ubs:UBSAGMember
ubs:OverTheCounterMember
2020-12-31
0001610520
ubs:UBSAGCrossBorderWealthManagementBusinessesLawsuitsMember
2021-12-31
0001610520
ubs:UBSFranceSACrossBorderWealthManagementBusinessesLawsuitsMember
2021-12-31
0001610520
ubs:CrossBorderWealthManagementBusinessesMember
2021-01-01
2021-12-31
0001610520
ubs:MadoffLuxembourgMember
2021-01-01
2021-12-31
0001610520
ubs:MadoffUSMember
2021-01-01
2021-12-31
0001610520
ubs:PuertoRicoCustomerArbitrationClaimsMember
2021-01-01
2021-12-31
0001610520
ubs:EmployeeRetirementSystemPuertoRicoMember
2021-01-01
2021-12-31
0001610520
ubs:PuertoRicoMattersMember
2021-01-01
2021-12-31
0001610520
ubs:PuertoRicoInsuranceCompaniesClaimsMember
2021-01-01
2021-12-31
0001610520
ubs:ForexRelatedCivilLitigationMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGCrossBorderWealthManagementBusinessesLawsuitsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSFranceSACrossBorderWealthManagementBusinessesLawsuitsMember
2021-01-01
2021-12-31
0001610520
ubs:CrossBorderWealthManagementBusinessesMember
2021-12-31
0001610520
ubs:TradingRelatedInquiriesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:TradingRelatedInquiriesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ForexRelatedCivilLitigationMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PuertoRicoInsuranceCompaniesClaimsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PuertoRicoMattersMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:EmployeeRetirementSystemPuertoRicoMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PuertoRicoCustomerArbitrationClaimsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MadoffUSMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MadoffLuxembourgMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CrossBorderWealthManagementBusinessesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAGCrossBorderWealthManagementBusinessesLawsuitsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSFranceSACrossBorderWealthManagementBusinessesLawsuitsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CrossBorderWealthManagementBusinessesMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAGCrossBorderWealthManagementBusinessesLawsuitsMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSFranceSACrossBorderWealthManagementBusinessesLawsuitsMember
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:PostmodelCreditLossExpenseAdjustmentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:ExpectedCreditLossesModelUpdatesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:NewTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToBookQualityMember
2021-01-01
2021-12-31
0001610520
ubs:WriteOffRecoveriesMember
2021-01-01
2021-12-31
0001610520
ubs:ForeignExchangeMovementsMember
2021-01-01
2021-12-31
0001610520
ubs:BaselineScenarioMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2020-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:WeightedAverageMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToBookQualityMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:WriteOffRecoveriesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ForeignExchangeMovementsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:PostmodelCreditLossExpenseAdjustmentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:ExpectedCreditLossesModelUpdatesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:FinancialInstrumentsNotCreditimpairedMember
ubs:UBSAGMember
ubs:NewTransactionsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UpsideScenarioMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:BaselineScenarioMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
2020-01-01
2020-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:TopOfRangeMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:BottomOfRangeMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SwissPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UKPensionPlanMember
2021-01-01
2021-12-31
0001610520
ubs:USPensionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:USPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:USPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:USPensionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:GermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:GermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:LargerGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:LargerGermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:SmallerGermanPensionPlansMember
ubs:TimeBandBeforeYear2010Member
2021-01-01
2021-12-31
0001610520
ubs:SmallerGermanPensionPlansMember
ubs:TimeBandFromYear2010TillYear2017Member
2021-01-01
2021-12-31
0001610520
ubs:SmallerGermanPensionPlansMember
ubs:TimeBandAfterYear2017Member
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SmallerGermanPensionPlansMember
ubs:TimeBandBeforeYear2010Member
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SmallerGermanPensionPlansMember
ubs:TimeBandFromYear2010TillYear2017Member
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SmallerGermanPensionPlansMember
ubs:TimeBandAfterYear2017Member
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:NewGermanPensionPlanMember
2021-01-01
2021-12-31
0001610520
ubs:NewGermanPensionPlanMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:GermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:GermanPensionPlansMember
2021-01-01
2021-12-31
0001610520
ubs:ExpectedCreditLossesModelUpdatesMember
2021-01-01
2021-12-31
0001610520
ubs:ChangesInExpectedCreditLossesScenariosMember
2021-01-01
2021-12-31
0001610520
ubs:PostmodelCreditLossExpenseAdjustmentMember
2021-01-01
2021-12-31
0001610520
ubs:PostmodelCreditLossExpenseAdjustmentCovid19Member
2020-01-01
2020-12-31
0001610520
ubs:PostmodelCreditLossExpenseAdjustmentOverlaysOtherMember
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:ChangesInExpectedCreditLossesScenariosMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PostmodelCreditLossExpenseAdjustmentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:PostmodelCreditLossExpenseAdjustmentCovid19Member
2020-01-01
2020-12-31
0001610520
ubs:UBSAGMember
ubs:PostmodelCreditLossExpenseAdjustmentOverlaysOtherMember
2020-01-01
2020-12-31
0001610520
ubs:SharebasedPaymentArrangementsUnvestedMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SharebasedPaymentArrangementsUnvestedMember
2021-12-31
0001610520
ifrs-full:InvestmentFundsMember
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-12-31
0001610520
ubs:ClearstreamFundCentreAGMember
2021-01-01
2021-12-31
0001610520
country:GB
ubs:UBSAGMember
2021-12-31
0001610520
country:GB
ubs:UBSAGMember
2020-12-31
0001610520
country:GB
2021-12-31
0001610520
country:GB
2020-12-31
0001610520
ubs:SponsoredMember
ubs:NonExistenceOfInterestMember
2021-12-31
0001610520
ubs:SponsoredMember
ubs:NonExistenceOfInterestMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:SponsoredMember
ubs:NonExistenceOfInterestMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SponsoredMember
ubs:NonExistenceOfInterestMember
2020-12-31
0001610520
ubs:UBSAustriaMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAustriaMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UbsWealthManagementInSpainMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UbsWealthManagementInSpainMember
2021-01-01
2021-12-31
0001610520
ubs:UbsWealthManagementInSpainMember
2021-12-31
0001610520
ubs:UbsWealthManagementInSpainMember
2021-01-01
2021-12-31
0001610520
ubs:UbsSwissFinancialAdvisersAgMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:UbsSwissFinancialAdvisersAgMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:WealthfrontMember
2021-12-31
0001610520
ubs:WealthfrontMember
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NotLaterThanOneYearMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
ubs:EurozoneMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2020-01-01
2020-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:GrossDomesticProductMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:ConsumerPriceInflationMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:US
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:NotLaterThanOneYearMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:UpsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:BaselineScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:MildDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember
ubs:UBSAGMember
ubs:SevereDownsideScenarioMember
ubs:UnemploymentRateMember
2021-01-01
2021-12-31
0001610520
country:CH
ubs:UBSAGMember
ubs:Age65Member
ubs:MortalityTableSwitzerlandMember
2021-12-31
0001610520
country:CH
ubs:UBSAGMember
ubs:Age65Member
ubs:MortalityTableSwitzerlandMember
2020-12-31
0001610520
country:CH
ubs:UBSAGMember
ubs:Age45Member
ubs:MortalityTableSwitzerlandMember
2021-12-31
0001610520
country:CH
ubs:UBSAGMember
ubs:Age45Member
ubs:MortalityTableSwitzerlandMember
2020-12-31
0001610520
country:CH
ubs:Age65Member
ubs:MortalityTableSwitzerlandMember
2021-12-31
0001610520
country:CH
ubs:Age65Member
ubs:MortalityTableSwitzerlandMember
2020-12-31
0001610520
country:CH
ubs:Age45Member
ubs:MortalityTableSwitzerlandMember
2021-12-31
0001610520
country:CH
ubs:Age45Member
ubs:MortalityTableSwitzerlandMember
2020-12-31
0001610520
country:GB
ubs:Age65Member
ubs:MortalityTableUKMember
2021-12-31
0001610520
country:GB
ubs:Age65Member
ubs:MortalityTableUKMember
2020-12-31
0001610520
country:GB
ubs:Age45Member
ubs:MortalityTableUKMember
2021-12-31
0001610520
country:GB
ubs:Age45Member
ubs:MortalityTableUKMember
2020-12-31
0001610520
country:GB
ubs:UBSAGMember
ubs:Age65Member
ubs:MortalityTableUKMember
2021-12-31
0001610520
country:GB
ubs:UBSAGMember
ubs:Age65Member
ubs:MortalityTableUKMember
2020-12-31
0001610520
country:GB
ubs:UBSAGMember
ubs:Age45Member
ubs:MortalityTableUKMember
2021-12-31
0001610520
country:GB
ubs:UBSAGMember
ubs:Age45Member
ubs:MortalityTableUKMember
2020-12-31
0001610520
country:US
ubs:UBSAGMember
ubs:Age65Member
ubs:MortalityTableUSAMember
2021-12-31
0001610520
country:US
ubs:UBSAGMember
ubs:Age65Member
ubs:MortalityTableUSAMember
2020-12-31
0001610520
country:US
ubs:UBSAGMember
ubs:Age45Member
ubs:MortalityTableUSAMember
2021-12-31
0001610520
country:US
ubs:UBSAGMember
ubs:Age45Member
ubs:MortalityTableUSAMember
2020-12-31
0001610520
country:US
ubs:Age65Member
ubs:MortalityTableUSAMember
2021-12-31
0001610520
country:US
ubs:Age65Member
ubs:MortalityTableUSAMember
2020-12-31
0001610520
country:US
ubs:Age45Member
ubs:MortalityTableUSAMember
2021-12-31
0001610520
country:US
ubs:Age45Member
ubs:MortalityTableUSAMember
2020-12-31
0001610520
country:DE
ubs:UBSAGMember
ubs:Age65Member
ubs:MortalityTableGermanyMember
2021-12-31
0001610520
country:DE
ubs:UBSAGMember
ubs:Age65Member
ubs:MortalityTableGermanyMember
2020-12-31
0001610520
country:DE
ubs:UBSAGMember
ubs:Age45Member
ubs:MortalityTableGermanyMember
2021-12-31
0001610520
country:DE
ubs:UBSAGMember
ubs:Age45Member
ubs:MortalityTableGermanyMember
2020-12-31
0001610520
country:DE
ubs:Age65Member
ubs:MortalityTableGermanyMember
2021-12-31
0001610520
country:DE
ubs:Age65Member
ubs:MortalityTableGermanyMember
2020-12-31
0001610520
country:DE
ubs:Age45Member
ubs:MortalityTableGermanyMember
2021-12-31
0001610520
country:DE
ubs:Age45Member
ubs:MortalityTableGermanyMember
2020-12-31
0001610520
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
ubs:UBSSwitzerlandAGGuarantorSubsidiariesMember
2021-01-01
2021-12-31
0001610520
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
ubs:UBSSwitzerlandAGGuarantorSubsidiariesMember
2020-01-01
2020-12-31
0001610520
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
ubs:UBSSwitzerlandAGGuarantorSubsidiariesMember
2019-01-01
2019-12-31
0001610520
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
srt:ConsolidationEliminationsMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
srt:ConsolidationEliminationsMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
srt:ConsolidationEliminationsMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
ubs:UBSSwitzerlandAGGuarantorSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
ubs:UBSSwitzerlandAGGuarantorSubsidiariesMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
ubs:UBSSwitzerlandAGGuarantorSubsidiariesMember
2019-01-01
2019-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
srt:ConsolidationEliminationsMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
srt:ConsolidationEliminationsMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:EquityAttributableToOwnersOfParentMember
srt:ConsolidationEliminationsMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2020-01-01
2020-12-31
0001610520
ifrs-full:NoncontrollingInterestsMember
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2019-01-01
2019-12-31
0001610520
ubs:CrossBorderWealthManagementBusinessesInvestigationInBelgiumMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:CrossBorderWealthManagementBusinessesInvestigationInBelgiumMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:ExpectedCreditLossesModelUpdatesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentIBMember
ubs:ExpectedCreditLossesModelUpdatesMember
2021-01-01
2021-12-31
0001610520
ubs:SegmentIBMember
ubs:ExpectedCreditLossesModelUpdatesMember
2021-01-01
2021-12-31
0001610520
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-01-01
2021-12-31
0001610520
ifrs-full:OtherAssetsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:OtherFinancialAssetsAtAmortisedCostMember
2021-01-01
2021-12-31
0001610520
ifrs-full:OtherAssetsMember
ubs:UBSAGMember
2021-01-01
2021-12-31
0001610520
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember
2021-01-01
2021-12-31
0001610520
ubs:NotesAndDebenturesIssuedMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:NotesAndDebenturesIssuedMember
2021-01-01
2021-12-31
0001610520
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2021-12-31
0001610520
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
ubs:UBSSwitzerlandAGGuarantorSubsidiariesMember
2021-12-31
0001610520
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2021-12-31
0001610520
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2020-12-31
0001610520
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
ubs:UBSSwitzerlandAGGuarantorSubsidiariesMember
2020-12-31
0001610520
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2020-12-31
0001610520
srt:ConsolidationEliminationsMember
ubs:UBSAGMember
2021-12-31
0001610520
srt:ConsolidationEliminationsMember
ubs:UBSAGMember
2020-12-31
0001610520
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2019-12-31
0001610520
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
ubs:UBSSwitzerlandAGGuarantorSubsidiariesMember
2019-12-31
0001610520
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2019-12-31
0001610520
srt:ParentCompanyMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2018-12-31
0001610520
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
ubs:UBSSwitzerlandAGGuarantorSubsidiariesMember
2018-12-31
0001610520
srt:NonGuarantorSubsidiariesMember
srt:ReportableLegalEntitiesMember
ubs:UBSAGMember
2018-12-31
0001610520
ubs:UBSAGMember
ubs:UBSAGSubsidiariesMember
2021-01-01
2021-12-31
0001610520
ubs:InvestmentFundsOnBalanceSheetMember
2021-12-31
0001610520
ubs:InvestmentFundsOnBalanceSheetMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InvestmentFundsOnBalanceSheetMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InvestmentFundsOnBalanceSheetMember
2020-12-31
0001610520
ubs:InvestmentFundsNotOnBalanceSheetMember
2021-12-31
0001610520
ubs:InvestmentFundsNotOnBalanceSheetMember
2020-12-31
0001610520
ubs:UBSAGMember
ubs:InvestmentFundsNotOnBalanceSheetMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:InvestmentFundsNotOnBalanceSheetMember
2020-12-31
0001610520
ubs:RelatedPartiesCompensationMember
2021-01-01
2021-12-31
0001610520
ubs:RelatedPartiesEquityHoldingsMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LoansAndReceivablesCategoryMember
ifrs-full:KeyManagementPersonnelOfEntityOrParentMember
2021-01-01
2021-12-31
0001610520
ifrs-full:LoansAndReceivablesCategoryMember
ifrs-full:AssociatesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ifrs-full:LoansAndReceivablesCategoryMember
ifrs-full:KeyManagementPersonnelOfEntityOrParentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ifrs-full:LoansAndReceivablesCategoryMember
ifrs-full:AssociatesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ifrs-full:LoansAndReceivablesCategoryMember
ifrs-full:ParentMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RelatedPartiesEquityHoldingsMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SponsoredMember
ubs:NonExistenceOfInterestMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SponsoredMember
ubs:NonExistenceOfInterestMember
2020-01-01
2020-12-31
0001610520
ubs:SponsoredMember
ubs:NonExistenceOfInterestMember
2021-01-01
2021-12-31
0001610520
ubs:SponsoredMember
ubs:NonExistenceOfInterestMember
2020-01-01
2020-12-31
0001610520
ifrs-full:ActuarialAssumptionOfMortalityRatesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ifrs-full:ActuarialAssumptionOfMortalityRatesMember
2021-01-01
2021-12-31
0001610520
ubs:UBSAGMember
ubs:SegmentNonSwissMember
2021-12-31
0001610520
ubs:SegmentNonSwissMember
2021-12-31
0001610520
ubs:RussiasInvasionOfUkraineNonadjustingEventAfterReportingPeriodMember
2021-12-31
0001610520
ubs:UBSAGMember
ubs:RussiasInvasionOfUkraineNonadjustingEventAfterReportingPeriodMember
2021-12-31
iso4217:CHF
iso4217:EUR
iso4217:THB
iso4217:USD
xbrli:pure
xbrli:shares
utr:Y
iso4217:USD
xbrli:shares
iso4217:CHF
xbrli:shares
1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
20-F
(Mark One)
☐
REGISTRATION
STATEMENT
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
OR
☑
ANNUAL REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the fiscal year ended
December 31, 2021
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from
to
.
OR
☐
SHELL COMPANY REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
UBS Group AG
Commission file number:
1-36764
UBS AG
Commission file number:
1-15060
(Exact Name of Registrants as Specified in Their Respective Charters)
Switzerland
(Jurisdiction of Incorporation or Organization)
UBS Group AG
Bahnhofstrasse 45
,
CH-8001
Zurich
, Switzerland
(Address of Principal Executive Office)
UBS AG
Bahnhofstrasse 45
,
CH-8001
Zurich
,
Switzerland
and
Aeschenvorstadt 1, CH-4051 Basel, Switzerland
(Address of Principal Executive Offices)
David Kelly
600 Washington
Boulevard
Stamford, CT
06901
Telephone: (
203
)
719 3000
(Name, Telephone,
E-mail and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of
the Act:
Please see page 3.
Securities registered or to be registered pursuant to Section 12(g) of
the Act:
Please see page 3.
Securities for which there is a reporting obligation pursuant to Section 15(d)
of the Act:
Please see page 3.
2
Indicate the number of outstanding shares of each of each issuer’s
classes of capital or common stock as of 31 December 2021:
UBS Group AG
Ordinary shares, par value CHF 0.10 per share:
3,702,422,995
ordinary shares
(including 302,815,328 treasury shares)
UBS AG
Ordinary shares, par value CHF 0.10 per share:
3,858,408,466
ordinary shares
(none of which are treasury shares)
Indicate by check mark if the registrants are well-known seasoned
issuers, as defined in Rule 405 of the Securities Act.
UBS Group AG
Yes
☐
No
☑
UBS AG
Yes
☐
No
☑
If this report is an annual or transition report, indicate by check mark if the registrants are not
required to file reports pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Yes
☐
No
☑
Note — Checking the box above will not relieve any registrant required to
file reports pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 from their obligations under those
Sections.
Indicate by check mark whether the Registrants (1) have filed all reports required
to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the Registrants were required
to file such reports) and (2) have been subject to such filing requirements for the past 90
days.
Yes
☑
No
☐
Indicate by check mark whether the registrants have submitted electronically
every Interactive Data File required to be
submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of
this chapter) during the preceding 12 months (or for such
shorter period that the registrants were required to submit such files).
Yes
☑
No
☐
Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer,
or a non-accelerated filer or an
emerging growth company.
See definition of “accelerated filer and large accelerated filer” and
“emerging growth company” in
Rule 12b-2 of the Exchange Act.
(Check One):
UBS Group AG
Large accelerated filer
☑
Accelerated filer
☐
Non-accelerated filer
☐
Emerging growth company
☐
UBS AG
Large accelerated filer
☐
Accelerated filer
☐
Non-accelerated filer
☑
Emerging growth company
☐
Indicate by check mark whether the registrant has filed a report on
and attestation to its management’s assessment of
the
effectiveness of its internal control over financial reporting under
Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.
7262(b)) by the registered public accounting firm that prepared
or issued its audit report.
UBS Group AG
Yes
☑
No
☐
UBS AG
Yes
☑
No
☐
Indicate by check mark which basis of accounting the registrants have used
to prepare the financial statements included in this
filing.
U.S. GAAP
☐
International Financial Reporting Standards
as issued by the International Accounting
Standards Board
☑
Other
☐
If “Other” has been checked in response to the previous question, indicate by
check mark which financial statement item the
registrants have elected to follow.
Item 17
☐
Item 18
☐
3
If this is an annual report, indicate by check mark whether the registrants are shell companies
(as defined in Rule 12b-2 of the
Exchange Act)
Yes
☐
No
☑
Securities registered or to be registered
pursuant to Section 12(b) of the Act:
UBS Group AG
Title of each class
Trading
symbol(s)
Name of each
exchange on
which registered
Ordinary Shares (par value of CHF 0.10 each)
UBS
New York
Stock
Exchange
UBS AG
Title of each class
Trading
symbol(s)
Name of each
exchange on
which registered
ETRACS Alerian Midstream Energy Index ETN due June 21, 2050
AMNA
NYSE Arca
ETRACS Alerian Midstream Energy High Dividend Index
ETN due July 19, 2050
AMND
NYSE Arca
ETRACS Alerian Midstream Energy Total
Return Index ETN due October 20, 2050
AMTR
NYSE Arca
ETRACS Alerian MLP Index ETN Series B due July 18, 2042
AMUB
NYSE Arca
ETRACS Quarterly Pay 1.5x Leveraged MVIS BDC Index ETN due June 10,
2050
BDCX
NYSE Arca
E-TRACS MVIS Business Development Companies Index ETN due
April 26, 2041
BDCZ
NYSE Arca
ETRACS Monthly Pay 1.5x Leveraged Closed-End Fund Index
ETN due June 10, 2050
CEFD
NYSE Arca
E-TRACS Bloomberg Commodity Index Total
Return Series B due October 31, 2039
DJCB
NYSE Arca
ETRACS 2x Leveraged MSCI USA ESG Focus TR ETN due September 15,
2061
ESUS
NYSE Arca
UBS AG FI Enhanced Large Cap Growth ETN due
June 19, 2024
FBGX
NYSE Arca
ETRACS 2x Leveraged IFED Invest with the Fed TR Index ETN due September
15, 2061
FEDL
NYSE Arca
UBS AG FI Enhanced Europe 50 ETN due February 12, 2026
FIEE
NYSE Arca
UBS AG FI Enhanced Global High Yield
ETN due March 3, 2026
FIHD
NYSE Arca
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility
ETN Series B due
October 21, 2049
HDLB
NYSE Arca
ETRACS IFED Invest with the Fed TR Index ETN due September 15,
2061
IFED
NYSE Arca
ETRACS 2x Leveraged US Value
Factor TR ETN due February 9, 2051
IWDL
NYSE Arca
ETRACS 2x Leveraged US Growth Factor TR ETN due February 9, 2051
IWFL
NYSE Arca
ETRACS 2x Leveraged US Size Factor TR ETN due February 9, 2051
IWML
NYSE Arca
E-TRACS Alerian MLP Infrastructure Index Series B due April 2, 2040
MLPB
NYSE Arca
ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN due
June 10, 2050
MLPR
NYSE Arca
ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN due February
9, 2051
MTUL
NYSE Arca
ETRACS Monthly Pay 1.5x Leveraged Mortgage REIT ETN due June 10, 2050
MVRL
NYSE Arca
ETRACS Monthly Pay 2xLeveraged Preferred Stock ETN due September
25, 2048
PFFL
NYSE Arca
ETRACS Linked to the NYSE® Pickens Core Midstream Index due August 20,
2048
PYPE
NYSE Arca
ETRACS 2x Leveraged MSCI US Quality Factor TR ETN due February
9, 2051
QULL
NYSE Arca
ETRACS 2x Leveraged US Dividend Factor TR ETN due February
9, 2051
SCDL
NYSE Arca
ETRACS Monthly Pay 2xLeveraged US Small Cap High Dividend
ETN Series B due
November 10, 2048
SMHB
NYSE Arca
E-TRACS CMCI Total Return
ETN Series B due April 5, 2038
UCIB
NYSE Arca
ETRACS 2x Leveraged MSCI US Minimum Volatility
Factor TR ETN due February 9, 2051
USML
NYSE Arca
Securities registered or to be registered
pursuant to Section 12(g) of the Act:
None
Securities for which there is a reporting obligation
pursuant to Section 15(d) of the Act:
None
4
Cautionary Statement:
Refer to the
Cautionary Statement Regarding Forward
-Looking Statements
section in the Annual
Report 2021 (page 586).
Cross-reference table
Set forth below are the respective items of SEC Form 20-F,
and the locations in this document where the corresponding
information can be found.
●
Annual Report
refers to the Annual Report 2021 of UBS Group AG and UBS AG annexed
hereto, which forms an
integral part hereof.
●
Supplement
refers to certain supplemental information contained in this forepart of
the Form 20-F,
starting on page
10 following the cross-reference table.
●
Financial Statements
refers to the consolidated financial statements of either UBS Group AG or UBS AG, or both,
depending upon the context, contained in the Annual Report.
In the cross-reference table below,
page numbers refer to either the Annual Report or the Supplement, as noted.
Please see page 9 of the Annual Report for definitions of terms used in this Form
20-F relating to UBS.
Form 20-F item
Response or location in this filing
Item 1
.
Identity of Directors,
Senior Management and
Advisors.
Not applicable.
Item 2
.
Offer Statistics and
Expected Timetable.
Not applicable.
Item 3.
Key Information
B – Capitalization and
Indebtedness.
Not applicable.
C – Reasons for the Offer and
Use of Proceeds.
Not applicable.
D – Risk Factors.
Annual Report,
Risk factors
(63-73).
Item 4
.
Information on the Company.
A – History and Development of
the Company
1-3: Annual Report,
Corporate information
and
Contacts
(6). The registrants' agent is
David Kelly, 600 Washington
Boulevard, Stamford, CT
06901.
4: Annual Report,
Our evolution
(14);
Our strategy
(16-19);
Our businesses
(21-32);
Note 30 to each set of Financial Statements (
Changes in organization and acquisitions
and disposals of subsidiaries and businesses
) (396 and 528)
5-6: Refer to our management discussion and analysis for a description of material
acquisitions and divestitures in Annual Report,
Our businesses
(21-32), as applicable,
Note 12 to each set of Financial Statements (
Property,
equipment and software)
(324
and 455) and
Note 30 to each set of Financial Statements (
Changes in organization and
acquisitions and disposals of subsidiaries and businesses
) (396 and 528).
7: Nothing to disclose.
8: Annual Report,
Information sources
(585).
B – Business Overview.
1, 2 and 5: Annual Report,
Our strategy, business model and environment
(16-73), Note
2a to each set of Financial Statements (
Segment reporting)
(308-309 and 439-440)
and
Note 2b to each set of Financial Statements (
Segment reporting by geographic location
)
(310 and 441). See also Supplement (10).
3: Annual Report,
Seasonal characteristics
(82).
4: Not applicable.
6: None.
7: Information as to the basis for these statements normally accompanies the
statements,
except where marked in the report as a statement based upon publicly
available
information or internal estimates, as applicable.
Annual Report,
Our businesses
(21-32),
as applicable.
8: Annual Report,
Regulation and supervision
(56-58)
and
Regulatory and legal
developments
(59-62).
Supplement (11).
5
C – Organizational Structure.
Annual Report,
Our evolution
(14)
and
Note 29 to each set of Financial Statements
(
Interests in subsidiaries and other entities)
(391-395 and 523-527).
D – Property, Plant and
Equipment.
Annual Report,
Property, plant and
equipment
(558 and 570)
,
Note 1, 7) to each set of
Financial Statements (
Summary of material accounting policies: Property,
equipment and
software
) (305 and 436), Note 12 to each set of Financial Statements (
Property,
equipment and software)
(324 and 455).
Information required by SEC
Regulation S-K Part 1400
Annual Report,
Information required
under SEC regulation S-K: Subpart 1400
(559-564
and 571-577),
Loss history statistics
(130), and Note 9 to each set of Financial Statements
(
Financial Statements at amortized cost and other positions in scope of expected
credit
loss measurement)
(317-321 and 448-452).
Item 4A
.
Unresolved Staff
Comments.
None.
Item 5
.
Operating and Financial Review and Prospects.
A – Operating Results.
1: Annual Report,
Our key figures
(8),
UBS AG consolidated key figures
(404)
, Targets,
aspirations and capital guidance
(20),
Our businesses
(21-32),
Group performance
(77-
83), financial and
operating performance by business division and Group Functions (84-
95), Note 2a to each set of Financial Statements (
Segment reporting)
(308-309
and 439-
440), and
Selected financial data
(554-557 and 566-569).
2: Not applicable
3: Annual Report,
Risk factors
(63-73),
Capital management
(151-168),
Currency
Management
(182) and Note 26 to each set of Financial Statements (
Hedge Accounting)
(373-376
and 505-508).
4:
Annual Report,
Our environment
(33-37),
Regulation and supervision
(56-58),
Regulatory and legal developments
(59-62),
Accounting and financial reporting
(76),
Note 1b to each set of Financial Statements (
Changes in accounting policies,
comparability and other adjustments
) (307 and 438).
A discussion on the results for the year 2020 compared with 2019
can be found on UBS
annual report 2020 filed with the SEC in Form 20-F on March 5, 2021, under
Financial
and operating performance
and under
Financial statements
of UBS Group AG and UBS
AG.
B – Liquidity and Capital
Resources.
1: Annual Report,
Risk factors
(63-73)
,
Group performance
(77-83)
,
financial and
operating performance by business division and Group
Functions (84-95),
Seasonal
characteristics
(82),
Interest rate risk in the banking book
(135-138),
Capital,
liquidity
and funding, and balance sheet
(150-185)
, Asset encumbrance
(174),
Note 23 to each set
of Financial Statements (
Restricted and transferred financial assets)
(366-368 and 498-
500)
and Note 29(b) to each set of Financial Statements (
Interests in associates and joint
ventures
) (393 and 525).
2: Annual Report,
Capital,
liquidity and funding, and balance sheet
(150-185),
Currency
Management
(182), Note 10 to each set of Financial Statements (
Derivative instruments)
(322-323
and 453-454), Note 11 to each set of Financial
Statements (
Financial assets
measured at fair value through
other comprehensive income
) (324 and 455), Note 15 to
each set of Financial Statements (
Amounts due to banks and customer deposits,
and
Amounts due to banks, customer deposits,
and funding from UBS Group
AG
,
respectively
)
(327 and 458), Note 16 to each set of Financial Statements (
Debt issued
designated at fair value)
(328 and 459), Note 17 to each set of Financial Statements
(
Debt issued measured at amortized cost
) (329 and 460), and Note 26 to each set of
Financial Statements (
Hedge Accounting
) (373-376 and 505-508).
3:
Annual Report,
Material cash requirements
(180),
Liquidity and funding management
(169-172), Note 24 to each set of Financial Statements (
Maturity analysis of financial
liabilities
) (369 and 501), and Note 12 to each set of Financial Statements (
Property,
equipment and software)
(324 and 455).
Liquidity and capital management is undertaken at UBS as an integrated asset and
liability management function. While we believe our 'working capital' is sufficient
for the
company's present requirements, it is our opinion that, as a bank, our liquidity
coverage
ratio (LCR) is the more relevant measure. For more information see, Annual
Report,
Liquidity coverage ratio
(171).
6
C—Research and Development,
Patents and Licenses, etc.
Not applicable.
D—Trend Information.
Annual Report,
Our businesses
(21-32),
Our environment
(33-37),
Regulatory and legal
developments
(59-62),
Risk factors
(63-73),
Financial and operating performance
(76-
95) and
Top and emerging
risks
(102).
E—Critical Accounting
Estimates
Not applicable.
Item 6.
Directors, Senior Management and Employees.
A – Directors and Senior
Management.
1, 2 and 3: Annual Report,
Board of Directors
(199-215) and
Group Executive Board
(216-222).
4, 5: None.
B – Compensation.
1: Annual Report,
Compensation
(227-272), Note 1a, 4) to each set of Financial
Statements (
Share-based and other deferred
compensation plans
) (303 and 434), Note 28
to each set of Financial Statements (
Employee benefits: variable compensation)
(387-390
and 519-522) and Note 31 to each set of Financial Statements (
Related parties)
(397-398
and 529-531).
2: Annual Report,
Compensation
(227-272), Note 27 to each set of Financial Statements
(
Post-employment benefit plans)
(377-386
and 509-518).
C – Board practices.
1: Annual Report,
Board of Directors
(199-215). The term of office for members of the
Board of Directors and its Chairman expires after completion of the next
Annual General
Meeting. The next Annual General Meeting is scheduled on 6 April 2022.
2: Annual Report,
Compensation
(227-272),
Clauses on change of control
(223), and
Note 31 to each set of Financial Statements (
Related parties
) (397-398 and 529-531).
3: Annual Report,
Audit Committee
(209)
and
Compensation Committee
(210).
Refer to the Supplement (15) for information on UBS AG's Board of Directors' executive
sessions.
D—Employees.
Annual Report,
Employees
(44-46), and
Selected financial data
(554-557 and 566-569).
During 2021, business-aligned operations were moved from Group
Functions into the
respective business divisions, resulting in a shift of personnel from Group
Functions to
the business divisions. Comparative figures have been restated accordingly
for both UBS
Group AG and UBS AG on the tables below.
UBS group AG (consolidated) personnel by business division and Group Functions:
As of
Full-time equivalents
31.12.21
31.12.20
31.12.19
Personnel (full-time equivalents)
71,385
71,551
68,601
Global Wealth Management
24,093
24,200
25,067
Personal & Corporate Banking
5,791
6,021
6,022
Asset Management
2,693
2,642
2,582
Investment Bank
7,665
7,552
7,423
Group Functions
31,144
31,136
27,507
UBS AG (consolidated) personnel by business division and Group Functions:
As of
Full-time equivalents
31.12.21
31.12.20
31.12.19
Personnel (full-time equivalents)
47,067
47,546
47,005
Global Wealth Management
22,986
23,039
23,982
Personal & Corporate Banking
4,993
5,131
5,156
Asset Management
2,375
2,351
2,314
Investment Bank
5,854
5,713
5,672
Group Functions
10,859
11,312
9,880
E—Share Ownership.
1 and 2: Annual Report,
Compensation
(227-272), Note 28 to each set of Financial
Statements (
Employee benefits: variable compensation
) (387-390 and 519-522) and Note
31b to each set of Financial Statements (
Equity holdings of key management personnel
)
(397
and 529).
7
Item 7.
Major Shareholders and Related Party Transactions.
A—Major Shareholders.
Annual Report,
Group structure and shareholders
(191),
Share capital structure
(192-
196)
and
Voting
rights, restrictions and representation
(197).
The number of shares of UBS Group AG held by the respective shareholders listed on
page 191 of the Annual Report registered in the UBS share register with 3% or more
of
total share capital as of 31 December 2021 is as follows:
Shareholder
Number of shares held
Chase Nominees Ltd., London
329,276,739
DTC (Cede & Co.), New York
214,183,469
Nortrust Nominees Ltd., London
177,762,902
According to the mandatory FMIA disclosure notifications filed with UBS Group
AG and
SIX, the following entities disclosed holding of more than 3% of the total share
capital of
UBS Group AG, with the following number of shares:
Shareholder
Number of shares held
Norges Bank, Oslo on 24 July 2019
115,997,262
BlackRock Inc., New York
on 26 May 2020
181,261,629
Artisan Partners Limited Partnership,
Milwaukee on 18 November 2020
121,591,630
Massachusetts Financial Services Company,
on
22 June 2021
116,145,996
Dodge & Cox International Stock Fund, on 24
January 2022
111,816,261
The number of shares of UBS AG held by UBS Group AG as of 31 December 2021 was
3,858,408,466 shares.
B—Related Party Transactions.
Annual Report,
Loans granted to GEB members
(270)
, Loans granted to BoD members
(270)
and
Note 31 to each set of Financial Statements (
Related parties
)
(397-398 and
529-531).
C—Interests of Experts and
Counsel.
Not applicable.
Item 8
.
Financial Information.
A—Consolidated Statements
and Other Financial
Information.
1, 2, 3, 4, 6: Please see Item 18 of this Form 20-F.
5: Not applicable.
7: Information on material legal and regulatory proceedings is in Note 18 to
each set of
Financial Statements (
Provisions and contingent liabilities
) (330-335
and 461-466).
For developments during the year, please see also the
note
Provisions and contingent
liabilities
in the Consolidated Financial Statements section in our respective
quarterly
reports for the First, Second and Third Quarters 2021, filed on Forms 6-K
dated April 27,
2021 (UBS Group AG) and April 30, 2021 (UBS AG), July 20, 2021 (UBS Group
AG)
and July 23, 2021 (UBS AG) and October 26, 2021 (UBS Group AG) and October
29,
2021 (UBS AG), respectively; as well as the
Provisions and contingent liabilities
section
in the Fourth Quarter 2021 Report, filed on Form 6-K dated February
1, 2022. The
disclosures in each such Quarterly Report speak only as of their respective
dates.
8: Annual Report,
Letter to Shareholders
(
2-4
)
, Our strategy
(16-19),
Investors
(43),
Dividend distribution
(182)
, Distributions to shareholders
(195).
B—Significant Changes.
Annual Report, Note 34 to each set of Financial Statements (
Events after the reporting
period
)
(400 and 533).
Item 9
.
The Offer and Listing.
A – Offer and Listing Details.
1, 2, 3, 5, 6, 7: Not applicable.
4: Annual Report,
Listing of UBS Group AG shares
(185).
B—Plan of Distribution.
Not applicable.
C—Markets.
Cover page (3).
Annual Report,
Listing of UBS Group AG shares
(185),
Shares and participation
certificates
(194-195).
D—Selling Shareholders.
Not applicable.
E—Dilution.
Not applicable.
F—Expenses of the Issue.
Not applicable.
8
Item 10
.
Additional Information.
A—Share Capital.
Not applicable.
B—Memorandum and Articles
of Association.
1: Supplement (15).
2: Annual Report,
Compensation governance
(236-237),
Compensation for the
Board of
Directors
(258-260).
Supplement (14-15).
3: Annual Report,
Share
capital structure
(192-196),
Shareholders' participation rights
(197-198),
Elections and terms of office
(207). Supplement (12-15).
4: Supplement (13).
5: Annual Report,
Shareholders' participation rights
(197-198). Supplement (13).
6: Annual Report,
Transferability,
voting rights and nominee registration
(196),
Shareholders' participation rights
(197-198). Supplement (12).
7: Annual Report,
Change of control and defense measures
(223).
8: Annual Report,
Significant Shareholders
(191).
9: Supplement (12-16).
10:
Supplement (12-16).
C—Material Contracts.
The Terms & Conditions
of the several series of capital instruments issued to date, and to
be issued pursuant to Deferred Capital Contingent Plans, are exhibits 4.1
through 4.21 to
this Form 20-F.
These notes are described under
Swiss SRB total loss-absorbing capacity
framework
on page 152-153 of the Annual Report and
Our deferred compensation plans
on page 252 of the Annual Report.
The Asset Transfer Agreement by which
certain assets and liabilities of UBS AG were
transferred to UBS Switzerland AG is filed as Exhibit 4.22, and is described
under
Joint
liability of UBS Switzerland AG
on page 536 of the Annual Report.
D—Exchange Controls.
Other than in relation to economic sanctions, there are no restrictions under
the Articles
of Association of UBS Group AG or UBS AG, nor under Swiss law,
as presently in force,
that limit the right of non-resident or foreign owners to hold UBS’s
securities freely.
There are currently no Swiss foreign exchange controls or other Swiss laws restricting
the
import or export of capital by UBS or its subsidiaries, nor restrictions affecting
the
remittance of dividends, interest or other payments to non-resident holders
of UBS
securities. The Swiss federal government may impose sanctions on particular
countries,
regimes, organizations or persons which may create restrictions
on exchange of control.
A current list, in German, French and Italian, of such sanctions can be found at
www.seco-admin.ch
. UBS may also be subject to sanctions regulations from other
jurisdictions where it operates imposing further restrictions.
E—Taxation.
Supplement (16-18).
F—Dividends and Paying
Agents.
Not applicable.
G—Statement by Experts.
Not applicable.
H—Documents on Display.
UBS files periodic reports and other information with the Securities and Exchange
Commission. You
may read and copy any document that we file with the SEC on the
SEC’s website,
www.sec.gov
. Much of this information may also be found on the UBS
website at
www.ubs.com/investors
.
I—Subsidiary Information.
Not applicable.
Item 11
.
Quantitative and Qualitative Disclosures About Market Risk.
(a) Quantitative Information
About Market Risk.
Annual Report,
Market risk
(131-139).
(b) Qualitative Information
About Market Risk.
Annual Report,
Market risk
(131-139).
(c) Interim Periods.
Not applicable.
Item 12.
Description of Securities Other than Equity Securities.
A – Debt Securities
Not applicable.
B – Warrants and
Rights
Not applicable.
C – Other Securities
Not applicable.
D – American Depositary Shares
Not applicable.
9
Item 13
.
Defaults, Dividend
Arrearages and Delinquencies.
There has been no material default in respect of any indebtedness of UBS or any of
its
significant subsidiaries or any arrearages of dividends or any other
material delinquency
not cured within 30 days relating to any preferred stock of UBS Group AG or any of its
significant subsidiaries.
Item 14.
Material Modifications
to the Rights of Security Holders
and Use of Proceeds.
None.
Item 15.
Controls and Procedures.
(a)
Disclosure Controls and
Procedures
Annual Report,
US disclosure requirements
(226), and
Exhibit 12 to this Form 20-F.
(b) Management’s Annual
Report on Internal Control over
Financial Reporting
Annual Report,
Management’s
report on internal control
over financial reporting
(276
and 406).
(c) Attestation Report of the
Registered Public Accounting
Firm
Annual Report,
Report of Independent Registered Public Accounting
Firm
(277
and 407).
(d) Changes in Internal Control
over Financial Reporting
None.
Item 16A.
Audit Committee
Financial Expert.
Annual Report,
Audit Committee
(209) and
Differences from corporate
governance
standards relevant
to US-listed companies
(190).
All Audit Committee members have accounting or related financial management
expertise and, in compliance with the rules established pursuant to the US Sarbanes-
Oxley Act of 2002, at least one member, the Chairperson
Jeremy Anderson, qualifies as a
financial expert.
Item 16B.
Code of Ethics.
Annual Report,
Code of Conduct and Ethics
(48) UBS's Code of Conduct and Ethics
("the Code") is published on our website under
https://www.ubs.com/code
.The UBS
Code of Business Conduct does not include a waiver option, and no waiver
from any
provision of the Code was granted to any employee in 2021.
Item 16C.
Principal Accountant
Fees and Services.
Annual Report,
Auditors
(224-225).
None of the non-audit services so disclosed were approved by the Audit Committee
pursuant to paragraph (c) (7)(i)(C) of Rule 2-01 of Regulation S-X.
Item 16D.
Exemptions from the
Listing Standards for Audit
Committees.
Not applicable.
Item 16E.
Purchases of Equity
Securities by the Issuer and
Affiliated Purchasers.
Annual Report,
Holding of UBS Group AG shares
(184).
UBS Group AG completed on 2 February 2021 its three-year share repurchase
program
launched in March 2018. As announced on 26 January 2021, UBS Group AG launched
in
February 2021 a new three-year share repurchase program of up to CHF 4 billion
until
the 2024 AGM. Further, UBS announced on
February 1, 2022 its intention to commence
a new 2022 repurchase program of up to USD 6 billion over two years,
and expects to
execute up to USD 5 billion of share repurchases under both the existing 2021
and the
new 2022 share buyback program by the end of 2022.
Item 16F.
Changes in
Registrant’s Certifying
Accountant.
Not applicable.
Item 16G.
Corporate
Governance.
Annual Report,
Differences from corporate
governance standards relevant
to US-listed
companies
(190).
Item 16H.
Mine Safety
Disclosure.
Not applicable.
Item 16I.
Disclosure Regarding
Foreign Jurisdictions that
Prevent Inspections
Not applicable.
Item 17.
Financial Statements.
Not applicable.
Item 18.
Financial Statements.
Annual Report,
Financial statements
(273-546),
Significant regulated subsidiary and
sub-group information
(547-549) and
Additional regulatory information
(551-576).
Item 19.
Exhibits
Supplement (19-20).
10
Supplemental information
Item 4. Information on the Company
B – Business Overview
Item 4.B.2.
Geographic breakdown of revenues
The operating regions
shown in the
table below correspond
to the regional
management structure of
the Group. The
allocation
of
operating
income
to
these
regions
reflects,
and
is
consistent
with,
the
basis
on
which
the
business
is
managed
and
its
performance is
evaluated. These
allocations involve
assumptions and
judgments that
management considers
to be
reasonable,
and may be refined to reflect changes in estimates or management structure.
The main principles of the
allocation methodology are that client revenues are
attributed to the domicile of the
client, and trading
and portfolio management revenues are
attributed to the country
where the risk is
managed. This revenue attribution is
consistent
with the
mandate of
the regional
Presidents. Certain
revenues, such
as those
related to
Non-core and
Legacy Portfolio
within
Group Functions, are managed at a Group level. These revenues are included
in the
Global
column.
USD billion
Business Division
FY
Americas
Asia Pacific
EMEA
Switzerland
Global
Total
Global Wealth
Management
2021
10.7
2.9
4.0
1.9
0.0
19.4
2020
9.0
2.7
3.6
1.7
0.0
17.0
2019
9.1
2.2
3.4
1.6
0.1
16.4
Personal &
Corporate Banking
2021
0.0
0.0
0.0
4.3
0.0
4.3
2020
0.0
0.0
0.0
3.7
0.0
3.7
2019
0.0
0.0
0.0
3.7
0.0
3.7
Asset Management
2021
0.6
0.5
0.5
0.8
0.0
2.6
2020
0.7
0.5
0.5
0.7
0.6
3.0
2019
0.5
0.4
0.4
0.6
(0.0)
1.9
Investment Bank
2021
3.2
3.0
2.5
0.8
(0.0)
9.5
2020
3.3
2.7
2.4
0.8
0.0
9.2
2019
2.5
2.1
2.0
0.7
(0.0)
7.3
Group Functions
2021
0.0
0.0
0.0
0.0
(0.4)
(0.4)
2020
0.0
0.0
0.0
0.0
(0.5)
(0.5)
2019
0.0
0.0
0.0
0.0
(0.4)
(0.4)
Group
2021
14.5
6.5
7.0
7.9
(0.3)
35.5
2020
13.0
6.0
6.5
6.9
0.1
32.4
2019
12.0
4.7
5.8
6.7
(0.3)
28.9
11
Disclosure Pursuant To
Section 219 of the Iran Threat Reduction And Syrian
Human Rights Act
Section 219 of the US Iran Threat Reduction and Syria Human Rights Act of
2012 (“ITRA”) added Section 13(r) to the US
Securities Exchange Act of 1934, as amended (the “Exchange Act”) requiring
each SEC reporting issuer to disclose in its
annual and, if applicable, quarterly reports whether it or any of its affiliates
have knowingly engaged in certain activities,
transactions or dealings relating to Iran or with the Government of Iran
or certain designated natural persons or entities
involved in terrorism or the proliferation of weapons of mass destruction during
the period covered by the report. The required
disclosure may include reporting of activities not prohibited by US or other
law, even if conducted outside
the US by non-US
affiliates in compliance with local law.
Pursuant to Section 13(r) of the Exchange Act, we note the following for
the period
covered by this annual report:
UBS has a Group Sanctions Policy that prohibits transactions involving
sanctioned countries, including Iran, and sanctioned
individuals and entities. However, UBS maintains
one account involving the Iranian government under the auspices of the
United Nations in Geneva after agreeing with the Swiss government that
it would do so only under certain conditions. These
conditions include that payments involving the account must: (1) be made within
Switzerland; (2) be consistent with paying
rent, salaries, telephone and other expenses necessary for its operations
in Geneva; and (3) not involve any Specially
Designated Nationals (SDNs) blocked or otherwise restricted under US or
Swiss law. In 2021, the gross revenues
for this UN-
related account were approximately USD 19,034.19. We
do not allocate expenses to specific client accounts in a way that
enables us to calculate net profits with respect to any individual account. UBS AG intends to
continue maintaining this account
pursuant to the conditions it has established with the Swiss Government and
consistent with its Group
Sanctions Policy.
As previously reported, UBS had certain outstanding legacy trade finance arrangements
issued on behalf of Swiss client
exporters in favor of their Iranian counterparties. In February 2012 UBS ceased accepting
payments on these outstanding
export trade finance arrangements and worked with the Swiss government
who insured these contracts (Swiss Export Risk
Insurance "SERV").
On December 21, 2012, UBS and the SERV
entered into certain Transfer and Assignment
Agreements
under which SERV
purchased all of UBS's remaining receivables under or in connection with Iran
-related export finance
transactions. Hence, the SERV
is the sole beneficiary of said receivables. There was no financial activity
involving Iran in
connection with these trade finance arrangements in 2021, and no gross revenue
or net profit.
In connection with these trade finance arrangements, UBS has maintained one
existing account relationship with an Iranian
bank.
This account was established prior to the US designation of this bank and maintained due
to the existing trade finance
arrangements.
In 2007, following the designation of the bank pursuant to sanctions issued by the US, UN and
Switzerland, the
account was blocked under Swiss law and remained subject to blocking
requirements until January 2016. Client assets as of 31
December 2021 were CHF 3,097.40. There have been no transactions involving
this account. The gross revenues to report for
2021 are CHF 2.35.
From August to December 2021, UBS processed six payments in connection
with Iran under an international program
designed to provide equitable access to COVID-19 vaccines, and UBS anticipates
that such activity may continue, There were
no revenues or profits associated with these transactions. In addition,
two payments were received by UBS under the same
international program in January and June 2021.
12
Item 10.
Additional Information.
B—Memorandum and Articles of Association.
Please see the Articles of Association of UBS Group AG and of UBS AG (Exhibits
1.1 and 1.2, respectively,
to this Form 20-
F) and the Organization Regulations of UBS Group AG and UBS AG (Exhibit
1.3 and 1.4, respectively,
to this Form 20-F).
Set forth below is a summary of the material provisions of the Articles of Association
of UBS Group AG (which we call the
“Articles” throughout this document), Organization
Regulations of UBS Group AG (which we call the “Organization
Regulations” throughout this document) and relevant Swiss laws, in particular
the Swiss Code of Obligations, relating to our
shares. This description does not purport to be complete and is qualified
in its entirety by references to Swiss law,
including
Swiss company law,
and to the Articles and Organization Regulations.
The Articles of Association and Organization Regulations of UBS AG are substantially
similar to the Articles and
Organization Regulations of UBS Group AG, so the following
description applies equally to UBS AG, except where indicated
that it refers to only one of the companies.
The principal legislation under which UBS Group AG and UBS AG operate, and under
which the ordinary shares of UBS
Group AG are issued, is the Swiss Code of Obligations.
The shares are registered shares with a par value of CHF 0.10 per share. The shares are fully
paid up, and there is no liability of
shareholders to further capital calls by the company.
The shares rank
pari passu
in all respects with each other, including
voting rights, entitlement to dividends, liquidation proceeds in case of
the liquidation of the company,
subscription or
preemptive rights in the event of a share issue (
Bezugsrechte
) and preemptive rights in the event of the issuance of equity-
linked securities (
Vorwegzeichnungsrechte
).
Each share carries one vote at our shareholders’ meetings. Voting
rights may be exercised only after a shareholder has been
recorded in our share register as a shareholder with voting rights. Registration with
voting rights is subject to certain
restrictions. See “Share Register and Transfer
of Shares” below.
The Articles provide that we may elect not to print and deliver certificates in respect
of registered shares. Shareholders may,
however, following registration in the
share register, request at any time that we issue a written statement
in respect of their
shares; however, the shareholder has no entitlement
to the printing and delivery of share certificates
Shares and Shareholders
Share Register and Transfer of Shares
UBS Group AG’s share register is kept
by UBS Shareholder Services, P.O.
Box, CH-8098 Zurich, Switzerland. Shareholder
Services is responsible for the registration of the global shares. It is split into two parts
– a Swiss register, which is maintained
by UBS Group, acting as Swiss share registrar,
and a US register, which is maintained by Computershare
Trust Company NA,
c/o Computershare Investor Services, P.O.
Box 505000, Louisville, KY 40233-5000, United States (US), as US transfer
agent.
Swiss law and the Articles of Association of UBS Group AG and UBS AG require
UBS to keep a share register in which the
names, addresses and nationality (for legal persons, the registered office)
of the owners (and beneficial owners) of registered
shares are recorded. The main function of the share register is to record
shareholders entitled to vote and participate in general
meetings, or to assert or exercise other rights related to voting rights.
The transfer of shares which exist in the form of intermediary-held
securities is effected by entries in securities accounts in
accordance with applicable law.
The transfer of uncertificated securities is effected by way of
a written declaration of
assignment and requires notice to the issuer.
In order to register shares in the share register,
a purchaser must file a share registration form with the share register.
Failing
such registration, the purchaser may not vote at or participate in shareholders’
meetings, but will be entitled to dividends, pre-
emptive and priority subscription rights, and liquidation proceeds.
Swiss law distinguishes between registration with and without voting rights.
Shareholders must be registered in the share
register as shareholders with voting rights in order to vote and participate
in general meetings or to assert or exercise other
rights related to voting rights. A purchaser of shares will be recorded
in our share register with voting rights upon disclosure of
its name and nationality (and for legal persons, the registered office).
However, we may decline a registration with voting
rights if the shareholder does not declare that it has acquired the shares in its own name and
for its own account. If the
shareholder refuses to make such declaration, it will be registered as a shareholder
without voting rights.
There is no limitation under Swiss law or our Articles on the right of non-Swiss residents
or nationals to own or vote our
shares.
13
General Meeting
Under Swiss law, annual
ordinary shareholders’ meetings must be held within six months after the
end of our financial year,
which is 31 December. Shareholders’
meetings may be convened by the Board of Directors (BoD) or,
if necessary, by the
statutory auditors, with twenty-days’ advance notice. The BoD is further required
to convene an extraordinary shareholders’
meeting if so resolved by a shareholders’ meeting or if so requested by shareholders
holding in aggregate at least 10% of our
nominal share capital. Shareholders representing shares with an aggregate
par value of at least CHF 62,500 have the right to
request that a specific proposal be put on the agenda and voted upon at the next
shareholders’ meeting. A shareholders’
meeting is convened by publishing a notice in the Swiss Official Commercial
Gazette (
Schweizerisches Handelsamtsblatt
) at
least 20 days prior to such meeting. An invitation will be sent to all registered shareholders.
The Articles do not require a minimum number of shareholders to be present in
order to hold a shareholders’ meeting.
Unless otherwise provided by law or the Articles (as indicated in this section),
resolutions require the approval of an “absolute
majority” of the votes cast, excluding blank and invalid ballots, at a shareholders’
meeting. Shareholders’ resolutions requiring
a vote by absolute majority include:
●
Amendments to the Articles (except for the changes requiring a higher quorum
as indicated below);
●
Elections of directors, Chairman of the BoD, members of the compensation
committee and statutory auditors;
●
Election of the independent proxy;
●
Approval of the management report and the consolidated financial statements;
●
Approval of the annual financial statements and the resolution on
the use of the balance sheet profit (declaration of
dividend);
●
Approval of the compensation for the BoD and the Group Executive Board (GEB)
of UBS Group AG, including the
approval of the maximum aggregate amount of compensation of the members of
the BoD for the period until the next
Annual General Meeting (AGM), the maximum aggregate amount of
fixed compensation of the GEB members for the
following financial year and the aggregate amount of variable compensation
of the GEB members for the preceding
financial year, with the exception of
a supplementary amount of up to 40% of the average of total annual
compensation paid or granted to the GEB during the previous three years for persons
joining or promoted within the
GEB;
●
Decisions to discharge directors and management from
liability for matters disclosed to the shareholders’ meeting;
and
●
Passing resolutions on matters which are by law or by the Articles reserved to the
shareholders’ meeting (e.g., the
ordering of an independent investigation into the specific matters proposed
to the shareholders’ meeting).
Under Swiss corporate law,
a resolution passed by at least two thirds of votes represented and an absolute majority of
the par
value of the shares represented is required in order to approve:
●
A change in our stated purpose in the Articles;
●
The creation of shares with preferential voting rights;
●
A restriction on transferability or registration of shares;
●
An increase in authorized or contingent capital or the creation of reserve capital
in accordance with Swiss banking
law;
●
An increase in share capital funded by equity capital, against contribution
in kind or to fund acquisitions in kind and
the granting of special privileges;
●
Changes to pre-emptive rights;
●
A change of domicile of the corporation; or
●
Dissolution of the corporation.
Under the Articles, a resolution passed at a shareholders’ meeting with a supermajority
of at least two thirds of the votes
represented at such meeting is required to:
●
Change the limits on BoD size in the Articles;
●
Remove one-fourth or more of the members of the BoD; or
●
Delete or modify these supermajority requirements.
At shareholders’ meetings, a shareholder can be represented by his or her
legal representative or under a written power of
attorney by another shareholder eligible to vote or,
under a written or electronic power of attorney,
by the independent proxy.
Votes
are taken electronically, by
written ballot or by a show of hands. Shareholders representing at least 3% of the votes
represented may always request that a vote or election take place electronically
or by
a written ballot.
UBS AG follows the abovementioned statutory quorum rules in lieu of the quorum
requirement of Rule 14.10(f)(3) of Cboe
BZX Exchange, Inc.
14
Net Profits and Dividends
Swiss law requires that at least 5% of the annual net profits of a corporation
must be retained as general reserves until these
equal 20% of the corporation’s paid
-up share capital. Any net profits remaining are at the disposal of the shareholders’
meeting, except that, if an annual dividend exceeds 5% of the nominal
share capital, then 10% of such excess must be retained
as general reserves, unless such corporation qualifies as a holding company.
Under Swiss law, dividends
may be paid out only if the corporation has sufficient distributable profits from
previous business
years or if the reserves of the corporation are sufficient to allow distribution
of a dividend. In either event, dividends may be
paid out only after approval by the shareholders’ meeting. The BoD may propose
to the shareholders that a dividend be paid
out. The auditors must confirm that the dividend proposal of the BoD conforms
with statutory law.
Dividends are usually due and payable after the shareholders’ resolution relating
to the allocation of profits has been passed.
Under Swiss law, the statute of
limitations in respect of dividend payments is five years.
Preemptive Rights
Under Swiss law, any share
issue, whether for cash or non-cash consideration or for no consideration,
is subject to the prior
approval of the shareholders’ meeting. Shareholders of a Swiss corporation
have certain preemptive rights to subscribe for new
issues of shares in proportion to the nominal amount of shares held. The Articles or
a resolution adopted at a shareholders’
meeting with a supermajority of at least two-thirds of the votes represented
and an absolute majority of the nominal value of
the shares represented at the meeting may,
however, limit or suspend preemptive rights in certain
limited circumstances.
Notices
Notices to shareholders are made by publication in the Swiss Official
Gazette of Commerce. The BoD may designate further
means of communication for publishing notices to shareholders.
Mandatory Tender
Offer
Under the applicable provisions of the Swiss Financial Market Infrastructure
Act, anyone who directly or indirectly or acting in
concert with third parties acquires more than 33 1/3% of the voting rights of
a Swiss-listed company will have to submit a
takeover bid to all remaining shareholders. A waiver from the mandatory
bid rule may be granted by our supervisory authority.
If no waiver is granted, the mandatory takeover bid must be made pursuant
to the procedural rules set forth in the Swiss
Financial Market Infrastructure Act and implementing ordinances.
Board of Directors
Borrowing Power
Neither Swiss law nor the Articles restrict in any way our power to borrow and raise funds, provided
that any such borrowing
is entered into on arms’ length terms.
Swiss law requires that the Articles determine the amount of loans that UBS Group
AG, as a listed company, may grant
to
members of its BoD. The Articles restrict UBS Group AG's ability to grant
loans to BoD members as follows: First, loans to
the independent members of the BoD shall be made in accordance with the
customary business and market conditions. Second,
loans to the non-independent members of the BoD shall be made in the ordinary
course of business on substantially the same
terms as those granted to UBS employees. Third, the total amount of such
loans shall not exceed CHF 20 million per member.
Conflicts of Interests
Swiss law does not have a general provision on conflicts of interests. However,
the Swiss Code of Obligations requires
directors and members of senior management to safeguard the interests of the corporation
and, as such, imposes a duty of care
and a duty of loyalty on directors and officers. This rule is generally
understood as disqualifying directors and senior officers
from participating in decisions that directly affect them.
Directors and officers are personally liable to the corporation for any
breach of these provisions. In addition, Swiss law contains a provision under
which payments made to a shareholder or a
director or any person associated therewith, other than at arm’s
length, must be repaid to us if the shareholder or director was
acting
in bad faith.
In addition, our Organization Regulations provide that,
subject to exceptional circumstances in which the best interests of UBS
dictate that the member of the BoD or senior management with a conflict of interest
shall not participate in the discussions and
decision-making involving the interest at stake, the member of the BoD or senior
management with a conflict of interest shall
participate in discussions and a double vote (meaning a vote with and a vote
without the conflicted individual) shall take place.
A binding decision on the matter requires the same outcome in both votes.
15
Retirement of Board members
There is no age-limit requirement for retirement of the members of the BoD. The term
of office for each Board member is one
year, and no Board member may serve for
more than 10 consecutive terms of office. In exceptional circumstances
the Board
can extend this limit.
Executive sessions
UBS AG's Organization Regulations require one-third of the members
of the Board of Directors of UBS AG to be
independent. While neither Swiss law applicable to UBS AG nor the Organization
Regulations require regularly scheduled
meetings of UBS AG's independent directors, the Organization
Regulations of UBS Group AG require independent members
of the Board of Directors of UBS Group AG to meet, without the participation
of the Chairman, at least twice a year.
All
members of UBS Group AG’s Board
of Directors are also members of UBS AG’s Board
of Directors and all meetings of UBS
Group AG’s Board of Directors are
held as combined meetings with the UBS AG's Board of Directors. As a result,
the practice
currently in place at UBS AG is that the independent members regularly meet in sessions of
independent members only.
In
addition to these joint meetings, standalone meetings of UBS AG’s
Board of Directors are held regularly
to discuss and agree
on finance, risk, compliance, operational risk, regulatory and other
topics related to UBS AG.
The Company
Repurchase of Shares
Swiss law limits a corporation’s ability
to hold or repurchase its own shares. We
and our Swiss subsidiaries may only
repurchase shares if we have sufficient free reserves to pay the purchase
price and if the aggregate nominal value of the shares
does not exceed 10% of our nominal share capital. Repurchases for cancellation
purposes approved by the shareholders’
meeting are exempted from the 10% threshold. Furthermore, such own
shares must be disclosed as negative items in our
shareholders’ equity.
Such shares held by us or our Swiss subsidiaries do not carry any rights to vote at shareholders’ meetings.
Sinking fund provisions
There are no provisions in the Swiss law or in the Articles requiring the company
to put resources aside for the exclusive
purpose of redeeming bonds or repurchasing shares.
Registration and Business Purpose
UBS Group AG was incorporated and registered as a corporation limited
by shares (
Aktiengesellschaft
) under the laws of
Switzerland. UBS Group AG was entered into the commercial register of
Canton Zurich on 10 June 2014 under the registration
number CHE-395.345.924 and has its registered domicile in Zurich,
Switzerland. The business purpose of UBS Group AG, as
set forth in article 2 of its Articles, is the acquisition, holding, management
and sale of direct and indirect participations in
enterprises of any kind, in particular in the area of banking, financial, advisory,
trading and service activities in Switzerland
and abroad. UBS Group may establish enterprises of any kind in
Switzerland and abroad, hold equity interests in these
companies, and conduct their management. UBS Group is authorized
to acquire, mortgage and sell real estate and building
rights in Switzerland and abroad. UBS Group may provide loans, guarantees and other
types of financing and security for
group companies and borrow and invest capital on the money and capital markets.
UBS AG was incorporated and registered as a corporation limited by shares (
Aktiengesellschaft
) under the laws of Switzerland.
It is entered into the commercial registers of Canton Zurich and Canton
Basel-City under the registration number CHE-
101.329.561 and has registered domiciles in Zurich and Basel, Switzerland.
The business purpose of UBS AG, as set forth in
article 2 of its Articles of Association, is the operation of a bank, with a scope of operations extending
to all types of banking,
financial, advisory,
trading and service activities in Switzerland and abroad. UBS AG is a wholly owned subsidiary of
UBS
Group AG.
Duration and Liquidation
UBS Group AG and UBS AG have unlimited duration.
Under Swiss law, we may be dissolved
at any time by a shareholders’ resolution which must be passed by a supermajority
of at
least two-thirds of the votes represented and an absolute majority of the nominal value
of the shares represented at the meeting.
Dissolution by law or court order is possible, for example, if we become bankrupt.
Under Swiss law, any surplus arising
out of a liquidation (after the settlement of all claims of all creditors) is distributed
to
shareholders in proportion to the paid-up nominal value of shares held.
16
Other
Ernst & Young Ltd
, Aeschengraben 9, CH-4051
Basel, Switzerland
, PCAOB number
1460
, have been appointed as statutory
auditors and as auditors of the consolidated accounts of both UBS Group AG
and UBS AG. The auditors are subject to election
by the shareholders at the ordinary general meeting on an annual basis.
E—Taxation.
This section outlines the material Swiss tax and US federal income tax consequences
of the ownership of UBS Group AG's
ordinary shares (defined as "UBS ordinary shares " in this section) by a US holder (as defined
below) who holds UBS ordinary
shares as capital assets. This discussion addresses only US federal income
taxation and Swiss income and capital taxation and
does not discuss all of the tax consequences that may be relevant to holders
in light of their individual circumstances, including
other foreign tax consequences, state or local tax consequences, estate and gift
tax consequences, and tax consequences arising
under the Medicare contribution tax on net investment income or the
alternative minimum tax.
It is designed to explain the
major interactions between Swiss and US taxation for US persons who
hold UBS ordinary shares.
The discussion does not address the tax consequences to persons who hold
UBS ordinary shares in particular circumstances,
such as tax-exempt entities, banks, financial institutions, life insurance
companies, broker-dealers, traders in securities that
elect to use a mark-to-market method of accounting for securities holdings,
holders that actually or constructively own 10% or
more of the total combined voting power of the voting stock of UBS Group
AG or of the total value of stock of UBS Group
AG, holders that hold UBS ordinary shares as part of a straddle or a hedging or conversion
transaction, holders that purchase or
sell UBS ordinary shares as part of a wash sale for tax purposes or holders whose
functional currency for US tax purposes is
not the US dollar. This discussion also
does not apply to holders who acquired their UBS ordinary shares through a tax-
qualified retirement plan, nor generally to unvested UBS ordinary shares
held under deferred compensation arrangements.
If a partnership (or other entity treated as a partnership) holds UBS ordinary shares,
the US federal income tax treatment of a
partner will generally depend on the status of the partner and the tax treatment
of the partnership. A partner in a partnership
holding the UBS ordinary shares should consult its tax advisor with regard to
the US federal income tax treatment of an
investment in the ordinary shares.
The discussion is based on the tax laws of Switzerland and the United States,
including the US Internal Revenue Code of 1986,
as amended, its legislative history,
existing and proposed regulations under the Internal Revenue Code, published rulings
and
court decisions, as in effect on the date of this document, as well as the Convention
between the United States of America and
the Swiss Confederation for the Avoidance
of Double Taxation with
Respect to Taxes on Income,
which we call the “Treaty,”
all of which may be subject to change or change in interpretation, possibly with
retroactive effect.
For purposes of this discussion, a “US holder” is any beneficial owner of UBS ordinary
shares that is for US federal income
tax purposes:
●
A citizen or resident of the United States;
●
A domestic corporation or other entity taxable as a corporation;
●
An estate, the income of which is subject to US federal income tax without regard to its source;
or
●
A trust, if a court within the United States is able to exercise primary supervision over
the administration of the trust
and one or more US persons have the authority to control all substantial decisions of
the trust.
Holders of UBS ordinary shares are urged to consult their tax advisors
regarding the US federal, state and local and the Swiss
and other tax consequences of owning and disposing of
these shares in their particular circumstances.
(a) Ownership of UBS Ordinary Shares - Swiss Taxation
Dividends and Distributions
Dividends paid by UBS Group AG to a holder of UBS ordinary shares (including dividends on
liquidation proceeds and stock
dividends) are in principle subject to a Swiss federal withholding tax
at a rate of 35%.
Under the Capital Contribution Principle, the repayment of capital
contributions, including share premiums made by the
shareholders after December 31, 1996 is in principle no longer subject to Swiss withholding
tax if certain requirements
regarding the booking of these capital contributions are met.
Swiss companies listed on a Swiss stock exchange such as UBS Group AG can repay
reserves from capital contributions to
their shareholders without deduction of Swiss withholding tax only
if they distribute at least the same amount of taxable
dividends. For this reason UBS Group AG pays half of the dividend
from capital contribution reserves and half of the dividend
from taxable dividends which is subject to 35% Swiss withholding
tax.
17
A US holder resident in the US that qualifies for Treaty
benefits may apply for a refund of the withholding tax withheld in
excess of the 15% Treaty rate (or for a full refund
in case of qualifying retirement arrangements). The claim for refund must be
filed with the Swiss Federal Tax
Administration, Eigerstrasse 65, CH-3003 Berne, Switzerland no later than
December 31 of
the third year following the end of the calendar year in which the income subject to withholding
was due. The form used for
obtaining a refund is one of the Swiss Tax Forms
82 (82 C for US companies; 82 E for other US entities; 82 I for individuals;
82 R for regulated investment companies), which may be obtained
from the Swiss Federal Tax
Administration at the address
above or downloaded from the web page of the Swiss Federal tax Administration.
The form must be filled out in triplicate with
each copy duly completed and signed before a notary public in the United
States. The form must be accompanied by evidence
of the deduction of withholding tax withheld at the source.
A US holder resident outside the US may be eligible for a withholding
tax reclaim. If the US holder is resident in Switzerland,
a full reclaim based on the Swiss withholding tax Act is possible provided all necessary
conditions are met. A US holder
resident neither in the US nor in Switzerland may be eligible for a partial reclaim provided
that a Treaty between Switzerland
and the country of residence is applicable and that all necessary conditions
are met.
Transfers of UBS Ordinary
Shares
The purchase or sale of UBS ordinary shares, whether by Swiss resident or non
-resident holders (including US holders), may
be subject to a Swiss securities transfer stamp duty of up to 0.15%
calculated on the purchase price or sale proceeds if it occurs
through or with a bank or other securities dealer as defined in the Swiss Federal Stamp
Tax Act in Switzerland
or the
Principality of Liechtenstein. In addition to the stamp duty,
the sale of UBS ordinary shares by or through a member of a
recognized stock exchange may be subject to a stock exchange levy.
Capital gains realized by a US holder upon the sale of UBS ordinary shares are not subject to Swiss income
or gains taxes,
unless such US holder holds such shares as business assets of a Swiss business operation
qualifying as a permanent
establishment for the purposes of the Treaty.
In the latter case, gains are taxed at ordinary Swiss individual or corporate income
tax rates, as the case may be, and losses are deductible for purposes of Swiss income taxes. Furthermore,
a US holder who is an
individual resident in Switzerland and holds such shares as business assets (as he qualifies
as a professional trader of securities
as per Swiss tax law) may be liable to Swiss income taxes on gains.
(b) Ownership of UBS Ordinary Shares - US Federal Income
Taxation
The tax treatment of the UBS ordinary shares will depend in part on whether or not UBS Group
AG is classified as a passive
foreign investment company,
or PFIC, for US federal income tax purposes. Except as discussed below under
“—Passive
Foreign Investment Company (PFIC) Rules”, this discussion assumes that UBS Group
AG is not classified as a PFIC for
United States federal income tax purposes.
Dividends and Distributions
A US holder will include in gross income and treat as a dividend the gross amount
of any distribution paid, before reduction
for Swiss withholding taxes, by UBS Group AG out of its current or accumulated
earnings and profits (as determined for US
federal income tax purposes), other than certain pro-rata distributions
of UBS ordinary shares,
when the distribution is actually
or constructively received by the US holder.
Distributions in excess of current and accumulated earnings and profits (as
determined for US federal income tax purposes) will be treated as a return
of capital to the extent of the US holder’s basis in its
UBS ordinary shares and thereafter as capital gain. However,
UBS Group AG does not expect to calculate earnings and profits
in accordance with US federal income tax principles. Accordingly,
a US holder should expect to generally treat distributions
we make on UBS ordinary shares as dividends.
Dividends paid to a noncorporate US holder that constitute qualified dividend
income will be taxable to the holder at
preferential rates, provided that the holder has a holding period in the shares of
more than 60 days during the 121-day period
beginning 60 days before the ex-dividend date and meets other holding period
requirements. Dividends paid by UBS Group
AG with respect to the ordinary shares will generally be qualified as dividend
income provided that, in the year that the US
holder receives the dividend, the UBS ordinary shares are readily tradable
on an established securities market in the United
States. The UBS ordinary shares are listed on the New York
Stock Exchange, and UBS Group AG therefore expects that
dividends will be qualified dividend income.
For US federal income tax purposes, a dividend will include a distribution
characterized under Swiss law as a repayment of
capital contributions if the distribution is made out of current or accumulated
earnings and profits, as described above.
18
Dividends will generally be income from sources outside the United States for foreign
tax credit limitation purposes, and will
generally be "passive" income for purposes of computing the foreign tax credit allowable
to the holder. However,
if (a) we are
50% or more owned, by vote or value, by US persons and (b) at least 10% of our
earnings and profits are attributable to
sources within the US, then for foreign tax credit purposes, a portion of our dividends
would be treated as derived from sources
within the US. With respect to any dividend paid
for any taxable year, the US source ratio of our dividends
for foreign tax
credit purposes would be equal to the portion of our earnings and profits from sources
within the United States for such taxable
year, divided by the total amount of our
earnings and profits for such taxable year. Special rules apply
in determining the
foreign tax credit limitation with respect to dividends that are subject to preferential
rates. The dividend will not be eligible for
the dividends-received deduction generally allowed to US corporations in
respect of dividends received from other US
corporations.
In the case of dividends that are paid in Swiss francs, the amount of the dividend distribution
included in income of a US
holder will be the US dollar value of the Swiss franc payments made, determined
at the spot Swiss franc/US dollar rate on the
date such dividend distribution is includible in the income of the US holder,
regardless of whether the payment is in fact
converted into US dollars. Generally,
any gain or loss resulting from currency exchange fluctuations during the period from
the
date the dividend payment is included in income to the date such dividend
payment is converted into US dollars will be treated
as ordinary income or loss and will not be eligible for the special tax rate applicable
to qualified dividend income. Such gain or
loss will generally be income or loss from sources within the United States for
foreign tax credit limitation purposes.
Subject to US foreign tax credit limitations, the nonrefundable Swiss tax withheld and
paid over to Switzerland will be
creditable or deductible against the US holder’s US federal
income tax liability. To
the extent a reduction or refund of the tax
withheld is available to a US holder under the laws of Switzerland or under the Treaty,
the amount of tax withheld that is
refundable will not be eligible for credit against the US holder’s US federal
income tax liability, whether
or not the refund is
actually obtained. See “(a) Ownership of UBS Ordinary Shares – Swiss Taxation”
above, for the procedures for obtaining a tax
refund.
Transfers of UBS Ordinary
Shares
A US holder that sells or otherwise disposes of UBS ordinary shares generally will recognize
capital gain or loss for US federal
income tax purposes equal to the difference between
the US dollar value of the amount realized and its tax basis, determined in
US dollars, in such UBS ordinary shares. Capital gain of a non-corporate
US holder is generally taxed at preferential rates if
the UBS ordinary shares were held for more than one year.
The gain or loss will generally be income or loss from sources
within the United States for foreign tax credit limitation purposes. A US holder will not
be allowed a foreign tax credit in
respect of any stamp duty or stock exchange levy that is imposed upon a transfer of
UBS ordinary shares.
Passive Foreign Investment Company (PFIC)
Rules
UBS Group AG believes that UBS ordinary shares should not currently be
treated as stock of a PFIC for US federal income tax
purposes, and does not expect to become a PFIC in the foreseeable future.
However, this conclusion is a factual determination
made annually and thus may be subject to change. It is therefore possible that
UBS Group AG could become a PFIC in a future
taxable year.
In general, UBS Group AG will be a PFIC with respect to a US holder if, for any taxable year
in which the US
holder held UBS ordinary shares, either (i) at least 75% of the gross income of
UBS Group AG for the taxable year is passive
income or (ii) at least 50% of the value, determined on the basis of a quarterly
average, of UBS’s assets is attributable to
assets
that produce or are held for the production of passive income (including cash). If
UBS Group AG were to be treated as a PFIC,
gain realized on the sale or other disposition of UBS ordinary shares would in general
not be treated as capital gain. Instead,
unless a US holder elects to be taxed annually on a mark-to-market basis with
respect to its UBS ordinary shares, such gain and
certain “excess distributions” would be treated as having been realized ratably
over the holder’s holding period for the shares
and generally would be taxed at the highest tax rate in effect for
each such year to which the gain was allocated, together with
an interest charge in respect of the tax attributable to each such year.
With certain exceptions, a holder’s UBS ordinary
shares
will be treated as stock in a PFIC if UBS Group AG was a PFIC at any time during the holder’s
holding period in the UBS
ordinary shares. In addition, dividends received from UBS Group AG would
not be eligible for the preferential tax rate
applicable to qualified dividend income if UBS Group AG were to be
treated as a PFIC either in the taxable year of the
distribution or the preceding taxable year,
but would instead be taxable at rates applicable to ordinary income.
19
Item 19.
Exhibits.
Exhibit
number
Description
1.1
Articles of Association of UBS Group AG dated 8 April 2021.
1.2
Articles of Association of UBS AG dated 26 April 2018
. (Incorporated by reference to Exhibit 1.2 to UBS's
Annual Report on Form 20-F for the fiscal year ended December 31, 2019)
1.3
Organization Regulations of UBS Group AG dated 14 February
2022.
1.4
Organization Regulations of UBS AG dated 14 February 2022
2(b)
Instruments defining the rights of the holders of long-term debt issued by
UBS Group AG and its subsidiaries.
We agree to furnish
to the SEC upon request, copies of the instruments, including indentures, defining
the rights of
the holders of our long-term debt and of our subsidiaries’ long-term debt.
2(d)
Description of securities registered under Section 12 or the Securities Exchange
Act of 1934
4.1
Fiscal agency agreement dated 17 August 2012 between UBS AG, acting through
its Stamford Branch, and U.S.
Bank N.A.
(Incorporated by reference to Exhibit 4.2 to UBS AG's Annual Report on Form 20
-F for the fiscal year
ended December 31, 2012)
4.2
Terms and Conditions
of Tier 2 Subordinated Notes of UBS AG due 2024, issued
15 May 2014
. (Incorporated by
reference to Exhibit 4.3 to UBS AG's Annual Report on Form 20-F for the fiscal
year ended December 31, 2014)
4.3
Terms and Conditions
of USD 1.25 billion 7% Tier 1 Subordinated Notes
issued by UBS Group AG on 19
February 2015
. (Incorporated by reference to Exhibit 4.4 to UBS AG's Annual Report on Form 20
-F for the fiscal
year ended December 31, 2014)
4.4
Terms and Conditions
of EUR 1 billion 5.75% Tier 1 Subordinated Notes
issued by UBS Group AG on 19
February 2015
. (Incorporated by reference to Exhibit 4.6 to UBS AG's Annual Report on Form 20
-F for the fiscal
year ended December 31, 2014)
4.5
Terms and Conditions
of USD 1.575 billion Tier 1 Subordinated Notes issued by
UBS Group AG on 7 August
2015
. (Incorporated by reference to Exhibit 4.8 to UBS's Annual Report on Form
20-F for the fiscal year ended
December 31, 2015)
4.6
Terms and Conditions
of additional Tier 1 capital instruments issued pursuant to
the Deferred Contingent Capital
Plan 2017/18.
(Incorporated by reference to Exhibit 4.15 to UBS's Annual Report on Form 20-F for
the fiscal year
ended December 31, 2017)
4.7
Terms and Conditions
of USD 2 billion 5.0% Tier 1 Subordinated Notes issued
on 31 January 2018 by UBS Group
AG (originally issued by UBS Group Funding (Switzerland) AG and guaranteed
by UBS Group AG, migrated to
UBS Group AG as issuer on 11 October 2019).
(Incorporated by reference to Exhibit 4.16 to UBS's Annual Report
on Form 20-F for the fiscal year ended December 31, 2017)
4.8
Terms and Conditions
of SGD 700 million 5.875% Tier 1 Subordinated
Notes issued on 28 November 2018 by
UBS Group AG (originally issued by UBS Group Funding (Switzerland)
AG and guaranteed by UBS Group AG,
migrated to UBS Group AG as issuer on 11 October
2019)
. (Incorporated by reference to Exhibit 4.17 to UBS's
Annual Report on Form 20-F for the fiscal year ended December 31, 2018)
20
4.9
Terms and Conditions
of USD 2.5 billion 7.00% Tier 1 Subordinated
Notes issued on 31 January 2019 by UBS
Group AG (originally issued by UBS Group Funding (Switzerland)
AG and guaranteed by UBS Group AG,
migrated to UBS Group AG as issuer on 11 October
2019)
. (Incorporated by reference to Exhibit 4.18 to UBS's
Annual Report on Form 20-F for the fiscal year ended December 31, 2018)
4.10
Terms and Conditions
of additional Tier 1 capital instruments issued pursuant to
the Deferred Contingent Capital
Plan 2018/19
. (Incorporated by reference to Exhibit 4.19 to UBS's Annual Report on Form 20
-F for the fiscal year
ended December 31, 2018)
4.11
Terms and Conditions
of AUD 700 million 4.375% Tier 1 Subordinated Notes
issued on 27 August 2019 by UBS
Group AG.
(Incorporated by reference to Exhibit 4.17 to UBS's Annual Report on Form 20-F for the fiscal
year
ended December 31, 2019)
4.12
Terms and Conditions
of SGD 750 million 4.85% Tier 1 Subordinated
Notes issued on 04 September 2019 by
UBS Group AG.
(Incorporated by reference to Exhibit 4.18 to UBS's Annual Report on
Form 20-F for the fiscal
year ended December 31, 2019)
4.13
Terms and Conditions
of CHF 275 million 3.00% Tier 1 Subordinated Notes issued
on 13 November 2019 by UBS
Group AG.
(Incorporated by reference to Exhibit 4.19 to UBS's Annual Report on Form 20-F for the fiscal
year
ended December 31, 2019)
4.14
Terms and Conditions
of additional Tier 1 capital instruments issued pursuant to
the Deferred Contingent Capital
Plan 2019/20
. (Incorporated by reference to Exhibit 4.19 to UBS's Annual Report on Form 20
-F for the fiscal year
ended December 31, 2020)
4.15
Terms and Conditions
of USD 750 million 5.125% Tier 1 Subordinated
Notes issued on 29 July 2020 by UBS
Group AG
. (Incorporated by reference to Exhibit 4.20 to UBS's Annual Report on Form 20-F for
the fiscal year
ended December 31, 2020)
4.16
Terms and Conditions
of USD 1.5 billion 4.375% Tier 1 Subordinated
Notes issued on 10 February 2021 by UBS
Group AG
. (Incorporated by reference to Exhibit 4.21 to UBS's Annual Report on Form 20-F for
the fiscal year
ended December 31, 2020)
4.17
Terms and Conditions
of additional Tier 1 capital instruments issued pursuant
to the Deferred Contingent Capital
Plan 2020/21
. (Incorporated by reference to Exhibit 4.22 to UBS's Annual Report on Form 20
-F for the fiscal year
ended December 31, 2020)
4.18
Terms and Conditions
of USD 750 million 3.875% Tier 1 Subordinated
Notes issued on 02 June 2021 by UBS
Group AG.
4.19
Terms and Conditions
of USD 1.5 billion 4.875% Tier 1 Subordinated
Notes issued on 12 January 2022 by UBS
Group AG.
4.20
Terms and Conditions
of CHF 265 million 3.375% Tier 1 Subordinated Notes
issued on 16 February 2022 by UBS
Group AG.
4.21
Terms and Conditions
of additional Tier 1 capital instruments issued pursuant
to the Deferred Contingent Capital
Plan 2021/22.
4.22
Asset Transfer Agreement between UBS AG and UBS Switzerland
AG dated 12 June 2015.
(Incorporated by
reference to Form 6-K of UBS AG filed on June 17, 2015)
8
Significant Subsidiaries of UBS Group AG.
Please see Note 29 to each set of Financial Statements (
Interests in subsidiaries and other entities),
on pages 391-
395 and 523-527 of the Annual Report.
12
The certifications required by Rule 13(a)-14(a) (17 CFR 240.13a
-14(a)).
13
The certifications required by Rule 13(a)-14(b) (17 CFR 240.13a-14(b))
and Section 1350 of Chapter 63 of Title
18 of the U.S. Code (18 U.S.C. 1350).
15.1
Consent of Ernst & Young
Ltd. with respect to UBS Group AG.
15.2
Consent of Ernst & Young
Ltd. with respect to UBS AG.
101
Interactive Data Files (sections of the Annual Report formatted in inline XBRL (Extensible
Business Reporting
Language)). Furnished electronically herewith.
21
SIGNATURES
The registrants hereby certify that they meet all
of the requirements for filing on Form 20-F and
that
they have duly caused the undersigned to sign this
annual report on their behalf.
UBS Group AG
_/s/ Ralph Hamers _______________
Name: Ralph Hamers
Title: Group Chief Executive Officer
_/s/ Kirt Gardner__________________
Name: Kirt Gardner
Title: Group Chief Financial Officer
_/s/ Christopher Castello ___________
Name: Christopher Castello
Title: Group Controller and Chief Accounting Officer
UBS AG
_/s/ Ralph Hamers ________________
Name: Ralph Hamers
Title: President of the Executive Board
_/s/ Kirt Gardner__________________
Name: Kirt Gardner
Title: Chief Financial Officer
_/s/ Christopher Castello____________
Name: Christopher Castello
Title: Controller and Chief Accounting Officer
Date: March 7, 2022
UBS Group AG
and UBS AG
Annual Report 2021
Our external reporting approach
The scope and content of our
external reports are determined
by
Swiss
legal
and
regulatory
requirements,
accounting
standards,
relevant
stock
and
debt
listing
rules,
including
regulations
promulgated
by
the
Swiss
Financial
Market
Supervisory
Authority
(FINMA),
the
SIX
Swiss
Exchange,
the
US Securities and
Exchange Commission (the
SEC) and other
regulatory requirements,
as well as by our
financial reporting
policies.
At
the
center
of
our
external
reporting
approach
is
the
annual report of UBS Group AG, which consists of disclosures
for UBS
Group AG and
its consolidated subsidiaries.
We also
provide
a
combined
annual
report
for
UBS
Group
AG
and
UBS AG
consolidated,
which
additionally
includes
the
consolidated
financial
statements
of
UBS
AG
,
as
well
as
supplemental disclosures required under SEC regulations, and
is the basis for our SEC Form 20-F filing.
Annual Reports
The
202
1
Annual
Reports
(the
UBS
Group
AG
Annual
Report 2021 and
the combined
UBS Group
AG and UBS
AG
Annual
Report
2021)
include
the
consolidated
financial
statements of
UBS Group
AG and
UBS AG, respectively,
and
provide comprehensive information about our firm,
including
our strategy, businesses, financial
and operating
performance,
and
other key
information. The
reports
are
presented
in US
dollars.
The
UBS
Group
AG
Annual
Report
2021
is
partly
translated into German,
with the German
translation available
as
of
1
1
March
202
2
under
“Annual
reporting”
at
ubs.com/investors.
The
consolidated
financial
statements
of
UBS
Group
AG
and
UBS
AG
have
been
prepared
in
accordance
with
International
Financial
Reporting
Standards
(IFRS).
The
sections
within
“Risk,
capital,
liquidity
and
funding,
and
balance sheet“
include certain
audited financial
information,
which forms
part of
the consolidated
financial statements.
The
Annual Reports also include the
statutory financial statements
of UBS
Group AG,
which are
the basis
for our appropriation
of retained earnings and a potential distribution of dividends,
subject
to
shareholder
approval
at
the
Annual
General
Meeting.
Sustainability Report
The
S
ustainability
R
eport
,
which
will
be
available
from
11 March 2022, provides disclosures on environmental, social
and governance topics for UBS Group.
Standalone reports of significant group entities
We
publish separate
standalone reports
of significant
group
e
ntities
for
UBS
AG
and
UBS
Switzerland
AG.
Selected
financial and regulatory
key figures for
these entities, as
well
as for UBS Europe SE and UBS Americas Holding LLC, are also
included
in
our
annual
reports.
The
UBS
Europe
SE
2021
financial
statements
and
complementary
disclosures
will
be
published on our website in the first half of 2022.
Pillar 3 Report
The
Pillar
3
Report
provides
detailed
quantitative
and
qualitative
information
about
risk,
capital,
leverage
and
liquidity
for
UBS
Group
and
prudential
key
figures
and
regulatory
information
for
UBS
AG
standalone,
UBS Switzerland AG standalone, UBS Europe SE consolidated
and UBS Americas Holding LLC consolidated.
We
provide
our
combined
Annual
Report,
the
Pillar 3
Report,
standalone
reports
of
significant
group
entities and
the Sustainability
Report as
web disclosures
at
ubs.com/investors
. Alternatively,
we provide
the
QR code on
the right
for rapid
access to
the above-mentioned
reports and
further information
on
investor relations-related topics.
Contents
2
Letter to shareholders
7
Highlights of the 2021 financial year
8
Our key figures
10
Our Board of Directors
12
Our Group Executive Board
14
Our evolution
1
Our strategy, business model and
environment
16
Our strategy
20
Targets,
aspirations and capital guidance
21
Our businesses
33
Our environment
38
How we create value for our stakeholders
56
Regulation and supervision
59
Regulatory and legal developments
63
Risk factors
2
Financial and
operating performance
76
Accounting and financial reporting
77
Group performance
84
Global Wealth Management
87
Personal & Corporate Banking
90
Asset Management
92
Investment Bank
94
Group Functions
95
Selected financial information of our business divisions
and Group Functions
3
Risk, capital, liquidity and funding,
and balance sheet
98
Risk management and control
150
Capital, liquidity and funding, and balance sheet
4
Corporate governance
and compensation
190
Corporate governance
228
Compensation
5
Financial
statements
283
UBS Group AG consolidated financial statements
413
UBS AG consolidated financial statements
6
Significant regulated subsidiary and sub-
group information
548
Financial and regulatory key figures for our significant
regulated subsidiaries and sub-groups
7
Additional
regulatory information
553
UBS Group AG consolidated supplemental disclosures
required under SEC regulations
565
UBS AG consolidated supplemental disclosures required
under SEC regulations
Appendix
579
Alternative performance measures
582
Abbreviations frequently used in our financial reports
585
Information sources
586
Cautionary statement
Annual Report 2021 | Letter to shareholders
2
Dear shareholders,
2021
was
the
second
year
shaped
by
the
pandemic,
which
challenged and affected every aspect of
society – from healthcare
to
economics,
to
politics,
to
human
interactions.
UBS’s
performance in
2021 speaks
to our
resilience, our
progress
and
our future path. In
2022 we intend to continue
making progress
on our
strategic goals,
and we
remain
dedicated to
our clients,
shareholders, employees and society.
The
current
geopolitical
situation
has
led
to
heightened
volatility across
global markets.
We are
shocked by
the violence
and tragedy caused by
Russia’s invasion of Ukraine.
Our hearts go
out to those affected and those who are suffering.
We
are
working
to
implement
sanctions
imposed
by
Switzerland, the US,
the EU, the
UK and others
– all of
which have
announced unprecedented levels of
sanctions against Russia and
certain Russian entities
and nationals. These
events, together with
counter-sanctions and other measures
taken by Russia,
will have
ongoing effects on the markets and the global economy.
2021 backdrop and our financial performance
Despite
the
continuing
pandemic,
market
conditions
were
constructive in 2021, with positive
investor sentiment throughout
the year. Growth rebounded, with
the global economy
expanding
6.1% after
contracting 3.1%
in 2020.
Global equities
delivered
total returns of 18.5%.
Economic, social and geopolitical
tensions
increased
during
the
year,
raising
questions
around
the
sustainability and shape of
the recovery.
The pandemic adversely
impacted certain economic sectors, while supply chains and labor
markets remained
challenging. A
potential resurgence
in global
inflation and tight labor
markets in many countries could
lead to
more
restrictive
monetary
policy,
and
this
has
become
an
additional concern for the market.
Within
this
environment,
we
delivered
a
strong
financial
performance in 2021.
We had the
highest pre-tax and net
profit
in 15 years, a 17.5% return
on CET1 capital and a 14.1% return
on tangible equity.
We maintained our
cost / income ratio
under
74%,
which is
in line
with 2020
and more
than six
percentage
points better than the two years before that. For the second year
in
a
row,
we
exceeded
all
our
targets,
with
all
regions
and
businesses
contributing
to
our
performance.
We
deepened
our
relationships
with
clients,
resulting
in
high
levels
of
activity
and
strong
flows across
all
our
segments. This
business
momentum
led to our highest revenues in over a decade.
Our results
included two exceptional
items. The first
item is a
loss of USD 861 million
that we incurred in the
first half of 2021
on
the
default
of
a
US-based
client
of
our
prime
brokerage
business. We have conducted a thorough
review, we have put in
place
appropriate
measures
to
strengthen
our
relevant
risk
management processes, and we have reflected
the matter in our
annual
performance
assessment
and
compensation
processes.
The second item
occurred in the
fourth quarter of
2021, when we
took additional
provisions of
EUR 650 million,
bringing the
total
to
EUR 1.1
billion
for
the
French
cross-border
matter.
As
announced in December 2021, we
have filed an appeal
with the
French
Supreme
Court
regarding
the
decision
of
the
Court
of
Appeal.
This
enables
us
to
thoroughly
assess
the
verdict
of
the
Court
of
Appeal
and
to
determine
the
next
steps
in
the
best
interests of our stakeholders.
Our purpose and strategic direction
In
2021,
we
reconfirmed
and
continued
to
implement
our
strategy. Last April, we introduced our purpose “Reimagining the
power of investing.
Connecting people for
a better world,”
which
unites all of UBS behind
a common goal. It´s the
starting point for
every strategic
decision; it
will shape our
future, help
us capture
opportunities
and
allow
us
to
grow
from
our
already
strong
position.
Our vision
is to
convene THE
global ecosystem
for
investing:
where
thought
leadership
is
impactful,
people
and
ideas
are
connected,
and
opportunities
are
brought
to
life.
In
order
to
achieve
this
vision,
we
identified
five
strategic
imperatives:
(i) supporting,
growing
and
aligning
our
network
of
clients,
connections and contributors;
(ii) increasing our focus
by playing
where
we
are
positioned
to
win;
(iii) enabling
technology
and
making
it
our
differentiator;
(iv) becoming
simpler
and
more
efficient
so
it
is
easier
for
our
clients
to
bank
with
us;
and
(v) mobilizing employees behind
our vision and
acting as one
firm.
Supporting clients, society and employees
We retained our
clients’ trust as they continued
to turn to us for
our content, advice and
solutions. This resulted in
USD 107 billion
in
net
new
fee-generating
assets
in
wealth
management
and
USD 48 billion of net new money in Asset Management. We also
helped clients finance
businesses, homes
and other
liquidity needs
by
extending
USD 28
billion
of
net
new
loans
to
clients
across
wealth
management
and
personal
banking.
We
now
manage
over
USD 4.6
trillion in
assets on
behalf of
our
clients.
And we
increased
our
philanthropic
activities,
both
with
and
for
clients
and as a firm.
At UBS,
we are
committed to
supporting the
communities in
which we work, to understand
the issues they face,
and develop
long-term
partnerships
to
catalyze
positive
change
in
people’s
lives.
We
focus
our
efforts
on
social
inequalities
by
supporting
education
and
skills
development
as
areas
where
we
can
drive
sustainable
change.
We
also
enable
our
employees
to
support
their
communities
through
volunteering
by
partnering
with
organizations
such
as
Powercoders
in
Switzerland,
which
trains
refugees in
computer science
and information
technology skills.
The pandemic meant we continued to provide COVID-19
relief to
the
most
vulnerable
in
2021,
including
recovery
and
rebuilding
efforts through our
community partners. Currently,
to help victims
of
the
war
in
Ukraine,
UBS
Optimus
Foundation
and
our
Community
Impact
teams
are
providing
emergency
relief
to
refugees
through
the
International
Rescue
Committee
and
are
matching the
first USD 5
million of
donations from
employees and
clients, creating a combined impact of USD 10 million.
3
Axel A. Weber
Chairman of the Board of Directors
Ralph A.J.G. Hamers
Group Chief Executive Officer
Due to the ongoing pressure placed on
employees by closures,
restrictions
and lockdowns,
we implemented
new
ways to
help
employees
through
these
difficult
times.
We
offered
tools
and
resources to support employees’ physical, mental and social well-
being, and provided
extra flexibility for
child and elderly
care. As
a result
of our
experience during
the pandemic,
we are
developing
more
permanent
ways
of
flexible
working
for
our
employees,
while supporting
a safe
return to
our offices
as economies
reopen.
We believe a hybrid
approach will support
a better work /
life
balance and make
us a more
attractive employer, appealing
to a
more
diverse
pool
of
applicants,
such
as
working
parents,
caregivers and
those in
continuing education.
Moreover, flexible
working, by the nature of its emphasis
on technology and virtual
collaboration, encourages an innovative
mindset across our firm
–
which is a
big part of our
strategy. In addition, we
are reshaping
our future real estate footprint, reducing the number of buildings
and square meters
we occupy,
while also investing
in our
locations
to
reimagine
our
workplace
and
support
our
sustainability
ambitions.
Capturing growth opportunities
After introducing
our purpose
and strategy
on a
page, we
took
steps to ensure UBS is
well positioned to capture
the areas we see
as having the greatest
growth potential. For example,
regionally,
we expect most wealth will be created in the US and Asia Pacific.
As a result,
we have identified
these as key
growth markets and
we have prioritized investments
in those regions. EMEA
continues
to be a core
region for us and
important to our global
footprint,
and a region
where we can
improve profitability and
drive focused
growth.
And
in
Switzerland,
we
are
further
building
on
our
position as a digital leader.
Affluent
clients
and
entrepreneurs
are
expected
to
generate
high
revenue
growth.
So
we
are
also
expanding
into
new
segments
to
reach
a
much
broader
set
of
clients.
Our
plans
to
acquire
Wealthfront,
announced
in
January
2022,
will
help
us
deliver
a
digital
wealth
management
offering
to
Millennial
and
Gen Z affluent investors in the
US, allow us to expand our
wallet
share, lower the cost to serve and drive long-term growth.
Technology plays a large part
in how we grow and
deliver the
personalized, relevant, on-time and
seamless services that clients
expect.
That
is
why
we
are
further
investing
in
digitalization,
including artificial intelligence, data and
analytics – areas we have
already been building up for years. We will digitalize what can be
made digital
and become
more agile
to deliver
faster. While
not
increasing our total expenditure on technology, we are increasing
the
amount
we
spend
on
our
strategic
priorities.
Our aim
is to
deliver around
USD 1
billion in-year
gross cost
saves by
2023 in
order to fund our growth initiatives.
Leading in sustainability – our path to Net Zero
Over the
years, UBS has
established itself as
a recognized
leader
for sustainability in the financial
sector. Recent ratings such as the
Dow Jones Sustainability
Index and CDP
have reconfirmed this.
To
maximize impact
and direct
capital to
where
it is
needed most,
we focus on three areas: (i) Planet, where
we are making climate
a
clear
priority
as
we
shift
toward
a
lower
carbon
future;
(ii)
People,
where
we
are
taking
action,
both
within
our
own
workplace
and
within
wider
society,
to
promote
a
diverse,
equitable
and
inclusive
society; and
(iii)
Partnerships,
where
we
are
uniting
with
others
and
bringing
people
together
around
common
goals
to
achieve
greater
impact.
To
meet
our
impact
goals,
we started
assigning all
Group
Executive Board
members
environmental, social
and governance (ESG)-related
objectives in
2021.
Sustainability
is not
just something
we focus
on because
we
think
it
is
the
right
thing
to
do.
We
also
have
a
duty:
to
help
private
clients
protect
and
grow
their
wealth,
to
help
firms
transition to sustainable ways
of doing business,
to ensure clients’
long
-
term
success
and
to
support
them
in
fulfilling
their
responsibility to
society. We
strongly believe
that this
is the
best
way to
remain profitable
and attractive
to clients,
investors and
talent in the long term. We are
seeing an ever-increasing demand
in
sustainable
investing
–
invested
assets
in
sustainability-focus
and
impact
strategies
increased
78%
in
2021
–
and
we
will
continue to meet this need by growing our offering.
Annual Report 2021 | Letter to shareholders
4
In
2021,
we
published
our
Net-Zero
and
Beyond
statement,
which sets out our commitment to transition our firm to net zero
and
help
our
clients
meet
their
transition
targets
by
2050.
We
have
developed
and
are
transparently
disclosing
a
climate
road
map
with
intermediate
targets
for
2025,
2030
and
2035.
The
“Say-on-Climate” advisory vote at the upcoming Annual General
Meeting (the AGM) is a key milestone on
our journey to net zero,
reflecting
our commitment
to our
shareholders having
their say
on our firm’s climate
roadmap. Furthermore, we strongly
believe
in cross-company and cross-industry collaboration when it comes
to achieving net
zero. As
such, we are
a founding member
of both
the Net Zero Asset
Managers Initiative and the Net-Zero
Banking
Alliance.
Updated targets and ambitions to create value across
stakeholders
We
are
aiming
to
create
sustainable
value
through
the
cycle.
Reflecting our improved operating performance over the last two
years,
we
updated
our
financial
targets
and
kept
our
capital
guidance
unchanged,
including
deploying
up
to
one-third
of
Group
risk-weighted
assets
(RWA)
and
leverage
ratio
denominator
(LRD)
in
the
Investment
Bank.
In
addition,
we
outlined selected commercial and
ESG aspirations to support the
achievement of these targets.
First, for society
at large, we
are committed to
building a better
world
through
our
sustainability
focus
and
the
numerous
commitments you can find in our 2021 Annual and Sustainability
Reports. For example,
we aim to reach
net-zero emissions across
our business
by 2050
and net-zero
emissions resulting
from our
own operations
by 2025.
We will also
help our
clients do
good,
as we aspire to raise USD 1 billion in philanthropy assets to reach
25 million
beneficiaries and
we are
targeting USD 400
billion in
sustainability-focus and impact investments by 2025.
Second,
for
our
clients,
we
will
assess
how
we
are
doing
through
our
commercial
aspirations.
We
are
optimistic
that
we
can maintain growth rates from net new fee-generating assets of
5% and
above over
the cycle.
As a
result,
we aspire
to surpass
USD 5 trillion, and then USD 6 trillion, in
invested assets as clients
entrust us with managing their investments.
And third, we are targeting a 15–18% return on CET1 capital.
This
is
significantly
higher
than
our
previous
target
range
and
reflects
the
progress
we have
made
over
the last
two
years. To
consistently achieve this, we are targeting a cost /
income ratio of
70–73%. We
have ambitious
growth plans
across our
franchise
and
are
retaining
our
target
to
grow
profits
in
global
wealth
management by 10–15% over the cycle.
Our capital returns today and in the future
Reflecting
the
step-up
in
profitability,
we
are
proposing
to
increase the dividend
to USD 0.50 per
share for the
2021 financial
year,
and
to
have
a
progressive
cash
dividend
thereafter.
Additional excess capital will be used to buy back our shares, and
we
repurchased
USD 2.6
billion
of
shares
in
2021.
Given
our
strong capital position, we are looking to
repurchase up to USD 5
billion in 2022.
Proposed elections to the Board of Directors
Axel
A.
Weber
is
reaching
the
ten-year
term
limit
set
in
our
Organization Regulations
as the
Chairman of the
Board and
will
therefore
be
stepping
down
in
April
2022.
On
20 November
2021, the Board of Directors of UBS Group AG announced that
it
will
nominate
Colm
Kelleher
as
the
new
Chairman
and
Lukas
Gähwiler as
the new Vice
Chairman for election
to the
Board at
the AGM on 6 April 2022.
Virtual AGM in 2022
To
protect the
health of
shareholders and
employees, in
light of
the COVID-19 pandemic and continued uncertainty, the Board of
Directors
has
decided
that
the
2022
AGM
will
be
held
as
a
webcast. As
such, it
will not
be possible
to physically
attend the
AGM.
Nevertheless,
we
look
forward
to
your
feedback
and
to
welcoming you to this year’s virtual AGM on 6 April.
Thank you for your ongoing support.
Yours sincerely,
Axel A. Weber
Ralph A.J.G. Hamers
Chairman of the
Group Chief Executive Officer
Board of Directors
5
6
Corporate information
UBS Group AG
is incorporated and domiciled in Switzerland
and operates
under Art. 620ff. of the Swiss Code of Obligations
as an Aktiengesellschaft, a
corporation limited by shares. Its registered office is at Bahnhofstrasse
45,
CH-8001 Zurich, Switzerland, telephone +41-44-234
11 11, and its corporate
identification number is CHE-395.345.924.
UBS Group AG was incorporated
on 10 June 2014 and was established in 2014
as the holding company of the
UBS Group. UBS Group AG shares are listed on the SIX Swiss
Exchange and
on the New York Stock Exchange (ISIN: CH0244767585; CUSIP: H42097107).
UBS Group AG owns 100% of the outstanding shares
of UBS AG.
UBS AG
is incorporated and domiciled in Switzerland
and operates under
Art. 620ff. of the Swiss Code of Obligations as an Aktiengesellschaft,
a
corporation limited by shares. The addresses and telephone
numbers of the
two registered offices of UBS AG are: Bahnhofstrasse 45, CH-8001
Zurich,
Switzerland, telephone +41-44-234 11 11;
and Aeschenvorstadt 1, CH-4051
Basel, Switzerland, telephone +41-61-288
50 50. The corporate identification
number is CHE-101.329.561. UBS AG is
a bank. The company was formed on
29 June 1998, when Union Bank of Switzerland
(founded in 1862) and
Swiss Bank Corporation (founded in 1872)
merged to form UBS AG.
Contacts
Switchboards
For all general inquiries
ubs.com/contact
Zurich +41-44-234 1111
London +44-207-567 8000
New York +1-212-821 3000
Hong Kong SAR +852-2971 8888
Singapore +65-6495 8000
Investor Relations
UBS’s Investor Relations team manages
relationships with institutional investors,
research analysts and credit rating agencies.
ubs.com/investors
Zurich +41-44-234 4100
New York +1-212-882 5734
Media Relations
UBS’s Media Relations team manages
relationships with global media and
journalists.
ubs.com/media
Zurich +41-44-234 8500
mediarelations@ubs.com
London +44-20-7567 4714
ubs-media-relations@ubs.com
New York +1-212-882 5858
mediarelations@ubs.com
Hong Kong SAR +852-2971 8200
sh-mediarelations-ap@ubs.com
Office of the Group Company Secretary
The Group Company Secretary handles
inquiries directed to the Chairman or to other
members of the Board of Directors.
UBS Group AG, Office of the
Group Company Secretary
P.O.
Box, CH-8098 Zurich, Switzerland
sh-company-secretary@ubs.com
Zurich +41-44-235 6652
Shareholder Services
UBS’s Shareholder Services team, a unit
of the Group Company Secretary’s office,
manages relationships with shareholders
and the registration of UBS Group AG
registered shares.
UBS Group AG, Shareholder Services
P.O.
Box, CH-8098 Zurich, Switzerland
sh-shareholder-services@ubs.com
Zurich +41-44-235 6652
US Transfer Agent
For global registered share-related
inquiries in the US.
Computershare Trust Company NA
P.O.
Box 505000
Louisville, KY 40233-5000, USA
Shareholder online inquiries:
www-us.computershare.com/
investor/contact
Shareholder website:
computershare.com/investor
Calls from the US
+1-866-305-9566
Calls from outside the US
+1-781-575-2623
TDD for hearing impaired
+1-800-231-5469
TDD for foreign shareholders
+1-201-680-6610
Corporate calendar UBS Group AG
Publication of the Sustainability Report 202
1
:
Friday, 11 March 2022
Annual General Meeting 2022 (webcast):
Wednesday, 6 April 2022
Publication of the first quarter 2022 report:
Tuesday,
26 April 2022
Publication of the second quarter 2022 report:
Tuesday,
26 July 2022
Publication of the third quarter 2022 report:
Tuesday,
25 October 2022
Corporate calendar UBS AG
Publication of the
first q
uarter 202
2
report:
Friday
,
29
April
202
2
Publication of the second
quarter 202
2
report:
Friday, 2
9
July 202
2
Additional publication dates of quarterly and
annual reports
will be made available as part of the corporate
calendar of UBS AG at
ubs.com/investors.
Imprint
Publisher: UBS Group AG, Zurich, Switzerland | ubs.com
Language: English
© UBS 2022. The key symbol and UBS are among
the registered and
unregistered trademarks of UBS. All rights reserved.
7
Annual Report 2021
8
Our key figures
As of or for the year ended
USD million, except where indicated
31.12.21
31.12.20
31.12.19
1
Group results
Operating income
35,542
32,390
28,889
Operating expenses
26,058
24,235
23,312
Operating profit / (loss) before tax
9,484
8,155
5,577
Net profit / (loss) attributable to shareholders
7,457
6,557
4,304
Diluted earnings per share (USD)
2
2.06
1.77
1.14
Profitability and growth
3
Return on equity (%)
12.6
11.3
7.9
Return on tangible equity (%)
14.1
12.8
9.0
Return on common equity tier 1 capital (%)
17.5
17.4
12.4
Return on risk-weighted assets, gross (%)
12.0
11.7
11.0
Return on leverage ratio denominator, gross (%)
4
3.4
3.4
3.2
Cost / income ratio (%)
73.6
73.3
80.5
Effective tax rate (%)
21.1
19.4
22.7
Net profit growth (%)
13.7
52.3
(4.7)
Resources
3
Total assets
1,117,182
1,125,765
972,194
Equity attributable to shareholders
60,662
59,445
54,501
Common equity tier 1 capital
5
45,281
39,890
35,535
Risk-weighted assets
5
302,209
289,101
259,208
Common equity tier 1 capital ratio (%)
5
15.0
13.8
13.7
Going concern capital ratio (%)
5
20.0
19.4
20.0
Total loss-absorbing capacity ratio (%)
5
34.7
35.2
34.6
Leverage ratio denominator
4,5
1,068,862
1,037,150
911,322
Common equity tier 1 leverage ratio (%)
4,5
4.24
3.85
3.90
Going concern leverage ratio (%)
4,5
5.7
5.4
5.7
Total loss-absorbing capacity leverage ratio (%)
5
9.8
9.8
9.8
Liquidity coverage ratio (%)
6
155
152
134
Net stable funding ratio (%)
6
119
119
111
Other
Invested assets (USD billion)
7
4,596
4,187
3,607
Personnel (full-time equivalents)
71,385
71,551
68,601
Market capitalization
8
61,230
50,013
45,661
Total book value per share (USD)
8
17.84
16.74
15.07
Total book value per share (CHF)
8
16.27
14.82
14.59
Tangible book value per share (USD)
8
15.97
14.91
13.28
Tangible book value per share (CHF)
8
14.56
13.21
12.86
1 Refer to the “Accounting
and financial reporting” and “Consolidated financial statements”
sections of this report for information about
the restatement of comparative information, where applicable.
2 Refer to
“Share information and earnings per share” in
the “Consolidated financial statements” section of
this report for more information.
3 Refer to the “Targets,
aspirations and capital guidance” section of
this report
for more information about our performance targets.
4 Leverage ratio denominators and leverage
ratios for year 2020 do not
reflect the effects of the temporary
exemption that applied from 25 March
2020 until
1 January 2021
and was
granted by
FINMA in
connection with
COVID-19. Refer
to the
“Regulatory and
legal developments”
section of
our Annual
Report 2020
for more
information.
5 Based on
the Swiss
systemically relevant bank framework
as of 1 January
2020. Refer to the
“Capital, liquidity and funding,
and balance sheet” section
of this report for
more information.
6 The final Swiss
net stable funding ratio
(NSFR) regulation became effective on 1 July 2021. Prior to this date,
the NSFR was based on estimated pro forma reporting. Refer
to the “Capital, liquidity and funding, and balance sheet” section of this report
for
more information.
7 Consists of invested assets for Global Wealth Management, Asset Management and Personal & Corporate Banking. Refer to “Note 32
Invested assets and net new money” in the “Consolidated
financial statements” section of this report for more information.
8 Refer to “UBS shares” in the “Capital, liquidity and funding, and balance sheet” section of this report for more information.
9
Alternative performance measures
An alternative performance measure (an APM) is a financial
measure of historical or future financial performance, financial position or
cash flows other than
a financial measure defined
or specified in
the applicable recognized accounting standards
or in other
applicable
regulations. We
report a
number of
APMs in
the discussion of
the financial
and operating
performance of
the Group,
our business
divisions and
our Group
Functions. We
use APMs
to provide
a more
complete picture
of our
operating performance
and to
reflect
management’s view of the fundamental drivers of our business
results. A definition of each APM, the method used to calculate it
and
the
information
content are
presented
under
“Alternative performance
measures”
in
the appendix
to
this
report.
Our APMs
may
qualify as non-GAAP measures as defined by US Securities and Exchange Commission (SEC) regulations.
1
2
4
Terms used in this report, unless the context requires otherwise
“UBS,” “UBS Group,” “UBS Group AG consolidated,” “Group,”
“the Group,” “we,” “us” and “our”
UBS Group AG and its consolidated subsidiaries
“UBS AG consolidated”
UBS AG and its consolidated subsidiaries
“UBS Group AG” and “UBS Group AG standalone”
UBS Group AG on a standalone basis
“UBS AG” and “UBS AG standalone”
UBS AG on a standalone basis
“UBS Switzerland AG” and “UBS Switzerland AG standalone”
UBS Switzerland AG on a standalone basis
“UBS Europe SE consolidated”
UBS Europe SE and its consolidated subsidiaries
“UBS Americas Holding LLC” and
“UBS Americas Holding LLC consolidated”
UBS Americas Holding LLC and its consolidated subsidiaries
In this report, unless the context requires otherwise, references to any gender shall apply to all genders.
10
Our Board of Directors
The
Board
of
Directors
(the
BoD)
of
UBS
Group
AG, under
the
leadership
of the
Chairman,
consists
of between
6 and
12 members
as per our Articles
of Association.
The BoD decides
on the strategy
of the Group
upon recommendation
by the Group
Chief Executive
Officer (the
Group CEO)
and is responsible
for the overall
direction,
supervision
and control of the
Group and its management,
as well
as
for
supervising
compliance
with
applicable
laws,
rules
and
regulations. The BoD exercises oversight over UBS Group AG and
its
subsidiaries and
is
responsible for
establishing a
clear
Group
governance
framework
to
provide
effective
steering
and
supervision of the Group, taking
into account the material
risks to
which UBS
Group AG
and its
subsidiaries
are exposed.
The BoD
has
ultimate
responsibility
for
the
success
of
the
Group
and
for
delivering
sustainable shareholder
value
within
a
framework of
prudent and
effective
controls,
approves
all financial
statements
for
issue
,
and
appoints
and
removes
all
Group
Executive
Board
(GEB) members.
11
1
Axel A. Weber
Chairman of the Board of Directors / Chairperson
of the
Corporate Culture and Responsibility Committee
/
Chairperson of the Governance and Nominating
Committee
2
Fred Hu
Member of the Governance and Nominating
Committee /
member of the Risk Committee
3
Claudia Böckstiegel
Member of the Board of Directors
4
Patrick Firmenich
Member of the Audit Committee / member of
the
Corporate Culture and Responsibility Committee
5
Reto Francioni
Member of the Compensation Committee
/
member of the Risk Committee
6
Jeremy Anderson
Vice Chairman and Senior Independent Director
/
Chairperson of the Audit Committee /
member of the Governance and Nominating
Committee
7
Julie G. Richardson
Chairperson of the Compensation Committee
/
member of the Governance and Nominating
Committee /
member of the Risk Committee
8
Nathalie Rachou
Member of the Risk Committee
9
William C. Dudley
Member of the Corporate Culture and
Responsibility Committee / member of the Governance
and
Nominating Committee / member of the Risk
Committee
10
Jeanette Wong
Member of the Audit Committee / member of
the
Compensation Committee / member of the Corporate
Culture
and Responsibility Committee
11
Mark Hughes
Chairperson of the Risk Committee /
member of the Corporate Culture and Responsibility
Committee
12
Dieter Wemmer
Member of the Audit Committee /
member of the Compensation Committee /
member of the Governance and Nominating
Committee
12
Our Group Executive Board
1
Ralph A.J.G. Hamers
Group Chief Executive Officer
2
Mike Dargan
Group Chief Digital and Information Officer
3
Tom Naratil
Co-President Global Wealth Management and
President UBS Americas
4
Christian Bluhm
Group Chief Risk Officer
5
Sabine Keller-Busse
President Personal & Corporate Banking
and
President UBS Switzerland
6
Edmund Koh
President UBS Asia Pacific
7
Markus Ronner
Group Chief Compliance and Governance
Officer
8
Suni Harford
President Asset Management
9
Barbara Levi (since 1 November 2021)
Group General Counsel
10
Robert Karofsky
President Investment Bank
11
Iqbal Khan
Co-President Global Wealth Management and
President UBS Europe, Middle East and Africa
12
Kirt Gardner
Group Chief Financial Officer
13
Markus U. Diethelm (until 31 October
2021)
Group General Counsel
13
UBS
Group
AG operates
under a
strict dual
board
structure,
as
mandated by Swiss
banking law, and therefore the
BoD delegates
the management
of the
business to
the GEB. Under
the leadership
of the Group CEO,
the GEB was comprised of 12
members as of
31 December 2021 and has executive management responsibility
for the steering
of the Group
and its business. It
assumes overall
responsibility
for
developing
the
strategies
of
the
Group,
the
business divisions and
Group Functions, and implements
the BoD-
approved strategies.
›
Refer to “Board of Directors” and “Group Executive
Board”
in the “Corporate governance” section
of this report or
to
ubs.com/bod
and
ubs.com/geb
for the full biographies of
our BoD and GEB members
14
Our evolution
Since
our
origins
in
the
mid
-
19th
century,
many
financial
institutions
have
become
part
of
the
history
of
our
firm
and
helped shape our development. 1998 was a major turning point:
two of the
three largest Swiss
banks, Union Bank
of Switzerland
and
Swiss
Bank
Corporation
(SBC),
merged
to
form
UBS.
Both
banks
were
well
established
and
successful
in
their
own
right.
Union Bank of Switzerland had grown organically to become
the
largest Swiss
bank. In
contrast, SBC
had grown
mainly through
strategic partnerships and acquisitions, including S.G. Warburg in
1995.
In 2000, we acquired PaineWebber,
a US brokerage and asset
management firm with roots going back to 1879, establishing us
as a significant player in the
US. Over the past 50 years, we have
also built
a strong
presence in
the Asia Pacific
region, where
we
are the
largest private
bank
1
, with
access to
asset management
and investment banking capabilities.
After incurring significant losses
in the 2008 financial
crisis, we
started
a
strategic
transformation
in
2011
toward
a
business
model
focused
on
our
traditional
businesses
:
wealth
management
,
and
personal
and
corporate
banking
in
Switzerland.
We
sought
to
revert
to
our
roots,
emphasizing a
client-centric model that requires less risk-taking and
capital, and
we successfully
completed that
transformation.
Today, we are
a leading
truly global
wealth manager,
2
with over
USD 3.3
trillion in
invested assets,
a leading
Swiss personal
and
corporate
bank,
a
large
-
scale
and
diversified
global
asset
manager,
and a focused investment bank.
In
2014,
we
began
adapting
our
legal
entity
structure
in
response
to
too-big-to-fail
requirements
and
other
regulatory
initiatives.
First,
we
established
UBS
Group
AG
as
the
ultimate
parent holding
company for
the Group.
In 2015,
we transferred
personal
and
corporate
banking
and
Swiss
-
booked
wealth
management businesses
from UBS
AG to
the newly
established
UBS
Switzerland
AG.
That
same
year
we
set
up
UBS
Business
Solutions
AG
as
the
Group’s
service
company.
In
2016,
UBS
Americas Holding LLC became
the intermediate holding company
for our US
subsidiaries and our
wealth management subsidiaries
across
Europe
were
merged
into
UBS
Europe
SE.
In
2019,
we
merged UBS Limited,
our UK-headquartered subsidiary,
into UBS
Europe SE, our Germany-headquartered European subsidiary.
The chart
below gives
an overview
of our
principal legal
entities
and our legal entity structure.
›
Refer to
ubs.com/history
for more information
›
Refer to the “Risk factors” and “Regulatory
and legal
developments”
sections
of this report for more information
1
Digital Wealth Management in Asia Pacific, KPMG 2021.
2
Statements of market position for Global Wealth Management are based on UBS’s
internal estimates and publicly available information about competitors’ invested assets.
The legal structure of the UBS Group
Our strategy,
business
model and
environment
Management report
1
Our strategy, business model and environment
| Our strategy
16
Our strategy
Our purpose
As the world’s leading wealth manager,
1
we have an opportunity
to make a difference for
our clients,
our employees,
and society
at
large.
It
all
starts
with
our
purpose:
Reimagining
the
power
of
investing.
Connecting
people
for
a
better
world.
Our
purpose unites
us behind
a common
goal, provides
direction on
the way forward and helps us build on our strengths.
We
will
reimagine
the
power
of
investing
by
developing
solutions that change how people look at finance and investing.
The power
of investing
can support
achieving one’s
personal
aspirations,
whether
through
buying
a
home,
growing
a
company, supporting future financial goals or having an impact.
We
will
connect
people,
both
internally
and
externally,
to
convene
an
ecosystem
where
ideas
and
opportunities
come
together to be successful and to make a difference.
We will
help build a
better world by
thinking sustainably
and
creating opportunities that
help reduce, rather
than contribute to,
inequalities.
Sustainability is at the core of our purpose
We know finance has a powerful influence on the
world. At UBS,
we are reimagining the power of
people and investments, to
help
create
a
better
world
for
everyone:
a
fairer
society,
a
more
prosperous
economy
and
a
healthier
environment.
We
are
partnering
with
our
clients
to
help
them
mobilize
their
capital
toward
a
more
sustainable
world.
It
is
why
we
have
put
sustainability
at
the
heart
of
our
own
purpose.
To
help
us
maximize our
impact and
direct capital
to where
it is
needed most,
we
are
focusing
on
three
key
areas
to
drive
the
sustainability
transition: planet, people, partnerships.
Planet:
We
are
making
climate
a
clear
priority
as
we
shift
toward
a
lower-carbon future.
We
will
provide
transparency on
our milestones
along the
way to
make sure
our progress
can be
tracked. We are
not only focused
on our own
journey; we are
also
supporting our clients in their own transitions.
People:
Through our
interactions, we
are working
to address
wealth
inequality,
sharpening
the
focus
of
our
client
and
corporate philanthropy, and
our employee-led community
affairs
activities centered on health and education.
Partnerships:
By
working
in
partnership
with
other
thought
leaders and standard setters,
our goal is to
make an impact on a
truly global scale. To create change, we realize that
all of us have
to
unite
around
common
goals.
That
is
why
we
engage
with
regulators,
policymakers
and
others
to
create
standards
and
support research and development across the financial sector.
Our promise to our clients
Helping
clients to
achieve
their financial
goals is
the essence
of
what we
do. We
aim to
differentiate our
service by
delivering a
client experience that is:
–
Personalized:
Our products
and services
are as
personal as
our
clients’ needs.
–
Relevant:
What
we
deliver
to
our
clients
is
relevant
and
matters to them.
–
On-time:
Clients
set
the
pace
and
can
act
on
opportunities
anytime and anywhere.
–
Seamless:
Interacting
with
us
is
simple,
seamless,
and
intuitive.
1
Based on Euromoney’s Award for Excellence, published on 10 September 2021:
euromoney.com/article/28teruws4k57c6h8c83k3/awards/awards
-for-excellence/worlds-best-bank-for-wealth-management-2021-ubs
.
17
Convening THE global ecosystem for investing
We are at our
best when our clients are able
to access all of UBS
through a single relationship, to
get a differentiated, personalized
experience, and
when they
are connected
to other
areas of
the
firm, to providers, and to other clients with similar goals.
With
our
global
footprint
and
USD 4.6
trillion
in
invested
assets, combined with
our thought
leadership, we not
only attract
clients, but are also interesting to external contributors.
We
are
uniquely
positioned
to
be
the
orchestrator
of
this
ecosystem. We
are a gateway
to a large
and diverse
client base,
we
have
strong
relationships
with
contributors
and
we
are
a
thought leader in
the industry.
This positions us
to curate
offerings
and
opportunities
in
the
ecosystem,
while
leveraging
our
networks, data,
and analytics,
to provide
ultimate matchmaking
between clients and contributors.
That is why our
vision is to convene
THE global ecosystem for
investing
–
where
thought
leadership
is
impactful,
people
and
ideas are connected, and opportunities are brought to life.
Our strategy, business model and environment
| Our strategy
18
Our strategic imperatives
Five strategic imperatives will help us deliver on
our strategy, bring our purpose to life, fulfill our client promise and achieve our
vision.
Behind these are a set of initiatives that will develop UBS along our strategic direction.
Clients, connections, contributors – delivering the power of investing
UBS is a firm that attracts clients, employees and thought leaders who have the power to enable change and
bring ideas to life, and who have capacity to do a lot of good. By bringing the best of UBS to our clients in a
seamless experience, growing our ecosystem and encouraging connections across it, we can deliver the full
power of investing to our clients. Client needs can be more broadly met. Our clients and the trust they place in us
will be put at the center of everything we do. Clients will benefit from having us as a trusted guide and thought
partner, having all our products and
services available at their fingertips and getting a differentiated and
personalized experience.
Focus – play where we are positioned to win
We intend to maintain our position as a leading global wealth manager and to build on this strength. We will
prioritize our efforts where we can add the most value and make a difference. To
achieve this we are working to
reduce duplication and reallocate resources as necessary,
all while growing our position as the world’s leading
wealth manager.
Technology
– make technology our differentiator
We will use our investments in technology to deliver a seamless client experience as part of our client promise.
We have been building our technology foundations over past years. We will move forward by focusing on how
clients experience UBS every day, becoming more
agile and focusing on outcomes through a modular approach.
With this mind, we intend to transform the way we use and consider technology, thinking about it as a
differentiator for us.
Simplification and efficiency – increase ease of doing business and enable our journey
We can make it easier for our clients to do business with us, as well as for our employees to make decisions and
take responsibility.
We intend to further streamline and standardize our functions, processes, entities and general
ways of doing business to increase efficiency and increase capacity to invest for future growth.
Culture – mobilize employees behind our future vision and act as one firm
We already have a strong, inclusive culture, grounded in our three keys to
success: our Pillars, Principles and
Behaviors. We will further strengthen our culture so we can do more and do it better.
Our purpose will unite us.
We will act as one firm, with common values and ambitions. In order to be successful on our journey,
we will
further develop our cultural priorities.
19
Leveling up technology
Introduction
The world is
faster,
more digital and
more data-driven
than ever
before,
with
clients
increasingly
demanding
service
s
that
are
digital first, anytime
and anywhere,
and underpinned by
first-class
technology.
In
addition,
the
financial
industry
ecosystem
is
constantly
evolving,
becoming
even
more
competitive,
open,
connected and location-independent every day.
This presents an
opportunity for
us to fully
embrace technology
and make it a
differentiator for our
firm. Doing so is
central to our
client promise
to deliver
a client
experience that
is personalized,
relevant, on-time and seamless.
To support
our ambitions,
we have
appointed a
Group Chief
Digital and Information
Officer to the
Group Executive Board. To
guide our digital transformation and
to enhance the way we
live
up to our
client promise, we
have also established
a Leveling up
strategy based
on five
key pillars:
Agile@UBS; quarterly
business
reviews
and
digital
roadmaps;
modern
tech;
automation;
and
engineering excellence (digital culture).
Agile@UBS
In order
to deliver
digital solutions
faster and
remain responsive
and adaptable, we
are introducing a unified
agile approach across
the whole firm.
To support
this, we
have developed
a robust
framework and
rollout plan, which
includes clearly
defined role
profiles, a
bespoke
playbook and a dedicated academy training suite.
Currently
,
we
have
10,000
employees
across
the
firm
transitioning
to
the
new
Agile@UBS
ways
of
working
and
we
expect this to increase
to more than 20,000 by
the end of 2022.
Relevant resources
and training
will also
be available
to all
staff,
enabling everyone to apply agile principles to their work, thereby
helping to deliver an even better client experience.
Quarterly business reviews and digital roadmaps
Quarterly business reviews (QBRs)
and digital roadmaps help
us to
manage our
technology investment portfolio
in a
more strategic
and flexible way. The QBRs serve as a
forum to agree on the
most
important objectives that
align with our
strategy and are
intended
to
ensure
we deliver
more
frequent
and
valuable outcomes
for
our clients. The digital roadmaps help us
to keep investment and
design
decisions
aligned
to
our
client
promise
and
our
longer-
term vision.
Modern tech
We
believe the
bank of
the future
will leverage
a lean,
modern
tech estate and
Cloud-based applications. Modern tech
makes a
shorter
time
to
market
possible,
removes
dependencies,
accelerates
digitalization
and
facilitates
connection
with
the
financial
industry
ecosystem
to
provide
better
and
faster
client
services.
In
line
with
our
modern
tech
ambitions,
we
migrated
over
1,000
applications
to
the Cloud
during
2021 and
established a
governance
framework
to
identify
and
decommission
legacy
technologies.
Automation
To
achieve
our
vision,
we
are
building
a
best-on-street
development and technology operations experience, powered by
modern development tools and automation techniques.
We have also introduced
a new Artificial Intelligence,
Data and
Analytics (ADA) center of expertise. ADA will bring together data
scientists and
analytics experts
from across
the firm
to ensure
a
consistent firm-wide approach to these topics. ADA will also help
empower
our
strategy
and
ecosystem,
using
AI
and
machine
learning for the benefit of our clients.
Engineering excellence (digital culture)
To succeed in making technology a differentiator for our firm, we
must attract and retain the best engineers, which is only
possible
by
creating
and
fostering
an
engineering
and
digital
culture
of
excellence.
Best-in-class tech
learning journeys
and curricula
for
our engineers, a respected
Certified and Distinguished Engineers
framework, an effective
hiring strategy, and targeted competency
assessments and development plans for our
technical staff will be
implemented to support this ambition.
›
Refer to the “Our businesses”
section of this report for more
information about how we deploy our technology
approach in
our businesses
Our strategy, business model and environment
| Targets, aspirations and
capital guidance
20
Targets, aspirations and capital guidance
We aim
to create sustainable
value through the
cycle. Reflecting
our improved
operating performance
over the
last two
years, in
February
2022
we
updated
our
financial
targets,
which
had
previously been set in January 2020.
In
addition,
we
have
outlined
selected
commercial
and
environmental,
social
and
governance
(ESG)
aspirations,
which
support these targets.
Our
capital
guidance
remains
unchanged.
We
intend
to
operate
with
a
CET1
capital
ratio
of
around
13%
and
a
CET1
leverage
ratio
of
greater
than
3.7%.
The
Investment
Bank
is
expected
to
represent
up
to
one-third
of
Group
risk-weighted
assets (RWA) and liquidity ratio denominator (LRD).
Performance against targets,
aspirations and capital
guidance
is taken into account when determining variable compensation.
The
table
below
shows
our
updated
financial
targets
and
aspirations,
based on reported results.
›
Refer to “Society” and “Our focus on sustainability
and climate”
in the “How we create value for our stakeholders”
section and
to the “Corporate governance” section
of this report for more
information about ESG
›
Refer to the “Compensation” section
of this report for more
information about variable compensation
›
Refer to “Alternative performance
measures” in the appendix to
this report for definitions of and further information
about our
performance measures
Targets
and aspirations
ESG
Selected aspirations
Commercial
Selected aspirations
Financial
Targets
Net-zero
own operations
(scopes
1 and 2) by 2025
USD 235 billion invested assets
aligned to net zero
by 2030, Asset Management
USD 1 billion philanthropy donations
to reach 25 million beneficiaries
raised by 2025
USD 400 billion invested assets
in sustainability-focus and impact
investing
1
by 2025
More than USD 6 trillion
invested assets across Global Wealth
Management, Asset Management and
Personal & Corporate Banking
More than 5% growth
2
in net new fee-generating assets
of Global Wealth Management
15–18%
return on CET1 capital
70–73%
cost / income ratio
10–15%
2
growth in Global Wealth Management
profit before tax
1
Sustainability-focus and impact investing: sustainability focus is strategies
where sustainability is an explicit part of the investment
guidelines, universe, selection, and
/ or investment process; impact investing is
strategies that have an explicit intention to generate measurable, verifiable,
positive sustainability outcomes. Impact generated is attributable to investor action and / or contribution.
2
Over the cycle.
21
Our businesses
Delivering one ecosystem
We
operate
through
four
business
divisions:
Global
Wealth
Management, Personal &
Corporate Banking, Asset
Management
and the Investment Bank. Our
global reach
and the
breadth of
our
expertise are
major assets
setting us
apart from our
competitors.
We
see
joint
efforts
as
key
to
our
growth,
both
within
and
between business divisions.
We aim
to unlock the
power of one
UBS through our
innovative solutions
and differentiated offerings.
We
are
at our
best when
we combine
our strengths
to provide
our clients more comprehensive and better solutions through, for
example,
a
Unified
Global
Markets
team
across
Global
Wealth
Management
and
the
Investment
Bank,
and
a
Global
Family
O
ffice
joint
venture
.
Initiatives
such
as
the
Group
Franchise
Awards
encourage employees to look for ways to connect across
teams and offer the whole firm to our clients.
How we deliver the whole firm to our clients – examples
Wealth management platforms
In all locations outside the Americas, we utilize
the Wealth Management Platform, which is
shared
between Global Wealth Management and Personal
& Corporate Banking in Switzerland.
This platform
can be navigated intuitively and supports
strong advice capabilities across all channels, helping our clients
to benefit from a broader universe of products and services,
simplified onboarding, and a better banking
experience. In the Americas, our clients
benefit from the Wealth Management Americas Platform,
as well
as our innovative partnership with Broadridge, which
is aimed at improving productivity and the user
experience by revamping the technology used for our
advisors’ workstations.
Separately managed accounts
In the US, we combined portfolio management
and execution resources within Asset Management
during 2020. Alongside this, we introduced a new
approach where Global Wealth Management clients
can access selected separately managed account
(SMA) strategies in the Americas with no
additional
management fees. This transformative
move allows our advisors to focus on delivering
the best ideas,
solutions and capabilities to our clients, regardless of
where they originate in the firm.
Shifts and referrals
To ensure that our clients are best served according to their needs and foster growth by offering a
universal bank delivery model in Switzerland,
we have introduced a holistic collaboration framework
for
Personal & Corporate Banking. We systematically
initiate client shifts from Personal Banking to
Global
Wealth Management when the clients’ investing
needs become sufficiently complex. In addition,
we
encourage our client advisors to continuously
generate leads for services provided by other business
divisions. Typical examples are corporate and institutional clients being introduced to Asset
Management
for mandate solutions or to the Investment Bank
for capital market transactions, thus providing
access to
our global expertise,
and entrepreneurs being introduced to Global Wealth Management,
ensuring
holistic coverage of their corporate and private
needs.
Global Family Office
Our Global Family Office unit brings together
the capabilities of Global Wealth Management,
Asset
Management and the Investment Bank to
leverage growth opportunities and deliver holistic
solutions. It
provides customized, institutional-style services to wealthy
families and individuals seeking access to
equity markets and advisory services,
and assisting clients with raising capital from public
and private
markets.
Global Lending Unit
As a further step in serving the financing
and lending needs of all UBS clients worldwide,
we set up a
division-agnostic Global Lending Unit in 2020. Its
key objective is delivering lending capabilities
to clients
of both the Investment Bank and Global
Wealth Management. The unit provides product expertise to
clients through collaboration with Investment
Bank bankers and Global Wealth Management
advisors. It
is organized with a regional focus by grouping existing
regional resources and competencies to best serve
respective markets and clients.
Unified Global Markets team
We are continuing to develop a strategic partnership
between Global Wealth Management and the
Investment Bank that is focused on growth – in our
ultra high net worth, middle market institutions
and
public finance businesses – and identifying
synergies across the supporting infrastructure. This
important
initiative includes a Unified Global Markets team,
integrating risk management systems
and simplifying
our regional operating processes.
Our strategy, business model and environment
| Our businesses
22
Global Wealth Management
As
a
leading
truly
global
wealth
manager,
1
with
over
USD 3.3
trillion in
invested assets, our
goal is to
provide tailored
financial
services,
advice
and
investable
solutions
to
wealthy
individuals
and
families
around
the
world.
The
spectrum
of
our
services
ranges
from
investment
management
to
estate
planning
and
corporate
finance
advice,
in
addition
to
specific
wealth
management
products
and
services.
The
business
is
managed
globally across the regions.
Organizational changes
As part
of the
Group-wide creation
of the
Artificial Intelligence,
Data
and Analytics
center of
expertise
in October
2021,
Global
Wealth
Management
established
the
Smart
Technologies
&
Advanced
Analytics
Team.
Leveraging
our
Evidence
Lab
Innovations
team’s
experience
and
expertise,
the
Smart
Technologies
& Advanced Analytics Team
focuses on developing
a
smart
ecosystem
that
applies
artificial
intelligence,
advanced
analytics and data science to empower
our advisors with insights
and tools that
help them anticipate
client needs and
deepen client
relationships.
On
1 July 2021,
the Global
Wealth
Management Operations
team was
formally integrated
into Global
Wealth Management,
following
the
Group-wide
decision
to
move
each
of
the
firm’s
business-aligned Operations
teams into
their respective
divisions
in
order
to
become
even
more
client-centric,
agile
and
digital,
while creating a seamless experience for our clients.
We
continually
review
all
our
businesses
for
growth
opportunities, future potential and
efficiency. As a result,
in 2021,
we
completed
the
sale
of
our
domestic
wealth
management
business in Austria.
We also announced
our intention to
sell our
domestic wealth
management business
in Spain.
As part
of the
latter sale, the parties aim to
negotiate a cooperation agreement
to
provide
clients
with
access
to
selected
UBS
products
and
services. We expect this deal to
close in the third quarter of
2022.
In
December
2021,
we
signed
an
agreement
to
sell
UBS
Swiss
Financial
Advisers
AG,
a
Switzerland-based
SEC-registered
investment advisor and FINMA-licensed securities firm
that offers
US clients tailored investment solutions. On 26 January 2022, we
entered into
an agreement
to acquire
Wealthfront, an
industry-
leading
digital
wealth
management
provider.
This
acquisition
is
aligned
with
our growth
strategy in
the Americas,
will broaden
our
reach
among
affluent
investors
and
add
a
new
digital-first
offering,
increasing our distribution capabilities.
Our focus
We
serve
high
net
worth
and
ultra
high
net
worth
individuals,
families and family offices worldwide,
as well as affluent clients
in
selected markets. Our
dedicated Global Family
Office unit
works
with ultra high
net worth individuals and
their families to
deliver
bespoke solutions
using the
best of
our global
capabilities from
the Investment Bank and Asset Management.
Already a
market leader
in the
ultra high
net worth
segment
outside the US,
1
we are also executing our strategy to be
the firm
of
choice
for
the
wealthiest
clients
in
the
US,
many
of
whom
already have relationships with UBS. Our global footprint enables
us to
capture growth
in the
largest and
fastest-growing
wealth
markets (the US and Asia Pacific, respectively).
Our
Chief
Investment
Office
(CIO)
celebrated
its
10th
anniversary in the
first quarter of
2021. Growing from
just three
employees in 2011 to over
1,100 by year-end 2021, our CIO has
a presence in
18 locations
and is
responsible for investment
advice
and management of more than USD 3.3 trillion in assets globally.
Our CIO’s
insights provide
the foundation
for the
global UBS
ecosystem,
which
connects
clients
with
content
and
solutions.
Close
integration
between
idea
generation
and
product
development results in CIO-aligned solutions delivering real value
to
clients
and
spurr
ing
innovations
such
as
the
investment
modules in
UBS Manage
Advanced [My
Way]
. In
Asia the
Direct
Investment
Insights
function
in
our
online
banking
platform
enables
clients
to
trade
directly
based
on
CIO
insights
via
their
smartphones or devices.
By
making
operational
processes
more
efficient,
we
also
enhance
advisor
productivity.
Our
investment
in
operating
platforms and tools that support our clients and advisors is
aimed
at better serving our
clients’ needs and improving
efficiency. As of
31 December
2021,
more
than 85%
of
invested
assets
outside
the Americas were booked on our strategic
Wealth Management
Platform
.
In
the
US,
in
collaboration
with
software
provider
Broadridge,
we are
building
the
Wealth
Management
Americas
Platform
,
for
which
we
continue
software
delivery,
with
full
conversion targeted for 2023. The development of our platforms
is happening
alongside enhancements
to our digital
capabilities,
for the benefit of our clients and advisors.
›
Refer to “Clients” in the “How
we create value for our
stakeholders” section and to “Leveling
up technology” in the
“Our strategy” section of this report for more information
about
innovation and digitalization
How we operate
Our
global
footprint
and
presence
in
the
world’s
largest
and
fastest-growing
markets
position
us
well
to
serve
clients
with
global interests and
demands. They also
make broad access
across
solutions and geographies
in different market conditions
possible.
The US
is our
largest market,
accounting for
around half
of our
invested
assets.
We
are
the largest
private
bank in
Asia Pacific
2
and
one
of
the
largest
in
Latin
America,
1
in
terms
of
invested
assets.
In Switzerland, we
hold the leading
market position
1
and can
deploy the
full range
of UBS’s
products and
services. Our
domestic
footprint
in
Western
and
Central
Europe,
the
Middle
East,
and
Africa enables us to provide locally tailored offerings and
ensures
we are close to our clients.
In
April
2021,
we
opened
a
wealth
management
advisory
office in Doha, Qatar,
as a further sign of our commitment to the
Middle East, an important and growing region for us.
1
Statements of market position for Global Wealth Management are based on UBS’s
internal estimates and publicly available information about competitors’ invested assets.
2
Digital Wealth Management in Asia Pacific, KPMG 2021.
23
Joint efforts
with the
Investment Bank,
Asset Management
and
selected external partners
enable us to
offer clients broad
access
to
financing,
global
capital
markets
and
bespoke
portfolio
solutions.
For
example,
in
the
Americas,
our
Private
Markets
OneBank Partnership has
established one centralized
function to
manage
the
origination
and
distribution
of
all
private
markets
transactions, side
by side
with the
cross-divisional origination
of
the
Investment Bank’s
Global Banking
business.
Additionally, to
ensure
we
a
re
placing
resources
close
to
clients,
dedicated
investment
bankers
are
now
embedded
in
G
lobal
W
ealth
Management’s Private Wealth Services Hubs across the US.
These
investment bankers work
side by side
with our financial
advisors
to
drive
focused,
proactive
coverage
of
investment
banking
business from our wealthiest clients.
›
Refer to “
Delivering one ecosystem
” in this section for examples
of the joint efforts of the business divisions
Our competitors
fall into
two categories:
peers with
a strong
position in the Americas but
more limited global footprints, such
as
Morgan
Stanley
and
JP
Morgan;
and
peers
with
similar
international
footprints
and
operating
models,
but
with
significantly smaller presences than UBS in the US, such as Credit
Suisse and Julius Baer. We have strategically built strong positions
in the
fastest-growing client segment
(ultra high
net worth) and
region
(Asia
Pacific).
The
size
and
the
diversification
of
our
footprint, as well
as our premium
brand and reputation,
would be
difficult and expensive to replicate.
What we offer
Our distinctive
approach
to wealth
management
is designed
to
help our clients pursue what matters most to them.
We
aim
to
offer
clients
the
best
solutions,
services
and
expertise
globally.
Our
experts
provide
thought
leadership,
investment analysis
and investment
strategies, and
develop and
source solutions for our clients.
The CIO provides our
UBS House
View
,
identifying
investment
opportunities
designed
to
protect
and increase our clients’ wealth over the longer term.
Regional
client
strategy
teams
use
direct
client
feedback,
findings from
periodic
Investor Watch
surveys and
insights from
the Smart Technologies
& Advanced
Analytics Team
to deepen
our
understanding
of
clients’
needs.
Our
product
specialists
deliver
inves
tment
solutions
,
including
our
flagship
investment
mandates, as well
as innovative
long-term themes
and sustainable
investment offerings.
Clients
benefit
from
our
comprehensive
expertise,
including
wealth
planning,
investing,
sustainability
and
impact
investing,
philanthropy,
corporate
and
banking
services,
as
well
as
family
advisory
services.
We
also
offer
extensive
mortgage,
securities-
based and structured lending expertise.
In 2020, we became the first
major global financial institution
to make sustainable
investments the preferred solution
for private
clients
investing
globally.
This
focus
led
to
high
levels
of
client
activity in
2021 and reflected
both our own
belief in sustainable
and
impact
investing
from
a
performance
perspective
and
increased
client
demand
for
relevant
advice
and
solutions.
Our
discretionary
offerings
aligned
to
our
s
ustainable
investing
strategic
asset
allocation
exceeded
USD 30
billion
in
invested
assets as of 31 December 2021.
Our
clients
accounted
for
75%
(USD 647
million)
of
MPM
Capital’s Oncology Impact
Fund 2 (OIF
2), which closed in
2021,
following the record-setting success of the
UBS Oncology Impact
Fund (OIF 1) in
2016. UBS clients
invested more than
USD 1 billion
across both
Funds. OIF 2
is one
of the
largest dedicated
impact
investment funds in biotech history.
1
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for more
information about sustainability matters
We also continue
to broaden our offering
across asset classes
and
themes,
collaborating
with
external
partners,
such
as
Rockefeller
Asset
Management,
Rethink
Impact
and
Bridge
Investment Group, to provide clients with access to differentiated
sustainable and impact investing opportunities.
We constantly
work on
responding swiftly
to changing
client
needs
and
further
differentiating
our
leading
discretionary
and
advisory mandate offerings. As part
of our long-term cooperation
with
Partners
Group,
we
have
enhanced
our
offering
by
broadening
access
to
private
equity.
Clients
can
diversify
their
mandates into
private equity
by accessing
fully paid-in
solutions
provided by Partners Group and UBS.
In
2020,
we
launched
UBS
Manage
Advanced
[My
Way]
,
a
solution
enabling
clients
to
truly
individualize
their
portfolios.
Based
on
strong
momentum,
client
demand
and
inflows,
we
intend to expand this solution into other markets.
›
Refer to “Clients” in the “How
we create value for our
stakeholders” section and “Leveling up
technology” in the “Our
strategy” section of this report for more information
about
innovation and digitalization
1
Based on a review of healthcare thematic funds using data from PitchBook as of August 2021; impact investing definitions may vary.
Our strategy, business model and environment
| Our businesses
24
25
Personal & Corporate Banking
As
a
leading
Swiss
personal
and
corporate
bank,
we
provide
comprehensive
financial
products
and
services
to
private,
corporate and institutional clients. Personal & Corporate Banking
is the core of our universal bank in Switzerland.
Organizational changes
On
1 July
2021,
the
Personal
&
Corporate
Banking
Operations
team was formally integrated into Personal & Corporate
Banking,
following
the
Group-wide
decision
to
move
each
of
the
firm’s
business-aligned Operations
teams into
their respective
divisions
in
order
to
become
even
more
client-centric,
agile
and
digital,
while creating a seamless experience for our clients.
Our focus
Continu
ed
innovation
and
constant
customer
focus
are
the
factors that differentiate us, as a market
leader across all business
areas we strive to grow at a rate higher than the market. We aim
to be digital at the core: our
client promise is to bring the bank
to
the app, enabling a user experience
that is personalized, relevant,
on-time
and
seamless.
Even
before
the
COVID-19
pandemic,
digitalization had become a major part of
our everyday lives. The
pandemic has increased its relevance and accelerated the pace of
technological change.
To
drive
this
transformation,
we
need
to
better
connect
business and
technology, focus
on the
needs of
our clients,
and
empower our
teams end to
end; in
other words, we
need to be
agile.
The agile
transformation is
essential for
every part
of our
organization.
Agile
is
not
new
to
us
–
we
previously
gained
experience with the
Digital Factory
and
Lighthouses
– but we are
now scaling it to
the next level. In 2021,
we set up a new
virtual
Agile Delivery Organization
.
›
Refer to “Clients” in the “How we create value
for our
stakeholders” section and “Leveling up
technology”
in the “Our
strategy” section of this report for more information
about
innovation and digitalization
In 2021,
we brought
additional sustainable
finance solutions
to
the
market.
We
introduced
Green
Mortgages
brokered
via
key4
, the first Swiss
real estate platform for investment
properties
offering
sustainable
mortgages
in
Switzerland.
In
addition,
we
now offer Swiss retail
clients
Renovation Mortgages
that provide
preferential interest rates
to support energy-efficient
renovations
and construction. On the investment side, we complemented our
UBS Vitainvest
product family
with a
passive solution,
making it
possible
to
invest
for
retirement
in
a
sustainable
way
through
Swiss third-pillar pension funds and vested benefits accounts. We
also launched the innovative
UBS Sustainability Analytics
offering,
helping
institutional
clients
to
achieve
full
transparency
by
screening their portfolios with regard to sustainability aspects.
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for more
information about sustainability-related topics
We
collaborate
with
other
companies
to
better
satisfy
our
clients’
diverse needs. For example, in 2021, we
started a project
with
Swiss
fintech
start-up
Yokoy
to
provide
extensive
cash
management
services
to
corporate
clients,
from
automated
generation of expense reports to validation of supplier invoices.
How we operate
We operate
primarily
in our Swiss
home market.
With our Personal
Banking and
Corporate & Institutional Clients business areas,
we
are
organized into
10
regions, covering
distinct Swiss
economic
areas. Due to increasing client demand for remote access
and the
increased offering via
our in-demand digital and remote
channels,
in the first quarter
of 2021 we reduced our
branch network by
44
branches
to 195
branches.
This followed
the closure
of 28
branches
in 2020.
We also
support
the international
business
activities
of our
Swiss
corporate
clients
through
local
hubs
in
New
York,
Frankfurt,
Singapore and
Hong
Kong
SAR.
No
other
Swiss bank
offers its
corporate clients
local banking
capabilities
abroad.
In
Personal Banking,
our
main
competitors are
Credit
Suisse,
PostFinance, Raiffeisen,
cantonal banks,
and
other
regional and
local
Swiss
banks;
we
also
face
competition from
international
neobanks and other national digital market participants. Areas of
competition
are
basic
banking
services,
mortgages
and
foreign
exchange, as
well as investment
mandates and
funds.
In
Corporate
&
Institutional
Clients,
Credit
Suisse,
cantonal
banks and globally active
foreign banks are our main competitors.
We
compete in
basic banking
services, cash management, trade
and
export
finance,
asset
servicing,
investment
advice
for
institutional clients, corporate finance and lending, and
cash and
securities
transactions
for banks.
Our strategy, business model and environment
| Our businesses
26
What we offer
Our personal banking
clients have access
to a comprehensive,
life-
cycle-based
offering,
a
broad
range
of
basic
banking
products,
from
payments
to
deposits,
cards,
and
convenient
online
and
mobile
banking,
as
well
as
lending
(predominantly
mortgages),
investments and retirement services. This is
complemented by our
UBS
KeyClub
reward
program,
which
provides
clients
in
Switzerland with exclusive and attractive offers (some from third-
party
partners).
We
work
closely
with
Global
Wealth
Management to provide our clients with access to leading private
banking and wealth management services.
Our
corporate
and
institutional
clients
benefit
from
our
financing and investment solutions
,
in particular access to
equity
and debt capital
markets, syndicated
and structured
credit, private
placements,
leasing,
and
traditional
financing.
We
offer
transaction banking solutions
for payment and
cash management
services, trade
and export
finance, and
global custody
solutions
for institutional clients.
We
work
closely
with
the
Investment
Bank
to
offer
capital
market and
foreign exchange
products, hedging
strategies, and
trading
capabilities,
as
well
as
corporate
finance
advice.
In
cooperation with
Asset Management,
we also
provide fund
and
portfolio management solutions.
›
Refer to “
Delivering one ecosystem
” in this section for examples
of the joint efforts of the business divisions
27
Asset Management
Asset
Management
is
a
large-scale
and
diversified
global
asset
manager,
with
USD 1.2
trillion
in
invested
assets.
We
offer
investment capabilities and
styles across all
major traditional and
alternative asset
classes, as
well as
advisory support to
institutions,
wholesale intermediaries and Global Wealth Management clients
around the world.
Organizational changes
Following the sale of our majority stake in 2020, in 2021 we sold
our remaining
minority investment
(48.8%) in Clearstream
Fund
Centre
AG
(previously
Fondcenter
AG)
to
Deutsche
Börse
AG.
Long-term commercial cooperation arrangements
remain in place
for
the
provision
of
services
by
Clearstream
to
UBS,
including
collaboration on jointly servicing banks and insurance
companies.
On 1 July 2021, the Asset Management
Operations team was
formally integrated
into Asset
Management, following
the Group-
wide
decision
to
move
each
of
the
firm’s
business-aligned
Operations
teams
into
their
respective
divisions
in
order
to
become even more client-centric, agile and digital, while creating
a seamless experience for our clients.
Our focus
Our
strategy
is
focused
on
capitalizing
on
the
areas
where
we
have
a
leading
position
and
differentiated
capabilities,
so
as
to
drive further profitable growth and scale.
Sustainable and impact investing remains a key area, as clients
increasingly
seek
solutions
that
combine
their
investment
goals
with sustainability objectives. We are continuing the
expansion of
our
world-class
capabilities
through:
product
and
service
innovation; dedicated research;
integrating environmental, social
and
governance
(ESG)
factors
into
our
investment processes
by
leveraging
our
proprietary
analytics;
and
active
corporate
engagement.
During
2021,
we
enhanced
our
ESG
methodology
and
data
sets, deepened the
integration of carbon
data into
our investment
processes,
and
worked
to
expand
our
ESG
integration
across
alternative
asset
classes.
We
also
increased
the
entire
range
of
UBS sustainable exchange-traded funds
(ETFs), which represented
USD 40 billion in invested assets
as of 31 December 2021. These
ETFs
provide
exposure
to
various asset
classes
with
significantly
lower carbon
intensity compared
with their
respective market
cap-
weighted parent
indices and
help investors
to both
reduce their
climate risks and benefit from opportunities arising from the shift
toward a lower-carbon economy.
In addition, we
continued to expand
our Climate Aware
suite
of
products
and
our
Climate
Aware
invested
assets
grew
to
USD 23
billion,
a
53%
increase
year
on
year.
Our
sustainability
focus and impact invested assets totaled
USD 172 billion, a 77%
increase year on year.
As
a
founding
member
of
the
Net
Zero
Asset
Managers
1
initiative, we published an
interim target and have
committed to
align USD 235
billion of invested
assets by
2030. We
are one of
the largest
and most
diversified firms
to have
set a
2030 target
and we
continue to
work with
our clients,
standard setters
and
industry bodies to
help develop
the new methodologies,
tools and
data needed by investors to effect further change.
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for more
information about sustainability matters
In
response
to
the
increasing
importance
of
private
markets
and
alternative
investments,
we
are
building
on
our
existing
expertise in these areas, including our real estate and hedge fund
businesses, as well as
our capabilities across
infrastructure, private
equity and private debt.
We
also
continue
to
develop
our
award-winning
2
indexed
businesses
globally,
including
ETFs
in
Europe,
Switzerland
and
Asia. We focus on sustainable
investing across our index product
range
and
provide
customization
while
leveraging
our
highly
scalable platform.
›
Refer to “Clients” in the “How we create value
for our
stakeholders” section and to “Leveling
up technology” in the
“Our strategy”
section of this report for more information
about
innovation and
digitalization
Geographically,
we
are
building
on
our
extensive
and
long-
standing presence in the Asia Pacific region.
In China, one of the
world’s fastest-growing asset management markets,
we continue
to
invest
in
our
leading
presence
and
products,
both
on-
and
off-shore, and are ranked as the number one foreign manager of
inbound invested assets in Greater China.
3
In the
rapidly evolving
and attractive
wholesale segment,
we
aim
to
significantly
expand
our
market
share
through
a
combination
of
measures:
a
continued
increase
in
the
share
of
clients’
business;
expansion
of
our
strategic
partnerships
with
distributors; the
build-out of
our client
service and product
shelf
offerings;
and
the
launch
of
new
white-labeling
and
implementation capabilities.
1
netzeroassetmanagers.org
2
Passive Manager of the Year in the Insurance Asset
Risk EMEA Awards, January 2021 and ranked fourth
largest ETF provider in Europe as of December 2021 (source: ETFGI).
3
Ranking compiled by Broadridge in October 2021.
Our strategy, business model and environment
| Our businesses
28
We
also
continue
our
joint
efforts
with
the
other
business
divisions, in particular with Global
Wealth Management, enabling
our
teams to
draw
on
the best
ideas,
solutions
and capabilities
from
across
the
firm
in
order
to
deliver
superior
investment
performance
and
experiences
for
our
clients.
For
example,
the
separately
managed
accounts
initiative
with
Global
Wealth
Management
in
the
US
generated
USD 27
billion
in
net
new
money inflows
in 2021
and USD 127
billion in
invested assets.
This
firmly
positions
us
to
capture
attractive
opportunities
in
other
channels by
leveraging our
world-class expertise
and capabilities
to meet growing client demand.
›
Refer to “
Delivering one ecosystem
” in this section for examples
of the joint efforts of the business divisions
To
support
our
growth,
we
are
focused
on
disciplined
execution
of
our
operational
excellence
initiatives.
This
includes
further
automation,
simplification,
process
optimization
and
offshoring /
nearshoring of
selected activities,
complemented by
continued modernization
of our
platform and development
of our
analytics and data capabilities.
How we operate
Our business division
is organized into
five areas: Client
Coverage,
Investments, Real Estate
& Private Markets,
Products and the
COO
(Operations).
We cover
the main
asset management
markets globally,
and
have
a
local
presence
in
23
locations
across
four
regions:
the
Americas, Asia Pacific,
EMEA and Switzerland.
We have nine
main
hubs: Chicago, New York,
London, Zurich, Singapore,
Hong Kong
SAR,
Shanghai, Tokyo and Sydney.
Our
main
competitors
are
global
firms
with
wide-ranging
capabilities and distribution
channels, such
as Amundi,
BlackRock,
DWS,
Goldman
Sachs
Asset
Management,
Invesco,
JPMorgan
Asset
Management,
Morgan
Stanley
Investment
Management
and Schroders,
as
well as
firms with
a
specific market
or
asset-
class focus.
What we offer
We offer clients a wide
range of investment products
and services
in
different
asset
classes,
in
the
form
of
segregated,
pooled
or
advisory
mandates,
as
well
as
registered
investment
funds
in
various jurisdictions.
Our
traditional
and
alternative
capabilities
include
equities,
fixed income,
hedge funds,
real estate
and private
markets, and
indexed
and
alternative
beta
strategies
(including
exchange-
traded
funds),
as
well
as
sustainable
and
impact
investing
products and solutions.
Our Investment Solutions
business draws on
the breadth of
our
capabilities
to
offer:
asset
allocation
and
currency
investment
strategies across the risk–return
spectrum; customized multi-asset
solutions,
advisory
and
fiduciary
services;
and
multi-manager
hedge fund solutions and advisory services.
29
Investment Bank
The Investment
Bank provides
services to institutional,
corporate
and wealth management
clients, helping them
raise capital,
invest
and manage risks, while targeting attractive and sustainable risk-
adjusted returns for shareholders. Our traditional strengths are in
equities, foreign exchange, research, advisory services and capital
markets, complemented by
a targeted rates
and credit platform.
We
use our
data-driven
research
and
technology capabilities
to
help clients
adapt to
evolving market
structures and
changes in
regulatory,
technological, economic and competitive landscapes.
Aiming
to
deliver
market-leading
solutions
by
using
our
intellectual capital and electronic platforms, we work closely with
Global Wealth
Management, Personal &
Corporate Banking and
Asset Management to
bring the best
of UBS’s capabilities
to our
clients.
We
do
so
with
a
disciplined
approach
to
balance
sheet
deployment and costs.
Organizational changes
In February 2021, we announced that Piero Novelli,
Co-President
Investment Bank,
would step down,
and, effective
1 April 2021,
Robert
Karofsky,
Co-President
Investment
Bank,
was
appointed
sole President Investment Bank.
On
1 July
2021,
the
Investment
Bank
Operations
team
was
formally
integrated
into
the
Investment
Bank,
following
the
Group-wide decision to move each of the firm’s business-aligned
Operations
teams
into
their
respective
divisions
in
order
to
become even more client-centric, agile and digital, while creating
a seamless experience for our clients.
In
January
2022,
Global
Research
and
the
Strategic
Insights
team, formerly part of Evidence Lab Innovations, were integrated
into the Investment Bank as Investment
Bank Research. This new
setup has better aligned our research coverage with the needs of
our
clients,
while
continuing
to
provide
research
and
analytical
services across the firm.
Our focus
Our priority
is provi
ding seamless
client
service and
high-quality
execution, through disciplined growth in
the capital-light advisory
and
execution
businesses,
while
accelerating
our
digital
transformation.
We
aspire
to
provide
best-in-class
services
and
solutions to our corporate, institutional and wealth management
clients through
an integrated,
solutions-led approach.
In Global
Banking,
we position
ourselves as
trusted advisors
via our
deep
client coverage and ability to
provide
access to the full capabilities
of UBS.
Our
global
coverage
model
utilizes
our
vast
international
industry expertise and product
capabilities to meet the
emerging
needs of clients. We
provide clients with excellence in
execution,
financing
and
structured
solutions
through
our
Global
Markets
franchise.
In
Global
Markets,
our
sharpest
competitive
edge
comes from coordinating
our services across
a wide range
of asset
classes and products. We provide
nimble, innovative and bespoke
access
to
solutions,
from
market
and
insight
tools
to
trading
strategies and execution.
Investment Bank Research continues to publish research based
on
primary
data
to
concentrate
on
data-driven
outcomes
and
offer
clients
key
insights
on
securities
and
themes
in
major
financial
markets
around
the
globe.
In
April
2021,
Research
entered into a strategic partnership
with Lynk Global, an artificial-
intelligence-driven
knowledge-as-a-service
platform,
to
help
clients
make
better,
more
informed
investment
and
business
decisions. In September 2021, we
announced a strategic research
redistribution
agreement
with
Wind,
the
leading
financial
information provider in China, to offer onshore content to clients
who invest
through Wind. Investment
Bank Research
was also a
founding
partner
and
investor
in
Visible
Alpha,
a
model
aggregation platform that
is now firmly
embedded in many
of the
workflows of our core clients.
Our digital strategy harnesses technology
to provide access to
a
wide
range
of
sources
of
global
liquidity
and
differentiated
content. The Investment Bank strives to be the digital investment
bank of
the future,
taking our
best ideas
and turning
them into
reality,
with
innovation-led
businesses
driving
efficiencies
and
solutions.
We
aim
to
develop
new
products
and
solutions
consistent
with
our
capital-efficient
business
model,
which
are
most
often
related
to
new
technologies
or
changing
market
standards.
In
February
2021,
we
announced
the
creation
of
a
single
Digital
Platforms
function
within
the
Investment
Bank
across
Global Markets and
Global Banking, utilizing
digital competencies
to
benefit
all
products
and
maximizing
the
return
on
our
technology
spend
in
close
partnership
with
Group
Technology.
Digital Platforms
combines product expertise with deep technical
know-how, aiming to reduce the number
of systems and increase
automation,
maximizing
client
impact,
revenue
and
digital
adoption. The
Digital Platforms
function was an
early adopter of
Agile@UBS
,
an
evolution
of
the
historically
close
collaboration
with
our
Chief Data
and Information
Office, creating
long-lived
teams that learn and continuously
improve,
which in turn attracts
the best talent.
Our
Investment
Bank
Accelerated
Digital
Agile
Platform
Transformation
initiatives form
the basis
of our
digital roadmap,
with
the
ambition
of
hav
ing
a
simplified
and
ultra
-
modern
technology landscape that is
secure and stable,
where we re-use
more
of
everything
and
where
the
platforms
work
together
to
drive progress toward our overall strategic imperatives.
›
Refer to “Clients” in the “How we create value
for our
stakeholders” section and to “Leveling
up technology” in the
“Our strategy” section of this report for more information
about
innovation and digitalization
Our strategy, business model and environment
| Our businesses
30
Our
global
reach
gives
attractive
options
for
growth.
In
the
Americas,
the
largest
investment
banking
fee
pool
globally,
we
focus on increasing market share in our
core Global Banking and
Global
Markets
businesses.
In
Asia
Pacific,
opportunities
arise
mainly from
expected market internationalization
and growth
in
China,
where
we
plan
to
grow
by
strengthening
our
presence,
both
onshore
and
offshore.
In
EMEA,
we
plan
to
leverage
our
strong base and brand recognition even further.
Joint
efforts
between
the
Investment
Bank
and
the
other
business
divisions
(for
example,
our
work
with
Global
Wealth
Management on the Unified Global
Markets team and the Global
Lending Unit) and, externally, strategic partnerships (for example,
UBS
BB
jointly
with
Banco do
Brasil,
focused on
Latin
America)
continue to be key strategic priorities. We expect
these initiatives
to
continue
to
lead
to
growth
by
delivering
global
products
to
each region, leveraging
our global connectivity
across borders and
sharing and strengthening our best client relationships.
›
Refer to “
Delivering one ecosystem
” in this section for examples
of the joint efforts of the business divisions
How we operate
Our business
division consists
of two
areas: Global
Banking and
Global
Markets
,
supported
by
Investment
Bank
Research.
Governed
by
the
Executive,
Operating,
Risk,
and
Asset
and
Liability
forums,
each
business
area
is
organized
globally
by
product.
Our
geographically
balanced
business
has
a
global
reach,
with a presence
in more
than 30
countries and
offices in
ten major
financial
hubs.
Competing
firms
operate
in
many
of
our
markets,
but
our
strategy differentiates us, with its focus on
leadership in the areas
where
we have
chosen to
compete, and
a
business model
that
leverages
talent and
technology rather
than balance
sheet. Our
main
competitors
are
the
major
global
investment
banks
(e.g.,
Morgan Stanley, Credit Suisse
and Goldman Sachs) and corporate
investment banks (e.g., Bank
of America, Barclays, Citigroup,
BNP
Paribas, Deutsche Bank
and JPMorgan Chase).
We also compete
with
boutique
investment
banks
and
fintech
firms
in
certain
regions and products.
Joint
efforts
with
Global
Wealth
Management
and
Asset
Management
enable
us
to
provide
clients
with
broad
access to
financing, global capital markets and portfolio solutions.
›
Refer to “
Delivering one ecosystem
” in this section for examples
of the joint efforts of the business divisions
What we offer
Our Global Banking business advises clients
on strategic business
opportunities,
such as mergers, acquisitions and related
strategic
matters, and helps them raise
capital, both on public and private
markets, to fund their activities.
Our
Global
Markets
business
enables
clients
to
buy,
sell
and
finance securities
on capital
markets worldwide,
and to
manage
their
risks
and
liquidity.
We
distribute,
trade,
finance
and
clear
cash
equity
and
equity-linked
products,
as
well
as
structuring,
originating and
distributing new
equity and
equity-linked issues.
From origination and distribution to managing risk and providing
liquidity in foreign
exchange, rates, credit
and precious metals,
we
help clients to realize their financial goals.
Our
Investment
Bank
Research
business
offers
clients
differentiated
content
about
major
financial
markets
and
securities around
the globe,
with coverage
of over
3,000 stocks
in 24
countries. The
Strategic Insights
team provides
timely and
relevant
information
and
insights
to
help
clients
quickly
make
decisions regarding their most important questions.
We
seek
to
develop
new
products
and
solutions
consistent
with our capital-efficient business model, typically related to new
technologies or changing market standards.
›
Refer to “Clients” in the “How we create value
for our
stakeholders” section and to “Leveling
up technology” in the
“Our strategy” section of this report for more information
about
innovation and digitalization
31
The Investment
Bank is
focused on
meeting the
needs of
clients
with
regard
to
environmental,
social
and
governance
(ESG)
considerations
and
sustainable
finance,
helping
to
reshape
business
models
and
investment
opportunities
and
to
develop
sustainable finance products and solutions
across the Investment
Bank. Since
2005, we
have addressed
increasing client
demand
for
sustainable
investing
by
providing
thematic
and
sector
research
and
investment
solutions
through
socially
responsible
and
impact
exchange-traded
funds
and
index-linked
notes.
In
addition,
we
offer
capital-raising
and
strategic
advisory
services
globally to companies that make positive contributions to climate
change
mitigation
and
adaptation.
We
provide
advice
on
innovative financing strategies, guiding clients through
inaugural
green issuances and
positioning them in
multi-currency markets.
In
September
2021,
we
announced
the
formation
of
our
ESG
Advisory team
in Global
Banking, aiming
to support
our clients’
sustainability
strategies.
As
part
of
the
Group’s
net-zero
commitments, the Investment Bank has developed science-based
intermediate emission targets for 2030 for its lending business in
priority sectors (fossil fuels and power generation).
In June 2021,
we
announced
the
inaugural
launch
of
two
senior
unsecured
green bonds under our Green Funding Framework.
›
Refer to the “Taking action on a net-zero future – our climate
report” section of the Sustainability Report
2021, available from
11 March 2022 under “Annual reporting” at
ubs.com/investors
,
for more information about the Investment
Bank’s targets for its
lending business
Our strategy, business model and environment
| Our businesses
32
Group Functions
Group
Functions
provides
services
to
the
Group,
focusing
on
effectiveness,
risk mitigation and efficiency. Group Functions also
includes the Non-core and Legacy Portfolio unit.
How we are organized
Group Functions
The
major
areas
within
Group
Functions
are
Group
Services
(
which
consist
s
of
Technology,
Corporate
Services,
Human
Resources,
Finance, Legal,
Risk Control,
Compliance, Regulatory
&
Governance
,
Communications
&
Branding
,
and
Group
Sustainability
and
Impact),
Group
Treasury
,
and
Non-core
and
Legacy Portfolio.
In
recent
years
,
we
have
aligned
support
functions
and
business
divisions.
The
vast
majority
of
such
functions
are
fully
aligned or shared among business
divisions, where they have full
management
responsibility.
By
keeping
the
activities
of
the
businesses and support
functions close,
we increase
efficiency and
create
a
working
environment
built
on
accountability
and
collaboration.
On 1
July
2021,
following
the Group
-wide decision
to
move
each
of
the
firm’s
business-aligned
Operations
teams
into
their
respective divisions
in order
to become
even more
client-centric,
agile
and
digital,
while
creating
a
seamless
experience
for
our
clients, each of the Operations
teams were formally moved out
of
Group
Functions
and
integrated
into
the
respective
business
divisions.
Non-core and Legacy Portfolio, a small residual set of activities
in Group Treasury
and certain other
costs that are
mainly related
to
deferred
tax
assets
and
costs
relating
to
our
legal
entity
transformation program are all retained centrally.
Group Treasury
Grou
p
Treasury
manages
balance
sheet
structural
risk
(e
.
g.,
interest
rate,
structural
foreign
exchange
and
collateral
risks)
and
the
risks
associated
with
our
liquidity
and
funding
portfolios.
Group
Treasury
serves
all
business
divisions
and
its
risk
management
is integrated
into
the Group
risk
governance
framework.
Non-core and Legacy Portfolio
Non-core
and
Legacy
Portfolio
manages
legacy
positions
from
businesses
exited
by
the
Investment
Bank,
following
a
largely
passive wind-down strategy. Overseen by a committee chaired by
the
Group
Chief
Financial
Officer
,
its
portfolio
also
includes
positions
relating
to
legal
matters
arising
from
businesses
transferred to it at the time of its formation.
›
Refer to “Note 18 Provisions and contingent
liabilities” in the
“Consolidated financial statements” section
of this report for
more information about litigation, regulatory and
similar
matters
33
Our environment
Market climate
Global economic developments in 2021
2021
was
a
positive
year
for
the
global
economy
and
most
markets. Growth rebounded,
with the global
economy expanding
6.1%,
after
contracting
3.0%
in
2020.
The
recovery
was
also
broad
based,
with
all
major
nations
experiencing
a
revival
in
demand as pandemic restrictions
were gradually relaxed
and the
policies of major central banks remained supportive.
Swiss GDP increased
3.5% in 2021,
after decreasing 2.5%
in
2020. US GDP grew 5.7%, after decreasing 3.4%. The Eurozone
economy
expanded
5.2%,
after
contracting
6.5%
in
the
prior
year. UK GDP
increased 7.2% in 2021,
after a decrease
of 9.4%
in 2020.
China’s economy
grew 8.1%,
up from
2.2% in
2020, although
momentum slowed toward
the end of
2021 and into
2022. Other
leading Asian economies recovered strongly in 2021, with India’s
GDP growing 8.7%, Singapore’s
GDP increasing 7.6% and South
Korea’s
GDP
expanding
3.9%.
Japan
experienced
less
growth,
with GDP increasing 1.7% after a 4.5% contraction in 2020.
Growth
in
the
top
emerging
markets
was
mixed,
with
a
moderate 1.7% growth
rate in Thailand
and 3.7% in
Indonesia,
compared with a more
robust 5.3% in
Mexico and 4.5%
in Brazil.
Elevated inflation emerged
as a
concern through 2021
in much
of the world, as the pandemic continued to disrupt supply chains
and shift patterns of demand. By the end of
the year, US inflation
was
running
at
the
fastest
pace
since
1982
on
a
year-on-year
basis.
This
caused
the
US
Federal
Reserve
to
move
toward
monetary
tightening,
announcing
a
scaling
back
of
asset
purchases and pointing toward rate rises. Inflation was contained
in
Switzerland, at
0.6%
for the
year,
but
climbed swiftly
in the
Eurozone,
from
0.3%
in
2020
to
2.6%
in
2021.
Meanwhile,
prices in Japan declined 0.2% in 2021, having been flat in 2020.
Financial
markets
,
both
equities
and
fixed
income
,
were
resilient in the
face of continuing
waves of COVID-19 infections.
Global equities delivered total
returns of 18.5% in
2021. The US
outperformed
:
MSCI
USA
delivered
total
returns
of
27%,
outperforming the MSCI
All Country
World index by
8 percentage
points
and
taking
its
share
of
the
global
index’s
market
capitalization to a
record level of
48%. The Eurozone,
Japanese,
Swiss and UK equity markets
all gained ground. China, however,
was an underperformer: after
reaching a record high
in February
2021,
MSCI
China declined
over the
rest
of
the year,
driven by
increased
regulation
on
the
technology
and
property
sectors,
energy
shortages,
and
a
slowing
economy.
The
index
delivered
negative
returns
of
22.4%
in
2021,
negatively
impacting
the
performance of the MSCI Emerging Markets
index overall, which
decreased 2.5% in 2021.
Government
bond
markets
were
also
resilient,
especially
against a backdrop of
historically high inflation. The
yield on 10-
year US Treasuries
ended the year
at 1.5%, only
a modest
increase
from
0.9%
at
the
start
of
the
year.
With
inflation
rising,
but
nominal yields staying
low, US real yields
traded as low as
minus
1.2%,
the
lowest
level
since
the
inception
of
the
Treasury
inflation-protected securities
(TIPS) market
in 1997.
The yield
on
10-year German Bunds remained negative through 2021, ending
the year at minus 0.18%.
Our strategy, business model and environment
| Our environment
34
Industry trends
Although
our
industry
has
been
heavily
affected
by
various
regulatory
developments
over
the
past
decade
,
technological
transformation
and
changing
client
expectations
are
further
emerging
as
key
drivers
of
change
today,
increasingly
affecting
the competitive landscape,
as well as
our products, service
models
and operations. In parallel,
our industry continues to
be materially
driven
by
changes
in
financial
market
and
macroeconomic
conditions.
Client expectations
As technology
progresses, clients
more rapidly
redefine the
way
they live, work and interact
with others. This is reshaping
clients’
expectations
toward
financial
services
firms,
as
their
reference
points are increasingly influenced by experiences with companies
outside our sector,
where technology-supported and
data-driven
solutions
are
progressively
enabling
a
more
seamless
and
improved
client
experience.
These
services
often
focus
on
convenience
and
personalization,
and
drive
toward
holistically
addressing
clients’
needs
and
facilitating
community
building.
Therefore
our
franchise
needs
to
evolve,
as
clients
measure
us
against new standards.
Sustainability
Markets
around
the
world
are
undergoing
a
profound
transformation as company business models evolve and investors
factor
in
the
transition
to
a
low-carbon
economy
and
other
sustainable themes with regard to investment risk and return.
Shifting societal
values and
greater regulation
are supporting
client
demand.
Investors
are
adding
sustainable
investing
strategies to
their portfolios,
with the
fastest growth
around funds
focused on
climate. Industry
inflows into
sustainable funds
have
accelerated during
the COVID-19
pandemic and
the sustainable
investing market share remains above pre-pandemic levels.
Our view is that this trend
plays to UBS’s strengths, as
we have
been at the forefront
of sustainable finance for
over two decades,
making
us
well
placed
to
continue
developing
the
innovative
products and solutions our institutional and private clients need.
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for more
information about sustainability matters
Digitalization
Digitalization in the financial
services industry is accelerating
and
has
been
given
further
momentum
by
the
ongoing
COVID-19
pandemic. Banks have
demonstrated their ability
to take on
a vast
increase
in
the
number
of
clients
switching
to
digital
channels
while
ensuring
operational
resilience.
As
a
result,
c
lients
increasingly trust
digital solutions
and are
now demanding
even
more seamless, personalized digital products and services
tailored
to
their
needs.
Regional
and
demographic
differences
in
the
acceptance and
use of digital
technologies are
narrowing across
all
client segments,
thus increasing
the number
of digital
users.
This
trend
requires
financial
institutions
to
focus
even
more
on
fully
digital
and
digitally
enhanced
service
models
and
digitally
enabled ecosystems.
As governments
reacted to
the outbreak
of the
pandemic by
impos
ing
restrictions
on
physical
interactions,
digital
communication,
with
clients
and
employees
alike,
established
new remote ways of working,
which are expected to also
be used
by some companies
in post-pandemic scenarios,
enabling them
to
attract
an
even
wider
array
of
talent
than
before.
The
digitalization
of
the
financial
services
industry
has
led
to
a
structural shift
in the
workforce: more
and better
engineers are
required to
keep banks at
the forefront
of technology, thus
setting
them into direct competition with technology companies beyond
the borders of the financial sector.
Continuous
investment
in
technology
is
driving
automation
and simplification
of labor-intensive processes,
improving banks’
operational efficiency and freeing up resources
to focus on client
needs.
Decision
making
is
becoming
increasingly
data-driven,
with advanced analytics
and artificial intelligence
enabling banks
to address client needs in an even more targeted manner.
Nascent
technologies,
such
as
distributed
ledger
technology,
are expected
to mature
over the
coming years
and are
likely to
reshape
our
industry.
They
provide
opportunities
to
overcome
existing financial system
frictions, broaden access
to underbanked
communities
and
make previously
unviable
products or
services
available to the financial services industry.
Consolidation
Many regions
and businesses
in the
financial services
sector are
still highly fragmented. We expect further consolidation, with the
key
drivers
being
ongoing
margin
pressure,
a
push
for
cost
efficiencies
and
increasing
scale
advantages
resulting
from
the
fixed
costs
of
technology,
and
regulatory
requirements.
Many
banks
currently
seek
increasing
exposure
and
access
to
regions
with attractive growth
profiles, such as Asia
and other emerging
markets, through local acquisitions or partnerships.
The increased
focus on
core capabilities
and geographical
footprint, as
well as
the
ongoing
simplification
of
business
models
to
reduce
operational and compliance
risks, is
likely to
drive further
disposals
of non-core
businesses and
assets. The
impact of
the COVID-19
pandemic
may
further
accelerate
consolidation,
as
banks
face
increasing
threats
from
digitalization,
low
interest
rates
and
intensified competition.
35
New competitors
Our competitive environment is
evolving. In addition
to traditional
competitors in
the asset-gathering
businesses, new
entrants are
targeting selected parts of
the value chain. However, we have
not
yet seen a fundamental unbundling
of the value chain and client
relationships,
which
might
ultimately
result
in
the
further
disintermediation
of
banks
by
new
competitors.
Over
the
long
term, we believe large platform companies
entering the financial
services industry could
pose a significant
competitive threat, given
their
strong
client
franchises
and
access
to
client
data,
if
they
decide
to broaden
the scope
of their
services. Fintech
firms are
gaining
momentum,
which
has
been
accelerated
by
the
COVID-19 pandemic, causing
increased use of
remote solutions.
However,
such
firms
have
not
to
date
materially
disrupted
our
asset-gathering
businesses.
The
trend
for
forging
partnerships
between
new
entrants
and
incumbent
banks
is
continuing,
as
technology and innovation help banks overcome new challenges.
Regulation
Although the
impact of
the COVID-19
pandemic is
still evident,
regulators are re-focusing their attention toward policy areas that
were
already
in
motion
before
the
pandemic
started,
including
prudential
regulation
and anti-money
laundering (AML),
and to
emerging
policy
topics,
particularly
in
the
areas
of
digital
innovation and environmental, social and governance (ESG).
Sustainable
finance
and
climate
risk
were
a
key
focus
of
policymakers in
2021, with
the United
Nations Climate
Change
Conference
(COP26)
acting
as
a
catalyst
for
action.
We
expect
further
policy
developments,
including
in
the
areas
of
climate-
related disclosures, climate-related financial risks and ESG.
The
acceleration
of
the
digital finance
agenda,
which
in
part
resulted from
the COVID-19
pandemic, continues
to trigger
action
from regulators and
this will likely
further intensify. Among
such
action,
we
expect
further
progress
on
the
regulation
of
cryptoassets and stablecoins,
as well as on
the ongoing work on
central bank digital currencies and digital engagement practices.
The national implementation
of the Basel
framework remains
another
important
focus
area,
but
there
is
a
significant
risk
of
divergence in
the timing
of implementation,
as well
as the
content
of
the
provisions.
EU
authorities
have
proposed
a
package
of
measures aimed at implementing the remaining
Basel III elements
by 2025, i.e., two years after
the timeline envisaged by the Basel
Committee
on
Banking
Supervision,
while
the
authorities
in
Switzerland and the
UK are expected
to consult on
their approach
in 2022. Implementation
in Switzerland is
expected in 2024
and
in the UK no earlier
than March 2023. Implementation in
the US
is still uncertain.
In
addition,
regulatory
authorities
continue
to
refine
existing
regulations,
including the finalization
of the Swiss
too-big-to-fail
framework,
with
a
current
focus
on
additional
liquidity
requirements for systemically important banks. The regulators are
also
advancing
the
regulatory
framework
in
key
policy
areas,
including
anti-money
laundering,
operational
resilience
and
outsourcing arrangements, and putting an emerging policy focus
on diversity and inclusion.
Finally,
central
banks
and
regulators
continue
to
learn
the
lessons
from
the
COVID-19
pandemic.
An
important
area
of
concern
is
understanding
the
effects
of
contagion
in
financial
markets, particularly financial stability
risks emanating from non-
bank financial institutions.
Many
of
these
developments
are
taking
place
in
an
environment
characterized
by
significant
political
uncertainties,
including
geopolitical
tensions
that
could
pose
additional
challenges to
the provision of
cross-border financial services
and
rapidly evolving societal
expectations toward financial
institutions.
We believe
the adaptations
made to
our business
model and
our
proactive
management
of
regulatory
change
put
us
in
a
strong
position
to
absorb
upcoming
changes
to
the
regulatory
environment.
›
Refer to the “Regulatory and legal developments”
and “Capital,
liquidity and funding, and balance sheet”
sections of this report
for more information
Wealth creation
1
Despite the economic tumult related to the pandemic, the global
high
net
worth
individual
population
and
financial
wealth
increased in 2020 6.3% and 7.6%, respectively.
The
United
States
continued
to
lead,
with
high
net
worth
individual wealth
growth of
12.3%; in
Asia Pacific,
such wealth
expanded 8.4% and in
Europe 4.5%. In line with
previous trends,
the ultra
high net
worth individual
segment led
wealth growth,
with an average
of 9.1%. Today,
44% of global
financial wealth
is
concentrated
in
North
America,
followed
by
Asia
(26%)
and
Europe (21%).
2
By
segment,
approximately
a
third
of
global
high
net
worth
individual wealth
is held
by individuals
with wealth
in excess
of
USD 30
million,
23%
by
individuals
with
wealth
ranging
from
USD 5 million to USD 30 million
and the remaining approximately
43%
is within
the wealth
segment between
USD 1 million
and
USD 5 million.
Wealth
is being
created at
a faster
rate for
a number
of key
client groups, including
female clients and
entrepreneurs. We also
see significant
wealth transition
to the
next generation
over the
coming decade.
The outlook for
wealth remains positive,
with North America,
Asia (excluding Japan)
and Western Europe
expected to account
for 87% of
new financial
wealth growth
worldwide between
now
and 2025.
2
Wealth transfer
Demographic
and
socioeconomic
developments
continue
to
generate shifts in wealth. Over the next 10 to 15 years, the “next
gen,” composed of individuals
currently between the ages
of 20
and
50,
will
be
an
influential
driver
of
future
growth,
as
those
people
accumulate
significant
financial
wealth
from
inheritance
or liquidity events.
2
1
All the figures are from
the Capgemini World
Wealth Report 2021
unless otherwise stated and
refer to the 2020
financial year.
The Capgemini World
Wealth Report 2021 defines
wealth segmentation as
follows:
those with wealth of greater than USD 30 million are classified as ultra high net worth individuals; USD 1–30 million for high net
worth individuals.
2
Based on BCG Global Wealth Report 2021. Wealth concentration is based on financial assets by regions
and excludes real assets and liabilities.
Our strategy, business model and environment
| Our environment
36
As
a
group,
next
gens
have
a
longer
investment
horizon,
a
greater appetite for risk
and often a desire
to use wealth to
create
a positive societal impact alongside investment
returns. As shown
in
the Wealth-X
report “World
Ultra
Wealth Report
2021,”
the
proportion of
ultra-wealthy women
has also
been on
a gradual
upward
trend
in
recent
years,
reflecting
changing
cultural
attitudes
and
growth
in
female
entrepreneurship,
as
well
as
wealth transfers between generations.
We
are
responding
to
the
evolving
wealth
landscape
with a
framework that addresses all aspects
of our clients’ financial lives,
called
UBS Wealth Way
. It begins with discovery
questions and a
conversation with clients about
what is most important
to them.
We
help
clients
organize
their
financial
life
along
three
key
strategies:
Liquidity
to
help
provide
cash
flow
for
short-term
expenses;
Longevity
for
long-term needs;
and
Legacy
for
needs
that go beyond their own and help improve
the lives of others, a
key part of wealth transfer planning.
Search for yield
Since
the beginning
of
the COVID-19
pandemic, investors
have
faced a very different investment landscape when compared with
the
last
decade,
with
higher
rates
of
economic
growth
in
developed markets and most notably higher inflation.
Nevertheless,
we expect
changes in
monetary policies
of
the
central banks of
Switzerland and
Europe, which have
kept interest
rates
at
historically
low
levels,
to
be
gradual.
The
US
Federal
Reserve has quickly adjusted to a higher-rate
path, but the overall
expected rates remain low
in a historical context.
Therefore, while
this will
create new
opportunities for
investors in
the bond
and
equity markets, the overall low-yield environment will continue.
As a result, investors searching for sustainable high returns for
the longer term
continue to diversify
into illiquid alternatives
(e.g.,
private equity, property, hedge funds and
infrastructure) that can
deliver
compelling
risk-adjusted
returns.
At
the
same
time,
investors continue to look
for low-cost, efficient
passive strategies
across
liquid
equity
markets.
We
believe
the
breadth
of
Asset
Management’s investment
expertise enables
us to
find the
right
solutions for clients across asset classes and regions.
37
Our response to COVID-19
In 2021,
the COVID-19
pandemic, which
had caused
a globally
unprecedented situation in 2020, continued to affect UBS and its
employees and
required our
ongoing focus
on safeguarding
the
well-being
of
our
employees
and
their
families,
on
serving
our
clients and ensuring operational continuity.
The rebound in economic activity in 2021 and
expectations of
further
economic
recovery
was
accompanied
by
the
spread
of
new variants that resulted
in all-time high numbers of
COVID-19
infections and associated disruption.
Our support for clients and the economies in which we
operate
We
continued
to
support
our
clients
with
advice
needed
to
manage their assets and liabilities, along with actively developing
investment solutions and global insights.
The program established
by the Swiss
Federal Council in
March
2020
to
support
small
and
medium-sized
entities
(SMEs)
by
guaranteeing
loans
granted
by
banks
closed
on
31 July
2020.
Outstanding
commitments
of
loans
granted
by
UBS
under
the
program
amounted
to
CHF 2.2
billion
on
31 December
2021,
with a total amount drawn of CHF 1.6 billion,
compared with the
peak commitments of CHF
3.3 billion and the
corresponding total
amount
drawn
of
CHF 1.7
billion
as
of
31 July
2020.
No
net
economic profits
have been
made since
the launch
of the
program
in 2020.
In
the
US,
we
continued
to
support
the
lending
programs
created under the CARES Act
for small businesses. Working with
a
partner,
we
provided
loans
of
USD 1.1
billion
under
the
Paycheck
Protection
Program
until
the
program
expired
in
May
2021. We donated around
USD 1 million of fees earned
on such
loans in 2021
to COVID-19
relief efforts
and around USD 2
million
in 2020.
Our support for communities
Following
earlier
donations
to
various
COVID-19-related
aid
projects
that
support
communities
across
regions
in
which
we
operate
,
and
recognizing
the
critical
importance
of
ensuring
access to COVID-19
vaccines globally, in 2021
UBS partnered with
Gavi, the global
vaccine alliance, to
raise funds for
its COVID-19
Vaccines
Global
Access
(COVAX)
facility
.
U
BS
Optimus
Foundation raised USD 2 million from clients for the Gavi COVAX
facility,
which,
with
matching
funds
from
UBS
and
the
Bill
&
Melinda
Gates
Foundation,
will
support
COVID-19
vaccinations
for
more
than
800,000
people
in
low
-
an
d
middle
-
income
countries.
More
recently,
we
have
committed
to
a
range
of
relief
programs in India
through the UBS
Optimus Foundation COVID-
19
Response
Fund.
Following
the
first
tranche
in
the
second
quarter
of
2021,
which
focused
on
the
delivery
of
oxygen
and
other medical supplies to those most in need,
the current tranche
centers
around
building
healthcare
worker
capacity
across
underserved
and
remote
locations,
as
well
as
supporting
the
mental health
of children
and young
people to
help them
cope
with the effects of the COVID-19 pandemic.
Our support for employees
Throughout
2021,
we
continued
to
prioritize
the
health
and
safety of
our employees
and clients
and to
adapt our
processes
related to office
work and
in-person meetings
in line
with country-
and location-specific developments.
Due to
the ongoing
pressure placed
on employees
by closed
workplaces and
schools, restricted
activities and
varying degrees
of lockdown, we continued with a
range of supportive measures
throughout 2021.
The offer
to our employees
included a
variety
of
tools
and
resources
to
support
employees’
physical,
mental,
financial and social
well-being, as well as
continuing flexibility to
manage various work / life demands.
Effects of the COVID-19 pandemic on our financial and
capital position
The negative
effects of
the COVID-19
crisis on
our financial and
capital
positions
remained
limited
in
2021,
despite
the
uncertainties caused by the pandemic.
We
maintained
a
strong
capital
and
liquidity
position
in
the
face of the COVID-19 pandemic.
Our strategy, business model and environment
| How we create value for our stakeholders
38
How we create value for our stakeholders
Stakeholder
group
Stakeholder needs:
what our stakeholders expect from us
Value proposition:
how we create value for our
stakeholders
Key topics discussed:
what was important to our
stakeholders in 2021
Stakeholder engagement:
how we engage with our stakeholders
Clients
Advice on a broad range of products
and services from trusted advisors
A mix of personal interaction with our
advisors in combination with digital
service anywhere and anytime
(convenient, seamless digital banking is
the expectation)
Top-quality solutions and the highest
standards in terms of asset safety, data
and information security,
confidentiality,
and privacy
A combination of global reach and local
capabilities targeting positive
investment outcomes
Competitively priced products and
services, risk management,
and liquidity
Delivering tailored advice and
customized solutions, using our
intellectual capital and digital platforms
Building long-term personalized
relationships with our clients
Developing new products, solutions
and strategic partnerships in response
to clients’ evolving needs,
including in
the digital age
Providing access to global capital
markets and bespoke financing
solutions
Meeting increasing sustainable
investment and private markets
demand from clients
Investment performance in
light of the
continued low-interest-rate
environment coupled with the threat of
rising inflation
Holistic goal-based financial planning
Sustainable finance and investing
opportunities
Data privacy and security
Products and services, including those
around digital banking
The need for even more personal advice
following the start of the COVID-19
pandemic
Individualized client meetings
Requests for regular client feedback,
feedback monitoring and complaint
handling
Primarily virtual client events and
conferences, including information on
key developments and opportunities
Client satisfaction surveys
Increasing levels of digital interaction
with clients
Investors
Disciplined execution of our strategy
leading to attractive capital returns
through dividends and share
repurchases
Comprehensive and clear disclosures on
quantitative and qualitative data
necessary to make informed investment
decisions
Recognizing and proactively addressing
strategic opportunities and challenges
Executing our strategy with discipline
and agility as the external environment
evolves, while aiming to deliver cost-
and capital-efficient growth
Providing transparent, timely and
reliable public disclosures
Strategic plans and updated targets
following the change of CEO in late
2020
Structural growth in and return
potential of our businesses
Cost efficiency and ability to generate
positive operating leverage
Ability to protect or even grow
revenues in a low-for-longer interest
rate environment
Incorporation of ESG factors into the
business model, compensation and risk
management
Financial reports, investor and analyst
conference calls, and webcasts, as well
as media updates on our performance
or other disclosures
General meetings of shareholders
Investor and analyst meetings
Digital interactions with investors as a
result of COVID-19 pandemic
restrictions, with limited impact on pre-
pandemic meeting schedules and
participation, given reliable virtual
solutions; the 2021 Annual General
Meeting was held virtually
Employees
A global, world-class employer, with
the expertise and breadth of
opportunity to empower people to
develop successful careers
A collaborative, engaging, supportive
and inclusive workplace culture
An environment that provides a sense
of belonging and the opportunities to
positively impact clients, shareholders
and society
Skill and career development
opportunities, including future-skills
development, and rewards for
performance and impact
Hiring great talent and investing in
development, now and for the future
Effective, fair people management and
compensation policies and practices
A strong workplace culture that aligns
with our purpose and values, enabling
employees to develop their careers and
unlock their full potential
Holistic support, including health and
well-being initiatives, that empowers
employees and fosters resilience
Comprehensive workforce data
analytics enable making better and
faster decisions to meet business needs
Our corporate culture, aligned to
purpose and enabled by our three keys
to success
A clear commitment to fair pay
A performance management process
that supports our strategic priorities
Hybrid working options for employees
Strategic focus on diversity, equity and
inclusion
A more agile future; accelerating new
ways of working
Regular CEO and GEB communications
and events, along with senior
leadership, regional and functional
sessions with employees
Employee surveys and other virtual
employee engagement activities
Group Franchise Awards and the Kudos
peer-to-peer recognition program
Health and well-being offerings,
employee volunteering and network
opportunities, flexible and hybrid-
working arrangements
Society
Facilitation of economic development
that is sustainable for the planet and
humankind
Maximization of our positive effects
and minimization of any negative
effects on society and the environment
Proactive management of the
environmental and societal impacts of
our businesses
Promoting significant and lasting
improvements to the well-being of
communities in which we operate
Taking an active role in the transition of
our economy toward environmentally
and socially sustainable solutions
Advising clients to align their business
models with ESG parameters and the
UN Sustainable Development Goals
Sustainable finance
Our climate strategy
Our client and corporate philanthropy
efforts
Reducing inequalities in our local
communities
Community investments and
partnerships with social institutions
Interaction with NGOs
Participation in forums and round
tables, as well as industry-, sector-
and
topic-specific debates
Dialogues with regulators and
governments
Support of COVID-19-related aid
projects across our communities
39
Clients
Our clients
are
the heart
of our
business. We
are
committed to
building and sustaining
long-term relationships based
on mutual
respect, trust and integrity.
Understanding our clients’ needs and
expectations enables us to best serve their interests and to create
value for them.
Our clients and what matters most to them
There is no typical UBS client. Our clients have varying needs, but
each
of
them
expects
outstanding
advice
and
service,
a
wide
range of choices, and an excellent client experience.
Global Wealth
Management focuses
on serving
the unique
and
sophisticated needs
of high
net worth
and ultra
high net
worth
individuals,
families
and
family
offices
worldwide,
as
well
as
affluent
clients
in
selected
markets.
We
give
them
access
to
outstanding
advice,
service
and
investment
opportunities
from
around the
globe, delivered
by experts they
can trust
and based
on the expertise
and insights of our
Chief Investment Office (the
CIO). Using a holistic,
goals-based approach to
financial planning,
we
deliver
a
personalized
wealth
management
experience
and
work side by side
with clients to
help them realize
their ambitions.
Our client-facing advisors and
the global teams supporting
them
focus on
developing
long-term client
relationships,
which
often
span generations. Clients look to us for expertise in helping them
to grow, protect
and transfer
their wealth, as
well as
helping them
make some
of the
most important
decisions in
their lives.
From
significant liquidity events
to professional milestones
and personal
turning
points,
we
aim
to
give
clients
the
confidence
to
move
forward and achieve their
goals. Through extensive research into
clients’
preferences
and
goals,
and
broader
analysis
of
investor
sentiment globally, we
constantly evolve our
offerings to meet
the
shifting priorities of
today’s wealthy
clients. This
includes investing
in digital capabilities and developing
products to help clients fund
their
lifestyles
and
manage
their
cash
flow,
as
well
as
offering
guidance on how they
can create a lasting
and positive impact
for
their communities
and the causes
they care about
most. We are
the
leading
global
wealth
manager
for
clients
interested
in
sustainable
investing,
1
with
a
commitment
to
developing
solutions that enable clients to
align their financial goals
and their
personal values.
›
Refer to “Global Wealth Management”
in the “Our businesses”
section of this report for more information about
sustainable
investment offerings
Personal & Corporate
Banking serves a
total of approximately
2.6 million
individual clients and
over 100,000
corporate clients,
companies
ranging
from
start-ups
to
multi-nationals,
including
specialized entities, such
as pension funds
and insurers, real
estate
companies,
commodity
traders
and
banks.
Our
clients
include
more
than
30%
of
Swiss
households,
more
than
90%
of
the
largest 250 Swiss corporations and more than 50% of midsize to
large pension funds in Switzerland. They look for financial advice
based on their needs
at each stage of
their individual or corporate
journey. We
aim to
deliver outstanding
advice to
all via
a multi-
channel approach. Clients have
access to digital banking,
a wide
network
of
branches
and
remote
advice.
These
channels
are
designed to
deliver a
superior, convenient
client experience
with
24/7
availability, security
and
value for
money,
resulting
in
high
levels of client satisfaction. Clients are also offered a broad range
of
products
and
services
in
all
relevant
areas:
basic
banking,
investing,
financing
(including
mortgages),
retirement
planning,
cash management, trade and export finance, global custody, and
company
succession, among
others.
Additionally, they
have full
access
to
the
solutions
of
the
Investment
Bank,
Asset
Management and Global Wealth Management.
In
Asset
Management,
we
deliver
investment
products
and
services directly to approximately 2,800 clients around the world,
including
sovereign
institutions,
central
banks,
supranational
corporations, pension
funds
and
insurers,
as
well
as
to
Global
Wealth Management and its clients,
wholesale intermediaries
and
financial
institutions.
By
building
long-term,
personalized
relationships
with
our
clients
and
partners,
underpinned
by
disciplined execution,
we aim to achieve a deep understanding of
their needs and
to earn
their trust. We
combine our global
scale
with the independent
thinking of our distinct
investment teams
to
utilize innovative ideas,
drawing on the breadth and depth of our
investment
capabilities,
across
traditional
and alternative,
active
and
indexed,
to deliver
the solutions
that clients
need.
The
Investment
Bank
provides
corporate,
institutional
and
wealth
management
clients
with
expert
advice,
financial
solutions,
execution
and
access
to
the
world’s
capital
markets.
Our business
model is
specifically built
around our
clients and
their
needs.
Corporate
clients
can
access
advisory
services,
debt
and
equity
capital market
solutions, and
bespoke
financing through
our
reshaped
Global
Banking
business.
Our
Global
Markets
business focuses on helping institutional clients
engage with local
markets
around
the
world,
offering
equities
and
equity-linked
products,
and
foreign
exchange,
rates
and
credit
products
and
services.
Our
equities
and
differentiated
content
offering
is
underpinned
by
Investment
Bank
Research.
The
differentiated
nature of
our research provides
access to
insight-ready data
sets
for
thousands
of
companies,
and
aims
to
give
clients
an
informational
edge.
In
2021,
approximately
45,000
research
reports were produced, with more than six million reads.
1
Euromoney Private Banking and Wealth Management Survey 2021: Overall Global Results.
Our strategy, business model and environment
| How we create value for our stakeholders
40
We know the security and confidentiality of our clients’
data is
of utmost importance to
them, as it
is for UBS.
That is why
we put
the highest
priority on
having comprehensive
measures in
place
that
are
designed
to
ensure
that client
data
confidentiality
and
integrity are
maintained. We
continually assess
and improve
our
control environment to mitigate
emerging cyber threats and
meet
expanding legal
and regulatory
expectations. Investments
in our
IT platforms preserve and improve
our IT security standards, with
a focus on giving clients secure access to their data via our digital
channels
and
protecting
that
data
from
unauthorized
access.
Although the
level of
sophistication and
the impact
and volume
of cyberattacks continue to grow
worldwide, we are ever vigilant,
maintaining
a
strong
and
agile
cybersecurity
and
information
security program to mitigate and
manage cyber risk by providing
robust, consistent, secure and resilient business processes.
Enhancing the client experience through innovation and
digitalization
We
streamline
and
simplify
interactions
with
clients
through
front-to-back digitalization and innovations.
In Global Wealth Management, we develop and deploy digital
tools that enhance the value
of human relationships, a factor
that
differentiates UBS. Clients expect
the convenience and speed
that
technology
offers but,
simultaneously, they
feel
that
a
personal
experience with
advisors is
more important
than ever.
Our advisors
use state-of-the-art
digital tools to
spend more
time with clients
and
better
evaluate
the
full
scope
of
their
financial
lives.
Our
clients appreciate
digital tools
that improve
their experience,
for
example, easy ways
to view their
portfolios or access
research that
is tailored to
their needs. They
also want multiple
ways in which
to interact with their
advisors. The COVID-19 pandemic,
and the
associated need for
physical distancing, has
led clients to
embrace
the
use
of
digital and
mobile
tools
more
than
ever
before.
We
continue to
introduce new
and better
tools to
meet and
exceed
clients’
expectations.
For
example,
our
UBS
Manage
Advanced
[My
Way]
app
offers
clients
in
selected
markets
an
at-a-glance
comprehensive view of their investment portfolio. With access to
more
than
60
professionally
managed
investment
modules
(building
blocks),
it
is
underpinned
by
continuous
portfolio
monitoring and
risk management.
The app
is interactive;
clients
can
work
with
their
advisors
on
a
tablet
to
design
their
own
portfolio, easily
including elements
such as
sustainable investing
and themes
to reflect
their individual
preferences and
priorities.
Based on the strong
momentum, client demand and inflows, we
intend
to
scale
up
and
further
develop
UBS
Manage
Advanced
[My
Way]
.
In
2021,
the
Direct
Investment
Insights
digital
investment service was
introduced in
Asia and
rolled out
in Europe
and
Switzerland.
This
service
provides
timely,
relevant
and
actionable investment insights and ideas from
the CIO directly to
clients’
mobile
and
desktop
devices,
linking
insights
with
execution
in
our
e-banking
and
mobile
app.
In
the
US,
we
announced
the
development
of
a
digital-led,
scalable
advice
model
for
affluent
clients.
As
a
trusted
brand
with
premium
content,
we see opportunities
to deliver
our expertise
to a broader
set of clients, combining digital experience with human advice.
In
Switzerland, our
UBS Mobile Banking
app has been enhanced so
clients can now
see relevant investment
views and access
our real-
time
quote
capabilities
before
logging
in.
At
a
broader
level,
progress continues on
our multi-year strategy
to serve clients
from
two platforms: the
Wealth Management Americas
Platform
in the
US and the
Wealth Management Platform
outside the US.
Personal
&
Corporate
Banking
continued
to
develop
simple,
smart,
secure
and
sustainable
solutions
in
2021,
reflecting
our
digital transformation progress. In May 2021,
we launched a new
Remote Sales &
Advice (RSA) unit
to offer Personal
Banking clients
more
flexibility
in
the
way
they
bank
through
extended
service
times and the option to receive professional advice
remotely. The
new RSA approach was
also successfully piloted for
Corporate &
Institutional
clients.
Following
the
excellent
results
of
the
2020
pilot, we initiated a
Switzerland-wide rollout of
UBS Multibanking
for corporate clients, an offering that integrates
third-party banks
for
full
transparency
across
accounts
and
convenient
payment
execution
via a
single platform.
To assist
clients throughout
the
onboarding phase, we
established a virtual
support team for
the
multi-banking
solution.
Moreover,
in
response
to
the
growing
number
of
client-support
requests
via
UBS
channels,
email
and
telephone,
we
introduced
the
UBS
Conversational
Platform
,
an
end-to-end platform enabling clients to get the right answers for
their issues quickly without a lot of interaction with call agents or
client advisors. To accelerate innovation in the payment business,
we announced our
UBS Virtual Credit Cards
, a new generation of
purely
digitally available
cards that
can be
used in
online shops
and
receive
deposits
from
TWINT, Apple
Pay,
Samsung
Pay
and
Google Pay. Since its introduction, more
than 30,000 virtual cards
have
been
issued.
For
banking
packages
,
we
have
launched
UBS me
to
replace
the
previous
pre-defined
banking
bundles.
Clients can
now put
together their
individual package
based on
their
own
needs
and
preferences,
and
are
only
charged
for
solutions they actually need. Our
UBS Atrium
mortgage platform
for
investment
properties
has
been
integrated
into
the
key4
brand, creating
a true
multi-channel and
multi-product offering.
As
a
result
of
the
integration,
clients
can
benefit
from
digital
offering
capabilities
of
the
innovative
mortgage
platform
for
owner
-
occupied
residential
property.
In
addition,
the
Green
Mortgage
for
income-producing
properties
is
available
via
key4
and offers
a financial advantage
on financing
to borrowers
who
hold recognized sustainability certificates. To
give clients access to
market-leading solutions beyond banking,
we have expanded our
network
of
partnerships.
We
have
joined
forces
with
a
Swiss
fintech
start-up to
provide corporate
clients with
extensive cash
management
functionalities,
from
automated
generation
of
expense
reports
to
validation
of
supplier
invoices.
To
make
progress in our
journey toward being
more agile, we
set up a
new
virtual
organization
as
a
collaboration
between
Personal
&
Corporate
Banking,
Global
Wealth
Management
and
the
Chief
Digital
and
Information
Office:
the
Agile
Delivery
Organization
.
With
more than
26
agile end-to-end
delivery
crews
focused
on
our clients’ needs, we are empowering teams, removing silos
and
evolving
toward
an
integrated
setup
to
deliver
responsive,
adaptable and
innovative products.
With sustainability
being a
top
strategic priority
for our
business and
our client
proposition, we
have
continuously
expanded
our
sustainability
agenda.
Our
platform for
volunteer work,
UBS Helpetica
, has
so far
received
286 project ideas
and published more than
180 projects with
over
70
non-profit
partners
across
its
focus
topics:
the environment,
social
issues,
education
and
entrepreneurship.
An
example
of
further
progress
in
our
sustainability
journey
came
when
the
UBS Strategy Funds
were repositioned toward
UBS Strategy Funds
Sustainable
in
2021,
which
led
to
the
transfer
of
a
significant
amount of existing custody assets to sustainable solutions.
41
In Asset
Management, we
are accelerating
our investment
in
digitalization.
We
have
extended
our
digital
client
relationship
management
pilot
tools,
technologies
and
data
capabilities
to
enhance the
experience of,
and service
for,
our clients,
to foster
innovation and to support alpha generation. For
example, we will
soon
launch
a
scalable
platform
to
ena
ble
more
efficient
development
and
management
of
theme-based
investment
products to meet growing
client demand. We continue
to expand
the
suite
of
tools
used
by
our
Quantitative
Evidence
&
Data
Science
team,
who
utilize
alternative
and
traditional
data
combined with statistical modeling to enhance and augment our
fundamental and systematic
investment processes.
To simplify
and
enhance our client servicing, we are introducing improvements in
client and data analytics.
The Investment Bank
strives to be the digital
investment bank
of the
future, with
innovation-led businesses
driving efficiencies
and solutions. In February 2021, we announced the creation of a
Digital
Platforms
function
within
the
Investment
Bank
across
Global
Markets
and
Global
Banking,
to
work
on
exponential
transformation
through
experimentation,
innovation,
and
external partnerships.
The
Digital Platforms
function is
critical to
deliver
ing
on
our
client
promise.
In
Global
Markets,
our
Technology-Enhanced Sales (TES)
teams work in close partnership
with
our
Data
Intelligence,
Group
Technology,
and
Client
Coverage teams
to embed
our data
and technology
capabilities
across all client
teams and enhance our
client service.
TES
allows
clients to
choose where
and how
we deliver
content and
uses data
modeling
to
customize
the
content
they
receive.
UBS
Neo
,
our
award-winning multi-channel platform and
enterprise ecosystem
for
digital
clients,
lets
our
professional
and
institutional
clients
access
a
comprehensive
suite of
products and
services
covering
the
full investment
life
cycle. Historically,
most clients
used only
one or two of the capabilities available to
them via
UBS Neo
. We
have
now
transformed
the
client
experience
through
a
new
personalized version
of the
platform, including
the launch
of an
app
store.
Investment
Bank
DigiOps
,
our
Operations
team
working
in
collaboration
with
Group
Technology
on
digital
innovation projects, is enhancing the
client experience through a
digital
platform
that continues
to
make progress
on
simplifying
Operation’s
technology
infrastructure,
increasing
front-to-back
efficiency
and
enhancing
our
decision
making
and relevance
to
clients. New non-bank
competitors have secured
a foothold
in our
markets,
while
fintech
firms
have
carved
out
and
dominated
entirely new
segments. In
response, we
created a
team focused
on
strategic
investments
and
fundamentally
new
market
infrastructure.
By
utilizing
distributed
ledger
technology,
Global
Markets is
transforming the
business models
of products
where
the Investment Bank has been
strong historically. One example is
UBS Gold
, our
global physical
gold transaction
network of
retail
investors,
gold
merchants,
institutional
investors
and
vault
providers that enables
clients to buy
and sell at
interbank prices.
A tokenized
representation of
underlying physical
gold provides
fractional
ownership
with
low-friction
transactional
capability.
Our vision
is to
accelerate the
tokenization of
financial products
traded
by UBS
clients. In
November 2021,
the Investment
Bank
helped
SIX
Group
to
launch
the
first
ever
Swiss
franc
-
denominated
digital
bond
offering,
which
is
listed,
traded
and
settled
on
the
newly
established
SIX
Digital
Exchange.
Global
Banking has also prioritized the client experience.
Global Banking
Data &
Analytics Lab
uses data
science, predictive
analytics and
quantitative models to develop solutions for our businesses.
UBS-
GUARD
applies
data
science
and
predictive
analytics
to
Global
Banking
business
users,
predicting
the
risk
of
companies
becoming
the
targets
of
activists,
identifying
deal opportunities
and helping navigate
client pitches. Our
SPAC database
is a fully
automated
database
of
in-market
special
purpose
acquisition
companies
(SPACs)
created
to
match
SPACs
with
potential
acquisition targets and
help increase efficiency and
collaboration
across sectors and regions.
Engaging with our clients
We
use
a
variety
of
channels
to
engage
with
clients,
including
regular client relationship and service meetings, as well as various
corporate
roadshows
and
dedicated
events.
Digital
interaction
with clients increased as the pandemic continued.
Global Wealth Management interacted with clients via various
settings in 2021, from personalized private briefings
with subject
matter experts
to segment-specific
virtual events
and large-scale
initiatives.
We
utilize
marketing
campaigns,
events,
advertising,
publications
and
digital-only
solutions
to
help
drive
greater
awareness of UBS
among prospective clients
and reinforce trust-
based relationships between advisors and clients.
Personal
&
Corporate
Banking
holds
regular
client
events
(mostly webcasts
and virtual
or hybrid
events since
the onset
of
the
COVID-19
pandemic),
covering
a
wide
range
of
topics.
In
2021, we
increasingly engaged
with clients
via online
channels,
such
as
social
media,
online
displays
and
search
engines,
and
further decreased our use of traditional out-of-home channels.
In Asset Management, we have a consistent program of client
events
and
engagement
activities
throughout
the
year.
This
includes our flagship
conferences, such
as the annual
UBS Reserve
Management
Seminar
,
and
we
held
our
inaugural
Alternatives
Conference
in 2021.
Alongside this, our
teams continued
the high
level of interaction
with clients
globally in 2021,
facilitated by new
digital tools,
and our
publication of
macro insights
and thought
leadership to provide
timely insights into
rapidly evolving markets.
We
also
hosted
a
broad
range
of
virtual
events,
including
our
Nobel
Perspectives
webinar
series,
to
help
our
clients
better
understand market challenges and investment opportunities, and
we continued
to engage
with clients
through our
social media
and
online channels.
Our strategy, business model and environment
| How we create value for our stakeholders
42
The Investment
Bank hosted
over 170
investor conferences
and
educational seminars globally in 2021, covering a broad range of
macro, sector, regional and
regulatory topics. Almost all of
those
conferences
were
held
virtually.
More
than
40,000
clients
took
part in
such events
in 2021,
providing insight
and access
to our
own opinion
leaders, policymakers
and leading
industry experts.
We
leverage our intellectual capital and relationships and use our
execution
capabilities,
differentiated
research
content,
bespoke
solutions, client
franchise model
and global
platform to
expand
coverage across a broad set of clients.
UBS Neo Question Bank
is
the largest global database of market
-related questions asked by
professional
investors,
while
UBS
Live
Desk
,
built
within
the
UBS Neo
platform,
provides
clients
with
a
stream
of
fast-paced
commentary from UBS traders.
How we measure client satisfaction
We use multiple techniques
to regularly assess our
achievements
and the satisfaction of our clients.
Global
Wealth
Management
is increasingly
using
technology
and
analytics
capabilities
to
collect
and
respond
to
client
feedback. Our
digital client
feedback tool
lets clients
submit, via
mobile and the web,
input about overall
satisfaction with advisors
and
UBS,
and
share
key
topics
they
wish
to
discuss
with
their
advisors. Advisors and their
teams have seamless, real-time
access
to
client
feedback,
enabling
them
to
be
highly
responsive.
The
tool is available in
the US and Asia Pacific,
as well as most EMEA
countries.
Personal &
Corporate Banking
has conducted
annual surveys
of
clients
in
Switzerland
since
2008,
consistently
covering
all
private and corporate
client segments
annually since
2015. Clients
provide
feedback
on
their
satisfaction
with
regard
to
various
topics (e.g.,
UBS overall,
branches, client
advisors, products
and
services)
and indicate
further
product
or
advisory needs.
Survey
responses are
distributed to
client advisors,
who follow
up with
each
respondent
individually.
In
2021,
we
had
an
all-time
high
client satisfaction
and net
promoter score
(NPS), and
achieved a
77% follow-up rate with survey participants.
The
Quality Feedback
system in
Global
Wealth Management
and Personal & Corporate Banking provides a comprehensive
and
systematic
platform
to
receive
and
process
client
feedback
and
suggestions. We
receive feedback
in various
forms and
through
different
channels,
including
in
writing,
electronically,
orally
to
client
advisors
and staff
in our
branches
and
other client
touch
points,
via
social
media
channels,
and
via
the
Swiss
Banking
Ombudsman.
Client
feedback,
including
complaints
and
suggestions, is vitally important, as
it shows direct and unfiltered
client needs, supports
the development and introduction
of new
products and
services and
hence fosters
the optimization
of our
offering in
a client-focused
manner. By
addressing client
feedback,
we
aim
to
strengthen
client
relationships,
improve
client
satisfaction and
make tangible improvements
to our services.
By
sharing their views, clients contribute
to quality improvements at
all
levels.
We
aim
to
respond
to
each
individual
who
provides
feedback. In 2021, key topics
and enhancements centered mostly
around
digital
banking
functionalities,
digital
client
onboarding
and the reorganization of UBS’s branches and services.
In Asset
Management, we
have an
integrated process
to record
and
manage
client
feedback
through
our
client
relationship
management tool. We also conduct regular surveys, covering our
wholesale and institutional clients
globally, inviting them to
assess
their satisfaction
with our
client service,
products and
solutions,
as well as
other factors relevant
to their investments.
The results
are
analyzed
to
identify
focus
areas
for
improvement
and
our
client
relationship
managers
follow
up
with
respondents
to
address specific feedback where required.
The
Investment
Bank
closely
monitors
client
satisfaction
via
individual
product
coverage
points.
Direct
client
feedback
is
actively
captured
and
tracked
in
our
systems.
Internal
regional
forums
serve
as
a
platform
for
senior
management
to
discuss
client
relationships,
possibilities
for
improvement,
potential
opportunities
and
specific
client
issues.
Other
processes
are
in
place to enable consolidated findings to
be shared within UBS as
appropriate. The
Investment Bank
also closely
monitors external
surveys,
which
provide
feedback
across
a
range
of
investment
banking services. We
continue to
make progress in
simplifying our
technology
infrastructure,
focusing
on
increasing
front-to-back
efficiency
and
enhancing
our
decision
making
and relevance
to
clients. In
November 2021,
we launched
the first
Annual Global
Markets Client Survey
to gauge
our clients’ experience
of UBS
and
the products and services that are
important to them, measuring
client
satisfaction
and
loyalty.
In
2021,
over
49%
of
Global
Markets clients surveyed
expected to increase
their market share
with
UBS
in
the
next
six
months.
When
ranking
the
most
important
factor
in
choosing
a
market
partner,
r
elationship
management
coverage
and
connectivity
were
a
priority,
further
underlining
the
importance
of
our
people.
When
asked
about
future capabilities, our clients ranked highly the need for profiled
personalization
of
products
and
services,
underlining
the
importance of our
Digital Platforms
and our
TES
initiative.
We
thoroughly
evaluate
the
feedback
we
receive,
including
complaints from clients,
and take measures
to address key
themes
identified.
For example,
in 2021,
Personal &
Corporate Banking
clients
expressed
an
increasing
need
for
security
and
trust.
The
ongoing optimization and
digitalization of products
has been well
received
by
clients
across
all
segments.
However,
in
light
of
ongoing branch closures, clients would
like further digitalization.
Furthermore,
feedback
in
dicated
that
clients
developed
high
levels
of
acceptance
for
telephone
or
video
advice
and
were
increasingly satisfied with the service received via Global
Banking.
43
Investors
We aim to create sustainable,
long-term value for
our investors by
executing
our
strategy
with
discipline,
maintain
risk
and
cost
discipline, and deliver attractive shareholder returns.
Investor base
Our investor
base is
well diversified.
A substantial
proportion of
our
institutional
shareholders
are
based
in
the
US,
the
UK
and
Switzerland.
›
Refer to the “Corporate governance”
section of this report for
more information about disclosed shareholdings
Alignment of interests
We aim to align the interests of our employees
with those of our
equity and
debt investors,
and this
approach
is reflected
in
our
compensation philosophy and practices.
›
Refer to “Our compensation philosophy”
in the “Compensation”
section of this report for more information
Driving growth while maintaining risk and cost discipline
We
are
focusing
on
growth,
as
we
expand
into
new
client
segments
and
accelerate
our
strategic
technology
investments.
Across the firm, we intend to maintain
our risk and cost discipline
to support our
growth plans, with
continual enhancement of
day-
to-day efforts.
We are
aiming to
create sustainable
value through
the cycle.
To
accomplish
this,
we
have
outlined
selected
commercial
and
environmental,
social
and
governance
(ESG)
aspirations,
which
should support our financial targets.
Our
primary
measurement
of
performance
for
the
Group
is
return on common
equity tier 1 (CET1),
as regulatory capital
is our
binding
constraint
and
drives
our
ability
to
return
capital
to
shareholders.
›
Refer to the “Targets, aspirations and capital guidance” section
of this report for more information
Active capital management to enable growth and deliver
attractive shareholder returns
Our first priority
is ensuring that
we can maintain
a strong balance
sheet.
This
includes
our
strong
capitalization,
in
line
with
our
capital
guidance
of
maintaining
a
CET1
capital
ratio
of
around
13% and a CET1 capital leverage ratio of greater than 3.7%.
As a second priority, we consider opportunities for investment
in growth.
Our
third
priority
is
returning
capital
to
shareholders
in
the
form
of
dividends,
and
we
intend
to
pay
progressive
cash
dividends. For 2021,
the Board of
Directors intends to
propose a
dividend to UBS Group AG shareholders of USD 0.50 per share.
After
these
three
priorities
have
been
met,
we
intend
to
distribute
excess
capital
to
shareholders
via
share
buybacks.
In
2021,
we
bought
back
USD 2.6
billion
of
our
shares.
Looking
ahead, we intend to buy
back up to USD 5 billion
of shares by the
end of 2022.
›
Refer to “UBS shares” in the “Capital, liquidity
and funding, and
balance sheet”
section of this report for more information
Communications
Our Investor Relations (IR) function is
the primary point of contact
between UBS and our shareholders. Our senior management and
IR regularly interact
with institutional investors,
financial analysts
and
other
market
participants,
such
as
credit
rating
agencies.
Clear,
transparent
and
relevant
disclosures,
and
regular
direct
interactions with existing and prospective
shareholders, form the
basis for our
communications. The IR
team relays the views
of and
feedback
on
UBS
from
institutional
investors
and
other
market
participants to our senior management.
IR
and
our
Corporate
Responsibility
function
work
together
and interact
with any
investors interested
in sustainability
topics
relevant to UBS and wider society.
›
Refer to the first nine pages
of the “Corporate governance”
section of this report and “Information policy”
in that same
section for more information
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for more
information
Our strategy, business model and environment
| How we create value for our stakeholders
44
Employees
At UBS, we know the meaning of long-term commitment; to our
clients, investors, employees,
communities and society.
With our
employees,
this
commitment
is
personal.
We
are
dedicated
to
being a world-class employer
where our employees can
leverage
and
continually enhance
their skills,
partnering
with
clients and
colleagues on solutions that make a real difference.
Our people
leadership approach
aligns with
our strategy
and
our purpose, as both
rely on engaged
and empowered individuals
to drive them forward. Our
employees are the key to
realizing our
ambitions.
Reimagining
the
power
of
people
and
making
connections are at the heart of what we
do. Every day, our global
team
connects
people
with
innovative
ideas
and
opportunities
that lead to better results
for UBS and for
our clients, as well as
to
progress in society.
Our purpose drives our strategy and culture
Our
purpose
articulates
why
we
do
what
we
do
and
why
it
matters.
Our
culture
affects
how
we
do
things
and
is
firmly
grounded in
our three
keys to success:
our
Pillars, Principles
and
Behaviors
. To help ensure that
our culture advances our
strategic
goals, we updated our
three keys to
success in 2021 to
reflect our
purpose,
client
promise
and
strategic
imperatives.
For
the
past
decade, these keys
have defined
how we work
together and what
we stand for, as
a firm and as
individuals. They continue to
drive
daily
business
decisions
and
are
integrated
into
our
people
management processes.
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for more
information about our Pillars,
Principles and Behaviors
We
promote
culture-building
behavior
through
a
number
of
global,
regional and divisional initiatives. Notably, since 2016, our
Group Franchise Awards
(GFA) program has rewarded employees
for
promoting
cross-divisional
collaboration
and
innovation.
A
related
idea-sharing
site
enables
employees
to
cooperate
on
solutions
for
operational,
client
service,
sustainability
and
technology challenges.
Nearly 6,000
ideas have
been submitted
since
its
launch,
with
approximately
450
ideas
implemented
or
supported for future implementation.
A
peer-to-peer
recognition
program
instituted
in
late
2020
encourages
employees
to
recognize
colleagues’
exemplary
behavior.
Called
Kudos
,
this
initiative
serves
to
bring
teams
together
and
increase
motivation,
engagement
and
employee
satisfaction,
with
a
total
of
around
4
20
,000
messages
of
recognition given since the program was launched.
45
Leadership,
engagement and culture
Connecting
people
with
transformative
ideas
and
becoming
a
more
agile
organization
starts
with
our
leaders.
In
2021,
we
updated
our
House
View
on
Leadership
to
reflect
the
behavior
that we
expect every
leader to
demonstrate toward
employees,
clients
and
business
activities.
Leaders
at
all
levels
are
also
expected
to
foster
simplification,
empowerment
and
accountability
in
their
teams
to
support
our
ongoing
transformation.
Key to maintaining a strong culture are listening to employees
and
acting
on
their
feedback.
Launched
in
mid-2021,
our
new
employee-listening strategy
uses Group-wide
surveys conducted
by
an
external
provider
to
measure
indicators
such
as
line
manager
effectiveness,
and
in-depth
research
to
solve
specific
business
issues.
As an
example,
an
Organizational
Health
Index
assesses
firm-wide
alignment
with
strategic
goals,
working
practices
and
adaptability.
Employee
responses
in
2021
directly
influenced
the
development
of
our
purpose,
our
new
performance management approach
and our increased
focus on
innovation, sustainability and impact.
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for more
information about our management practices,
and to the
foldout page of this report for more information
about our
purpose
Toward a more agile future
Driven
by our
strategic
imperatives
and
in
response
to
evolving
client
needs,
we
are
accelerating
the
adoption
of
new
ways
of
working together. In particular, agile working practices, and agile
teams
where
th
ey
make
sense,
will
enable
us
to
be
more
responsive,
adaptive and
innovative in
everything we
do. Multi-
disciplinary
teams
working
across
the
firm
will
create
better
outcomes
for
clients
and
improve
our
employees’
work
experience. In 2021,
we launched a
first wave of the
Agile@UBS
program ahead
of a broader
implementation in 2022.
Currently,
we have
10,000 employees
transitioning to
the new
Agile@UBS
ways of working
by the end
of the first
quarter of 2022
and we
are
on
track
to
have
over
20
,000
employees
working
in
Agile@UBS
by the
end of
2022.
Participants’ experiences,
along
with coaching
and specialized training
delivered through
the Agile
Academy
within
our
UBS
University,
will
enable
us
to
systematically
roll
out
Agile@UBS
to
more business
areas
going
forward.
Our commitment to diversity, equity and inclusion (DE&I)
In our experience,
diverse teams better
understand and relate
to
our
equally
diverse
clients
and
their
needs
.
Furthermore,
employees
with
different
backgrounds
and
experiences
drive
innovation and
better decision making.
Our aim,
therefore, is to
shape
a
diverse
and
inclusive
organization
that
is
innovative,
provides
outstanding
service
to
our
clients
and
offers
equitable
opportunities so that all employees may thrive.
Our
broad
approach
encompasses
a
range
of
aspects,
including
inclusive
leadership,
gender,
ethnicity,
LGBTQ+
and
disability.
Along
with
a
concerted
focus
on
building
inclusive
leadership
skills,
increasing
gender
and
ethnic
diversity
,
and
ensuring equitable
policies and practices
were priorities in
2021.
Regarding gender, we aspire to
have 30% of Director and
above
roles
held by
women by
2025. At
the end
of 2021,
that figure
stood
at
26.7%,
up
from
26.0%
in
2020.
Similarly,
our
2025
aspiration is to achieve a 26% representation of ethnic minorities
at Director level
and above in
the UK and
the US. As
of the end
of 2021, this figure was 20.1% in the US and 21.3% in the UK.
Initially launched in
Switzerland in 2016,
our global
UBS Career
Comeback
program continues to help us increase
our pipeline of
female leaders. To date, the program
has helped 196 women and
19 men relaunch their careers.
In
addition
to
strategic
initiatives,
each
year
we
sponsor
numerous
activities
to
promote
inclusivity
and
a
culture
of
belonging.
Chief among
them are
activities
provided by
our 48
employee networks
across the
firm. Employee
volunteers regularly
host educational
events and
initiatives focused
on gender, culture,
ethnicity,
LGBTQ+
/
Pride,
disability,
veterans,
parenting,
elder
care
and
other
topics.
Our
employee
networks
also
raise
the
visibility of employees’
needs and help
shape our DE&I
program,
local benefits
offerings, and
more. Disability
is a
key focus
area:
as such, the firm became
a member of The Valuable 500 in
2021,
committing to make disability inclusion
part of the firm’s
business
leadership agenda.
›
Refer to
ubs.com/diversity
for more information about our DE&I
priorities, commitments and progress
Personnel by region
As of
% change from
Full-time equivalents
31.12.21
31.12.20
31.12.19
31.12.20
Americas
21,317
21,394
21,036
0
of which: USA
20,537
20,528
20,232
0
Asia Pacific
15,618
15,353
13,956
2
Europe, Middle East and Africa (excluding Switzerland)
14,091
13,899
12,918
1
of which: UK
6,051
6,069
5,704
0
of which: rest of Europe (excluding Switzerland)
7,826
7,652
7,048
2
of which: Middle East and Africa
215
178
166
21
Switzerland
20,359
20,904
20,691
(3)
Total
71,385
71,551
68,601
0
Our strategy, business model and environment
| How we create value for our stakeholders
46
Practices that help us remain an employer of choice
Compensating employees fairly
and consistently is
key to
ensuring
equal opportunities.
We pay
for performance,
and we
take pay
equity
seriously.
A strong
commitment to
both
is embedded
in
our compensation policies, and we conduct both internal reviews
and independent external audits as
quality checks. If we uncover
gaps that cannot be explained by business
factors or appropriate
personal
factors
–
such
as
experience,
role,
responsibility,
performance
or
location –
we explore
the root
causes
of
those
gaps and address them. Additionally,
our regular monitoring and
review processes also allow us to maintain our certification status
with the EQUALSALARY Foundation
for our equal
pay practices in
Switzerland, the US, the UK, Hong Kong SAR and
Singapore. The
firm
also
successfully
completed
an
equal
pay
analysis
in
Switzerland
in
2020,
as
required
by
the
Swiss
Federal
Act
on
Gender Equality. The results of the analysis confirmed that
we are
fully
compliant
with
Swiss
equal
pay
standards.
These
holistic
certifications
are
a
testament
to
our
well-established
equal
opportunity
environment
and
the
strength
of
our
human
resources practices,
including performance and
reward. In 2021,
we
continued
to
monitor
pay
fairness
and
addressed
any
unexplained gaps to ensure
that all employees are
paid fairly.
All
employees
have
access
to
competitive
benefits,
including
insurance, retirement and personal leave.
›
Refer to the “Compensation” section
of this report for more
information about compensation-related
topics
Meeting employees’ needs while improving services for clients
Working both from
home and from
the office became
the norm
for
many
employees
in
2021
,
with
surveys
indicating
strong
support for
continued flexibility.
Following a
global analysis
that
considered
factors
such as
regulation,
risk
and productivity,
we
determined that
approximately 75%
of our
employees could
be
eligible to
work in a
hybrid setup. In
addition to
fostering better
work
/ life
balance,
a
hybrid model
makes
us a
more
attractive
employer to
a wider pool
of applicants,
such as
early-career talent,
working parents and
those in continuing
education. The
emphasis
on
technology
and
virtual
collaboration
also
sparks
innovative
thinking that
will make us
more agile
and further improve
client
service.
We
are
implementing
hybrid
working
on
a
country-by-
country
basis,
along
with
wide-ranging
support
to
ensure
that
employees, teams and our culture all continue to thrive.
Health and well-being
Supporting employee health
and well-being remained a
priority in
2021.
We
are
committed
to
helping
employees
thrive
in
their
current
roles
and
deliver
sustainable
performance
over
time.
Regular
“pulse”
surveys
gauged
employees’
views
on
remote
work, stress, communication
and other
aspects. Resources to
help
employees
support
holistic
well-being
featured
a
bespoke
eLearning
curriculum,
physical
and
mental
health
initiatives,
volunteering opportunities, increased benefits offerings in certain
locations, and financial education.
Employee representation
We
maintain
an
open
dialogue
with
our
formal
employee
representation groups,
all of
which are
in Europe,
as part
of our
commitment
to
being
a
responsible
employer.
These
groups
represent
17
countries
and
consider
issues
that
may
affect
our
performance, operations and
prospects. Collectively, these
groups
represent approximately 49% of our global workforce.
Attracting, developing and retaining the best talent
Fostering an
agile and
connected workforce
is a
priority for
the
near term. We therefore need to have processes in place that are
designed
to
ensure
that
we
have
the
best
people,
in
the
right
roles,
at
the
right
time,
to
achieve
our
strategic
goals.
Comprehensive
workforce
data
dashboards
help
us
analyze
all
aspects
of
the
employee
life
cycle,
including
recruitment,
performance
management,
training,
internal
mobility
and
attrition,
along with
demographic and
diversity aspects,
such as
gender
and
ethnicity.
This
helps
us
identify
trends
quickly
and
make fact-based decisions grounded in human resources data.
Throughout
2021,
we
hired
new
talent
where
necessary
to
launch or expand businesses
and to fill gaps
in our workforce. We
recruit
for
potential
and
cultural
fit,
hiring
beyond
immediately
relevant
skills
to
include
the
person’s
experience,
competencies
and digital aptitude.
We hired a
total of 9,363
external candidates
in 2021,
adding more
than 1,700
graduates and
other trainees,
apprentices
and
interns
through
our
various
junior
talent
programs. We
invest in
young talent
in every
region, supporting
national apprenticeship programs in Switzerland
and the UK and
summer internship programs
in many
locations.
In Singapore, UBS
worked
with
the
government
to
set
up
a
program
to
support
ongoing employability
during the
pandemic and
to increase
the
resilience
of
regional
banking
infrastructure.
Our
approach
has
garnered numerous external
accolades in 2021,
including a top-
50
ranking
in
the
World’s
Most
Attractive
Employer
s
from
employer-branding experts
Universum, for
the 13th
consecutive
year.
›
Refer to
ubs.com/employerawards
for more information about
our most recent employer rewards
Focusing on performance and development
Resetting
the
firm’s
strategic
course
sparked
a
comprehensive
review of our
performance management practices
in 2021. As
a
result, we introduced a new approach called
MyImpact
that aims
to better support our strategic
priorities and reinforce our culture,
as
well
as
making
our
year-end
review,
objective
setting
and
employee feedback processes simpler and more transparent.
Key to our
talent management strategy
is offering employees
opportunities
to build
interesting
careers.
Our innovative
digital
Career
Navigator
platform,
which
now
features
short
-
term
rotation opportunities,
promotes internal
mobility across
teams,
functions
and
business
divisions.
Employees
can
explore
career
paths, search for jobs
and connect with colleagues
while allowing
our recruiters
to more easily
source internal talent.
The tool
also
identifies
potential
competency
gaps
and
automatically
recommends
appropriate
training.
Since
inception,
Career
Navigator
has helped 47,600 employees
search for short-term job
opportunities
or
find
internal
experts,
discover
possible
career
paths and
match themselves
to open
roles. More
than 160,000
skills were added to
our employee skills-sharing platform in
2021.
Our
in-house
UBS
University
plays
a
central
role
in
fostering
diversity of
thought within
the firm,
and in
building employees’
skills
for
use
now
along
with
capabilities
for
the
future.
Our
offering
includes
line
manager
and
leadership
development,
advisory and
sales training,
and industry-leading
certification for
client advisors,
as well
as data
literacy, agile
working and
health
and
well-being
topics.
Altogether
in
2021,
our
permanent
employees
completed
more
than
1,425,000
learning
activities,
including mandatory training
on compliance, business
and other
topics, resulting in an average of more
than two training days per
employee.
47
Society
The
world’s social
and environmental
problems are
too big
and
complex
to
tackle
alone.
Lasting
change
can
only
be
achieved
when philanthropists
and public
and private
organizations work
collectively to maximize
positive impact for
people and the
planet.
Our
clients
can
maximize
the
positive
effect
of
their
giving
through
our
diverse
social
impact
offering:
UBS
Philanthropy
Services and the
grant-making UBS Optimus
Foundation, as well
as UBS Global Visionaries and UBS Community Impact.
Reimagining client philanthropy
With nearly
70 philanthropy
experts around
the globe,
we help
clients
to maximize
their
impact
locally,
nationally and
globally.
We have
partnered for
more than
two decades
with clients
and
their
families
by
using
an
investment-based
approach
and
connecting
them
to
an
international
network
of
expertise
and
support.
To best serve
our clients, we
base our approach
on three pillars:
Advice,
Insights
and Execution.
Advice
–
consulting with
clients
who
are
considering
setting
up
their
first
charitable
fund
and
guiding them on
tax-efficient giving, thus
maximizing the value
of
charitable
giving.
Insights
–
connecting
our
clients
to
a
global
network of
experts, both
within and
outside UBS
(e.g., through
insight
trips,
publications,
events
with
fellow
philanthropists,
thought
leaders
and
social
entrepreneurs,
such
as
UBS
Global
Visionaries).
Execution
– providing clients with flexible options for
managing their philanthropic giving,
including structures such as
our donor-advised
funds
(DAFs) and our new
UBS Collectives
, and
supporting curated programs via UBS Optimus Foundation.
Donor-advised funds
A DAF
offers clients
an easy,
flexible and
efficient alternative
to
setting up their own foundation. UBS has offered DAF services in
the US
for some
time, and
in 2014
we established a
DAF in
the
UK, which has
since had over
GBP 450 million in
donations. The
UBS
Philanthropy
Foundation
was
launched
in
Switzerland
in
2020: it has raised more than USD 10 million in donations and in
its first year of operations
launched its first thematic fund,
which
is dedicated to the environment.
UBS Optimus Foundation
With
a
track
record
of
over
two
decades
,
UBS
Optimus
Foundation is recognized globally
as both a
philanthropic thought
leader and
a pioneer
in the
social finance
space, through
which
we leverage solutions to mobilize
private capital in new and
more
efficient ways. The
foundation uses an evidence-based
approach
and
focuses
on
programs
that
have
the
potential
to
be
transformative,
scalable
and
sustainable.
It
conducts
extensive
due diligence
and only
recommends what
it considers
to be
the
most innovative programs that have the capacity to achieve long-
term, measurable impact.
UBS also makes
matching contributions
to the foundation, to help our clients’ donations go even further.
The
UBS
Collectives
also
utilize
an
evidence-based
approach
and bring together philanthropists to pool their funds,
share their
expertise and achieve a longer-term impact. The
Collectives
are a
three-year learning journey during which philanthropists follow a
curriculum, network with peers and engage in
programs with the
goals of preventing
family separation, mitigating
climate change
and
funding
programs
linked
to
measurable
results.
In
2021,
USD 21 million in
funding was raised for
this long-term systems-
level change approach.
UBS Global Visionaries
The
private
sector
has
a
crucial
role
to
play
in
supporting
innovative,
sustainable
solutions
to
some
of
the
world’s
most
pressing
problems.
This
is
why
we
launched
the
UBS
Global
Visionaries
program
in
2016
with
two
main
goals:
(i) to
create
opportunities for our clients and prospective clients to connect in
person (or
virtually) with
leading social
entrepreneurs; and
(ii)
to
help
our
UBS
Global
Visionaries
scale
their
positive
change
by
expanding
their
global
network,
building
capacity
and
raising
awareness about their work. Since the program
started, we have
supported
63
entrepreneurs
across
the
globe,
who
all
work
toward
achieving
a
variety
of
the
UN
Sustainable
Development
Goals.
At
the
end
of
2021,
20
of
those
entrepreneurs
were
engaged in
the program
as active
Global Visionaries,
more than
60
prospective
clients
and
clients
had
been
directly
connected
with
them,
and
80
events
hosted
by
UBS
at
which
they
were
featured speakers. Over 29,000 stakeholders (such as prospective
clients
,
clients
and
employees
)
part
icipated
in
these
events.
Feedback
from
our
clients
shows
this
gives
them
new
ways
to
engage
i
n
their
passions
and
learn
about
new
topics
or
technologies. In
return, our
UBS Global
Visionaries benefit
from
clients sharing their skills, experience and contacts.
UBS Community Impact
We
are
committed to
supporting the
communities in
which we
work. Our employees,
clients and shareholders
expect us to
play
our part in addressing social issues – and we believe it is the right
thing to do. Direct cash contributions, including
support through
our Community
Impact program,
UBS’s affiliated
foundations in
Switzerland, the
UBS Foundation
of Economics
in Society
at the
University
of
Zurich
and
contributions
to
UBS
Optimus
Foundation,
amounted
to
a
total
of
USD 59
million
in
2021.
During
2021,
we
focused
on
addressing
social
and
wealth
inequality
in
our local
communities through
education
and
skill
building. Given the ongoing impact of the pandemic in 2021, we
continued to
provide some
COVID-19 relief
to support the
most
vulnerable, as
well as
supporting recovery
and rebuilding
efforts
through our community partners.
Following the announcement
of UBS’s purpose in
April 2021,
we undertook a review of our global Community Impact strategy
in light of UBS’s new sustainability commitment. We will increase
our focus on education and skills with the implementation of our
revised strategy in 2022.
UBS’s overall
charitable contributions
are measured
using the
industry
-
leading
Business
Investment
for
Soci
etal
Impact
framework (B4SI). This includes cash, employee time, and in-kind
support.
›
Refer to “UBS’s charitable contributions”
in the “What” section
of the Sustainability Report 2021,
available from 11 March 2022
under “Annual reporting” at
ubs.com/investors
, for more
information
Our strategy, business model and environment
| How we create value for our stakeholders
48
Our focus on sustainability and climate
Our
commitment
to
sustainability
starts
with
our
purpose.
We
know finance has a powerful influence on the world. At UBS, we
reimagine the
power of people
and investment, to
help create a
better
world
for
everyone:
a
fairer
society,
a
more
prosperous
economy
and
a
healthier
environment.
That
is
why
we
partner
with our clients to
help them mobilize their
capital toward a more
sustainable world and why we
have put sustainability at the
heart
of our own business.
We are
guided by
the goal
of being
the financial
provider of
choice
for
clients
that
want
to
mobilize
capital
toward
the
achievement of the
17 Sustainable Development
Goals (the SDGs)
of the United Nations
(the UN) and
the orderly transition to
a low-
carbon economy. We are advancing toward
2030, the designated
deadline to achieve
the SDGs. The
SDGs focus on
issues such as
climate
change,
equality
and
healthcare
–
major
challenges
for
our world now and over the coming years.
To help us
maximize our impact
and direct capital
to where it
is needed
most, we
are focusing
on three
key areas
to drive
the
sustainability transition: planet, people, partnerships.
–
Planet:
Climate
is
a
clear
focus
for
us
as
we
shift
toward
a
lower-carbon future.
We have
committed to
achieving net-zero
greenhouse
gas
emissions
resulting
from
all
aspects
of
our
business by 2050.
–
People:
We believe in a diverse,
equitable and inclusive society.
We are
taking action to
get there, within
our own workplace
and beyond.
–
Partnerships:
By
working
in
partnership
with
other
thought
leaders and standard
setters, our goal
is to achieve impact
on
a truly global scale.
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for more
information about how UBS is advancing
sustainability in the
financial sector and beyond
Our sustainability and impact governance
Sustainability
activities,
including
sustainable
finance,
are
overseen
at
the highest
level
of UBS
,
by the
Board
of
Directors
(the
BoD)
and
the
Group
Executive
Board
(the
GEB),
and
are
grounded in our Code of Conduct and Ethics (the Code).
Code of Conduct
and Ethics
In our Code of Conduct and Ethics, the BoD and the GEB set out
the principles and practices that define
our ethical standards and
the
way
we
do
business
,
which
appl
y
to
all
aspects
of
our
business. All employees must affirm annually that they have
read
and will adhere to
the Code and other key
policies, supporting a
culture
where
ethical
and
responsible
behavior
is
part
of
our
everyday
operations.
In
our
Code
we
make
a
commitment
to
acting with the
long term in
mind and creating
value for clients,
employees and shareholders. We aspire to do our
part to create a
fairer,
more
prosperous
society,
championing
a
healthier
environment and addressing
inequalities at their
root. This ethos
underpins
our
purpose
and
is
in
line
with
our
external
commitments,
such
as
our
pledge
to
help
making
progress
toward the SDGs.
In
2021,
we
revised
the
Code
in
line
with
our
focus
on
simplification,
making it shorter,
sharper and better
aligned to our
strategic imperatives.
›
Refer to the Code of Conduct and Ethics
of UBS, available at
ubs.com/code
, for more information
Board of Directors and Group Executive Board
The BoD is
responsible for setting
UBS’s values and
standards to
ensure the Group’s obligations to stakeholders are met. Both the
Chairman
of
the
BoD
and
the
Group
CEO
play
a
key
role
in
safeguarding
our
reputation
and
ensuring
we
communicate
effectively with all of our stakeholders.
The
BoD’s
Corporate
Culture
and
Responsibility
Committee
(the
CCRC)
is
the
UBS
body
primarily
responsible
for
corporate
culture, responsibility
and sustainability.
The CCRC
oversees our
sustainability
and
impact
strategy
and
activities
and
approves
Group-wide sustainability and impact objectives. The
Group CEO
has delegated to the GEB lead for
sustainability and impact, Suni
Harford, the responsibility for setting the
firm’s sustainability and
impact strategy, in agreement with fellow GEB members.
The GEB sets the overall risk appetite for the firm and resolves
overarching
matters
relating
to
sustainability
and
climate
risks,
including
risk management
framework, policies,
and
disclosure.
Group
Risk
Control
is
responsible
for
the
development
and
implementation
of
principles
and
an
appropriate
independent
control framework for sustainability and climate risks within UBS,
and the integration of
the principles and the framework
into the
firm’s overall risk management and risk appetite frameworks.
Group Sustainability
and Impact
The
Group
Sustainability
and
Impact
(GSI)
organization
was
created
in
2021
to
support
the
GEB
lead
for
sustainability
and
impact
with
carrying
out
her
responsibilities.
GSI
comprises
the
Chief Sustainability and
Social Impact
offices, headed by
the Chief
Sustainability Officer
(the CSO)
and the
Head Social
Impact. The
CSO is responsible
for driving the
implementation of the
Group-
wide sustainability and
impact strategy,
including reporting on
our
progress
toward
net
zero,
and
the
execution
thereof
by
the
business divisions and Group Functions.
The Head Social Impact
is
responsible
for
driving
and
implementing
our
social
impact
strategy,
including
UBS
Community
Impact,
UBS
Philanthropy
Services
and
UBS
Global Visionaries.
Progress
toward the
firm’s
sustainability and impact strategy, including climate strategy,
and
associated
targets is
reviewed at
least annually
by the
GEB and
the CCRC.
49
Sustainability
Risk,
Finance,
Compliance
and Legal functions
The
Chief
Risk
Officer
for
Sustainability
oversees
sustainability
activities relating
to risk, including
the climate risk
program, and
supports
the
GEB
by
providing
leadership
on
sustainability
in
cooperation with the business divisions and Group Functions.
The
Sustainability
Chief
Financial
Officer,
a
member
of
the
Group Finance function, ensures
that sustainability considerations
are embedded into
the firm’s financial
decision-making processes,
supports the
expanding external
sustainability disclosures
arising
from
both
new
regulatory
requirements
and
voluntary
commitments
made
by
our
firm,
and
oversees
the
continued
development
of
the
firm’s
financial
control
environment
that
underpins our disclosures.
The Sustainability Expert Group
within the GCRG function was
established
in
2021
due
to
the
strategic
importance
of
sustainability to UBS, the rapidly evolving
nature of the regulatory
and policy agenda
in this area,
and GCRG’s desire
to ensure the
firm
is
able
to
interact
effectively
and
proactively
with
policy-
makers,
the
regulatory
supervisors
of
the
Group
and
other
relevant stakeholders.
The
global
environmental, social
and governance
(ESG)
legal
team
within
the
Group
General
Counsel
function
advises
the
business on sustainability-related
risks across UBS’s operations.
It
plays an important role in advising the business teams on existing
and
emerging
rules
and
regulations
governing
sustainable
investing and sustainable lending.
›
Refer to “Board of Directors” in the “Corporate
governance”
section of this report for more information about
the CCRC
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for more
information about our governance
of sustainability and impact
Our approach to sustainable finance
The UN estimates the gap in
funding needed to achieve the SDGs
by 2030 at USD 2.5 trillion to USD 3 trillion annually,
1
with some
experts
putting
the
number
even
higher.
We
recognize
this
as
both a challenge for
society and an opportunity
for our clients.
As
a global financial institution, we
have a role in reaching
the SDGs,
by directing capital to where it is needed the most.
Our
clients
turn
to
us
for
advice
on
how
they
can
help
to
finance
the
transition
to
a
low-carbon
economy,
support
sustainable
finance,
align
their
investments
with
their
personal
values,
and
better
risk
manage
their
portfolios
and
businesses.
They want
to take
advantage of
these opportunities,
while also
managing
the
risks
associated
with
this
transformational
challenge.
Our
clients’
growing
interest
in
sustainable
finance
is
clearly
shown
in
a
number
of
key
surveys.
According
to
a
global
UBS
Investor
Sentiment
survey,
2
66%
of
investors
see
sustainable
investing as
highly important
to their
portfolio strategy.
When it
comes
to
business
owners,
61%
believe
sustainability
could
generate
more
revenue
,
57%
believe
it
could
improve
client
relationships
and
55%
believe
it
could
do
the
same
for
relationships with employees.
A global survey published
in 2021 titled “Resetting
the agenda
How
ESG
is
shaping
our
future”
3
found
that
three-quarters
of
institutional
investors
agree
that
the
COVID-19
pandemic
will
accelerate
the
general
interest
in
ESG
and
capital
inflows
into
sustainable investments over the
next three to five
years. Of those
surveyed, 65%
plan to
integrate ESG
into at
least 25%
of their
assets under
management for
the next
12 months.
Importantly,
almost
three-quarters
of
survey
respondents
agreed
that
investments integrating
ESG factors
performed better
financially
than equivalent traditional investments in the three years prior to
2020.
We are committed
to serving our
clients’ growing sustainable
finance needs and expectations. More
fundamentally, we believe
sustainable finance is the
future of finance. Recognition
of impact
on
financial
performance,
regulatory
developments,
evolving
societal
norms,
investor
demand
and
consumer
preference
are
factors
that
contribute
to
drive
the
continued
evolution
of
mainstream
investing
toward
more
holistic
long-term-oriented
approaches.
We are looking to create more
scalable sustainable and impact
investing solutions that
deliver competitive financial
returns, and
to advise
our corporate
clients on risks
to their business
models,
while driving positive outcomes.
Fundamentally, for the benefit
of
our clients, we are helping to shape
the landscape of sustainable
finance by using thought leadership, innovation and partnerships
to support them in their sustainability efforts.
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for more
information about our sustainability and
impact strategy and
activities
›
Refer to the sub-section below for more information
about our
climate governance, strategy, risk management, and metrics
and
targets and to the UBS Climate Report 2021,
available from
11 March 2022 under “Annual reporting” at
ubs.com/investors
,
for the full UBS climate disclosures
Defining sustainable
finance
Sustainable finance refers broadly to any form of financial service
that
aims
to
achieve
positive
sustainability
outcomes,
including
through the integration
of ESG
criteria into
business or
investment
decisions. This encompasses sustainable
investing and sustainable
financing
solutions.
Sustainable
finance
has
long
been
a
topic
firm-wide
and
there
is
now
a
sharpened
understanding
in
the
market
of
its
importance,
accelerated
by
factors
such
as
the
COVID-19
pandemic
and
a
changing
climate.
Our
aim
is
to
continue to help
our clients meet their
investment and financing
objectives through sustainable finance.
1
un.org/sustainabledevelopment/sg-finance-strategy
2
About the survey: UBS surveyed 3,004 investors and 1,202 business owners with at least USD
1 million in investable assets (for investors) or at least USD 1 million in annual
revenue and at least one employee other
than themselves (for business owners), between 28 September and 18 October 2021. The global sample was split across 15 locations:
Argentina, Brazil, Mainland China, France, Germany, Hong Kong SAR, Italy, Japan,
Mexico, Russia, Singapore, Switzerland, the UAE, the
UK and the US.
3
The survey was conducted
by the Economist Intelligence Unit,
commissioned by UBS, and
surveyed 450 institutional investors working
in asset and wealth management
firms, corporate pension
funds, endowment
funds, family offices, government agencies, hedge funds,
insurance companies, pension funds, sovereign wealth funds and reinsurers
in North America, Europe and Asia Pacific.
Our strategy, business model and environment
| How we create value for our stakeholders
50
Sustainable
investment
Sustainable investment
(SI) focuses
on investment
decisions that
seek to make a difference, while generating competitive financial
returns. SI
strategies aim
to better
risk manage
portfolios in
line
with 21st-century
challenges and
/ or
to align
investments with
investors’
sustainability
values,
while
also
targeting
improved
portfolio risk and return characteristics.
We have
long recognized
that clients
and other
stakeholders
need
transparency
about
the
sustainability
objectives
of
our
various investment products. During 2021, the European Union’s
Sustainable Finance Disclosure
Regulation (the SFDR)
provided the
first formal, comprehensive legislative
framework establishing an
important
marker
for
the
industry’s
efforts
in
this
area.
Consequently, we have further evolved our own definitions of SI,
which now include the following two categories.
–
Sustainability
focus:
strategies
that
have
explicit
sustainable
intentions
or
objectives
that
drive
the
strategy.
Underlying
investments may contribute to positive sustainability
outcomes
through products / services / use of proceeds.
–
Impact
investing:
investment
strategies
that
have
an
explicit
intention
of
generating
measurable,
verifiable,
positive
sustainability
outcomes.
Impact
generated
is
attributable
to
investor action and / or contribution.
ESG integration
and exclusion
We also identify two approaches that consider ESG factors in the
investment process
to varying
degrees,
but which
on their
own
are not considered sustainable investment.
–
ESG
integration
:
considers
ESG
factors
alongside
traditional
financial
metrics
to
assess
the
risk-return
profile
in
the
investment
process.
This
approach
is
rapidly
becoming
an
industry
standard,
as
the
inclusion
of
such
factors
has
been
shown to benefit overall investment
risk-return considerations.
–
Exclusion
: when
individual companies
or entire
industries are
excluded from
portfolios because
their activities
do not
meet
certain
ESG
criteria and
/ or
do
not
align
with
the
values of
clients and / or UBS.
Sustainable
financing
We
offer
products
and
solutions,
including
access
to
capital
markets,
to
clients
looking
to
finance
assets
that
demonstrate
sustainability
characteristics
and /
or
support the
transition to
a
low-carbon economy. Financing
activities can be
on-balance sheet
(such as
loans and
mortgages) or
off-balance sheet (such
as access
to
debt
and
equity
markets).
We
also
provide
advice
on
ESG
factors
(both
financial
and
non-financial),
such
as
integrated
disclosure requirements.
We
use
regulatory
and
market
standards
where
these
are
available; for
example, in
the debt
capital markets
business, we
refer
to
the
International
Capital
Market
Association
(ICMA)
Green, Social or
Sustainability-Linked Bond Principles.
Where such
guidelines
or
standards
are
not
available,
we
aim
to
align
with
market
best
practice.
This
is
the case,
for
example,
with
equity
capital markets activities.
Our established sustainability and climate risk
(SCR, previously
known at UBS
as environmental
and social
risk, or
ESR) framework
is used to analyze
potential transactions and client
relationships in
order to
limit any
negative impact
on the environment
and society.
Moreover,
as
one
of
the
world’s
largest
asset
gathering
businesses,
we
are
in
a
privileged
position
to
leverage
the
experience
gained
from
our
Climate
Aware
framework,
established
in 2019
by our
Asset Management
business, to
the
benefit of our financing clients.
›
Refer to the “Key achievements in 2021”
chart in the
Sustainability Report 2021, available from 11
March 2022 under
“Annual reporting” at
ubs.com/investors
In
2021,
we
noted
continued
strong
momentum
in
our
sustainable
finance
activities. SI
assets
grew
to
USD 251
billion,
compared with USD 141
billion in 2020,
and assets subject
to ESG
integration
and
to
exclusions
grew
to
USD 813
billion
in
2021,
compared
with
USD 645
billion
in
2020.
Jointly,
SI
assets
and
assets subject
to ESG integration
and to exclusions
reached over
23% of client
invested assets, up
from 18.8% in
2020. In addition
to generally supportive
markets, the growth
was driven by
client
demand,
our
focus
on
advancing
sustainable
solutions,
and
converting traditional funds to sustainable ones.
51
UBS total invested assets
1,2
For the year ended
% change from
USD billion, except where indicated
GRI
31.12.2021
31.12.20
31.12.19
31.12.20
Sustainable investments
Sustainability focus
3
FS11
222.7
127.7
46.4
74.4
Impact investing
4
FS11
28.5
13.1
9.1
117.1
Total sustainable investments
5
251.2
140.8
55.5
78.4
SI proportion of total invested assets (%)
5.5
3.4
1.5
ESG integration
6
FS11
558.0
512.8
372.3
8.8
Exclusion
7
FS11
255.1
132.2
52.2
93.0
Total ESG integration and exclusion
FS11
813.2
645.0
424.5
26.1
ESG integration and exclusion proportion of total invested assets (%)
FS11
17.7
15.4
11.8
UBS total invested assets
4,596.2
4,187.2
3,606.6
9.8
1
We are refocusing our sustainable investment reporting on those investment strategies exhibiting an
explicit sustainability intention. ESG integration and exclusion approaches,
although considering ESG aspects in
the investment process,
are in and
of themselves not
considered sustainable investment
strategies.
2
FS represents the
performance indicators defined
in the Financial
Services Sector Supplement
of the Global
Reporting Initiative (GRI) reporting framework.
3
Strategies that have explicit sustainable
intentions or objectives that drive
the strategy. Underlying
investments may contribute to positive
sustainability outcomes
through products / services /
use of proceeds. Examples
include Global Wealth Management’s
Discretionary Manage SI mandate
solution and Asset Management’s
strategies such as its
Global Sustainable Equities
product.
4
Strategies that have explicit intentions of generating measurable, verifiable and positive
sustainability outcomes. Impact generated is attributable to investor action and /
or contributions. Examples include
Global Wealth Management’s Oncology Impact funds and Asset Management’s Global Engage for Impact Equity funds.
5
In 2021, UBS converted funds to the sustainability focus and impact investment categories,
in line with corresponding
changes to the funds’
underlying investment policies.
The main impact
was on sustainability
focus and impact strategies
in Asset Management
of USD 38 billion
and sustainability focus
fund conversions in Global Wealth Management.
6
Strategies that integrate ESG factors into the
fundamental financial analysis to improve risk /
return.
7
Strategies that avoid investments in companies
that do
not meet certain ESG criteria and / or do not align with the values of clients and / or UBS. The enhancement of the UBS ESG exclusion policy to include a broader set of exclusions in the third quarter of 2021 was
the
main driver (>50%) of the increase in exclusion assets in 2021.
Our offering
to clients
Our
private
clients
benefit
from
fully
diversified
sustainable
portfolios,
as
well
as
advisory
options.
In
2020,
we
made
sustainable investments
the preferred
solution for
private clients
investing
globally.
In
July
2021,
we
expanded
our
sustainable
investing offering
with a
new advisory
solution that
enables clients
to
tailor
their
sustainable
investments
to
their
personal
preferences.
In
2021,
our
flagship
SI
mandates,
based
on
our
sustainable investing strategic asset allocation (SI SAA), exceeded
USD 30 billion under management.
Our institutional clients benefit from the holistic integration of
ESG
factors into
the investment
decision-making
process across
the entire suite of investment funds and strategies. Underpinning
our
ESG
integration
activities
is
a
robust
stewardship
program,
including engagement
and proxy
voting.
We have
continued to
build
on
our
position
as
a
leading
provider
of
sustainable
exchange-traded funds (ETFs), launching 17 new sustainable
ETFs
in 2021,
including a
full suite
of benchmarks
aligned with
the Paris
Agreement.
We
remain
firmly
positioned
as
Europe’s
second-
largest sustainable ETF-provider,
with an SI
asset base of
USD 40
billion as of 31 December 2021.
Our retail clients in Switzerland
have access to appropriate and
relevant SI products.
Interest in SI
solutions continued
to be
strong
in
2021.
UBS
ManageTM
SI
,
a
Global
Wealth
Management
product, represented almost 70% of Personal Banking’s
mandate
sales. In addition, 47%
of total custody
assets in Personal
Banking
are composed of sustainable investments.
For our
Swiss corporate
and institutional
clients, supplier
and
producer transactions in commodity
trade finance are monitored
according
to
our
SCR
standards.
Furthermore,
our
sustainable
finance
advice
extends
to
strategic
positioning
of
business
models, disclosure practices and benchmarking.
Our
corporate
clients
benefit
from
a
range
of
financing
and
advisory solutions
at all
stages on
their
sustainability journey.
In
2021, Global Banking, within
our Investment Bank, set
up an ESG
Advisory
team
to
assist
established
corporate
clients
with
the
integration
of
ESG
risks
and
opportunities
into
their
decisions
related to strategy, operations
and financing, thereby supporting
their
positioning in
the financial
markets.
They also
help
young
ESG-driven companies
with the raising
of private and
/ or public
financing.
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for more
information about our sustainable investing
and financing
offering, including financing solutions, advisory
and research
and insights
Managing sustainability and climate risks
At UBS, SCR is defined as the risk that
UBS is negatively impacted
by
or
negatively
impacts
climate
change,
loss
of
biodiversity,
human rights infringements, and other environmental, social and
governance matters. We apply an SCR policy framework with the
aim of identifying
and managing potential
adverse impacts on
the
environment and
/ or
to human
rights, as
well as
the associated
environmental and social risks
to which our clients’ and
our own
assets are exposed.
›
Refer to “Sustainability and climate
risk” in the “Risk
management and control” section of this
report for more
information
Our strategy, business model and environment
| How we create value for our stakeholders
52
Our sustainability targets and progress
We work with a
long-term focus on
providing appropriate returns
to all
of our
stakeholders in
a responsible
manner.
To
underline
our commitment,
we provide
transparent targets
and report
on
progress
made
against
them
wherever
possible.
In
2021,
we
included new targets, in particular pertaining to our commitment
to becoming a net-zero
bank. Our targets, as
set out below,
can
therefore
only
partly
be
compared
with
what
we
set
out
in
previous years.
Our key targets
Planet, people, partnerships
–
USD 400 billion
invested assets
in sustainable
investments by
2025.
Planet
–
Set decarbonization targets for 2030 for financing
of the fossil
fuel,
power
generation
and
real
estate
sectors
(from
2020
levels):
–
reduce
absolute
financed
emissions
associated
with
UBS
loans to fossil fuel companies by 71%;
–
reduce
emissions
intensity
associated
with
UBS
loans
to
power generation companies by 49%;
–
reduce emissions
intensity of
UBS’s commercial
real estate
lending portfolio by 44%; and
–
reduce
emissions
intensity
of
UBS’s
residential
real
estate
lending portfolio by 42%.
–
Align USD 235
billion of
invested assets
to net
zero by
2030
(Asset Management).
–
A
chieve
net
-
zero
emissions
across
discretionary
client
portfolios by 2050.
–
Achieve net-zero emissions resulting from our own operations
(scopes
1 and 2) by 2025; cut energy consumption by 15% by
2025 (compared with 2020).
–
Offset historical
emissions back
to the
year 2000
by sourcing
carbon offsets (achieved by the end of
2021) and by offsetting
credit
delivery
and
full
retirement
in
registry
(by
the
end
of
2025).
–
Engage with our key vendors on targeting net zero by 2035.
People
–
30% global female representation
at Director level and above
by 2025.
–
26%
US
ethnic
minority
representation
at
Director
level
and
above by 2025.
–
26%
UK
ethnic minority
representation
at
Director
level
and
above by 2025.
–
Raise
USD 1
billion
in
donations
to
our
client
philanthropy
foundations
and
funds
and
reach
25
million
beneficiaries
by
2025 (cumulative for 2021–2025).
–
Support
one
million
beneficiaries
through
our
community
impact activities by 2025 (cumulative for 2020–2024).
Partnerships
–
Establish UBS as a leading facilitator of discussion, debate and
idea generation.
–
Drive
standards,
research
and
development,
and
product
development
through
partnerships
across
the
financial
ecosystem.
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for more
information about UBS’s sustainability achievements in 2021
and
our progress on key targets
Taking climate action
1
Our climate
governance
As
part
of
its
annual
approval
of
our
sustainability
and
impact
objectives, the CCRC
also oversees UBS’s
climate strategy, as
set
by the GEB. During its six meetings throughout the course
of the
year,
the
CCRC
reviews
the
GEB’s
activities
in
executing
our
climate
strategy
and,
jointly
with
the
BoD’s
Risk
Committee,
evaluates the
progress of
our climate
risk program.
The committee
also
reviews
the
alignment
of
our
climate
disclosures
with
the
recommendations of
the Task
Force on
Climate-related Financial
Disclosures (the TCFD).
We
manage
these
annual
plans
and
goals
through
our
ISO
14001-certified
environmental
management
system
(the
EMS),
with management accountabilities across
our firm. The
EMS helps
us
reduce
environmental
risks,
seize
market
opportunities,
and
continually
improve
our
environmental,
climate
and
resource-
efficiency performance.
In
May
2021,
we
established
a
net-zero
task
force
to
help
progress toward our ambition
of reaching net zero
by 2050. The
GEB lead for
sustainability and impact
chairs the task
force. Senior
representatives from across our firm, including from the business,
risk and finance, attend the task force’s monthly meetings.
›
Refer to the UBS Climate Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for UBS’s
full climate disclosures
1
This sub-section provides key information from the UBS Climate Report 2021, which contains our full
climate disclosures and follows the recommendations provided by the TCFD. The Climate Report
is available
from 11 March 2022 under “Annual reporting” at
ubs.com/investors
, integrated in the UBS Sustainability Report 2021 or as a standalone document.
53
Our climate
strategy
In
April 2021,
we
committed
to achieving
net-zero
greenhouse
gas emissions
resulting from
all aspects of
our business by
2050
(scope 1,
2
and
3
emissions).
We
are
publishing
our
journey
toward this ambition in our climate roadmap.
Our climate strategy
covers two
main areas: managing
climate-
related
financial
risks
and
acting
for
a
low
-
carbon
future
.
Underpinning these two areas are four strategic pillars.
1. Protecting our clients’ assets
As
a
global
financial
institution,
it
is
our
responsibility
to
help
clients navigate through the challenges of the transition
to a low-
carbon economy. We help our clients assess, manage and protect
their
assets
from
climate-related
risks
by
offering
innovative
products and
services in
investment, financing and
research. We
work
collaboratively
across
our
industry
and
with
our
clients,
ensuring they
have access
to best practice,
robust science-based
approaches,
standardized
methodologies,
and
quality
data
for
measuring
and
mitigating
climate
risks.
Our
activities
include
engaging on climate topics
with the companies we
invest in. For
example,
our
Asset
Management
business
division
has
implemented an
engagement program
with 46
companies from
the
oil
and
gas,
electric
and
other
utilities,
metals
and
mining,
construction materials, chemicals,
and automotive sectors.
During
2021, we also supported 70 climate-related resolutions.
2. Protecting our own assets
We
seek
to
protect
our
assets
by
limiting
our
risk
appetite
for
carbon-related
assets.
We
use
scenario-based
stress-testing
approaches
and
other
forward-looking
portfolio
analyses
to
estimate
our
vulnerability
to
climate-related
risks.
As
of
31 December
2021,
we
had
reduced
our
lending
exposure
to
carbon-related
assets
to
9.9%
(USD 45.6
billion)
of
our
total
customer
lending exposure.
This was
down
from
10.4% at
the
end of 2020 and 10.7% at the end of 2019.
3. Reducing our climate impact
We
are
committed
to
achieving
net-zero
emissions
in
our
own
operations
(scopes
1
and
2)
by
2025
by
replacing
fossil
fuel
heating
systems,
maintaining
our
100%-renewable
electricity
coverage
and
investing
in
credible
carbon
removal
projects
(including
negative
emissions
technology).
We
will
also
compensate for our
historical scope 1 and
2 emissions back
to the
year
2000
by
using
credible
and
clear
carbon
offsets
and
investments
in
nature-based
solutions.
Furthermore,
we
are
currently
working
to
understand
and
quantify
the
scope 3
emissions
in
our
supply
chain.
We
are
engaging
with
our
key
vendors on targeting net zero by 2035.
4. Mobilizing capital
We mobilize private and institutional capital through investments
that
help
the
world
mitigate
and
adapt
to
climate
change. We
were
the
first
major
global
financial
institution
to
have
made
sustainable
investments
the
preferred
solution
for
our
private
clients
wishing
to
invest
globally.
We
also
support
our
goal
of
mobilizing capital as
a lender and
corporate advisor. For
corporate
clients, we support
the issuance
of green, social,
sustainability and
sustainability
-
linked
bonds
–
and
the
raising
of
capital
in
international
capital
markets
–
in
line
with
recognized
market
guidelines,
such
as
the
ICMA
Green
Bond
Principles.
We
also
extend green and
sustainable loans in
line with the
Loan Market
Association.
In
2021,
we
began
offering
borrowers
Green
Mortgages
via
the
key4
platform,
the
first
Swiss
real
estate
platform
for
investment
properties
that
promotes
sustainable
mortgages.
›
Refer to the UBS Climate Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for a full
description of UBS’s climate strategy
Our strategy, business model and environment
| How we create value for our stakeholders
54
Our management of climate risks
Climate
risks
can
arise
from
either
changing
climate
conditions
(physical
risks)
or
from
efforts
to
mitigate
climate
change
(transition risks). The physical
and transition risks from
a changing
climate contribute
to a
structural change
across economies
and,
consequently, can
affect banks
and the
financial sector
through
financial and non-financial impacts.
In
March
2020,
Group
Risk
Control
established
our
firm’s
climate risk program to further integrate climate risk in the firm’s
risk
management
framework
and
standard
processes.
The
program
follows
a
multi-year
roadmap
to
address
regulatory
expectations and is engaging with stakeholders and experts both
internally
and
externally
to
further
develop
climate
risk
methodologies,
to
deliver
on
ongoing
climate
stress
testing
exercises
and
to
build
capacity
to
respond
to
climate
risk
management expectations.
We
currently
identify
and
manage
climate
risks
in
our
own
operations, our balance sheet, client assets and the supply
chain.
To
protect
our
clients’ and
our
own
assets
from
climate-related
risks, in
2021, we
continued to
drive the
integration of
climate-
related risk into our standard risk management framework.
We further integrated climate
risk in:
(i) risk identification and
measurement
;
(ii)
monitoring
and
risk
appetite
setting
;
(iii) management and
control; and (iv)
reporting processes across
the organization.
›
Refer to “Sustainability and climate
risk” in the “Risk
management and control” section of this
report
›
Refer to the UBS Climate Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for a full
description of UBS’s management of climate risks
Our climate-related metrics and targets
For
many
years,
we
have
been
developing
methodologies
that
enable
us
to
disclose
climate-related
metrics
more
robustly
and
transparently. Most recently, regulators and standard setters have
provided more guidance
on metrics. We firmly
aim to keep
pace
with
these
new
developments
and
requirements
and
further
evolve our
climate-related metrics. This
commitment remains,
as
does our determination to continue
leading the way in efforts to
mitigate climate change.
UBS supports the goals
of the Paris Agreement,
which includes
aligning
our
own
operations
and
business
activities
with
a
pathway
of
a
five-step
net-zero
plan
to:
(i) measure
carbon
emissions;
(ii) define
a
roadmap
and
set
targets;
(iii) reduce
climate
impact;
(iv) finance
climate
action
and
support
the
transition of our clients; and (v) communicate and engage.
›
Refer to the UBS Climate Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for a full
description of UBS’s net-zero targets, including baselines and
pathways
55
Climate-related metrics 2021
For the year ended
% change from
31.12.21
31.12.20
31.12.19
31.12.20
Risk management
Carbon-related assets (USD billion)
1,2
45.6
45.4
40.1
0.4
of which: UBS AG (standalone)
3
7.0
7.6
7.5
(8.7)
of which: UBS Switzerland AG (standalone)
3
37.9
37.1
31.9
2.4
Proportion of total customer lending exposure, gross (%)
9.9
10.4
10.7
Total exposure to climate-sensitive sectors, transition risk (USD billion)
2,4
37.5
37.5
33.4
0.0
of which: UBS AG (standalone)
3
4.6
5.4
5.8
(15.9)
of which: UBS Switzerland AG (standalone)
3
32.8
31.7
27.3
3.4
Proportion of total customer lending exposure, gross (%)
8.2
8.6
9.0
Total exposure to climate-sensitive sectors, physical risk (USD billion)
2,4
25.5
26.2
25.6
(2.8)
of which: UBS AG (standalone)
3
10.8
11.5
13.1
(6.1)
of which: UBS Switzerland AG (standalone)
3
13.6
13.5
11.7
1.4
Proportion of total customer lending exposure, gross (%)
5.6
6.0
6.9
Identified significant climate-related financial risk on balance sheet
5
None
None
None
Opportunities
Number of green, sustainability, and sustainability-linked bond deals
6
98
29
26
237.9
Total deal value of green, sustainability, and sustainability-linked bond deals (USD billion)
6
63.3
19.3
15.6
UBS apportioned deal value of above (USD billion)
13.2
5.7
3.4
Stewardship – voting
Number of climate-related resolutions voted upon
7
89
50
44
78.0
Proportion of supported climate-related resolutions (%)
78.6
88.0
81.8
Own operations
(reporting period: July to June)
Net GHG footprint (1,000 metric tons CO
2
e)
8
30
75
104
(60.0)
Change from baseline 2004 (%)
(92.0)
(79.0)
(71.2)
Share of renewable electricity (%)
100
85
72
1 The carbon-related assets
metric has been updated to
cover the four non-financial groups
as defined by the TCFD,
i.e., energy, transportation,
materials and buildings,
and agriculture, food and for
est products.
2 Includes total
loans and advances to customers and guarantees as well as irrevocable loan commitments (within the scope of expected credit loss).
3 Based on standalone IFRS numbers.
4 Climate-sensitive sectors are defined as those business
activities that are rated as having high,
moderately high or moderate vulnerability
to transition risks and physical risks.
For more details, refer
to the “UBS lending to climate-sensitive sectors”
table under “Sustainability and climate
risk” in the “Risk management
and control” section of this report
and “Climate scenario analysis” in the
“What” section of the Sustainability Report
2021, available from 11 March 2022
under “Annual reporting” at
ubs.com/investors
.
Physical risk number includes USD 4 billion of
loans backed by real estate in
regions with elevated physical climate risks.
Global Wealth Management corporate lending
to customers represents 1.1% of all on- and
off-balance sheet
loans and advances to customers,
and is excluded from the climate-sensitive
sectors analysis in 2021.
5
M
ethodologies for assessing climate-related financial risk are
emerging and may change over time,
as described in the UBS
Climate Report 2021, available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
.
6
Such as, but not limited to, ICMA Green Bond
Principles, Sustainability Bond Principles, and Sustainability-linked Bond Principles.
7 This excludes proposals related to Japanese companies that included changes to
the companies’ articles of association. 2021 numbers include shareholder and management
proposals, 2020 and 2019 numbers shareholder proposals
only. This reflects the increasingly common market
practice of climate-related proposals being presented by management.
8 Net greenhouse gas (GHG) footprint equals gross
GHG emissions minus GHG reductions from renewable
electricity and CO
2
e offsets (gross GHG
emissions include: direct GHG emissions
by UBS; indirect GHG
emissions associated with the generation
of imported / purchased
electricity (grid average emission
factor), heat or steam;
and
other indirect GHG emissions associated with business travel, paper consumption and waste disposal).
A breakdown of our GHG emissions (scopes 1, 2 and 3) is provided in appendix
4 to the Sustainability Report 2021, available from
11 March 2022 under “Annual reporting” at
ubs.com/investors
.
Reporting to our stakeholders on our sustainability
strategy and activities
Information about all our
sustainability efforts and commitments
is
provided
in
our
Sustainability
Report
2021,
available
under
“Annual
reporting”
at
ubs.com/investors
.
The
content
of
the
Sustainability Report 2021 has been prepared in accordance with
Global Reporting Initiative (GRI) Standards
(the “comprehensive”
option) and with the
German rules implementing the
EU Directive
on
disclosure
of
non-financial
and
diversity
information
(2014/95/EU). Our
reporting on sustainability
has been
reviewed
on a limited assurance basis by Ernst & Young Ltd
against the GRI
Standards.
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for an
overview of non-financial disclosures in accordance
with the
German rules implementing EU Directive 2014/95
and for
information on UBS AG and UBS Europe SE
disclosures pursuant
to EU Taxonomy Art. 8
Our strategy, business model and environment
| Regulation and supervision
56
Regulation and supervision
As a financial
services
provider based
in Switzerland,
UBS is subject
to
consolidated
supervision
by
the
Swiss
Financial
Market
Supervisory Authority
(FINMA). Our entities are also regulated
and
supervised
by
authorities
in
each
country
where
they
conduct
business.
Through UBS AG
and UBS Switzerland
AG, both licensed
as banks
in Switzerland,
UBS may
engage in
a full
range of
financial
services
activities in
Switzerland and
abroad,
including personal
banking,
commercial
banking,
investment
banking
and
asset
management.
As
a
global
systemically
important
bank
(
a
G
-
SIB),
as
designated
by
the
Financial
Stability
Board,
and
a
systemically
relevant bank
(an SRB)
in Switzerland,
we are
subject to
stricter
regulatory
requirements
and
supervision
than
most
other
Swiss
banks.
›
Refer to the “Our evolution” section
of this report for more
information
›
Refer to the “Regulatory and legal developments”
and “Risk
factors” sections of this report for more information
Regulation and supervision in Switzerland
Supervision
UBS
Group
AG
and
its
subsidiaries are
subject
to
consolidated
supervision by
FINMA
under
the
Swiss Banking
Act
and
related
ordinances, which
impose standards for
matters such as minimum
capital,
liquidity,
risk
concentration
and
internal
organization
standards. FINMA
meets
its
statutory supervisory
responsibilities
through licensing, regulation,
supervision, and enforcement. It
is
responsible for prudential
supervision
and mandates audit
firms to
perform regulatory
audits and
other supervisory
tasks on
its behalf.
Capital adequacy and liquidity regulation
As an
internationally
active Swiss
SRB, we
are subject
to capital
and
total loss-absorbing
capacity requirements that are based on both
RWA and LRD and
are among the most
stringent in
the world. We
are also subject to short-term liquidity coverage ratio rules and to
long-term minimum
funding requirements.
›
Refer to the “Capital, liquidity and funding,
and balance sheet”
section of this report for more information about
the Swiss SRB
framework and the Swiss too-big-to-fail
requirements
›
Refer to “Liquidity coverage ratio” in the
“Capital, liquidity and
funding, and balance sheet” section of
this report for more
information about liquidity coverage ratio
requirements
›
Refer to the “Regulatory and legal developments”
section of this
report for more information about the introduction of
the net
stable funding ratio
›
Refer to “Industry trends” in the “Our environment”
section of
this report for more information about revisions of the
Swiss
too-big-to-fail liquidity framework
Regulation and supervision outside Switzerland
Regulation and supervision in the US
In the
US, UBS
is subject
to regulation
and supervision
by the
Board
of Governors of
the Federal
Reserve System (the
Federal Reserve
Board) under a
number of laws. UBS
Group AG and
UBS AG are
both subject
to the Bank
Holding Company
Act, pursuant
to which
the Federal
Reserve Board
has supervisory authority
over the
US
operations
of both UBS
Group AG and
UBS AG.
In
addition
to
being
a
financial
holding
company
under
the
Bank Holding Company Act, UBS AG has US branches, which are
authorized and supervised by the
Office of the Comptroller of
the
Currency.
UBS AG
is
registered
as
a
swap
dealer
with
the
Commodity
Futures
Trading
Commission
(the
CFTC)
and
as
a
securities-based
swap
dealer
with
the
Securities
and
Exchange
Commission (the SEC).
UBS Americas Holding LLC, the
intermediate holding company
for
our
operations
in
the
US
outside
of
the
UBS
AG
branch
network,
as
required
under
the
Dodd–Frank
Act,
is
subject
to
requirements established by the
Federal Reserve Board related
to
risk-based
capital,
liquidity,
the
Comprehensive
Capital
Analysis
and
Review
stress
testing
and
capital
planning
process,
and
resolution planning and governance.
UBS
Bank
USA,
a
Federal
Deposit
Insurance
Corporation-
insured depository institution subsidiary, is licensed and regulated
by state regulators in Utah.
UBS Financial
Services Inc.,
UBS Securities
LLC and several
other
US subsidiaries of
UBS are
subject to
regulation by
a
number of
different government agencies
and
self-regulatory organizations,
including the SEC, the Financial Industry
Regulatory Authority,
the
CFTC,
the
Municipal
Securities
Rulemaking
Board
and
national
securities
exchanges,
depending on
the nature
of their business.
Regulation and supervision in the UK
Our regulated
UK operations
are mainly
subject to
the authority
of the Prudential Regulation Authority (the PRA), which is part of
the
Bank
of
England,
and
the Financial
Conduct
Authority
(the
FCA).
We
are
also
subject
to
the
rules
of
the
London
Stock
Exchange
and
other
securities
and
commodities
exchanges
of
which UBS AG is a member.
UBS AG has a
UK-registered branch in
London, which serves
as
a global
booking center
for our
Investment Bank.
Our regulated
subsidiaries in the UK that
provide asset management services are
authorized and regulated mainly by the FCA, with one entity also
subject to the authority of the PRA.
Regulation and supervision in Germany / the EU
UBS Europe SE is
subject to the
direct supervision of the
European
Central
Bank,
as
well
as
to
continued
conduct,
consumer
protection and
anti-money laundering-related
supervision by the
German
Federal
Financial
Supervisory
Authority
(the
BaFin)
and
supervisory
support
by
the
German
Bundesbank.
The
entity
is
subject to
EU and
German laws and
regulations. UBS
Europe SE
maintains
branches
in
Denmark,
France, Italy,
Luxembourg,
the
Netherlands,
Poland,
Spain,
Sweden
and
Switzerland,
and
is
subject to
conduct supervision
by authorities
in all
those countries.
57
Regulation and supervision in Asia Pacific
We operate in
13 locations in
Asia Pacific and are
subject to the
regulation
and supervision
by local
financial
regulators.
Our regional
hubs
are Singapore
and Hong
Kong SAR.
In
Singapore,
we
conduct
our
operations
primarily
through
UBS AG Singapore Branch and UBS Securities Pte. Ltd., which are
supervised
by
the
Monetary
Authority
of
Singapore
and
the
Singapore Exchange.
UBS AG Hong
Kong Branch is
primarily supervised by
the Hong
Kong Monetary
Authority. UBS
Securities Hong
Kong Limited,
UBS
Securities Asia Limited and UBS Asset Management (Hong Kong)
Limited are primarily supervised by the Hong Kong Securities and
Futures
Commission.
In
addition,
UBS
Securities
Hong
Kong
Limited is supervised
by the Hong
Kong Stock Exchange
and the
Hong Kong Futures Exchange.
In Mainland
China, UBS
has multiple
licenses to
operate its
core
business
lines
,
and
the
various
UBS
entities
are
subject
to
regulation
by
a
number
of
different
government
agencies.
The
People’s
Bank
of
China
oversees
the
macro
capital
markets
policies
and ensures
coordinated supervisory
approaches
by the
China
Banking
and Insurance
Commission,
the
China Securities
and Regulatory Commission, and the exchanges.
Financial crime prevention
Combating money laundering
and terrorist financing
has been a
major
focus
of
many
governments
in
recent
years.
Laws
and
regulations, including
the US Bank
Secrecy Act,
require effective
policies,
procedures
and
controls
to
detect,
prevent
and
report
money laundering and
terrorist financing, and
the verification of
client
identities.
Failure
to
introduce
and
maintain
adequate
programs to prevent
money laundering
and terrorist financing
can
result in significant legal and reputation risk and fines.
We are also subject
to laws and
regulations prohibiting corrupt
or
illegal
payments
to
government
officials
and
other
persons,
including the US Foreign
Corrupt Practices Act and
the UK Bribery
Act.
We
maintain
policies,
procedures
and
internal
controls
intended to comply with those regulations.
›
Refer to “Non-financial risk” in the “Risk
management and
control” section of this report for more information
Data protection
We are subject
to regulations concerning the
use and protection
of
customer,
employee,
and
other
personal
and
confidential
information.
This
includes
provisions
under
Swiss
law,
the
EU
General Data Protection Regulation (the GDPR) and laws of other
jurisdictions.
›
Refer to the “Risk factors” section of
this report for more
information about regulatory change
Recovery and resolution
Swiss too-big-to-fail (TBTF) legislation
requires each Swiss
SRB to
establish
an
emergency
plan
to
maintain
systemic
functions
in
case
of
impending
insolvency.
In
response
to
these
Swiss
requirements,
and
similar
ones
in
other
jurisdictions,
UBS
has
developed
recovery
plans
and
resolution
strategies,
as
well
as
plans
for
restructuring
or
winding
down
businesses
if
the
firm
could not be stabilized otherwise.
In 2013, FINMA stated its
preference for a single point
of entry
(SPE) strategy for globally active SRBs, such as
UBS, with a bail-in
at
the
group
holding-company
level.
UBS
has
made
structural,
financial and operational changes
to facilitate an SPE
strategy and
is
confident
that
a
resolution
of
the
bank
is
operationally
executable
and
legally
enforceable.
FINMA
published
its
most
recent
assessment
of
Swiss
SRBs’
emergency
and
recovery
and
resolution plans
in March 2021,
which confirmed
that our Swiss
emergency plan
is effective,
subject to
further reduction
of joint
and
several
liabilities.
Since
the
previous
assessment,
UBS
has
reduced
its
joint
and
several
liabilities
to
the
requested
level.
FINMA acknowledged progress
made in UBS’s
overall resolvability,
by building up the necessary capabilities or removing obstacles to
the implementation of the resolution strategy.
UBS’s crisis management framework
Our crisis management framework
includes three key governance
bodies (see chart
on the following
page), which take
responsibility
and action depending on
the nature of the
stress incident and the
scale of the response needed.
–
For
incident,
risk
and
crisis
management,
the
Group
Crisis
Management
Committee
works
with
incident
management
teams that provide monitoring and early-warning indicators at
local / regional
level, without needing
to activate protocols
at
the Group
level. If
a local
response is
insufficient, global
task
forces and
crisis management teams
provide decision-making
guidance
and
coordination,
including
crisis
management
plans,
protocols
and
playbooks,
and
contingency
funding
plans.
–
The Group Executive
Board and the
Board of
Directors would
evaluate
and
decide
upon
the
need
to
activate
the
Global
Recovery
Plan
(the
GRP)
if
a
stress
event
reached
a
severity
requiring that, based on the GRP’s risk indicators.
–
FINMA
has
the
authority
to
determine
whether
the
point
of
non-viability
(PONV)
as
defined
by
Swiss
law
(referred
to
as
“impending insolvency” in the Banking Act) has been reached
and, in
such cases,
as part
of the
resolution strategy,
has the
power
to
order
the
bail-in
of
creditors
to
recapitalize
and
stabilize the
Group, limit
payments of
dividends and
interest,
alter our
legal structure,
take actions
to reduce
business risk,
and order a restructuring of the bank.
Our strategy, business model and environment
| Regulation and supervision
58
Global Recovery Plan
The
GRP
gives
senior
management
a
tool
to
restore
financial
strength if UBS comes under severe capital and liquidity stress.
Quantitative
and qualitative
triggers are
monitored daily
and
subject
to
predefined
governance
and
escalation
processes.
Recovery
options
are
linked
to
owners
and
checklists
with
the
objectives
being
capital
preservation,
capital
raising
and
raising
funding,
and disposal or wind-down of businesses.
Global Resolution Strategy
FINMA
is responsible
for developing
the resolution
strategy
for UBS.
The planning
includes
measures
that
FINMA
can take
to resolve
UBS
in an
orderly manner
if the
Group enters
into resolution.
FINMA
has
the ultimate authority
and responsibility
to execute the resolution,
in
cooperation with
the
Swiss
National
Bank,
the
Swiss
Federal
Department of Finance and
other key authorities. The
SPE bail-in
strategy would
involve writing
down the Group’s
remaining equity
and additional
tier 1
and tier
2 instruments,
as well
as bail-in
of total
loss-absorbing (TLAC)-eligible
senior unsecured bonds at
the UBS
Group
AG
level.
An
internal recapitalization
of
undercapitalized
subsidiaries
would be made
simultaneously
with losses
transmitted
to
UBS
AG
and,
ultimately,
UBS
Group
AG.
Post-resolution
restructuring
measures
could
include
disposal
and winding
down
of
businesses
and assets.
FINMA
noted that
we have
already
taken key
preparatory
steps
and
made
good
progress
regarding
global
resolvability.
Local recovery and resolution plans
The Swiss
emergency plan
demonstrates how
UBS’s systemically
important
functions
and
critical
operations
in
Switzerland
can
continue if
the UBS
Group cannot
be restructured. This
is achieved
mainly
by
maintaining
UBS
Switzerland
AG
as
a
separate
legal
entity.
FINMA
has
confirmed
that
the
Swiss
emergency
plan
is
effective,
subject
to
further
reduction
of
joint
and
several
liabilities.
The US resolution
plan sets out
the steps that
could be taken
to
resolve
the
UBS
Americas
Holding
LLC
group
if
it
suffered
material
financial
distress
and
the
UBS
Group
was
unable
or
unwilling
to
provide
financial
support.
As
required
by
US
regulations, our US plan
contemplates that UBS
Americas Holding
LLC
will
commence
US
bankruptcy
proceedings.
Prior
to
commencement
thereof,
the
plan
envisages
UBS
Americas
Holding LLC down-streaming financial
resources to subsidiaries to
facilitate orderly wind-down or disposal of businesses.
Following
the
cross-border
merger
of
UBS
Limited
into
UBS Europe SE,
the enlarged
European operating
subsidiary has
developed
resolution
plans
based
on
Single
Resolution
Board
requirements.
Given
the
relatively
small
size
of
UBS
Europe
SE
compared
with
the
overall
Group,
emphasis
is
placed
on
the
recovery
plan and
the resolution
strategy for
the UBS
Group to
provide
the
tools
necessary
to
recapitalize
and
restructure
the
entity in case of material financial distress.
Other
local
recovery
and
resolution
plans
exist
for
various
Group entities and jurisdictions.
59
Regulatory and legal developments
Developments regarding Sanctions and Export Controls
As
a
result
of
the
Russian
invasion
of
Ukraine
on
24 February
2022,
Switzerland,
the
US,
the
EU,
the
UK
and
others
have
announced unprecedented levels
of sanctions
and other
measures
against
Russia
and
certain
Russian
entities
and
nationals.
UBS’s
policy
is
to
comply
with
all
applicable
laws,
including
sanctions
and export
controls, in
the jurisdictions
in which
it operates.
At
present,
numerous
complex
regimes
are
developing
rapidly
in
response
to the
escalating conflict
and UBS
is working
carefully
and assiduously
to comply
with all
relevant requirements
and to
address their potential consequences.
Developments regarding the too-big-to-fail regulation
In March 2021,
the Swiss Financial Market
Supervisory Authority
(FINMA)
published
its
annual
assessment
of
the
recovery
and
resolution plans of
systemically important financial
institutions in
Switzerland. The report shows that FINMA approved UBS’s group
recovery plan and assessed its
Swiss Emergency Plan as effective.
It also
highlighted that
UBS made
further progress
in improving
its global
resolvability by
building up
the necessary
capabilities and
removing
obstacles
to
the
implementation
of
the
resolution
strategy, while pointing out areas for further improvement.
In June 2021, the
Swiss Federal Council issued the
results of its
bi-annual
review
of
the
Swiss
too-big-to-fail
regulatory
framework.
The
Swiss
Federal
Council
concluded
that
no
fundamental
changes
to
the
framework
are
needed.
Potential
areas for
adjustment identified
include further
tightening of
the
liquidity
requirements
for
systemically
important
banks
and
the
alignment of incentive systems to support a bank’s resolvability.
In September 2021,
the Swiss Federal
Department of Finance
launched
a
consultation
on
proposed
revisions
to
the
Swiss
Liquidity Ordinance, with
the aim of
strengthening the
resilience
of systemically important banks
in Switzerland. As proposed,
the
revisions
would
increase
the
regulatory
minimum
liquidity
requirements for
systemically important banks,
including UBS.
The
final rule is expected to be published later this year.
Reactivation of the Swiss countercyclical buffer
In January 2022,
the Swiss
Federal Council decided,
at the request
of
the SNB,
to reactivate
the countercyclical
capital buffer,
at a
maximum
level
of
2.5%
on
risk-weighted
positions
that
are
directly
or
indirectly
backed
by
residential
properties
in
Switzerland. This is
expected to increase
our common equity
tier
1 (CET1) minimum capital requirement by approximately 30 basis
points. The reactivated
countercyclical capital buffer
will become
effective on 30 September 2022.
International developments regarding capital regulation
In
March
2021,
US
banking
regulators,
including
the
Federal
Reserve
Board
(the
FRB),
the
OCC
and
the
Federal
Deposit
Insurance
Corporation
(the
FDIC)
decided
not
to
extend
the
temporary
exclusion
of
central
bank
deposits
and
US
Treasury
securities
from
the
leverage
exposure
calculation
for
the
supplementary leverage ratio
beyond March 2021.
The temporary
exemption was applicable to UBS Americas Holding LLC (UBSAH)
with
respect
to
US
regulatory
capital
requirements.
In
addition,
the
Federal
Reserve
announced
that
the
limits
on
capital
distributions imposed
during the
COVID-19 pandemic
would be
removed after
30 June 2021. As
a result,
capital distributions by
UBSAH
will
generally
be
permitted
for
as
long
as
it
meets
regulatory capital
requirements, including
the incremental
stress
capital buffer set by the FRB as part of its Comprehensive Capital
Analysis and Review stress test (CCAR). Following the completion
of
the
annual
Dodd–Frank
Act Stress
Tests
(DFAST)
and
CCAR,
UBSAH
was
assigned
a
stress
capital
buffer
(an
SCB)
of
7.1%
(previously 6.7%) under the SCB rule as of 1 October 2021.
In
July
2021,
the
European
Central
Bank
announced
its
decision
to
remove
COVID
-
19
-
related
restrictions
on
capital
distributions
and
share
buybacks
by
banks
with
effect
from
1 October 2021.
In October 2021,
the European Commission
(the EC) published
a legislative proposal
to amend the
EU’s prudential rules
for banks
to implement the remaining elements
of Basel III and revised rules
on
resolution.
Once
finalized,
the
EC
envisages
that
these
requirements are likely to take effect
beginning in 2025 and UBS
Europe SE will be subject to these final provisions.
In addition,
the proposal,
which may
be adjusted
in the
political
process
and
is
expected
to
be
finalized
by
the
end
of
2023,
includes
a
requirement
that
certain
banking
and
investment
services must be provided
through a branch in
the EU. UBS Group
entities currently provide such
services in the EU
on a cross-border
basis. UBS will
assess the final
requirements to determine
whether
changes are required ahead
of the new framework entering
into
force.
Swiss stamp duty and withholding tax
In June 2021, the Swiss Parliament approved
an extension of the
current
withholding
tax
exemption
for
total
loss-absorbing
capacity instruments, including
additional tier 1, from
2021 until
the end of 2026.
In
December
2021,
the
Swiss
Parliament
also
adopted
a
legislation that
will abolish
the withholding
tax on bond
interest
payments (for bonds issued from the beginning of 2023 onward)
and will
eliminate the
securities transfer
stamp tax
on domestic
bonds.
However,
the
withholding
tax
on
interest
paid
on
bank
deposits
of
natural
persons
with
tax
domicile
in
Switzerland
is
maintained.
The
reform
intends
to
strengthen
the
debt
capital
market
in
Switzerland,
and
is
expected
to
take
effect
in
2023,
subject to an optional referendum.
Our strategy, business model and environment
| Regulatory and legal developments
60
OECD corporate tax reform
In October 2021, the G20
endorsed the final political agreement
on the
two-pillar solution
reached by
the OECD
/ G20
Inclusive
Framework on
Base Erosion
and Profit
Shifting (BEPS).
The two-
pillar solution
consists of Pillar 1,
which provides
taxing rights to
the
market
jurisdiction
from
where
the
profits
are
derived, and
Pillar 2, which introduces a
minimum corporate tax rate of
15%.
The G20 called for all the
rules to enter into force
at a global level
by 2024,
with some
to be
implemented in
2023. At
the time
of
publication
in
October
2021,
137
of
the
141
members
of
the
Framework had agreed to the reform and planned to incorporate
the new
rules into
their respective
national legislation,
including
Switzerland. As financial services are expected to be out of scope
of Pillar 1, UBS will primarily be affected by Pillar 2.
The impact of
the
reform
on
UBS
will
depend
on
implementation
by
the
adhering countries of the reform.
In January 2022,
the Swiss Federal
Council presented the
key
aspects
of
the
implementation
in
Switzerland.
The
relevant
changes will
require a constitutional
amendment, which triggers
a mandatory referendum.
The government aims
to implement the
minimum tax rate as of 1 January 2024.
Revision of the Swiss Anti-Money-Laundering Act
In
March
2021,
the Swiss
Parliament
granted final
approval
for
the
revision
of
the
Swiss
Anti-Money-Laundering
(AML)
Act,
which incorporates
several but
not all,
of the
recommendations
from the enhanced follow-up process of
the Financial Action Task
Force on Money
Laundering (the FATF). The revision will
introduce
into
Swiss
law
further
specifications
of
the
obligation
to
file
suspicious
activity
reports
and
increase
the
frequency
of
client
data
reviews.
It
will also
improve
transparency
by incorporating
additional legal
requirements for
associations with
elevated risks
of
terrorist
financing.
However,
the
FATF’s
recommendation
to
extend the
scope of
the Swiss
AML Act
to advisors
(e.g., attorneys,
fiduciaries,
and
tax
advisors)
was
not
adopted
by
the
Swiss
Parliament.
On 1 October 2021, the Federal Council issued a
draft revision
of
the
Anti-Money-Laundering
Ordinance
(AMLO)
to
detail
the
implementation of
the changes.
The consultation
on the
AMLO
ended
on
17 January
2022,
and
the
revisions
are
expected
to
enter into
force by
mid-2022. UBS
is in
the process
of adjusting
its AML processes to reflect the new requirements.
Developments regarding environmental, social and
governance matters
2021
saw
a
significant
number
of
sustainability-related
policy
developments, with a
particular focus on
disclosure requirements,
across various jurisdictions.
In
March
2021,
the
EU
Sustainable
Finance
Disclosures
Regulation
(the
SFDR)
came
into
effect.
The
regulation
defines
standards regarding, among other matters, how investors should
be
informed
about
sustainability
risks
and
how
the
impact
of
investments on the environment and society should be disclosed.
This
regulation
concerns
any
prospectus
of
UBS’s
EU-domiciled
and EU-marketed funds.
In
April
2021,
the
EC
published
a
legislative
proposal
for
a
revised
Non-Financial
Reporting
Directive
(NFRD)
requiring
firms
to publish enhanced information
about their activities
with regard
to environmental, social and governance (ESG)-related matters.
In
July
2021,
the
EC
adopted
regulations
prescribing
the
content,
methodology
and
presentation
of
climate-related
disclosures
that
are
required
under
Art.
8
of
the
EU
Taxonomy
Regulation.
As
part
of
their
non-financial
reporting,
credit
institutions will be
required to disclose
a green asset
ratio covering
the banking book and
certain trading portfolios, as well
as other
key
performance
indicators
(KPIs),
including
the
proportion
of
green
taxonomy-aligned
off-balance
sheet
exposures
and
fees
and
commission income.
Starting with
the annual
reporting
for
2021, taxonomy-eligible
assets are
required to
be disclosed;
the
remaining
set
of
KPIs
is
to
be
fully
phased
in
for
our
annual
reporting
for
2025.
These
disclosure
requirements
will
apply
to
UBS AG and UBS Europe SE.
In August
2021, the
Swiss Federal
Council decided
to introduce
mandatory
reporting
requirements
for
large
Swiss
companies
based
on
the
recommendations
of
the
Financial
Stability
Board
(the FSB) Task
Force on Climate-related
Financial Disclosures (the
TCFD).
A
consultation
on
the draft
proposal
is
planned
in
mid-
2022,
with
mandatory
requirements
expected
to
apply
to
the
2023 annual reporting. Our disclosures
are already largely aligned
with
the
2017
TCFD
recommendations
and
we
expect
to
fully
implement those by the end of 2022.
In November 2021,
the Swiss Federal
Council published several
recommendations
to
increase
transparency
regarding
climate-
related
information
and
reporting
in
the
Swiss
financial
center,
including that: i)
financial market
participants use comparable
and
meaningful climate compatibility
indicators to create
transparency
for all financial products and client portfolios; and ii) the financial
sector
joins
international
net-zero
alliances.
UBS
has
joined
the
Glasgow
Financial
Alliance
for
Net
Zero
(GFANZ)
and
is
participating in an industry-wide
working group led by
the Swiss
Federal
Department
of
Finance
(the
FDF)
to
develop
climate
compatibility
indicators.
The
Swiss
Federal
Council
has
also
instructed
the
FDF
to
work
with
the
Department
of
the
Environment,
Transport,
Energy
and
Communications
(DETEC)
and
FINMA
to
jointly
assess,
by
the
end
of
2022,
whether
any
changes to financial
market rules may
help avoid greenwashing,
and, if necessary, to propose binding guidelines.
In November 2021, FINMA issued guidance on preventing and
combating
greenwashing in
the context
of sustainability-related
collective
investment
schemes.
The
guidance
sets
out
FINMA’s
expectations
regarding:
the
advertised
sustainability
characteristics
in
fund
documents
of
respective
Swiss
collective
investment
schemes;
appropriate
organizational
structures
of
institutions
that
manage
sustainability-related
Swiss
or
foreign
collective
investment
schemes;
and
the
integration
of
ESG
considerations into the process of advising clients.
In
November
2021,
the
Swiss
Environmental
Commission
of
the
Council
of
States
agreed
to
start
work
on
an
indirect
counterproposal
to
the
“Glacier
Initiative.”
Both
the
original
initiative and the counterproposal aim to embed
in national law a
net-zero
target
to
be
achieved
by
2050.
The
Environmental
Commission of the National Council
will formulate a draft
in early
2022, but the public vote will not take place before 2023.
In
November
2021,
the
Basel Committee
on
Banking
Supervision (the BCBS) issued a consultation on
Principles for the
effective management and
supervision of climate-related
financial
risks.
The
consultation
paper proposes
18
principles
to
improve
climate-related
financial
risk
management
by
banks
and
supervisors.
The
proposal
states
that
banks
should
incorporate
climate risks into their capital
and liquidity adequacy assessments.
61
In
November
2021,
the
International
Financial
Reporting
Standards (IFRS) Foundation Trustees announced
the creation of a
new
standard-setting
board,
the
International
Sustainability
Standards
Board
(ISSB),
which
will
be
tasked
with
developing a
comprehensive global baseline for
sustainability-related disclosure
standards
that
will
provide
investors
and
other
capital
market
participants
with
information
about
companies’
sustainability-
related
risks
and
opportunities
in
order
to
help
them
make
informed decisions.
In
December
2021,
the
Swiss
Federal
Council
opened
the
consultation
on
the
revised
CO
2
Act
following
its
rejection
in
a
public vote earlier
in 2021. The
new proposal contains
measures
to reduce carbon
emissions for the
period from 2025
to 2030 and
mandates
FINMA
and
the
Swiss
National
Bank
to
report
on
climate-related financial risks.
In
December
2021,
the
Federal
Council
specified
new
due
diligence requirements
to implement the
counterproposal to the
Responsible
Business
Initiative.
The
changes
to
the
Code
of
Obligations
require
large
Swiss
companies
to
report
on
risks
of
their
business
activities
in
the
areas
of
the
environment,
social
issues,
employee concerns,
human rights,
and the
fight against
corruption,
as
well as
on
the measures
taken
to
mitigate
these
risks. Companies active in sensitive areas with a risk of child labor
and conflict
minerals must
comply with
additional due
diligence
and reporting
obligations. The
details of
these requirements
are
outlined in a separate ordinance. The
new provisions entered into
force on
1 January 2022.
The law grants
companies one
year to
adapt to the new obligations.
These will therefore be applied
for
the first time in the 2023 financial year.
In
December
2021,
the
US
Office
of
the
Comptroller
of
the
Currency (the OCC)
issued a consultation
on supervisory guidance
regarding
firms’
climate
risk
management
practices.
While
the
proposal broadly aligns
with that
issued by the
BCBS in November,
it also represents the first
step of US banking
regulators regarding
expectations of supervised firms in their
capacity to measure and
control exposures to potential climate change issues.
Starting with our
2021 annual reporting,
we comply with
the
revised
FINMA
Circular
2016/1
“Disclosure
–
banks,”
which
includes climate risk-related
disclosure requirements. We
provide
information
required by
Art. 8
of
the EU
Taxonomy Regulation,
starting with the
disclosure of taxonomy-eligible
assets of UBS
AG
and UBS Europe SE on a standalone basis for year-end 2021.
Developments regarding digitalization and innovation in
finance
Regulatory discussions on various
aspects of digital
innovation in
finance
and,
in
particular,
virtual
assets
have
increased
and
continued to evolve. However, national regulatory approaches on
the subject still differ widely.
In
June
2021,
the
BCBS
consulted
on
an
approach
to
the
prudential
treatment
of
virtual
assets
as
part
of
a
multi-year
process to develop internationally aligned prudential rules.
In
October
2021,
the
Committee
on
Payments
and
Market
Infrastructures
and
the
International
Organization
of
Securities
Commissions (IOSCO) consulted
on guidance proposing
that the
Principles for Financial Market Infrastructures should also
apply to
systemically important stablecoin arrangements.
In
October
2021,
the FATF
updated
its
2019
Guidance for
a
risk-based
approach
to
virtual
assets
and
virtual
asset
service
providers
(VASPs),
who
are
subject
to
the
same
relevant
FATF
measures that
apply to
financial institutions.
The guidance
aims
to
help
countries
and
VASPs
understand
their
obligations
regarding
anti-money
laundering
and
terrorist
financing
and
effectively implement the FATF’s requirements.
In
November
2021,
EU
legislators
made
further
progress
toward agreement
on the
Markets in
Crypto-Assets Regulation,
which
aims
to
establish
a
comprehensive
EU-wide
regulatory
framework for
the issuance
of, and
provision of
services related
to, various types of virtual assets.
The legislation is expected to be
finalized by mid-2022.
In
November
2021,
the
US
President’s
Working
Group
on
Financial Markets released a paper on stablecoins recommending
that US Congress enact
legislation to restrict issuers
of stablecoins
to supervised, deposit-taking banks. In the absence of legislation,
the
US Financial
Stability Oversight
Council could
designate the
activity
as
systemically
important
and
place
them
under
the
authority of the Federal Reserve.
In 2021,
several central
banks continued
their efforts
to actively
explore
central
bank
digital
currencies
(CBDC),
including
with
each
other,
with
the
BIS
Innovation
Hub
network
and
with
commercial
banks.
For
example,
UBS
participated
in
SNB-
and
Swiss Infrastructure and Exchange (SIX)-led
CBDC projects named
Helvetia
and
Jura.
The
introduction
of
CBDC
could
potentially
have
a
significant
impact
on
the
financial
sector,
though
the
implications
are
not
yet
fully
understood.
In
January
2022,
the
Federal
Reserve
released its
discussion paper
on
CBDC, seeking
public
input
on
the
advantages
and
disadvantages
of
these
products and the preservation
of monetary and financial
stability
while complementing existing means of payment.
In February
2022, the
Swiss Federal
Council published
its report
on framework conditions for digital finance
in Switzerland, which
includes
measures
linked
to
12
prioritized
action
areas.
The
Federal
Department
of
Finance
will
implement
the
measures
in
2022
and
subsequent
years
in
close
coordination
with
relevant
stakeholders, including
the private
sector. Among
the policy
topics
addressed
are
open
finance,
artificial
intelligence,
distributed
ledger
technology, cybersecurity,
green
fintech, the
Cloud,
data
sharing and cross-border data flows.
Operational resilience and cybersecurity
In
2021,
there
were
several
regulatory
developments
on
operational resilience and cybersecurity.
In
March
2021,
the
BCBS
published
its
Principles
for
Operational
Resilience
(the
BCBS
Principles),
providing
global
standards intended
to strengthen
the ability
of banks
to absorb
operational
risk-related
events
that
could
cause
significant
operational failures or widescale disruption in financial markets.
In March 2021,
the Prudential Regulation
Authority (the PRA)
and
the
Financial
Conduct
Authority
(the
FCA)
published
their
final rules
on the
UK operational
resilience framework.
The new
rules require firms to
identify their important
business services, set
impact tolerances for such
and commence testing against
severe
but plausible scenarios by
31 March 2022. Firms are
expected to
introduce
any
required
resilience
reinforcements
by
31 March
2025. The
rules in
the UK
will apply
to UBS
AG London
Branch
and other Group entities that provide services to UBS AG London
Branch.
Our strategy, business model and environment
| Regulatory and legal developments
62
In the fourth quarter of 2021, both the Monetary Authority of
Singapore
and
the
Hong
Kong
Monetary
Authority
issued
consultations
on
proposed
rules
to
incorporate
the
BCBS
Principles
for
Operational
Resilience
into
their
regulatory
and
supervisory
frameworks.
Rules
in
the
UK,
Singapore
and
Hong
Kong SAR are broadly aligned to the BCBS Principles.
UBS
established
a
global
Enhanced
Operational
Resilience
program in
August 2020
with the
aim of
ensuring implementation
and alignment
with key
regulatory requirements
on operational
resilience.
In November
2021, the
US banking
regulators, including
the
FRB,
the
OCC
and
the
FDIC
published
final
rules
regarding
computer
security
incident
reporting
requirements,
including
thresholds and timing, that apply to supervised banks and service
providers and become effective in April 2022.
In
January
2022,
the
Swiss
Federal
Council
initiated
a
consultation on a proposal to introduce a reporting obligation
for
cyberattacks
on
critical
infrastructures,
including
banks.
The
proposal defines
the tasks
of the
National Cybersecurity
Centre,
the designated
central recipient
of the
reports. The
consultation
will
last
until
14 April
2022.
Once
finalized,
UBS
will
need
to
adjust its reporting processes accordingly.
Developments regarding the relationship between
Switzerland and the European Union
In May
2021, the
Swiss Federal
Council terminated
negotiations
on
the
Institutional
Framework
Agreement
(the
IFA)
between
Switzerland and
the European
Union (the
EU) due to
substantial
differences
of opinion
regarding
key
aspects of
the agreement.
The IFA would
have formed
a mutually
agreed basis to
consolidate
and
further
develop
Switzerland’s
bilateral
market
access
approach with
the EU. As
a result, the
EU is unlikely
to be ready
to
conclude
new
market
access
agreements
–
including
on
financial services – with Switzerland in the near future.
In
November
2021,
the
Swiss
Federal
Council
decided
to
extend the existing measure protecting the Swiss stock exchange
infrastructure
(which
was due
to
expire on
31 December
2021)
until
31 December
2025
and
to
open
a
consultation
on
incorporating
this
measure
into
the
Financial
Market
Infrastructure
Act.
In
the
absence
of
mutual
recognition
of
equivalence
by
both
Swiss
and
EU
authorities,
the
measure
requires EU
investment firms
to trade
Swiss equities
on Swiss
stock
exchanges. UBS
had previously
adjusted its
internal processes
to
reflect this measure.
Revision of the Swiss Banking Act
In December 2021,
the Swiss Parliament
adopted a revision of
the
Banking
Act.
The
legislative
amendment
aims
to
strengthen
depositor
protection
and
promote
financial
system
stability
by
reducing the time needed to pay out
protected deposits through
the
depositor
protection
scheme
in
the
event
a
bank
enters
bankruptcy.
Among other measures,
it will also
require banks
to
deposit 50% of the contribution obligations in securities or Swiss
francs. The
revision also
introduces amendments
with regard
to
insolvency law
and segregation,
in particular
the introduction
of
a
more
detailed
and
solid
legal
basis
for
bail-in,
including
the
ranking of claims
subject to bail
in, ensuring legal certainty
for the
operationalization of a
bail-in. The new
provisions also provide for
the
subordination
of
bail-in-bonds,
with
the
exception
of
such
bail-in-bonds issued by
a holding company
if other debt
ranking
pari passu does
not exceed 5%
of the total
bail-in-bond debt. The
revised Banking Act
will enter into
force at the
beginning of 2023.
We
expect moderate
costs for
all Switzerland-based
UBS Group
entities that are within the scope of the revision.
Review of restrictions on the business model of
PostFinance AG
In
January
2021,
the
Swiss
Federal
Council
announced
that
it
intends
to
privatize
PostFinance
AG,
a
Swiss
systemically
important bank, which is held by the state-owned Swiss
Post AG.
As
a
result,
the
prohibition
on
PostFinance
AG
granting
mortgages and other types
of loans would be
lifted, among other
changes. As the envisaged changes
require a revision
of the Post
Organization Act,
the Swiss
Parliament will
ultimately decide
on
any changes.
In June 2021,
the Swiss Federal
Council submitted a
dispatch
to
the
Swiss
Parliament.
If
the
revision
passes
the
legislative
process,
which
is
expected
to
start
in
2022,
the
reform
could
further intensify competition in the Swiss mortgage market.
Registration under the US security-based swaps
regulations
In
October
2021,
FINMA
and
the
US
Securities
and
Exchange
Commission (the SEC) finalized
a memorandum of understanding
relating
to
cooperation
in
oversight
of
Swiss
entities
registered
under the
SEC’s security-based
swaps regulations.
The SEC
also
published
a
substituted
compliance
order
modifying
the
application
of
certain
of
its
regulations
for Swiss
security-based
swap dealers. Under
SEC regulations, UBS
AG has been
registered
as a security-based swap dealer since 1 November 2021.
Developments regarding LIBOR
In March
2021, the FCA
confirmed that the
one-week and two-
month
US
dollar
London
Interbank
Offered
Rate
(USD
LIBOR)
settings, along
with all
GBP,
EUR, CHF,
and JPY
LIBOR settings,
would, immediately
after 31 December 2021,
either cease to
be
provided by
any administrator
or no
longer be
representative of
the
underlying
market.
The
FCA
further
confirmed
that
the
remaining
USD
LIBOR
settings
will
cease
immediately
after
30 June 2023.
In October 2021,
the FRB issued
guidance that banks
should,
with
limited
exceptions,
cease
to
enter
into
new
contracts
referencing USD
LIBOR as soon
as practicable
and, in
any event,
no later than 31 December 2021.
63
Risk factors
Certain
risks,
including
those
described
below,
may
affect
our
ability to execute
our strategy or our
business activities, financial
condition, results of operations and
prospects. We are inherently
exposed to
multiple risks, many
of which
may become apparent
only with
the benefit
of hindsight.
As a
result, risks
that we
do
not
consider
to
be
material,
or
of
which
we
are
not
currently
aware, could
also adversely
affect us.
Within each category,
the
risks that we consider to be most material are presented first.
Market, credit and macroeconomic risks
Performance in the financial services industry is affected by
market conditions and the macroeconomic climate
Our
businesses
are
materially
affected
by
market
and
macroeconomic
conditions.
A
market
downturn
and
weak
macroeconomic
conditions
can be
precipitated
by
a
number of
factors, including geopolitical events, such as international
armed
conflicts, the
imposition of
sanctions, global
trade or
global supply
chain disruptions, changes in
monetary or fiscal
policy, changes in
trade
policies
or
international
trade
disputes,
significant
inflationary
or
deflationary
price
changes,
disruptions
in
one
or
more
concentrated
economic
sectors,
natural
disasters,
pandemics,
civil unrest,
acts of
violence, war
or terrorism.
Such
developments can have unpredictable and destabilizing effects.
For example, as a
result of the Russian
invasion of Ukraine on
24 February
2022
and
the
ongoing
hostilities,
Switzerland,
the
US, the EU, the UK and others have announced sanctions against
certain Russian
banks, companies
and individuals,
as well
as the
Russian Central
Bank, and
have announced
that certain
Russian
banks
will
be
barred
from
using
the
Society
for
Worldwide
Interbank
Financial
Telecommunication
(SWIFT)
messaging
system. In
addition, it
is estimated
that one
million people
have
been displaced
inside Ukraine and
many of
those displaced
may
seek
refuge
in
Poland
and
other
neighboring
countries,
as
the
conflict continues these
numbers are likely to
increase. The scale
of
the
conflict
and
the
unprecedented
speed
and
extent
of
sanctions
may
produce
many
of
the
effects
described
above,
including in ways that cannot now be anticipated.
Adverse
changes
in
interest
rates,
credit
spreads,
securities
prices,
market
volatility
and
liquidity,
foreign
exchange
rates,
commodity
prices,
and
other
market
fluctuations,
as
well
as
changes
in
investor
sentiment,
can
affect
our
earnings
and
ultimately our financial and capital positions. As financial
markets
are
global
and
highly
interconnected,
local
and
regional
events
can have
widespread effects well
beyond the
countries in
which
they occur.
Any of
these developments
may adversely
affect our
business or financial results.
If
individual
countries
impose
restrictions
on
cross-border
payments, trade, or other exchange or
capital controls, or change
their currency (for example, if one or more countries should leave
the
Eurozone
or
as
result
of
the
imposition
of
sanctions
on
individuals,
entities
or
countries),
we
could
suffer
losses
from
enforced default by counterparties,
be unable to access our
own
assets, or be unable to effectively manage our risks.
Should the
market experience
significant volatility, a
decrease
in
business and
client activity
and market
volumes could
result,
which would
adversely affect
our ability
to generate
transaction
fees,
commissions
and
margins,
particularly
in
Global
Wealth
Management and the Investment Bank, as we experienced in the
fourth quarter
of 2018. A
market downturn would
likely reduce
the volume and valuation of assets that
we manage on behalf of
clients, which would reduce recurring fee income that
is charged
based on
invested assets
in Global
Wealth Management
and Asset
Management and performance-based
fees in Asset
Management.
Such a downturn could also cause a decline in the value of assets
that we own and account for as investments or
trading positions.
In addition, reduced market liquidity or volatility may
limit trading
opportunities
and
may
therefore
reduce
transaction-based
income and may also impede our ability to manage risks.
We could be
materially affected if
a crisis develops,
regionally
or
globally,
as
a
result
of
disruptions
in
markets
due
to
macroeconomic
or
political
developments,
or
as
a
result
of
the
failure
of
a
major
market
participant.
Over
time,
our
strategic
plans
have
become
more
heavily
dependent
on
our
ability
to
generate
growth
and
revenue
in
emerging
markets,
including
China, causing us to be
more exposed to the
risks associated with
such markets.
Global
Wealth
Management
derives
revenues
from
all
the
principal
regions,
but
has
a
greater
concentration
in
Asia
than
many
peers
and
a
substantial
presence
in
the
US,
unlike
many
European peers.
The Investment
Bank’s business
is more
heavily
weighted to Europe and Asia than our peers, while its derivatives
business
is
more
heavily
weighted
to
structured
products
for
wealth
management
clients,
in
particular
with
European
and
Asian
underlyings.
Our
performance
may
therefore
be
more
affected by political, economic
and market developments in
these
regions
and
businesses
than
some
other
financial
service
providers.
Our strategy, business model and environment
| Risk factors
64
Our results of operations and financial condition may be
adversely affected by the COVID-19 pandemic and the response
to it
The COVID-19
pandemic and
the governmental measures
taken
to manage it, as well as labor
market displacements, supply chain
disruptions, and inflationary pressures, may continue to adversely
affect
global
and
regional
economic
conditions,
resulting
in
contraction
in
the
global
economy,
substantial
volatility
in
the
financial markets, crises in markets
for goods and services,
as well
as significant
disruptions in
certain regional
real estate
markets,
increased unemployment, increased
credit and counterparty risk,
and
operational
challenges.
Governments
and
central
banks
around
the world
reacted
to
the economic
crisis caused
by
the
pandemic by
implementing stimulus
and liquidity
programs and
cutting
interest
rates
and
have
begun
to
phase
out
pandemic
relief.
In
addition,
while
vaccination
campaigns
have
had
significant success
in some
regions and
a number
of economies
are recovering, outbreaks in locations where vaccination rates are
low
or
vaccines
are
unavailable
on
a
large
scale, as
well as
the
spread of new variants of COVID-19, create uncertainty around a
sustainable recovery. Resurgence of the
pandemic, ineffectiveness
of
vaccines
and
continuance
or
imposition
of
new
pandemic
control measures
may result
in additional
adverse effects
on the
global economy
negatively affecting
UBS’s results
of operations
and financial condition.
The COVID-19 pandemic affected all of UBS’s
businesses, and
these effects
could be greater
in the future
if adverse conditions
persist or
worsen. These
effects included
declines in
some asset
prices,
spikes
in
volatility,
inflationary
pressures,
supply
chain
disruptions,
lower
or
negative interest
rates,
widening
of
credit
spreads
and
credit
deterioration.
These
effects
have
resulted
in
decreases in the valuation of
loans and commitments, an
increase
in the allowance
for credit losses
and lower valuations
of certain
classes
of
trading
assets.
While
many
of
these
effects
have
reversed as economies have reopened
and economic stimulus has
been
maintained, or
were offset
by high
levels
of client
activity
and
by
improved
asset
prices
in
many
sectors
in
2021,
these
favorable
conditions
may
not
persist.
In
particular,
real
estate
markets in some regions may be significantly disrupted
as a result
of
repeated
temporary
closures
of
business,
sheltering-in-place
directives,
and
remote
work
protocols
enacted
to
respond
to
seasonal increases in infection rates of COVID-19.
Should
inflationary
pressures
or
other
adverse
global
market
conditions
persist,
or
should
the
pandemic
lead
to
additional
economic
or
market
disruptions,
we
may
experience
reduced
client activity
and demand
for our
products and
services, increased
utilization of
lending commitments,
significantly increased
client
defaults, continued
and increasing
credit and
valuation losses
in
our
loan
portfolios,
loan
commitments
and
other
assets,
and
impairments of other financial assets.
A
fall
in
equity
markets
and
consequent
decline
in
invested
assets
would
also
reduce
recurring
fee
income
in
our
Global
Wealth Management
and Asset
Management businesses.
These
factors and other consequences of
the COVID-19 pandemic may
negatively
affect
our
financial
condition,
including
possible
constraints
on
capital
and
liquidity,
as
well
as
a
higher
cost
of
capital, and possible downgrades to our credit ratings.
The
extent
to
which
the
pandemic,
and
the
related
adverse
economic conditions, affect
our businesses, results
of operations
and
financial
condition,
as
well
as
our
regulatory
capital
and
liquidity ratios, will
depend on future
developments, including the
scope and duration of the pandemic
and any recovery period, the
adequacy
of
vaccine
distribution
plans
and
execution
of
those
plans,
as
well as
the efficacy
of
vaccines
against
potential
virus
variants, future actions
taken by governmental
authorities, central
banks and
other third
parties in
response to
the pandemic,
and
the
effects
on
our
customers,
counterparties,
employees
and
third-party service providers.
Our credit risk exposure to clients, trading counterparties and
other financial institutions would increase under adverse or other
economic conditions
Credit risk
is an
integral part
of many
of our
activities, including
lending, underwriting and
derivatives activities. Adverse
economic
or
market
conditions,
or
the
imposition
of
sanctions
or
other
restrictions on clients, counterparties or financial
institutions, may
lead
to
impairments
and
defaults
on
these
credit
exposures.
Losses may
be exacerbated
by declines
in the
value of
collateral
securing
loans
and
other
exposures.
In
our
prime
brokerage,
securities
finance
and
Lombard
lending
businesses,
we
extend
substantial
amounts
of
credit
against
securities
collateral,
the
value
or
liquidity of
which
may decli
ne rapidly.
Market
closures
the imposition of exchange controls, sanctions or other measures
may limit our ability to settle existing transactions or to realize on
collateral, which may result in unexpected increases in exposures.
Our Swiss mortgage and
corporate lending portfolios are
a large
part of our
overall lending. We
are therefore
exposed to the
risk
of
adverse
economic
developments
in
Switzerland,
including
property
valuations
in
the
housing
market,
the
strength
of
the
Swiss
franc
and
its
effect
on
Swiss
exports,
prevailing
negative
interest
rates
applied
by
the
Swiss
National
Bank,
economic
conditions within
the Eurozone
or the
EU, and
the evolution
of
agreements
between
Switzerland
and
the
EU
or
European
Economic
Area,
which
represent
Switzerland’s
largest
export
market.
We
have
exposures
related
to
real
estate
in
various
countries,
including
a
substantial
Swiss
mortgage
portfolio.
Although
we
believe
this
portfolio
is
prudently
managed,
we
could
nevertheless
be
exposed
to
losses
if
a
substantial
deterioration in the Swiss real estate market were to occur.
As we experienced
in 2020, under
the IFRS
9 expected credit
loss (ECL) regime, credit loss expenses may increase rapidly at the
onset
of
an
economic
downturn
as
a
result
of
higher
levels
of
credit impairments (stage 3), as
well as higher ECL from
stages 1
and 2. Substantial increases in
ECL could exceed expected
loss for
regulatory
capital
purposes
and
adversely
affect
our
common
equity tier 1 (CET1) capital and regulatory capital ratios.
Interest rate trends and changes could negatively affect our
financial results
The
low
or
negative
interest
rate
environment,
particularly
in
Switzerland and the
Eurozone, may further
erode interest margins
and
adversely
affect
the
net
interest
income
generated
by
the
Personal &
Corporate Banking
and Global
Wealth Management
businesses. The Swiss National Bank permits
Swiss banks to make
deposits
up to
a
threshold
at
zero
interest.
Any reduction
in or
limitation
on
the
use
of
this
exemption
from
the
otherwise
applicable negative interest
rates would exacerbate
the effect of
negative interest rates in Switzerland on our business.
65
Low
and
negative
interest
rates
may
also
affect
customer
behavior and
hence our
overall balance
sheet structure.
Mitigating
actions that we have taken, or
may take in the future,
such as the
introduction of
selective deposit
fees or
minimum lending
rates,
have
resulted
and
may
further
result
in
the
loss
of
customer
deposits (a key
source of
funding for
us), net new
money outflows
and
a
declining
market
share
in
our
Swiss
lending
business.
Interest rates in
the US and
some other markets
are expected to
increase as
central banks
respond to
higher inflation.
As returns
for alternatives to deposits,
such as money
market funds, increase
with
interest
rates,
we
may
experience
outflows
of
customer
deposits
or
a
higher
cost
of
deposit
funding
if
customers
shift
from deposits to alternative products.
Our
shareholders’
equity
and
capital
are
also
affected
by
changes in interest rates.
In particular, the calculation
of our Swiss
pension plan’s net defined benefit assets and liabilities is
sensitive
to
the applied
discount
rate and
to
fluctuations in
the value
of
pension plan
assets. Any
further reduction
in interest
rates may
lower the
discount rates
and result
in pension
plan deficits
as a
result of the long duration
of corresponding liabilities. This could
lead to a corresponding reduction in our equity and CET1 capital.
Currency
fluctuation may have an adverse effect on our profits,
balance sheet and regulatory capital
We are subject to currency
fluctuation risks. Although
our change
from
the
Swiss
franc
to
the
US
dollar
as
our
functional
and
presentation currency
in 2018
reduces our
exposure to
currency
fluctuation
risks
with
respect
to
the
Swiss
franc,
a
substantial
portion of our assets and liabilities are denominated in currencies
other than the US
dollar. Additionally,
in order to hedge
our CET1
capital
ratio,
our
CET1
capital
must
have
foreign
currency
exposure, which
leads to currency
sensitivity.
As a consequence,
it is
not possible
to simultaneously fully
hedge both
the amount
of
capital and
the capital
ratio. Accordingly,
changes in
foreign
exchange rates
may adversely
affect our
profits, balance sheet
and
capital, leverage and liquidity coverage ratios.
Regulatory and legal risks
Material legal and regulatory risks arise in the conduct of our
business
As
a
global
financial
services
firm
operating
in
more
than
50
countries,
we are
subject
to many
different
legal,
tax and
regulatory
regimes, including
extensive regulatory
oversight, and are
exposed
to
significant liability
risk.
We
are
subject to
a
large
number of
claims, disputes,
legal proceedings
and government
investigations,
and we expect
that our ongoing
business activities
will continue
to
give rise to such matters in the future. The extent of our
financial
exposure
to
these
and
other
matters
is
material
and
could
substantially
exceed
the level
of provisions
that
we have
established.
We
are
not
able
to
predict
the
financial
and
non-financial
consequences
these matters
may have when
resolved.
We
may
be
subject to
adverse
preliminary determinations or
court
decisions
that may
negatively
affect
public
perception
and our
reputation, result in prudential actions
from regulators, and cause
us to record additional provisions for such matters even when we
believe
we
have
substantial
defenses
and
expect
to
ultimately
achieve a
more favorable
outcome. This
risk is
illustrated by
the
award of
aggregate penalties and damages of
EUR 4.5 billion by
the court of first
instance in France.
This award was reduced
to an
aggregate of EUR 1.8 billion
by the Court of Appeal, and UBS has
further appealed
this judgment.
Resolution of regulatory proceedings may require us
to obtain
waivers
of
regulatory
disqualifications
to
maintain
certain
operations; may entitle regulatory authorities to limit, suspend or
terminate licenses and regulatory authorizations; and may permit
financial
market
utilities
to
limit,
suspend
or
terminate
our
participation
in
them.
Failure
to
obtain
such
waivers,
or
any
limitation, suspension
or termination of licenses, authorizations
or
participations,
could have
material adverse
consequences
for us.
Our settlements
with governmental
authorities in
connection
with foreign
exchange, London
Interbank Offered
Rates (LIBOR)
and
other
benchmark
interest
rates
starkly
illustrate
the
significantly increased level of financial and reputational risk now
associated
with
regulatory
matters
in
major
jurisdictions.
In
connection
with
investigations
related
to
LIBOR
and
other
benchmark
rates and
to foreign
exchange and
precious
metals,
very large fines
and disgorgement amounts
were assessed against
us,
and
we
were
required
to
enter
guilty
pleas
despite
our
full
cooperation with the authorities
in the investigations, and
despite
our receipt
of conditional leniency
or conditional
immunity from
anti-trust authorities in
a number of
jurisdictions, including the
US
and Switzerland.
For a number of
years we have been,
and we continue to
be,
subject to
a very
high level
of regulatory
scrutiny and
to certain
regulatory
measures
that
constrain
our
strategic
flexibility.
We
believe we have remediated
the deficiencies that led
to significant
losses in
the past
and made
substantial changes
in our
controls
and conduct risk frameworks to address the issues highlighted
by
the
LIBOR-related,
foreign
exchange
and
precious
metals
regulatory resolutions. We have also undertaken extensive efforts
to implement new regulatory requirements and meet heightened
expectations.
We continue to be in active dialog with
regulators concerning
the
actions
we
are
taking
to
improve
our
operational
risk
management,
risk
control,
anti
-
money
laundering,
data
management and other frameworks, and otherwise seek to
meet
supervisory expectations, but there can
be no assurance that our
efforts will have the desired effects. As a result of this history, our
level
of
risk
with
respect
to
regulatory
enforcement
may
be
greater than that of some of our peers.
Substantial changes in regulation may adversely affect our
businesses and our ability to execute our strategic plans
Since
the
financial
crisis
of
2008,
we
are
subject
to
significant
regulatory
requirements,
including
recovery
and
resolution
planning, changes in capital and
prudential standards, changes in
taxation
regimes
as
a
result
of
changes
in
governmental
administrations, as well as new and
revised market standards and
fiduciary duties. Notwithstanding attempts
by regulators to align
their
efforts,
the
measures
adopted
or
proposed
for
banking
regulation
differ
significantly
across
the
major
jurisdictions,
making it
increasingly difficult
to manage a
global institution.
In
addition, Swiss regulatory changes with
regard to such matters as
capital
and
liquidity
have
often
proceeded
more
quickly
than
those in other major jurisdictions,
and Switzerland’s requirements
for major international banks
are among the strictest
of the major
financial
centers. This
could put
Swiss banks,
such as
UBS, at
a
disadvantage
when
competing
with
peer
financial
institutions
subject to more lenient regulation or
with unregulated non-bank
competitors.
Our strategy, business model and environment
| Risk factors
66
Our implementation of additional regulatory
requirements and
changes in supervisory standards, as well
as our compliance with
existing
laws
and
regulations,
continue
to
receive
heightened
scrutiny
from
supervisors.
If
we
do
not
meet
supervisory
expectations in relation to these or other matters, or
if additional
supervisory or
regulatory issues arise,
we would likely
be subject
to further regulatory
scrutiny as well
as measures that may
further
constrain our strategic flexibility.
Resolvability
and
resolution
and
recovery
planning:
We
have
moved
significant
operations
into
subsidiaries
to
improve
resolvability and meet other regulatory
requirements, and this has
resulted in substantial implementation
costs, increased our capital
and funding
costs and
reduced operational
flexibility. For
example,
we
have
transferred
all
of
our
US
subsidiaries
under
a
US
intermediate
holding
company
to
meet
US
regulatory
requirements, and have
transferred substantially
all the
operations
of
Personal
&
Corporate
Banking
and
Global
Wealth
Management
booked
in
Switzerland
to
UBS
Switzerland
AG to
improve resolvability.
These
changes
create
operational,
capital,
liquidity,
funding
and tax inefficiencies. Our
operations in subsidiaries are
subject to
local capital,
liquidity, stable
funding, capital planning
and stress
testing
requirements.
These
requirements
have
resulted
in
increased
capital
and
liquidity
requirements
in
affected
subsidiaries, which
limit our operational
flexibility and negatively
affect our ability to
benefit from synergies between
business units
and to distribute earnings to the Group.
Under
the
Swiss
too-big-to-fail
(TBTF)
framework,
we
are
required to
put in
place viable
emergency plans
to preserve
the
operation
of
systemically
important
functions
in
the
event
of
a
failure. Moreover, under this framework
and similar regulations in
the
US,
the
UK,
the
EU
and
other
jurisdictions
in
which
we
operate,
we
are
required
to
prepare
credible
recovery
and
resolution
plans
detailing
the measures
that would
be taken
to
recover in
a significant
adverse event
or in
the event
of winding
down
the
Group
or
the
operations
in
a
host
country
through
resolution
or
insolvency
proceedings.
If
a
recovery
or
resolution
plan that
we produce
is determined
by the
relevant authority
to
be inadequate or not credible, relevant regulation
may permit the
authority to place limitations on the scope or size of our business
in that jurisdiction, or oblige us to hold higher amounts of capital
or liquidity or to change
our legal structure or
business in order to
remove the relevant impediments to resolution.
Capital and
prudential standards:
As an
internationally active
Swiss systemically relevant
bank (an
SRB), we are
subject to
capital
and
total
loss-absorbing
capacity
(TLAC)
requirements
that
are
among the
most stringent
in the
world. Moreover,
many of
our
subsidiaries
must
comply
with
minimum
capital,
liquidity
and
similar requirements and, as a result, UBS Group AG and UBS AG
have contributed a significant portion of their capital and provide
substantial liquidity
to these
subsidiaries. These
funds are
available
to meet funding and
collateral needs in the relevant
entities, but
are generally not
readily available
for use
by the Group
as a
whole.
We expect our
risk-weighted assets (RWA)
to further increase
as the effective date for additional capital standards promulgated
by the Basel Committee
on Banking Supervision (the
BCBS) draws
nearer.
Increases
in capital
and liquidity
standards
could significantly
curtail
our
ability
to
pursue
strategic
opportunities
or
to
return
capital to shareholders.
Market
regulation
and
fiduciary
standards:
Our
wealth
and
asset
management
businesses
operate
in
an
environment
of
increasing
regulatory
scrutiny
and
changing
standards
with
respect to fiduciary and other standards of care and the focus on
mitigating or eliminating conflicts of interest between a manager
or advisor and the
client, which require effective implementation
across the global systems
and processes of investment
managers
and
other
industry
participants.
For
example,
we
have
made
material changes to
our business
processes, policies and
the terms
on which
we interact
with these
clients in
order to
comply with
SEC Regulation
Best Interest,
which is
intended to
enhance and
clarify
the
duties
of
brokers
and
investment
advisers
to
retail
customers, the Volcker Rule, which limits our
ability to engage in
proprietary
trading,
as
well
as
changes
in
European
and
Swiss
market
conduct regulation.
Future
changes in
the regulation
of
our duties to
customers may require us
to make further
changes
to our
businesses, which
would result
in additional
expense and
may adversely
affect our
business. We
may also
become subject
to
other
similar
regulations
substantively
limiting
the
types
of
activities
in
which
we
may
engage
or
the
way
we
conduct
our
operations.
In many instances, we provide services on
a cross-border basis,
and we are
therefore sensitive to
barriers restricting market
access
for third-country
firms. In
particular, efforts
in the
EU to
harmonize
the regime for third-country firms to access the European market
may have the effect of creating new barriers that adversely affect
our
ability
to
conduct
business
in
these
jurisdictions
from
Switzerland. In addition, a
number of jurisdictions are
increasingly
regulating
cross-border
activities
based
on
determinations
of
equivalence of
home country regulation,
substituted compliance
or
similar
principles
of
comity.
A
negative
determination
with
respect to Swiss equivalence could limit
our access to the market
in those
jurisdictions and
may negatively
influence our
ability to
act as
a global
firm. For
example, the
EU declined
to extend
its
equivalence determination
for Swiss exchanges,
which lapsed as
of 30 June 2019.
UBS experienced cross-border outflows
over a number of
years
as
a
result
of
heightened
focus
by
fiscal
authorities
on
cross-
border investment and fiscal
amnesty programs, in anticipation
of
the
implementation
in
Switzerland
of
the
global
automatic
exchange of tax information, and as a result of
the measures UBS
has implemented in
response to these
changes. Further changes
in local tax laws
or regulations and their enforcement,
additional
cross-border
tax
information
exchange
regimes,
national
tax
amnesty or
enforcement programs
or similar
actions may
affect
our clients’ ability or willingness to do business with us and could
result in additional cross-border outflows.
67
If we experience financial difficulties, FINMA has the power to
open restructuring or liquidation proceedings or impose
protective measures in relation to UBS Group AG, UBS AG or
UBS Switzerland AG, and such proceedings or measures may
have a material adverse effect on our shareholders and creditors
Under
the
Swiss
Banking
Act,
FINMA
is
able
to
exercise
broad
statutory
powers
with
respect
to
Swiss banks
and
Swiss parent
companies of
financial groups,
such as
UBS Group
AG, UBS
AG
and
UBS
Switzerland
AG,
if
there
is
justified
concern
that
the
entity is over-indebted, has serious liquidity problems or, after the
expiration
of
any
relevant
deadline,
no
longer
fulfills
capital
adequacy requirements. Such powers include ordering protective
measures,
instituting
restructuring
proceedings
(and
exercising
any
Swiss
resolution
powers
in
connection
therewith),
and
instituting
liquidation
proceedings,
all
of
which
may
have
a
material
adverse
effect
on
shareholders
and
creditors
or
may
prevent
UBS
Group
AG,
UBS
AG
or
UBS
Switzerland
AG
from
paying dividends or making payments on debt obligations.
UBS would have
limited ability to
challenge any such
protective
measures, and creditors and
shareholders would also have
limited
ability under Swiss
law or in
Swiss courts to
reject them, seek
their
suspension, or challenge
their imposition,
including measures that
require or result in the deferment of payments.
If
restructuring
proceedings
are
opened
with
respect
to
UBS
Group AG, UBS
AG or UBS
Switzerland AG, the
resolution powers
that FINMA
may exercise
include the
power to:
(i) transfer all
or
some of the assets, debt and other
liabilities, and contracts of the
entity
subject
to
proceedings
to
another
entity;
(ii) stay
for
a
maximum
of
two
business
days
(a)
the
termination
of,
or
the
exercise of rights to terminate,
netting rights, (b) rights to
enforce
or
dispose
of
certain
types
of
collateral
or
(c)
rights
to
transfer
claims, liabilities or
certain collateral, under
contracts to which
the
entity
subject to
proceedings is
a
party; and
/ or
(iii) partially or
fully
write
down
the
equity
capital
and
regulatory
capital
instruments and,
if such
regulatory capital
is fully
written down,
convert debt instruments of
the entity subject to
proceedings into
equity. Shareholders and
creditors would have
no right to
reject,
or to
seek the
suspension of,
any restructuring
plan pursuant to
which such resolution
powers are exercised.
They would have
only
limited
rights
to
challenge
any
decision
to
exercise
resolution
powers
or
to
have
that
decision
reviewed
by
a
judicial
or
administrative process or otherwise.
Upon
full or
partial write-down
of
the equity
and
regulatory
capital
instruments
of
the
entity
subject
to
restructuring
proceedings,
the
relevant
shareholders
and
creditors
would
receive
no
payment
in
respect
of
the
equity
and
debt
that
is
written
down,
the
write-down
would
be
permanent,
and
the
investors would likely not, at
such time or at any time
thereafter,
receive any
shares or
other participation
rights, or
be entitled
to
any
write-up
or
any
other
compensation
in
the
event
of
a
potential subsequent recovery of
the debtor. If FINMA orders
the
conversion
of
debt
of
the
entity
subject
to
restructuring
proceedings
into
equity,
the
securities
received
by
the
investors
may
be
worth
significantly less
than
the original
debt
and
may
have
a
significantly
different
risk
profile.
In
addition,
creditors
receiving equity would be effectively subordinated to all creditors
of the
restructured entity
in the
event of
a subsequent
winding
up,
liquidation
or
dissolution
of
the
restructured
entity,
which
would increase
the risk
that investors
would lose
all or
some of
their investment.
FINMA has significant discretion
in the exercise of its
powers in
connection with
restructuring proceedings.
Furthermore, certain
categories of
debt obligations, such
as certain
types of deposits,
are
subject
to
preferential
treatment.
As
a
result,
holders
of
obligations
of
an
entity
subject
to
a
Swiss
restructuring
proceeding may have their
obligations written down or
converted
into
equity
even
though
obligations
ranking
on
par
with
such
obligations are not written down or converted.
We may be unable to fully realize our sustainability, climate,
environmental and social goals, which could damage our
business prospects, reputation and lead to increased regulatory
scrutiny and increased risk of litigation
We
have
set
ambitious
goals
for
environmental,
social
and
governance
matters.
These
goals
include
our
ambitions
for
environmental
sustainability in
our
operations, including
carbon
emissions, in the business we do with clients
and in products that
we offer.
They also include goals or ambitions for diversity in
our
workforce and
supply chain, and
support for the
United Nations
Sustainable Development
Goals. There
is substantial
uncertainty
as
to
the
scope
of
actions
that
may
be
required
of
us,
governments and
others to
achieve
the goals
we have
set, and
many
of
our
goals
and
objectives
are
only
achievable
with
a
combination
of
government
and
private
action.
National
and
international
standards,
industry
and
scientific
practices,
and
regulatory
taxonomies
and
disclosure
obligations
addressing
these matters
are in
a state
of rapid
development. Although we
have defined and disclosed our
goals based on the standards that
exist
today,
there
can
be
no
assurance
that
the
various
ESG
regulatory
and
disclosure
regimes
under
which
we operate
will
not
come
into
conflict
with
one
another
or
that
the
current
standards
will
not
be
interpreted
differently
than
our
understanding or change in a manner that substantially increases
the cost or
effort for us
to achieve such
goals or that
such goals
may prove to be considerably more difficult or even impossible to
achieve. If
we are
not able
to achieve
the goals
we have
set, or
can only do so at significant expense to our business, we may fail
to meet regulatory expectations, incur
damage to our reputation
or be exposed to risk of litigation or other adverse action.
Our strategy, business model and environment
| Risk factors
68
Our financial results may be negatively affected by changes to
assumptions and valuations, as well as changes to accounting
standards
We prepare
our consolidated financial
statements in accordance
with
International
Financial
Reporting
Standards
(IFRS).
The
application
of
these
accounting
standards
requires
the
use
of
judgment based on
estimates and assumptions
that may involve
significant uncertainty at the time they are made.
This is the case,
for
example,
with
respect
to
the
measurement
of
fair
value
of
financial instruments,
the recognition
of deferred
tax assets,
the
assessment of the impairment of goodwill, expected credit losses
and estimation
of provisions
for litigation,
regulatory and
similar
matters. Such judgments, including the underlying estimates and
assumptions,
which
encompass
historical
experience,
expectations
of
the
future
and
other
factors,
are
regularly
evaluated
to
determine
their
continuing
relevance
based
on
current
conditions. Using
different
assumptions could
cause the
reported
results
to differ.
Changes in
assumptions, or
failure
to
make the
changes necessary
to reflect
evolving market
conditions,
may have
a significant
effect
on the
financial statements
in the
periods
when
changes
occur.
Estimates
of
provisions
may
be
subject
to
a
wide
range
of
potential
outcomes
and
significant
uncertainty.
For example, the broad range of potential outcomes
in our
proceeding in
France increases
the uncertainty
associated
with
assessing
the
appropriate
provision.
If
the
estimates
and
assumptions in
future periods
deviate from
the current
outlook,
our financial results may also be negatively affected.
Changes
to
IFRS
or
interpretations
thereof
may
cause
future
reported
results
and
financial
position
to
differ
from
current
expectations, or
historical results
to differ
from those
previously
reported
due
to
the
adoption
of
accounting
standards
on
a
retrospective basis.
Such changes
may also
affect our
regulatory
capital and ratios.
For example, the introduction
of the expected
credit loss
(ECL) framework
under IFRS
9 in
2018 fundamentally
changed
how credit
risk arising
from
loans, loan
commitments,
guarantees and certain revocable facilities
is accounted for. Under
the regime, credit loss expenses may increase rapidly at the onset
of
an
economic
downturn
as
a
result
of
higher
levels
of
credit
impairments (stage 3), as well as higher ECL from stages 1 and 2,
only gradually diminishing
once the economic
outlook improves.
As we observed in
2020, this effect may be
more pronounced in
a
deteriorating
economic
environment.
Substantial
increases
in
ECL
could
exceed
expected
loss
for
regulatory
capital
purposes
and adversely affect
our CET1 capital
and regulatory capital
ratios.
We may be unable to maintain our capital strength
Capital
strength
enables
us to
grow
our
businesses
and absorb
increases in
regulatory and
capital requirements.
It reassures
our
clients and stakeholders, allows
us to maintain our
capital return
policy and contributes to our credit
ratings. Our capital ratios are
driven
primarily
by
RWA,
the
leverage
ratio
denominator
and
eligible capital, all of
which may fluctuate based on
a number of
factors,
some
of
which
are
outside
our
control.
Our
ability
to
maintain our capital ratios is subject
to numerous risks, including
the
financial
results of
our
businesses,
the effect
of
changes
to
capital
standards,
methodologies
and
interpretations
that
may
adversely affect the calculation of our CET1 ratios, the imposition
of risk add-ons
or capital buffers,
and the
application of additional
capital,
liquidity
and
similar
requirements
to
subsidiaries.
The
results
of
our
businesses
may
be
adversely
affected
by
events
arising
from
other
risk
factors
described
herein.
In
some
cases,
such as litigation
and regulatory risk
and operational risk
events,
losses
may
be
sudden
and
large.
These
risks
could
reduce
the
amount of capital available for return to shareholders and
hinder
our ability
to achieve
our capital
returns target
of a
progressive
cash dividend coupled with a share repurchase program.
Our eligible capital
may be reduced
by losses recognized
within
net
profit
or
other
comprehensive
income.
Eligible
capital
may
also
be
reduced
for
other
reasons,
including acquisitions
which
change
the
level
of
goodwill, changes
in
temporary
differences
related to deferred tax assets
included in capital, adverse currency
movements affecting the
value of equity,
prudential adjustments
that may be required due
to the valuation uncertainty associated
with
certain
types
of
positions,
changes
in
regulatory
interpretations on the inclusion or exclusion of items contributing
to our
shareholders equity
in regulatory
capital, and
changes in
the
value of
certain pension
fund assets
and liabilities
or in
the
interest rate and other assumptions
used to calculate the
changes
in
our
net
defined
benefit
obligation
recognized
in
other
comprehensive income.
RWA are driven
by our business
activities,
by changes in
the risk
profile
of
our
exposures,
by
changes
in
our
foreign
currency
exposures
and
foreign
exchange
rates,
and
by
regulation.
For
instance, substantial
market volatility,
a widening of
credit spreads,
adverse
currency
movements,
increased
counterparty
risk,
deterioration
in the
economic
environment
or increased
operational
risk
could
result
in
an
increase
in
RWA.
We
have
significantly
reduced
our
market
risk
and
credit
risk
RWA
in
recent
years.
However,
increases
in
operational
risk
RWA,
particularly
those
arising
from
litigation,
regulatory
and
similar
matters,
and
regulatory
changes in
the calculation
of RWA, as
well as regulatory
add-ons
to RWA,
have offset
a substantial
portion
of this
reduction.
Changes in
the calculation of
RWA, the
imposition of additional
supplemental
RWA
charges
or
multipliers
applied
to
certain
exposures
and
other
methodology
changes,
as
well
as
the
implementation
of the capital standards
promulgated by the Basel
Committee on
Banking Supervision, which
are proposed
to
take
effect in 2023,
are expected
to increase
our RWA.
The
leverage
ratio
is
a
balance
sheet-driven
measure
and
therefore limits balance sheet-intensive activities, such as
lending,
more than
activities that
are less
balance sheet
intensive, and
it
may
constrain
our
business
even
if
we
satisfy
other
risk-based
capital requirements. Our leverage ratio denominator is
driven by,
among other things, the level of client activity, including deposits
and loans, foreign
exchange rates, interest
rates and other
market
factors. Many of these factors are
wholly or partly outside of our
control.
69
The effect of taxes on our financial results is significantly
influenced by tax law changes and reassessments of our
deferred tax assets
Our effective
tax rate
is highly sensitive
to our performance,
our
expectation of
future profitability
and any
potential increases
or
decreases in statutory
tax rates, such as
any potential increase
in
the US
federal corporate
tax rate.
Further,
based on
prior years’
tax
losses,
we
have
recognized
deferred
tax
assets
(DTAs)
reflecting the probable
recoverable level based
on future taxable
profit
as
informed
by
our
business
plans.
If
our
performance
is
expected
to
produce
diminished
taxable
profit
in
future
years,
particularly in the US,
we may be required
to write down all or
a
portion
of
the
currently
recognized
DTAs
through
the
income
statement in excess of anticipated amortization.
This would have
the effect of increasing our effective
tax rate in the year in which
any
write-downs
are
taken.
Conversely,
if
we
expect
the
performance of entities in
which we have unrecognized tax
losses
to improve, particularly in the US or
the UK, we could potentially
recognize
additional
DTAs.
The
effect
of
doing
so
would be
to
reduce our effective tax rate in years
in which additional DTAs are
recognized and
to increase
our effective
tax rate in
future years.
Our effective tax
rate is also
sensitive to any
future reductions
in
statutory tax rates, particularly
in the US, which would
cause the
expected
future
tax
benefit
from
items
such
as
tax
loss
carry-
forwards
in
the
affected
locations
to
diminish
in
value.
This,
in
turn,
would
cause
a
write-down
of
the
associated
DTAs.
For
example,
the
reduction
in
the
US
federal
corporate
tax
rate
to
21%
from
35%
introduced
by
the
US
Tax
Cuts
and
Jobs
Act
resulted in a USD 2.9 billion net write-down in the
Group’s DTAs
in
the
fourth
quarter
of
2017.
Conversely,
an
increase
in
US
corporate
tax
rates
would
result
in
an
increase
in
the
Group’s
DTAs.
We
generally
revalue
our
DTAs
in
the
fourth
quarter
of
the
financial
year
based
on
a
reassessment
of
future
profitability
taking into account our updated business plans. We consider the
performance
of
our
businesses
and
the
accuracy
of
historical
forecasts,
tax
rates
and
other
factors
in
evaluating
the
recoverability of our DTAs, including the remaining tax loss carry-
forward
period
and
our
assessment
of
expected
future
taxable
profits
over
the
life
of
DTAs.
Estimating
future
profitability
is
inherently
subjective
and
is
particularly
sensitive
to
future
economic,
market
and
other
conditions,
which
are
difficult
to
predict.
Our results
in past
years have
demonstrated
that changes
in
the recognition of
DTAs can have a
very significant effect on
our
reported results. Any
future change in
the manner in
which UBS
remeasures DTAs could affect UBS’s effective tax rate, particularly
in the year in which the change is made.
Our full-year
effective tax
rate could
change if
aggregate tax
expenses
in
respect
of
profits
from
branches
and
subsidiaries
without loss coverage differ from
what is expected, or if branches
and subsidiaries generate tax
losses that we cannot
benefit from
through the
income statement. In
particular, losses
at entities or
branches
that
cannot
offset
for
tax
purposes
taxable
profits
in
other group
entities, and
which do
not result
in additional
DTA
recognition, may
increase our
effective tax
rate. In
addition, tax
laws or the
tax authorities in
countries where we
have undertaken
legal
structure
changes
may
cause
entities
to
be
subject
to
taxation as permanent
establishments or may
prevent the transfer
of
tax
losses
incurred
in
one legal
entity
to
newly
organized
or
reorganized subsidiaries or affiliates or may impose limitations on
the
utilization
of
tax
losses
that
relate
to
businesses
formerly
conducted
by
the
transferor.
Were
this
to
occur
in
situations
where there were
also limited planning
opportunities to utilize
the
tax losses in the originating entity, the DTAs associated with such
tax
losses
may
be
required
to
be
written
down
through
the
income statement.
Changes in tax law may materially affect our
effective tax rate,
and,
in
some
cases,
may
substantially
affect
the
profitability
of
certain activities. In addition, statutory
and regulatory changes, as
well
as
changes to
the
way in
which
courts and
tax authorities
interpret tax laws,
including assertions that
we are required
to pay
taxes
in
a
jurisdiction
as
a
result
of
activities
connected
to
that
jurisdiction
constituting
a
permanent
establishment
or
similar
theory, and changes in our assessment of uncertain tax positions,
could cause the
amount of taxes
we ultimately pay
to materially
differ from the amount accrued.
Strategy, management and operation
al risks
Operational risks affect our business
Our businesses
depend on our
ability to
process a
large number
of transactions, many
of which are
complex, across multiple
and
diverse
markets
in
different
currencies,
to
comply
with
requirements
of many
different
legal and
regulatory
regimes
to
which we are
subject and
to prevent, or
promptly detect and
stop,
unauthorized,
fictitious
or
fraudulent
transactions.
We
also
rely
on access
to, and
on the
functioning of,
systems maintained
by
third parties,
including clearing
systems, exchanges,
information
processors and central counterparties. Any failure of our or third-
party systems could have an adverse
effect on us. These risks may
be greater as we deploy newer technologies, such as blockchain,
or products
that rely on
these technologies. Our
operational risk
management and control systems
and processes are
designed to
help ensure that the
risks associated with
our activities –
including
those
arising
from
process
error,
failed
execution,
misconduct,
unauthorized
trading,
fraud,
system
failures,
financial
crime,
cyberattacks,
breaches
of
information
security,
inadequate
or
ineffective
access
controls
and
failure
of
security
and
physical
protection –
are appropriately
controlled. If
our internal controls
fail or
prove ineffective
in identifying and
remedying these
risks,
we could
suffer operational
failures that
might result
in material
losses,
such
as
the
substantial
loss
we
incurred
from
the
unauthorized trading incident announced in September 2011.
As
a
significant
proportion
of
our
staff
have
been
and
will
continue working
from outside
the offices
as a
consequence of
the
COVID-19
pandemic,
we
have
faced,
and
will
continue
to
face,
new
challenges
and
operational
risks,
including
maintenance of
supervisory and
surveillance controls,
as well
as
increased
fraud
and
data
security
risks.
While
we
have
taken
measures to manage these risks, such measures
have never been
tested on the
scale or duration
that we are
currently experiencing,
and there is risk that
these measures will prove not
to have been
effective in the current unprecedented operating environment.
Our strategy, business model and environment
| Risk factors
70
We use automation as
part of our efforts
to improve efficiency,
reduce
the
risk
of
error
and
improve
our
client
experience.
We
intend to expand the use of robotic processing, machine learning
and artificial intelligence to further these
goals. Use of these tools
presents their
own risks,
including the
need for
effective design
and
testing;
the
quality
of
the
data
used
for
development
and
operation of machine learning and
artificial intelligence tools may
adversely
affect their
functioning and
result
in
errors and
other
operational risks.
For financial institutions, cybersecurity
risks have increased due
to the
widespread use
of digital
technologies, cloud
computing
and mobile
devices to
conduct financial
business and
transactions.
In
addition,
cyberattacks
by
hackers,
terrorists,
criminal
organizations, nation states and extremists have also increased in
frequency
and
sophistication.
Current
geopolitical
tensions
also
may lead
to increased
risk of
cyberattack from
foreign state
actors.
In particular,
the Russian
invasion of
Ukraine and
the imposition
of significant sanctions on Russia by Switzerland,
the US, the EU,
the
UK
and
others
may
result
in
an
increase
in
the
risk
of
cyberattacks.
We
and
other
financial
services
firms
have
been
subject
to
breaches of
security and
to cyber-
and other
forms of
attack, some
of which are sophisticated and targeted
attacks intended to gain
access to
confidential information
or systems,
disrupt service
or
destroy
data.
These
attacks
may
be
attempted
through
the
introduction of
viruses or
malware, phishing
and other
forms of
social engineering, distributed denial of service attacks and other
means. These attempts may occur directly, or using equipment or
security passwords of our employees,
third-party service providers
or
other
users.
In
addition
to
external
attacks,
we
have
experienced
loss
of
client
data
from
failure
by
employees
and
others
to
follow
internal
policies
and
procedures
and
from
misappropriation of
our data
by employees
and others.
We may
not
be
able
to
anticipate,
detect
or
recognize
threats
to
our
systems
or
data
and
our
preventative
measures
may
not
be
effective to prevent an attack or a security breach. In the event
of
a security breach,
notwithstanding our preventative
measures, we
may not immediately detect a particular breach or attack. Once a
particular attack is detected,
time may be required
to investigate
and
assess
the
nature
and
extent
of
the
attack.
A
successful
breach or circumvention
of security of our
systems or data could
have
significant
negative
consequences
for
us,
including
disruption
of
our
operations,
misappropriation
of
confidential
information
concerning
us
or
our
customers,
damage
to
our
systems, financial losses
for us or
our customers, violations
of data
privacy and
similar laws,
litigation exposure
and damage
to our
reputation.
We
may
be
subject
to
enforcement
actions
as
regulatory
focus
on
cybersecurity
increases
and
regulators
have
announced
new
rules,
guidance
and
initiatives
on
ransomware
and other cybersecurity-related issues.
We are subject
to complex and
frequently changing laws
and
regulations governing the protection of
client and personal data,
such as the EU General Data Protection Regulation. Ensuring that
we comply with applicable laws and regulations
when we collect,
use
and
transfer
personal
information
requires
substantial
resources
and
may
affect
the
ways
in
which
we
conduct
our
business. In the event that we
fail to comply with applicable laws,
we may
be exposed
to regulatory
fines and
penalties and
other
sanctions.
We
may
also
incur
such
penalties
if
our
vendors
or
other service providers
or clients or
counterparties fail to
comply
with these
laws or
to maintain
appropriate controls
over protected
data. In addition, any loss or exposure of client or other data may
adversely
damage
our
reputation
and
adversely
affect
our
business.
A major
focus of
US and
other countries’
governmental policies
relating
to
financial
institutions
in
recent
years
has
been
on
fighting
money
laundering
and
terrorist
financing.
We
are
required to maintain effective policies,
procedures and controls to
detect,
prevent
and
report
money
laundering
and
terrorist
financing, and to verify
the identity of our
clients under the laws
of many of
the countries in
which we operate.
We are also
subject
to laws and regulations related to corrupt and
illegal payments to
government
officials by
others, such
as
the
US
Foreign Corrupt
Practices
Act
and
the
UK
Bribery
Act.
We
have
implemented
policies,
procedures
and
internal
controls
that
are
designed
to
comply with such laws and regulations. Notwithstanding this, US
regulators have found deficiencies in the design and operation of
anti-money laundering
programs in our
US operations.
We have
undertaken
a
significant
program
to
address
these
regulatory
findings
with
the
objective
of
fully
meeting
regulatory
expectations for our
programs. Failure to
maintain and implement
adequate
programs
to
combat
money
laundering,
terrorist
financing or
corruption, or
any failure
of our
programs in
these
areas,
could
have
serious
consequences
both
from
legal
enforcement action and
from damage to
our reputation. Frequent
changes in sanctions imposed and increasingly complex sanctions
imposed on
countries, entities and
individuals, as
exemplified by
the breadth
and scope
of the
sanctions imposed
in relation
the
Russian invasion of
Ukraine, increase our
cost of monitoring and
complying with sanctions requirements and increase the risk that
we will not
identify in a
timely manner client
activity that is
subject
to a sanction.
As a
result of
new and
changed regulatory
requirements and
the
changes
we
have
made
in
our
legal
structure,
the
volume,
frequency and
complexity of
our regulatory
and other
reporting
has
remained
elevated.
Regulators
have
also
significantly
increased expectations regarding
our internal reporting
and data
aggregation, as well as management
reporting. We have incurred
and continue to
incur significant
costs to implement
infrastructure
to
meet
these
requirements.
Failure
to
meet
external
reporting
requirements accurately and in a timely
manner or failure to meet
regulatory
expectations
of
internal
reporting,
data
aggregation
and management reporting could result in enforcement action or
other adverse consequences for us.
In
addition,
despite
the
contingency
plans
that
we
have
in
place, our
ability to
conduct business
may be
adversely affected
by a disruption in
the infrastructure that supports
our businesses
and
the
communities
in
which
we
operate.
This
may
include
a
disruption due to natural disasters,
pandemics, civil unrest, war
or
terrorism
and
involve
electrical, communications,
transportation
or other services that we
use or that are
used by third parties with
whom we conduct business.
71
We may not be successful in the ongoing execution of our
strategic plans
We
have
transformed
UBS
to
focus
on
our
Global
Wealth
Management
business
and
our
universal
bank
in
Switzerland,
complemented by Asset
Management and a
significantly smaller
and more capital-efficient Investment Bank; we
have substantially
reduced the risk-weighted assets and leverage ratio denominator
usage in Group
Functions; and made
significant cost reductions.
Risk remains that going
forward we may
not succeed in
executing
our
strategy
or
achieving
our
performance
targets,
or
may
be
delayed
in
doing
so.
Macroeconomic
conditions,
geopolitical
uncertainty,
changes
to
regulatory
requirements
and
the
continuing costs
of meeting
these requirements
have prompted
us to
adapt
our
targets and
ambitions
in
the past
and we
may
need to do so again in the future.
To achieve our strategic plans, we expect to continue
to make
significant
expenditures
on
technology
and
infrastructure
to
improve
client
experience,
improve
and
further
enable
digital
offerings and increase efficiency. We also may seek to implement
our
strategy
through
acquisitions
or
strategic
partnerships
to
expand
or
improve
our
product
offerings
or
target
additional
client
segments.
Our
investments
in
new
technology
and
our
acquisitions and
strategic partnerships
may not
fully achieve
our
objectives or improve
our ability to
attract and retain
customers.
In
addition,
we
face
competition
in
providing
digitally
enabled
offerings from both
existing competitors and
new financial service
providers
in
various
portions
of
the
value
chain.
For
example,
technological
advances
and
the
growth
of
e-commerce
have
made
it possible
for e-commerce
firms and
other companies
to
offer products and services that were traditionally offered only by
banks. These
advances have
also allowed financial
institutions and
other
companies
to
provide
digitally
based
financial
solutions,
including electronic
securities
trading, payments
processing and
online automated
algorithmic-based investment
advice at
a low
cost to their customers. We may have
to lower our prices, or risk
losing customers as a
result. Our ability to
develop and implement
competitive
digitally enabled
offerings and
processes will
be an
important factor in our ability to compete.
As
part
of
our
strategy,
we
seek
to
improve
our
operating
efficiency, in part by controlling our costs. We may not be able to
identify feasible
cost reduction
opportunities that
are consistent
with our business goals and cost reductions may be realized later
or
may
be
smaller
than
we
anticipate.
Higher
temporary
and
permanent
regulatory
costs
and
higher
business
demand
than
anticipated
have
partly
offset
cost
reductions
and
delayed
the
achievement
of
our
past
cost
reduction
targets,
and
we
could
continue to be challenged in
the execution of our ongoing
efforts
to improve operating efficiency.
Changes
in
our
workforce
as
a
result
of
outsourcing,
nearshoring, offshoring, insourcing
or staff reductions
or, changes
which
arise
from the
introduction
of
work
from home
or
other
flexible
ways
of
working
or
agile
work
methodologies
may
introduce new operational risks that, if
not effectively addressed,
could
affect our
ability
to
achieve
cost and
other benefits
from
such changes, or could result in operational losses.
As
we
implement
effectiveness
and
efficiency
programs,
we
may
also
experience
unintended
consequences,
such
as
the
unintended
loss
or
degradation
of
capabilities
that
we
need
in
order to maintain
our competitive position,
achieve our targeted
returns
or
meet
existing
or
new
regulatory
requirements
and
expectations.
We depend on our risk management and control processes to
avoid or limit potential losses in our businesses
Controlled risk-taking is a major
part of the business
of a financial
services firm. Some
losses from risk-taking activities
are inevitable,
but to be successful over time,
we must balance the risks we take
against
the
returns
generated.
Therefore,
we
must
diligently
identify, assess, manage and
control our risks, not only in normal
market
conditions
but
also
as
they
might
develop
under
more
extreme,
stressed conditions,
when concentrations
of exposures
can lead to severe losses.
We have not always been able to
prevent serious losses arising
from
risk
management
failures
and
extreme
or
sudden
market
events.
We
recorded
substantial
losses
on
fixed-income
trading
positions in the
2008 financial crisis, in
the unauthorized trading
incident in 2011
and, more recently,
positions resulting from
the
default of a US prime brokerage client. We revise and strengthen
our risk management and control frameworks to
seek to address
identified
shortcomings.
Nonetheless,
we
could
suffer
further
losses in the future if, for example:
–
we do not
fully identify the
risks in our portfolio,
in particular
risk concentrations and correlated risks;
–
our
assessment
of
the
risks
identified,
or
our
response
to
negative trends, proves
to be untimely,
inadequate, insufficient
or incorrect;
–
our
risk
models
prove
insufficient
to
predict
the
scale
of
financial risks the bank
faces;
–
markets move in
ways that we
do not expect
– in terms
of their
speed,
direction,
severity
or
correlation
–
and
our
ability
to
manage
risks
in
the
resulting
environment
is,
therefore,
affected;
–
third
parties
to
whom
we
have
credit
exposure
or
whose
securities we hold
are severely affected
by events
and we suffer
defaults and impairments beyond the
level implied by our risk
assessment; or
–
collateral or other security provided by
our counterparties and
clients proves inadequate to cover their obligations at
the time
of default.
We
also
hold
legacy
risk
positions,
primarily
in
Group
Functions,
that,
in
many
cases,
are
illiquid
and
may
again
deteriorate in value.
We also manage risk
on behalf of
our clients. The performance
of assets we hold for our clients may be adversely affected by the
same
factors
mentioned
above.
If
clients
suffer
losses
or
the
performance of their
assets held with
us is
not in
line with relevant
benchmarks against which
clients assess
investment performance,
we may suffer
reduced fee income and
a decline in
assets under
management, or withdrawal of mandates.
Investment positions, such as equity investments made as part
of strategic initiatives
and seed investments
made at the
inception
of
funds
that
we manage,
may also
be
affected
by market
risk
factors. These investments
are often not
liquid and generally
are
intended or required to be
held beyond a normal trading
horizon.
Deteriorations in
the fair
value of
these positions
would have
a
negative effect on our earnings.
Our strategy, business model and environment
| Risk factors
72
We may not be successful in implementing changes in our
wealth management businesses to meet changing market,
regulatory and other conditions
In recent years, inflows
from lower-margin segments and markets
have been replacing
outflows from higher-margin
segments and
markets,
in
particular
for
cross-border
clients.
This
dynamic,
combined with
changes in
client product
preferences as
a result
of which
low-margin products
account for
a larger
share of
our
revenues than in the past, has put downward pressure on Global
Wealth Management’s margins.
We
are
exposed
to
possible
outflows
of
client
assets
in
our
asset-gathering
businesses
and
to
changes
affecting
the
profitability
of
Global
Wealth
Management,
in
particular.
Initiatives
that
we
may
implement
to
overcome
the
effects
of
changes in the business environment on our profitability, balance
sheet
and
capital
positions
may
not
succeed
in
counteracting
those
effects
and
may
cause
net
new
money
outflows
and
reductions in client deposits, as happened with our balance sheet
and capital optimization program
in 2015. There
is no assurance
that we will
be successful
in our
efforts to offset
the adverse
effect
of these or similar trends and developments.
We may be unable to identify or capture revenue or competitive
opportunities, or retain and attract qualified employees
The
financial
services
industry
is
characterized
by
intense
competition,
continuous
innovation,
restrictive,
detailed,
and
sometimes fragmented
regulation and
ongoing consolidation.
We
face
competition
at
the
level
of
local
markets
and
individual
business
lines,
and
from
global
financial
institutions
that
are
comparable to us in their
size and breadth, as well
as competition
from new
technology-based market
entrants, which may
not be
subject
to
the
same
level
of
regulation.
Barriers
to
entry
in
individual
markets
and
pricing
levels
are
being
eroded
by
new
technology. We expect
these trends to continue and competition
to increase.
Our competitive strength
and market
position could
be
eroded
if
we
are
unable
to
identify
market
trends
and
developments, do not respond
to such trends and
developments
by
devising
and
implementing adequate
business
strategies, do
not adequately
develop or
update our
technology including
our
digital channels
and tools,
or are
unable to
attract or
retain the
qualified people needed.
The
amount and
structure
of our
employee
compensation
is
affected not only by our business results,
but also by competitive
factors and regulatory considerations.
In response to the demands of various
stakeholders, including
regulatory
authorities
and
shareholders,
and
in
order
to
better
align the
interests of
our staff
with other
stakeholders, we
have
increased
average
deferral
periods
for
stock
awards,
expanded
forfeiture
provisions
and,
to
a
more
limited
extent,
introduced
clawback
provisions
for
certain
awards
linked
to
business
performance.
We
have
also
introduced
individual
caps
on
the
proportion of fixed to variable pay for the Group Executive Board
(GEB) members, as well as certain other employees.
Constraints
on
the
amount
or
structure
of
employee
compensation, higher
levels of
deferral, performance
conditions
and
other
circumstances
triggering
the
forfeiture
of
unvested
awards may
adversely affect
our ability
to retain
and attract
key
employees, particularly
where we
compete with
companies that
are not subject to these constraints.
The loss of key staff and
the
inability
to
attract
qualified
replacements
could
seriously
compromise our ability to
execute our strategy and
to successfully
improve our operating and control environment, and could affect
our
business performance.
Swiss law
requires
that
shareholders
approve the
compensation of
the Board
of Directors
(the BoD)
and
the
GEB
each
year.
If
our
shareholders
fail
to
approve
the
compensation for the GEB or the BoD, this
could have an adverse
effect on our ability to retain
experienced directors and our senior
management.
Our reputation is critical to our success
Our
reputation
is
critical
to
the
success
of
our
strategic
plans,
business
and
prospects.
Reputational
damage
is
difficult
to
reverse,
and
improvements
tend
to
be
slow
and
difficult
to
measure. In the
past, our reputation has
been adversely affected
by
our
losses
during
the
financial
crisis,
investigations
into
our
cross-border
private
banking
services,
criminal
resolutions
of
LIBOR-related
and
foreign
exchange
matters,
as
well
as
other
matters. We believe that reputational damage as a result of
these
events
was an
important
factor in
our
loss
of
clients and
client
assets
across
our
asset-gathering
businesses.
New
events
that
cause reputational
damage could
have a
material adverse
effect
on our results of operation and financial condition, as well as our
ability to achieve our strategic goals and financial targets.
As UBS Group AG is a holding company, its operating results,
financial condition and ability to pay dividends and other
distributions and / or to pay its obligations in the future depend
on funding, dividends and other distributions received directly or
indirectly from its subsidiaries, which may be subject to
restrictions
UBS Group
AG’s ability
to pay
dividends and
other distributions
and to pay its obligations in the
future will depend on the level of
funding, dividends
and other
distributions, if
any,
received from
UBS AG and other subsidiaries. The
ability of such subsidiaries to
make loans
or distributions,
directly
or indirectly,
to UBS
Group
AG
may
be
restricted
as
a
result
of
several
factors,
including
restrictions
in
financing
agreements
and
the
requirements
of
applicable
law
and
regulatory,
fiscal
or
other
restrictions.
In
particular,
UBS
Group
AG’s
direct
and
indirect
subsidiaries,
including
UBS
AG,
UBS Switzerland
AG,
UBS Americas
Holding
LLC and UBS Europe
SE, are subject
to laws and regulations
that
restrict dividend
payments, authorize
regulatory bodies
to block
or reduce the flow of funds from
those subsidiaries to UBS Group
AG, or
could affect
their ability
to
repay
any loans
made to,
or
other investments
in, such
subsidiary by
UBS Group AG
or another
member
of
the
Group.
For
example,
in
the
early
stages
of
the
COVID-19
pandemic,
the
European
Central
Bank
ordered
all
banks under its
supervision to
cease dividend
distributions and
the
Federal
Reserve
Board
has
limited
capital
distributions
by
bank
holding
companies
and
intermediate
holding
companies.
Restrictions
and
regulatory
actions
of
this
kind
could
impede
access
to
funds
that
UBS
Group
AG
may
need
to
meet
its
obligations or
to pay dividends
to shareholders.
In addition, UBS
Group AG’s right to
participate in a distribution of
assets upon a
subsidiary’s
liquidation
or
reorganization
is
subject
to
all
prior
claims of the subsidiary’s creditors.
Our capital instruments
may contractually prevent
UBS Group
AG from proposing the distribution of
dividends to shareholders,
other
than
in
the
form
of
shares
and
from
engaging
in
repurchases
of
shares,
if
we
do
not
pay
interest
on
these
instruments.
73
Furthermore,
UBS
Group
AG
may
guarantee
some
of
the
payment obligations
of certain
of the
Group’s subsidiaries
from
time
to
time.
These
guarantees
may
require
UBS
Group
AG
to
provide substantial funds
or assets
to subsidiaries or
their creditors
or
counterparties
at
a
time
when
UBS
Group
AG
is
in
need
of
liquidity to fund its own obligations.
The credit ratings of UBS Group AG or its subsidiaries used for
funding purposes could be lower than the ratings of
the Group’s
operating
subsidiaries,
which
may
adversely
affect
the
market
value of the securities and other obligations of UBS Group
AG or
those subsidiaries on a standalone basis.
Liquidity and funding risk
Liquidity and funding management are critical to UBS’s ongoing
performance
The viability of our
business depends on
the availability of
funding
sources, and our success depends
on our ability to obtain
funding
at
times,
in
amounts,
for
tenors and
at
rates
that enable
us to
efficiently
support
our
asset
base
in
all
market
conditions.
Our
funding sources have
generally been stable, but
could change in
the
future
because
of,
among
other
things,
gener
al
market
disruptions or widening
credit spreads, which could
also influence
the cost of
funding. A substantial
part of our
liquidity and funding
requirements
are
met
using
short-term
unsecured
funding
sources,
including retail
and wholesale
deposits and
the regular
issuance of money
market securities. A
change in the
availability
of short-term funding could occur quickly.
The addition of loss-absorbing debt as a component of capital
requirements, the regulatory
requirements to maintain
minimum
TLAC at UBS’s holding
company and at
subsidiaries, as well
as the
power
of
resolution
authorities
to
bail
in
TLAC
and
other
debt
obligations,
and
uncertainty
as
to
how
such
powers
will
be
exercised, will increase
our cost of
funding and could
potentially
increase the total amount
of funding required, in
the absence of
other changes in our business.
Reductions
in
our
credit
ratings
may
adversely
affect
the
market value of the securities
and other obligations and increase
our
funding
costs,
in
particular
with
regard
to
funding
from
wholesale unsecured
sources, and
could affect
the availability of
certain kinds of
funding. In addition,
as experienced in
connection
with Moody’s
downgrade of
UBS AG’s
long-term debt
rating in
June 2012,
rating downgrades
can require
us to
post additional
collateral
or
make
additional
cash
payments
under
trading
agreements. Our credit ratings,
together with our capital strength
and
reputation,
also
contribute
to
maintaining
client
and
counterparty
confidence,
and
it
is
possible
that
rating
changes
could influence the performance of some of our businesses.
The requirement to maintain a liquidity coverage ratio of
high-
quality
liquid
assets
to
estimated
stressed
short-term
net
cash
outflows,
and
other
similar
liquidity
and
funding
requirements,
oblige us to
maintain high
levels of overall
liquidity, limit
our ability
to
optimize
interest
income and
expense,
make
certain
lines
of
business less attractive
and reduce our overall
ability to generate
profits.
In
particular,
UBS
AG
is
subjected
to
increased
liquidity
coverage requirements under the
direction of FINMA. Regulators
may consider it
necessary to increase
these requirements in
light
of the anticipated economic stresses
resulting from the COVID-19
pandemic.
The
liquidity
coverage
ratio
and
net
stable
funding
ratio requirements are
intended to ensure that
we are not overly
reliant
on short-term
funding and
that we
have sufficient
long-
term
funding
for
illiquid
assets.
The
relevant
calculations
make
assumptions about the
relative likelihood and
amount of outflows
of funding and available sources of additional funding in market-
wide and firm-specific
stress situations.
There can be
no assurance
that in an actual stress
situation our funding outflows would
not
exceed the assumed amounts.
Financial and
operating
performance
Management report
2
Financial and operating performance | Accounting and financial reporting
76
Accounting and financial reporting
Critical accounting estimates and judgments
In
preparing
our
financial
statements
in
accordance
with
International Financial Reporting
Standards (IFRS), as
issued by the
International
Accounting
Standards
Board
(the
IASB),
we
apply
judgment and make estimates and assumptions that may involve
significant
uncertainty
at
the time
they are
made. We
regularly
reassess
those
estimates
and
assumptions,
which
encompass
historical
experience,
expectations
of
the
future
and
other
pertinent factors,
to determine
their continuing
relevance based
on current conditions, and update them as
necessary. Changes in
estimates
and
assumptions
may
have
significant
effects
on
the
financial
statements.
Furthermore,
actual
results
may
differ
significantly from
our estimates, which
could result
in significant
losses to the Group, beyond what we expected or provided for.
Key areas
involving a
high degree
of judgment
and areas
where
estimates
and
assumptions
are
significant
to
the
consolidated
financial statements include:
–
expected credit loss measurement;
–
fair value measurement;
–
income taxes;
–
provisions and contingent liabilities;
–
post-employment benefit plans;
–
goodwill; and
–
consolidation of structured entities.
›
Refer to “Note 1a Material accounting
policies” in the
“Consolidated financial statements” section
of this report for
more information
›
Refer to the “Risk factors” section of
this report for more
information
Significant accounting and financial reporting changes in
2021
Amendments to IFRS as a consequence of
Interest Rate
Benchmark Reform
Effective
from
1 January
2021,
we
have
adopted
Interest
Rate
Benchmark
Reform
–
Phase
2,
Amendments
to
IFRS 9,
IAS 39,
IFRS 7,
IFRS 4
and
IFRS 16
,
addressing
a
number
of
issues
in
financial reporting
areas that
arise when
interbank offered
rates
(IBORs) are reformed
or replaced,
in particular
in the
area of
hedge
accounting.
The
amendments
also
introduced
additional
disclosure
requirements
covering
how
we
are
managing
the
transition to
alternative benchmark
rates, our
progress as
of the
reporting date and the risks to which we are
exposed because of
the transition.
›
Refer to “Note 1b Changes in accounting
policies, comparability
and other adjustments” and “Note 25 Interest
rate benchmark
reform” in the “Consolidated financial statements”
section of
this report for more information
77
Group performance
Income statement
For the year ended
% change from
USD million
31.12.21
31.12.20
31.12.19
31.12.20
Net interest income
6,705
5,862
4,501
14
Other net income from financial instruments measured
at fair value through profit or loss
5,850
6,960
6,842
(16)
Credit loss (expense) / release
148
(694)
(78)
Fee and commission income
24,372
20,961
19,110
16
Fee and commission expense
(1,985)
(1,775)
(1,696)
12
Net fee and commission income
22,387
19,186
17,413
17
Other income
452
1,076
212
(58)
Total operating income
35,542
32,390
28,889
10
Personnel expenses
18,387
17,224
16,084
7
General and administrative expenses
5,553
4,885
5,288
14
Depreciation, amortization and impairment of non-financial
assets
2,118
2,126
1,940
0
Total operating expenses
26,058
24,235
23,312
8
Operating profit / (loss) before tax
9,484
8,155
5,577
16
Tax expense / (benefit)
1,998
1,583
1,267
26
Net profit / (loss)
7,486
6,572
4,310
14
Net profit / (loss) attributable to non-controlling interests
29
15
6
92
Net profit / (loss) attributable to shareholders
7,457
6,557
4,304
14
Comprehensive income
Total comprehensive income
5,119
8,312
5,091
(38)
Total comprehensive income attributable to non-controlling interests
13
36
2
(64)
Total comprehensive income attributable to shareholders
5,106
8,276
5,089
(38)
Financial and operating performance | Group performance
78
2021 compared with 2020
Results
In
202
1
,
net
profit
attributable
to
shareholders
increased
by
USD 900 million, or 14%, to
USD 7,457 million, which included
a
net tax expense of USD 1,998 million.
Profit before
tax increased
by USD 1,
329 million,
or 16%,
to
USD 9,484
million,
reflecting
higher
operating
income,
partly
offset
by an
increase
in operating
expenses.
Operating
income
increased by USD
3,152 million, or 10%, to USD 3
5,542 million,
mainly
reflecting
a
USD 3,201
million
increase
in
net
fee
and
commission
income.
Net
credit
loss
releases
were
USD 148
million,
compared
with
net
credit
loss
expenses
of
USD 694
million in
2020.
This was partly
offset by
USD 624 million
lower
other income and
a USD 267 million
decrease in total
combined
net
interest
income
and
other
net
income
from
financial
instruments
measured
at
fair
value
through
profit
or
loss.
Operating
expenses
increased
by USD
1,823
million,
or 8%,
to
USD
2
6
,
058
million.
This
increase
was
mai
nly
driven
by
USD
1,
1
63
million
high
er
personnel
expenses
and
USD
668
million higher
general and
administrative
expenses.
Operating income
Operating
income
increased
by
USD 3,152
million,
or
10%,
to
USD 35,542 million.
Net interest income and other net income from financial
instruments measured at fair value through profit or loss
Total
combined net
interest income
and other
net income
from
financial instruments measured at fair value through profit or
loss
decreased by USD 267 million to USD 12,555 million.
The
Investment
Bank
de
creased
by
USD
57
6
million
to
USD 5,067 million,
largely driven
by a
USD 713
million decrease
in our Financing business in Global Markets, primarily reflecting a
loss of
USD 861 million
incurred in
the first
half of
2021 on
the
default
of
a
US-based
client
of
our
prime
brokerage
business,
partly
offset
by
higher
capital
markets
financing
revenues
.
Derivatives & Solutions increased by USD 169 million,
mainly due
to higher revenues from
equity derivatives, partly offset
by lower
income from foreign exchange, rates and credit products.
Group
Functions
recognized
negative
income
of
USD 397
million, compared with negative income of USD 302 million. This
was largely
due to
USD 113 million
lower net
income in
Group
Treasury,
mainly
reflecting
net
effects
related
to
accounting
asymmetries,
including
hedge
accounting
ineffectiveness,
partly
offset
by
lower
negative
revenues
related
to
centralized
Group
Treasury
risk
management
services.
In
addition,
2021
included
valuation
gains
of
USD 58
million
on
auction
rate
securities
in
Non-core and Legacy Portfolio, compared with
valuation losses of
USD 9 million in the prior year.
Global Wealth
Management increased
by USD 302
million to
USD 5,341 million,
mainly driven
by higher
net interest
income,
largely reflecting growth
in lending revenues
from higher volumes
and margins, partly offset by
lower deposit revenues, mainly due
to
lower
US
dollar
interest
rates
and
despite
higher
deposit
volumes.
Personal & Corporate
Banking increased by
USD 98 million to
USD 2,557
million,
mainly
due
to
higher
net
interest
income,
driven by proactive deposit management.
›
Refer to “Note 3 Net interest income and
other net income from
financial instruments measured at fair value through
profit or
loss” in the “Consolidated financial statements”
section of this
report for more information
Net interest income and other net income from financial instruments measured at fair value through profit or loss
For the year ended
% change from
USD million
31.12.21
31.12.20
31.12.19
31.12.20
Net interest income from financial instruments measured
at amortized cost and fair value through other
comprehensive income
5,274
4,563
3,490
16
Net interest income from financial instruments measured
at fair value through profit or loss
1,431
1,299
1,011
10
Other net income from financial instruments measured
at fair value through profit or loss
5,850
6,960
6,842
(16)
Total
12,555
12,822
11,343
(2)
Global Wealth Management
5,341
5,039
4,913
6
of which: net interest income
4,244
4,027
3,947
5
of which: transaction-based income from foreign exchange and other
intermediary activity
1
1,097
1,012
966
8
Personal & Corporate Banking
2,557
2,459
2,436
4
of which: net interest income
2,120
2,049
1,992
3
of which: transaction-based income from foreign exchange and other
intermediary activity
1
437
409
443
7
Asset Management
(13)
(16)
(13)
(16)
Investment Bank
2
5,067
5,643
4,189
(10)
Global Banking
596
585
414
2
Global Markets
4,471
5,057
3,775
(12)
Group Functions
(397)
(302)
(182)
31
1 Mainly includes spread-related income in connection with client-driven transactions,
foreign currency translation effects and income and expenses from precious metals,
which are included in the income statement
line Other net income from financial instruments measured
at fair value through profit or loss.
The amounts reported on this
line are one component of Transaction
-based income in the management discussion and
analysis of
Global Wealth
Management and
Personal &
Corporate Banking
in the
“Global Wealth
Management” and
“Personal &
Corporate Banking”
sections of
this report,
respectively.
2 Investment Bank
information is provided at the
business line level rather than by
financial statement reporting line in
order to reflect the underlying
business activities, which is consistent with the
structure of the management discussion
and analysis in the “Investment Bank” section of this report.
79
Net fee and commission income
Net fee
and commission
income increased
by USD 3,201
million
to USD 22,387 million.
Fees for
portfolio management and
related services increased
by
USD 1,753
million
to
USD 9,762
million,
driven
by
Global
Wealth
Management,
reflecting
higher
average
fee-generating
assets,
due
to
positive
market
performance
and
net
new
fee-
generating assets.
Investment
fund
fees
increased
by
USD
501
million
to
USD 5,790 million, mainly driven by
Global Wealth Management,
reflecting
higher
average
fee-generating
assets.
Management
fees in Asset
Management increased on
a higher average
invested
asset base, partly offset by lower performance-based fee income,
compared with the particularly high levels in 2020.
Underwriting fees increased by USD 378 million to USD 1,463
million,
largely
driven
by
higher
equity
underwriting
revenues
from public offerings in the Investment Bank.
M&A and corporate finance fees increased by
USD 366 million
to
USD 1,102
million,
primarily
reflecting
higher
revenues
from
M&A
transactions
in
our
Global
Banking
business
in
the
Investment Bank, due
to an
increase in
the number
of transactions
that closed in 2021.
Net brokerage fees
increased by
USD 265 million to
USD 4,123
million
,
reflecting
higher
levels
of
client
activity
in
the
Cash
Equities
business
of
the
Investment
Bank,
as
well
as
in
Global
Wealth Management.
›
Refer to “Note 4 Net fee and commission
income” in the
“Consolidated financial statements” section
of this report for
more information
Other income
Other income decreased
by USD 624 million to
USD 452 million,
mainly
driven by
lower
gains
from
disposals
of
subsidiaries
and
associates, largely
reflecting a
USD 37 million
gain from
the sale
of our remaining minority investment in
Clearstream Fund Centre
AG (previously Fondcenter AG) in 2021, compared with a gain of
USD 631
million
from
the
partial
sale
of
Fondcenter
AG
(now
Clearstream
Fund
Centre
AG)
in
2020
.
In
2021
,
we
also
recognized
a
gain
of
USD 100
million
from
the
sale
of
our
domestic wealth management business in Austria
and income of
USD 51 million
related to a
legacy bankruptcy claim.
In the prior
year,
we
recognized
a
USD 215
million
gain
from
the
sale
of
intellectual
property
rights
associated
with
the
Bloomberg
Commodity Index family.
›
Refer to “Note 5 Other income” in the “Consolidated
financial
statements”
section of this report for more information
›
Refer to “Note 30 Changes in organization
and acquisitions and
disposals of subsidiaries and businesses”
in the “Consolidated
financial statements” section of this
report for more information
about the sale of our remaining investment
in Clearstream Fund
Centre AG and the sale of our domestic wealth
management
business in Austria
Credit loss expense / release
Total net
credit loss
releases were
USD 148 million,
compared with
net
credit
loss
expenses
of
USD 694
million
in
the
prior
year,
reflecting net
releases of
USD 123 million related
to stage 1 and
2 positions
and net
releases of
USD 25 million
related to
credit-
impaired (stage 3) positions.
›
Refer to “Note 9 Financial assets at amortized
cost and other
positions in scope of expected credit loss measurement”
and
“Note 20
Expected credit loss measurement” in the
“Consolidated financial statements” section
of this report for
more information about credit loss expenses
/ releases
›
Refer to the “Risk factors” section of
this report for more
information
Credit loss (expense) / release
USD million
Global
Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
Total
For the year ended 31.12.21
Stages 1 and 2
28
62
0
34
0
123
Stage 3
1
24
(1)
0
0
25
Total credit loss (expense) / release
29
86
(1)
34
0
148
For the year ended 31.12.20
Stages 1 and 2
(48)
(129)
0
(88)
0
(266)
Stage 3
(40)
(128)
(2)
(217)
(42)
(429)
Total credit loss (expense) / release
(88)
(257)
(2)
(305)
(42)
(694)
For the year ended 31.12.19
Stages 1 and 2
3
23
0
(4)
0
22
Stage 3
(23)
(44)
0
(26)
(7)
(100)
Total credit loss (expense) / release
(20)
(21)
0
(30)
(7)
(78)
Financial and operating performance | Group performance
80
Operating expenses
Operating
expenses
increased
by
USD 1,823
million,
or
8%,
to
USD 26,058 million.
Personnel expenses
Personnel
expenses
increased
by
USD
1,1
63
million
to
USD
1
8
,
387
million,
including
net
r
estructuring
expenses
of
USD 200
million,
compared
with
USD 106
million
in
the
prior
year.
Total
restructuring expenses in
2021 are net
of curtailment
gains
of
USD
80
million,
which
represent
a
reduction
in
the
defined benefit obligation
(DBO) related to
the Swiss pension
plan
resulting
from
a
decrease
in
headcount
following
restructuring
activities.
Financial advisor
compensation increased
by USD 769
million
to
USD
4,860
million
,
due
to
an
increase
in
compensable
revenues.
Salary
costs
increased
by
USD
316
million
to
USD
7,
339
million, mainly driven
by foreign
currency translation
effects and
higher restructuring expenses.
Social
security
expenses
increased
by
USD
79
million
to
USD 978 million, broadly in line with higher salary expenses.
›
Refer to the “Compensation” section
of this report for more
information
›
Refer to “Note 6 Personnel expenses,” “Note
27 Post-
employment benefit plans” and “Note 28
Employee benefits:
variable compensation” in the “Consolidated
financial
statements”
section of this report for more information
General and administrative expenses
General
and
administrative
expenses
increased
by
USD 668
million to USD 5,553 million,
mainly driven by a USD 740
million
(EUR 650
million) increase
in litigation
provisions for
the French
cross-border
matter
and
USD 106
million
higher
IT
expenses.
These
effects
were
partly
offset
by
lower
consulting
fees
and
outsourcing costs.
Net expenses for the
UK and German bank
levies were USD 58
million
in
2021 and
included a
USD 16
million
credit
related to
prior years.
In 2020, net
expenses for
the UK
and German
bank
levies were
USD 55 million
and included
a USD 27
million credit
related to prior years.
We
believe
that
the
industry
continues
to
operate
in
an
environment
in
which
expenses
associated
with
litigation,
regulatory
and
similar
matters
will
remain
elevated
for
the
foreseeable future, and
we continue to
be exposed to
a number
of significant
claims and
regulatory matters.
The outcome
of many
of
these
matters,
the
timing
of
a
resolution,
and
the
potential
effects of
resolutions on
our future
business, financial
results or
financial condition are extremely difficult to predict.
›
Refer to “Note 7 General and administrative
expenses” and
“Note 18 Provisions and contingent liabilities”
in the
“Consolidated financial statements” section
of this report for
more information
Depreciation, amortization and impairment
Depreciation,
amortization
and
impairment
of
non-financial
assets
decreased
by USD 8
million
to USD 2,118
million, mainly
driven
by
lower
impairment
expenses
on
internally
generated
software,
a decrease
in
depreciation
expenses
related
to leased
properties
and
lower
amortization
of
intangible
assets,
partly
offset
by
higher
depreciation
expenses
on
internally
generated
software.
›
Refer to “Note 12 Property, equipment and software” and
“Note
13 Goodwill and intangible assets”
in the “Consolidated
financial statements”
section of this report for more information
Operating expenses
For the year ended
% change from
USD million
31.12.21
31.12.20
31.12.19
31.12.20
Personnel expenses
18,387
17,224
16,084
7
of which: salaries
7,339
7,023
6,518
4
of which: variable compensation
3,419
3,429
3,001
0
of which: relating to current year
1
2,979
2,634
2,352
13
of which: relating to prior years
2
440
795
5
650
(45)
of which: financial advisor compensation
3
4,860
4,091
4,043
19
of which: other personnel expenses
4
2,768
2,680
5
2,521
3
General and administrative expenses
5,553
4,885
5,288
14
of which: net expenses for litigation, regulatory and similar
matters
911
197
165
363
of which: other general and administrative expenses
4,642
4,688
5,122
(1)
Depreciation, amortization and impairment of non-financial
assets
2,118
2,126
1,940
0
Total operating expenses
26,058
24,235
23,312
8
1 Includes expenses relating to performance awards and other variable compensation for the respective performance year.
2 Consists of amortization of prior years’ awards relating to performance awards and other
variable compensation.
3 Financial advisor compensation consists of formulaic compensation based directly on compensable revenues generated by financial
advisors and supplemental compensation calculated on
the basis of financial advisor
productivity, firm tenure,
assets and other variables.
It also includes expenses related
to compensation commitments with financial
advisors entered into at the
time of recruitment that
are subject
to vesting
requirements.
4 Consists of
expenses related
to contractors,
social security,
post-employment benefit
plans, and
other personnel
expenses. Refer
to “Note 6
Personnel expenses”
in the
“Consolidated financial statements” section of this report for more information.
5 During 2020, UBS modified the conditions for
continued vesting of certain outstanding deferred compensation awards for qualifying
employees, resulting in an expense of approximately USD 280 million, of which USD 240 million is disclosed
within Variable compensation and USD 40 million within Other personnel expenses in this table.
81
Tax
Income
tax
expenses
of
USD 1,998 million
were
recognized
for
the Group
in 2021, representing
an effective
tax rate of
21.1%,
compared
with
USD 1,583 million
for
2020,
which
represented
an effective tax rate of 19.4%.
The income tax expenses for
2021
included Swiss tax
expenses of USD 714
million and non-Swiss
tax
expenses of USD 1,284 million.
The
Swiss
tax
expenses
included
current
tax
expenses
of
USD 680 million related to taxable profits of UBS Switzerland AG
and other Swiss entities.
They also included deferred tax
expenses
of
USD
34
million,
which
reflect
movements
in
temporary
differences.
The non-Swiss
tax expenses
included current
tax expenses
of
USD 884
million
related
to
taxable
profits
earned
by
non-Swiss
subsidiaries
and
branches
and
net
deferred
tax
expenses
of
USD 400
million.
Expenses
of
USD 734
million,
which
primarily
relate
d
to
the
amortization
of
deferred
tax
assets
(DTAs)
previously recognized in relation to tax losses carried forward and
deductible
temporary
differences
of
UBS
Americas
Inc.,
were
partly
offset
by
a
benefit
of
USD 334
million
in
respect
of
the
remeasurement
of
DTAs.
This
benefit
included
upward
revaluations
of
DTAs
of
USD 152
million
for
certain
entities,
primarily in connection with our
business planning process. It also
included USD 113 million
in respect of
additional DTA recognition
that primarily
related to
the contribution of
real estate
assets by
UBS
AG
to
UBS
Americas
Inc.
and
UBS
Financial
Services
Inc.,
which
allowed
the
full
recognition
of
DTAs
in
respect
of
the
associated
historic
real
estate
costs
that
were
previously
capitalized for US tax purposes
under elections that were made
in
the fourth quarter of
2018. In addition,
it included USD 69
million
in
respect
of
an
increase
in
the
expected
value
of
future
tax
deductions for deferred compensation
awards, due to
an increase
in the Group’s share price during the year.
The pre-tax expense that was recognized in the year in respect
of the increase in litigation provisions
for the French cross-border
matter did not result in any tax benefit.
Excluding
any
potential
effects
from
the
remeasurement
of
DTAs
in
connection
with
next
year’s
business
planning
process
and any potential US corporate
tax rate changes or other
material
jurisdictional
statutory
tax
rate
changes
that
could
be
enacted
during the year, we expect a tax rate for 2022 of around 24%.
›
Refer to “Note 8 Income taxes” in
the “Consolidated financial
statements”
section of this report for more information
›
Refer to the “Risk factors” section of
this report for more
information
Total comprehensive income attributable to shareholders
In 2021, total comprehensive income attributable
to shareholders
was USD 5,106 million, reflecting net profit of USD 7,457 million
and
negative
other comprehensive
income
(OCI),
net of
tax, of
USD 2,351 million.
OCI
related
to
cash
flow
hedges
was
negative
USD 1,675
million, mainly
reflecting net
gains on
hedging instruments
that
were reclassified from
OCI to the
income statement
as the
hedged
forecast cash flows affected profit or loss.
Foreign
currency
translation
OCI
was
negative
USD
535
million, mainly due to the weakening of the euro (7%), the Swiss
franc (3%) and the Japanese yen (10%) against the US dollar.
OCI
associated
with
financial
assets
measured
at
fair
value
through
OCI
was
negative
USD 157
million,
primarily
reflecting
net unrealized losses
of USD 203
million following increases
in the
relevant US dollar long-term interest rates.
OCI related
to cost
of hedging
was negative
USD 26 million,
mainly driven
by a
tightening of
the US dollar
/ euro
cross-currency
basis that decreased the fair value of the cross-currency swaps.
Defined
benefit
plan
OCI,
net
of
tax,
was
negative
USD 5
million.
Total
net
pre-tax
OCI related
to
the Swiss
pension
plan
was
negative
USD 336
million.
This
was
mainly
driven
by
an
extraordinary
employer
contribution
of
USD
2
54
million
that
increased the gross plan assets and a pension plan curtailment of
USD 80 million that reduced the DBO against profit or
loss. These
effects led to an offsetting
OCI loss, as no
net pension asset could
be recognized on the balance sheet as of
31 December 2021 due
to
the
asset
ceiling.
As
announced
in
2018,
UBS
agreed
to
mitigate
the
effects
from
changes
to
the
Swiss
pension
plan
implemented
in
2019
by
contributing
up
to
CHF 720
million
(USD 790 million at the closing exchange rate as of 31 December
2021)
in
three
installments
in
2020,
2021
and
2022.
The
extraordinary contribution of
USD 254 million in the
first quarter
of 2021
reflected the second installment paid (first installment
in
the first quarter of 2020: USD 235 million).
Total pre-tax
OCI related
to our
non-Swiss pension
plans was
positive USD 339
million, mainly
driven by
the UK
pension plan,
which recorded positive
net pre-tax OCI
of USD 207 million.
The
positive OCI in
the UK plan
reflected gains of
USD 277 million due
to
a
positive
return
on
plan
assets,
partly
offset
by
losses
of
USD
71
million
from
remeasurement
of
the
DBO
.
The
DBO
remeasurement
effect
was
mainly
driven
by
a
loss
of
USD 316
million
due to
an increase
in the
applicable inflation
rate and
a
USD
59
million
experience
loss
repres
enting
the
effects
of
differences between the previous actuarial
assumptions and what
actually occurred, partly
offset by a
USD 319 million gain
due to
an increase in the applicable discount rate.
OCI related
to own credit
on financial liabilities
designated at
fair value was positive USD 46
million, primarily reflecting effects
from time decay.
›
Refer to “Statement of comprehensive income”
in the
“Consolidated financial statements” section
of this report for
more information
›
Refer to “Note 21 Fair value measurement”
in the “Consolidated
financial statements” section of this
report for more information
about own credit on financial liabilities designated
at fair value
›
Refer to “Note 26 Hedge accounting”
in the “Consolidated
financial statements”
section of this report for more information
about cash flow hedges of forecast transactions
›
Refer to “Note 27 Post-employment
benefit plans” in the
“Consolidated financial statements” section
of this report for
more information about OCI related to defined benefit
plans
Financial and operating performance | Group performance
82
Sensitivity to interest rate movements
As of 31 December 2021, we estimate
that a parallel shift in yield
curves by +100 basis points could lead to a combined increase
in
annual
net
interest
income
of
approximately
USD 1.8
billion
in
Global Wealth
Management and
Personal &
Corporate Banking
in the first year after
such a shift. Of this
increase, approximately
USD 1.2 billion and USD 0.2 billion would result
from changes in
US
dollar
and
Swiss
franc
interest
rates,
respectively.
A
parallel
shift in yield curves
by –100 basis points
could lead to a
combined
decrease in annual net interest income of approximately USD 0.8
billion in
Global Wealth
Management and Personal
& Corporate
Banking in
the first
year after
such a shift,
predominantly driven
by positions denominated in US dollars.
These
estimates
are
based
on
a
hypothetical
scenario
of
an
immediate change in
interest rates, equal
across all currencies and
relative to implied forward rates as of 31 December 2021 applied
to our banking book. These
estimates further assume no change
to
balance
sheet
size
and
structure,
constant
foreign
exchange
rates and no specific management action.
Seasonal characteristics
Our
revenues
may
show
seasonal
patterns,
notably
in
the
Investment
Bank
and
transaction-based
revenues
for
Global
Wealth
Management,
and
typically
reflect
the
highest
client
activity levels in the first
quarter, with lower levels throughout the
rest
of
the
year,
especially
during
the
summer
months
and
the
end-of-year holiday season.
Key figures
Below
we
provide
an
overview
of
selected
key
figures
of
the
Group. For further
information about
key figures related
to capital
management,
refer
to
the
“Capital,
liquidity
and
funding,
and
balance sheet” section of this report.
Cost / income ratio
The
cost
/
income
ratio
was
73.6%,
compared
with
73.3%,
reflecting
higher
operating
expenses
,
with
a
partly
offset
ting
effect
driven
by
an
increase
in
operating
income.
The
cost
/
income
ratio
is
measured
based
on
income
before
credit
loss
expenses or releases.
Common equity tier 1 capital
Common equity tier 1 (CET1) capital increased by USD 5.4 billion
to USD 45.3
billion, mainly as
a result
of operating profit
before
tax
of
USD
9.5
billion,
a
USD
0.
5
billion
increase
in
eligible
deferred
tax
assets
on
temporary
differences,
a
USD 0.4
billion
decrease in
deduction of goodwill
resulting from
the sale of
our
remaining
minority
investment
in
Clearstream
Fund
Centre
AG
(previously
Fondcenter
AG)
and
an
increase
of
USD 0.2
billion
related
to
the launch
of
our new
operational partnership
entity
with
Sumitomo
Mitsui
Trust
Holdings,
Inc.
These
effects
were
partly offset
by dividend
accruals of
USD 1.7 billion,
current
tax
expenses
of
USD 1.6
billion,
share
repurchases
under
our share
repurchase program of USD 0.6 billion, negative foreign currency
effects of
USD 0.6 billion, compensation-
and own share
-related
capital components of USD 0.4 billion,
and negative effects from
defined benefit plans of USD 0.2 billion.
Our
share
repurchases
in
2021
decreased
CET1
capital
by
USD 0.6
billion,
reflecting
shares
repurchased
under
our
share
repurchase programs
of USD 2.6
billion, partly
offset by
the use
of the
capital reserve
for potential share
repurchases of
USD 2.0
billion.
The
capital
reserve
for
potential
share
repurchases
was
fully utilized during 2021.
Return on CET1 capital
Our return on CET1 capital (RoCET1) was 17.5%, compared with
1
7
.
4
%,
reflecting
a
USD
900
m
illion
in
crease
in
net
profit
attributable to shareholders,
with a partly offsetting effect driven
by USD 5.0 billion higher average CET1 capital.
Risk-weighted assets
R
isk
-
weighted
assets
(RWA)
increased
by
USD
13.1
billion
to
USD
302
.
2
billion,
primarily
driven
by
increases
of
USD
12.0
billion in credit and counterparty
credit risk RWA, USD 1.0 billion
in operational risk RWA and USD 0.9 billion in non-counterparty-
related
risk. These
increases were
partly offset
by a
decrease of
USD 0.8 billion in market risk RWA.
Common equity tier 1 capital ratio
Our CET1 capital ratio increased
1.2 percentage points to 15.0%,
reflecting a USD 5.4
billion increase in
CET1 capital
that was
partly
offset by the aforementioned increase in RWA.
Leverage ratio denominator
The
leverage
ratio
denominator
(the
LRD)
increased
by
USD 32
billion
(excluding
the
temporary
exemption
that
applied
from
25 March
2020
until
1 January
2021
and
was
granted
by
the
Swiss
Financial
Market
Supervisory
Authority
(
FINMA)
)
to
USD 1,069 billion,
driven by
asset size
and other
movements of
USD 54 billion, partly offset by a decrease due to currency effects
of USD 23 billion.
Common equity tier 1 leverage ratio
Our
CET1
leverage
ratio
increased
to
4.24%
from
3.85
%
(excluding the temporary exemption that
applied from 25 March
2020
until
1 January
2021
and was
granted
by
FINMA),
as
the
aforementioned
USD 5.4
billion
increase
in
CET1
capital
was
partly offset by the aforementioned increase in the LRD.
Going concern leverage ratio
Our going
concern leverage ratio
increased to
5.7% from
5.4%
(excluding the temporary exemption that
applied from 25 March
2020
until
1 January
2021
and was
granted
by
FINMA),
as
the
USD 4.3 billion
increase in
our going
concern capital
was partly
offset by the aforementioned increase in the LRD.
Personnel
The number of personnel
employed as of 31 December
2021 was
broadly stable at 71,385 (full-time equivalents), a net decrease of
166 compared with 31 December 2020.
83
Return on equity and CET1 capital
As of or for the year ended
USD million, except where indicated
31.12.21
31.12.20
31.12.19
Net profit
Net profit attributable to shareholders
7,457
6,557
4,304
Equity
Equity attributable to shareholders
60,662
59,445
54,501
Less: goodwill and intangible assets
6,378
6,480
6,469
Tangible equity attributable to shareholders
54,283
52,965
48,032
Less: other CET1 deductions
9,003
13,075
12,497
CET1 capital
45,281
39,890
35,535
Return on equity
Return on equity (%)
12.6
11.3
7.9
Return on tangible equity (%)
14.1
12.8
9.0
Return on common equity tier 1 capital (%)
17.5
17.4
12.4
Financial and operating performance | Global Wealth Management
84
Global Wealth Management
Global Wealth Management
1
As of or for the year ended
% change from
USD million, except where indicated
31.12.21
31.12.20
31.12.20
Results
Net interest income
4,244
4,027
5
Recurring net fee income
2
11,170
9,372
19
Transaction-based income
2
3,836
3,576
7
Other income
168
159
5
Income
19,419
17,134
13
Credit loss (expense) / release
29
(88)
Total operating income
19,449
17,045
14
Total operating expenses
14,665
13,026
13
Business division operating profit / (loss) before tax
4,783
4,019
19
Performance measures and other information
Financial advisor variable compensation
3,4
4,382
3,589
22
Compensation commitments with recruited financial advisors
3,5
479
502
(5)
Pre-tax profit growth (year-on-year, %)
2
19.0
18.3
Cost / income ratio (%)
2
75.5
76.0
Average attributed equity (USD billion)
6
18.8
17.1
10
Return on attributed equity (%)
2,6
25.4
23.6
Risk-weighted assets (USD billion)
6
99.8
87.2
15
Leverage ratio denominator (USD billion)
6,7
399.6
371.2
8
Goodwill and intangible assets (USD billion)
5.0
5.1
(1)
Net new fee-generating assets (USD billion)
2
106.9
40.8
Fee-generating assets (USD billion)
2
1,482
1,277
16
Fee-generating asset margin (bps)
2
82.6
86.2
Net new money (USD billion)
2
111.1
43.3
Invested assets (USD billion)
2
3,303
3,016
10
Loans, gross (USD billion)
8
234.1
213.1
10
Customer deposits (USD billion)
8
369.8
348.0
6
Recruitment loans to financial advisors
3
1,830
1,872
(2)
Other loans to financial advisors
3
623
697
(11)
Impaired loan portfolio as a percentage of total loan portfolio, gross (%)
2,9
0.2
0.4
Advisors (full-time equivalents)
9,329
9,575
(3)
1 Comparatives may differ as a result of adjustments following organizational changes, restatements due to the
retrospective adoption of new accounting standards or changes in accounting policies, and events after
the reporting period.
2 Refer to “Alternative performance measures” in the appendix
to this report for the definition
and calculation method.
3 Relates to licensed professionals with the
ability to provide investment
advice to
clients in
the Americas.
4 Financial advisor
variable compensation
consists of
formulaic compensation
based directly
on compensable
revenues generated
by
financial advisors
and supplemental
compensation calculated on
the basis of
financial advisor productivity,
firm tenure, new
assets and other
variables.
5 Compensation commitments with
recruited financial advisors
represent expenses related
to
compensation commitments granted to financial advisors at the time of recruitment that are subject to vesting requirements.
6 Refer to the “Capital, liquidity and funding, and balance sheet” section of this report
for more information.
7 The leverage ratio denominator
calculated as of the respective date in 2020 does not
reflect the effects of the temporary exemption that applied from
25 March 2020 until 1 January 2021
and was granted by FINMA in connection
with COVID-19. Refer to the “Regulatory and
legal developments” section of our Annual Report 2020 for
more information.
8 Loans and Customer deposits in this table
include customer brokerage receivables
and payables, respectively,
which are presented in a separate
reporting line on the balance sheet.
9 Refer to the “Risk management
and control” section of this report
for
more information about (credit-)impaired exposures. Excludes loans to financial advisors.
85
2021 compared with 2020
Results
Profit
before
tax
increased
by
USD 764
million,
or
19%,
to
USD 4,783
million,
driven
by
higher
operating
income,
partly
offset by
higher operating
expenses, which
included a
USD 657
million increase in litigation provisions for
the French cross-border
matter.
Operating income
Total
operating income increased by USD 2,404
million, or 14%,
to
USD 19,449
million,
driven
by
increases
across
all
operating
income lines.
Net
interest
income
increased
by
USD 217
million
to
USD 4,244 million, mostly
reflecting growth
in loan
revenues from
higher
volumes
and
margins,
partly
offset
by
lower
deposit
revenues, mainly due to lower US
dollar interest rates and despite
higher deposit volumes.
Recurring
net
fee
income
increased
by
USD 1,798
million
to
USD 11,170
million,
primarily
driven
by
higher
average
fee-
generating assets, reflecting
positive market performance
and net
new fee-generating assets.
Transaction
-based
income
increased
by
USD 260
million
to
USD 3,836 million, reflecting higher
levels of client activity in
the
Americas, EMEA and Switzerland.
Other income
increased by USD 9
million to USD 168
million,
primarily driven
by a
gain of
USD 100 million
related to
the sale
of our domestic
wealth management business
in Austria to
LGT.
2020 included a
gain of USD 60
million from the
sale of a
majority
stake in Fondcenter AG (now Clearstream Fund Centre AG).
Net
credit
loss
releases
were USD 29
million,
compared
with
net expenses of USD 88 million. Stage 1 and 2 credit
loss releases
were USD 28
million, largely resulting
from a partial
release of a
post-model adjustment of USD 12 million during the year,
as well
as
model
updates.
Stage 3
net
credit
loss
releases
were
USD 1
million.
Operating expenses
Total
operating
expenses
increased
by
USD 1,639
million
to
USD 14,665
million.
This
was
mainly
driven
by
an
increase
in
financial
advisor
variable
compensation,
reflecting
higher
compensable
revenues,
and
by
the
aforementioned
USD 657
million increase in litigation provisions for
the French cross-border
matter.
Pre-tax profit growth
Pre-tax profit growth in 2021 was 19.0%, compared with 18.3%
in 2020. Our target range is 10–15% over the cycle.
Cost / income ratio
The
cost
/
income
ratio
decreased
to
75.5%
from
76.0%,
reflecting positive operating leverage.
Fee-generating assets
Fee-generating assets
increased
by USD 205
billion,
or 16%,
to
USD 1,482
billion,
predominantly
driven
by
net
new
fee-
generating
assets
of
USD 106.9
billion,
with
inflows
across
all
regions,
and
net
positive
market
performance
and
foreign
currency effects of USD 98.0 billion.
Loans
Loans
increased
by
USD 21.0
billion,
or
10%,
to
USD 234.1
billion,
primarily
driven
by
net
new
loans
of
USD 25.1
billion,
partly offset
by USD 3.0
billion from
negative foreign
exchange
effects
and
USD 1.1
billion
from
the
reclassification
of
loans
to
disposal
groups
held
for
sale
in
connection
with
the
upcoming
sales of our domestic wealth
management business in Spain and
UBS
Swiss
Financial
Advisers
AG.
Net
new
loans
were
largely
driven
by
an
increase
in
Lombard
loans
and
mortgages.
Loan
penetration was stable at 7.1% in 2021.
›
Refer to the “Risk management and control”
section of this
report for more information
Financial and operating performance | Global Wealth Management
86
Regional breakdown of performance measures
As of or for the year ended 31.12.21
USD billion, except where indicated
Americas
1
Switzerland
EMEA
2
Asia Pacific
Global Wealth
Management
3
Total operating income (USD million)
10,672
1,906
3,953
2,901
19,449
Total operating expenses (USD million)
8,671
1,156
3,141
1,664
14,665
Operating profit / (loss) before tax (USD million)
2,001
750
812
1,237
4,783
Cost / income ratio (%)
4
81.4
60.8
79.6
57.4
75.5
Loans, gross
92.0
5
43.2
49.6
48.6
234.1
Net new loans
19.6
2.3
3.8
(0.5)
25.1
Loan penetration (%)
4,6
5.0
15.3
7.6
9.3
7.1
Fee-generating assets
4
900
130
334
116
1,482
Net new fee-generating assets
4
64.3
10.6
18.8
13.7
106.9
Invested assets
4
1,842
283
654
521
3,303
Net new money
4
60.3
0.7
24.5
26.4
111.1
Advisors (full-time equivalents)
6,218
685
1,494
852
9,329
1 Including the following business units:
United States and Canada; and
Latin America.
2 Including the following business
units: Europe; Central & Eastern
Europe, Greece and Israel;
and Middle East and Africa.
3 Including minor functions, which are not
included in the four regions individually presented
in this table, with USD 16
million of total operating income,
USD 34 million of total operating expenses,
USD 17 million
of operating loss before tax, USD 0.6 billion
of loans, USD 0.0 billion of net new
loan outflows, USD 1 billion of fee-generating assets, USD 0.5 billion
of net new fee-generating asset outflows, USD 3 billion of
invested
assets, USD 0.8 billion of net new money outflows and 80 advisors in 2021.
4 Refer to “Alternative performance measures” in the appendix to this report for the definition and calculation method.
5 Loans include
customer brokerage receivables, which are presented
in a separate reporting line on the balance sheet.
6 Loans, gross as a percentage of invested assets.
Regional comments: 2021 compared with 2020
Americas
Profit
before
tax
increased
by
USD 641
million
to
USD 2,001
million.
Operating
income
increased
by
USD 1,645
million
to
USD 10,672
million,
driven
by
higher
recurring
net
fee,
net
interest
and
transaction-based
income.
The
cost
/
income
ratio
decreased
to
81.4%
from
84.4%.
Loans
increased
27%
to
USD 92 billion, reflecting USD 19.6 billion
of net new loans. Fee-
generating
assets
increased
19%
to
USD 900
billion,
mainly
driven
by
positive
market
performance
and
net
new
fee-
generating assets of USD 64.3 billion.
Switzerland
Profit before tax
increased by USD 108
million to USD 750
million.
This
included
an
USD 85
million
increase
in
litigation provisions
for the
French cross-border
matter.
Operating income
increased
by USD 206 million to USD 1,906 million, mainly driven by
higher
recurring net fee, net interest and transaction-based income. The
cost
/
income
ratio
decreased
to
60.8%
from
61.7%.
Loans
increased
3%
to
USD 43
billion,
driven
by
net
new
loans
of
USD 2.3 billion, partly offset by negative foreign currency effects.
Fee-generating assets
increased 17%
to USD 130
billion, mainly
driven by
net new
fee-generating assets of
USD 10.6 billion
and
net positive market performance and foreign currency effects.
EMEA
Profit
before
tax
decreased
by
USD
145
million
to
USD
812
million,
driven
by
a
USD 572
million
increase
in
litigation
provisions for
the French cross
-border matter.
Operating income
increased by USD 397 million to
USD 3,953 million, due to higher
recurring net fee income and other
income, which was driven by
the
aforementioned
gain
from
the
sale of
our
domestic
wealth
management
business
in
Austria, as
well as
higher
transaction-
based income.
The cost
/ income ratio
increased to
79.6% from
72.7%. Loans
increased 3%
to USD 50
billion, mainly
reflecting
USD 3.8 billion of net new loans,
partly offset by negative foreign
currency
effects
and
the
aforementioned
reclassification
of
USD 0.7
billion
of
loans
to
disposal
groups
held
for
sale.
Fee-
generating assets increased 9% to USD 334 billion, mainly driven
by
net
new
fee-generating
assets
of
USD 18.8
billion
and
net
positive market performance and foreign currency effects.
Asia Pacific
Profit
before
tax
increased
by
USD 176
million
to
USD 1,237
million.
Operating
income
increased
by
USD 166
million
to
USD 2,901
million,
mostly
driven
by
recurring
net
fee
and
net
interest income. The cost
/ income ratio decreased
to 57.4% from
61.2%. Loans decreased
2% to USD 49
billion, driven by
negative
foreign
currency effects
and net
new
loan outflows
of
USD 0.5
billion,
as clients
reduced their
debts in
light of
market uncertainty.
Fee-generating assets
increased 13%
to USD 116
billion, mainly
driven by net new fee-generating assets of USD 13.7 billion.
87
Personal & Corporate Banking
Personal & Corporate Banking – in Swiss francs
1
As of or for the year ended
% change from
CHF million, except where indicated
31.12.21
31.12.20
31.12.20
Results
Net interest income
1,941
1,916
1
Recurring net fee income
2
774
676
15
Transaction-based income
2
1,079
985
10
Other income
110
74
49
Income
3,904
3,650
7
Credit loss (expense) / release
79
(243)
Total operating income
3,984
3,407
17
Total operating expenses
2,397
2,233
7
Business division operating profit / (loss) before tax
1,587
1,175
35
Performance measures and other information
Average attributed equity (CHF billion)
3
8.4
8.3
1
Return on attributed equity (%)
2,3
19.0
14.1
Pre-tax profit growth (%) (year-on-year, %)
2
35.1
(18.0)
Cost / income ratio (%)
2
61.4
61.2
Net interest margin (bps)
2
140
142
Risk-weighted assets (CHF billion)
3
66.7
63.8
4
Leverage ratio denominator (CHF billion)
3,4
221.7
219.9
1
Business volume for Personal Banking (CHF billion)
2
184
179
3
Net new business volume for Personal Banking (CHF billion)
2
5.3
11.6
Net new business volume growth for Personal Banking (%)
2
3.0
6.9
Active Digital Banking clients in Personal Banking (%)
2,5
70.3
66.1
Active Digital Banking clients in Corporate & Institutional
Clients (%)
2
79.3
77.9
Mobile Banking log-in share in Personal Banking (%)
2
73.5
68.0
Client assets (CHF billion)
2
751
702
7
Loans, gross (CHF billion)
139.3
136.4
2
Customer deposits (CHF billion)
162.1
161.1
1
Secured loan portfolio as a percentage of total loan portfolio, gross (%)
2
92.7
92.9
Impaired loan portfolio as a percentage of total loan portfolio, gross (%)
2,6
0.9
1.1
1 Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after
the reporting period.
2 Refer to “Alternative
performance measures” in the
appendix to this report
for the definition and
calculation method.
3 Refer to the “Capital,
liquidity and funding, and
balance sheet”
section of this report for more information.
4 The leverage ratio denominator calculated
as of the respective date in 2020
does not reflect the effects of the temporary
exemption that applied from 25 March
2020
until 1 January 2021
and was granted by
FINMA in connection with
COVID-19. Refer to
the “Regulatory and legal
developments” section of our
Annual Report 2020 for
more information.
5 In 2021, 86.4% of
clients of Personal Banking were “activated users”
of Digital Banking (i.e., clients who had logged
into Digital Banking at least once in the course of their
relationship with UBS).
6 Refer to the “Risk management
and control” section of this report for more information about (credit-)impaired exposures.
Financial and operating performance | Personal & Corporate Banking
88
2021 compared with 2020
Results
Profit
before
tax
increased
by
CHF
41
2
million,
or
35%,
to
CHF 1,587
million,
reflecting
higher
operating
income,
partly
offset by higher operating expenses.
Operating income
Total operating income increased by CHF 577 million, or 17%, to
CHF 3,984
million,
reflecting
net
credit
loss
releases,
compared
with net credit loss expenses in the
prior year, as well as increases
across all income lines.
Net interest income increased by CHF 25 million to CHF 1,941
million, mainly driven by proactive deposit management.
Recurring
net
fee
income
increased
by
CHF 98
million
to
CHF 774 million, primarily driven by
higher custody, mandate and
investment
fund
fees,
resulting
from
an
increase
in
average
custody assets, reflecting
net new
investment product inflows
and
positive market performance.
Transaction-based
income
increased
by
CHF 94
million
to
CHF 1,079 million,
largely driven
by higher
revenues from
credit
card
and
foreign
exchange
transactions,
reflecting
a
continued
increase in spending on travel and leisure by clients following the
easing
of
COVID-19-related
restrictions
in
certain
countries
relative
to
2020.
The
third
quarter
of
2020
included
a
CHF 17
million gain related to the sale of an equity investment.
Other income increased by CHF 36 million to CHF 110 million,
mostly driven by a gain of CHF 26 million from the sale of several
small properties in the second quarter of 2021.
Net
credit
loss
releases
were
CHF 79
million,
compared
with
net expenses
of CHF 243
million. Stage 1
and 2
credit loss
releases
were CHF 57
million, largely
resulting from
a partial
release of
a
post-model adjustment during the
year, as well
as model updates.
Prior-year stage 1
and 2
net
credit loss
expenses
were CHF 123
million, which mainly reflected
expenses for selected exposures
to
large
Swiss
corporate
clients,
small
and
medium-sized
entities,
financial intermediaries, and, to a lesser extent, real estate. These
modeled
expected
losses
were
predominantly
driven
by
the
update
to
the
forward-looking
scenarios
and
their
associated
weightings, factoring in updated macroeconomic assumptions to
reflect
the
effects
of
the
COVID
-
19
pandemic.
Stage
3
net
releases
were
CHF 23
million,
compared
with
net
expenses
of
CHF
120
million
,
which
includ
ed
expenses
of
CHF
54
million
related
to
a
case
of
fraud
at
a
commodity
trade
finance
counterparty.
Operating expenses
Total operating expenses increased by CHF 164 million, or
7%, to
CHF 2,397
million,
mostly
driven
by
a
CHF 76
million
(USD 83
million) increase in
litigation provisions
for the French
cross-border
matter,
as
well as
higher
investments
in
technology and
higher
variable compensation.
Cost / income ratio
The cost / income
ratio slightly increased to
61.4% from 61.2%,
reflecting
higher
operating
expenses,
partly
offset
by
higher
income.
89
Personal & Corporate Banking – in US dollars
1
As of or for the year ended
% change from
USD million, except where indicated
31.12.21
31.12.20
31.12.20
Results
Net interest income
2,120
2,049
3
Recurring net fee income
2
846
725
17
Transaction-based income
2
1,178
1,054
12
Other income
119
79
50
Income
4,263
3,908
9
Credit loss (expense) / release
86
(257)
Total operating income
4,349
3,651
19
Total operating expenses
2,618
2,392
9
Business division operating profit / (loss) before tax
1,731
1,259
37
Performance measures and other information
Average attributed equity (USD billion)
3
9.2
8.9
3
Return on attributed equity (%)
2,3
18.9
14.2
Pre-tax profit growth (%) (year-on-year, %)
2
37.5
(12.6)
Cost / income ratio (%)
2
61.4
61.2
Net interest margin (bps)
2
142
143
Risk-weighted assets (USD billion)
3
73.2
72.1
1
Leverage ratio denominator (USD billion)
3,4
243.2
248.3
(2)
Business volume for Personal Banking (USD billion)
2
202
202
0
Net new business volume for Personal Banking (USD billion)
2
5.8
12.3
Net new business volume growth for Personal Banking (%)
2
2.9
7.1
Active Digital Banking clients in Personal Banking (%)
2,5
70.3
66.1
Active Digital Banking clients in Corporate & Institutional
Clients (%)
2
79.3
77.9
Mobile Banking log-in share in Personal Banking (%)
2
73.5
68.0
Client assets (USD billion)
2
824
793
4
Loans, gross (USD billion)
152.8
154.0
(1)
Customer deposits (USD billion)
177.8
181.9
(2)
Secured loan portfolio as a percentage of total loan portfolio, gross (%)
2
92.7
92.9
Impaired loan portfolio as a percentage of total loan portfolio, gross (%)
2,6
0.9
1.1
1 Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting
policies, and events after
the reporting period.
2 Refer to “Alternative
performance measures” in the appendix
to this report for
the definition and calculation
method.
3 Refer to the “Capital, liquidity
and funding, and balance sheet”
section of this report for more information.
4 The leverage ratio denominator calculated as
of the respective date in 2020 does
not reflect the effects of the temporary exemption
that applied from 25 March 2020
until 1 January 2021
and was granted by
FINMA in connection with COVID
-19. Refer to the “Regulatory
and legal developments” section of
our Annual Report 2020
for more information.
5 In 2021, 86.4% of
clients of Personal Banking were “activated users” of Digital Banking
(i.e., clients who had logged into Digital Banking
at least once in the course of their relationship with UBS).
6 Refer to the “Risk management
and control” section of this report for more information about (credit-)impaired exposures.
Financial and operating performance | Asset Management
90
Asset Management
Asset Management
1
As of or for the year ended
% change from
USD million, except where indicated
31.12.21
31.12.20
31.12.20
Results
Net management fees
2
2,320
1,950
19
Performance fees
260
455
(43)
Net gain from disposal of an associate / a subsidiary
37
571
(93)
Credit loss (expense) / release
(1)
(2)
Total operating income
2,616
2,974
(12)
Total operating expenses
1,586
1,519
4
Business division operating profit / (loss) before tax
1,030
1,455
(29)
Performance measures and other information
Average attributed equity (USD billion)
3
2.0
2.0
1
Return on attributed equity (%)
3,4
51.8
74.2
Pre-tax profit growth (year-on-year, %)
4
(29.2)
173.6
Cost / income ratio (%)
4
60.6
51.0
Risk-weighted assets (USD billion)
3
6.9
6.9
(1)
Leverage ratio denominator (USD billion)
3,5
2.9
5.8
(51)
Goodwill and intangible assets (USD billion)
1.2
1.2
(2)
Net margin on invested assets (bps)
4
9
16
(42)
Gross margin on invested assets (bps)
4
23
32
(29)
Information by business line / asset
class
Net new money (USD billion)
4
Equities
10.3
65.1
Fixed Income
22.7
7.3
of which: money market
(3.1)
(7.4)
Multi-asset & Solutions
6.8
6.6
Hedge Fund Businesses
5.7
(1.1)
Real Estate & Private Markets
(0.6)
2.3
Total net new money
44.9
80.1
of which: net new money excluding money market
48.0
87.5
Invested assets (USD billion)
4
Equities
580
506
15
Fixed Income
285
274
4
of which: money market
92
97
(5)
Multi-asset & Solutions
193
172
12
Hedge Fund Businesses
55
48
15
Real Estate & Private Markets
98
93
5
Total invested assets
1,211
1,092
11
of which: passive strategies
540
457
18
Information by region
Invested assets (USD billion)
4
Americas
287
254
13
Asia Pacific
190
181
5
Europe, Middle East and Africa (excluding Switzerland)
334
294
14
Switzerland
399
363
10
Total invested assets
1,211
1,092
11
Information by channel
Invested assets (USD billion)
4
Third-party institutional
707
648
9
Third-party wholesale
145
128
13
UBS’s wealth management businesses
359
316
13
Total invested assets
1,211
1,092
11
1 Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after
the reporting period.
2 Net management fees include transaction
fees, fund administration
revenues (including net interest and
trading income from lending activities
and foreign exchange hedging as part
of the
fund services offering), distribution fees, incremental fund-related expenses, gains or losses from seed money and co-investments, funding costs, the negative pass-through impact of third-party performance fees, and
other items that are not Asset Management’s performance fees.
3 Refer to the “Capital, liquidity and funding, and balance sheet” section of this report for
more information.
4 Refer to “Alternative performance
measures” in the
appendix to this
report for the
definition and
calculation method.
5 The leverage
ratio denominator
calculated as of
the respective
date in 2020
does not reflect
the effects of
the temporary
exemption that applied from 25 March 2020 until 1 January 2021 and was granted by FINMA in
connection with COVID-19. Refer to the “Regulatory and legal developments” section of our Annual Report
2020 for
more information.
91
2021 compared with 2020
Results
Profit
before
tax
decreased
by
USD 425
million,
or
29%,
to
USD 1,030 million. This reflected
a gain of USD 571 million
from
the sale
of a
majority stake
in Fondcenter
AG (now
Clearstream
Fund
Centre
AG)
in
the
third
quarter
of
2020
and
a
gain
of
USD 37
million
related
to
the
sale
of
our
remaining
minority
investment in
Clearstream Fund
Centre AG (previously
Fondcenter
AG)
to
Deutsche
Börse
AG
in
the
second
quarter
of
2021.
Excluding
these
gains,
profit
before
tax
increased
by
USD 109
million, or 12%, to USD 993 million, reflecting positive operating
leverage.
›
Refer to “Note 30 Changes in organization
and acquisitions and
disposals of subsidiaries and businesses”
in the “Consolidated
financial statements” section of this report
for more information
about the aforementioned sales
Operating income
Total operating income decreased
by USD 358 million, or
12%, to
USD 2,616
million.
Excluding
the
aforementioned
gains
from
sales,
total
operating
income
increased
by
USD 176
million,
or
7%.
Net management fees increased by
USD 370 million, or 19%,
to
USD 2,320
million
on
a
higher
average
invested
asset
base,
reflecting a
combination of
a constructive
market backdrop
and
strong net new money generation.
Performance
fees
decreased
by
USD 195
million
to
USD 260
million,
mainly
in
our
Hedge
Fund
Businesses
and
our
Equities
business,
compared
with
the
particularly
high
levels
of
performance fees in 2020.
Operating expenses
Total
operating expenses increased by USD
67 million, or 4%, to
USD 1,586
million,
mainly
driven
by
higher
personnel
expenses
and foreign
currency effects,
partly offset
by lower
general and
administrative expenses.
Cost / income ratio
The
cost
/
income
ratio
was
60.6%,
compared
with
51.0%
in
2020. Excluding
the aforementioned
gains from
sales, the cost
/
income ratio was 61.5%, compared with 63.2% in 2020.
Invested assets
Invested
assets
increased
to
USD 1,211
billion
from
USD 1,092
billion, reflecting positive market performance of USD 102 billion
and
net
new
money
inflows
of
USD 45
billion,
partly
offset
by
negative
foreign
currency
effects
of
USD 28
billion.
Excluding
money market flows, net new money was USD 48 billion.
Investment
performance
2021
saw
risk
assets
perform
strongly
and
subdued
market
volatility.
Expansive
monetary
policy
supported
a
continued,
broad economic recovery
across the globe.
Shortages in supplies
to
meet
heightened
global
demand led
to
higher energy
prices
and strong
inflation over the
year,
and central
banks, led by
the
US
Federal
Reserve,
started
to
reconsider
their
future
monetary
policy.
As of year-end 2021, Morningstar assigned a four-
or five-star
rating to
64% of
our retail
and institutional
funds (both
actively
managed and
passive), on
an assets
under management
(AuM)-
weighted basis. Furthermore,
55% of
our actively managed
open-
ended retail funds
and actively managed
institutional AuM (which
account in total for 44% of our relevant AuM)
are ranked, on an
AuM-weighted basis
over a
three-year investment period,
above
their respective peer median.
Investment performance as of 31 December 2021
In %
Total traditional
investments
Equities
Fixed income
Multi-asset
% of UBS Asset Management fund assets rated as 4- or 5-star
1,2
64
66
65
49
% of UBS Asset Management above peer median over a 3-year
investment period
2,3
55
48
61
65
1 Percentage of AuM to which Morningstar has assigned a four- or five-star rating. AuM reflect the AuM
of Asset Management’s retail and institutional funds (both actively managed and passive) across all domiciles
for which Asset Management owns the investment performance, i.e., Asset Management is either
the sole portfolio manager or co-portfolio manager. Source:
Morningstar (Morningstar® Essentials Quantitative Star
Rating & Rankings;
© 2022 Morningstar).
Universe is approximately
31% of all
active and passive
traditional assets of
Asset Management (Equities,
Fixed Income excluding
money market, and
Multi-asset) as of
31
December 2021.
2 Morningstar® Essentials Quantitative Star Rating & Rankings; © 2022 Morningstar. All Rights Reserved. The information contained herein: (i) is proprietary to Morningstar and / or its content
providers; (ii) may not be copied or
distributed; and (iii) is not warranted
to be accurate, complete
or timely. Neither Morningstar
nor its content providers are responsible
for any damages or losses arising
from any
use
of
this
information.
Past
performance
is
no
guarantee
of
future
results.
For
more
detailed
information
about
the
Morningstar
Rating,
including
its
meth
odology,
refer
to:
https://s21.q4cdn.com/198919461/files/doc_downloads/othe_disclosure_materials/MorningstarRatingforFunds.pdf.
3 Percentage of AuM
above peer median over
a three-year investment period.
AuM reflect the
AuM of
Asset Management’s
actively managed
open-ended retail
funds across
all domiciles
and actively
managed institutional
AuM for
which Asset
Management owns
the investment
performance, i.e.,
Asset
Management is either the
sole portfolio manager or
co-portfolio manager.
Source: Morningstar (Morningstar®
Essentials Quantitative Star Rating
& Rankings; © 2022
Morningstar) extract date
11 January 2022,
eVestment extract date 4
February 2022, KGAST extract
date 4 February 2022. Universe
is approximately 44% of all
active traditional assets of Asset
Management (Equities, Fixed Income
excluding money market,
and Multi-asset) as of 31 December 2021.
Financial and operating performance | Investment Bank
92
Investment Bank
Investment Bank
1
As of or for the year ended
% change from
USD million, except where indicated
31.12.21
31.12.20
31.12.20
Results
Advisory
988
634
56
Capital Markets
2,170
1,744
24
Global Banking
3,158
2,378
33
Execution Services
2
1,894
1,857
2
Derivatives & Solutions
3,422
3,609
(5)
Financing
979
1,674
(42)
Global Markets
6,296
7,141
(12)
of which: Equities
4,581
4,502
2
of which: Foreign Exchange, Rates and Credit
1,715
2,638
(35)
Income
9,454
9,519
(1)
Credit loss (expense) / release
34
(305)
Total operating income
9,488
9,214
3
Total operating expenses
6,858
6,732
2
Business division operating profit / (loss) before tax
2,630
2,482
6
Performance measures and other information
Pre-tax profit growth (year-on-year, %)
3
5.9
216.6
Average attributed equity (USD billion)
4
13.0
12.6
3
Return on attributed equity (%)
3,4
20.3
19.7
Cost / income ratio (%)
3
72.5
70.7
Risk-weighted assets (USD billion)
4
92.2
94.3
(2)
Return on risk-weighted assets, gross (%)
3
10.0
10.0
Leverage ratio denominator (USD billion)
4,5
319.2
315.5
1
Return on leverage ratio denominator, gross (%)
3,5
2.9
3.1
Goodwill and intangible assets (USD billion)
0.1
0.2
(14)
Average VaR (1-day, 95% confidence, 5 years of historical data)
11
12
(9)
1 Comparative
figures in this
table may differ
as a result
of adjustments following
organizational changes,
restatements due to
the retrospective
adoption of
new accounting
standards or changes
in accounting
policies, and events
after the reporting
period.
2 Execution &
Platform, which was
disclosed in
previous periods,
has been renamed
Execution Services.
3 Refer to
“Alternative
performance measures”
in the
appendix to this report for the definition and calculation method.
4 Refer to the “Capital, liquidity and funding, and balance
sheet” section of this report for more information.
5 The leverage ratio denominators
calculated as of the respective dates in
2020 do not reflect the effects
of the temporary exemption that
applied from 25 March 2020 until
1 January 2021 and was
granted by FINMA in connection
with COVID-19.
Refer to the “Regulatory and legal developments” section of our Annual Report 2020 for more information.
93
2021 compared with 2020
Results
Profit
before
tax
increased
by
USD
14
8
million,
or
6%,
to
USD 2,630
million,
driven
by
higher
operating
income,
partly
offset by higher operating expenses.
Operating income
Total
operating income increased
by USD 274 million,
or 3%, to
USD 9,488 million,
reflecting higher
revenues in
Global Banking
and net
credit loss
releases compared with
net credit
loss expenses
in 2020, partly offset by lower revenues in Global Markets.
Global Banking
Global Banking revenues
increased by USD 780
million, or 33%,
to
USD 3,158
million,
driven
by
Capital
Markets
and
Advisory
revenues, and compared
with an overall global
fee pool increase
of 39%.
Advisory revenues
increased
by USD 354
million, or
56%, to
USD 988 million, largely
due to
higher revenues from
an increased
number
of
merger
and
acquisition
transactions
that
closed
in
2021,
and compared with a 64% increase in the global fee pool.
Capital
Markets
revenues
increased
by
USD 426
million,
or
24%, to USD 2,170
million, mainly reflecting a
USD 358 million,
or
52%,
increase
in
Equity
Capit
al
Markets
(ECM)
revenues,
compared with an increase in the global ECM fee pool of 34%.
Global Markets
Global Markets revenues decreased by USD 845 million, or 12%,
to USD 6,296
million, driven
by lower
revenues in
our Financing
and
Derivatives
&
Solutions
businesses,
partly
offset
by
higher
revenues in Execution Services.
Execution
Services
revenues
increased
by
USD 37
million,
or
2%,
to
USD 1,894
million.
Revenue
increases
in
cash
equities
were partly offset by decreases from other products.
Derivatives
&
Solutions
revenues
decreased
by
USD 187
million,
or
5%,
to
USD 3,422
million,
mainly
due
to
the
third
quarter of 2020 including
a USD 215 million gain from
the sale of
intellectual
property
rights
associated
with
the
Bloomberg
Commodity Index family. Excluding that gain, revenues
increased
by USD 28 million, or 1%.
Financing revenues decreased by USD 695 million, or 42%,
to
USD 979 million,
predominantly due
to an
USD 861 million
loss
incurred
in
the
first
half
of
2021
on
the
default
of
a
US-based
client
of
our
prime
brokerage
business.
Excluding
that
loss,
revenues increased by USD 166 million, or 10%.
›
Refer to “Note 21 Fair value measurement”
in the “Consolidated
financial statements”
section of this report for more information
about the loss in the prime brokerage business
Global Markets Equities revenues increased by USD 79 million,
or 2%, to USD 4,581 million. Equity derivatives and cash equities
products
revenues increased,
while Financing
revenues included
the aforementioned loss in our prime brokerage business.
Global Markets
Foreign Exchange,
Rates and
Credit revenues
decreased
by
USD 923
million,
or
35%,
to
USD 1,715
million,
compared with strong revenues in 2020.
Credit loss expense / release
Net credit
loss releases
were USD 34
million, primarily
related to
stage 1 and 2 positions, resulting from model updates, as well as
a partial net release
of a post-model adjustment
during the year.
Prior-year net
credit loss
expenses were
USD 305 million,
driven
by the effects of the COVID-19 pandemic.
Operating expenses
Total operating expenses increased by USD 126 million,
or 2%, to
USD 6,858 million, largely driven by foreign currency effects.
Cost / income ratio
The
cost
/
income
ratio
increased
to
72.5%
from
70.7%,
as
income decreased by 1% compared with a strong prior year, and
operating expenses increased by 2%.
Risk-weighted assets
Risk-weighted assets (RWA) decreased
by USD 2 billion,
or 2%, to
USD 92
billion,
primarily
due
to
a
USD 3
billion
decrease
in
operational risk RWA and a
USD 1 billion decrease in
market risk
RWA, partly
offset by a
USD 2 billion increase
in credit risk
RWA
due to higher loans and loan commitments.
›
Refer to the “Capital, liquidity and funding,
and balance sheet”
section of this report for more information
Leverage ratio denominator
The leverage ratio
denominator increased
by USD 4
billion, or
1%,
to
USD 319
billion,
mainly reflecting
a
USD 9 billion
increase in
on
-
balance
sheet
exposures
,
partly
offset
by
a
USD
4
billion
decrease
in
derivative
and
securities
financing
transaction
exposures.
›
Refer to the “Capital, liquidity and funding,
and balance sheet”
section of this report for more information
Financial and operating performance | Group Functions
94
Group Functions
Group Functions
1
As of or for the year ended
% change from
USD million, except where indicated
31.12.21
31.12.20
31.12.20
Results
Total operating income
(360)
(494)
(27)
Total operating expenses
330
567
(42)
Operating profit / (loss) before tax
(689)
(1,060)
(35)
of which: Group Treasury
(446)
(341)
31
of which: Non-core and Legacy Portfolio
(79)
(269)
(71)
of which: Group Services
(165)
(450)
(63)
Additional information
Risk-weighted assets (USD billion)
2
30.1
28.7
5
Leverage ratio denominator (USD billion)
2,3
104.0
96.2
8
1 Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after
the reporting period.
2 Refer to the “Capital, liquidity and funding,
and balance sheet” section of this report
for more information.
3 The leverage ratio
denominator calculated as of the respective date
in 2020
does not
reflect the
effects of
the temporary
exemption that
applied from
25 March
2020 until
1 January
2021 and
was granted
by FINMA
in connection
with COVID
-19. Refer
to the
“Regulatory and
legal
developments” section of our Annual Report 2020 for more information.
2021 compared with 2020
Results
Group Functions
recorded
a loss
before
tax of
USD 689 million,
compared with a loss of USD 1,060 million.
Group Treasury
The
Group
Treasury
result
was
negative
USD 446
million,
compared with negative USD 341 million.
Income
from
accounting
asymmetries,
including
hedge
accounting
ineffectiveness,
was
net
negative
USD 341
million,
compared with net positive of USD 6 million.
Revenues
related
to
centralized
Group
Treasury
risk
management
services
were
negative
USD 63
million,
compared
with
negative
USD 279
million.
The
increased
expense
in
2020
was
driven
by
additional
liquidity
costs
related
to
COVID-19
market stress in the first half of that year.
Operating
expenses
decreased
by
USD 30
million
to
USD 42
million.
Non-core and Legacy Portfolio
The
Non-core
and
Legacy
Portfolio
result
was
negative
USD 79
million, compared with negative USD 269 million. This result was
partly due
to valuation
gains of
USD 58 million
on our
USD 1.6
billion
portfolio
of
auction
rate
securities
(ARS),
compared
with
valuation
losses
of
USD 9
million
in
2020.
Our
remaining
exposures
to
ARS
were
all
rated
investment
grade
as
of
31 December 2021. In
addition, 2021 included
income of USD 51
million related to a legacy bankruptcy claim, while 2020 included
a
credit
loss
expense
of
USD 42
million
on
an
energy-related
exposure.
Group Services
The
Group
Services
result
was
negative
USD 165
million,
compared
with
negative
USD 450
million.
There
were
lower
expenses relating to our legal entity transformation
program and
decreased
funding
costs
on
deferred
tax
assets.
Also,
2020
included real estate costs
of USD 72 million related to
early lease
terminations
and
associated
provisions,
an
impairment
of
internally generated software of USD 67 million, and expenses of
USD 54 million related to the modification of certain outstanding
deferred compensation awards.
›
Refer to the “Group performance” section
and “Note 1b Changes
in accounting policies, comparability
and other adjustments” in
the “Consolidated financial statements”
section of this report for
more information about the modification
of deferred
compensation awards
95
Selected financial information of our business
divisions and Group Functions
Performance of our business divisions and Group Functions
1
For the year ended 31.12.21
USD million
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Manage-
ment
Investment
Bank
Group
Functions
Total
Operating income
19,449
4,349
2,616
9,488
(360)
35,542
of which: gain from the sale of UBS’s domestic wealth management business
in Austria
100
100
Operating expenses
14,665
2,618
1,586
6,858
330
26,058
of which: net restructuring expenses
2
87
17
17
74
21
216
Operating profit / (loss) before tax
4,783
1,731
1,030
2,630
(689)
9,484
For the year ended 31.12.20
USD million
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Manage-
ment
Investment
Bank
Group
Functions
Total
Operating income
17,045
3,651
2,974
9,214
(494)
32,390
of which: net gain from the sale of a majority stake in Fondcenter AG
60
571
631
of which: gain on the sale of intellectual property rights
215
215
of which: net gains from properties sold or held for sale
64
64
of which: valuation gain on auction rate securities in the fourth quarter of
2020
3
134
134
of which: gain related to investment in associates
6
19
26
of which: gain on the sale of equity investment measured
at fair value through profit or loss
4
18
22
Operating expenses
13,026
2,392
1,519
6,732
567
24,235
of which: acceleration of expenses in relation to outstanding deferred
compensation awards in
the third quarter of 2020
4
46
3
22
229
58
359
of which: expenses associated with terminated real estate
leases
72
72
of which: impairment of internally generated software
5
67
67
of which: net restructuring expenses
72
5
6
24
0
107
Operating profit / (loss) before tax
4,019
1,259
1,455
2,482
(1,060)
8,155
For the year ended 31.12.19
USD million
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Manage-
ment
Investment
Bank
Group
Functions
Total
Operating income
16,353
3,715
1,938
7,269
(385)
28,889
of which: net foreign currency translation losses
6
(35)
(35)
of which: net losses from properties held for sale
(29)
(29)
Operating expenses
12,955
2,274
1,406
6,485
192
23,312
of which: impairment of goodwill
110
110
of which: net restructuring expenses
68
17
33
168
(2)
284
Operating profit / (loss) before tax
3,397
1,441
532
784
(577)
5,577
1 The components
of operating income
and operating expenses
disclosed in this
table are items
that are not recurring
or necessarily representative
of the underlying
business performance for
the reporting period
specified.
2 Includes curtailment gains of USD 80
million, which represent a reduction in the defined benefit
obligation related to the Swiss pension plan resulting
from a decrease in headcount following restructuring
activities.
3 Reflects a valuation gain recognized in the fourth quarter of 2020 as a result of a recovery in underlying market conditions, following a change
in valuation methodology. This gain was more than offset
by valuation losses recognized earlier in the year.
4 Reflects the accelerated expense recognized in the third quarter of 2020 when the conditions for continued vesting of certain outstanding deferred compensation
awards were modified. This
amount
includes approximately USD 80
million of accelerated expense
that would otherwise have
been recognized in the
fourth quarter of 2020.
The full year effect
was an expense of
approximately USD 280 million (Global Wealth Management: USD 30 million, Asset Management:
USD 10 million, Investment Bank: USD 180 million, Group Functions: USD 60 million).
5 Relates to impairment of
internally generated software resulting
from a decision in the fourth
quarter of 2020 to not
proceed with an internal busines
s
transfer from UBS Switzerland
AG to UBS AG.
6 Relates to the disposal
or closure of
foreign operations.
Risk, capital,
liquidity and
funding, and
balance sheet
Management report
3
Audited information according to IFRS 7 and IAS 1
Risk and
capital disclosures provided
in line
with the
requirements of
International Financial Reporting
Standard 7
(IFRS 7),
Financial
Instruments:
Disclosures,
and
International
Accounting
Standard
1
(IAS
1),
Presentation
of
Financial
Statements,
form
part
of
the
financial
statements
included
in
the
“Consolidated
financial
statements”
section
of
this
report
and
audited
by
the
independent
registered public accounting firm Ernst & Young Ltd, Basel. This information is marked as “Audited”
within this section of the report.
The
risk profile
of
UBS AG
consolidated does
not differ
materially from
that of
UBS Group
AG consolidated.
Audited information
provided in the “Risk management and control” and “Capital, liquidity and funding, and
balance sheet” sections applies to both UBS
Group AG consolidated and UBS AG consolidated.
Signposts
The
Audited |
signpost that is displayed at the beginning
of a section, table or chart indicates that
those items have been audited. A triangle
symbol –
p
–
indicates the end of the audited section, table
or chart.
Risk management
and control
Table of contents
99
Overview of risks arising from our business activities
100
Risk categories
102
Top
and emerging risks
103
Risk governance
105
Risk appetite framework
108
Internal risk reporting
109
Model risk management
110
Risk measurement
113
Credit risk
131
Market risk
140
Country risk
143
Sustainability and climate risk
147
Non-financial risk
99
Risk management and control
Overview of risks arising from our business activities
The scale of
our activities
depends on the
capital available to
cover
risks,
the
size
of
our
on-
and
off-balance
sheet
assets
via
their
contribution to our
capital, leverage and
liquidity ratios, and
our
risk appetite.
Despite
our
credit
book
growing
over
the course
of
2021,
our
overall
credit
risk
profile
was
broadly
unchanged
,
and
we
continued
to manage market
risks at generally
low levels.
Operational resilience, conduct and the prevention of financial
crime remain key focus topics.
Key risks by business division and Group Functions
Business divisions and Group Functions
Key risks arising from business activities
Global Wealth Management
Credit risk
from lending against securities collateral, including
derivative trading activity, and lending
against residential and commercial real estate collateral, as
well as corporate and other lending
Market risk
from municipal securities and taxable fixed-income
securities
Personal & Corporate Banking
Credit risk
from retail business, mortgages, secured and unsecured corporate
lending, commodity trade
finance, lending to banks and other regulated clients,
as well as a small amount of derivatives trading
activity
Minimal contribution to
market risk
Asset Management
Small amounts of credit and market risk for on-balance
sheet items
Investment Bank
Credit risk
from lending (take-and-hold, as well as temporary
loan underwriting activities), derivatives
trading and securities financing
Market risk
from primary underwriting activities and
secondary trading
Group Functions
Credit
and
market risk
arising from management of the Group’s balance
sheet, capital, profit or loss
and liquidity portfolios
Non-financial risks,
which include operational, financial crime,
compliance,
conduct,
model, and reputational risks, are an inevitable consequence
of being
in business and can arise as a result of our past
and current business activities across all business
divisions and Group Functions.
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
100
Risk categories
We
categorize the
risk exposures
of
our
business divisions
and
Group
Functions as
outlined
in
the
table
below.
Our risk
appetite
framework is designed to capture all risk categories.
›
Refer to “Risk appetite framework” in this
section for more information
Risk managed by
Independent
oversight by
Financial risks
Audited |
Credit risk:
the risk of loss resulting from the failure of a client or counterparty
to meet its
contractual obligations toward UBS. This includes
settlement risk, loan underwriting risk and
step-in risk.
Settlement risk:
the risk of loss resulting from transactions that involve
exchange of value (e.g.,
security versus cash) where we must deliver without
first being able to determine with certainty
that
we will receive the countervalue.
Loan underwriting risk:
the risk of loss arising during the holding
period of financing transactions
that are intended for further distribution.
Step-in risk:
the risk that UBS may decide to provide financial
support to an unconsolidated entity
that is facing stress in the absence of, or in excess of,
any contractual obligations to provide such
support.
p
Business management
Risk Control
Audited |
Market risk
(traded and non-traded):
the risk of loss resulting from adverse movements
in
market variables. Market variables include observable
variables, such as interest rates, foreign exchange
rates, equity prices, credit spreads and commodity (including
precious metal) prices, as well as variables
that may be unobservable or only indirectly observable,
such as volatilities and correlations. Market risk
includes issuer risk and investment risk.
Issuer risk:
the risk of loss from changes in fair value resulting from
credit-related events affecting
an issuer to which we are exposed through tradable securities
or derivatives referencing the issuer.
Investment risk:
issuer risk associated with positions held
as financial investments.
p
Business management
and Group Treasury
Risk Control
Country risk:
the risk of losses resulting from country-specific events.
Includes transfer risk, which
involves a country’s authorities preventing or restricting
the payment of an obligation, as well
as
systemic risk events arising from country-specific political
or macroeconomic developments.
Business management
Risk Control
Sustainability and climate risk
(previously known at UBS as environmental and social
risk):
the risk
that UBS is negatively impacted by or negatively
impacts climate change, loss of biodiversity, human
rights infringements, or other environmental,
social or governance (ESG) matters. Climate
risks can arise
from either changing climate conditions (physical
risks) or from efforts to mitigate climate change
(transition risks). Sustainability and climate risks
may manifest as credit, market, liquidity and operational
risks for UBS, resulting in potential adverse financial,
liability and reputation impacts. They
may also
negatively impact the value of investments.
Business management
Risk Control
Treasury risk:
the market risks that arise from structural
exposures, including pension risks, and the risk
of insufficient funding or liquidity.
Group Treasury
Risk Control
Audited |
Liquidity risk:
the risk that the firm will not be able to
efficiently meet both expected and
unexpected current and forecast cash flows and collateral
needs without affecting either daily
operations or the financial condition of the
firm.
p
Audited |
Funding risk:
the risk that the firm will be unable, on
an ongoing basis, to borrow funds in
the market on an unsecured (or even secured) basis at
an acceptable price to fund actual or
proposed commitments; i.e., the risk that UBS’s funding
capacity is not sufficient to support the
firm’s current business and desired strategy.
p
Structural foreign exchange risk:
the risk of decreases in our capital due to changes
in foreign
exchange rates with an adverse translation
effect on capital held in currencies other than the US
dollar.
Pension risk:
the risk of a negative impact on our capital
as a result of deteriorating funded status
from decreases in the fair value of assets held in defined
benefit pension funds and / or changes in
the value of defined benefit pension obligations
due to changes in actuarial assumptions
(e.g.,
discount rate, life expectancy, rate of pension increase, etc.) and / or changes
to plan designs.
Group Treasury and
Human Resources
Risk Control
and Finance
Business risk:
the potential negative impact on earnings
from lower-than-expected business volumes
and / or margins, to the extent they are not offset by a decrease
in expenses.
Business management
Finance and Risk Control
101
Risk managed by
Independent
oversight by
Non-financial risks
Operational risk:
the risk resulting from inadequate or failed internal
processes, people or systems, or
from external causes (deliberate, accidental
or natural), that have an impact (either financial
or non-
financial) on UBS, its clients or the markets in
which it operates. Events may be direct financial losses
or
indirect, in the form of revenue forgone as a result of business
suspension. They may also result in
damage to our reputation and to our franchise that
has longer-term financial consequences.
Business management
Group Compliance,
Regulatory &
Governance (GCRG)
Legal risk:
the financial or reputational implications resulting
from the risk of: (i) being held liable for
a breach of applicable laws, rules or regulations; (ii) being
held liable for a breach of contractual or
other legal obligations; (iii) an inability or failure to
enforce or protect contractual rights or non-
contractual rights sufficiently to protect UBS’s interests, including
the risk of being party to a claim in
respect of any of the above (and the risk of loss
of attorney–client privilege in the context
of any such
claim); (iv) a failure to adequately develop, supervise
and resource legal teams or adequately supervise
external legal counsel advising on business
legal risk and other matters; and (v)
a failure to adequately
manage any potential, threatened and commenced
litigation and legal proceedings, including civil,
criminal, arbitration and regulatory proceedings,
and / or litigation risk or any dispute or investigation
that may lead to litigation or threat of any litigation.
Legal
Employment risk:
the risk incurred by the firm by not adhering
to the applicable employment law,
regulatory requirements and human resources practices, as well as our
own internal standards. Such
risk is managed by business management,
with independent overview by Human Resources.
Human Resources
Cybersecurity and information security risk:
the risk of a malicious internal or
external act leading
to a material impact on confidentiality, integrity or availability of UBS data
or information systems.
Cyberattacks are manifestations of a cyber threat into
an act of aggression or criminal activity causing
financial, regulatory or reputational harm or loss.
Business management
and Chief Digital and
Information Office
(CDIO)
GCRG
Conduct risk:
the risk that the conduct of the firm or its
individuals unfairly impacts clients or
counterparties, undermines the integrity of the
financial system or impairs effective competition
to the
detriment of consumers.
Business management
GCRG
Compliance risk:
the risk incurred by the firm by not adhering to
the applicable laws, rules and
regulations, and our own internal standards.
Business management
GCRG
Financial crime risk:
the risk that UBS fails to detect criminal
activities, including internal and
external
theft and fraud, money laundering, bribery
and corruption, and fails to comply with sanctions
and
embargoes, or fails to report or respond to requests from relevant authorities
related to these matters.
Business management,
Financial Crime
Prevention (FCP), and
GCRG COO
GCRG
Model risk:
the risk of adverse consequences via
financial loss or non-financial impact
(e.g., poor
business and / or strategic decision making,
or damage to the firm’s reputation) resulting from decisions
based on incorrect or misused model outputs and
reports. Model risk may result from a number of
sources: inputs, methodology, implementation or use.
Model owner
Risk Control
Reputational risk:
the risk of damage to our reputation from the point
of view of our stakeholders,
such as clients, shareholders and staff, and the general
public.
All businesses and
functions
All control functions
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
102
Top and emerging risks
The top and emerging risks disclosed below reflect those that we
currently think
have the
potential to
materialize within
one year
and which
could significantly
affect the
Group. Investors
should
also carefully
review all information
set out in
the “Risk factors”
section of this report, where
we discuss these and other material
risks
that
we
consider
could
have
an
effect
on
our
ability
to
execute
our
strategy
and
may
affect
our
business
activities,
financial condition, results of operations and business prospects.
–
The
COVID-19
pandemic,
and
its
impact
on
growth,
employment,
debt
dynamics
and
supply
chains,
remains
an
important driver of risk,
and we expect this
to be the case for
at
least
the
near
future.
The
Omicron
variant
continues
to
spread,
and
there
is
uncertainty
about
when
restrictions
introduced in many countries will be eased.
–
There continue to
be concerns regarding
a resurgence in
global
inflation,
and
the
timing
and
extent
of
central
bank
policy
responses
(i.e.,
interest
rate
hikes
and
the
tapering
of
quantitative
easing)
will
be
an
area
of
focus
in
the
coming
months.
There
are
related
concerns
about
increasing
energy
and other
commodity prices
in a
number of
countries, while
mounting global supply chain stresses and tight labor markets
are
creating
negative
pressure
on
growth.
China
is
facing
several challenges, including a slowing economy following the
post-pandemic boom.
–
We remain
watchful of
a range
of geopolitical
developments
in
Europe
and
Asia
and
political
changes
in
a
number
of
countries.
Our
current
focus
is
on
the
Russian
invasion
of
Ukraine.
Our
current
direct
exposure
to
Russia,
Ukraine
and
Belarus
is
limited,
as
is
our
exposure
to
peripheral
European
countries
.
However,
market
closures,
the
imposition
of
exchange controls, sanctions
or other measures
may limit our
ability to settle existing
transactions or to realize on
collateral,
which
may
result
in
unexpected
increases
in
exposures.
In
addition,
we
have
significant
country
risk
exposure
to
major
economies,
which
could
also
be
affected,
including
the
US,
China, Switzerland, Germany, the UK and France.
–
We are exposed to a
number of macroeconomic issues,
as well
as general market conditions. As noted in “Market, credit and
macroeconomic
risks”
in
the
“Risk
factors”
section
of
this
report, these external pressures may have a significant adverse
effect
on
our
business
activities
and
related
financial
results,
primarily
through
reduced
margins
and
revenues,
asset
impairments
and
other
valuation
adjustments.
Accordingly,
these
macroeconomic
factors
are
considered
in
the
development
of
stress
testing
scenarios
for
our
ongoing
risk
management activities.
–
We are exposed to
substantial changes in the
regulation of our
businesses
that
could
have
a
material
adverse
effect
on
our
business,
as
discussed
in
the
“Regulatory
and
legal
developments” section
of this
report and
in “Regulatory
and
legal risks” in the “Risk factors” section of this report.
–
As
a
global
financial
services
firm,
we
are
subject
to
many
different
legal,
tax
and
regulatory
regimes
and
extensive
regulatory oversight. We
are exposed to
significant liability risk,
and
we
are
subject
to
various
claims,
disputes,
legal
proceedings
and
government
investigations,
as
noted
in
“Regulatory
and
legal
risks”
in the
“Risk
factors”
section
of
this report. Information about litigation, regulatory and similar
matters
we
consider
significant
is
disclosed
in
“Note 18
Provisions
and
contingent
liabilities”
in
the
“Consolidated
financial statements” section of this report.
–
Cyber threats continue to
evolve at pace, not least
due to the
Russian
invasion
of
Ukraine,
and
can
impact
the industry,
as
well as
critical infrastructure
which it relies
on. More
recently,
ransomware attacks
with a
possible widespread
impact have
increased
significantly.
Additionally,
as
a
result
of
the
operational complexity of
all our businesses,
we are continually
exposed
to
operational
resilience
scenarios
such
as
process
error, failed execution, system failures and fraud.
–
Conduct
risks
are
inherent
in
our
businesses.
Achieving
fair
outcomes
for
our
clients,
upholding
market
integrity
and
cultivating the
highest standards
of employee
conduct are
of
critical importance to UBS. Management of conduct risks is an
integral part of our risk management framework.
–
Financial
crime
–
including
money
laundering,
terrorist
financing, sanctions violations, fraud, bribery and corruption –
presents
significant
risk.
Heightened
regulatory
expectations
and attention require investment in people and systems, while
emerging technologies and changing geopolitical
risks further
increase the complexity of identifying and preventing financial
crime
.
Refer
to
“Non
-
financial
risk”
in
this
section
and
“Strategy,
management
and
operational
risks”
in
the
“Risk
factors” section of this report for more information.
–
Environmental, social
and governance
(ESG) risks
are a
growing
area
of
focus
for
regulators
and
other
stakeholders
,
in
particular
climate
risks
and
concerns
about
greenwashing,
where
UBS
may
be
subject
to
reputational
risk
if
not
fully
aligned
with
the
stated
purpose
of
the
firm.
New
standards
and rules are developing in several
jurisdictions with the risk of
divergent rules increasing and leading to an increased risk
that
UBS
may
not
comply
with
all
relevant
regulations.
Refer
to
“Non-financial risk” in this section.
103
Risk governance
Our
risk
governance
framework
operates
along
three
lines
of
defense.
Our first
line of
defense, business
management, owns
its risk
exposures and is
accountable for maintaining effective
processes
and
systems
to
manage
its
risks
in
compliance
with
applicable
laws,
external
regulations
and
internal
requirements,
including
identifying control weaknesses and inadequate processes.
Our second line of defense, control functions, is separate
from
the
business
and
reports
directly
to
the
Group
CEO.
Control
functions provide independent oversight,
challenge financial and
non-financial risks
arising from the
firm’s business
activities, and
establish
independent
frameworks
for
risk
assessment,
measurement,
aggregation
and
reporting,
protecting
against
non-compliance with applicable laws and regulations.
Our third line of
defense, Group Internal Audit, reports
to the
Chairman and to the
Audit Committee. This function
assesses the
design and operating effectiveness and sustainability
of processes
to
define
risk
appetite,
governance,
risk
management,
internal
controls, remediation activities
and processes to
comply with legal
and
regulatory
requirements
and
internal
governance
requirements.
The
key
roles
and
responsibilities
for
risk
management
and
control
are
shown
in
the
chart
below
and
described
on
the
following pages.
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
104
Audited
|
The
Board
of
Directors
(the
BoD)
approves
the
risk
management and control framework of the Group, including the
Group
and
business
division
overall
risk
appetite.
The
BoD
is
supported
by
its
Risk
Committee,
which
monitors and
oversees
the
Group’s
risk
profile
and
the
implementation
of
the
risk
framework approved
by the BoD,
and approves
the Group’s risk
appetite methodology.
The Corporate Culture
and Responsibility
Committee (the CCRC) helps the BoD
meet its duty to safeguard
and
advance
UBS’s
reputation
for
responsible
and
sustainable
conduct,
reviewing
stakeholder
concerns
and
expectations
pertaining
to
UBS’s
societal
contribution
and
corporate
culture.
The
Audit
Committee
assists
the
BoD
with
its
oversight
duty
relating to financial
reporting and internal
controls over financial
reporting,
and
the
effectiveness
of
whistleblowing
procedures
and the external and internal audit functions.
The
Group
Executive Board
(the GEB) has overall responsibility
for establishing and
implementing a risk
management and control
framework in the Group,
managing the risk profile
of the Group
as a whole.
The
Group
Chief
Executive
Officer
has
responsibility
and
accountability
for the
management
and performance
of the
Group,
has risk authority over
transactions, positions and exposures, and
allocates
business
divisions
and
Group
Functions
risk
limits
approved by
the BoD.
The
business division Presidents
and
Group function heads
are
responsible for the
operation and management
of their business
divisions,
including
controlling the
dedicated
financial
resources
and risk appetite of the business division.
The
regional
Presidents
are
responsible
for
cross
-
divisional
collaboration in their
regions and
are mandated
to inform
the GEB
about
any
activities
/
issues
that
may
give
rise
to
actual
or
potentially material regulatory or reputational concerns.
The
Group Chief
Risk Officer
(the Group
CRO) is
responsible
for
developing
the
Group’s
risk
management
and
control
framework (including
risk principles
and risk
appetite) for
credit,
market,
country,
treasury,
model
and
sustainability
and
climate
risks. This
includes risk
measurement and
aggregation, portfolio
controls
and
risk reporting.
The
Group
CRO
sets
risk limits
and
approves credit and
market risk transactions
and exposures. Risk
Control is
also the
central function
for model
risk management
and control
for all
models used
in UBS.
A framework
of policies
and authorities support the risk control process.
The
Group
Chief
Compliance
and
Governance
Officer
is
responsible
for
developing
the
Group’s
operational
risk
framework,
which
sets
the
general
requirements
for
identification,
management,
assessment
and
mitigation
of
operational risk,
and for
ensuring that
all non-financial
risks are
identified, owned and managed according to the operational risk
appetite objectives, supported by an effective control framework.
The
Group
Chief
Financial
Officer
is
responsible
for
transparency in assessing the financial performance of the Group
and the
business divisions,
and for
managing the
Group’s financial
accounting,
controlling,
forecasting,
planning
and
reporting.
Additional responsibilities
include managing
UBS’s tax
affairs, as
well as treasury
and capital management,
including funding and
liquidity risk and UBS’s regulatory capital ratios.
The
Group
General Counsel
is
responsible for
managing the
Group’s legal
affairs (including litigation involving UBS),
ensuring
effective
and timely
assessment
of legal
matters
impacting
the
Group
or its
businesses,
and managing
and reporting
all litigation
matters.
The
Head of
Human Resources
is responsible for
independent
oversight
and challenge
of employment-related
risks.
Group
Internal
Audit
(GIA)
independently
assesses
the
effectiveness of processes to define
strategy and risk appetite
and
overall
adherence
to
the
approved
strategy.
It
also
assesses
the
effectiveness
of
governance
processes
and
risk
management,
including compliance with legal and regulatory requirements and
internal
governance
documents.
The
Head
GIA
reports
to
the
Chairman of the BoD.
GIA also has a
functional reporting line to
the BoD Audit Committee.
Some
of
these
roles
and
responsibilities
are
replicated
for
certain significant legal entities of the Group. The
legal entity risk
officers
are responsible for
independent oversight and
control of
financial
and
non-financial
risks
for
certain
significant
legal
entities of the
Group as part
of the
legal entity control
framework,
which
complements
the
Group’s
risk
management
and
control
framework.
p
105
Risk appetite framework
We have a
defined Group-level
risk appetite,
covering
all financial
and non-financial
risk types,
via a complementary
set of qualitative
and
quantitative
risk appetite
statements.
This is reviewed
and recalibrated
annually and
presented to
the BoD for
approval.
Our
risk
appetite
is
defined
at
the
aggregate
Group
level
and
reflects the types of
risk that we are
willing to accept or avoid.
It
is set via complementary qualitative and quantitative risk
appetite
statements
defined
at
a
firm-wide
level
and
is
embedded
throughout
our
business
divisions
and
legal
entities
by
Group,
business division
and legal
entity policies,
limits and
authorities.
We are subject to consolidated supervision
by the Swiss Financial
Market
Supervisory
Authority
(FINMA)
and
related
ordinances,
which
impose,
among
other
requirements,
minimum
standards
for capital, liquidity,
risk concentration and internal organization.
Our risk appetite
is reviewed
and recalibrated
annually,
with the
aim of ensuring that risk-taking at every level of the organization
is
in
line
with
our
strategic
priorities,
our
capital
and
liquidity
plans,
our
Pillars,
Principles
and
Behaviors
,
and
minimum
regulatory
requirements.
The
“Risk
appetite
framework”
chart
below
shows
the
key
elements
of
the
framework,
described
in
detail in this section.
Qualitative risk appetite statements aim to
ensure we maintain
the desired
risk culture.
Quantitative risk
appetite objectives
are
designed
to
enhance
UBS’s
resilience
against
the
effect
s
of
potential
severe
adverse
economic or
geopolitical
events. These
risk appetite objectives cover
UBS’s minimum capital and
leverage
ratios, solvency,
earnings, liquidity,
and funding,
and are
subject
to periodic review, including the
yearly business planning process.
These
objectives
are
complemented
by
operational
risk
appetite
objectives,
which
are
set
for
each
of
our
non-financial
risk
categories,
including
market
conduct,
theft,
fraud,
data
confidentiality and technology
risks. A standardized
financial firm-
wide operational risk appetite
has been established
at Group level
and is embedded
throughout our business
divisions. Operational
risk events exceeding predetermined risk tolerances, expressed as
percentages of UBS’s operating income, must be escalated as per
the
firm-wide
escalation
framework
to
the
respective
business
division President or higher, as appropriate.
The
quantitative
risk
appetite
objectives
are
supported
by
a
comprehensive suite
of risk
limits set
at a
portfolio level
to monitor
specific portfolios and to control potential risk concentrations.
The status
of risk
appetite objectives is evaluated each
month
and reported
to the
BoD and
the GEB.
As our
risk appetite may
change
over
time,
portfolio
limits
and
associated
approval
authorities
are subject
to periodic
reviews and
changes, particularly
in the context
of our annual
business
planning process.
Our risk
appetite framework
is governed
by a single
overarching
policy and conforms
to the Financial Stability
Board’s Principles
for
an Effective
Risk Appetite
Framework.
›
Refer to “Risk principles and risk culture”
and “Quantitative risk
appetite objectives” on the following
pages for more
information
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
106
Risk principles and risk culture
Maintaining a
strong
risk culture
is a
prerequisite
for success
in
today’s
highly
complex
operating
environment
and
a
source
of
sustainable
competitive
advantage.
Placing
prudent
and
disciplined
risk-taking
at
the
center
of
every
decision
has
three
principal
goals:
delivering
unrivaled
client
satisfaction;
creating
long-term
value
for
stakeholders;
and
making
UBS
one
of
the
world’s most attractive companies to work for.
Our
risk
appetite
framework
combines
all
the
important
elements of our
risk culture, expressed
in our
Pillars, Principles and
Behaviors
, our risk management and control principles, our Code
of Conduct and Ethics, and our Total Reward Principles. Together,
these
aim
to
align
our
decisions
with
the
Group’s
strategy,
principles and
risk appetite.
They help
create a
solid foundation
for promoting
risk awareness,
leading to
appropriate risk-taking
and
the
establishing
of
robust
risk
management
and
control
processes. These principles are supported by a range of initiatives
covering employees at all levels, for example
the
UBS House View
on Leadership
, which
is a
set of
explicit expectations
for leaders
that
establishes
consistent
leadership
standards
across
UBS.
Another
example
is
our
Principles
of
Good
Supervision,
which
establish clear
expectations of
managers and
employees regarding
supervisory
responsibilities,
specifically:
to
take
responsibility;
to
know and organize
their business; to
know their employees
and
what they do;
to create a
good risk culture;
and to respond
to and
resolve issues.
›
Refer to the foldout pages of this report for
more information
about our Pillars, Principles and Behaviors
›
Refer to the Code of Conduct and Ethics
of UBS at
ubs.com/code
for more information
Risk management and control principles
Protection of financial strength
Protecting UBS’s financial strength by controlling our risk
exposure and avoiding potential risk
concentrations at individual exposure levels,
at specific portfolio levels and at an aggregate firm-wide
level across all risk types
Protection of reputation
Protecting our reputation through a sound risk culture characterized
by a holistic and integrated view of
risk, performance and reward, and through full compliance
with our standards and principles, particularly
our Code of Conduct and Ethics
Business management accountability
Maintaining management accountability, whereby business management owns
all risks assumed
throughout the Group and is responsible for the continuous
and active management of all risk exposures
to provide for balanced risk and return
Independent controls
Independent control functions that monitor the
effectiveness of the businesses’ risk management
and
oversee risk-taking activities
Risk disclosure
Disclosure of risks to senior management, the BoD,
investors, regulators, credit rating agencies and other
stakeholders with an appropriate level of comprehensiveness
and transparency
Whistleblowing
policies
and
procedures
exist
to
support
an
environment where staff are comfortable
raising concerns. There
are multiple
channels via which
individuals may, either
openly or
anonymously,
escalate
suspected
breaches
of
laws,
regulations,
rules
and
other
legal
requirements,
our
Code
of
Conduct
and
Ethics, policies, or relevant professional
standards. Our program is
designed to ensure that whistleblowing concerns
are investigated
and
that
appropriate
and
consistent
action
is
taken.
We
are
committed
to
ensuring
appropriate
training
for
and
communication
to
staff
and
legal
entity
representatives
are
available
on
an
ongoing
basis,
including
with
regard
to
new
regulatory requirements.
Mandatory
training
programs
cover
various
compliance
and
risk-related
topics,
including
operational
risk
and
anti-money
laundering. Additional specialized training is provided
depending
on employees’
specific roles
and responsibilities,
e.g.,
credit risk
and market risk
training for those
working in trading
areas. Failure
to
complete
mandatory
training
sessions
within
an
appropriate
timeframe can
lead to
consequences, including
disciplinary action.
Our operational risk and conduct risk frameworks
aim to identify
and manage financial, regulatory
and reputational risks,
as well as
risks to clients and markets.
Quantitative risk appetite objectives
Our quantitative
risk appetite
objectives
aim
to
ensure
that our
aggregate
risk
exposure
remains
within
desired
risk
capacity,
based on capital and business plans. The specific
definition of risk
capacity for each
objective is aimed
at ensuring we
have sufficient
capital, earnings, funding
and liquidity
to protect
our businesses
and
exceed
minimum
regulatory
requirements
under
a
severe
stress event. The risk appetite objectives are evaluated during the
annual business planning process
and approved by
the BoD. The
comparison
of
risk
exposure
with
risk
capacity
is
a
key
consideration
in
decisions
on
potential
adjustments
to
the
business
strategy
and
risk
profile
of
UBS
and
capital
returns
to
shareholders.
The annual
business planning
process reviews
UBS’s business
strategy,
assesses
the
risk
profile
our
operations
and
activities
result in,
and stress tests
that risk profile.
We use both
scenario-
based stress
tests and
statistical risk measurement
techniques to
assess effects
of severe
stress events
at a
firm-wide level.
These
complementary frameworks capture
exposures to
all material risks
across our business divisions and Group Functions.
›
Refer to “Risk measurement” in this section
for more
information about our stress testing and statistical
stress
frameworks
107
Our risk
capacity is
underpinned by
performance targets
and
capital guidance as per our business plan. When determining our
risk capacity
in case
of a
severe stress
event, we
estimate projected
earnings
under
stress,
factoring
in
lower
expected
income
and
also lower expenses.
We also consider
capital impacts
under stress
from deferred
tax assets,
pension plan
assets and
liabilities, and
accruals for capital returns to shareholders.
Risk
appetite
objectives
define
the
aggregate
risk
exposure
acceptable
at
the
firm-wide
level,
given
our
risk
capacity.
The
maximum acceptable
risk exposure
is supported
by a
full set
of
risk limits, triggers and targets, which are cascaded to businesses
and
portfolios.
These
limits,
triggers
and
targets
aim
to
ensure
that our total risks remain in line with risk appetite.
Risk
appetite
statements
at
the
business
division
level
are
derived from
the firm-wide
risk appetite.
They may
also include
division-specific strategic goals
related to that
division’s activities
and
risks. Risk
appetite
statements are
also set
for certain
legal
entities, which must
be consistent with
the firm-wide risk
appetite
framework
and
approved
in
accordance
with
Group
and
legal
entity regulations.
Differences may
exist
that reflect
the specific
nature, size, complexity and regulations applicable
to the relevant
legal entity.
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
108
Internal risk reporting
Comprehensive and transparent reporting of
risks is central
to our
risk governance
framework’s control and
oversight responsibilities
and
required
by
our
risk
management
and
control
principles.
Accordingly,
risks are
reported at
a frequency
and level of
detail
commensurate with the extent
and variability of the
risk and the
needs
of
the
various
governance
bodies,
regulators
and
risk
authority holders.
The
Group
Risk
Report
provides
a
detailed
qualitative
and
quantitative monthly
overview of
developments in
financial and
non-financial risks at the firm-wide level, along with
breakdowns
of
risks
at
the
divisional
level,
including
the
status
of
our
risk
appetite objectives and the results of
firm-wide stress testing. The
Group Risk
Report is
distributed internally
to the
BoD and
the GEB,
and senior members of Risk Control, GIA, Finance and Legal. Risk
reports
are also
produced for
significant Group
entities (entities
subject
to
enhanced
standards
of
corporate
governance)
and
significant branches.
Granular divisional
risk reports
are provided
to the
respective
business
division
CROs
and
business
division
Presidents.
This
monthly reporting
is supplemented
with daily
or weekly reports,
at various levels
of granularity, covering
market and credit
risks for
the
business
divisions
to
enable
risk
officers
and
senior
management to monitor and control the Group’s risk profile.
Our internal
risk
reporting
covers
financial
and non-financial
risks
and is
supported by risk data
and measurement systems that are
also
used
for
external
disclosure
and
regulatory
reporting.
Dedicated
units
within
Risk
Control
assume
responsibility
for
measurement,
analysis and
reporting
of risk and
for overseeing
the
quality
and
integrity
of
risk-related
data.
Our
risk
data
and
measurement
systems
are
subject
to
periodic
review
by
GIA,
following a
risk-based
audit approach.
109
Model risk management
Introduction
We
rely
on
models
to
derive
risk
management
and
control
decisions,
to
measure
risks
or
exposures,
value
instruments
or
positions, conduct stress
testing, assess adequacy
of capital, and
manage clients’
assets and
our own
assets. Models
may also
be
used
to
measure
and
monitor
compliance
with
rules
and
regulations,
for
surveillance
activities,
or
to
meet
financial
or
regulatory reporting requirements.
Model risk is defined as
the risk of adverse consequences
(e.g.,
financial losses
or reputational
damage) resulting
from incorrect
models.
Model governance framework
Our
model
governance
framework establishes
requirements
for
identifying,
measuring,
monitoring,
reporting,
controlling
and
mitigating model risks. All
the models that we use
are subject to
governance
and
controls
throughout
their
life
cycles.
This
is
designed
to
ensure
that
risks
arising
from
model
use
are
identified,
understood,
managed,
monitored,
controlled
and
reported
on
both
a
model-specific
and
an
aggregated
level.
Before
they
can
be
granted
approval
for
use
from
the
model
sponsor,
all
our models
are
independently validated
across
four
model
risk
dimensions:
(i) model
input;
(ii) model
methodology;
(iii) model implementation; and (iv) model use.
Once
validated
and
approved
for
use,
a
model
is
subject
to
ongoing
model
performance
monitoring
and
annual
model
confirmation, ensuring that the model is only
used if it continues
to
be
found
fit
for
purpose.
All
models
are
subject
to
periodic
model re-validation, with
rigor, depth and frequency
determined
by the model’s materiality and complexity.
Our model risk
governance framework follows
our overarching
risk governance framework, with the three lines of defense (LoD)
assigned as follows.
–
First LoD:
model sponsors,
model owners,
model developers,
and model users
–
Second
LoD:
Chief
Model
Risk
Officer,
Model
Risk
Management & Control
–
Third LoD: Group Internal Audit
An important difference
as compared
with how LoD
are usually
defined in financial and non-financial risk
is that some models are
owned by traditionally second LoD functions, such
as risk control,
finance or compliance.
Model risk appetite framework and statement
The
model
risk
appetite
framework
sets
out
the
model
risk
appetite statement, defines the relevant
metrics and lays out how
appropriate adherence is assessed.
Model oversight
Model oversight committees and forums
ensure that model risk is
overseen
at
different
levels
of
the
organization,
appropriate
model risk management
and control actions
are taken and,
where
necessary, escalated to the next level.
The Group
Model Governance
Committee is
our most
senior
oversight and escalation
body for
all models
in scope
of our model
governance
framework.
It
is
co-chaired
by
the
Group CRO
and
the Group CFO and is
responsible for: (i) reviewing and approving
changes to the framework;
(ii) approving the model risk
appetite
statement;
(iii) overseeing
adherence
to
the
UBS
model
risk
governance framework; and (iv) monitoring
model risk at a
firm-
wide level.
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
110
Risk measurement
Audited |
We apply
a variety
of methodologies
and measurements
to
quantify
the
risks
of
our
portfolios
and
potential
risk
concentrations. Risks
that are
not fully
reflected within
standard
measures
are
subject
to
additional
controls,
which
may
include
preapproval of specific transactions
and the application
of specific
restrictions.
Models
to
quantify
risk
are
generally
developed
by
dedicated
units
within
control
functions
and
are
subject
to
independent validation.
p
›
Refer to “Credit risk,” “Market risk” and “Non-financial
risk” in
this section for more information about model
confirmation
procedures
Stress testing
We perform stress
testing to
estimate losses that
could result from
extreme
yet
plausible
macroeconomic
and
geopolitical
stress
events to
identify,
better understand
and manage
our potential
vulnerabilities and risk
concentrations. Stress testing
has a
key role
in our
limits framework at
the firm-wide, business
division, legal
entity and portfolio
levels. Stress test results
are regularly reported
to
the
BoD
and
the
GEB.
As
described
in
“Risk
appetite
framework,”
stress
testing,
along with
statistical loss
measures,
has
a
central
role
in
our
risk
appetite
and
business
planning
processes.
Our
stress
testing
framework
has
three
pillars:
(i) combined
stress tests; (ii) an extensive set of portfolio-
and risk type-specific
stress tests; and (iii) reverse stress testing.
Our
combined stress testing
(CST) framework is
scenario-based
and
aims
to
quantify
overall
firm-wide
losses
that
could
result
from
various
potential
global
systemic
events.
The
framework
captures
all
material
risks,
as
covered
in
“Risk
categories.”
Scenarios
are
forward-looking
and
encompass
macroeconomic
and
geopolitical
stress
events
calibrated
to
different
levels
of
severity.
We
implement
each
scenario
through
the
expected
evolution of market indicators and economic variables under that
scenario
and
then
estimate
the
overall
loss
and
capital
implications were the scenario
to occur. At least
once a year, the
Risk Committee
approves the
most relevant
scenario, known
as
the binding scenario, for use as the main
scenario for regular CST
reporting and for monitoring risk
exposure against our minimum
capital, earnings and leverage ratio objectives in our risk appetite
framework.
We
provide
detailed
stress
loss
analyses
to
FINMA
and
regulators
of
our
legal
entities
in
accordance
with
their
requirements.
Our Enterprise-wide Stress Forum (the ESF) aims
to ensure the
consistency and adequacy of the assumptions and scenarios used
for firm-wide
stress measures.
As part
of its
responsibilities, the
ESF
with
input
from
the
Think
Tank,
a
panel
of
senior
representatives
from
the
business
divisions,
Risk
Control
and
economic research, seeks to
ensure that the set
of stress scenarios
adequately
reflects
current
and
potential
developments
in
the
macroeconomic
and
geopolitical
environment,
current
and
planned
business
activities,
and
actual
or
potential
risk
concentrations and vulnerabilities in our portfolios.
Each
scenario
captures
a
wide
range
of
macroeconomic
variables,
including
GDP,
equity
prices,
interest
rates,
foreign
exchange
rates,
commodity
prices,
property
prices
and
unemployment.
We
use
assumed
changes
in
these
macroeconomic
and
market
variables in
each
scenario
to
stress
the
key
risk
drivers
of
our
portfolios.
For
example,
lower
GDP
growth and rising interest rates may reduce the income of clients
we have lent money to, which changes the credit risk parameters
for
probability
of
default,
loss
given
default
and
exposure
at
default,
and
results
in
higher
predicted
credit
losses
within
the
stress scenario.
We also
capture the
business risk
resulting from
lower
fee,
interest
and
trading
income
net
of
lower
expenses.
These
effects
are
measured
for
all
businesses
and
material
risk
types to calculate
the aggregate estimated effect
of the scenario
on
profit
or
loss,
other comprehensive
income,
RWA,
LRD and,
ultimately,
capital
and
leverage
ratios.
The
assumed
changes
in
macroeconomic variables are updated
periodically to account for
changes in the current and possible future market environment.
In 2021, the binding
scenario for CST was
the internal
Global
Crisis scenario
, which is characterized by a deterioration of global
economic conditions leading to sovereign
defaults in Europe and
a global recession.
The scenario was
updated over the
course of
2021
to
incorporate
current
risks
related
to
COVID
-
19
,
in
particular
macroeconomic
assumptions,
such
as
deteriorating
GDP and rising unemployment
.
Continued weakness in economic
data
and
tensions
between
European
countries
about
debt
mutualization undermines market confidence in the sustainability
of peripheral
debt, leading
to a
sharp spike
in bond
yields. Italy,
Spain,
Portugal
and
Cyprus
receive
bailout
packages,
on
the
condition
of
substantial
debt
restructuring,
while
Greece
leaves
the
Eurozone.
In
addition
to
the
effects
of
COVID-19,
the
macroeconomic
impact
is
severe,
as
is
the
immediate
market
impact.
Weak
consumer
and
business
confidence
and
a
fall
in
global trade as
a result of
protectionism lead to
a global recession.
China
is
hit
severely
by
trade
protectionism
and
a
confidence
shock, which lead to a hard landing
.
111
As part
of the
CST framework,
we routinely
monitored three
additional stress scenarios throughout 2021:
–
The
US Monetary Crisis
scenario
explores a loss of
confidence
in the
US, which
leads to
a sell-off
of US
dollar-denominated
assets, sparking an abrupt
and substantial depreciation of
the
US dollar. The US economy
is hit hard, financial markets
enter
a
period
of
high
volatility
and
other
industrialized
countries
replicate
the
cyclical
pattern
of
the
US.
Regional
inflation
trends
diverge
as
the
US
experiences
significant
inflationary
pressures while other developed markets experience deflation.
–
The
Severe Global Interest Rate Steepening
scenario explores a
sharp and persistent rise
in inflation leading
to a significant
rise
in long-term interest rates and a
period of market turbulence.
Economic activity slows across the globe as
both business and
household
sentiment
collapse,
while
credit
conditions
deteriorate.
Despite
weakness
in
activity,
inflation
remains
stubbornly
high,
forcing
central
banks
to
begin
hiking
their
policy rates and thereby prolonging the weakness in
economic
activity and asset prices.
–
The
Extreme
Coronavirus
scenario
explores
a
resurgence
of
COVID-19 and subsequent
containment policies, which
lead to
a severe global
downturn with long-term
scarring impacts. The
lack
of
adherence
to
containment
measures
leads
to
rapid
resurgences in the number of cases and
fatalities, which force
countries to
enforce increasingly
stringent lockdown
policies.
Vaccines prove to be ineffective in the
near term, due to either
logistical constraints
of vaccine distribution,
vaccine hesitancy
or virus variants undermining the efficacy of current vaccines.
We
have
updated
the
binding
stress
scenario
in
our
CST
framework for
2022. The
updated Global
Crisis scenario reflects
the
weaker
fiscal
conditions
resulting
from
the
COVID-19
pandemic, which leads
to sovereign defaults in
several emerging
markets. The scenario continues to
assume a Eurozone crisis and
a hard landing in China.
Portfolio-specific stress tests
are measures tailored to
the risks
of
specific
portfolios.
Our
portfolio
stress
loss
measures
are
derived
from
data
on
past
events,
but
also
include
forward-
looking
elements
(
e.g.,
we
derive
the
expected
market
movements
in
our
liquidity-adjusted
stress
metric
using
a
combination of
historical market
behavior, based
on an
analysis
of
historical
events,
and
forward-looking
analysis,
including
consideration of defined scenarios not
modeled on any historical
events). Results of portfolio-specific stress tests may be subject to
limits to explicitly
control risk-taking or
may be monitored
without
limits to identify vulnerabilities.
Reverse
stress
testing
starts
from
a
defined
stress
outcome
(e.g.,
a
specified
loss
amount,
reputational
damage,
a
liquidity
shortfall
or
a
breach
of
regulatory
capital
ratios)
and
works
backward to
identify economic
or financial
scenarios that
could
result
in
such
an
outcome.
As
such,
reverse
stress
testing
is
intended to complement scenario-based
stress tests by assuming
“what if” outcomes
that could extend
beyond the range
normally
considered,
and
thereby
potentially
challenge
assumptions
regarding severity and plausibility.
We also routinely
analyze the effect
of increases
or decreases
in interest rates and changes in the structure of yield curves.
Within
Group
Treasury,
we
also
perform
stress
testing
to
determine the
optimum asset
and liability
structure, enabling
us
to
maintain
an
appropriately
balanced
liquidity
and
funding
position under
various scenarios.
These scenarios
differ from
those
outlined
above,
because
they
focus
on
specific
situations
that
could
generate
liquidity
and
funding
stress,
as
opposed
to
the
scenarios used
in the CST
framework, which focus
on the effect
on profit or loss and capital.
›
Refer to “Credit risk” and “Market risk” in this section
for more
information about stress loss measures
›
Refer to the “Capital, liquidity and funding,
and balance sheet”
section of this report for more information about
stress testing
Statistical measures
We
complement
the
scenario-based
CST
measures
with
our
statistical stress framework to calculate and aggregate risks using
statistical techniques to derive stress events at chosen confidence
levels.
This framework is
used to
derive a
loss distribution, considering
effects on both income and expenses, based on the simulation
of
historically
observed
financial
and
economic
risk
factors
in
combination
with
the
firm’s
actual
earnings
and
relevant
risk
exposures.
From
that,
we
determine
earnings-at-risk
(EaR),
measuring
the potential
shortfall
in earnings
(i.e.,
the
deviation
from forecast earnings) at a 95% confidence
level and evaluated
over
a
one-year horizon.
EaR
is used
for
the assessment
of
the
earnings objectives in our risk appetite framework.
We extend the EaR measure, incorporating
the effects of gains
and losses
recognized through
other comprehensive
income, to
derive
a
distribution
of
potential
effects
of
stress
events
on
common equity tier 1
capital. From
this distribution, we
derive our
capital-at-risk (CaR) buffer measure at a 95%
confidence level to
assess our capital and
leverage ratio risk
appetite objectives, and
derive our CaR solvency
measure at a 99.9%
confidence level to
assess our solvency risk appetite objective.
We use
the CaR
solvency measure
as a
basis for
deriving the
contributions of the business divisions to risk-based capital (RBC),
which is
a component of
our equity attribution
framework. RBC
measures the potential capital impairment from an
extreme stress
event at a 99.9% confidence level.
›
Refer to the “Capital, liquidity and funding,
and balance sheet”
section of this report for more information about
the equity
attribution framework
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
112
Portfolio and position limits
UBS maintains a
comprehensive set of
risk limits across
its major
risk
portfolios.
These
portfolio
limits
are
set
based
on
our
risk
appetite
and
periodically
reviewed
and
adjusted
as
part
of
the
business planning process.
Firm-wide
stress and
statistical metrics
are
complemented by
more granular
portfolio and
position limits,
triggers and
targets.
Combining
these
measures
provides
a
comprehensive
control
framework
to
apply
to
our
business
divisions,
as
well
as
the
significant legal
entities, as
relevant to
the key
risks arising
from
their businesses.
We apply
limits to
a variety
of exposures
at portfolio
level, using
statistical
and
stress-based
measures,
such
as
value-at-risk,
liquidity-adjusted stress, loan underwriting limits, economic value
sensitivity and portfolio default simulations for loan books. These
are complemented
with a set
of controls for
net interest income
sensitivity, mark-to-market
losses on
available-for-sale portfolios,
and
the
effect
of
foreign
exchange
movements
on
capital
and
capital ratios.
Portfolio
measures
are
supplemented
with
position-level
controls. Risk measures for position controls are based on market
risk
sensitivities
and
counterparty-level
credit
risk
exposures.
Market risk sensitivities include sensitivities to
changes in general
market
risk
factors
(e.g.,
equity
indices,
foreign
exchange
rates
and interest rates)
and sensitivities to
issuer-specific factors (e.g.,
changes in
an issuer’s
credit spread
or default
risk). We
monitor
numerous
market
and
treasury
risk
controls
on
a
daily
basis.
Counterparty measures
capture the
current and
potential future
exposure to an individual counterparty, considering collateral and
legally enforceable netting agreements.
›
Refer to “Credit risk” in this section for more information
about
counterparty limits
›
Refer to “Risk appetite framework” in this
section for more
information about the risk appetite
framework
Risk concentrations
Audited
|
Risk
concentrations
may
exist
where
one
or
several
positions within or
across different
risk categories could
result in
significant
losses relative
to UBS’s
financial
strength.
Identifying
such risk concentrations
and assessing their
potential impact is a
critical component of our risk management and control process.
For financial risks, we consider a number
of elements, such as
shared
characteristics
of
positions, the
size
of
the portfolio
and
the
sensitivity
of
positions
to
changes
in
the
underlying
risk
factors.
Also
important
in our
assessment
is the
liquidity of
the
markets where the positions are traded, as well as the availability
and
effectiveness
of
hedges
or
other
potential
risk-mitigating
factors. This includes an assessment of the provider of
the hedge
and market liquidity where the hedge might be traded. Particular
attention is given
to identification of
wrong-way risk and
risk on
risk. Wrong-way risk
is defined as
a positive correlation
between
the size of
the exposure and the
likelihood of a
loss. Risk on
risk
is when a position and
its risk mitigation can be impacted
by the
same event.
For non-financial risks, risk concentrations may result from,
for
example,
a single
operational
risk issue
that is
large on
its
own
(i.e., has
the potential
to produce
a single
high-impact loss
or a
number
of
losses
that
together are
high
impact)
or
related
risk
issues that may link together to create a high impact.
Risk concentrations
are subject
to increased
oversight by
Group
Risk Control
and Group
Compliance, Regulatory
& Governance,
and
assessed
to
determine
whether
they
should
be
reduced
or
mitigated,
depending
on
the
available
means
to
do
so.
It
is
possible
that
material
losses
could
occur
on
financial
or
non-
financial
risks,
particularly
if
the
correlations
that
emerge
in
a
stressed environment differ
markedly from those
envisaged by risk
models.
p
›
Refer to “Credit risk” and “Market risk” in this
section for more
information about the composition of our
portfolios
›
Refer to the “Risk factors” section of
this report for more
information
113
Credit risk
Key developments
In
Global
Wealth
Management
,
the
Lombard
and
mortgage
books showed
significant growth
primarily in
the Americas
over
the course of 2021,
while keeping a stable
risk profile with regard
to concentrations and with no material losses.
Across
the
firm,
our
lending
portfolios performed
well,
with
c
redit
loss
expenses
below
expectations
.
Nevertheless,
we
continue to
be exposed
to the development
of the global
economy
and
the
effects of
the
ongoing and
highly
uncertain COVID-19
pandemic.
We incurred a loss of USD 861 million in the
first half of 2021
on
the
default
of
a
US-based
client
of
our
prime
brokerage
business. We have conducted a thorough review and put in
place
appropriate
measures
to
strengthen
our
relevant
client
onboarding and
risk management
and control
processes. Across
the items
identified for
remediation and
beyond, we
have made
changes to our organization to drive wider improvements in both
first and
second lines
of defense.
Our prime
brokerage business
remains a strategic element of UBS’s offering.
Credit loss expense / release
Total
net
credit
loss
releases
were
USD 148
million
in
2021,
compared with net credit loss expenses of USD 694 million in the
prior
year,
reflecting
net
releases
of
USD 123
million
related
to
stage 1 and 2 positions
and net releases of
USD 25 million related
to credit-impaired (stage 3) positions.
Stage 1
and
2
net
credit
loss
releases
of
USD 123
million
in
2021 included a partial net
release of a post-model adjustment
of
USD 68
million,
due
to
the
continued
positive
trend
in
macroeconomic
scenario
input
data
during
the
year,
a
USD 45
million
net
release
from
a
number
of
model
and
methodology
changes,
a
residual
USD 10
million
net
release
from
remeasurements
within
the
loan
book,
and
derecognized
transactions, partially
offset by
expenses from
new transactions.
Stage 3 net
releases of USD 25
million were
recognized across a
number
of
defaulted
positions,
primarily
corporate
lending
positions in Personal & Corporate Banking.
›
Refer to “Note 1 Summary of material accounting
policies,”
“Note 9 Financial assets at amortized cost
and other positions in
scope of expected credit loss measurement” and “Note
20
Expected credit loss measurement”
in the “Consolidated
financial
statements”
section of this report for more information about
IFRS 9 and expected credit losses
Audited |
Main sources of credit risk
–
Global
Wealth
Management
predominant
ly
conduct
s
securities-based (Lombard) lending and mortgage lending.
–
A substantial portion of lending exposure arises from Personal
&
Corporate
Banking,
which
offers
mortgage
loans,
secured
mainly
by
residential
properties
and
income-producing
real
estate, as
well as
corporate loans,
and therefore
depends on
the performance of the Swiss economy.
–
The
Investment
Bank’s
credit
exposure
arises
mainly
from
lending,
derivatives
trading
and
securities
financing.
Derivatives
tra
ding
and
securities
financing
are
mainly
investment
grade.
Loan
underwriting
activity
can
be
lower
rated and give rise to temporary concentrated exposure.
–
Credit
risk
within
Non-core
and
Legacy
Portfolio
relates
to
derivative transactions and securitized positions.
p
Credit loss (expense) / release
USD million
Global
Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
Total
For the year ended 31.12.21
Stages 1 and 2
28
62
0
34
0
123
Stage 3
1
24
(1)
0
0
25
Total credit loss (expense) / release
29
86
(1)
34
0
148
For the year ended 31.12.20
Stages 1 and 2
(48)
(129)
0
(88)
0
(266)
Stage 3
(40)
(128)
(2)
(217)
(42)
(429)
Total credit loss (expense) / release
(88)
(257)
(2)
(305)
(42)
(694)
For the year ended 31.12.19
Stages 1 and 2
3
23
0
(4)
0
22
Stage 3
(23)
(44)
0
(26)
(7)
(100)
Total credit loss (expense) / release
(20)
(21)
0
(30)
(7)
(78)
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
114
Audited |
Overview of measurement, monitoring and
management techniques
–
Credit risk
from transactions
with individual
counterparties is
based on our estimates of probability
of default (PD), exposure
at
default
(EAD)
and
loss
given
default
(LGD).
Limits
are
established for individual counterparties and groups of related
counterparties covering banking and traded products,
and for
settlement amounts. Risk authorities are approved by the BoD
and
are
delegated
to
the
Group
CEO,
the
Group
CRO
and
divisional
CROs,
based
on
risk
exposure
amounts,
internal
credit rating and potential for losses.
–
Limits apply
not only
to the
current outstanding
amount but
also
to
contingent
commitments
and
the
potential
future
exposure of traded products.
–
The
Investment
Bank
monitoring,
measurement
and
limit
framework
distinguishes
between
exposures
intended
to
be
held to maturity (take-and-hold
exposures) and those intended
for distribution or risk transfer (temporary exposures).
–
We
use
models
to
derive
portfolio
credit
risk
measures
of
expected loss, statistical loss and stress
loss at Group-wide and
business division levels, and to establish portfolio limits.
–
Credit
risk
concentrations
can
arise
if
clients
are
engaged
in
similar
activities,
located
in
the
same
geographical
region
or
have comparable economic
characteristics, e.g., if
their ability
to meet contractual obligations would be
similarly affected by
changes
in
economic,
political
or
other
conditions.
To
avoid
credit
risk
concentrations,
we
establish
limits
/
operational
controls that constrain
risk concentrations
at portfolio and
sub-
portfolio
levels
for
sector
exposure,
country
risk
and
specific
product exposures.
p
Credit risk profile of the Group
The exposures detailed
in this
section are based
on management’s
view
of
credit
risk,
which
differs
in
certain
respects
from
the
expected credit loss (ECL) measurement requirements of IFRS.
Internally,
we
put
credit
risk
exposures
into
two
broad
categories:
banking
products
and
traded
products.
Banking
products
include
drawn
loans,
guarantees
and
loan
commitments,
amounts
due
from
banks
,
balances
at
central
banks
,
and
other
financial
assets
at
amortized
cost
.
Traded
products
include
over-the-counter
(OTC)
derivatives,
exchange-
traded
derivatives
(ETDs)
and
securities
financing
transactions
(
SFTs
)
,
consisting
of
securities
borrowing
and
lending
,
and
repurchase and reverse repurchase agreements.
Banking products
Breakdowns of banking products
exposures in the “Banking
and
traded
products
exposure
in
our
business
divisions
and
Group
Functions”
table
on
the
next
page
reflect
the
total
exposures
within
the
scope
of
ECL
requirements
and
are
gross
before
allowances and provisions for ECL and credit hedges. Guarantees
and
loan
commitments are
shown on
a notional
basis, without
applying credit conversion factors.
›
Refer to “Note 1 Summary of material accounting
policies” in the
“Consolidated financial statements” section
of this report for
more information about our accounting policy
for allowances
and provisions for ECL
›
Refer to “Note 9 Financial assets at amortized
cost and other
positions in scope of expected credit loss measurement”
and
“Note 20 Expected credit loss measurement” in the
“Consolidated financial statements” section
of this report for
more information about ECL measurement requirements
under IFRS
›
Refer to “Note 14a Other financial assets
measured at amortized
cost” in the “Consolidated financial
statements” section of this
report for more details
115
Banking and traded products exposure in our business divisions and Group Functions
31.12.21
USD million
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
Total
Banking products
1,2
Gross exposure
337,266
229,334
1,520
59,352
65,514
692,985
of which: loans and advances to customers (on-balance sheet)
228,598
152,847
0
13,720
3,445
398,611
of which: guarantees and loan commitments (off-balance sheet)
10,772
29,737
0
14,994
4,947
60,450
Traded products
2,3
Gross exposure
9,582
783
0
35,950
46,314
of which: over-the-counter derivatives
7,186
766
0
9,767
17,719
of which: securities financing transactions
0
0
0
18,566
18,566
of which: exchange-traded derivatives
2,396
17
0
7,617
10,030
Other credit lines, gross
4
12,947
24,174
0
3,629
28
40,778
Total credit-impaired exposure, gross (stage 3)
1
729
1,617
0
264
0
2,610
Total allowances and provisions for expected credit losses (stages 1 to 3)
264
709
0
188
4
1,165
of which: stage 1
89
126
0
64
4
282
of which: stage 2
41
146
0
34
0
220
of which: stage 3 (allowances and provisions for credit-impaired
exposures)
135
438
0
90
0
662
31.12.20
USD million
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
Total
Banking products
1,2
Gross exposure
300,368
227,139
3,374
56,237
52,199
639,317
of which: loans and advances to customers (on-balance sheet)
208,324
153,975
1
13,964
4,324
380,589
of which: guarantees and loan commitments (off-balance sheet)
10,153
28,814
0
15,936
3,550
58,453
Traded products
2,3
Gross exposure
9,919
1,201
0
40,215
51,335
of which: over-the-counter derivatives
6,946
1,182
0
11,236
19,364
of which: securities financing transactions
0
0
0
21,753
21,753
of which: exchange-traded derivatives
2,973
19
0
7,227
10,218
Other credit lines, gross
4
12,201
24,950
0
2,952
31
40,134
Total credit-impaired exposure, gross (stage 3)
1
1,324
1,997
0
450
7
3,778
Total allowances and provisions for expected credit losses (stages 1 to 3)
318
842
1
298
10
1,468
of which: stage 1
103
130
0
70
3
306
of which: stage 2
54
216
0
63
0
333
of which: stage 3 (allowances and provisions for credit-impaired
exposures)
160
497
1
165
6
829
1 ECL gross exposure including other financial
assets at amortized cost, but excluding cash,
receivables from securities financing transactions,
cash collateral receivables on derivative
instruments, financial assets at
FVOCI, irrevocable committed prolongation
of existing loans and
unconditionally revocable committed credit lines
and forward starting reverse repurchase
and securities borrowing agreements.
2 Internal management
view of credit risk,
which differs in certain
respects from IFRS.
3 As counterparty
risk for traded
products is managed at
counterparty level, no
further split between exposures
in the Investment Bank
and Group
Functions is provided.
4 Unconditionally revocable committed credit lines.
Global Wealth Management
Gross
banking
products
exposure
within
Global
Wealth
Management increased to USD 337 billion from USD 300 billion.
Our
Global
Wealth
Management
loan
portfolio
is
mainly
secured
by
securities
(Lombard
loans)
and
by
residential
real
estate. Most Lombard loans were of high quality, with
93% rated
as
investment
grade
based
on
our
internal
ratings,
and
are
typically short term in nature, with an average loan-to-value (LTV)
of 46%.
Moreover, Lombard
loans can
be canceled
immediately
if the collateral quality deteriorates and
margin calls are not met.
In 2021, the Lombard book, including traded products, increased
approximately 10%,
while keeping
a stable
risk profile
with regard
to collateral concentrations
with no material
losses. The increase
was
mainly
driven
by
higher
loan
volumes
in
the
US
that
are
collateralized by highly liquid and
diversified securities. The share
of
non-standard Lombard
loans, for
example
with less
liquid or
concentrated
collateral,
was stable
at
approximately
4%
of
the
total Lombard book.
The mortgage book increased by approximately 8%, driven by
higher volumes of mortgage loans
in the US residential
real estate
portfolios (average LTV 51%).
Other
financings
and
non-standard
loans
represent
approximately 3%
of the
total banking
products exposures
and
are consolidated in a corporate and other portfolio
that increased
approximately
57%
in
2021,
mainly
driven
by
private
equity
subscription
facilities
in
the
US,
which
are
mostly
investment
grade rated.
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
116
Global Wealth Management and Personal & Corporate Banking loans and advances to customers, gross
1
Global Wealth Management
Personal & Corporate Banking
USD million
31.12.21
31.12.20
31.12.21
31.12.20
Secured by residential real estate
58,655
60,021
110,041
111,554
Secured by commercial / industrial real estate
3,338
3,273
18,878
19,623
Secured by cash
34,175
22,722
3,114
2,860
Secured by securities
115,901
104,652
2,214
2,003
Secured by guarantees and other collateral
14,138
15,605
7,435
6,942
Unsecured loans and advances to customers
2,391
2,051
11,166
10,994
Total loans and advances to customers, gross
228,598
208,324
152,847
153,975
Allowances
(168)
(190)
(574)
(676)
Total loans and advances to customers, net of allowances
228,431
208,134
152,273
153,299
1 Collateral arrangements generally incorporate
a range of collateral, including
cash, securities, real estate
and other collateral. UBS applies a
risk-based approach that generally prioritizes collateral
according to its
liquidity profile. In 2021, the collateral allocation was refined
to reflect additional cash collateral and custody accounts
that are also available as security for
certain on-balance sheet lending. This resulted in an
increase
in loans secured by cash, with an offsetting reduction in loans secured by residential real estate and loans secured by securities.
Personal
& Corporate
Banking
Gross
banking
products
exposure
(excluding
exposure
re-
allocated
from
Group
Treasury)
within
Personal
&
Corporate
Banking
was
largely
unchanged
in
our
reporting
currency
at
USD
18
6
billion
(CHF
170
billion)
,
compared
with
USD
187
billion
(CHF 165
billion).
Net
banking
products
exposure
was
USD
186
billion
(CHF
16
9
billion)
,
compared
with
USD
1
86
billion
(CHF
16
5
billion)
,
of
which
approximately
65
%
was
classified
as investment
grade,
unchanged
from
2020.
Around
50% of
the exposure
is categorized
in the
lowest
LGD bucket
,
i.e.,
0–25%,
similar
to
2020.
Personal
&
Corporate
Banking’s
gross
loan
portfolio
was
USD
15
3
billion
(CHF
13
9
billion)
compared
with
USD 154
billion
(CHF 136
billion)
in 2020.
This
portfolio
is predominantly
denominated
in Swiss
francs and
the
increase in
Swiss franc term
s
was more than offset
by the effect
of the US dollar appreciating
.
As of 31 December
2021, 93% of
this
portfolio
was
secured
by
collateral,
mainly
residential
and
commercial
property.
Of
the
total
unsecured
amount,
83%
related
to cash
flow-based
lending
to corporate
counterparties
and
4%
related
to
lending
to public
authorities.
Based
on our
internal ratings,
50% of the unsecured
loan portfolio
was rated
as investment
grade, compared
with 45% in
2020.
The improved macroeconomic
environment for most
industries
along with
the supporting
measures of
the Swiss
Government and
Cantons, such as
COVID-19 loans, short-time
work compensation
and
subsidies,
as
well
as
our
careful
risk
management,
led
to
numerous credit loss releases during 2021.
Our
Swiss
corporate
banking
products
portfolio,
which
was
USD 36
billion
(CHF 33
billion)
compared
with
USD 35
billion
(CHF 31 billion)
in 2020,
consists of
loans, guarantees
and loan
commitments to multi-national and domestic counterparties. The
small and
medium-sized entity
(SME) portfolio,
in particular,
is well
diversified across industries. However, such companies
are reliant
on
the
domestic
economy
and
the
economies
to
which
they
export, in particular the EU and
the US. In addition, the change
in
the EUR / CHF exchange rate is an important
risk factor for Swiss
corporate clients.
Our commodity trade finance portfolio focuses on energy and
base-metal trading
companies,
where the related
commodity price
risk
is
hedged
to
a
large
extent
by
the
commodity trader.
The
majority of
limits in
this business
are uncommitted, transactional
and
short-term
in
nature.
Our
portfolio
size
was
USD 8
billion
(CHF 7
billion)
as
of
31 December 2021,
compared with
USD 6
billion (CHF
5 billion) in
2020, with the
increase in
exposure mainly
driven by
the strong
appreciation
of commodity
prices in
2021.
Our exposure to
banks consists primarily
of contingent claims
and was USD 6 billion (CHF 5 billion), unchanged compared with
2020.
The
delinquency ratio
was 0.3%
for
the
corporate
portfolio,
compared with 0.4% at the end of 2020.
›
Refer to “Credit risk models” in this section
for more information
about loss given default, rating grades and
rating agency
mappings
Swiss mortgage loan portfolio
Our
Swiss
mortgage
loan
portfolio
secured
by
residential
and
commercial real estate in Switzerland
continues to be our largest
loan
portfolio.
These
mortgage
loans,
totaling
USD 167
billion
(CHF 152
billion),
mainly
originate
from
Personal
&
Corporate
Banking,
but
also
from
Global
Wealth
Management
Region
Switzerland. Of these mortgage
loans, USD 152 billion (CHF 138
billion)
related
to
residential
properties
that
the
borrower
was
either
occupying
or
renting
out,
with
full
recourse
to
the
borrower.
Of
this
USD 152
billion
(CHF 138
billion),
USD 110
billion
(CHF 100 billion)
is related
to properties
occupied by
the
borrower, with an average
LTV ratio of 52%,
compared with 54%
as of
31 December 2020.
The average
LTV
for newly
originated
loans for
this portfolio
was 64%,
compared with
67% in
2020.
The
remaining
USD
4
2
bi
llion
(CHF
38
billion)
of
the
Swiss
residential
mortgage
loan
portfolio
related
to
properties
rented
out by
the borrower
and the
average LTV
of that
portfolio was
52%, compared with 53%
as of 31 December 2020.
The average
LTV
for
newly
originated
Swiss
residential
mortgage
loans
for
properties rented out by
the borrower was 55%, compared
with
56% in 2020.
As
illustrated
in
the
“Swiss
mortgages:
distribution
of
net
exposure at default (EAD) across exposure segments and loan-to-
value (LTV) buckets” table
on the following
page, more than
99%
of
the
aggregate
amount
of
Swiss
residential
mortgage
loans
would continue to be covered by the real estate
collateral even if
the value
assigned to
that collateral were
to decrease 20%,
and
more than 98%
would remain covered
by the
real estate collateral
even if the
value assigned
to that
collateral were to
decrease 30%.
In this
table, the
amount of
each mortgage loan
is allocated
across
the LTV buckets to indicate the portion at
risk at the various value
levels shown; for example, a loan of 75 with an LTV ratio of 75%
(i.e., a collateral value of 100) would result in allocations of
30 in
the less-than-30%
LTV bucket, 20
in the
31–50% bucket,
10 in
the 51–60% bucket, 10 in
the 61–70% bucket and 5 in
the 71–
80% bucket.
117
Personal & Corporate Banking: distribution of banking products exposure across internal UBS ratings and loss given
default (LGD) buckets
1
USD million, except where indicated
31.12.21
31.12.20
LGD buckets
Weighted
average
LGD (%)
Weighted
average
LGD (%)
Internal UBS rating
2
Exposure
0–25%
26–50%
51–75%
76–100%
Exposure
Investment grade
121,520
68,547
41,738
9,347
1,889
27
121,386
26
Sub-investment grade
63,141
24,301
25,306
11,646
1,888
34
63,266
33
of which: 6−9
57,955
22,540
23,195
10,513
1,706
34
58,141
33
of which: 10−13
5,185
1,760
2,110
1,133
181
36
5,125
35
Defaulted / Credit-impaired
1,617
32
1,332
252
0
42
1,997
41
Total exposure before deduction of allowances and provisions
186,278
92,880
68,376
21,245
3,777
29
186,648
29
Less: allowances and provisions
(674)
(795)
Net banking products exposure
1
185,604
185,853
1 Excluding balances at central banks and Group Treasury
reallocations.
2 The ratings of the major credit rating agencies,
and their mapping to our internal rating scale, are shown in
the “Internal UBS rating scale
and mapping of external ratings” table in this section.
Personal & Corporate Banking: unsecured loans by industry sector
31.12.21
31.12.20
USD million
%
USD million
%
Construction
166
1.5
157
1.4
Financial institutions
2,786
25.0
2,553
23.2
Hotels and restaurants
119
1.1
133
1.2
Manufacturing
1,555
13.9
1,572
14.3
Private households
1,488
13.3
1,648
15.0
Public authorities
419
3.8
472
4.3
Real estate and rentals
574
5.1
498
4.5
Retail and wholesale
1,971
17.7
1,756
16.0
Services
1,908
17.1
1,896
17.3
Other
180
1.6
309
2.8
Exposure, gross
11,166
100.0
10,994
100.0
Swiss mortgages: distribution of net exposure at default (EAD) across exposure segments and loan-to-value (LTV)
buckets
USD billion, except where indicated
31.12.21
31.12.20
LTV buckets
Exposure segment
≤30%
31–50%
51–60%
61–70%
71–80%
81–100%
>100%
Total
Total
Residential mortgages
Net EAD
89.0
38.6
10.2
4.6
1.2
0.2
0.1
143.9
143.9
as a % of row total
62
27
7
3
1
0
0
Income-producing real estate
Net EAD
14.5
5.7
1.3
0.5
0.2
0.0
0.0
22.2
22.8
as a % of row total
65
25
6
2
1
0
0
Corporates
Net EAD
7.1
2.6
0.7
0.4
0.2
0.1
0.0
10.9
10.8
as a % of row total
65
23
6
3
1
1
0
Other segments
Net EAD
0.6
0.2
0.0
0.0
0.0
0.0
0.0
0.9
0.8
as a % of row total
68
20
5
3
2
2
0
Mortgage-covered exposure
Net EAD
111.2
47.0
12.2
5.5
1.5
0.3
0.1
177.9
178.3
as a % of total
63
26
7
3
1
0
0
Mortgage-covered exposure 31.12.20
Net EAD
108.8
47.3
13.0
6.4
2.0
0.5
0.2
178.3
as a % of total
61
27
7
4
1
0
0
100
Asset Management
Gross banking products exposure within Asset Management was
USD 1.5 billion as of 31
December 2021, compared with USD
3.4
billion
as
of
31 December
2020.
The
reduction
was
driven
by
lower allocated balances at central banks.
Investment Bank
The
Investment
Bank’s
lending
activities
are
largely
associated
with corporate
and non-bank
financial institutions.
The business
is broadly
diversified across industry
sectors, but concentrated
in
North America.
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
118
The
gross
banking
products
exposure
including
balances
at
central banks and
Group Treasury
reallocations was USD 59
billion
as
of
31 December
2021,
compared
with
USD 56
billion
as
of
31 December 2020.
Gross banking
products exposure
excluding
balances
at
central
banks
and
Group
Treasury
reallocations
decreased to USD 35 billion from
USD 37 billion, mostly driven by
decreases in irrevocable loan commitments.
Based on our internal
ratings,
53%
of
this
gro
ss
banking
products
exposure
was
classified
as
investment
grade.
The
vast
majority
of
the
gross
banking products exposure had an estimated LGD below 50%.
Our
loan
underwriting
business’s
overall
ability
to
distribute
risk
remained
sound.
Total
mandated
t
emporary
loan
underwriting exposure ended 2021 at USD 6.6
billion, compared
with
USD
4.
9
billion
at
the
end
of
the
prior
year
.
Loan
underwriting exposures are classified as held for trading,
with fair
values reflecting market conditions at the end of 2021.
›
Refer to “Credit risk models” in this section
for more information
about LGD, rating grades and rating
agency mappings
Investment Bank: distribution of banking products exposure across internal UBS ratings and loss given default (LGD)
buckets
1
USD million, except where indicated
31.12.21
31.12.20
LGD buckets
Weighted
average
LGD (%)
Weighted
average
LGD (%)
Internal UBS rating
2
Exposure
0–25%
26–50%
51–75%
76–100%
Exposure
Investment grade
18,302
6,486
7,673
3,069
1,073
36
19,303
36
Sub-investment grade
16,250
5,022
6,111
5,020
97
20
16,785
17
of which: 6−9
10,467
3,269
2,163
4,938
97
14
12,030
11
of which: 10−13
5,783
1,753
3,948
82
0
31
4,756
30
Defaulted / Credit-impaired
264
58
196
9
0
33
450
53
Banking products exposure
1
34,815
11,566
13,981
8,098
1,170
28
36,538
27
1 Excluding balances at central banks and Group Treasury
reallocations.
2 The ratings of the major credit rating agencies,
and their mapping to our internal rating scale, are shown in the “Internal
UBS rating scale
and mapping of external ratings” table in this section.
Investment Bank: banking products exposure by geographical region
1
31.12.21
31.12.20
USD million
%
USD million
%
Asia Pacific
5,154
14.8
7,216
19.7
Latin America
1,327
3.8
1,584
4.3
Middle East and Africa
212
0.6
428
1.2
North America
16,282
46.8
15,462
42.3
Switzerland
453
1.3
720
2.0
Rest of Europe
11,387
32.7
11,129
30.5
Exposure
1
34,815
100.0
36,538
100.0
1 Excluding balances at central banks and Group Treasury reallocations.
Investment Bank: banking products exposure by industry sector
1
31.12.21
31.12.20
USD million
%
USD million
%
Banks
4,908
14.1
5,846
16.0
Chemicals
645
1.9
876
2.4
Electricity, gas, water supply
359
1.0
448
1.2
Financial institutions, excluding banks
13,353
38.4
14,570
39.9
Manufacturing
1,692
4.9
1,681
4.6
Mining
1,024
2.9
1,558
4.3
Public authorities
619
1.8
1,273
3.5
Real estate and construction
1,581
4.5
1,421
3.9
Retail and wholesale
2,793
8.0
2,041
5.6
Technology and communications
3,736
10.7
3,443
9.4
Transport and storage
414
1.2
445
1.2
Other
3,691
10.6
2,937
8.0
Exposure
1
34,815
100.0
36,538
100.0
1 Excluding balances at central banks and
Group Treasury reallocations.
Clearing houses are now classified under Financial institutions,
excluding banks (31 December 2021: USD 1,196
million; 31 December 2020:
USD 1,440 million).
119
Group Functions
Gross banking products exposure
within Group Functions, which
arises primarily in connection with treasury activities,
increased by
USD 13 billion
to USD 66
billion from
balances at
central banks.
The
cash
inflow
was
generated
mainly
from
lower
funding
consumption
by
the
Investment
Bank,
shifts
within
the
high-
quality liquid asset (HQLA) portfolio from securities
into cash, and
net
new
issuances
of
long-term
debt
issued
measured
at
amortized cost.
›
Refer to “Balance sheet assets” in the “Capital,
liquidity and
funding, and balance sheet” section of
this report for more
information
›
Refer to the “Group Functions”
section of this report for
more information
Traded products
Audited
|
Counterparty
credit
risk
(CCR)
arising
from
traded
products, which include OTC
derivatives, ETD exposures
and SFTs,
originating
in
the
Investm
ent
Bank
,
Non
-
core
and
Legacy
Portfolio,
and Group
Treasury
,
is generally
managed on
a close-
out
basis.
This
takes
into
account
possible
effects
of
market
movements
on
the
exposure
and
any
associated
collateral
over
the time
it would
take to
close out
our positions. In
the Investment
Bank,
limits
are
applied
to
the
potential
future
exposure
per
counterparty,
with
the
size
of
the
limit
dependent
on
the
counterparty’s creditworthiness
(as determined
by Risk
Control).
Limit
frameworks
are
also
used
to
control
overall
exposure
to
specific classes or
categories of
collateral on a
portfolio level. Such
portfolio
limits
are
monitored
and
reported
to
senior
management.
Trading
in
OTC
derivatives
is
conducted
through
central
counterparties
(CCPs)
where
practicable.
Where
CCPs
are
not
used, we
have clearly
defined policies
and processes
for trading
on a bilateral
basis. Trading is
typically conducted under bilateral
International Swaps
and Derivatives
Association (ISDA)
or similar
master
netting
agreements,
which generally
allow for
close-out
and netting
of transactions
in case
of default,
subject to
applicable
law.
For
most
major
market
participant
counterparties,
we
use
two-way collateral
agreements under
which either
party can
be
required to
provide collateral
in the
form of
cash or
marketable
securities
when
the
exposure
exceeds
specified
levels.
This
collateral typically consists
of well-rated government
debt or other
collateral
permitted
by
applicable
regulations.
For
certain
counterparties, an
initial margin
is taken
to cover
some or
all of
the
calculated
close-out
exposure.
This
is
in
addition
to
the
variation
margin
taken
to
settle
changes
in
market
value
of
transactions. Regulations on margining
uncleared OTC derivatives
continue to evolve. These generally expand
the scope of bilateral
derivatives
activity
subject
to
margining.
They
will
also
result
in
greater amounts
of initial
margin received
from, and
posted to,
certain bilateral trading counterparties than had been required in
the past. These changes should result in lower close-out risk over
time.
p
In the tables on the following page, OTC
derivatives exposures
are generally
presented as
net positive
replacement values
after
the application of legally enforceable netting agreements and
the
deduction of cash
and marketable securities
held as collateral.
SFT
exposures
are
reported
taking
into
account
collateral
received,
and ETD exposures take into account collateral margin calls.
The
“Banking
and
traded
products exposure
in
our
business
divisions
and
Group
Functions”
table
in
this
section
provides
information on the split by divisions and products, and the tables
on the next page provide information about the OTC
derivatives,
SFT
and
ETD
exposures
of
the
Investment
Bank,
Non-core
and
Legacy Portfolio, and Group Treasury.
›
Refer to “Note 10
Derivative
instruments”
in the “Consolidated
financial
statements”
section of this report for more information
about OTC derivatives settled through central
counterparties
›
Refer to “Note 22
Offsetting
financial
assets
and financial
liabilities”
in the “Consolidated
financial
statements”
section of this report
for more information about the effect of netting
and collateral
arrangements on derivative exposures
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
120
Investment Bank, Non-core and Legacy Portfolio and Group Treasury:
traded products exposure
USD million
OTC derivatives
SFTs
ETDs
Total
Total
31.12.21
31.12.20
Total exposure, before deduction of credit valuation adjustments and hedges
9,767
18,566
7,617
35,950
40,215
Less: credit valuation adjustments and allowances
(34)
0
0
(34)
(54)
Less: credit protection bought (credit default swaps, notional)
(119)
0
0
(119)
(126)
Net exposure after credit valuation adjustments, allowances and hedges
9,615
18,566
7,617
35,797
40,035
Investment Bank, Non-core and Legacy Portfolio and Group Treasury:
distribution of net OTC derivatives and SFT
exposure across internal UBS ratings and loss given default (LGD) buckets
USD million, except where indicated
31.12.21
31.12.20
LGD buckets
Weighted
average
LGD (%)
Weighted
average
LGD (%)
Internal UBS rating
1
Exposure
0–25%
26–50%
51–75%
76–100%
Exposure
Net OTC derivatives exposure
Investment grade
9,297
272
7,770
704
552
47
10,436
49
Sub-investment grade
317
44
54
131
88
59
620
55
of which: 6−9
249
25
53
90
81
62
487
55
of which: 10−12
46
0
1
39
7
64
114
62
of which: 13 and defaulted
22
19
0
3
0
14
19
12
Total net OTC derivatives exposure, after credit valuation adjustments
and hedges
9,615
317
7,824
835
639
48
11,056
49
Net SFT exposure
Investment grade
17,937
159
15,655
1,812
310
40
21,155
40
Sub-investment grade
629
0
296
50
283
69
598
59
Total net SFT exposure
18,566
159
15,951
1,862
593
41
21,753
40
1 The ratings of the major credit rating agencies, and
their mapping to our internal rating scale, are shown in the “Internal UBS rating
scale and mapping of external ratings” table in this section.
Investment Bank, Non-core and Legacy Portfolio and Group Treasury:
net OTC derivatives and SFT exposure
by geographical region
Net OTC derivatives exposure
Net SFT exposure
31.12.21
31.12.20
31.12.21
31.12.20
USD million
%
USD million
%
USD million
%
USD million
%
Asia Pacific
1,586
16.5
2,139
19.3
5,380
29.0
5,123
23.6
Latin America
111
1.2
162
1.5
20
0.1
18
0.1
Middle East and Africa
112
1.2
263
2.4
360
1.9
939
4.3
North America
1,830
19.0
2,539
23.0
4,473
24.1
4,778
22.0
Switzerland
688
7.2
667
6.0
559
3.0
1,329
6.1
Rest of Europe
5,288
55.0
5,286
47.8
7,774
41.9
9,566
44.0
Exposure
9,615
100.0
11,056
100.0
18,566
100.0
21,753
100.0
Investment Bank, Non-core and Legacy Portfolio and Group Treasury:
net OTC derivatives and SFT exposure
by industry sector
Net OTC derivatives exposure
Net SFT exposure
31.12.21
31.12.20
31.12.21
31.12.20
USD million
%
USD million
%
USD million
%
USD million
%
Banks
1
986
10.3
1,877
17.0
1,654
8.9
1,653
7.6
Chemicals
14
0.1
10
0.1
0
0.0
0
0.0
Electricity, gas, water supply
103
1.1
127
1.2
0
0.0
0
0.0
Financial institutions, excluding banks
1
7,174
74.6
6,742
61.0
15,866
85.5
18,049
83.0
Manufacturing
50
0.5
68
0.6
0
0.0
0
0.0
Mining
51
0.5
12
0.1
0
0.0
0
0.0
Public authorities
810
8.4
1,339
12.1
926
5.0
2,050
9.4
Retail and wholesale
22
0.2
44
0.4
0
0.0
0
0.0
Transport, storage and communication
255
2.6
481
4.3
0
0.0
0
0.0
Other
150
1.6
356
3.2
120
0.6
1
0.0
Exposure
9,615
100.0
11,056
100.0
18,566
100.0
21,753
100.0
1 Clearing houses have been reclassified from Banks to Financial institutions, excluding banks.
Prior-period numbers have been restated accordingly
121
Credit risk mitigation
Audited |
We actively manage credit
risk in our portfolios by
taking
collateral against exposures and by utilizing credit hedging.
p
Lending secured by real estate
Audited |
We use
a scoring
model as
part of
a standardized
front-
to-back process
for credit
decisions on
originating or
modifying
Swiss mortgage
loans. The
model’s two
key factors
are
the LTV
ratio and an affordability calculation relative to gross income.
p
The
calculation
of
affordability
takes
into
account
interest
payments,
minimum
amortization
requirements,
potential
property maintenance costs and, for
rental properties, the level of
rental income. Interest
payments are estimated
using a predefined
framework, which
considers the
potential for
significant interest
rates increases over the
lifetime of the
loan. The interest
rate is set
at 5% per annum in the context of the current environment.
For
residential
properties
occupied
by
the
borrower,
the
maximum LTV for the
standard approval process is
80% and 60%
for holiday homes and luxury
real estate. For other properties,
the
maximum
LTV
allowed
within
the
standard
approval
process
ranges from 30% to 80%, depending on
the type and age of the
property, and the amount of renovation work needed.
Audited |
The value
we assign
to each
property is
based on
the
lowest
value
determined
from
model
-
derived
valuations,
the
purchase
price,
an asset
value for
income-producing
real estate
(IPRE),
and,
in
some
cases,
an
additional
external
valuation
for
owner-occupied residential properties (ORPs).
p
Two separate
models
provided
by
a
market-leading
external
vendor are used to
derive property valuations for
ORPs and IPRE.
We estimate the
current value of
an ORP using
a regression model
(a hedonic model) based on statistical comparison
against current
transaction
data.
We
derive
the
value
of
a
property
from
the
characteristics
of
the
real
estate
itself,
as
well
as
those
of
its
location.
In addition
to the
initial valuation,
values for
ORPs are
updated
quarterly
over
the
lifetime
of
the
loan
using
region-
specific real
estate price
indices. The
price indices
are sourced
from
an
external
vendor
and
subject
to
internal
validation
and
benchmarking.
We
use
these
valuations
quarterly
to
compute
indexed LTV
for all
ORPs. A
portfolio-specific monitoring
system
considers these
along with
other risk
measures (e.g.,
rating and
behavioral information)
to identify
higher-risk loans and
triggers
an assessment
and reappraisal
by client
advisors and
credit officers
as needed.
For IPRE, the capitalization rate
model is used to determine
the
property
valuation
by
discounting
estimated
sustainable
future
income
using
a
capitalization
rate
based
on
various
attributes.
These
attribu
tes
consider
regional
and
specific
property
characteristics,
such
as
market
and
location
data
(e.g.,
vacancy
rates),
benchmarks
(e.g.,
for
running
costs)
and
certain
other
standardized input
parameters (e.g.,
property condition).
Updated
information regarding rental income from
IPRE is requested from
the
client
at
least
once
every
three
years.
Our
portfolio-specific
monitoring system alerts
us to changes
in rental income
and other
risk
measures
(e.g.,
LTV,
rating,
behavioral
information),
and
triggers
an
assessment
and
reappraisal
by
client
advisors
and
credit officers as needed.
To take
market developments
into account
for these
models,
the
external
vendor
regularly
updates
the
parameters
and
/
or
refines
the
architecture
for
each
model.
Model
changes
and
parameter updates are subject to the same validation procedures
as our internally developed models.
Audited
|
We
similarly
apply
underwriting
guidelines
for
our
Global
Wealth
Management
Region
Americas
mortgage
loan
portfolio,
taking
into
account
loan
affordability
and
collateral
sufficiency.
LTV
standards
are
defined
for
the
various
mortgage
types,
such
as
residential
mortgages
or
investment
properties,
based on associated risk factors, such as property type, loan
size,
and
purpose.
The
maximum
LTV
allowed
within
the
standard
approval
process
ranges from
45
% to
80
%. In
addition
to
LTV,
other
credit
risk
metrics,
such
as
debt-to-income
ratios,
credit
scores
and
required
client
reserves,
are
also
part
of
our
underwriting guidelines.
A
risk
limit
framework
is
applied
to
the
Global
Wealth
Management
Region
Americas
mortgage
loan
portfolio.
Limits
are
set
to
govern
exposures
within
LTV
categories,
geographic
concentrations,
portfolio
growth
and
high-risk
mortgage
segments,
such as interest-only loans. These limits are
monitored
by a specialized
credit risk
monitoring team
and reported to
senior
management. Supplementing this limit framework is a real estate
lending policy
and procedures
framework, set
up to
govern real
estate
lending
activities.
Quality
assurance
and
quality
control
programs monitor
compliance with
mortgage underwriting
and
documentation requirements.
For
our
mortgage
loan
portfolio
in
the
Global
Wealth
Management regions of
EMEA and Asia
Pacific, we apply
global
underwriting
guidelines
with
regional
variations
to
allow
for
regulatory
and
market
differentials.
As
in
other
regions,
the
underwriting
guidelines
take
into
account
affordability
and
collateral sufficiency. Affordability is
assessed at a stressed
interest
rate using,
for residential
real estate,
the borrowers’
sustainable
income and declared liabilities,
and for commercial real estate the
quality and sustainability of rental
income. For interest-only loans,
a declared
and evidenced
repayment strategy
must be
in place.
The applicable LTV for each mortgage is based on the quality and
liquidity
of
the
property
and
assessed
against
valuations
from
bank-appointed
third-party
valuers.
Maximum
LTV
varies
from
30
% to
70
%, depending
on the
type and
location of
the property,
as
well
as
other
factors.
Collateral
sufficiency
is
often
further
supported by personal guarantees from the borrower. The overall
portfolio is centrally assessed against a
number of stress scenarios
to ensure that exposures
remain within predefined stress
limits.
p
›
Refer to “Swiss mortgage loan portfolio”
in this section for more
information about LTV in our Swiss mortgage portfolio
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
122
Lombard lending
Audited
|
Lombard
loans
are
secured
by
pledges
of
marketable
securities,
guarantees
and
other
forms
of
collateral.
Eligible
financial
securities
are
primarily
liquid
and
actively
traded
transferable
securities
(such
as
bonds
and
equities),
and
other
transferable securities,
such as approved
structured products
for
which
regular
prices are
available and
the issuer
of the
security
provides a market. To
a lesser degree, less
liquid collateral is also
used.
We derive
lending values
by applying
discounts (haircuts)
to the
pledged
collateral
’
s
market
value.
H
aircuts
for
ma
rketable
securities are calculated
to cover possible
change in value
over a
given close-out
period and
confidence level.
Less liquid
or more
volatile collateral will typically have larger haircuts.
We assess concentration and
correlation risks across collateral
posted
at
a
counterparty
level,
and
at
a
divisional
level
across
counterparties. We
also perform targeted Group-wide reviews of
concentration.
Concentration
of
collateral
in
single
securities,
issuers
or
issuer
groups,
industry
sectors,
countries,
regions
or
currencies may result
in higher risk and
reduced liquidity. In such
cases, the
lending value
of the
collateral, margin
call and
close-
out levels are adjusted accordingly.
p
Exposures and
collateral values
are
monitored daily,
with
the
aim
of
ensuring
that
the
credit
exposure
is
always
within
the
established
risk
tolerance.
A
shortfall
occurs
when
the
lending
value
drops
below
the
exposure;
if
it
exceeds
a
defined
trigger
level,
a
margin
call
is
initiated,
requiring
the
client
to
provide
additional collateral, reduce the
exposure or take other
action to
bring
exposure
in
line
with
the
agreed
lending
value
of
the
collateral.
If
a
shortfall
increases
and
exceeds
a
further
trigger
level, or the
shortfall is not
corrected within the
required period,
a close-out
is initiated,
through which
collateral is
liquidated, open
derivative positions are closed and guarantees are called.
We
conduct
stress
testing
of
collateralized
exposures
to
simulate
market
events
that
reduce
collateral
value,
increase
exposure
of
traded
products,
or
do
both.
For
certain
classes of
counterparties,
limits
on
such
calculated
stress
exposures
are
applied
and
controlled
at
a
counterparty
level.
Also,
portfolio
limits are applied across certain businesses or collateral types.
›
Refer to “Stress loss” in this section for more
information about
our stress testing
Credit hedging
Audited |
We use
single-name credit
default swaps
(CDSs),
credit-
index CDSs, bespoke protection and other instruments to
actively
manage
credit
risk
in
the
Investment
Bank
and
Non-core
and
Legacy Portfolio. The
aim is to reduce
concentrations of risk from
specific
counterparties,
sectors
or
portfolios
and,
for
CCR,
the
profit
or
loss
effect
arising
from
changes
in
credit
valuation
adjustments (CVAs).
We have
strict guidelines
with regard
to taking
credit hedges
into
account
for
credit
risk
mitigation
purposes.
For
example,
when
monitoring
exposures
against
counterparty
limits,
we
do
not
usually
apply
certain
credit
risk
mitigants
,
such
as
proxy
hedges (credit
protection on
a correlated
but different
name) or
credit
-
index
CDSs
,
to
reduce
counterparty
exposures
.
Buying
credit protection
also creates
credit exposure
with regard
to the
protection
provider.
We
monitor
and
limit
exposures
to
credit
protection providers, and also
monitor the effectiveness of
credit
hedges
as
part
of
our
overall
credit
exposures
to
the
relevant
counterparties.
Trading
with
such
counterparties
is
typically
collateralized.
For
credit
protection
purchased
to
hedge
the
lending portfolio,
this includes
monitoring mismatches
between
the maturity
of credit
protection purchased
and the
maturity of
the associated loan. Such mismatches result in basis risk and may
reduce the effectiveness of the credit
protection. Mismatches are
routinely
reported
to
credit
officers
and
mitigating
actions
are
taken when necessary.
p
›
Refer to “Note 10 Derivative instruments”
in the “Consolidated
financial statements”
section of this report for more information
Mitigation of settlement risk
To mitigate
settlement risk, we reduce actual settlement volumes
by
us
ing
multi
-
lateral
and
bilateral
agreements
with
counterparties, including payment netting.
Foreign exchange transactions are
our most significant source
of
settlement
risk.
We
are
a
member
of
Continuous
Linked
Settlement
(CLS), an
industry utility
that provides
a multi-lateral
framework
to
settle
transactions
on
a
delivery-versus-payment
basis,
th
us
reducing
foreign
exchange
-
related
settlement
risk
relative
to
the
volume
of
business.
However,
mitigation
of
settlement
risk
through
CLS
and
other
means
does
not
fully
eliminate
credit
risk
in
foreign
exchange
transactions
resulting
from
changes
in
exchange
rates
prior
to
settlement,
which
is
managed as
part of
our overall
credit
risk management
of OTC
derivatives.
Credit risk models
Basel III – A-IRB credit risk models
Audited |
We have
developed tools
and models
to estimate
future
credit losses that may be implicit in our current portfolio.
Exposures
to
individual
counterparties
are
measured
using
three
generally
accepted
parameters:
PD,
EAD
and
LGD.
For
a
given credit facility, the product of these three parameters results
in
the
expected
loss.
These
parameters
are
the
basis
for
the
majority of our internal measures of credit
risk, and key inputs for
regulatory capital calculation under
the advanced internal
ratings-
based
(A-IRB)
approach of
the Basel III
framework.
We also
use
models
to
derive
the
portfolio credit
risk
measures
of
expected
loss, statistical loss and stress loss.
p
The “Key features of our main credit risk
models” table on the
next page shows the number
and key features of the models
we
use to derive PD, LGD and
EAD for our main portfolios and asset
classes,
and is
followed
by
more detailed
explanations
of
these
models and parameters.
›
Refer to the 31 December 2021 Pillar 3
Report,
available under
“Pillar 3 disclosures” at
ubs.com/investors
,
for more information
about the regulatory capital calculation
under the advanced
internal ratings-based approach
123
Key features of our main credit risk models
Portfolio in scope
Asset class
Model
approach
Number of
main models
Main drivers
Number of
years of loss
data
1
Probability of
default
Sovereigns and central banks
Central governments and
central banks
Scorecard
1
Political, institutional and economic indicators
>10
Owner-occupied mortgages in
Switzerland and the US
Retail: residential
mortgages
Scorecard
2
Behavioral data, affordability relative to income,
property type, loan-to-value. Separate models for
mortgages in Switzerland and the US
27
Income-producing real estate
mortgages
Retail: residential
mortgages,
Corporates: specialized
lending
Scorecard
1
Loan-to-value, debt service coverage, financial data
(for large corporates only), behavioral data. Weights
of risk drivers differ between corporate and private
clients
27
Lombard lending
Retail: other
Merton type
1
Loan-to-value, historical asset returns, behavioral
data
15
Small and medium-sized
enterprises
Corporates: other lending
Scorecard
1
Financial data including balance sheet ratios and
profit and loss, behavioral data. Weights of risk
drivers differ depending on the corporate client sub-
segment
27
Credit cards in Switzerland
Retail: qualifying
revolving retail and other
retail,
Corporates: other lending
Scorecard
1
Client type and characteristics (revolver, transactor,
new client, dormant client), and behavioral data
14
Banks
Banks and securities
dealers
Scorecard
4
Financial data including balance sheet ratios and
profit and loss. Separate models for banks –
developed markets, banks – emerging markets,
broker-dealers and investment banks, and private
banks
14
Commodity traders
Corporates: specialized
lending
Scorecard
1
Financial data including balance sheet ratios and
profit and loss, as well as non-financial criteria
23
Aircraft financing
Corporates: other lending
Scorecard
1
Loan-to-value, AuM, strength of legal framework of
source of wealth, and behavioral factors
15
Large corporates
Corporates: other lending
Scorecard /
market data
3
Financial data including balance sheet ratios and
profit and loss, and market data. Separate rating
tools for corporates with publicly traded and highly
liquid stocks (market intelligence tool), private
corporates, and leveraged corporates
14
Other portfolios
Corporates: other
lending,
Public-sector entities and
multi-lateral development
banks
Scorecard /
pooled rating
approach /
rating
template
9
Financial data and/or historical portfolio performance
for pooled ratings. Separate models for hedge funds,
managed funds, insurance companies, commercial
real estate loans, debt REITs, mortgage originators,
public-sector entities and multi-lateral development
banks / supranationals
14
Loss given default
Owner-occupied mortgages in
Switzerland and the US
Retail: residential
mortgages
Statistical
model
2
Loan-to-value, time since last valuation. Separate
models for mortgages in Switzerland and the US
11
Income-producing real estate
mortgages
Retail: residential
mortgages, Corporates:
specialized lending
Statistical
model
1
Loan-to-value, time since last valuation, property
type, location indicator
11
Lombard lending
Retail: other
Statistical
model,
simulation
1
Historical observed loss rates
13
Small and medium-sized
enterprises
Corporates: other lending
Statistical
model
2
Separate models for mortgage and non-mortgage
LGDs. Mortgage models: loan-to-value, time since
last valuation, property type, location indicator. Non-
mortgage models: historical observed loss rates
11–17
Investment Bank – all
counterparties
Across the asset classes
Statistical
model
2
Counterparty and facility specific, including industry
segment, collateral, seniority, legal environment and
bankruptcy procedures. Specific model for sovereign
LGDs based on econometric modeling of past default
events using GDP per capita, government debt, and
other quantitative and qualitative factors such as the
share of multi-lateral debt service, the size of the
banking sector and institutional quality
5–10
Exposure at default
Banking products
Across the asset classes
Statistical
model
3
Separate models based on exposure type (committed
credit lines, revocable credit lines, contingent
products)
>10
Traded products
Across the asset classes
Statistical
model
2
Product-specific market drivers, e.g., interest rates.
Separate models for OTC derivatives, ETDs and SFTs
that generate the simulation of risk factors used for
the credit exposure measure
n/a
1 For sovereign and Investment Bank PD models, the length of internal portfolio history is
shown in “Number of years of loss data.”
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
124
Audited |
Internal UBS rating scale and mapping of external ratings
Internal UBS rating
1-year PD range in %
Description
Moody’s Investors
Service mapping
S&P mapping
Fitch mapping
0 and 1
0.00–0.02
Investment grade
Aaa
AAA
AAA
2
0.02–0.05
Aa1 to Aa3
AA+ to AA–
AA+ to AA–
3
0.05–0.12
A1 to A3
A+ to A–
A+ to A–
4
0.12–0.25
Baa1 to Baa2
BBB+ to BBB
BBB+ to BBB
5
0.25–0.50
Baa3
BBB–
BBB–
6
0.50–0.80
Sub-investment grade
Ba1
BB+
BB+
7
0.80–1.30
Ba2
BB
BB
8
1.30–2.10
Ba3
BB–
BB–
9
2.10–3.50
B1
B+
B+
10
3.50–6.00
B2
B
B
11
6.00–10.00
B3
B–
B–
12
10.00–17.00
Caa1 to Caa3
13
>17
Ca to C
CCC to C
CCC to C
Counterparty is in default
Default
Defaulted
D
D
p
Probability of default
PD
estimates
the
likelihood of
a
counterparty defaulting
on
its
contractual obligations over
the next
12
months. PD
ratings are
used for
credit risk measurement and
are an
important input for
determining
credit risk
approval authorities.
For calculating
RWA, a
three-basis-point
PD floor is
applied to banks,
corporates
and retail
exposures,
as required under the Basel
III framework.
We apply an
eight-basis-point
PD floor
for Swiss
owner-occupied
mortgages
and
a four-basis-point
PD floor for
Lombard loans.
PD
is
assessed
using
rating
tools
tailored
to
the
various
categories
of
counterparties.
Statistically
developed
scorecards,
based on key attributes
of the obligor, are
used to determine PD
for many
corporate clients
and loans
secured by
real estate.
Where
available, market data may also
be used to derive the
PD for large
corporate counterparties. For low-default portfolios, we take into
account available relevant external default data when developing
rating tools. For
Lombard loans,
our rating approach
uses Merton-
type historical
return-based model
simulations taking
into account
potential
changes in
securities collateral
value. These
categories
are also calibrated to our internal
credit rating scale (masterscale),
designed
to
ensure
a
consistent
assessment
of
default
probabilities
across
counterparties.
Our
masterscale
expresses
one-year default probabilities determined
using our various rating
tools by means of distinct classes, with each class incorporating a
range
of
default
probabilities.
Counterparties
move
between
rating classes as our assessment of their PD changes.
The ratings of major credit rating agencies, and their mapping
to
our
masterscale
and
internal
PD
bands,
are
shown
in
the
“Internal UBS rating scale and mapping of external ratings” table
above. For Moody’s
and S&P, the
mapping is based on
the long-
term average of one-year default
rates available from these rating
agencies, with Fitch ratings
being mapped to the equivalent
S&P
ratings. For each
external rating category,
the average default
rate
is compared
with our
internal PD
bands to
derive a
mapping to
our internal rating
scale. Our
internal rating of
a counterparty
may
thus diverge from
one or more
of the correlated
external ratings
shown in the
table. Observed defaults
by rating agencies
may vary
through economic
cycles, and
we do
not necessarily
expect the
actual number of defaults in
our equivalent rating band to
equal
the rating agencies’ average
in any given period.
We periodically
assess
the
long-term
average
default
rates
of
credit
rating
agencies’ ratings and
adjust their mapping to
our masterscale as
needed to reflect any material changes.
Exposure at default
EAD is
the amount
we expect
to be
owed by
a counterparty
at
the time
of possible
default. We
derive EAD
from current exposure
to the counterparty and possible future exposure development.
The EAD of
an on-balance
sheet loan
is its
notional amount.
For
off
-
balance
sheet
co
mmitments
that
are
not
drawn,
credit
conversion factors (CCFs) are used in order to obtain an expected
on
-
balance
sheet
amount.
Such
CCFs
are
based
on
historical
observations
.
To
comply
with
regulatory
guidance,
we
floor
individual observed CCF values at zero in the CCF model; i.e., we
assume
that the
drawn EAD
will be
no less
than the
drawn amount
one year prior
to default.
For traded products, we derive EAD
by modeling the range of
possible
exposure
outcomes
at various
points
in time
using scenario
and statistical techniques.
We assess the net amount that may be
owed to us or
that we may owe
to others, taking
into account
the
effect of market movements
over the potential time it would take
to
close
out
positions. For
ETDs,
calculation of
EAD
takes
into
account
collateral
margin
calls.
When
measuring
individual
counterparty
exposure
against
credit
limits,
we
consider
the
maximum likely exposure measured to a high level of confidence.
However, when aggregating exposures
to different counterparties
for
portfolio
risk
measurement
purposes,
we
use
the
expected
exposure to each counterparty
at a given time period (usually one
year) generated
by the same
model.
125
We
assess
exposures
where
there
is
a
material
correlation
between the factors driving the credit quality of the counterparty
and
those
driving
the
potential
future
value
of
our
traded
products
exposure
(wrong-way
risk),
and
we
have
established
specific controls to mitigate such risks.
Loss given default
LGD is
the magnitude
of the
likely loss
if there
is a
default. Our
LGD estimates, which consider downturn conditions, include loss
of principal,
interest and
other amounts (such
as workout
costs,
including
the
cost
of
carrying
an
impaired
position
during
the
workout
process)
less
recovered
amounts.
We
determine
LGD
based
on
the
likely
recovery
rate
of
claims
against
defaulted
counterparties, which
depends on
the type
of counterparty
and
any
credit
mitigation
due
to
collateral
or
guarantees.
Our
estimates
are
supported
by
internal
loss
data
and
external
information,
where
available.
If
we
hold
collateral,
such
as
marketable securities or a mortgage on a property, LTV
ratios are
typically
a
key
parameter
in
determining
LGD.
For
low-default
portfolios, where available,
we take into
account relevant external
default data in
the rating tool
development. In RWA
calculation,
a regulatory
LGD floor
of 10%
is applied
for exposures
secured
by residential properties. Additionally,
we apply a 25% LGD floor
for Lombard loans in Global Wealth Management outside Region
Americas
and
a
20%
LGD
floor
for
Lombard
loans
in
Global
Wealth Management Region Americas.
All other LGDs
are subject
to a 5% floor.
Expected loss
Credit
losses
are
an
inherent
cost
of
doing
business
and
the
occurrence and amount of
credit losses can be
erratic. We use the
concept of expected loss to quantify future credit losses that may
be implicit in
our current portfolio.
The expected loss for
a given
credit
facility
is
a
product
of
the
three
components
described
above,
i.e., PD, EAD
and LGD. We
aggregate the expected
loss for
individual counterparties
to derive
expected portfolio
credit losses.
Expected
loss
(EL)
for
regulatory
and
internal
risk
control
purposes
is
a
statistical
measure
used
to
estimate
the
average
annual costs we expect to experience
from positions that become
impaired.
EL
is
the
basis
for
quantifying
credit
risk
in
all
our
portfolios. We use a statistical
modeling approach to estimate
the
loss profile of each of our credit portfolios over a one-year period
to
a
specified
level
of
confidence.
The
mean
value
of
this
loss
distribution is the
expected loss. EL
provides an indication
of the
level of
risk in
our portfolio
and it
may change
over time.
Some
parameters have to be estimated on a conservative basis
in order
to
meet
the
regulatory
requirements
for
banks
applying
the
internal ratings-based approach to determine RWA.
IFRS 9 – ECL credit risk models
Comparison of Basel III EL and IFRS 9 ECL credit risk models
The IFRS 9 expected
credit loss (ECL) concept
has a number of
key
differences from our standard
credit risk models, both in the loss
estimation
process
and
the
r
esult
thereof.
Most
notably,
regulatory
Basel
III
EL
parameters
are
through
-
the
-
cycle
/
downturn
estimates,
which
might
include
a
margin
of
conservatism, while
IFRS 9 ECL parameters
are typically
point-in-
time, reflecting
current economic conditions
and future outlook.
The
table
on
the
next
page
summarizes
the
main
differences.
Stage 1
and
2
ECL
releases
in
2021
were
USD 123
million
and
respective
allowances
and
provisions
as
of
31 December
2021
were
USD
50
3
mi
llion
.
This
includes
ECL
allowances
and
provisions
of
USD
436
million
related
to
positions
under
the
Basel III advanced internal ratings-based approach. Basel III EL
for
non-defaulted positions increased
by USD 34 million to
USD 919
million.
›
Refer to “Note 1 Summary of material accounting
policies” in the
“Consolidated financial statements” section
of this report for
more information about our accounting policy
for allowances
and provisions for ECL including key definitions
relevant for the
ECL calculation under IFRS 9
Expected credit loss
ECL are defined as the difference between contractual cash
flows
and
those
UBS
expects
to
receive,
discounted
at
the
effective
interest rate (EIR). For
loan commitments and
other credit facilities
in
scope
of
ECL
requirements,
expected
cash
shortfalls
are
determined
by
considering
expected
future
drawdowns.
Rather
than focusing
on an
average through-the-cycle
expected annual
loss,
the
purpose
of
ECL
is
to
estimate
the
amount
of
losses
inherent
in
a
portfolio
based
on
current
conditions
and
future
outlook (a point-in-time
measure), whereby such a
forecast has to
include all
information available
without undue
cost and
effort,
and
address
multiple
scenarios
where
there
is
perceived
non-
linearity between changes
in economic conditions
and their effect
on
credit
losses.
From
a
credit
risk
modeling
perspective,
ECL
parameters
are
generally
derivations
of
the factors
assessed
for
regulatory Basel III EL.
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
126
The table below shows the main differences between the two expected loss measures.
Basel III EL (advanced internal
ratings-based approach)
IFRS 9 ECL
Scope
The Basel III advanced internal ratings-based
(A-IRB)
approach applies to most credit risk exposures. It includes
transactions measured at amortized cost, at fair value
through profit or loss and at fair value through OCI,
including loan commitments and financial guarantees.
The IFRS 9 ECL calculation mainly applies to financial
assets
measured at amortized cost and debt instruments
measured at fair
value through OCI, as well as loan commitments
and financial
guarantees not at fair value through profit or loss.
12-month versus
lifetime expected
loss
The Basel III A-IRB approach takes into account expected
losses resulting from expected default events occurring
within the next 12 months.
In the absence of a significant increase in credit risk
(SICR), a
maximum 12-month ECL is recognized to reflect lifetime
cash
shortfalls that will result if a default event occurs in
the 12 months
after the reporting date (or a shorter period if the
expected lifetime
is less). Once an SICR event has occurred, a lifetime
ECL is
recognized considering expected default events
over the life of the
transaction.
Exposure at default
(EAD)
EAD is the amount we expect a counterparty
to owe us at
the time of a possible default. For banking products,
EAD
equals book value as of the reporting date; for traded
products, such as securities financing transactions,
EAD is
modeled. EAD is expected to remain constant over
a 12-
month period. For loan commitments, a credit
conversion
factor is applied to model expected future drawdowns
over
the 12-month period, irrespective of the actual maturity
of a
particular transaction. The credit conversion factor includes
downturn adjustments.
EAD is generally calculated on the basis of the
cash flows that are
expected to be outstanding at the individual
points in time during
the life of the transaction, discounted to the reporting
date using
the effective interest rate. For loan commitments, a credit
conversion factor is applied to model expected
future drawdowns
over the life of the transaction without including
downturn
assumptions. In both cases, the time period
is capped at 12
months, unless an SICR has occurred.
Probability of
default
(PD)
PD estimates are determined on a through-the-cycle (TTC)
basis. They represent historical average PDs, taking into
account observed losses over a prolonged historical
period,
and therefore are less sensitive to movements in the
underlying economy.
PD estimates will be determined on a point-in-time
(PIT) basis,
based on current conditions and incorporating forecasts
for future
economic conditions at the reporting date.
Loss given default
(LGD)
LGD includes prudential adjustments, such
as downturn LGD
assumptions and floors. Similar to PD, LGD
is determined on
a TTC basis.
LGD should reflect the losses that are reasonably expected
and
prudential adjustments should therefore not be applied.
Similar to
PD, LGD is determined on the basis of a PIT
approach.
Use of scenarios
n / a
Multiple forward-looking scenarios have to be taken
into account
to determine a probability-weighted ECL.
Further key aspects of credit risk models
Stress loss
We complement our statistical modeling approach with scenario-
based
stress
loss
measures.
Stress
tests
are
run
regularly
to
monitor potential
effects of
extreme, but
nevertheless plausible,
events on
our portfolios, under
which key credit
risk parameters
are
assumed
to
deteriorate
substantially.
Where
we
consider
it
appropriate, we apply limits on this basis.
Stress scenarios
and methodologies
are tailored
to portfolios’
natures,
ranging
from
regionally
focused
to
global
systemic
events,
and
varying
in
time
horizon.
For
example,
for
our
loan
underwriting
portfolio,
we
apply
a
global
market
event
under
which,
simultaneously,
the
market
for
loan
syndication
freezes,
market
conditions
significantly
worsen,
and
credit
quality
deteriorates.
Similarly,
for
Lombard
lending
we
use
a
range
of
scenarios
representing
instantaneous
market
shocks
to
all
collateral
and
exposure
positions,
taking
into
consideration
liquidity and potential concentration.
The portfolio-specific stress
test for
our mortgage
lending business
in Switzerland
reflects a
multi-year
event,
and
the
overarching
stress
test
for
global
wholesale
and
CCR
exposure
to
corporations
uses
a
one-year
global stress event
and takes into
account exposure concentration
to single counterparties.
›
Refer to “Stress testing” in this section for
more information
about our stress testing framework
127
Credit risk model confirmation
Our approach
to model
confirmation involves
both quantitative
methods,
e.g.,
monitoring
compositional
changes
in
portfolios
and results
of backtesting,
and qualitative
assessments, such
as
feedback from users on model output as a practical
indicator of a
model’s performance and reliability.
Material changes
in portfolio
composition may
invalidate the
conceptual soundness of a
model. We therefore perform
regular
analyses
of the evolution of portfolios to identify such changes in
the structure
and credit
quality of
portfolios. This
includes analyses
of changes
in key
attributes, changes
in portfolio
concentration
measures and changes in RWA.
›
Refer to “Risk measurement” in this section
for more
information about our approach to model confirmation
procedures
Backtesting
We
monitor
the
performance
of
models
by
backtesting
and
benchmarking them, with
model outcomes compared with
actual
results, based on our internal experience
and externally observed
results. To
assess the predictive power
of credit exposure models
for traded
products,
such as
OTC derivatives
and ETD
products,
we statistically compare predicted future
exposure distributions at
different forecast horizons with realized values.
For
PD,
we
use
statistical
modeling
to
derive
a
predicted
distribution of
the number
of defaults.
The observed
number of
defaults
is
compared
with
this
distribution,
letting
us
derive
a
statistical level of confidence in the
model conservatism. We
also
derive a lower and upper limit for the average
default rate. If the
portfolio average
PD lies
outside the
derived interval,
the rating
tool is, as a general rule, recalibrated.
For
LGD,
backtesting
statistically
tests
whether
the
mean
difference between the observed
and predicted LGD is
zero. If the
test fails,
there is
evidence that
our predicted
LGD is
too low.
In
such cases, and where these differences
are outside expectations,
models are recalibrated.
Main credit risk models backtesting by regulatory asset class
Length of time series
used for the calibration
(in years)
Actual rates in %
Estimated average rates
at the start of
2021 in %
Average of last
5 years
1
Min. of last
5 years
2
Max. of last
5 years
2
Probability of default
3
Central governments and central banks
>10
4
0.00
0.00
0.00
0.22
Banks and securities dealers
>10
0.13
0.00
0.53
0.69
Public-sector entities, multi-lateral development banks
>10
0.04
0.00
0.21
0.21
Corporates: specialized lending
>10
0.36
0.14
0.60
1.24
Corporates: other lending
>10
0.27
0.20
0.33
0.46
Retail: residential mortgages
>20
0.22
0.16
0.28
0.54
Retail: other
>10
0.02
0.00
0.10
0.25
Loss given default
Central governments and central banks
>10
42.49
Banks and securities dealers
>10
48.69
Public-sector entities, multi-lateral development banks
>10
24.55
Corporates: specialized lending
>10
0.19
0.00
0.92
22.77
Corporates: other lending
>10
18.12
0.46
27.00
38.28
Retail: residential mortgages
>20
0.58
0.00
0.92
21.34
Retail: other
>10
1.77
0.00
17.90
26.64
Credit conversion factors
Corporates
>10
21.06
6.93
37.91
38.72
1 Average of
all observations
over the last
five years.
2 Minimum /
maximum annual average
of observations
in any single
year from the
last five years.
Yearly averages
are only calculated
where five or
more
observations occurred during that year.
3 Average PD estimation is based on all
rated clients in the portfolio.
4 Sovereign PD model is calibrated to UBS
masterscale, length of time series shows
span of internal
history for this portfolio.
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
128
CCFs,
used
for
the
calculation
of
EAD
for
undrawn
facilities
with
corporate
counterparties,
are
dependent
on
several
credit
facility
contractual
dimensions.
We
compare
the
predicted
amount
drawn with
observed historical
use
of
such facilities
by
defaulted counterparties. If any statistically significant deviation
is
observed, the relevant CCFs are redefined.
The “Main
credit risk
models backtesting
by regulatory
asset
class”
table
on
the
previous
page
compares
the
current
model
calibration for PD,
LGD and CCFs
with historical observed
values
over the last five years.
Changes to models and model parameters during the period
As
part
of
our
continuous
efforts
to
enhance
models
to
reflect
market
developm
ents
and
newly
available
data
,
w
e
updat
ed
several models in 2021.
In Personal & Corporate Banking, we introduced a new model
for credit card exposures, new rating models for the
public-sector
entities portfolio and a
new LGD and
CCF model for
the industrial
goods leasing portfolio.
In Global Wealth
Management, a new
model was introduced
for the aircraft financing portfolio.
F
or
the
income
-
producing
real
estate
mortgages
,
w
e
recalibrated the
risk parameters
and for mortgages
in Switzerland,
we updated the LGD model.
In
the
Investment
Bank,
a
new
LGD
model
for
leveraged
finance
was
introduced
and
the
multi-nationals
and
financials
LGD was recalibrated.
In
Group
Functions,
we
extended
the
use
of
internal
Group
models to the
sovereign portfolio of
the Group Liquidity
Reserve
(GLR). Additionally, further
exposures in GLR (e.g.,
covered bonds)
have been moved to the standardized approach.
For CCR models, we recalibrated
the market parameters in the
SFT model. The
transition from LIBOR
required a number
of model
changes
for
CCR
models,
for
traded
products
to
be
able
to
consume the new alternative reference rate curves.
Where
required,
changes
to
models
and
model
parameters
were approved by FINMA before being made.
›
Refer to “Risk-weighted assets” in the “Capital,
liquidity and
funding, and balance sheet” section of
this report for more
information about the effect of the changes
to models and
model parameters on credit risk RWA
Future credit risk-related regulatory capital developments
In December 2017, the Basel Committee
on Banking Supervision
(the BCBS) announced the finalization of the Basel III
framework,
with an
implementation date
of 1 January
2023. We
expect the
Swiss
regulations
to
come
into
force
in
2024.
The
updated
framework makes
a number
of revisions
to the
internal ratings-
based (IRB) approaches, namely:
(i) removing the option of
using
the A-IRB
approach for
certain asset
classes (including
large and
medium-sized
corporate
clients,
and
banks
and
other
financial
institutions); (ii) placing floors
on certain model
inputs under the
IRB
approach,
e.g.,
PD
and
LGD;
and
(iii) introducing
various
requirements to reduce RWA variability (e.g.,
for LGD).
The published
framework has a
number of
requirements that
are
subject
to
national
discretion.
Also,
revisions
to
the
credit
valuation adjustment (CVA) framework were published, including
the
removal
of
the
advanced
CVA
approach.
UBS
has
a
close
dialogue
with
FINMA
to
discuss
in
detail
the
implementation
objectives
and
prepare
for
a
smooth
transition
of
the
capital
regime for credit risk.
›
Refer to “Capital management objectives,
planning and
activities” in the “Capital, liquidity and
funding, and balance
sheet” section of this report for more information about
the
development of RWA
›
Refer to “Risk measurement” in this section
for more
information about our approach to model confirmation
procedures
›
Refer to the “Regulatory and legal developments”
and “Risk
factors” sections of this report for more information
Credit policies for distressed assets
The “Exposure categorization”
chart on the
next page shows
how
we
categorize
banking
products
and
securities
financing
transactions as
non-performing, defaulted
/ credit
-impaired
and
purchased or originated credit-impaired.
Non-performing
Audited |
In line with the regulatory definition, we report a claim as
non-performing when: (i) it is more than
90 days past due; (ii) it
is
subject
to
restructuring
proceedings,
where
preferential
conditions
concerning
interest
rates,
subordination,
tenor,
etc.
have been
granted in order
to avoid default
of the
counterparty
(forbearance);
(iii) the
counterparty
is
subject
to
bankruptcy
/
enforced
liquidation
proceedings
in
any
form,
even
if
there
is
sufficient collateral to cover
the due payment;
or (iv) there is
other
evidence that
payment obligations
will not
be fully
met without
recourse to collateral.
129
Default and credit-impaired
UBS uses
a single
definition of
default for
classifying assets
and
determining the PD of
its obligors for
risk modeling purposes. The
definition
of
default
is
based
on
quantitative
and
qualitative
criteria.
A
counterparty
is
classified
as
defaulted
when
material
payments of interest, principal or fees are overdue
for more than
90 days, or
more than 180
days for certain exposures
in relation
to loans to
private and commercial
clients in Personal
& Corporate
Banking
and
to
private
clients
of
Global
Wealth
Management
Region
Switzerland.
UBS
does
not
consider
the
general
90-day
presumption
for
default
recognition
appropriate
for
those
portfolios,
given the cure rates, which
show that strict application
of the
90-day criterion
would not accurately
reflect the
inherent
credit
risk. Counterparties
are also
classified as
defaulted when:
bankruptcy,
insolvency proceedings
or enforced
liquidation have
commenced;
obligations have
been restructured
on preferential
terms
(forbearance);
or
there
is
other
evidence
that
payment
obligations will not
be fully
met without
recourse to collateral.
The
latter may
be the
case even
if, to date,
all contractual
payments
have been made when due. If one claim against a counterparty
is
defaulted
on,
generally
all
claims
against
the
counterparty
are
treated as defaulted.
An
instrument
is
classified
as
credit
-
impaired
if
the
counterparty is
classified as
defaulted and
/ or
the instrument
is
identified as
purchased or
originated credit-impaired
(POCI). An
instrument is POCI if it has been purchased at a deep discount to
its
carrying
amount
following
a
risk
event
of
the
issuer
or
originated with a defaulted counterparty. Once
a financial asset is
classified
as
defaulted
/
credit-impaired
(except
POCI),
it
is
reported as
a stage 3
instrument and
remains as
such unless
all
past due amounts have
been rectified, additional payments
have
been
made
on
time,
the
position
is
not
classified
as
credit-
restructured, and
there is
general evidence
of credit
recovery. A
three-month probation period is applied before
a transfer back to
stages 1 or 2
can be triggered.
However, most instruments
remain
in stage 3 for a longer
period. As of 31 December 2021,
we had
no instruments classified as POCI on our books.
p
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
130
Forbearance (credit restructuring)
Audited
|
If
payment
default
is
imminent
or
default
has
already
occurred,
we
may
grant
concessions
to
borrowers
in
financial
difficulties
that we
would otherwise
not consider
in the
normal
course
of
business,
such
as
offering
preferential
interest
rates,
extending maturity, modifying the schedule of
repayments, debt /
equity
swap,
subordination,
etc.
When
a
forbearance
measure
takes place, each case is considered individually and the exposure
is
generally
classified
as
defaulted.
Forbearance
classification
remains
until
the
loan
is
repaid
or
written
off,
non-preferential
conditions are granted that
supersede the preferential conditions,
or the counterparty has recovered and the preferential conditions
no longer exceed our risk tolerance.
Contractual
adjustments
when
there
is
no
evidence
of
imminent
payment
default,
or
where
changes
to
terms
and
conditions are within our usual risk
tolerance, are not considered
to be forborne.
p
Loss history statistics
An instrument
is classified
as credit-impaired
if the
counterparty
has
defaulted.
This
also
includes
credit-impaired
exposures
for
which no
loss has
occurred or
for which
no allowance
has been
recognized
(for example
because we
expect to
fully recover
the
exposures via collateral held).
The
“Loss
history
statistics”
table
below
provides
a
five-year
history of credit
loss experience for
loans and advances
to banks
and customers, and ratios of those credit losses relative to
credit-
impaired and
non-performing loans
and advances
to banks
and
customers.
For
2017,
the
amounts
are
based
on
IAS 37
and
IAS 39; for 2018 and onward, the amounts are based on IFRS 9.
›
The majority of the credit-impaired exposure relates to
loans
and advances in our Swiss domestic business.
Refer to “Note 9
Financial assets at amortized cost and other
positions in scope of
expected credit loss measurement” and “Note 20
Expected credit
loss measurement” in the “Consolidated financial
statements”
section of this report for more information about
ECL
measurement
›
Refer to “Note 14a Other financial assets
measured at amortized
cost” in the “Consolidated financial
statements” section of this
report for more details
Loss history statistics
USD million, except where indicated
31.12.21
IFRS 9
31.12.20
IFRS 9
31.12.19
IFRS 9
31.12.18
IFRS 9
31.12.17
IAS 37, IAS 39
Loans and advances to banks and customers (gross)
414,099
396,049
340,003
338,000
342,604
Credit-impaired loans and advances to banks and customers
2,150
2,945
2,309
2,300
1,104
Non-performing loans and advances to banks and customers
2,387
3,176
2,466
2,419
2,149
ECL allowances and provisions for credit losses
1,2
1,165
1,468
1,029
1,054
712
of which: allowances for loans and advances to banks and customers
1
857
1,076
770
780
678
Write-offs
137
356
142
210
101
of which: write-offs for loans and advances to banks and customers
118
348
122
192
101
Credit loss (expense) / release
3
148
(694)
(78)
(118)
(131)
Ratios
Credit-impaired loans and advances to banks and customers as
a percentage of loans and advances to banks
and customers (gross)
0.5
0.7
0.7
0.7
0.3
Non-performing loans and advances to banks and customers as
a percentage of loans and advances to banks
and customers (gross)
0.6
0.8
0.7
0.7
0.6
ECL allowances for loans and advances to banks and customers as a percentage
of loans and advances to
banks and customers (gross)
0.2
0.3
0.2
0.2
0.2
Write-offs as a percentage of average loans and advances to banks
and customers (gross) outstanding during
the period
0.0
0.1
0.0
0.1
0.0
1 Includes collective loan loss
allowances for 31 December
2017. Until 31 December
2017 did not include allowances
for other receivables (USD
19 million).
2 Includes provisions for ECL
of guarantees and loan
commitments and allowances
for securities
financing transactions.
3 Includes credit
loss (expense) /
release for other
financial assets at
amortized cost,
guarantees, loan
commitments, and
securities financing
transactions.
131
Market risk
Key developments
Market
risk remained
at low
levels as
a
result
of
our continued
focus on managing
tail risks. Average
management value-at-risk
(VaR)
(1-day, 95%
confidence level) decreased to USD 11
million
from USD 13 million in 2020, mainly as a result of
the Investment
Bank’s
equities
trading
business.
The
number
of
negative
backtesting
exceptions
within
a
250-business-day
window
increased to
4 from
3 by
the end
of 2021.
As these
backtesting
exceptions
remained
below
5,
the
FINMA
VaR
multiplier
for
market risk RWA remained unchanged
at 3.0 as of 31 December
2021.
Audited |
Main sources of market risk
Market
risks
arise
from
both
trading
and
non-trading
business
activities.
–
Trading
market
risks
are mainly
connected
with
primary
debt and
equity underwriting
and
securities and
derivatives trading
for
market-making
and client
facilitation
in our Investment
Bank, as
well as
the remaining
positions
in Non-core
and Legacy
Portfolio
in Group
Functions
and our
municipal
securities
trading
business
in Global Wealth
Management.
–
Non-trading
market
risks
arise
predominantly
in
the
form
of
interest
rate
and
foreign
exchange
risks
connect
ed
with
personal
banking
and
lending
in
our
wealth
management
business, our Swiss
personal and corporate
banking business,
the Investment Bank’s lending business,
and treasury activities.
–
Group
Treasury
assumes
market
risks
in
the
process
of
managing
interest
rate
risk,
structural
foreign
exchange
risk
and the Group’s liquidity and funding profile, including HQLA.
–
Equity and debt investments can also give rise to market
risks,
as
can
some
aspects
of
employee
benefits,
such
as
defined
benefit pension schemes.
p
Audited |
Overview of measurement, monitoring and
management techniques
–
Market risk limits are set for the Group, the business divisions,
Group Treasury and Non-core and Legacy Portfolio at granular
levels
in
the
various business
lines,
reflecting
the nature
and
magnitude of the market risks.
–
Management VaR
measures exposures
under the
market risk
framework,
including
trading
market
risks
and
some
non-
trading market risks. Non-trading
market risks not included
in
VaR
are
also
covered
in
the
risks
controlled
by
Market
&
Treasury Risk Control, as set out below.
–
Our
primary
portfolio
measures
of
market
risk
are
liquidity-
adjusted
stress
(LAS)
loss
and
VaR.
Both
are
common
to
all
business divisions and
subject to
limits that
are approved
by the
Board of Directors (the BoD).
–
These
measures
are
complemented
by
concentration
and
granular limits for general and specific market
risk factors. Our
trading
businesses
are
subject
to
multiple
market
risk
limits,
which
take
into
account
the
extent
of
market
liquidity
and
volatility,
available
operational
capacity,
valuation
uncertainty
and, for our single-name exposures, issuer credit quality.
–
Trading
market
risks
are
managed
on
an
integrated
basis
at
portfolio
level. As
risk factor
sensitivities change
due to
new
transactions, transaction
expiries or
changes in
market levels,
risk factors
are dynamically
rehedged to
remain within
limits.
Thus
we
do
not
generally
seek
to
distinguish
in
the
trading
portfolio between specific positions and associated hedges.
–
Issuer
risk
is
controlled
by
limits
applied
at
business
division
level
based
on
jump-to-zero
measures,
which
estimate
maximum
default
exposure
(the
default
event
loss
assuming
zero recovery).
–
Non-trading foreign exchange
risks are
managed under
market
risk limits, with the exception
of Group Treasury management
of consolidated capital activity.
Our Market &
Treasury Risk Control
function applies a
holistic
risk
framework,
set
ting
the
appetite
for
treasury
-
related
risk
-
taking
activities
across
the
Group.
A
key
element
of
the
framework is
an overarching
economic value sensitivity
limit, set
by the
BoD. Th
is limit
is linked
to
the
level
of Basel III
common
equity
tier 1
(CET1)
capital,
and takes
into account
risks arising
from interest rates,
foreign exchange and
credit spreads. Also,
the
sensitivity
of
net
interest
income
to
changes
in
interest
rates
is
monitored against targets set by the Group CEO, so as
to analyze
the outlook and volatility
of net interest income
based on market-
expected interest rates. Limits
are also set by
the BoD to balance
the effect
of foreign
exchange movements
on our
CET1
capital
and
CET1
capital
ratio.
Non-trading
interest
rate
and
foreign
exchange
risks
are
included
in
Group-wide
statistical
and
stress
testing metrics, which flow into our risk appetite framework.
Equity
and
debt
investments
are
subject
to
a
range
of
risk
controls,
including
preapproval of
new
investments
by
business
management
and
Risk
Control
and
regular
monitoring
and
reporting.
They
are
also
included
in
Group-wide
statistical
and
stress testing metrics.
p
›
Refer to “Currency management” in the “Capital,
liquidity and
funding, and balance sheet” section of
this report for more
information about Group Treasury’s management of foreign
exchange risks
›
Refer to the “Capital, liquidity and funding,
and balance sheet”
section of this report for more information about
the sensitivity
of our CET1 capital and CET1 capital ratio
to currency
movements
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
132
Market risk stress loss
We measure and
manage market risks through
a comprehensive
framework of non
-statistical measures and
related limits,
as well
as VaR. This
includes an extensive set of
stress tests and scenario
analyses,
continuously
evaluated
to
ensure
that
losses
resulting
from
an
extreme
yet
plausible
event
do
not
exceed
our
risk
appetite.
Liquidity-adjusted stress
LAS is our
primary stress loss
measure for Group-wide
market risk.
The LAS framework captures
the economic losses that could arise
under specified stress scenarios. This is partially done
by replacing
the standard 1-day and
10-day holding period assumptions used
for
management
and
regulatory
VaR
with
liquidity-adjusted
holding
periods,
as
explained
below.
Shocks
are
applied
to
positions based
on expected
market movements
in the
liquidity-
adjusted holding periods resulting from the specified scenario.
The holding
periods used
for LAS are
calibrated to reflect
the
time needed to
reduce or
hedge the
risk of
positions in
each major
risk
factor
in
a
stressed
environment,
assuming
maximum
utilization
of
the
relevant
position
limits.
We
apply
minimum
holding
periods,
regardless
of
observed
liquidity
levels,
as
identification
of
and
reaction
to
a
crisis
may
not
always
be
immediate.
The expected
market movements
are
derived using
historical
market
behavior
(
based
on
analysis
of
historical
events
)
and
forward
-
looking
analysis
includ
ing
consideration
of
defined
scenarios that have not occurred in the past.
LAS
-
based
limits
appl
y
at
several
levels:
Group,
business
division,
Group
Treasury
and
Non-core
and
Legacy
Portfolio;
business area; and
sub-portfolio. LAS is also
the core market risk
component of our combined stress test framework and therefore
integral to our overall risk appetite framework.
›
Refer to “Risk appetite framework” in this
section for more
information
›
Refer to “Stress testing” in this section for
more information
about our stress testing framework
Value-at-risk
VaR definition
Audited |
VaR is a statistical
measure of market
risk, representing the
potential
market
risk
losses
over
a
set
time
horizon
(holding
period)
at
an
established
level
of
confidence.
VaR
assumes
no
change in the
Group’s trading positions over
the set time
horizon.
We
calculate
VaR
daily.
The
profit
or
loss
distribution
VaR
is
derived from our
internally developed
VaR model, which
simulates
returns over the
holding period for
those risk factors
our trading
positions are sensitive to, and subsequently quantifies the profit /
loss effect
of these
risk factor
returns on
trading positions.
Risk
factor
returns
associated
with
general
interest
rate,
foreign
exchange and commodities risk
factor classes are based on
a pure
historical
simulation
approach,
us
ing
a
five
-
year
look
-
back
window. Risk factor returns
for selected issuer-based risk factors,
e.g., equity price and credit
spreads, are split into systematic and
residual
issuer-specific
components
using
a
factor
model
approach. Systematic
returns are
based on
historical simulation,
and
residual
returns
on
a
Monte
Carlo
simulation.
VaR
model
profit
or
loss distribution
is derived
from
the
sum of
systematic
and residual
returns in
such a
way that
we consistently
capture
systematic and
residual risk.
Correlations among
risk factors
are
implicitly
captured
via
a
historical
simulation
approach.
When
modeling
risk
factor
returns
we
consider
the
stationarity
properties
of
the
historical
time
series
of
risk
factor
changes.
Depending on the stationarity properties of
the risk factors within
a given
factor class,
we model
the factor
returns using
absolute
returns or logarithmic returns.
Risk factor return distributions
are
updated fortnightly.
Our VaR
model does
not
have full
revaluation
capability, but
we source full revaluation grids
and sensitivities from front-office
systems, enabling us
to capture material
non-linear profit or
loss
effects.
We
use
a
single
VaR
model
for
both
internal
management
purposes
and
determining
market
risk
R
WA,
although
we
consider
different
confidence
levels
and
time
horizons.
For
internal
management
purposes,
we
establish
risk
limits
and
measure exposures
using VaR
at a
95
% confidence
level with
a
1-day
holding
period, aligned
to
the
way we
consider
the risks
associated with
our trading
activities. The
regulatory measure of
market risk used to
underpin the market risk
capital requirement
under Basel III requires
a measure equivalent
to a
99
% confidence
level using a 10-day holding
period. To calculate a 10-day
holding
period
VaR,
we
use
10
-
day
risk
factor
returns,
with
all
observations equally weighted.
Additionally,
the
portfolio
population
for
management
and
regulatory
VaR
is
slightly
different.
The
one
for
regulatory
VaR
meets
regulatory
requirements
for
inclusion
in
regulatory
VaR.
Management
VaR
includes
a
broader
range
of
positions.
For
example,
regulatory
VaR
excludes
credit
spread
risks
from
the
securitization
portfolio,
which
are
treated
instead
under
the
securitization approach for regulatory purposes.
133
We also use
stressed VaR (SVaR)
for the calculation
of market
risk RWA. SVaR uses broadly the
same methodology as regulatory
VaR and is
calculated using the
same population, holding
period
(10-day) and
confidence level
(
99
%). Unlike
regulatory VaR,
the
historical
data
set
for
SVaR
is
not
limited
to
five
years,
instead
covering from 1 January
2007 to the
present. In deriving
SVaR, we
seek the largest 10-day holding period VaR for the current Group
portfolio across
all
one-year look-back
windows from
1 January
2007 to the present. SVaR is computed weekly.
p
›
Refer to the 31 December 2021 Pillar 3
Report, available under
“Pillar 3 disclosures” at
ubs.com/investors
, for more information
about the regulatory capital calculation
under the advanced
internal ratings-based approach
Management VaR for the period
The tables below show
minimum, maximum, average and
period-
end management VaR
by business division and Group
Functions,
and
by
general
market
risk
type.
We
continued
to
maintain
management VaR
at low
levels, with
average VaR
decreasing to
USD 11 million from USD 13 million in 2020.
Audited |
Management value-at-risk (1-day, 95% confidence, 5 years of historical data) of our business divisions and Group
Functions by general market risk type
1
For the year ended 31.12.21
USD million
Equity
Interest
rates
Credit
spreads
Foreign
exchange
Commodities
Min.
1
7
5
1
2
Max.
35
13
11
9
5
Average
7
9
7
3
3
31.12.21
8
11
7
6
3
Total management VaR, Group
4
36
11
12
Average (per business division and risk type)
Global Wealth Management
1
3
1
2
0
1
2
0
0
Personal & Corporate Banking
0
0
0
0
0
0
0
0
0
Asset Management
0
0
0
0
0
0
0
0
0
Investment Bank
3
36
11
11
7
9
7
3
3
Group Functions
4
8
5
4
0
4
4
1
0
Diversification effect
2,3
(
6
)
(
5
)
0
(
5
)
(
5
)
(
1
)
0
For the year ended 31.12.20
USD million
Equity
Interest
rates
Credit
spreads
Foreign
exchange
Commodities
Min.
3
6
5
2
2
Max.
29
11
11
7
6
Average
10
8
7
4
4
31.12.20
6
8
8
3
3
Total management VaR, Group
8
31
13
11
Average (per business division and risk type)
Global Wealth Management
0
2
1
1
0
1
1
0
0
Personal & Corporate Banking
0
0
0
0
0
0
0
0
0
Asset Management
0
0
0
0
0
0
0
0
0
Investment Bank
7
32
12
10
10
7
6
4
4
Group Functions
4
7
5
6
0
4
3
1
0
Diversification effect
2,3
(
5
)
(
8
)
0
(
4
)
(
4
)
(
1
)
0
1 Statistics at individual levels may not be
summed to deduce the corresponding aggregate
figures. The minima
and maxima for each level may well occur
on different days, and likewise,
the VaR for each
business
line or risk type, being driven by the extreme loss tail of the corresponding distribution of simulated profits and
losses for that business line or risk type, may well be driven by different days in the
historical time series,
rendering invalid the simple summation of figures to arrive at the aggregate total.
2 Difference between the sum of the standalone VaR for the business divisions and Group Functions and the VaR for the Group as
a whole.
3 As the minima and maxima for different business divisions and Group Functions occur on different days, it is not meaningful
to calculate a portfolio diversification effect.
p
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
134
VaR limitations
Audited |
Actual realized
market risk
losses may
differ
from
those
implied by VaR for a variety of reasons.
–
VaR is calibrated to
a specified level of
confidence and may
not
indicate potential losses beyond this confidence level.
–
The 1-day time horizon used for VaR for internal management
purposes
(10-day
for
regulatory
VaR)
may
not
fully
capture
market risk
of positions
that cannot
be closed
out or
hedged
within the specified period.
–
In
some
cases,
VaR
calculations
approximate
the
effect
of
changes in
risk factors
on the
values of
positions and
portfolios.
This may happen due to the number of risk factors included in
the VaR model needing to be limited.
–
Effects
of extreme
market movements
are subject to
estimation
errors, which
may result
from non-linear risk
sensitivities, and
the potential for actual volatility and correlation levels to differ
from assumptions implicit in VaR calculations.
–
Using a
five-year window
means sudden
increases in
market
volatility will tend
not to increase VaR
as quickly as the
use of
shorter
historical observation
periods, but
such increases
will
affect VaR
for a longer
period of
time. Similarly,
after periods
of increased volatility, as markets stabilize,
VaR predictions will
remain
more conservative
for a
period of
time influenced
by
the length of the historical observation period.
SVaR is subject to the limitations noted for VaR above, but the
use of one-year data sets avoids the smoothing effect of the five-
year
data
set
used
for
VaR
and
the
absence
of
the
five-year
window gives a longer history of potential loss events. Therefore,
although
the significant
period of
stress
during
the
2007–2009
financial
crisis
is
no
longer
contained
in
the
historical
five-year
period used for management and regulatory
VaR, SVaR continues
to use
that data.
This approach aims
to reduce
the procyclicality
of the regulatory capital requirements for market risks.
We recognize
that no
single measure
can encompass
all risks
associated
with
a
position
or
portfolio.
Thus
we
use
a
set
of
metrics with both overlapping and complementary characteristics
to
create
a
holistic
framework
that
aims
to
ensure
material
completeness
of
risk
identification
and
measurement.
As
a
statistical aggregate risk measure, VaR supplements
our liquidity-
adjusted stress and comprehensive stress testing frameworks.
We also
have a
framework to
identify and
quantify potential
risks not
fully captured by
our VaR model
and refer to
such risks
as risks not in VaR.
The framework underpins these potential risks
with regulatory capital, calculated as a multiple of regulatory VaR
and stressed VaR.
p
Backtesting of VaR
VaR backtesting is a performance measurement process
in which
a 1-day VaR prediction is compared with the realized 1-day profit
or
loss
(P&L)
.
We
compute
backtesting
VaR
using
a
99%
confidence level and 1-day holding period for the regulatory
VaR
population. Since
99% VaR
at UBS
is defined
as a
risk measure
that
operates
on
the
lower
tail
of
the
P&L
distribution,
99%
backtesting
VaR
is
a
negative
number.
Backtesting
revenues
exclude
non-trading
revenues,
such
as
valuation
reserves,
fees
and commissions, and revenues from intraday trading, to provide
for
a
like-for-like
comparison.
A
backtesting
exception
occurs
when
backtesting
revenues
are
lower
than
the
previous
day’s
backtesting VaR.
135
Statistically, given the
99% confidence level,
2 or 3
backtesting
exceptions a year can be expected. More than 4 exceptions could
indicate
that the
VaR model
is not
performing appropriately,
as
could too few
exceptions over a
long period. However,
as noted
for
VaR
limitations
above,
a
sudden
increase
(or
decrease)
in
market volatility
relative to
the five-year
window could lead
to a
higher
(or
lower)
number
of
exceptions.
Therefore,
Group-level
backtesting
exceptions
are
investigated,
as
are
exceptional
positive backtesting revenues, with
the results reported to
senior
business
management,
the
Group
CRO
and
the
Group
Chief
Market & Treasury Risk Officer.
Internal and external auditors and
relevant regulators are also informed of backtesting exceptions.
The “Group: development
of regulatory backtesting
revenues
and actual trading
revenues against
backtesting VaR” chart
on the
previous page
shows the
12-month development
of backtesting
VaR against the Group’s backtesting
revenues and actual trading
revenues for
2021. The
chart shows
both the
99% and
the 1%
backtesting
VaR.
The
asymmetry
between
the
negative
and
positive tails is due to the long gamma risk profile historically
run
in the Investment Bank.
The actual
trading revenues
include backtesting
and intraday
revenues.
The number of
negative backtesting exceptions
within a 250-
business-day window increased
to 4
from 3
by the
end of the
year.
As
these
backtesting
exceptions
remained
below
5,
the
FINMA
VaR multiplier for market
risk RWA remained unchanged
at 3.0 as
of 31 December 2021.
VaR model confirmation
As well
as for
regulatory-purposes backtesting
described above,
we conduct extended
backtesting for internal
model confirmation
purposes. This includes
observing model performance
across the
entire
P&L
distribution
(not just
the tails),
and at
multiple levels
within the business division hierarchies.
›
Refer to “Risk measurement” in this section
for more
information about our approach to model confirmation
procedures
VaR model developments in 2021
Audited
|
There
were
no
material
changes
to
the
VaR
model
in 2021.
p
Future market risk-related regulatory capital developments
In
January
2019,
the
Basel
Committee
on
Banking
Supervision
(the BCBS) published the final
standards on the minimum capital
requirements
for
market
risk
(the
Fundamental
Review
of
the
Trading
Book).
We
do
not
expect
these
standards
to
become
mandatory
in
Switzerland
until
after
the
BCBS
target
effective
date of 1 July 2024.
Key
elements
of
the
revised
market
risk
framework
include:
(i) changes
to
the
internal
model-based
approach,
including
changes
to
the
model approval
and
performance
measurement
process; (ii) changes to
the standardized approach
with the aim
of
it being
a credible
fallback method
for an
internal model-based
approach; and (iii) a revised boundary between trading book and
banking
book.
UBS
maintains
a
close
dialogue
with
FINMA
to
discuss
the
implementation
objectives
in
more
detail
and
to
provide a smooth transition of the capital regime for market risk.
In
September
2021
FINMA
mandated
UBS
to
hold
an
RWA
add-on for
the omission
of time
decay in
regulatory VaR
and SVaR.
The
add-on
reflects
the
outcome
of
discussions
with
FINMA
regarding our regulatory
VaR model,
which started in
late 2019.
The
integration
of
time
decay
into
the
regulatory
VaR
model,
which would replace the add-on, is subject to
further discussions
between FINMA and UBS.
›
Refer to “Risk-weighted assets” in the “Capital,
liquidity and
funding, and balance sheet” section of
this report for more
information about the development
of RWA including the
regulatory add-on
›
Refer to “Risk measurement” in this section
for more
information about our approach to model confirmation
procedures
›
Refer to the “Regulatory and legal developments”
and “Risk
factors” sections of this report for more information
Interest rate risk in the banking book
Interest rate risk in the banking book disclosure
Our financial reports’
interest rate risk
in the
banking book (IRRBB)
disclosure
is
aligned
to
the
Pillar 3
requirements
set
by
FINMA
Circular “2019/2 Interest Rate
Risk – Banks,”
which sets minimum
standards
for measuring,
managing,
monitoring and
controlling
IRRBB. In particular, the economic value of equity (EVE) sensitivity
is assessed under the six
regulatory rate-shock scenarios set in
the
FINMA
circular,
which
are
currency-specific
and
not
subject
to
flooring.
Sources of interest rate risk in the banking book
Audited |
IRRBB arises
from
balance sheet
positions such
as
Loans
and
advances
to
banks
,
Loans
and
advances
to
customers
,
Financial assets at
fair value not held
for trading
,
Financial assets
measured
at
amortized
cost
,
Customer
deposits
,
Debt
issued
measured
at
amortized
cost
,
and
derivatives,
including
those
subject to
hedge accounting. Fair
value changes to
these positions
may
affect
other
comprehensive
income
(OCI)
or
the
income
statement, depending on their accounting treatment.
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
136
Our
largest
banking
book
interest
rate
exposures
arise
from
customer
deposits
and
lending
products
in
Global
Wealth
Management
and
Personal
&
Corporate
Banking.
The
inherent
interest
rate
risks
are
generally
transferred
from
Global
Wealth
Management
and
Personal
&
Corporate
Banking
to
Group
Treasury,
to
manage
them
centrally. This
enables
the netting
of
interest
rate
risks
across
different
sources,
while
leaving
the
originating
businesses
with
commercial
margin
and
volume
management. The residual interest
rate risk is mainly
hedged with
interest rate swaps, to the vast majority of which we apply hedge
accounting.
Short-term
exposures
and
high-quality
liquid
assets
classified as
Financial assets at
fair value not
held for trading
are
hedged with derivatives
accounted for on
a mark-to-market basis.
Long-term
fixed-rate
debt
issued
is
hedged
with
interest
rate
swaps designated in fair value hedge accounting relationships.
Risk management and governance
IRRBB
is
measured
using
several
metrics,
the
most
relevant
of
which are the following.
–
Interest
rate
sensitivities
to
changes
in
yield
curves
are
calculated as changes in the present value of
future cash flows
irrespective of
accounting treatment.
These are
also the
key risk
factors for statistical and stress-based measures, e.g., value-at-
risk
and
stress
scenarios
(including
EVE
sensitivity),
and
are
measured
and
reported
daily.
EVE
sensitivity
is
the
exposure
arising from the most adverse regulatory interest rate scenario
after
netting
across
currencies.
As
well
as
the
regulatory
measure,
we
appl
y
an
internal
EVE
sensitivity
me
tric
that
includes
additional
tier 1
(AT1)
capital
instruments
and
modeled
interest
rate
duration
assigned
to
equity,
goodwill
and real estate.
–
Net interest
income (NII) sensitivity
assesses NII
change over a
set
time
horizon
compared
with
baseline
NII,
wh
ich
we
internally calculate by
assuming interest rates
in all currencies
develop according
to their
market-implied forward
rates and
assum
ing
constant
business
volumes
and
no
specific
management actions.
This internally
calculated
NII sensitivity,
which,
unlike
the
FINMA
Pillar 3
disclosure
requirements,
includes
the
contribution
from cash
held
at
central
banks, is
measured and reported monthly.
We actively
manage IRRBB,
aiming to
reduce the
volatility of
NII, while keeping the EVE
sensitivity within set internal risk
limits.
EVE and
NII sensitivity
are monitored
against limits
and triggers,
at consolidated and
significant legal entity
levels. We also
assess
the sensitivity of EVE and NII under stressed market conditions by
applying a suite
of parallel
and non-parallel interest
rate scenarios,
as well as specific economic scenarios.
The Group
Asset and
Liability Committee
(ALCO) and,
where
relevant,
ALCOs
at
a
legal
entity
level
perform
independent
oversight over the management of IRRBB,
which is also subject to
Group Internal Audit and model governance.
›
Refer to “Group Internal Audit” in the “Corporate
governance”
section of this report and to “Risk measurement”
in this section
for more information
Key modeling assumptions
The cash flows
from customer deposits
and lending products
used
in calculation
of EVE
sensitivity exclude
commercial margins
and
other spread
components, are
aggregated by
daily time
buckets
and are
discounted using
risk-free
rates. Our
external issuances
are
discounted
using
UBS’s
senior
debt
curve,
and
capital
instruments are modeled
to the
first call date.
NII sensitivity, which
includes commercial
margins, is
calculated over
a one-year
time
horizon, assuming constant balance sheet structure and volumes,
and
considers
the
flooring
effect
of
embedded
interest
rate
options.
The average
repricing maturity
of non-maturing
deposits and
loans is determined via
replication portfolio strategies designed
to
protect
product
margin.
Optimal
replicating
portfolios
are
determined
at
granular
currency-
and
product-specific
levels
by
simulating
and
applying
a
real-world
market
rate
model
to
historically calibrated client rate and volume models.
We
use
an
econometric
prepayment
model
to
forecast
prepayment
rates on
US mortgage
loans
in UBS
Bank USA
and
agency
mortgage-backed
securities
(MBSs)
held
in
various
liquidity
portfolios
of
UBS
Americas
Holding
LLC
consolidated.
These prepayment rates are used to forecast both mortgage loan
and MBS
balances under
various macroeconomic
scenarios. The
prepayment model is used for
a variety of purposes, including
risk
management and regulatory
stress testing. Swiss
mortgages and
fixed-term deposits generally do not carry similar
optionality, due
to prepayment and early redemption penalties.
p
137
Effect of interest rate changes on shareholders’ equity and
CET1 capital
The “Accounting and
capital effect
of changes in
interest rates”
table below shows
the effects on
shareholders’ equity and
CET1
capital of
gains and
losses from
changes in
interest rates
in the
main banking
book positions.
For instruments held
at fair
value,
changes in interest rates result
in an immediate fair value gain or
loss, recognized
either in
the income statement
or through
OCI.
Typically,
increases
in
interest
rates
would
lead
to
immediate
reductions
in the value of our long-term
assets held at fair value,
but
we
would
expect
such
reductions
to
be
offset
over
time
through higher NII on core banking products.
For assets and
liabilities measured at
amortized cost, changes
in interest
rates do
not result
in changes
in the
carrying amount
of
the
instruments,
but
could
affect
the
amount
of
interest
income or expense
recognized over time
in the income
statement.
In
addition
to
the
differing
accounting
treatments,
banking
book
positions
have
different
sensitivities
to
different
points on
yield
curves.
For example,
portfolios of
debt securities,
whether
measured
at
amortized
cost
or
at
fair
value,
and
interest
rate
swaps, whether designated as cash flow hedges
or transacted as
economic
hedges,
are
generally
more
sensitive
to
changes
in
longer-duration interest rates, whereas deposits and
a significant
portion
of loans
contributing
to NII
are more
sensitive to
short-
term rates.
These factors
are important,
as yield
curves may
not
shift on
a parallel
basis and
could, for
example, exhibit
an initial
steepening followed by a flattening over time.
Due to
the accounting
treatment and
yield curve
sensitivities
outlined above, in a rising rate scenario we would expect to have
an initial decrease in shareholders’ equity,
as a result of fair value
losses recognized
in OCI.
This would
be compensated
over time
by increased
NII, as
increases in
interest rates
affect the
shorter
end
of
the
yield
curve
in
particular.
The
effect
on
CET1
capital
would
be less
pronounced, as
gains
and
losses
on
interest
rate
swaps
designated
as
cash
flow
hedges
are
not
recognized
for
regulatory
capital
purposes.
Fair
value
losses
on
instruments
designated at fair value should be offset by economic hedges.
Accounting and capital effect of changes in interest rates
1
Recognition
Shareholders’ equity
CET1 capital
Timing
Income statement / OCI
Gains
Losses
Gains
Losses
Loans and deposits at amortized cost
2,3
Gradual
Income statement
l
l
l
l
Other financial assets and liabilities measured at amortized
cost
2
Gradual
Income statement
l
l
l
l
Debt issued measured at amortized cost
2,3
Gradual
Income statement
l
l
l
l
Receivables and payables from securities financing transactions
2
Gradual
Income statement
l
l
l
l
Financial assets at fair value not held for trading
Immediate
Income statement
l
l
l
l
Financial assets at fair value through other comprehensive income
Immediate
OCI
l
l
l
Derivatives designated as cash flow hedges
Immediate
OCI
4
l
l
Derivatives designated as fair value hedges
5
Immediate
Income statement
l
l
l
l
Derivatives transacted as economic hedges
Immediate
Income statement
l
l
l
l
1 Refer to the “Reconciliation of IFRS equity to Swiss SRB
common equity tier 1 capital” table in the “Capital, liquidity and
funding, and balance sheet” section of this report for more information about the
differences
between shareholders’ equity and CET1 capital.
2 For fixed-rate financial
instruments, changes in interest rates
affect the income statement when these instruments
roll over and reprice.
3 For hedge accounted
items, a fair value adjustment is applied in line with the treatment of the hedging derivatives.
4 Excluding hedge ineffectiveness that is recognized in the income statement in accordance with IFRS.
5 The fair value
of the derivatives is offset by the fair value adjustment of the
hedged items. Under the fair value hedge program applied to cross-currency swaps and foreign currency debt, the foreign
currency basis spread is excluded
from the hedge designation and accounted for through OCI, which is included in CET1.
Net interest income sensitivity
The NII sensitivity of Global
Wealth Management and Personal &
Corporate
Banking
is
assessed
using
a
number
of
scenarios
assuming
parallel
and
non-parallel
shifts
in
yield
curves,
with
various
degrees
of
severity.
The
results
are
compared
with
a
baseline
NII,
calculated
assuming
that
interest
rates
in
all
currencies
develop
according
to
their
market-implied
forward
rates and under
the assumption
of constant business
volumes and
no specific management actions.
In
addition
to
the
above
scenario
analysis,
we
monitor
NII
sensitivity to
immediate parallel
shocks of
–200 and
+200 basis
points
against the
defined
thresholds,
under
the assumption
of
constant balance sheet volume and structure.
As of 31 December 2021, the projected NII was approximately
14% lower
than the
baseline NII
under a
parallel shock
of –200
basis points,
whereas under
a parallel
+200-basis-point shock
it
was approximately 57% higher than the baseline NII.
To shelter our
NII level from
the persistently low
and negative
interest rate environment, in particular in Swiss francs, we rely on
self-funding our
lending businesses
through our
deposit base
in
Global Wealth Management
and Personal &
Corporate Banking,
along
with
appropriate
additional
adjustments
to
our
interest
rate-linked
product
pricing. The
loss of
such equilibrium
on the
balance sheet, for example
due to unattractive pricing relative
to
peers
for
either
mortgages
or
deposits,
could
lead
to
our
NII
decreasing
in
a
persistently
low
and
negative
interest
rate
environment.
As
we
assume
constant
business
volumes,
these
risks do not appear in the aforementioned interest rate scenarios.
Moreover,
should
the
low
and
negative
interest
rate
environment
worsen,
our
NII
could
come
under
additional
pressure and we could face additional costs for holding our Swiss
franc
HQLA portfolio.
A reduction
of
the Swiss
National
Bank’s
deposit exemption threshold for banks would also reduce
our NII,
as
we
might
not
be
able
to
offset
higher
costs
for
our
cash
holdings,
for
example
by
passing
on
some
of
the
costs
to
our
depositors.
Should
euro
interest
rates
also
decline
further,
that
could likewise increase liquidity costs and put NII
generated from
euro-denominated loans and deposits under
pressure. Depending
on the overall economic
and market environment, sustained and
significant
negative
rates
could
also
lead
to
Global
Wealth
Management
and
Personal
&
Corporate
Banking
clients
paying
down their loans, along
with reducing any excess
cash they hold
with us
as deposits.
That would
reduce the
underlying business
volume and lower our NII accordingly.
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
138
The NII impact of a net decrease in deposits would depend on
various factors,
including the
currency, its
interest rate
level and
the
balance
sheet
situation, as
the
impact
could be
offset by
a
reduction
in
negative-yielding
liquidity
portfolios
or
require
alternative funding. If funding were required, the cost would also
significantly depend on term and nature of replacement funding,
whether
such
funding
is
raised
in
wholesale
markets
or
from
swapping
with
available
other
currency-denominated
funding.
Furthermore,
imbalances
leading
to
an
excess
deposit
position
could require additional investments at negative yields,
which our
excess deposit
balance charging
mechanisms might
not be
able
to sufficiently compensate for.
Economic value sensitivity
Audited
|
Interest
rate
risk
in
the
banking
book
is
subject
to
a
regulatory EVE
sensitivity threshold
of
15
% of tier 1
capital. The
exposure
is
calculated
as
the
theoretical
change
in
the
present
value
of
the
banking
book
under
the
most
adverse
of
the
six
FINMA interest rate scenarios.
As
of
31 December
2021,
the
interest
rate
sensitivity
of
our
banking book to a +1-basis-point parallel shift in yield curves was
negative
USD
29.9
million,
compared
with
negative
USD
27.2
million as of
31 December 2020. The
change in the
interest rate
sensitivity was driven
by the execution of
transactions in the first
quarter
of
2021
that were
aimed at
protecting our
net interest
income should interest
rates decrease. The
reported interest rate
sensitivity
excludes
the
AT1
capital
instruments,
as
per
FINMA
Pillar 3
disclosure
requirements,
with
a
sensitivity
of
USD
4.5
million per
basis point,
and our
equity, goodwill
and real
estate,
with a modeled sensitivity of USD
22.1
million per basis point, of
which
USD
15.6
million
and
USD
5.5
million
are
attributable to
the US dollar and the Swiss franc portfolios, respectively.
The
most
adverse
of
the
six
FINMA
interest
rate
scenarios
would
be
the
“Parallel
up”
scenario,
which
would
result
in
a
change
in
the
economic
value
of
equity
of
negative
USD
6.0
billion,
representing
a
pro
forma
reduction
of
10.0
%
of
tier 1
capital, which would
be well below
the regulatory outlier
test of
15
% of
tier 1 capital.
The immediate
effect of
the “Parallel
up”
scenario
on
tier 1
capital
as
of
31 December
2021
would
be
a
reduction of
1.8
%, or USD
1.1
billion, arising from the
part of our
banking book that is measured at fair value through profit or loss
and
from
Financial assets
measured
at
fair value
through
other
comprehensive
income
.
Over
time
this
scenario
would
have
a
positive effect on net interest income.
p
›
Refer to “Note 11 Financial assets measured
at fair value
through other comprehensive income”
in the “Consolidated
financial statements”
section of this report for more information
›
Refer to the “Group performance”
section of this report for more
information about sensitivity to interest rate
movements
Audited |
Interest rate risk – banking book
USD million
+1 bp
Parallel up
1
Parallel down
1
Steepener
2
Flattener
3
Short-term up
4
Short-term down
5
CHF
(
5.1
)
(
724.1
)
806.3
(
254.3
)
117.1
(
158.7
)
162.5
EUR
(
1.1
)
(
196.6
)
231.9
(
69.0
)
37.4
(
24.1
)
27.4
GBP
0.1
33.3
(
32.8
)
(
31.1
)
35.3
45.4
(
43.7
)
USD
(
23.5
)
(
5,068.3
)
4,124.2
(
821.4
)
(
362.3
)
(
2,165.9
)
2,315.6
Other
(
0.4
)
(
85.8
)
19.9
(
3.7
)
(
34.5
)
(
59.6
)
3.8
Total effect on economic value of equity as per Pillar 3 requirement as of
31.12.21
(
29.9
)
(
6,041.4
)
5,149.5
(
1,179.6
)
(
207.0
)
(
2,362.9
)
2,465.6
Additional tier 1 (AT1) capital instruments
4.5
853.4
(
928.4
)
(
9.6
)
197.1
531.5
(
553.3
)
Total including AT1 capital instruments as of 31.12.21
(
25.4
)
(
5,188.0
)
4,221.1
(
1,189.2
)
(
10.0
)
(
1,831.4
)
1,912.3
1 Rates across all tenors move by ±150 bps for
Swiss franc, ±200 bps for euro and US dollar and ±250 bps for
pound sterling.
2 Short-term rates decrease and long-term rates increase.
3 Short-term rates increase
and long-term rates decrease.
4 Short-term rates increase more than long-term rates.
5 Short-term rates decrease more than long-term rates.
p
Other market risk exposures
Own credit
We are
exposed to
changes in
UBS’s own
credit reflected
in the
valuation
of
financial
liabilities
designated
at
fair
value
when
UBS’s own credit
risk would be
considered by market
participants,
except
for
fully
collateralized
liabilities
or
other
obligations
for
which
it
is
established
market
practice
to
not
include
an
own-
credit component.
›
Refer to “Note 21 Fair value measurement”
in the “Consolidated
financial statements” section of this
report for more information
about own credit
Structural foreign exchange risk
Upon
consolidation,
assets
and
liabilities
held
in
foreign
operations
are
translated
into
US
dollars
at
the
closing
foreign
exchange rate
on the
balance sheet
date. Value
changes (in
US
dollars)
of
non-US
dollar
assets
or
liabilities
due
to
foreign
exchange movements are recognized in
OCI and therefore affect
shareholders’ equity and CET1 capital.
Group Treasury uses strategies
to manage this foreign
currency
exposure, including matched funding
of assets and liabilities
and
net investment hedging.
›
Refer to the “Capital, liquidity and funding,
and balance sheet”
section of this report for more information about
our exposure
to and management of structural foreign exchange
risk
›
Refer to “Note 10 Derivative instruments”
in the “Consolidated
financial statements” section of this
report for more information
about our hedges of net investments
in foreign operations
Equity investments
Audited |
We make direct investments
in a variety
of entities and
buy
equity holdings in
both listed
and unlisted companies,
for a
variety
of purposes, including investments
such as exchange and
clearing
house
memberships
held
to
support our
business activities.
We
may also make investments in
funds that we manage in
order to
fund
or
seed
them
at
inception
or
to
demonstrate
that
our
interests
align
with
those
of
investors.
We
also
buy,
and
are
sometimes
required
by
agreement
to
buy,
securities
and
units
from funds that we have sold to clients.
139
The fair value of equity
investments tends to be influenced by
factors specific
to the
individual investments.
Equity investments
are generally
intended to
be held
for the
medium or
long term
and may be subject to lock-up
agreements. For these reasons, we
generally
do
not
control
these
exposures
by
using
market
risk
measures
applied
to
trading
activities.
However,
such
equity
investments are subject to a different range of controls, including
preapproval
of
new
investments
by
business
management
and
Risk
Control,
portfolio
and
concentration
limits,
and
regular
monitoring
and reporting
to
senior
management. They
are also
included in
our Group-wide
statistical and
stress testing
metrics,
which flow into our risk appetite framework.
As
of
31 December
2021,
we
held
equity
investments
and
investment fund units totaling USD
3.0
billion, of which USD
1.8
billion was
classified as
Financial assets
at fair
value not
held for
trading
and USD
1.2
billion as
Investments in associates
.
p
›
Refer to “Note 21 Fair value measurement”
and “Note 29
Interests in subsidiaries and other entities” in
the “Consolidated
financial statements”
section of this report for more information
›
Refer to “Note 1 Summary of material accounting
policies” in the
“Consolidated financial statements” section
of this report for
more information about the classification
of financial
instruments
Debt investments
Audited |
Debt investments classified as
Financial assets measured
at
fair value
through OCI
as of
31 December 2021
were measured
at fair
value with
changes in
fair value
recorded through
Equity
,
and can broadly
be categorized
as money market
instruments and
debt securities primarily
held for statutory,
regulatory or liquidity
reasons.
The
risk
control
framework
applied
to
debt
instruments
classified as
Financial assets
measured at
fair value
through OCI
depends
on
the nature
of
the instruments
and the
purpose
for
which we
hold them.
Our exposures
may be
included in
market
risk
limits
or
be
subject
to
specific
monitoring
and
interest
rate
sensitivity
analysis.
They
are
also
included
in
our
Group-wide
statistical
and
stress
testing
metrics,
which
flow
into
our
risk
appetite framework.
Debt instruments classified as
Financial assets measured at fair
value
through
OCI
had
a
fair
value
of
USD
8.8
billion
as
of
31
December
2021
compared
with
USD
8.3
billion
as
of
31 December 2020.
p
›
Refer to “Note 21 Fair value measurement”
in the “Consolidated
financial statements”
section of this report for more information
›
Refer to “Economic value sensitivity” in
this section for more
information
›
Refer to “Note 1 Summary of material accounting
policies” in the
“Consolidated financial statements” section
of this report for
more information about the classification
of financial
instruments
Pension risk
We
provide
a
number
of
pension
plans
for
past
and
current
employees, some
classified as
defined benefit
pension plans
under
IFRS that can have
a material effect on
our IFRS equity and CET1
capital.
Pension risk is
the risk that
defined benefit plans’
funded status
might
decrease,
negatively
affecting
our
capital.
This
can
result
from
falls
in
the
value
of
a
plan’s
assets
or
in
the
investment
returns, increases in defined benefit obligations,
or combinations
of the above.
Important risk factors affecting the fair value of pension plans’
assets include
equity market
returns, interest
rates, bond
yields,
and real estate prices. Important risk factors affecting the present
value
of
expected
future
benefit
payments
include
high-grade
bond yields, interest rates, inflation rates, and life expectancy.
Pension risk is included in our Group-wide statistical and stress
testing metrics, which flow into our risk appetite framework. The
potential effects are
thus captured in the
post-stress capital ratio
calculations.
›
Refer to “Note 1 Summary of material accounting
policies”
and
“Note 27 Post-employment benefit plans”
in the “Consolidated
financial statements” section of this
report for more information
about defined benefit plans
UBS own share exposure
Group Treasury holds UBS Group
AG shares to
hedge future share
delivery
obligations
related
to
employee
share-based
compensation awards, and also
holds shares purchased under
the
share repurchase program.
In addition, the
Investment Bank holds
a limited number
of UBS Group
AG shares, primarily
in its capacity
as
a
market-maker
with
regard
to
UBS
Group
AG
shares
and
related
derivatives, and
to hedge
certain
issued structured
debt
instruments.
›
Refer to “UBS shares” in the “Capital, liquidity
and funding, and
balance sheet”
section of this report for more information
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
140
Country risk
Country risk framework
Country
risk
includes
all
country-specific
events
occurring
in
a
sovereign
jurisdiction
that
may
lead
to
impairment
of
UBS’s
exposures.
It may
take the
form of:
sovereign risk,
which is
the
ability
and
willingness
of
a
government
to
honor
its
financial
commitments; transfer
risk, which
arises
if a
counterparty or
issuer
cannot
acquire
foreign
currencies
following
a
moratorium
by
a
central
bank on
foreign exchange
transfers; or
“other” country
risk. “Other” country risk may
manifest itself through, on the
one
hand, increased and multiple counterparty and issuer default
risk
(systemic risk)
and, on
the other
hand, events
that may
affect a
country’s
standing,
such
as
adverse
shocks
affecting
political
stability or institutional
and / or
legal frameworks. We
have a well-
established risk control framework to assess the risk profiles
of all
countries where we have exposure.
We assign a country rating to each country, which reflects our
view of the country’s creditworthiness and of the probability of a
country
risk
event
occurring.
Country
ratings
are
mapped
to
statistically
derived
default
probabilities
,
described
under
“Probability
of
default”
in
this
section.
We
use
this
internal
analysis
to
set
the
credit
ratings
of
governments
and
central
banks, estimate the probability of a transfer event occurring, and
establish
rules
on
how
aspects
of
country
risk
should
be
incorporated
in
counterparty
ratings
of
non-sovereign
entities
domiciled in the respective country.
Country ratings
are also
used to
define our
risk appetite
and
risk
exposure
to
foreign
countries.
A
country
risk
limit
(i.e.,
maximum
aggregate
exposure)
applies
to
exposures
to
counterparties or issuers of securities and financial investments in
the given
foreign country.
We may
limit the
extension of
credit,
transactions in traded products or positions in securities based
on
a
country
risk
ceiling
even
if
our
exposure
to
a
counterparty
is
otherwise acceptable.
For internal measurement and control
of country risk, we also
consider the financial effect of
market disruptions arising prior to,
during and
after a
country crisis.
These may
take the
form of
a
severe
deterioration
in
a
country’s
debt,
equity
or
other
asset
markets
or
a
sharp
depreciation
of
its
currency.
We
use
stress
testing
to
assess
potential
financial
effects
of
severe
country or
sovereign
crises.
This involves
the developing
of
plausible
stress
scenarios
for
combined
stress
testing
and
the
identification
of
countries
that
may
potentially
be
subject
to
a
crisis
event,
determining
potential
losses
and
making
assumptions
about
recovery
rates
depending
on
the
types
of
credit
transactions
involved and their
economic importance to
the affected countries.
Our exposures to market risks
are subject to regular
stress tests
covering major
global scenarios,
which are
also used
for combined
stress
testing,
where
we
apply
market
shock
factors
to
equity
indices, interest
rates and
currency rates
in all
relevant countries
and consider the potential liquidity of the instruments.
Country risk exposure
Country risk exposure measure
The
presentation
of
country
risk
follows
our
internal
risk
view,
where the basis for measuring exposures
depends on the product
category in which
we classified the
exposures. In addition
to the
classification
of
exposures
into
banking
products
and
traded
products,
covered
in
“Credit
risk
profile
of
the
Group”
in
this
section, in the
trading inventory
we classify issuer
risk on
securities
such as bonds
and equities, as
well as risk
relating to underlying
reference assets for derivative positions.
As we manage the
trading inventory on
a net basis, we
net the
value
of
long
positions
against
short
positions
with
the
same
underlying issuer. Net exposures are, however, floored at zero per
issuer in the figures presented in the following tables. As a result,
we
do
not
recognize
potentially
offsetting
benefits
of
certain
hedges and short positions across issuers.
We
do
not
recognize
any
expected
recovery
values
when
reporting
country
exposures
as
exposure
before
hedges,
except
for
risk-reducing
effects
of
master
netting
agreements
and
collateral held in
either cash or
portfolios of diversified
marketable
securities,
which
we
deduct
from
the
positive
exposure
values.
Within
banking
products
and
traded
products,
risk-reducing
effects
of credit
protection are taken
into account
on a
notional
basis when determining the net of hedge exposures.
Country risk exposure allocation
In general, exposures
are shown against
the country of domicile
of the contractual
counterparty
or the issuer
of the security.
For
some
counterparties
whose
economic
substance
in
terms
of
assets
or
source
of
revenues
is
primarily
located
in
a
different
country,
the exposure
is allocated
to the
risk domicile
of those
assets or
revenues.
We apply a
specific approach for
banking products exposures
to branches of banks that are located in a country other than the
legal entity’s domicile.
In such cases,
exposures are recorded
in full
against
the
country
of
domicile
of
the
counterparty
and
additionally
in
full
against
the
country
wh
ere
the
branch
is
located.
In
the
case
of
derivatives,
we
show
counterparty
risk
associated
with
positive
replacement
value
(PRV)
against
the
counterparty’s
country
of
domicile
(presented
within
traded
products). In
addition, risk
associated
with an
instantaneous
fall
in
value
of
underlying
reference
assets
to
zero
(assuming
no
recovery) is
shown against
the country
of domicile
of the
issuer
of the
reference asset
(presented
within trading
inventory).
This
approach
allows
us
to
capture
both
counterparty
and,
where
applicable,
issuer
elements
of
risk
arising
from
derivatives
and
applies comprehensively for all derivatives, including single-name
credit default swaps (CDSs)
and other credit derivatives.
141
CDSs are primarily
bought and
sold in relation
to our trading
businesses,
and,
to a
much lesser
degree,
used to
hedge credit
valuation
adjustments
(CVAs).
Holding
CDSs
for
credit
default
protection
does
not
necessarily
protect
the
buyer
of
protection
against losses, as
contracts only pay
out under certain
scenarios.
The effectiveness of our CDS
protection as a hedge of default
risk
is
influenced
by
a
number
of
factors,
including
the
contractual
terms under
which a given
CDS was written.
Generally, only the
occurrence of credit
events as
defined by
the CDS contract’s
terms
(which
may
include,
among
other
events,
failure
to
pay,
restructuring
or
bankruptcy)
result
s
in
payments
under
the
purchased
credit
protection
contracts.
For
CDS
contracts
on
sovereign
obligations,
repudiation
can
also
be
deemed
as
a
default event. The determination as to
whether a credit event has
occurred
is
made
by
the
relevant
International
Swaps
and
Derivatives
Association
(ISDA)
determination
committees
(composed of various ISDA member firms) based on the terms of
the CDS and the facts and circumstances surrounding the event.
Top 20 country risk exposures
The
table
below
shows
our
20
largest
country
exposures
by
product
type,
excluding
our
home
country,
as
of
31 December
2021 compared with 31 December 2020.
Compared
with
the
prior
year,
our
net
exposure
to
the
UK
increased by
USD 8.8 billion,
driven by
central bank
exposures due
to treasury activities.
Net exposure to
the US increased
by USD 6.3
billion, solely driven by
banking products, largely related
to nostro
balances
at
the
Federal
Reserve
due
to
t
reasury
a
ctivities,
mortgages and Investment Bank loans. Those increases in the US
were partly offset by
tradable assets related to treasury
activities.
Net
exposure
to
Australia
increased
by
USD
2.9
billion,
predominantly
driven
by
trading
inventory
due
to
loan
underwriting projects
and central
bank exposures.
Net exposure
to
Germany
decreased
by
USD 2.8
billion,
driven
by
trading
inventory due to
loan underwriting projects
and sovereign issuer
risk.
Net
exposure
to
China
decreased
by
USD 2.0
billion,
predominantly driven
by trading
inventory across
issuer risk
and
margin loans, as
well as banking
products.
Net exposure to
France
decreased by
USD 1.0 billion,
driven by
trading inventory
due to
treasury activities.
Based on
the sovereign
rating categories,
as of
31 December
2021,
84% of our emerging
market country exposure was
rated
investment grade, compared with 83% as of
31 December 2020.
Russia
Our direct
country risk
exposure
to Russia
contributed USD 634
million to our total
emerging market exposure of USD 20.9
billion
as of 31 December 2021. This
includes trade finance exposures in
Personal
&
Corporate
Banking,
a
single
loan
in
the
Investment
Bank with a
non-Russian entity with key
facilities spread globally
including Russia and
the Commonwealth of
Independent States,
Nostro
and
cash
accounts
balances,
issuer
risk
on
trading
inventory within the
Investment Bank, and
derivatives within the
Investment Bank. These exposures have been reduced since year-
end 2021.
Not included
in this
figure
are net
assets held
in our
Russian subsidiary,
with a net asset value
of USD 51 million. UBS
is
also
currently
monitoring
settlement
risk
on
certain
open
transactions with Russian
banks and non
-bank counterparties or
Russian
underlyings
,
as
market
closures,
the
imposition
of
exchange
controls,
sanctions
or
other
measures
may
limit
our
ability
to
settle
existing
transactions
or
to
realize
on
collateral,
which may result in unexpected increases in exposures.
As
of
3 March
2022,
UBS
also
had
approximately
USD 0.2
billion
exposure
arising
from
reliance
on
Russian
assets
as
collateral
on
Lombard
lending
and
other
secured
financing
in
Global Wealth Management.
As of
3 March 2022,
we identified
a small
number of
Global
Wealth
Management
clients
subject
to
the
recently
introduced
sanctions,
with total loans outstanding of under USD 10 million.
Our market
risk exposure
to
Russia as
of 3 March
2022 was
limited.
We had no material direct country
risk exposures to Ukraine or
to Belarus
as of
31 December 2021
and no
material reliance
on
Ukrainian or to Belarusian
collateral within our
Lombard portfolio.
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
142
Top
20 country risk net exposures by product type
USD million
Total
Banking products
(loans, guarantees, loan
commitments)
Traded products
(counterparty risk from derivatives
and securities financing)
after master netting agreements
and net of collateral
Trading inventory
(securities and potential
benefits / remaining
exposure from derivatives)
Net of hedges
1
Net of hedges
1
Net of hedges
Net long per issuer
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
United States
116,388
110,041
79,647
62,950
8,371
9,786
28,371
37,305
United Kingdom
34,837
26,083
24,788
16,154
7,465
8,541
2,585
1,388
Japan
14,764
14,974
10,572
5,625
3,508
2,972
684
6,378
Germany
10,564
13,336
3,397
2,447
1,232
1,217
5,934
9,672
Singapore
8,993
8,950
3,110
3,875
2,557
2,431
3,326
2,644
Australia
6,397
3,465
2,674
1,475
1,786
1,329
1,937
661
France
6,301
7,344
1,356
1,306
1,711
1,409
3,235
4,628
China
5,344
7,392
1,823
2,553
830
1,010
2,691
3,828
Canada
3,933
3,792
1,199
1,483
1,044
832
1,689
1,477
Luxembourg
3,453
3,292
2,438
2,128
58
145
958
1,019
Hong Kong SAR
3,388
2,840
1,914
1,498
367
395
1,107
946
Netherlands
3,020
3,048
1,183
656
830
782
1,007
1,610
South Korea
2,479
2,259
462
426
418
526
1,599
1,307
Sweden
1,617
2,326
647
657
194
260
776
1,410
Thailand
1,469
1,494
208
146
26
41
1,235
1,306
Austria
1,220
1,664
265
197
97
616
858
851
Norway
1,215
1,669
25
22
206
337
983
1,310
India
1,119
903
991
727
87
86
41
90
Monaco
1,022
1,016
984
994
28
17
10
5
Brazil
915
1,119
488
474
40
88
387
557
Total
2
228,438
217,006
138,171
105,793
30,853
32,819
59,414
78,394
1 Before deduction of IFRS 9 ECL allowances and provisions.
2 Excluding Switzerland, supranationals and global funds.
Emerging markets¹ net exposure² by internal UBS country rating category
USD million
31.12.21
31.12.20
Investment grade
17,608
19,580
Sub-investment grade
3,261
4,005
Total
20,869
23,585
1 We classify countries as emerging
markets based on per capita
GDP,
historical real GDP growth, alignment with
international institutions (such as BIS,
World Bank, IMF,
MSCI) and other factors.
2 Net of credit
hedges (for banking products and for traded products); net long per issuer (for trading inventory). Before deduction of IFRS
9 ECL allowances and provisions.
143
Sustainability and climate risk
Sustainability risk
Sustainability and
climate risk
(SCR, previously
known at
UBS as
environmental and
social risk,
or ESR)
is defined
as the
risk that
UBS
is
negatively
impacted
by
or
negatively
impacts
climate
change, loss of biodiversity, human rights infringements, or other
environmental, social or governance
(ESG) matters. Sustainability
and
climate
risks
may
manifest
as
credit,
market,
liquidity
or
operational risks for
UBS and can
result in financial
or reputational
impacts for the firm.
They may also negatively
impact the value of
investments. The
management of sustainability
and climate
risks
is gaining importance amid a global
drive to meet the Sustainable
Development
Goals
(the
SDGs)
and
transition
to
net
zero,
as
defined
by
the
Paris
Agreement.
In
addition,
regulators
across
jurisdictions
increasingly
seek
to
understand
the
potential
financial impacts of climate change. Our broad and wide-ranging
SCR
policy framework
governs client
and
supplier relationships,
applies
firm-wide
to
all
activities,
and
is
integrated
in
management practices
and control principles.
The SCR
framework
is
embedded
in
our
standard
risk,
compliance
and
operations
processes and applied through:
–
risk identification and measurement;
–
risk monitoring and appetite setting;
–
risk management and control; and
–
risk reporting.
The
aforementioned
processes
include
client
onboarding,
transaction due
diligence, product
development and
investment
decision
processes,
own
operations,
supply chain
management,
and
portfolio
reviews.
This
framework
is
geared
toward
identifying clients,
transactions or
suppliers potentially
in breach
of our standards or
otherwise subject to significant
controversies
related to sustainability, human rights or climate change.
›
Refer to “Sustainability and climate
risk policy framework” in
appendix 6 to the Sustainability Report
2021, available from
11 March 2022 under “Annual reporting” at
ubs.com/investors
,
for more information
Climate risk
Climate
risk
can
arise
either
from
changing
climate
conditions
(physical
risks)
or
from
efforts
to
mitigate
climate
change
(transition risks). The physical
and transition risks from
a changing
climate contribute
to a
structural change
across
economies and
consequently can affect banks and the financial
sector as a whole
through financial and non-financial impacts.
In order to protect our clients’ assets and our own assets from
climate-related risks,
we have established
a climate
risk program
to further
integrate climate
risk into
the firm’s risk
management
framework and standard processes. The program follows a multi-
year roadmap to address regulatory expectations and is engaging
with
stakeholders and
experts across
the
firm and
externally
to
further
develop
climate
risk
methodologies,
deliver
on
climate
stress test exercises, and build
capacity to respond to climate
risk
management expectations.
We
currently
identify
and
manage
climate
risk
in
our
own
operations, our balance sheet, client assets and the supply
chain.
We
have
continually
reduced
our
exposure
to
carbon-related
assets
and
advanced
our
multi
-
year
efforts
to
develop
methodologies that
enable robust
and transparent
disclosure of
climate metrics. This work supports our efforts to
ensure that we
are
prepared
to
respond
to
increased
climate
risk
-
related
regulatory
requirements,
align
our
disclosure
with
the
Financial
Stability
Board’s
Task
Force
on
Climate
-
related
Financial
Disclosures (the
TCFD) recommendations
and collaborate
within
the financial sector to close gaps.
We
approach
climate
risk
identification
through
climate
risk
heatmaps,
developed
in
collaboration
with
the
United
Nations
Environment
Programme
Finance
Initiative
(UNEP
FI)
TCFD
working group.
As part of this effort, we have
defined an inventory of climate-
sensitive sectors based on elevated climate risk ratings defined by
the
TCFD,
regulators
and
rating
agencies.
We
initially
disclosed
our exposure
to climate
sensitive sectors
(transition risks)
in our
Annual Report
2020. Over
the course
of 2021,
we have
refined
the
disclosure
of
transition
risks
and
introduced
an
initial
disclosure of
physical risks.
We summarize
our current
exposure
to climate-sensitive sectors for both risk
types in the table on the
next page.
Exposures may
appear either under
one or under
both of the
risk
types, as
the physical
and transition
risk methodologies
are
distinct
in
their
approach
and
application
and
should
not
be
added up
as one
total exposure
figure. Climate
risk analysis
is a
novel area of research, and, as the methodologies,
tools and data
availability improve, we will further develop our risk identification
and measurement approaches.
›
Refer to “Taking action on a net-zero future – our climate
report” in the Sustainability Report 2021,
available from
11 March 2022 under “Annual reporting” at
ubs.com/investors
,
for more information
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
144
UBS lending to climate-sensitive sectors
1
Climate-sensitive exposure:
elevated transition risks,
as of 31.12.21
2
Climate-sensitive exposure:
elevated physical risks,
as of 31.12.21
2
USD million, except where indicated
Trend (%) 2019–2021
Gross exposure
3
Share of total in %
Trend (%) 2019–2021
Gross exposure
3
Share of total in %
Climate-sensitive sector
4
Aerospace and defense
¯
831
0.18
¯
338
0.07
Automotive
¯
703
0.15
¯
1,042
0.23
Business services
¯
853
0.19
Chemicals
¯
1,112
0.24
¯
991
0.22
Constructions and materials
¯
3,637
0.79
¯
302
0.07
Consumer products and retail
®
355
0.08
650
0.14
Entertainment, leisure and services
¯
1,308
0.28
Food and beverage
®
2
0.00
1,334
0.29
Industrial materials
¯
121
0.03
¯
243
0.05
Information technology
¯
274
0.06
Machinery and equipment
1,040
0.23
2,732
0.60
Medical equipment and services
408
0.09
Mining
¯
2,920
0.64
1,153
0.25
Oil and gas
¯
5,823
1.27
¯
5,538
1.21
Pharmaceuticals/biotechnology
1,400
0.30
®
814
0.18
Plastic and rubber
¯
299
0.07
¯
280
0.06
Primary materials
®
13
0.00
®
320
0.07
Real estate management
¯
18,029
3.93
528
0.12
Sovereigns and financials
¯
4,371
0.95
Transportation and equipment
¯
849
0.18
¯
419
0.09
Utilities
¯
375
0.08
1,579
0.34
Total, climate-sensitive sectors
2
¯
37,510
8.17
¯
25,476
5.55
Total, all sectors
459,061
100.00
459,061
100.00
1 Not additive across transition risks and physical risks.
2 Global Wealth Management corporate lending to customers represents 1.1% of all on- and off-balance sheet loans and
advances to customers, and is not
rated.
3 Reported as IFRS9 expected credit loss (ECL) calculation, and represents both on-balance sheet: total loans and advances to customers and off-balance sheet: guarantees and irrevocable loan commitments
(within the scope of ECL). Physical risk exposures include
USD ~4 billion in loans backed by real estate.
4 The table includes only those sector exposures that are defined as climate-sensitive. Climate-sensitive sectors
defined as business activities rated as
having high, moderately high or
moderate vulnerability to transition
and physical risks. Transition
risk methodology was initially developed
in collaboration with UNEP
FI TCFD
working group and disclosed in
Phase II “From disclosure
to action – a
guide to implementing the TCFD
framework within financial institutions”
report. Physical risk methodology
is based on country,
sectoral and
value chain risk factors derived from a range of academic and expert sources. Both methodologies
have been adapted internally and enhanced.
Climate
risk
heatmaps
enable
us
to
use
a
materiality-driven
approach
when
defining
our
climate
risk
management
strategy
by:
–
helping
us
to
identify
concentrations
of
exposure
with
high
climate
risk
vulnerability,
which,
in
turn,
enables
resource
prioritization for detailed
risk analysis and
management action;
–
supporting a
client-centric strategy
in order
to best
assist clients
that
may benefit
from UBS
products and
services to
support
their climate strategies; and
–
providing
information
to
senior
management
to
support
decision
making
and
the
provision
of
external
disclosure
to
stakeholders.
Our
climate
risk
heatmap
s
rate
cross
-
sectoral
credit
risk
exposure to
climate sensitivity,
from high
to low,
through a
risk
segmentation process. The
transition risk methodology,
reflected
in the
climate risk
heatmap on
the next
page, divides
economic
sectors
into
segments
with
similar
risk
characteristics
and
rates
those
segments
according
to
their
vulnerability
to
mitigative
climate
policies,
low-carbon
technology
risks
and
revenue
or
demand shifts under an
aggressive approach to meeting the
well-
below
-
2˚C
Paris
goal.
The
physica
l
risk
methodology
groups
corporate counterparties
based on
exposure to
key physical
risk
factors,
through
rating
sectoral,
geographic,
and
value
chain
vulnerabilities
in
a
climate
change
trajectory
in
which
no
additional
policy
action
is
taken.
Counterparties
are
assigned
a
climate
vulnerability
rating
based
on
the
primary
industry
code
(Global Industry
Classification Standard,
GICS) and
risk domicile
in UBS data systems.
›
For our physical risk heatmap, refer to “Taking action on a net-
zero future – our climate report” in the Sustainability
Report
2021, available from 11 March 2022 under “Annual
reporting” at
ubs.com/investors
145
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
146
Scenario analysis and stress tests
exercises
We
have
been
using
scenario-based
approaches
since
2014
to
assess
our
exposure
and
the
potential
impacts
of
physical
and
transition
risks
stemming
from
climate
change.
Novel
in-house
scenario analyses
have been followed
by a series
of assessments
performed through industry collaborations in order to harmonize
approaches
in
addressing
methodological
and
data
gaps.
We
have
performed
both
top-down
balance
sheet
stress
testing
(across
the
firm)
and
targeted
bottom-up
analyses
of
specific
sector
exposures
covering
short
-
,
mid
-
and
long
-
term
time
horizons. Starting in 2021, UBS
participates in regulatory scenario
analysis and stress test exercises,
including the Bank of England’s
“2021 Climate Biennial Exploratory Scenario:
Financial risks from
climate change” and
the European
Central Bank’s climate
stress
test. In addition, in 2021
UBS participated in a top-down
climate
risk
assessment
performed
jointly
by
FINMA
and
the
Swiss
National Bank in Switzerland.
›
For more information about our climate risk approach
and
physical risk heatmap, refer to “Taking action on a net-zero
future – our climate report” in the Sustainability
Report 2021,
available from 11 March 2022 under “Annual reporting”
at
ubs.com/investors
147
Non-financial risk
Key developments
We have identified
seven non-financial risk
themes as key
to the
firm for 2022. These are:
–
digital transformation and cyber and operational resilience;
–
use of data;
–
new ways of working and change delivery;
–
investor protection and market interaction;
–
strategic growth initiatives and partnerships;
–
the evolving
nature of
anti-money-laundering (AML)
/ know-
your-client (KYC) programs and sanctions;
and
–
environmental, social and governance (ESG) risks.
We
are
continuing
our
efforts
regarding
innovation
and
digitalization
to
create
value
for
our
clients.
As
part
of
the
resulting
transformation, we
are
focusing
on
timely
changes
to
frameworks, including
consideration of
new or
revised controls,
working practices
and oversight,
with the
aim of
mitigating any
new risks introduced, including those related to data ethics.
Increases in
the sophistication
of cyberattacks
and frauds
are
noted
worldwide,
especially
with
ransomware
attacks.
To
date,
our security controls,
regular communications to help
employees
stay alert to cyber
threats while working remotely
and enhanced
monitoring
of
cyber
threats
have
resulted
in
no
cyber
security
incidents having a material effect on our operations during 2021.
UBS continues to
be vigilant, particularly
in view of
the potential
for
intensifying
cyber
threats,
both
in
terms
of
volume
and
sophistication, driven by current geopolitical events.
Operational resilience
continues to
be a
focus area
for us,
as
well
as
for
regulators
globally.
We
have
a
global
program
to
enhance
our
operational-resilience
capabilities,
including
addressing developing regulatory requirements.
The
existing
resilience
built
into
our
operations
and
the
effectiveness
of
our
business
continuity
management
and
operational
risk processes (including
those for
third-party service
providers) have
been critical
in handling
the ongoing
COVID-19
pandemic.
They
have
enabled
us
to
maintain
stable
operations
while
complying
with
governmental
measures
to
contain
COVID-19;
continuing
to
serve
our
clients
without
material
impact; and to support the safety and well-being of our staff.
Hybrid
working arrangements
can
lead to
increased conduct
risk, inherent risk
of fraudulent
activities, potential increases
in the
number
of
suspicious
transactions
and
increased
information
security
risks.
We have
implemented
additional
monitoring and
supervision
intended
to
mitigate
these
risks.
In
addition,
as
we
move
to
a
post-pandemic
new
normal,
changes
to
the
work
environment, including permanent hybrid and
the introduction of
agile
ways
of
working,
may
introduce
new
challenges
for
supervision and monitoring.
Achieving
fair
outcomes
for
our
clients,
upholding
market
integrity
and
cultivating
the
highest
standards
of
employee
conduct
are
of
critical
importance
to
the
firm.
We
maintain
a
conduct risk framework across our activities, which is
designed to
align
our
standards
and
conduct
with
these
objectives
and
maintain momentum on fostering a strong culture.
Competition
to
find
new
business
opportunities
across
the
financial
services
industry,
both
for
firms
and
customers,
is
increasing. Thus suitability risk, product
selection, cross-divisional
service
offerings,
quality
of
advice
and
price
transparency
also
remain areas of heightened focus for UBS and for the industry as
a
whole,
as
low
interest
rates,
market
volatility
and
major
legislative change
programs (such as
the Swiss
Financial Services
Act (FIDLEG)
in
Switzerland,
Regulation
Best Interest
(Reg
BI)
in
the
US
,
and
the
Markets
in
Fin
ancial
Instruments
Directive
II
(MiFID II) in the EU) all significantly affect the industry and require
adjustments
to
control
processes
on
a
geographically
aligned
basis. We
regularly monitor
our suitability,
product and
conflicts
of
interest
control
frameworks
to
assess
whether
they
are
reasonably designed
to facilitate
adherence to
applicable laws
and
regulatory expectations.
Cross-border risk
remains an
area of
regulatory attention
for
global
financial
institutions,
with
a
strong
focus
on
fiscal
transparency, as
well as
market access,
particularly third-country
market access into the European Economic Area. There is also an
ongoing
high
level
of
attention
regarding
the
risk
that
tax
authorities
may,
on
the
basis
of
new
interpretations
of
existing
law,
seek
to
impose
taxation
based
on
the
existence
of
a
permanent
establishment.
We
maintain
a
series
of
controls
designed to address these risks.
Financial
crime,
including
money
laundering,
terrorist
financing,
sanctions
violations,
fraud,
bribery
and
corruption,
continues to present a major
risk, as technological innovation
and
geopolitical
developments
increase
the
complexity
of
doing
business
and
heightened
regulatory
attention
continues.
An
effective
financial
crime
prevention
program
therefore
remains
essential
for
UBS.
Money
laundering
and
financial
fraud
techniques
are
becoming
increasingly
sophisticated,
and
geopolitical
volatility
makes
the
sanctions
landscape
more
challenging,
as
new
or
novel
sanctions
may
be
imposed
that
require
complex
implementation
in
a
short
timeframe,
as
evidenced
by
the
existing,
and
potential
escalation
of
new
sanctions arising from the
Russian invasion of Ukraine.
New risks
continue
to
emerge,
such
as
virtual
currencies
and
related
activities or investments.
In the US, the Office of the
Comptroller of the Currency issued
a Cease and Desist Order
against the firm in May
2018 relating to
our US branch KYC and AML programs. In response, we initiated
an
extensive
program
for
the
purpose
of
ensuring
sustainable
remediation of US-relevant
Bank Secrecy Act
/ AML issues across
all our US legal entities.
We introduced significant improvements
to the framework between 2019 and 2021 and
are continuing to
implement
these.
We
believe
they
will
yield
the
planned
enhancements to our AML controls.
We
continued
to
focus
on
strategic
enhancements
to
our
global AML /
KYC and sanctions
programs to address
evolving risk
profiles and regulatory expectations,
including the exploration of
new technologies and more sophisticated monitoring.
In
line
with
our
firm-wide
purpose,
ESG
topics
and
the
risks
related to them
are high on
our agenda, particularly
considering
the increasing regulatory focus on ESG disclosure, climate-related
stress testing and greenwashing, as well as the
potential for new
and diverse regulations being deployed across jurisdictions.
›
Refer to “Sustainability and climate
risk” in this section for more
information about risks related to sustainability
and climate risk
Risk, capital, liquidity and funding, and balance sheet | Risk management and control
148
Operational risk framework
Operational risk is
an inherent part
of the firm’s
business. Losses
can
result
from
inadequate
or
failed
internal
processes,
people
and systems, or from
external causes. UBS follows
a Group-wide
operational risk framework
(an ORF) that
establishes requirements
for identifying,
managing, assessing
and mitigating
operational,
compliance
and
conduct
risks
to
achieve
an
agreed
balance
between risk and return. It is built on the following pillars:
–
classifying
inherent
risks
through
the
operational
risk
taxonomy, which
defines the
universe of
material operational
risks
that
can
arise
as
a
consequence
of
the
firm’s
business
activities and external factors;
–
assessing
the
design
and
operating
effectiveness
of
controls
through the control assessment process;
–
proactively
and
sustainably
remediating
identified
control
deficiencies;
–
defining
operational
risk
appetite
(including
a
financial
operational
risk
appetite
statement
at
Group,
UBS
AG
and
business
division
levels
for
operational
risk
events)
through
quantitative metrics
and thresholds
and qualitative
measures,
and assessing risk exposure against appetite; and
–
assessing
inherent
and
residual
risk
through
risk
assessment
processes,
and
determining
whether
additional
remediation
plans are required to address identified deficiencies.
Divisional
Presidents
are
accountable
for
the
effectiveness
of
operational risk management and for the
robustness of the front-
to-back control
environment within
their business
divisions, and
legal entity responsible executives are responsible
for operational
risk management within their
legal entities. Group
function heads
are accountable for supporting the divisional Presidents and legal
entity responsible executives of our legal entities in the
discharge
of
this
responsibility,
by
confirming
completeness
and
effectiveness
of
the
control
environment
and
operational
risk
management within their Group functions. Collectively, divisional
Presidents,
central
Group
function
heads
and
legal
entity
responsible
executives
are
in
charge
of
implementing
the
operational risk framework.
Compliance & Operational
Risk Control (C&ORC)
is responsible
for providing an independent and objective view of the adequacy
of operational
risk management across
the Group, and
ensuring
that operational,
compliance and
conduct risks
are understood,
owned and managed in accordance with
the firm’s risk appetite.
C&ORC-aligned
teams
sit
within
the
Group
Compliance,
Regulatory
&
Governance
(GCRG)
function,
reporting
to
the
Group
Chief
Compliance
and
Governance
Officer,
who
is
a
member
of
the
Group
Executive
Board.
The
ORF
forms
the
common
basis
for
managing
and
assessing
operational,
compliance
and
conduct
risk,
and
there
are
additional
C&ORC
activities
intended
to
ensure
UBS
is
able
to
demonstrate
compliance with applicable laws, rules and regulations.
In
2021,
UBS
continued
to
review
and
enhance
the
ORF
through
the
established
ORF
design
authority,
considering
feedback and input from both internal and
external stakeholders,
including
implementing
Group-wide
control
portfolio
analytics,
supporting consistency across the control portfolio.
All functions within UBS are required to
assess the design and
operating effectiveness of
their internal controls
periodically. The
output of
these assessments
forms the
basis for
the assessment
and testing of
internal controls
over financial reporting
as required
by the Sarbanes–Oxley Act, Section 404 (SOX 404).
Key control
deficiencies identified
during the
internal control
and risk assessment
processes must
be reported in
the operational
risk inventory,
and sustainable
remediation must
be defined
and
executed.
These
control
deficiencies
are
assigned
to
owners
at
senior
management
level
and
the
remediation
progress
is
reflected
in
the
respective
managers’
annual
performance
measurement
and
management
objectives.
To
assist
with
prioritizing the
most material control
deficiencies and measuring
aggregated risk exposure, irrespective of origin, a common rating
methodology is applied across
all three lines of
defense, as well as
by external audit.
149
Advanced measurement approach model
The
operational
risk
framework
outlined
above
underpins
the
calculation
of
regulatory
capital
for
operational
risk,
which
enables
us
to
quantify
operational
risk
and
define effective
risk
mitigating
management
incentives
as
part
of
the
related
operational
risk
capital
allocation
approach
to
the
business
divisions.
We
measure
Group
operational
risk
exposure
and
calculate
operational
risk
regulatory
capital
using
the
advanced
measurement
approach
(AMA)
in
accordance
with
FINMA
requirements.
An
entity-specific
AMA
model
has
been
applied
for
UBS
Switzerland
AG,
while
for
other
regulated
entities
the
basic
indicators or standardized approaches are adopted for regulatory
capital in agreement with local
regulators. Also, the methodology
of the Group AMA is leveraged for entity-specific Internal Capital
Adequacy Assessment Processes.
Currently, the model includes
16 AMA
units of
measure (UoM),
which are
aligned with
our operational
risk taxonomy
as closely
as possible. Frequency and severity distributions are calibrated for
each of the model’s UoM. The modeled distribution functions for
both frequency and severity are used to generate
the annual loss
distribution. The
resulting
99.9% quantile
of
the overall
annual
operational
risk
loss
distribution
across
all
UoM
determines
the
required regulatory capital.
Currently,
we do
not reflect
mitigation
through
insurance
or
any
other
risk
transfer
mechanism
in
our
AMA model.
AMA model calibration and review
A
key
assumption
when
calibrating
data-driven
frequency
and
severity
distributions
is
that
historical
losses
form
a
reasonable
proxy for
future events.
In line
with regulatory
expectations, the
AMA
methodology
utilizes
both
historical
internal
losses
and
external
losses
suffered
by
the
broader
industry
for
model
calibration.
Initial
model outputs
driven by
loss
history
are
reviewed and
adjusted to reflect
fast-changing external developments,
such as
new
regulations,
geopolitical
change,
volatile
market
and
economic
conditions,
and
int
ernal
factors
(e.g.
,
changes
in
business
strategy
and
control
framework
enhancements).
The
resulting baseline data-driven frequency and severity distributions
are
reviewed
by
subject
matter
experts
and
where
necessary
adjusted based
on a
review of
qualitative information
about the
business
environment
and
internal
control
factors,
as
well
as
expert judgment, with the aim of forecasting losses.
Our model is reviewed regularly to maintain risk sensitivity
and
recalibrated
at least
annually.
Any changes
to regulatory
capital
as
a
result
of
a
recalibration
or
methodology
changes
are
presented
to
FINMA
for
approval
prior
to
use
for
disclosure
purposes.
AMA model governance
The
Group
and
entity-specific
AMA
models
are
subject
to
an
independent validation performed by Model Risk Management &
Control
in
line
with
the
Group’s
model
risk
management
framework.
Expected transition of capital regime under Basel III capital
regulations
The
AMA
is
expected
to
be
replaced
by
the
standardized
measurement
approach
for
regulatory
capital
determination
purposes in
line with
the relevant
Basel Committee
for Banking
Supervision Basel III
capital regulations.
UBS is interacting
closely
with the relevant Swiss authorities to discuss the
implementation
details and related implementation timeline.
›
Refer to “Capital planning and activities”
in the “Capital,
liquidity and funding, and balance sheet”
section of this report
for more information about the development
of risk-weighted
assets
›
Refer to “Risk measurement” in this section
for more
information about our approach to model confirmation
procedures
›
Refer to the “Risk factors” section of
this report for more
information
Capital, liquidity
and funding,
and balance sheet
Table of contents
151
Capital management
151
Capital management objectives, planning and activities
152
Swiss SRB total loss-absorbing capacity framework
154
Total
loss-absorbing capacity
158
Risk-weighted assets
161
Leverage ratio denominator
163
UBS AG consolidated total loss-absorbing capacity and
leverage ratio information
168
Equity attribution and return on attributed equity
169
Liquidity and funding management
169
Strategy, objectives and governance
169
Liquidity management
171
Funding management
171
Liquidity coverage ratio
172
Net stable funding ratio
173
Balance sheet and off-balance sheet
173
Balance sheet
179
Off-balance sheet
181
Cash flows
182
Currency management
183
UBS shares
151
Capital management
Capital management objectives, planning and activities
Capital management objectives
Audited |
An adequate level of
total loss-absorbing capacity (TLAC)
meeting both internal assessment and regulatory requirements
is
a prerequisite for conducting our business activities.
p
We
are
therefore
committed
to
maintaining
a
strong
TLAC
position
and
sound
TLAC
ratios
at
all
times,
in
order
to
meet
regulatory capital requirements and
our target capital ratios,
and
to support the growth of our businesses.
As
of
31 December
2021,
our
common
equity
tier 1
(CET1)
capital ratio was
15.0% and our
CET1 leverage ratio
4.24%, each
above our capital guidance,
and also above the
requirements for
Swiss systemically relevant banks (SRBs) and the Basel Committee
on Banking Supervision (the BCBS) requirements. We believe that
our capital strength
is a source
of confidence for
our stakeholders,
contributes
to
our
sound
credit
ratings
and
is
one
of
the
foundations of our success.
The BCBS
announced
the finalization
of the
Basel III framework
in December 2017, and published the final
rules on the minimum
capital requirements
for market
risk from
the Fundamental
Review
of
the Trading
Book
(the FRTB)
in
January 2019.
In response
to
COVID-19,
the Group
of Central
Bank Governors
and Heads
of
Supervision, which
acts as
the BCBS’s
oversight body,
endorsed
the deferral of the implementation date by one year,
to 1 January
2023.
The
accompanying
transitional
arrangements
for
the
output floor were also
extended by one year,
to 1 January 2028.
We expect the
Swiss regulations to
come into force
in 2024 and
we continue
to make
progress on
our infrastructure
design and
operational governance
ahead of
the upcoming adoption
of these
rules. We
currently estimate
that the
revised Basel III
framework
may lead
to a further
net increase in
risk-weighted assets (RWA)
of
around
USD 20
billion
in
2024,
before
taking
into
account
mitigating
acti
ons.
The
e
stimate
includes
credit
risk
and
operational
risk
RWA
from
the
finalization
of
the
Basel
III
framework, as well as
market risk and credit
valuation adjustment
(CVA) RWA
from the
FRTB, based
on our
current understanding
of
the
relevant
standards.
It
may
change
as
a
result
of
new
or
changed
regulatory
interpretations,
particularly
those
regarding
the
treatment
of
historical
operational
losses
,
as
well
as
the
appropriate
conservatism
in
model
calibration
,
the
implementation of
Basel III standards
into national
law, changes
in business growth, market conditions and other factors.
›
Refer to the “Our strategy” and “Targets, aspirations and capital
guidance” sections of this report for more information
about our
capital and resource guidelines
›
Refer to “We may be unable to maintain our
capital strength” in
the “Risk factors” section of this report for more
information
about capital ratio-related risks
Capital
planning and activities
Audited
|
We
manage
our
balance
sheet,
RWA,
leverage
ratio
denominator (LRD) and TLAC ratio levels based on our regulatory
requirements
and
within
our
internal
limits
and
targets.
Our
strategic focus
is on
achieving an optimal
attribution and
use of
financial
resources
between
our
business
divisions
and
Group
Functions, as well
as between our legal
entities, while remaining
within
the
limits
defined
for
the
Group
and
allocated
to
the
business
divisions
by
the
Board
of
Directors
(the
BoD).
These
resource
allocations, in
turn, affect
business plans
and earnings
projections, which are reflected in our capital plans.
The
annual
strategic
planning
process
includes
a
capital
-
planning component that is
key in defining our
capital targets. It
is based on
an attribution of
Group RWA and
LRD internal limits
to the business divisions.
Limits and
targets are
established at
the Group
and business
division levels, and
are approved by
the BoD at
least annually. In
the target-setting process,
we take into
account the current
and
potential future TLAC
requirements, our aggregate
risk exposure
in
terms
of
capital-at-risk,
the
assessment
by
rating
agencies,
comparisons
with
peers
and
the
effect
of
expected
accounting
policy changes.
p
Monitoring
is based
on
these internal
limits and
targets
and
provides
indications
if
any
changes
are
required. Any
breach
of
limits in place triggers a series of required remediating actions.
Group
Treasury
plans
for
and
monitors
consolidated
TLAC
information
on
an
ongoing
basis,
reflecting
business
and
legal
entity requirements, as well as regulatory developments in capital
regulations.
In
addition,
capital
planning
and
monitoring
are
performed at the
legal entity level
for our significant
subsidiaries
and
sub-groups
that
are
subject
to
prudential
supervision
and
must meet capital and other supervisory requirements.
›
Refer to “Capital and capital ratios of
our significant regulated
subsidiaries” in this section for more information
Risk, capital, liquidity and funding, and balance sheet | Capital management
152
Swiss SRB total loss-absorbing capacity framework
The disclosures in this section are provided for UBS Group AG on
a consolidated
basis and
focus on
key developments
during the
reporting period and information
in accordance with the
Basel III
framework, as applicable to Swiss SRBs.
Additional
regulatory
disclosures
for
UBS
Group
AG
on
a
consolidated basis are provided in our 31 December 2021 Pillar 3
Report. The Pillar 3 Report
further includes information
relating to
our
significant
regulated
subsidiaries
and
sub-groups
(UBS AG
standalone,
UBS
Switzerland
AG
standalone,
UBS Europe
SE
consolidated and
UBS Americas
Holding LLC
consolidated) as
of
31 December 2021 and is available under “Pillar
3 disclosures” at
ubs.com/investors
.
Capital
and
other
regulatory
information
for
UBS AG
consolidated
in
accordance
with
the
Basel III
framework,
as
applicable to Swiss SRBs, is provided in the combined UBS Group
AG
and
UBS AG
Annual Report
2021,
available
under
“Annual
reporting” at
ubs.com/investors
.
Regulatory framework
The
Basel III
framework
came
into
effect
in
Switzerland
on
1 January 2013 and
is embedded
in the Swiss
Capital Adequacy
Ordinance
(the CAO).
The CAO
also includes
the too-big-to-fail
provisions applicable to
Swiss SRBs,
which have
been fully
phased-
in since 1 January 2020.
Under
the
Swiss
SRB
framework,
going
and
gone
concern
requirements
represent
the
Group’s
TLAC
requirement.
TLAC
encompasses
regulatory
capital,
such
as
CET1,
loss-absorbing
additional tier 1 (AT1) and
tier 2 capital instruments,
and liabilities
that
can
be
written
down
or
converted
into
equity
in
case
of
resolution or for the purpose of restructuring measures.
Capital and other instruments contributing to our total
loss-absorbing capacity
In addition to CET1
capital, the following instruments
contribute
to our loss-absorbing capacity:
–
loss-absorbing
AT1 capital
instruments
(high-
and low-trigger);
–
loss-absorbing
tier 2 capital
instruments
(high-
and low-trigger);
–
non-Basel III-compliant tier 2 capital instruments; and
–
TLAC-eligible senior unsecured debt instruments.
Under the Swiss
SRB rules,
going concern
capital includes
CET1
and
high-trigger
loss-absorbing
AT1
capital
instruments.
Our
existing
outstanding
low-trigger
loss-absorbing
AT1
capital
instruments
are
available
to
meet
the
going
concern
capital
requirements until
their first
call date.
As of
their first
call date,
these
instruments
are
eligible
to
meet
the
gone
concern
requirements.
Outstanding high-
and low-trigger loss-absorbing tier 2 capital
instruments, non-Basel III-compliant tier 2
capital instruments and
TLAC-eligible
senior
unsecured
debt
instruments
are
eligible
to
meet gone concern
requirements until one
year before maturity.
A maximum
of
25%
of the
gone
concern requirements
can be
met with instruments that have a remaining maturity of between
one and
two years (i.e., are
in the last year
of eligibility). However,
once at least
75% of the
gone concern requirement
has been met
with instruments that
have a remaining
maturity of greater
than
two
years,
all
instruments
that
have
a
remaining
maturity
of
between one and two years
remain eligible to be included in
the
total gone concern capital.
›
Refer to “Bondholder information,” available
at
ubs.com/investors
, for more information about the eligibility
of
capital and senior unsecured debt instruments
and key features
and terms and conditions of capital instruments
Total loss-absorbing capacity and leverage ratio requirements
Going concern capital requirements
Under the Swiss SRB requirements, total going concern minimum
requirements for all Swiss
SRBs are a capital ratio
requirement of
12.86%
of
RWA
and
a
leverage
ratio
requirement
of
4.5%.
In
addition
to
these
minimum
requirements,
an
add-on
reflecting
the
degree
of
systemic importance
is applied,
based
on market
share and LRD. The applicable market share add-on requirements
for
UBS
increased
0.36%
to
0.72%
of
RWA
and
0.125%
to
0.25% of LRD, reflecting an increase in
UBS’s market share in the
Swiss credit business to more than 17%. The applicable
LRD add-
on
requirements
remained
unchanged
at
0.72%
of
RWA
and
0.25% of LRD, as our Group LRD remained within the same add-
on bucket.
Effective
from
27 March
2020,
the
Swiss
Federal
Council
deactivated the countercyclical buffer requirement of 2% on risk-
weighted
positions
that
are
directly
or
indirectly
backed
by
residential
properties
in
Switzerland
to
support
the
lending
capacity of
banks. Even
though the
Swiss countercyclical
buffer
requirement
was
not
active
in
2021
,
we
continued
to
apply
additional countercyclical buffer requirements
introduced in other
BCBS
member jurisdictions,
which result
in an
additional
buffer
requirement of
0.02%. In
January 2022, the
Swiss Federal
Council
decided, at the
request of the
Swiss National Bank,
to reactivate
the
countercyclical
capital
buffer,
at
a
maximum level
of
2.5%.
The reactivated
countercyclical capital
buffer will
become effective
on
30 September
2022
and
is
expected
to
increase
our
CET1
capital requirement by approximately 30 basis points.
The
total
going
concern
capital
requirements
applicable
are
14.32%
of
RWA
(including
countercyclical
buffer
requirements)
and
5.00%
of
LRD.
Furthermore,
of
the
total
going
concern
capital requirement of 14.32% of RWA, at least
10.02% must be
met
with
CET1
capital,
while
a
maximum
of
4.3%
can
be
met
with
high-trigger
loss-absorbing
AT1
capital
instruments
(including
our
existing
outstanding
low
-
trigger
AT1
capital
instruments, which qualify
until their first call
date as mentioned
above).
Similarly, of the total going
concern leverage ratio requirement
of 5.00%, at least
3.5% must be met with
CET1 capital, while a
maximum of
1.5% can
be met
with high-trigger
loss-absorbing
AT1 capital
instruments (including
our existing
outstanding low-
trigger AT1
capital instruments, which
qualify until their
first call
date as mentioned above).
153
Gone concern loss-absorbing capacity requirements
As an internationally active Swiss SRB, UBS
is also subject to gone
concern loss-absorbing capacity requirements. The gone
concern
requirements also include add-ons for market share and LRD.
Under the Swiss
SRB framework, banks
are eligible for
a rebate
on
the
gone
concern
requirement
if
they
take
actions
that
facilitate
recovery
and
resolvability
beyond
the
minimum
requirements. The amount
of the rebate
for improved resolvability
is
assessed
annually
by
FINMA.
Based
on
actions
we
had
completed
by
December
2020
to
improve
resolvability,
FINMA
granted a rebate on
the gone concern
requirement of 55% of
the
aforementioned
maximum
rebate
in
the
third
quarter
of
2021,
which resulted
in a
reduction of
3.14 percentage points
for the
RWA-based
requirement
and
1.10 percentage
points
for
the
LRD-based requirement.
Our
gone
concern
requirements
are
further
reduced
when
higher
quality
capital
instruments
(
CET1
capital,
low
-
trigger
loss
-
absorbing
AT1
or
certain
low
-
trigger
tier
2
capital
instruments)
are used to meet gone concern
requirements. As of
31
December
202
1
,
UBS
used
low
-
trigger
tier
2
capital
instruments
to
fulfill
gone
concern
requirements,
resulting
in
a
reduction
o
f
0.4
3
percentage
points
for
the
RWA
-
based
requirement
and
0.
1
2
percentage
points
for
the
LRD
-
based
requirement.
Until 31 December 2021, the gone concern
requirement after
the
application
of
the
rebate
for
resolvability
measures
and
the
reduction
for
the
use
of
higher
quality
capital
instruments
was
floored
at
8.6%
and
3%
for
the
RWA
-
and
LRD
-
based
requirements
,
respectively.
From
1
January
2022
onward,
this
floor increased to 10% and 3.75%
for the RWA- and LRD-based
requirements,
respectively.
In
this
report
,
we
refer
to
the
RWA
-
based
gone
concern
requirements
as
gone
concern
loss-absorbing
capacity
requirements and
the RWA-based
gone concern
ratio is
referred
to as the gone concern loss-absorbing capacity ratio.
The
table
below
provides
the
RWA
-
and
LRD
-
based
requirements and information as of 31 December 2021.
Swiss SRB going and gone concern requirements and information
As of 31.12.21
RWA
LRD
USD million, except where indicated
in %
in %
Required going concern capital
Total going concern capital
14.32
1
43,281
5.00
1
53,443
Common equity tier 1 capital
10.02
30,286
3.50
2
37,410
of which: minimum capital
4.50
13,599
1.50
16,033
of which: buffer capital
5.50
16,621
2.00
21,377
of which: countercyclical buffer
0.02
66
Maximum additional tier 1 capital
4.30
12,995
1.50
16,033
of which: additional tier 1 capital
3.50
10,577
1.50
16,033
of which: additional tier 1 buffer capital
0.80
2,418
Eligible going concern capital
Total going concern capital
20.02
60,488
5.66
60,488
Common equity tier 1 capital
14.98
45,281
4.24
45,281
Total loss-absorbing additional tier 1 capital
3
5.03
15,207
1.42
15,207
of which: high-trigger loss-absorbing additional tier 1 capital
4.23
12,783
1.20
12,783
of which: low-trigger loss-absorbing additional tier 1 capital
0.80
2,425
0.23
2,425
Required gone concern capital
Total gone concern loss-absorbing capacity
4
10.74
32,444
3.78
40,388
of which: base requirement
5
12.86
38,864
4.50
48,099
of which: additional requirement for market share and LRD
1.44
4,352
0.50
5,344
of which: applicable reduction on requirements
(3.56)
(10,772)
(1.22)
(13,056)
of which: rebate granted (equivalent to 55% of maximum rebate)
(3.14)
(9,474)
(1.10)
(11,757)
of which: reduction for usage of low-trigger tier 2 capital instruments
(0.43)
(1,298)
(0.12)
(1,298)
Eligible gone concern capital
Total gone concern loss-absorbing capacity
14.65
44,264
4.14
44,264
Total tier 2 capital
1.04
3,144
0.29
3,144
of which: low-trigger loss-absorbing tier 2 capital
0.86
2,596
0.24
2,596
of which: non-Basel III-compliant tier 2 capital
0.18
547
0.05
547
TLAC-eligible senior unsecured debt
13.61
41,120
3.85
41,120
Total loss-absorbing capacity
Required total loss-absorbing capacity
25.06
75,725
8.78
93,831
Eligible total loss-absorbing capacity
34.66
104,752
9.80
104,752
Risk-weighted assets / leverage ratio denominator
Risk-weighted assets
302,209
Leverage ratio denominator
1,068,862
1 Includes applicable add-ons of 1.44% for
RWA and 0.50% for LRD.
2 Our minimum CET1 leverage ratio requirement of 3.5%
consists of a 1.5% base requirement, a 1.5%
base buffer capital requirement, a 0.25%
LRD add-on requirement and a 0.25% market
share add-on requirement based on our Swiss credit business.
3 Includes outstanding low-trigger loss-absorbing additional tier 1 (AT1)
capital instruments, which are
available under the Swiss SRB
framework to meet the going concern
requirements until their first call
date. As of their first call
date, these instruments are eligible to
meet the gone concern requirements.
4 A maximum
of 25% of the gone concern requirements can be met with instruments that have a remaining maturity of between one and two years. Once at least 75% of the minimum gone concern
requirement has been met with
instruments that have a remaining
maturity of greater than
two years, all instruments
that have a remaining
maturity of between one
and two years remain
eligible to be included in
the total gone concern
capital.
5 The gone concern requirement after the application of the rebate for resolvability measures and the reduction for the use of higher quality capital instruments is floored at 8.6% and 3% for the RWA-
and LRD-based
requirements, respectively. This means that the combined reduction may not exceed 5.7 percentage points for the RWA-based requirement of 14.3% and
2.0 percentage points for the LRD-based requirement of 5.0%.
Risk, capital, liquidity and funding, and balance sheet | Capital management
154
Total loss-absorbing capacity
Swiss SRB going and gone concern information
USD million, except where indicated
31.12.21
31.12.20
Eligible going concern capital
Total going concern capital
60,488
56,178
Total tier 1 capital
60,488
56,178
Common equity tier 1 capital
45,281
39,890
Total loss-absorbing additional tier 1 capital
15,207
16,288
of which: high-trigger loss-absorbing additional tier 1 capital
12,783
13,711
of which: low-trigger loss-absorbing additional tier 1 capital
2,425
2,577
Eligible gone concern capital
Total gone concern loss-absorbing capacity
44,264
45,545
Total tier 2 capital
3,144
7,744
of which: low-trigger loss-absorbing tier 2 capital
2,596
7,201
of which: non-Basel III-compliant tier 2 capital
547
543
TLAC-eligible senior unsecured debt
41,120
37,801
Total loss-absorbing capacity
Total loss-absorbing capacity
104,752
101,722
Risk-weighted assets / leverage ratio denominator
Risk-weighted assets
302,209
289,101
Leverage ratio denominator
1,068,862
1,037,150
1
Capital and loss-absorbing capacity ratios (%)
Going concern capital ratio
20.0
19.4
of which: common equity tier 1 capital ratio
15.0
13.8
Gone concern loss-absorbing capacity ratio
14.6
15.8
Total loss-absorbing capacity ratio
34.7
35.2
Leverage ratios (%)
1
Going concern leverage ratio
5.7
5.4
of which: common equity tier 1 leverage ratio
4.24
3.85
Gone concern leverage ratio
4.1
4.4
Total loss-absorbing capacity leverage ratio
9.8
9.8
1 The leverage ratio
denominator (LRD) and leverage ratios
for 31 December 2020 do
not reflect the effects of the
temporary exemption that applied
from 25 March 2020 until
1 January 2021 and was
granted by
FINMA in connection
with COVID-19.
Refer to the
“Regulatory and legal
developments” section
and to
“Application
of the temporary
COVID-19-related FINMA
exemption of central
bank sight deposits”
in the
“Capital, liquidity and funding, and balance sheet” sections of our Annual Report 2020 for more information.
Audited |
Reconciliation of IFRS equity to Swiss SRB common equity tier 1 capital
USD million
31.12.21
31.12.20
Total IFRS equity
61,002
59,765
Equity attributable to non-controlling interests
(
340
)
(
319
)
Defined benefit plans, net of tax
(
270
)
(
41
)
Deferred tax assets recognized for tax loss carry-forwards
(
4,565
)
(
5,617
)
Deferred tax assets on temporary differences, excess over threshold
(
49
)
(
5
)
Goodwill, net of tax
1
(
5,838
)
(
6,319
)
Intangible assets, net of tax
(
180
)
(
296
)
Compensation-related components (not recognized in net
profit)
(
1,700
)
(
1,349
)
Expected losses on advanced internal ratings-based portfolio less provisions
(
482
)
(
330
)
Unrealized (gains) / losses from cash flow hedges, net of tax
(
628
)
(
2,321
)
Own credit related to gains / losses on financial liabilities
measured at fair value that existed at the balance sheet date
315
382
Own credit related to gains / losses on derivative financial instruments
that existed at the balance sheet date
(
50
)
(
45
)
Unrealized gains related to debt instruments at fair value through
OCI, net of tax
(
68
)
(
152
)
Prudential valuation adjustments
(
167
)
(
150
)
Accruals for dividends to shareholders
(
1,700
)
(
1,314
)
Capital reserve for potential share repurchases
(
2,000
)
Other
1
0
Total common equity tier 1 capital
45,281
39,890
1 Includes goodwill
related to significant
investments in financial
institutions of USD
22
million as of 31
December 2021 (31
December 2020: USD
413
million) presented on
the balance sheet
line Investments in
associates.
p
155
Total loss-absorbing capacity and movement
Our total
loss-absorbing capacity increased
by USD 3.0 billion
to
USD 104.8 billion as of 31 December 2021.
Going concern capital and movement
Audited |
Our
CET1
capital mainly
consists of:
share
capital; share
premium,
which
primarily
consists
of
additional
paid-in
capital
related
to
shares
issued;
and
retained
earnings.
A
detailed
reconciliation of
IFRS
equity
to
CET1
capital
is
provided
in
the
“Reconciliation of IFRS equity to Swiss
SRB common equity tier 1
capital” table.
Our
CET1
capital
increased
by
USD
5.4
billion
to
USD
45.3
billion as
of 31 December
2021, mainly
as a
result of
operating
profit before
tax of
USD
9.5
billion, a
USD
0.5
billion increase
in
eligible deferred
tax assets
on temporary
differences, a
USD
0.4
billion decrease
in deduction
of goodwill
resulting from
the sale
of
our
remaining
minority
investment
in
Clearstream
Fund
Centre AG (previously Fondcenter
AG) and
an increase of
USD
0.2
billion related
to the
launch of
our new
operational partnership
entity
with
Sumitomo
Mitsui
Trust
Holdings,
Inc.
These
effects
were partly offset by dividend accruals of USD
1.7
billion, current
tax expenses
of USD
1.6
billion, share
repurchases under
our share
repurchase program of USD
0.6
billion, negative foreign currency
effects of
USD
0.6
billion, compensation- and
own share-related
capital components of USD
0.4
billion, and negative effects from
defined benefit plans of USD
0.2
billion.
Our
share
repurchases
in
2021
decreased
CET1
capital
by
USD
0.6
billion,
reflecting
shares
repurchased
under
our
share
repurchase programs
of USD
2.6
billion, partly
offset by
the use
of the
capital reserve
for potential share
repurchases of
USD
2.0
billion.
The
capital
reserve
for
potential
share
repurchases
was
fully utilized during 2021.
›
Refer to “UBS shares” in this section for more
information about
our share repurchase programs
Our loss-absorbing additional tier 1 (AT1) capital decreased by
USD
1.1
billion
to
USD
15.2
billion,
mainly
due
to
two
calls
of
USD
2.6
billion
of
AT1
capital
instruments
denominated
in
US
dollars
and
foreign
currency
translation
and
interest
rate
risk
hedge effects,
partly offset
by two issuances
of USD
2.25
billion
of AT1 capital instruments denominated in US dollars.
p
Gone concern loss-absorbing capacity and movement
Audited |
Our total gone
concern loss-absorbing capacity decreased
by USD 1.3
billion to
USD
44.3
billion as
of 31 December
2021 and
included
USD
41.1
billion
of
TLAC-eligible
senior
unsecured
debt.
p
The
decrease
was
mainly
due
to
four
TLAC-eligible
senior
unsecured debt instruments
denominated in US dollars,
euro and
Swiss francs
that ceased to
be eligible as
they had less
than one
year to maturity, the call of a low-trigger tier 2 capital instrument
denominated
in euro,
a
low-trigger loss-absorbing
tier 2
capital
instrument denominated
in US
dollars that
ceased to
be eligible
as it
had less
than one
year to
maturity, and
the call
of a
TLAC-
eligible senior
unsecured debt
instrument denominated
in euro,
as well as
interest rate risk
hedge, foreign
currency translation and
other effects. These
decreases were partly
offset by 16
issuances
of TLAC-eligible senior unsecured debt instruments
denominated
in euro,
US dollars,
Swiss francs,
pounds sterling
and Australian
dollars.
Loss-absorbing capacity and leverage ratios
Our CET1 capital ratio increased
1.2 percentage points to 15.0%,
reflecting a USD 5.4
billion increase in
CET1 capital
that was
partly
offset by a USD 13.1 billion increase in RWA.
Our CET1
leverage ratio
increased 0.39
percentage points
to
4.24% as of 31 December 2021, as the aforementioned increase
in CET1
capital was
partly offset
by a
USD 32 billion
increase in
LRD.
Our gone
concern loss-absorbing
capacity ratio
decreased from
15.8% to 14.6% and our gone concern leverage ratio decreased
from
4.4%
to
4.1%,
mainly
driven by
an
increase in
RWA and
LRD,
respectively,
and
the
aforementioned
decrease
in
gone
concern loss-absorbing capacity.
Risk, capital, liquidity and funding, and balance sheet | Capital management
156
Swiss SRB total loss-absorbing capacity movement
USD million
Going concern capital
Swiss SRB
Common equity tier 1 capital as of 31.12.20
39,890
Operating profit before tax
9,484
Current tax (expense) / benefit
(1,564)
Deferred tax assets on temporary differences
544
Goodwill and intangible assets
519
Accruals for proposed dividends to shareholders
(1,700)
Share repurchase program
(2,612)
Capital reserve for potential share repurchases
2,000
Foreign currency translation effects before tax
(570)
Compensation-
and own share-related capital components
(441)
Defined benefit plans
1
(234)
Other
(34)
Common equity tier 1 capital as of 31.12.21
45,281
Loss-absorbing additional tier 1 capital as of 31.12.20
16,288
Issuance of high-trigger loss-absorbing additional tier 1 capital
2,250
Call of high-trigger loss-absorbing additional tier 1 capital
(2,600)
Interest rate risk hedge, foreign currency translation and other effects
(731)
Loss-absorbing additional tier 1 capital as of 31.12.21
15,207
Total going concern capital as of 31.12.20
56,178
Total going concern capital as of 31.12.21
60,488
Gone concern loss-absorbing capacity
Tier 2 capital as of 31.12.20
7,744
Call of low-trigger loss-absorbing tier 2 capital
(2,415)
Debt no longer eligible as gone concern loss-absorbing capacity
due to residual tenor falling to below one year
(2,020)
Interest rate risk hedge, foreign currency translation and other effects
(166)
Tier 2 capital as of 31.12.21
3,144
TLAC-eligible senior unsecured debt as of 31.12.20
37,801
Issuance of TLAC-eligible senior unsecured debt
11,956
Call of TLAC-eligible senior unsecured debt
(2,027)
Debt no longer eligible as gone concern loss-absorbing capacity
due to residual tenor falling to below one year
(4,248)
Interest rate risk hedge, foreign currency translation and other effects
(2,362)
TLAC-eligible senior unsecured debt as of 31.12.21
41,120
Total gone concern loss-absorbing capacity as of 31.12.20
45,545
Total gone concern loss-absorbing capacity as of 31.12.21
44,264
Total loss-absorbing capacity
Total loss-absorbing capacity as of 31.12.20
101,722
Total loss-absorbing capacity as of 31.12.21
104,752
1 Includes a pension
plan curtailment of USD
80 million that reduced
the defined benefit obligation
and a USD 254
million payment of
the second installment to
employees’ retirement assets in
the Swiss pension
fund. As announced in 2018, a similar contribution will be made in the first quarter of 2022. Refer to “Note
29 Pension and other post-employment benefit plans” in the “Consolidated
financial statements” section
of the Annual Report 2019 for more information.
Additional information
Active management of sensitivity to foreign exchange
movements
Group
Treasury
is
mandated
to
minimize
adverse
effects
from
changes
in
foreign
currency
rates
on
our
CET1
capital
and / or
CET1 capital
ratio. A
significant portion
of our
CET1 capital
and
RWA
is denominated
in Swiss
francs, euro,
pounds sterling
and
other currencies.
In order
to hedge
the CET1
capital ratio,
CET1
capital
needs
to
have
foreign
currency
exposure,
leading
to
foreign currency rates sensitivity of CET1 capital.
As
a
consequence,
it
is
not
possible
to
simultaneously
fully
hedge CET1 capital and the CET1 capital ratio. As the proportion
of
RWA
denominated
in
currencies
other
than
the
US
dollar
outweighs
CET1
capita
l
in
such
currencies,
a
significant
appreciation of the
US dollar
against such currencies
could benefit
our capital ratios, while a significant depreciation of the US dollar
against these currencies could adversely affect our capital ratios.
The Group Asset and Liability Committee (the Group ALCO), a
committee of
the Group
Executive Board,
has mandated
Group
Treasury to
adjust the
currency mix of
CET1 capital,
within limits
set
by
the
BoD,
to
balance
the
effect
of
foreign
exchange
movements on CET1 capital and the CET1 capital ratio. Limits are
in
place
for
the
sensitivity
of
both
CET1
capital
and
the
CET1
capital
ratio
to
an
appreciation
or
depreciation
of
10%
in
the
value of the US dollar against other currencies.
Sensitivity to currency movements
Risk-weighted assets
We
estimate
that
a 10%
depreciation
of
the
US dollar
against
other
currencies
would
have
increased
our
RWA
by
USD 13
billion
and
our
CET1
capital
by
USD
1.
4
billion
as
of
31
December
202
1
(31
December
2020
:
USD
1
3
billion
and
USD 1.3
billion,
respectively
)
and
decreased
our
CET1
capital
ratio 15
basis points
(31 December
2020:
15 basis points)
.
Conversely,
we
estimate
that
a
10%
appreciation
of
the
US
dollar against other currencies
would have decreased our RWA
by
USD
1
1
billion
and
our
CET1
capital
by
USD
1.
3
billion
(31
December
20
20
:
USD
1
2
billion
and
USD
1.
2
billion,
respectively)
and increased our
CET1 capital ratio
14 basis points
(31 December 2020: 15 basis points).
157
Leverage ratio denominator
Our
leverage
ratio
is
also
sensitive
to
foreign
exchange
movements as a result of
the currency mix of our
capital and LRD.
When adjusting
the currency
mix in
capital, potential
effects on
the going concern
leverage ratio are
taken into account
and the
sensitivity of the
going concern leverage ratio
to an appreciation
or depreciation of 10% in
the value of the
US dollar against other
currencies is actively monitored.
We estimate that a 10% depreciation of
the US dollar against
other currencies would have increased our LRD
by USD 63 billion
as
of
31 December
2021
(31 December
2020:
USD 65
billion)
and
decreased
our
Swiss
SRB
going
concern
leverage
ratio
15 basis points (31 December 2020:
16
basis points). Conversely,
we
estimate
that
a
10%
appreciation
of
the
US
dollar
against
other currencies would have decreased our LRD by
USD 57 billion
(31 December 20
20:
USD 58
billion) and increased our Swiss
SRB
going concern leverage
ratio 16 basis points
(31 December 20
20:
16
basis points)
.
The
aforementioned
sensitivities
do
not
consider
foreign
currency translation effects related to defined benefit plans other
than those related to the currency translation of the net equity of
foreign operations.
Estimated effect on capital from litigation, regulatory and similar
matters subject to provisions and contingent liabilities
We
have estimated
the
loss
in
capital
that
we
could
incur
as
a
result
of
the
risks
associated
with
the
matters
described
in
“
Note
18
Provisions
and
contingent
liabilities
”
in
the
“Consolidated
financial
statements”
section
of
this
report.
We
have
employed
for
this
purpose
the
advanced
measurement
approach (AMA) methodology that
we use when
determining the
capital requirements associated with operational risks,
based on a
99.9%
confidence
level
over
a
12-month
horizon.
The
methodology
takes
into
consideration
UBS
and
industry
experience for
the AMA
operational risk
categories to
which those
matters correspond, as well as the
external environment affecting
risks of
these types,
in isolation
from other
areas. On
this basis,
we estimate the maximum loss in
capital that we could incur over
a 12-month
period as
a result
of our
risks associated
with these
operational risk
categories at
USD 4.0 billion
as of
31 December
2021,
with
no
change
to
prior
year-end.
This
estimate
is
not
related
to
and
does
not
take
into
account
any
provisions
recognized
for
any
of
these
matters
and
does
not
constitute
a
subjective
assessment
of
our
actual
exposure
in
any
of
these
matters.
›
Refer to “Non-financial risk” in the “Risk
management and
control” section of this report for more information
›
Refer to “Note 18 Provisions and contingent
liabilities” in the
“Consolidated financial statements”
section of this report for
more information
Capital and capital ratios of our significant regulated subsidiaries
UBS Group AG is
a holding company conducting substantially
all
operations through UBS AG and
subsidiaries thereof. UBS Group
AG and
UBS AG
have
contributed a
significant portion
of
their
respective
capital
to,
and
provide
d
substantial
liquidity
to
,
subsidiaries. Many of these subsidiaries are subject to regulations
requiring compliance
with minimum
capital, liquidity
and similar
requirements. Regulatory capital
components and capital
ratios of
our
significant
regulated
subsidiaries
determined
under
the
regulatory
framework of
each subsidiary’s
home jurisdiction
are
provided
in
the
“Financial
and
regulatory
key
figures
for
our
significant regulated subsidiaries and
sub-groups” section of this
report. Supervisory authorities
generally have discretion
to impose
higher
requirements
,
or
to
otherwise
limit
the
activities
of
subsidiaries.
Supervisory
authorities
also
may
require
entities
to
measure capital and
leverage ratios on a
stressed basis,
and may
limit the
ability of
the entity
to engage
in new
activities or
take
capital actions based on the results of those tests.
›
Refer to the 31 December 2021 Pillar 3
Report,
available under
“Pillar 3 disclosures” at
ubs.com/investors
,
for more capital and
other regulatory information about our significant
regulated
subsidiaries and sub-groups
Joint liability of UBS AG and UBS Switzerland AG
In
June
2015,
upon
the
transfer
of
the
Personal
&
Corporate
Banking and
Global Wealth
Management businesses
booked in
Switzerland from
UBS AG
to UBS
Switzerland AG,
UBS AG
and
UBS
Switzerland
AG
assumed
joint
liability
for
obligations
transferred
to
UBS
Switzerland
AG
and
existing
at
UBS
AG,
respectively.
Under certain circumstances,
the Swiss Banking
Act
and FINMA’s
Banking Insolvency
Ordinance
authorize FINMA
to
modify,
extinguish
or
convert
to
common
equity
liabilities
of
a
bank in connection with a resolution or insolvency of such bank.
The
joint
liability
amounts
have
declined
as
obligations
matured, terminated or were
novated following the transfer
date.
As
of
31 December
2021,
the
liability
of
UBS
Switzerland
AG
amounted to CHF 5.2 billion (the equivalent of USD 5.7 billion),
a
decrease
of
CHF
3.7
billion
(USD
4.4
billion)
compared
with
31 December 2020.
The respective
liability of
UBS AG
has been
substantially extinguished.
Risk, capital, liquidity and funding, and balance sheet | Capital management
158
Risk-weighted assets
RWA development in 2021
During
2021, RWA
increased
by USD 13.1
billion
to USD 302.2
billion, primarily
driven by
increases
of USD 12.0
billion in
credit
and counterparty
credit risk
RWA,
USD 1.0 billion
in operational
risk
RWA
and
USD 0.9
billion
in
non-counterparty-related
risk.
These increases were partly
offset by a
decrease of USD 0.8
billion
in market risk RWA.
›
Refer to the 31 December 2021 Pillar 3
Report,
available under
“Pillar 3 disclosures” at
ubs.com/investors
, for more information
about RWA movements and definitions of RWA movement key
drivers
Movement in risk-weighted assets by key driver
USD billion
RWA as of
31.12.20
Currency
effects
Methodology
and policy
changes
Model
updates /
changes
Regulatory
add-ons
Asset size and
Other
1
RWA as of
31.12.21
Credit and counterparty credit risk
2
178.1
(4.1)
2.0
5.3
3.1
5.8
190.1
Non-counterparty-related risk
3
23.4
(0.3)
1.2
24.3
Market risk
11.8
(0.1)
3.1
4
(3.7)
11.1
Operational risk
75.8
1.0
76.7
Total
289.1
(4.4)
2.0
6.1
6.2
3.2
302.2
1 Includes
the Pillar
3 categories
“Asset
size,”
“Credit quality
of counterparties,”
“Acquisitions
and disposals”
and “Other.”
Refer to
the 31
December 2021
Pillar 3
Report under
“Pillar 3
disclosures”
at
ubs.com/investors for more
information.
2 Includes settlement
risk, credit valuation
adjustments, equity
exposures in the
banking book and
securitization exposures in
the banking book.
3 Non-counterparty-
related risk includes deferred tax assets recognized for temporary
differences, property, equipment, software
and other items.
4 As of 31 December 2021, the regulatory add-on related to
time decay was USD 3.5
billion.
Credit and counterparty credit risk
Credit
and counterparty
credit risk
RWA
increased
by USD 12.0
billion to USD 190.1
billion as
of 31 December
2021. This increase
was partly driven
by asset size and
other movements of
USD 5.8
billion,
due to an increase
in asset size
of USD 8.8 billion, mainly
due to loan growth
in Global Wealth
Management, partly offset
by asset
quality movements
of USD 3.1
billion, mainly
reflecting
improvements in counterparty
ratings and
loss given
default (LGD)
in
Global
Wealth
Management
and
Personal
&
Corporate
Banking.
Also,
2021 included
increases
from
model
updates of
USD 5.3
billion,
regulatory
add-ons
of
USD 3.1
billion,
and
methodology
and
policy
changes
of
USD 2.0
billion.
These
increases were partly offset by decreases from currency effects of
USD 4.1 billion.
Movement in credit and counterparty credit risk RWA by key driver
1
USD billion
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
Group
Total credit and counterparty credit risk RWA as of 31.12.20
46.7
62.8
2.9
58.5
7.2
178.1
Asset size
5.5
1.1
0.3
1.8
0.1
8.8
Asset quality
(1.3)
(1.1)
0.0
(0.4)
(0.3)
(3.1)
Model updates
4.3
1.2
0.0
(0.2)
0.0
5.3
Methodology and policy changes
1.7
0.3
0.0
0.0
0.0
2.0
Regulatory add-ons
0.2
0.7
0.0
2.3
(0.1)
3.1
Acquisitions and disposals
0.0
0.0
0.0
0.0
0.0
0.0
Foreign exchange movements
(0.6)
(1.6)
0.0
(1.4)
(0.5)
(4.1)
Other
0.4
(0.4)
0.0
0.0
0.0
0.1
Total movement
10.2
0.2
0.3
2.1
(0.8)
12.0
Total credit and counterparty credit risk RWA as of 31.12.21
56.9
63.0
3.2
60.5
6.4
190.1
1 Refer to the 31 December 2021 Pillar 3 Report under “Pillar 3 disclosures” at ubs.com/investors for the definitions of credit and
counterparty credit risk RWA movement categories.
159
Model updates
The
increase
in
credit
and
counterparty
credit
risk
RWA
from
model
updates
of
USD 5.3
billion
was
primarily
driven
by
the
phase-in impacts for structured margin
loans and similar products
in
Global
Wealth
Management
of
USD 2.1
billion
and
by
new
probability
of
default
(PD)
and
LGD
models
for
the
mortgage
portfolio
in
the
US
of
USD
2.0
billion.
In
addition,
we
have
updated
the
LGD
model
for
mortgages
in
Switzerland,
which
resulted
in
an
RWA
increase
of
USD 0.9
billion
and
was
partly
offset
by
an
RWA
reduction
of
USD 0.3
billion
related
to
the
introduction
of
new
models
for
the
leasing
of
aircraft
and
industrial goods.
›
Refer to “Credit risk models” in the “Risk management
and
control” section of this report for more information about
model
updates
Methodology changes
The
increase
in
credit
and
counterparty
credit
risk
RWA
from
methodology changes
of USD 2.0 billion
was primarily driven
by
a
change
related
to
credit
valuation
adjustment
(CVA)
risk
for
derivative
exposures
with
Lombard
clients
that
resulted
in
an
increase of
USD 1.1 billion
in
RWA.
Additionally,
the
approach
used
for
the
covered
bonds
within
the
high-quality
liquid
asset
(HQLA) portfolio
has been
changed from
the advanced
internal
ratings-based (A-IRB) approach
to the standardized
approach, as
requested
by
FINMA,
resulting
in
an
RWA
increase
of
USD 1.0
billion.
Regulatory add-ons
The
increase
in
credit
and
counterparty
credit
risk
RWA
from
regulatory add-ons of USD
3.1 billion was
primarily driven by
add-
ons
for
prime
brokerage
clients
of
USD 2.4
billion,
credit
card
exposures
in
Switzerland
of
USD 0.5
billion,
as
well
as
clients
leasing aircraft and industrial goods of USD 0.4 billion.
›
Refer to the “Risk management and control”
section of this
report and the 31 December 2021
Pillar 3 Report,
available under
“Pillar 3 disclosures” at
ubs.com/investors
, for more information
about credit and counterparty credit risk developments
We
expect
that
further
methodology
changes
and
model
updates,
as
well
as
regulatory
add-ons,
will
increase
credit
and
counterparty credit
risk RWA
by around
USD 10 billion
in 2022.
The extent and timing of RWA changes
may vary as methodology
changes and model
updates are completed
and receive regulatory
approval. In addition, changes in
the composition of the relevant
portfolios and other market factors will affect RWA.
Risk, capital, liquidity and funding, and balance sheet | Capital management
160
Non-counterparty-related risk
Non-counterparty credit risk RWA increased by USD 0.9 billion to
USD 24.3
billion as of 31 December 202
1, primarily driven by an
increase in deferred tax assets on temporary differences.
Market risk
Market risk RWA decreased by USD 0.8
billion to USD 11.1 billion
as
of
31
December
202
1
,
primarily
driven
by
a
decrease
of
USD 3.7 billion from
portfolio and market movements
,
mostly in
the
Investment Bank’s
Global Markets
business.
This was
partly
offset by an increase
from regulatory add-ons of
USD 3.1 billion,
primarily related to time decay. The integration of time
decay into
the
regulatory
VaR
model
is
subject
to
further
discussions
between FINMA and UBS.
›
Refer to the “Risk management and control”
section of this
report and the 31 December 2021 Pillar 3 Report,
available under
“Pillar 3 disclosures” at
ubs.com/investors,
for more information
about market risk developments
Operational risk
Operational
risk RWA
increased
by USD
1.0 billion
to
USD 76.7
billion as of
31 December 2021,
driven by
the annual
recalibration
of
the
AMA
model
used
for
the
calculation
of
operational
risk
capital. Allocations to
the business divisions
changed in the
fourth
quarter of 2021,
as certain historical
losses dropped from
the time
window that is relevant for the internal allocation approach.
We are
assessing the effect
of the
verdict in
the French
cross-
border
matter
and
the
corresponding
changes
in
provisions
for
litigation, regulatory and similar matters on operational risk RWA
in
consultation
with
FINMA.
We
expect
to
reflect
additional
operational risk RWA in the first quarter of
2022, with a potential
single
-
digit
billion
US
dollar
operational
risk
RWA
impact
following completion of this assessment.
›
Refer to “Advanced measurement approach model”
in the “Risk
management and control” section of this report for
more
information about the AMA model
Risk-weighted assets by business division and Group Functions
USD billion
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Manage-
ment
Investment
Bank
Group
Functions
Total
RWA
31.12.21
Credit and counterparty credit risk
1
56.9
63.0
3.2
60.5
6.4
190.1
Non-counterparty-related risk
2
6.2
2.0
0.6
3.5
12.0
24.3
Market risk
1.6
0.0
8.1
1.5
11.1
Operational risk
35.2
8.1
3.0
20.2
10.3
76.7
Total
99.8
73.2
6.9
92.2
30.1
302.2
31.12.20
Credit and counterparty credit risk
1
46.7
62.8
2.9
58.5
7.2
178.1
Non-counterparty-related risk
2
6.2
2.1
0.7
3.6
10.7
23.4
Market risk
1.4
0.0
9.0
1.4
11.8
Operational risk
32.8
7.2
3.3
23.2
9.3
75.8
Total
87.2
72.1
6.9
94.3
28.7
289.1
31.12.21 vs 31.12.20
Credit and counterparty credit risk
1
10.2
0.2
0.3
2.1
(0.8)
12.0
Non-counterparty-related risk
2
0.0
(0.1)
(0.1)
(0.2)
1.2
0.9
Market risk
0.1
0.0
(0.9)
0.1
(0.8)
Operational risk
2.4
0.9
(0.3)
(3.0)
1.0
1.0
Total
12.7
1.1
(0.1)
(2.0)
1.5
13.1
1 Includes settlement risk, credit
valuation adjustments, equity exposures in the banking
book and securitization exposures in
the banking book.
2 Non-counterparty-related risk includes deferred
tax assets recognized
for temporary differences (31 December 2021: USD 11.4
billion; 31 December 2020: USD 10.0 billion), as well
as property, equipment, software and
other items (31 December 2021: USD 12.9 billion; 31
December
2020: USD 13.4 billion).
161
Leverage ratio denominator
LRD increased by USD 32 billion
to USD 1,069 billion as of 31 December
2021, driven by asset size and
other movements of USD 54
billion,
partly offset by a decrease due to currency effects of USD 23 billion.
Movement in leverage ratio denominator by key driver
USD billion
LRD as of
31.12.20
1
Currency
effects
Asset size and
other
LRD as of
31.12.21
On-balance sheet exposures (excluding derivative exposures
and SFTs)
2
806.6
(17.0)
57.8
847.4
Derivative exposures
96.6
(2.7)
(3.0)
90.9
Securities financing transactions
115.3
(2.3)
(3.9)
109.2
Off-balance sheet items
31.3
(0.7)
2.2
32.8
Deduction items
(12.8)
0.1
1.2
(11.5)
Total
1,037.1
(22.6)
54.3
1,068.9
1 The respective period shown ending on 31 December 2020 does not reflect the effects of the temporary exemption that applied from 25 March 2020 until 1 January 2021 and was granted by FINMA in connection
with COVID-19. Refer
to the “Regulatory and
legal developments” section and
to “Application
of the temporary COVID
-19-related FINMA exemption of
central bank sight deposits”
in the “Capital, liquidity
and
funding, and balance
sheet” section of
our Annual Report
2020, available under
“Annual reporting”
at ubs.com/investors,
for more information.
2 The exposures
exclude derivative financial
instruments, cash
collateral receivables on
derivative instruments,
receivables from SFTs,
and margin loans,
as well as prime
brokerage receivables
and financial assets
at fair value
not held for trading,
both related to SFTs.
These
exposures are presented separately under Derivative exposures and Securities financing transactions in
this table.
The LRD movements described below exclude currency effects.
On-balance
sheet
exposures
(excluding
derivative
exposures
and SFTs)
increased by
USD 58 billion,
mainly driven
by an
increase
in central
bank balances
partly offset
by disposal
of high-quality
liquid asset (HQLA) securities in Group
Treasury, as well as higher
lending
balances,
mainly
in
Global
Wealth
Management,
and
trading assets in the Investment Bank.
Derivative
exposures
de
creased
by
USD
3
billion,
reflecting
market-driven movements and lower client volumes mainly in the
Investment Bank.
SFTs
decreased
by
USD 4
billion,
mainly
due
to
lower
prime
brokerage receivables and
margin loan repayments
as a result of
client activities in the Investment Bank.
›
Refer to “Balance sheet and off-balance sheet”
in this section for
more information about balance sheet movements
Risk, capital, liquidity and funding, and balance sheet | Capital management
162
Leverage ratio denominator by business division and Group Functions
USD billion
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
Total
31.12.21
Total IFRS assets
395.2
225.4
25.6
346.4
124.5
1,117.2
Difference in scope of consolidation
1
0.0
0.0
(21.5)
(0.1)
0.0
(21.6)
Less: derivative exposures and SFTs
2
(25.9)
(11.8)
(0.1)
(159.2)
(51.2)
(248.2)
On-balance sheet exposures
369.3
213.6
4.1
187.1
73.3
847.4
Derivative exposures
5.8
1.4
0.0
79.0
4.7
90.9
Securities financing transactions
22.6
10.9
0.0
45.7
29.9
109.2
Off-balance sheet items
7.2
17.5
0.0
7.6
0.5
32.8
Items deducted from Swiss SRB tier 1 capital
(5.3)
(0.2)
(1.2)
(0.3)
(4.4)
(11.5)
Total
399.6
243.2
2.9
319.2
104.0
1,068.9
31.12.20
3
Total IFRS assets
367.7
231.7
28.6
369.7
128.1
1,125.8
Difference in scope of consolidation
1
(0.1)
(21.1)
0.0
0.1
(21.2)
Less: derivative exposures and SFTs
2
(34.0)
(16.7)
(0.7)
(191.6)
(54.9)
(298.0)
On-balance sheet exposures
333.6
215.0
6.7
178.0
73.3
806.6
Derivative exposures
6.6
2.0
0.0
82.7
5.3
96.6
Securities financing transactions
30.1
15.1
0.7
46.5
22.9
115.3
Off-balance sheet items
6.1
16.3
0.0
8.5
0.4
31.3
Items deducted from Swiss SRB tier 1 capital
(5.2)
(0.1)
(1.6)
(0.3)
(5.5)
(12.8)
Total
371.2
248.3
5.8
315.5
96.2
1,037.1
31.12.21 vs 31.12.20
Total IFRS assets
27.5
(6.3)
(2.9)
(23.3)
(3.6)
(8.6)
Difference in scope of consolidation
1
0.1
0.0
(0.4)
(0.1)
(0.1)
(0.5)
Less: derivative exposures and SFTs
2
8.1
4.9
0.7
32.5
3.7
49.8
On-balance sheet exposures
35.7
(1.4)
(2.7)
9.1
0.0
40.8
Derivative exposures
(0.8)
(0.6)
0.0
(3.7)
(0.6)
(5.7)
Securities financing transactions
(7.5)
(4.2)
(0.7)
(0.8)
7.0
(6.2)
Off-balance sheet items
1.1
1.2
(0.9)
0.1
1.5
Items deducted from Swiss SRB tier 1 capital
(0.1)
0.0
0.4
0.0
1.1
1.3
Total
28.4
(5.1)
(2.9)
3.7
7.7
31.7
1 Represents the
difference between the
IFRS and the
regulatory scope of
consolidation, which is
the applicable scope
for the LRD
calculation.
2 The exposures
consist of derivative
financial instruments,
cash
collateral receivables on derivative instruments, receivables from SFTs,
and margin loans, as well as prime brokerage receivables and financial assets at fair value not held for trading,
both related to SFTs, all of which
are in accordance with the regulatory scope of consolidation. These exposures
are presented separately under Derivative exposures and Securities financing
transactions in this table.
3 The respective period shown
ending on 31 December 2020 does
not reflect the effects of the temporary
exemption that applied from 25 March
2020 until 1 January 2021
and was granted by FINMA
in connection with COVID-19. Refer
to the
“Regulatory and legal
developments” section and
to “Application
of the temporary
COVID-19-related FINMA
exemption of central
bank sight deposits”
in the “Capital,
liquidity and funding,
and balance sheet”
section of our Annual Report 2020, available under “Annual
reporting” at ubs.com/investors, for more information.
163
UBS AG consolidated total loss-absorbing capacity and leverage
ratio information
Going and gone concern requirements and information
UBS
is
considered
an
SRB
under
Swiss
banking
law
and,
on
a
consolidated basis, both UBS Group AG
and UBS AG are required
to
comply
with
regulations
based on
the Basel III
framework as
applicable for Swiss SRBs.
The
Swiss
SRB
framework
and
requirements
applicable
to
UBS AG
consolidated
are
consistent
with
those
applicable
to
UBS Group
AG
consolidated
and
are
described
in
the
“Capital,
liquidity and funding, and balance sheet” section of this report.
›
Refer to “Regulatory framework” in
this section for more
information about total loss-absorbing
capacity, leverage ratio
requirements and gone concern rebate
UBS AG is subject to
going and gone concern requirements
on
a standalone
basis. Capital
and other
regulatory information
for
UBS
AG
standalone
is
provided
under
“Holding
company
and
significant
regulated
subsidiaries
and
sub-groups”
at
ubs.com/investors
and
in the
31 December 2021
Pillar 3
Report
available under “Pillar 3 disclosures” at
ubs.com/investors
.
The table on the next page provides the RWA- and LRD-based
requirements
and
information
as
of
31 December
2021
for
UBS AG consolidated.
Risk, capital, liquidity and funding, and balance sheet | Capital management
164
Swiss SRB going and gone concern requirements and information
As of 31.12.21
RWA
LRD
USD million, except where indicated
in %
in %
Required going concern capital
Total going concern capital
14.32
1
42,824
5.00
1
53,384
Common equity tier 1 capital
10.02
29,966
3.50
2
37,369
of which: minimum capital
4.50
13,455
1.50
16,015
of which: buffer capital
5.50
16,445
2.00
21,354
of which: countercyclical buffer
0.02
66
Maximum additional tier 1 capital
4.30
12,857
1.50
16,015
of which: additional tier 1 capital
3.50
10,465
1.50
16,015
of which: additional tier 1 buffer capital
0.80
2,392
Eligible going concern capital
Total going concern capital
18.54
55,434
5.19
55,434
Common equity tier 1 capital
13.91
41,594
3.90
41,594
Total loss-absorbing additional tier 1 capital
3
4.63
13,840
1.30
13,840
of which: high-trigger loss-absorbing additional tier 1 capital
3.82
11,414
1.07
11,414
of which: low-trigger loss-absorbing additional tier 1 capital
0.81
2,426
0.23
2,426
Required gone concern capital
4
Total gone concern loss-absorbing capacity
5
10.74
32,100
3.78
40,343
of which: base requirement
12.86
38,452
4.50
48,046
of which: additional requirement for market share and LRD
1.44
4,306
0.50
5,338
of which: applicable reduction on requirements
(3.56)
(10,658)
(1.22)
(13,041)
of which: rebate granted (equivalent to 55% of maximum rebate)
(3.14)
(9,374)
(1.10)
(11,744)
of which: reduction for usage of low-trigger tier 2 capital instruments
(0.43)
(1,284)
(0.12)
(1,297)
Eligible gone concern capital
Total gone concern loss-absorbing capacity
14.80
44,264
4.15
44,264
Total tier 2 capital
1.05
3,144
0.29
3,144
of which: low-trigger loss-absorbing tier 2 capital
0.87
2,596
0.24
2,596
of which: non-Basel III-compliant tier 2 capital
0.18
547
0.05
547
TLAC-eligible senior unsecured debt
13.75
41,120
3.85
41,120
Total loss-absorbing capacity
Required total loss-absorbing capacity
25.06
74,923
8.78
93,727
Eligible total loss-absorbing capacity
33.34
99,698
9.34
99,698
Risk-weighted assets / leverage ratio denominator
Risk-weighted assets
299,005
Leverage ratio denominator
1,067,679
1 Includes applicable
add-ons of 1.44%
for RWA
and 0.50% for
LRD.
2 Our minimum
CET1 leverage ratio
requirement of 3.5%
consists of a
1.5% base requirement,
a 1.5% base
buffer capital requirement,
a 0.25% LRD add-on requirement and a 0.25% market
share add-on requirement based on our Swiss credit
business.
3 The relevant capital instruments were
issued after the new Swiss SRB framework
had been
implemented and qualify
as going concern
capital at the
UBS AG
consolidated level, as
agreed with FINMA.
4 A maximum of
25% of the
gone concern requirements
can be met
with instruments that
have a
remaining maturity of between one
and two years. Once at least
75% of the minimum gone
concern requirement has been met
with instruments that have a
remaining maturity of greater than
two years, all instruments
that have a remaining maturity
of between one and two
years remain eligible to be
included in the total gone
concern capital.
5 The gone concern
requirement after the application of
the rebate for resolvability
measures and the
reduction for the
use of higher
quality capital instruments
is floored at
8.6% and 3%
for the RWA-
and LRD-based requirements,
respectively. This
means that the
combined reduction
may not
exceed 5.7 percentage points for the RWA-based requirement of 14.3% and 2.0 percentage points for the LRD-based requirement
of 5.0%.
165
Swiss SRB going and gone concern information
USD million, except where indicated
31.12.21
31.12.20
Eligible going concern capital
Total going concern capital
55,434
52,610
Total tier 1 capital
55,434
52,610
Common equity tier 1 capital
41,594
38,181
Total loss-absorbing additional tier 1 capital
13,840
14,430
of which: high-trigger loss-absorbing additional tier 1 capital
11,414
11,854
of which: low-trigger loss-absorbing additional tier 1 capital
1
2,426
2,575
Eligible gone concern capital
Total gone concern loss-absorbing capacity
44,264
45,545
Total tier 2 capital
3,144
7,744
of which: low-trigger loss-absorbing tier 2 capital
2,596
7,201
of which: non-Basel III-compliant tier 2 capital
547
543
TLAC-eligible senior unsecured debt
41,120
37,801
Total loss-absorbing capacity
Total loss-absorbing capacity
99,698
98,155
Risk-weighted assets / leverage ratio denominator
Risk-weighted assets
299,005
286,743
Leverage ratio denominator
1,067,679
1,036,771
2
Capital and loss-absorbing capacity ratios (%)
Going concern capital ratio
18.5
18.3
of which: common equity tier 1 capital ratio
13.9
13.3
Gone concern loss-absorbing capacity ratio
14.8
15.9
Total loss-absorbing capacity ratio
33.3
34.2
Leverage ratios (%)
2
Going concern leverage ratio
5.2
5.1
of which: common equity tier 1 leverage ratio
3.90
3.68
Gone concern leverage ratio
4.1
4.4
Total loss-absorbing capacity leverage ratio
9.3
9.5
1 The relevant capital instruments were issued after the new Swiss SRB framework had been
implemented and qualify as going concern capital of UBS AG, as agreed with FINMA.
2 The leverage ratio denominator
(LRD) and leverage ratios for 31 December
2020 do not reflect the effects of the
temporary exemption that applied from 25
March 2020 until 1 January 2021
and was granted by FINMA in connection
with COVID-
19. Refer to “UBS AG consolidated total loss-absorbing capacity and leverage ratio information” in the “Capital, liquidity and funding, and balance sheet” section of
the combined UBS Group AG and UBS AG Annual
Report 2020, available under “Annual reporting” at
ubs.com/investors, for more information.
Risk, capital, liquidity and funding, and balance sheet | Capital management
166
UBS Group AG vs UBS AG consolidated loss-absorbing
capacity and leverage ratio information
The going
concern capital of
UBS AG consolidated
was USD 5.1
billion
lower
than
the
going
concern
capital
of
UBS
Group
AG
consolidated
as
of
31 December
2021,
reflecting
lower
CET1
capital of USD 3.7 billion and
lower going concern loss-absorbing
additional tier 1 (AT1) capital of USD 1.4 billion.
The
aforementioned
difference in
CET1
capital was
primarily
due to a
lower UBS AG
consolidated IFRS equity
of USD 2.6
billion
and
higher
UBS
AG
accruals
for
dividends,
as
well
as
a
higher
capital
deduction
at
the
UBS
AG
consolidated
level
related
to
deferred tax assets
on temporary
differences. The aforementioned
factors
were
partly
offset
by
compensation-related
regulatory
capital accruals at the UBS Group AG level.
The
going
concern
loss-absorbing
AT1
capital
of
UBS
AG
consolidated was
USD 1.4 billion
lower than
that of
UBS Group
AG
consolidated
as
of
31
December
202
1
,
mainly
reflecting
deferred contingent capital plan
awards granted at Group
level to
eligible employees for
the performance years
2016 to
2020, partly
offset by
two loss-absorbing
AT1 capital
instruments on-lent
by
UBS Group AG to UBS AG.
Differences
in
capital
between
UBS
Group
AG
consolidated
and
UBS
AG
consolidated
related
to
employee
compensation
plans will reverse to the extent underlying services are performed
by employees of,
and are consequently
charged to, UBS
AG and
its
subsidiaries.
Such
reversal
generally
occurs
over
the
service
period of the employee compensation plans.
The
leverage
ratio
framework
for
UBS
AG
consolidated
is
consistent
with
that
of
UBS
Group
AG
consolidated.
As
of
31 December 2021, the going concern
leverage ratio of UBS AG
consolidated was
0.5 percentage points
lower than
that of
UBS
Group AG
consolidated, mainly
because the
going concern
capital
of UBS AG consolidated was USD 5.1 billion lower.
Audited |
Reconciliation of IFRS equity to Swiss SRB common equity tier 1 capital (UBS Group AG vs UBS AG consolidated)
As of 31.12.21
USD million
UBS Group AG
(consolidated)
UBS AG
(consolidated)
Difference
Total IFRS equity
61,002
58,442
2,559
Equity attributable to non-controlling interests
(
340
)
(
340
)
Defined benefit plans, net of tax
(
270
)
(
270
)
Deferred tax assets recognized for tax loss carry-forwards
(
4,565
)
(
4,565
)
Deferred tax assets on temporary differences, excess over threshold
(
49
)
(
350
)
302
Goodwill, net of tax
(
5,838
)
(
5,838
)
Intangible assets, net of tax
(
180
)
(
180
)
Compensation-related components (not recognized in net
profit)
(
1,700
)
(
1,700
)
Expected losses on advanced internal ratings-based portfolio less provisions
(
482
)
(
482
)
Unrealized (gains) / losses from cash flow hedges, net of tax
(
628
)
(
628
)
Own credit related to gains / losses on financial liabilities
measured at fair value that existed at the balance sheet date
315
315
Own credit related to gains / losses on derivative financial instruments
that existed at the balance sheet date
(
50
)
(
50
)
Unrealized gains related to debt instruments at fair value through
OCI, net of tax
(
68
)
(
68
)
Prudential valuation adjustments
(
167
)
(
167
)
Accruals for dividends to shareholders
(
1,700
)
(
4,200
)
2,500
Other
1
(
24
)
25
Total common equity tier 1 capital
45,281
41,594
3,687
p
167
Swiss SRB going and gone concern information (UBS Group AG vs UBS AG consolidated)
As of 31.12.21
USD million, except where indicated
UBS Group AG
(consolidated)
UBS AG
(consolidated)
Difference
Eligible going concern capital
Total going concern capital
60,488
55,434
5,054
Total tier 1 capital
60,488
55,434
5,054
Common equity tier 1 capital
45,281
41,594
3,687
Total loss-absorbing additional tier 1 capital
15,207
13,840
1,368
of which: high-trigger loss-absorbing additional tier 1 capital
12,783
11,414
1,369
of which: low-trigger loss-absorbing additional tier 1 capital
2,425
2,426
(1)
Eligible gone concern capital
Total gone concern loss-absorbing capacity
44,264
44,264
0
Total tier 2 capital
3,144
3,144
0
of which: low-trigger loss-absorbing tier 2 capital
2,596
2,596
0
of which: non-Basel III-compliant tier 2 capital
547
547
0
TLAC-eligible senior unsecured debt
41,120
41,120
0
Total loss-absorbing capacity
Total loss-absorbing capacity
104,752
99,698
5,054
Risk-weighted assets / leverage ratio denominator
Risk-weighted assets
302,209
299,005
3,204
Leverage ratio denominator
1,068,862
1,067,679
1,183
Capital and loss-absorbing capacity ratios (%)
Going concern capital ratio
20.0
18.5
1.5
of which: common equity tier 1 capital ratio
15.0
13.9
1.1
Gone concern loss-absorbing capacity ratio
14.6
14.8
(0.2)
Total loss-absorbing capacity ratio
34.7
33.3
1.3
Leverage ratios (%)
Going concern leverage ratio
5.7
5.2
0.5
of which: common equity tier 1 leverage ratio
4.24
3.90
0.34
Gone concern leverage ratio
4.1
4.1
0.0
Total loss-absorbing capacity leverage ratio
9.8
9.3
0.5
Risk, capital, liquidity and funding, and balance sheet | Capital management
168
Equity attribution and return on attributed equity
Under
our
equity
attribution
framework,
tangible
equity
is
attributed
based on
a weighting
of 50%
each for
average
risk-
weighted assets
(RWA)
and average
leverage ratio
denominator
(LRD),
which
both
include
resource
allocations
from
Group
Functions to
the business
divisions (the
BDs). Average
RWA
and
LRD
are
converted
to
common
equity
tier 1
(CET1)
capital
equivalents using
capital ratios
of 12.5%
and 3.75%,
respectively.
If the
attributed tangible
equity calculated
under the
weighted-
driver approach
is less
than the
CET1
capital equivalent
of
risk-
based capital (RBC)
for any
BD, the
CET1 capital
equivalent of RBC
is used as a floor for that BD.
In addition to tangible equity, we allocate equity to the BDs to
support goodwill and intangible assets.
Furthermore, we
allocate to
the BDs
attributed equity
related
to
certain
CET1
deduction
items, such
as
compensation-related
components
and
expected
losses
on
the
advanced
internal
ratings-based portfolio less provisions.
We attribute
all remaining
Basel III capital
deduction items
to
Group Functions.
These items
include deferred
tax assets
(DTAs)
recognized
for
tax
loss
carry
-
forwards
,
DTAs
on
temporary
differences
in
excess
of
the
threshold,
accruals
for
shareholder
returns,
and unrealized gains from cash flow hedges.
›
Refer to “Balance sheet and off-balance sheet”
in this section for
more information about movements in equity
attributable to
shareholders
Average attributed equity
For the year ended
USD billion
31.12.21
31.12.20
31.12.19
Global Wealth Management
18.8
17.1
16.6
Personal & Corporate Banking
9.2
8.9
8.4
Asset Management
2.0
2.0
1.8
Investment Bank
13.0
12.6
12.3
Group Functions
16.3
17.4
15.1
of which: deferred tax assets
1
5.9
6.7
7.1
of which: related to retained RWA and LRD
2,3
3.2
3.4
2.8
of which: accruals for shareholder returns and others
4
7.2
7.2
5.1
Average equity attributed to business divisions and Group Functions
59.3
57.8
54.2
1 Includes average attributed equity related to
the Basel III capital deduction items for deferred tax assets (deferred
tax assets recognized for tax loss carry-forwards and
deferred tax assets on temporary differences,
excess over threshold), as
well as retained
RWA and LRD related
to deferred tax assets.
2 Excludes average
attributed equity related
to retained RWA
and LRD related to
deferred tax assets.
3 The temporary
exemption that
applied from
25 March
2020 until
1 January
2021 and
was granted
by FINMA
in connection
with COVID-19
was not
applied when
calculating average
attributed equity
for 2020.
Refer to
the
“Regulatory and legal developments” section
of our Annual Report 2020
for more information.
4 Includes attributed equity related
to dividend accruals,
unrealized gains from cash flow
hedges, and a
balancing
item for capital held in excess of the 12.5% / 3.75% capital and leverage ratio calibration thresholds for equity attribution.
Return on attributed equity
1
For the year ended
In %
31.12.21
31.12.20
31.12.19
Global Wealth Management
25.4
23.6
20.5
Personal & Corporate Banking
18.9
14.2
17.1
Asset Management
51.8
74.2
29.7
Investment Bank
20.3
19.7
6.4
1 Return on attributed equity for Group Functions is not shown, as it is not meaningful.
169
Liquidity and funding management
We
manage
the structural
risks
of
our
balance sheet,
including
interest
rate
risk, structural
foreign
exchange
risk and
collateral
risk,
as
well as
liquidity and
funding
risks. This
section provides
information
about
regulatory
requirements
and
the
firm’s
governance
structure,
liquidity
and
funding
management
(including sources of
liquidity and
funding), contingency
planning,
and stress testing. The balances
disclosed in this section represent
year-end
positions,
unless
indicated
otherwise.
Intra-period
balances
fluctuate
in
the
ordinary
course
of
business
and
may
differ from year-end positions.
Strategy, objectives and governance
Audited |
Our management of
balance sheet, liquidity
and funding
positions
has
the
overall
objective
of
optimizing
our
franchise’s
value across a
broad range of
market conditions while
considering
current and
future regulatory
constraints. We
employ a
number
of measures to
monitor these positions
under normal and
stressed
conditions.
In
particular,
we
use
stress
scenarios
to
apply
behavioral
adjustments
to
our
balance
sheet
and
calibrate
the
results
from
internal
stress
models
while
in
compliance
with
external measures, primarily the liquidity coverage ratio (the LCR)
and
the
net
stable
funding
ratio
(the
NSFR).
Our
liquidity
and
funding strategy is proposed by Group Treasury
and approved by
the
Group
Asset
and
Liability
Committee
(the
Group
ALCO),
which is a
committee of the
Group Executive Board (the
GEB) that
is overseen by the
Risk Committee of the
Board of Directors
(the
BoD).
p
Group Treasury monitors
and oversees the
implementation and
execution of our liquidity and funding strategy and is responsible
for adherence to policies, limits, triggers and targets.
This enables
close control of both
our cash and collateral,
including our high-
quality liquid assets, and centralizes
the Group’s general access
to
wholesale cash
markets in
Group Treasury.
In addition,
should a
crisis require contingency funding measures
to be invoked, Group
Treasury is
responsible for
coordinating liquidity
generation with
representatives
of
the
relevant
business
areas.
Group
Treasury
reports
on
the
Group’s
overall
liquidity
and
funding
position,
including funding status and
concentration risks, at
least monthly,
to the Group ALCO and the Risk Committee of the BoD.
Audited
|
Liquidity
and funding
limits
,
triggers
and targets
are
set
at
Group
and,
where
appropriate,
at
legal
entity
and
business
division
levels,
and
are
reviewed
and
reconfirmed
at
least
once
a
year
by
the
BoD,
the
Group
ALCO,
the
Group
Chief Financial
Officer,
the Group
Chief Risk
Officer,
the Group
Treasurer
and the
business
divisions,
taking
into
consideration
current
and projected
business
strategy
and risk
tolerance.
The
principles
underlying
our
limit
,
trigger
and
target
framework
are designed
to maximize
and sustain
the value of
our business
franchise
and maintain
an appropriate
balance
in the asset
and
liability
structure.
Structural
limits
,
triggers
and
targets
focus
on
the
structure
and
composition
of
the
balance
sheet,
with
supplementary
limits
,
triggers
and
targets
designed
to
drive
the
utilization,
diversification
and
allocation
of
funding
resources.
To complement
and support
this framework,
Group
Treasury
monitors
the
markets
for
early
warning
indicators
regarding
the
current
liquidity
situation.
These
indicators
are
used
at
the
Group
level
to
assess
both
the
overall
global
and
regional
liquidity
status
for
potential
threats.
Treasury
Risk
Control
provides
independent
oversight
over
liquidity
and
funding
risks.
p
›
Refer to the “Corporate governance”
and “Risk management
and control” sections
of this report for more information
Liquidity management
Audited |
Our liquidity risk
management aims to
ensure that the firm
has
sufficient
liquidity
or
access
to
funding
sources
to
meet
its
liabilities
when
due,
to
meet
prudential
requirements
and
to
survive
a
severe
three-month
idiosyncratic
and
market-wide
liquidity stress
event,
allowing for
discrete
management actions
instructed by
the Group
Treasurer
in addition
to monetizing
the
firm’s liquidity reserves.
Our liquid assets
are managed using limits,
triggers and targets
to
maintain
an
appropriate
level
of
diversification
(issuer,
tenor
and
other
risk
characteristics)
in
response
to
any
expected
or
un
expected
volatility
in
funding
availability
or
requirements
caused
by
adverse
market,
operational
or
other
firm-specific
events. The liquid asset
portfolio size is managed
dynamically,
so
as to operate at all
times within the risk appetite of
the BoD and
relevant Group and subsidiary liquidity requirements.
p
Stress testing
Audited |
We perform stress
testing to determine the
optimal asset
and liability structure that enables
us to maintain an
appropriately
balanced liquidity
and funding
position under
various scenarios.
Liquidity crisis scenario
analysis and contingency
funding planning
support the liquidity management process
and aim to ensure that
immediate
corrective
measures
to
absorb
potential
sudden
liquidity shortfalls can be put into effect.
p
We
model
our
liquidity
exposures
under
two
main
potential
scenarios:
a
structural
market-wide
scenario
and
a
combined
market
and
idiosyncratic
scenario.
We
continuously
refine
the
assumptions
used
to
maintain
a
robust,
actionable
and
tested
contingency plan.
›
Refer to “Risk measurement” in the “Risk management
and
control” section of this report for more information about
stress
testing
Risk, capital, liquidity and funding, and balance sheet | Liquidity and funding management
170
Structural market-wide scenario
As a
liquidity crisis
could have
a myriad
of causes,
the structural
market-wide scenario encompasses potential stress effects across
all markets,
currencies
and products,
but it
is typically
not firm-
specific. In addition
to the loss
of the ability
to replace maturing
wholesale
funding,
it
assumes
a
gradual
decline
of
otherwise
stable
client
deposits
and
liquidity
outflows
corresponding
to
a
one
-
notch
downgrade
in
our
long
-
term
credit
rating
,
and
a
corresponding downgrade in our short-term rating.
We use
a cash
capital metric
that incorporates
the structural
market-wide
scenario
and
measures
the
amount
of
long-term
funding available
to fund
franchise and
illiquid assets.
Franchise
assets consist
of lending exposure
to clients or
assets to support
franchise
client
activities.
The
illiquid
assets
cannot
easily
and
readily be sold or exchanged for
cash without a substantial loss in
value
within
the
scenario
horizon.
Long-term
funding
used
as
cash capital
to support
franchise and
illiquid assets
is composed
of unsecured funding
with a remaining
time to maturity
of at least
one year, deposits that have a behavioral maturity of
at least one
year and shareholders’ equity.
Combined market and idiosyncratic scenario
The
combined
scenario
represents
an
extreme
stress
event
that
combines
a
firm-specific
crisis
with
market
disruption.
This
scenario
assumes:
(i)
substantial
outflows
o
f
otherwise
stable
client
deposits, mainly
due on
demand; (ii) inability
to renew
or
replace
maturing
unsecured
wholesale
funding;
(iii)
unusually
large drawdowns on
loan commitments; (iv) reduced
capacity to
g
enerate
liquidity
from
trading
assets;
(v)
liquidity
outflows
corresponding
to
a
three-notch
downgrade
in
our
long-term
credit rating,
and a
corresponding downgrade
in our
short-term
rating; (vi) triggering contractual obligations to unwind derivative
positions
or
to
deliver
additional
collateral;
(vii)
additional
collateral requirements due
to adverse movements in the
market
values of
derivatives;
and (viii) elevated
liquidity requirements
in
supp
ort
of
continuous
payment
and
settlement
activity
.
The
combined scenario is run
daily to project potential
cash outflows
under
it
and
is
assessed
as
part
of
ongoing
risk
management
activities.
Contingency Funding Plan
Audited |
Our Group Contingency Funding
Plan is an integral
part of
our
global
crisis management
framework,
which
covers
various
types of crisis events. This
Contingency Funding Plan contains an
assessment of contingent
funding sources and
liquidity generative
actions
in
a
stressed
environment,
early
warning indicators
and
metrics, and contingency procedures.
Our funding diversification
and global scope
help to protect
our liquidity position
in the event
of
a
crisis.
We
regularly
assess and
test all
material
known and
expected cash flows,
as well as
the level and
availability of high-
quality collateral that could be used
to raise additional funding if
required. Our contingent funding
sources include our
high-quality
liquid
asset
(HQLA)
portfolios,
available
and
unutilized
liquidity
facilities at several
major central banks,
contingent reductions of
liquid
trading
portfolio
assets
,
and
other
available
business
management actions.
p
Funding management
Audited
|
Group
Treasury
regularly
monitors
our
funding
status,
including concentration risks, aiming
to ensure that
we maintain
a
well-balanced
and
diversified
liability
structure.
Our
funding
management team looks
to create
the optimal asset
and liability
structure
to
finance
our
businesses
reliably
and
cost-efficiently.
Our
funding
activities
are
planned
by
analyzing
the
overall
liquidity
and
funding
profile
of
our
balance
sheet,
taking
into
account the
amount of
stable funding
that would
be needed
to
support
ongoing
business
activities
through
periods
of
difficult
market conditions.
p
The funding
strategy of
UBS Group
AG is
set annually
in the
Funding Plan
and is
reviewed on
a quarterly
basis. The
Funding
Plan is developed by
Group Treasury and approved
by the Group
ALCO. Group Treasury proposes, sets and oversees limits, triggers
an
d
targets
for
funding
generation
,
including
concentration
limits,
weighted
average
maturity
limits
and
volume.
Funding
diversification is monitored continuously, with a focus on product
type, single-counterparty exposure (as a percentage
of the total),
mat
urity
profile,
and
the
overall
contribution
of
a
particular
funding source to the liability mix.
›
Refer to “Balance sheet and off-balance sheet”
in this section for
more information about the development of
our short-term and
long-term debt during 2021
Global
Wealth
Management
and
Personal
&
Corporate
Banking
provide
significant,
cost-efficient
and
stable
sources
of
funding. These include core deposits
and debt issued through the
Swiss central
mortgage institutions,
which
use a
portion of
our
portfolio of Swiss
residential mortgages as
collateral to generate
long-term funding. In
addition, we have
several short-, medium-
and
long-term
funding
programs
under
which
we
issue
senior
unsecured debt and structured notes, as well as
short-term debt.
These programs enable institutional and
private investors who are
active
in
the
markets
of
Europe,
the
US
and
Asia
Pacific
to
customize
their
investments
in
UBS’s
debt.
Collectively,
these
broad product
offerings and
funding sources,
together with
the
global
scope
of
our
business
activities,
support
our
funding
stability.
Internal funding and funds transfer pricing
We use
an integrated liquidity and funding framework to govern
the
liquidity
management
of
all
our
branches
and
subsidiaries,
and our major sources of liquidity are
channeled through entities
that
are
fully
consolidated.
Group
Treasury
meets
internal
demands
for
funding
by
channeling
funds
from
entities
generating surplus
cash to
those in
need of
financing, except
in
circumstances where transfer restrictions exist.
Funding
costs
and
benefits
are
allocated
to
our
business
divisions according to our liquidity and funding risk management
framework.
Our internal
funds transfer
pricing
system, which
is
governed
by
Group
Treasury,
is
designed
to
provide
the
proper
liability
structure to
support the
assets and
planned activities
of
each business division.
171
Credit ratings
Credit
ratings
can
affect
the
cost
and
availability
of
funding,
especially funding from
wholesale unsecured sources.
Our credit
ratings
can
also
influence
the
performance
of
some
of
our
businesses and
the levels
of client
and counterparty
confidence.
Rating
agencies
take
into
account
a
range
of
factors
when
assessing
creditworthiness
and
setting
credit
ratings.
These
include the
company’s strategy, its business
position and
franchise
value,
stability
and
quality
of
earnings,
capital
adequacy,
risk
profile and management, liquidity
management, diversification of
funding sources, asset
quality, and
corporate governance. Credit
ratings reflect the opinions of
the rating agencies and
can change
at any time.
In
evaluating
our
liquidity
and
funding
requirements,
we
consider the potential
effect of a
reduction in our
long-term credit
ratings and a
corresponding reduction in
short-term ratings. If
our
credit ratings were
to be
downgraded, rating trigger
clauses could
result
in
an
immediate
cash
settlement
or
the
need
to
deliver
additional
collateral
to
counterparties
from
contractual
obligations related to over-the-counter (OTC) derivative
positions
and
other
obligations.
Based
on
our
credit
ratings
as
of
31
December
2021,
in
the
event
of
a
one-notch
reduction
in
our
long-term credit ratings, we would have been
required to provide
USD 0.0 billion
in cash or
other collateral. In
the event of a
two-
notch
reduction
it
would
have
been
USD
0.5
billion
and
for
a
three-notch
downgrade
USD
0.7
billion.
In
all
scenarios
these
collateral
requirements
predominantly
relate
to
OTC
derivative
positions.
There was
one main
rating action
with regard
to UBS
Group
AG’s and
UBS AG’s
solicited credit
ratings in
2021. On
2 March
2021, Fitch
Ratings revised
the outlooks for
the issuer ratings
of
UBS Group AG, UBS AG and the rated subsidiaries from negative
back to stable, reversing
the outlook change on 31 March
2020,
which
was part
of a
series of
rating actions
over several
weeks
across
the
sector
to
reflect
the
disruption
caused
by
the
COVID-19 pandemic.
›
Refer to “Liquidity and funding management
are critical to UBS’s
ongoing performance” in the “Risk factors”
section of this report
for more information
Liquidity coverage ratio
The LCR
measures the
short-term resilience
of a
bank’s liquidity
profile
by
comparing
whether
sufficient
HQLA
are
available
to
survive
expected
net
cash
outflows
from
a
significant
liquidity
stress scenario, as defined by the relevant regulator.
For
UBS,
HQLA
are
low-risk
unencumbered assets
under
the
control
of
Group
Treasury
that
are
easily
and
immediately
convertible into cash at little or no loss
of value, in order to meet
liquidity
needs.
Our
HQLA
predominantly
consist
of
assets
that
qualify as
Level 1 in
the LCR
framework, including
cash, central
bank reserves
and government
bonds. Group
HQLA are
held by
UBS AG
and its
subsidiaries, and
may include
amounts that
are
available
to
meet
funding
and
collateral
needs
in
certain
jurisdictions, but are not readily available for use by the Group as
a
whole.
These
limitations
are
typically
the
result
of
local
regulatory requirements,
including local
LCR and
large exposure
requirements.
Funds
that
are
effectively
restricted
are
excluded
from the calculation
of Group HQLA
to the extent
they exceed the
outflow
assumptions
for
the
subsidiary
that
holds
the
relevant
HQLA. On this basis, USD 44 billion of assets were excluded from
our
daily
average
Group
HQLA
for
the
fourth
quarter
of
2021.
Amounts held in
excess of local
liquidity requirements that
are not
subject
to
other
restrictions
are
generally
available
for
transfer
within the Group.
Basel
Committee
on
Banking
Supervision
(BCBS)
standards
require an
LCR of
at least
100%. In
a period
of financial
stress,
the
Swiss
Financial
Market
Supervisory
Authority
(FINMA)
may
allow banks
to use
their HQLA
and let
their LCR
temporarily fall
below
the
minimum
threshold.
We
monitor
the
LCR
in
all
significant
currencies
in
order
to
manage
any
currency
mismatches between
HQLA and the
net expected
cash outflows
in times of stress.
Our
daily
average
LCR
for
the
fourth
quarter
of
2021
was
155%,
compared
with
152%
in
the
fourth
quarter
of
2020,
remaining
above
the
prudential
requirement
communicated
by
FINMA.
The
average
LCR
increase
was
driven
by
a
USD 14
billion
increase
in
average
HQLA
to
USD 228
billion,
driven
by
higher
average cash balances,
which was partly
offset by an
increase in
average net
cash outflows
of USD 6
billion to
USD 147 billion,
due
to higher
outflows from
customer deposit
balances and
secured
financing transactions.
›
Refer to the 31 December 2021 Pillar 3
Report,
available under
“Pillar 3 disclosures” at
ubs.com/investors
,
for more information
about the LCR
›
Refer to the “Significant regulated subsidiary
and sub-group
information”
section of this report
for more information about
the LCR of UBS AG and UBS Switzerland
AG
Liquidity coverage ratio
USD billion, except where indicated
Average 4Q21
1
Average 4Q20
1
High-quality liquid assets
228
214
Net cash outflows
147
141
Liquidity coverage ratio (%)
2
155
152
1 Calculated based on an average
of 66 data points in the
fourth quarter of 2021 and
63 data points in the fourth
quarter of 2020.
2 Calculated after the application of
haircuts and inflow and outflow rates,
as
well as, where applicable, caps on Level 2 assets and cash inflows.
Risk, capital, liquidity and funding, and balance sheet | Liquidity and funding management
172
Net stable funding ratio
The net stable funding ratio
(NSFR) framework is intended to
limit
overreliance
on
short-term
wholesale
funding,
to
encourage
a
better assessment
of funding
risk across
all on-
and off-balance
sheet items
and to
promote funding
stability.
The NSFR has
two
components:
available
stable
funding
(ASF)
and
required
stable
funding (RSF). ASF is the portion of
capital and liabilities expected
to be
available over
the period
of one
year.
RSF is
a measure
of
the stable funding requirement of an asset based on its maturity,
encumbrance
and
other
characteristics, as
well as
the
potential
for
contingent
calls on
funding
liquidity
from
off-balance
sheet
exposures. The BCBS NSFR regulatory
framework requires a ratio
of at least 100%.
The NSFR
regulation was
finalized in
the fourth
quarter of
2020
with the
release of the
revised FINMA Circular
2015/2 “Liquidity
risks – banks” and became effective on 1 July 2021.
As of 31 December 2021, our NSFR was unchanged at 119%.
This
reflected
USD 15
billion
higher
available
stable
funding,
mainly driven
by an
increase in
debt issued
designated at fair
value
and
an
increase
in
required
stable
funding
of
USD 15
billion,
mainly reflecting higher loans and advances to customers.
Net stable funding ratio
USD billion, except where indicated
31.12.21
31.12.20
1
Available stable funding
578
563
Required stable funding
488
473
Net stable funding ratio (%)
119
119
1 “Net stable funding ratio” is based on estimated pro forma reporting.
173
Balance sheet and off-balance sheet
Balance sheet
The
balances
disclosed
in
this
section
represent
year
-
end
positions,
unless
indicated
otherwise.
Intra-period
balances
fluctuate in
the ordinary
course of business
and may differ
from
year-end positions.
Balance sheet assets
As of 31 December
2021, balance sheet
assets totaled USD 1,117
billion, a
decrease of
USD 9 billion
compared with
31 December
20
20
,
which
included
a
decrease
from
currency
effects
of
approximately
USD 21
billion.
Derivatives
and
cash
collateral
receivables
on
derivative
instruments
decr
eased
by
USD
44
billion.
This
decrease
predominantly reflected decreases in foreign exchange contracts,
mainly in our Derivatives &
Solutions and Financing businesses in
the
Investment
Bank,
driven
by
net
roll-offs,
partly
offset
by
market-driven
movements.
In
addition,
interest
rate
contracts
decreased,
mainly
in
our
Derivatives
&
Solutions
and
Financing
businesses
and
in
Non-core
and
Legacy
Portfolio,
reflecting
market-driven movements as long-term
interest rates increased in
the year.
Other
financial
assets
measured
at
amortized
cost
and
fair
value decreased by USD 21 billion, largely due to shifts
within the
high-quality liquid asset (HQLA)
portfolio from securities into cash
within Group Treasury. Brokerage receivables decreased by USD 3
billion, mainly
in our
Financing business
in the
Investment Bank,
with growth in
lending more than
offset by an
associated increase
in netting effects.
These decreases were partly offset by
a USD 35 billion increase
in Cash
and balances
at central
banks, predominantly
in Group
Treasury
.
The
cash
inflow
was
generated
mainly
from
lower
funding
consumption
by
th
e
Investment
Bank,
the
aforementioned shifts
within the
HQLA portfolio
from securities
into
cash,
and
net
new
issuances
of
long
-
term
debt
issued
measured at
amortized cost.
These inflows
were partly
offset by
outflows from higher margin requirements and an increase in net
receivables
from
securities
financing
transactions,
as
well
as
currency effects.
Lending assets
increased by
USD 18 billion,
of which
USD 21
billion
was
in
Global
Wealth
Management
and
predominantly
reflect
ed
increases
in
Lombard
loans
and
mortgage
loans
,
primarily
in
the
Americas,
partly
offset
by
currency
effects.
In
Personal & Corporate
Banking, lending
assets decreased by
USD 1
billion as increases in mortgage
loans and corporate lending were
more
than
offset
by
currency
effects.
Trading
portfolio
assets
increased by USD 5 billion,
mainly in our Financing
business in the
Investment Bank, reflecting higher inventory held
to hedge client
positions.
›
Refer to the “Consolidated financial statements”
section of this
report for more information
Assets
As of
% change from
USD billion
31.12.21
31.12.20
31.12.20
Cash and balances at central banks
192.8
158.2
22
Lending
1
413.2
395.0
5
Securities financing transactions at amortized cost
75.0
74.2
1
Trading portfolio
2
130.8
125.4
4
Derivatives and cash collateral receivables on derivative instruments
148.7
192.4
(23)
Brokerage receivables
21.8
24.7
(11)
Other financial assets measured at amortized cost and fair
value
3
73.8
95.1
(22)
Non-financial assets and financial assets for unit-linked investment contracts
61.0
60.9
0
Total assets
1,117.2
1,125.8
(1)
1 Consists of loans and advances to banks
and customers.
2 Consists of financial assets at fair value
held for trading.
3 Consists of financial assets at fair value
not held for trading, financial assets measured
at
fair value through other comprehensive income and other financial assets measured at amortized cost, but excludes financial assets for unit-linked
investment contracts.
Risk, capital, liquidity and funding, and balance sheet | Balance sheet and off-balance sheet
174
Asset encumbrance
The
table
below
provides
a
breakdown
of
on-
and
off-balance
sheet assets
between encumbered
assets, unencumbered
assets
and assets that cannot be pledged as collateral.
Assets are presented
as
Encumbered
if they have
been pledged
as
collateral
against
an
existing
liability
or
are
otherwise
not
available
for
securing
additional
funding.
Included
within
the
latter category are assets protected under
client asset segregation
rules, financial assets
for unit-linked investment
contracts, assets
held in certain jurisdictions to comply with explicit minimum local
asset maintenance requirements.
›
Refer to “Note 23 Restricted and transferred
financial assets” in
the “Consolidated financial statements”
section of this report for
more information
Assets that
cannot be
pledged as
collateral
represents assets
that are
not encumbered
but by
their nature
are not
considered
available to secure funding or meet collateral needs.
All other
assets are
presented as
Unencumbered
. Assets
that
are
considered
to
be
readily
available
to
secure
funding
on
a
Group and / or legal entity level are shown separately and consist
of
cash
and securities
readily realizable
in the
normal course
of
business. These
include our
HQLA and
unencumbered positions
in our trading
portfolio. Unencumbered assets
that are considered
to be
available to
secure funding
on a
legal entity
level may
be
subject
to
restrictions
that
limit
the
total
amount
of
assets
available to
the Group
as a
whole. Other
unencumbered assets,
which are not considered to
be readily available to secure
funding
on a
Group and
/ or
legal entity
level, primarily
consist of
loans
and advances to banks.
Asset encumbrance as of 31 December 2021
USD billion
Encumbered
Unencumbered
Assets that
cannot be
pledged as
collateral
Total Group
Assets
pledged
as collateral
Assets
otherwise
restricted and
not available
to secure
funding
Cash and
securities
available to
secure funding
on a Group and /
or legal entity
level
Other
realizable
assets
Balance sheet
Cash and balances at central banks
192.8
192.8
Loans and advances to banks
3.4
12.1
15.5
Receivables from securities financing transactions
75.0
75.0
Cash collateral receivables on derivative instruments
4.7
25.8
30.5
Loans and advances to customers
18.2
1.2
375.5
2.9
397.8
Other financial assets measured at amortized cost
2.2
0.1
16.6
1.4
5.9
26.2
Total financial assets measured at amortized cost
20.4
9.5
209.4
388.9
109.6
737.8
Financial assets at fair value held for trading
63.7
1
0.4
62.2
4.5
130.8
Derivative financial instruments
118.1
118.1
Brokerage receivables
21.8
21.8
Financial assets at fair value not held for trading
1.0
1
22.8
22.7
7.8
5.9
60.1
Total financial assets measured at fair value through profit or loss
64.7
23.2
84.8
12.3
145.9
330.9
Financial assets measured at fair value through other comprehensive income
0.0
0.9
7.9
8.8
Non-financial assets
0.0
5.3
14.1
20.3
39.7
Total balance sheet assets as of 31 December 2021
85.1
33.5
307.5
415.4
275.7
1,117.2
Total balance sheet assets as of 31 December 2020
89.5
32.3
284.0
395.6
324.3
1,125.8
Off-balance sheet
Fair value of securities accepted as collateral as of 31 December 2021
367.4
16.3
106.5
7.6
497.8
Fair value of securities accepted as collateral as of 31 December 2020
367.3
12.4
113.4
7.7
500.7
Total balance sheet assets and off-balance sheet securities accepted as collateral as of
31 December 2021
452.5
49.8
414.0
423.0
275.7
1,615.0
of which: high-quality liquid assets
232.8
Total balance sheet assets and off-balance sheet securities accepted as collateral as of
31 December 2020
456.8
44.7
397.3
403.3
324.3
1,626.5
of which: high-quality liquid assets
214.1
1 Includes assets pledged as collateral that may be sold
or repledged by counterparties. The respective amounts are disclosed in “Note 23 Restricted financial assets”
in the “Consolidated financial statements” section
of this report.
Assets available to secure funding on a Group and / or legal entity level by currency
USD billion
31.12.21
31.12.20
Swiss franc
111.4
109.2
US dollar
174.7
163.3
Euro
46.6
48.1
Other
81.2
76.7
Total
414.0
397.3
175
Balance sheet liabilities
Total
liabilities as
of 31 December
2021 were
USD 1,056 billion,
a decrease of
USD 10 billion compared with
31 December 2020,
which included a decrease from currency effects of approximately
USD 20
billion.
Derivatives
and
cash
collateral
payables
on
derivative
instruments
decreased
by
USD
45
billion
,
in
line
with
the
movement on the
asset side. Trading portfolio liabilities
decreased
by
USD 2
billion,
predominantly
due
to
lower
levels
of
short
positions held to
hedge client positions.
Other financial liabilities
measured
at
amortized
cost
and fair
value
decreased
by
USD 2
billion
,
mainly
in
Group
Treasury
due
to
higher
netting
on
securities
financing
transactions
measured
at
fair
value.
Short-
term borrowings decreased by USD 2 billion, mainly due to lower
short-term
debt
issued
in
Global
Wealth
Management,
partly
offset
by
higher
amounts
due
to
banks
in
our
Derivatives
&
Solutions business in the Investment Bank.
These decreases were
partly offset by an
increase in customer
deposits of USD 17
billion. An increase of
USD 22 billion in
Global
Wealth Management, mainly
in the Americas,
was partly offset
by
a
decrease
of
USD 4
billion
in
Personal
&
Corporate
Banking
driven by currency effects.
As of 31 December 2021, our ratio of
customer
deposits
to
outstanding
loan
balances
was
136%
(31 December 2020: 138%).
Debt issued designated at fair value
and long-term debt issued
measured at
amortized cost
increased by
USD 16 billion,
mainly
driven
by
USD 13
billion
higher
debt
issued
designated
at
fair
value,
mainly
reflecting
net
new
issuances
of
equity-linked
and
rates-linked
debt
instruments,
as
well
as
market-driven
movements
in
our
Derivatives
&
Solutions
business
in
the
Investment Bank. In addition, long-term debt issued measured at
amortized
cost
increased
by
USD 3
billion,
driven
by
net
new
issuance
s
,
partly
offset
by
f
oreign
exchange
and
hedge
accounting
effects.
During
2021,
net
new
issuances
of
TLAC-
eligible
benchmark
instruments
and
senior
unsecured
debt
USD
12
billion
w
ere
partly
offset
by
USD
4
billion
of
net
redemptions
of
covered
bon
d
s
and
subordinated
debt
instruments.
During
2022,
USD 1.4
billion
equivalent
of
TLAC-eligible
benchmark
instruments
and
USD 2.0
billion
of
loss-absorbing
tier 2
capital
instruments
will
mature.
In
February
2022,
loss-
absorbing
additional
tier 1
capital
instruments
equivalent
to
USD 1.1
billion
were
called
and
USD 2.8
billion
equivalent
of
TLAC-eligible
benchmark
instruments
matured.
UBS
is
already
compliant
with
its
2022
going
and
gone
concern
capital
requirements and
expects to
act rationally
and strategically
with
respect to the refinancing of
any callable capital instruments and
any potential incremental issuances.
›
Refer to the document titled “UBS Group AG consolidated
capital instruments and TLAC-eligible senior
unsecured debt,”
available under “Bondholder information”
at
ubs.com/investors
,
for more information
Brokerage
payables increased
by USD 5
billion, mainly
in the
Financing business of our Investment Bank, due
to an increase in
client
credit
and
short
positions,
partly
offset
by
higher
netting
effects from increased lending.
Non-financial liabilities
and financial
liabilities related
to unit-
linked
investment
contracts
increased
by
USD 2
billion,
mainly
reflecting
a
reclassification
of
assets
in
Global
Wealth
Management as disposal groups
held for sale in connection
with
the upcoming sales
of our domestic
wealth management
business
in Spain
and UBS
Swiss Financial
Advisers AG.
The increase
also
included
market
-
driven
increases
from
unit
-
linked
investment
contracts in Asset Management.
›
Refer to the “Consolidated financial statements”
section of this
report for more information
Equity
Equity
attributable
to
shareholders
increased
b
y
USD
1,217
million to USD 60,662 million as of 31 December 2021.
This increase was
mainly driven by
total comprehensive income
attributable
to
shareholders
of
positive
USD
5,106
million,
reflecting
net
profit
of
USD 7,457
million
and
negative
other
comprehensive
income
(OCI)
of
USD 2,351
million.
OCI
mainly
included
negative
cash
flow
hedge
OCI
of
USD 1,675
million,
negative OCI
related to
foreign currency
translation of
USD 535
million and negative OCI related
to debt instruments measured at
fair
value
through
OCI
of
USD
157
million
.
In
addition,
amortization
of
deferred
share-based
compensation
awards
increased share
premium by
USD 643 million
and the
launch of
our
new
operational
partnership
entity
with
Sumitomo
Mitsui
Trust
Holdings,
Inc.
resulted
in
an
equity
increase
of
USD 155
million.
These increases were partly offset by net
treasury share activity
that decreased equity by USD 3,326
million. This was mainly due
to share repurchases
with an
acquisition cost
of USD 2,500
million
under
our
2021
share
repurchase
program
,
repurchases
of
USD 112 million under
our 2018–2021 program
and purchases of
USD 545
million
from
the
market
to
hedge
our
share
delivery
obligations
related
to
employee
share-based
compensation
awards. In
addition, distributions to
shareholders reduced equity
by USD 1,301 million, reflecting a dividend payment of USD 0.37
per share.
In
the
second
quarter
of
2021,
we
canceled
156,632,400
shares
purchased
under
our
2018–2021
share
repurchase
program,
as
approved
by
shareholders
at
the
2021
Annual
General
Meeting.
The
cancellation
of
shares
resulted
in
reclassifications within
equity but
had no
net effect
on our
total
equity attributable to shareholders.
›
Refer to the “Group performance” and “Consolidated
financial
statements”
sections of this report for more information about
OCI
›
Refer to “UBS shares” in this section for more
information about
our share repurchase programs
›
Refer to “Note 30 Changes in organization
and acquisitions and
disposals of subsidiaries and businesses”
in the “Consolidated
financial statements” section of this
report for more information
about our partnership with Sumitomo
Mitsui Trust Holdings, Inc.
Risk, capital, liquidity and funding, and balance sheet | Balance sheet and off-balance sheet
176
Liabilities and equity
As of
% change from
USD billion
31.12.21
31.12.20
31.12.20
Short-term borrowings
1
56.2
57.7
(3)
Securities financing transactions at amortized cost
5.5
6.3
(12)
Customer deposits
542.0
524.6
3
Debt issued designated at fair value and long-term debt issued measured
at amortized cost
2
169.9
153.8
10
Trading portfolio
3
31.7
33.6
(6)
Derivatives and cash collateral payables on derivative instruments
153.1
198.4
(23)
Brokerage payables
44.0
38.7
14
Other financial liabilities measured at amortized cost and fair
value
4
17.6
19.1
(8)
Non-financial liabilities and financial liabilities related
to unit-linked investment contracts
36.1
33.7
7
Total liabilities
1,056.2
1,066.0
(1)
Share capital
0.3
0.3
(5)
Share premium
15.9
16.8
(5)
Treasury shares
(4.7)
(4.1)
15
Retained earnings
43.9
38.8
13
Other comprehensive income
5
5.2
7.6
(32)
Total equity attributable to shareholders
60.7
59.4
2
Equity attributable to non-controlling interests
0.3
0.3
6
Total equity
61.0
59.8
2
Total liabilities and equity
1,117.2
1,125.8
(1)
1 Consists of
short-term debt issued
measured at amortized
cost and amounts
due to banks.
2 The
classification of debt
issued measured at
amortized cost
into short-term and
long-term is based
on original
contractual maturity and therefore long-term debt also includes debt with a
remaining time to maturity of less than one year. This classification does not consider any
early redemption features.
3 Consists of financial
liabilities at fair value held for trading.
4 Consists of other financial liabilities measured at amortized cost
and other financial liabilities designated at fair value,
but excludes financial liabilities related to unit-linked
investment contracts.
5 Excludes other comprehensive income related to defined benefit plans and own credit, which is recorded directly in Retained earnings.
177
Liabilities by product and currency
USD billion
As a percentage of total liabilities
All currencies
All currencies
USD
CHF
EUR
Other
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
Short-term borrowings
56.2
57.7
5.3
5.4
3.1
3.0
0.4
0.6
0.6
1.0
1.3
0.9
of which: amounts due to banks
13.1
11.0
1.2
1.0
0.3
0.3
0.4
0.5
0.1
0.1
0.4
0.1
of which: short-term debt issued
1
43.1
46.7
4.1
4.4
2.7
2.7
0.0
0.0
0.5
0.9
0.8
0.8
Securities financing transactions at
amortized cost
5.5
6.3
0.5
0.6
0.5
0.5
0.0
0.0
0.0
0.0
0.0
0.1
Customer deposits
542.0
524.6
51.3
49.2
23.9
19.7
18.0
20.1
5.2
5.2
4.3
4.2
of which: demand deposits
246.4
236.4
23.3
22.2
8.7
7.4
6.7
7.2
4.4
4.3
3.5
3.4
of which: retail savings / deposits
247.2
220.9
23.4
20.7
11.9
8.3
11.0
11.8
0.5
0.5
0.0
0.0
of which: time deposits
48.4
67.3
4.6
6.3
3.2
4.0
0.3
1.1
0.3
0.4
0.8
0.8
Debt issued designated at fair value
and long-term debt issued
measured at amortized cost
2
169.9
153.8
16.1
14.4
9.5
7.6
1.7
1.6
3.3
3.7
1.5
1.5
Trading portfolio
3
31.7
33.6
3.0
3.2
1.3
1.3
0.1
0.1
0.6
0.5
1.0
1.2
Derivatives and cash collateral
payables on derivative instruments
153.1
198.4
14.5
18.6
12.0
15.2
0.2
0.2
1.4
2.0
0.9
1.1
Brokerage payables
44.0
38.7
4.2
3.6
3.1
2.7
0.0
0.0
0.3
0.2
0.8
0.7
Other financial liabilities measured at
amortized cost and fair value
4
17.6
19.1
1.7
1.8
0.9
1.1
0.1
0.2
0.4
0.2
0.3
0.3
Non-financial liabilities and financial
liabilities related to unit-linked
investment contracts
36.1
33.7
3.4
3.2
0.6
0.6
0.2
0.2
0.3
0.2
2.3
2.2
Total liabilities
1,056.2
1,066.0
100.0
100.0
54.7
51.6
20.8
23.0
12.1
13.1
12.4
12.3
1 Short-term debt issued consists of certificates of deposit, commercial paper,
acceptances and promissory notes, and other money market paper.
2 The classification of debt issued measured at amortized cost into
short-term and long-term is based
on original contractual
maturity and therefore long-term
debt also includes debt
with a remaining time to
maturity of less than
one year.
This classification does
not consider any
early redemption features.
3 Consists of financial liabilities at fair value held for trading.
4 Consists of other financial liabilities measured at amortized cost and other financial liabilities designated at fair value, but
excludes financial liabilities related to unit-linked investment contracts.
Risk, capital, liquidity and funding, and balance sheet | Balance sheet and off-balance sheet
178
Maturity analysis of assets and liabilities
The
table
below
provides
an
analysis
of
carrying
amounts
of
balance
sheet assets
and
liabilities,
as
well as
off-balance
sheet
exposures
by
residual
contractual
maturity
as
of
the
reporting
date.
The
residual
contractual
maturity
of
assets
includes
the
effect
of
callable
features.
The
residual
contractual
maturity
of
liabilities and off-balance sheet exposures is based on the earliest
date on which
we could be
required to
pay.
The presentation of
liabilities at
the carrying
amount in
this table
differs from
“Note
24 Maturity
analysis of
financial liabilities”
in the
“Consolidated
financial statements” section of
this report, where
such liabilities
are
presented
on
an
undiscounted
basis,
as
required
by
International Financial Reporting Standards (IFRS).
Derivative
financial
instruments
and
f
inancial
assets
and
liabilities
at
fair
value
held
for
trading
are
assigned
to
the
Due
within
1
month
column
,
although
one
should
note
that
the
respective
contractual
maturities
may
extend
over
significantly
longer periods.
Assets
held
to
hedge
unit-linked
investment
contracts
(presented within
Financial assets
at fair
value not
held for
trading
)
are assigned to the
Due within 1 month
column, consistent with
the
maturity
assigned
to
the
related
amounts
due
under
unit-
linked
investment
contracts
(presented
within
Other
financial
liabilities designated at fair value
).
Other
financial
assets
and
liabilities
with
no
contractual
maturity, such as equity securities,
are included in the
Perpetual /
Not applicable
time bucket. Undated
or perpetual instruments
are
classified
based
on
the
contractual
notice
period
that
the
counterparty of the instrument is
entitled to give. Where there
is
no contractual notice
period, undated or perpetual
contracts are
included in the
Perpetual / Not applicable
time bucket.
Non-financial assets and liabilities
with no contractual maturity
are
generally
included
in
the
Perpetual
/
Not
applicable
time
bucket.
Loan
commitments
are
classified
on
the
basis
of
the
earliest
date they can be drawn down.
Maturity analysis of assets and liabilities
USD billion
Due
within
1 month
Due
between
1 and 3
months
Due
between
3 and 6
months
Due
between
6 and 9
months
Due
between
9 and 12
months
Due
between
1 and 2
years
Due
between
2 and 5
years
Due over
5 years
Perpetual /
Not
applicable
Total
Assets
Total financial assets measured at amortized cost
453.7
45.9
19.1
12.4
11.7
53.7
64.1
77.3
737.8
Loans and advances to customers
157.2
28.7
16.3
10.4
10.5
49.6
54.9
70.1
397.8
Total financial assets measured at fair value through profit or
loss
300.5
5.8
3.6
2.6
1.9
5.2
7.1
2.5
1.8
330.9
Financial assets at fair value not held for trading
29.7
5.8
3.6
2.6
1.9
5.2
7.1
2.5
1.8
60.1
Financial assets measured at fair value through other
comprehensive income
0.1
0.4
0.5
0.2
0.1
0.1
0.4
7.1
8.8
Total non-financial assets
7.7
0.5
0.1
0.0
0.0
0.2
1.4
0.3
29.4
39.7
Total assets as of 31 December 2021
761.9
52.6
23.3
15.1
13.6
59.2
73.0
87.2
31.2
1,117.2
Total assets as of 31 December 2020
748.1
64.2
32.7
18.6
17.8
53.0
79.9
79.6
31.8
1,125.8
Liabilities
Total financial liabilities measured at amortized cost
581.6
20.1
21.3
15.0
12.1
17.0
35.6
24.4
13.5
740.6
Customer deposits
530.1
5.2
2.0
0.6
0.7
1.6
1.5
0.3
542.0
Debt issued measured at amortized cost
3.7
12.1
16.5
13.7
9.6
14.9
32.5
22.7
13.5
139.2
Total financial liabilities measured at fair value through
profit or loss
237.7
12.0
5.2
6.1
3.3
18.8
5.6
12.2
300.9
Debt issued designated at fair value
12.5
11.6
5.1
5.8
3.2
18.6
5.4
11.5
73.8
Total non-financial liabilities
9.3
3.0
0.0
0.0
0.0
0.0
0.0
0.0
2.4
14.7
Total liabilities as of 31 December 2021
828.6
35.1
26.5
21.1
15.5
35.8
41.2
36.6
15.9
1,056.2
Total liabilities as of 31 December 2020
865.1
37.3
24.1
17.1
14.4
27.2
33.2
30.5
17.1
1,066.0
Guarantees, loan commitments and forward
starting transactions
1
Guarantees, loan commitments and forward starting
transactions as of 31 December 2021
60.9
0.5
0.4
0.2
0.0
0.0
0.0
0.0
0.0
62.1
Guarantees, loan commitments and forward starting
transactions as of 31 December 2020
61.3
0.5
0.3
0.1
0.0
0.0
0.0
0.0
0.0
62.2
1 The notional amounts associated with derivative loan
commitments, as well as forward starting repurchase
and reverse repurchase agreements, measured at fair
value through profit or loss are presented together
with notional amounts related to derivative instruments and have been
excluded from the table above. Refer to “Note 10 Derivative
instruments” in the “Consolidated financial statements” section
of this report for
information about the notional amounts of these instruments.
179
Off-balance sheet
In
the
normal
course
of
business,
we
enter
into
transactions
where, pursuant to IFRS, the maximum contractual exposure may
not be recognized in whole
or in part on
our balance sheet. These
transactions
include
derivative
instruments,
guarantees,
loan
commitments and similar arrangements.
When we
incur an
obligation or
become entitled
to an
asset
through these arrangements, we
recognize them on the
balance
sheet.
It
should
be
noted
that
in
certain
instances
the
amount
recognized on the balance
sheet does not represent the
full gain
or loss potential inherent in such arrangements.
›
Refer to “Note 1a Material accounting
policies” items 1, 2a and
2c, and “Note 29 Interests in subsidiaries and
other entities” in
the “Consolidated financial statements”
section of this report for
more information
The
following
paragraphs
provide
more
information
about
certain
off-balance
sheet
arrangements.
Additional
off-balance
sheet information is
primarily provided in
Notes 9, 10, 18,
20, 21i,
23 and 29
in the “Consolidated
financial statements” section
of
this report, and
in the 31 December
2021 Pillar 3
Report, available
under “Pillar 3 disclosures” at
ubs.com/investors.
Guarantees,
loan commitments and similar arrangements
In
the
normal
course
of
business,
we
issue
various
forms
of
guarantees,
commitments
to
extend
credit,
standby
and
other
letters
of
credit
to
support
our
clients,
forward
starting
transactions,
note
issuance
facilities
and
revolving
underwriting
facilities. With the exception of
related premiums, generally these
guarantees and
similar obligations
are kept
as off-balance
sheet
items,
unless
a
provision
to
cover
probable
losses
or
expected
credit losses is required.
Guarantees
represent
irrevocable
assurances
that,
subject
to
the satisfying of certain conditions, we will make payments if our
clients
fail
to
fulfill
their
obligations
to
third
parties.
As
of
31 December 2021, the
net exposure (i.e.,
gross values less
sub-
participations)
from
guarantees
and
similar
instruments
was
USD 19 billion, compared with USD 15 billion as of 31 December
2020. The increase of
USD 4 billion reflected higher
guarantees in
Group Treasury and an increase in guarantees issued
to corporate
clients in Personal & Corporate Banking. Fee income from issuing
guarantees was not significant to
total revenues in 2021 or 2020.
We also enter
into commitments to
extend credit in
the form
of credit lines available
to secure the liquidity
needs of clients. The
majority of loan commitments range in maturity from one month
to one year. Committed unconditionally revocable credit lines are
generally open-ended.
During
2021, loan
commitments decreased
by USD 2
billion,
mainly
in
Personal
&
Corporate
Banking
,
predominantly
in
Personal Banking Switzerland.
Committed
unconditionally
revocable
credit
lines
remained
broadly
stable.
Forward
starting
reverse
repurchase
agreements
de
creased
by
USD
2
billion
and
f
orward
starting
repurchase
agreements
increased
by
USD 1
billion,
both
predominantly
in
Group Treasury.
Off-balance sheet
As of
% change from
USD billion
31.12.21
31.12.20
31.12.20
Guarantees
1
18.9
15.0
26
Loan commitments
1,2
39.5
41.4
(5)
Committed unconditionally revocable credit lines
40.8
40.1
2
Forward starting reverse repurchase agreements
2
1.4
3.2
(56)
Forward starting repurchase agreements
2
1.0
0.4
178
1 Guarantees and Loan
commitments are shown
net of sub-participations.
2 The exposures
related to loan commitments,
forward starting repurchase
and reverse repurchase agreements
measured at fair value
through profit or loss are not included in this table but are reflected as notional amounts in “Note 10 Derivative instruments” in the “Consolidated
financial statements” section of this report.
If
customers
fail
to
meet
their
obligations,
our
maximum
exposure
to
credit
risk
is
the
contractual
amount
of
these
instruments. The
risk is
similar to
the
risk involved
in extending
loan
facilities
and
is
subject
to
the
same
risk
management
and
control framework.
In 2021,
we recognized net
credit loss
releases
of USD 46
million related to
loan commitments,
guarantees and
other
credit
facilities
in
the
scope
of
expected
credit
loss
measurement
,
compared
with
net
credit
loss
expenses
of
USD 138
million
in
2020.
Provisions
recognized
for
guarantees,
loan
commitments
and
other
credit
facilities
in
the
scope
of
expected
credit
loss
measurement
were
USD 196
million
as
of
31
December
202
1
,
compared
wi
th
USD
257
million
as
of
31 December 2020.
›
Refer to “Note 9 Financial
assets at
amortized
cost and
other
positions
in scope
of expected
credit loss
measurement”
and
“Note 20 Expected
credit loss
measurement”
in the “Consolidated
financial
statements”
section of this report for more information
about provisions for expected credit losses
Risk, capital, liquidity and funding, and balance sheet | Balance sheet and off-balance sheet
180
For certain obligations we
enter into partial sub-participations
to mitigate various risks from guarantees and loan commitments.
A sub-participation
is an
agreement by
another
party
to
take a
share of the loss in the event that the obligation is not fulfilled by
the
obligor
and,
where
applicable,
to
fund
a
part
of
the
credit
facility.
We
retain
the
contractual
relationship
with
the
obligor,
and the sub-participant has only an indirect relationship. We only
enter into sub-participation
agreements with banks
to which we
ascribe a credit rating equal to or better than that of the obligor.
W
e
also
provide
representa
tions,
warranties
and
indemnifications to third parties in the normal
course of business.
Support provided to non-consolidated investment funds
In 2021, the Group did not
provide material support, financial or
otherwise, to unconsolidated
investment funds
when the Group
was
not
contractually
obligated
to
do
so,
nor
does
it
have
an
intention to do so.
Clearing house and exchange memberships
We
are
a
member
of
numerous
securities
and
derivative
exchanges and clearing houses. In
connection with some of these
memberships, we may be required to pay a share of the financial
obligations
of
another
member
who
defaults,
or
we
may
be
otherwise exposed
to additional
financial obligations.
While the
membership rules
vary,
obligations generally
would arise
only if
the exchange or
clearing house had
exhausted its resources.
We
consider the probability of a material loss due to such obligations
to be remote.
Deposit insurance
Swiss banking law
and the deposit
insurance system require Swiss
banks and securities dealers to jointly
guarantee an amount of
up
to CHF 6
billion for
privileged client
deposits in
the event
that a
Swiss
bank
or
securities
dealer
becomes
insolvent.
As
of
31 December
2021,
FINMA
estimates
our
share
in
the
deposit
insurance
system
to
be
CHF
0.9
billion.
This
represents
a
contingent payment obligation and exposes us
to additional risk.
As
of
31 December
2021,
we
considered
the
probability
of
a
material loss from our obligations to be remote.
UBS
is
also
subject
to
,
or
is
a
member
of,
other
deposit
protection
schemes
in
other
countries.
However,
no
contingent
payment
obligation
existed
as
of
31 December
2021
from
any
other material scheme.
Material cash requirements
The Group’s material cash requirements as of 31 December 2021
are
represented
by
the
residual
contractual
maturities
for
non-
derivative and non-trading financial
liabilities included in the
table
presented in “Note 24
Maturity analysis of financial
liabilities” in
the
“Consolidated
financial
statements”
section
of
this
report.
Included
in
the
table
are
debt
issued
designated
at
fair
value
(USD 82 billion)
and long-term
debt issued
measured at
amortized
cost
(USD 106
billion).
The
amounts
represent
estimated
future
interest and principal payments on an undiscounted basis.
In the
normal course
of business,
we also
issue or
enter into
various forms of guarantees, loan commitments and other
similar
arrangements that may result in an outflow of cash in the future.
The maturity profile of
these obligations, which
are presented off-
balance
sheet,
are
included
in
“Note 24
Maturity
analysis
of
financial
liabilities”
in
the
“Consolidated
financial
statements”
section of this report.
›
Refer to “Guarantees, loan commitments
and similar
arrangements” in this section for more information
181
Cash flows
As a
global financial
institution, our cash
flows are
complex and
often may bear
little relation
to our net
earnings and net
assets.
Consequently,
we believe
that a
traditional cash
flow analysis
is
less
meaningful
when evaluating
our liquidity
position than
the
liquidity,
funding
and
capital
management
frameworks
and
measures described elsewhere in this section.
Cash and cash equivalents
As
of 31
December
2021,
cash
and
cash
equivalents
totaled
USD 207.9 billion, an increase of USD 34.3 billion compared with
31 December
2020,
driven
by
net
cash
inflows
from
operating
and
financing
activities.
These
effects
were
partly
offset
by
net
cash outflows
from
investing activities,
as well
as the
effects
of
exchange rate
differences
on cash
and cash
equivalents, mainly
reflecting
the
appreciation
of
the
US
dollar
against
the
Swiss
franc, Japanese yen and euro in 2021.
Operating activities
Net cash
inflows from
operating activities
were USD 31.4
billion
in
20
2
1
,
compared
with
USD
37
.0
billion
in
2020
.
The
n
et
operating
cash
flow,
before
changes
in
operating
assets
and
liabilities
and
income
taxes
paid,
was
an
inflow
of
USD 13.5
billion. Changes
in operating
assets and liabilities
resulted in
net
cash inflows
of USD 18.0
billion, mainly driven
by net inflows
of
USD
29.8
billion
related
to
customer
deposit
s
and
USD
1
9
.
6
billion from financial assets and liabilities at fair value
not held for
trading and other
financial assets
and liabilities, as
well as
USD 8.1
billion
from
brokerage
receivables
and
payables.
These
inflows
were
partly
offset
by
a
net
outflow
from
lending
balances
to
customers of
USD 27.5
billion and
a net
outflow from
financial
assets and
liabilities at
fair value
held for
trading and
derivative
financial instruments of USD 10.5 billion.
Investing activities
Investing activities
resulted in
a net
cash outflow
of USD 2.1
billion
in 2021, compared with USD 6.8 billion in
2020, primarily related
to a
cash outflow
of USD 1.8
billion from
purchase of
property,
equipment and software.
Financing activities
Financing
activities
resulted in
a net cash
inflow of
USD 10.3
billion
in 2021, compared with
USD 12.4 billion in
2020, mainly due to
net issuance
proceeds of USD
18.4
billion from debt
designated
at
fair
value
and
long-term debt
measured
at
amortized cost.
This
inflow was
partly offset
by the net repayment
of USD 3.1
billion of
short
-
term
debt
,
net
cash
used
to
acquire
treasury
shares
of
USD 3.3
billion
and
a
dividend
distribution
to
shareholders
of
USD 1.3
billion.
›
Refer to “Primary financial statements and
share information” in
the “Consolidated financial statements”
section of this report for
more information about cash flows
Statement of cash flows (condensed)
For the year ended
USD billion
31.12.21
31.12.20
Net cash flow from / (used in) operating activities
31
37
Net cash flow from / (used in) investing activities
(2)
(7)
Net cash flow from / (used in) financing activities
10
12
Effects of exchange rate differences on cash and cash equivalents
(5)
11
Net increase / (decrease) in cash and cash equivalents
34
54
Cash and cash equivalents at the end of the year
208
174
Risk, capital, liquidity and funding, and balance sheet | Currency management
182
Currency management
Strategy, objectives and governance
Group
Treasury
focuses
on
three
main
areas
of
currency
risk
management:
(i)
currency-matched
funding
and
investment
of
non-US
dollar
assets
and
liabilities;
(ii) sell-down
of
foreign
currency
IFRS
profits
and
losses;
and
(iii) selective
hedging
of
anticipated non-US
dollar profits
and losses to
further mitigate
the
effect
of
structural
imbalances
in
the
balance
sheet.
Group
Treasury
also
manages
structural
currency
composition
at
the
consolidated Group level.
Currency-matched funding and investment of non-US dollar
assets and liabilities
For monetary
balance sheet
items and
other investments,
as far
as is
practical and
efficient, we
follow the
principle of
matching
the currencies
of our
assets and
liabilities for
funding purposes.
This
avoids
profits
and
losses
arising
from
the
translation
of
non-US dollar assets and liabilities.
Net investment
hedge accounting
is applied
to non-US
dollar
core
investments
to
balance
the
effect
of
foreign
exchange
movements on both CET1 capital and the CET1 capital ratio.
›
Refer to “Note 1a Material accounting
policies” and “Note 26
Hedge accounting” in the “Consolidated
financial statements”
section of this report for more information
›
Refer to “Capital management” in
this section for more
information about our active management
of sensitivity to
currency movements and the effect thereof on our key
ratios
Sell-down of non-US dollar reported profits and losses
Income statement
items of
foreign subsidiaries
and branches
of
UBS AG
with a
functional currency
other than
the US
dollar are
translated
into US
dollars at
average
exchange rates.
To
reduce
earnings
volatility
on
the
translation
of
previously
recognized
earnings
in
foreign
currencies,
Group
Treasury
centralizes
the
profits and losses (under IFRS) arising in UBS AG and its branches
and
sells
or
buys the
profit
or loss
for
US
dollars
on a
monthly
basis. Our foreign subsidiaries follow
a similar monthly sell-down
process into their own functional currencies. Retained earnings in
foreign subsidiaries with a
functional currency other than
the US
dollar are integrated and managed
as part of our net investment
hedge accounting program.
Hedging of anticipated non-US dollar profits and losses
The
Group
ALCO
may
at
any
time
instruct
Group
Treasury
to
execute hedges to protect anticipated future profits and losses in
foreign
currencies
against
possible
adverse
trends
of
foreign
exchange
rates.
Although
intended
to
hedge
future
earnings,
these transactions
are accounted
for as
open currency
positions
and
subject
to
internal
market
risk
limits
for
value-at-risk
and
stress loss limits.
Dividend distribution
UBS
Group
AG
declares
dividends
in
US
dollars.
Shareholders
holding
shares
through
SIX
(ISIN: CH0244767585)
will
receive
dividends
in
Swiss
francs,
based
on
a
published
exchange
rate
calculated up
to five
decimal places,
on the
day prior
to the
ex-
dividend
date.
Shareholders
holding
shares
through
DTC
(ISIN: CH0244767585; CUSIP: H42097107) will be paid
dividends
in US dollars.
›
Refer to the “Standalone financial statements”
section of this
report for more information about the proposed dividend
distribution of UBS Group AG
183
UBS
shares
UBS Group AG shares
Audited
|
As
of
31
December
20
2
1
,
IFRS
equity
attributable
to
shareholders
amounted
to
USD
60,662
million,
represented
by
3,702,422,995
shares
issued.
Shares
issued
decreased
by
157
million
in 2021,
as the
156,632,400
shares acquired
under the
2018–2021 share
repurchase program
were canceled
by means of
a
capital
reduction,
as
approved
by
shareholders
at
the
2021
Annual General
Meeting (AGM).
Each share has
a nominal value
of CHF
0.10
, carries one
vote
if entered into the
share register as having
the right to vote,
and
also
entitles
the
holder
to
a
proportionate
share
of
distributed
dividends.
All
shares
are
fully
paid
up.
As
the
Articles
of
Association of UBS Group AG indicate, there are no other classes
of shares and no preferential rights for shareholders.
p
›
Refer to the “Corporate governance”
section of this report for
more information about UBS shares
UBS Group share information
As of or for the year ended
% change from
31.12.21
31.12.20
31.12.20
Shares issued
3,702,422,995
3,859,055,395
(4)
Treasury shares
1
302,815,328
307,477,002
(2)
of which: related to share repurchase program 2018–2021
148,975,800
(100)
of which: related to share repurchase program 2021
2
152,596,273
Shares outstanding
3,399,607,667
3,551,578,393
(4)
Basic earnings per share (USD)
3
2.14
1.83
17
Basic earnings per share (CHF)
4
1.96
1.71
15
Diluted earnings per share (USD)
3
2.06
1.77
16
Diluted earnings per share (CHF)
4
1.88
1.65
14
Equity attributable to shareholders (USD million)
60,662
59,445
2
Less: goodwill and intangible assets (USD million)
6,378
6,480
(2)
Tangible equity attributable to shareholders (USD million)
54,283
52,965
2
Ordinary cash dividends per share (USD)
5,6
0.50
0.37
35
Total book value per share (USD)
17.84
16.74
7
Tangible book value per share (USD)
15.97
14.91
7
Share price (USD)
7
18.01
14.08
28
Market capitalization (USD million)
61,230
50,013
22
1 Based on a settlement date view.
2 Our active share repurchase program of up to
CHF 4 billion was started in February
2021. The program was
initially planned to run over a three-year period,
but we currently
expect to
complete it
in the
first half
of 2022.
We therefore
refer to
this program
as “share
repurchase program
2021” throughout
this report.
3 Refer
to “Share
information and
earnings per
share” in
the
“Consolidated financial statements” section of this report for more
information.
4 Basic and diluted earnings per share in Swiss
francs are calculated based on a translation of
net profit / (loss) under our US dollar
presentation currency.
5 Dividends and / or distributions out of the capital contribution
reserve are normally approved and paid in the
year subsequent to the reporting period.
6 Refer to “Statement of proposed
appropriation of total profit and dividend distribution out of total profit and capital contribution reserve” in the “Standalone financial statements” section of this report for more information.
7 Represents the share
price as listed on the SIX Swiss Exchange, translated to US dollars using the closing exchange rate
as of the respective date.
Risk, capital, liquidity and funding, and balance sheet | UBS shares
184
Holding of UBS Group AG shares
Group
Treasury
holds
UBS Group AG
shares
to
hedge
future
share
delivery
obligations
related
to
employee
share-based
compensation awards, and also
holds shares purchased under
the
share repurchase
program. As
of 31 December
2021, we
held a
total
of
302
,
815
,
328
treasury
shares
(31
December
20
20
:
307,477,002),
or
8.2%
(31 December
2020:
8.0%)
of
shares
issued.
Our 2018–2021 share repurchase program was
completed on
2 February
2021
with the
purchase of
an
additional
7.7
million
shares
in
2021
for
a
total
acquisition
cost
of
CHF 100
million
(USD 112
million).
The
156.6
million
shares
repurchased
under
this program
were canceled
by means
of a
capital reduction,
as
approved by shareholders at the 2021 AGM.
On
8 February
2021,
we
commenced
a
new
2021
share
repurchase program of up
to CHF 4 billion.
Shares acquired under
this program totaled 152.6
million as of 31 December 2021 for a
total
acquisition
cost
of
CHF 2,294
million
(USD 2,500
million)
and are intended to be canceled by means of a capital reduction,
pending approval by shareholders at the 2022 AGM.
Looking
ahead,
we
intend
to
commence
a
new
2022
share
repurchase
program
of
up
to
USD 6
billion
over
two
years
and
expect to execute
up to USD 5 billion
of repurchases under both
the existing
2021 repurchase
program and
the new
2022 program
by the end of 2022.
Treasury
shares
held
to
hedge
our
share
delivery
obligations
related
to
employee
share-based
compensation
awards
totaled
1
48
.
8
milli
on
shares
as
of
31
December
202
1
(31
December
20
20
:
157.1
million).
Share
delivery
obligations
related
to
employee share-based
compensation awards totaled
175 million
shares as of 31 December 2021
(31 December 2020: 172 million)
and
are
calculated
on
the
basis of
undistributed
notional
share
awards,
taking into
account applicable
performance conditions.
Treasury
shares
held
are
delivered
to
employees
at
exercise
or
vesting. As
of 31 December
2021, up
to 122
million UBS Group
AG
shares
(31 December
2020:
122
million)
could
have
been
issued
out
of
conditional
capital
to
satisfy
share
delivery
obligations
of
any
future
employee
share
option
programs
or
similar awards.
The
Investment
Bank
also
holds
a
limited
number
of
UBS Group AG shares, primarily in its capacity as a market-maker
with regard to UBS Group AG shares and related derivatives, and
to hedge certain issued structured debt instruments.
The table below
outlines the market
purchases of UBS Group
AG shares by Group
Treasury. It does not
include the activities of
the Investment Bank.
Treasury
share purchases
Share repurchase programs
1
Other treasury shares purchased
2
Month of purchase
3
Number of shares
Average price in CHF
Remaining volume of
2018–2021 share
repurchase program in
CHF million at month-end
Remaining volume of
2021 share repurchase
program in CHF million
at month-end
Number of shares
Average price in USD
January 2021
5,250,000
13.06
31
February 2021
22,861,600
13.89
0
3,714
March 2021
39,377,000
14.64
3,137
April 2021
7,400,415
14.56
3,030
May 2021
15,858,110
13.97
2,808
5,585,000
16.11
June 2021
2,808
14,415,000
16.31
July 2021
7,730,000
14.71
2,694
August 2021
17,140,000
15.36
2,431
September 2021
11,241,248
15.36
2,259
October 2021
4,500,000
16.58
2,184
November 2021
28,800,000
16.54
1,708
December 2021
94,500
16.23
1,706
4
12,770,000
17.73
1 In March 2018, UBS initiated a share repurchase
program of up to CHF 2 billion over
a three-year period and this program was
completed on 2 February 2021. UBS
has an active share repurchase program to buy
back up to CHF 4 billion of its own shares over the
three-year period started in February 2021. The share repurchase information in this table is disclosed in Swiss francs as the share buybacks were transacted in Swiss
francs on a separate trading line on the SIX Swiss Exchange.
2 This table excludes purchases for the purpose of hedging derivatives linked
to UBS Group AG shares and for market-making in UBS Group AG
shares.
The table also excludes UBS Group AG shares purchased by post-employment benefit funds
for UBS employees, which are managed by a board of UBS management and employee
representatives in accordance with
Swiss law. UBS’s post-employment benefit funds purchased 906,951 UBS Group AG shares during the year and held 14,073,132
UBS Group AG shares as of 31 December 2021.
3 Based on the transaction date of
the respective treasury share
purchases.
4 The remaining
volume of the 2021
share repurchase program
as of 31 December
2021 was USD 1,871
million. This was
calculated based on
the remaining volume
of
CHF 1,706 million as of 31 December 2021 and the respective closing exchange rate as of this date.
Trading volumes
For the year ended
1,000 shares
31.12.21
31.12.20
31.12.19
SIX Swiss Exchange total
2,514,259
5,095,908
4,161,555
SIX Swiss Exchange daily average
9,899
20,222
16,713
New York Stock Exchange total
137,366
260,681
203,967
New York Stock Exchange daily average
545
1,030
809
Source: Reuters
185
Listing of UBS Group AG shares
UBS Group AG shares are
listed on the SIX
Swiss Exchange (SIX).
They are also
listed on the New
York
Stock Exchange (the
NYSE)
as
global
registered
shares.
As
such,
they
can
be
traded
and
transferred
across
applicable
borders
,
without
the
need
for
conversion,
with
identical
shares
traded
on
different
stock
exchanges in different currencies.
During 2021,
the average daily
trading volume of
UBS Group
AG shares was 9.9 million shares
on SIX and 0.5 million shares
on
the
NYSE.
SIX
is
expected
to
remain
the
main
venue
for
determining the
movement in
our share
price, because
of the
high
volume traded on this exchange.
During
the
hours
in
which
both
SIX
and
the
NYSE
are
simultaneously open for trading
(generally 3:30 p.m. to
5:30 p.m.
Central
European
Time),
price
differences
between
these
exchanges
are
likely
to
be
arbitraged
away
by
professional
market-makers.
Accordingly,
the
share
price
will
typically
be
similar
between
the
two
exchanges
when
considering
the
prevailing
US
dollar
/
Swiss
franc
exchange
rate.
When
SIX
is
closed for trading, globally traded volumes will typically be lower.
However, the
specialist firm
making a
market in
UBS Group AG
shares on the NYSE is required to facilitate sufficient liquidity and
maintain an orderly
market in UBS Group
AG shares throughout
normal NYSE trading hours.
Ticker symbols UBS Group AG
Trading exchange
SIX / NYSE
Bloomberg
Reuters
SIX Swiss Exchange
UBSG
UBSG SW
UBSG.S
New York Stock Exchange
UBS
UBS UN
UBS.N
Security identification codes
ISIN
CH0244767585
Valoren
24 476 758
CUSIP
CINS H42097 10 7
Corporate
governance and
compensation
Management report
4
Audited information according to the Swiss law and applicable regulatory
requirements and guidance
Disclosures provided
are in
line with
the requirements
of Art.
663c para.
1 and
3 of
the Swiss Code
of Obligations
(supplementary
disclosures
for
companies
whose
shares
are
listed
on
a
stock
exchange:
shareholdings)
and
the
Ordinance
against
Excessive
Compensation in Listed Stock Corporations (tables containing such information are marked as “Audited” throughout this section), as
well as other applicable regulations and guidance.
188
189
Corporate governance
Corporate governance and compensation | Corporate governance
190
Corporate governance
UBS Group AG is subject to, and complies with, all relevant Swiss
legal
and
regulatory
requirements
regarding
corporate
governance,
including
the
SIX
Swiss
Exchange’s
Directive
on
Information
relating
to
Corporate
Governance
(the
SIX
Swiss
Exchange
Corporate
Governance
Directive)
and
the
standards
established
in
the
Swiss
Code
of
Best
Practice
for
Corporate
Governance, including the appendix on executive compensation.
As a foreign
company with shares
listed on the
New York Stock
Exchange
(the
NYSE),
UBS
Group
AG
also
complies
with
all
relevant
corporate
governance
standards
applicable
to
foreign
private issuers.
The Organization
Regulations of
UBS Group
AG, adopted
by
the Board of Directors (the BoD) based on Art. 716b of
the Swiss
Code
of
Obligations
and
articles
25
and
27
of
the
Articles
of
Association of
UBS Group
AG, constitute
our primary
corporate
governance guidelines.
To
the
extent
practicable,
the
governance
structures
of
UBS
Group
AG
and
UBS
AG
are
aligned.
UBS
AG
complies
with
all
relevant
Swiss
legal
and
regulatory
corporate
governance
requirements. As a
foreign private issuer
with debt securities
listed
on
the
NYSE,
UBS
AG
also
complies
with
the
relevant
NYSE
corporate
governance
standards.
The
discussion
in
this
section
refers
to
both
UBS
Group
AG
and
UBS
AG,
unless
specifically
noted
otherwise
or
unless
the information
discussed is
relevant
only
to
listed
companies
and
therefore
only
applicable
to
UBS Group
AG.
This
approach
is
in
line
with
US
Securities
and
Exchange Commission (SEC) regulations and NYSE standards.
›
Refer to the Articles of Association of
UBS Group AG and of
UBS AG, and to the Organization Regulations
of UBS Group AG,
available at
ubs.com/governance
and
ubs.com/ubs-ag-
governance,
for more information
›
The SIX Swiss Exchange Corporate Governance
Directive is
available at
ser-ag.com/dam/downloads/regulation/listing/
directives/DCG-en.pdf,
the Swiss Code of Best Practice for
Corporate Governance at
economiesuisse.ch/en/publications/
swiss-code-best-practice-corporate-governance
and the NYSE
rules at
nyse.wolterskluwer.cloud/listed-company-manual
Differences from corporate governance standards relevant
to US-listed companies
The
NYSE
standards
on
corporate
governance
require
foreign
private
issuers
to
disclose
any
significant
ways
in
which
their
corporate governance practices differ from those that have to
be
followed by
domestic companies. Such
differences are
discussed
below.
Responsibility of the Audit Committee regarding independent
auditors
Our
Audit
Committee
is
responsible
for
the
compensation,
retention
and oversight
of independent
auditors. It
assesses the
performance and
qualifications of
external auditors
and submits
proposals
for
appointment,
reappointment
or
removal
of
independent auditors to the BoD. As required by the Swiss Code
of
Obligations,
the
BoD
submits its
proposals
for a
shareholder
vote
at
the
Annual
General
Meeting
(the
AGM).
Under
NYSE
standards
audit
committees
are
responsible
for
appointing
independent auditors.
Discussion of risk assessment and risk management policies by
the Risk Committee
As
per
the
Organization
Regulations
of
UBS
Group
AG
and
UBS AG, the Risk Committee, instead of
the Audit Committee, as
per NYSE standards, oversees our risk
principles and risk capacity
on
behalf
of
the
BoD.
The
Risk
Committee
is
responsible
for
monitoring our adherence to those risk principles and monitoring
whether business divisions and
control units maintain appropriate
systems of risk management and control.
Supervision of the internal audit function
Although under NYSE standards only audit
committees supervise
internal audit functions, the Chairman of the BoD
(the Chairman)
and the Audit Committee share the supervisory responsibility and
authority with respect to the internal audit function.
Responsibility of the Compensation Committee for performance
evaluations of senior management of UBS Group AG
In
line
with Swiss
law,
our Compensation
Committee, together
with the BoD, proposes for shareholder approval at the AGM the
maximum aggregate
amount of
compensation for
the BoD,
the
maximum
aggregate
amount
of
fixed
compensation
for
the
Group Executive
Board (the
GEB) and
the aggregate
amount of
variable
compensation
for
the
GEB.
The
members
of
the
Compensation Committee are
elected by the AGM.
Under NYSE
standards it
is the
responsibility of
compensation committees
to
evaluate
senior
management’s
performance
and
to
determine
and
approve,
as
a
committee
or
together
with
the
other
independent directors, the compensation thereof.
Proxy statement reports of the Audit Committee and the
Compensation Committee
NYSE
standards
require
the
aforementioned
committees
to
submit
their
reports
directly
to
shareholders.
However,
under
Swiss
law
all
reports
to
shareholders,
including
those
from
the
aforementioned committees, are
provided to and
approved by
the
BoD, which has ultimate responsibility to the shareholders.
Shareholder votes on equity compensation plans
NYSE standards require shareholder
approval for the establishing
of
and
material
revisions
to
all
equity
compensation
plans.
However,
as
per
Swiss
law,
the
BoD
approves
compensation
plans.
Shareholder
approval
is
only
mandatory
if
equity-based
compensation plans require an increase
in capital. No shareholder
approval is required
if shares for such
plans are purchased
in the
market.
›
Refer to “Board of Directors” in this section for more
information about the BoD’s committees
›
Refer to “Share capital structure” in this section
for more
information about UBS Group AG’s capital
191
Group structure and shareholders
Operational Group structure
As of 31 December 2021, the operational structure of the Group
is
composed
of
the
Global
Wealth
Management,
Personal
&
Corporate
Banking,
Asset
Management
and
Investment
Bank
business divisions, as well as Group Functions.
›
Refer to the “Our businesses” section on
page 21 of this report
for more information about our business
divisions and Group
Functions
›
Refer to “Financial and operating performance”
on page 75 and
to “Note
2 Segment reporting
” in the “Consolidated financial
statements”
section on page 306 of this report
for more
information
›
Refer to the “Our evolution” section
on page 14 of this report
for more information
Listed and non-listed companies belonging to the Group
The Group
includes a
number of
consolidated entities,
of which
only UBS Group AG shares are listed.
UBS
Group
AG’s
registered
office
is
at
Bahnhofstrasse
45,
CH-8001 Zurich, Switzerland. UBS Group AG shares are listed on
the SIX Swiss
Exchange (ISIN: CH0244767585)
and on the
NYSE
(CUSIP: H42097107).
›
Refer to “
UBS shares
” in the “
Capital, liquidity and funding, and
balance sheet
” section on page 183 of this report for
information about UBS Group AG’s market capitalization and
shares held by Group entities
›
Refer to “Note 29 Interests in subsidiaries and
other entities” in
the “
Consolidated financial statements
” section on page 391 of
this report for more information about the significant
subsidiaries of the Group
Significant shareholders
General rules
Under the
Swiss
Federal
Act on
Financial
Market
Infrastructures
and
Market Conduct in
Securities and Derivatives Trading
of 19 June
2015 (the FMIA), anyone directly
or indirectly, or acting in concert
with third
parties,
holding
shares in
a company
listed
in Switzerland
or
holding derivative rights
related to
shares in
such a
company
must notify the company and
the SIX Swiss
Exchange (SIX) if the
holding
reaches,
falls
below
or
exceeds
one
of
the
following
percentage thresholds:
3, 5, 10, 15, 20, 25, 33
1
⁄
3
, 50 or 66
2
⁄
3
% of
voting
rights, regardless
of
whether
or
not
such
rights
may
be
exercised. Nominee companies that cannot autonomously decide
how
voting
rights
are
exercised
are
not
required
to
notify
the
company and
SIX if
they reach,
exceed or
fall below
the above-
mentioned thresholds.
Pursuant
to
the
Swiss
Code
of
Obligations,
we
disclose
in
“Note
2
3
Significant
shareholders”
to
the
UBS
Group
AG
standalone
financial
statements
the
identity
of
any
shareholder
with a holding of more than 5% of the total share capital of UBS
Group AG.
Shareholders subject to FMIA disclosure notifications
According
to the
mandatory
FMIA disclosure
notifications
filed with
UBS Group
AG and
SIX, as
of 31 December 2021,
the following
entities
held
more
than
3%
of
the
total
share
capital
of
UBS Group AG:
Massachusetts
Financial
Services
Company,
Boston, which
disclosed a
holding of
3.01%
on
22 June
2021;
Artisan Partners
Limited Partnership,
Milwaukee, which
disclosed
a
holding
of
3.15%
on
18 November 2020;
BlackRock Inc.,
New
York,
which disclosed a holding of
4.70% on 26 May
2020; and
Norges Bank,
Oslo, which
disclosed a holding
of 3.01% on 24
July
2019.
As
registration
in
the
UBS
share
register
is
optional,
shareholders crossing
the aforementioned
thresholds requiring
SIX
notification under
the FMIA do not necessarily appear
in the table
below.
On 24 January
2022, Dodge
& Cox International
Stock Fund,
San
Francisco,
disclosed
a
holding
of
3.02%
of
the
total
share
capital
of
UBS
Group
AG
.
No
n
ew
disclosures
of
significant
shareholdings have been made since that date.
In accordance with the
FMIA, the aforementioned holdings
are
calculated in relation
to the total
share capital of
UBS Group AG
reflected in the
Articles of
Association at
the time
of the
respective
disclosure notification.
Information
on
disclosures
under
the
FMIA
is
available
at
ser-ag.com/en/resources/notifications-market-
participants/significant-shareholders.html.
Shareholders registered in the UBS share register with 3% or
more of the share capital of UBS Group AG
As
a
supplement
to
the
mandatory
disclosure
requirements
according
to
the
SIX
Swiss
Exchange
Corporate
Governance
Directive, we disclose in the
table below the
shareholders (acting
in
their
own
name
or
in
their
capacity
as
nominees
for
other
investors
or
beneficial
owners)
that
were
registered
in
the
UBS
share register with
3% or more
of the total
share capital of
UBS
Group AG as of 31 December 2021.
›
Refer to “Shareholders’ participation rights”
on page 197 of this
section for more information about voting
rights, restrictions
and representation
Cross-shareholdings
UBS
Group
AG
has
no
cross-shareholdings
where
reciprocal
ownership would
be in
excess of
5% of
capital or
voting rights
with any other company.
Audited |
Shareholders registered in the UBS share register with 3% or more of the total share capital
1
% of share capital
31.12.21
31.12.20
31.12.19
Chase Nominees Ltd., London
2
8.89
10.39
10.94
DTC (Cede & Co.), New York
2,3
5.78
4.99
7.57
Nortrust Nominees Ltd., London
2
4.80
5.15
4.90
1 As registration in the UBS share
register is optional, shareholders crossing the
threshold percentages requiring SIX notification
under the FMIA do not necessarily appear
in this table.
2 Nominee companies and
securities clearing organizations
cannot autonomously
decide how voting
rights are
exercised and
are therefore
not obligated
to notify
UBS and
SIX if
they reach, exceed
or fall
below the
threshold percentages
requiring disclosure notification under
the FMIA. Consequently,
they do not appear
in the “Shareholders subject
to FMIA disclosure notifications”
section above.
3 DTC (Cede & Co.),
New York, “The
Depository
Trust Company,”
is a US securities clearing organization.
p
Corporate governance and compensation | Corporate governance
192
Share capital structure
Ordinary share capital
At
year-end
2021,
UBS
Group
AG
had
3,702,422,995
issued
shares with a
nominal value
of CHF 0.10
each, equating
to a
share
capital of CHF 370,242,299.50.
Under
Swiss
company
law,
shareholders
must
approve,
in
a
general meeting of shareholders, any increase or reduction in the
ordinary share capital or the creation of conditional or authorized
share capital.
In 2021, our
shareholders were asked
to approve a
reduction
of
share
capital
by
way
of
canceling
156,632,400
registered
shares
repurchased
under
the
2018–2021
share
buyback
program.
In
2021,
our
shareholders
were
not
asked
to
approve
the
creation of conditional or authorized share capital.
No
shares
were
issued
out
of
existing
conditional
capital,
as
there
were
no
employee
options
and
stock
appreciation
rights
outstanding.
Distribution of UBS shares
As of 31 December 2021
Shareholders registered
Shares registered
Number of shares registered
Number
%
Number
% of shares issued
1–100
21,973
11.4
1,210,904
0.0
101–1,000
98,460
51.1
46,829,775
1.3
1,001–10,000
65,295
33.9
192,251,772
5.2
10,001–100,000
6,421
3.3
152,692,476
4.1
100,001–1,000,000
523
0.3
152,003,230
4.1
1,000,001–5,000,000
94
0.0
202,245,394
5.5
5,000,001–37,024,229 (1%)
26
0.0
291,114,743
7.9
1–2%
3
0.0
142,657,900
3.9
2–3%
0
0.0
0
0.0
3–4%
0
0.0
0
0.0
4–5%
1
0.0
177,762,902
4.8
Over 5%
2
1
0.0
543,460,208
14.7
Total registered
192,798
100.0
1,902,229,304
2
51.4
Unregistered
3
1,800,193,691
48.6
Total
192,798
100.0
3,702,422,995
100.0
1 On 31 December 2021, Chase Nominees Ltd., London, entered as a nominee, was registered with 8,89% of all UBS shares issued. However, according to the provisions of UBS Group AG,
voting rights of nominees
are limited to a maximum of 5% of all UBS shares issued. The US securities clearing organization DTC (Cede & Co.), New York, was registered with 5.78% of all UBS shares issued and is not subject to this 5% voting
limit as a securities clearing organization.
2 Of the total shares registered, 295,987,073 shares did not carry voting rights.
3 Shares not entered in the UBS share register as of 31 December 2021.
193
Conditional share capital
At
year-end
2021,
the
following
conditional
share
capital
was
available to UBS Group AG’s BoD:
–
A
maximum
of
CHF 38,000,000
represented
by
up
to
380,000,000 fully paid registered shares
with a nominal value
of
CHF 0.10
each,
to
be
issued
through
the
voluntary
or
mandatory
exercise
of
conversion
rights
and
/
or
warrants
granted
in
connection
with
the
issuance
of
bonds
or
similar
financial
instruments
on
national
or
international
capital
markets.
This
conditional
capital
allowance
was
approved
at
the
Extraordinary
G
eneral
Meeting
(
the
EGM)
held
on
26 November
2014,
having
originally
been
approved
at
the
AGM of UBS AG on 14 April 2010.
The BoD has not made use
of such allowance.
–
A maximum
of CHF 12,170,583
represented by
121,705,830
fully paid
registered shares
with a
nominal value
of CHF 0.10
each,
to
be
issued
upon
exercise
of
employee
options
and
stock appreciation rights issued to employees and members of
the
management
and
of
the
BoD
of
UBS
Group
AG
and
its
subsidiaries. This
conditional capital
allowance was
approved
by the shareholders at the same EGM in 2014.
›
Refer to article 4a of the Articles of Association
of UBS Group AG
for more information about the terms and
conditions of the
issue of shares out of existing conditional capital.
The Articles of
Association are available at
ubs.com/governance
›
Refer to the “Our evolution” section on
page 14 of this report
for more information
Conditional capital of UBS Group AG
As of 31 December 2021
Maximum number of shares to
be issued
Year approved by Extraor-
dinary General Meeting
% of shares issued
Employee equity participation plans
121,705,830
2014
3.29
Conversion rights / warrants granted in connection with bonds
380,000,000
2014
10.26
Total
501,705,830
13.55
Authorized share capital
UBS
Group
AG
had
no
authorized
capital
available
to
issue
on
31 December
2021
.
Changes in capital
In
accordance
with
International
Financial
Reporting
Standards
(IFRS),
Group
equity
attributable
to
shareholders
was
USD 60.7
billion
as
of
31 December
2021
(2020:
USD 59.4
billion;
2019:
USD 54.5 billion). The equity of UBS Group AG shareholders
was
represented
by 3,702,422,995
issued shares
as of
31 December
2021
(31 December 2020:
3,859,055,395 shares;
31 December
2019: 3,859,055,395 shares).
›
Refer to “Statement of changes in
equity” in the “
Consolidated
financial statements
” section on page 286 of this report for more
information about changes in shareholders’
equity over the last
three years
Ownership
Ownership of UBS
Group AG shares
is widely spread.
The tables
in this
section provide information
about the distribution
of UBS
Group AG shareholders by
category and
geographic location. This
information
relates
only
to
shareholders
registered
in
the
UBS
share register and cannot
be assumed to
be representative of UBS
Group
AG’s
entire
investor
base
or
the
actual
beneficial
ownership. Only
shareholders
registered
in the
share register
as
“shareholders with
voting rights”
are entitled
to exercise
voting
rights.
›
Refer to “Shareholders’ participation rights” in
this section for
more information
As
of
31
December
202
1
,
1,606,242,
231
UBS
Group
AG
shares
were
registered
in
the
share
register
and
carried
voting
rights, 295,987,073
shares were
registered in
the share
register
without
voting
rights,
and
1,800,193,691
shares
were
not
registered in the
UBS share register.
All shares were
fully paid up
and
eligible
for
dividends.
There
are
no
preferential
rights
for
shareholders, and no other classes of
shares have been issued by
UBS Group AG.
Corporate governance and compensation | Corporate governance
194
Shareholders, legal entities and nominees: type and geographical distribution
Shareholders registered
As of 31 December 2021
Number
%
Individual shareholders
188,892
98.0
Legal entities
3,724
1.9
Nominees, fiduciaries
182
0.1
Total registered shares
Unregistered shares
Total
192,798
100.0
Individual shareholders
Legal entities
Nominees
Total
Number
%
Number
%
Number
%
Number
%
Americas
1,752
0.9
102
0.1
81
0.0
1,935
1.0
of which: USA
1,244
0.6
54
0.0
78
0.0
1,376
0.7
Asia Pacific
5,024
2.6
98
0.1
24
0.0
5,146
2.7
Europe, Middle East and Africa
11,988
6.2
218
0.1
45
0.0
12,251
6.4
of which: Germany
3,715
1.9
25
0.0
3
0.0
3,743
1.9
of which: UK
4,580
2.4
9
0.0
7
0.0
4,596
2.4
of which: rest of Europe
3,419
1.8
180
0.1
34
0.0
3,633
1.9
of which: Middle East and Africa
274
0.1
4
0.0
1
0.0
279
0.1
Switzerland
170,128
88.2
3,306
1.7
32
0.0
173,466
90.0
Total registered shares
Unregistered shares
Total
188,892
98.0
3,724
1.9
182
0.1
192,798
100.0
At
year-end 2021,
UBS
owned 302,81
5,328
UBS
Group
AG
registered shares,
which corresponded
to 8.18%
of the
total share
capital of UBS Group AG.
At the same time, UBS had
acquisition
positions relating to 327,114,543 voting rights of UBS Group AG
and
disposal
positions
relating
to
184,989,1
49
such
rights,
corresponding to 8.84%
and 5.00% of the
total voting rights of
UBS
Group
AG,
respectively.
Of
the
disposal
positions,
174,354,474
related
to
voting
rights
on
shares
deliverable
in
respect of employee awards.
The calculation methodology for
the
acquisition
and
disposal positions
is based
on
the
Ordinance of
the
Swiss
Financial
Market
Supervisory
Authority
on
Financial
Market
Infrastructures
and
Market
Conduct
in
Securities
and
Derivatives
Trading,
which
states
that
all
future
potential
share
delivery obligations,
irrespective of
the contingent
nature of
the
delivery, must be considered.
Employee share ownership
Employee share ownership is encouraged and made possible in a
variety
of
ways.
Our
Equity
Plus
Plan
is
a
voluntary
plan
that
provides eligible employees with
the opportunity to purchase
UBS
Group
AG shares
at
market value
and
receive,
at
no additional
cost,
one
notional
UBS
Group
AG
share
for
every
three
shares
purchased. The
Equity Ownership
Plan (the
EOP) is
a mandatory
deferral
plan
for
all
employees
with
regulatory-driven
deferral
requirements
or
total
compensation
greater
than
USD
/
CHF 300,000,
excluding
selected
senior
leaders.
EOP
recipients
receive a portion of their deferred performance award in notional
shares (and / or
notional funds for Asset
Management). Selected
senior leaders receive
the equity-based Long-Term
Incentive Plan
(the
LTIP)
instead
of
the
EOP.
Both
the
EOP
and
LTIP
include
provisions
that
allow
the
firm
to
reduce
or
fully
forfeit
the
unvested deferred
portion of
an award
if an
employee commits
certain harmful
acts, and
in most
cases trigger
forfeiture
where
employment has been
terminated. To
reinforce our
emphasis on
sustainable performance and risk management, and our focus
on
achieving
growth
ambitions,
EOP
and
LTIP
awards
granted
to
certain
employees
will
only
vest
if
predetermined
performance
conditions are met.
On
31 December
2021,
UBS
employees
held
at
least
7%
of
UBS shares outstanding (including approximately 5% in unvested
notional shares from our
compensation programs). These figures
are
based
on
known
shareholding
information
from
employee
participation
plans,
personal
holdings
with
UBS
and
selected
individual retirement plans.
At the end
of 2021, at
least 30% of
all employees held UBS shares through the firm’s employee share
participation plans.
›
Refer to the “Compensation”
section on page 228 of this report
for more information
Trading restrictions in UBS shares
UBS employees
with regular access to unpublished price-sensitive
information about
the firm
are
subject to
specific restrictions
in
respect to UBS financial
instruments, including, but
not limited to,
pre-clearance
requirements
and
regular
blackout
periods.
Such
UBS
employees
are
not
permitted
to
trade
UBS
financial
instruments in
the period
starting
from
the close
of
business in
New York
on the seventh business day
of the final month
of the
financial quarter of UBS Group AG and ending
on the day of the
publication of the quarterly financial results.
Shares and participation certificates
UBS Group
AG has a
single class of
shares, which are
registered
shares in the form of uncertificated securities (in the
sense of the
Swiss Code
of Obligations)
and intermediary-held
securities (in
the
sense of the Swiss Federal
Act on Intermediated Securities). Each
registered share has a nominal value of CHF 0.10 and carries one
vote,
subject
to
the
restrictions
set
out
under
“Transferability,
voting rights and nominee registration” below.
We have no participation certificates outstanding.
195
Shares registered
Number
%
407,015,326
11.0
532,743,019
14.4
962,470,959
26.0
1,902,229,304
51.4
1,800,193,691
48.6
3,702,422,995
100.0
Individual shareholders
Legal entities
Nominees
Total
Number of shares
%
Number of shares
%
Number of shares
%
Number of shares
%
2,353,309
0.1
38,231,738
1.0
314,298,798
8.5
354,883,845
9.6
895,352
0.0
32,243,999
0.9
314,079,349
8.5
347,218,700
9.4
20,738,978
0.6
12,399,087
0.3
8,213,841
0.2
41,351,906
1.1
44,135,588
1.2
70,477,887
1.9
623,075,242
16.8
737,688,717
19.9
12,300,749
0.3
1,303,330
0.0
10,696,165
0.3
24,300,244
0.7
19,457,985
0.5
288,377
0.0
578,307,924
15.6
598,054,286
16.2
11,187,562
0.3
30,050,555
0.8
33,946,355
0.9
75,184,472
2.0
1,189,292
0.0
38,835,625
1.0
124,798
0.0
40,149,715
1.1
339,787,451
9.2
411,634,307
11.1
16,883,078
0.5
768,304,836
20.8
407,015,326
11.0
532,743,019
14.4
962,470,959
26.0
1,902,229,304
51.4
0
0
0
1,800,193,691
48.6
407,015,326
11.0
532,743,019
14.4
962,470,959
26.0
3,702,422,995
100.0
Our shares are
listed on the
NYSE as global
registered shares.
As
such,
they
can
be
traded
and
transferred
across
applicable
borders,
without
the
need
for
conversion,
with
identical
shares
traded on different stock exchanges in different currencies.
›
Refer to “
UBS shares
” in the “
Capital, liquidity and funding, and
balance sheet
” section on page 183 of this report for
more
information
Distributions to shareholders
The decision
to pay
a dividend
and the
amount of
any dividend
depend
on
a
variety
of
factors, including
our
profits,
cash
flow
generation and capital ratios.
At the 2022 AGM,
the BoD intends
to propose to shareholders
for
approval
a
dividend
of
USD 0.50
per
share
for
the
2021
financial year. Shareholders whose
shares are held
through SIX SIS
AG
will
receive
dividends
in
Swiss
francs,
based
on
a
public
exchange
rate
on
the
day
prior
to
the
ex-dividend
date.
Shareholders
holding
shares
through
The
Depository
Trust
Company in New York and Computershare will be paid dividends
in US dollars.
In compliance with Swiss tax law, 50% of the dividend will be
paid out of retained earnings and the balance will
be paid out of
the
capital
contribution
reserve.
Dividends
paid
out
of
capital
contribution reserves are
not subject
to Swiss
withholding tax.
The
portion
of
the
dividend
paid
out
of
retained
earnings
will
be
subject to
a 35%
Swiss withholding
tax. For
US federal
income
tax
purposes,
we
expect
that
the
dividend
will
be
paid
out
of
current or accumulated earnings and profits.
Provided
that
the
proposed
dividend
distribution
out
of
retained earnings and
out of the capital
contribution reserve will
be
approved
at
the
AGM
on
6 April
2022,
the
payment
of
USD 0.50 per share
will be made
on 14 April 2022
to holders of
shares on the
record date 13 April
2022. The shares
will be traded
ex-dividend as of 12 April
2022 and, accordingly, the
last day on
which the
shares may
be traded
with entitlement
to receive
the
dividend will be 11 April 2022.
In
February 2021,
the
BoD
launched
a
new
three-year
share
buyback program.
At the
2021 AGM,
the shareholders
authorized
the
BoD
to
buy
back
shares
for
cancellation
purposes
in
an
aggregate value of up
to CHF 4 billion until
the 2024 AGM. Any
shares
bought
back
under
the
program
are
intended
to
be
canceled
by
way
of
capital
reduction,
which
will
be
subject
to
shareholder approval at
one or several
subsequent AGMs, and
the
acquisition and holding of
such shares are not
subject to the 10%
threshold for UBS Group AG’s own shares within the meaning of
Art. 659 para. 1 of the Swiss Code of Obligations. Since the start
of
this
2021
share
repurchase
program
in
February
2021
until
18 February
2022,
we
have
bought
back
CHF
2.78
billion
of
shares.
These shares
are expected
to be
canceled by means
of a
capital reduction, to be proposed for shareholder approval at
the
2022 AGM.
Looking
ahead,
we
intend
to
commence
a
new
2022
share
buyback
program
of
up
to
USD 6
billion over two
years
and
expect to execute up to USD 5 billion of share repurchases under
both the existing
2021 and the
new 2022 share
buyback program
by the end of 2022.
›
Refer to “
UBS shares
” in the “
Capital, liquidity and funding, and
balance sheet
” section on page 183 of this report for
more
information about the share repurchase programs
Corporate governance and compensation | Corporate governance
196
Transferability, voting rights and nominee registration
We
do
not
apply
any
restrictions
or
limitations
on
the
transferability of
shares. Voting
rights may
be exercised
without
any restrictions
by shareholders entered
into the share
register if
they
expressly
render
a
declaration
of
beneficial
ownership
according to the provisions of the Articles of Association.
We
have
special
provisions
for
the
registration
of
nominees.
Nominees are entered
in the share
register with voting
rights up
to a total of
5% of all issued
UBS Group AG shares if
they agree
to disclose, upon our request, beneficial owners holding 0.3% or
more of all issued UBS Group AG shares.
An exception to the 5%
voting
limit
rule is
in
place
for
securities
clearing organizations,
such as The Depository Trust Company in New York.
›
Refer to “Shareholders’ participation rights” in
this section for
more information
Convertible bonds and options
As
of
31
December
2021
,
there
were
no
contingent
capital
securities or convertible bonds outstanding
requiring the issuance
of new shares.
›
Refer to the “
Capital, liquidity and funding, and balance
sheet
”
section on page 150 of this report for more information
about
our outstanding capital instruments
As of 31 December
2021, there
were no employee
options and
stock
appreciation
rights
outstanding.
Option
-
based
compensation
plans
are
sourced
by
issuing
new
shares
out
of
conditional
capital.
As
of
31
December
2021
,
121,705,830
unissued UBS Group
AG shares in
conditional share capital
were
available for the issuance of new shares for this purpose.
›
Refer to “Conditional share capital” in this section
for more
information
›
Refer to “Note 28
Employee benefits: variable compensation
” in
the “
Consolidated financial statements
” section on page 387 of
this report for more information about outstanding
options and
stock appreciation rights
197
Shareholders’ participation rights
We
are
committed
to
shareholder
participation
in
decision-
making
processes.
Our
online
voting
platform
offers
registered
shareholders
a
convenient
log-in
and
online
voting
process.
Registered
shareholders
are
sent
personal
invitations
to
the
general
meetings.
Together
with
the
invitation
materials,
they
receive a personal one-time password and a QR
code to easily log
in to the
online voting platform,
where they can enter
their voting
instructions or order an admission card for the general meeting.
Shareholders
who
choose
not
to
receive
the
comprehensive
invitation materials
are informed
of upcoming
general meetings
by a
short letter containing
a personal one-time
password, a QR
code for online voting and a
reference to
ubs.com/agm
,
where all
information for the upcoming meeting is available.
General meetings
offer shareholders
the opportunity
to raise
questions
for
the
BoD,
GEB
and
internal
and
external
auditors.
Also,
prior
to
our
virtual
general
meetings,
we
offer
all
shareholders the opportunity to contact us with questions, which
are answered in writing or during the general meeting.
Voting rights, restrictions and representation
We
place
no
restrictions
on
share
ownership
and
voting rights.
However,
pursuant to general
principles formulated
by the BoD,
nominee companies, which normally represent a large number of
individual
shareholders
and
may
hold
an
unlimited
number
of
shares,
have
voting
rights
limited
to
a
maximum
of
5%
of
all
issued UBS
Group AG
shares. This
is to
avoid large
shareholders
being entered
in UBS’s
share register
via nominee
companies so
as
to
exercise
influence
without
directly
registering
their
shares
with
UBS.
Securities
clearing
organizations,
such
as
The
Depository Trust
Company in
New York,
are
not subject
to this
5% voting limit.
Shareholders
can
exercise
voting
rights
conferred
by
shares
only if they are registered in our share register
with voting rights.
To
register,
shareholders
must
confirm
that
they
have
acquired
UBS
Group
AG
shares
in
their
own
name
and
for
their
own
account. Nominee companies
are required to
sign an agreement
confirming
their
willingness
to
disclose,
upon
our
request,
individual beneficial owners holding more than
0.3% of all issued
UBS Group AG shares.
All
shareholders
registered
with
voting
rights
are
entitled
to
participate in
general meetings.
If they
do not
wish to
attend in
person, they
may issue
instructions to
support, reject
or abstain
for each individual item
on the meeting agenda,
either by giving
instructions
to an
independent proxy
in
accordance
with article
14
of
the
Articles
of
Association
(the
AoA)
or
by
appointing
another
registered
shareholder
of
their
choice
to
vote
on
their
behalf.
Alternatively,
registered
shareholders
may
issue
their
voting
instructions
to
the
independent
proxy
electronically
through our online
voting platform.
Nominee companies
normally
submit the
proxy material
to the
beneficial owners
and forward
the collected votes to the independent proxy.
In 2021,
physical attendance
at the
AGM was
not possible, due
to COVID-19-related restrictions in Switzerland, and voting rights
could only
be exercised
through the
independent proxy.
Due to
the ongoing
pandemic, the
BoD has
decided to
also hold
the 2022
AGM without the physical participation of shareholders.
›
Refer to article 14 of the Articles of Association
of UBS Group
AG, available at
ubs.com/governance
, for more information
about the issuing of instructions to independent
voting right
representatives
Statutory quorums
Motions are decided at a
general meeting by
an absolute majority
of
the
votes
cast,
excluding
blank
and
invalid
ballots.
For
the
approval of certain
specific issues, the Swiss Code
of Obligations
requires
a
positive
vote from
a two-thirds
majority of
the
votes
represented at
the given general
meeting, and from
an absolute
majority of the nominal value of
shares represented thereat. Such
issues
include
creating
shares
with
privileged
voting
rights,
introducing restrictions on the transferability of registered shares,
conditional
and
authorized
capital
increases
and
restricting
or
excluding shareholders’ preemptive rights.
The AoA
also require
a two-thirds
majority of
votes represented
for
approval
of
any
change
to
their
provisions
regarding
the
number of BoD members, any decision to remove one-quarter or
more of the BoD members and
any modification to the provision
establishing this qualified quorum.
Votes
and elections
are
generally
conducted electronically
to
ascertain
the
exact
number
of
votes
cast.
Voting
by
a
show
of
hands
is possible
if
a
clear majority
is predictable.
Shareholders
representing
at
least
3%
of
the
votes
represented
may
request
that a
vote or election
be carried out
electronically or
by written
ballot. To
allow shareholders
to clearly express
their views on
all
individual topics, each agenda
item is separately put
to a vote and
BoD members are elected on a person-by-person basis.
Corporate governance and compensation | Corporate governance
198
Convocation of general meetings of shareholders
The
AGM
must
be
held
within
six
months
of
the
close
of
the
financial
year
(i.e.,
31 December).
In
2022,
the
AGM
will
take
place on 6 April.
Extraordinary
General
Meetings
(EGMs)
may
be
convened
whenever
the
BoD
or
the
auditors
consider
it
necessary.
Shareholders individually
or jointly
representing at
least 10%
of
the
share
capital
may
at
any
time,
including
during
an
AGM,
require, by way of
a written statement, that
an EGM be convened
to address a specific issue they put forward.
A
personal
invitation,
including
a
detailed
agenda,
is
made
available to every registered shareholder
at least 20 days
ahead of
each
scheduled
general
meeting.
The
items
on
the
agenda
are
also published in the Swiss Official Gazette of Commerce, as well
as at
ubs.com/agm.
Placing of items on the agenda
Pursuant
to
our
AoA,
shareholders
individually
or
jointly
representing shares with an
aggregate minimum nominal
value of
CHF 62,500 may submit
proposals for matters
to be
placed on
the
agenda
for
consideration
at
the
next
general
meeting
of
shareholders.
At
the
beginning
of
January,
the
invitation
to
submit
such
proposals is published in the Swiss Official
Gazette of Commerce
and
at
ubs.com/agm.
Requests
for
items
to
be
placed
on
the
agenda
must
include
the
actual
motions
to
be
put
forward,
together
with
a
short
explanation.
Such
requests
must
be
submitted
to
the
BoD
50
days
prior
to
the
general
meeting
of
shareholders,
including
a
statement
from
the
depository
bank
confirming
the
number
of
shares
held
by
the
requesting
shareholder(s)
and that
these shares
are blocked
from
sale until
the
end
of
the
general
meeting
of
shareholders.
The
BoD
formulates
opinions
on
the
proposals,
which
are
published
together with the motions.
Registrations in the share register
The
share
register
of
UBS
Group
AG,
where
around
190,000
shareholders
are
directly
registered,
is
an
internal,
non-public
register
subject
to
statutory
confidentiality,
secrecy,
privacy
and
data protection regulations protecting registered shareholders. In
general, third
parties and shareholders
have no inspection
rights
with
regard to
data related
to other
shareholders.
Disclosure of
such data is
permitted only in
specific and limited
instances. In line
with the
Swiss Federal
Act on
Data Protection,
the disclosure
of
personal
data
as
defined
thereunder
is
only
allowed
with
the
consent of the registered shareholder and in cases where there is
an overriding private or public interest or if
explicitly provided for
by
Swiss
law.
The
Swiss
Federal
Act
on
Financial
Market
Infrastructures and
Market Conduct in
Securities and
Derivatives
Trading
contains specific
reporting
duties, such
as
in relation
to
significant shareholders (refer
to “Significant shareholders”
in this
section for more information). Disclosure may also be required or
requested
by
a
court
of
a
competent
jurisdiction,
by
any
regulatory body that
regulates the conduct
of UBS Group
AG or
by other statutory provisions.
The general
rules for
entry into
our Swiss
share register
with
voting rights are described in article 5
of our AoA. The same rules
apply to our US transfer agent
that operates the US share register
for
all
UBS Group
AG shares
in a
custodian account
in
the US,
where some 230,000 US shareholders are indirectly registered via
nominee
companies.
In order
to
determine
the voting
rights of
each shareholder, our share register generally closes two business
days
prior
to
a
general
meeting.
Our
independent
proxy
agent
processes
voting
instructions
from
shareholders
as
long
as
technically possible, generally also until two business days before
a
general
meeting.
Such
technical
closure
of
our
share
register
facilitates the
determination of
the actual
voting rights
of every
shareholder
that
issued
a
voting
instruction.
Irrespective
of
this
technical closure,
shares that
are registered
in our
share register
are
never
immobilized
and
are
freely
tradable
at
any
time,
irrespective of any issued voting instructions.
›
Refer to article 5 of the Articles of Association
of UBS Group AG,
available at
ubs.com/governance
, for more information about
the general rules for entry into our Swiss
share register
199
Board of Directors
The
BoD
of
UBS
Group
AG,
led
by
the
Chairman,
consists
of
between 6 and 12 members, as per our AoA.
The
BoD
decides
on
the
strategy
of
the
Group,
upon
recommendation by the Group
Chief Executive Officer (the
Group
CEO), and is responsible for the overall direction, supervision and
control of
the Group
and its
management. It
is also
responsible
for
supervising
compliance
with
applicable
laws,
rules
and
regulations. The BoD exercises oversight over UBS Group AG and
its subsidiaries,
and is
responsible for
establishing a
clear Group
governance
framework
to
provide
effective
steering
and
supervision of the Group,
taking into account the
material risks to
which UBS
Group AG
and its
subsidiaries are
exposed. The
BoD
has ultimate
responsibility for
the success
of the
Group and
for
delivering
sustainable
shareholder
value
within
a
framework
of
prudent and effective controls.
It approves all financial
statements
and appoints and removes all GEB members.
The
BoD
of
UBS AG,
led
by
the
Chairman,
decides
on
the
strategy of UBS AG upon recommendation by the President of its
Executive
Board
and
exercises
the
ultimate
supervision
of
management. Its ultimate
responsibility for the
success of
UBS AG
is exercised subject to the parameters set by the Group.
Members of the Board of Directors
At
the
AGM
on
8 April
2021,
Jeremy
Anderson,
William
C.
Dudley,
Reto Francioni, Fred Hu,
Mark Hughes, Nathalie Rachou,
Julie G. Richardson, Dieter Wemmer and Jeanette Wong were re-
elected as members of the BoD. Beatrice
Weder di Mauro did not
stand for
re-election; the
biography of
Ms. Weder
di Mauro can
be found on
page 190 of
the UBS Group
AG Annual Report
2020,
available under “Annual reporting” at
ubs.com/investors
. Claudia
Böckstiegel
and
Patrick
Firmenich
were
elected
for
their
first
terms.
At
that
same
AGM,
Axel
A.
Weber
was
re-elected
Chairman,
and
Julie
G.
Richardson,
Reto
Francioni,
Dieter
Wemmer
and
Jeanette
Wong
were
elected
as
members
of
the
Compensation Committee. ADB Altorfer Duss
& Beilstein AG was
elected as independent
proxy
agent. Following his
re-election, the
BoD
appointed
Jeremy
Anderson
as
Vice
Chairman
and
Senior
Independent Director of UBS Group AG.
On
20 November
2021,
the
BoD
announced
that
Colm
Kelleher
would
be
nominated
for
election
to
the
BoD
of
UBS
Group AG and UBS AG to succeed Axel A.
Weber as Chairman at
the forthcoming AGMs.
Mr. Kelleher was
the President of
Morgan
Stanley
&
Company,
and
responsible
for
Institutional
Securities
and
Wealth
Management
from
2016
to
2019.
In
his
30-year
career with Morgan Stanley,
he held various senior
management
positions,
including
Chief
Financial
Officer
during
the
financial
crisis
in
2008.
In
addition,
the
BoD
announced
that
Lukas
Gähwiler
would
be
nominated
for
election
to
the
BoD
of
UBS
Group
AG
and
UBS
AG
as
Vice
Chairman
at
the
forthcoming
AGMs.
Having joined
UBS in
2010 as
a member
of the
GEB of
UBS
AG
and
President
UBS
Switzerland,
Mr.
Gähwiler
stepped
down
from
those
roles
in 2016
and
has been
Chairman
of
the
board of directors of UBS
Switzerland AG since 2017.
He will step
down from the board of directors of
UBS Switzerland AG as of 5
April 2022.
Article
31
of
our
AoA
limits
the
number
of
mandates
that
members
of
the
BoD
may
hold
outside
UBS
Group
to
four
mandates
in
listed
companies
and
five
additional
mandates
in
non-listed companies. Mandates in companies that are
controlled
by
us
or
that
control
us
are
not
subject
to
this
limitation.
In
addition,
members
of
the
BoD
may
hold
no
more
than
10
mandates
at
UBS’s
request
and
10
mandates
in
associations,
charitable
organizations,
foundations,
trusts,
and
employee
welfare foundations. As
of 31 December 2021,
no member of
the
BoD reached the thresholds described in article 31 of our AoA.
The following biographies provide
information about the BoD
members
who
were in
office in
2021 and
the Group
Company
Secretary.
In
addition
to
information
on
mandates,
the
biographies
include
information
on
memberships
or
other
activities
or
functions,
as
required
by
the
SIX
Swiss
Exchange
Corporate Governance Directive.
No member of the BoD currently carries out or has carried out
over
the past
three years
operational management
tasks within
the Group; therefore, all members
of the Board are non-executive
members.
All members of UBS
Group AG’s BoD are
also members of UBS
AG’s
BoD,
and
committee
membership
is
the
same
for
both
entities. The Senior Independent Director
function relates only to
UBS Group AG.
In 2021, UBS AG’s BoD had three permanent committees: the
Audit
Committee,
the
Compensation
Committee
and
the
Risk
Committee.
In
addition
to
those
permanent
committees,
UBS
Group
AG
also
had
the
Corporate
Culture
and
Responsibility
Committee and the Governance and Nominating Committee.
Corporate governance and compensation | Corporate governance
200
Axel A. Weber
Chairman of the Board of Directors and non-executive member
of
the Board since 2012
–
Chairperson of the Corporate Culture and Responsibility Committee
since 2013
–
Chairperson of the Governance and Nominating
Committee
since 2012
Nationality:
German |
Year of birth:
1957
Axel
A.
Weber
was
elected
Chairman
of
UBS
in
2012.
He
gained
international recognition
as the
President of
the Deutsche
Bundesbank.
During
his
six-year
tenure
there,
he
also
served
as
a
member
of
the
Governing Council of the
European Central Bank, a member
of the Board
of Directors of
the Bank for International Settlements,
German governor
of the
International Monetary
Fund and
a member
of the
G7 and
G20
Ministers
and
Governors.
As
an
expert
in
international
and
monetary
economics, Mr. Weber strove to
strengthen the Bundesbank’s
importance
in the
group of the
17 European central
banks and led
the Bundesbank
through the events of the
global real estate and
financial crisis. Before the
Deutsche Bundesbank, he
had a career as
a renowned expert in
monetary
and
currency
theories
through
his
academic
posts
at
several
German
universities.
Professional experience
2011 – 2012
Visiting professor, University of Chicago Booth School of
Business, USA (on leave, University of Cologne, Germany)
2011
Member of the Steering Committee, the European
Systemic Risk Board
2010 – 2011
Member of the Steering Committee, the Financial
Stability Board
2004 – 2011
President, Deutsche Bundesbank
2002 – 2004
Member, German Council of Economic Experts
2001 – 2004
Professor of International Economics and Director of the
Centre for Financial Research, University of Cologne
1998 – 2001
Professor for Applied Monetary Economics and Director
of the Center for Financial Studies, Goethe University
Frankfurt am Main
1994 – 1998
Professor of Economic Theory, University of Bonn
Education
–
Master’s degree, economics, University of Constance
–
Doctorate (Dr. rer.
pol.) and habilitation, economics,
University of Siegen, Germany
Other activities and functions
–
Vice Chairman of the Swiss Bankers Association
–
Member of the Board of Trustees of Avenir Suisse
–
Member of the Board of the Swiss Finance Council
–
Chairman of the Board of the Institute of International
Finance
–
Member of the European Financial Services Round Table
–
Member of the European Banking Group
–
Member of the International Advisory Councils
of the China Banking
and Insurance Regulatory Commission and the
China Securities
Regulatory Commission
–
Member of the International Advisory Panel,
Monetary Authority
of Singapore
–
Member of the Group of Thirty, Washington, DC
–
Member of the Advisory Board of the Department of
Economics,
University of Zurich
–
European Chairman of the Trilateral Commission
Key competencies
–
Finance, audit, accounting
–
Risk management, compliance and legal
–
Regulatory authority, central bank
–
ESG (environmental, social and governance)
Leadership experience
–
CEO, Chairman
201
Jeremy Anderson
Vice Chairman and Senior Independent Director
since 2020 and
non-executive member of the Board since 2018
–
Member of the Governance and Nominating
Committee since 2019
–
Chairperson of the Audit Committee since 2018
Nationality:
British |
Year of birth:
1958
Jeremy Anderson is a financial services veteran, with more than 30 years’
experience working
in the
banking and
insurance sector
in an
advisory
capacity,
covering a broad
range of topics,
including strategy,
audit and
risk management,
technology-enabled transformation,
mergers, and
bank
restructuring. Before retiring from KPMG in
2017, he was its Chairman
of
Global Financial Services.
Mr. Anderson is also an IT
expert, having started
out
as
a
software
developer
in
the
early
1980s,
before
working
in
IT
consulting and developing a broad
knowledge of systems integration
and
IT outsourcing services,
as well as
software development.
He cemented
his
reputation as a
tech specialist by
becoming a
founding sponsor
of KPMG’s
Global Fintech Network in 2014.
Professional experience
2010 – 2017
Chairman of Global Financial Services,
KPMG International
2008
–
2011
Head of Clients and Markets KPMG Europe,
KPMG International
2006 – 2011
Head of Financial Services KPMG Europe,
KPMG International
2004 – 2006
Head of Financial Services KPMG UK,
KPMG International
2002 – 2004
Member of the Group Management Board and
Head of UK operations, Atos Origin SA
1985 – 2002
KPMG consulting UK, KPMG
1980 – 1985
Software developer, Triad
Computing Systems
Education
–
Bachelor’s degree, economics, University College London
Listed company boards
–
Member of the Board of Prudential plc
Other activities and functions
–
Trustee of the UK’s Productivity Leadership Group
–
Trustee of Kingham Hill Trust
–
Trustee of St. Helen’s Bishopsgate
Key competencies
–
Banking (wealth management, asset management,
personal and corporate banking) and insurance
–
Finance, audit, accounting
–
Risk management, compliance and legal
–
Technology,
cybersecurity
Leadership experience
–
Executive board leadership
Claudia Böckstiegel
Non-executive member of the Board since 2021
Nationality:
Swiss and German |
Year of birth:
1964
Claudia
Böckstiegel
has
been
General
Counsel
and
a
member
of
the
Enlarged
Executive
Committee
of
Roche
Holding
AG
since
2020.
She
started
her
professional
career
as
an
attorney
in
private
practice
in
Germany,
then joined the Swiss
pharmaceutical company in Germany in
2001 and subsequently held various global management positions in the
legal sector in Switzerland. Ms. Böckstiegel brings
a wealth of know-how
in
a
highly
regulated
sector.
Her
responsibilities
at
Roche
Holding
AG
include
a
broad
range
of
additional
topics,
such
as
safety,
health
&
environment,
patents,
audit
and
risk
advisory,
compliance
and
sustainability.
Professional experience
2020 – date
General Counsel and member of the Enlarged Executive
Committee, Roche Holding AG
2016 – 2020
Head of Legal Diagnostics, F. Hoffmann-La Roche Ltd.,
Basel, Switzerland, Roche Group
2010 – 2016
Head Legal Business, Roche Diagnostics International
Ltd,
Rotkreuz, Switzerland, Roche Group
2005 – 2010
Head Legal Business, Roche Diagnostics GmbH,
Mannheim, Germany, Roche Group
2001 – 2005
Legal Counsel, Roche Diagnostics GmbH,
Mannheim, Germany, Roche Group
1995 – 2001
Attorney (Partner), Philipp & Littig, Mannheim, Germany
1992 – 1995
Attorney (Associate), Dr. Hermann Büttner,
Karlsruhe, Germany
Education
–
Master’s degree, law, Universities of Mannheim and Heidelberg
–
Master of Laws (LL.M.), Georgetown University, Washington, DC
Key competencies
–
Risk management, compliance and legal
–
Finance, audit, accounting
–
ESG (environmental, social and governance)
–
Regulatory authority, central bank
Leadership experience
–
Executive board leadership
Other activities and functions
None
Corporate governance and compensation | Corporate governance
202
William C. Dudley
Non-executive member of the Board since 2019
–
Member of the Governance and Nominating
Committee since 2020
–
Member of the Corporate Culture and Responsibility Committee
since 2019
–
Member of the Risk Committee since 2019
Nationality:
American (US) |
Year of birth:
1953
William C. Dudley served as
the President and CEO of the
Federal Reserve
Bank of New York for nine
years. He demonstrated
exceptional leadership
in monetary
policy and as
a top
regulator,
including during the
years of
the global financial crisis. During that period, his additional area
of focus
included
cultural
behavior
and
social
and
governance
topics
in
the
financial
services
industry.
He
also
served
as
the
Vice
Chairman
and
a
permanent member of the Federal Open Market Committee. Mr.
Dudley
brings a
wealth of
experience in
banking and
research thanks to
his former
management positions at
Goldman Sachs
Group and
Morgan Guaranty
Trust.
Professional experience
2009 – 2018
President and CEO, Federal Reserve Bank of New York,
USA
2007 – 2009
Executive Vice President and Head Markets Group,
Federal Reserve Bank of New York, USA
2006
Senior advisor (part-time), Goldman Sachs Group, USA
2002 – 2005
Partner and Director US Economic Research Group,
Goldman Sachs Group, USA
1996 – 2002
Managing Director and Director US Economic Research
Group, Goldman Sachs Group, USA
1983 – 1996
Economist at Goldman Sachs Group, Morgan Guaranty
Trust Company,
and Board of Governors of the Federal
Reserve System
Education
–
Bachelor of Arts, New College of Florida
–
Doctorate, economics, University of California, Berkeley
Non-listed company boards
–
Member of the Board of Treliant LLC
Other activities and functions
–
Senior Advisor to the Griswold Center for Economic
Policy Studies,
Princeton University
–
Member of the Group of Thirty
–
Member of the Council on Foreign Relations
–
Chair of the Bretton Woods Committee Board of Directors
–
Member of the Board of the Council for Economic
Education
Key competencies
–
Investment banking, capital markets
–
Risk management, compliance and legal
–
Regulatory authority, central bank
–
ESG (environmental, social and governance)
Leadership experience
–
CEO, Chairman
Patrick Firmenich
Non-executive member of the Board since 2021
–
Member of the Audit Committee since 2021
–
Member of the Corporate Culture and Responsibility Committee
since 2021
Nationality:
Swiss |
Year of birth:
1962
Patrick
Firmenich
has
been
Chairman
of
the
Board
of
Firmenich
International
SA,
the
world’s
largest
privately
owned
fragrances
and
flavorings company, since 2016,
after leading the
company as CEO
during
a
12-year
tenure.
He
demonstrated
his
entrepreneurial
leadership
by
significantly
advancing
the
Firmenich
group’s
global
position
through
organic and in-organic growth and successfully continuously
transformed
the organization to respond to client needs and the market
environment.
He developed
an ambitious
sustainability strategy
for the
group to
lead
the
industry
in
health,
safety
and
environmental
performance.
Before
joining
Firmenich,
he
held
several
positions
in
the
legal
and
banking
sectors, including working
as an international
investment banking
analyst.
Professional experience
2014 – 2016
Vice Chairman of the Board, Firmenich International
SA
2002 – 2014
CEO, Firmenich SA, Geneva
2001 – 2002
Corporate Vice President, Special Operations,
Firmenich SA, Geneva
1997 – 2001
Vice President Fine Fragrance worldwide and Président
Directeur Général, Firmenich & Cie, Paris and
Firmenich Inc, New York
1993
–
1997
Vice President Fine Fragrance North America,
Firmenich Inc, New York
1990 – 1993
Account Manager, Firmenich & Cie, Paris
1988 – 1989
Analyst, International Investment Banking,
Credit Suisse
First Boston
1988
Production administrator, Firmenich SA de CV, Mexico
1984 – 1986
Attorney, Business Law, Patry,
Junet, Simon & Le Fort,
Geneva
Education
–
Master’s degree, law, University of Geneva, admitted to the bar
in Geneva
–
MBA, INSEAD Fontainebleau
Non-listed company boards
–
Member of the Board of Jacobs Holding AG
Other activities and functions
–
Member of the Board of INSEAD and INSEAD World Foundation
–
Member of the Advisory Council of the Swiss Board Institute
Key competencies
–
Risk management, compliance and legal
–
Finance, audit, accounting
–
ESG (environmental, social and governance)
–
Banking (wealth management, asset management, personal
and
corporate banking) and insurance
Leadership experience
–
CEO, Chairman
203
Reto Francioni
Non-executive member of the Board since 2013
–
Member of the Compensation Committee since 2019
–
Member of the Risk Committee since 2015
Nationality:
Swiss |
Year of birth:
1955
Reto Francioni, as the former CEO of Deutsche Börse, can draw on many
years of
experience in
the financial
world. Prior
to his
role at
Deutsche
Börse, he
was Chairman
of the
Supervisory Board
and President
of the
SWX Group, Zurich,
placing him at
the heart of
digitalization within the
financial sector. In both positions, he
drove a fundamental transformation
to
reshape
the firms
as
world
leaders
in
technology.
Mr.
Francioni
has
been
a
professor
of applied
capital markets
theory at
the University
of
Basel since 2006
and is the
author of several
highly respected books
on
capital markets issues. He
has also served as
an independent director on
the boards of various major corporations.
Professional experience
2005 – 2015
CEO, Deutsche Börse AG
2002 – 2005
Chairman of the Supervisory Board and President,
SWX Group, Zurich
2000 – 2002
Co-CEO and Spokesman for the Board of Directors,
Consors AG, Nuremberg
1999 – 2000
Deputy CEO, Deutsche Börse AG, Frankfurt am Main
1993 – 2000
Member of the Executive Board, Deutsche Börse AG,
Frankfurt am Main
1992 – 1993
Director, Corporate Finance, Hoffmann-La Roche, Basel
1989 – 1992
Deputy Director and deputy CEO, Association Tripartite
Bourses, Zurich
1985 – 1988
Equity sales and legal, Credit Suisse, New York and Zurich
1981 – 1984
Union Bank of Switzerland
Education
–
Master’s degree and doctorate, law, University of Zurich
Listed company boards
–
Member of the Board of Coca-Cola HBC AG (Senior Independent
Non-Executive Director, chair of the nomination committee)
Non-listed company boards
–
Chairman of the Board of Swiss International
Air Lines AG
–
Vice Chairman of the Board of MTIP AG
Other activities and functions
–
Member of the Board of economiesuisse
Key competencies
–
Investment banking, capital markets
–
Risk management, compliance and legal
–
Human resources management, including compensation
–
Technology,
cybersecurity
Leadership experience
–
CEO, Chairman
Fred Hu
Non-executive member of the Board since 2018
–
Member of the Governance and Nominating
Committee since 2020
–
Member of the Risk Committee since 2020
Nationality:
Chinese |
Year of birth:
1963
Fred Hu has been the Chairman
and CEO of Primavera Capital
Group , an
Asia-based private investment firm focused on emerging technology and
innovative industries,
since founding
it in
2010. Prior
to that,
he was
a
partner and Chairman for Greater China at
Goldman Sachs, building the
firm’s
Asia
Pacific
franchise.
Mr.
Hu
has
a
profound
understanding
of
Chin
a’s
economy
and
rapidly
developing
financial
system,
and
vast
amount of experience advising and investing in leading firms in the tech,
consumer and health
care sectors in
China and globally.
He has worked
at the IMF and advised the Chinese government
on economic policy.
Professional experience
2010
–
date
Founder, Chairman & CEO,
Primavera Capital Group, China
2008 – 2010
Partner and Chairman of Greater China, Goldman Sachs
2004 – 2008
Partner and Co-Head, Investment Banking, China,
Goldman Sachs
2003 – 2004
Managing Director and Co-Head, Investment Banking,
China, Goldman Sachs
1997 – 2003
Executive Director, then Managing Director and Chief
Economist and Strategist, Greater China, Goldman Sachs
1996 – date
Co-Director, the National Center for Economic Research
1996 – date
Adjunct Professor, Economics,
Tsinghua University
Education
–
Master’s degree, engineering science, Tsinghua University
–
Master’s degree and doctorate, economics, Harvard University
Listed company boards
–
Non-executive Chairman of the Board of Yum China Holdings
(chair of the nomination and governance committee)
–
Member of the Board of ICBC
Non-listed company boards
–
Chairman of Primavera Capital Ltd
–
Member of the Board of Ant Group
–
Member of the Board of Minsheng Financial Leasing Co.
Other activities and functions
–
Trustee of the China Medical Board
–
Governor of the Chinese International
School in Hong Kong SAR
–
Co-Chairman of the Nature Conservancy Asia Pacific Council
–
Member of the Board of Trustees,
the Institute for Advanced Study
–
Director and member of the Executive Committee of China
Venture
Capital and Private Equity Association Ltd.
Key competencies
–
Investment banking, capital markets
–
Risk management, compliance and legal
–
Technology,
cybersecurity
–
Regulatory authority, central bank
Leadership experience
–
CEO, Chairman
Corporate governance and compensation | Corporate governance
204
Mark Hughes
Non-executive member of the Board since 2020
–
Chairperson of the Risk Committee since 2020
–
Member of the Corporate Culture and Responsibility Committee
since 2020
Nationality:
Canadian, British and American (US) |
Year of birth:
1958
Mark
Hughes
is a
veteran in
the financial
services sector,
having spent
more
than
35
years
working
for
the
Royal
Bank
of
Canada
(RBC)
in
Canada, in the US and
the UK. In his final
role as Group Chief Risk Officer
of RBC,
he was
responsible for
the strategic management
of risk
on an
enterprise-wide basis
and oversaw all
risk functions. During
his career, Mr.
Hughes has also held
senior management positions
in the front office
and
key operational roles. Currently, he is a
visiting lecturer at Leeds
University
and is chair of the Global Risk Institute, bringing
an enormous amount of
experience as a risk specialist to the Board of Directors of UBS.
Professional experience
2014 – 2018
Group Chief Risk Officer and member Group Executive
Committee, Royal Bank of Canada
2013
Deputy Chief Risk Officer, Royal Bank of Canada
2008 – 2013
Chief Operating Officer, RBC Capital Markets, Royal Bank
of Canada
2001 – 2008
Head of Global Credit, Royal Bank of Canada
1999 – 2001
Head of Debt Products, Royal Bank of Canada
1998 – 1999
Senior Vice President and General Manager USA,
Royal Bank of Canada
1997 – 1998
Senior Vice President Financial Services, Royal Bank
of Canada
1982 – 1996
Various positions, Royal Bank of Canada
Education
–
Bachelor of Laws (LL.B.), University of Leeds
–
MBA, finance, University of Manchester
Other activities and functions
–
Chair of the Board of Directors of the Global Risk Institute
–
Visiting lecturer at the University of Leeds
–
Senior advisor to McKinsey & Company
Key competencies
–
Banking (wealth management, asset management,
personal and corporate banking) and insurance
–
Investment banking, capital markets
–
Risk management, compliance and legal
–
Technology,
cybersecurity
Leadership experience
–
Executive board leadership
Nathalie Rachou
Non-executive member of the Board since 2020
–
Member of the Risk Committee since 2020
Nationality:
French |
Year of birth:
1957
Nathalie Rachou is
a seasoned expert
in financial services,
having held a
number of banking positions, such as CEO of Prime Brokerage and Head
of a business line in
Capital Markets at Crédit
Agricole Indosuez in the
UK
and in France.
In 1999, she founded a London-based asset management
company that
merged with a
French asset
manager and continued
as a
senior
adviser
until
2020.
Alongside
these
roles,
Ms.
Rachou
brings
extensive experience from serving
as a board member
of Société Générale
for 12 years and is currently on
the boards of two other listed companies,
including the pan-European bourse, Euronext N.V.
Professional experience
2015
–
2020
Senior Advisor, Clartan Associés
(formerly Rouvier Associés), France
1999
–
2014
Founding partner and CEO,
Topiary Finance Ltd., UK
1996
–
1999
Head of Global Foreign Exchange and Currency Options,
Crédit Agricole Indosuez (formerly Banque Indosuez), UK
1991 – 1996
Corporate Secretary and Secretary to the
Board of Directors, Crédit
Agricole Indosuez, France
1986 – 1991
COO, Carr Futures, France (owned by Banque Indosuez),
Crédit Agricole Indosuez, France
1983 – 1986
Head of Asset
and Liability
Management
& Market
Risks,
Crédit Agricole
Indosuez,
France
1978 – 1982
Position in Forex Exchange Sales, Crédit Agricole Indosuez,
France and UK
Education
–
Master’s degree, management, HEC Paris
–
MBA, INSEAD Fontainebleau
Listed company boards
–
Member of the Board of Euronext N.V.
(chair of the remuneration committee)
–
Member of the Board of Veolia Environnement SA
(chair of the audit committee)
Other activities and functions
–
Member of the Board of the African Financial Institutions
Investment
Platform
Key competencies
–
Banking (wealth management, asset management,
personal and corporate banking) and insurance
–
Investment banking, capital markets
–
Risk management, compliance and legal
–
Finance, audit, accounting
205
Julie G. Richardson
Non-executive member of the Board since 2017
–
Chairperson of the Compensation Committee since 2019
–
Member of the Governance and Nominating
Committee since 2019
–
Member of the Risk Committee since 2017
Nationality:
American (US) |
Year of birth:
1963
Julie G.
Richardson spent more
than 25 years
on Wall
Street as
a senior
investment banker with
a focus on
telecom, media and
technology. She
began her career at Merrill
Lynch, before moving to JPMorgan,
where she
headed
the
telecommunications,
media
and
technology
investment
banking group. Later, she moved into private equity,
as head of the New
York
office
of
Providence
Equity
Partners.
Throughout
her
career,
Ms. Richardson has spent significant time with both
incumbent and new
technology
companies,
including
being
a
board
member
of
a
digital
knowledge management company and a leading cloud monitoring
firm.
Professional experience
2012 – 2014
Senior advisor, Providence Equity Partners, New York
2003
–
2012
Partner and Head of the New York office,
Providence Equity Partners, New York
1998
–
2003
Vice Chairman of the Investment Banking division
of
JPMorgan Chase & Co. and Head of its Global
Telecommunications, Media and Technology
group
1986 – 1998
Various position at Merrill Lynch, final position:
Managing Director Media and Communications
Investment Banking
Education
–
Bachelor’s degree, business administration, University of
Wisconsin–Madison
Listed company boards
–
Member of the Board of Yext (chair of the audit committee)
–
Member of the Board of Datadog (chair of the audit committee)
Key competencies
–
Investment banking, capital markets
–
Risk management, compliance and legal
–
Human resources management, including compensation
–
Technology,
cybersecurity
Dieter Wemmer
Non-executive member of the Board since 2016
–
Member of the Governance and Nominating
Committee since 2020
–
Member of the Audit Committee since 2019
–
Member of the Compensation Committee since 2018
Nationality:
Swiss
and German
|
Year of
birth:
1957
Dieter Wemmer
began his
esteemed
career in the
insurance
sector with
the
Zurich Group
in 1986, retiring
in 2017 as CFO of Allianz.
As a long-serving
CFO of
two large
multi-national
companies
in the
financial
services
sector, he
brings
deep experience
across a broad
range of highly
relevant
topics to
the
table. Mr.
Wemmer brings
to
the
BoD
knowledge covering accounting,
finance
and audit,
including
capital markets,
investments,
risk management,
as well
as asset
management.
His know-how
includes
hands-on
experience
in
M&A and
management
of large
organizations
with
a dedication
to strategy.
Professional experience
2013 –
2017
CFO, Allianz SE
2012
–
2013
Member of the Board of Management, responsible for the
insurance business in France, Benelux, Italy, Greece and
Turkey and for the “Global Property & Casualty” Center of
Competence, Allianz SE
2007 –
2011
CFO, Zurich Insurance Group
2010 –
2011
Regional Chairman of Europe, Zurich Insurance Group
2004 –
2007
CEO of the Europe General Insurance business
and member of Zurich’s Group Executive Committee,
Zurich Insurance Group
2003 –
2004
COO of Europe General Insurance, Zurich Insurance Group
1999 –
2003
Head of Mergers and Acquisitions, Zurich Insurance Group
1997 –
1999
Head of Financial Controlling, Zurich Insurance Group
Education
–
Master’s degree and doctorate, mathematics, University
of Cologne
Listed company boards
–
Member of the Board of Ørsted A/S
(chair of the audit and risk committee)
Non-listed company boards
–
Chairman of Marco Capital Holdings Limited,
Malta and subsidiaries
Other activities and functions
–
Member of the Berlin Center of Corporate Governance
Key competencies
–
Banking (wealth management, asset management,
personal and corporate banking)
and insurance
–
Investment banking, capital markets
–
Finance, audit, accounting
–
Risk management, compliance and legal
Leadership experience
–
Executive board leadership
Corporate governance and compensation | Corporate governance
206
Jeanette Wong
Non-executive member of the Board since 2019
–
Member Compensation Committee since 2020
–
Member of the Corporate Culture and Responsibility Committee
since 2020
–
Member of the Audit Committee since 2019
Nationality:
Singaporean |
Year of birth:
1960
Jeanette
Wong
has
spent more
than 30
years working
in
the financial
sector in Singapore. She retired from DBS Group in 2019, where she was
Group Executive responsible for the institutional banking business,
a post
which
encompassed
corporate
banking,
global
transaction
services,
strategic advisory and
mergers and acquisitions.
Prior to that, she
held the
position of
CFO at
DBS
Bank. During
a
16-year career
with JPMorgan,
Ms. Wong helped build
up its Asia
and emerging markets
business. She
brings extensive
experience from
serving as
a member
of the
board of
directors of two highly valued listed companies.
Professional experience
2008 – 2019
Group Executive institutional banking business,
DBS Bank, Singapore
2003 – 2008
CFO, DBS Bank
2003
Chief Administration Officer, DBS Bank, Singapore
1997 – 2002
Country Manager Singapore, JPMorgan Chase, Singapore
1986 – 1997
Various roles in Global Markets and Emerging Markets
Sales and Trading business, Asia,
JPMorgan Chase,
Singapore
1984 – 1986
Manager, Private Banking,
Citibank, Singapore
1982 – 1984
Manager, Corporate Banking, Paribas, Singapore
Education
–
Bachelor’s degree, business administration, the National University
of Singapore
–
MBA, University of Chicago
Listed company boards
–
Member of the Board of Prudential plc
–
Member of the Board of Singapore Airlines Limited
Non-listed company boards
–
Member of the Board Risk Committee of GIC Pte Ltd
–
Member of the Board of Jurong Town Corporation
–
Member of the Board of PSA International
Other activities and functions
–
Chairman of the CareShield Life Council
–
Member of the Securities Industry Council
–
Member of the Board of Trustees of the National University
of Singapore
Key competencies
–
Banking (wealth management, asset management,
personal and corporate banking) and insurance
–
Investment banking, capital markets
–
Finance, audit, accounting
–
ESG (environmental, social and governance)
Leadership experience
–
Executive board leadership
Markus Baumann
Group Company Secretary since 2017
Nationality:
Swiss |
Year of birth:
1963
Markus Baumann
joined UBS
in 1979
as a
banking apprentice
and has now been with the firm
for more than 40 years. Earlier
in his
career,
he worked
in Japan
for four
years, as
Corporate
Planning Officer
and assistant
to the
CEO. He
then worked
as
COO
EMEA for
UBS
Asset Management
and
has
since
held a
broad range of leadership roles across the Group
in Switzerland,
the US and Japan, including
COO of Group Internal Audit from
2006 to 2015.
Professional experience
2017 – date
Group Company Secretary of UBS Group AG
and Company Secretary of UBS AG
2015 – 2016
Chief of Staff to the Chairman of the Board of
Directors, UBS
2006 – 2015
COO, Group Internal Audit, UBS
2005 – 2006
Head Global Reporting & Controlling,
Global Asset Management, UBS
2002 – 2004
Head Management Support CEO EMEA,
Global Asset Management, UBS
1998 – 2002
COO EMEA, Global Asset Management, UBS
1979 – 1997
Various positions, Union Bank of Switzerland
Education
–
Swiss Federal Diploma as a Business Analyst
–
MBA, INSEAD Fontainebleau
207
Elections and terms of office
Shareholders annually elect each member of the
BoD individually,
as well as
the Chairman and
the members of
the Compensation
Committee, based on proposals from the BoD.
As set out in
the Organization Regulations, BoD
members are
normally expected to serve for at least three years. BoD members
are limited to
serving for a maximum
of 10 consecutive
terms of
office;
in
exceptional
circumstances
the
BoD
may
extend
that
limit.
›
Refer to “Skills, expertise and training
of the Board of Directors”
in this section for more information
Organizational principles and structure
Following each AGM, the
BoD meets to appoint
one or more Vice
Chairmen,
a
Senior
Independent
Director,
the
BoD
committee
members
(other
than
the
Compensation
Committee
members,
who
are
elected
by
the
shareholders)
and
the
respective
committee Chairpersons. At the same meeting
the BoD appoints
the
Group
Company
Secretary,
who,
pursuant
to
the
Organization
Regulations,
acts
as
secretary
to
the
BoD
and
its
committees.
Pursuant
to
the
AoA
and
the
Organization
Regulations,
the
BoD meets as often as business
requires, but it must meet at
least
six times
a
year.
Due
to
the
continued COVID-19
pandemic,
all
meetings were organized as video calls, with the
exception of the
meeting
held
in
October
2021.
Additional
video
calls
were
organized
during
the
reporting
period
to
facilitate
social
engagement and
interaction between
the members
of the
BoD.
During 2021, a total of 24 BoD meetings were held, 12 of
which
were attended by
GEB members.
Average participation in
the BoD
meetings was 99%. In addition to the BoD meetings attended by
GEB members, the Group CEO attended
some of the meetings of
the BoD without GEB participation. The meetings had an
average
duration of
130 minutes
and covered
both UBS
Group AG
and
UBS AG. Additionally, 10 ad hoc calls were held, 6 of which were
attended by
GEB members.
The BoD
held a
number of
strategy
workshops throughout
the year,
during which
the results
of the
new CEO’s in-depth strategy review were
covered. These strategy
workshops
included
deep
dives
on
each
business
division
and
geographical
region,
and
topics
such
as
the
definition
of
the
p
urpose,
vision
and
strategic
imperatives
,
as
well
as
the
digitalization
of
the
business,
sustainable
finance,
cultural
and
behavioral
aspects
,
including
agile
approaches
to
ways
of
working.
The
strategy
discussions
were
completed
in
October
2021,
when the
overarching strategy
and implementation
plans
were agreed upon.
At
the
BoD
meetings,
each
committee
Chairperson
provides
the
BoD
with
an
update
on
current
activities
of
his
or
her
committee and important committee issues.
In 2021, four UBS AG BoD meetings were held with members
of
the
Executive
Board
in
attendance.
Standalone
meetings are
held regularly
to discuss
and agree
on finance,
risk, compliance,
operational risk,
regulatory and
other topics
related to
UBS AG.
We
also
continued
with
the
coordination
and
exchange
of
information
between
UBS
Group
AG
and
its
significant
group
entities. Joint meetings
between the BoD
of UBS Group
AG and
the boards of directors of the significant group entities, as well
as
between the
respective chairs
of the
risk and
audit committees,
have been held. As in prior years, an
annual workshop, attended
by
independent
members
of
the
boards
of
the
Group
and
significant group entities, was held.
Corporate governance and compensation | Corporate governance
208
Performance assessment
Every third year, an external
assessment of
the effectiveness of
the
BoD is
conducted. In
2022, this
review
concluded that
the UBS
BoD and committees
operate effectively, in line
with best
practice,
and set a high standard in
comparison with leading international
peers. The review
also confirmed that
the BoD agenda
covers all
important
and
relevant
topics
and
that
these
are
addressed
professionally and
in great
depth. It
further found
that the
BoD
members are
independent, highly committed
and of the
highest
integrity, and that the Chairman provides effective
leadership and
direction. The
review emphasized
that the
cooperation between
the
BoD
and
the
GEB
is
based
on
mutual
trust,
respect
and
constructive dialogue.
The mix
of expertise
in the
BoD is
broad-
based and the quality of BoD members is high. The BoD and GEB
have
responded
well
to
the
economic
environment,
including
successfully managing the firm through
the COVID-19 pandemic
and
other
significant
challenges,
while
maintaining
an
appropriate
focus
on
control
and
regulatory
issues.
The
review
highlights the successful CEO
transition and onboarding and
the
well-planned
and
professionally
executed
Chairman
succession
process. No significant weaknesses were
identified in the review,
areas
to
be
further
focused
on
included
the
maintaining
of
a
balanced
agenda
that
provides
sufficient
room
for
business
performance, strategic review and growth initiatives.
BoD committees
The
committees listed
on the
following pages
assist the
BoD in
the
performance
of
its
responsibilities.
These
committees
and
their
charters
are
described
in
our
Organization
Regulations,
available at
ubs.com/governance.
The committees meet
as often
as their business requires, but
no less than four
times a year in
the
case
of
the
Audit
Committee,
the
Risk
Committee
and
the
Compensation Committee,
and no less
than two times
a year in
the case of
the Corporate Culture
and Responsibility Committee
and
the
Governance
and
Nominating
Committee.
Topics
of
common
interest
or
affecting
more
than
one
committee
are
discussed at joint committee meetings.
During
2021,
a
total of
nine joint
committee meetings
were
held
for
UBS
Group
AG
(seven
joint
committee
meetings
were
held simultaneously
for UBS
AG). The
Risk Committee
held two
meetings
with
the
Compensation
Committee,
two
with
the
Corporate
Culture
and
Responsibility
Committee,
and
five
with
the Audit Committee.
Board of Directors
Members in 2021
Meeting attendance
without GEB
3
Meeting attendance
with GEB
4
Key responsibilities include:
Axel A. Weber, Chairman
12/12
100%
12/12
100%
The Board has ultimate responsibility for the success of
the Group and
for delivering sustainable shareholder value within
a framework of
prudent and effective controls. It decides on the Group’s
strategy and
the necessary financial and human resources upon recommendation
of
the Group CEO and sets the Group’s values and standards to
ensure
that its obligations to shareholders and other stakeholders
are met.
›
Refer to the Organization Regulations of UBS Group
AG,
available at
ubs.com/governance
, for more information
Jeremy Anderson
12/12
100%
12/12
100%
Claudia Böckstiegel
1
10/10
100%
8/8
100%
William C. Dudley
12/12
100%
12/12
100%
Patrick Firmenich
1
10/10
100%
8/8
100%
Reto Francioni
12/12
100%
12/12
100%
Fred Hu
11/12
92%
11/12
92%
Mark Hughes
12/12
100%
12/12
100%
Nathalie Rachou
12/12
100%
12/12
100%
Julie G. Richardson
12/12
100%
12/12
100%
Beatrice Weder di Mauro
2
2/2
100%
4/4
100%
Dieter Wemmer
12/12
100%
12/12
100%
Jeanette Wong
12/12
100%
12/12
100%
1
Claudia Böckstiegel and Patrick Firmenich were elected to the Board at the 2021 AGM; indicated are their attended and total meetings after their election.
2
Beatrice Weder di Mauro did not stand for re-election at
the 2021 AGM; indicated are her attended and total meetings up to the 2021 AGM.
3
Additionally, four ad hoc calls took place in 2021.
4
Additionally, six ad hoc calls took place in 2021.
209
Audit Committee
Throughout
2021,
the
Audit
Committee
consisted
of
four
BoD
members, all
of whom
were determined
by the
BoD to
be fully
independent. As a group, members
of the Audit Committee
must
have
the
necessary
qualifications
and
skills
to
perform
all
their
duties and together
must possess financial
literacy and experience
in banking and risk management.
The Audit
Committee itself
does not
perform audits;
instead,
it oversees the
work of the external
auditors, Ernst & Young
Ltd,
who
in
turn
are
responsible
for
auditing
the
annual
financial
statements of UBS Group AG
and UBS AG and for reviewing
the
quarterly financial statements.
In particular, the
Audit Committee monitors
the integrity of
the
financial
statements
of
UBS
Group
AG
and
UBS
AG
and
any
announcements
related
to
financial
performance,
and
reviews
significant
financial
reporting
judgments
contained
in
them,
before recommending their approval
to the BoD or
proposing any
adjustments the Audit Committee considers appropriate.
The
Audit
Committee
oversees
the
relationship
with,
and
assesses the qualifications, expertise,
effectiveness, independence
and
performance
of,
the
external
auditors
and
the
lead
audit
partner,
and
supports
the
BoD
in
reaching
decisions
on
the
appointment, reappointment or dismissal of the external auditors
and the rotation of the lead
audit partner. The BoD then submits
proposals for shareholder approval at the AGM.
During
2021,
the
Audit
Committee
held
13
committee
meetings, with
a participation
rate of
100%. The
meetings had
an average
duration of
approximately 145
minutes and
covered
both UBS Group AG
and UBS AG. Additional attendees
included
the Chairman
of the
BoD, the
Group CEO,
the Group
CFO, the
Group Controller and
Chief Accounting Officer,
the Head Group
Internal
Audit (GIA)
and the
external
auditors.
The
Chairperson
and
the
committee
continued
to
maintain
regular
contact
with
core supervisory authorities.
All
Audit
Committee
members
have
accounting
or
related
financial management expertise
and, in compliance with
the rules
established pursuant to the 2002 US Sarbanes–Oxley Act, at
least
one member
qualifies as
a financial
expert. The
NYSE standards
on corporate governance and Rule 10A-3 under the
US Securities
Exchange Act set
more stringent independence requirements
for
members of audit committees than for the other members of the
BoD. Throughout 2021, all
members of the Audit
Committee, in
addition
to
satisfying
our
independence
criteria,
satisfied
these
requirements,
in
that
they
did
not
receive,
directly
or
indirectly,
any consulting, advisory or compensatory
fees from any member
of the
Group other
than in
their capacity as
a BoD
member, did
not hold, directly or
indirectly, UBS Group AG shares
in excess of
5%
of
the
outstanding
capital,
and
did
not
serve
on
the
audit
committees of more than two other public companies.
Audit Committee
Members in 2021
Meeting attendance
3
Key responsibilities include:
Jeremy Anderson (Chairperson)
13/13
100%
The function of the Audit Committee is to support
the Board in fulfilling its oversight duty relating
to financial reporting and internal controls over financial
reporting, the effectiveness of the
external and internal audit functions,
and the effectiveness of whistleblowing procedures.
Management is responsible for the preparation, presentation
and integrity of the financial
statements, while the external auditors
are responsible for auditing financial statements. The
Audit
Committee’s responsibility is one of oversight
and review.
›
Refer to the Organization Regulations of UBS Group
AG,
available at
ubs.com/governance,
for more information
Patrick Firmenich
1
9/9
100%
Beatrice Weder di Mauro
2
4/4
100%
Dieter Wemmer
13/13
100%
Jeanette Wong
13/13
100%
1
Patrick Firmenich was elected to this committee at the 2021 AGM; indicated
are his attended and total meetings after his election.
2
Beatrice Weder di Mauro did not stand for re-election
at the 2021 AGM; indicated
are her attended and total meetings up to the 2021 AGM.
3
Additionally, the Audit Committee held one ad hoc call.
Corporate governance and compensation | Corporate governance
210
Compensation Committee
The
Compensation
Committee
consisted
of
four
independent
BoD members throughout 2021, as indicated
in the table below.
In addition to the key responsibilities indicated in the
same table,
the
Compensation
Committee
reviews
the
compensation
disclosures included in this report.
During
2021,
the
Co
mpensation
Committee
held
nine
meetings,
with
a
n
average
participation
rate
of
97%.
The
meetings had
an average
duration of
approximately 90
minutes
and covered both UBS Group AG and UBS
AG. All meetings were
held
in the
presence of
the
Chairman
and the
Group CEO
and
most
were
attended
by
external
advisors.
In
2021
,
the
Chairperson met regularly with core supervisory authorities.
›
Refer to “Compensation for the Board of Directors”
in the
“Compensation” section on page 258 of
this report for more
information about the Compensation
Committee’s decision-
making procedures
Corporate Culture and Responsibility Committee
In
2021,
the
Corporate
Culture
and
Responsibility
Committee
consisted
of
the
Chairperson
and
four
independent
BoD
members.
The Group
CEO, the
Group
Chief Regulatory
Officer,
the President Asset
Management and GEB lead
for Sustainability
and
Impact,
and
the
Chief Sustainability
Officer
are
permanent
guests
of
the
Corporate
Culture
and
Responsibility
Committee.
During 2021, six meetings were held, with a
participation rate of
100
%.
The
average
duration
of
each
of
the
meetings
was
approximately 80 minutes.
Compensation Committee
Members in 2021
Meeting attendance
1
Key responsibilities include:
Julie G. Richardson (Chairperson)
9/9
100%
The Compensation Committee is responsible for:
(i)
supporting the Board in its duties to set guidelines
on compensation and benefits;
(ii)
approving the total compensation for the Chairman
and the non-independent Board members;
(iii) proposing, upon proposal of the Chairman, financial
and non-financial performance targets
and objectives for the Group CEO for approval by the
Board and reviewing,
upon the proposal
of the Group CEO, the performance f
ramework for the other GEB members;
(iv) proposing, upon proposal of the Chairman, the Group CEO’s
performance assessment for
approval by the Board, as well as informing the Board of the performance
assessments of
all GEB members, including the Group CEO
;
(v)
proposing, upon proposal
of the Chairman, the total compensation
for the Group CEO for
approval by the Board; and
(vi)
proposing, upon proposal of the Group CEO, the individual total
compensation for the other
GEB members for approval by the Board.
›
Refer to the Organization Regulations of UBS Group
AG,
available at
ubs.com/governance,
for more information
Reto Francioni
8/9
89%
Dieter Wemmer
9/9
100%
Jeanette Wong
9/9
100%
1
Additionally, the Compensation Committee held four ad hoc calls.
Corporate Culture and Responsibility Committee
Members in 2021
Meeting attendance
Key responsibilities include:
Axel A. Weber (Chairperson)
6/6
100%
The Corporate Culture and Responsibility Committee
supports the Board in its duties to safeguard
and advance the Group’s reputation for responsible and sustainable
conduct. Its function is
forward-looking in that it monitors and reviews societal
trends and transformational developments
and assesses their potential relevance for the Group.
In undertaking this assessment, it reviews stakeholder
concerns and expectations pertaining
to the
societal performance of UBS and to the development
of its corporate culture. The Corporate
Culture and Responsibility Committee’s function
also encompasses the monitoring of the
current
state and implementation of the programs and initiatives
within the Group pertaining to corporate
culture and corporate responsibility,
including sustainability.
›
Refer to the Organization Regulations of UBS Group
AG,
available at
ubs.com/governance
, for more information
William C. Dudley
6/6
100%
Patrick Firmenich
1
4/4
100%
Mark Hughes
6/6
100%
Beatrice Weder di Mauro
2
2/2
100%
Jeanette Wong
6/6
100%
1
Following the 2021 AGM, Patrick Firmenich became a member of this committee; indicated are his attended and total meetings after his election.
2
Beatrice Weder di Mauro did not stand for re-election at the 2021
AGM; indicated are her attended and total meetings up to the 2021 AGM.
211
Governance and Nominating Committee
In 2021,
the Governance
and Nominating
Committee consisted
of the Chairperson and five independent members. During 2021,
nine meetings were held,
with a participation rate of 100%.
The
average duration
of each of
the meetings was
approximately 75
minutes. The Group CEO attended meetings as appropriate.
Risk Committee
In
2021,
the
Risk
Committee
consisted
of
six
independent
members.
During 2021,
the Risk
Committee held
11 committee
meetings,
with
a
participation
rate
of
100%.
The
average
duration of each
of the meetings
was approximately 205
minutes,
covering both UBS Group
AG and UBS AG.
The Group CEO,
the
Group CFO, the Group Chief Risk Officer,
Group COO and later
the
Group
Chief
Digital
and
Information
Officer,
the
Group
Treasurer,
the Group Chief Compliance
and Governance Officer,
the
Group
General
Counsel,
and
the
Head
GIA
attended
the
meetings.
In
2021,
the
Chairperson
or
the
full
committee
met
with core supervisory authorities.
Ad hoc committees
The Special
Committee and
the Strategy
Committee are
two ad
hoc
committees,
which
have
a
standing
composition
and
hold
meetings as and when required.
Leading
up
the
2021
AGM,
the
Special
Committee
was
composed
of
four BoD
members.
Jeremy
Anderson
chaired the
Special
Committee,
with
Nathalie
Rachou,
Julie
G.
Richardson,
and
Axel
A.
Weber
as
its
members;
after
the
AGM,
Claudia
Böckstiegel joined
the Special
Committee. Its
primary purpose
is
to
oversee
activities
related
to
key
litigation
and
investigation
matters, review
management’s respective
proposals and
send to
the BoD
recommendations for
decisions. In
2021, the
key focus
was
the
French
cross-border
matter.
The
Group
CEO
and
the
Group General
Counsel are
permanent guests.
During 2021,
six
meetings were held, covering both UBS Group AG and UBS AG.
The Strategy
Committee is
composed of
four BoD
members.
Its primary purpose is to
support management and the BoD with
regard to the assessment of strategic considerations and to assist
with
the
planning of
the annual
strategy meetings
for
the BoD
and
the
GEB.
The
committee
sends
recommendations
for
decisions
to
the
BoD.
Axel
A.
Weber
chaired
the
Strategy
Committee, with William C. Dudley, Fred Hu and Dieter
Wemmer
as
its
members.
During
2021,
one
meeting
was
held,
covering
both
UBS
Group
AG and
UBS AG.
The
Group
CEO,
the
Group
CFO and the
Head Corporate Development
& Performance were
present.
Governance and Nominating Committee
Members in 2021
Meeting attendance
1
Key responsibilities include:
Axel A. Weber (Chairperson)
9/9
100%
The function of the Governance and
Nominating Committee is to support the Board in fulfilling
its
duty to establish best practices in corporate governance
across the Group, including conducting a
Board assessment, establishing and maintaining
a process for appointing new Board and GEB
members, as well as for the annual performance
assessment of the Board.
›
Refer to the Organization Regulations of UBS Group
AG,
available at
ubs.com/governance
, for more information
Jeremy Anderson
9/9
100%
William C. Dudley
9/9
100%
Fred Hu
9/9
100%
Julie G. Richardson
9/9
100%
Dieter Wemmer
9/9
100%
1
Additionally, the Governance and Nominating Committee held five ad hoc calls.
Risk Committee
Members in 2021
Meeting attendance
1
Key responsibilities include:
Mark Hughes (Chairperson)
11/11
100%
The function of the Risk Committee is to oversee
and support the Board in fulfilling its duty to set
and supervise an appropriate risk management
and control framework in the areas of:
(i)
financial and non
-
financial risks
; and
(ii)
balance sheet, treasury and capital management, including
funding,
liquidity and
equity attribution.
›
Refer to the Organization Regulations of UBS Group
AG,
available at
ubs.com/governance
, for more information
William C. Dudley
11/11
100%
Reto Francioni
11/11
100%
Fred Hu
11/11
100%
Nathalie Rachou
11/11
100%
Julie G. Richardson
11/11
100%
1
Additionally, the Risk Committee held four ad hoc calls.
Corporate governance and compensation | Corporate governance
212
Roles and responsibilities of the Chairman of the Board of
Directors
At
the
2022
AGM,
Axel
A.
Weber
will
step
down
and
Colm
Kelleher will
stand for
election as
the full-time
Chairman of
the
BoD. The
Chairman coordinates
tasks within
the BoD,
calls BoD
meetings
and
sets
their
agendas.
He
presides
over
all
general
meetings
of
shareholders
and
works
with
the
committee
Chairpersons
to
coordinate
the
work
of
all
BoD
committees.
Together
with
the
Group
CEO,
the
Chairman
undertakes
responsibility for UBS’s reputation, and is responsible for
effective
communication
with
shareholders
and
other
stakeholders,
including
government
officials,
regulators
and
public
organizations. This is
in addition to
establishing and maintaining
close working
relationships with
the Group
CEO and
other GEB
members, and providing advice and support when appropriate.
›
Refer to “Employees” in the “How we
create value for our
stakeholders” section on page 44 and
the fold-out pages of this
report for information about our Pillars, Principles
and Behaviors
In
2021,
the
Chairman
met
regularly
with
core
supervisory
authorities
in
all
major
locations
where
UBS
is
active.
Meetings
with important
supervisory authorities
were scheduled
on an
ad
hoc or needs-driven basis.
Roles and responsibilities of the Vice Chairmen and the
Senior Independent Director
The
BoD
appoints
one
or
more
Vice
Chairmen
and
a
Senior
Independent
Director.
If
the
BoD
appoints
more
than
one
Vice
Chairman, at
least one
of them
must be
independent. Both
the
Vice Chairman and
the Senior Independent
Director support
the
Chairman with
regard
to his
responsibilities and
authorities and
provide him
with advice.
In conjunction
with the
Chairman and
the Governance and Nominating Committee, they facilitate good
Group-wide corporate governance,
as well as
balanced leadership
and
control
within
the
Group,
the
Board
and
the
committees.
Jeremy
Anderson
has
been
the
Vice
Chairman
and
Senior
Independent
Director
since
2020
and
it
is
planned
that
he
will
remain
Senior
Independent
Director
following
the
2022
AGM.
Lukas Gähwiler will be appointed as Vice Chairman following the
2022
AGM. The
Vice
Chairman is
required
to
lead and
has
led
meetings of the BoD
in the temporary absence of
the Chairman.
Together
with the Governance and Nominating Committee, he is
tasked with the ongoing
monitoring and the annual
evaluation of
the Chairman. He also represents UBS on behalf of the Chairman
in
meetings
with
internal
or
external
stakeholders.
The
Senior
Independent Director
enables and
supports communication
and
the flow
of information
among the
independent BoD
members.
At
least
twice
a
year,
he
organizes
and
leads
a
meeting
of
the
independent
BoD
members
without
the
participation
of
the
Chairman.
In 2021,
two independent
BoD meetings
were held,
covering
both
UBS
Group
AG
and
UBS
AG,
with
an
average
participation
rate
of
81%
and
an
average
duration
of
approximately 85 minutes.
The Senior Independent
Director also
relays
to
the
Chairman
any
issues
or
concerns
raised
by
the
independent
BoD
members
and
acts
as
a
point
of
contact
for
shareholders
and
stakeholders
seeking
discussions
with
an
independent BoD member.
Important business connections of independent members
of the Board of Directors
As a global financial services
provider and a major Swiss
bank, we
enter
into
business
relationships
with
many
large
companies,
including some in which our BoD members have management or
independent
board
responsibilities.
The
Governance
and
Nominating Committee determines in each instance whether the
nature of the Group’s business relationship with such a company
might
compromise
our
BoD
members’
capacity
to
express
independent judgment.
Our
Organization
Regulations
require
three-quarters
of
the
UBS Group AG
BoD members and one-third
of those at UBS
AG
to be independent. For this purpose,
independence is determined
in
accordan
ce
with
FINMA
Circular
2017/1
“Corporate
governance – banks” and the NYSE rules.
In
2021,
our
BoD
met
the
standards
of
the
Organization
Regulations
for the
percentage of
directors who
are
considered
independent
under
the
criteria
described
above.
Since
our
Chairman has a
full-time contract with UBS
Group AG, he is
not
considered independent. No other BoD member has a
significant
business
connection
to
UBS
or
any
of
its
subsidiaries.
No
BoD
member
currently
carries
out,
or
has
carried
out
over
the
past
three years, operational management tasks within the Group.
All
relationships
and
transactions
with
UBS
Group
AG’s
independent BoD members are conducted in
the ordinary course
of business and are
on the same terms as
those prevailing at the
time for comparable
transactions with non-affiliated
persons. All
relationships
and
transactions
with
BoD
members’
associated
companies are conducted at arm’s length.
›
Refer to “Note 31 Related parties” in the “
Consolidated financial
statements
” section on page 397 of this report
for more
information
Checks and balances: Board of Directors and Group
Executive Board
We operate
under a strict
dual board
structure, as
mandated by
Swiss banking law. The separation of responsibilities between the
BoD
and
the
GEB
is
clearly
defined
in
the
Organization
Regulations. The BoD decides on the strategy
of the Group,
upon
recommendations
by
the
Group
CEO,
and
exercises
ultimate
supervision over
management; whereas
the GEB, headed
by the
Group
CEO,
has
executive
management
responsibility.
The
functions
of
Chairman
and
Group
CEO
are
assigned
to
two
different people, leading to a separation
of power. This
structure
establishes
checks
and
balances
and
preserves
the
institutional
independence of the BoD from the executive
management of the
Group, for which responsibility
is delegated to
the GEB, under
the
leadership
of
the
Group
CEO.
No
member
of
one
board
may
simultaneously be a member of the other.
Supervision and control
of the GEB remain
with the BoD. The
authorities and responsibilities of the two bodies are governed
by
the AoA and the Organization Regulations.
213
Skills, expertise and training of the Board of Directors
The BoD is
composed of members
with a broad spectrum
of skills,
educational backgrounds, experience and expertise from
a range
of sectors that reflect the nature
and scope of the firm’s
business.
With a view to recruiting needs, the Governance
and Nominating
Committee uses a
competencies and experience
matrix to identify
any
gaps
in
the
competencies
considered
most
relevant
to
the
BoD, taking
into consideration the
firm’s business
exposure, risk
profile, strategy and geographic reach.
We
asked
our
BoD
membe
rs
to
select
their
four
key
competencies from the following eight categories and to indicate
whether
they
have
ever
been
a
CEO
or
chairperson
of
a
listed
company or a member
of the executive board
of such a company:
Key competencies
–
banking
(wealth
management,
asset
management,
personal
and corporate banking) and insurance
–
investment banking, capital markets
–
finance, audit, accounting
–
risk management, compliance and legal
–
human resources management, including compensation
–
technology, cybersecurity
–
regulatory authority, central bank
–
environmental,
social and governance (ESG)
Leadership experience
–
experience as CEO or chairperson
–
executive board leadership experience
(e.g., as CFO, chief
risk
officer or COO of a listed company)
The
Governance
and
Nominating
Committee
reviews
these
categories and ratings annually
to confirm that the
BoD continues
to
possess
the
most
relevant
experience
and
competencies
to
perform its duties.
With
regard
to
the
BoD
composition
after
the
2021
AGM,
members
thereof
identified
all
of
the
target
competencies
as
being
their
key
competencies.
Particularly
strong
levels
of
experience and expertise existed in these areas:
–
financial services
–
risk management, compliance and legal
–
finance, audit, accounting
Furthermore, 10 of
the 12 BoD
members have held
or currently
hold chairperson,
CEO or
other executive
board-level leadership
positions.
Moreover,
education
remained
an
important
priority
for
our
BoD members. In addition to
a comprehensive induction program
for new BoD
members, continuous
training and
topical deep
dives
are part of the BoD agenda.
›
Refer to “Risk governance” in the
“
Risk management and
control
” section on page 103 of this report for information
about
our risk governance framework
Corporate governance and compensation | Corporate governance
214
Succession planning
Succession planning is one
of the key responsibilities of
both the
BoD
and
the
GEB.
Across
all
divisions
and
regions,
an
inclusive
talent
development
and
succession
planning process
is
in
place
that
aims
to
foster
the
personal
development
and
Group-wide
mobility
of
our
employees.
Although
the
recruiting
process
for
BoD and
GEB members
takes into
account a
broad spectrum
of
factors, such as skills, backgrounds, experience
and expertise, our
approach
with
regard
to
diversity
considerations
does
not
constitute a diversity
policy within the
meaning of
the EU
Directive
on Non-Financial Reporting, and
Swiss law does not
require UBS
to maintain such a policy.
In 2021, the
Chairman and the
members of the
BoD and the
GEB
launched
several
strategic
initiatives
with
the
close
involvement of the
BoD and with
the aim of
further strengthening
UBS. The succession plans
for the GEB and
the management layer
below it are managed under the
lead of the Group CEO. The
BoD
reviews and approves the succession plans of the GEB.
For
the
BoD,
the
Chairman
leads
a
systematic
succession
planning process as illustrated in the chart below.
Our strategy and
the business environment
constitute the main
drivers in our succession planning process for
new BoD members,
as they define the key competencies required on the BoD. Taking
the diversity and the tenure of the existing BoD into account, the
Governance
and
Nominating
Committee
defines
the
recruiting
profile
for
the
search.
Both
external
and
internal
sources
contribute to
identifying suitable
candidates. The
Chairman and
the
members
of
the
Governance
and
Nominating
Committee
meet with potential
candidates and, with
the support of
the full
BoD, nominations
are submitted
to the
AGM for
approval. New
BoD members follow
an in-depth onboarding
process designed to
enable them to integrate efficiently and become effective in their
new
role.
Due
to
this
succession
planning
process,
the
composition
of
the
BoD
is
in
line
with
the
demanding
requirements of a leading global financial services firm.
The succession
of both
the CEO
and Chairman,
as well
as of
GEB
members,
was smoothly
planned
and is
being
carried out,
demonstrating
the
strength
and
success
of
the
succession
planning at UBS.
215
Information and control instruments with regard to the
Group Executive Board
The BoD is
kept informed of
the GEB’s activities in
various ways,
including
regular
meetings
between
the
Chairman,
the
Group
CEO and GEB members.
The Group CEO and
other GEB members
also
participate
in
BoD
meetings
to
update
its
members
on
all
significant
issues.
The
BoD
also
receives
regular
comprehensive
reports, covering
financial, capital,
funding, liquidity,
regulatory,
compliance
and
legal
developments,
as
well
as
performance
against
plan
and
forecasts
for
the
remainder
of
the
year.
For
important developments, BoD
members are
also updated by
the
GEB in between meetings. In addition, the Chairman receives the
meeting material and minutes of the GEB meetings.
BoD members
may request
from other
BoD or
GEB members
any
information about
matters concerning
the Group
that they
require
in
order
to
fulfill
their
duties.
When
these
requests
are
raised outside BoD meetings, such requests must
go through the
Group Company Secretary and be addressed to the Chairman.
The
BoD
is
supported
in
discharging
its
governance
responsibilities by GIA,
which independently assesses
whether risk
management,
control
and
governance
processes
are
designed
and operating sustainably and effectively.
The Head GIA
reports directly
to the
Chairman. In
addition, GIA
has
a
functional
reporting
line
to
the
Audit
Committee
in
accordance with
its responsibilities
as set
forth in
our Organization
Regulations.
The
Audit
Committee
assesses
the
independence
and performance of
GIA and the
effectiveness of both
the Head
GIA and GIA
as an organization,
approves GIA’s annual
audit plan
and objectives and monitors GIA’s discharge of these objectives.
The
committee is
also in
regular contact
with the
Head GIA.
GIA issues quarterly
reports that
provide an overview
of significant
audit results and key
issues, as well as
themes and trends, based
on
results
of
individual
audits,
continuous
risk
assessment
and
issue
assurance.
The
reports
are
provided to
the Chairman,
the
members
of
the
Audit
and
the
Risk
Committees,
the
GEB
and
other stakeholders. The
Head GIA regularly
updates the Chairman
and the Audit
Committee on
GIA’s activities, processes,
audit plan
execution,
resourcing
requirements
and
other
important
developments.
GIA
issues
an
annual
Activity
Report,
which
is
provided to
the Chairman
and the
Audit Committee
to support
their assessment of GIA’s effectiveness.
›
Refer to “Group Internal Audit” in this section
for more
information
›
Refer to “Internal risk reporting” in the
“
Risk management and
control
” section on page 108 of this report for information
about
reporting to the BoD
Corporate governance and compensation | Corporate governance
216
Group Executive Board
The BoD delegates the
management of the business
to the Group
Executive Board (the GEB).
Responsibilities, authorities and organizational principles
of the Group Executive Board
As of
31 December 2021,
the GEB,
under the
leadership of
the
Group
CEO,
consisted
of
12
members.
It
has
executive
management responsibility
for the
steering of
the Group and
its
business
and
assumes
overall
responsibility
for
developing
the
strategies of
the Group,
business divisions
and Group
Functions
and implements the BoD approved strategies. The GEB is also the
risk
council
of
the
Group,
with
overall
responsibility
for
establishing
and
supervising
the
implementation
of
risk
management and control
principles, as well as for
managing the
risk profile of
the Group, as determined by
the BoD and the Risk
Committee.
In 2021,
the GEB
held a
total of
66 meetings
for UBS
Group
AG.
At UBS
AG, management
of the
business is
also delegated,
and
its
Executive
Board,
under
the
leadership
of
its
President,
has
executive management responsibility for
UBS AG and
its business.
In
2021,
all
members
of
the
GEB
were
members
of
UBS
AG’s
Executive Board,
with the exception
of Sabine Keller-Busse,
who
served as President
UBS Switzerland AG.
The Executive Board
held
66
combined
meetings
with
the
GEB
and
four
st
andalone
meetings for UBS AG in 2021.
›
Refer to the Organization Regulations
of UBS Group AG,
available at
ubs.com/governance
, for more information about
the authorities of the Group Executive Board
Changes to the Group Executive Board
Effective 1 February
2021, Axel
P.
Lehmann ended
his tenure
at
UBS and Sabine Keller-Busse
succeeded to the posts of President
Personal & Corporate Banking
and President UBS
Switzerland. In
addition
to
his
responsibility
as
Co-President
Global
Wealth
Management,
Iqbal
Khan
assumed
the
role
of
President
UBS
EMEA from
Sabine Keller-Busse
as of
1 February 2021.
Effective
1
April
2021,
Robert
Karofsky
was
appointed
sole
President
Investment Bank, following Piero
Novelli’s decision to step
down
as Co-President
Investment Bank as
of 31 March
2021. Effective
1 May 2021,
Mike Dargan
was appointed Group
Chief Digital
and
Information Officer
(CDIO) and
member of
the GEB.
The Group
CDIO
organization
succeeded
the
function
of
the
Group
Chief
Operating Officer. Effective 1 November 2021, and after 13 years
of
service,
Markus
U.
Diethelm
stepped
down
from
his
role
as
Group General Counsel and
member of the GEB;
he remains with
UBS
into
2022
as
a
senior
advisor
for
selected
legacy
litigation
matters. Barbara Levi assumed
the role of Group General
Counsel
and
member
of
the
GEB.
Ms.
Levi
joined
UBS
from
Rio
Tinto
Group,
where she served as Chief Legal Officer & External Affairs
and before that as Group
General Counsel and a member of
the
Executive Committee.
On 1 December
2021, UBS
announced that
Kirt Gardner
will
step
down
from
his
role
as
Group
CFO
in
May
2022.
Sarah
Youngwood
will join
UBS and
the
GEB in
March
2022 and
will
take over as Group CFO in May 2022.
Ms. Youngwood has been
CFO of JPMorgan Chase’s consumer
and community banking line
of
business
since
2016.
She
also
led
Finance
for
its
Global
Technology unit.
The
biographies
on
the
following
pages
provide
information
about the
GEB members in
office as
of 31 December
2021. The
biographies of Piero
Novelli and Markus
U. Diethelm can
be found
on page 208 and 203 of
the UBS Group AG Annual
Report 2020,
available
under
“Annual
reporting”
at
ubs.com/investors
.
In
addition
to
information
on
mandates,
the
biographies
include
memberships and other activities or functions, as required
by the
SIX Swiss Exchange Corporate Governance Directive.
In line with Swiss law, article 36 of UBS Group AG’s Articles of
Association
limits
the
number
of
mandates
that
GEB
members
may hold outside UBS Group to
one mandate in a listed company
and five additional mandates
in non-listed companies. Mandates
in companies
that are
controlled by UBS
or that
control UBS
are
not subject to this
limitation. In addition, GEB
members may not
hold
more
than
10
mandates
at
a
time
at
the
request
of
the
company
and
eight
mandates
in
associations,
charitable
organizations,
foundations,
trusts
and
employee
welfare
foundations.
On
31
December
2021,
no
member
of
the
GEB
reached the aforementioned thresholds.
Responsibilities and authorities of the Asset and Liability
Committees
The Asset and Liability
Committees (the ALCOs)
of UBS Group
AG
and
UBS AG
are
sub-committees of
the
GEB and
the Executive
Board
that are
responsible
for managing
assets and
liabilities in
line with the strategy,
risk appetite, regulatory commitments and
the interests
of shareholders
and other
stakeholders. The
ALCO
of
UBS
Group
AG
proposes
the
framework
for
capital
management,
capital
allocation,
funding
and
liquidity
risk,
and
proposes limits and
targets for the
Group to the
BoD for approval.
It
oversees
the
balance
sheet
management
of
the
Group,
its
business
divisions and
Group
Functions. In
2021,
the
ALCOs of
UBS Group AG and UBS AG held 11 meetings.
Management contracts
We
have
not
entered
into
management
contracts
with
any
companies or natural persons that do not belong to the Group.
217
Ralph Hamers
Group Chief Executive Officer, member of the GEB since 2020
Nationality:
Dutch |
Year of birth:
1966
Ralph Hamers
has been
Group CEO
of UBS
Group AG
and President
of
the Executive Board of
UBS AG since
November 2020. Before
joining UBS,
he served
as CEO
and Chairman
of the
Executive Board
of ING
Group.
During his time
as CEO of
ING, he steered
the bank to
profitability after
the financial crisis
and supported the
firm’s digital transformation.
He also
played
a
leading
role
in
driving
sustainability
efforts
in
the
financial
industry, and firmly continues to do so.
Professional experience
2020 – date
Group CEO of UBS Group AG and President of the
Executive Board of UBS AG
2013 – 2020
CEO and Chairman of the Executive Board, ING
Supervisory Board member of NN Group (2014 – 2015);
Management Board Banking and Management Board NN
Group (2013 – 2014)
2011 – 2013
CEO of ING Belgium and Luxembourg, ING
2010 – 2011
Head of Network Management for Retail Banking Direct &
International, ING
2007 – 2010
Global Head of the Commercial Banking network, ING
2005 – 2007
CEO of ING Bank Netherlands, ING
2002 – 2005
General Manager of the ING Bank branch network,
ING
1999 – 2002
General Manager of ING Romania, ING
Education
–
Master’s degree, business econometrics and operations research,
Tilburg University
Other activities and functions
–
Member of the Board of the Swiss-American Chamber of
Commerce
–
Member of the Institut International d’Etudes
Bancaires
–
Member of the IMD Foundation Board
–
Member of the McKinsey Advisory Council
–
Member of the World Economic Forum International
Business Council
–
Governor of the World Economic Forum (Financial
Services)
Christian Bluhm
Group Chief Risk Officer, member of the GEB since 2016
Nationality:
German |
Year of birth:
1969
Christian Bluhm
has been
Group Chief
Risk Officer
since 2016.
He held
several positions in
academia before starting
his banking career
in 1999
with Deutsche Bank
in credit risk
management, and
subsequently working
for Hypovereinsbank
and Credit
Suisse in
the same
area.
Before joining
UBS, he
used his
expertise and
skills as
Chief Risk
& Financial
Officer at
FMS Wertmanagement. Mr. Bluhm is responsible for the development of
the
Group’s
risk
management
and
control
framework
for
various
risk
categories and implementation of its independent
control frameworks.
Professional experience
2016 – date
Group Chief Risk Officer of UBS Group AG and Chief Risk
Officer of UBS AG
2012 – 2015
Spokesman of the Executive Board,
FMS Wertmanagement
2010 – 2015
Chief Risk & Financial Officer, FMS Wertmanagement
2004 – 2009
Managing Director, Credit Risk Management (Switzerland
and Private Banking worldwide), Credit Suisse
2008 – 2009
Head Credit Risk Management Analytics & Instruments,
Credit Suisse
2004 – 2008
Head of Credit Portfolio Management, Credit Suisse
2001 – 2004
Head Structured Finance Analytics, Group Credit Portfolio
Management, Hypovereinsbank
1999 – 2000
Credit Risk Management, Deutsche Bank
Education
–
Master’s degree, mathematics and informatics, and doctorate,
mathematics, University of Erlangen-Nuremberg
Other activities and functions
–
Member of the Board of UBS Switzerland AG
–
Member of the Foundation Board of the UBS Pension
Fund
–
Member of the Foundation Board – International
Financial
Risk Institute
Corporate governance and compensation | Corporate governance
218
Mike Dargan
Group Chief Digital and Information Officer,
member of the GEB since 2021
Nationality:
British |
Year of birth:
1977
Mike Dargan was appointed Group Chief Digital and Information Officer
(CDIO) in May 2021. The Group CDIO organization consists
of the Group
Technology
teams and
Group
Corporate Services.
In October
2021, he
took up
the additional
role of
UBS GEB
sponsor to co-lead
the AI,
Data
and Analytics
center of
expertise, along
with Robert
Karofsky.
From his
former
roles
at
Standard
Chartered
Bank,
Mr.
Dargan
brings
proven
experience in technology strategy and operations.
Professional experience
May 2021 – date
Group CDIO, UBS Group AG and UBS AG
Oct. 2021 – date
President of the Executive Board,
UBS Business Solutions AG
2016 – 2021
Head Group Technology,
UBS
2015 – 2016
CIO for Corporate and
Institutional Banking, Standard Chartered Bank
2014 – 2015
Global Group Technology and Operations Head for
Global Markets, Wealth Management, Private Banking
and Securities Services, Group Technology and
Operations Engineering, Standard Chartered Bank
2013 – 2014
CIO for Financial Markets, Standard Chartered Bank
2009 – 2013
Global Head of Strategy and Corporate M&A, Global
Markets, Standard Chartered Bank
2005 – 2009
Head Corporate Strategy & M&A, EMEA and Pacific
Rim, Merrill Lynch
1999 – 2005
Head of Corporate and Institutional Banking Practice,
Asia Pacific, Oliver Wyman
Education
–
Master’s degree, politics, philosophy and economics,
St. John’s College, Oxford University
Non-listed company boards
–
Member of the Board of Directors of Done Next Holdings
AG
Other activities and functions
–
Member of the Board of UBS Business Solutions AG
–
Member of the Board of Trustees of the Inter-Community
School Zurich
Kirt Gardner
Group Chief Financial Officer, member of the GEB since 2016
Nationality:
American (US) |
Year of birth:
1959
Kirt Gardner became Group CFO in 2016. Earlier in his
career, he worked
for the
management and
technology consulting
firms BearingPoint
and
Barents Group in
the US, Asia, Latin America
and Europe. Before
joining
UBS
as
CFO
Wealth
Management
in
2013,
Mr.
Gardner
held
various
leadership
positions
at
Citigroup,
including
CFO
and
Head
of
Strategy
within Global
Transaction
Services, Head
of Strategy,
Planning and
Risk
Strategy for the Corporate and Institutional Division, and Head
of Global
Strategy and Cost Management for the Consumer Bank.
Professional experience
2016 – date
Group CFO of UBS Group AG and CFO of UBS AG
2013 – 2015
CFO Wealth Management, UBS
2010 – 2013
CFO and Head of Strategy Global Transaction Services,
Citigroup
2006 – 2010
Head of Strategy, Planning and Risk Strategy for the
Corporate and Institutional Division, Citigroup
2004
–
2006
Head of Global Strategy and Cost Management for
the
Consumer Bank, Citigroup
2000 – 2004
Global Head of Financial Services Strategy, BearingPoint
1994
–
2000
Managing Director and Head of Financial Services
Consulting, Barents Group
Education
–
Master’s degree, international studies, University of
Pennsylvania
–
MBA, finance, the Wharton School
Other activities and functions
–
Member of the Board of UBS Business Solutions AG
219
Suni Harford
President Asset Management, member of the GEB since 2019
Nationality:
American (US) |
Year of birth:
1962
Suni Harford was appointed President Asset Management in 2019 and is
the Chair of
UBS Optimus Foundation.
Ms. Harford has been
the UBS GEB
lead for
Sustainability and Impact
since May
2021. She
started her
Wall
Street
career
at
Merrill
Lynch
&
Co.,
in
investment
banking
,
before
embarking on
a
24-year career
at Citigroup
Inc.,
the last
nine years
of
which
she
was
the
Regional
Head
of
Markets
for
North
America.
Ms. Harford then joined UBS, bringing with her a
broad experience from
across
the
industry,
including
in
research,
client
coverage
and
risk
management, and
successfully led
UBS Asset
Management’s integrated
investments capabilities, driving performance for its clients.
Professional experience
2019 – date
President Asset Management, UBS Group AG
and UBS AG
2017 – 2019
Head of Investments, Asset Management, UBS
2008 – 2017
Regional Head of Markets for North Americas,
Citigroup Inc.
2004 – 2008
Global Head of Fixed Income Research, Citigroup Inc.
Education
–
Bachelor’s degree, physics and mathematics, Denison University, Ohio
–
MBA, Tuck School of Business, Dartmouth College
Other activities and functions
–
Chairman of the Board of Directors of UBS Asset Management
AG
–
Chair of the Board of UBS Optimus Foundation
–
Member of the Leadership Council of the Bob Woodruff Foundation
Robert Karofsky
President Investment Bank, member of the GEB since 2018
Nationality:
American (US) |
Year of birth:
1967
Robert Karofsky
was appointed
Co-President of
the Investment
Bank in
2018.
He
became sole
President
in April
2021.
Before
joining UBS,
he
acquired
know-how
in
investment
banking
as
an
analyst
and
trader,
working
for
various
financial
institutions
such
as
Morgan
Stanley,
Deutsche Bank,
and AllianceBernstein. He
then became
Global Head
of
Equities at UBS, responsible for driving UBS’s growth strategy for
equities
globally. In
October 2021, Mr.
Karofsky was appointed to
the additional
role of
UBS GEB sponsor
to co-lead the
AI, Data and
Analytics center of
expertise, along with Mike Dargan.
Professional experience
Apr. 2021 – date
President Investment Bank, UBS Group AG and UBS AG
2018 – Mar. 2021
Co-President Investment Bank, UBS
2015 – 2021
President UBS Securities LLC, UBS
2014 – 2018
Global Head Equities, UBS
2011 – 2014
Global Head of Equity Trading, AllianceBernstein
2008 – 2010
Co-Head of Global Equities, Deutsche Bank
2005 – 2008
Head of North American Equities, Deutsche Bank
1994 – 2005
Head of North American Trading, Morgan Stanley
Education
–
Bachelor’s degree, economics, Hobart and William
Smith Colleges
–
MBA, finance and statistics, University of Chicago’s
Booth School
of Business
Other activities and functions
–
Member of the Board of UBS Americas Holding LLC
–
Member of the Board of UBS Optimus Foundation
–
Trustee of the UBS Americas Inc. Political Action Committee
Corporate governance and compensation | Corporate governance
220
Sabine Keller-Busse
President Personal & Corporate Banking and
President UBS Switzerland, member of the GEB since
2016
Nationality:
Swiss and German |
Year of birth:
1965
Sabine
Keller-Busse
was
appointed
President
Personal
&
Corporate
Banking
and
President
UBS
Switzerland
in
2021,
heading
the
leading
Universal
Bank
in
Switzerland.
In
her
previous
role,
Group
COO,
she
overs
aw
global
functions
such
as
technology,
oper
ations,
human
resources and corporate services. She has been pivotal in driving
business
alignment, and digital and
cultural transformation, while also facilitating
business
growth as
President UBS
Europe,
Middle East
and
Africa.
Ms.
Keller-Busse
also
brings in-depth
experience regarding
financial market
infrastructure, having served on the Board of SIX Group for nine years.
Professional experience
Feb. 2021 – date
President Personal & Corporate Banking and
President UBS Switzerland, UBS Group AG
Feb. 2021 – date
President of the Executive Board, UBS Switzerland AG
2018 – 2021
Group COO of UBS and President of the Executive
Board, UBS Business Solutions AG
2019 – 2021
President UBS Europe, Middle East and Africa, UBS
2016 – 2021
Member of the Executive Board of UBS AG
2014 – 2017
Group Head Human Resources, UBS
2010
–
2014
COO UBS Switzerland, UBS
2008 – 2010
Head Private Clients Region Zurich, Credit Suisse
1995 – 2008
Partner (2002), McKinsey & Company
Education
–
Master’s degree and doctorate, economics, University of
St. Gallen
Listed company boards
–
Member of the Board of Zurich Insurance Group
Other activities and functions
–
Member of the Foundation Council of the UBS International
Center
of Economics in Society
–
Member of the Board and Board Committee of Zurich Chamber
of Commerce
–
Member of the Board of the University Hospital Zurich
Foundation
Iqbal Khan
Co-President Global Wealth Management and
President UBS EMEA, member of the GEB since 2019
Nationality:
Swiss |
Year of birth:
1976
Iqbal Khan has been Co-President Global Wealth
Management, which he
leads
with
Tom
Naratil,
since
2019.
He
was
appointed
President
UBS
EMEA in
February 2021.
Mr.
Khan joined
Ernst &
Young
(EY) in
2001,
holding
many
leadership
positions
and
becoming
the
youngest
ever
partner of the firm’s Swiss arm; when leaving EY,
he was lead auditor of
UBS.
In
2013,
he
moved
to
Credit
Suisse,
holding
senior
leadership
positions as
CFO Private
Banking & Wealth
Management and
later CEO
International Wealth Management.
Professional experience
2019 – date
Co-President Global Wealth Management,
UBS Group AG and UBS AG
Feb. 2021 – date
President UBS Europe, Middle East and Africa,
UBS Group AG and UBS AG
2015 – 2019
CEO International Wealth Management, Credit Suisse
2013 – 2015
CFO Private Banking & Wealth Management,
Credit Suisse
2011 – 2013
Managing Partner Assurance and Advisory Services –
Financial Services, Ernst & Young
2009 – 2011
Industry Lead Partner Banking and Capital Markets,
Switzerland and EMEA Private Banking, Ernst
& Young
2001 – 2009
Various positions in Ernst & Young
Education
–
Swiss Certified Public Accountant
–
Advanced Master of International Business Law degree
(LLM),
University of Zurich
Other activities and functions
–
Member of the Supervisory Board of UBS Europe SE
–
Member of the Board of UBS Optimus Foundation
–
Member of the Board of Room to Read Switzerland
221
Edmund Koh
President UBS Asia Pacific, member of the GEB since
2019
Nationality:
Singaporean |
Year of birth:
1960
Edmund
Koh
has
been
President
UBS
Asia
Pacific
since
2019.
He
is
a
financial sector
veteran, with
more than 30
years in
senior roles
in financial
services,
including
as
Head
Wealth
Management
Asia
Pacific,
Country
Head Singapore and Head Wealth Management South
East Asia and Asia
Pacific Hub for UBS. Before working for DBS
Bank in Singapore, Mr.
Koh
was CEO for Prudential Assurance and
Alverdine Pte Ltd, both companies
based in
Singapore. He
joined UBS
from Taiwan
-based Ta
Chong Bank,
where he served as President and Director.
Professional experience
2019 – date
President UBS Asia Pacific at UBS Group AG and UBS AG
2016 – 2018
Head Wealth Management Asia Pacific, UBS
2012 – 2018
Country Head Singapore, UBS
2012 – 2015
Head Wealth Management South East Asia and
Asia Pacific Hub, UBS
2008 – 2012
President and Director, Ta
Chong Bank, Taiwan
2001 – 2008
Managing Director and Regional Head, Consumer Banking
Group, DBS Bank, Singapore
Education
–
Bachelor’s degree, psychology, University of Toronto
Non-listed company boards
–
Member of the Board of Trustees of the Wealth Management
Institute, Singapore
–
Member of the Board of Next50 Limited, Singapore
–
Member of the Board of Medico Suites (S) Pte Ltd
Other activities and functions
–
Member of a sub-committee of the Singapore Ministry
of Finance’s Committee on the Future Economy
–
Member of the Financial Centre Advisory Panel of the
Monetary
Authority
of Singapore
–
Council member of the Asian Bureau of Finance and
Economic Research
–
Council member of the KidSTART program of the Early Childhood
Development Agency, Singapore (until 31 January 2022)
–
Trustee of the Cultural Matching Fund, Singapore
–
Member of University of Toronto’s International Leadership
Council for Asia
Barbara Levi
Group General Counsel, member of the GEB since 2021
Nationality:
Italian |
Year of birth:
1971
Barbara Levi
has been
Group General
Counsel since
November 2021. A
qualified attorney-at-law, she has
been admitted to
the Supreme Court
of
the United States, the New York State bar and the
bar of Milan, Italy, and
has worked in
several law firms
in New York
and Milan. Ms.
Levi began
her corporate career
with Novartis Group
in 2004 and
worked there for
16 years,
holding a
number of
senior legal
roles
across
Europe.
Before
joining UBS,
she served
as Chief
Legal Officer
&
External Affairs
at
Rio
Tinto Group and, before that, as General Counsel. In both roles, she was
a member of that company’s executive committee.
Professional experience
Nov. 2021 – date
Group General Counsel for UBS Group AG and UBS AG
2021
Chief Legal Officer & External Affairs, Rio Tinto Group
2020 – 2021
Group General Counsel, Rio Tinto Group
2019
Group Legal Head, M&A and Strategic Transactions,
Novartis
2016
–
2019
Global General Counsel, Sandoz International GmbH,
Novartis
2014 – 2016
Global Legal Head, Product Strategy &
Commercialization, Novartis
2013 – 2014
Global Legal Head, TechOps, Primary Care and
Established Medicines, Novartis
2009 – 2013
Head of Legal & Compliance, Region Asia-Pacific,
Middle East, and African Countries, Region Group
Emerging Markets, Novartis
Education
–
Master’s degree, law, University of Milan
–
LL.M., banking, corporate and finance law, Fordham University
School of Law, New York
Other activities and functions
–
Member of the Employers’ Board of the Global Institute
for
Women’s Leadership, King’s College London
–
Member of the Board of Directors of the European General
Counsel Association
Corporate governance and compensation | Corporate governance
222
Tom
Naratil
Co-President Global Wealth Management and
President UBS Americas, member of the GEB since
2011
(UBS Group AG: 2014, UBS AG: 2011)
Nationality:
American (US) |
Year of birth:
1961
Tom
Naratil
has
been
Co-President
Global
Wealth
Management
since
2018, which
he leads
with Iqbal
Khan. He also
is CEO
of UBS
Americas
Holding LLC. He started his career in finance
in 1983, when he joined the
brokerage
firm
Paine
Webber
Jackson
&
Curtis,
and
is
an
experienced
veteran in the banking sector. UBS acquired Paine Webber in 2000; since
then, Mr.
Naratil has
held various
senior management
positions at
UBS
Group,
including
CFO
and
COO.
He
served
as
President
Wealth
Management Americas from 2016 and was
also appointed President UBS
Americas at UBS Group AG and UBS AG in 2016.
Professional experience
2018 – date
Co-President Global Wealth Management,
UBS Group AG and UBS AG
2016 – date
President UBS Americas,
UBS Group AG and UBS AG
2016 – date
CEO of UBS Americas Holding LLC
2016 – 2018
President Wealth Management Americas, UBS
2015 – 2016
President of the Executive Board,
UBS Business Solutions AG
2014 – 2015
Group COO, UBS
2011 – 2015
Group CFO, UBS
2009 – 2011
CFO and Chief Risk Officer,
Wealth Management Americas, UBS
1983 – 2009
Various positions
at PaineWebber and UBS
Education
–
Bachelor’s degree, history, Yale University
–
MBA, economics, New York University
Other activities and functions
–
Member of the Board of UBS Americas Holding LLC
–
Member of the Board of the American Swiss Foundation
Markus Ronner
Group Chief Compliance and Governance Officer,
member of the GEB since 2018
Nationality:
Swiss |
Year of birth:
1965
Markus
Ronner
has
been
Group
Chief
Compliance
and
Governance
Officer since 2018.
He has been
with UBS for
40 years and
held various
positions across the firm,
including manager of the Group-wide
too-big-
to-fail program, COO Wealth Management & Swiss Bank, Head Products
and
Services
of
Wealth
Management
&
Swiss
Bank,
COO
Asset
Management, and Head Group Internal Audit. In his current
position, he
is
responsible
at
the
Group
level
for
compliance
and
operational
risk
control, governmental and regulatory
affairs, as well as investigations
and
governance matters.
Professional experience
2018 – date
Group Chief Compliance and Governance Officer,
UBS Group AG and UBS AG
2012 – 2018
Head Group Regulatory and Governance, UBS
2011
–
2013
Manager Group-wide too-big-to-fail program, UBS
2010 – 2011
COO Wealth Management & Swiss Bank, UBS
2009 – 2010
Head Products and Services of Wealth Management &
Swiss Bank, UBS
2007 – 2009
COO Asset Management, UBS
2001 – 2007
Head Group Internal Audit, UBS
Education
–
Swiss Banking Diploma
Other activities and functions
None
223
Change of control and defense measures
Our
Articles
of
Association
do
not
provide
any
measures
for
delaying, deferring or preventing a change of control.
Duty to make an offer
Pursuant
to
the
Swiss
Federal
Act
on
Financial
Market
Infrastructures and
Market Conduct in
Securities and
Derivatives
Trading
of
19 June
2015,
an
investor
who
has
acquired
(whether
directly,
indirectly
or
in
concert
with
third
parties)
more
than
33
1
⁄
3
%
of
all
voting
rights
of
a
company
listed
in
Switzerland,
whether
such
rights
are
exercisable
or
not,
is
required
to
submit
a
takeover
offer
for
all
listed
shares
outstanding.
We have
not elected
to change
or opt
out of
this
rule.
Clauses on change of control
Neither the full-time
contract with the
Chairman of the
BoD nor
any
employment
contracts
with
GEB
members
or
employees
holding
key
functions
within
the
company
contain
change
of
control clauses.
All employment contracts
with GEB members
stipulate a
notice
period of six months. During the notice
period, GEB members are
entitled
to
their
salaries
and
the
continuation
of
existing
employment benefits and
may be eligible
to be
considered for a
discretionary
performance
award
based
on
their
contribution
during their tenure.
In
case
of
a
change
of
control,
we
may,
at
our
discretion,
accelerate
the
vesting
of
and
/
or
relax
applicable
forfeiture
provisions of employees’ awards.
›
Refer to the “Compensation” section
of this report on page 228
for more information
Corporate governance and compensation | Corporate governance
224
Auditors
Audit
is
an
integral
part
of
corporate
governance.
While
safeguarding
their
independence,
the
external
auditors
closely
coordinate their work with Group Internal Audit (GIA). The Audit
Committee and, ultimately, the BoD
supervise the effectiveness
of
audit work.
›
Refer to “Board of Directors” in this section for more
information about the Audit Committee
External independent auditors
The AGM
in 2021
re-elected Ernst &
Young
Ltd (EY)
as auditors
for the Group
for a one-year term
of office. EY
assumes virtually
all auditing functions
according to laws,
regulatory requests
and
the AoA. Bob Jacob is the EY
lead partner in charge of the overall
coordination of the
UBS Group financial
and regulatory audits
and
the
co-signing
partner
of
the
financial
audit.
In
2020,
Maurice
McCormick
became
the
lead
audit
partner
for
the
financial
statement
audit
and
has
an
incumbency
limit
of
five
years.
In
2021,
Hannes
Smit
became
the
Lead
Auditor
to
the
Swiss
Financial
Market
Supervisory
Authority
(FINMA)
with
an
incumbency limit
of seven years.
Daniel Martin has
been the co-
signing
partner
for
the
FINMA
audit
since
2019,
with
an
incumbency limit of seven years.
During 2021, the Audit Committee held 13 meetings with the
external auditors.
Review of UBS Group AG and UBS AG audit engagement
EU rules require UBS
Europe SE to rotate
its external auditor
in the
financial year 2024. In connection with this required change, and
in
consideration
of
governance
best
practices,
the
Board
of
Directors considered whether it would propose
to shareholders a
rotation of the Group auditor concurrent with the change at UBS
Europe
SE.
Under
the
direction
of
the
Audit
Committee,
UBS
conducted
a
formal
review
of
the
Group
audit
engagement
including
soliciting
proposals
from
potential
auditors.
Based
on
the results of this assessment, the Board of Directors has decided
to retain Ernst & Young as the Group’s
external auditor.
Audit effectiveness assessment
The
Audit
Committee
assesses
the
performance,
effectiveness
and
independence
of
the external
auditors
on
an
annual
basis.
The
assessment
is
generally
based
on
interviews
with
senior
management and
survey feedback
from stakeholders
across the
Group.
Assessment
criteria
include
quality
of
service
delivery,
quality and competence of the
audit team, value added as
part of
the
audit,
insightfulness,
and
the
overall
relationship
with
EY.
Based on
its own
analysis and
the assessment
results,
including
feedback
received
as
part
of
the
review
of
the
Group
audit
engagement
described
above,
the
Audit
Committee
concluded
that EY’s audit has been effective.
Fees paid to external independent auditors
UBS Group
AG and
its subsidiaries
(including UBS
AG) paid
the following
fees (including
expenses) to
their external
independent
auditors.
For the year ended
USD million
31.12.21
31.12.20
Audit
Global audit fees
53
53
Additional services classified as audit (services required
by law or statute, including work of a non-recurring nature mandated by
regulators)
8
10
Total audit
1
61
64
Non-audit
Audit-related fees
9
8
of which: assurance and attestation services
4
3
of which: control and performance reports
5
5
of which: consultation concerning financial accounting and
reporting standards
0
0
Tax fees
1
1
All other fees
0
0
Total non-audit
1
10
9
1 Total audit and non-audit fees amounted to USD 72 million for UBS Group AG consolidated as of 31
December 2021 (31 December 2020: USD 73 million), of which USD 43 million related to UBS AG consolidated
(31 December 2020: USD 46 million).
225
Special auditors for potential capital increases
At the AGM on
8 April 2021, BDO AG
was reappointed as special
auditors for
a three-year
term of
office. Special
auditors provide
audit
opinions
in
connection
with
potential
capital
increases
independently from other auditors.
Services performed and fees
The Audit Committee oversees all
services provided to UBS by
the external auditors. For services requiring the approval
from the
Audit
Committee,
a
preapproval
may
be
granted
either
for
a
specific
mandate
or
in
the
form
of
a
blanket
preapproval
authorizing a limited and well-defined type and
scope of services.
The
fees (including
expenses) paid
to
EY are
set forth
in
the
table
on
the
previous
page.
In
addition,
EY
received
USD 34.1
million in 2021 (USD 32.7 million in 2020) for services performed
on
behalf
of
our
investment
funds,
many
of
which
have
independent fund boards or trustees.
Audit work includes all services necessary to perform the audit
for the
Group in
accordance with
applicable laws
and generally
accepted auditing
standards, as
well as
other assurance
services
that
conventionally
only
the
auditor
can
provide.
These
include
statutory
and
regulatory
audits,
attestation
services
and
the
review
of
documents
to
be
filed
with
regulatory
bodies.
The
additional
services
classified
as
audit
in
2021
included
several
engagements
for
which
EY
was
mandated
at
the
request
of
FINMA.
Audit-related work
consists of
assurance and
related services
traditionally
performed
by
auditors,
such
as
attestation
services
related
to
financial
reporting,
internal
control
reviews
and
performance standard reviews,
as well as consultation
concerning
financial accounting and reporting standards.
Tax
work
involves
services
performed
by professional
staff
in
EY’s tax division and
includes tax compliance and
tax consultation
with respect to our own affairs.
“Other”
services
are
permitted
services,
which
include
technical IT security control reviews and assessments.
Group Internal Audit
GIA
performs
the
internal
auditing
role
for
the
Group.
It
is
an
independent
function
that
provides
expertise
and
insights
to
confirm
controls
are
functioning
correctly
and
highlight
where
UBS needs to better
manage current and emerging risks.
In 2021,
it operated with
an average headcount
of 586 full-time
equivalent
employees.
GIA
supports
the
BoD
in
discharging
its
governance
responsibilities
by
taking
a
dynamic
approach
to
audit,
issue
assurance
and
risk
assessment,
calling
attention
to
key
risks
in
order to drive action
to prevent unexpected loss
or damage to the
firm’s reputation. To
support the achievement
of UBS’s objectives,
GIA independently, objectively and systematically assesses the:
(i)
soundness of the Group’s risk and control culture;
(ii)
reliability
and
integrity
of
financial
and
operational
information,
including
whether
activities
are
properly,
accurately
and
completely
recorded,
and
the
quality
of
underlying data and models; and
(iii)
design, operating effectiveness and sustainability of:
–
processes to define strategy and risk appetite, as well
as
the overall adherence to the approved strategy;
–
governance processes;
–
risk
management,
including
whether
risks
are
appropriately identified and managed;
–
internal
controls,
specifically
whether
they
are
commensurate with the risks taken;
–
remediation activities; and
–
processes
to
comply
with
legal
and
regulatory
requirements,
internal
policies,
and
the
Group’s
constitutional documents and contracts.
Audit reports that include significant
issues are provided to the
Group
CEO,
relevant
GEB
members
and
other
responsible
management. The Chairman,
the Audit Committee
and the Risk
Committee of the BoD are regularly informed of such issues.
In
addition,
GIA
provides
independent
assurance
on
the
effective
and
sustainable
remediation
of
control
deficiencies
within its mandate, taking a prudent
and conservative risk-based
approach and assessing at the issue
level whether the root cause
and the potential exposure for the firm have been holistically and
sustainably
addressed.
GIA
also
cooperates
closely
with
risk
control
functions
and
internal
and
external
legal
advisors
on
investigations into major control issues.
To
ensure
GIA’s
independence
from
management,
the
Head
GIA
reports
to
the
Chairman
of
the
BoD
and
to
the
Audit
Committee, which
assesses annually
whether GIA
has sufficient
resources to perform its function, as
well as its independence and
performance.
In
the
Audit
Committee’s
assessment,
GIA
is
sufficiently
resourced
to
fulfill
its
mandate
and
complete
its
auditing
objectives.
GIA’s
role,
position,
responsibilities
and
accountability are set out
in our Organization Regulations
and the
Charter
for
GIA,
available
at
ubs.com/governance.
The
Charter
also
applies
to
UBS
AG’s
internal
audit
function.
GIA
has
unrestricted
access
to
all
accounts,
books,
records,
systems,
property
and
personnel,
and
must
be
provided
with
all
information
and
data
that
it
needs
to
fulfill
its
auditing
responsibilities. GIA also conducts special audits at the request of
the Audit Committee, or other BoD members, committees or the
Group CEO in consultation with the Audit Committee.
GIA enhances
the efficiency of
its work
through coordination
and close cooperation with the external auditors.
Corporate governance and compensation | Corporate governance
226
Information policy
We
provide
regular
information to
our
shareholders
and to
the
wider financial community.
Financial reports for UBS Group AG are expected to be
published on the following dates:
First quarter 2022
26 April 2022
Second quarter 2022
26 July 2022
Third quarter 2022
25 October 2022
The annual general meetings of the shareholders of UBS
Group AG will take place on the following dates:
2022
6 April 2022
2023
5 April 2023
›
Refer to the corporate calendar at
ubs.com/investors
for future
financial report publication and other key
dates, including UBS
AG’s financial report publication dates
We meet
with institutional
investors worldwide
throughout the
year and regularly
hold results presentations,
attend and present
at
investor
conferences,
and,
from
time
to
time,
host
investor
days. When
appropriate, investor
meetings are
hosted by
senior
management
and
are
attended
by
members
of
our
Investor
Relations team. We use
various technologies, such as
webcasting,
audio
links
and
cross-location
videoconferencing,
to
widen
our
audience and maintain contact with shareholders globally.
We
make
our
publications
available
to
all
shareholders
simultaneously to provide them with equal access to our financial
information.
All our financial
publications are
available at
ubs.com/investors
.
Shareholders
may
opt
to
receive
a
printed
copy
of
our
annual
report. Additionally, they
may also
access our
digital annual
review
at
ubs.com/annualreview
, which reflects
on specific initiatives
and
achievements
of
the
Group
and
provides
an
overview
of
the
Group’s
activities
during
the
year,
as
well
as
key
financial
information.
›
Refer to
ubs.com/investors
for a complete set of published
reporting documents and a selection of senior
management
industry conference presentations
›
Refer to the “Information sources” section
on page 585 of this
report for more information
›
Refer to “Corporate information” and
“Contacts” on page 6 of
this report for more information
Financial disclosure principles
We
fully
support
transparency,
and
consistent
and
informative
disclosure. We
aim to communicate
our strategy and results
in a
manner that enables
stakeholders to gain
a good understanding
of how our Group operates, what our growth prospects are, and
the
risks that
our
businesses and
our strategy
entail. We
assess
feedback
from
analysts
and
investors
on
a
regular
basis
and,
where
appropriate,
reflect
this
in
our
disclosures.
To
continue
achieving
these
goals,
we
apply
the
following
principles
in
our
financial reporting and disclosure:
–
transparency
that
enhances
the
understanding
of
economic
drivers and builds trust and credibility;
–
consistency
within
each
reporting
period
and
between
reporting periods;
–
simplicity that allows readers to gain a good understanding of
the performance of our businesses;
–
relevance,
by
focusing
not
only
on
what
is
required
by
regulation
or
statute
but
also
on
what
is
relevant
to
our
stakeholders; and
–
best practice that leads to improved standards.
We regard
the continuous
improvement of
our disclosures
as
an ongoing commitment.
Financial reporting policies
We report
our Group’s
results
for each
financial
quarter, including
a
breakdown of
results by
business division and
disclosures or
key
developments relating to
risk
management and
control, capital,
liquidity
and
funding
management.
Each
quarter,
we
publish
quarterly
financial
reports
for
UBS Group
AG,
on the
same
day
as the
earnings
releases.
The consolidated
financial
statements
of UBS
Group
AG and
UBS
AG are
prepared
in accordance
with
International
Financial
Reporting
Standards
as
issued
by the
International
Accounting
Standards
Board.
›
Refer to “Note
1
Summary of material accounting policies”
in the
“Consolidated financial statements”
section on page 292 of this
report for more information about the basis of accounting
We
are
committed
to
maintaining
the
transparency
of
our
reported results
and to
allowing analysts
and investors
to make
meaningful
comparisons
with
prior
periods.
If
there
is
a
major
reorganization
of
our
business
divisions
or
if
changes
to
accounting standards or interpretations lead to a material
change
in
the
Group’s
reported
results,
our
results
are
restated
for
previous periods as
required by applicable
accounting standards.
These
restatements
show
how
our
results
would
have
been
reported on
the new
basis and
provide clear
explanations of
all
relevant changes.
US disclosure requirements
As
a
foreign
private
issuer,
we
must
file
reports
and
other
information,
including
certain
financial
reports,
with
the
US
Securities
and Exchange
Commission
(the
SEC)
under
the US
federal
securities laws.
We file an annual report on Form 20-F
and furnish
our quarterly
financial
reports
and other
material
information
under
cover
of
Form
6-K
to
the
SEC.
These
reports
are
available
at
ubs.com/investors
and on the SEC’s
website,
sec.gov.
An evaluation
of the effectiveness
of our disclosure
controls
and
procedures (as defined
in Rule
13a–15e) under the
US Securities
Exchange Act of 1934
has been carried
out, under the supervision
of management,
including
the Group
CEO, the
Group CFO
and the
Group
Controller
and
Chief
Accounting
Officer.
Based
on
that
evaluation,
the Group
CEO and the
Group CFO
concluded
that our
disclosure
controls
and
procedures
were
effective
as
of
31 December
2021. No
significant
changes
have been
made to
our
internal controls or to
other factors that could
significantly affect
these controls
subsequent
to the date
of their evaluation.
›
Refer to the “Consolidated financial statements”
section on page
274 of this report for more information
Compensation
228
Compensation
Julie G. Richardson
Chairperson of the
Compensation Committee
of the Board of Directors
Dear Shareholders,
The Board of Directors (the BoD) and I wish to thank you for your
support
once
again
at
last
year’s
Annual
General
Meeting
(the
AGM) and for sharing your
views on our compensation practices
over
the
past
year.
As
the
Chairperson
of
the
Compensation
Committee, I am
pleased to present our
Compensation Report for
2021.
The arrival of our new CEO in late 2020 and the launch of our
purpose
in early
2021 resulted
in
a
review of
our
Total
Reward
Principles and
compensation framework
to ensure
that they
are
fully
aligned
with
our
purpose
and
strategic
imperatives.
Throughout
2021,
the
BoD
Compensation
Committee
also
continued to oversee that reward reflects
performance,
that risk-
taking is appropriate and
that employee interests are
aligned with
those
of
our
stakeholders.
Following
these
reviews,
we
applied
selected enhancements to
our principles while
keeping our overall
compensation
framework broadly
unchanged, as
we concluded
that
it
still
remains
well
suited
to
support
us
in
achieving
our
ambitions
for
the
Group
and
that
it
provides
strong
alignment
with shareholders’
interests. Nevertheless,
we have
updated our
G
roup
-
wide
performance
management
approach
,
including
evolving our Group Executive Board (GEB) performance review to
reflect our
strategic refresh,
digital initiatives
and elevated
focus
on
sustainability.
The
restructured
approach
fosters
an
even
greater
focus
on
GEB
priorities
and
the
success
of
the
overall
Group
by
assessing
all
GEB
members
against
Group
financial
targets.
Strategy execution
We made significant progress in delivering on our strategic vision
and
putting
clients
at
the
center
of
all
we
do.
The
benefits
of
delivering our ecosystem to clients in a seamless way as One UBS
are visible in our financial performance for 2021.
Our clients
continued to
put their
trust in
us, as
was evident
from
the
ongoing
momentum
in
flows
and
volume
growth
throughout the
year. Together
with favorable
market conditions
and
investor sentiment,
this
led to
growth
across
the
firm. Our
business momentum, our focus
on fueling growth and
disciplined
execution led to strong financial results.
Sustainability is core to our purpose and ecosystem; to help us
maximize our
impact and
direct capital
to where
it is
needed most,
we
are
focusing
on
three
key
areas
to
drive
the
sustainability
transit
ion:
P
lanet
,
People
and
P
artnerships.
As
a
result,
our
sustainability focus
and impact
investing assets
grew 78%
in 2021
and amounted
to USD 251
billion. Furthermore,
UBS was
again
named as
a member
of the
Dow Jones
Sustainability Index
and
we
are
proud
to
be
recognized
once
again
for
our
industry
leadership in the Environmental dimension.
›
Refer to “Financial and operating performance”
in our Annual
Report 2021 for further details about our
Group and business
division performance
Alignment to purpose
–
Our purpose articulates
why we do
what we do,
and why it
matters. Our
culture impacts how
we do things,
and it is
firmly
grounded in our three keys to success: our Pillars, Principles
and Behaviors. We refreshed our three keys to
success in 2021 to
reflect our purpose, client promise and strategic imperatives, and to help ensure that our culture advances our strategic goals.
–
For the past decade, those keys have defined how we work together and what
we stand for, as a firm and as individuals. They
continue
to
drive
daily
business
decisions
and
are
integrated
into
our
people
management
processes,
including
hiring,
performance management, compensation, promotion, talent development, training, and succession planning.
–
Following the
launch of
the purpose,
we reviewed
our
Total Reward
Principles, performance
management approach,
and compensation framework
to ensure they are fully aligned with our purpose
and strategic imperatives. While we made
modest adjustments, no fundamental changes were made to our compensation framework for 2021 as a result of our review.
–
Fair and effective people management processes
are key for our long-term success. Our
global performance management
approach
underwent a
comprehensive review
in 2021
as part
of our
broader strategic
refresh. Consequently,
we made changes
to
our
year-end review,
objective-setting
and
employee
feedback
processes
that
aim
to
support
our
strategic
priorities,
to
reinforce our
high performance
culture and
to be
simpler and
more transparent.
Additionally, our
GEB performance
review
process
includes
more
tangible measurement
on
quantitative outcomes
and
a
greater
focus on
strategy,
digitalization
and
sustainability matters.
Find out more:
ubs.com/global/en/our-firm/our-purpose
229
Financial performance
In
2021,
the
ongoing
momentum
in
flows
and
volume
growth
together with favorable
market conditions and
investor sentiment
led to growth across the firm. Our
financial results outperformed
our
financial
targets
and
we
saw
the
highest
profit
before
tax
since
2006. This
growth
outpaces our
performance award
pool
development.
We
also
maintained
our
high
level
of
return
on
CET1 capital.
Commitment to return capital to shareholders
We
remain
committed
to
returning
excess
capital
to
our
shareholders. We
repurchased USD 2.6
billion of
shares in
2021
and we intend to
repurchase up to USD 5 billion
during 2022. For
2021,
the
BoD
intends
to
propose
a
dividend
of
USD 0.50
per
share for approval at
the Annual General
Meeting of shareholders
in 2022.
2021 performance award pool
The performance
award pool
continues to
reflect our
strict pay-
for
-
performance
philosophy
,
our
disciplined
approach
in
managing
compensation
over
business
cycles
and
alignment
to
shareholder interests.
The
2021
performance
award
pool
was
USD 3.7
billion,
an
increase
of
10%
compared
with
2020.
It
factors
in
the
strong
financial
performance,
as
well
as
the
financial
and
reputational
impact resulting from
the loss related
to the default
of a US-based
client
of
our
prime
brokerage
business.
The
seriousness
of
this
event
led
to
a
significant
downward
revision
of
the
Group
performance
award
pool.
As
a
reminder
regarding
the
French
cross-border
matter,
in
2019
we
reflected
this
matter
in
our
compensation decisions, including
linking a
meaningful portion
of
GEB compensation
(as well
as the
Chairman’s compensation)
to
the final outcome of this matter which is still not resolved.
Furthermore,
our
performance
award
pool
decision
also
reflected
our
achievements
relative
to
non-financial
objectives,
such as our good progress toward delivering on our sustainability
strategy,
as well
as the
positive total
shareholder return
(TSR) of
UBS
shares. It
also
reflected
other
factors,
such as
the growing
competition to attract
and retain a
talented and diverse
workforce
that continues to deliver on our purpose and strategy.
For
2021,
the
GEB
performance
award
pool
was
CHF 79.8
million, a reduction
of 1% on
a per capita
basis and a
reduction
of 6%
overall. This
decrease in
an otherwise
exceptionally good
financial year contrasts with
the Group pool increase
of 10%. The
decision for
the GEB
pool considers
the excellent
financial result
offset by
a proportionally
larger downward
adjustment than
the
Group pool
to reflect
the accountability
of the
GEB for
the loss
resulting
from
the
default
of
a
US-based
client
of
our
prime
brokerage business.
›
Refer to the “2021 key compensation
themes” section of this
report for more information about the compensation
impact
resulting from the significant loss event, the
French cross-border
matter, environmental, social and governance (ESG)
achievements,
and other key compensation themes
›
Refer to the “Group compensation” section
of this report for
more information
2022
Annual General Meeting
At the
2022 AGM
on 6 April,
we will
seek your
support on
the
following compensation-related items:
–
the maximum aggregate amount
of compensation for the
BoD
for the period from the 2022 AGM to the 2023 AGM;
–
the
maximum
aggregate
amount
of
fixed
compensation
for
the GEB for 2023;
–
the aggregate
amount of
variable compensation
for the
GEB
for 2021; and
–
shareholder
endorsement
in
an
advisory
vote
for
this
Compensation Report.
On
behalf
of
the
Compensation
Committee
and
the
BoD,
I
thank
you
again
for
your
feedback
and
we
respectfully
ask
for
your continued support at the upcoming AGM.
Julie G. Richardson
Chairperson of the Compensation Committee of the
Board of Directors
Advisory vote
Corporate governance and compensation | Compensation
230
2021 key compensation themes
The feedback
we seek
from our
shareholders on
compensation-
related
topics
is
very
important
to
us,
as
we
are
committed
to
maintaining a strong link between the interests of our employees
and
those
of
our
shareholders.
We
continued
engaging
with
shareholders
during 2021 and
received overall
positive feedback
about our compensation framework.
The text
below summarizes
key compensation
themes for
2021
and provides answers to
the questions we most
frequently receive
from shareholders.
Summary of 2021 key compensation themes / responses to frequently asked questions
How was the loss resulting from the default of a US-based
client of our prime brokerage business reflected in the
compensation process?
Despite
our
excellent
financial
performance
in
2021,
our
reputation
and
financial
results
were
negatively
impacted
by
a
significant
USD 861 million
pre-tax
loss
that
we incurred
in
the
first half of 2021
related to the default
of a US-based client
of our
prime brokerage business.
We
conducted
a
thorough
review
of
the
event
and
its
root
causes, and took decisive
actions reflecting the significance of
the
event
and
its
impact
on
our
shareholders
and
reputation.
The
outcomes
of the
review
and the
actions taken
by management
were reviewed by
the Joint Risk and Compensation
Committees,
as well as other internal governance bodies, as appropriate.
The
2021
Group
performance
award
pool
was
reduced
significantly
as
a
consequence
of
this
event.
Our
funding
approach for the performance award
pool resulted in a
direct and
substantial reduction, which
was supplemented by
an additional
and
significant
negative
adjustment
to
the
pool.
Overall,
compensation was reduced by an amount equivalent to over half
of
the
post-tax
loss.
This
reduction
had
a
direct
impact
on
compensation for
business and
control
functions, as
well as
for
the Group Executive Board (the GEB).
The GEB performance
award pool had
a proportionally larger
downward
adjustment
than
the
Group
pool
,
to
reflect
the
accountability
of
the
GEB
for
the
event.
The
GEB
per-capita
performance pool
decreased in
an otherwise
exceptionally good
financial year.
On an individual level, we conducted a detailed accountability
review
of
employees
involved
in
the event.
The
fact-finding for
the review was supported by
external legal counsel, as
well as our
internal investigation
functions. The
accountability review covered
30
employees,
including
relevant
individuals
in
the
GEB.
The
outcomes
of
the
review
impacted
performance
reviews
and
compensation decisions substantially, where
appropriate.
How
do
the
refreshed
financial
targets
announced
in
February 2022 impact compensation?
The
compensation
decisions
for
2021
reflect
the
achievements
relative
to
the 2021
objectives
that
were
set
in early
2021 and
consider the previous externally communicated
targets. Similarly,
we
have
set
objectives
for
2022
that
consider
the
refreshed
targets as communicated in February 2022.
In addition, for our
Long-Term Incentive Plan (LTIP)
awards for
2021
performance,
we
have
reviewed
the
three-year
average
return on common equity
tier 1 (RoCET1)
performance metric to
reflect our strategic return ambitions, our revised
financial targets
and cost of capital.
Specifically,
for
our
awards
granted
in
early
2022
for
2021
performance,
the
required
performance
threshold
for
the
minimum payout
has been
raised to
8%, from
6% in
prior-year
awards,
to reflect our new financial targets. The required RoCET1
performance
for
a
maximum
payout
is
set
at
18%,
which
represents the
upper end of
our target
range. The
raised threshold
also
increases
the
mid-point
of
the
payout
thresholds
to
better
reflect
our
cost
of
capital.
The
linear
payout
design
between
threshold and maximum level supports our
growth ambitions and
our
focus
on
delivering
sustainable
performance
without
encouraging excessive risk-taking.
231
How does UBS support diversity and pay fairness?
Ensuring
fair
treatment
and
strengthening
our
commitment
to
diversity,
equity and
inclusion (DE&I)
are
vital to
our sustainable
business
success.
We
find diverse
teams
better
understand
and
relate
to
the
needs
of
our
equally
diverse
clients.
Through
the
diversity
of
our
employees’
backgrounds
and
experiences,
we
drive innovation and better decision making.
Gender
diversity
is
a
key
priority
for
the
firm.
We
are
particularly focused on
increasing the representation
of women at
senior management levels. We take a multi-pronged approach in
this respect, analyzing
and adapting various
factors that support
the hiring, development and retention of women at all levels.
Increasing the
ethnic minority
diversity of
our workforce,
and
a
related
commitment
to
support
underrepresented
talent
and
communities, is also a top
priority across all business
divisions and
regions. We focus on four areas:
accountability and transparency;
investing in our talent; improving our culture;
and leveraging our
business strengths in underrepresented communities.
Compensating
employees
fairly
and
consistently
is
key
to
ensuring equal
opportunities. We
pay for
performance, and
we
take
pay
equity
seriously.
A
strong
commitment
to
both
is
embedded
in
our
compensation
policies,
and
we
regularly
conduct both internal reviews and
independent external audits as
quality
checks.
Additionally,
these
reviews
also
allow
us
to
maintain
our
certification
status
from
the
EQUAL
-
SALARY
Foundation for our equal
pay practices in Switzerland,
the US, the
UK, Hong Kong SAR and Singapore.
How is litigation considered in the compensation process?
Litigation
and
regulatory
matters,
and
their
resolution
and
remediation,
are
taken
into
consideration
throughout
the
compensation
decision-making
process.
The
Compensation
Committee
distinguishes
between
current
matters,
where
the
underlying
issues
are
within
the
responsibility
of
management,
and
legacy
matters,
where
management
is
accountable
for
resolving them but not responsible for the underlying issue.
Current
matters
have
a
direct
impact
on
the
performance
award
pool,
individual
performance
assessments
and
resulting
compensation decisions, as
well as
the payout
of deferred
awards.
For
legacy
matters,
the
Compensation
Committee
seeks
to
incentivize
management
to
resolve
these
matters
in
the
best
interest
of shareholders
and we
hold
management accountable
for
the
effective
and
efficient
resolution
of
these
matters.
Therefore,
the
performance
and
compensation
assessment
reflects
management’s
responsibility
for
achieving
a
resolution
without
creating
an
incentive
to
settle
inappropriately
or
take
excessive risks
on such
matters. In
addition, the
use of
RoCET1,
which
includes
both
current
and
legacy
matters,
in
our
performance assessment for GEB performance,
as well as the LTIP
design,
supports
the
focus
on
ensuring
the
cost
of
litigation
matters
has
in
our
compensation
plans
a
direct
impact
on
the
compensation
awarded
to
and
realized
by
our
most
senior
leaders, including the GEB.
What progress has been made on resolving the French
cross-border matter and how is this reflected in GEB
compensation?
In December 2021, UBS filed an appeal with the French Supreme
Court regarding
the decision
of the
Court of
Appeal relating
to
the French cross-border matter. This matter remains ongoing and
was
considered
in
the
decision-making
process
for
our
2021
performance award pool.
The
use
of
the
RoCET1
metric
aims
to
ensure
the
cost
of
litigation
matters, including
the French
cross-border matter,
has
an ongoing and direct impact on the compensation awarded and
realized
by
our
most
senior
leaders,
including
the
GEB.
Additionally,
when
determining
the
2019
performance
award
pool,
the
impact
of
the
French
cross
-
border
matter
was
considered in our decision making.
Furthermore,
as
outlined
in
our 2019
Compensation Report,
up to CHF 7.9 million,
or 30%, of the 2019
LTIP awards at grant
for GEB members active in
March 2017, as well as the
Chairman
of the
BoD’s unvested
share award,
continues to
be at
risk and
directly
linked
to
the final
resolution of
the French
cross-border
matter.
In
addition,
a
malus
clause
allows
the
Compensation
Committee to assess any
new information that becomes
available
in the future and
to retrospectively reduce the
2019 LTIP award by
up
to
the
full
amount
if
such
new
information
would
have
impacted
our
compensation
decision
in
2
019.
This
matter
continues to
be ongoing
and, once
resolved, the
final outcome
will be reflected in the final amounts delivered to relevant current
and former employees.
Impact of litigation matters on the LTIP
Advisory vote
Corporate governance and compensation | Compensation
232
How is ESG considered in the compensation process?
ESG objectives are considered in
the compensation determination
process
in
objective
setting,
performance
award
pool
funding,
performance evaluation and compensation decisions.
ESG-related objectives have been
embedded in our Pillars and
Principles since they
were established in
2011. In
2021, we revised
the Group CEO
and GEB scorecards
and further enhanced
the link
between
ESG
and
compensation
by
introducing
explicit
sustainability objectives
under “Strategic
& Growth” in
the non-
financial goal
category. These
sustainability objectives
are linked
to
our
priorities,
and
their
progress
is
measured
via
robust
quantitative
metrics
and
qualitative
criteria
.
Sustainability
objectives
are
individually
assessed
for
each
GEB
member,
and
consequently directly
impact their
performance assessments
and
compensation decisions.
In addition, in the performance award pool funding across the
Group,
ESG is
also reflected
through an
assessment of
progress
made toward
targets linked
to our focus
areas of Planet,
People
(including
progress
made
toward
our
diversity
ambitions)
and
Partnerships, alongside other key dimensions.
Therefore
ESG
is
taken
into
consideration
when
the
Compensation
Committee
assesses
not
only
what
results
were
achieved but also how they were achieved.
For
2021,
we
established
robust
and
concrete
targets,
and
made
good
progress
toward
achieving
them.
We
continue
to
increase our focus on this topic.
›
Refer to “Environmental, Social and Governance
considerations”
in the “Compensation philosophy and
governance” section of
this report for more information
How does
UBS promote
and support
the health
and well-
being of employees?
Supporting employee health
and well-being remained a
priority in
2021.
We
are
committed
to
helping
employees
thrive
in
their
current
roles
and
deliver
sustainable
performance
over
time.
Regular
“pulse”
surveys
gauged
employees’
views
on
remote
work,
stress,
communication
and
other
aspects.
Resources
to
support
holistic
well-being
featured
a
bespoke
eLearning
curriculum,
physical
and
mental
health
initiatives,
volunteering
opportunities,
increased
certain
local
benefits
offerings,
and
financial education events.
›
Refer to the Sustainability Report 2021,
available from 11 March
2022 under “Annual reporting” at
ubs.com/investors
, for more
information
How
does
UBS
respond
to the
increasing
competition
for
talent?
We
continue
to
see
increasing
competition
for
talent.
These
pressures
come
from
our
direct
competit
ors
but
also
other
organizations including technology, consulting
and new entrants
or disruptors, such
as fintech firms. As
a recognized employer of
choice,
we
continue
to
broaden
and
deepen
our
talent
pools
through ongoing
talent development
and continued
investment
in our employees. We take careful consideration to
reflect pay for
performance
and
competitive
pay
in
our
decision
making.
Furthermore, as our compensation
approach includes substantial
deferral, we
balance incentivizing
performance with retention
in
order to promote a sustainable workforce.
233
Say-on-pay
Say-on-pay votes at the AGM
In line with the Swiss Ordinance
against Excessive Compensation
in
Listed
Stock
Corporations,
we
seek
binding
shareholder
approval
for
the
aggregate
compensation
awarded
to
the
GEB
and the
BoD. Prospective
approval of
the fixed compensation
of
the BoD and GEB provides the firm and its governing bodies with
the
certainty
needed
to
operate
effectively.
R
etrospective
approval
of
the
GEB’s
variable
compensation
aligns
their
compensation with performance and contribution.
These binding votes
on compensation and
the advisory vote
on
our compensation report reflect our commitment to shareholders
having their say on pay.
›
Refer to “Provisions of the Articles of Association
related to
compensation” in the “Supplemental
information” section of
this report for more information
Audited |
Approved fixed compensation
At the 2020 AGM, shareholders approved a maximum aggregate
fixed
compensation
amount
of
CHF 33.0
million
for
GEB
members
for
the
2021
performance
year.
This
budget
reflects
base
salaries,
role-based
allowances
in
response
to
EU
Capital
Requirements Directive
IV,
and estimated standard
contributions
to retirement benefit plans, as well as other benefits.
Our expenses related to
fixed compensation for
our continuing
GEB members
were within
the budget;
however, the
amount of
fixed compensation
related to
the hiring
of Barbara
Levi as
new
Group
General
Counsel
resulted
in
exceeding
this
budget.
Therefore,
as authorized
by article
46 para.
5
of our
Articles of
Association, an
amount of
CHF 2.2 million
was used
to pay
the
portion of
her fixed
compensation (including
replacement awards)
that exceeded the approved amount.
p
›
Refer to “2021
total compensation for the GEB members”
in the
“Compensation for GEB members” section
of this report
Say on pay – compensation-related votes at the 2021
AGM
2021 AGM say-on-pay voting schemes
2021 AGM actual shareholder votes
Vote “for”
Binding vote on GEB variable compensation
Shareholders approved CHF 85,000,000 for the 2020 financial
year
1,2,3
84.8%
Binding vote on GEB fixed compensation
Shareholders approved CHF 33,000,000 for the 2022
financial year
1,2,3
91.8%
Binding vote on BoD compensation
Shareholders approved CHF 13,000,000 for the period
from the 2021 AGM
to the 2022
AGM
1,2,4
91.1%
Advisory
vote on the Compensation Report
Shareholders approved the UBS Group AG Compensation Report
2020 in an advisory vote
85.7%
1
Local currencies are converted into Swiss francs at
the exchange rates stated in “Note 33
Currency translation rates” in the “Consolidated
financial statements” section of our Annual Report
2021.
2
Excludes the
portion related to the legally required employer’s
social security contributions.
3
As stated in “Group Executive Board” in the “Corporate governance”
section of our Annual Report 2021, twelve GEB
members were
in office on 31 December 2021 and thirteen GEB members on 31 December 2020.
4
Twelve BoD members were in office on 31 December 2021.
Advisory vote
Corporate governance and compensation | Compensation
234
Compensation-related proposals for 2022
At the
2022
AGM, we
will ask
our shareholders
to vote
on the
variable
compensation
for
the
GEB
for
2021,
the
fixed
compensation for the
GEB for
2023 and the
compensation for the
BoD from the 2022 AGM to the 2023 AGM.
In
addition, we will also
ask shareholders for
an advisory vote
on our Compensation Report, which describes our compensation
policy,
including framework and governance.
The
table
below
outlines
our
compensation
proposals,
including
supporting
rationales,
that
we
plan
to
submit
to
the
2022
AGM
for
binding
votes
(in
line
with
the
Swiss
Ordinance
against Excessive Compensation in Listed Stock Corporations and
our Articles of Association (AoA)).
Compensation-related proposals for binding votes at the 2022
AGM
Item
Proposal
Rationale
GEB variable
compensation
The Board of Directors proposes an
aggregate amount of variable
compensation of CHF 79,750,000
for the members of the GEB for the
2021 financial year.
The proposed amount reflects a reduction of 1% on a per capita
basis and a reduction of 6%
overall compared with the previous year.
This decrease in an otherwise exceptionally good
financial
year contrasts with the Group pool increase of 10%.
The decision for the GEB pool considers the
excellent financial result offset by a proportionally larger downward
adjustment than the Group
pool to reflect the accountability of the GEB for the loss
resulting from the default of a US-based
client of our prime brokerage business.
GEB fixed
compensation
The Board of Directors proposes a
maximum aggregate amount of
fixed compensation of
CHF 33,000,000 for the members
of the GEB for the 2023 financial
year.
The proposed amount is unchanged from the previous year, reflecting consistency in planning
over
time and unchanged base salaries for the
Group CEO and other GEB members. In addition to
the
base salaries, it also includes role-based allowances
in response to EU Capital Requirements
Directive IV, estimated standard contributions to retirement benefit plans, and other benefits. The
proposed amount provides flexibility in light of potential
changes of GEB composition or roles,
competitive considerations
where potential additional role-based allowances may
be required, and
other factors (e.g., changes in FX rates or
benefits).
BoD
compensation
The Board of Directors proposes a
maximum aggregate amount of
compensation of CHF 13,000,000
for the members of the Board of
Directors for the period from the
2022 AGM to the 2023 AGM.
The proposed amount is unchanged compared with the
previous period and includes the total
compensation of the nominated Chairman and
Vice Chairman. For the new Chairman
we expect
his total compensation would be approximately
CHF 0.4 million lower compared with the current
Chairman (a reduction of approximately 8%). The fees for
BoD members other than the nominated
Chairman and Vice Chairman are unchanged.
235
Compensation
philosophy
and governance
Our compensation philosophy
Total Reward Principles
Our Total
Reward Principles provide a
strong link to our strategic
imperatives
and
encourage
employees
to
live
our
strong
and
inclusive culture that is grounded
in our three keys to
success: our
Pillars, Principles and Behaviors.
These
guiding
principles
underpin
our
approach
to
compensation and define our compensation
framework. In 2021,
following
the
launch
of
our
purpose,
we
reviewed
our
Total
Reward Principles and
compensation framework to
confirm they
are
fully
aligned
with
our
purpose
and
support
our
strategic
imperatives.
This
ensures
that
the
interests
of
our
employees
are
aligned
with those of our clients and other stakeholders.
Therefore,
our
compensation
approach
supports
our
capital
strength
and
risk
management,
and
provides
for
simplification
and
efficiency.
It
encourages
employees
to
focus
on
client
centricity,
connectivity
and
sustainable
impact
in
everything
we
do. Moreover,
we reward
behaviors that
help build
and protect
the
firm’s
reputation,
specifically
accountability
with
integrity,
collaboration and
innovation. Compensation
for each
employee
is
based
on
individual,
team,
business
division
and
Group
performance,
within
the
context
of
the
markets
in
which
we
operate.
Total Reward Principles
Our Total
Reward Principles
apply to
all employees
globally,
but vary
in certain
locations according
to local
legal requirements
and
regulations and practices. The table below provides a summary of our Total
Reward Principles.
Support our purpose and strategy
Our compensation approach supports the firm’s
purpose and strategy, fosters engagement among
employees and aligns their long-term interests
with those of clients and stakeholders.
Attract, retain and connect a diverse, talented
workforce
We embrace a culture of diversity, equity, and inclusiveness. Pay at UBS is fair, reflects equal
treatment and is competitive. In this way, our investment in a connected workforce
supports the
sustainability of the organization.
Apply a pay-for-performance approach to
support development and our ways of
working
The setting of clear objectives and a thorough
evaluation of what was achieved and how
it was
achieved, combined with effective communication,
promote clarity, accountability and establish a
strong link between pay and performance. This
approach emphasizes our Behaviors, which are
accountability with integrity, collaboration and innovation.
Reinforce sustainable growth and support long-
term value creation
Compensation is appropriately balanced between
fixed and variable elements and delivered over
an
appropriate period to support our growth ambitions
and sustainable performance.
Support risk awareness and appropriate risk-
taking
Our compensation structure encourages employees
to have a focus on risk management and behave
consistently with the firm’s risk framework
and appetite, thereby anticipating and managing
risks
effectively to protect our capital and reputation.
Our Total Reward approach
At
UBS,
we
apply
a
holistic
Total
Reward
approach,
generally
consist
ing
of
fixed
compensation
(base
salary
and
role
-
b
a
sed
allowances,
if
applicable),
performance
awards
,
pension
contributions
and
benefits.
Our
Total
Reward
approach
is
structured to support sustainable results and growth ambitions.
For
employees
whose
total
compensation
exceeds
certain
levels,
performance
awards
are
delivered
in
a
combination
of
cash,
deferred
contingent
capital
awards
and
deferred
share-
based awards.
A substantial
portion of
performance award
s
is deferred
and
vests
over
a
five-year
period
(or
longer
for
certain
regulated
employees).
This
deferral
approach
supports
alignment
of
employee and investor interests, our
capital base and the
creation
of sustainable shareholder value.
›
Refer to “Compensation elements
for all employees” in the
“Group compensation” section of this report for more
information
Advisory vote
Corporate governance and compensation | Compensation
236
Compensation governance
Board of Directors and Compensation Committee
The BoD is ultimately
responsible for approving the compensation
strategy
and
principles
proposed
by
the
Compensation
Committee,
which
determines
compensation-related
matters
in
line with the principles set forth in the AoA.
As
determined
in
the
AoA
and
the
firm’s
Organization
Regulations,
the
Compensation
Committee
supports
the
BoD
with its duties to set guidelines on compensation and benefits,
to
oversee
implementation
thereof,
to
approve
certain
compensation
and
to
scrutinize
executive
compensation.
The
Compensation
Committee
consist
s
of
independent
BoD
members, who are elected annually by shareholders at the AGM,
and
is
responsible
for
governance
and
oversight
of
our
compensation process and
practices. This includes the
alignment
between
pay
and
performance,
and
ensuring
that
the
compensation
framework
supports
appropriate
risk
awareness
and management, as
well as appropriate
risk-taking. In 2021, to
additionally support
the connection
between the
Compensation
Committee
and
the
Risk
Committee,
the
Compensation
Committee
Chair
person
was
also
a
member
of
the
Risk
Committee.
A
nnual
ly,
and
on
behalf
of
the
BoD,
the
Compensation
Committee:
–
reviews our Total Reward Principles;
–
approves
key
features
of
the
compensation
framework
and
plans
for
the
non-independent
Board
members
and
GEB
members;
–
reviews performance award
funding throughout the
year and
proposes, upon
proposal of
the Group
CEO, the
final annual
Group performance award pool for BoD approval;
–
upon
proposal
of
the
Group
CEO,
reviews
the
performance
framework of the other GEB members;
–
upon proposal
of the
Group CEO,
proposes the
performance
assessments
and
the
individual
total
compensation
for
the
other GEB members for approval by the BoD;
–
upon proposal
of the
Chairman, proposes
financial and
non-
financial
performance
targets
and
objectives
for
the
Group
CEO
and
the
Group
CEO’s
performance
assessment
for
approval by the Board;
–
approves
the
total
compensation
for
the
Chairman
and
the
non-independent Board members;
–
proposes,
upon
proposal
of
the
Chairman,
the
total
compensation for the Group CEO for approval by the Board;
–
proposes to the BoD the
maximum aggregate amounts of
BoD
compensation and GEB fixed
compensation and the
aggregate
amount of variable compensation for
the GEB for approval by
the general meeting of the shareholders;
–
upon proposal of
the Chairman, proposes
the remuneration /
fee framework
for independent
Board members
for approval
by the Board;
–
upon proposal of the Chairman and Group CEO, approves the
remuneration / fee
frameworks for external supervisory
board
members
of
Significant
Group
Entities
and
be
informed
of
remuneration / fee
frameworks for external
supervisory board
members of Significant Regional Entities; and
–
proposes
to
the
BoD
for
approval
the
annual
compensation
report and
approves other
material public
disclosures on
UBS
compensation matters.
The Compensation Committee
is required to meet
at least four
times each
year. All meetings
in 2021
were held in
the presence
of the Chairman and the Group CEO and most were attended by
external
advisors.
Individuals,
including
the
Chairman
and
the
Group CEO, are not permitted to attend a meeting or participate
in a discussion on their own performance and compensation.
After
the
meetings,
the
Chairperson
of
the
Compensation
Committee reports
to the
BoD on
the Compensation
Committee’s
activities and discussions
and, if necessary,
submits proposals for
approval
by
the
full
BoD.
Compensation
Committee
meeting
minutes are also sent to all members of the BoD.
On
31 December
2021,
the
members
of
the
Compensation
Committee
were
Julie
G.
Richardson
(Chair
person
),
Reto
Francioni, Dieter Wemmer and Jeanette Wong.
›
Refer to “Board of Directors” in the “Corporate
governance”
section of our Annual Report 2021 for
more information
External advisors
The
Compensation
Committee
may
retain
external
advisors
to
support it
in fulfilling
its duties. In
2021, HCM
International Ltd.
(HCM)
provided
independent
advice
on
compensation
matters.
HCM
holds
no
other
mandates
with
UBS.
Additionally,
Willis
Towers Watson provided the Compensation
Committee with
data
on
market
trends
and
pay
levels.
Various
subsidiaries
of
Willis
Towers
Watson provide
similar information to
Human Resources
in relation to compensation for employees. Willis Towers
Watson
holds no other compensation-related mandates with UBS.
The Risk Committee’s role in compensation
The Risk Committee, a committee of the BoD, works closely with
the Compensation
Committee to
ensure that
our compensation
framework
appropriately
reflects
risk
awareness
and
management,
and
ensures
appropriate
risk-taking.
It
supervises
and sets appropriate risk management
and risk control principles
and
is
regular
ly
brief
ed
on
how
risk
is
factored
into
the
compensation process. It also monitors the involvement of Group
Risk
Con
trol
and
Compliance
and
Operational
Risk
in
compensation
and
reviews
risk-related
aspects
of
the
compensation process.
›
Refer to
ubs.com/governance
for more information
237
Compensation Committee 2021 / 2022 key activities and timeline
May
June
July
Sept
Oct
Nov¹
Dec¹
Jan
Feb
Strategy, policy and governance
Total Reward Principles
l
Sustainability / ESG in the compensation process
l
l
l
Compensation disclosure and stakeholder communication matters
l
l
l
l
l
AGM reward-related items
l
l
Compensation Committee governance
l
Annual compensation review
Accruals and full-year forecast of the performance award pool
funding
l
l
l
l
l
l
Performance targets and performance assessment of the Group CEO
and GEB members
l
l
l
Group CEO and GEB members’ salaries and individual performance
awards
l
l
l
Update on market practice, trends and peer group matters
l
l
l
Pay for performance, including governance on certain higher-paid employees, and
non-standard compensation arrangements
l
l
l
l
l
l
l
Board of Directors remuneration
l
l
Compensation framework
Compensation framework and deferred compensation matters
l
l
l
l
l
Risk and regulatory
Risk management in the compensation approach and
joint meeting with
BoD Risk Committee
l
l
l
l
l
Regulatory activities impacting employees and engagement
with regulators
l
l
l
l
l
l
l
l
1
The Compensation Committee held two meetings in November 2021 and three meetings in December 2021.
Compensation governance
The table below provides an overview of compensation governance by specific role.
Recipients
Compensation recommendations proposed by
Approved by
Chairman of the BoD
Chairperson of the Compensation Committee
Compensation Committee
1
Independent BoD members
(remuneration / fee framework)
Compensation Committee and Chairman of
the BoD
BoD
1
Group CEO
Compensation Committee and Chairman of
the BoD
BoD
1
Other GEB members
Compensation Committee and Group CEO
BoD
1
Key Risk Takers (KRTs)
/
senior employees
Respective GEB member and functional management
team
Individual compensation for KRTs and senior employees:
Group CEO
1
Aggregate variable compensation and maximum aggregate amount of fixed compensation for the GEB,
as well as aggregate remuneration for the BoD, are subject to shareholder approval.
Advisory vote
Corporate governance and compensation | Compensation
238
Environmental, Social and Governance considerations
ESG in the compensation determination process
ESG objectives are considered in the compensation determination
process
in
objective
setting,
performance
award
pool
funding,
performance
evaluation
and compensation
decisions.
ESG-related objectives have been
embedded in our Pillars and
Principles since they
were established in
2011. In
2021, we revised
the Group CEO
and GEB scorecards
and further enhanced
the link
between
ESG
and
compensation
by
introducing
explicit
sustainability objectives
under “Strategic
& Growth” in
the non-
financial goal
category. These
sustainability objectives
are linked
to
our
priorities
,
and
their
progress
is
measured
via
robust
quantitative
metrics
and
qualitative
criteria.
The
table
below
provides
an
overview
of
our
metrics
and
progress
achieved
in
2021. Sustainability
objectives are
individually assessed
for each
GEB member, and consequently
directly impact their
performance
assessments and compensation decisions.
In addition, in the performance award pool funding across the
Group,
ESG is
also reflected
through an
assessment of
progress
made against
targets linked
to our focus
areas of Planet,
People
(including
progress
made
against
our
diversity
ambitions)
and
Partnerships,
alongside
other
key
dimensions.
Therefore
ESG
is
taken
into
consideration
when
the
Compensation
Committee
assesses not
only what
results were
achieved but
also how
they
were achieved.
For
2021,
we
established
robust
and
concrete
targets,
and
made
good
progress
toward
achieving
them.
We
continue
to
increase our focus on this topic.
›
Refer to “GEB performance assessments“
in the “Compensation
for GEB members” section of this report for more
information
about the GEB performance measurement
process
›
Refer to “Our focus on sustainability and climate,”
“Employees”
and “Society” in the “How we create value
for our stakeholders”
section of our Annual Report 2021 for
more information
›
Refer to
ubs.com/gri
for more information about ESG-related
topics
Fair pay and pay for performance
Compensating employees
fairly and consistently
is key to ensuring
equal opportunities. We
pay
for
performance, and
we
take
pay
equity seriously.
A strong commitment
to both is
embedded in
our
compensation policies,
and we conduct both internal reviews and
independent external
audits as quality checks. If we uncover gaps
that
c
annot
be
explained
by
business
factors
or
appropriate
personal
factors
–
such
as
experience,
role,
responsibility,
performance
or location
– we
explore the
root causes
of those
gaps
and address them.
Additionally, our regular monitoring and review processes also
allow
us
to
maintain
our
certification status
with
the
EQUAL-
SALARY Foundation
for our equal
pay practices
in Switzerland,
the
US,
the
UK,
Hong
Kong
SAR
and
Singapore.
The
firm
also
successfully
completed
an equal
pay analysis
in Switzerland
in 2020,
as required
by the
Swiss Federal
Act on
Gender
Equality. The
results
of the
analysis confirmed that
we are
fully compliant with
Swiss
equal pay standards.
These holistic
certifications
are a testament
to
our
well
-
established
equal
opportunity
environment
and
the
strength of our human resources
practices,
including performance
and reward.
In 2021,
we continued
to monitor
pay fairness and
addressed any unexplained gaps to ensure that all
employees are
paid fairly.
239
Our targets and progress
Our priorities
Our targets
Our progress in 2021
Planet,
people,
partnerships
USD 400 billion invested assets in sustainable
investments
by 2025.
Increased invested assets in sustainable investments
to
USD 251 billion (compared with USD 141 billion in
2020).
Planet
Set decarbonization targets for 2030 for financing
of the
fossil fuels, power generation and real estate sectors
(from
2020 levels):
–
reduce absolute financed emissions associated with
UBS
loans to fossil fuel companies by 71%;
–
reduce emissions intensity associated with UBS
loans to
power generation companies by 49%;
–
reduce emissions intensity of UBS’s commercial real
estate lending portfolio by 44%; and
–
reduce emissions intensity of UBS’s residential real estate
lending portfolio by 42%.
Estimated baselines and development of net-zero-aligned
pathways for the fossil fuel, power generation
and real
estate (commercial and residential) sectors.
Align USD 235 billion of invested assets to
net zero by
2030 (Asset Management).
Established Asset Management baseline covering
the
weighted average carbon intensity of the respective
benchmark for each strategy and fund included
in our
target.
Achieve net-zero emissions across discretionary client
portfolios by 2050.
Expanded discretionary offering with climate transition-
focused solutions and built more detailed carbon
footprint
data into our research and reporting toolkits.
Achieve net-zero energy emissions resulting from our own
operations (scope 1 and 2) by 2025; cut
energy
consumption by 15% by 2025 (compared with 2020).
Reduced net greenhouse gas footprint for scope 1
and 2
emissions by 75% and energy consumption
by 5%
(compared with 2020); continued implementation
of the
replacement of fossil fuel heating systems and investing
in
credible carbon removal projects; maintained 100%
renewable electricity coverage.
Offset historical emissions back to the year 2000
by
sourcing carbon offsets (by end 2021) and by offsetting
credit delivery and full retirement in registry (by end 2025).
Completed the sourcing process for a portfolio of
transparent carbon offsets from the voluntary carbon
market across a range of project types and geographies.
Engage with key vendors on targeting net
zero by 2035.
Commenced working on understanding
and quantifying
the scope 3 emissions in our supply chain.
People
30% global female representation at Director level and
above by 2025.
Increased to 26.7% (2020: 26.0%) female representation
at Director level and above.
26% US ethnic minority representation at Director level
and above by 2025.
Increased to 20.1% (2020: 19.5%) ethnic minority
representation at Director level and above in the US.
26% UK ethnic minority representation at Director level
and above by 2025.
Increased to 21.3% (2020: 20.7%) ethnic minority
representation at Director level and above in the UK.
Raise USD 1 billion in donations to our client philanthropy
foundations and funds and reach 25 million beneficiaries
by 2025 (cumulative for years 2021-2025).
Achieved UBS Optimus Foundation donations
volume of
USD 161 million (including UBS matching contributions)
and reached 4.6 million beneficiaries.
Support one million beneficiaries through our community
impact activities by 2025 (cumulative for years
2020-
2024).
Reached 1.199 million beneficiaries through strategic
community impact activities cumulatively during
2020 and
2021, surpassing our 2025 target in two
years.
Partnerships
Establish UBS as a leading facilitator of discussion,
debate
and idea generation.
Launched the UBS Sustainability and Impact
Institute, with
the objective of delivering original, best-in-class
sustainability and impact thought leadership.
Drive standards, research and development, and product
development through partnerships across the financial
ecosystem.
Continued implementation of the Principles
for
Responsible Banking by expanding the scope of
our
impact analyses and improving upon our existing
methodologies in partnership with the UN
Environment
Program and peers.
›
Refer to the Sustainability Report 2021,
available from 11 March 2022 under “Annual reporting“
at
ubs.com/investor
s, for more
information
Advisory vote
Corporate governance and compensation | Compensation
240
Our commitment to diversity, equity and inclusion
Ensuring
fair
treatment
and
strengthening
our
commitment
to
DE&I are vital to our sustainable
business success. We find diverse
teams better
understand and
relate
to the
needs of
our equally
diverse
clients.
Through
the
diversity
of
our
employees’
backgrounds
and
experiences,
we
drive
innovation
and
better
decision
making.
Our
aim,
therefore,
is
to
shape
a
diverse
and
inclusive
organization
that
is
innovative,
provides
outstanding
service
to
our
clients and
offers
equitable
opportunities
so that
every employee can thrive.
UBS is a
strong supporter of
the UN Standards
of Conduct for
Business
anti-discrimination
guidelines.
Additionally,
we
are
signatories to the UN-backed Women’s Empowerment Principles,
the UK’s
Women in
Finance Charter
and Race
at Work
Charter,
and
the Corporate
Call to
Action in
the US.
Philosophically, we
take a
broad approach
to DE&I,
focusing on
a range
of aspects,
including
inclusive
leadership,
age,
gender,
race
and
ethnicity,
LGBTQ+,
disability,
and
veterans.
Building
inclusive
leadership
skills, increasing
gender and
ethnic diversity,
and equitable
policies
and practices were our leading priorities in 2021.
Gender diversity is
a key priority
for the firm.
We are particularly
focused
on
increasing
the
representation
of
women
at
senior
management
levels.
We
take
a
multi-pronged
approach
in
this
respect, analyzing
and adapting
various factors
that support
the
hiring,
development
and
retention
of
women
at
all
levels.
For
example,
our
interviews
for
open
roles
are
expected
to
include
qualified diverse candidates, and
our interview questions seek
to
gauge inclusive leadership competencies for executive roles.
To ensure we are making progress, we
hold ourselves and our
leaders accountable. For
example, in
early 2020 we
publicly stated
our aspiration to have
30% of all
Director and above roles
held by
women by 2025. At
the end of 2021,
that figure stood at
26.7%,
up from 26.0% in
2020. As of 31 December
2021, 25% of GEB
members were
female and
we expect
to increase this
ratio to
33%
in early
2022 after
the designated
Group Chief
Financial Officer
joins the firm. In addition, 27%
of senior managers who reported
directly
to
the
Group
Executive
Board
(the
GEB)
in
2021
were
female. These aspirations
are considered in
the determination of
the
annual
performance
award
pool
and
are
included
in
the
explicit
sustainability objectives
under
“Strategic &
Growth” for
the GEB, as outlined in the table on the previous page.
Increasing the
ethnic minority diversity
of our
workforce, and
a
related
commitment
to
support
underrepresented
talent
and
communities, is also a top
priority across all business
divisions and
regions. We focus on four areas:
accountability and transparency;
investing in our talent; improving our culture;
and leveraging our
business strengths in underrepresented communities.
We take a country-by-country approach, in close collaboration
with relevant
business and
jurisdictional entities.
This is
because
legislation,
legal
requirements
and
progress
toward
racial
and
ethnic equality vary significantly across the
locations in which we
do business. In
the short term,
the largest
share of our
efforts is
focused on
Switzerland, the
US and
the UK.
In Switzerland,
we
began
collecting
ethnicity
data
on
a
voluntary
basis
in
2021,
aimed
at
understanding
the
current
representation
within
our
local
workforce.
Our
2025
aspiration
is
to
achieve
a
26%
representation of ethnic
minorities at Director
level and above
in
the UK and
the US. As
of the end
of 2021, our
representation was
20.1% in the US and 21.3% in the UK.
Our
employee
networks
are
strong
partners
in
our
ethnic
diversity
strategy.
Throughout
2021,
our
ethnicity-focused
MOSAIC networks
globally facilitated
numerous events
for staff
in every region to increase awareness and personal accountability
along with specialized
educational sessions
for network members.
In addition, a
community of more
than 480 Diversity
and Inclusion
Ambassadors acts
as a resource
for employee
advice and
coaching
on
conversations
about
various
diversity
and
inclusion-related
topics.
We are
committed to
ensuring a
workplace where
employees
are fairly
treated, with
equitable employment
and advancement
opportunities for all. We do not tolerate
harassment of any kind,
including sexual harassment, and we take
measures to prevent all
forms of
harassment, bullying,
victimization and
retaliation. Our
policies, procedures, employee
and line manager
education, and
awareness materials
all encourage
employees to
raise concerns,
which
they
may
do
openly
or
anonymously.
An
internal
anti-
harassment
officer
appointed
by
the
Group
Head
Human
Resources
provides
an
independent
view
of
the
firm’s
various
processes
and
procedures
to
prevent
harassment
and
sexual
misconduct.
›
Refer to
ubs.com/diversity
for additional information about our
priorities, commitments and progress, and the Sustainability
Report 2021, available from 11 March 2022 under “Annual
reporting” at
ubs.com/investors
, for our management practices
and detailed employee data, including
gender-
and region-
specific data
›
Refer to ”Employees”
in the ”How we create value for our
stakeholders”
section of our Annual Report 2021
for more
information.
241
Performance award pool funding
Our compensation philosophy focuses on balancing performance
with
appropriate
risk-taking,
retaining
talented
employees
and
shareholder returns. Our overall
performance award pool funding
percentage reduces as financial
performance increases. In
years of
strong
financial
performance
,
this
prevents
excessive
compensation
and
results
in
an
increased
proportion
of
profit
before
performance
awards
being
available
for
distribution
to
shareholders
or
growing
the
Group’s
capital.
In
years
where
performance declines, the performance award pool will generally
decrease; however,
the funding percentage may increase.
Our performance award
pool funding
framework is based
on
Group and
business division
performance, including
achievements
against defined performance
measures. In
assessing performance,
we
also
consider
industry
peers,
market
competitiveness
of
our
results and pay position,
as well as progress against
our strategic
objectives,
including
returns,
risk
-
weighted
assets
and
cost
efficiency.
The Risk and Compliance functions
support our holistic
reflection
and
consideration
of
the
financial
and
non-financial
impact (including reputation) of risk matters. We further consider
the firm’s risk profile and culture, the extent to
which operational
risks and audit
issues have been
identified and resolved,
and the
success of risk reduction initiatives including significant events.
The
funding
for
Group
Functions
is
linked
to
overall
Group
performance
and
reflects
headcount,
workforce
location
and
demographics.
For
each
functional
area
quantitative
and
qualitative assessments evaluate service quality, risk management
and
financial
achievements.
O
ur
decision
s
also
balance
consideration
of
financial
performance
with
a
range
of
factors,
including
DE&I
and
other
ESG
metrics,
the
impact
of
litigation,
regulatory
costs,
the
effect
of
changes
in
financial
accounting
standards, capital returns, and relative total shareholder return.
Before making its final
proposal to the
BoD, the Compensation
Committee considers
the CEO’s
proposals and
can apply
a positive
or
negative
adjustment
to
the
performance
award
pool.
For
example,
despite
our
excellent
financial
results
in
2021,
our
reputation and financial
results were negatively
impacted by a
loss
related to the default
of a US-based client of
our prime brokerage
business.
As a consequence, the 2021 Group
performance award
pool
was
reduced
significantly.
Our
funding
approach
for
the
performance
award
pool
resulted
in
a
direct
and
substantial
reduction,
which
was
supplemented
by
a
significant
negative
adjustment to the pool.
Taking into consideration
the above
proposals and
factors, over
the past
nine years
the Compensation
Committee has
approved
adjustments
to
the
performance
award
pool,
resulting
in
downward adjustments in all but one year.
›
Refer to “2021
Group performance outcomes” in the “Group
compensation” section of this report
›
Refer to the “Group performance” section
of our Annual Report
2021 for more information about our results
Advisory vote
Corporate governance and compensation | Compensation
242
Performance award pool funding process – illustrative overview
243
Compensation for GEB members
GEB compensation framework
In
2021,
we
made
no
changes
to
our
GEB
compensation
framework.
The
chart
below
illustrat
es
the
compensation
elements,
pay
mix
and
key
features
for
GEB
members.
Of
the
annual performance award, 20% is paid
in the form of cash and
80%
is
deferred
over
a
period
of
five
years
1
,
with
50%
of
the
annual
performance
awards
granted
under
the
Long-Term
Incentive Plan (the LTIP)
and 30% under the Deferred Contingent
Capital Plan (the DCCP).
›
Refer to “Our deferred compensation plans”
in the “Group
compensation” section of this report for more
information
2021 compensation framework for GEB members (illustrative example)
›
Refer to the “Group Compensation” section
of this report for more information
›
Refer to “Regulated staff” in the “Supplemental
information” section of this report for more information
Pay-for-performance safeguards for GEB members
Performance
award caps
–
Cap on the total GEB performance award pool
(2.5% of profit before tax)
1
–
Caps on individual performance awards (for the
Group CEO capped at five times the fixed compensation
and at seven times for
the other
GEB members)
–
Cap of 20% of performance award in cash
Delivery and
deferral
–
80% of performance awards are at risk of forfeiture
–
Long-term deferral over five years (or longer
for certain regulated GEB members)
–
Alignment with shareholders (through the LTIP)
and bondholders (through the DCCP)
–
Final payout of equity-based LTIP
award (50% of performance award) subject to absolute
and relative performance
conditions (three-year
performance period)
Contract
terms
–
No severance terms
–
Six-month notice period
Other
safeguards
–
Share ownership requirements
–
No hedging allowed
1
The Compensation Committee may consider adjustments to profit for items that are not reflective of underlying performance.
Advisory vote
Corporate governance and compensation | Compensation
244
GEB share ownership requirements
To
align
the
interests
of
GEB
members
with
those
of
our
shareholders
and
to
demonstrate
personal
commitment
to
the
firm, we require
the Group CEO
and the other
GEB members to
hold
a
substantial
number
of
UBS
shares.
GEB
members
must
reach their minimum shareholding requirements
within five years
from their appointment and
retain it throughout their
tenure. The
total number of
UBS shares held by
a GEB member
consists of any
vested
or
unvested
shares
and
any
privately
held
shares.
GEB
members
may
not
sell
any
UBS
shares
before
they
reach
the
minimum ownership thresholds mentioned
below. At
the end of
2021, all GEB members met their share ownership
requirements,
except
for
those
appointed
within
the
last
four
years,
who
still
have time to build up and meet the required share ownership.
As of 31 December 2021,
our GEB members held shares
with
an
aggregate
value
of
approximately
USD
191
million
,
demonstrating their
commitment to
our strategy
and alignment
with shareholders.
Share ownership requirements
Group CEO
min. 1,000,000 shares
Must be built up within five years from their appointment
and retained throughout
their tenure.
Other GEB members
min. 500,000 shares
GEB base salary and role-based allowance
Each GEB member receives a
fixed base salary, which is reviewed
annually by the
Compensation Committee. The
2021 annual base
salary
for
the
Group
CEO
role
was
CHF 2.5
million
and
has
remained unchanged
since 2011.
The other
GEB members
each
received
a
base
salary
of
CHF 1.5
million
(or
local
currency
equivalent), also unchanged since 2011.
Over the course of 2021, two GEB
members held a UK Senior
Management
Function (SMF)
role for
one of
our UK
entities.
In
addition to
base salary,
role-based allowances
were part
of their
fixed compensation.
At the AGM, shareholders are asked to approve the maximum
aggregate amount
of fixed
compensation for
GEB members
for
the following financial year.
›
Refer to the “Supplemental information”
section of this report
for more information about MRTs and SMFs
›
Refer to the “Say-on-pay” section of
this report for more
information about the AGM vote on fixed
compensation for the
GEB
Caps on the GEB performance award pool
The
size
of
the
GEB
performance
award
pool
may
not
exceed
2.5% of
the Group
profit before
tax. This
limits the
overall GEB
compensation based on the firm’s profitability.
For 2021, the
Group’s profit
before tax
was USD 9.5
billion and
the total GEB performance award
pool was CHF 79.8 million. The
GEB
performance
award
pool
as
a
percentage
of
Group
profit
before tax was 0.9%, well below the 2.5% cap.
In line
with the
individual compensation
caps on
the proportion
of fixed
pay to
variable pay
for all
GEB members
(introduced in
2013), the Group CEO’s granted
performance award is capped at
five times
his fixed
compensation. Granted
performance awards
of
other
GEB
members
are
capped
at
seven
times
their
fixed
compensation
(or
two
times
for
GEB
members
who
are
also
Material
Risk
Takers
(
MRTs
)
)
.
For
202
1
,
performance
awards
granted to GEB members
and the Group CEO
were, on average,
3.2
times
their
fixed
compensation
(excluding
one
-
time
replacement
awards,
benefits
and
contributions
to
retirement
plans).
›
Refer to “Performance award pool funding” in
the
“Compensation philosophy and governance”
section of this
report for more information
GEB employment contracts and severance terms
GEB
members’
employment contracts
do
not include
severance
terms
or
supplementary
pension
plan
contributions
and
are
subject to a
notice period of at
least six months.
A GEB member
leaving
UBS
before
the
end
of
a
performance
year
may
be
considered for a performance award.
Such awards are subject to
approval
by the
BoD, and
ultimately
by the
shareholders at
the
AGM.
Benchmarking for GEB members
When
recommending
performance
awards
for
the
Group
CEO
and
the
other
GEB
members,
the
Compensation
Committee
reviews the respective total compensation for
each role against a
financial industry peer group.
The peer group is
selected based on
comparability of their
size, business
mix, geographic presence
and
the
extent
to
which
they
compete
with
us
for
talent.
The
Compensation
Committee
considers
our
peers’
strategies,
practices and pay
levels, as well
as their regulatory
environment;
it
also
periodically
reviews
other
firms’
pay
levels
or
practices,
including
both
financial
and
non-financial
sector
peers
as
applicable. The
total compensation
for a
GEB member’s
specific
role
considers
the
compensation
paid
by
our
peers
for
a
comparable
role
and
performance
within
the
context
of
our
organizational profile. The Compensation Committee periodically
reviews and approves the peer group composition.
The table below
presents the composition
of our peer
group as
approved
by
the
Compensation
Committee
for
the
202
1
performance year.
Bank of America
Goldman Sachs
Barclays
HSBC
BlackRock
JPMorgan Chase
BNP Paribas
Julius Baer
Citigroup
Morgan Stanley
Credit Suisse
Standard Chartered
Deutsche Bank
State Street
245
GEB performance assessments
For 2021, we
have further enhanced
the performance assessment
for GEB members to ensure it is fully aligned
with the firm’s new
purpose and strategic
objectives. We assess
GEB members against
a
set
of
Group
financial
targets,
non-financial
objectives
and
Behaviors. Under
the non-financial
objectives we
introduced the
new
categories of
Core
Job, which
covers job-specific,
risk and
people
objectives,
as
well
as
Strategic
&
Growth,
which
covers
strategy,
digital
and
ESG
objectives.
The
restructured
approach
fosters an even greater focus on GEB priorities and the success
of
the Group overall
among all GEB
members, and strengthens
the
understanding
and
importance
of
interdependence
within
and
across
the GEB.
At the
same time,
it creates
stronger individual
accountability, and further increases
the focus on core activities.
The
Compensation
Committee
exercises
its
judgment
with
respect to the performance achieved
relative to the prior
year, the
strategic
plan and
competitors, and
considers the
Group
CEO’s
proposals.
The Compensation Committee’s proposals are
subject
to approval by the BoD.
The Compensation Committee, and then the full BoD, follows
a
similar
process
for
the
Group
CEO,
except
that
the
proposal
comes from the Chairman of the BoD.
Overview of the GEB compensation determination process
The compensation for the
Group CEO and the
other GEB members is
governed by a
rigorous process under Compensation Committee
and BoD oversight. The chart below shows how compensation for all GEB members is determined.
Advisory vote
Corporate governance and compensation | Compensation
246
Overview of performance assessment measures
We apply
a range
of quantitative measures
to assess GEB
member performance
against financial
and non-financial
objectives while
Behaviors are assessed qualitatively.
The table below provides a summary of the main metrics and measures used for 2021.
Financial measures
(60%)
–
Reported Group profit before tax
–
Reported Group cost / income ratio
–
Reported Return on CET1 capital
Non-
financial
measures
(30%)
Core Job
Job-specific
–
Business-specific criteria such as net new investable
asset targets and client engagement-level objectives
–
Operating income growth targets for specific client
segments and total cost goals
–
Post-stress CET1 objectives and Capital ratio guidance
–
Execution progress on key client and internal initiatives;
e.g., cross-divisional collaboration initiatives,
efficiency and cost saving initiates
Risk
–
Operating within risk appetite constraints
–
Progress to deliver on risk reduction initiatives
People
–
Employee listening / sentiment results and feedback
–
Progress to meet 2025 ambitions
for female representation and for ethnic minority
representation in the
US and UK at Director and above levels (as per
ESG disclosure)
–
People development, mobility, turnover and succession plan metrics
Strategic &
Growth
Strategy
–
Progress on group-wide transformation initiatives
–
Delivery on division / function-specific strategic
programs and initiatives
Digital
–
Progress on digital transformation initiatives
–
Delivery of digital offering and user experience for
clients
ESG
–
Refer to the ”Our targets and progress” table in the ”Environmental,
Social and Governance
considerations”
section of this report
Behaviors
(10%)
Accountability with integrity
Qualitative assessment
against expected
Behaviors:
–
Responsible for what they say and do
–
Takes ownership and makes things happen
–
Steps up and acts when something is
not right
Collaboration
–
Trusts others and helps them to be successful
–
Delivers One UBS, together with their colleagues
–
Fosters a diverse, inclusive and equitable work
environment
Innovation
–
Challenges perspectives and looks at every
opportunity to improve
–
Actively seeks and provides feedback
–
Learns from every success and failure
Performance assessment categories
The table
below presents
the three
performance categories
for the
assessment of
the performance
against non-financial
objectives
related
to
Core
Job,
Strategic
&
Growth
and
Behaviors.
The
achievement
score
represents
the
maximum
percentage,
and
the
Compensation Committee may apply downward adjustments.
Non-financial measures
Needs focus
Good contribution
Excellent contribution
Achievement score: up to 33%
Achievement score: up to 66%
Achievement score: up to 100%
Behaviors
Needs focus
Expected behavior
Exemplary behavior
Achievement score: up to 33%
Achievement score: up to 66%
Achievement score: up to 100%
247
2021 performance for the Group CEO
The
performance
award
for
the
Group
CEO
is
based
on
the
achievement
of
financial performance
targets
and non-financial
objectives related
to his
Core Job,
Strategic &
Growth initiatives
and Behaviors, as described earlier in this section.
These
objectives
were
set
to
reflect
the
strategic
priorities
determined by the Chairman and the BoD.
›
Refer to “GEB compensation framework”
in this section of this
report for more information
Performance assessment for the Group CEO
The
BoD recognized
that Ralph
Hamers
successfully focused
on
building on UBS’s strong
business momentum, which resulted
in
very strong
financial results
for 2021.
He led
the Group
toward
stronger client centricity
and improved the delivery
of the bank’s
ecosystem
to
clients.
He
also
delivered
a
successful
strategic
refresh in 2021 and
re-positioned the bank’s
sustainability efforts.
Mr.
Hamers successfully
led the
development of
the purpose
statement,
established
the
client
promise,
and
strategic
imperatives,
including
development
of
concrete
transformation
initiatives to position the firm for
future growth. He was the most
important
ambassador
for
the
firm’s
refreshed
culture
and
behavior program.
Furthermore,
Ralph
Hamers
continuously
displayed
high
risk
awareness and
set a strong
and consistent
tone from
the top to
promote
an
effective
risk
culture.
He
also
demonstrated
strong
leadership
and
accountability
in
dealing
with
the
loss
event
resulting
from
the
default
of
a
US-based
client
of
our
prime
brokerage business.
Additionally,
the BoD
recognized that
Mr.
Hamers personally
championed the drive towards
becoming more digital
across the
organization, along with his continuous push for technology as a
differentiator for both clients and employees.
The BoD acknowledged that Mr. Hamers also championed key
changes across the organization to further promote agile ways of
working,
simplification
and
empowerment.
He
continued
to
increase
the
Group’s
focus
on
delivering
against
diversity
and
ethnicity ambitions.
Mr.
Hamers
demonstrated
strong
leadership
on
ESG
topics,
including
establishing
a
group-wide
sustainability
and
impact
organization.
He
drove
the
definition
of
a
net-zero
framework
and
focused
the
organization
on
delivering
against
select
UN
Sustainable Development goals, as well as establishing ambitions
and making progress on key focus areas,
including Planet, People
and Partnerships.
The
table
below
illustrates
the
assessment
criteria
used
to
evaluate the achievements of Mr. Hamers in 2021.
Financial performance
Weight
Performance measures
2021
targets
2021
results
Achieve-
ment
2
Weighted
assess-
ment
2021 commentary
20%
Reported Group Profit
before Tax
USD 6.9bn
USD 9.5bn
100%
2
20%
–
Profit before tax increased 16% to USD 9.5 billion,
reflecting strong business momentum with income
up
in all regions and good cost control. This result
significantly exceeds the 2021 performance
target and also represents the highest result
since 2006.
20%
Reported Cost / Income
Ratio
75%
1
73.6%
100%
2,3
20%
–
The cost / income ratio was 73.6%,
better than the
2021 performance target
, despite the increase in
litigation provisions of USD 740 million taken for
the
French cross-border matter.
20%
Reported Return on CET1
Capital
16%
1
17.5%
100%
2
20%
–
The return on CET1 capital (RoCET1) was
17.5%,
compared with 17.4% in 2020,
exceeding the 2021
performance target
.
1
The return on
CET1 capital and
cost / income
ratio performance targets
are set based
on the previously
communicated targets a
nd reflect a
stretch-target level relative
to the Group
return on CET1
capital target range of 12–15% and the cost / income ratio target range of 75–78%
in the spirit of setting ambitious goals to reach a 100% performance achievement.
2
Achievement score capped at
100%.
3
For the assessment of the cost / income ratio,
each 1% difference between actual and target affects the score by 10%.
Advisory vote
Corporate governance and compensation | Compensation
248
Performance assessment for the Group CEO (continued)
Non-financial performance and Behaviors
Weight
Performance
measures
Achieve-
ment
Weighted
assess-
ment
2021 commentary
30%
Good
contribution
(66%)
20%
–
The evaluation of each non-financial objective
considers
quantitative metrics
that are
assessed against internal targets / plan:
Core Job
(Job specific,
Risk, People)
Core Job
–
Progressed on execution of
digital transformation
initiatives
–
Delivered improved
digital offering
and
user experience for clients
–
Operated within
risk appetite
constraints
–
Progressed on
risk reduction initiatives
and strengthened the
control framework
–
Improved
employee listening / sentiment results
across key categories
–
Increased the
ratio of female leaders
, stayed on track to meet the 2025 target
–
Stayed on track toward the 2025 ambition for ratios
of US and UK
employees from ethnic
minorities
–
Improved statistics on
employee mobility and turnover
Strategic &
Growth
(Strategy, Digital,
ESG)
Strategic & Growth
–
Developed and launched UBS’s
purpose
–
Delivered the refreshed
strategy
–
Launched new client promise and strategic imperatives
–
Refreshed the
Sustainability
strategy
–
Progressed on the execution of key
growth initiatives
–
Refreshed culture and behavior program
–
See
ESG
metrics and progress in separate table in this report
10%
Behaviors
(Accountability
with integrity,
Collaboration,
Innovation)
Expected
behavior
(66%)
7%
The assessment of the Behavior objectives is
qualitative
and has resulted in the following
summary assessment:
–
Mr. Hamers acted as a
role model
in accepting
ownership and accountability
. He further
strengthened
collaboration
across the Group and at the same time pushed
individual
accountability
and empowerment across the organization
–
He drove
innovation
in UBS and built the foundation for
a successful digitalization through
new ways of working
. He continuously promoted simplification, more radical
challenge
and innovative thinking and action
Total weighted assessment
(maximum 100%)
87%
In addition to the
overall 2021 performance
of the Group and
Mr.
Hamers’
achievements
outlined
in
the
performance
evaluation
table above,
the BoD
also considered
other factors,
such as
the
impact of
the significant
risk event
related
to a
loss from
a US-
based client of our prime brokerage business.
The
BoD
approved
the
proposal
by
the
Compensation
Committee to grant Mr. Hamers
a performance award of
CHF 8.5
million, resulting
in a
total compensation
for 2021
of CHF
11.0
million
(excluding
benefits
and
contributions
to
his
retirement
benefit plan).
Aligned
with
the
GEB
compensation
framework,
the
Group
CEO’s performance award
will be delivered
20% (CHF 1.7
million)
in
cash
and
the
remaining
80%
(CHF
6.8
million)
subject
to
deferral and forfeiture provisions,
as well as meeting
performance
conditions over the next five years.
249
2021 total compensation for the GEB members
The aggregate performance award
pool for the
GEB for 2021
was
CHF 79.8
million
(USD 87.1
million);
on
a
per
capita
basis
this
reflects
a
decrease
of
1%
compared
with
2020.
This
contrasts
with
the
change
in
the
overall
performance
award
pool
of
the
firm,
which
increased
10%
compared
with
2020.
The
GEB
performance award
pool had
a proportionally
larger downward
adjustment than
the Group
pool, to
reflect the
accountability of
the GEB for the significant risk event in the first half of
2021. The
Group’s profit before tax was USD 9.5 billion, up 16% compared
with 2020.
The
Compensation
Committee
has
confirmed
that
performance conditions for all GEB members’ awards due to vest
in March 2022 have
been satisfied and the
awards will therefore
vest in full.
At
the
2022
AGM,
shareholders
will
vote
on
the
aggregate
2021 total variable compensation
for the GEB in
Swiss francs. The
tables
below provide
the awarded
compensation for
the Group
CEO and the GEB members
in Swiss francs and, for
reference, the
total
amounts
in
US
dollars
for
comparability
with
financial
performance.
The
individual
variable
performance
awards
for
each
GEB
member
will
only
be
confirmed
upon
shareholder
approval at the AGM
›
Refer to “Provisions of the Articles of Association
related to
compensation” in the “Supplemental
Information” section of
this report for more information
Audited |
Total
compensation for GEB members
CHF, except where indicated
USD (for reference)
1
For the
year
Base salary
Contribution
to retirement
benefit plans
Benefits
2
Total fixed
compensa-
tion
Cash
3
Performance
award
under LTIP
4
Performance
award
under
DCCP
5
Total
variable
compensa-
tion
Total fixed
and vari-
able com-
pensation
6
Total fixed
compensa-
tion
Total
variable
compensa-
tion
Total fixed
and vari-
able com-
pensation
6
Highest Paid Executive (for 2021 Ralph
A.J.G Hamers and for 2020 Sergio P. Ermotti)
2021
2,500,000
246,415
251,856
2,998,271
1,700,000
4,250,000
2,550,000
8,500,000
11,498,271
3,275,763
9,286,681
12,562,444
2020
7
2,500,000
244,353
78,891
2,823,244
2,100,000
5,250,000
3,150,000
10,500,000
13,323,244
Group CEO Ralph A.J.G. Hamers (reflects compensation
since joining UBS per 1 September
2020)
2020
833,333
62,124
314,260
1,209,717
600,000
1,500,000
900,000
3,000,000
4,209,717
Aggregate of all GEB members
8,9,10,11,12
2021
24,853,521
2,064,009
1,179,512
28,097,041
15,950,000
39,875,000
23,925,000
79,750,000
107,847,041
30,697,441
87,130,916
117,828,357
2020
27,469,369
2,249,276
1,145,489
30,864,135
16,625,062
42,874,938
25,500,000
85,000,000
115,864,135
1 Swiss franc
amounts have been
translated into US
dollars for reference
at the 2021
performance award currency
exchange rate of
CHF / USD
1.092551.
2 All benefits
are valued at
market price.
3 For GEB
members who are also MRTs or SMFs, the cash portion includes blocked
shares.
4 LTIP awards for performance year 2021 were awarded
at a value of 67.7% of maximum which reflects our best estimate of the fair
value of the award. The maximum number of
shares is determined by dividing the awarded amount by the estimated
fair value of the award at grant, divided
by CHF 19.194 or USD 20.700, the average closing price
of UBS shares over the last ten trading days leading up to and including the grant date.
5 The amounts reflect the amount of the notional additional tier
1 (AT1) capital instrument excluding future notional interest.
6 Excludes the portion related to the
legally required employer’s social security contributions for 2021 and 2020, which are estimated
at grant at CHF 4,997,243 and CHF 5,497,811,
respectively, of which CHF 763,059
and CHF 880,496, respectively, are
for the highest-paid GEB member.
The legally required employees’
social security contributions are included in the
amounts shown in the table above,
as appropriate.
7 Reflects
compensation for 12 months until
the end of his GEB
employment on 31 December 2020.
8 As stated in “Group
Executive Board” in the
“Corporate governance” section of our
Annual Report 2021, twelve
GEB
members were in office on
31 December 2021 and thirteen
GEB members on 31 December
2020.
9 Includes compensation paid under
employment contracts during notice
periods for GEB members
who stepped
down during the respective years.
10 Includes compensation for newly appointed GEB members for their time in office as
GEB members during the respective years.
11 For 2021, Barbara Levi received a
one-time
replacement award of
CHF 7,081,474. This
replacement award is
not included in the
above table; including
this, the 2021
total aggregate compensation
of all GEB members
is CHF 114,928,515.
For 2020,
Ralph
A.J.G. Hamers received a
one-time replacement award of CHF
163,399. This replacement award
is not included in the above
table; including this, the 2020
total aggregate compensation of all GEB
members is CHF
116,027,534.
12 Base salary may include role-based allowances in line with market practice
in response to regulatory requirements.
p
Advisory vote
Corporate governance and compensation | Compensation
250
Total realized compensation for the Group CEO
The realized
compensation reflects
the total
amount paid
out in
the
year.
It
includes
the
base
salary,
cash
performance
award
payments,
and
all
deferred
performance
awards
vested
in
the
year.
As such,
realized pay
is the
natural culmination
of awards
granted and approved by shareholders in previous years.
To
illustrate
the
effect
of
our
long-term
deferral
approach,
which
has
been
in
place
since
2012,
we
disclose
the
annual
realized
compensation
of
Mr.
Hamers,
including
a
comparison
with his total awarded compensation.
Total
realized compensation vs awarded compensation for Ralph A.J.G Hamers¹
CHF
Realized
Awarded
For the year
Base salary
Cash award
2
Deferred cash
award
2
Performance
award under
equity plans
2
Performance
award under
DCCP
2
Total realized
fixed and variable
compensation
Total awarded
fixed and variable
compensation
3,4
2021
2,500,000
600,000
0
0
0
3,100,000
11,000,000
2020
1
833,333
0
0
0
0
833,333
3,833,333
1 Includes compensation for 4 months as Ralph A.J.G. Hamers joined UBS on
1 September 2020.
2 Excludes dividend / interest payments.
3 Excludes contributions to retirement benefit plans and benefits. Includes
social security contributions paid by Ralph A.J.G. Hamers but excludes the portion related to
the legally required social security contributions paid by UBS.
4 Excludes the one-time replacement award.
251
Group compensation
Compensation elements for all employees
A
ll
elements
of
pay
are
considered
when
making
our
compensation decisions.
We
regularly
review our
principles and
compensation
framework
in
order
to
remain
competitive
and
aligned with stakeholders.
In 2021, we
made no material
changes
to
our
overall
framew
ork.
We
will
continue
to
review
our
approach to salaries
and performance
awards,
considering market
developments, our
performance and
our commitment
to deliver
sustainable returns to shareholders.
Base salary and role-based allowance
Employees’
fixed
compensation
(e.g.,
base
salary)
reflects
their
level of skill, role and experience, as well as local market practice.
Base salaries
are usually
paid monthly
or fortnightly,
in line
with
local
market
practice.
We
offer
competitive
base
salaries
that
reflect
location,
function
and
role.
Salary
increases
generally
consider
promotions,
skill
set,
performance
and
overall
responsibility.
In addition
to base salary,
and as
part of
fixed compensation,
some
employees
may
receive
a
role-based
allowance.
This
allowance is
a shift
in the
compensation mix
between fixed
and
variable compensation,
not an increase
in total
compensation. It
reflects
the
market
value
of
a
specific
role
and
is
fixed,
non-
forfeitable compensation. Unlike salary, a role-based allowance is
paid only
if the employee
is in a
specific role. Similar
to previous
years,
2021
role-based
allowances
consisted
of
a
cash
portion
and, where applicable, a blocked UBS share award.
Pensions and benefits
We
offer
certain
benefits
for
all
employees,
such
as
health
insurance and
retirement benefits.
These vary
depending on
the
employee’s
location
and
are
reviewed
periodically
for
competitiveness.
Pension
contributions
and
pension
plans
also
vary in
accordance with
local requirements
and market
practice.
However, pension plan rules in any one location are generally the
same for all employees, including management.
GEB members’
pension contributions
and benefits
are in
line
with local practices
for other employees.
There are no
enhanced
or supplementary pension contributions for the GEB.
Performance award
Most
of
our
employees
are
eligible
for
an
annual
performance
award
.
The
level
of
this
award,
where
applicable,
generally
depends
on
the
firm’s
overall
performance,
the
employee’s
business division, team
and individual performance,
and behavior,
reflecting
their
overall
contribution
to
the
firm’s
results.
These
awards
are
in
line
with
applicable
local
employment
conditions
and at the discretion of the firm.
In addition to the firm’s Pillars
and Principles, Behaviors related
to accountability
with integrity,
collaboration and
innovation are
part of the
performance management approach.
Therefore, when
assessing performance, we consider
not only what was
achieved
but also how it was achieved.
Advisory vote
Corporate governance and compensation | Compensation
252
Our deferred compensation plans
To
reinforce
our
emphasis
on sustainable
performance and
risk
management,
and our focus on
achieving growth ambitions,
we
deliver
part
of
our
employees’
annual
variable
compensation
through
deferred
compensation
plans
.
We
believe
that
our
approach,
with
a
single
incentive
decision
and
a
mandatory
deferral
,
is
transparent
and
well
suited
to
implementing
our
compensation
philosophy
and
delivering
sustainable
performance.
This
aligns
the
interests
of
our
employees
and
shareholders and
appropriately links compensation
to longer-term
sustainable performance.
Our mandatory deferral
approach applies to
all employees with
regulatory
-
driven
deferral
requirements
or
total
compensation
greater
than USD
/
CHF 300,000. Certain
regulated employees,
such as
Senior Management
Functions
(SMFs) and
Material Risk
Takers
(MRTs),
are
subject
to
additional
requirements
(e.g.,
an
additional
non-financial
conduct-related
performance
metric
under
the
LTIP,
more
stringent deferral
requirements,
additional
blocking
periods).
In
addition,
SMFs
and
MRTs
receive
50%
of
their cash portion
in the form
of immediately vested
shares, which
are blocked for 12 months after grant.
The deferred amount increases at higher marginal rates in line
with the
value of
the performance
award. The
effective deferral
rate therefore depends on the amount
of the performance award
and the amount of total compensation.
We believe our deferral regime has
one of the longest vesting
periods in the industry. The weighted average deferral period (for
non-regulated
employees)
is
4.4
years
for
GEB
members
and
ranges
from
3.5
to
4
years
for
employees
below
GEB
level
.
Additionally, from
time to
time, we
may utilize
alternative deferred
compensation
arrangements
to
remain
competitive
in
specific
business areas.
To
further
promote
sustainable
performance,
all
of
our
deferred compensation plans include employment
conditions and
malus conditions. These
enable the firm to
reduce or fully forfeit
unvested deferred awards
under certain circumstances, pursuant
to performance
and harmful
acts provisions.
In addition,
forfeiture
is triggered in cases
where employment has been
terminated for
cause.
Our share delivery obligations related to notional
share awards
are satisfied by delivering treasury shares, which are purchased in
the market, to employees at vesting.
›
Refer to “Note 28 Employee benefits: variable
compensation” in
the “Consolidated financial statements”
section of our Annual
Report 2021
for more information
›
Refer to the “Supplemental information”
section of this report
for more information about MRTs and SMFs
Variable compensation elements by employee category
253
Long-Term Incentive Plan
The
LTIP
is
a
mandatory
deferral
plan
for
senior
leaders
of
the
Group (i.e., GEB members and selected senior management). For
the
2021
performance
year,
we
granted
LTIP
awards
to
117
employees at a
fair value of
67.7% of maximum.
The value was
calculated by an independent third party using a well-established
valuation methodology.
The
performance
metrics of
the share-based
LTIP awards
are
average
return
on
CET1
capital
(RoCET1)
and
relative
total
shareholder
return
(rTSR)
over
a
three-year
performance
period
starting on 1 January in the year of grant. Performance outcomes
and
actual
payout
levels
will
be
disclosed
at
the
end
of
the
performance period.
The
three-year
average
RoCET1
performance
metric
reflects
our strategic return ambitions and
considers our revised financial
targets,
as well as our cost of capital as outlined below:
–
the required RoCET1
performance for a
maximum payout is
set
at 18%, which represents the upper end of our target range;
–
the required performance
threshold for the
minimum payout
has been raised to 8%
from 6% in prior-year
awards to reflect
our
new
financial
targets
communicated
in
February
2022,
increasing
the
mid-point
of
the
payout
thresholds
to
better
reflect our cost of capital; and
–
the
linear
payout
design
between
threshold
and
maximum
level
supports
our
growth
ambitions
and
our
focus
on
delivering
sustainable
performance
without
encour
ag
ing
excessive risk-taking.
The rTSR
performance metric
over the
three-year period
further
aligns the interests of employees with those of shareholders:
–
the metric
compares the total
shareholder return
(the TSR) of
UBS
with
the
TSR
of
an
index
consisting
of
listed
Global
Systemically
Important
Banks
(G-SIBs)
as
determined
by
the
Financial Stability Board (excluding UBS Group);
–
the
G-SIBs
are
independently
defined
and
reflect
companies
with
a
comparable
risk
profile
and
impact
on
the
global
economy;
–
the
index,
which
includes
publicly
traded
G-SIBs,
is
equal
weighted,
calculated
in
Swiss
francs
and
maintained
by
an
independent index
provider,
so as to
ensure independence
of
the TSR calculation; and
–
the payout interval of
±25 percentage points versus the
index
performance
demonstrates
our
ambition
of
delivering
attractive
relative
returns
to
shareholders.
The
linear
payout
and
the threshold
level
set below
index performance
further
support sustainability of results and prudent risk-taking.
Global Systemically Important Banks (G-SIBs) that are listed companies
1
Agricultural Bank of China
Goldman Sachs
Santander
Bank of America
Groupe Crédit Agricole
Société Générale
Bank of China
HSBC
Standard Chartered
Bank of New York Mellon
ING Bank
State Street
Barclays
ICBC
Sumitomo Mitsui FG
BNP Paribas
JPMorgan Chase
Toronto-Dominion
China Construction Bank
Mitsubishi UFJ FG
UniCredit
Citigroup
Mizuho FG
Wells Fargo
Credit Suisse
Morgan Stanley
Deutsche Bank
Royal Bank of Canada
1
As of November 2021. Excludes UBS Group.
Dividend
equivalents
(granted
where
applicable
regulation
permits)
are
subject
to
the
same
terms
as
the
underlying
LTIP
award.
LTIP award
s
reflect the
long-term focus
of our
compensation
framework. The final number of shares as determined at
the end
of
the
three-year
performance
period
will
vest
in
three
equal
installments in each of the three years following the performance
period for GEB members,
and cliff vest in
the first year following
the performance period
for selected senior
management (longer
deferral periods may apply for regulated employees).
LTIP payout illustration
–
The final number of notional
shares vesting will vary based on
the achievement versus the
performance metrics.
–
Linear payout between threshold
and maximum performance.
–
Vesting levels are a percentage of
the maximum opportunity of the
LTIP and cannot exceed 100%.
–
Full forfeiture for performance
below the predefined threshold
levels.
–
SMFs and UK MRTs are subject to
an additional non-financial metric
based on a conduct assessment
with a potential downward
adjustment of up to 100% of the
entire award.
Performance metric:
average RoCET1 (50% of award)
Below threshold (<8%)
Threshold (8%) up to
maximum (<18%)
Maximum and above (>18%)
Full forfeiture
(payout 0%)
Partial vest
(payout between 33% and <100%)
Full vest
(payout 100%)
Performance metric:
rTSR vs G-SIBs index (50% of award)
Below threshold (<–25 pps)
Threshold (–25 pps) up to
maximum (+25 pps)
Maximum and above (>+25 pps)
Full forfeiture
(payout 0%)
Partial vest
(payout between 33% and <100%)
Full vest
(payout 100%)
Advisory vote
Corporate governance and compensation | Compensation
254
Equity Ownership Plan
The EOP
is the
deferred
compensation plan
for employees
who
are
subject
to
deferral
requirements
but
do
not
receive
LTIP
awards. For the 2021 performance year,
we granted EOP awards
to 4,228 employees.
Delivering sustainable performance
is a key objective
for UBS,
and
we
therefore
link
EOP
award
vesting
with
minimum
performance thresholds over
a multi-year time
horizon. Our EOP
creates a direct link with
shareholder returns as a notional equity
award
and
have
no
upward
leverage.
This
approach
promotes
growth and sustainable performance.
EOP
awards
generally
vest
over
three
years.
For
certain
employee populations, EOP awards
can be adjusted downwards,
including
to
zero,
based
on
the
average
RoCET1
over
the
applicable
performance
period.
The
Compensation
Committee
sets the
minimum future
performance threshold and
may adjust
the
award
if
the
performance
metric
does
not
reflect
a
fair
measure of performance.
Asset Management employees receive some or all of
their EOP
in the
form of
notional funds
to align
their compensation
more
closely with industry standards.
This plan is generally
delivered in
cash and vests over five years.
›
Refer to “Vesting of outstanding awards granted in prior
years
subject to performance conditions” in
the “Supplemental
information” section of this report for more information
Deferred Contingent Capital Plan
The DCCP
is a
key component
of our
compensation framework
and supports alignment
of the interests
of our senior
employees
with those of our stakeholders.
All employees
subject to
deferral requirements
receive
DCCP
awards.
For the
2021 performance
year, we
granted DCCP
awards
to 4,303 employees.
DCCP
replicates
many
of
the
features
of
the
loss-absorbing
bonds that
we issue
to investors
and may
be paid
at
vesting in
cash
or,
at
the
discretion
of
the
firm,
a
perpetual,
marketable
additional tier 1 (AT1)
capital instrument. Employees can
elect to
have
their
DCCP
awards
denominated
in
Swiss
francs
or
US
dollars.
DCCP
awards
vest
in
full
after
five
years
(longer
deferral
periods may
apply for
regulated employees).
DCCP awards
bear
notional interest paid annually (except as
limited by regulation for
MRTs), subject
to review and
confirmation by the
Compensation
Committee.
The
notional
interest
rate
for
grants
in
2022
was
3.7%
for
awards
denominated
in
Swiss
francs
and
5.7%
for
awards denominated in US dollars. These interest rates are based
on
the
current
market
rates
for
similar
AT1
capital
instruments
issued by UBS Group.
Awards are
forfeited if
a viability
event occurs,
i.e., if
FINMA
notifies the firm that the
DCCP awards must be written down
to
mitigate the risk of an insolvency, bankruptcy or failure of UBS or
if the
firm receives a
commitment of extraordinary
support from
the public sector that
is necessary to
prevent such an
event. DCCP
awards
are
also
written down
for
GEB
members
if
the
Group’s
CET1 capital ratio falls below 10%
and for all other employees if
it falls below 7%.
In
addition,
GEB
members
forfeit
20%
of
DCCP
awards
for
each
loss-making
year
during
the
vesting
period.
This
means
100% of the
award is subject
to risk of
forfeiture. The forfeiture
features of DCCP create
a strong alignment with
our debt holders
and support the sustainability of the firm.
Over the last
five years, USD 1.7
billion of DCCP
awards have
been
issued,
contributing
to
the
Group’s
total
loss-absorbing
capacity
(TLAC).
Therefore
,
DCCP
awards
not
only
support
competitive
pay
but
also
provide
a
loss
absorption
buffer
that
protects the firm’s capital position.
The following table illustrates
the contribution of the DCCP
to our AT1 capital
and the effect on
our TLAC ratio.
›
Refer to the “Supplemental information”
section of this report
for more information about performance award and
personnel-
related expenses
›
Refer to the “Supplemental information”
section of this report
for more information about longer vesting
and clawback periods
for MRTs and SMFs
Contribution of the Deferred Contingent Capital Plan to our loss-absorbing capacity
1
USD million, except where indicated
31.12.21
31.12.20
Deferred Contingent Capital Plan (DCCP), eligible
as high-trigger loss-absorbing additional
tier 1 capital
1,730
1,875
DCCP contribution to the total loss-absorbing capacity
ratio (%)
0.6
0.6
1 Refer to “Bondholder information” at ubs.com/investors for more information about the capital instruments of UBS Group
AG and UBS AG both on a consolidated and a standalone basis.
255
Replacement awards and forfeitures
In line
with industry
practice, our
compensation framework
and
plans include provisions
generally requiring reduction
/ forfeiture
of
a
terminated
employee’s
unvested
or
deferred
awards.
In
particular, these provisions apply if the terminated employee
joins
another financial services organization and / or violates restrictive
covenants, such as solicitation of clients or employees.
Conversely, to
support talent
acquisition, and
consistent with
industry
practice,
we
may
offer
replacement
awards
to
attract
senior
candidates
by
offse
t
t
ing
deferred
compensation
being
forfeited
at
their
previous
employer
as
a
result
of
joining
UBS.
When
making
such
awards
,
we
aim
to
match
the
pre
vious
employer’s
terms and
conditions for
the awards
to be
forfeited
upon joining
UBS. The total
2021 forfeitures
of USD 258 million
of
previously
awarded
deferred
compensation
offset
the
2021
total sign-on payments,
replacement payments and
guarantees of
USD 137 million.
Barbara
Levi
succeeded
Markus
Diethelm
as
Group
General
Counsel effective 1 November 2021.
Consistent with the
terms of
the original
awards and
included in
the above
figures, she
received
replacement
awards
for
compensation
forfeited at
her
previous
employer
as
a
result
of
joining
UBS.
Ms.
Levi’s
replacement
payment had a total value of CHF 7,081,474 and consisted of an
EOP share award representing 430,732 UBS shares (denominated
in Swiss francs), a deferred
cash award as well as replacement of
cash items. The deferred portion of the award will vest
in various
installments between 2022 and 2027. These replacement awards
are subject to UBS’s harmful acts provisions.
Other variable compensation components
To
support hiring
and retention,
particularly at
senior levels,
we
may offer other compensation components,
such as:
–
retention payments
to key employees
to induce them
to stay,
particularly during critical periods for
the firm, such as
a sale or
wind-down of a business;
–
on
a
limited
basis,
guarantees
may
be
required
to
attract
individuals with certain
skills and
experience –
these awards
are
fixed
incentives
subject
to
our
standard
deferral
rules
and
limited to the first full year of employment;
–
award
grants
to
employees
hired
late
in
the
year
to
replace
performance
awards
that
they
would
have
earned
at
their
previous employers, but have foregone by joining UBS – these
awards are generally structured with the same level of deferral
as for employees at a similar level at UBS; and
–
in
exceptional
cases,
candidates
may
be
offered
a
sign-on
award to increase the chances of them accepting our offer.
These other variable compensation components are subject to
a
comprehensive
governance
process,
which
may
involve
the
Compensation Committee, depending on
the amount or type of
such payments.
Below-GEB
level
employees
who
are
made
redundant
may
receive severance
payments. Our
severance terms
comply with
the
applicable
local
laws
(legally
obligated
severance).
In
certain
locations, we
may provide
severance packages
that are
negotiated
with our local
social partners and
may go beyond
the applicable
minimum
legal
requirements
(standard
severance).
Such
payments are governed by location
-specific severance policies. In
addition, we
may make
severance payments
that exceed
legally
obligated or
standard severance
payments where
we believe
these
are
aligned
with
market
practice
and
appropriate
under
the
circumstances
(supplemental
severance).
GEB
members
do
not
receive severance payments.
Sign-on payments, replacement payments, guarantees and severance payments
Total 2021
of which: non-deferred
cash
of which: deferred
compensation
awards
Total 2020
Number of beneficiaries
USD million, except where indicated
2021
2020
Total sign-on payments
1
26
18
8
20
226
99
of which: Key Risk Takers
2
9
4
5
2
6
3
Total replacement payments
3
94
11
83
58
310
200
of which: Key Risk Takers
2
34
5
29
17
12
13
Total guarantees
3
17
11
6
16
40
32
of which: Key Risk Takers
2
2
1
1
5
1
2
Total severance payments
1,4
160
200
5
0
134
1,477
1,019
of which: Key Risk Takers
2
3
0
0
0
10
0
1 GEB members are not eligible for sign-on or severance payments.
2 Expenses for Key Risk Takers are full-year
amounts for individuals in office on 31 December 2021. Key Risk Takers
as defined by UBS, including
all employees with a total compensation
exceeding USD / CHF 2.5 million
(Highly Paid Employees).
3 Includes replacement payments for one
GEB member in 2021 and for
another GEB member in 2020.
No GEB
member received a guarantee
in 2021 or
2020.
4 Includes legally obligated
and standard severance
payments as well as
payments in lieu
of notice.
5 Represents expense recognized
in 2021 associated
with
payments made in 2021 as well as provisions for expected payments in 2022.
Forfeitures
1
Total 2021
Total 2020
USD million, except where indicated
Total forfeitures
258
145
of which: former GEB members
23
0
of which: Key Risk Takers
2
8
6
1 For notional share awards,
forfeitures are calculated as units forfeited
during the year,
valued at the share price on
31 December 2021 (USD 17.87)
for 2021. The 2020 data
is valued using the share
price on 31
December 2020 (USD 14.13). For LTIP
the forfeited units reflect the fair value awarded at grant.
For the notional funds awarded to
Asset Management employees under the EOP,
this represents the forfeiture credits
recognized in 2021 and 2020. For the DCCP, the fair value at grant of the forfeited awards during the year is reflected. Numbers presented may differ from the effect on the income statement in accordance with IFRS.
2 Key Risk Takers as defined by UBS,
including all employees with a total compensation exceeding USD / CHF 2.5 million (Highly Paid Employees) and excluding former GEB members who forfeited awards in 2021 or
2020.
Advisory vote
Corporate governance and compensation | Compensation
256
Benchmarking for employees other than GEB members
We
generally consider
market practice
in our
pay decisions
and
framework. Our
market review
reflects several
factors, including
the comparability of the
business division, location, scope
and the
diversity of our
businesses. For certain
businesses or roles, we
may
consider practices at other major international banks, other large
Swiss private
banks, private
equity firms,
hedge funds
and non-
financial
firms.
W
e
also
internally
benchmark
employee
compensation
for
comparable
roles
within
and
across
business
divisions and locations.
Employee share ownership
According
to
available
records
on
employee
shareholdings,
including
unvested
deferred
compensation,
as
of
31 December
2021, employees
held at
least USD 4.5
billion of
UBS shares
(of
which approximately USD 2.9
billion were
unvested), representing
approximately 7% of our total shares issued.
The Equity Plus Plan is our
employee share purchase program.
It
allows
employees
at
Executive
Director
level
and
below
to
voluntarily invest up
to 30% of
their base salary
and / or
regular
commission payments to purchase UBS shares.
In addition (where
offered),
eligible
employee
s
can
invest
up
to
35%
of
their
performance
award
under
the
program.
Participation
in
the
program
is
capped
at
USD
/
CHF 20,000
annually.
Eligible
employees may purchase
UBS shares at market
price and receive
one additional share
for every three
shares purchased through
the
program. Additional shares
vest after a maximum
of three years,
provided
the
employee
remains
employed
by
UBS
and
has
retained the purchased shares throughout the holding period.
›
Refer to “Note 28 Employee benefits: variable
compensation” in
the “Consolidated financial statements”
section of our Annual
Report 2021
for more
information
Compensation for US financial advisors in Global Wealth
Management
In
line
with
market
practice
for
US
wealth
management
businesses, the
compensation for
US financial advisors
in Global
Wealth Management
predominantly includes
production payout
and
deferred
compensation
awards.
Production
payout,
paid
monthly,
is
primarily
based
on
compensable
revenue.
Financial
advisors
may
also
qualify
for
deferred
compensation
awards,
which
generally
vest
over
a
six-year
period.
These
awards
are
based on
strategic performance
measures, including
production
and
length
of
service
with
UBS.
Production
payout
rates
and
deferred compensation awards may be reduced for, among other
things,
errors,
negligence
or
carelessness,
or
failure
to
comply
with the
firm’s rules, standards,
practices and /
or policies, and
/
or applicable laws and regulations.
257
2021 Group performance outcomes
Performance
awards granted
for the 2021
performance
year
The “Variable
compensation” table below
shows the amount
of
variable
compensation
awarded
to
employees
for
the
2021
performance year, together with the number of beneficiaries for
each type of
award granted. In
the case of
deferred awards,
the
final
amount
paid
to
an
employee
depends
on
performance
conditions and consideration
of relevant forfeiture provisions. The
deferred
share
award
amount
is
based
on
the
market
value
of
these awards on the date of grant.
Variable compensation
1
Expenses recognized
in the IFRS income
statement
Expenses deferred to
future periods
4
Accounting
adjustments
4
Total
Number of beneficiaries
USD million, except where indicated
2021
2020
2021
2020
2021
2020
2021
2020
2021
2020
Non-deferred cash
2,383
2,167
0
0
0
0
2,383
2,167
57,783
58,843
Deferred compensation awards
405
341
797
756
65
51
1,267
1,148
4,202
3,937
of which: Equity Ownership Plan
183
137
393
306
46
5
35
5
623
478
3,807
3,566
of which: Deferred Contingent Capital Plan
140
112
299
280
0
0
438
392
4,170
3,910
of which: Long-Term Incentive Plan
54
42
50
50
18
5
16
5
122
109
117
115
of which: Asset Management EOP
29
49
56
120
0
0
84
169
374
335
Variable compensation – performance award pool
2,788
2,508
797
756
65
51
3,650
3,315
57,793
58,850
Variable compensation – other
2
191
126
215
181
(121)
6
(74)
6
285
233
Total variable compensation excluding financial advisor
variable compensation
2,979
2,634
1,012
938
(56)
(23)
3,935
3,548
Financial advisor (FA) variable compensation
3
4,175
3,378
1,097
822
0
0
5,272
4,200
6,218
6,305
Total variable compensation including FA variable
compensation
7,155
6,012
2,109
1,760
(56)
(23)
9,207
7,749
1 Expenses under “Variable compensation – other” and “Financial advisor variable
compensation” are not part of UBS’s performance award pool.
2 Consists of replacement payments, forfeiture credits,
severance
payments, retention plan payments and interest
expense related to the Deferred
Contingent Capital Plan.
3 Financial advisor compensation consists
of formulaic compensation based directly on
compensable revenues
generated by
financial advisors
and supplemental
compensation calculated
based on financial
advisor productivity,
firm tenure,
new assets and
other variables.
It also includes
expenses related
to compensation
commitments with financial advisors entered into at the time of recruitment
that are subject to vesting requirements.
4 Estimates as of 31 December 2021 and 2020. Actual amounts
to be expensed in future periods
may vary, e.g., due to forfeiture of awards.
5 Represents estimated post-vesting transfer restriction and permanent forfeiture discounts.
6 Included in expenses deferred to future periods is an amount of USD 121
million (2020: USD 74 million) in interest expense related to the Deferred Contingent Capital Plan. As the amount recognized as performance award represents the present value of the award
at the date it is granted
to the employee, this amount is excluded.
2021
performance award pool and expenses
The performance award pool, which includes performance-based
variable
awards
for
2021,
was
USD 3.7
billion,
reflecting
an
increase
of
10%
compared
with
2020.
Performance
award
expenses
for
2021
decreased
1%
to
USD 3.2
billion,
reflecting
increased
performance
award
expenses
accrued
in
the
performance
year,
offset
by
lower
expenses
related
to
prior
performance
years,
as
2020
included
additional
expenses
that
resulted from modifying
the terms
of certain
outstanding deferred
compensation
awards.
The
“Performance
award
pool
and
expenses”
table
below
compares
the
performance
award
pool
with performance award expenses.
Performance award pool and expenses
USD million, except where indicated
2021
2020
% change
Performance award pool
1
3,650
3,315
10
of which: expenses deferred to future periods and accounting
adjustments
2,3
862
807
7
Performance award expenses accrued in the performance year
2,788
2,508
11
Performance award expenses related to prior performance years
402
701
(43)
Total performance award expenses recognized for the year
4
3,190
3,209
(1)
1 Excluding employer-paid
taxes and social
security.
2 Estimate as
of the end
of the performance
year.
Actual amounts expensed
in future
periods may
vary, e.g.,
due to forfeiture
of awards.
3 Accounting
adjustments represent estimated
post-vesting transfer
restriction and permanent
forfeiture discounts.
4 Refer to
“Note 28 Employee benefits:
variable compensation” in
the “Consolidated financial
statements”
section of our Annual Report 2021 for more information
Advisory vote
Corporate governance and compensation | Compensation
258
Compensation for the Board of Directors
Chairman of the BoD
Under the
leadership of
the Chairman,
Axel A.
Weber,
the BoD
determines,
among
other
things,
the
strategy
for
the
Group,
based on recommendations by
the Group CEO, exercises ultimate
supervision over management and appoints all GEB members.
The
Chairman
leads
all
general
meetings
and
BoD
meetings
and works
with the
committee chairpersons
to coordinate
their
work. Together with the Group CEO, the Chairman is responsible
for effective communication with shareholders and
stakeholders,
including
clients,
government
officials,
regulators
and
public
organizations. The
Chairman works
closely with
the Group
CEO
and
other
GEB
members,
providing
advice
and
support
when
appropriate
,
and
continues
to
strengthen
and
promote
our
culture
through
the
three
keys
to
success:
our
Pillars,
Principles
and Behaviors.
The Chairman’s total compensation
for the period from
AGM
to
AGM is
contractually
fixed without
any
variable
component.
For the current period from the
2021
AGM to the 2022 AGM,
his
total compensation
was CHF 4.9
million, excluding
benefits and
pension fund
contributions. The
Chairman’s total
compensation
for
the
current
period
consisted
of
a
cash
payment
of
CHF 3.5
million and
a share
component of
CHF 1.4 million
consisting of
72,939
UBS
shares
at
CHF
19.19
4
per
share.
The
share
component aligns the
Chairman’s pay with
the Group’s
long-term
performance.
Thus, Mr. Weber’s
total reward, including
benefits and pension
fund
contributions,
for
his
service
as
Chairman
for
the
current
period,
was CHF 5,224,913.
The Chairman’s employment
agreement does not
provide for
severance terms or
supplementary contributions to
pension plans.
The benefits
for the Chairman
are in line
with local practices
for
UBS
employees.
The
Chair
person
of
the
Compensation
Committee proposes and
the Compensation
Committee approves
the Chairman’s
compensation annually
for the
upcoming AGM-
to-AGM
period,
taking
into
consideration
fee
or
compensation
levels
for comparable
roles
based on
our core
financial industry
peers and other relevant leading Swiss companies included in the
Swiss Market Index.
›
Refer to “Board of Directors” in the “Corporate
governance”
section of our Annual Report 2021
for more information about
the responsibilities of the Chairman
Audited |
Compensation details and additional information for non-independent BoD members
CHF, except where indicated
USD
(for reference)
Name, function
1
For the period
AGM to AGM
Base salary
Annual share
award
2
Contributions
to retirement
plans and
benefits
3
Total
4
Total
4,5
Axel A. Weber, Chairman
2021/2022
3,500,000
1,400,000
324,913
5,224,913
5,708,482
2020/2021
3,500,000
1,400,000
343,283
5,243,283
1 Axel A.
Weber was the
only non-independent member
in office on
31 December 2021
and 31 December 2020.
2 These shares
are blocked for
four years.
3 Includes the
estimated portion related
to UBS’s
contribution to the statutory pension scheme and
estimated benefits valued at market
price, as applicable.
For the period from
the 2020 AGM to the 2021
AGM, the actual amount was CHF
336,050.
4 Excludes
the portion related to the legally required social security contributions paid by UBS, which for the period from the 2021 AGM to the 2022 AGM is estimated at CHF 336,428 and for the period from the 2020 AGM
to
the 2021 AGM at CHF 332,243. The legally required social security contributions paid by the non-independent BoD members are included in the amounts shown in this table, as appropriate.
5 Swiss franc amounts
have been translated into US dollars for reference at the 2021 performance award currency exchange rate
of CHF / USD 1.092551.
p
259
Independent BoD members
As
outlined
in
the
table
below,
all
BoD
members,
except
the
Chairman,
are
deemed
independent
and
receive
fixed
fees
for
their services
on the
BoD and
its committees.
Independent BoD
members
do
not
receive
performance
awards,
severance
payments,
benefits or pension contributions.
In the current period, the roles of Senior Independent Director
and Vice
Chairman are
both held
by one
BoD member,
but the
additional fee is only paid once. Independent BoD members
must
use
a
minimum
of
50%
of
their
fees
to
purchase
UBS
shares,
which are blocked for four years, and they may elect to use up to
100% of
their fees to
purchase blocked UBS
shares. In all
cases,
the number of
shares is calculated
based on the
average closing
price of the 10 trading
days leading up to and
including the grant
date.
At
each
AGM,
shareholders
are
invited
to
approve
the
aggregate amount of BoD
remuneration, including compensation
for the
Chairman, which
applies until
the next
AGM. The
tables
below
and
on
the
following
page
provide
details
on
the
fee
structure for the independent BoD members.
The
fee structure
for independent
BoD
members is
reviewed
annually based on the Chairman’s proposal to the Compensation
Committee,
which
in
turn
submits
a
proposal
to
the
BoD
for
approval.
In
our
regular
review
of
the
BoD
fee
structure,
we
concluded
that
our
overall
approach
for
independent
BoD
member compensation remains
appropriate and thus
unchanged.
Remuneration framework for independent BoD members
Advisory vote
Corporate governance and compensation | Compensation
260
Audited |
Total
payments to BoD members
CHF, except where indicated
USD (for reference)
For the period AGM to AGM
Total
1
Total
1,2
Aggregate of all BoD members
2021/2022
12,124,913
13,247,082
2020/2021
11,843,283
1 Includes social security contributions paid by the BoD members but excludes the portion related to the legally required
social security contributions paid by UBS, which for the period from the 2021 AGM to the 2022
AGM is
estimated at grant
at CHF
739,615 and
for the
period from the
2020 AGM
to the 2021
AGM at
CHF 719,763.
2 Swiss franc
amounts have
been translated
into US dollars
for reference
at the
2021
performance award currency exchange rate of CHF / USD 1.092551
p
Audited |
Remuneration details and additional information for independent BoD members
CHF, except where indicated
Name, function
1
Audit Committee
Compensation
Committee
Corporate Culture and
Responsibility
Committee
Governance and
Nominating Committee
Risk Committee
For the period
AGM to AGM
Base fee
Committee
fee(s)
Additional
payments
2
Total
3
Share
percentage
4
Number of
shares
5,6
Jeremy Anderson,
Vice Chairman and Senior
Independent Director
C
M
2021/2022
300,000
400,000
150,000
850,000
50
22,142
C
M
2020/2021
300,000
400,000
150,000
850,000
50
30,774
Claudia Böckstiegel, member
2021/2022
300,000
0
300,000
50
7,814
2020/2021
-
-
-
-
William C. Dudley, member
M
M
M
2021/2022
300,000
350,000
650,000
50
16,932
M
M
M
2020/2021
300,000
350,000
650,000
50
23,533
Patrick Firmenich, member
M
M
2021/2022
300,000
250,000
550,000
100
27,275
2020/2021
-
-
-
-
Reto Francioni, member
M
M
2021/2022
300,000
300,000
600,000
50
15,629
M
M
2020/2021
300,000
300,000
600,000
50
21,723
Fred Hu, member
M
M
2021/2022
300,000
300,000
600,000
100
23,062
M
M
2020/2021
300,000
300,000
600,000
100
32,053
Mark Hughes, member
M
C
2021/2022
300,000
400,000
700,000
50
18,234
M
C
2020/2021
300,000
400,000
700,000
50
25,343
Nathalie Rachou, member
M
2021/2022
300,000
200,000
500,000
50
13,024
M
2020/2021
300,000
200,000
500,000
50
18,102
Julie G. Richardson, member
C
M
M
2021/2022
300,000
500,000
800,000
50
20,839
C
M
M
2020/2021
300,000
500,000
800,000
50
28,964
Beatrice Weder di Mauro,
former member
2021/2022
-
-
-
-
M
M
2020/2021
300,000
250,000
550,000
50
19,913
Dieter Wemmer, member
M
M
M
2021/2022
300,000
400,000
700,000
50
18,234
M
M
M
2020/2021
300,000
400,000
700,000
50
25,343
Jeanette Wong, member
M
M
M
2021/2022
300,000
350,000
650,000
100
24,988
M
M
M
2020/2021
300,000
350,000
650,000
100
34,730
Total 2021/2022
6,900,000
Total 2021/2022 in USD
(for reference)
7
7,538,600
Total 2020/2021
6,600,000
Legend: C = Chairperson of the respective Committee, M = Member of the respective Committee
1 Eleven independent BoD members were in office on 31 December 2021. At the 2021 AGM, Claudia Böckstiegel and Patrick Firmenich were newly elected and Beatrice Weder di Mauro did not stand for re-election.
Ten independent BoD members were in
office on 31 December 2020.
2 These payments are associated with the Vice
Chairman and the Senior Independent Director function.
3 Excludes UBS’s portion related to
the legally required social security contributions, which for the period from the 2021 AGM to the 2022 AGM is estimated at grant at CHF 403,187 and which for the period from the 2020 AGM to the 2021 AGM was
estimated at grant at CHF 387,520. The legally required social security contributions paid by the independent
BoD members are included in the amounts shown in this table, as appropriate.
4 Fees are paid 50% in
cash and 50% in blocked UBS shares. However, independent BoD members may elect to have 100% of their remuneration paid in blocked UBS shares.
5
For 2021, UBS shares were valued at CHF 19.194 (average
closing price of UBS shares over the
last 10 trading days leading
up to and including the grant
date). For 2020, UBS
shares, valued at
CHF 13.810 (average closing price of
UBS shares over the last 10
trading days
leading up to and including the grant date). These shares are blocked for four years.
6 Number of shares is reduced in case of the 100% election to deduct legally required contributions. All remuneration payments
are, where applicable, subject to
social security contributions and / or withholding tax.
7 Swiss franc amounts have been translated
into US dollars for reference at the 2021
performance award currency exchange
rate of CHF / USD 1.092551.
p
261
Supplemental information
Fixed and variable compensation for GEB members
Fixed and variable compensation for GEB members
1,2,3
Total for 2021
Not deferred
Deferred
4
Total for 2020
CHF million, except where indicated
Amount
%
Amount
%
Amount
%
Amount
Total compensation
Amount
5
105
100
41
39
64
61
112
Number of beneficiaries
15
16
Fixed compensation
5,6
25
24
25
100
0
0
27
Cash-based
22
21
22
0
24
Equity-based
3
3
3
0
4
Variable compensation
80
76
16
20
64
80
85
Cash
7
16
15
16
0
17
Long-Term Incentive Plan (LTIP)
8
40
38
0
40
43
Deferred Contingent Capital Plan (DCCP)
8
24
23
0
24
26
1 The figures include all GEB members in office during
the respective years.
2 Includes compensation paid under the employment contract
during the notice period for GEB members who stepped down
during the
respective years.
3 Includes compensation for
newly appointed GEB members
for their time in
office as a GEB
member during the respective
years.
4 Based on the
specific plan vesting and
reflecting the total
award value at grant, which may
differ from the expense recognized in the income
statement in accordance with IFRS.
5 Excludes benefits and employer’s
contributions to retirement benefit plans.
Includes social
security contributions paid by GEB members but excludes the portion related to the legally required
social security contributions paid by UBS. For
2021, Barbara Levi received a one-time replacement award
of CHF 7
million. This replacement award is not included in the above table;
including this, the 2021 total aggregate compensation of all GEB members
is CHF 112 million. For 2020, Ralph A.J.G.
Hamers received a one-time
replacement award of CHF
0.2 million. This replacement
award is not included
in the above table;
including this, the 2020
total aggregate compensation of
all GEB members is CHF
113 million.
6 Includes base
salary and role-based allowances, rounded
to the nearest million.
7 Includes allocation of vested but blocked
shares, in line with the remuneration
section of the UK Prudential Regulation Authority Rulebook.
8
For the GEB members who are also MRTs (or SMFs), the awards do not include dividend and interest payments. Accordingly, the amounts reflect for the LTIP
the fair value of the non-dividend-bearing awards and for
the DCCP the fair value of the granted non-interest-bearing awards.
Advisory vote
Corporate governance and compensation | Compensation
262
Regulated staff
Key Risk Takers
KRTs
are defined as those employees who, by the
nature of their
roles, have been
determined to materially set,
commit or control
significant
amounts
of
the
firm’s
resources
and
/
or
exert
significant influence
over its
risk profile. This
includes employees
that
work
in
front-office
roles,
logistics
and
control
functions.
Identifying KRTs globally is part of our risk
control framework and
an important element in ensuring we incentivize only
appropriate
risk-taking.
For
2021,
in
addition
to
GEB
members,
699
employees
were
classified
as
KRTs
throughout
UBS
Group
globally,
including
all
employees
with
a
total
compensation
exceeding
USD
/
CHF 2.5
million
(Highly
Paid
Employees),
who
may
not
have
been
identified
as
KRTs
during
the
performance
year.
In
line
with
regulatory
requirements,
the
performance
of
employees
identified
as
KRTs
during
the
performance
year
is
evaluated by the
control functions. In
addition, KRTs’ performance
awards are subject to
a mandatory deferral rate
of at least 50%,
regardless
of
whether
the
deferral
threshold
has
been
met
(excluding KRTs
with de
minimis performance
awards below
a pre-
determined
threshold
where
standard
deferral
rates
apply).
A
KRT’s
deferred
compensation award
will
only
vest
if
the
Group
performance
conditions
are
met.
Consistent
with
all
other
employees, the deferred
portion of a KRT’s
compensation is also
subject to forfeiture or
reduction if the KRT
commits harmful acts.
Fixed and variable compensation for Key Risk Takers
1
Total for 2021
Not deferred
Deferred
2
Total for 2020
USD million, except where indicated
Amount
%
Amount
%
Amount
%
Amount
Total compensation
Amount
1,561
100
895
57
666
43
1,400
Number of beneficiaries
699
647
Fixed compensation
3,4
477
31
477
100
0
0
417
Cash-based
474
30
474
417
Equity-based
3
0
3
1
Variable compensation
1,084
69
418
39
666
61
983
Cash
5
418
27
418
365
Long-Term Incentive Plan (LTIP) / Equity Ownership
Plan (EOP)
6
423
27
423
404
Deferred Contingent Capital Plan (DCCP)
6
243
16
243
213
1 Includes employees
with a total
compensation exceeding
USD / CHF
2.5 million (Highly
Paid Employees),
excluding GEB members
who were in
office during
the performance year,
except the new
GEB member
appointed during 2021, who is included for compensation received
in their role as a KRT
prior to being appointed to the GEB.
2 Based on the specific plan vesting and reflecting the
total value at grant, which may
differ from the expense recognized in the income statement
in accordance with IFRS.
3 Excludes benefits and employer's contributions to retirement benefits
plan. Includes social security contributions paid by KRTs
but excludes the legally required social security contributions paid by UBS.
4 Includes base salary and role-based allowances.
5 Includes allocation of vested but blocked shares, in line with regulatory requirements
where applicable.
6 KRTs who are also MRTs
do not receive dividend and interest payments.
Accordingly, the amounts for
the EOP / LTIP
reflect the fair value of the non-dividend-bearing
awards and for the DCCP
the fair value of the granted non-interest-bearing awards.
263
GEB and KRTs deferred compensation
The table
below shows
the current
economic value
of unvested
outstanding
deferred
variable
compensation
awards
subject
to
ex-post adjustments. For share-based plans, the economic value
is determined
based on
the closing
share price
on 31 December
202
1
.
For
notional
funds
,
it
is
determined
using
the
latest
available market price for the underlying funds at year-end 2021,
and
for
deferred
cash
plans
,
it
is
determined
based
on
the
outstanding amount of cash owed to award recipients.
GEB and KRTs
deferred compensation
1,2,3
USD million, except where indicated
Relating to awards
for 2021
4
Relating to
awards for prior
years
5
Total
of which: exposed to
ex-post explicit and /
or implicit adjustments
Total deferred
compensation
year-end 2020
Total amount of
deferred compensation
paid out in 2021
6
GEB
Deferred Contingent Capital Plan
26
72
98
100%
126
8
Equity Ownership Plan (including notional funds)
78
78
100%
102
19
Long-Term Incentive Plan
44
76
119
100%
85
KRTs
Deferred Contingent Capital Plan
244
940
1,183
100%
1,000
172
Equity Ownership Plan (including notional funds)
357
1,057
1,414
100%
1,059
344
Long-Term Incentive Plan
67
169
235
100%
109
Total GEB and KRTs
736
2,391
3,127
2,480
544
1 Based
on the
specific plan
vesting and
reflecting the
economic value
of the
outstanding awards,
which may
differ from
the expense
recognized in
the income
statement in
accordance with
IFRS. Year
-to-year
reconciliations would also need
to consider the imp
acts of additional items
including off-cycle awards,
FX movements, population
changes, and dividend
equivalent reinvestments.
2 Refer to “Note
28 Employee
benefits: variable compensation”
in the “Consolidated
financial statements” section
of the Annual
Report 2021 for
more information.
3 GEB members
and KRTs who
are also MRTs
do not receive dividend
and
interest payments.
Accordingly, the
amounts for
the EOP
/ LTIP
reflect the
fair value
of the
non-dividend-bearing awards
and for
the DCCP
the fair
value of
the granted
non-interest-bearing awards.
4 Where
applicable, amounts are translated into US dollars at the performance award
currency exchange rate. LTIP
values reflect the fair value awarded at grant.
5 Takes into account the ex-post implicit adjustments,
given
the share price movements since grant. Where applicable,
amounts are translated from award currency into US dollars
using FX rates as of 31 December 2021. LTIP
values reflect the fair value awarded at grant.
6
Valued at distribution price and FX rate for all awards distributed in 2021.
The table below shows the value of actual ex-post explicit and
implicit adjustments to outstanding
deferred compensation in the
2021
financial year for GEB members and KRTs.
Ex-post adjustments
occur after
an award
has been
granted.
Explicit
adjustments
occur
when
we
adjust
compensation
by
forfeiting deferred
awards. Implicit
adjustments are
unrelated to
any
action
taken
by
the
firm
and
occur
as
a
result
of
price
movements that affect the value of an award.
The
total
value
of
ex-post
explicit
adjustments
made
to
UBS
share
awards
in
2021,
based
on
the
approximately
8.1
million
shares forfeited during 2021, is a reduction of USD 142 million.
GEB and KRTs
ex-post explicit and implicit adjustments to deferred compensation
Ex-post explicit adjustments
to unvested awards
1
Ex-post implicit adjustments
to unvested awards
2
USD million
31.12.21
31.12.20
31.12.21
31.12.20
GEB
Deferred Contingent Capital Plan
0
0
0
0
Equity Ownership Plan (including notional funds, if applicable)
0
0
17
13
Long-Term Incentive Plan
0
0
21
5
KRTs
Deferred Contingent Capital Plan
(14)
(3)
0
0
Equity Ownership Plan (including notional funds)
(16)
(3)
250
98
Long-Term Incentive Plan
(1)
0
47
6
Total GEB and KRTs
(31)
(6)
335
122
1 For notional share awards,
ex-post explicit adjustments are calculated
as units forfeited during the
year, valued
at the share price on 31
December 2021 (USD 17.87) for
2021 (which may differ from
the expense
recognized in the income statement in accordance with IFRS). The 2020 data is valued using the
share price on 31 December 2020 (USD 14.13). For LTIP
the forfeited units reflect the fair value awarded at grant. For
the notional funds awarded to Asset Management employees under the EOP, this represents the forfeiture credits recognized in 2021 and 2020. For the DCCP,
the fair value at grant of the forfeited awards during the
year is reflected.
2 Ex-post implicit adjustments for UBS shares
are calculated based on the difference
between the weighted average grant date
fair value and the share price
at year-end. The amount
for notional
funds is calculated using the mark-to-market change during 2021 and 2020. For the GEB
member who was appointed to the GEB during 2021, awards have been fully reflected in the GEB entries.
Advisory vote
Corporate governance and compensation | Compensation
264
Material Risk Takers
For relevant
EU- or
UK-regulated entities,
we identify individuals
who are deemed
to be
Material Risks
Takers (MRTs) based on local
regulatory requirements, including the respective EU Commission
Delegated
Regulation,
the
fifth
iteration
of
the
EU
Capital
Requirements Directive (CRD V) and equivalent UK requirements,
as
applicable.
This
group
consists
of
senior
management,
risk
takers, selected
staff in
control or
support functions
and certain
highly-compensated
employees.
For
2021,
UBS
identified
683
MRTs
in relation to its relevant EU or UK entities.
Variable
compensation
awarded
to
MRTs
is
subject
to
additional
deferral
and
other
requirements.
These
include
a
maximum variable to fixed
compensation ratio of
200% based on
approval through relevant shareholder votes, a minimum deferral
rate of 40% or 60% (depending on
role / variable compensation
level) on performance awards and delivery of at least 50% of any
upfront
performance
award
in
UBS
shares
that
are
vested
but
blocked for 12 months after grant.
Deferred
awards
granted
to
MRTs
under
UBS’s
deferred
compensation plans for their performance
in 2021 are subject to
6- or 12-month blocking periods post vesting and do not pay out
dividends or interest during the deferral period.
For up to seven
years after grant,
performance awards granted
to MRTs are subject to
clawback provisions, which allow the
firm
to claim repayment
of both the
upfront and the
vested deferred
element
of
any
performance
award
if
an
individual
is
found
to
have contributed
substantially to
significant financial
losses for
the
Group
or
corporate
structure
in
scope,
a
material
downward
restatement of disclosed results,
or engaged in misconduct
and /
or failed
to take
expected actions
that contributed
to significant
reputational harm.
LTIP awards
granted to
UK MRTs
and SMFs
are subject
to an
additional non-financial conduct-related metric as required by UK
regulation.
UK Senior Managers and Certification Regime
The Senior Managers and Certification Regime (the SMCR) of the
UK
Prudential
Regulation
Authority
and
Financial
Conduct
Authority requires
that individuals
with specified
responsibilities,
performing certain
significant functions and
/ or
those in certain
other identified categories be designated as SMFs.
Subject
to
de
minimis
and
other
compensation-related
considerations,
variable
compensation
awards
made
to
SMFs
must comply
with specific
requirements, including longer
deferral,
blocking
and
clawback
periods.
The
deferral
period
for SMFs
is
seven
years,
with
the
deferred
performance
awards
vesting
no
faster than pro
rata from
years 3
to 7,
except those who
have total
compensation
below
GBP 500,000
and
variable
incentive
accounting for less than 33% of total compensation, for whom
a
five-year deferral
period (instead of
a seven-year
period) applies.
Such awards are also subject to a 12-month blocking period post
vesting. The clawback policy for SMFs permits clawback for up to
10 years from
the date of
performance award grants
(applicable
if
an
individual
is
subject
to
an
investigation
at
the
end
of
the
initial seven-year clawback period).
All SMFs are
also MRTs and,
as
such,
subject to
the same
prohibitions on
dividend and
interest
payments.
Control functions and Group Internal Audit
Our control
functions must
be independent
in order
to monitor
risk
effectively.
Therefore
,
their
compensation
is
determined
separately from the revenue areas that they oversee, supervise or
monitor.
Their
performance
award
pool
is
based
not
on
the
performance of these businesses, but
on the performance of the
Group as
a whole.
We also
consider other
factors, such
as how
effectively the
function has
performed and
our market
position.
Decisions on individual compensation for the
senior managers of
the
control
functions
are
made
by
the
function
heads
and
approved
by
the
Group
CEO.
Decisions
on
individual
compensation for the members of Group Internal Audit (GIA) are
made by the Head GIA and
approved by the Chairman. Following
a proposal by the
Chairman, total compensation
for the Head
GIA
is approved by the Compensation Committee.
265
2021 Group personnel expenses
The number of personnel
employed as of 31 December
2021 was
broadly stable, at 71,385 (full-time
equivalents), a net decrease
of
166 compared with 31 December 2020.
The table below shows our total personnel expenses for 2021,
including salaries, pension expenses, social security contributions,
variable
compensation
and
other
personnel
costs.
Variable
compensation includes cash
performance awards paid
in 2022
for
the
2021
performance
year,
amortization
of
unvested
deferred
awards
granted in previous years and the
cost of deferred awards
granted
to
employees
that
are
eligible
for
retirement
in
the
context of the compensation framework at the date of grant.
The performance award pool
reflects the value
of performance
awards granted relating to the 2021
performance year, including
awards that are paid
out immediately
and those that
are deferred.
To
determine our variable compensation expenses,
the following
adjustments are required in order to reconcile the performance
award
pool to
the expenses
recognized in
the Group’s
financial
statements prepared in accordance with IFRS:
–
reduction for
expenses deferred
to future
periods (amortization
of unvested awards
granted in 2022
for the 2021
performance
year) and accounting adjustments; and
–
addition
for
2021 amortization
of
unvested
deferred
awards
granted in prior years.
As a
large part
of compensation
consists of
deferred awards,
the
amortization
of
unvested
deferred
awards
granted
in
prior
years forms
a significant
part of
the IFRS
expenses in
both 2021
and 2022.
›
Refer to “Note 6 Personnel expenses” and
“Note 28 Employee
benefits: variable compensation” in the
“Consolidated financial
statements” section of our Annual Report
2021 for more
information
Personnel expenses
Expenses recognized in the IFRS income statement
USD million
Related to the
performance year 2021
Related to prior
performance years
Total expenses
recognized in
2021
Total expenses
recognized in
2020
Total expenses
recognized in
2019
Salaries
1
7,339
0
7,339
7,023
6,518
Non-deferred cash
2,383
(10)
2,373
2,141
1,868
Deferred compensation awards
405
412
817
1,068
887
of which: Equity Ownership Plan
183
180
363
463
422
of which: Deferred Contingent Capital Plan
140
158
297
463
375
of which: Long-Term Incentive Plan
54
19
73
54
39
of which: Asset Management EOP
29
56
84
88
51
Variable compensation – performance awards
2
2,788
402
3,190
3,209
2,755
Variable compensation – other
2,3
191
38
229
220
246
Total variable compensation excluding financial advisor variable compensation
2,979
440
3,419
3,429
3,001
Contractors
381
0
381
375
381
Social security
926
53
978
899
799
Pension and other post-employment benefit plans
4
833
0
833
845
787
Financial advisor variable compensation
2,5
4,175
685
4,860
4,091
4,043
Other personnel expenses
560
16
576
561
555
Total personnel expenses
17,193
1,194
18,387
17,224
16,084
1 Includes role-based allowances.
2 Refer to “Note 28 Employee benefits: variable compensation” in the “Consolidated financial statements”
section of our Annual Report 2021 for more information.
3 Consists
of replacement
payments, forfeiture
credits, severance
payments, retention
plan payments
and interest
expense related
to the
Deferred Contingent
Capital Plan.
4 Refer
to “Note
27 Pension
and other
post-
employment benefit plans”
in the “Consolidated
financial statements” section
of our Annual
Report 2021
for more information.
5 Consists of
formulaic compensation based
directly on compensable
revenues
generated by
financial advisors
and supplemental
compensation calculated
based on financial
advisor productivity,
firm tenure,
new assets and
other variables.
It also includes
expenses related
to compensation
commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements.
Advisory vote
Corporate governance and compensation | Compensation
266
Deferred compensation
Vesting of outstanding awards granted in prior years subject to performance conditions
The tables
below show
the extent
to which
the performance
conditions for
awards granted
in prior
years have
been met
and the
percentage of the installment that will vest in 2022.
Equity Ownership Plan (EOP) 2016
/ 2017,
EOP 2017
/ 2018,
EOP 2018
/ 2019 and EOP 2019 / 2020
Performance conditions
Performance achieved
1
% of installment vesting
Return on common equity tier 1 capital
(RoCET1) and divisional return on
attributed equity
The Group and divisional performance conditions
have been satisfied. For EOP
2016 / 2017, the third and final installment for
the Group Executive Board (the
GEB) members vests in full. For EOP 2017
/ 2018, the second installment for the
GEB members vests in full. For EOP 2018
/ 2019, the first installment for the GEB
members and the second installment for
all other employees covered under the
plan vest in full. For EOP 2019 / 2020, the
first installment for all other employees
covered under the plan vests in full.
100%
Deferred Contingent Capital Plan (DCCP) 2016
/ 2017
Performance conditions
Performance achieved
1
% of installment vesting
Common equity tier 1 (CET1) capital
ratio, viability event and, additionally for
GEB, Group profit before tax
The performance conditions have been satisfied.
DCCP 2016
/ 2017
vests in full.
100%
1
Performance may be adjusted for disclosed items generally not representative of underlying business performance.
.
267
List of tables
Page
Share ownership / entitlements of GEB members
268
Total of all vested and unvested shares
of GEB members
268
Number of shares of BoD members
269
Total of all blocked and unblocked shares
of BoD members
269
Loans granted to GEB members
270
Loans granted to BoD members
270
Compensation paid to former BoD and GEB members
270
Advisory vote
Corporate governance and compensation | Compensation
268
Audited |
Share ownership / entitlements of GEB members
1
Name, function
on
31 December
Number of
unvested
shares / at
risk
2
Number of
vested shares
Total number
of shares
Potentially
conferred
voting
rights in %
Ralph A.J.G. Hamers, Group Chief Executive Officer
2021
122,453
2,673
125,126
0.008
2020
14,841
0
14,841
0.001
Christian Bluhm, Group Chief Risk Officer
2021
654,579
226
654,805
0.041
2020
582,787
218
583,005
0.035
Mike Dargan, Group Chief Digital and Information Officer
2021
240,343
82,743
323,086
0.020
2020
-
-
-
-
Markus U. Diethelm, former Group General Counsel
2021
-
-
-
-
2020
706,845
617,858
1,324,703
0.079
Kirt Gardner, Group Chief Financial Officer
2021
780,640
236,421
1,017,061
0.063
2020
696,500
165,223
861,723
0.051
Suni Harford, President Asset Management
2021
636,122
22,199
658,321
0.041
2020
352,329
0
352,329
0.021
Robert Karofsky, President Investment Bank
2021
851,520
357,064
1,208,584
0.075
2020
627,748
357,621
985,369
0.059
Sabine Keller-Busse, President Personal & Corporate Banking and President UBS Switzerland
2021
798,457
421,491
1,219,948
0.076
2020
639,087
349,834
988,921
0.059
Iqbal Khan, Co-President Global Wealth Management and President
EMEA
2021
898,111
113,715
1,011,826
0.063
2020
742,546
68,253
810,799
0.048
Edmund Koh, President Asia Pacific
2021
501,322
493,977
995,299
0.062
2020
421,930
337,062
758,992
0.045
Axel P. Lehmann, former President Personal & Corporate Banking and President UBS Switzerland
2021
-
-
-
-
2020
690,537
331,677
1,022,214
0.061
Barbara Levi, Group General Counsel
2021
430,732
0
430,732
0.027
2020
-
-
-
-
Tom Naratil, Co-President Global Wealth Management and President UBS Americas
2021
1,374,044
950,682
2,324,726
0.145
2020
1,383,854
770,780
2,154,634
0.128
Piero Novelli, former Co-President Investment Bank
2021
-
-
-
-
2020
660,240
408,897
1,069,137
0.064
Markus Ronner, Group Chief Compliance and Governance Officer
2021
418,452
57,856
476,308
0.030
2020
302,584
130,097
432,681
0.026
Total
2021
7,706,776
2,739,047
10,445,823
0.650
2020
7,821,828
3,537,520
11,359,348
0.675
1 Includes all vested and unvested
shares of GEB members, including those held by
related parties. No options were held in 2021 and
2020 by any GEB member or
any of its related parties. Refer to “Note
28 Employee
benefits: variable compensation” in the “Consolidated
financial statements” section of our Annual
Report 2021 for more information.
2 Includes shares granted under variable
compensation plans with forfeiture
provisions. LTIP
values reflect the
fair value
awarded at grant.
The actual number
of shares vesting in
the future will be
calculated under the terms
of the plans.
Refer to the
“Group compensation” section
of this
report for more information about the plans.
p
Audited |
Total
of all vested and unvested shares of GEB members
1,2
Total
of which: vested
of which: vesting
2022
2023
2024
2025
2026
2027
Shares on 31 December 2021
10,445,823
2,739,047
1,463,440
1,688,568
2,112,516
1,488,544
877,856
75,852
2021
2022
2023
2024
2025
2026
Shares on 31 December 2020
11,359,348
3,537,520
1,424,063
1,854,660
2,070,158
1,656,600
774,416
41,931
1 Includes shares held by related parties.
2 Includes shares granted under variable compensation plans with forfeiture provisions. The actual number of shares vesting in the future will be calculated under the terms
of the plans. Refer to the “Group compensation” section of this report for more information.
p
269
Audited |
Number of shares of BoD members
1
Name, function
on 31 December
Number of shares held
Voting rights in %
Axel A. Weber, Chairman
2021
1,148,369
0.071
2020
1,046,994
0.062
Jeremy Anderson, Vice Chairman and Senior Independent Director
2021
97,518
0.006
2020
66,744
0.004
Claudia Böckstiegel, member
2
2021
0
0.000
2020
-
-
William C. Dudley, member
2021
49,714
0.003
2020
26,181
0.002
Patrick Firmenich, member
2
2021
0
0.000
2020
-
-
Reto Francioni, member
2021
139,609
0.009
2020
154,086
0.009
Fred Hu, member
2021
74,481
0.005
2020
42,428
0.003
Mark Hughes, member
2021
30,263
0.002
2020
4,920
0.000
Nathalie Rachou, member
2021
18,102
0.001
2020
0
0.000
Julie G. Richardson, member
2021
117,365
0.007
2020
88,401
0.005
Beatrice Weder di Mauro, former member
2
2021
-
-
2020
198,578
0.012
Dieter Wemmer, member
2021
114,086
0.007
2020
88,743
0.005
Jeanette Wong, member
2021
68,452
0.004
2020
33,722
0.002
Total
2021
1,857,959
0.116
2020
1,750,797
0.104
1 Includes blocked and unblocked shares held by BoD members,
including those held by related parties. No options were granted in 2021 and 2020.
2 At the 2021 AGM, Claudia Böckstiegel and Patrick Firmenich
were newly elected and Beatrice Weder di Mauro did not stand for re-election.
p
Audited |
Total
of all blocked and unblocked shares of BoD members
1
Total
of which:
unblocked
of which: blocked until
2022
2023
2024
2025
Shares on 31 December 2021
1,857,959
701,594
178,603
305,947
329,875
341,940
2021
2022
2023
2024
Shares on 31 December 2020
1,750,797
658,642
205,961
197,395
332,743
356,056
1 Includes shares held by related parties.
p
Advisory vote
Corporate governance and compensation | Compensation
270
Audited |
Loans granted to GEB members
1
In line with article 38 of the Articles of Association of UBS Group
AG, GEB members may be granted loans. Such
loans are made in
the ordinary course of
business on substantially
the same terms
as
those
granted
to
other
employees,
including
interest
rates
and collateral,
and neither
involve more
than the
normal risk
of
collectability nor
contain any
other unfavorable
features
for the
firm.
The
total
amount
of
such
loans
must
not
exceed
CHF 20
million per GEB member.
CHF, except where indicated
2
USD
(for reference)
Name, function
on 31 December
Loans
3
Loans
3
Christian Bluhm, Group Chief Risk Officer (highest loan
in 2021)
2021
7,059,000
7,742,947
Markus U. Diethelm, Group General Counsel (highest loan in 2020)
2020
6,131,500
Aggregate of all GEB members
4
2021
29,635,590
32,506,982
2020
31,830,394
1 No loans have been
granted to related parties
of the GEB members
at conditions not customary
in the market.
2 Swiss franc and
US dollar amounts disclosed
represent local currency amounts
translated at the
relevant year-end closing exchange rate.
3 All loans granted are secured loans.
4 No unused uncommitted credit facilities in 2021 and 2020.
p
Audited |
Loans granted to BoD members
1
In line with article 33 of the Articles of Association of UBS Group
AG, loans to independent
BoD members are made
in the ordinary
course of
business at
general market
conditions. The
Chairman,
as
a
non-independent
member,
may
be
granted
loans
in
the
ordinary
course
of
business
on
substantially
the
same
terms
as
those
granted
to
employees,
including
interest
rates
and
collateral,
and
neither
involve
more
than
the
normal
risk
of
collectability nor
contain any
other unfavorable
features
for the
firm.
The
total
amount
of
such
loans
must
not
exceed
CHF 20
million per BoD member.
CHF, except where indicated
2
USD
(for reference)
on 31 December
Loans
3,4
Loans
3,4
Aggregate of all BoD members
2021
1,500,000
1,645,335
2020
2,100,000
1 No loans have been granted
to related parties of the
BoD members at conditions not customary
in the market.
2 Swiss franc
and US dollar amounts disclosed represent
local currency amounts translated
at the
relevant year-end closing exchange
rate.
3 All loans granted are secured loans.
4 CHF 1,500,00 for Reto Francioni
in 2021 and CHF 600,000 for Reto
Francioni and CHF 1,500,000 for
Beatrice Weder di Mauro
in 2020.
p
Audited |
Compensation paid to former BoD and GEB members
1
CHF, except where indicated
2
USD
(for reference)
For the year
Compensation
Benefits
Total
Total
Former BoD members
2021
0
2020
0
0
0
Aggregate of all former GEB members
3
2021
187,876
187,876
205,264
2020
0
206,048
206,048
Aggregate of all former BoD and GEB members
2021
187,876
187,876
205,264
2020
0
206,048
206,048
1 Compensation or remuneration that is related to the former
members’ activity on the BoD or GEB or that
is not at market conditions.
2 Swiss franc and US dollar amounts disclosed
represent local currency amounts
translated at the relevant year-end closing exchange rate.
3 Includes benefit payments in 2021 and 2020 to two former GEB members.
271
Provisions of the Articles of Association related to compensation
Swiss say-on-pay provisions give
shareholders of companies listed in
Switzerland significant influence over
board and management compensation.
At UBS, this is achieved by means of an
annual binding say-on-pay vote in
accordance with the following provisions
of the Articles of Association (the AoA).
Say on pay
In line with article 43 of the AoA of UBS
Group AG, the General Meeting approves
proposals from the BoD in relation to:
a) the maximum aggregate amount of
compensation of the BoD for the period
until the next AGM;
b) the maximum aggregate amount of
fixed compensation of the GEB for the
following financial year; and
c) the aggregate amount of variable
compensation of the GEB for the
preceding financial year.
The BoD may submit for approval by the
General Meeting deviating or additional
proposals relating to the same or different
periods. If the General Meeting does not
approve a proposal from the BoD, the
BoD will determine, taking into account
all relevant factors, the respective
(maximum) aggregate amount or
(maximum) partial amounts and submit
the amount(s) so determined for approval
by the General Meeting. UBS Group AG
or companies controlled by it may pay or
grant compensation prior to approval by
the General Meeting, subject to
subsequent approval.
Principles of compensation
In line with articles 45 and 46 of the AoA
of UBS Group AG, compensation of the
members of the BoD includes base
remuneration and may include other
compensation elements and benefits.
Compensation of the members of the
BoD is intended to recognize the
responsibility and governance nature of
their role, to attract and retain qualified
individuals, and to ensure alignment with
shareholders’ interests.
Compensation of the members of the
GEB includes fixed and variable
compensation elements. Fixed
compensation includes the base salary
and may include other compensation
elements and benefits. Variable
compensation elements are governed by
financial and non-financial performance
measures that take into account the
performance of UBS Group AG and / or
parts thereof, targets in relation to the
market, other companies or comparable
benchmarks, short- and long-term
strategic objectives, and / or individual
targets. The BoD or, where delegated to
it, the Compensation Committee
determines the respective performance
measures, the overall and individual
performance targets, and their
achievement. The BoD or, where
delegated to it, the Compensation
Committee aims to ensure alignment with
sustainable performance and appropriate
risk-taking through adequate deferrals,
forfeiture conditions, caps on
compensation, harmful acts provisions
and similar means with regard to parts of
or all of the compensation. Parts of
variable compensation are subject to a
multi-year vesting period.
Additional amount for GEB members
appointed after the vote on the
aggregate amount of compensation by
the AGM
In line with article 46 of the AoA of UBS
Group AG, if the maximum aggregate
amount of compensation already
approved by the General Meeting is not
sufficient to also cover the compensation
of a person who becomes a member of or
is being promoted within the GEB after
the General Meeting has approved the
compensation, UBS Group AG, or
companies controlled by it, is authorized
to pay or grant each such GEB member a
supplementary amount during the
compensation period(s) already approved.
The aggregate pool for such
supplementary amounts per
compensation period cannot exceed 40%
of the average of total annual
compensation paid or granted to the GEB
during the previous three years.
›
Refer to
ubs.com/governance
for more
information
Advisory vote
Corporate governance and compensation | Compensation
272
Financial
statements
5
274
Consolidated
financial statements
Table of contents
276
Management’s report on internal control over financial
reporting
277
Report of the independent registered public accounting
firm on internal control over financial reporting
278
Report of the independent registered public accounting
firm on the consolidated financial statements
283
UBS Group AG consolidated financial statements
283
Primary financial statements and share information
283
Income statement
284
Statement of comprehensive income
285
Balance sheet
286
Statement of changes in equity
288
Share information and earnings per share
289
Statement of cash flows
291
Notes to the UBS Group AG consolidated financial
statements
291
1
Summary of material accounting policies
308
2
Segment reporting
311
Income statement notes
311
3
Net interest income and other net income from
financial instruments measured at fair value through
profit or loss
312
4
Net fee and commission income
312
5
Other income
313
6
Personnel expenses
313
7
General and administrative expenses
314
8
Income taxes
317
Balance sheet notes
317
9
Financial assets at amortized cost and other
positions in scope of expected credit loss
measurement
322
10
Derivative instruments
324
11
Financial assets measured at fair value through
other comprehensive income
324
12
Property,
equipment and software
325
13
Goodwill and intangible assets
327
14
Other assets
327
15
Amounts due to banks and customer deposits
328
16
Debt issued designated at fair value
329
17
Debt issued measured at amortized cost
330
18
Provisions and contingent liabilities
336
19
Other liabilities
337
Additional information
337
20
Expected credit loss measurement
348
21
Fair value measurement
364
22
Offsetting financial assets and financial liabilities
366
23
Restricted and transferred financial assets
369
24
Maturity analysis of financial liabilities
370
25
Interest rate benchmark reform
373
26
Hedge accounting
377
27
Post-employment benefit plans
387
28
Employee benefits: variable compensation
391
29
Interests in subsidiaries and other entities
396
30
Changes in organization and acquisitions and
disposals of subsidiaries and businesses
397
31
Related parties
399
32
Invested assets and net new money
400
33
Currency translation rates
400
34
Events after the reporting period
401
35
Main differences between IFRS and Swiss GAAP
275
403
UBS AG consolidated financial information
404
UBS AG consolidated key figures
405
Comparison between UBS Group AG consolidated and
UBS AG consolidated
406
Management’s report on internal control over financial
reporting
407
Report of the independent registered public accounting
firm on internal control over financial reporting
409
Report of the independent registered public accounting
firm on the consolidated financial statements
413
UBS AG consolidated financial statements
413
Primary financial statements and share information
413
Income statement
414
Statement of comprehensive income
415
Balance sheet
416
Statement of changes in equity
418
Share information and earnings per share
419
Statement of cash flows
422
Notes to the UBS AG consolidated financial statements
422
1
Summary of material accounting policies
439
2
Segment reporting
442
Income statement notes
442
3
Net interest income and other net income from
financial instruments measured at fair value
through profit or loss
443
4
Net fee and commission income
443
5
Other income
444
6
Personnel expenses
444
7
General and administrative expenses
445
8
Income taxes
448
Balance sheet notes
448
9
Financial assets at amortized cost and other
positions in scope of expected credit loss
measurement
453
10
Derivative instruments
455
11
Financial assets measured at fair value through
other comprehensive income
455
12
Property,
equipment and software
456
13
Goodwill and intangible assets
458
14
Other assets
458
15
Amounts due to banks, customer deposits, and
funding from UBS Group AG
459
16
Debt issued designated at fair value
460
17
Debt issued measured at amortized cost
461
18
Provisions and contingent liabilities
467
19
Other liabilities
468
Additional information
468
20
Expected credit loss measurement
479
21
Fair value measurement
496
22
Offsetting financial assets and financial liabilities
498
23
Restricted and transferred financial assets
501
24
Maturity analysis of financial liabilities
502
25
Interest rate benchmark reform
505
26
Hedge accounting
509
27
Post-employment benefit plans
519
28
Employee benefits: variable compensation
523
29
Interests in subsidiaries and other entities
528
30
Changes in organization and acquisitions and
disposals of subsidiaries and businesses
529
31
Related parties
532
32
Invested assets and net new money
533
33
Currency translation rates
533
34
Events after the reporting period
534
35
Main differences between IFRS and Swiss GAAP
536
36
Supplemental guarantor information required
under SEC regulations
276
Management’s report on internal control over financial
reporting
Management’s responsibility for internal control over financial
reporting
The Board of Directors and management of UBS Group AG (UBS)
are responsible for
establishing and
maintaining adequate
internal
control
over
financial
reporting.
UBS’s
internal
control
over
financial
reporting
is
designed
to
provide
reasonable
assurance
regarding
the
preparation
and
fair
presentation
of
published
financial
statements
in
accordance
with
International
Financial
Reporting
Standards
(IFRS),
as
issued
by
the
International
Accounting Standards Board (IASB).
UBS’s
internal
control
over
financial
reporting
includes
those
policies and procedures that:
–
pertain
to
the
maintenance
of
records
that,
in
reasonable
detail, accurately and
fairly reflect
transactions and dispositions
of assets;
–
provide reasonable assurance that transactions
are recorded as
necessary
to
permit
preparation
and
fair
presentation
of
financial statements, and that receipts and
expenditures of the
company
are
being
made
only
in
accordance
with
authorizations of UBS management; and
–
provide
reasonable
assurance
regarding
prevention
or
timely
detection of unauthorized
acquisition, use or disposition
of the
company’s
assets
that
could
have
a
material
effect
on
the
financial statements.
Because
of
its
inherent
limitations,
internal
control
over
financial reporting may
not prevent
or detect misstatements.
Also,
projections of any
evaluation of effectiveness
to future periods
are
subject to the risk that controls may become inadequate because
of changes
in conditions,
or that the
degree of
compliance with
the policies or procedures may deteriorate.
Management’s assessment of internal control over financial
reporting as of 31 December
2021
UBS management has assessed
the effectiveness of UBS’s
internal
control over financial
reporting as of
31 December 2021
based on
the
criteria
set
forth
by
the
Committee
of
Sponsoring
Organizations
of
the
Treadway
Commission
(COSO)
in
Internal
Control – Integrated Framework
(2013 Framework). Based
on this
assessment, management believes that,
as of 31 December
2021,
UBS’s internal control over financial reporting was effective.
The
effectiveness
of
UBS’s
internal
control
over
financial
reporting as of
31 December 2021
has been
audited by
Ernst &
Young Ltd,
UBS’s independent
registered
public
accounting
firm, as
stated in their report appearing on page 277, which expresses an
unqualified opinion on the effectiveness of UBS’s
internal control
over financial
reporting
as of 31 December
2021.
277
278
279
280
281
282
283
UBS Group AG consolidated financial
statements
Primary financial statements and share information
Audited |
Income statement
For the year ended
USD million
Note
31.12.21
31.12.20
31.12.19
Interest income from financial instruments measured at
amortized cost and fair value through
other comprehensive income
3
8,533
8,810
10,684
Interest expense from financial instruments measured at
amortized cost
3
(
3,259
)
(
4,247
)
(
7,194
)
Net interest income from financial instruments measured
at fair value through profit or loss
3
1,431
1,299
1,011
Net interest income
3
6,705
5,862
4,501
Other net income from financial instruments measured
at fair value through profit or loss
3
5,850
6,960
6,842
Credit loss (expense) / release
20
148
(
694
)
(
78
)
Fee and commission income
4
24,372
20,961
19,110
Fee and commission expense
4
(
1,985
)
(
1,775
)
(
1,696
)
Net fee and commission income
4
22,387
19,186
17,413
Other income
5
452
1,076
212
Total operating income
35,542
32,390
28,889
Personnel expenses
6
18,387
17,224
16,084
General and administrative expenses
7
5,553
4,885
5,288
Depreciation, amortization and impairment of non-financial
assets
12, 13
2,118
2,126
1,940
Total operating expenses
26,058
24,235
23,312
Operating profit / (loss) before tax
9,484
8,155
5,577
Tax expense / (benefit)
8
1,998
1,583
1,267
Net profit / (loss)
7,486
6,572
4,310
Net profit / (loss) attributable to non-controlling interests
29
15
6
Net profit / (loss) attributable to shareholders
7,457
6,557
4,304
Earnings per share (USD)
Basic
2.14
1.83
1.17
Diluted
2.06
1.77
1.14
Consolidated financial statements | UBS Group AG consolidated financial statements
284
Statement of comprehensive income
For the year ended
USD million
Note
31.12.21
31.12.20
31.12.19
Comprehensive income attributable to shareholders
Net profit / (loss)
7,457
6,557
4,304
Other comprehensive income that may be reclassified to the income
statement
Foreign currency translation
Foreign currency translation movements related to net assets of foreign operations, before tax
(
1,076
)
2,103
200
Effective portion of changes in fair value of hedging instruments
designated as net investment hedges, before tax
498
(
936
)
(
134
)
Foreign currency translation differences on foreign operations reclassified to the
income statement
(
2
)
(
7
)
52
Effective portion of changes in fair value of hedging instruments
designated as net investment hedges reclassified
to
the income statement
10
2
(
14
)
Income tax relating to foreign currency translations, including the effect of
net investment hedges
35
(
67
)
0
Subtotal foreign currency translation, net of tax
(
535
)
1,095
104
Financial assets measured at fair value through other comprehensive income
11
Net unrealized gains / (losses), before tax
(
203
)
223
189
Net realized gains / (losses) reclassified to the income statement
from equity
(
9
)
(
40
)
(
31
)
Income tax relating to net unrealized gains / (losses)
55
(
48
)
(
41
)
Subtotal financial assets measured at fair value through other comprehensive
income, net of tax
(
157
)
136
117
Cash flow hedges of interest rate risk
26
Effective portion of changes in fair value of derivative instruments designated
as cash flow hedges, before tax
(
992
)
2,012
1,571
Net (gains) / losses reclassified to the income statement from
equity
(
1,073
)
(
770
)
(
175
)
Income tax relating to cash flow hedges
390
(
231
)
(
253
)
Subtotal cash flow hedges, net of tax
(
1,675
)
1
1,011
1,143
Cost of hedging
26
Cost of hedging, before tax
(
32
)
(
13
)
Income tax relating to cost of hedging
6
0
Subtotal cost of hedging, net of tax
(
26
)
(
13
)
Total other comprehensive income that may be reclassified to the income statement, net
of tax
(
2,393
)
2,230
1,363
Other comprehensive income that will not be reclassified to the income
statement
Defined benefit plans
27
Gains / (losses) on defined benefit plans, before tax
2
(
327
)
(
146
)
Income tax relating to defined benefit plans
(
7
)
109
(
41
)
Subtotal defined benefit plans, net of tax
(
5
)
(
218
)
(
186
)
Own credit on financial liabilities designated at fair value
21
Gains / (losses) from own credit on financial liabilities designated
at fair value, before tax
46
(
293
)
(
400
)
Income tax relating to own credit on financial liabilities designated
at fair value
0
0
8
Subtotal own credit on financial liabilities designated at
fair value, net of tax
46
(
293
)
(
392
)
Total other comprehensive income that will not be reclassified to the income statement,
net of tax
42
(
511
)
(
578
)
Total other comprehensive income
(
2,351
)
1,719
785
Total comprehensive income attributable to shareholders
5,106
8,276
5,089
Comprehensive income attributable to non-controlling
interests
Net profit / (loss)
29
15
6
Total other comprehensive income that will not be reclassified to the income statement,
net of tax
(
16
)
21
(
4
)
Total comprehensive income attributable to non-controlling interests
13
36
2
Total comprehensive income
Net profit / (loss)
7,486
6,572
4,310
Other comprehensive income
(
2,367
)
1,740
781
of which: other comprehensive income that may be reclassified
to the income statement
(
2,393
)
2,230
1,363
of which: other comprehensive income that will not be reclassified
to the income statement
26
(
490
)
(
582
)
Total comprehensive income
5,119
8,312
5,091
1 Mainly reflects the reclassification of net gains on hedging instruments from OCI to the
income statement as the hedged forecast cash flows affected profit or loss and a decrease in net
unrealized gains on US dollar
hedging derivatives resulting from increases in the relevant long-term US dollar interest rates.
285
Balance sheet
USD million
Note
31.12.21
31.12.20
Assets
Cash and balances at central banks
192,817
158,231
Loans and advances to banks
9
15,480
15,444
Receivables from securities financing transactions
9, 22
75,012
74,210
Cash collateral receivables on derivative instruments
9, 22
30,514
32,737
Loans and advances to customers
9
397,761
379,528
Other financial assets measured at amortized cost
9, 14a
26,209
27,194
Total financial assets measured at amortized cost
737,794
687,345
Financial assets at fair value held for trading
21
130,821
125,397
of which: assets pledged as collateral that may be sold or repledged
by counterparties
43,397
47,098
Derivative financial instruments
10, 21, 22
118,142
159,617
Brokerage receivables
21
21,839
24,659
Financial assets at fair value not held for trading
21
60,080
80,364
Total financial assets measured at fair value through profit or loss
330,882
390,037
Financial assets measured at fair value through other comprehensive income
11, 21
8,844
8,258
Investments in associates
29b
1,243
1,557
Property, equipment and software
12
12,888
13,109
Goodwill and intangible assets
13
6,378
6,480
Deferred tax assets
8
8,876
9,212
Other non-financial assets
14b
10,277
9,768
Total assets
1,117,182
1,125,765
Liabilities
Amounts due to banks
15
13,101
11,050
Payables from securities financing transactions
22
5,533
6,321
Cash collateral payables on derivative instruments
22
31,798
37,312
Customer deposits
15
542,007
524,605
Debt issued measured at amortized cost
17
139,155
139,232
Other financial liabilities measured at amortized cost
19a
9,001
9,729
Total financial liabilities measured at amortized cost
740,595
728,250
Financial liabilities at fair value held for trading
21
31,688
33,595
Derivative financial instruments
10, 21, 22
121,309
161,102
Brokerage payables designated at fair value
21
44,045
38,742
Debt issued designated at fair value
16, 21
73,799
61,243
Other financial liabilities designated at fair value
19b, 21
30,074
30,387
Total financial liabilities measured at fair value through profit or loss
300,916
325,069
Provisions
18a
3,518
2,828
Other non-financial liabilities
19c
11,151
9,854
Total liabilities
1,056,180
1,066,000
Equity
Share capital
322
338
Share premium
15,928
16,753
Treasury shares
(
4,675
)
(
4,068
)
Retained earnings
43,851
38,776
Other comprehensive income recognized directly in equity, net of tax
5,236
7,647
Equity attributable to shareholders
60,662
59,445
Equity attributable to non-controlling interests
340
319
Total equity
61,002
59,765
Total liabilities and equity
1,117,182
1,125,765
Consolidated financial statements | UBS Group AG consolidated financial statements
286
Statement of changes in equity
USD million
Share
capital
Share
premium
Treasury shares
Retained
earnings
Balance as of 31 December 2018
338
20,843
(
2,631
)
30,416
Effect of adoption of IFRIC 23
(
11
)
Balance as of 1 January 2019 after the adoption of IFRIC 23
338
20,843
(
2,631
)
30,405
Acquisition of treasury shares
(
1,771
)
2
Delivery of treasury shares under share-based compensation
plans
(
886
)
983
Other disposal of treasury shares
(
2
)
94
2
Premium on shares issued and warrants exercised
29
Share-based compensation expensed in the income statement
619
Tax (expense) / benefit
11
Dividends
(
2,544
)
3
Translation effects recognized directly in retained earnings
(
9
)
New consolidations / (deconsolidations) and other increases
/ (decreases)
(
6
)
Total comprehensive income for the year
3,726
of which: net profit / (loss)
4,304
of which: OCI, net of tax
(
578
)
Balance as of 31 December 2019
338
18,064
(
3,326
)
34,122
Acquisition of treasury shares
(
1,584
)
2
Delivery of treasury shares under share-based compensation
plans
(
628
)
719
Other disposal of treasury shares
(
11
)
123
2
Share-based compensation expensed in the income statement
691
Tax (expense) / benefit
18
Dividends
(
1,304
)
3
(
1,304
)
3
Translation effects recognized directly in retained earnings
(
49
)
Share of changes in retained earnings of associates and
joint ventures
(
40
)
New consolidations / (deconsolidations) and other increases
/ (decreases)
4
(
76
)
Total comprehensive income for the year
6,046
of which: net profit / (loss)
6,557
of which: OCI, net of tax
(
511
)
Balance as of 31 December 2020
338
16,753
(
4,068
)
38,776
Acquisition of treasury shares
(
3,521
)
2
Delivery of treasury shares under share-based compensation
plans
(
675
)
789
Other disposal of treasury shares
7
81
2
Cancellation of treasury shares related to the 2018–2021
share repurchase program
5
(
16
)
(
236
)
2,044
(
1,792
)
Share-based compensation expensed in the income statement
643
Tax (expense) / benefit
(
88
)
Dividends
(
651
)
3
(
651
)
3
Equity classified as obligation to purchase own shares
(
7
)
Translation effects recognized directly in retained earnings
18
Share of changes in retained earnings of associates and
joint ventures
1
New consolidations / (deconsolidations) and other increases
/ (decreases)
6
182
Total comprehensive income for the year
7,499
of which: net profit / (loss)
7,457
of which: OCI, net of tax
42
Balance as of 31 December 2021
322
15,928
(
4,675
)
43,851
1 Excludes other comprehensive income related to defined benefit plans and own credit, which is recorded directly in Retained
earnings.
2 Includes treasury shares acquired and disposed of by the Investment Bank
in its capacity as a market-maker with regard to UBS shares and related derivatives, and to hedge certain issued structured debt instruments. These acquisitions and disposals are reported based on the sum of the net
monthly movements.
3 Reflects the payment of
an ordinary cash dividend of
USD
0.37
(2020: USD
0.73
, 2019: CHF
0.70
) per dividend-bearing share.
From 2020 onward, Swiss
tax law effective 1 January
2020
requires that Switzerland-domiciled companies
with shares listed on
a stock exchange pay
no more than
50
% of dividends from
capital contribution reserves,
with the remainder required
to be paid from
retained
earnings.
4 Mainly relates
to the establishment
of a banking
partnership with Banco
do Brasil. In
2020, UBS issued
a
49.99
% stake in
UBS Brasil Serviços
in exchange for
exclusive access to
Banco do Brasil’s
corporate clients. Upon completion of the transaction in 2020, equity attributable to non-controlling
interests increased by USD
115
million, with no material effect on equity attributable to shareholders.
5 Reflects
the cancellation of
156,632,400
shares purchased under UBS’s 2018–2021 share repurchase
program as approved by shareholders at the 2021 Annual General
Meeting. For shares repurchased from 2020 onward,
Swiss tax law effective
1 January 2020 requires
Switzerland-domiciled companies with
shares listed on a
Swiss stock exchange to
reduce capital contribution reserves
by at least
50
% of the total
capital reduction
amount exceeding the
nominal value upon
cancellation of the
shares.
6 Includes the effects
related to the launch
of UBS’s
new operational partnership
entity with Sumitomo
Mitsui Trust
Holdings, Inc.
Refer to
Note 30 for more information.
287
Other comprehensive
income recognized
directly in equity,
net of tax
1
of which:
foreign currency
translation
of which:
financial assets at
fair value through OCI
of which:
cash flow
hedges
of which:
cost of hedging
Total equity
attributable to
shareholders
Non-controlling
interests
Total equity
3,930
3,924
(
103
)
109
52,896
176
53,071
(
11
)
(
11
)
3,930
3,924
(
103
)
109
52,885
176
53,060
(
1,771
)
(
1,771
)
97
97
92
92
29
29
619
619
11
11
(
2,544
)
(
8
)
(
2,552
)
9
0
9
0
0
(
6
)
5
(
1
)
1,363
104
117
1,143
5,089
2
5,091
4,304
6
4,310
1,363
104
117
1,143
785
(
4
)
781
5,303
4,028
14
1,260
54,501
174
54,675
(
1,584
)
(
1,584
)
90
90
112
112
691
691
18
18
(
2,607
)
(
6
)
(
2,613
)
49
0
49
0
0
(
40
)
(
40
)
65
65
(
12
)
115
103
2,230
1,095
136
1,011
(
13
)
8,276
36
8,312
6,557
15
6,572
2,230
1,095
136
1,011
(
13
)
1,719
21
1,740
7,647
5,188
151
2,321
(
13
)
59,445
319
59,765
(
3,521
)
(
3,521
)
114
114
88
88
0
0
643
643
(
88
)
(
88
)
(
1,301
)
(
4
)
(
1,305
)
(
7
)
(
7
)
(
18
)
0
(
18
)
0
0
0
1
1
182
12
193
(
2,393
)
(
535
)
(
157
)
(
1,675
)
(
26
)
5,106
13
5,119
7,457
29
7,486
(
2,393
)
(
535
)
(
157
)
(
1,675
)
(
26
)
(
2,351
)
(
16
)
(
2,367
)
5,236
4,653
(
7
)
628
(
39
)
60,662
340
61,002
Consolidated financial statements | UBS Group AG consolidated financial statements
288
Share information and earnings per share
Ordinary share capital
As
of
31
December
2021,
UBS
Group
AG
had
3,702,422,995
issued shares
with a nominal value
of CHF
0.10
each, leading to
a share
capital of CHF
370,242,299.50
. Shares
issued decreased
by
157
million and
share capital
decreased by
USD
16
million in
2021, as the
156,632,400
shares acquired under the 2018–2021
share
repurchase
program
were canceled
by means
of a
capital
reduction,
as
approved
by
shareholders
at
the
2021
Annual
General Meeting.
Conditional share capital
As of 31 December 2021, the
following conditional share capital
was available to UBS Group AG’s Board of Directors (BoD):
–
A
maximum
of
CHF
38,000,000
represented
by
up
to
380,000,000
fully paid registered shares with a
nominal value
of
CHF
0.10
each,
to
be
issued
through
the
voluntary
or
mandatory
exercise
of
conversion
rights
and
/
or
warrants
granted
in
connection
with
the
issuance
of
bonds
or
similar
financial
instruments
on
national
or
international
capital
markets. This conditional
capital
allowance
was approved
at
the
Extraordinary
General
Meeting
(the
EGM)
held
on
26 November
2014,
having
originally
been
approved
at
the
Annual General Meeting (AGM) of UBS
AG on 14 April 2010.
The BoD has not made use of such allowance.
–
A maximum
of CHF
12,170,583
represented by
121,705,830
fully paid
registered shares
with a
nominal value
of CHF
0.10
each,
to
be
issued
upon
exercise
of
employee
options
and
stock appreciation rights issued to employees and members of
the
management
and
of
the
BoD
of
UBS Group
AG
and
its
subsidiaries. This
conditional capital
allowance was
approved
by the shareholders at the same EGM in 2014.
Authorized share capital
UBS
Group
AG
had
no
authorized
capital
available
to
issue
on
31 December
2021
.
Share repurchase programs
In March
2018, UBS
initiated a
share repurchase
program of
up
to CHF
2
billion over a
three-year period. Under
this program, UBS
repurchas
ed
8
million
sha
res
for
a
total
acquisition
cost
of
USD
112
million
in
2021
(2020:
31
million
shares
for
a
total
acquisition cost of USD
364
million).
The 2018–2021
program was completed
on 2 February 2021
and the
156,632,400
shares acquired
under the
2018–2021 share
repurchase
program
were
canceled
by
means
of
a
capital
reduction,
as
approved
by
shareholders
at
the
2021
Annual
General Meeting.
In
February
2021,
UBS
commenced
a
new
three-year
share
repurchase program
of up
to CHF
4
billion. Under
this program,
UBS repurchased
153
million shares in 2021
for a total acquisition
cost of USD
2,500
million (CHF
2,294
million)
.
As of or for the year ended
31.12.21
31.12.20
31.12.19
Shares outstanding
Shares issued
Balance at the beginning of the year
3,859,055,395
3,859,055,395
3,855,634,749
Shares issued
3,420,646
Shares canceled
(
156,632,400
)
1
Balance at the end of the year
3,702,422,995
3,859,055,395
3,859,055,395
Treasury shares
Balance at the beginning of the year
307,477,002
243,021,296
166,467,802
Acquisitions
214,270,175
128,372,257
146,876,692
Disposals
(
62,299,449
)
(
63,916,551
)
(
70,323,198
)
Cancellation of second trading line treasury shares
(
156,632,400
)
1
Balance at the end of the year
302,815,328
307,477,002
243,021,296
Shares outstanding
3,399,607,667
3,551,578,393
3,616,034,099
Basic and diluted earnings (USD million)
Net profit / (loss) attributable to shareholders for basic
EPS
7,457
6,557
4,304
Less: (profit) / loss on own equity derivative contracts
0
(
1
)
0
Net profit / (loss) attributable to shareholders for diluted
EPS
7,457
6,556
4,304
Weighted average shares outstanding
Weighted average shares outstanding for basic EPS
2
3,482,963,682
3,583,176,189
3,663,278,238
Effect of dilutive potential shares resulting from notional
employee shares, in-the-money options and warrants
outstanding
3
144,277,693
123,852,137
103,881,600
Weighted average shares outstanding for diluted EPS
3,627,241,375
3,707,028,326
3,767,159,838
Earnings per share (USD)
Basic
2.14
1.83
1.17
Diluted
2.06
1.77
1.14
Potentially dilutive instruments
4
Employee share-based compensation awards
5,886,945
2,536,789
Other equity derivative contracts
6,553,051
11,414,728
21,632,879
Total
12,439,996
13,951,517
21,632,879
1 Reflects the cancellation of shares purchased
under UBS’s 2018–2021 share
repurchase program as approved by shareholders
at the 2021 Annual General
Meeting.
2 The weighted average shares
outstanding
for basic EPS are calculated by taking the
number of shares at the beginning of the period,
adjusted by the number of shares acquired or
issued during the period, multiplied by a time-weighted factor
for the period
outstanding. As a result, balances are affected
by the timing of acquisitions and issuances
during the period.
3 The weighted average
number of shares for notional employee
awards with performance conditions
reflects all potentially dilutive shares that are expected to vest under the terms of the awards.
4 Reflects potential shares that could dilute basic earnings per share in the future, but were
not dilutive for the periods
presented.
289
Statement of cash flows
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Cash flow from / (used in) operating activities
Net profit / (loss)
7,486
6,572
4,310
Non-cash items included in net profit and other adjustments:
Depreciation, amortization and impairment of non-financial
assets
2,118
2,126
1,940
Credit loss expense / (release)
(
148
)
694
78
Share of net profits of associates and joint ventures and impairment
related to associates
(
105
)
(
84
)
(
45
)
Deferred tax expense / (benefit)
434
352
477
Net loss / (gain) from investing activities
(
230
)
(
698
)
220
Net loss / (gain) from financing activities
100
3,246
6,493
Other net adjustments
3,802
(
8,076
)
854
Net change in operating assets and liabilities:
Loans and advances to banks and amounts due to banks
2,148
3,586
(
4,336
)
Securities financing transactions
(
2,316
)
9,588
8,678
Cash collateral on derivative instruments
(
3,312
)
(
3,487
)
2,839
Loans and advances to customers
(
27,460
)
(
33,656
)
(
3,128
)
Customer deposits
29,825
51,805
23,217
Financial assets and liabilities at fair value held for trading and derivative financial
instruments
(
10,516
)
11,259
(
18,829
)
Brokerage receivables and payables
8,115
(
5,199
)
(
2,347
)
Financial assets at fair value not held for trading and other financial assets
and liabilities
19,609
320
33
Provisions and other non-financial assets and liabilities
3,010
(
387
)
55
Income taxes paid, net of refunds
(
1,134
)
(
1,002
)
(
804
)
Net cash flow from / (used in) operating activities
31,425
36,958
19,705
Cash flow from / (used in) investing activities
Purchase of subsidiaries, associates and intangible assets
(
1
)
(
46
)
(
26
)
Disposal of subsidiaries, associates and intangible assets
1
593
674
114
Purchase of property, equipment and software
(
1,841
)
(
1,854
)
(
1,584
)
Disposal of property, equipment and software
295
366
11
Purchase of financial assets measured at fair value through other
comprehensive income
(
5,802
)
(
6,290
)
(
3,424
)
Disposal and redemption of financial assets measured at
fair value through other comprehensive income
5,052
4,530
3,913
Net (purchase) / redemption of debt securities measured
at amortized cost
(
415
)
(
4,166
)
(
562
)
Net cash flow from / (used in) investing activities
(
2,119
)
(
6,785
)
(
1,558
)
Table
continues on the next page.
Consolidated financial statements | UBS Group AG consolidated financial statements
290
Statement of cash flows (continued)
Table
continued from previous page.
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Cash flow from / (used in) financing activities
Net short-term debt issued / (repaid)
(
3,093
)
23,845
(
17,149
)
Net movements in treasury shares and own equity derivative
activity
(
3,341
)
(
1,387
)
(
1,559
)
Distributions paid on UBS shares
(
1,301
)
(
2,607
)
(
2,544
)
Issuance of debt designated at fair value and long-term debt measured
at amortized cost
98,272
80,255
65,047
Repayment of debt designated at fair value and long-term debt measured
at amortized cost
(
79,909
)
(
87,098
)
(
68,883
)
Net cash flows from other financing activities
(
282
)
(
575
)
(
526
)
Net cash flow from / (used in) financing activities
10,345
12,432
(
25,614
)
Total cash flow
Cash and cash equivalents at the beginning of the year
173,531
119,873
126,079
Net cash flow from / (used in) operating, investing and financing
activities
39,651
42,605
(
7,467
)
Effects of exchange rate differences on cash and cash equivalents
(
5,307
)
11,052
1,261
Cash and cash equivalents at the end of the year
2
207,875
173,531
119,873
of which: cash and balances at central banks
3
192,706
158,088
106,957
of which: loans and advances to banks
13,942
14,028
11,386
of which: money market paper
4
1,227
1,415
1,530
Additional information
Net cash flow from / (used in) operating activities includes:
Interest received in cash
11,163
11,915
15,315
Interest paid in cash
4,707
6,320
10,769
Dividends on equity investments, investment funds and associates
received in cash
5
2,531
1,901
3,145
1 Includes cash proceeds from the sale of UBS’s
investment in Clearstream Fund Centre AG (previously Fondcenter
AG). UBS’s majority stake
was sold in 2020 and the remaining minority investment
was sold in the
second quarter of 2021. Refer to Note 30 for more information. Also
includes dividends received from associates.
2 USD
3,408
million, USD
3,828
million and USD
3,192
million of cash and cash equivalents (mainly
reflected in Loans and advances to banks)
were restricted as of 31 December 2021, 31
December 2020 and 31 December 2019,
respectively. Refer to Note
23 for more information.
3 Includes only balances with
an original maturity
of three
months or
less.
4 Money market
paper is
included in the
balance sheet
under Financial assets
at fair value
held for
trading, Financial
assets measured
at fair value
through other
comprehensive income, Financial assets at fair
value not held for trading
and Other financial assets measured at amortized
cost.
5 Includes dividends received from associates reported
within Net cash flow from /
(used in) investing activities.
Changes in liabilities arising from financing activities
USD million
Debt issued
measured at
amortized cost
of which:
short-term
1
of which:
long-term
2
Debt issued
designated at fair
value
Over-the-
counter debt
instruments
3
Total
Balance as of 1 January 2020
110,497
21,837
88,660
66,809
2,022
179,327
Cash flows
22,428
23,845
(
1,417
)
(
5,420
)
(
6
)
17,002
Non-cash changes
6,308
984
5,324
(
146
)
44
6,207
of which: foreign currency translation
4,980
984
3,995
1,764
81
6,824
of which: fair value changes
(
1,909
)
(
37
)
(
1,946
)
of which: hedge accounting and other effects
1,328
1,328
1,328
Balance as of 31 December 2020
139,232
46,666
92,566
61,243
2,060
202,535
Cash flows
5,070
(
3,093
)
8,163
10,076
124
15,270
Non-cash changes
(
5,148
)
(
475
)
(
4,673
)
2,480
(
56
)
(
2,724
)
of which: foreign currency translation
(
3,175
)
(
475
)
(
2,700
)
(
1,617
)
(
65
)
(
4,857
)
of which: fair value changes
4,097
9
4,106
of which: hedge accounting and other effects
(
1,972
)
(
1,972
)
(
1,972
)
Balance as of 31 December 2021
139,155
43,098
96,057
73,799
2,128
215,082
1 Debt with an original contractual maturity of less than one year.
2 Debt with an original maturity greater than or equal to one year. The classification of debt issued into short-term and long-term does not consider
any early redemption features.
3 Included in balance sheet line Other financial liabilities designated at fair value.
291
Notes to the UBS Group AG consolidated financial statements
Note 1
Summary of material accounting policies
The following table provides an overview of information included in this Note.
292
a)
Material accounting policies
292
Basis of accounting
292
1)
Consolidation
293
2)
Financial instruments
293
a.
Recognition
293
b.
Classification, measurement and presentation
297
c.
Loan commitments and financial guarantees
297
d.
Interest income and expense
297
e.
Derecognition
297
f.
Fair value of financial instruments
298
g.
Allowances and provisions for expected
credit losses
301
h.
Restructured and modified financial assets
301
i.
Offsetting
302
j.
Hedge accounting
302
3)
Fee and commission income and expenses
303
4)
Share-based and other deferred compensation plans
304
5)
Post-employment benefit plans
304
6)
Income taxes
305
7)
Property,
equipment and software
305
8)
Goodwill
305
9)
Provisions and contingent liabilities
306
10)
Foreign currency translation
306
11)
Equity, treasury
shares and contracts
on UBS Group AG shares
307
b)
Changes in accounting policies, comparability
and other adjustments
307
c)
International Financial Reporting Standards and
Interpretations to be adopted in 2022 and later
and other changes
Consolidated financial statements | UBS Group AG consolidated financial statements
292
Note 1
Summary of material accounting policies
(continued)
a)
Material accounting policies
This Note describes the
material accounting policies
applied in the
preparation of the
consolidated financial
statements (the
Financial
Statements)
of
UBS
Group
AG
and
its
subsidiaries
(UBS
or
the
Group).
On
24 February
2022,
the
Financial
Statements
were
authorized for issue by the Board of Directors.
Basis of accounting
The Financial Statements have been prepared in accordance with
International Financial Reporting
Standards (IFRS), as
issued by the
International
Accounting
Standards
Board
(the
IASB),
and
are
presented in US dollars (USD).
Disclosures
marked
as
audited
in
the
“Risk,
capital,
liquidity
and funding,
and balance
sheet” section
of this
report form
an
integral part of the Financial
Statements. These disclosures relate
to requirements
under IFRS 7,
Financial Instruments:
Disclosures
,
and
IAS
1,
Presentation
of
Financial
Statements
,
and
are
not
repeated in this section.
The
accounting
policies
described
in
this
Note
have
been
applied consistently in all years presented unless otherwise stated
in Note 1b.
Critical accounting estimates and judgments
Preparation of these Financial
Statements under IFRS requires
management
to apply
judgment
and make
estimates
and assumptions
that affect
reported
amounts
of
assets,
liabilities,
income
and
expenses
and
disclosure
of
contingent
assets and
liabilities,
and may
involve
significant
uncertainty
at the
time they are made. Such
estimates and
assumptions
are based on the best
available
information.
UBS
regularly
reassesses
such
estimates
and
assumptions, which
encompass historical experience,
expectations of
the
future and other pertinent factors, to determine their continuing relevance
based on current conditions,
updating them
as necessary. Changes
in those
estimates and
assumptions may have
a
significant effect on
the Financial
Statements. Furthermore, actual results may differ significantly from UBS’s
estimates,
which could
result in
significant
losses to
the Group,
beyond what
was anticipated
or provided
for.
The
following areas
contain estimation
uncertainty or
require
critical
judgment
and
have
a
significant
effect
on
amounts
recognized
in
the
Financial Statements:
–
expected credit loss measurement (refer to item 2g in this Note and to
Note 20);
–
fair value measurement (refer to item 2f in this Note
and to Note 21);
–
income taxes (refer to item 6 in this Note and to Note
8);
–
provisions and contingent liabilities (refer to item 9
in this Note and to
Note 18);
–
post-employment benefit
plans (refer to item
5 in this Note
and to Note
27);
–
goodwill (refer to item 8 in this Note and to Note
13); and
–
consolidation of structured entities (refer to
item 1 in this Note
and to
Note 29).
1) Consolidation
The Financial Statements comprise the
financial statements of the
parent company
(UBS Group
AG) and
its subsidiaries,
presented
as
a
single
economic
entity
;
intercompany
transactions
and
balances have been
eliminated. UBS consolidates
all entities that
it
controls,
including
structured
entities
(SEs),
which
is
the
case
when
it
has:
(i)
power
over
the
relevant
activities
of
the
entity;
(ii) exposure to
an entity‘s
variable returns;
and (iii)
the ability
to
use its power to affect its own returns.
Consideration
is
given
to
all
facts
and
circumstances
to
determine whether the Group has
power over another entity,
i.e.,
the current ability
to direct the
relevant activities of
an entity when
decisions about those activities need to be made.
Subsidiaries,
including
SEs,
are
consolidated
from
the
date
when control
is gained
and deconsolidated
from the
date when
control ceases.
Control, or
the lack thereof,
is reassessed
if facts
and circumstances indicate that there is a change to one or more
elements required to establish that control is present.
Business combinations are accounted for using the acquisition
method. The amount of any non-controlling
interest is measured
at
the
non-controlling
interest’s
proportionate
share
of
the
acquiree’s identifiable net assets.
›
Refer to Note
29
for more information
Critical accounting estimates and judgments
Each
individual
entity
is
assessed
for
consolidation
in
line
with
the
aforementioned consolidation principles.
The assessment of control
can be
complex
and
requires
the
use
of
significant
judgment,
in
particular
in
determining whether
UBS has
power over
the entity.
As the
nature and
extent of UBS’s involvement is unique for each entity,
there is no uniform
consolidation outcome
by
entity.
Certain entities
within
a
class may
be
consolidated while
others may
not. When
carrying out
the consolidation
assessment, judgment
is exercised
considering all
the relevant
facts and
circumstances, including the
nature and activities
of the investee,
as well as
the substance of voting and similar rights.
›
Refer to Note
29
for more information
293
Note 1
Summary of material accounting policies
(continued)
2) Financial instruments
a. Recognition
UBS recognizes financial instruments when it
becomes a party to
contractual
provisions
of an
instrument. UBS
applies settlement
date
accounting
to
all
standard
purchases
and
sales
of
non-
derivative financial instruments.
In transactions
where UBS
acts as
a transferee,
to the
extent
the financial
asset transfer
does not qualify
for derecognition by
the transferor, UBS does not recognize the transferred
instrument
as its asset.
UBS also acts in a fiduciary capacity, which results in it holding
or
placing
assets
on
behalf
of
individuals,
trusts,
retirement
benefit plans and
other institutions. Unless
these items meet the
definition
of
an
asset
and
the
recognition
criteria
are
satisfied,
they are
not recognized
on UBS’s
balance sheet
and the
related
income is excluded from the Financial Statements.
Client
cash balances
associated with
derivatives
clearing and
execution
services
are
not
recognized
on
the
balance
sheet
if,
through
contractual
agreement,
regulation
or
practice,
UBS
neither obtains benefits from nor controls such cash balances.
b. Classification, measurement and presentation
Financial assets
All financial instruments
are on initial recognition
measured at fair
value
and
classified
as
measured
at
amortized
cost,
fair
value
through
other
comprehensive
income
(FVOCI)
or
fair
value
through
profit
or
loss
(FVTPL)
.
For
financial
instruments
subsequently measured at amortized cost or
FVOCI, the initial fair
value is adjusted for directly attributable transaction costs.
Where the
contractual terms
of a
debt instrument
result in
cash
flows that are
solely payments of
principal and interest
(SPPI) on
the
principal
amount
outstanding,
the
debt
instrument
is
classified
as
measured
at
amortized
cost
if
it
is
held
within
a
business model that has
an objective of holding
financial assets to
collect
contractual
cash flows,
or
at
FVOCI if
it
is held
within a
business
model
with
the
objective
being
achieved
by
both
collecting contractual cash flows and selling financial assets.
All
other
financial
assets
are
measured
at
FVTPL,
including
those
held
for
trading
or
those
managed
on
a
fair
value
basis,
except for derivatives
designated in a
hedge relationship, in
which
case hedge accounting requirements apply (refer
to item 2j in this
Note for more information).
Business model assessment and contractual cash flow
characteristics
UBS determines the
nature of a
business model by
considering the
way financial assets are managed to achieve a particular business
objective.
In
assessing
whether
contractual
cash
flows
are
SPPI,
the
Group
considers whether
the contractual
terms of
the
financial
asset contain a
term that could
change the timing
or amount of
contractual cash flows arising over the life of the instrument.
Financial liabilities
Financial liabilities measured at amortized cost
Debt
issued
measured
at
amortized
cost
includes
contingent
capital instruments containing
contractual provisions under
which
the principal amounts
would be written
down or converted
into
equity upon either
a specified common
equity tier 1 (CET1)
ratio
breach
or
a
determination
by
the
Swiss
Financial
Market
Supervisory Authority (FINMA) that a viability event has occurred.
Such contractual provisions are not
derivatives, as the underlying
is deemed to be a non-financial variable specific to a party to
the
contract.
If a debt
were to be written
down or converted into
equity in
a future
period, it
would be
partially or
fully derecognized,
with
the difference between
its carrying amount
and the fair
value of
any equity issued recognized in the income statement.
A gain or loss is recognized in
Other income
when debt issued
is subsequently repurchased
for market-making
or other activities.
A
subsequent
sale
of
own
bonds
in
the
market
is
treated
as
a
reissuance of debt.
Financial liabilities measured at fair value through profit or loss
UBS
designates
certain
issued
debt
instruments
as
financial
liabilities at fair value
through profit or loss, on
the basis that such
financial instruments
include embedded
derivatives and
/ or
are
managed on a fair
value basis (refer to
the table below for
more
information),
in
which
case
bifurcation
of
the
embedded
derivative
component
is
not
required.
Financial
instruments
including
embedded
derivatives
arise
predominantly
from
the
issuance of certain structured debt instruments.
Measurement and presentation
After initial recognition, UBS
classifies, measures and presents
its
financial
assets
and
liabilities
in
accordance
with
IFRS
9,
as
described in the table on the following pages.
Consolidated financial statements | UBS Group AG consolidated financial statements
294
Note 1
Summary of material accounting policies (continued)
Classification, measurement and presentation
of financial assets
Financial assets classification
Significant items included
Measurement and presentation
Measured at
amortized cost
This classification includes:
–
cash and balances at central banks;
–
loans and advances to banks;
–
receivables from securities financing transactions;
–
cash collateral receivables on derivative instruments;
–
residential and commercial mortgages;
–
corporate loans;
–
secured loans, including Lombard loans, and
unsecured loans;
–
loans to financial advisors;
and
–
debt securities held as high-quality liquid
assets
(HQLA).
Measured at amortized cost using the effective interest
method less allowances for expected credit losses
(ECL)
(refer to items 2d and 2g in this Note for more information).
The following items are recognized in the income
statement:
–
interest income, which is accounted for in accordance
with item 2d
in this Note;
–
ECL and reversals;
and
–
foreign exchange (FX) translation gains and losses.
When a financial asset at amortized cost is derecognized,
the gain or loss is recognized in the income statement.
For amounts arising from settlement of certain derivatives,
refer to the next page.
Measured
at FVOCI
Debt instruments
measured at
FVOCI
This classification primarily includes debt securities
and
certain asset-backed securities held as HQLA.
Measured at fair value,
with unrealized gains and losses
reported in
Other comprehensive income,
net of applicable
income taxes, until such investments are derecognized.
Upon derecognition, any accumulated balances in
Other
comprehensive income
are reclassified to the income
statement and reported within
Other income.
The following items, which are determined on the
same
basis as for financial assets measured at amortized cost,
are
recognized in the income statement:
–
interest income, which is accounted for in accordance
with item 2d
in this Note;
–
ECL and reversals;
and
–
FX translation gains and losses.
295
Note 1
Summary of material accounting policies (continued)
Classification, measurement and presentation
of financial assets
Financial assets classification
Significant items included
Measurement and presentation
Measured at
FVTPL
Held for
trading
Financial assets held for trading include:
–
all derivatives with a positive replacement value,
except
those that are designated and effective hedging
instruments; and
–
other financial assets acquired principally for the
purpose of selling or repurchasing in the near term, or
that are part of a portfolio of identified financial
instruments that are managed together and for
which
there is evidence of a recent actual pattern of short-term
profit taking. Included in this category are debt
instruments (including those in the form of
securities,
money market paper,
and traded corporate and bank
loans) and equity instruments.
Measured at fair value,
with changes recognized in the
income statement.
Derivative assets (including derivatives that
are designated
and effective hedging instruments) are generally
presented as
Derivative financial instruments
, except those
exchange-traded (ETD) and over-the-counter
(OTC)-
cleared derivatives that are legally settled on a daily
basis
or in substance net settled on a daily basis,
which are
presented within
Cash collateral receivables on derivative
instruments.
Changes in fair value, initial transaction costs,
dividends
and gains and losses arising on disposal or redemption
are
recognized in
Other net income from financial
instruments measured at fair value through
profit or loss
,
except interest income on instruments other than
derivatives (refer to item 2d in this Note), interest on
derivatives designated as hedging instruments
in hedges
of interest rate risk and forward points on certain short-
and long-duration FX contracts acting as economic
hedges, which are reported in
Net interest income.
Changes in the fair value of derivatives that
are
designated and effective hedging instruments are
presented either in the income statement or
Other
comprehensive income
, depending on the type of hedge
relationship (refer to item 2j in this Note for more
information).
Mandatorily
measured at
FVTPL – Other
This classification includes financial assets
mandatorily
measured at FVTPL that are not held for trading, as
follows:
–
certain structured loans, certain commercial loans, and
receivables from securities financing transactions are
managed on a fair value basis;
–
loans managed on a fair value basis, including those
hedged with credit derivatives;
–
certain debt securities held as HQLA and
managed on a
fair value basis;
–
certain investment fund holdings and assets
held to
hedge delivery obligations related to cash-settled
employee compensation plans;
–
brokerage receivables, for which contractual cash flows
do not meet the SPPI criterion because the aggregate
balance is accounted for as a single unit of
account,
with interest being calculated on the individual
components;
–
auction rate securities, for which contractual cash
flows
do not meet the SPPI criterion because interest may
be
reset at rates that contain leverage;
–
equity
instruments;
and
–
assets held under unit-linked investment contracts.
Consolidated financial statements | UBS Group AG consolidated financial statements
296
Note 1
Summary of material accounting policies (continued)
Classification, measurement and presentation
of financial liabilities
Financial liabilities classification
Significant items included
Measurement and presentation
Measured at amortized cost
This classification includes:
–
demand and time deposits;
–
retail savings / deposits;
–
payables
from securities financing transactions;
–
non-structured fixed-rate bonds;
–
subordinated debt;
–
certificates of deposit and covered bonds; and
–
cash collateral payables on derivative instruments.
Measured at amortized cost using the effective interest
method.
When a financial liability at amortized cost is
derecognized, the gain or loss is recognized in the income
statement.
Measured at
fair value
through
profit or loss
Held for trading
Financial liabilities held for trading include:
–
all derivatives with a negative replacement value
(including certain loan commitments),
except those
that are designated and effective hedging
instruments; and
–
obligations to deliver financial instruments,
such as
debt and equity instruments, that UBS has
sold to
third parties but does not own (short positions).
Measurement and presentation of financial liabilities
classified at FVTPL follow the same principles
as for
financial assets classified at FVTPL, except that
the amount
of change in the fair value of a financial liability
designated at FVTPL that is attributable to changes
in
UBS’s own credit risk is presented in
Other comprehensive
income
directly within
Retained earnings
and is never
reclassified to the income statement.
Derivative liabilities (including derivatives that
are
designated and effective hedging instruments)
are
generally presented as
Derivative financial instruments
,
except those exchange-traded and OTC-cleared
derivatives that are legally settled on a daily basis
or in
substance net settled on a daily basis, which
are
presented within
Cash collateral payables on derivative
instruments.
Designated at
FVTPL
UBS designates
at FVTPL the following financial
liabilities:
–
issued hybrid debt instruments that primarily
include
equity-linked, credit-linked and rates-linked bonds
or
notes;
–
issued debt instruments managed on a fair
value
basis;
–
certain payables from securities financing transactions;
–
amounts due under unit-linked investment contracts
the cash flows of which are linked to financial
assets
measured at FVTPL and eliminate an accounting
mismatch;
and
–
brokerage payables, which arise in conjunction with
brokerage receivables and are measured at FVTPL to
achieve measurement consistency.
297
Note 1
Summary of material accounting policies (continued)
c. Loan commitments and financial guarantees
Loan
commitments
are
arrangements
to
provide
credit
under
defined terms and
conditions. Irrevocable loan
commitments are
classified
as:
(i)
derivative
loan
commitments
measured
at
fair
value through profit
or loss; (ii) loan
commitments designated at
fair
value
through
profit
or
loss;
or
(iii)
loan
commitments
not
measured at
fair value.
Financial guarantee
contracts are
contracts
that
require
UBS
to
make
specified
payments
to
reimburse
the
holder
for
an
incurred
loss
because
a
specified
debtor
fails
to
make
payments
when
due
in
accordance
with
the
terms
of
a
specified debt instrument.
d. Interest income and expense
Interest
income
and
expense
are
recognized
in
the
income
statement
based
on
the
effective
interest
method
.
When
calculating
the
effective
interest
rate
(the
EIR)
for
financial
instruments
(other
than
credit-impaired
financial
instruments),
UBS estimates future cash flows considering all contractual terms
of
the
instrument,
but
not
expected
credit
losses,
with
the
EIR
applied to the gross carrying amount of the financial asset
or the
amortized cost
of a
financial liability.
However,
when a
financial
asset
becomes
credit-impaired
after
initial
recognition,
interest
income is determined by
applying the EIR to
the amortized cost
of
the
instrument,
which
represents
the
gross
carrying
amount
adjusted for any credit loss allowance.
Upfront
fees,
including
fees
on
loan
commitments
not
measured at fair value where a loan is expected to be issued, and
direct
costs
are
included
within
the
initial
measurement
of
a
financial
instrument
measured
at
amortized
cost
or
FVOCI
and
recognized over the expected
life of the instrument
as part of its
EIR.
Fees related
to loan
commitments where
no loan
is expected
to be issued, as well as loan syndication fees where UBS does not
retain a portion of
the syndicated loan or where
UBS does retain
a
portion
of
the syndicated
loan at
the
same effective
yield
for
comparable risk as other participants, are included in
Net fee and
commission
income
and
either
recognized
over
the
life
of
the
commitment or when syndication occurs.
›
Refer to item 3 in this Note for more information
Interest
income
on
financial
assets,
excluding
derivatives,
is
included in interest income when positive and in interest expense
when negative.
Similarly, interest
expense on
financial liabilities,
excluding derivatives, is
included in interest
expense, except when
interest rates are
negative, in which case
it is included in
interest
income.
›
Refer to item 2b
in this Note and Note
3
for more information
e. Derecognition
Financial assets
UBS derecognizes
a transferred
financial asset,
or a
portion of
a
financial asset,
if the
purchaser has
received substantially
all the
risks and rewards of the asset or
a significant part of the risks
and
rewards
combined
with
a
practical
ability
to
sell
or
pledge
the
asset.
Where
financial
assets
have
been
pledged
as
collateral
or
in
similar
arrangements,
they
are
considered
to
have
been
transferred if the counterparty has received the contractual rights
to the cash flows of
the pledged assets, as may be
evidenced by,
for example,
the counterparty’s
right to
sell or
repledge the
assets.
In transfers where control over the financial asset is retained, UBS
continues
to recognize
the asset
to the
extent of
its
continuing
involvement, determined
by the extent
to which it
is exposed to
changes
in
the
value
of
the
transferred
asset
following
the
transfer.
Certain
OTC
derivative
contracts
and
most
exchange-traded
futures
and
option
contracts
cleared
through
central
clearing
counterparties and
exchanges are
considered to
be settled
on a
daily basis,
as the
payment or
receipt of
variation margin
on a
daily
basis
represents
legal
or
economic
settlement,
which
results
in
derecognition of the associated derivatives.
›
Refer to Note 22 and
Note
23
for more information
Financial liabilities
UBS derecognizes a financial liability when
it is extinguished, i.e.,
when
the
obligation
specified
in
the
contract
is
discharged,
canceled
or
expires.
When
an
existing
financial
liability
is
exchanged for a
new one from
the same lender
on substantially
different
terms,
or
the
terms
of
an
existing
liability
are
substantially modified, the original
liability is derecognized
and a
new
liability
recognized
with
any
difference
in
the
respective
carrying amounts recognized in the income statement.
f. Fair value of financial instruments
UBS accounts
for a
significant portion
of its
assets and
liabilities
at fair value. Fair value is the price on the measurement date that
would be
received for
the sale
of an
asset or
paid to
transfer a
liability in
an orderly
transaction between
market participants
in
the principal market,
or in the most
advantageous market in the
absence of a principal market.
›
Refer to Note 21 for more information
Consolidated financial statements | UBS Group AG consolidated financial statements
298
Note 1
Summary of material accounting policies (continued)
Critical accounting estimates and judgments
The use
of valuation techniques, modeling
assumptions and estimates
of
unobservable market
inputs in
the fair
valuation of
financial instruments
requires
significant judgment and could affect the
amount of gain or loss
recorded
for
a
particular
position.
Valuation
techniques
that
rely
more
heavily on unobservable
inputs and sophisticated
models inherently require
a higher
level of judgment
and may
require adjustment to
reflect factors
that market
participants would
consider in
estimating fair
value, such
as
close-out costs, which are presented in Note 21d.
UBS‘s governance framework over
fair value measurement is described
in Note 21b,
and UBS provides
a sensitivity analysis
of the estimated
effects
arising from
changing significant unobservable
inputs in
Level 3 financial
instruments to reasonably possible alternative
assumptions in Note 21g.
›
Refer to Note 21 for more information
g. Allowances and provisions for expected credit losses
ECL
are
recognized
for
financial
assets
measured
at
amortized
cost,
financial
assets
measured
at
FVOCI,
fee
and
lease
receivables,
financial
guarantees
,
and
loan
commitments
not
measured at
fair value. ECL
are also
recognized on the
undrawn
portion
of
committed
unconditionally
revocable
credit
lines,
which include UBS’s credit
card limits and master
credit facilities,
as
UBS
is
exposed
to
credit
risk
because
the
borrower
has
the
ability
to
draw
down
funds
before
UBS
can
take
credit
risk
mitigation actions.
Recognition of expected credit losses
ECL are recognized on the following basis:
–
Stage 1 instruments: Maximum 12-month
ECL are recognized
from initial recognition,
reflecting the portion
of lifetime cash
shortfalls that would
result if a default
occurs in the 12
months
after
the
reporting
date,
weighted
by
the
risk
of
a
default
occurring.
–
Stage 2
instruments:
Lifetime
ECL
are
recognized
if
a
significant
increase
in
credit
risk
(
an
SICR)
is
observed
subsequent
to
the
instrument’s
initial
recognition,
reflecting
lifetime
cash
shortfalls
that
would
result
from
all
possible
default events over the expected life of a financial instrument,
weighted by
the risk
of a
default occurring.
When an
SICR is
no longer observed, the instrument will move back to stage 1.
–
Stage 3
instruments:
Lifetime
ECL
are
always
recognized
for
credit-impaired
financial
instruments,
as
determined
by
the
occurrence of one or more loss events, by estimating
expected
cash
flows
based
on
a
chosen
recovery
strategy.
Credit
-
impaired
exposures
may
include
positions
for
which
no
allowance has been recognized, for example because they are
expected to be fully recoverable through collateral held.
–
Changes
in
lifetime
ECL
since
initial
recognition
are
also
recognized for
assets that
are purchased
or originated
credit-
impaired (POCI). POCI financial instruments include those that
are purchased
at a
deep discount
or newly
originated with
a
defaulted counterparty; they
remain a separate
category until
derecognition.
All
or
part
of
a
financial
asset
is
written
off
if
it
is
deemed
uncollectible or forgiven.
Write-offs reduce the
principal amount
of a
claim and
are charged
against related
allowances for
credit
losses. Recoveries, in part or in full, of
amounts previously written
off are generally credited to
Credit loss (expense) / release
.
ECL
are
recognized
in
the
income
statement
in
Credit
loss
(expense) / release
. A corresponding ECL allowance is reported as
a decrease in the carrying amount of financial assets measured at
amortized cost on the balance sheet.
For financial assets that are
measured at
FVOCI, the
carrying amount
is not
reduced, but
an
accumulated
amount
is
recognized
in
Other
comprehensive
income
.
For
off-balance
sheet
financial
instruments
and
other
credit lines, provisions for ECL are presented in
Provisions.
Default and credit impairment
UBS
applies
a
single
definition
of
default
for
credit
risk
management
purposes,
regulatory
reporting
and
ECL,
with
a
counterparty
classified
as
defaulted
based
on
quantitative
and
qualitative criteria.
›
Refer to “Credit policies for distressed assets”
in the “Risk
management and control” section of this report for
more
information
Measurement of expected credit losses
IFRS
9
ECL
reflect
an
unbiased,
probability-weighted
estimate
based
on
loss
expectations
resulting
from
default
events.
The
method
used
to
calculate
ECL
applies
the
following
principal
factors: probability
of default
(PD), loss
given default
(LGD) and
exposure
at default
(EAD). Parameters
are
generally determined
on an
individual financial
asset level. Based
on the materiality
of
the
portfolio,
for
credit
card
exposures
and
personal
account
overdrafts
in
Switzerland,
a
portfolio
approach
is
applied
that
derives an average
PD and LGD
for the entire
portfolio. PDs and
LGDs used in the ECL calculation are point-in-time (PIT)-based for
key portfolios and consider both current conditions and expected
cyclical
changes.
For
material
portfolios,
PDs
and
LGDs
are
determined for
different scenarios,
whereas EAD
projections are
treated as scenario independent.
For the
purpose of
determining the
ECL-relevant parameters,
UBS leverages its
Pillar 1 internal
ratings-based (IRB) models
that
are also used in determining expected loss (EL) and risk-weighted
assets under
the Basel III
framework and
Pillar 2 stress
loss models.
Adjustments have been made to these models and IFRS 9-related
models
have
been
developed
that
consider
the
complexity,
structure and
risk profile
of relevant
portfolios and
take account
of the fact that PDs and LGDs used in the ECL calculation are PIT-
based,
as
opposed
to
the
corresponding
Basel III
through-the-
cycle (TTC) parameters.
All models that
are relevant for
measuring
expected credit
losses are
subject to
UBS’s model
validation and
oversight processes.
299
Note 1
Summary of material accounting policies (continued)
Probability of default:
PD represents the
probability of a
default
over
a
specified
time
period.
A
12-month
PD
represents
the
probability of
default determined
for the
next 12
months and
a
lifetime
PD
represents
the
probability
of
default
over
the
remaining lifetime of
the instrument.
PIT PDs
are derived from
TTC
PDs and scenario forecasts.
The modeling is region-,
industry- and
client
segment-specific
and
considers
both
macroeconomic
scenario dependencies and client-idiosyncratic information.
Exposure
at
default:
EAD
represents
an
estimate
of
the
exposure to credit risk
at the time of
a potential default
occurring,
considering
expected
repayments,
interest
payments
and
accruals, discounted at
the EIR. Future
drawdowns on facilities
are
considered
through
a
credit
conversion
factor
(a
CCF)
that
is
reflective
of
historical
drawdown
and
default
patterns
and
the
characteristics of the respective portfolios.
Loss given
default:
LGD represents
an estimate
of the loss
at the
time of a potential
default occurring,
taking into
account expected
future cash
flows from
collateral
and other
credit
enhancements,
or
expected
payouts
from
bankruptcy
proceedings
for
unsecured
claims and, where applicable, time to realization of collateral and
the seniority
of claims.
LGD is
commonly
expressed
as a percentage
of EAD.
Estimation of expected credit losses
Number of scenarios and estimation of scenario weights
Determination of probability
-weighted ECL
requires evaluating
a
range
of
diverse
and
relevant
future
economic
conditions,
especially
with
a
view
to
modeling
the
non-linear
effect
of
assumptions about macroeconomic factors on the estimate.
To
accommodate
this
requirement,
UBS
uses
different
economic
scenarios
in
the
ECL
calculation
.
Each
scenario
is
represented
by
a
specific
scenario
narrative,
which
is
relevant
considering the exposure of key portfolios to economic risks, and
for
which
a
set
of
consistent
macroeconomic
variables
is
determined. The estimation
of the appropriate weights
for these
scenarios
is
predominantly
judgement-based.
The
assessment
is
based on a
holistic review of
the prevailing economic
or political
conditions,
which
may
exhibit
different
levels
of
uncertainty.
It
takes
into
account
the
impact
of
changes
in
the
nature
and
severity
of
the underlying
scenario
narratives
and
the
projected
economic variables.
The
determined
weights
constitute
the
probabilities
that
the
respective
set
of
macroeconomic
conditions
will
occur
and
not
that
the
chosen
particular
narratives
with
the
related
macroeconomic variables will materialize.
Macroeconomic and other factors
The
range
of
macroeconomic,
market
and
other
factors
that
is
modeled
as
part
of
the
scenario
determination
is
wide,
and
historical information is
used to support
the identification of
the
key factors.
As the
forecast horizon
increases, the
availability of
information
decreases,
requiring
an
increase
in
judgment.
For
cycle-sensitive PD and LGD determination purposes, UBS projects
the relevant
economic factors
for a
period of
three years
before
reverting, over a specified period, to
cycle-neutral PD and LGD
for
longer-term projections.
Factors relevant
for ECL
calculation vary
by type
of exposure.
Regional
and
client-segment
characteristics
are
generally
taken
into
account,
with
specific
focus
on
Switzerland
and
the
US,
considering UBS’s key ECL-relevant portfolios.
For
UBS,
the
following
forward-looking
macroeconomic
variables represent the most relevant factors for ECL calculation:
–
GDP growth rates, given
their significant effect on
borrowers’
performance;
–
unemployment
rates, given
their significant
effect on
private
clients’ ability to meet contractual obligations;
–
house price indices, given their
significant effect on mortgage
collateral valuations;
–
interest rates,
given their
significant effect
on counterparties’
abilities to service debt;
–
consumer
price
indices,
given
their
overall
relevance
for
companies’
performance,
private
clients’
purchasing
power
and economic stability; and
–
equity indices,
given that
they are
an important
factor in
our
corporate rating tools.
Scenario generation, review process and governance
A
team
of
economists,
who
are
part
of
Group
Risk
Control,
develop
the
forward-looking
macroeconomic
assumptions
with
involvement from a broad range of experts.
The
scenarios, their
weight and
the key
macroeconomic and
other
factors
are
subject
to
a
critical
assessment
by
the
IFRS
9
Scenario Sounding Sessions and ECL Management Forum, which
include senior management from Group Risk and Group Finance.
Important aspects
for the
review include
whether there
may be
particular credit
risk concerns
that may
not be
capable of
being
addressed systematically and
require post-model adjustments
for
stage allocation and ECL allowance.
The
Group
Model
Governance
Committee
,
as
the
highest
authority under UBS’s
model governance framework, ratifies
the
decisions taken by the ECL Management Forum.
›
Refer to Note 20 for more information
ECL measurement period
The period for which lifetime ECL are determined is based on the
maximum
contractual period
that UBS
is exposed
to
credit
risk,
taking
into
account
contractual
extension,
termination
and
prepayment
options.
For
irrevocable
loan
commitments
and
financial guarantee contracts,
the measurement period
represents
the maximum contractual period for which
UBS has an obligation
to extend credit.
Consolidated financial statements | UBS Group AG consolidated financial statements
300
Note 1
Summary of material accounting policies (continued)
Additionally,
some
financial
instruments
include
both
an
on-
demand loan and
a revocable undrawn
commitment, where the
contractual
cancellation
right
does
not
limit
UBS’s
exposure
to
credit risk
to the
contractual notice
period, as
the client
has the
ability to
draw down
funds before
UBS can
take risk-mitigating
actions. In such cases UBS is required to estimate
the period over
which it is exposed to credit risk. This applies to UBS’s credit card
limits, which do not have a
defined contractual maturity date, are
callable
on
demand
and
where
the
drawn
and
undrawn
components are managed as one exposure.
The exposure arising
from UBS’s credit
card limits is not
significant and is managed
at
a portfolio level,
with credit actions
triggered when balances
are
past due.
An ECL
measurement period
of seven
years is
applied
for credit card
limits, capped at
12 months for
stage 1 balances,
as a proxy for the period that UBS is exposed to credit risk.
Customary
master
credit
agreements
in
the
Swiss
corporate
market
also
include
on-demand
loans
and
revocable
undrawn
commitments.
For
smaller
commercial
facilities,
a
risk-based
monitoring
(RbM)
approach
is
in
place
that
highlights
negative
trends
as
risk
events,
at
an
individual
facility
level,
based
on
a
combination
of
continuously
updated
risk
indicators.
The
risk
events trigger additional
credit reviews by
a risk officer,
enabling
informed credit
decisions to
be taken.
Larger corporate
facilities
are not subject
to RbM, but
are reviewed
at least
annually through
a
formal
credit
review.
UBS
has
assessed
these
credit
risk
management practices and
considers both
the RbM approach
and
formal credit
reviews as
substantive credit
reviews resulting
in a
re-origination
of
the
given
facility.
Following
this,
a
12-month
measurement
period
from
the
reporting
date
is
used
for
both
types of facilities as
an appropriate proxy of
the period over
which
UBS is exposed to credit risk, with 12 months also
used as a look-
back
period
for
assessing
SICR,
always
from
the
respective
reporting date.
Significant increase in credit risk
Financial
instruments
subject
to
ECL
are
monitored
on
an
ongoing
basis.
To
determine
whether
the
recognition
of
a
maximum
12-month
ECL
continues
to
be
appropriate,
an
assessment
is made
as
to
whether
an
SICR
has
occurred
since
initial
recognition
of
the
financial
instrument
,
applying
both
quantitative
and qualitative
factors.
Primarily,
UBS
assesses
changes
in
an
instrument’s
risk
of
default
on
a
quantitative
basis
by
comparing
the
annualized
forward-looking
and
scenario-weighted
lifetime
PD
of
an
instrument determined at two different dates:
–
at the reporting date; and
–
at inception of the instrument.
If, based on UBS’s
quantitative modeling, an increase exceeds
a
set
threshold,
an
SICR
is
deemed
to
have
occurred
and
the
instrument is transferred to stage 2 with lifetime ECL recognized
.
The threshold
applied varies
depending on
the original
credit
quality of the borrower,
with a higher SICR
threshold set for
those
instruments
with
a
low
PD
at
inception.
The
SICR
assessment
based on PD changes
is made at
an individual financial asset
level.
A high-level
overview of
the SICR
trigger, which
is a
multiple of
the
annualized
remaining
lifetime
PIT
PD
expressed
in
rating
downgrades,
is
provided
in
the
“SICR
thresholds”
table
below.
The actual SICR
thresholds applied are
defined on a
more granular
level by interpolating between the values shown in the table.
SICR thresholds
Internal rating at origination
of the instrument
Rating downgrades /
SICR trigger
0–3
3
4–8
2
9–13
1
›
Refer to the “
Risk management and control
” section of this
report for more details about UBS’s internal grading system
Irrespective
of
the
SICR
assessment
based
on
default
probabilities, credit
risk is
generally deemed
to have
significantly
increased for an instrument if the contractual payments are more
than
30
days
past
due.
For
certain
less
material
portfolios,
specifically
the
Swiss
credit
card
portfolio,
the
30-day
past
due
criterion
is
used
as
the
primary
indicator
of
an
SICR.
Where
instruments are transferred to stage 2 due
to the 30-day past
due
criterion,
a
minimum
period
of
six
months
is
applied
before
a
transfer
back
to
stage 1
can
be
triggered.
For
instruments
in
Personal &
Corporate Banking
and Global
Wealth Management
Region Switzerland
that are
between 90
and 180
days past
due
but
have
not
been
reclassified
to
stage 3,
a
one-year
period
is
applied before a transfer back to stage 1 can be triggered.
Additionally,
based
on
individual
counterparty-specific
indicators,
external
market
indicators
of
credit
risk
or
general
economic
conditions,
counterparties may
be moved
to a
watch
list, which is used as a
secondary qualitative indicator for an SICR.
Exception management is further applied,
allowing for individual
and collective adjustments
on exposures
sharing the same
credit
risk characteristics
to take
account of
specific situations
that are
not otherwise fully reflected.
In
general,
the
overall
SICR
determination
process
does
not
apply
to
Lombard
loans,
securities
financing
transactions
and
certain other asset-based
lending transactions, because
of the risk
management
practices
adopted,
including
daily
monitoring
processes with strict margining. If margin calls are not satisfied, a
position
is
closed
out
and
classified
as
a
stage 3
position.
In
exceptional
cases,
an
individual
adjustment
and
a
transfer
into
stage 2 may be made to take account of specific facts.
301
Note 1
Summary of material accounting policies (continued)
Credit risk
officers are
responsible for
the identification
of an
SICR,
which for accounting purposes is in some respects different
from
internal
credit
risk
management processes.
This difference
mainly
arises
because
ECL
accounting
requirements
are
instrument-specific,
such
that
a
borrower
can
have
multiple
exposures
allocated
to
different
stages,
and
maturing
loans
in
stage 2 will
migrate to
stage 1 upon
renewal irrespective
of the
actual
credit
risk
at
that
time.
Under
a
risk-based
approach,
a
holistic counterparty
credit assessment
and the
absolute level
of
risk at any given date
will determine what risk-mitigating actions
may be warranted.
›
Refer to the “
Risk management and control
” section of this
report for more information
Critical accounting estimates and judgments
The calculation of ECL requires management
to apply significant judgment
and make estimates and assumptions
that can result in significant
changes
to the timing and amount of ECL recognized.
Determination of a significant increase in
credit risk
IFRS 9 does
not include
a definition of
what constitutes an
SICR,
with UBS’s
assessment considering qualitative and quantitative criteria. An IFRS 9 ECL
Management Forum
has been
established to
review and challenge
the SICR
results.
Scenarios, scenario weights and macroeconomic
variables
ECL
reflect
an
unbiased
and
probability-weighted
amount,
which
UBS
determines
by
evaluating
a
range
of
possible
outcomes.
Management
selects
forward-looking
scenarios
that
include
relevant
macroeconomic
variables
and
management’s
assumptions
around
future
economic
conditions. IFRS
9 Scenario Sounding
Sessions,
in addition
to the IFRS
9 ECL
Management
Forum,
are
in
place
to
derive,
review
and
challenge
the
scenario selection and weights,
and to determine
whether any additional
post-model adjustments are required that may significantly
affect ECL.
ECL measurement period
Lifetime ECL are
generally determined
based upon the
contractual maturity
of the transaction,
which significantly
affects ECL. For credit
card limits and
Swiss callable
master credit
facilities, judgment
is required,
as UBS
must
determine the period over
which it is exposed
to credit risk.
A seven-year
period is
applied for
credit card
limits, capped
at 12
months for
stage 1
positions, and a 12-month period applied for
master credit facilities.
Modeling and post-model adjustments
A number
of complex
models have
been developed
or modified
to calculate
ECL,
with
additional
post-model
adjustments
required
which
may
significantly affect
ECL. The
models are governed
by UBS’s
model validation
controls and
approved by
the Group Model
Governance Committee (the
GMGC)
.
The
post
-
model
adjustments
are
approved
by
the
ECL
Management Forum and endorsed by the
GMGC.
A
sensitivity
analysis
covering
key
macroeconomic
variables
,
scenario
weights and SICR trigger points
on ECL measurement is provided
in Note
20f.
›
Refer to Note 20 for more information
h. Restructured and modified financial assets
When payment default is expected,
or where default has already
occurred,
UBS
may
grant
concessions
to
borrowers
in
financial
difficulties that
it would not
consider in
the normal course
of its
business, such as
preferential interest rates, extension
of maturity,
modifying
the
schedule
of
repayments,
debt
/
equity
swap,
subordination,
etc. When a concession or forbearance measure is
granted, each case
is considered individually
and the exposure
is
generally classified as
being in default.
Forbearance classification
will
remain
until
the
loan
is
collected
or
written
off,
non-
preferential
conditions
superseding
preferential
conditions
are
granted
or
until
the
counterparty
has
recovered
and
the
preferential conditions no longer exceed UBS’s risk tolerance.
Modifications result in an alteration of future contractual cash
flows and can occur within UBS’s normal risk tolerance or as part
of
a
credit
restructuring
where
a
counterparty
is
in
financial
difficulties. The
restructuring or
modification of
a financial
asset
could lead
to a
substantial change
in the
terms and
conditions,
resulting in the
original financial asset
being derecognized and
a
new
financial
asset
being
recognized.
Where
the
modification
does
not
result
in
a
derecognition,
any
difference
between
the
modified contractual cash
flows discounted at
the original
EIR and
the existing
gross carrying amount
of the
given financial asset
is
recognized in the
income statement as
a modification gain
or loss.
i. Offsetting
UBS
presents
financial
assets
and
liabilities on
its
balance
sheet
net if (i) it has a legally enforceable right to set
off the recognized
amounts
and
(ii)
it
intends
either
to
settle
on
a
net
basis
or
to
realize
the
asset
and
settle
the
liability
simultaneously.
Netted
positions include, for example, certain derivatives and repurchase
and reverse
repurchase transactions
with various
counterparties,
exchanges and clearing houses.
In assessing whether
UBS intends
to either settle
on a net
basis,
or
to
realize
the
asset
and
settle
the
liability
simultaneously,
emphasis is placed on the effectiveness of operational settlement
mechanics
in
eliminating
substantially
all
credit
and
liquidity
exposure
between
the
counterparties.
This
condition
precludes
offsetting on the balance
sheet for substantial amounts
of UBS’s
financial assets and liabilities, even
though they may be
subject to
enforceable netting arrangements.
Repurchase arrangements and
securities
financing
transactions
are
presented
net
only
to
the
extent
that
the
settlement
mechanism
eliminates,
or
results
in
insignificant,
credit
and
liquidity
risk,
and
processes
the
receivables and payables in a single settlement process or cycle.
›
Refer to Note
22
for more information
Consolidated financial statements | UBS Group AG consolidated financial statements
302
Note 1
Summary of material accounting policies
(continued)
j
. Hedge accounting
The Group
applies
hedge accounting
requirements
of IFRS
9, unless
stated otherwise
below, where the criteria for documentation
and
hedge
effectiveness are
met.
If
a
hedge
relationship no
longer
meets
the
criteria
for
hedge
accounting,
hedge
accounting
is
discontinued. Voluntary
discontinuation of
hedge
accounting is
permitted under
IAS 39 but
not under
IFRS 9.
Fair value hedges of interest rate risk related to debt instruments
and loan assets
The fair value change
of the hedged item
attributable
to a hedged
risk is
reflected as
an
adjustment to
the
carrying amount of
the
hedged item, and recognized
in the income statement along with
the change
in the fair
value
of the
hedging
instrument.
Fair value hedges of portfolio interest rate risk related to loans
designated under IAS 39
Prior to discontinuation in December 2021, the fair value change
of the
hedged item
attributable to
a hedged
risk is
reflected within
Other
financial
assets
measured
at
amortized
cost
or
Other
financial liabilities measured
at amortized cost
and recognized in
the income statement
along with the
change in the
fair value of
the hedging instrument.
Fair value hedges of FX risk related to debt instruments
The
fair
value
change
of
the
hedged
item
attributable
to
the
hedged risk
is reflected
in the measurement
of the
hedged item
and recognized
in the
income statement
along with
the change
in the fair value of
the hedging instrument. The foreign
currency
basis
spread
of
cross-currency
swaps
designated
as
hedging
derivatives is excluded from the designation and
accounted for as
a cost of hedging with
amounts deferred in
Other comprehensive
income
within
Equity
. These amounts are released
to the income
statement over the term of the hedged item.
Discontinuation of fair value hedges
Discontinuations
for
reasons
other
than
derecognition
of
the
hedged
item
result
in
an
adjustment to
the
carrying
amount,
which
is
amortized to the income statement over the remaining life of the
hedged
item using
the effective
interest
method.
If the
hedged
item
is derecognized,
the unamortized
fair value adjustment
or deferred
cost of
hedging amount is recognized immediately in the income
statement
as part
of any
derecognition
gain or
loss.
Cash flow hedges of forecast transactions
Fair value gains
or losses associated with
the effective portion
of
derivatives designated as cash
flow hedges for
cash flow repricing
risk are recognized initially in
Other comprehensive income
within
Equity
and
reclassified
to
the
income
statement
in
the
periods
when
the
hedged
forecast
cash
flows
affect
profit
or
loss,
including discontinued
hedges for which
forecast cash
flows are
expected
to
occur.
If
the
forecast
transactions
are
no
longer
expected to
occur,
the deferred
gains or
losses are
immediately
reclassified to the income statement.
Hedges of net investments in foreign operations
Gains or losses on the hedging
instrument
relating to the effective
portion of a hedge are recognized
directly in
Other comprehensive
income
within
Equity,
while
any
gains
or
losses
relating
to
the
ineffective
and / or undesignated
portion (for
example, the
interest
element
of
a
forward
contract)
are
recognized
in
the
income
statement.
Upon
disposal
or
partial
disposal
of
the
foreign
operation,
the cumulative
value
of any
such
gains
or losses
recognized
in
Equity
associated
with the
entity
is reclassified
to
Other income
.
Interest Rate Benchmark Reform
UBS
can
continue
hedge
accounting
during
the
period
of
uncertainty before existing interest rate benchmarks are replaced
with
alternative
risk-free
interest
rates.
During
this
period,
UBS
can
assume
that
the
current
benchmark
rates
will
continue
to
exist,
such
that
forecast
transactions
are
considered
highly
probable
and
hedge
relationships
remain,
with
little
or
no
consequential
impact
on
the
financial
statements.
Upon
replacement
of
existing
interest
rate
benchmarks
by
alternative
risk-free
interest
rates
expected
in
2021
and
beyond,
UBS
will
apply the requirements of
Amendments to IFRS 9, IAS 39, IFRS 7,
IFRS 4 and IFRS 16 (Interest Rate Benchmark Reform – Phase 2).
›
Refer to Note 1b for more information
3) Fee and commission income and expenses
UBS
earns
fee
income
from
the
diverse
range
of
services
it
provides to its
clients. Fee income can
be divided into two
broad
categories:
fees
earned
from
services
that
are
provided
over
a
certain
period
of
time,
such
as
management
of
clients’
assets,
custody
services
and
certain
advisory
services;
and
fees
earned
from
point-in-time
services,
such
as
underwriting
fees,
deal-
contingent
merger
and
acquisitions
fees,
and
brokerage
fees
(e.g.,
securities
and
derivative
s
execution
and
clearing).
UBS
recognizes
fees
earned
from
point-in-time
services
when
it
has
fully
provided
the
service
to
the
customer.
Where
the
contract
requires
services to be
provided over
time, income
is recognized
on a systematic basis over the life of the agreement.
Consideration
received
is
allocated
to
the
separately
identifiable performance
obligations in
a contract.
Owing to
the
nature
of
UBS’s
business,
contracts
that
include
multiple
performance obligations are typically those that
are considered to
include
a
series of
similar performance
obligations fulfilled
over
time
with
the
same
pattern
of
transfer
to
the
client,
e.g.,
management
of
client
assets
and
custodial
services.
As
a
consequence, UBS is not
required to apply
significant judgment in
allocating
the
consideration
received
across
the
various
performance obligations.
303
Note 1
Summary of material accounting policies
(continued)
Point-in-time
services
are
generally
for
a
fixed
price
or
dependent on
deal size,
e.g., a
fixed number
of basis
points of
trade
size,
where
the
amount
of
revenue
is
known
when
the
performance
obligation
is
met.
Fixed
over-time
fees
are
recognized on
a straight-line
basis over
the performance period.
Custodial
and
asset
management
fees
can
be
variable
through
reference to the size of the customer portfolio. However,
they are
generally
billed
on
a
monthly
or
quarterly
basis
once
the
customer’s portfolio
size is
known or
known with
near certainty
and
therefore
also
recognized
ratably
over
the
performance
period.
UBS
does
not
recognize
performance
fees
related
to
management
of
clients’
assets
or
fees
related
to
contingencies
beyond UBS’s control until such uncertainties are resolved.
UBS’s fees are generally
earned from short-term contracts.
As
a result, UBS’s contracts do
not include a financing
component or
result in the
recognition of
significant receivables or
prepayment
assets.
Furthermore,
due
to
the
short-term
nature
of
such
contracts, UBS has not capitalized any material costs to obtain or
fulfill
a
contract
or
generated any
significant
contract
assets
or
liabilities.
UBS presents expenses primarily in line with their nature in the
income
statement,
differentiating
between
expenses
that
are
directly
attributable
to
the
satisfaction
of
specific
performance
obligations associated with the
generation of revenues, which
are
generally
presented
within
Total
operating
income
as
Fee
and
commission
expense
,
and
those
that
are
related
to
personnel,
general and administrative expenses,
which are presented within
Total operating
expenses
. For
derivatives execution
and clearing
services (where UBS
acts as an
agent), UBS only
records its specific
fees in the
income statement, with
fees payable to
other parties
not recognized
as an
expense but
instead directly
offset against
the associated income collected from the given client.
›
Refer to Note 4 for more information, including
the
disaggregation of revenues
4) Share-based and other deferred compensation plans
UBS recognizes expenses for deferred compensation awards over
the
period
that
the
employee
is
required
to
provide
service
to
become
entitled
to
the
award.
Where
the
service
period
is
shortened,
for
example
in
the
case
of
employees
affected
by
restructuring programs or
mutually agreed termination
provisions,
recognition
of
such
expense
is
accelerated
to
the
termination
date. Where no
future service is
required, such
as for employees
who are eligible for
retirement or who have
met certain age and
length-of-service criteria, the services are presumed to have been
received
and
compensation
expense
is
recognized
over
the
performance year or, in the case of off-cycle awards, immediately
on the grant date.
Share-based compensation plans
Share-based compensation
expense is
measured by
reference to
the
fair
value
of
the
equity
instruments
on
the
date
of
grant,
taking
into
account
the
terms
and
conditions
inherent
in
the
award,
including,
where
relevant,
dividend
rights,
transfer
restrictions in effect
beyond the vesting date,
market conditions,
and non-vesting conditions.
For equity-settled
awards, fair
value is
not remeasured
unless
the
terms
of
the
award
are
modified
such
that
there
is
an
incremental increase in value. Expenses
are recognized, on a per-
tranche basis, over the service period based
on an estimate of the
number
of
instruments
expected
to
vest
and
are
adjusted
to
reflect the actual outcomes of service or performance conditions.
For
equity-settled
awards,
forfeiture
events
resulting
from
a
breach of
a non-vesting
condition (i.e.,
one that
does not
relate
to
a
service
or
performance
condition)
do
not
result
in
any
adjustment to the share-based compensation expense.
For cash-settled
share-based awards,
fair value
is remeasured
at each reporting
date, so that
the cumulative
expense recognized
equals the cash distributed.
Other deferred compensation plans
Compensation expense for other deferred
compensation plans is
recognized on a
per-tranche or straight-line
basis, depending on
the nature of
the plan. The
amount recognized is
measured based
on the
present
value of
the amount
expected to
be paid
under
the
plan and
is remeasured
at each
reporting
date,
so that
the
cumulative expense
recognized equals
the cash
or the
fair value
of respective financial instruments distributed.
›
Refer to Note
28
for more information
Consolidated financial statements | UBS Group AG consolidated financial statements
304
Note 1
Summary of material accounting policies (continued)
5) Post-employment benefit plans
Defined benefit plans
Defined
benefit
plans
specify
an
amount
of
benefit
that
an
employee
will
receive,
which
usually
depends
on
one
or
more
factors,
such
as
age,
years
of
service
and
compensation.
The
defined
benefit
liability
recognized
in
the
balance
sheet
is
the
present value
of the
defined benefit
obligation, measured
using
the projected unit
credit method, less
the fair value of
the plan’s
assets
at
the
balance
sheet
date,
with
changes
resulting
from
remeasurements
recorded
immediately
in
Other
comprehensive
income
.
If
the
fair
value
of
the plan
’s assets
is
higher
than
the
present value of the
defined benefit obligation, the
recognition of
the resulting net asset is limited to the present value of economic
benefits
available
in
the
form
of
refunds
from
the
plan
or
reductions in future
contributions to the plan.
Calculation of the
net
defined
benefit
obligation
or
asset
takes
into
account
the
specific
features
of
each
plan,
including
risk
sharing
between
employee
and
employer,
and
is
calculated
periodically
by
independent qualified actuaries.
Critical accounting estimates and judgment
s
The net defined benefit liability or asset at the balance sheet date and the
related personnel expense
depend on the
expected future benefits
to be
provided,
determined
using
a
number
of
economic
and
demographic
assumptions.
A
range
of
assumptions
could
be
applied,
and
different
assumptions could
significantly alter
the defined
benefit liability
or asset
and pension expense
recognized. The most
significant assumptions
include
life expectancy, discount rate, expected salary increases, pension increases
and
interest
credits
on
retirement
savings
account
balances.
Sensitivity
analysis for reasonable possible movements in each significant
assumption
for UBS‘s post-employment obligations is provided
in Note 27.
›
Refer
to Note 27
for more information
Defined contribution plans
A
defined
contribution
plan
pays
fixed
contributions
into
a
separate entity
from which
post-employment and other
benefits
are paid. UBS
has no
legal or
constructive obligation
to pay
further
amounts
if
the
plan
does
not
hold
sufficient
assets
to
pay
employees the benefits relating
to employee service in
the current
and prior periods. Compensation expense
is recognized when the
employees have rendered
services in exchange for
contributions.
This is generally in the year of contribution. Prepaid contributions
are recognized
as an
asset to
the extent that
a cash
refund or
a
reduction in future payments is available.
6) Income taxes
UBS is subject to the income tax laws
of Switzerland and those of
the non-Swiss jurisdictions in which UBS has business operations.
The Group’s provision for income
taxes is composed of current
and deferred
taxes. Current
income taxes
represent taxes
to be
paid or refunded for the current period or previous periods.
Deferred
taxes
are
recognized
for
temporary
differences
between
the
carrying
amounts
and
tax
bases
of
assets
and
liabilities that will
result in taxable
or deductible amounts
in future
periods and are measured using the applicable tax rates and laws
that have been
enacted or substantively
enacted by the
end of the
reporting period and that
will be in effect when
such differences
are expected to reverse.
Deferred
tax
assets arise
from a
variety
of
sources, the
most
significant being:
(i) tax
losses that
can be
carried forward
to be
used against profits in future years; and (ii) temporary differences
that
will
result
in
deductions
against
profits
in
future
years.
Deferred tax assets
are recognized only to
the extent it
is probable
that sufficient taxable profits will be
available against which these
differences can be
used. When an
entity or tax
group has a
history
of
recent
losses,
deferred
tax
assets
are
only
recognized
to
the
extent there are
sufficient taxable temporary differences
or there
is convincing
other evidence
that sufficient
taxable profit
will be
available against which the unused tax losses can be utilized.
Deferred tax liabilities
are recognized for
temporary differences
between
the
carrying
amounts
of
assets
and
liabilities
in
the
balance sheet
that reflect
the expectation
that certain
items will
give rise to taxable income in future periods.
Deferred and current tax assets and
liabilities are offset when:
(i) they arise in the
same tax reporting group; (ii)
they relate to the
same tax authority; (iii)
the legal right to
offset exists; and (iv)
they
are intended to be settled net or realized simultaneously.
Current
and
deferred
taxes
are
recognized
as
income
tax
benefit
or
expense in
the income
statement,
except for
current
and deferred taxes recognized in relation to:
(i) the acquisition of
a subsidiary (for which such amounts would
affect the amount of
goodwill arising from the acquisition); (ii) gains
and losses on the
sale of
treasury shares
(for which
the tax
effects are
recognized
directly
in
Equity
);
(iii)
unrealized
gains
or
losses
on
financial
instruments that are classified at
FVOCI; (iv) changes in fair
value
of
derivative
instruments
designated
as
cash
flow
hedges;
(v)
remeasurements
of defined
benefit plans;
or (vi)
certain foreign
currency translations
of foreign
operations. Amounts
relating to
points
(iii)
through
(vi)
above
are
recognized
in
Other
comprehensive income
within
Equity
.
UBS reflects
the potential effect
of uncertain tax
positions for
which acceptance by
the relevant tax
authority is not
considered
probable
by
adjusting
current
or
deferred
taxes,
as
applicable,
using either
the most
likely amount
or expected
value methods,
depending on which method is deemed a
better predictor of the
basis
on
which,
and
extent
to
which,
the
uncertainty
will
be
resolved.
305
Note 1
Summary of material accounting policies (continued)
Critical accounting estimates and judgments
Tax
laws
are
complex,
and
judgment
and
interpretations
about
the
application of such
laws are required
when accounting for
income taxes.
UBS
considers
the
performance
of
its
businesses
and
the
accuracy
of
historical forecasts and other factors when evaluating the recoverability of
its
deferred
tax
assets,
including
the
remaining
tax
loss
carry-forward
period, and its
assessment of expected
future taxable profits
in the forecast
period
used
for
recognizing
deferred
tax
assets.
Estimating
future
profitability
and
business
plan
forecasts
is
inherently
subjective
and
is
particularly sensitive to future economic,
market and other conditions.
Forecasts are reviewed
annually, but adjustments
may be made
at other
times, if required. If recent losses have been incurred, convincing evidence
is required to prove there is sufficient future profitability given the
value of
UBS’s deferred tax
assets may
be affected, with
effects primarily
recognized
through the income statement.
In
addition,
judgment
is
required
to
assess
the
expected
value
of
uncertain
tax
positions
and
the
related
probabilities,
including
interpretation of tax laws,
the resolution of any income
tax-related appeals
and litigation.
›
Refer to Note 8 for more information
7) Property, equipment and software
Property,
equipment
and
software
is
measured
at
cost
less
accumulated
dep
reciation
and
impairment
losses
.
Software
development
costs
are
capitalized
only
when
the
costs
can
be
measured reliably and it is
probable that future economic
benefits
will
arise.
Depreciation
of
property,
equipment
and
software
begins
when
they
are
available
for
use
and
is
calculated
on
a
straight line basis over an asset’s estimated useful life.
Property,
equipment
and
software
are
generally
tested
for
impairment
at
the
appropriate
cash
-
generating
unit
level,
alongside goodwill and intangible assets as described in item 8 in
this Note.
An impairment
charge is
recognized for
such assets
if
the
recoverable
amount
is
below
its
carrying
amount
.
The
recoverable amounts of such assets, other than property that has
a market price,
are generally determined
using a replacement
cost
approach
that
reflects
the
amount
that
would
be
currently
required by a market participant to replace the service capacity
of
the
asset.
If
such
assets
are
no
longer
used,
they
are
tested
individually for impairment.
›
Refer to Note
12
for more information
8) Goodwill
Goodwill represents the
excess of
the consideration over the
fair
value
of
identifiable
assets,
liabilities
and
contingent
liabilities
acquired
that
arises
in
a
business combination.
Goodwill is
not
amortized,
but
is
assessed
for
impairment
at
the
end
of
each
reporting period,
or when indicators
of impairment
exist.
UBS tests
goodwill for impairment annually,
irrespective of whether there is
any indication
of impairment.
An impairment charge
is recognized in the income
statement if
the carrying
amount exceeds
the recoverable
amount.
Critical accounting estimates and judgments
UBS‘s methodology for
goodwill impairment testing is
based on a
model
that
is
most
sensitive
to
the
following
key
assumptions:
(i)
forecasts
of
earnings available to shareholders in years one to three; (ii) changes in the
discount rates; and (iii) changes in the long-term
growth rate.
Earnings available
to shareholders
are estimated
on the basis
of forecast
results,
which
are
part
of
the
business
plan
approved
by
the
Board
of
Directors.
The
discount
rates
and
growth
rates
are
determined
using
external information, and
also considering inputs
from both
internal and
external analysts and the view of management.
The
key assumptions
used
to determine
the recoverable
amounts of
each cash-generating unit are tested for sensitivity by applying reasonably
possible changes to those assumptions.
›
Refer to Notes
2
and
13
for more information
9) Provisions and contingent liabilities
Provisions
are
liabilities
of
uncertain
timing
or
amount,
and
are
generally
recognized
in
accordance
with
IAS
37,
Provisions,
Contingent Liabilities and Contingent Assets
, when: (i) UBS has a
present obligation as a
result of a
past event; (ii) it
is probable that
an outflow
of resources will
be required
to settle
the obligation;
and (iii) a reliable estimate
of the amount of the
obligation can be
made.
The majority of UBS’s provisions
relate to litigation, regulatory
and
similar
matters,
restructuring,
and
employee
benefits.
Restructuring
provisions
are
generally
recognized
as
a
consequence of
management agreeing
to materially
change the
scope
of
the
business
or
the
manner
in
which
it
is
conducted,
including
changes
in
management
structures.
Provisions
for
employee
benefits
relate
mainly
to
service
anniversaries
and
sabbatical
leave,
and
are
recognized
in
accordance
with
measurement principles set out in item 4
in this Note. In addition,
UBS presents
expected credit loss
allowances within
Provisions
if
they relate to a loan commitment,
financial guarantee contract or
a revolving revocable credit line.
IAS 37 provisions are
measured considering the
best estimate
of the
consideration required
to settle
the present
obligation at
the balance sheet date.
When conditions required
to recognize
a provision
are not met,
a
contingent
liability
is
disclosed,
unless
the
likelihood
of
an
outflow
of
resources
is
remote.
Contingent
liabilities
are
also
disclosed for
possible obligations that
arise from past
events the
existence
of
which
will
be
confirmed
only
by
uncertain
future
events not wholly within the control of UBS.
Consolidated financial statements | UBS Group AG consolidated financial statements
306
Note 1
Summary of material accounting policies
(continued)
Critical accounting estimates and judgments
Recognition of provisions
often involves significant judgment
in assessing
the
existence
of
an
obligation
that
results
from
past
events
and
in
estimating the
probability, timing and
amount of
any outflows
of resources.
This
is particularly
the case
for litigation,
regulatory and
similar matters,
which, due to their nature,
are subject to many uncertainties,
making their
outcome
difficult to predict.
The amount of any provision
recognized is sensitive to the
assumptions
used
and
there
could
be
a
wide
range
of
possible
outcomes
for
any
particular matter.
Management regularly reviews
all the available
information regarding
such
matters,
including
legal
advice,
to
assess
whether
the
recognition
criteria for provisions have been satisfied and to determine the timing and
amount of any potential outflows
.
›
Refer to Note
18
for more information
10) Foreign currency translation
Transactions
denominated
in
a
foreign
currency
are
translated
into
the
functional
currency
of
the
reporting
entity
at
the
spot
exchange rate
on the
date of
the transaction.
At the
balance sheet
date, all monetary
assets, including those
at FVOCI, and
monetary
liabilities denominated in foreign currency
are translated into the
functional currency
using the
closing exchange
rate. Translation
differences
are
reported
in
Other
net
income
from
financial
instruments measured at fair value through profit or loss
.
Non-monetary items measured at historical cost are translated
at the exchange rate on the date of the transaction.
Upon consolidation, assets and liabilities of
foreign operations
are translated into US
dollars, UBS’s presentation currency, at the
closing exchange rate
on the balance sheet date, and income
and
expense items and other comprehensive income are translated at
the
average
rate
for
the
period.
The
resulting
foreign
currency
translation differences are recognized in
Equity
and reclassified to
the
income
statement when
UBS
disposes of,
partially or
in
its
entirety,
the
foreign
operation and
UBS
no
longer
controls
the
foreign operation.
Share
capital
issued,
share premium
and treasury
shares held
are
translated
at the historic
average rate,
with
the difference
between
the historic
average rate
and the
spot rate
realized
upon repayment
of
share capital
or
disposal of
treasury shares
reported as
Share
premium.
Cumulative
amounts
recognized
in
Other comprehensive
income
in
respect
of
cash
flow
hedg
es
and
financial
assets
measured at FVOCI are translated at the closing exchange rate as
of the
balance sheet
dates, with
any translation effects
adjusted
through
Retained earnings
.
›
Refer to Note 33 for more information
11) Equity, treasury shares and contracts on UBS Group AG
shares
UBS Group AG shares held (treasury shares)
UBS
Group
AG
shares
held
by
the
Group,
including
those
purchased
as
part of
market-making activities,
are
presented
in
Equity
as
Treasury
shares
at
their
acquisition
cost
and
are
deducted
from
Equity
until
they
are
canceled
or
reissued.
The
difference
between
the
proceeds
from
sales
of
treasury
shares
and their weighted average cost (net of tax, if any)
is reported as
Share premium
.
Net cash settlement contracts
Contracts involving
UBS Group
AG shares
that require
net cash
settlement, or provide the counterparty or UBS with a settlement
option that includes a choice of settling net in cash, are classified
as derivatives held for trading.
307
Note 1
Summary of material accounting policies (continued)
b)
Changes in accounting policies, comparability and other adjustments
Amendments to IAS 1,
Presentation of Financial Statements
, and
IFRS Practice Statement 2,
Making Materiality Judgements
Effective from 1 January
2021, UBS early
adopted amendments to
IAS 1,
Presentation
of
Financial
Statements
,
and
IFRS
Practice
Statement 2,
Making
Materiality
Judgements
, issued
by
IASB in
February 2021.
The disclosure
of material
accounting policies
in
Note 1a has been refined through adopting these amendments.
Amendments to IAS 39, IFRS 9 and IFRS 7 (
Interest Rate
Benchmark Reform – Phase 2
)
On
1 January
2021,
UBS
adopted
Interest
Rate
Benchmark
Reform – Phase
2 (Amendments to
IFRS 9, IAS 39, IFRS 7,
IFRS 4
and IFRS 16)
, addressing a number of issues in financial reporting
areas that arise
when interbank
offered rates (IBORs)
are reformed
or replaced.
The amendments
provide a
practical expedient
that
permits
certain
changes
in
the
contractual
cash
flows
of
debt
instruments
attributable
to
the
replacement
of
IBORs
with
alternative
reference
rates
(ARRs)
to
be
accounted
for
prospectively by
updating a
given instrument’s
effective interest
rate
(EIR),
provided
(i)
the
change
is
necessary
as
a
direct
consequence
of
IBOR
reform
and
(ii)
the
new
basis
for
determining the contractual cash
flows is economically equivalent
to the
previous basis.
UBS has
adopted the
amendments, which
had no material effect on the Group’s financial statements.
T
he
amendments
also
provide
various
hedge
accounting
reliefs, with the following adopted by UBS:
–
D
esignate
an
ARR
as
a
non
-
contractually
specified
risk
component, even if it is
not separately identifiable at the
date
when it
was designated, provided
UBS can reasonably
expect
that it will meet
the requirements within 24
months of the first
designation and the risk component is reliably
measurable. As
of
31 December
2021,
the
principal
ARRs
that
UBS
has
designated as
the hedged risk
in fair
value hedges
of interest
rate risk related to debt instruments, mortgages and
cash flow
hedges
of
forecast
transactions
were
the
Secured
Overnight
Financing
Rate
(SOFR),
the
Swiss
Average
Rate
Overnight
(SARON) and the Sterling Overnight Index Average (SONIA).
–
Amend
hedge
documentation
for
the
fair
value
hedges
of
interest
rate
risk
related
to
debt
instruments
for
which
the
hedged risk changed due
to IBOR reform,
which allowed UBS
to
continue
the
hedge
relationship
in
accordance
with
the
requirements of the phase 2 amendment.
–
The
cash
flow
hedges
of
IBOR forecast
transactions
in
Swiss
francs
and
pounds
sterling
were
discontinued
and
replaced
with
new
ARR
designations in
December
2021. The
amount
accumulated in
the cash
flow hedge
reserve is
deemed to
be
based on the ARR on which the hedged future cash
flows will
be based.
Amounts will
be released
to the
income statement
when the forecast ARR
cash flows affect
the income statement
or are no longer expected to occur.
›
Refer to Note 26 for more information
The
amendments
also
introduced
additional
disclosure
requirements
regarding
the
Group’s
management
of
the
transition
to
alternative
benchmark
rates,
its
progress
as
at
the
reporting date
and the
risks to
which it
is exposed
arising from
financial instruments because of the transition.
›
Refer to Note 25 for more information
c)
International Financial Reporting Standards and Interpretations to be adopted in 2022 and later and other changes
IFRS 17,
Insurance Contracts
In May 2017, the IASB issued
IFRS 17,
Insurance Contracts
, which
sets out
the accounting
requirements
for contractual
rights and
obligations
that
arise
from
insurance
contracts
issued
and
reinsurance
contracts
held.
IFRS 17
is
effective
from
1 January
2023.
UBS
is
assessing
the
standard,
but
does
not
expect
it
to
have a material effect on the Group’s financial statements.
Consolidated financial statements | UBS Group AG consolidated financial statements
308
Note 2a
Segment reporting
UBS’s
businesses
are
organized
globally
into
four
business
divisions:
Global
Wealth
Management,
Personal
&
Corporate
Banking,
Asset Management
and the
Investment Bank.
All four
business divisions
are supported
by Group
Functions and
qualify
as
reportable
segments
for
the
purpose
of
segment
reporting.
Together with Group Functions, the four business divisions reflect
the management structure of the Group.
–
Global
Wealth
Management
provides
financial
services,
advice and solutions to private clients, in particular in the ultra
high
net
worth
and
high
net
worth
segments.
Its
offering
ranges from
investment management
to estate
planning and
corporate
finance
advice,
in
addition
to
specific
wealth
management
products
and
services.
The
business
division
is
managed globally across the regions.
–
Personal & Corporate Banking
serves its private, corporate,
and
institutional
client
s
’
needs
,
from
basic
banking
to
retirement, financing,
investments and
strategic transactions,
in
Switzerland
,
through
its
branch
network
and
digital
channels.
–
Asset
Management
is
a
large-scale
and
diversified
global
asset
manager.
It
offers
investment
capabilities
and
styles
across all major traditional
and alternative asset classes,
as well
as
advisory
support
to
institutions,
wholesale
intermediaries
and wealth management clients globally.
–
The
Investment
Bank
provides
a
range
of
services
to
institutional,
corporate
and
wealth
management
clients
globally,
to
help
them
raise
capital,
grow
their
businesses,
invest and manage risks. Its offering includes advisory services,
facilitating clients raising debt
and equity from the
public and
private
markets
and
capital
markets,
cash
and
derivatives
trading across equities and fixed income,
and financing.
–
Group
Functions
is
made
up
of
the
following
major
areas:
Group
Se
rvices
(
which
consists
of
Technology,
Corporate
Services,
Human
Resources
,
Finance,
Legal,
Risk
Control,
Compliance,
Regulatory
&
Governance,
Communications
&
Branding and Group
Sustainability and Impact),
Group Treasury
and Non-core and Legacy Portfolio.
Financial
information
about
the
four
business
divisions
and
Group Functions is presented
separately in internal management
reports
to
the
Group
Executive
Board
(the
GEB),
which
is
considered
the
“chief
operating
decision
maker”
pursuant
to
IFRS 8,
Operating Segments
.
UBS’s internal accounting policies,
which include management
accounting policies
and service
level agreements,
determine the
revenues
and
expenses
directly
attributable
to
each
reportable
segment.
Transactions
between
the
reportable
segments
are
carried
out
at
internally
agreed
rates
and
are
reflected
in
the
operating
results
of
the
reportable
segments.
Revenue-sharing
agreements
are
used
to
allocate
external
client
revenues
to
reportable
segments
where
several
reportable
segments
are
involved in the value
creation chain. Total intersegment
revenues
for the Group are immaterial, as the majority
of the revenues are
allocated
across
the
segments
by
means
of
revenue-sharing
agreements.
Interest
income
earned
from
managing
UBS’s
consolidated equity is allocated to the reportable
segments based
on
average
attributed
equity
and
currency
composition.
Assets
and liabilities of the reportable segments are funded
through and
invested
with
Group
Functions,
and
the
net
interest
margin
is
reflected in the results of each reportable segment.
Segment
assets
are
based
on
a
third-party
view
and
do
not
include intercompany
balances. This
view is
in line
with internal
reporting to the
GEB. If one
operating segment is
involved in an
external transaction together with another operating segment or
Group Functions,
additional criteria
are considered
to determine
the segment that
will report
the associated
assets. This
will include
a
consideration
of
which
segment’s
business
needs
are
being
addressed by the transaction and which segment is providing the
funding
and
/
or
resources.
Allocation
of
liabilities
follows
the
same principles.
Non-current
assets disclosed
for segment
reporting
purposes
represent assets that are expected
to be recovered more than
12
months after the reporting
date, excluding financial instruments,
deferred tax assets and post-employment benefits.
309
Note 2a
Segment reporting (continued)
USD million
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
UBS
For the year ended 31 December 2021
Net interest income
4,244
2,120
(
15
)
481
(
127
)
6,705
Non-interest income
15,175
2,143
2,632
8,972
(
233
)
28,689
Income
19,419
4,263
2,617
9,454
(
359
)
35,393
Credit loss (expense) / release
29
86
(
1
)
34
0
148
Total operating income
19,449
4,349
2,616
9,488
(
360
)
35,542
Total operating expenses
14,665
2,618
1,586
6,858
330
26,058
Operating profit / (loss) before tax
4,783
1,731
1,030
2,630
(
689
)
9,484
Tax expense / (benefit)
1,998
Net profit / (loss)
7,486
Additional information
Total assets
395,235
225,370
25,639
346,431
124,507
1,117,182
Additions to non-current assets
56
16
1
30
1,989
2,091
USD million
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
UBS
For the year ended 31 December 2020
Net interest income
4,027
2,049
(
17
)
284
(
481
)
5,862
Non-interest income
1
13,107
1,858
2,993
9,235
30
27,222
Income
17,134
3,908
2,975
9,519
(
452
)
33,084
Credit loss (expense) / release
(
88
)
(
257
)
(
2
)
(
305
)
(
42
)
(
694
)
Total operating income
17,045
3,651
2,974
9,214
(
494
)
32,390
Total operating expenses
13,026
2,392
1,519
6,732
567
24,235
Operating profit / (loss) before tax
4,019
1,259
1,455
2,482
(
1,060
)
8,155
Tax expense / (benefit)
1,583
Net profit / (loss)
6,572
Additional information
Total assets
367,714
231,657
28,589
369,683
128,122
1,125,765
Additions to non-current assets
5
12
385
150
2,294
2,847
USD million
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
UBS
For the year ended 31 December 2019
Net interest income
3,947
1,992
(
25
)
(
669
)
(
744
)
4,501
Non-interest income
12,426
1,744
1,962
7,968
367
24,467
Income
16,373
3,736
1,938
7,299
(
378
)
28,967
Credit loss (expense) / release
(
20
)
(
21
)
0
(
30
)
(
7
)
(
78
)
Total operating income
16,353
3,715
1,938
7,269
(
385
)
28,889
Total operating expenses
12,955
2,274
1,406
6,485
192
23,312
Operating profit / (loss) before tax
3,397
1,441
532
784
(
577
)
5,577
Tax expense / (benefit)
1,267
Net profit / (loss)
4,310
Additional information
Total assets
309,766
209,405
34,565
315,855
102,603
972,194
Additions to non-current assets
68
10
0
1
5,217
5,297
1 Includes a USD
631
million net gain on the sale of a majority stake
in Fondcenter AG (now Clearstream Fund Centre
AG), of which USD
571
million was recognized in Asset Management and USD
60
million was
recognized in Global Wealth Management.
Consolidated financial statements | UBS Group AG consolidated financial statements
310
Note 2b
Segment reporting by geographic location
The
operating
regions
shown
in
the
table
below
correspond to
the regional management
structure of the
Group. The allocation
of
operating
income
to
these regions
reflects,
and
is consistent
with,
the
basis
on
which
the
business
is
managed
and
its
performance is
evaluated. These
allocations involve
assumptions
and judgments that
management considers to
be reasonable, and
may
be
refined
to
reflect
changes in
estimates
or
management
structure. The
main principles of
the allocation
methodology are
that
client
revenues
are
attributed
to
the
domicile
of
the
given
client
and
trading
and
portfolio
management
revenues
are
attributed to the country where the
risk is managed. This revenue
attribution
is
consistent
with
the
mandate
of
the
regional
Presidents.
Certain
revenues, such
as
those
related
to Non-core
and Legacy Portfolio in
Group Functions, are managed
at a Group
level. These revenues are included in the
Global
line.
The geographic analysis
of non-current assets
is based on
the
location of the entity in which the given assets are recorded.
For the year ended 31 December 2021
Total operating income
Total non-current assets
USD billion
Share %
USD billion
Share %
Americas
14.5
41
9.0
44
of which: USA
13.5
38
8.5
41
Asia Pacific
6.5
18
1.5
7
Europe, Middle East and Africa (excluding Switzerland)
7.0
20
2.9
14
Switzerland
7.9
22
7.1
35
Global
(
0.3
)
(
1
)
0.0
0
Total
35.5
100
20.5
100
For the year ended 31 December 2020
Total operating income
Total non-current assets
USD billion
Share %
USD billion
Share %
Americas
13.0
40
9.0
42
of which: USA
11.7
36
8.4
40
Asia Pacific
6.0
18
1.5
7
Europe, Middle East and Africa (excluding Switzerland)
6.5
20
3.0
14
Switzerland
6.9
21
7.6
36
Global
0.1
0
0.0
0
Total
32.4
100
21.1
100
For the year ended 31 December 2019
Total operating income
Total non-current assets
USD billion
Share %
USD billion
Share %
Americas
12.0
42
8.9
44
of which: USA
10.9
38
8.5
42
Asia Pacific
4.7
16
1.4
7
Europe, Middle East and Africa (excluding Switzerland)
5.8
20
3.0
15
Switzerland
6.7
23
7.1
35
Global
(
0.3
)
(
1
)
0.0
0
Total
28.9
100
20.3
100
311
Income statement notes
Note 3
Net interest
income and other
net income
from financial
instruments
measured at
fair value
through profit
or loss
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Net interest income from financial instruments measured
at fair value through profit or loss
1,431
1,299
1,011
Other net income from financial instruments measured
at fair value through profit or loss
5,850
6,960
6,842
of which: net gains / (losses) from financial liabilities designated
at fair value
1
(
6,582
)
1,509
(
8,748
)
Total net income from financial instruments measured at fair value through profit or loss
7,281
8,259
7,853
Net interest income
Interest income from loans and deposits
2
6,488
6,690
8,008
Interest income from securities financing transactions
3
513
862
2,005
Interest income from other financial instruments measured
at amortized cost
284
335
364
Interest income from debt instruments measured at fair
value through other comprehensive income
115
101
120
Interest income from derivative instruments designated as cash
flow hedges
1,133
822
188
Total interest income from financial instruments measured at amortized cost and fair
value through other comprehensive income
8,533
8,810
10,684
Interest expense on loans and deposits
4
523
1,031
2,634
Interest expense on securities financing transactions
5
1,102
870
1,152
Interest expense on debt issued
1,533
2,237
3,285
Interest expense on lease liabilities
102
110
122
Total interest expense from financial instruments measured at amortized cost
3,259
4,247
7,194
Total net interest income from financial instruments measured at amortized cost and fair
value through other comprehensive income
5,274
4,563
3,490
Total net interest income from financial instruments measured at fair value through profit or loss
1,431
1,299
1,011
Total net interest income
6,705
5,862
4,501
1 Excludes fair value changes of hedges related to financial liabilities designated at fair value and foreign currency translation effects arising from translating foreign currency transactions into the respective functional
currency, both of which are reported within Other net income from financial instruments measured at fair value through profit or loss.
2021 included net losses of USD
2,068
million (net losses of USD
72
million and
USD
1,830
million in 2020 and 2019,
respectively), driven by financial liabilities
related to unit-linked investment
contracts, which are
designated at fair value
through profit or loss.
This was offset
by net gains of
USD
2,068
million (net gains
of USD
72
million and USD
1,830
million in 2020
and 2019, respectively),
related to financial
assets for unit-linked
investment contracts that
are mandatorily measured
at fair value
through profit or loss not
held for trading.
2 Consists of interest income
from cash and balances at
central banks, loans and advances to banks and
customers, and cash collateral receivables on derivative instruments,
as well as negative interest on amounts due to banks, customer deposits, and cash collateral payables on derivative
instruments.
3 Includes interest income on receivables from securities financing transactions and
negative interest, including
fees, on
payables from
securities financing
transactions.
4 Consists
of interest
expense on
amounts due
to banks,
cash collateral
payables on
derivative instruments,
and customer
deposits, as well as negative
interest on cash and balances
at central banks, loans
and advances to banks,
and cash collateral receivables
on derivative instruments.
5 Includes interest expense on
payables from
securities financing transactions and negative interest, including fees, on receivables from securities
financing transactions.
Consolidated financial statements | UBS Group AG consolidated financial statements
312
Note 4
Net fee and commission income
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Fee and commission income
Underwriting fees
1,463
1,085
741
M&A and corporate finance fees
1,102
736
774
Brokerage fees
4,382
4,132
3,248
Investment fund fees
5,790
5,289
4,858
Portfolio management and related services
9,762
8,009
7,656
Other
1,874
1,710
1,832
Total fee and commission income
1
24,372
20,961
19,110
of which: recurring
15,410
13,009
12,544
of which: transaction-based
8,692
7,491
6,402
of which: performance-based
269
461
163
Fee and commission expense
Brokerage fees paid
259
274
310
Distribution fees paid
611
589
590
Other
1,115
912
797
Total fee and commission expense
1,985
1,775
1,696
Net fee and commission income
22,387
19,186
17,413
of which: net brokerage fees
4,123
3,858
2,938
1 For the
year ended 31
December 2021, reflects
third-party fee and
commission income of
USD
14,545
million for Global
Wealth Management, USD
1,644
million for Personal
& Corporate Banking,
USD
3,337
million for Asset
Management, USD
4,814
million for
the Investment Bank
and USD
33
million for Group
Functions (for the
year ended
31 December 2020:
USD
12,475
million for Global
Wealth Management,
USD
1,426
million for Personal & Corporate Banking, USD
3,129
million for Asset Management, USD
3,882
million for the Investment Bank and USD
49
million for Group Functions; for the year ended 31 December
2019: USD
11,694
million for Global Wealth Management,
USD
1,307
million for Personal &
Corporate Banking, USD
2,659
million for Asset Management,
USD
3,355
million for the Investment Bank and
USD
94
million for Group Functions).
Note 5
Other income
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Associates, joint ventures and subsidiaries
Net gains / (losses) from acquisitions and disposals of
subsidiaries
1
(
11
)
635
2
(
36
)
Net gains / (losses) from disposals of investments in associates
41
0
4
Share of net profits of associates and joint ventures
105
84
46
Impairments related to associates
0
0
(
1
)
Total
135
719
13
Net gains / (losses) from disposals of financial assets measured
at fair value through other comprehensive income
9
40
31
Income from properties
3
23
26
27
Net gains / (losses) from properties held for sale
100
4
76
5
(
19
)
Other
185
6
216
7
160
Total other income
452
1,076
212
1 Includes foreign exchange gains
/ (losses) reclassified
from other comprehensive income
related to the disposal
or closure of foreign
operations.
2 Includes a USD
631
million net gain on
the sale of a
majority
stake in Fondcenter AG
(now Clearstream Fund Centre AG).
3 Includes rent received from third parties.
4 Mainly relates to the sale of a
property in Basel.
5 Includes net gains of USD
140
million arising from
sale-and-leaseback transactions, primarily
related to a property in
Geneva, partly offset by
remeasurement losses relating to properties
that were reclassified as held
for sale.
6 Includes a gain of
USD
100
million
from the sale of
UBS's domestic wealth management
business in Austria. Refer
to Note 30 for
more information.
7 Includes a
USD
215
million gain on the
sale of intellectual property
rights associated with the
Bloomberg Commodity Index family.
313
Note 6
Personnel expenses
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Salaries
1
7,339
7,023
6,518
Variable compensation – performance awards
2
3,190
3,209
3
2,755
Variable compensation – other
2
229
220
246
Financial advisor compensation
2,4
4,860
4,091
4,043
Contractors
381
375
381
Social security
978
899
3
799
Post-employment benefit plans
5
833
6
845
787
of which: defined benefit plans
470
502
461
of which: defined contribution plans
363
343
326
Other personnel expenses
576
561
3
555
Total personnel expenses
18,387
17,224
16,084
1 Includes role-based allowances.
2 Refer to Note 28 for more information.
3 During 2020, UBS modified the conditions for continued vesting of certain
outstanding deferred compensation awards for qualifying
employees, resulting in an
expense of approximately USD
280
million, of which USD
240
million is disclosed within Variable
compensation – performance awards,
USD
20
million within Social security and
USD
20
million within
Other personnel
expenses.
4 Financial
advisor compensation
consists of
grid-based
compensation based
directly on
compensable
revenues generated
by financial
advisors and
supplemental
compensation calculated on the basis
of financial advisor productivity,
firm tenure, assets and
other variables. It
also includes expenses related
to compensation commitments with financial
advisors entered into at
the time of
recruitment that are
subject to vesting
requirements.
5 Refer to
Note 27 for
more information.
6 Includes curtailment gains
of USD
80
million, which represent
a reduction in
the defined benefit
obligation related to the Swiss pension plan resulting from a decrease in headcount following restructuring activities.
Note 7
General and administrative expenses
1
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Outsourcing costs
893
951
1,072
IT expenses
1,055
949
860
Consulting, legal and audit fees
540
646
850
Real estate and logistics costs
634
671
662
Market data services
417
413
414
Marketing and communication
242
217
270
Travel and entertainment
72
84
298
Litigation, regulatory and similar matters
2
911
197
165
Other
788
757
696
of which: UK and German bank levies
3
58
55
41
Total general and administrative expenses
5,553
4,885
5,288
1 In 2021, UBS changed
the presentation of the line
items within general and administrative expenses. Prior-period
information reflects the new presentation
structure, with no effect on Total general
and administrative
expenses.
2 Reflects the net increase in provisions for litigation, regulatory and similar matters recognized in the income statement. Refer to Note 18 for more information. Also, includes recoveries from third parties
of USD
1
million in 2021 (USD
3
million and USD
11
million in 2020 and 2019, respectively).
3 UK bank levy expenses of USD
22
million (USD
38
million for 2020 and USD
30
million for 2019) included a credit of
USD
16
million (USD
27
million for 2020 and USD
31
million for 2019) related to prior years.
Consolidated financial statements | UBS Group AG consolidated financial statements
314
Note 8
Income taxes
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Tax expense / (benefit)
Swiss
Current
680
482
365
Deferred
34
116
265
Total Swiss
714
598
630
Non-Swiss
Current
884
749
426
Deferred
400
236
211
Total non-Swiss
1,284
985
637
Total income tax expense / (benefit) recognized in the income statement
1,998
1,583
1,267
Income tax recognized in the income statement
Income
tax
expenses
of
USD
1,998
million
were
recognized
for
the Group
in 2021, representing
an effective
tax rate of
21.1
%.
These included
Swiss tax
expenses of
USD
714
million and
non-
Swiss tax expenses of USD
1,284
million.
The
Swiss
tax
expenses
included
current
tax
expenses
of
USD
680
million related to taxable profits of UBS Switzerland AG
and other Swiss entities.
They also included deferred tax
expenses
of
USD
34
million,
which
reflect
movements
in
temporary
differences.
The non-Swiss
tax expenses
included current
tax expenses
of
USD
884
million
related
to
taxable
profits
earned
by
non-Swiss
subsidiaries
and
branches
,
and
net
deferred
t
ax
expenses
of
USD
400
million.
Expenses
of
USD
734
million,
which
primarily
related to
the amortization
of deferred
tax assets
(DTAs) previously
recognized in relation to
tax losses carried
forward and deductible
temporary differences of UBS Americas Inc.,
were partly offset by
a benefit of USD
334
million in respect of
the remeasurement of
DTAs.
This
benefit
included
upward
revaluations
of
DTAs
of
USD
152
million for certain
entities, primarily in
connection with
our business planning process. It also included
USD
113
million in
respect of additional DTA recognition that primarily related to the
contribution of real estate assets by UBS AG to
UBS Americas Inc.
and UBS Financial Services
Inc., which allowed the
full recognition
of DTAs in respect of the associated historic
real estate costs that
were
previously
capitalized
for
US
tax
purposes
under
elections
that
were
made
in
the
fourth
quarter
of
2018.
In
addition,
it
included USD
69
million in respect of an increase in the expected
value of future tax
deductions for deferred
compensation awards,
due to an increase in the Group’s share price during the year.
The pre-tax expense that was recognized in the year in respect
of the increase in litigation provisions for
the French cross-border
matter did not result in any tax benefit.
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Operating profit / (loss) before tax
9,484
8,155
5,577
of which: Swiss
3,334
3,403
2,571
of which: non-Swiss
6,150
4,752
3,006
Income taxes at Swiss tax rate of
18.5
% for 2021,
19.5
% for 2020 and
20.5
% for 2019
1,755
1,590
1,143
Increase / (decrease) resulting from:
Non-Swiss tax rates differing from Swiss tax rate
234
110
82
Tax effects of losses not recognized
124
144
131
Previously unrecognized tax losses now utilized
(
179
)
(
212
)
(
265
)
Non-taxable and lower-taxed income
(
278
)
(
394
)
(
351
)
Non-deductible expenses and additional taxable income
510
385
732
Adjustments related to prior years – current tax
(
40
)
(
67
)
(
5
)
Adjustments related to prior years – deferred tax
(
10
)
12
(
6
)
Change in deferred tax recognition
(
342
)
(
381
)
(
294
)
Adjustments to deferred tax balances arising from changes
in tax rates
(
5
)
234
(
9
)
Other items
231
161
107
Income tax expense / (benefit)
1,998
1,583
1,267
315
Note 8
Income taxes (continued)
The components of operating profit before tax, and the differences between income tax expense reflected in the financial statements
and the amounts calculated at the Swiss tax rate, are provided in the table on the previous page and explained below.
Component
Description
Non-Swiss tax rates
differing from Swiss tax
rate
To the extent that Group profits or losses arise outside Switzerland, the applicable local tax
rate may differ from the Swiss tax
rate. This item reflects, for such profits, an adjustment
from the tax expense that would arise at the
Swiss tax rate to the tax
expense that would arise at the applicable local
tax rate. Similarly, it reflects, for such losses, an adjustment from the tax
benefit that would arise at the Swiss tax rate
to the tax benefit that would arise at the
applicable local tax rate.
Tax effects of losses not
recognized
This item relates to tax losses of entities arising in the
year that are not recognized as DTAs and where no tax benefit arises in
relation to those losses. Therefore, the tax benefit calculated
by applying the local tax rate to those losses
as described above
is reversed.
Previously unrecognized
tax losses now utilized
This item relates to taxable profits of the year that are offset by tax losses
of previous years for which no DTAs were previously
recorded. Consequently, no current tax or deferred tax expense arises in relation to those taxable
profits and the tax expense
calculated by applying the local tax rate on
those profits is reversed.
Non-taxable and lower-
taxed income
This item relates to tax deductions for the year in
respect of permanent differences. These include deductions in
respect of
profits that are either not taxable or are taxable at a lower rate
of tax than the local tax rate. They also
include deductions
made for tax purposes, which are not reflected in the
accounts.
Non-deductible expenses
and additional taxable
income
This item relates to additional taxable income for
the year in respect of permanent differences. These include
income that is
recognized for tax purposes by an entity but is not
included in its profit that is reported in the financial
statements, as well as
expenses for the year that are non-deductible (e.g.,
client entertainment costs are not deductible
in certain locations).
Adjustments related to
prior years – current tax
This item relates to adjustments to current tax expense for
prior years (e.g., if the tax payable for a year is
agreed with the tax
authorities in an amount that differs from the amount previously
reflected in the financial statements).
Adjustments related to
prior years – deferred tax
This item relates to adjustments to deferred tax positions
recognized in prior years (e.g., if a tax loss
for a year is fully
recognized and the amount of the tax loss agreed with
the tax authorities is expected to differ from the
amount previously
recognized as DTAs in the accounts).
Change in deferred tax
recognition
This item relates to changes in DTAs, including changes in DTAs previously recognized resulting from reassessments of
expected future taxable profits. It also includes changes
in temporary differences in the year, for which deferred tax is not
recognized.
Adjustments to deferred
tax balances arising from
changes in tax rates
This item relates to remeasurements of DTAs and liabilities recognized due to changes
in tax rates. These have the effect of
changing the future tax saving that is expected from tax
losses or deductible tax differences and therefore the amount
of
DTAs recognized or, alternatively,
changing the tax cost of additional taxable income
from taxable temporary differences and
therefore the deferred tax liability.
Other items
Other items include other differences between profits or losses
at the local tax rate and the actual local tax
expense or
benefit, including movements in provisions for uncertain
positions in relation to the current year and other items.
Income tax recognized directly in equity
A net tax
benefit of USD
479
million was recognized
in
Other comprehensive income
(2020: net expense
of USD
237
million) and a
net tax expense of USD
88
million was recognized in
Share premium
(2020: benefit of USD
18
million).
Consolidated financial statements | UBS Group AG consolidated financial statements
316
Note 8
Income taxes (continued)
Deferred tax assets and liabilities
The Group has gross
DTAs, valuation
allowances and recognized
DTAs related to tax loss carry-forwards and deductible temporary
differences,
and also
deferred tax
liabilities in
respect of
taxable
temporary differences, as
shown in the
table below. The valuation
allowances reflect DTAs
that were not recognized
because, as of
the last
remeasurement period,
management did not
consider it
probable
that
there
would
be
sufficient
future
taxable
profits
available
to
utilize
the
related
tax
loss
carry
-
forwards
and
deductible temporary differences.
The
recognition of
DTAs is
supported by
forecasts of
taxable
profits
for
the
entities
concerned.
In
addition,
tax
planning
opportunities are
available that
would result
in additional
future
taxable income and these would be utilized, if necessary.
Deferred tax liabilities are recognized in respect of investments
in
subsidiaries,
branches
and
associates,
and
interests
in
joint
arrangements,
except
to
the extent
that the
Group can
control
the
timing
of
the
reversal
of
the
associated
taxable
temporary
difference
and
it
is
probable
that
such
will
not
reverse
in
the
foreseeable
future.
However,
as
of
31
December
202
1
,
this
exception was not
considered to apply
to any taxable
temporary
differences.
USD million
31.12.21
31.12.20
Deferred tax assets
1
Gross
Valuation
allowance
Recognized
Gross
Valuation
allowance
Recognized
Tax loss carry-forwards
13,636
(
9,193
)
4,443
14,108
(
8,715
)
5,393
Temporary differences
5,133
(
700
)
4,433
4,384
(
565
)
3,819
of which: related to real estate costs capitalized for US
tax
purposes
2,272
0
2,272
2,268
0
2,268
of which: related to compensation and benefits
1,222
(
209
)
1,013
1,128
(
173
)
955
of which: other
1,639
(
491
)
1,148
989
(
392
)
564
Total deferred tax assets
18,769
(
9,893
)
8,876
2
18,492
(
9,280
)
9,212
2
of which: related to the US
8,521
8,780
of which: related to other locations
355
431
Deferred tax liabilities
Cash flow hedges
118
425
Other
183
139
Total deferred tax liabilities
300
564
1 After offset of DTLs, as applicable.
2 As of 31 December 2021, the Group recognized DTAs
of USD
77
million (31 December 2020: USD
138
million) in respect of entities that incurred losses in either
the current
or preceding year.
In general, US federal tax losses
incurred prior to 31 December
2017 can be
carried forward for
20 years. However,
US federal tax
losses incurred after 31 December 2017 and UK tax losses can be
carried forward indefinitely, although
the utilization of
such losses
is limited to 80% of the entity’s
future year taxable profits for the
US and generally to 25% thereof for
the UK. The amounts of US
tax
loss
carry-forwards
that are
included
in the
table below
are
based
on their
amount for
federal tax
purposes
rather than
for
state and local tax purposes.
Unrecognized tax loss carry-forwards
USD million
31.12.21
31.12.20
Within 1 year
141
146
From 2 to 5 years
1,026
638
From 6 to 10 years
13,283
13,257
From 11 to 20 years
2,093
3,858
No expiry
18,147
17,227
Total
34,690
35,127
of which: related to the US
1
14,870
16,256
of which: related to the UK
14,909
13,848
of which: related to other locations
4,911
5,023
1 Related to UBS AG's US branch.
317
Balance sheet notes
Note 9
Financial assets at amortized cost and other positions in scope of expected credit loss measurement
The
tables
on
the
following
pages
provide
information
about
financial
instruments and
certain credit
lines that
are
subject to
expected
credit
loss
(ECL)
requirements.
UBS’s
ECL
disclosure
segments or “ECL segments” are aggregated portfolios based on
shared
risk
characteristics
and
on
the
same
or
similar
rating
methods
applied.
The
key
segments
are
presented
in
the
table
below.
›
Refer to Note 20 for more information about
expected credit
loss measuremen
t
Segment
Segment description
Description of credit risk sensitivity
Business division / Group Functions
Private clients with
mortgages
Lending to private clients secured by
owner-occupied real estate and
personal account overdrafts of those
clients
Sensitive to the interest rate environment,
unemployment
levels, real estate collateral
values and other regional aspects
–
Personal & Corporate Banking
–
Global Wealth Management
Real estate financing
Rental or income-producing real estate
financing to private and corporate
clients secured by real estate
Sensitive to unemployment
levels, the
interest rate environment, real estate
collateral values and other regional
aspects
–
Personal & Corporate Banking
–
Global Wealth Management
–
Investment Bank
Large corporate clients
Lending to large corporate and multi-
national clients
Sensitive to GDP developments,
unemployment levels,
seasonality,
business cycles and collateral values
(diverse collateral,
including real estate
and other collateral types)
–
Personal & Corporate Banking
–
Investment Bank
SME clients
Lending to small and medium-sized
corporate clients
Sensitive to GDP developments,
unemployment levels, the interest rate
environment and, to some extent,
seasonality,
business cycles and collateral
values (diverse collateral,
including real
estate and other collateral types)
–
Personal & Corporate Banking
Lombard
Loans secured by pledges of marketable
securities, guarantees and other forms
of collateral
Sensitive to equity and debt markets
(e.g.,
changes in collateral values)
–
Global Wealth Management
Credit cards
Credit card solutions in Switzerland and
the US
Sensitive to unemployment levels
–
Personal & Corporate Banking
–
Global Wealth Management
Commodity trade
finance
Working capital financing of commodity
traders, generally extended on a self-
liquidating transactional basis
Sensitive primarily to the strength of
individual transaction structures and
collateral values (price volatility of
commodities),
as the primary source for
debt service is directly linked to the
shipments financed
–
Personal & Corporate Banking
Financial intermediaries
and hedge funds
Lending to financial institutions and
pension funds, including exposures to
broker-dealers and clearing houses
Sensitive to GDP development, the
interest rate environment, price and
volatility risks in financial markets, and
regulatory and political risk
–
Personal & Corporate Banking
–
Investment Bank
›
Refer to Note 20f for more details regarding sensitivity
Consolidated financial statements | UBS Group AG consolidated financial statements
318
Note 9
Financial assets at amortized cost and other positions in scope of expected credit loss measurement (continued)
The
tables below
and on
the following
pages provide
ECL exposure
and ECL
allowance and
provision
information about
financial
instruments and certain non-financial instruments that are subject to ECL.
USD million
31.12.21
Carrying amount
1
ECL allowances
Financial instruments measured at amortized cost
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Cash and balances at central banks
192,817
192,817
0
0
0
0
0
0
Loans and advances to banks
15,480
15,453
26
1
(
8
)
(
7
)
(
1
)
0
Receivables from securities financing transactions
75,012
75,012
0
0
(
2
)
(
2
)
0
0
Cash collateral receivables on derivative instruments
30,514
30,514
0
0
0
0
0
0
Loans and advances to customers
397,761
380,564
15,620
1,577
(
850
)
(
126
)
(
152
)
(
572
)
of which: Private clients with mortgages
152,479
143,505
8,262
711
(
132
)
(
28
)
(
71
)
(
33
)
of which: Real estate financing
43,945
40,463
3,472
9
(
60
)
(
19
)
(
40
)
0
of which: Large corporate clients
13,990
12,643
1,037
310
(
170
)
(
22
)
(
16
)
(
133
)
of which: SME clients
14,004
12,076
1,492
436
(
259
)
(
19
)
(
15
)
(
225
)
of which: Lombard
149,283
149,255
0
27
(
33
)
(
6
)
0
(
28
)
of which: Credit cards
1,716
1,345
342
29
(
36
)
(
10
)
(
9
)
(
17
)
of which: Commodity trade finance
3,813
3,799
7
7
(
114
)
(
6
)
0
(
108
)
Other financial assets measured at amortized cost
26,209
25,718
302
189
(
109
)
(
27
)
(
7
)
(
76
)
of which: Loans to financial advisors
2,453
2,184
106
163
(
86
)
(
19
)
(
3
)
(
63
)
Total financial assets measured at amortized cost
737,794
720,079
15,948
1,767
(
969
)
(
161
)
(
160
)
(
647
)
Financial assets measured at fair value through other comprehensive income
8,844
8,844
0
0
0
0
0
0
Total on-balance sheet financial assets in scope of ECL requirements
746,638
728,923
15,948
1,767
(
969
)
(
161
)
(
160
)
(
647
)
Total exposure
ECL provisions
Off-balance sheet (in scope of ECL)
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Guarantees
20,972
19,695
1,127
150
(
41
)
(
18
)
(
8
)
(
15
)
of which: Large corporate clients
3,464
2,567
793
104
(
6
)
(
3
)
(
3
)
0
of which: SME clients
1,353
1,143
164
46
(
8
)
(
1
)
(
1
)
(
7
)
of which: Financial intermediaries and hedge funds
9,575
9,491
84
0
(
17
)
(
13
)
(
4
)
0
of which: Lombard
2,454
2,454
0
0
(
1
)
0
0
(
1
)
of which: Commodity trade finance
3,137
3,137
0
0
(
1
)
(
1
)
0
0
Irrevocable loan commitments
39,478
37,097
2,335
46
(
114
)
(
72
)
(
42
)
0
of which: Large corporate clients
23,922
21,811
2,102
9
(
100
)
(
66
)
(
34
)
0
Forward starting reverse repurchase and securities borrowing agreements
1,444
1,444
0
0
0
0
0
0
Committed unconditionally revocable credit lines
40,778
38,207
2,508
63
(
38
)
(
28
)
(
10
)
0
of which: Real estate financing
7,328
7,046
281
0
(
5
)
(
4
)
(
1
)
0
of which: Large corporate clients
5,358
4,599
736
23
(
7
)
(
4
)
(
3
)
0
of which: SME clients
5,160
4,736
389
35
(
15
)
(
11
)
(
3
)
0
of which: Lombard
8,670
8,670
0
0
0
0
0
0
of which: Credit cards
9,466
9,000
462
4
(
6
)
(
5
)
(
2
)
0
of which: Commodity trade finance
117
117
0
0
0
0
0
0
Irrevocable committed prolongation of existing loans
5,611
5,527
36
48
(
3
)
(
3
)
0
0
Total off-balance sheet financial instruments and credit lines
108,284
101,971
6,006
307
(
196
)
(
121
)
(
60
)
(
15
)
Total allowances and provisions
(
1,165
)
(
282
)
(
220
)
(
662
)
1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective
ECL allowances.
319
Note 9
Financial assets at amortized cost and other positions in scope of expected credit loss measurement (continued)
USD million
31.12.20
Carrying amount
1
ECL allowances
Financial instruments measured at amortized cost
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Cash and balances at central banks
158,231
158,231
0
0
0
0
0
0
Loans and advances to banks
15,444
15,260
184
0
(
16
)
(
9
)
(
5
)
(
1
)
Receivables from securities financing transactions
74,210
74,210
0
0
(
2
)
(
2
)
0
0
Cash collateral receivables on derivative instruments
32,737
32,737
0
0
0
0
0
0
Loans and advances to customers
379,528
356,948
20,341
2,240
(
1,060
)
(
142
)
(
215
)
(
703
)
of which: Private clients with mortgages
148,175
138,769
8,448
959
(
166
)
(
35
)
(
93
)
(
39
)
of which: Real estate financing
43,429
37,568
5,838
23
(
63
)
(
15
)
(
44
)
(
4
)
of which: Large corporate clients
15,161
12,658
2,029
474
(
279
)
(
27
)
(
40
)
(
212
)
of which: SME clients
14,872
11,990
2,254
628
(
310
)
(
19
)
(
23
)
(
268
)
of which: Lombard
133,850
133,795
0
55
(
36
)
(
5
)
0
(
31
)
of which: Credit cards
1,558
1,198
330
30
(
38
)
(
11
)
(
11
)
(
16
)
of which: Commodity trade finance
3,269
3,214
43
12
(
106
)
(
5
)
0
(
101
)
Other financial assets measured at amortized cost
27,194
26,377
348
469
(
133
)
(
34
)
(
9
)
(
90
)
of which: Loans to financial advisors
2,569
1,982
137
450
(
108
)
(
27
)
(
5
)
(
76
)
Total financial assets measured at amortized cost
687,345
663,763
20,873
2,709
(
1,211
)
(
187
)
(
229
)
(
795
)
Financial assets measured at fair value through other comprehensive income
8,258
8,258
0
0
0
0
0
0
Total on-balance sheet financial assets in scope of ECL requirements
695,603
672,021
20,873
2,709
(
1,211
)
(
187
)
(
229
)
(
795
)
Total exposure
ECL provisions
Off-balance sheet (in scope of ECL)
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Guarantees
17,081
14,687
2,225
170
(
63
)
(
14
)
(
15
)
(
34
)
of which: Large corporate clients
3,710
2,048
1,549
113
(
20
)
(
4
)
(
5
)
(
12
)
of which: SME clients
1,310
936
326
48
(
13
)
(
1
)
(
1
)
(
11
)
of which: Financial intermediaries and hedge funds
7,637
7,413
224
0
(
17
)
(
7
)
(
9
)
0
of which: Lombard
641
633
0
8
(
2
)
0
0
(
2
)
of which: Commodity trade finance
1,441
1,416
25
0
(
2
)
(
1
)
0
0
Irrevocable loan commitments
41,372
36,894
4,374
104
(
142
)
(
74
)
(
68
)
0
of which: Large corporate clients
24,209
20,195
3,950
64
(
121
)
(
63
)
(
58
)
0
Forward starting reverse repurchase and securities borrowing agreements
3,247
3,247
0
0
0
0
0
0
Committed unconditionally revocable credit lines
40,134
35,233
4,792
108
(
50
)
(
29
)
(
21
)
0
of which: Real estate financing
6,328
5,811
517
0
(
12
)
(
5
)
(
7
)
0
of which: Large corporate clients
4,909
2,783
2,099
27
(
9
)
(
2
)
(
7
)
0
of which: SME clients
5,827
4,596
1,169
63
(
16
)
(
12
)
(
4
)
0
of which: Lombard
9,671
9,671
0
0
0
(
1
)
0
0
of which: Credit cards
8,661
8,220
430
11
(
8
)
(
6
)
(
2
)
0
of which: Commodity trade finance
242
242
0
0
0
0
0
0
Irrevocable committed prolongation of existing loans
3,282
3,277
5
0
(
2
)
(
2
)
0
0
Total off-balance sheet financial instruments and credit lines
105,116
93,337
11,396
382
(
257
)
(
119
)
(
104
)
(
34
)
Total allowances and provisions
(
1,468
)
(
306
)
(
333
)
(
829
)
1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the
respective ECL allowances.
Consolidated financial statements | UBS Group AG consolidated financial statements
320
Note 9
Financial assets at amortized cost and other positions in scope of expected credit loss measurement (continued)
Coverage
ratios are
calculated
for
the
core loan
portfolio
by
taking ECL
allowances and
provisions divided
by the
gross carrying
amount of
the exposures.
Core loan
exposure is
defined as
the
sum of
Loans and
advances to
customers
and
Loans to
financial
advisors
.
These ratios are influenced by the following key factors:
–
Lombard loans
are generally
secured with
marketable securities
in
portfolios
that
are,
as
a
rule,
highly
diversified,
with
strict
lending policies
that are
intended to
ensure that
credit risk
is
minimal under most circumstances;
–
mortgage loans to private clients and
real estate financing are
controlled by
conservative eligibility
criteria, including
low loan-
to-value ratios and strong debt service capabilities;
–
the amount of unsecured retail lending (including credit cards)
is insignificant;
–
lending in Switzerland includes
government-backed COVID-19
loans;
–
contractual maturities in the loan portfolio, which
are a factor
in the
calculation of
ECLs, are
generally short,
with Lombard
lending
typically having
average contractual
maturities
of
12
months or
less, real
estate lending
generally between
2 years
and 3 years in Switzerland with longer
dated maturities in the
US and
corporate lending
between 1
to 2
years with
related
loan commitments up to 4 years; and
–
write-offs of
ECL allowances
against the
gross loan
balances
when all
or part of a financial asset is deemed uncollectible or
forgiven, reduces the coverage ratios
.
Coverage ratios for core loan portfolio
31.12.21
Gross carrying amount (USD million)
ECL coverage (bps)
On-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Private clients with mortgages
152,610
143,533
8,333
744
9
2
85
446
Real estate financing
44,004
40,483
3,512
10
14
5
114
231
Large corporate clients
14,161
12,665
1,053
443
120
18
148
2,997
SME clients
14,263
12,095
1,507
661
182
16
103
3,402
Lombard
149,316
149,261
0
55
2
0
0
5,026
Credit cards
1,752
1,355
351
46
204
72
255
3,735
Commodity trade finance
3,927
3,805
7
115
290
15
3
9,388
Other loans and advances to customers
18,578
17,493
1,010
75
25
9
15
3,730
Loans to financial advisors
2,539
2,203
109
226
338
88
303
2,791
Total
1
401,150
382,893
15,882
2,374
23
4
98
2,673
Gross exposure (USD million)
ECL coverage (bps)
Off-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Private clients with mortgages
9,123
8,798
276
49
3
3
9
15
Real estate financing
8,766
8,481
285
0
9
7
88
0
Large corporate clients
32,748
28,981
3,630
136
34
25
110
1
SME clients
8,077
7,276
688
114
38
19
151
585
Lombard
14,438
14,438
0
0
1
0
0
0
Credit cards
9,466
9,000
462
4
7
5
34
0
Commodity trade finance
3,262
3,262
0
0
4
4
0
0
Financial intermediaries and hedge funds
12,153
11,784
369
0
15
12
120
0
Other off-balance sheet commitments
8,806
8,507
296
4
15
6
30
0
Total
2
106,840
100,527
6,006
307
18
12
100
486
1 Includes Loans and
advances to customers
of USD
398,611
million and Loans
to financial advisors
of USD
2,539
million which are
presented on the
balance sheet line Other
assets measured at
amortized cost.
2 Excludes Forward starting reverse repurchase and securities borrowing agreements.
321
Note 9
Financial assets at amortized cost and other positions in scope of expected credit loss measurement (continued)
Coverage ratios for core loan portfolio
31.12.20
Gross carrying amount (USD million)
ECL coverage (bps)
On-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Private clients with mortgages
148,341
138,803
8,540
998
11
2
108
390
Real estate financing
43,492
37,583
5,883
27
15
4
75
1,414
Large corporate clients
15,440
12,684
2,069
686
181
21
192
3,089
SME clients
15,183
12,010
2,277
896
204
16
101
2,991
Lombard
133,886
133,800
0
86
3
0
0
3,592
Credit cards
1,596
1,209
342
46
240
91
333
3,488
Commodity trade finance
3,375
3,219
43
113
315
16
2
8,939
Other loans and advances to customers
19,274
17,781
1,402
91
31
14
25
3,563
Loans to financial advisors
2,677
2,009
142
526
404
135
351
1,446
Total
1
383,266
359,099
20,697
3,470
30
5
106
2,247
Gross exposure (USD million)
ECL coverage (bps)
Off-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Private clients with mortgages
6,285
6,083
198
3
7
6
16
197
Real estate financing
7,056
6,576
481
0
21
9
185
0
Large corporate clients
32,828
25,026
7,598
205
46
27
92
565
SME clients
9,121
7,239
1,734
148
40
19
63
779
Lombard
14,178
14,170
0
8
2
1
0
1,941
Credit cards
8,661
8,220
430
11
9
8
44
0
Commodity trade finance
1,683
1,658
25
0
10
8
15
8,279
Financial intermediaries and hedge funds
7,690
7,242
448
0
26
13
248
166
Other off-balance sheet commitments
14,366
13,876
482
8
13
7
11
12,414
Total
2
101,869
90,090
11,396
382
25
13
91
894
1 Includes Loans and
advances to customers
of USD
380,589
million and Loans
to financial advisors
of USD
2,677
million which are presented
on the balance
sheet line Other assets
measured at amortized
cost.
2 Excludes Forward starting reverse repurchase and securities borrowing agreements.
Consolidated financial statements | UBS Group AG consolidated financial statements
322
Note 10
Derivative instruments
Overview
Over-the-counter
(OTC)
derivative
contracts
are
usually
traded
under
a
standardized
International
Swaps
and
Derivatives
Association
(ISDA)
master
agreement
between
UBS
and
its
counterparties. Terms
are negotiated directly with counterparties
and the contracts have industry-standard settlement mechanisms
prescribed
by
ISDA.
Other
OTC
derivatives
are
cleared
through
clearing houses, in particular interest rate swaps
with LCH, where
a
settled-to-market method
has
been
generally adopted
,
under
which cash collateral exchanged
on a daily basis
is considered to
legally
settle
the
market
value
of
the
derivatives.
Regulators
in
various
jurisdictions
have
begun
a
phased
introduction
of
rules
requiring
the
payment
and
collection
of
initial
and
variation
margins on
certain OTC
derivative contracts,
which may
have a
bearing
on
price
and
other
relevant
terms.
Due
to
challenges
brought
on
by
COVID
-
19
,
the
International
Organization
of
Securities
Commissions
(IOSCO)
has
extended
the
deadline
for
completion of the final phase-in of margin requirements for non-
centrally cleared derivatives,
to 1 September 2022.
Other
derivative
contracts
are
standardized
in
terms
of
their
amounts
and
settlement
dates,
and
are
bought
and
sold
on
regulated
exchanges.
These
are
commonly
referred
to
as
exchange-traded derivatives (ETD) contracts.
Exchanges offer the
benefits of pricing transparency,
standardized daily settlement of
changes in value and, consequently,
reduced credit risk.
Most of the Group’s derivative transactions relate to sales and
market-making activity. Sales activities
include the structuring
and
marketing of derivative products to customers to
enable them to
take, transfer, modify or
reduce current or expected
risks. Market-
making aims to
directly support the
facilitation and execution
of
client activity,
and involves
quoting bid
and offer
prices to
other
market participants with
the aim
of generating revenues
based on
spread
and
volume.
The
Group
also
uses
various
derivative
instruments for hedging purposes.
›
Refer to Notes 16 and 21 for more information
about derivative
instruments
›
Refer to Note 26 for more information about
derivatives
designated in hedge accounting relationships
Risks of derivative instruments
The derivative financial assets shown on the
balance sheet can be
an
important
component
of
the
Group’s
credit
exposure;
however, the
positive replacement
values related
to a
respective
counterparty
are
rarely
an
adequate
reflection
of
the
Group’s
credit exposure in
its derivatives business
with that counterparty.
This is generally the case because, on the one hand, replacement
values can
increase over
time (potential
future exposure),
while,
on the
other hand,
exposure may
be mitigated
by entering
into
master netting agreements and bilateral collateral
arrangements.
Both
the
exposure
measures
used
internally
by
the
Group
to
control
credit
risk
and
the
capital
requirements
imposed
by
regulators reflect these additional factors.
›
Refer to Note 22 for more information about
derivative financial
assets and liabilities after consideration
of netting potential
allowed under enforceable netting arrangements
›
Refer to the “Risk management and control”
section of this
report for more information about the risks arising
from
derivative instruments
323
Note 10
Derivative instruments (continued)
Derivative instruments
31.12.21
31.12.20
USD billion
Derivative
financial
assets
Notional
amounts
related to
derivative
financial
assets
2,3
Derivative
financial
liabilities
Notional
amounts
related to
derivative
financial
liabilities
2,3
Other
notional
amounts
2,4
Derivative
financial
assets
Notional
amounts
related to
derivative
financial
assets
2,3
Derivative
financial
liabilities
Notional
amounts
related to
derivative
financial
liabilities
2,3
Other
notional
amounts
2,4
Interest rate contracts
33.2
991.2
28.7
943.1
8,675.1
50.9
928.0
43.9
880.4
11,291.5
of which: forward contracts (OTC)
1
0.1
29.4
0.2
28.6
443.6
0.0
19.8
0.4
21.9
2,602.5
of which: swaps (OTC)
26.4
394.3
19.2
344.1
7,549.4
40.8
407.0
30.9
364.8
8,105.2
of which: options (OTC)
6.6
545.2
9.2
553.6
10.1
447.5
12.5
460.5
of which: futures (ETD)
525.0
480.6
of which: options (ETD)
0.0
22.4
0.0
16.8
157.1
0.0
53.6
0.0
33.1
103.3
Credit derivative contracts
1.4
44.7
1.8
46.3
2.4
57.6
2.9
64.8
of which: credit default swaps (OTC)
1.3
39.4
1.6
44.1
2.2
53.6
2.6
62.3
of which: total return swaps (OTC)
0.1
1.3
0.2
1.7
0.1
1.9
0.3
2.5
Foreign exchange contracts
53.3
3,030.8
54.1
2,938.8
1.2
68.7
2,951.1
70.5
2,820.4
1.4
of which: forward contracts (OTC)
23.8
1,008.9
23.8
1,043.2
27.3
779.1
29.0
853.3
of which: swaps (OTC)
24.3
1,606.3
24.9
1,480.3
34.3
1,727.3
34.4
1,567.3
of which: options (OTC)
5.2
412.6
5.3
408.6
7.1
440.9
7.1
394.7
Equity contracts
28.2
456.9
34.9
603.9
80.1
34.8
449.6
41.2
581.3
91.3
of which: swaps (OTC)
4.7
105.7
9.3
154.8
6.4
89.4
9.8
108.4
of which: options (OTC)
4.6
61.4
6.5
102.3
7.0
87.1
10.9
146.2
of which: futures (ETD)
71.2
67.9
of which: options (ETD)
10.2
289.6
9.8
346.3
8.8
10.7
273.1
11.3
326.8
23.5
of which: client-cleared transactions (ETD)
8.6
9.4
10.7
9.1
Commodity contracts
1.6
57.8
1.6
56.4
14.7
2.2
57.8
2.0
49.7
10.1
of which: swaps (OTC)
0.5
19.9
0.8
25.4
0.5
17.7
0.8
18.0
of which: options (OTC)
0.4
14.0
0.2
10.4
1.0
23.5
0.7
17.8
of which: futures (ETD)
13.9
9.3
of which: forward contracts (ETD)
0.0
18.1
0.0
15.2
0.0
8.0
0.0
6.3
of which: client-cleared transactions (ETD)
0.6
0.4
0.5
0.3
Loan commitments
measured at FVTPL (OTC)
0.0
0.8
0.0
8.2
0.0
10.2
Unsettled purchases of non-derivative
financial instruments
5
0.1
13.3
0.2
10.6
0.3
18.3
0.2
10.0
Unsettled sales of non-derivative financial
instruments
5
0.2
18.2
0.1
9.4
0.2
17.2
0.3
12.9
Total derivative instruments,
based on IFRS netting
6
118.1
4,613.8
121.3
4,616.6
8,771.1
159.6
4,479.5
161.1
4,429.7
11,394.4
1 Includes certain forward starting repurchase and reverse repurchase agreements that
are classified as measured at fair value through profit or loss
and are recognized within derivative instruments.
2 In cases where
derivative financial instruments
are presented on
a net basis
on the balance
sheet, the respective
notional
amounts of the
netted derivative financial
instruments are still
presented on a
gross basis.
3 Notional
amounts of client-cleared ETD and OTC
transactions through central clearing counterparties
are not disclosed, as they have significantly different
risk profile.
4 Other notional amounts relate to derivatives that
are
cleared through either a central counterparty or an exchange. The fair value
of these derivatives is presented on the balance sheet net of the corresponding cash margin under Cash collateral
receivables on derivative
instruments and Cash collateral
payables on derivative
instruments and was not
material for all periods presented.
5 Changes in the fair
value of purchased and sold
non-derivative financial instruments between
trade date and settlement date
are recognized as derivative financial instruments.
6 Derivative financial assets and liabilities are
presented net on the balance sheet
if UBS has the unconditional
and legally enforceable
right to offset the recognized amounts, both in the normal course of business and in the event of default, bankruptcy or insolvency
of the entity and all of the counterparties, and intends either to settle on a net basis
or to realize the asset and settle the liability simultaneously. Refer to Note 22 for more information on
netting arrangements.
On a notional amount basis,
approximately
40
% of OTC interest
rate contracts held as of
31 December 2021 (31 December 2020:
50
%) mature
within one
year,
36
% (31
December 2020:
30
%)
within one to
five years and
25
% (31 December
2020:
20
%) after
five years.
Notional
amounts
of
interest
rate
contracts
cleared
through
either
a
central
counterparty
or
an
exchange
that
are
legally
settled
on
a
daily
basis
are
presented
under
Other
notional
amounts
in
the
table
above
and
are
categorized
into
maturity
buckets
on
the
basis
of
contractual
maturities
of
the
cleared
underlying
derivative
contracts. Other
notional
amounts
related
to interest rate contracts decreased
by USD
2.6
trillion compared
with
31 December
2020,
mainly
reflecting
trade
compressions,
which
included
activity
as
part
of
the
ongoing
transition
to
alternative reference rates, and maturities.
Consolidated financial statements | UBS Group AG consolidated financial statements
324
Note 11
Financial assets measured at fair value through other comprehensive income
USD million
31.12.21
31.12.20
Financial assets measured at fair value through other comprehensive income
1
Debt instruments
Governments and government agencies
8,522
8,155
of which: USA
7,507
7,727
Banks
322
103
Total financial assets measured at fair value through other comprehensive income
8,844
8,258
Unrealized gains / (losses) recognized in Other comprehensive
income
Unrealized gains, before tax
67
204
Unrealized (losses), before tax
(
80
)
(
4
)
Net unrealized gains / (losses), before tax
(
13
)
200
Net unrealized gains / (losses), after tax
(
7
)
151
1 Refer to Note 21c for more information about product type and fair value hierarchy categorization. Refer also to Note 9 and
Note 20 for more information about expected credit loss measurement.
Note 12
Property, equipment and software
At historical cost less accumulated depreciation
USD million
Owned
properties and
equipment
1
Leased
properties and
equipment
2
Software
Projects in
progress
2021
2020
Historical cost
Balance at the beginning of the year
13,185
4,249
7,768
1,036
26,238
24,431
Additions
273
213
228
1,376
2,090
2,312
Disposals / write-offs
3
(
430
)
(
223
)
(
98
)
0
(
751
)
(
990
)
Reclassifications
4
323
0
808
(
1,149
)
(
18
)
(
590
)
Foreign currency translation
(
303
)
(
66
)
(
64
)
(
12
)
(
445
)
1,074
Balance at the end of the year
13,048
4,174
8,642
1,250
27,113
26,238
Accumulated depreciation
Balance at the beginning of the year
8,060
1,082
3,987
0
13,129
11,628
Depreciation
635
498
945
0
2,078
1,997
Impairment
5
9
1
0
0
10
72
Disposals / write-offs
3
(
424
)
(
215
)
(
98
)
0
(
737
)
(
855
)
Reclassifications
4
(
12
)
0
0
0
(
12
)
(
328
)
Foreign currency translation
(
196
)
(
20
)
(
28
)
0
(
243
)
616
Balance at the end of the year
8,072
1,346
4,807
0
14,225
13,129
Net book value
Net book value at the beginning of the year
5,126
3,167
3,780
1,036
13,109
12,804
Net book value at the end of the year
4,976
2,828
3,835
1,250
6
12,888
13,109
1 Includes leasehold
improvements and IT
hardware.
2 Represents right-of-use
assets recognized by UBS
as lessee. UBS
predominantly enters into
lease contracts, or
contracts that include
lease components,
in
relation to real estate, including
offices, retail branches
and sales offices. The
total cash outflow for leases during
2021 was USD
657
million (2020: USD
679
million). Interest expense on lease
liabilities is included
within Interest expense from
financial instruments measured at
amortized cost and Lease
liabilities are included within
Other financial liabilities measured
at amortized cost. Refer
to Notes 3 and
19a, respectively.
There were no material gains
or losses arising from sale-and-leaseback
transactions in 2021 (2020: USD
140
million).
3 Includes write-offs of fully
depreciated assets.
4 The total reclassification
amount for the
respective periods represents net reclassifications
to Properties and other
non-current assets held for
sale.
5 Impairment charges recorded in
2021 generally relate to
assets that are no longer
used, for which the
recoverable amount based on a value in use approach was determined to be zero.
6 Consists of USD
1,087
million related to software and USD
163
million related to Owned properties and equipment.
325
Note 13
Goodwill and intangible assets
Introduction
UBS
performs
an
impairment
test
on
its
goodwill
assets
on
an
annual basis or when indicators of impairment exist.
UBS considers Asset Management, as it is reported in
Note 2a,
as a separate cash-generating unit (a
CGU), as that is the level at
which the
performance of investment
(and the related
goodwill)
is reviewed and
assessed by management.
Given that a
significant
amount of goodwill in Global Wealth Management relates to the
PaineWebber
acquisition
in
2000,
which
mainly
affected
the
Americas portion of
the business,
this goodwill remains
separately
monitored
by
the
Americas,
despite
the
formation
of
Global
Wealth
Management
in
2018.
Therefore,
goodwill
for
Global
Wealth Management
is separately
considered for
impairment at
the
level
of
two
CGUs:
Americas;
and
Switzerland
and
International (consisting of EMEA, Asia Pacific and Global).
The
impairment
test
is
performed
for
each
CGU
to
which
goodwill is
allocated by
comparing the
recoverable amount,
based
on
its
value
in
use,
with
the
carrying
amount
of
the
respective
CGU. An impairment charge is recognized if the carrying amount
exceeds the recoverable amount.
As
of
31 December
2021,
total
goodwill
recognized
on
the
balance sheet
was USD
6.1
billion, of which
USD
3.7
billion was
carried
by
the
Global
Wealth
Management
Americas
CGU,
USD
1.2
billion
was
carried
by the
Global
Wealth
Management
Switzerland
and
International
CGU
,
and
USD
1.2
billion
was
carried by
Asset Management.
Based on
the impairment
testing
methodology described below,
UBS concluded that
the goodwill
balances
as
of
31 December
2021 allocated
to
these
CGUs are
not impaired.
Methodology for goodwill impairment testing
The recoverable amounts are determined using
a discounted cash
flow model, which has
been adapted to use inputs
that consider
features of the banking
business and its regulatory
environment.
The recoverable
amount of
a CGU
is the
sum of
the discounted
earnings attributable to shareholders from the first three forecast
years and the terminal value, adjusted
for the effect of the capital
assumed to
be needed
over the next
three years
and to
support
growth beyond
that period. The
terminal value,
which covers all
periods
beyond
the third
year,
is calculated
on the
basis
of
the
forecast of third
-year profit, the
discount rate and
the long-term
growth rate, as well as the implied perpetual capital growth.
The carrying amount for each CGU is determined by reference
to
the
Group’s
equity
attribution
framework.
Within
this
framework,
which
is
described
in
the
“Capital,
liquidity
and
funding, and balance sheet” section of this
report, UBS attributes
equity to the businesses on the basis of their risk-weighted assets
and
leverage
ratio
denominator
(both
metrics
include
resource
allocations from Group
Functions to the business
divisions), their
goodwill and
their intangible
assets, as
well as
attributed equity
related
to
certain
CET1
deduction
items.
The
framework
is
primarily used for
the purpose of
measuring the performance
of
the
businesses
and
includes
certain
management
assumptions.
Attributed equity is
equal to the
capital a CGU
requires to conduct
its
business
and
is
currently
considered
a
reasonable
approximation
of
the
carrying
amount
of
the
CGUs.
The
attributed
equity
methodology
is
also
applied
in
the
business
planning process,
the inputs
from which
are used
in calculating
the recoverable amounts of the respective CGU.
›
Refer to the “Capital, liquidity and funding,
and balance sheet”
section of this report for more information about
the equity
attribution framework
Assumptions
Valuation
parameters
used
within
the
Group’s
impairment
test
model
are
linked
to
external
market
information,
where
applicable. The model used to determine the recoverable amount
is most
sensitive to changes
in the
forecast earnings available
to
shareholders
in
years
one
to
three,
to
changes
in
the
discount
rates and
to changes
in the
long-term growth
rate. The
applied
long-term
growth
rate is
based on
long-term economic
growth
rates
for
different
regions
worldwide.
Earnings
available
to
shareholders are estimated on the basis of forecast results, which
are part of the business plan approved by the Board of Directors.
The discount
rates are
determined by
applying a
capital asset
pricing model-based approach,
as well as
considering quantitative
and
qualitative
inputs
from
both
internal
and
external
analysts
and
the
view
of
management.
T
hey
also
take
int
o
account
regional differences in risk-free rates at
the level of the individual
CGUs.
In
line
with
discount
rates,
long-term
growth
rates
are
determined
at
the regional
level
based
on
nominal
or
real GDP
growth rate forecasts.
Consolidated financial statements | UBS Group AG consolidated financial statements
326
Note 13
Goodwill and intangible assets (continued)
Key assumptions
used to determine
the recoverable
amounts
of eac
h
CGU are
tested
for sensitivity
by applying
a reasonably
possible
change
to
those
assumptions.
Forecast
earnings
available
to
shareholders
were
changed
by
20
%,
the
discount
rates were changed by
1.5
percentage points, and the long-term
growth rates were changed by
0.75
percentage points. Under all
scenarios,
reasonably
possible
changes
in
key
assumptions
did
not
result
in
an
impairment
of
goodwill
or
intangible
assets
reported
by
Global
Wealth
Management
Americas,
Global
Wealth
Management
Switzerland
and
International,
and
Asset
Management.
If
the
estimated
earnings
and
other
assumptions
in
future
periods deviate
from the
current outlook,
the value
of goodwill
attributable
to
Global
Wealth
Management
Americas,
Global
Wealth
Management
Switzerland
and
International,
and
Asset
Management may
become impaired
in the
future, giving
rise to
losses in the income
statement. Recognition of any
impairment of
goodwill
would
reduce IFRS
equity and
net profit.
It
would
not
affect cash flows
and, as goodwill
is required to
be deducted from
capital under
the Basel III capital
framework, no effect
would be
expected on the Group’s capital ratios.
Discount and growth rates
Discount rates
Growth rates
In %
31.12.21
31.12.20
31.12.21
31.12.20
Global Wealth Management Americas
9.5
9.5
4.0
5.1
Global Wealth Management Switzerland and International
8.5
8.5
3.1
3.7
Asset Management
8.5
8.5
2.9
3.5
USD million
Goodwill
Intangible
assets
1
2021
2020
Historical cost
Balance at the beginning of the year
6,182
1,683
7,865
7,820
Additions
1
1
147
Disposals
(
3
)
(
3
)
(
158
)
Write-offs
(
41
)
(
41
)
(
35
)
Foreign currency translation
(
53
)
(
30
)
(
83
)
91
Balance at the end of the year
6,126
1,612
7,739
7,865
Accumulated amortization and impairment
Balance at the beginning of the year
1,385
1,385
1,351
Amortization
31
31
55
Impairment / (reversal of impairment)
2
(
1
)
(
1
)
2
Disposals
0
0
Write-offs
(
41
)
(
41
)
(
35
)
Foreign currency translation
(
13
)
(
13
)
11
Balance at the end of the year
1,360
1,360
1,385
Net book value at the end of the year
6,126
252
6,378
6,480
of which: Global Wealth Management Americas
3,720
41
3,760
3,770
of which: Global Wealth Management Switzerland and International
1,204
72
1,276
1,320
of which: Asset Management
1,202
1,202
1,226
of which: Investment Bank
139
139
161
of which: Group Functions
0
4
1 Intangible
assets mainly
include customer
relationships, contractual
rights and
the fully
amortized branch
network intangible
asset recognized
in connection
with the
acquisition of
PaineWebber Group,
Inc.
2 Impairment charges recorded in
2020 relate to
assets for which the
recoverable amount was
determined considering their
value in use
(recoverable amount of
the impaired intangible
assets: USD
5
million for
2020).
The table below presents estimated aggregated amortization expenses for intangible assets.
USD million
Intangible assets
Estimated aggregated amortization expenses for:
2022
29
2023
27
2024
23
2025
23
2026
23
Thereafter
126
Not amortized due to indefinite useful life
2
Total
252
327
Note 14
Other assets
a) Other financial assets measured at amortized cost
USD million
31.12.21
31.12.20
Debt securities
18,858
18,801
of which: government bills / bonds
9,833
9,789
Loans to financial advisors
2,453
2,569
Fee-
and commission-related receivables
1,972
2,014
Finance lease receivables
1,356
1,447
Settlement and clearing accounts
455
614
Accrued interest income
520
591
Other
594
1,158
Total other financial assets measured at amortized cost
26,209
27,194
b) Other non-financial assets
USD million
31.12.21
31.12.20
Precious metals and other physical commodities
5,258
6,264
Deposits and collateral provided in connection with litigation,
regulatory and similar matters
1
1,526
1,418
Prepaid expenses
1,108
1,081
VAT and other tax receivables
638
433
Properties and other non-current assets held for sale
32
246
Assets of disposal groups held for sale
2
1,093
Other
621
326
Total other non-financial assets
10,277
9,768
1 Refer to Note 18 for more information.
2 Refer to Note 30 for more information.
Note 15
Amounts due to banks and customer deposits
USD million
31.12.21
31.12.20
Amounts due to banks
13,101
11,050
Customer deposits
542,007
524,605
of which: demand deposits
246,417
236,447
of which: retail savings / deposits
247,224
220,898
of which: time deposits
1
48,365
67,260
Total amounts due to banks and customer deposits
555,108
535,655
1 Includes customer deposits in UBS AG Jersey Branch placed by UBS Switzerland AG on behalf
of its clients.
Consolidated financial statements | UBS Group AG consolidated financial statements
328
Note 16
Debt issued designated at fair value
USD million
31.12.21
31.12.20
Issued debt instruments
Equity-linked
1
47,059
41,069
Rates-linked
16,369
11,038
Credit-linked
1,723
1,933
Fixed-rate
2,868
3,604
Commodity-linked
2,911
1,497
Other
2,868
2,101
of which: debt that contributes to total loss-absorbing capacity
2,136
1,190
Total debt issued designated at fair value
73,799
61,243
of which: issued by UBS AG with original maturity greater than one
year
2
57,967
46,427
of which: life-to-date own credit (gain) / loss
347
418
1 Includes investment fund unit-linked instruments issued.
2 Based on original contractual maturity without considering any early redemption features. As of 31 December
2021,
100
% of the balance was unsecured
(31 December 2020:
100
%).
As of 31 December
2021 and 31
December 2020, the contractual
redemption amount at maturity
of debt issued designated at
fair
value through profit or
loss was not materially different
from the
carrying amount.
The table below shows the
residual contractual maturity of the
carrying
amount
of
debt
issued
designated
at
fair
value,
split
between
fixed-rate
and
floating-rate
instruments
based
on
the
contractual
terms,
and
does
not
consider
any
early
redemption
features. Interest rate ranges for future interest
payments related
to debt issued designated at fair value have
not been included in
the table below,
as the majority
of the debt
instruments issued are
structured
products
and
therefore
the
future
interest
payments
are
highly
dependent
upon
the
embedded
derivative
and
prevailing market conditions
at the point
in time that
each interest
payment is made.
›
Refer to Note 24 for maturity information
on an undiscounted
cash flow basis
Contractual maturity of carrying amount
USD million
2022
2023
2024
2025
2026
2027–2031
Thereafter
Total
31.12.21
Total
31.12.20
UBS Group AG
1
Non-subordinated debt
Fixed-rate
0
0
0
0
0
0
2,340
2,340
1,375
UBS AG
2
Non-subordinated debt
Fixed-rate
4,296
1,658
716
495
226
273
1,732
9,397
9,409
Floating-rate
19,338
15,621
5,067
5,816
3,840
8,364
3,238
61,284
49,528
Subtotal
23,635
17,279
5,783
6,311
4,066
8,637
4,971
70,682
58,937
Other subsidiaries
3
Non-subordinated debt
Fixed-rate
6
0
0
0
0
423
0
429
539
Floating-rate
150
47
145
0
0
0
7
349
392
Subtotal
156
47
145
0
0
423
7
778
931
Total
23,791
17,325
5,929
6,311
4,066
9,060
7,317
73,799
61,243
1 Consists of instruments issued by the legal entity UBS Group AG.
2 Consists of instruments issued by the legal entity UBS AG.
3 Consists of instruments issued by subsidiaries of UBS AG.
329
Note 17
Debt issued measured at amortized cost
USD million
31.12.21
31.12.20
Certificates of deposit and commercial paper
40,640
41,151
Other short-term debt
2,458
5,515
Short-term debt
1
43,098
46,666
Senior unsecured debt that contributes to total loss-absorbing
capacity (TLAC)
38,984
36,611
Senior unsecured debt other than TLAC
27,590
21,340
of which: issued by UBS AG with original maturity greater than one
year
2
23,307
18,464
Covered bonds
1,389
2,796
Subordinated debt
18,640
22,157
of which: high-trigger loss-absorbing additional tier 1 capital
instruments
11,052
11,837
of which: low-trigger loss-absorbing additional tier 1 capital
instruments
2,425
2,577
of which: low-trigger loss-absorbing tier 2 capital instruments
2,596
7,201
of which: non-Basel III-compliant tier 2 capital instruments
547
543
Debt issued through the Swiss central mortgage institutions
9,454
9,660
Other long-term debt
0
3
Long-term debt
3
96,057
92,566
Total debt issued measured at amortized cost
4
139,155
139,232
1 Debt with an original contractual maturity of
less than one year.
2 Based on original contractual maturity without considering
any early redemption features. As
of 31 December 2021,
100
% of the balance was
unsecured (31 December 2020:
100
%).
3 Debt with an original contractual
maturity greater than or equal
to one year.
The classification of debt
issued into short-term and long-term
does not consider any early
redemption features.
4 Net of bifurcated embedded derivatives, the fair value of which was
not material for the periods presented.
The Group uses interest
rate and foreign exchange
derivatives to
manage
the
risks
inherent
in
certain
debt
instruments
held
at
amortized
cost.
In
some
cases,
the
Group
applies
hedge
accounting for interest rate risk as discussed in item 2j in Note 1a
and Note
26. As a
result of applying
hedge accounting, the
life-
to-date adjustment to the carrying amount of debt issued was
an
increase
of
USD
478
million
as
of
31
December
2021
and
an
increase of USD
2,401
million as of 31
December 2020, reflecting
changes in fair value due to interest rate movements.
Subordinated debt consists of unsecured debt obligations that
are
contractually
subordinated
in
right
of
payment
to
all
other
present and future
non-subordinated obligations of
the respective
issuing
entity.
All
of
the
subordinated
debt
instruments
outstanding as of 31 December 2021 pay a fixed rate of interest.
The table below shows the
residual contractual maturity of
the
carrying
amount
of
debt
issued,
split
between
fixed-rate
and
floating-rate
based
on
the
contractual
terms,
and
does
not
consider any early redemption
features. The effects from interest
rate
swaps,
which
are
used
to
hedge
various
fixed-rate
debt
issuances
by
changing
the
repricing
characteristics
into
those
similar to
floating-rate debt, are
also not considered
in the
table
below.
›
Refer to Note 24 for maturity information
on an undiscounted
cash flow basis
Contractual maturity of carrying amount
USD million
2022
2023
2024
2025
2026
2027–2031
Thereafter
Total
31.12.21
Total
31.12.20
UBS Group AG
1
Non-subordinated debt
Fixed-rate
3,769
4,027
5,145
5,052
6,748
12,534
3,294
40,569
33,578
Floating-rate
492
2,183
0
0
0
0
0
2,676
5,890
Subordinated debt
Fixed-rate
0
0
0
0
0
0
13,477
13,477
14,413
Subtotal
4,261
6,211
5,145
5,052
6,748
12,534
16,771
56,722
53,881
UBS AG
2
Non-subordinated debt
Fixed-rate
38,647
5,578
1,964
349
3,439
1,381
1,213
52,571
52,618
Floating-rate
9,807
2,093
1,922
907
508
0
0
15,238
15,299
Subordinated debt
Fixed-rate
2,020
0
2,596
337
210
0
0
5,163
7,744
Subtotal
50,474
7,671
6,482
1,594
4,158
1,381
1,213
72,972
75,661
Other subsidiaries
3
Non-subordinated debt
Fixed-rate
907
1,007
1,072
1,173
1,045
3,674
582
9,460
9,690
Subtotal
907
1,007
1,072
1,173
1,045
3,674
582
9,460
9,690
Total
55,642
14,889
12,698
7,818
11,951
17,590
18,566
139,155
139,232
1 Consists of debt issued by the legal entity UBS Group AG.
2 Consists of debt issued by the legal entity UBS AG.
3 Consists of debt issued by subsidiaries of UBS AG.
Consolidated financial statements | UBS Group AG consolidated financial statements
330
Note 18
Provisions and contingent liabilities
a) Provisions
The table below presents an overview of total provisions.
USD million
31.12.21
31.12.20
Provisions other than provisions for expected credit losses
3,322
2,571
Provisions for expected credit losses
196
257
Total provisions
3,518
2,828
The following table presents additional information for provisions other than provisions for expected credit losses.
USD million
Litigation,
regulatory and
similar matters
1
Restructuring
Other
3
Total 2021
Balance at the beginning of the year
2,135
72
363
2,571
Increase in provisions recognized in the income statement
986
297
78
1,361
Release of provisions recognized in the income statement
(
74
)
(
30
)
(
32
)
(
136
)
Provisions used in conformity with designated purpose
(
189
)
(
165
)
(
80
)
(
434
)
Capitalized reinstatement costs
0
0
32
32
Foreign currency translation / unwind of discount
(
59
)
(
3
)
(
10
)
(
72
)
Balance at the end of the year
2,798
172
2
352
3,322
1 Consists of provisions for losses
resulting from legal, liability and compliance
risks.
2 Primarily consists of personnel-related restructuring provisions of USD
125
million as of 31 December 2021 (31 December 2020:
USD
18
million) and provisions
for onerous contracts
of USD
47
million as of
31 December 2021 (31 December 2020: USD
49
million).
3 Mainly includes provisions
related to real
estate, employee benefits
and
operational risks.
Restructuring
provisions
primarily
relate
to
personnel
-
related
provisions and onerous contracts. Personnel-related restructuring
provisions
are
used
within
a
short
period
of
time
but
potential
changes in amount may be
triggered when natural staff
attrition
reduces the
number of
people affected
by a
restructuring event
and therefore the estimated
costs. Onerous contracts
for property
are
recognized
when
UBS
is
committed
to
pay
for
non-lease
components,
such
as
utilities,
service
charges,
taxes
and
maintenance, when
a property
is vacated
or not
fully recovered
from sub-tenants.
Information
about
provisions
and
contingent
liabilities
in
respect of
litigation, regulatory
and similar
matters, as
a class, is
included in Note
18b. There are
no material contingent liabilities
associated with the other classes of provisions.
b) Litigation, regulatory and similar matters
The
Group
operates in
a legal
and regulatory
environment
that
exposes
it
to
significant
litigation
and
similar
risks
arising
from
disputes and regulatory
proceedings. As a
result, UBS (which
for
purposes of this Note
may refer to UBS
Group AG and/or one or
more
of
its
subsidiaries,
as
applicable)
is
involved
in
various
disputes
and
legal
proceedings,
including
litigation,
arbitration,
and regulatory and criminal investigations.
Such
matters
are
subject
to
many
uncertainties,
and
the
outcome and the
timing of
resolution are often
difficult to
predict,
particularly in the earlier
stages of a case.
There are also situations
where
the
Group
may
enter
into
a
settlement
agreement.
This
may occur in order
to avoid the expense,
management distraction
or reputational implications of continuing to
contest liability, even
for
those
matters
for
which
the
Group
believes
it
should
be
exonerated. The
uncertainties inherent
in all
such matters
affect
the amount and
timing of any
potential outflows for
both matters
with respect to which provisions have been established and other
contingent
liabilities.
The
Group
makes
provisions
for
such
matters brought against
it when, in
the opinion of
management
after seeking legal advice,
it is more
likely than not that
the Group
has a
present legal
or constructive
obligation as
a result
of past
events, it is
probable that an
outflow of
resources will be
required,
and the
amount
can be
reliably estimated.
Where these
factors
are otherwise satisfied, a
provision may be established
for claims
that
have
not
yet
been
asserted
against
the
Group,
but
are
nevertheless
expected
to
be,
based
on
the
Group’s
experience
with similar asserted claims. If any of those conditions is not met,
such matters
result in
contingent liabilities.
If the
amount of
an
obligation cannot be reliably estimated,
a liability exists that is
not
recognized
even
if
an
outflow
of
resources
is
probable.
Accordingly,
no
provision
is
established
even
if
the
potential
outflow
of
resources
with
respect
to
such
matters
could
be
significant. Developments relating to
a matter that
occur after the
relevant
reporting
period,
but
prior
to
the
issuance
of
financial
statements,
which
affect
management’s
assessment
of
the
provision
for
such
matter
(because,
for
example,
the
developments provide
evidence of
conditions that
existed at
the
end
of
the
reporting
period),
are
adjusting
events
after
the
reporting
period
under
IAS
10
and
must
be
recognized
in
the
financial statements for the reporting period.
331
Note 18
Provisions and contingent liabilities (continued)
Specific litigation,
regulatory and
other matters
are described
below, including
all such
matters that management
considers to
be
material
and
others
that
management
believes
to
be
of
significance
due
to
potential
financial,
reputational
and
other
effects. The amount of
damages claimed, the size
of a transaction
or other information is provided where
available and appropriate
in order to assist
users in considering the magnitude
of potential
exposures.
In
the
case of
certain
matters below,
we state
that we
have
established a
provision, and
for the
other matters,
we make
no
such
statement.
When
we
make
this
statement
and
we
expect
disclosure of the amount of a provision to
prejudice seriously our
position with other
parties in the
matter because it
would reveal
what
UBS
believes
to
be
the
probable
and
reliably
estimable
outflow, we
do not
disclose that
amount. In
some cases
we are
subject
to
confidentiality
obligations
that
preclude
such
disclosure. With respect to the matters for which we do not state
whether we have established
a provision, either: (a)
we have not
established a
provision, in
which case
the matter
is treated
as a
contingent liability
under the
applicable accounting
standard; or
(b) we have
established a provision
but expect disclosure
of that
fact to
prejudice seriously
our position
with other
parties in
the
matter
because
it
would
reveal
the
fact
that
UBS
believes
an
outflow of resources to be probable and reliably estimable.
With respect
to certain
litigation, regulatory
and similar
matters
for which we have established provisions, we
are able to estimate
the expected timing
of outflows. However,
the aggregate amount
of the expected outflows for those matters for which we are able
to estimate
expected timing
is immaterial
relative to
our current
and expected levels of liquidity over the relevant time periods.
The
aggregate
amount
provisioned
for
litigation,
regulatory
and similar matters as a class
is disclosed in the “Provisions” table
in Note
18a above.
It is
not practicable
to provide
an aggregate
estimate
of
liability
for
our
litigation,
regulatory
and
similar
matters as a class of contingent liabilities. Doing so would
require
UBS
to
provide
speculative
legal
assessments
as
to
claims
and
proceedings
that
involve
unique
fact
patterns
or
novel
legal
theories, that have not yet been initiated or are at early
stages of
adjudication,
or
as
to
which
alleged
damages
have
not
been
quantified
by
the
claimants.
Although
UBS
therefore
cannot
provide a numerical estimate of the
future losses that could arise
from litigation,
regulatory and
similar matters,
UBS believes
that
the aggregate
amount of
possible future
losses from
this class
that
are
more than
remote
substantially exceeds
the level
of
current
provisions.
Litigation,
regulatory
and
similar
matters
may
also
result
in
non-monetary
penalties
and
consequences.
A guilty
plea
to,
or
conviction of, a crime could have material consequences for UBS.
Resolution of
regulatory proceedings
may require
UBS to
obtain
waivers
of
regulatory
disqualifications
to
maintain
certain
operations, may entitle regulatory authorities to limit, suspend or
terminate licenses and regulatory authorizations, and may permit
financial
market
utilities
to
limit,
suspend
or
terminate
UBS’s
participation in such
utilities. Failure to
obtain such
waivers, or
any
limitation, suspension or
termination of licenses,
authorizations or
participations, could have material consequences for UBS.
The risk of
loss associated with
litigation, regulatory and
similar
matters
is
a
component
of
operational
risk
for
purposes
of
determining
capital
requirements.
Information
concerning
our
capital requirements
and the
calculation of
operational risk
for this
purpose
is
included
in
the
“Capital,
liquidity
and
funding,
and
balance sheet” section of this report.
Provisions for litigation, regulatory and similar matters
by business division and in Group Functions
1
USD million
Global
Wealth
Manage-
ment
Personal &
Corporate
Banking
Asset
Manage-
ment
Investment
Bank
Group
Functions
Total 2021
Balance at the beginning of the year
861
115
0
227
932
2,135
Increase in provisions recognized in the income statement
754
84
9
107
32
986
Release of provisions recognized in the income statement
(
60
)
(
11
)
0
(
4
)
0
(
74
)
Provisions used in conformity with designated purpose
(
175
)
(
1
)
(
1
)
(
10
)
(
2
)
(
189
)
Foreign currency translation / unwind of discount
(
42
)
(
6
)
0
(
11
)
0
(
59
)
Balance at the end of the year
1,338
181
8
310
962
2,798
1 Provisions, if any,
for the matters described
in items 3 and
4 of this Note are
recorded in Global Wealth
Management, and provisions,
if any, for
the matters described in
item 2 are recorded in
Group Functions.
Provisions, if any, for the matters described in items 1 and 6 of this Note are allocated between Global Wealth Management and
Personal & Corporate Banking, and provisions, if any, for the matters described in item
5 are allocated between the Investment Bank and Group Functions.
Consolidated financial statements | UBS Group AG consolidated financial statements
332
Note 18
Provisions and contingent liabilities (continued)
1. Inquiries regarding cross-border wealth management
businesses
Tax
and
regulatory
authorities
in
a
number
of
countries
have
made
inquiries,
served
requests
for
information
or
examined
employees located
in their
respective jurisdictions
relating to
the
cross-border
wealth management
services provided
by UBS
and
other financial institutions.
It is possible
that the implementation
of
automatic
tax
information
exchange
and
other
measures
relating to
cross-border provision
of financial
services could
give
rise to further inquiries in
the future. UBS has
received disclosure
orders from the Swiss Federal
Tax Administration (FTA) to transfer
information
based
on
requests
for
international
administrative
assistance in tax matters. The
requests concern a number of UBS
account numbers pertaining to
current and former clients and
are
based
on
data
from
2006
and
2008.
UBS
has
taken
steps
to
inform
affected
clients
about
the
administrative
assistance
proceedings
and
their
procedural
rights,
including
the
right
to
appeal. The requests
are based on
data received from the
German
authorities, who seized certain
data related to UBS clients
booked
in
Switzerland
during
their
investigations
and
have
apparently
shared
this
data
with
other
European
countries.
UBS
expects
additional countries to file similar requests.
Since
2013,
UBS
(France)
S.A.,
UBS
AG
and
certain
former
employees
have
been
under
investigation
in
France
for
alleged
complicity
in
unlawful
solicitation
of
clients
on
French
territory,
regarding
the laundering
of proceeds
of tax
fraud, and
banking
and financial solicitation
by unauthorized persons.
In connection
with this
investigation, the investigating
judges ordered
UBS AG
to provide
bail (“
caution
”) of
EUR
1.1
billion and
UBS (France)
S.A.
to post
bail of
EUR
40
million, which
was reduced
on appeal
to
EUR
10
million.
On
20 February
2019,
the
court
of
first
instance
returned
a
verdict finding UBS AG guilty of unlawful
solicitation of clients on
French territory and aggravated laundering of
the proceeds of tax
fraud,
and
UBS
(France)
S.A.
guilty
of
aiding
and
abetting
unlawful solicitation and of laundering the proceeds of tax fraud.
The court
imposed fines aggregating
EUR
3.7
billion on
UBS AG
and
UBS
(France)
S.A.
and
awarded
EUR
800
million
of
civil
damages to the French
state. A trial
in the French Court
of Appeal
took place in
March 2021.
On 13 December
2021, the
Court of
Appeal
found
UBS
AG
guilty
of
unlawful
solicitation
and
aggravated
laundering
of
the
proceeds
of
tax
fraud.
The
court
ordered
a
fine
of
EUR
3.75
million,
the
confiscation
of
EUR
1
billion, and
awarded civil
damages to
the French
state of
EUR
800
million. The
court also
found UBS
(France) SA
guilty of
the aiding and abetting of
unlawful solicitation and ordered it
to
pay a fine of EUR
1.875
million. UBS AG has filed an appeal with
the
French
Supreme
Court
to
preserve
its
rights.
The
appeal
enables UBS AG
to thoroughly assess the
verdict of the
Court of
Appeal
and
to
determine
next
steps
in
the
best
interest
of
its
stakeholders. The fine
and confiscation imposed
by the Court
of
Appeal are
suspended during the
appeal. The civil
damages award
has been
paid to
the French
state (EUR
99
million of
which was
deducted from the bail), subject to the result of UBS’s appeal.
Our balance
sheet at
31 December 2021
reflected provisions
with
respect
to
this
matter
in
an
amount
of
EUR
1.1
billion
(USD
1.252
billion
at
31
December
2021).
The
wide
range
of
possible
outcomes
in
this
case
contributes
to
a
high
degree
of
estimation uncertainty and
the provision reflects
our best estimate
of
possible
financial
implications,
although
actual
penalties and
civil
damages
could
exceed
(or
may
be
less
than)
the
provision
amount.
In 2016,
UBS was
notified by
the Belgian
investigating judge
that it
was under
formal investigation
(“
inculpé
”) regarding
the
allegations of
laundering of
proceeds of
tax fraud,
banking and
financial
solicitation
by
unauthorized
persons,
and
serious
tax
fraud.
In
November
2021,
the
Council
Chamber
approved
a
settlement with the Brussels
Prosecution Office for EUR
49
million
without
recognition
of
guilt
with
regard
to
the
allegations
of
banking
and
financial
solicitation
by
unauthorized
persons
and
serious tax fraud. The allegation of laundering of proceeds of tax
fraud was dismissed.
Our balance
sheet at
31 December
2021 reflected
provisions
with respect to matters described
in this item 1 in
an amount that
UBS believes
to be
appropriate under
the applicable
accounting
standard.
As
in
the
case
of
other
matters
for
which
we
have
established provisions, the
future outflow of resources
in respect
of
such
matters
cannot
be
determined
with
certainty
based
on
currently
available
information
and
accordingly
may
ultimately
prove
to
be
substantially
greater
(or
may
be
less)
than
the
provision that we have recognized.
2. Claims related to sales of residential mortgage-backed
securities and mortgages
From 2002 through
2007, prior to the
crisis in the US
residential
loan market, UBS was
a substantial issuer and
underwriter of US
residential
mortgage-backed
securities
(RMBS)
and
was
a
purchaser and seller of US residential mortgages.
In November 2018,
the DOJ
filed a
civil complaint
in the
District
Court for
the Eastern
District of
New York.
The complaint
seeks
unspecified
civil
monetary
penalties
under
the
Financial
Institutions
Reform,
Recovery
and
Enforcement
Act
of
1989
related
to
UBS’s
issuance,
underwriting
and
sale
of
40
RMBS
transactions
in
2006
and
2007.
UBS
moved
to
dismiss
the
civil
complaint
on
6 February
2019.
On
10 December
2019,
the
district court denied UBS’s motion to dismiss.
Our balance sheet at
31 December 2021 reflected a
provision
with respect to matters described
in this item 2 in
an amount that
UBS believes
to be
appropriate under
the applicable
accounting
standard.
As
in
the
case
of
other
matters
for
which
we
have
established provisions, the
future outflow of resources
in respect
of
this
matter
cannot
be
determined
with
certainty
based
on
currently
available
information
and
accordingly
may
ultimately
prove
to
be
substantially
greater
(or
may
be
less)
than
the
provision that we have recognized.
333
Note 18
Provisions and contingent liabilities (continued)
3. Madoff
In
relation
to
the
Bernard
L.
Madoff
Investment
Securities
LLC
(BMIS) investment
fraud, UBS
AG, UBS
(Luxembourg) S.A.
(now
UBS
Europe
SE,
Luxembourg
branch)
and
certain
other
UBS
subsidiaries
have
been
subject
to
inquiries
by
a
number
of
regulators,
including
the
Swiss
Financial
Market
Supervisory
Authority
(FINMA)
and
the
Luxembourg
Commission
de
Surveillance du Secteur Financier.
Those inquiries concerned
two
third-party funds established
under Luxembourg
law, substantially
all
assets
of
which
were
with
BMIS,
as
well
as
certain
funds
established in
offshore
jurisdictions with
either direct
or indirect
exposure
to
BMIS.
These
funds
faced
severe
losses,
and
the
Luxembourg
funds
are
in
liquidation.
The
documentation
establishing
both
funds
identifies
UBS
entities
in
various
roles,
including
custodian,
administrator,
manager,
distributor
and
promoter,
and
indicates
that
UBS
employees
serve
as
board
members.
In
2009
and
2010,
the
liquidators
of
the
two
Luxembourg
funds
filed
claims
against
UBS
entities,
non-UBS
entities
and
certain individuals, including current
and former UBS employees,
seeking
amounts
totaling
approximately
EUR
2.1
billion,
which
includes
amounts
that
the
funds
may
be
held
liable
to
pay
the
trustee for the liquidation of BMIS (BMIS Trustee).
A
large
number
of
alleged
beneficiaries
have
filed
claims
against UBS
entities (and
non-UBS entities)
for purported
losses
relating
to
the
Madoff
fraud.
The
majority
of
these
cases
have
been filed in
Luxembourg, where decisions
that the claims
in eight
test
cases
were
inadmissible
have
been
affirmed
by
the
Luxembourg
Court
of
Appeal,
and
the
Luxembourg
Supreme
Court has dismissed a further appeal in one of the test cases.
In the
US, the
BMIS Trustee
filed claims
against UBS
entities,
among others, in relation to the two Luxembourg funds and
one
of
the
offshore
funds.
The
total
amount
claimed
against
all
defendants
in
these
actions
was
not
less
than
USD
2
billion.
In
2014, the US Supreme
Court rejected the BMIS
Trustee’s motion
for leave to appeal decisions dismissing
all claims except those for
the
recovery
of
approximately
USD
125
million
of
payments
alleged to
be fraudulent
conveyances and
preference payments.
In 2016, the bankruptcy court dismissed
these claims against the
UBS entities. In February 2019, the Court of Appeals reversed the
dismissal
of
the
BMIS
Trustee’s
remaining
claims,
and
the
US
Supreme Court subsequently denied a
petition seeking review of
the Court
of Appeals’
decision. The
case has
been remanded
to
the Bankruptcy Court for further proceedings.
4. Puerto Rico
Declines since 2013 in the market prices of Puerto Rico municipal
bonds and of
closed-end funds
(funds) that
are sole-managed and
co-managed
by
UBS
Trust
Company
of
Puerto
Rico
and
distributed by UBS
Financial Services Incorporated of
Puerto Rico
(UBS PR)
led to
multiple regulatory
inquiries, which
in 2014
and
2015, led to settlements
with the Office
of the Commissioner of
Financial Institutions
for the
Commonwealth of
Puerto Rico,
the
US Securities
and Exchange
Commission (SEC)
and the
Financial
Industry Regulatory Authority.
Since then,
UBS clients
in Puerto
Rico who
own the
funds or
Puerto Rico municipal bonds and/or
who used their UBS account
assets
as
collateral
for
UBS
non-purpose
loans
filed
customer
complaints and arbitration demands seeking aggregate
damages
of USD
3.4
billion, of
which USD
3.1
billion have
been resolved
through
settlements,
arbitration
or
withdrawal
of
claims.
Allegations include
fraud, misrepresentation
and unsuitability
of
the funds and of the loans.
A
shareholder
derivative
action
was
filed
in
2014
against
various UBS
entities and
current and
certain former
directors of
the funds, alleging hundreds
of millions of US
dollars in losses in
the funds. In
2021, the
parties reached an
agreement to settle
this
matter for USD
15
million, subject to court approval.
In 2011,
a purported
derivative action
was filed
on behalf
of
the Employee Retirement
System of
the Commonwealth of
Puerto
Rico
(System)
against
over
40
defendants,
including
UBS
PR,
which
was
named
in
connection
with
its
underwriting
and
consulting
services.
Plaintiffs
alleged
that
defendants
violated
their
purported
fiduciary
duties
and
contractual
obligations
in
connection
with the
issuance and
underwriting
of USD
3
billion
of
bonds
by
the
System
in
2008
and
sought
damages
of
over
USD
800
million. In 2016, the court granted the System’s request
to
join
the
action
as
a
plaintiff.
In
2017,
the
court
denied
defendants’ motion to
dismiss the complaint.
In 2020, the
court
denied plaintiffs’ motion for summary judgment.
Beginning in 2015, certain
agencies and public corporations
of
the
Commonwealth
of
Puerto
Rico
(Commonwealth)
defaulted
on certain
interest payments
on Puerto
Rico bonds.
In 2016,
US
federal
legislation
created
an
oversight
board
with
power
to
oversee
Puerto
Rico’s
finances
and
to
restructure
its
debt.
The
oversight
board
has
imposed
a
stay
on
the
exercise
of
certain
creditors’
rights.
In
2017,
the oversight
board placed
certain of
the
bonds
into
a
bankruptcy-like
proceeding
under
the
supervision of a Federal District Judge.
In
May
2019,
the
oversight
board
filed
complaints in
Puerto
Rico federal
district court
bringing claims
against financial,
legal
and
accounting
firms
that
had
participated
in
Puerto
Rico
municipal
bond
offerings,
including
UBS,
seeking
a
return
of
underwriting
and
swap
fees
paid
in
connection
with
those
offerings. UBS
estimates that
it received
approximately USD
125
million in fees in the relevant offerings.
In August
2019, and
February and
November 2020,
four US
insurance companies that insured issues of Puerto Rico municipal
bonds
sued
UBS
and
several
other
underwriters
of
Puerto
Rico
municipal bonds
in three
separate cases.
The actions
collectively
seek
recovery
of
an
aggregate
of
USD
955
million
in
damages
from
the
defendants.
The
plaintiffs
in
these
cases
claim
that
defendants failed to
reasonably investigate financial
statements in
the
offering
materials
for
the
insured
Puerto
Rico
bonds
issued
between 2002 and 2007, which plaintiffs argue they relied
upon
in agreeing to insure the
bonds notwithstanding that they had
no
contractual
relationship
with
the
underwriters.
Defendants’
motions
to
dismiss
were
granted
in
two
of
the
cases;
those
decisions are
being appealed
by the
plaintiffs. In
the third
case,
defendants’
motion
to
dismiss
was
denied,
but
on
appeal
that
ruling was reversed and the motion to dismiss was granted.
Consolidated financial statements | UBS Group AG consolidated financial statements
334
Note 18
Provisions and contingent liabilities (continued)
Our balance
sheet at
31 December 2021
reflected
provisions
with respect
to matters described
in this
item 4 in
amounts that
UBS believes
to be
appropriate under
the applicable
accounting
standard.
As
in
the
case
of
other
matters
for
which
we
have
established provisions, the future
outflow of resources
in respect
of
such
matters
cannot
be
determined
with
certainty
based
on
currently
available
information
and
accordingly
may
ultimately
prove
to
be
substantially
greater
(or
may
be
less)
than
the
provisions that we have recognized.
5. Foreign exchange, LIBOR and benchmark rates, and other
trading practices
Foreign exchange-related regulatory matters:
Beginning in 2013,
numerous
authorities
commenced
investigations
concerning
possible manipulation of foreign
exchange markets and precious
metals prices. As a
result of these investigations,
UBS entered into
resolutions
with
Swiss,
US
and
United
Kingdom
regulators
and
the
European
Commission.
UBS
was
granted
conditional
immunity by the
Antitrust Division of
the DOJ and
by authorities
in other jurisdictions
in connection with
potential competition law
violations
relating
to
foreign
exchange
and
precious
metals
businesses.
Foreign exchange-related
civil litigation:
Putative class
actions
have
been
filed
since
2013
in
US
federal
courts
and
in
other
jurisdictions against
UBS and
other banks
on behalf
of putative
classes of persons
who engaged in
foreign currency transactions
with
any
of
the
defendant
banks.
UBS
has
resolved
US
federal
court class
actions relating
to foreign
currency transactions
with
the
defendant
banks
and
persons
who
transacted
in
foreign
exchange futures
contracts and options
on such futures
under a
settlement agreement that provides for UBS
to pay an aggregate
of
USD
141
million
and
provide
cooperation
to
the
settlement
classes.
Certain
class
members
have
excluded
themselves
from
that settlement and have
filed individual actions in
US and English
courts against UBS and other banks, alleging violations of US
and
European competition laws and unjust enrichment.
In
2015,
a
putative
class
action
was
filed
in
federal
court
against UBS and numerous other banks on behalf of persons and
businesses in the
US who
directly purchased foreign
currency from
the defendants
and alleged co-conspirators
for their
own end
use.
In March
2017, the
court granted
UBS’s (and
the other
banks’)
motions to dismiss the complaint. The plaintiffs filed an amended
complaint in August
2017. In March
2018, the court
denied the
defendants’ motions to dismiss the amended complaint.
LIBOR
and
other
benchmark-related
regulatory
matters:
Numerous
government
agencies
conducted
investigations
regarding potential improper attempts by UBS,
among others, to
manipulate
LIBOR
and
other
benchmark
rates
at
certain
times.
UBS
reached
settlements
or
otherwise
concluded
investigations
relating
to
benchmark
interest
rates
with
the
investigating
authorities. UBS
was granted
conditional leniency
or conditional
immunity
from
authorities
in
certain
jurisdictions,
including
the
Antitrust
Division
of
the
DOJ
and
the
Swiss
Competition
Commission
(WEKO),
in
connection
with
potential
antitrust
or
competition law violations related to certain
rates. However, UBS
has not reached a final settlement with WEKO,
as the Secretariat
of WEKO has asserted
that UBS does
not qualify for full
immunity.
LIBOR and
other benchmark-related
civil litigation:
A number
of
putative
class
actions
and
other
actions
are
pending
in
the
federal courts
in New
York against
UBS and
numerous other
banks
on
behalf
of
parties
who
transacted
in
certain
interest
rate
benchmark-based derivatives. Also
pending in the
US and in
other
jurisdictions are a number of
other actions asserting losses
related
to various products whose
interest rates were linked to
LIBOR and
other benchmarks, including
adjustable rate mortgages,
preferred
and debt securities, bonds
pledged as collateral, loans,
depository
accounts,
investments
and
other
interest-bearing
instruments.
The
complaints
allege
manipulation,
through
various
means, of
certain
benchmark
interest rates,
including USD
LIBOR, Euroyen
TIBOR, Yen
LIBOR, EURIBOR, CHF LIBOR,
GBP LIBOR, SGD
SIBOR
and
SOR
and
Australian
BBSW,
and
seek
unspecified
compensatory and other damages under varying legal theories.
USD LIBOR class and individual actions
in the US:
In 2013 and
2015,
the
district
court
in
the
USD LIBOR
actions
dismissed,
in
whole
or
in
part,
certain
plaintiffs’
antitrust
claims,
federal
racketeering
claims, CEA
claims, and
state common
law claims,
and
again
dismissed
the
antitrust
claims
in
2016
following
an
appeal. In
December 2021,
the Second
Circuit affirmed
the district
court’s dismissal in part and
reversed in part and
remanded to the
district court for further proceedings. The Second
Circuit, among
other things,
held that
there was
personal jurisdiction
over UBS
and other
foreign defendants
based on
allegations that
at least
one alleged
co-conspirator undertook an
overt act in
the United
States. Separately, in
2018, the Second
Circuit reversed in
part the
district
court’s
2015
decision
dismissing
certain
individual
plaintiffs’ claims and certain of
these actions are now
proceeding.
In
2018,
the
district
court
denied
plaintiffs’
motions
for
class
certification
in the
USD class actions
for
claims pending
against
UBS, and plaintiffs sought permission to appeal that ruling to the
Second
Circuit.
In
July
2018,
the
Second
Circuit
denied
the
petition to
appeal of
the class
of USD lenders
and in
November
2018 denied
the petition
of the
USD exchange class.
In January
2019, a putative class action
was filed in the District
Court for the
Southern District
of New
York against
UBS and
numerous other
banks
on
behalf
of
US
residents
who,
since
1 February
2014,
directly
transacted
with
a
defendant
bank
in
USD LIBOR
instruments.
The
complaint
asserts
antitrust
claims.
The
defendants moved to
dismiss the complaint
in August 2019.
On
26 March 2020 the
court granted defendants’ motion to
dismiss
the complaint in
its entirety. Plaintiffs
have appealed the
dismissal.
In
August
2020,
an
individual
action
was
filed
in
the
Northern
District
of
California
against
UBS
and
numerous
other
banks
alleging that the
defendants conspired to
fix the interest
rate used
as
the
basis
for
loans
to
consumers
by
jointly
setting
the
USD LIBOR
rate
and
monopolized
the
market
for
LIBOR-based
consumer
loans
and
credit
cards. Defendants
moved
to
dismiss
the complaint in September 2021.
335
Note 18
Provisions and contingent liabilities (continued)
Other benchmark class actions in the US:
Yen
LIBOR / Euroyen TIBOR –
In 2014, 2015 and 2017, the court
in
one
of
the
Yen
LIBOR
/
Euroyen
TIBOR
lawsuits
dismissed
certain
of
the
plaintiffs’
claims,
including
the
plaintiffs’
federal
antitrust
and
racketeering
claims.
In
August
2020,
the
court
granted defendants’
motion for
judgment on
the pleadings
and
dismissed the lone remaining claim in the action as impermissibly
extraterritorial.
Plaintiffs
have
appealed.
In
2017,
the
court
dismissed
the
other
Yen
LIBOR
/
Euroyen
TIBOR
action
in
its
entirety
on
standing
grounds.
In
April
2020,
the
appeals
court
reversed the dismissal and in August 2020 plaintiffs
in that action
filed
an
amended
complaint
focused
on
Yen
LIBOR.
The
court
granted in part and denied in part defendants’ motion to dismiss
the amended complaint in
September 2021 and plaintiffs and
the
remaining defendants have moved for reconsideration.
CHF LIBOR
– In
2017, the
court dismissed the
CHF LIBOR action
on standing grounds and failure
to state a claim. Plaintiffs
filed an
amended complaint, and the court granted a renewed motion to
dismiss
in
September
2019.
Plaintiffs
appealed.
In
September
2021,
the
Second
Circuit
granted
the
parties’
joint
motion
to
vacate the dismissal and
remand the case for
further proceedings.
EURIBOR
– In 2017,
the court in
the EURIBOR lawsuit
dismissed
the case as
to UBS and
certain other foreign defendants
for lack
of personal jurisdiction. Plaintiffs have appealed.
SIBOR / SOR
– In October
2018, the court
in the SIBOR
/ SOR
action
dismissed
all
but
one
of
plaintiffs’
claims
against
UBS.
Plaintiffs
filed
an
amended
complaint,
and
the
court
granted
a
renewed
motion
to
dismiss
in
July
2019.
Plaintiffs
appealed.
In
March 2021,
the Second
Circuit reversed
the dismissal.
Plaintiffs
filed an amended
complaint in October
2021, which defendants
have moved to dismiss.
BBSW
–
In
November
2018,
the
court
dismissed
the
BBSW
lawsuit as to UBS and certain other
foreign defendants for lack of
personal jurisdiction. Plaintiffs
filed an
amended complaint
in April
2019,
which
UBS
and
other
defendants
moved
to
dismiss.
In
February
2020,
the
court
granted
in
part
and
denied
in
part
defendants’
motions
to
dismiss
the
amended
complaint.
In
August 2020,
UBS and
other BBSW
defendants joined
a motion
for
judgment
on
the pleadings,
which
the
court denied
in May
2021.
GBP
LIBOR
–
The
court
dismissed
the
GBP
LIBOR
action
in
August 2019. Plaintiffs have appealed.
Government bonds:
Putative class actions
have been filed since
2015 in US federal courts against UBS and other banks on behalf
of persons who
participated in markets for US
Treasury securities
since 2007. A consolidated complaint was filed
in 2017 in the US
District Court for the
Southern District of New
York alleging that
the banks colluded with
respect to, and manipulated
prices of, US
Treasury securities
sold at auction
and in the
secondary
market and
asserting
claims
under the
antitrust
laws and
for unjust
enrichment.
Defendants’ motions
to
dismiss the
consolidated complaint was
granted
in
March
2021.
Plaintiffs filed
an
amended
complaint,
which
defendants moved
to
dismiss in
June
2021.
Similar
class
actions have
been filed
concerning European government bonds
and other government
bonds.
In
May
2021,
the
European
Commission
issued
a
decision
finding that
UBS
and
six other
banks breached
European Union
antitrust
rules
in
2007–2011
relating
to
European
government
bonds. The European
Commission
fined UBS EUR
172
million. UBS
is appealing
the amount
of the fine.
With
respect
to
additional
matters
and
jurisdictions
not
encompassed
by
the
settlements
and
orders
referred
to
above,
our balance
sheet at
31 December 2021
reflected a
provision in
an
amount
that
UBS
believes
to
be
appropriate
under
the
applicable accounting
standard. As
in the
case of
other matters
for which
we have
established provisions,
the future
outflow of
resources in
respect of
such matters
cannot be
determined with
certainty based on
currently available information
and accordingly
may ultimately
prove to
be substantially
greater (or
may be
less)
than the provision that we have recognized.
6. Swiss retrocessions
The Federal Supreme Court of Switzerland
ruled in 2012, in
a test
case
against
UBS,
that
distribution
fees
paid
to
a
firm
for
distributing
third-party
and
intra-group
investment
funds
and
structured products must be
disclosed and surrendered to clients
who have
entered into
a discretionary
mandate agreement
with
the firm, absent
a valid
waiver.
FINMA issued
a supervisory
note
to all Swiss
banks in response to
the Supreme Court decision.
UBS
has met
the FINMA
requirements and
has notified all
potentially
affected clients.
The
Supreme
Court
decision
has
resulted,
and
continues
to
result,
in
a
number
of
client
requests
for
UBS
to
disclose
and
potentially
surrender
retrocessions.
Client
requests
are
assessed
on a case-by-case basis. Considerations taken into account when
assessing these cases
include, among other
things, the existence
of
a
discretionary
mandate
and
whether
or
not
the
client
documentation
contained
a
valid
waiver
with
respect
to
distribution fees.
Our balance sheet at
31 December 2021 reflected a
provision
with respect to matters described
in this item 6 in
an amount that
UBS believes
to be
appropriate under
the applicable
accounting
standard.
The
ultimate
exposure
will
depend
on
client
requests
and the resolution thereof, factors that
are difficult to predict and
assess. Hence, as in the
case of other matters for
which we have
established provisions, the
future outflow of resources
in respect
of
such
matters
cannot
be
determined
with
certainty
based
on
currently
available
information
and
accordingly
may
ultimately
prove
to
be
substantially
greater
(or
may
be
less)
than
the
provision that we have recognized.
Consolidated financial statements | UBS Group AG consolidated financial statements
336
Note 19
Other liabilities
a) Other financial liabilities measured at amortized cost
USD million
31.12.21
31.12.20
Other accrued expenses
1,876
1,696
Accrued interest expenses
1,094
1,355
Settlement and clearing accounts
1,304
1,199
Lease liabilities
3,558
3,927
Other
1,167
1,553
Total other financial liabilities measured at amortized cost
9,001
9,729
b) Other financial liabilities designated at fair value
USD million
31.12.21
31.12.20
Financial liabilities related to unit-linked investment contracts
21,466
20,975
Securities financing transactions
6,377
7,317
Over-the-counter debt instruments
2,128
2,060
Other
103
35
Total other financial liabilities designated at fair value
30,074
30,387
of which: life-to-date own credit (gain) / loss
(
32
)
(
36
)
c) Other non-financial liabilities
USD million
31.12.21
31.12.20
Compensation-related liabilities
7,257
7,468
of which: Deferred Contingent Capital Plan
1,628
1,858
of which: financial advisor compensation plans
1,512
1,500
of which: other compensation plans
2,846
2,740
of which: net defined benefit liability
633
722
of which: other compensation-related liabilities
1
638
648
Deferred tax liabilities
300
564
Current tax liabilities
1,398
1,009
VAT and other tax payables
590
523
Deferred income
240
228
Liabilities of disposal groups held for sale
2
1,298
Other
68
61
Total other non-financial liabilities
11,151
9,854
1 Includes liabilities for payroll taxes and untaken vacation.
2 Refer to Note 30 for more information.
337
Additional information
Note 20
Expected credit loss measurement
a) Expected credit losses in the period
Total
net
credit
loss
releases
were
USD
148
million
in
2021,
reflecting
net
credit
loss
releases
of
USD
123
million
related
to
stage 1 and 2
positions and USD
25
million net credit loss
releases
related to credit-impaired (stage 3) positions.
Stage 1
and
2
net
credit
loss
releases
of
USD
123
million
included
a
USD
68
million
partial
net
release
of
a
post-model
adjustment,
due
to
the
continued
positive
trend
in
macroeconomic
scenario
input
data
during
the
year,
a
USD
45
million
net
release
from
a
number
of
model
and
methodology
changes
and
a
residual
USD
10
million
net
release
from
remeasurements
within
the
loan
book,
derecognized
transactions, partially offset by expenses from new transactions
.
›
Refer to Note 20b
for more information regarding changes to
ECL model, scenarios,
scenario weights and the post-model
adjustment and to Note 20c for more information
regarding
the development of ECL allowances and
provisions
Stage 3 net releases of USD
25
million were recognized across
a number of defaulted
positions with a USD
24
million net release
in Personal & Corporate Banking.
Credit loss (expense) / release
USD million
Global
Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
Total
For the year ended 31.12.21
Stages 1 and 2
28
62
0
34
0
123
Stage 3
1
24
(
1
)
0
0
25
Total credit loss (expense) / release
29
86
(
1
)
34
0
148
For the year ended 31.12.20
Stages 1 and 2
(
48
)
(
129
)
0
(
88
)
0
(
266
)
Stage 3
(
40
)
(
128
)
(
2
)
(
217
)
(
42
)
(
429
)
Total credit loss (expense) / release
(
88
)
(
257
)
(
2
)
(
305
)
(
42
)
(
694
)
For the year ended 31.12.19
Stages 1 and 2
3
23
0
(
4
)
0
22
Stage 3
(
23
)
(
44
)
0
(
26
)
(
7
)
(
100
)
Total credit loss (expense) / release
(
20
)
(
21
)
0
(
30
)
(
7
)
(
78
)
Consolidated financial statements | UBS Group AG consolidated financial statements
338
Note 20
Expected credit loss measurement (continued)
b) Changes to ECL models, scenarios, scenario weights and key inputs
Refer to
Note 1a
for information
about the
principles governing
expected credit loss
(ECL) models, scenarios,
scenario weights and
key inputs applied.
Governance
Comprehensive
cross-functional and
cross-divisional
governance
processes
are
in
place
and
are
used
to
discuss
and
approve
scenario
updates
and
weights,
to
assess
whether
significant
increases in credit risk resulted in stage transfers, to
review model
outputs
and
to
reach
conclusions
regarding
post-model
adjustments.
Model changes
During 2021, the model review
and enhancement process led to
adjustments of
the probability
of default
(PD), loss
given default
(LGD)
and
credit
conversion
factor
(CCF)
models,
resulting
in
a
USD
45
million decrease
in ECL
allowances. An
amount of
USD
25
million related
to the
Large corporate
clients
segment in
the
Investment
Bank. The
remainder
related
to
various segments
in
Personal & Corporate Banking and Global Wealth Management.
Scenario and key input updates
During
2021,
the
scenarios
and
related
macroeconomic
factors
were updated
from those
that were
applied at
the end
of 2020
by
taking
into
account
the
prevailing
economic
and
political
conditions
and
uncertainty.
As
the
economic
development
was
more
positive
than
anticipated
following
the
COVID-19-related
downturn,
the
forward-looking
scenarios
benefited
from
an
improved forecast starting level.
The projections of
the baseline scenario,
which are aligned
to
the
economic
and
market assumptions
used
for
UBS’s business
planning purposes, are broadly in line with external data, such as
from
Bloomberg
Consensus,
Oxford
Economics
and
the
International
Monetary
Fund
World
Economic
Outlook.
The
economic
performance
during
2021
in
relevant
markets,
especially in the
US and in
Switzerland, highlighted an
accelerated
improvement
after
the
COVID-19-related
shocks.
The
scenario
assumes continued growth in 2022 in
all key markets, albeit at a
slower rate than
seen in 2021,
and unemployment rates
are not
expected to fall noticeably below the current levels. Interest rates
are expected to
remain low in
line with the
central bank policies
pursued in the Eurozone and Switzerland, and any potential rises
in the US would be
limited in the foreseeable
future. House prices
are
expected
to
reflect
the
momentum
and
continue
to
rise,
especially in Switzerland and, to a lesser degree, in the US.
The
narrative
of
the
hypothetical
severe
downside
scenario,
which
is the
Group’s binding
stress
scenario, has
been adapted
and assumes that, while
the immediate risks
from COVID-19 have
decreased,
the
associated
disruptions
and
the
consequences
of
the
unprecedented
monetary
and
fiscal
stimulus
measures
will
remain
critical.
Concerns
regarding
the
sustainability
of
public
debt, following the
marked deterioration of
fiscal positions, lead
to
a
loss
of
confidence
and
market
turbulence,
while
protectionism results
in a
fall in
global trade.
Governments and
central banks have limited
scope to support the economies.
As a
consequence,
the
Eurozone
and
China
suffer
a
hard
landing,
under
this
scenario
which
severely
affects
the
Swiss
export-
oriented
economy,
and
the
US
economy
contracts
as
global
demand
is
significantly
affected.
Given
the
severity
of
the
macroeconomic
impact,
unemployment
rates
rise
to
historical
highs and real estate sectors contract sharply.
With effect
from the
second quarter,
the hypothetical
upside
and mild downside scenarios, which
were viewed as less
plausible
as
of
31
December
2020 and
had
a
probability
weight
of
zero
attached,
were
redesigned
and
reintroduced
in
the
ECL
calculation.
These
two
scenarios
have
become
more
relevant
following
this
update,
as
they
better
reflect
a
more
positive
outlook
with
regard
to
COVID-19
and
market
expectations
regarding a potential change in
central bank policies, respectively.
The
upside
scenario
is
based
on
positive
developments
following
COVID-19 and
strong economic
activity
supported by
pent-up demand in certain
sectors, as well
as the expectation
that
interest rates
will remain
relatively low
in the
near future.
Asset
prices rise significantly, but
a view that currently
observed higher
inflation rates are temporary and spare economic
capacity would
mean that
consumer prices
remain moderate
in the
first year
of
the scenario.
The
mild
downside
scenario
focuses
on
the
implications
of
rising concerns regarding inflationary trends
following a recovery
from
COVID-19.
Higher-than-expected
inflation
data
triggers
a
steepening of
yield curves
across the
globe and
leads to
market
volatility.
Higher
interest
rates
lead
to
a
sell-off
in
assets
and
a
period
of
deleveraging
under
this
scenario
.
With
inflation
remaining high, central
banks start hiking
their policy rates
after
a few
quarters, leading
to further
increases in
interest rates
and
impacting corporate
and private
debt sustainability.
A recessionary
period is the consequence.
The table
on the
following page
details the
key assumptions
for the four scenarios applied as of 31 December 2021.
339
Note 20
Expected credit loss measurement (continued)
Scenario weights and post-model adjustments
With the weighting of
four scenarios above 0%
and considering
the generally
more positive
outlook regarding
an abating
effect
on
the
world
economy
from
the
COVID-19
pandemic,
the
distribution of
weights shifted
during 2021.
As of
31 December
2021, 5 percentage points of the weight of the baseline scenario
and 10 percentage
points of
the severe
downside scenario were
redistributed to the upside
scenario (5%) and the mild downside
scenario (10%), as shown in the table below.
Although the scenarios and
weight allocation were
established
in
line
with
the
general
market
sentiment
that
COVID-19
has
passed its peak
and a gradual return
to normal is the
most likely
path,
significant
uncertainties
still
remain.
Models,
which
are
based
on
supportable
statistical
information
from
past
experiences
regarding
interdependencies
of
macroeconomic
factors
and
their
implications
for
credit
risk
portfolios,
cannot
comprehensively reflect extraordinary events, such as a pandemic
or a fundamental change in the world political order. Especially
in
these
uncertain
times,
it
is
in
the
realm
of
possibilities
that
the
generally accepted view that the effects of COVID-19 are abating
may prove to be disappointed by
the emergence of new variants
of
the
virus,
which
may
be
more
harmful
and
may
undermine
current
vaccination
efforts.
Political
events
involving
tensions
between
major
global
forces
may
introduce
unforeseen
challenges, such
as disruptions
in the
global supply
chain and
a
distortion of energy markets. Such events could affect economies
severely and change
the baseline assumptions
significantly. Rather
than
creating multiple
additional
scenarios
to
gauge these
risks
and applying model
parameters that lack
supportable information
and
cannot
be
robustly
validated,
management
continued
to
apply
significant
post
-
model
adjustments.
These
adjustments
were
benchmarked
against
coverage
ratio
levels
as
of
30 June
2021
,
when
a
partial
n
et
release
of
USD
91
million
was
recognized, corresponding to one third of
the accumulated effect
of
scenario
improvements,
following
comprehensive
expert
assessment and judgment, and
were also deemed appropriate
for
year-end 2021 reporting. The post-model adjustments relating to
COVID-19 amounted to
USD
224
million as
of 31 December
2021
(2020: USD
117
million in addition to
overlays of USD
16
million
for
other
aspects,
where
model
results
were
deemed
to
be
uncertain).
ECL scenario
Assigned weights in %
31.12.21
31.12.20
Upside
5.0
0.0
Baseline
55.0
60.0
Mild downside
10.0
0.0
Severe downside
30.0
40.0
Scenario assumptions
One year
Three years cumulative
31.12.21
Upside
Baseline
Mild
downside
Severe
downside
Upside
Baseline
Mild
downside
Severe
downside
Real GDP growth (% change)
United States
9.1
4.4
(
0.1
)
(
5.9
)
17.8
10.1
1.8
(
3.8
)
Eurozone
9.4
3.9
(
0.1
)
(
8.7
)
17.3
7.5
0.9
(
10.3
)
Switzerland
5.5
2.4
(
0.9
)
(
6.6
)
13.1
5.8
(
0.1
)
(
5.7
)
Consumer price index (% change)
United States
3.1
2.2
5.7
(
1.2
)
9.5
6.3
13.0
0.4
Eurozone
2.3
1.4
4.2
(
1.3
)
8.0
4.8
10.4
(
1.7
)
Switzerland
1.8
0.3
3.5
(
1.8
)
6.1
1.7
9.0
(
1.6
)
Unemployment rate (end-of-period level, %)
United States
3.0
3.9
6.1
10.9
3.0
3.5
7.2
10.8
Eurozone
6.2
7.4
8.7
12.9
6.0
7.2
9.1
15.1
Switzerland
2.3
2.5
3.4
5.2
1.6
2.3
4.2
5.9
Fixed income: 10-year government bonds (change in yields, basis points)
USD
50.0
16.5
259.2
(
50.0
)
170.0
41.2
329.2
(
15.0
)
EUR
40.0
11.1
283.8
(
35.0
)
140.0
34.9
349.3
(
25.0
)
CHF
50.0
12.1
245.5
(
70.0
)
150.0
34.4
307.3
(
35.0
)
Equity indices (% change)
S&P 500
12.0
14.1
(
27.0
)
(
50.2
)
35.5
24.7
(
21.8
)
(
40.1
)
EuroStoxx 50
16.0
12.3
(
23.4
)
(
57.6
)
41.6
20.7
(
19.9
)
(
50.4
)
SPI
14.0
12.1
(
22.9
)
(
53.6
)
37.9
19.1
(
19.6
)
(
44.2
)
Swiss real estate (% change)
Single-Family Homes
5.1
4.4
(
4.3
)
(
17.0
)
15.5
7.4
(
8.8
)
(
30.0
)
Other real estate (% change)
United States (S&P / Case-Shiller)
10.0
3.5
(
2.3
)
(
9.5
)
21.7
7.1
(
8.7
)
(
26.3
)
Eurozone (House Price Index)
8.4
5.1
(
4.0
)
(
5.4
)
17.8
9.6
(
7.6
)
(
10.8
)
Consolidated financial statements | UBS Group AG consolidated financial statements
340
Note 20
Expected credit loss measurement (continued)
Scenario assumptions
One year
Three years cumulative
31.12.20
Baseline
Severe downside
Baseline
Severe downside
Real GDP growth (% change)
United States
2.7
(
5.9
)
9.1
(
3.8
)
Eurozone
2.5
(
8.7
)
9.9
(
10.3
)
Switzerland
3.3
(
6.6
)
9.0
(
5.7
)
Consumer price index (% change)
United States
1.7
(
1.2
)
5.5
0.4
Eurozone
1.4
(
1.3
)
3.9
(
1.7
)
Switzerland
0.3
(
1.8
)
0.9
(
1.6
)
Unemployment rate (end-of-period level, %)
United States
5.5
12.1
4.5
9.9
Eurozone
9.5
14.1
8.0
16.4
Switzerland
3.8
6.1
3.2
6.8
Fixed income: 10-year government bonds (change in yields, basis points)
USD
22.0
(
50.0
)
46.0
(
15.0
)
EUR
4.0
(
35.0
)
21.0
(
25.0
)
CHF
13.0
(
70.0
)
31.0
(
35.0
)
Equity indices (% change)
S&P 500
(
2.9
)
(
50.2
)
(
1.7
)
(
40.1
)
EuroStoxx 50
3.8
(
57.6
)
13.5
(
50.4
)
SPI
(
0.8
)
(
53.6
)
5.8
(
44.2
)
Swiss real estate (% change)
Single-Family Homes
3.4
(
17.0
)
7.1
(
30.0
)
Other real estate (% change)
United States (S&P / Case-Shiller)
2.5
(
15.3
)
9.2
(
28.7
)
Eurozone (House Price Index)
1.1
(
22.9
)
7.2
(
35.4
)
c) Development of ECL allowances and provisions
The ECL
allowances and
provisions recognized
in the
period are
impacted by a variety of factors, such as:
–
origination of new instruments during the period;
–
effect of passage of time as the ECLs on an instrument for the
remaining
lifetime
decrease
(all
other
factors
remaining
the
same);
–
discount
unwind
within ECLs
as
it
is
measured
on
a
present
value basis;
–
derecognition of instruments in the period;
–
change in individual asset quality of instruments;
–
effect
of
updating
forward-looking
scenarios
and
the
respective weights;
–
movements from a
maximum 12-month
ECL to the
recognition
of
lifetime ECLs
(and
vice versa)
following transfers
between
stages 1 and 2;
–
movements
from
stages 1
and
2
to
stage 3
(credit-impaired
status) when
default has
become certain
and PD
increases to
100% (or vice versa);
–
changes in models or updates to model parameters;
–
write-off; and
–
foreign
exchange
translations
for
assets
denominated
in
foreign currencies and other movements.
341
Note 20
Expected credit loss measurement (continued)
The following table explains the changes in
the ECL allowances and provisions for on-
and off-balance sheet financial instruments and
credit lines in
scope of ECL requirements
between the beginning and the
end of the period due
to the factors listed on
the previous
page.
Development of ECL allowances and
provisions
USD million
Total
Stage 1
Stage 2
Stage 3
Balance as of 31 December 2020
(
1,468
)
(
306
)
(
333
)
(
829
)
Net movement from new and derecognized transactions
1
(
59
)
(
72
)
13
0
of which: Private clients with mortgages
(
7
)
(
10
)
3
0
of which: Real estate financing
(
7
)
(
11
)
4
0
of which: Large corporate clients
(
13
)
(
21
)
7
0
of which: SME clients
(
8
)
(
8
)
0
0
of which: Other
(
24
)
(
23
)
(
2
)
0
of which: Financial intermediaries and hedge funds
(
21
)
(
18
)
(
4
)
0
of which: Loans to financial advisors
0
(
1
)
1
0
Remeasurements with stage transfers
2
(
40
)
8
0
(
49
)
of which: Private clients with mortgages
(
9
)
4
(
13
)
0
of which: Real estate financing
(
3
)
1
(
4
)
0
of which: Large corporate clients
2
(
2
)
12
(
8
)
of which: SME clients
(
27
)
5
4
(
36
)
of which: Other
(
3
)
0
2
(
4
)
of which: Financial intermediaries and hedge funds
2
(
1
)
3
0
of which: Loans to financial advisors
0
1
(
1
)
0
Remeasurements without stage transfers
3
203
55
74
74
of which: Private clients with mortgages
33
8
26
(
1
)
of which: Real estate financing
30
13
13
3
of which: Large corporate clients
44
5
21
17
of which: SME clients
53
(
1
)
1
53
of which: Other
44
29
14
2
of which: Financial intermediaries and hedge funds
27
15
12
0
of which: Loans to financial advisors
6
8
1
(
3
)
Model changes
4
45
29
16
0
Movements with profit or loss impact
5
148
19
104
25
Movements without profit or loss impact (write-off, FX and other)
6
154
5
9
141
Balance as of 31 December 2021
(
1,165
)
(
282
)
(
220
)
(
662
)
1 Represents the
increase and decrease
in allowances
and provisions resulting
from financial instruments
(including guarantees
and facilities) that
were newly originated,
purchased or renewed
and from the
final
derecognition of loans or facilities on
their maturity date or earlier.
2 Represents the remeasurement between 12-month and lifetime
ECL due to stage transfers.
3 Represents the change in allowances and provisions
related to
changes in
model inputs
or assumptions,
including changes
in forward
-looking macroeconomic
conditions,
changes in
the exposure
profile,
PD and
LGD changes,
and unwinding
of the
time value.
4 Represents the change in the allowances and provisions related to changes in models and methodologies.
5 Includes ECL movements from new and derecognized transactions, remeasurement changes, model and
methodology changes.
6 Represents the
decrease in
allowances and
provisions resulting
from write-offs
of the ECL
allowance against
the gross carrying
amount when all
or part of
a financial asset
is deemed
uncollectible or forgiven and movements in foreign exchange rates.
In
2021,
ECL
allowances
and
provisions
decreased
by
USD
148
million from net credit loss releases impacting profit or loss:
–
a
USD
59
million
net
increase
from
new
and
derecognized
transactions
that
resulted
from
a
USD
72
million
stage 1
increase
primarily
in
the
corporate
lending
and
real
estate
lending portfolio,
offset by
a USD
13
million net release
from
stage 2
positions,
driven
by
positions
that
were
terminated
before their contractual maturity;
–
a USD
163
million net decrease from book quality movements
that
resulted
from
a
USD
203
million
net
decrease
from
remeasurements
without
stage transfers,
with
approximately
half of
that related to
corporate lending –
another significant
portion related to
real estate-related lending,
primarily due to
the partial release of a
post-model adjustment, partially offset
by USD
40
million from transactions moving
from stages 1 and
2
into
stages 2
and
3,
respectively,
primarily
related
to
SME
clients;
and
–
a USD
45
million net decrease that resulted from a number
of
model changes.
An amount of
USD
25
million related to
the
Large corporate
clients
segment in
the Investment
Bank. The
remainder related to various
segments in Personal &
Corporate
Banking and Global Wealth Management.
In
addition
to
the
movements
impacting
profit
or
loss,
allowances decreased by USD
154
million as a result
of USD
137
million
of
write-offs and
USD
18
million
from
foreign
exchange
and other movements, both of which
did not impact the income
statement.
Consolidated financial statements | UBS Group AG consolidated financial statements
342
Note 20
Expected credit loss measurement (continued)
Development of ECL allowances and
provisions
USD million
Total
Stage 1
Stage 2
Stage 3
Balance as of 31 December 2019
(
1,029
)
(
181
)
(
160
)
(
688
)
Net movement from new and derecognized transactions
1
(
28
)
(
90
)
17
46
of which: Private clients with mortgages
(
2
)
(
3
)
2
0
of which: Real estate financing
(
3
)
(
5
)
2
0
of which: Large corporate clients
(
32
)
(
29
)
(
4
)
0
of which: SME clients
(
16
)
(
14
)
(
3
)
0
of which: Other
26
(
39
)
20
46
of which: Securities financing transactions REIT
32
(
1
)
15
17
of which: Loans to financial advisors
9
(
1
)
9
0
of which: Lombard loans
23
(
6
)
0
29
of which Financial intermediaries
(
20
)
(
15
)
(
5
)
0
Remeasurements with stage transfers
2
(
427
)
45
(
134
)
(
338
)
of which: Private clients with mortgages
(
19
)
(
2
)
(
17
)
0
of which: Real estate financing
(
6
)
3
(
9
)
0
of which: Large corporate clients
(
224
)
34
(
83
)
(
175
)
of which: SME clients
(
43
)
(
1
)
(
11
)
(
31
)
of which: Other
(
134
)
11
(
14
)
(
131
)
of which: Securities financing transactions REIT
(
36
)
0
(
18
)
(
19
)
of which: Loans to financial advisors
(
12
)
7
(
7
)
(
11
)
of which: Lombard loans
(
36
)
0
0
(
36
)
of which Commodity trade finance
(
59
)
0
0
(
59
)
Remeasurements without stage transfers
3
(
271
)
(
88
)
(
47
)
(
136
)
of which: Private clients with mortgages
(
34
)
(
19
)
(
8
)
(
7
)
of which: Real estate financing
(
14
)
(
4
)
(
11
)
1
of which: Large corporate clients
(
149
)
(
53
)
(
17
)
(
79
)
of which: SME clients
(
13
)
0
(
7
)
(
6
)
of which: Other
(
60
)
(
11
)
(
4
)
(
44
)
of which: Loans to financial advisors
(
18
)
(
12
)
(
3
)
(
3
)
of which: Lombard loans
(
3
)
6
0
(
9
)
of which: Credit cards
(
12
)
0
0
(
12
)
Model changes
4
32
21
11
0
Movements with profit or loss impact
5
(
694
)
(
112
)
(
154
)
(
429
)
Movements without profit or loss impact (write-off, FX and other)
6
254
(
14
)
(
19
)
287
Balance as of 31 December 2020
(
1,468
)
(
306
)
(
333
)
(
829
)
1 Represents the
increase and decrease
in allowances
and provisions resulting
from financial instruments
(including guarantees
and facilities) that
were newly originated,
purchased or renewed
and from the
final
derecognition of loans or facilities on
their maturity date or earlier.
2 Represents the remeasurement between 12-month and lifetime
ECL due to stage transfers.
3 Represents the change in allowances and provisions
related to
changes in
model inputs
or assumptions,
including changes
in forward
-looking macroeconomic
conditions,
changes in
the exposure
profile,
PD and
LGD changes,
and unwinding
of the
time value.
4 Represents the change in the allowances and provisions related to changes in models and methodologies.
5 Includes ECL movements from new and derecognized transactions, remeasurement changes, model and
methodology changes.
6 Represents the
decrease in
allowances and
provisions resulting
from write-offs
of the ECL
allowance against
the gross carrying
amount when all
or part of
a financial
asset is
deemed
uncollectible or forgiven and movements in foreign exchange rates.
As explained in Note
1a, the assessment of
a significant increase
in
credit
risk
(
SICR
)
considers
a
number
of
qualitative
and
quantitative
factors
to
determine
whether
a
stage
transfer
between
stage 1
and
stage 2
is
required,
although
the
primary
assessment considers changes in PD based
on rating analyses and
economic
outlook.
Additionally,
UBS
takes
into
consideration
counterparties that
have moved
to a
credit watch
list and
those
with payments that are at least 30 days past due.
ECL stage 2 (“significant deterioration
in credit risk”) allowances / provisions as of 31 December
2021 – classification by trigger
USD million
Stage 2
of which:
PD layer
of which:
watch list
of which:
≥30 days
past due
On-and off-balance sheet
(
220
)
(
158
)
(
22
)
(
39
)
of which: Private clients with mortgages
(
71
)
(
54
)
0
(
17
)
of which: Real estate financing
(
43
)
(
38
)
0
(
4
)
of which: Large corporate clients
(
55
)
(
40
)
(
15
)
0
of which: SME clients
(
30
)
(
19
)
(
7
)
(
4
)
of which: Financial intermediaries and hedge funds
(
6
)
(
6
)
0
0
of which: Loans to financial advisors
(
3
)
0
0
(
3
)
of which: Credit cards
(
11
)
0
0
(
11
)
of which: Other
(
1
)
(
1
)
0
0
343
Note 20
Expected credit loss measurement (continued)
d) Maximum exposure to credit risk
The
tables
below
provide
the
Group’s
maximum
exposure
to
credit
risk for
financial instruments
subject to
ECL requirements
and
the
respective
collateral
and
other
credit
enhancements
mitigating credit risk for these classes of financial instruments.
The
maximum
exposure
to
credit
risk
includes
the
carrying
amounts of financial
instruments recognized on
the balance sheet
subject
to
credit
risk
and
the
notional
amounts
for
off-balance
sheet arrangements.
Where information
is available,
collateral is
presented at fair value.
For other collateral, such as
real estate, a
reasonable alternative
value is
used. Credit
enhancements, such
as credit derivative contracts
and guarantees, are included
at their
notional amounts. Both are capped at the maximum
exposure to
credit risk for which
they serve as
security. The “Risk management
and control” section of this
report describes management’s view
of credit risk and
the related exposures,
which can differ
in certain
respects from the requirements of IFRS.
Maximum exposure to credit risk
31.12.21
Collateral
1,2
Credit enhancements
1
Exposure to
credit risk
after collateral
and credit
enhancements
USD billion
Maximum
exposure to
credit risk
Cash
collateral
received
Collateralized
by securities
Secured by
real estate
Other
collateral
3
Netting
Credit
derivative
contracts
Guarantees
Financial assets measured at
amortized cost on the balance sheet
Cash and balances at central banks
192.8
192.8
Loans and advances to banks
4
15.5
0.1
0.1
15.3
Receivables from securities financing transactions
75.0
0.0
68.0
6.9
0.0
Cash collateral receivables on derivative instruments
5,6
30.5
18.4
12.1
Loans and advances to customers
7
397.8
37.5
128.7
191.3
20.2
4.0
16.2
Other financial assets measured at amortized cost
26.2
0.2
0.1
0.0
1.3
24.6
Total financial assets measured at amortized cost
737.8
37.7
196.9
191.3
28.4
18.4
0.0
4.0
261.0
Financial assets measured at fair value
through other comprehensive income – debt
8.8
8.8
Total maximum exposure to credit risk
reflected on the balance sheet in scope of ECL
746.6
37.7
196.9
191.3
28.4
18.4
0.0
4.0
269.8
Guarantees
8
20.9
1.3
6.5
0.2
2.5
2.3
8.1
Loan commitments
8
39.4
0.5
4.0
2.4
7.3
0.3
1.7
23.1
Forward starting transactions, reverse repurchase
and securities borrowing agreements
1.4
1.4
0.0
Committed unconditionally revocable credit lines
40.7
0.3
9.0
6.2
3.9
0.5
20.9
Total maximum exposure to credit risk not
reflected on the balance sheet, in scope of ECL
102.5
2.2
20.9
8.7
13.7
0.0
0.3
4.5
52.1
31.12.20
Collateral
1,2
Credit enhancements
1
Exposure to
credit risk
after collateral
and credit
enhancements
USD billion
Maximum
exposure to
credit risk
Cash
collateral
received
Collateralized
by securities
Secured by
real estate
Other
collateral
3
Netting
Credit
derivative
contracts
Guarantees
Financial assets measured at
amortized cost on the balance sheet
Cash and balances at central banks
158.2
158.2
Loans and advances to banks
4
15.4
0.1
15.3
Receivables from securities financing transactions
74.2
0.0
67.1
7.0
0.0
Cash collateral receivables on derivative instruments
5,6
32.7
21.1
11.6
Loans and advances to customers
7
379.5
25.8
118.2
194.6
21.7
4.4
14.8
Other financial assets measured at amortized cost
27.2
0.1
0.2
1.3
25.5
Total financial assets measured at amortized cost
687.3
26.0
185.7
194.6
30.1
21.1
0.0
4.4
225.5
Financial assets measured at fair value
through other comprehensive income – debt
8.3
8.3
Total maximum exposure to credit risk
reflected on the balance sheet in scope of ECL
695.6
26.0
185.7
194.6
30.1
21.1
0.0
4.4
233.7
Guarantees
8
17.0
0.7
5.0
0.2
1.7
2.5
7.0
Loan commitments
8
41.2
0.0
4.2
2.1
6.8
0.4
2.4
25.3
Forward starting transactions, reverse repurchase
and securities borrowing agreements
3.2
3.2
0.0
Committed unconditionally revocable credit lines
40.1
0.1
10.3
6.2
2.7
0.0
20.7
Total maximum exposure to credit risk not
reflected on the balance sheet, in scope of ECL
101.6
0.8
22.7
8.5
11.2
0.0
0.4
4.9
53.0
1 Of which: USD
1,443
million for 31 December 2021 (31 December 2020: USD
1,983
million) relates to total credit-impaired financial assets measured at amortized cost and USD
130
million for 31 December 2021
(31 December 2020: USD
154
million) to total off-balance sheet
financial instruments and credit
lines for credit-impaired positions.
2 Collateral arrangements generally
incorporate a range of
collateral, including
cash, securities, real estate and other collateral. UBS applies
a risk-based approach that generally prioritizes collateral according to its
liquidity profile.
3 Includes but is not limited to life
insurance contracts, inventory,
mortgage loans, gold and other commodities.
4 Loans and advances to banks include amounts held with third-party banks on behalf of clients.
The credit risk associated with these balances may be borne by those
clients.
5 Included within Cash collateral receivables
on derivative instruments are margin balances due
from exchanges or clearing houses.
Some of these margin balances reflect amounts
transferred on behalf of
clients who retain the associated credit risk.
6 The amount shown in the “Netting” column represents the netting potential not recognized on the balance sheet. Refer to Note 22 for more information.
7 In 2021,
the collateral allocation was updated
to reflect additional cash collateral
and custody accounts that are also
available as security for certain
on-balance sheet lending. This resulted
in an increase in loans secured
by
cash, with an offsetting reduction in loans secured by real estate and loans secured by securities.
8 The amount shown in the “Guarantees” column includes sub-participations.
Consolidated financial statements | UBS Group AG consolidated financial statements
344
Note 20
Expected credit loss measurement (continued)
e) Financial assets subject to credit risk by rating category
The
table
below
shows
the
credit
quality
and
the
maximum
exposure to credit risk based on the Group’s internal credit rating
system and year-end
stage classification. Under IFRS 9, the credit
risk rating reflects the Group’s assessment
of
the
probability
of
default of
individual
counterparties,
prior
to
substitutions.
The
amounts presented are gross of impairment allowances.
›
Refer to the “Risk management and control”
section of this
report for more details
regarding the Group’s internal grading
system
Financial assets subject to credit risk by rating
category
USD million
31.12.21
Rating category
1
0–1
2–3
4–5
6–8
9–13
Credit-
impaired
(defaulted)
Total gross
carrying
amount
ECL
allowances
Net carrying
amount
(maximum
exposure to
credit risk)
Financial assets measured at amortized cost
Cash and balances at central banks
191,015
1,802
0
0
0
0
192,817
0
192,817
of which: stage 1
191,015
1,802
0
0
0
0
192,817
0
192,817
Loans and advances to banks
407
12,623
1,171
795
490
1
15,488
(
8
)
15,480
of which: stage 1
407
12,623
1,146
795
488
0
15,460
(
7
)
15,453
of which: stage 2
0
0
24
0
2
0
27
(
1
)
26
of which: stage 3
0
0
0
0
0
1
1
0
1
Receivables from securities financing transactions
34,386
11,267
10,483
17,440
1,439
0
75,014
(
2
)
75,012
of which: stage 1
34,386
11,267
10,483
17,440
1,439
0
75,014
(
2
)
75,012
Cash collateral receivables on derivative instruments
7,466
13,476
5,878
3,647
47
0
30,514
0
30,514
of which: stage 1
7,466
13,476
5,878
3,647
47
0
30,514
0
30,514
Loans and advances to customers
5,295
232,233
67,620
69,892
21,423
2,148
398,611
(
850
)
397,761
of which: stage 1
5,295
231,153
65,084
62,796
16,362
0
380,690
(
126
)
380,564
of which: stage 2
0
1,080
2,536
7,096
5,061
0
15,773
(
152
)
15,620
of which: stage 3
0
0
0
0
0
2,148
2,148
(
572
)
1,577
Other financial assets measured at amortized cost
12,564
6,702
321
6,072
394
264
26,318
(
109
)
26,209
of which: stage 1
12,564
6,693
307
5,863
317
0
25,745
(
27
)
25,718
of which: stage 2
0
10
13
209
77
0
309
(
7
)
302
of which: stage 3
0
0
0
0
0
264
264
(
76
)
189
Total financial assets measured at amortized cost
251,133
278,103
85,472
97,846
23,793
2,414
738,762
(
969
)
737,794
On-balance sheet financial instruments
Financial assets measured at FVOCI – debt instruments
3,996
4,771
0
77
0
0
8,844
0
8,844
Total on-balance sheet financial instruments
255,130
282,874
85,472
97,923
23,793
2,414
747,606
(
969
)
746,638
Off-balance sheet positions subject to expected
credit loss by rating category
USD million
31.12.21
Rating category
1
0–1
2–3
4–5
6–8
9–13
Credit-
impaired
(defaulted)
Total off -
balance sheet
exposure
(maximum
exposure to
credit risk)
ECL provisions
Off-balance sheet financial instruments
Guarantees
4,457
7,064
4,535
3,757
1,009
150
20,972
(
41
)
of which: stage 1
4,457
7,037
4,375
3,075
752
0
19,695
(
18
)
of which: stage 2
0
27
160
682
258
0
1,127
(
8
)
of which: stage 3
0
0
0
0
0
150
150
(
15
)
Irrevocable loan commitments
2,797
14,183
7,651
8,298
6,502
46
39,478
(
114
)
of which: stage 1
2,797
13,917
7,416
7,127
5,840
0
37,097
(
72
)
of which: stage 2
0
266
235
1,171
663
0
2,335
(
42
)
of which: stage 3
0
0
0
0
0
46
46
0
Forward starting reverse repurchase and securities borrowing agreements
0
0
55
1,389
0
0
1,444
0
Total off-balance sheet financial instruments
7,254
21,247
12,241
13,444
7,512
196
61,894
(
155
)
Credit lines
Committed unconditionally revocable credit lines
2,636
15,594
8,627
9,752
4,107
63
40,778
(
38
)
of which: stage 1
2,636
15,250
8,304
8,346
3,671
0
38,207
(
28
)
of which: stage 2
0
344
323
1,406
436
0
2,508
(
10
)
of which: stage 3
0
0
0
0
0
63
63
0
Irrevocable committed prolongation of existing loans
17
2,438
1,422
1,084
602
48
5,611
(
3
)
of which: stage 1
17
2,438
1,422
1,082
568
0
5,527
(
3
)
of which: stage 2
0
0
0
1
34
0
36
0
of which: stage 3
0
0
0
0
0
48
48
0
Total credit lines
2,653
18,032
10,049
10,836
4,709
111
46,390
(
41
)
1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and
control” section of this report for more information on rating categories.
345
Note 20
Expected credit loss measurement (continued)
Financial assets subject to credit risk by rating
category
USD million
31.12.20
Rating category
1
0–1
2–3
4–5
6–8
9–13
Credit-
impaired
(defaulted)
Total gross
carrying
amount
ECL
allowances
Net carrying
amount
(maximum
exposure to
credit risk)
Financial assets measured at amortized cost
Cash and balances at central banks
156,250
1,981
0
0
0
0
158,231
0
158,231
of which: stage 1
156,250
1,981
0
0
0
0
158,231
0
158,231
Loans and advances to banks
543
12,129
1,344
1,182
260
1
15,460
(
16
)
15,444
of which: stage 1
543
12,074
1,277
1,145
231
0
15,269
(
9
)
15,260
of which: stage 2
0
55
67
37
29
0
189
(
5
)
184
of which: stage 3
0
0
0
0
0
1
1
(
1
)
0
Receivables from securities financing transactions
22,998
16,009
15,367
17,995
1,842
0
74,212
(
2
)
74,210
of which: stage 1
22,998
16,009
15,367
17,995
1,842
0
74,212
(
2
)
74,210
Cash collateral receivables on derivative instruments
8,196
13,477
7,733
3,243
88
0
32,737
0
32,737
of which: stage 1
8,196
13,477
7,733
3,243
88
0
32,737
0
32,737
Loans and advances to customers
5,813
214,307
67,270
69,217
21,038
2,943
380,589
(
1,060
)
379,528
of which: stage 1
5,813
212,970
63,000
59,447
15,860
0
357,090
(
142
)
356,948
of which: stage 2
0
1,338
4,269
9,770
5,178
0
20,556
(
215
)
20,341
of which: stage 3
0
0
0
0
0
2,943
2,943
(
703
)
2,240
Other financial assets measured at amortized cost
15,404
4,018
280
6,585
481
560
27,327
(
133
)
27,194
of which: stage 1
15,404
4,015
269
6,334
389
0
26,410
(
34
)
26,377
of which: stage 2
0
3
11
251
91
0
357
(
9
)
348
of which: stage 3
0
0
0
0
0
560
560
(
90
)
469
Total financial assets measured at amortized cost
209,204
261,922
91,993
98,223
23,709
3,505
688,556
(
1,211
)
687,345
On-balance sheet financial instruments
Financial assets measured at FVOCI – debt instruments
3,212
5,014
0
32
0
0
8,258
0
8,258
Total on-balance sheet financial instruments
212,417
266,936
91,993
98,255
23,709
3,505
696,815
(
1,211
)
695,603
Off-balance sheet positions subject to expected
credit loss by rating category
USD million
31.12.20
Rating category
1
0–1
2–3
4–5
6–8
9–13
Credit-
impaired
(defaulted)
Total off -
balance sheet
exposure
(maximum
exposure to
credit risk)
ECL provisions
Off-balance sheet financial instruments
Guarantees
3,482
4,623
3,522
4,293
991
170
17,081
(
63
)
of which: stage 1
3,482
4,219
2,688
3,558
739
0
14,687
(
14
)
of which: stage 2
0
404
834
736
252
0
2,225
(
15
)
of which: stage 3
0
0
0
0
0
170
170
(
34
)
Irrevocable loan commitments
3,018
14,516
8,583
9,302
5,850
104
41,372
(
142
)
of which: stage 1
3,018
13,589
6,873
8,739
4,676
0
36,894
(
74
)
of which: stage 2
0
927
1,711
563
1,174
0
4,374
(
68
)
of which: stage 3
0
0
0
0
0
104
104
0
Forward starting reverse repurchase and securities borrowing agreements
82
150
0
3,015
0
0
3,247
0
Total off-balance sheet financial instruments
6,583
19,289
12,105
16,610
6,840
273
61,700
(
205
)
Credit lines
Committed unconditionally revocable credit lines
574
13,505
5,958
8,488
11,501
108
40,134
(
50
)
of which: stage 1
574
12,940
4,517
6,609
10,593
0
35,233
(
29
)
of which: stage 2
0
565
1,441
1,879
908
0
4,792
(
21
)
of which: stage 3
0
0
0
0
0
108
108
0
Irrevocable committed prolongation of existing loans
14
1,349
931
632
357
0
3,282
(
2
)
of which: stage 1
14
1,349
930
630
355
0
3,277
(
2
)
of which: stage 2
0
1
1
2
1
0
5
0
of which: stage 3
0
0
0
0
0
0
0
0
Total credit lines
588
14,854
6,889
9,119
11,858
109
43,416
(
52
)
1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and
control” section of this report for more information on rating categories.
Consolidated financial statements | UBS Group AG consolidated financial statements
346
Note 20
Expected credit loss measurement (continued)
f) Sensitivity information
As
outlined
in
Note
1a,
ECL
estimates
involve
significant
uncertainties at the time they are made.
ECL model
The models applied
to determine
point-in-time
PD and LGD rely
on
market
and
statistical
data,
which
has
been
found
to
correlate
well
with
historically
observed
defaults
in
sufficiently
homogeneous
segments.
The
risk
sensitivities
for
each
of
the
ECL reporting
segments to such
factors are
summarized in
Note
9.
Forward-looking scenarios
Depending on the scenario selection
and related macro-economic
assumptions for the
risk factors, the
components of the
relevant
weighted
average
ECL
change.
This
is
particularly
relevant
for
interest rates,
which can
move in
both directions
under a
given
growth assumption
(for example,
low growth
with high
interest
rates
in a
stagflation
scenario,
versus
low growth
and falling
interest
rates
in
a
recession).
Management generally
looks
for
scenario
narratives
that reflect
the key risk
drivers of
a given credit
portfolio.
As forecasting models are complex, due to the combination
of
multiple
factors,
simple
what-if
analyses
involving
a
change
of
individual
parameters
do
not
necessarily
provide
realistic
information
on
the
exposure
of
segments
to
changes
in
the
macroeconomy. Portfolio
-specific analyses based on their key risk
factors would also not be meaningful, as potential compensatory
effects
in
other
segments
would
be
ignored.
The
table
below
indicate
s
some
sensitivities
to
ECL
s
if
a
key
macroeconomic
variable for the forecasting period is amended
across all scenarios
with all other factors remaining unchanged.
Potential effect on stage 1 and stage 2
positions from changing key parameters as of
31 December 2021
USD million
Baseline
Upside
Mild downside
Severe downside
Weighted average
Change in key parameters
Fixed income: Government bonds (absolute change)
–0.50%
(
1
)
0
(
29
)
(
9
)
(
4
)
+0.50%
1
1
39
11
5
+1.00%
4
2
88
23
14
Unemployment rate (absolute change)
–1.00%
(
2
)
(
2
)
(
30
)
(
48
)
(
13
)
–0.50%
(
1
)
(
1
)
(
17
)
(
27
)
(
7
)
+0.50%
1
1
21
31
8
+1.00%
3
2
47
68
18
Real GDP growth (relative change)
–2.00%
4
2
8
17
10
–1.00%
2
1
4
8
5
+1.00%
(
1
)
0
(
10
)
(
8
)
(
4
)
+2.00%
(
2
)
0
(
14
)
(
16
)
(
7
)
House Price Index (relative change)
–5.00%
6
4
50
73
24
–2.50%
3
2
24
34
12
+2.50%
(
2
)
(
1
)
(
26
)
(
31
)
(
11
)
+5.00%
(
4
)
(
3
)
(
46
)
(
31
)
(
13
)
Equity (S&P500, EuroStoxx, SMI) (relative change)
–10.00%
2
2
5
6
5
–5.00%
1
0
2
3
2
+5.00%
(
1
)
0
(
2
)
(
3
)
(
2
)
+10.00%
(
2
)
0
(
4
)
(
6
)
(
3
)
347
Note 20
Expected credit loss measurement (continued)
Sensitivities can be more meaningfully
assessed in the context
of
coherent
scenarios
with
consistently
developed
macroeconomic factors.
The table on
the previous page
outlines
favorable and
unfavorable effects,
based on
reasonably possible
alternative changes
to the
economic conditions
for stage 1
and
stage 2
positions.
The
ECL
impact
is
calculated
for
material
portfolios and disclosed for each scenario.
The
forecasting
horizon
is
limited
to
three
years,
with
a
model-based
mean
reversion
of
PD
and
LGD
assumed
thereafter.
Changes
to
these
timelines
may
have
an
effect
on
ECLs:
depending
on
the
cycle,
a
longer
or
shorter
forecasting
horizon will lead to different
annualized lifetime
PD and average
LGD estimations.
This is currently
not deemed to be material
for
UBS,
as
a
large
proportion
of
loans,
including
mortgages
in
Switzerland,
have
maturities
that
are
within
the
forecasting
horizon.
Scenario weights
ECL
is
sensitive
to
changing
scenario
weights,
in
particular
if
narratives and
parameters are
selected that
are not
close to
the
baseline scenario, highlighting the non-linearity of credit losses.
As shown
in
the
table
on the
bottom
of
this
page,
the
ECL
for
stage 1
and
stage
2
positions
would
have
been
USD
387
million
(31
December
2020:
USD
442
million)
instead
o
f
USD
503
million
(31 December
2020:
USD
639
million)
if
ECL
had
been
determined
solely
on
the
baseline
scenario.
The
weighted
average
ECL
therefore
amounts
to
130
%
(31 December 2020:
145
%) of the baseline value. The effects of
weighting
each
of
the
four
scenarios
100%
are
shown
in
the
table below.
Stage allocation and SICR
The
determination
of
what
constitutes
a
n
SICR
is
based
on
management
judgment, as
explained in
Note 1a. Changing
the
SICR trigger
will have
a direct
effect on
ECLs, as
more or
fewer
positions would be subject to lifetime ECLs under any scenario.
The
relevance
of
the
SICR
trigger
on
overall
ECL
is
demonstrated
in
the
table
below
with
the
indication
that
the
ECL allowances
and provisions
for stage 1 and
stage 2 positions
would have been USD
1,060
million if all non-impaired
positions
across
the
portfolio
had
been
measured
for
lifetime
ECLs
irrespective
of their actual SICR status. This
amount compares to
actual
stage 1
and
2
allowances
and
provisions
of
USD
503
million as
of 31 December
2021.
Potential
effect on
stage 1
and stage
2 positions
from changing
scenario
weights
or moving
to an ECL
lifetime
calculation
as of 31
December
2021
Actual ECL
allowances and
provisions,
including staging
(as per Note 9)
Pro forma ECL allowances and provisions, including staging
and assuming application of 100% scenario weighting
Pro forma ECL
allowances and
provisions,
assuming all
positions being
subject to lifetime
ECL
Scenarios
Weighted average
100% Baseline
100% Upside
100% Mild
downside
100% Severe
downside
Weighted average
USD million, except where indicated
Segmentation
Private clients with mortgages
(
95
)
(
53
)
(
52
)
(
119
)
(
207
)
(
277
)
Real estate financing
(
62
)
(
50
)
(
48
)
(
101
)
(
97
)
(
118
)
Large corporate clients
(
150
)
(
116
)
(
107
)
(
148
)
(
244
)
(
257
)
SME clients
(
65
)
(
56
)
(
55
)
(
71
)
(
91
)
(
117
)
Other segments
(
130
)
(
112
)
(
108
)
(
135
)
(
166
)
(
291
)
Total
(
503
)
(
387
)
(
370
)
(
574
)
(
806
)
(
1,060
)
Maturity profile
The maturity profile is an important driver for changes
in ECL due
to transfers
to stage 2
and from
stage 2 to
stage 1. The
current
maturity profile of most lending books is relatively
short; hence a
movement
to
stage 2
may
have
a
moderate
effect
on
ECLs.
A
significant portion
of our
lending to
SMEs is
documented under
multi-purpose
credit agreements,
which allow
for various
forms
of
utilization
but
are
unconditionally
cancelable
by
UBS
at
any
time. For drawings under such agreements with a
fixed maturity,
the respective term is applied for ECL calculations,
or a maximum
of 12 months in stage 1. For unused credit lines and all
drawings
that have no fixed
maturity (e.g., current accounts),
UBS generally
applies a
12-month maturity
from the
reporting date,
given the
credit review policies, which require either
continuous monitoring
of key indicators
and behavioral patterns
for smaller positions
or
an annual
formal review
for any
other limit.
The ECLs
for these
products
are
sensitive
to
shortening
or
extending
the
maturity
assumption.
Consolidated financial statements | UBS Group AG consolidated financial statements
348
Note 21
Fair value measurement
a) Valuation principles
All
financial
and non-financial
assets
and liabilities
measured
or
disclosed at fair value are categorized into one of three
fair value
hierarchy levels
in accordance
with IFRS.
The fair
value hierarchy
is based on the
transparency of inputs to
the valuation of an
asset
or liability as
of the measurement
date. In certain
cases, the inputs
used to
measure fair
value may fall
within different
levels of
the
fair
value
hierarchy.
For
disclosure
purposes,
the
level
in
the
hierarchy within which an
instrument is classified in its entirety
is
based on the lowest level input
that is significant to the position’s
fair value measurement:
–
Level 1
–
quoted
prices
(unadjusted)
in
active
markets
for
identical assets and liabilities;
–
Level 2 –
valuation techniques
for which
all significant
inputs
are, or are based on, observable market data; or
–
Level 3 – valuation techniques
for which significant inputs are
not based on observable market data.
Fair
values
are
determined
using
quoted
prices
in
active
markets for
identical assets
or liabilities,
where available.
Where
the
market
for
a
financial
instrument
or
non-financial
asset
or
liability
is
not
active,
fair
value
is
established
using
a
valuation
technique, including
pricing models.
Valuation adjustments
may
be made to
allow for additional
factors, including model,
liquidity,
credit and funding
risks, which are
not explicitly captured
within
the
valuation
technique,
but
which
would
nevertheless
be
considered by market participants when establishing
a price. The
limitations
inherent
in
a
particular
valuation
technique
are
considered in the determination
of the classification of
an asset or
liability
within
the
fair
value
hierarchy.
Generally,
the
unit
of
account
for
a
financial
instrument
is
the
individual
instrument,
and UBS applies
valuation adjustments at
an individual instrument
level,
consistent
with
that
unit
of
account.
However,
if
certain
conditions are met, UBS may estimate the fair value
of a portfolio
of
financial
assets
and
liabilities
with
substantially
similar
and
offsetting risk exposures on the basis of the net open risks.
›
Refer to Note 21d for more information
b) Valuation governance
UBS’s fair value measurement and model governance framework
includes numerous controls and other procedural safeguards that
are intended to
maximize the quality of
fair value measurements
reported in the financial statements. New products and valuation
techniques must
be reviewed
and approved
by key
stakeholders
from the risk and finance control functions. Responsibility for the
ongoing measurement of financial and non-financial instruments
at fair value is with the business divisions.
Fair
value
estimates
are
validated
by
the
risk
and
finance
control
functions,
which
are
independent
of
the
business
divisions. Independent
price verification
is performed
by Finance
through benchmarking the business divisions’
fair value estimates
with observable market prices
and other independent sources.
A
governance
framework
and
associated
controls
are
in
place
in
order to monitor
the quality of third
-party pricing sources
where
used.
For
instruments
where
valuation
models
are
used
to
determine
fair
value,
independent
valuation
and
model
control
groups within Finance and Risk
Control evaluate UBS’s models on
a regular basis,
including valuation and
model input parameters,
as well as pricing. As a result of the
valuation controls employed,
valuation
adjustments
may
be
made
to
the
business
divisions’
estimates of fair value to
align with independent market
data and
the relevant accounting standard.
›
Refer to Note 21d for more information
349
Note 21
Fair value measurement (continued)
c) Fair value hierarchy
The table below provides
the fair value hierarchy
classification of
financial and
non-financial assets
and liabilities
measured at
fair
value.
The
narrative
that
follows describes
valuation
techniques
used
in
measuring
their
fair
value
of
different
product
types
(including significant valuation
inputs and assumptions
used), and
the
factors
considered
in
determining
their
classification
within
the fair value hierarchy.
Determination of fair values from quoted market
prices or valuation techniques
1
31.12.21
31.12.20
USD million
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
Financial assets measured at fair value on a recurring basis
Financial assets at fair value held for trading
113,697
14,825
2,299
130,821
107,507
15,553
2,337
125,397
of which:
Equity instruments
97,958
1,090
149
99,197
90,307
1,101
171
91,579
Government bills / bonds
7,135
1,351
10
8,496
9,028
2,207
10
11,245
Investment fund units
7,843
1,364
21
9,229
7,374
1,794
23
9,192
Corporate and municipal bonds
708
7,604
556
8,868
789
8,356
817
9,961
Loans
0
3,099
1,443
4,542
0
1,860
1,134
2,995
Asset-backed securities
53
317
120
489
8
236
181
425
Derivative financial instruments
522
116,479
1,140
118,142
795
157,068
1,754
159,617
of which:
Foreign exchange contracts
255
53,043
7
53,305
319
68,424
5
68,749
Interest rate contracts
0
32,747
494
33,241
0
50,353
537
50,890
Equity / index contracts
0
27,861
384
28,245
0
33,990
853
34,842
Credit derivative contracts
0
1,179
236
1,414
0
2,008
350
2,358
Commodity contracts
0
1,590
16
1,606
0
2,211
6
2,217
Brokerage receivables
0
21,839
0
21,839
0
24,659
0
24,659
Financial assets at fair value not held for trading
2
27,278
28,622
4,180
60,080
40,986
35,435
3,942
80,364
of which:
Financial assets for unit-linked investment contracts
21,110
187
6
21,303
20,628
101
2
20,731
Corporate and municipal bonds
123
13,937
306
14,366
290
16,957
372
17,619
Government bills / bonds
5,624
3,236
0
8,860
19,704
3,593
0
23,297
Loans
0
4,982
892
5,874
0
7,699
862
8,561
Securities financing transactions
0
5,704
100
5,804
0
6,629
122
6,751
Auction rate securities
0
0
1,585
1,585
0
0
1,527
1,527
Investment fund units
338
574
117
1,028
278
447
105
831
Equity instruments
83
2
681
765
86
0
544
631
Other
0
0
495
495
0
10
408
418
Financial assets measured at fair value through other comprehensive income on
a recurring basis
Financial assets measured at fair value through other comprehensive
income
2
2,704
6,140
0
8,844
1,144
7,114
0
8,258
of which:
Asset-backed securities
0
4,849
0
4,849
0
6,624
0
6,624
Government bills / bonds
2,658
27
0
2,686
1,103
47
0
1,150
Corporate and municipal bonds
45
1,265
0
1,310
40
444
0
485
Non-financial assets measured at fair value on a recurring basis
Precious metals and other physical commodities
5,258
0
0
5,258
6,264
0
0
6,264
Non-financial assets measured at fair value on a non-recurring basis
Other non-financial assets
3
0
0
26
26
0
1
245
246
Total assets measured at fair value
149,459
187,905
7,645
345,010
156,696
239,831
8,278
404,805
Consolidated financial statements | UBS Group AG consolidated financial statements
350
Note 21
Fair value measurement (continued)
Determination of fair values from quoted market
prices or valuation techniques (continued)
1
31.12.21
31.12.20
USD million
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
Financial liabilities measured at fair value on a recurring basis
Financial liabilities at fair value held for trading
25,413
6,170
105
31,688
26,888
6,652
55
33,595
of which:
Equity instruments
18,328
513
83
18,924
22,519
425
40
22,985
Corporate and municipal bonds
30
4,219
17
4,266
31
4,048
9
4,089
Government bills / bonds
5,883
826
0
6,709
3,642
1,036
0
4,678
Investment fund units
1,172
555
6
1,733
696
1,127
5
1,828
Derivative financial instruments
509
118,558
2,242
121,309
746
156,884
3,471
161,102
of which:
Foreign exchange contracts
258
53,800
21
54,078
316
70,149
61
70,527
Interest rate contracts
0
28,398
278
28,675
0
43,389
527
43,916
Equity / index contracts
0
33,438
1,511
34,949
0
38,870
2,306
41,176
Credit derivative contracts
0
1,412
341
1,753
0
2,403
528
2,931
Commodity contracts
0
1,503
63
1,566
0
2,003
24
2,027
Financial liabilities designated at fair value on a recurring basis
Brokerage payables designated at fair value
0
44,045
0
44,045
0
38,742
0
38,742
Debt issued designated at fair value
2
0
59,606
14,194
73,799
0
50,273
10,970
61,243
Other financial liabilities designated at fair value
2
0
29,258
816
30,074
0
29,671
716
30,387
of which:
Financial liabilities related to unit-linked investment contracts
0
21,466
0
21,466
0
20,975
0
20,975
Securities financing transactions
0
6,375
2
6,377
0
7,317
0
7,317
Over-the-counter debt instruments
0
1,334
794
2,128
0
1,363
697
2,060
Total liabilities measured at fair value
25,922
257,637
17,357
300,916
27,635
282,222
15,212
325,069
1 Bifurcated embedded derivatives are presented on the same balance sheet lines
as their host contracts and are not included in this table. The fair value of these derivatives was not
material for the periods presented.
2 As of 31 December 2021, USD
17
billion (31 December 2020: USD
21
billion) of Financial assets at fair value not
held for trading, USD
8
billion (31 December 2020: USD
8
billion) of Financial assets measured at
fair value through other
comprehensive income, USD
36
billion (31 December 2020:
USD
16
billion) of Debt issued
designated at fair value
and USD
1
billion (31 December 2020:
USD
1
billion) of Other financial
liabilities designated at fair value are expected to be recovered or settled after 12 months.
3 Other non-financial assets primarily consist of properties and other non-current assets held for sale, which are
measured
at the lower of their net carrying amount or fair value less costs to sell.
351
Note 21
Fair value measurement (continued)
Valuation techniques
UBS uses widely recognized valuation techniques for determining
the fair
value of
financial and
non-financial instruments
that are
not
actively
traded
and
quoted.
The
most
frequently
applied
valuation
techniques include
discounted value
of expected
cash
flows, relative value and option pricing methodologies.
Discounted
value
of
expected
cash
flows
is
a
valuation
technique
that
measures
fair
value
using
estimated
expected
future
cash
flows
from
assets
or
liabilities
and
then
discounts
these
cash
flows
using a
discount
rate
or
discount
margin that
reflects the credit and
/ or funding spreads
required by the market
for instruments with similar risk
and liquidity profiles to produce
a
present
value. When
using such
valuation
techniques, expected
future
cash
flows
are
estimated
using
an
observed
or
implied
market
price
for
the
future
cash
flows
or
by
using
industry-
standard cash flow projection
models. The discount factors
within
the calculation are
generated using industry-standard yield
curve
modeling techniques and models.
Relative value models measure fair
value based on the market
prices
of
equivalent
or
comparable
assets
or
liabilities,
making
adjustments
for
differences
between
the
characteristics
of
the
observed instrument and the instrument being valued.
Option pricing models
incorporate assumptions regarding
the
behavior of future
price movements of
an underlying referenced
asset or assets
to generate a
probability-weighted future expected
payoff for
the option.
The resulting
probability-weighted expected
payoff is
then discounted using
discount factors generated
from
industry-standard
yield
curve
modeling
techniques
and
models.
The
option
pricing
model
may be
implemented
using a
closed-
form analytical
formula or
other mathematical
techniques (e.g.,
binomial tree or Monte Carlo simulation).
Where available,
valuation techniques
use market-observable
assumptions and inputs.
If such data
is not available,
inputs may
be derived
by reference
to similar
assets in
active markets,
from
recent
prices
for
comparable
transactions
or
from
other
observable
market
data.
In
such
cases,
the
inputs
selected
are
based
on
historical
experience
and
practice
for
similar
or
analogous instruments, derivation of input levels based on
similar
products with
observable price
levels,
and knowledge
of current
market conditions and valuation approaches.
For
more
complex instruments,
fair
values may
be
estimated
using
a
combination
of
observed
transaction
prices,
consensus
pricing services and relevant quotes. Consideration
is given to the
nature of
the quotes
(e.g.,
indicative
or firm)
and the
relationship
of
recently
evidenced
market
activity
to
the
prices
provided
by
consensus
pricing
services.
UBS
also
uses
internally
developed
models,
which
are
typically
based
on
valuation
methods
and
techniques
recognized
as standard
within
the industry.
Assumptions
and inputs
used in
valuation
techniques
include
benchmark
interest
rate curves,
credit and
funding spreads
used in estimating
discount
rates, bond
and equity
prices,
equity index
prices,
foreign exchange
rates, levels of market volatility and correlation. Refer to Note 21f
for
more
information.
The
discount
curves
used
by
the
Group
incorporate
the
funding
and
credit
characteristics
of
the
instruments
to which they
are applied.
Financial instruments excluding derivatives: valuation and classification in the fair value hierarchy
Product
Valuation and classification in the fair value hierarchy
Government bills
and bonds
Valuation
–
Generally valued using prices obtained directly
from the market.
–
Instruments not priced directly using active-market data
are valued using discounted cash
flow valuation
techniques that incorporate market data
for similar government instruments.
Fair value hierarchy
–
Generally traded in active markets with prices that can be obtained directly from these markets, resulting
in classification as Level 1,
while the remaining positions are classified
as Level 2 and Level 3.
Corporate and
municipal bonds
Valuation
–
Generally
valued
using
prices
obtained
directly
from
the
market
for
the
security,
or
similar
securities,
adjusted for seniority, maturity and liquidity.
–
When prices
are not
available, instruments are
valued using
discounted cash
flow valuation
techniques
incorporating the credit spread of the
issuer or similar issuers.
–
For convertible bonds
without directly
comparable prices,
issuances may
be priced using
a convertible
bond
model.
Fair value hierarchy
–
Generally classified as Level 1 or Level 2, depending
on the depth of trading activity behind price
sources.
–
Level 3 instruments have no suitable pricing information
available.
Traded loans and
loans measured at
fair value
Valuation
–
Valued directly
using market prices
that reflect recent
transactions or quoted
dealer prices, where
available.
–
Where no
market price
data is
available, loans
are valued
by relative
value benchmarking
using pricing
derived from debt instruments in comparable entities or different products in the same entity, or by using
a credit default
swap valuation technique,
which requires inputs
for credit spreads,
credit recovery rates
and interest
rates. Recently
originated commercial real
estate loans
are measured
using a
securitization
approach based on rating agency guidelines.
Fair value hierarchy
–
Instruments with suitably deep and liquid pricing
information are classified as Level 2.
–
Positions requiring the use of
valuation techniques, or for
which the price sources have
insufficient trading
depth, are classified as Level 3.
Consolidated financial statements | UBS Group AG consolidated financial statements
352
Note 21
Fair value measurement (continued)
Product
Valuation and classification in the fair value hierarchy
Investment fund
units
Valuation
–
Predominantly exchange-traded, with
readily available quoted prices in liquid markets.
–
Where market prices are not available, fair
value may be measured using net asset
values (NAVs).
Fair value hierarchy
–
Listed units
are classified
as
Level 1, provided
there is
sufficient trading
activity to
justify active-market
classification, while other positions are classified
as Level 2.
–
Positions for which NAVs are not available
are classified as Level 3.
Asset-backed
securities (ABS)
Valuation
–
For liquid securities, the valuation
process will use trade
and price data, updated for movements
in market
levels between the time of trading and the
time of valuation. Less liquid instruments are measured using
discounted expected
cash flows
incorporating price
data for instruments
or indices with
similar risk profiles.
Fair value hierarchy
–
Residential
mortgage
-
backed
securities
,
c
ommercial
mortgage
-
backed
securities
and
other
ABS
are
generally classified as Level 2. However,
if significant inputs are unobservable,
or if market or fundamental
data is not available, they are classified as Level
3.
Auction rate
securities (ARS)
Valuation
–
ARS
are
valued
utilizing
a
discounted
cash
flow
methodology.
The
model
captures
interest
rate
risk
emanating from the note coupon, credit risk attributable to the
underlying closed-end fund investments,
liquidity risk as a function of the level of trading volume in these positions, and extension risk, as ARS
are
perpetual instruments that require an assumption
regarding their maturity or issuer redemption
date.
Fair value hierarchy
–
Granular and liquid pricing information is generally not available for
ARS. As a result, these securities are
classified as Level 3.
Equity instruments
Valuation
–
Listed equity instruments are generally valued
using prices obtained directly from the market.
–
Unlisted equity holdings,
including private equity
positions, are initially
marked at their
transaction price
and are
revalued when
reliable evidence of
price movement
becomes available
or when
the position
is
deemed to be impaired.
Fair value hierarchy
–
The majority
of equity
securities are actively
traded on
public stock
exchanges where quoted
prices are
readily and regularly available, resulting in Level
1 classification.
Financial assets for
unit-linked
investment
contracts
Valuation
–
The majority of assets are listed on exchanges
and fair values are determined using quoted
prices.
Fair value hierarchy
–
Most assets are classified as Level 1 if actively traded,
or Level 2 if trading is not active.
–
Instruments for which prices are not readily available
are classified as Level 3.
Securities financing
transactions
Valuation
–
These instruments are valued using discounted expected cash flow techniques. The discount rate applied
is based on funding curves that are relevant
to the collateral eligibility terms.
Fair value hierarchy
–
Collateral funding curves for
these instruments are generally
observable and, as a
result, these positions
are classified as Level 2.
–
Where the collateral
terms are non-standard,
the funding curve
may be considered
unobservable and
these
positions are classified as Level 3.
Brokerage
receivables and
payables
Valuation
–
Fair value is determined based on the value of
the underlying balances.
Fair value hierarchy
–
Due to their on-demand nature, these receivables
and payables are deemed as Level 2.
Amounts due under
unit-linked
investment
contracts
Valuation
–
The
fair
values
of
investment
contract
liabilities
are
determined
by
reference
to
the
fair
value
of
the
corresponding assets.
Fair value hierarchy
–
The liabilities themselves are not actively traded,
but are mainly referenced to instruments
that are actively
traded and are therefore classified as Level 2.
353
Note 21
Fair value measurement (continued)
Derivative instruments: valuation and classification in the
fair value hierarchy
The
curves
used
for
discounting
expected
cash
flows
in
the
valuation
of
collateralized
derivatives
reflect
the
funding
terms
associated
with
the
relevant
collateral
arrangement
for
the
instrument
being
valued.
These
collateral
arrangements
differ
across
counterparties
with
respect
to
the
eligible
currency
and
interest
terms
of
the
collateral.
The
majority
of
collateralized
derivatives are measured using
a discount curve based
on funding
rates
derived
from
overnight
interest
in
the
cheapest
eligible
currency for the respective counterparty collateral agreement.
Uncollateralized
and
partially
collateralized
derivatives
are
discounted
using
the
alternative
reference
rate
(the
ARR)
(or
equivalent) curve for the currency
of the instrument. As described
in
Note
2
1
d
,
the
fair
value
of
uncollateralized
and
partially
collateralized
derivatives
is
then
adjusted
by
credit
valuation
adjustments
(
CVA
s)
,
debit
valuation
adjustments
(
DVA
s)
and
funding valuation adjustments (FVAs), as
applicable, to reflect an
estimation
of
the
effect
of
counterparty
credit
risk,
UBS’s
own
credit risk, and funding costs and benefits.
›
Refer to Note 10 for more information about
derivative
instruments
Derivative product
Valuation and classification in the fair value hierarchy
Interest rate
contracts
Valuation
–
Interest rate swap contracts
are valued by estimating
future interest cash flows
and discounting those
cash
flows using
a rate
that reflects the
appropriate funding rate
for the
position being
measured. The yield
curves used to estimate future index
levels and discount rates are generated using
market-standard yield
curve models using interest rates associated with
current market activity. The key inputs to the
models are
interest rate swap rates, forward rate agreement rates, short-term interest rate futures prices,
basis swap
spreads and inflation swap rates.
–
Interest rate option contracts
are valued using various
market-standard option models, using inputs that
include interest rate yield curves, inflation curves,
volatilities and correlations.
–
When the maturity
of an interest
rate swap or
option contract exceeds
the term for
which standard market
quotes are observable for
a significant input parameter,
the contracts are valued
by extrapolation from the
last observable point using standard assumptions
or by reference to another observable comparable
input
parameter to represent a suitable proxy for that
portion of the term.
Fair value hierarchy
–
The majority of interest
rate swaps are classified
as Level 2,
as the standard market
contracts that form the
inputs for yield curve models are generally traded
in active and observable markets.
–
Options are
generally treated
as Level 2,
as the calibration
process enables
the model
output to
be validated
to active-market
levels. Models
calibrated in
this way
are then
used to
revalue the
portfolio of
both standard
options and more exotic products.
–
Interest rate swap
or option contracts
are classified as
Level 3 when the
terms
exceed standard market-
observable quotes.
–
Exotic options for
which appropriate volatility
or correlation input
levels cannot be implied
from observable
market data are classified as Level 3.
Credit derivative
contracts
Valuation
–
Credit derivative
contracts are
valued using
industry-standard models
based primarily
on
market credit
spreads, upfront pricing points and implied recovery rates. Where a derivative credit spread is not directly
available, it may be derived from the price of
the reference cash bond.
–
Asset-backed credit
derivatives are
valued using
a valuation
technique similar
to that
of the
underlying
security with an adjustment to reflect
the funding differences between cash
and synthetic form.
Fair value hierarchy
–
Single-entity and
portfolio
credit derivative
contracts are
classified as
Level 2
when credit
spreads and
recovery rates
are determined
from actively
traded observable
market data.
Where the
underlying reference
name(s) are not actively traded
and the correlation cannot be
directly mapped to actively traded tranche
instruments, these contracts are classified
as Level 3.
–
Asset-backed
credit
derivatives
follow
the
characteristics
of
the
underlying
security
and
are
therefore
distributed across Level 2 and Level 3.
Consolidated financial statements | UBS Group AG consolidated financial statements
354
Note 21
Fair value measurement (continued)
Derivative product
Valuation and classification in the fair value hierarchy
Foreign exchange
contracts
Valuation
–
Open spot foreign exchange (FX)
contracts are valued using the FX spot rate
observed in the market.
–
Forward FX contracts are valued using the FX spot rate adjusted for forward pricing points observed from
standard market-based sources.
–
Over-the-counter (OTC) FX
option contracts are
valued using
market-standard option valuation
models.
The models used for shorter-dated options (i.e., maturities of
five years or less) tend
to be different than
those used for
longer-dated
options because
the models needed
for longer-dated
OTC FX contracts
require
additional consideration of interest rate and FX
rate interdependency.
–
The valuation for
multi-dimensional FX
options uses a
multi-local volatility model,
which is calibrated
to the
observed FX volatilities for all relevant FX pairs.
Fair value hierarchy
–
The
markets
for
FX
spot
and
FX
forward
pricing
points
are
both
actively
traded
and
observable
and
therefore such FX contracts are generally classified
as Level 2.
–
A significant proportion of
OTC FX option contracts are
classified as Level 2 as
inputs are derived mostly
from standard market contracts traded in
active and observable markets.
–
OTC FX
option contracts
classified as
Level 3 include
multi-dimensional FX
options and
long-dated FX
exotic
option contracts where there is no active market
from which to derive volatility or correlation
inputs.
Equity / index
contracts
Valuation
–
Equity forward
contracts have a
single stock
or index
underlying and are
valued using
market-standard
models. The key inputs to the models are
stock prices, estimated dividend rates and equity funding rates
(which are implied
from prices of
forward contracts observed
in the market).
Estimated cash flows
are then
discounted using market-standard discounted cash flow models using a rate that reflects the appropriate
funding rate for
that portion
of the portfolio.
When no market
data is available
for the instrument
maturity,
they are
valued by
extrapolation of
available data,
use of
historical dividend
data, or
use of
data for
a
related equity.
–
Equity option contracts are valued
using market-standard models that
estimate the equity forward level
as
described
for
equity
forward
contracts
and
incorporate
inputs
for
stock
volatility
and
for
correlation
between
stocks
within
a
basket.
The
probability-weighted
expected
option
payoff
generated
is
then
discounted
using
market-standard
discounted
cash
flow
models
applying
a
rate
that
reflects
the
appropriate funding rate
for that portion of
the portfolio. When
volatility, forward or
correlation inputs are
not
available,
they
are
valued
using
extrapolation
of
available
data,
historical
dividend,
correlation
or
volatility data, or the equivalent data for
a related equity.
Fair value hierarchy
–
As inputs are
derived mostly from standard
market contracts traded in
active and observable markets,
a
significant proportion of equity forward contracts
are classified as Level 2.
–
Equity option positions for which inputs are derived
from standard market contracts traded in active and
observable markets are also classified
as Level 2. Level 3 positions are those
for which volatility, forward or
correlation inputs are not observable.
Commodity
contracts
Valuation
–
Commodity forward
and swap
contracts are
measured using
market-standard models
that use
market
forward levels on standard instruments.
–
Commodity
option
contracts
are
measured
using
market-standard
option
models
that
estimate
the
commodity forward level
as described for
commodity forward and
swap contracts, incorporating
inputs
for the volatility of the underlying
index or commodity. For commodity
options on baskets of commodities
or
bespoke
commodity
indices,
the
valuation
technique
also
incorporates
inputs
for
the
correlation
between different commodities or commodity
indices.
Fair value hierarchy
–
Individual
commodity contracts
are
typically classified
as
Level 2,
because
active
forward and
volatility
market data is available.
355
Note 21
Fair value measurement (continued)
d) Valuation adjustments and other items
The output of a
valuation technique is
always an estimate of
a fair
value
that
cannot
be
measured
with
complete
certainty.
As
a
result, valuations are adjusted, where appropriate and when such
factors would be considered by market participants
in estimating
fair value, to
reflect close-out costs,
credit exposure, model-driven
valuation
uncertainty,
funding
costs
and
benefits,
trading
restrictions and other factors.
The table below summarizes the
valuation adjustment reserves
recognized on the balance sheet. Details about each category are
provided further below.
Valuation adjustment reserves on the balance sheet
As of
Life-to-date gain / (loss), USD million
31.12.21
31.12.20
31.12.19
Deferred day-1 profit or loss reserves
418
269
146
Own credit adjustments on financial liabilities designated at fair value
(
315
)
(
381
)
(
88
)
CVAs, FVAs,
DVAs and other valuation adjustments
(
1,004
)
(
959
)
(
706
)
Deferred day-1 profit or loss reserves
For
new
transactions
where
the
valuation
technique
used
to
measure fair
value requires
significant inputs
that are
not based
on
observable
market
data,
the
financial
instrument
is
initially
recognized
at
the
transaction
price.
The
transaction
price
may
differ
from
the fair
value obtained
using a
valuation technique,
where any such difference is deferred and not initially recognized
in the income statement.
Deferred
day-1
profit
or
loss
is generally
released
into
Other
net
income
from
financial
instruments
measured
at
fair
value
through profit or loss
when pricing of equivalent products or the
underlying
parameters
become
s
observable
or
when
the
transaction is closed out.
The
table
below
summarizes
the
changes
in
deferred
day-1
profit or loss reserves during the respective period.
Deferred day-1 profit or loss reserves
USD million
2021
2020
2019
Reserve balance at the beginning of the year
269
146
255
Profit / (loss) deferred on new transactions
459
362
171
(Profit) / loss recognized in the income statement
(
308
)
(
238
)
(
278
)
Foreign currency translation
(
2
)
0
(
2
)
Reserve balance at the end of the year
418
269
146
Own credit
Own
credit
risk
is
reflected
in
the
valuation
of
UBS’s
fair
value
option liabilities where
this component is considered relevant
for
valuation
purposes
by
UBS’s
counterparties
and
other
market
participants.
Changes in
the fair
value of
financial liabilities
designated at
fair
value
through
profit
or
loss
related
to
own
credit
are
recognized
in
Other
comprehensive
income
directly
within
Retained
earnings,
with
no
reclassification
to
the
income
statement in future periods.
This presentation does not
create or
increase an accounting mismatch in the
income statement, as the
Group does not hedge changes in own credit.
Own
credit
is
estimated
using
own
credit
adjustment
(OCA)
curves,
which
incorporate
observable
market
data,
including
market-observed
secondary
prices
for
UBS’s
debt,
UBS’s
credit
default swap spreads
and debt curves
of peers. In
the table below,
the
change
in
unrealized
own credit
consists of
changes
in
fair
value that are attributable
to the change in
UBS’s credit spreads,
as well
as the
effect of
changes in
fair values
attributable to
factors
other than credit spreads, such as redemptions, effects from time
decay
and changes
in
interest and
other
market rates.
Realized
own credit is recognized
when an instrument with
an associated
unrealized OCA
is repurchased
prior to
the contractual
maturity
date.
Life-to-date
amounts
reflect
the
cumulative
unrealized
change since initial recognition.
›
Refer to Note 16 for more information about
debt issued
designated at fair value
Consolidated financial statements | UBS Group AG consolidated financial statements
356
Note 21
Fair value measurement (continued)
Own credit adjustments on financial liabilities
designated at fair value
Included in Other comprehensive income
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Recognized during the period:
Realized gain / (loss)
(
14
)
2
8
Unrealized gain / (loss)
60
(
295
)
(
408
)
Total gain / (loss), before tax
46
(
293
)
(
400
)
As of
USD million
31.12.21
31.12.20
31.12.19
Recognized on the balance sheet as of the end of the period:
Unrealized life-to-date gain / (loss)
(
315
)
(
381
)
(
88
)
Credit valuation adjustments
In order to measure
the fair value of
OTC derivative instruments,
including
funded
derivative
instruments
that
are
classified
as
Financial assets at
fair value
not held for
trading,
CVAs are needed
to
reflect
the
credit
risk
of
the
counterparty
inherent
in
these
instruments. This
amount represents
the estimated
fair value
of
protection required
to hedge the counterparty credit
risk of such
instruments.
A
CVA
is
determined
for
each
counterparty,
considering
all
exposures
with
that
counterparty,
and
is
dependent
on
the
expected
future
value
of
exposures,
default
probabilities
and
recovery
rates,
applicable
collateral
or
netting
arrangements,
break
clauses,
funding
spreads
,
and
other
contractual factors.
Funding valuation adjustments
FVAs
reflect
the
costs
and
benefits
of
funding
associated
with
uncollateralized and
partially collateralized
derivative receivables
and
payables
and
are
calculated
as
the
valuation
effect
from
moving
the
discounting
of
the
uncollateralized
derivative
cash
flows from the ARR to OCA using the CVA framework, including
the probability of counterparty default.
An FVA is
also applied to
collateralized derivative
assets in
cases where the
collateral cannot
be sold or repledged.
Debit valuation adjustments
A DVA
is estimated to incorporate own
credit in the valuation of
derivatives
where
an
FVA
is
not
already
recognized.
The
DVA
calculation
is
effectively
consistent
with
the
CVA
framework,
being
determined
for
each
counterparty,
considering
all
exposures
with
that
counterparty
and
taking
into
account
collateral
netting
agreements,
expected
future
mark-to-market
movements and UBS’s credit default spreads.
Other valuation adjustments
Instruments that are measured as part of a portfolio of combined
long and short
positions are valued at
mid-market levels to
ensure
consistent
valuation
of
the
long-
and
short-component
risks.
A
liquidity valuation adjustment is
then made to the
overall net long
or
short
exposure
to
move
the
fair
value
to
bid
or
offer
as
appropriate, reflecting current levels of market liquidity.
The bid–
offer spreads used in
the calculation of this valuation adjustment
are obtained from market transactions
and other relevant sources
and are updated periodically.
Uncertainties
associated
with
the
use
of
model
-
based
valuations
are
incorporated
into
the
measurement
of
fair
value
through
the
use
of
model
reserves.
These
reserves
reflect
the
amounts
that
the
Group
estimates
should
be
deducted
from
valuations
produced
directly
by
models
to
incorporate
uncertainties in the relevant modeling assumptions, in the
model
and market inputs used, or in the calibration
of the model output
to
adjust
for
known
model
deficiencies.
In
arriving
at
these
estimates,
the
Group
considers
a
range
of
market
practices,
including how it
believes market participants
would assess these
uncertainties. Model reserves
are reassessed periodically
in light
of
data
from
market
transactions,
consensus
pricing
services
and
other relevant sources.
Other items
In the first half of 2021,
UBS incurred a loss of
USD
861
million as
a
result
of
closing
out
a
significant
portfolio
of
swaps
with
a
US-based
client
of
its
prime
brokerage
business
and
the
unwinding of
related hedges,
following the
client’s default.
This
loss
is
presented
within
Other
net
income
from
financial
instruments measured at fair value through profit or loss
.
Valuation adjustments on financial instruments
As of
Life-to-date gain / (loss), USD million
31.12.21
31.12.20
Credit valuation adjustments
1
(
44
)
(
66
)
Funding valuation adjustments
(
49
)
(
73
)
Debit valuation adjustments
2
0
Other valuation adjustments
(
913
)
(
820
)
of which: liquidity
(
341
)
(
340
)
of which: model uncertainty
(
571
)
(
479
)
1 Amounts do not include reserves against defaulted counterparties.
357
Note 21
Fair value measurement (continued)
e) Transfers between Level 1 and Level 2
Assets and liabilities transferred
from Level 2 to
Level 1 during 2021 were
not material. Assets and
liabilities transferred from Level 1
to Level 2 during 2021 were also not material.
f) Level 3 instruments: valuation techniques and inputs
The
table
below
presents
material
Level 3
assets
and
liabilities,
together
with
the
valuation
techniques
used
to
measure
fair
value,
the
inputs
used
in
a
given
valuation
technique
that
are
considered significant as
of 31 December
2021 and
unobservable,
and a range of values for those unobservable inputs.
The
range
of
values represents
the
highest-
and lowest-level
inputs
used in
the valuation
techniques. Therefore,
the range
does
not reflect the level of
uncertainty regarding a particular input or
an assessment
of the
reasonableness of
the Group’s
estimates and
assumptions, but rather the different underlying
characteristics of
the relevant
assets and
liabilities held
by the
Group. The
ranges
will
therefore
vary
from
period
to
period
and
parameter
to
parameter
based
on
characteristics
of
the
instruments
held
at
each balance
sheet date.
Furthermore, the
ranges of
unobservable
inputs may differ across other financial institutions, reflecting the
diversity of the products in each firm’s inventory.
Valuation techniques and inputs used in the fair value measurement
of Level 3 assets and liabilities
Fair value
Significant
unobservable
input(s)
1
Range of inputs
Assets
Liabilities
Valuation
technique(s)
31.12.21
31.12.20
USD billion
31.12.21
31.12.20
31.12.21
31.12.20
low
high
weighted
average
2
low
high
weighted
average
2
unit
1
Financial assets and liabilities at fair value held for trading and Financial assets at fair
value not held for trading
Corporate and municipal
bonds
0.9
1.2
0.0
0.0
Relative value to
market comparable
Bond price equivalent
16
143
98
1
143
100
points
Discounted expected
cash flows
Discount margin
434
434
268
268
basis
points
Traded loans, loans
measured at fair value,
loan commitments and
guarantees
2.8
2.4
0.0
0.0
Relative value to
market comparable
Loan price equivalent
0
101
99
0
101
99
points
Discounted expected
cash flows
Credit spread
175
800
436
190
800
398
basis
points
Market comparable
and securitization
model
Credit spread
28
1,544
241
40
1,858
333
basis
points
Auction rate securities
1.6
1.5
Discounted expected
cash flows
Credit spread
115
197
153
100
188
140
basis
points
Investment fund units
3
0.1
0.1
0.0
0.0
Relative value to
market comparable
Net asset value
Equity instruments
3
0.8
0.7
0.1
0.0
Relative value to
market comparable
Price
Debt issued designated at
fair value
4
14.2
11.0
Other financial liabilities
designated at fair value
0.8
0.7
Discounted expected
cash flows
Funding spread
24
175
42
175
basis
points
Derivative financial instruments
Interest rate contracts
0.5
0.5
0.3
0.5
Option model
Volatility of interest
rates
65
81
29
69
basis
points
Credit derivative contracts
0.2
0.3
0.3
0.5
Discounted expected
cash flows
Credit spreads
1
583
1
489
basis
points
Bond price equivalent
2
136
0
100
points
Equity / index contracts
0.4
0.9
1.5
2.3
Option model
Equity dividend yields
0
11
0
13
%
Volatility of equity
stocks, equity and
other indices
4
98
4
100
%
Equity-to-FX
correlation
(
29
)
76
(
34
)
65
%
Equity-to-equity
correlation
(
25
)
100
(
16
)
100
%
1 The ranges of significant
unobservable inputs are represented in
points, percentages and basis
points. Points are a
percentage of par (e.g., 100
points would be 100% of par).
2 Weighted averages are
provided
for most non-derivative financial
instruments and were calculated
by weighting inputs based on
the fair values of the
respective instruments. Weighted
averages are not provided
for inputs related to Other
financial
liabilities designated at
fair value
and Derivative
financial instruments,
as this would
not be meaningful.
3 The
range of
inputs is not
disclosed, as there
is a dispersion
of values
given the diverse
nature of the
investments.
4 Debt issued designated at fair value primarily consists of UBS structured notes, which include variable maturity notes with various equity and foreign exchange underlying risks,
rates-linked and credit-
linked notes, all of which have embedded derivative parameters that are considered to be unobservable.
The equivalent derivative instrument parameters are presented in the respective derivative financial instruments
lines in this table.
Consolidated financial statements | UBS Group AG consolidated financial statements
358
Note 21
Fair value measurement (continued)
Significant unobservable inputs in Level 3 positions
This section discusses the significant unobservable inputs
used in the valuation of Level
3 instruments and assesses the potential
effect
that a change in each
unobservable input in isolation
may have on a
fair value measurement. Relationships
between observable and
unobservable inputs have not been included
in the summary below.
Input
Description
Bond price equivalent
–
Where market
prices are
not available
for a
bond, fair
value is
measured by comparison
with observable
pricing data
from
similar instruments. Factors considered when
selecting comparable instruments include credit
quality, maturity and industry of
the issuer. Fair value may be measured either by a direct price comparison or by conversion of
an instrument price into a yield
(either as an outright yield or as a spread to
the relevant benchmark rate).
–
For corporate and municipal bonds,
the range represents the range
of prices from reference issuances
used in determining fair
value. Bonds priced at 0 are distressed to the point that no recovery
is expected, while prices significantly in excess of 100 or
par
relate
to
inflation-linked
or
structured
issuances
that
pay
a
coupon
in
excess
of
the
market
benchmark
as
of
the
measurement date.
–
For credit derivatives, the bond price range
represents the range of prices used for
reference instruments, which are typically
converted to an equivalent yield or credit
spread as part of the valuation process.
Loan price equivalent
–
Where market prices are not available
for a traded loan, fair value is measured
by comparison with observable
pricing data for
similar instruments.
Factors considered
when selecting
comparable instruments include
industry segment, collateral
quality,
maturity and issuer-specific covenants. Fair value may be measured either by a direct price comparison
or by conversion of an
instrument price
into a yield.
The range represents
the range
of prices
derived from
reference issuances
of a similar
credit quality
used to
measure fair
value for
loans classified
as Level 3.
Loans priced
at 0
are distressed
to the
point that
no recovery
is
expected, while a current price of 100 represents
a loan that is expected to be repaid in full.
Credit spread
–
Valuation models for many credit derivatives
require an input for the credit
spread, which is a reflection of the
credit quality of
the associated referenced
underlying. The credit
spread of a
particular security is
quoted in relation
to the yield
on a benchmark
security or reference rate, typically either US Treasury or ARR,
and is generally expressed in terms of basis points. An increase
/
(decrease) in credit
spread will increase
/ (decrease) the
value of credit
protection offered by
credit default swaps
and other
credit derivative
products. The
income statement
effect from
such changes
depends on
the nature
and direction
of the
positions
held. Credit spreads may
be negative where the asset
is more creditworthy than the
benchmark against which the spread
is
calculated. A
wider credit spread
represents decreasing creditworthiness. The
range represents a
diverse set
of underlyings,
with the lower
end of the
range representing
credits of the
highest quality
and the upper
end of the
range representing
greater
levels of credit risk.
Discount margin
–
The discount margin (DM) spread represents the
discount rates applied to present value
cash flows of an asset
to reflect the
market return required for uncertainty in the
estimated cash flows. DM spreads are
a rate or rates applied on top of a floating
index (e.g., Secured Overnight Financing
Rate (SOFR)) to discount expected
cash flows. Generally, a decrease
/ (increase) in the
DM in isolation would result in a higher / (lower)
fair value.
–
The high end
of the
range relates
to securities
that are priced
low within
the market
relative to the
expected cash
flow schedule.
This indicates
that the
market is
pricing an
increased risk
of credit
loss into
the security
that is
greater than
what is
being
captured by the
expected cash
flow generation process.
The low e
nds of
the ranges are
typical of funding
rates on
better-
quality instruments.
Funding spread
–
Structured financing transactions are valued using synthetic funding curves that best represent the assets that are pledged as
collateral for the transactions. They are not representative
of where UBS can fund itself on an unsecured basis, but
provide an
estimate of where UBS can source and deploy secured funding with counterparties for a given type of collateral. The funding
spreads are expressed in terms of basis points,
and if funding spreads widen, this increases the
effect of discounting.
–
A small proportion of structured
debt instruments and non-structured
fixed-rate bonds within financial
liabilities designated at
fair value had an exposure to funding spreads that
was longer in duration than the actively traded
market.
Volatility
–
Volatility measures the variability of future prices
for a particular instrument and is generally
expressed as a percentage, where
a higher number reflects a more volatile instrument, for which future price movements are
more likely to occur. Volatility is a
key input
into option
models, where it
is used
to derive
a probability-based
distribution of
future prices
for the
underlying
instrument. The effect
of volatility on
individual positions within
the portfolio is
driven primarily by
whether the option
contract
is a
long or
short position.
In most
cases, the
fair value
of an
option increases
as a
result of
an increase
in volatility
and is
reduced by
a decrease
in volatility.
Generally,
volatility used
in the
measurement of fair
value is
derived from
active-market
option prices
(referred to
as implied
volatility). A
key feature
of implied
volatility is
the volatility
“smile” or
“skew,” which
represents the effect of pricing options of
different option strikes at different implied volatility
levels.
–
Volatilities of low interest rates tend to be much higher than volatilities of high interest rates. In addition, different currencies
may have significantly different implied volatilities.
359
Note 21
Fair value measurement (continued)
Input
Description
Correlation
–
Correlation measures the interrelationship between the movements of two variables. It is expressed as a percentage between
–100% and
+100%, where
+100% represents
perfectly correlated
variables (meaning
a movement
of one
variable is
associated
with a
movement of the
other variable in
the same direction)
and –100% implies
that the variables
are inversely correlated
(meaning a movement
of one variable
is associated with
a movement of
the other variable
in the opposite
direction). The
effect
of correlation on the measurement of fair value depends on the specific terms of the instruments being valued, reflecting the
range of different payoff features within
such instruments.
–
Equity-to-FX correlation is important for equity options based on
a currency other than the
currency of the underlying stock.
Equity-to-equity correlation is particularly important for complex options that incorporate, in some
manner, different equities
in the projected payoff.
Equity dividend yields
–
The derivation of
a forward price
for an individual
stock or index
is important for
measuring fair value
for forward or
swap
contracts and for measuring fair value using option pricing models. The relationship between the current stock price and
the
forward price is based on a combination of expected future dividend levels and
payment timings, and, to a lesser extent, the
relevant funding rates applicable
to the stock in question.
Dividend yields are generally expressed
as an annualized percentage
of the share price,
with the lowest limit
of 0% representing
a stock that is
not expected to pay
any dividend. The
dividend yield
and timing represent the
most significant parameter in determining
fair value for instruments
that are sensitive to
an equity
forward price.
g) Level 3 instruments: sensitivity to changes in unobservable input assumptions
The table
below summarizes
those financial
assets and
liabilities
classified
as
Level 3
for
which
a
change
in
one
or
more
of
the
unobservable inputs
to reflect
reasonably possible
favorable and
unfavorable
alternative
assumptions
would
change
fair
value
significantly,
and
the estimated
effect
thereof.
The
table
below
does
not
represent
the
estimated
effect
of
stress
scenarios.
Interdependencies between Level 1, 2 and 3
parameters have not
been
incorporated
in
the
table.
Furthermore,
direct
inter-
relationships between the
Level 3 parameters discussed
below are
not a significant element of the valuation uncertainty.
Sensitivity
data
is
estimated
using
a
number
of
techniques,
including
the
estimation
of
price
dispersion
among
different
market
participants,
variation
in
modeling
approaches
and
reasonably possible
changes to assumptions
used within
the fair
value measurement process. The sensitivity ranges are not always
symmetrical
around
the
fair
values,
as
the
inputs
used
in
valuations are not always precisely in
the middle of the favorable
and unfavorable range.
Sensitivity data
is determined
at a
product or
parameter level
and
then
aggregated
assuming
no
diversification
benefit.
Diversification
would
incorporate
estimated
correlations
across
different sensitivity results and, as such, would result in an overall
sensitivity
that
would
be
less
than
the
sum
of
the
individual
component
sensitivities.
However,
the
Group
believes
that
the
diversification benefit is not significant to this analysis.
Sensitivity of fair value measurements to changes
in unobservable input assumptions
1
31.12.21
31.12.20
USD million
Favorable
changes
Unfavorable
changes
Favorable
changes
Unfavorable
changes
Traded loans, loans designated at fair value, loan commitments and guarantees
19
(
13
)
29
(
28
)
Securities financing transactions
41
(
53
)
40
(
52
)
Auction rate securities
66
2
(
66
)
2
105
(
105
)
Asset-backed securities
20
(
20
)
41
(
41
)
Equity instruments
173
(
146
)
129
(
96
)
Interest rate derivative contracts, net
29
(
19
)
11
(
16
)
Credit derivative contracts, net
5
(
8
)
10
(
14
)
Foreign exchange derivative contracts, net
19
(
11
)
20
(
15
)
Equity / index derivative contracts, net
368
(
335
)
318
(
294
)
Other
50
(
73
)
91
(
107
)
Total
790
(
744
)
794
(
768
)
1 Sensitivity of issued and
over-the-counter debt instruments
is reported with the equivalent
derivative or securities financing
instrument.
2 Includes refinements applied in estimating
valuation uncertainty across
various parameters and a change in assumptions regarding the underlying statistical distribution.
Consolidated financial statements | UBS Group AG consolidated financial statements
360
Note 21
Fair value measurement (continued)
h) Level 3 instruments: movements during the period
The
table below
presents
additional
information about
material
movements in Level 3 assets and
liabilities measured at fair
value
on a recurring basis, excluding any related hedging activity.
Assets
and
liabilities
transferred
into
or
out
of
Level 3
are
presented as
if those
assets or
liabilities had
been transferred
at
the beginning of the year.
Movements of Level 3 instruments
Total gains / losses
included in
comprehensive income
USD billion
Balance
as of
31 December
2019
Net gains /
losses
included in
income
1
of which:
related to
Level 3
instruments
held at the
end of the
reporting
period
Purchases
Sales
Issuances
Settlements
Transfers
into
Level 3
Transfers
out of
Level 3
Foreign
currency
translation
Balance
as of
31 December
2020
Financial assets at fair value held for
trading
1.8
(
0.1
)
(
0.1
)
0.8
(
1.4
)
1.0
0.0
0.3
0.0
0.0
2.3
of which:
Investment fund units
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Corporate and municipal bonds
0.5
0.0
0.0
0.7
(
0.5
)
0.0
0.0
0.1
0.0
0.0
0.8
Loans
0.8
0.0
(
0.1
)
0.0
(
0.7
)
1.0
0.0
0.1
0.0
0.0
1.1
Other
0.4
0.0
0.0
0.1
(
0.3
)
0.0
0.0
0.2
0.0
0.0
0.4
Derivative financial instruments –
assets
1.3
0.3
0.4
0.0
0.0
0.7
(
0.5
)
0.1
(
0.2
)
0.1
1.8
of which:
Interest rate contracts
0.3
0.2
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.5
Equity / index contracts
0.6
0.1
0.1
0.0
0.0
0.6
(
0.3
)
0.0
(
0.1
)
0.0
0.9
Credit derivative contracts
0.4
0.0
0.0
0.0
0.0
0.1
(
0.2
)
0.1
0.0
0.0
0.3
Other
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Financial assets at fair value not held
for trading
4.0
0.0
0.1
0.8
(
0.9
)
0.0
0.0
0.1
0.0
0.0
3.9
of which:
Loans
1.2
0.0
0.0
0.3
(
0.7
)
0.0
0.0
0.0
0.0
0.0
0.9
Auction rate securities
1.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.5
Equity instruments
0.5
0.0
0.0
0.1
(
0.1
)
0.0
0.0
0.0
0.0
0.0
0.5
Other
0.7
0.0
0.0
0.4
(
0.2
)
0.0
0.0
0.0
0.0
0.0
1.0
Derivative financial instruments –
liabilities
2.0
1.3
1.2
0.0
0.0
1.2
(
0.9
)
0.4
(
0.6
)
0.1
3.5
of which:
Interest rate contracts
0.1
0.3
0.3
0.0
0.0
0.3
(
0.2
)
0.2
(
0.2
)
0.0
0.5
Equity / index contracts
1.3
1.0
0.8
0.0
0.0
0.8
(
0.6
)
0.1
(
0.2
)
0.0
2.3
Credit derivative contracts
0.5
0.0
0.0
0.0
0.0
0.1
(
0.1
)
0.1
(
0.2
)
0.0
0.5
Other
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
Debt issued designated at fair value
9.9
0.2
0.0
0.0
0.0
7.6
(
5.7
)
0.5
(
1.7
)
0.2
11.0
Other financial liabilities designated
at fair value
0.8
0.1
0.1
0.0
0.0
0.3
(
0.5
)
0.0
0.0
0.0
0.7
1 Net gains / losses
included in comprehensive income
are composed of Net interest
income, Other net
income from financial instruments
measured at fair value
through profit or loss
and Other income.
2 Total
Level 3 assets as of 31 December 2021 were USD
7.6
billion (31 December 2020: USD
8.3
billion). Total Level 3 liabilities as of 31 December 2021 were USD
17.4
billion (31 December 2020: USD
15.2
billion).
361
Note 21
Fair value measurement (continued)
Total gains / losses
included in
comprehensive income
Balance
as of
31 December
2020
2
Net gains /
losses
included in
income
1
of which:
related to
Level 3
instruments
held at the
end of the
reporting
period
Purchases
Sales
Issuances
Settlements
Transfers
into
Level 3
Transfers
out of
Level 3
Foreign
currency
translation
Balance
as of
31 December
2021
2
2.3
0.0
(
0.1
)
0.3
(
1.6
)
1.2
0.0
0.3
(
0.3
)
0.0
2.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.8
0.0
0.0
0.2
(
0.4
)
0.0
0.0
0.0
(
0.1
)
0.0
0.6
1.1
0.0
0.0
0.0
(
0.8
)
1.2
0.0
0.0
(
0.2
)
0.0
1.4
0.4
0.0
0.0
0.1
(
0.4
)
0.0
0.0
0.3
0.0
0.0
0.3
1.8
(
0.2
)
(
0.1
)
0.0
0.0
0.5
(
0.7
)
0.1
(
0.3
)
0.0
1.1
0.5
0.1
0.1
0.0
0.0
0.1
(
0.2
)
0.0
(
0.1
)
0.0
0.5
0.9
(
0.1
)
(
0.1
)
0.0
0.0
0.3
(
0.4
)
0.0
(
0.2
)
0.0
0.4
0.3
(
0.1
)
(
0.1
)
0.0
0.0
0.0
(
0.1
)
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.9
0.1
0.1
1.0
(
0.6
)
0.0
0.0
0.1
(
0.3
)
0.0
4.2
0.9
0.0
0.0
0.6
(
0.3
)
0.0
0.0
0.0
(
0.3
)
0.0
0.9
1.5
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.6
0.5
0.1
0.1
0.1
(
0.1
)
0.0
0.0
0.0
0.0
0.0
0.7
1.0
0.0
(
0.1
)
0.3
(
0.2
)
0.0
0.0
0.0
0.0
0.0
1.0
3.5
0.2
0.0
0.0
0.0
0.9
(
1.8
)
0.0
(
0.5
)
0.0
2.2
0.5
(
0.1
)
(
0.1
)
0.0
0.0
0.0
(
0.1
)
0.0
0.0
0.0
0.3
2.3
0.3
0.1
0.0
0.0
0.8
(
1.5
)
0.0
(
0.4
)
0.0
1.5
0.5
(
0.1
)
(
0.1
)
0.0
0.0
0.0
0.0
0.0
(
0.1
)
0.0
0.3
0.1
0.1
0.0
0.0
0.0
0.0
(
0.1
)
0.0
0.0
0.0
0.1
11.0
0.7
0.6
0.0
0.0
8.0
(
4.2
)
0.2
(
1.2
)
(
0.2
)
14.2
0.7
0.0
0.0
0.0
0.0
0.4
(
0.2
)
0.0
0.0
0.0
0.8
Consolidated financial statements | UBS Group AG consolidated financial statements
362
Note 21
Fair value measurement (continued)
i) Maximum exposure to credit risk for financial instruments measured at fair value
The
tables
below
provide
the
Group’s
maximum
exposure
to
credit risk for financial instruments
measured at fair value and
the
respective
collateral
and
other
credit
enhancements
mitigating
credit risk for these classes of financial instruments.
The
maximum
exposure
to
credit
risk
includes
the
carrying
amounts of financial
instruments recognized on
the balance sheet
subject
to
credit
risk
and
the
notional
amounts
for
off-balance
sheet arrangements.
Where information
is available,
collateral is
presented at fair value.
For other collateral, such as
real estate, a
reasonable alternative
value is
used. Credit
enhancements, such
as credit derivative contracts
and guarantees, are included
at their
notional amounts. Both are capped at the maximum
exposure to
credit risk for which
they serve as
security. The “Risk management
and control” section of this
report describes management’s view
of credit risk and
the related exposures,
which can differ
in certain
respects from the requirements of IFRS.
Maximum exposure to credit risk
31.12.21
Maximum
exposure to
credit risk
Collateral
Credit enhancements
Exposure to
credit risk
after collateral
and credit
enhancements
USD billion
Cash
collateral
received
Collateral-
ized by
securities
Secured by
real estate
Other
collateral
Netting
Credit
derivative
contracts
Guarantees
Financial assets measured at
fair value on the balance sheet
1
Financial assets at fair value
held for trading – debt instruments
2,3
22.4
22.4
Derivative financial instruments
4,5
118.1
4.2
103.2
10.7
Brokerage receivables
21.8
21.6
0.2
Financial assets at fair value not
held for trading – debt instruments
6
37.0
11.2
25.7
Total financial assets measured at fair value
199.4
0.0
37.1
0.0
0.0
103.2
0.0
0.0
59.1
Guarantees
7
0.2
0.2
0.0
31.12.20
Maximum
exposure to
credit risk
Collateral
Credit enhancements
Exposure to
credit risk
after collateral
and credit
enhancements
USD billion
Cash
collateral
received
Collateral-
ized by
securities
Secured by
real estate
Other
collateral
Netting
Credit
derivative
contracts
Guarantees
Financial assets measured at
fair value on the balance sheet
1
Financial assets at fair value
held for trading – debt instruments
2,3
24.6
24.6
Derivative financial instruments
4,5
159.6
6.0
138.4
15.2
Brokerage receivables
24.7
24.4
0.3
Financial assets at fair value not
held for trading – debt instruments
6
58.2
13.2
45.0
Total financial assets measured at fair value
267.1
0.0
43.6
0.0
0.0
138.4
0.0
0.0
85.1
Guarantees
7
0.5
0.1
0.3
0.0
1 The maximum exposure to loss is generally equal to the carrying amount and subject
to change over time with market movements.
2 These positions are generally managed under the market
risk framework. For
the purpose of this disclosure, collateral
and credit enhancements were not considered.
3 Does not include investment fund units.
4 Includes USD
0
million (31 December 2020: USD
0
million) fair values of loan
commitments and forward starting reverse repurchase agreements classified as derivatives.
The full contractual committed amount of forward starting reverse repurchase agreements (generally highly collateralized) of
USD
27.8
billion (31 December 2020:
USD
21.9
billion) and derivative
loan commitments (generally
unsecured) of USD
8.2
billion, of which
USD
0.8
billion has been sub-participated
(31 December 2020: USD
9.4
billion, of which USD
0.8
billion had been sub-participated), is
presented in Note 10 under notional
amounts.
5 The amount shown in
the “Netting” column represents the netting
potential not recognized on the
balance sheet. Refer to
Note 22 for more information.
6 Financial assets at fair
value not held for
trading collateralized by
securities consisted of structured
loans and reverse repurchase
and securities borrowing
agreements.
7 The amount shown in the “Guarantees” column largely relates to sub-participations.
363
Note 21
Fair value measurement (continued)
j) Financial instruments not measured at fair value
The table below provides the estimated fair values of financial instruments not measured at fair value.
Financial instruments not measured at fair value
31.12.21
31.12.20
Carrying
amount
Fair value
Carrying
amount
Fair value
USD billion
Total
Carrying
amount
approximates
fair value
1
Level 1
Level 2
Level 3
Total
Total
Carrying
amount
approximates
fair value
1
Level 1
Level 2
Level 3
Total
Assets
2
Cash and balances at central banks
192.8
192.7
0.1
0.0
0.0
192.8
158.2
158.1
0.1
0.0
0.0
158.2
Loans and advances to banks
15.5
14.8
0.0
0.7
0.0
15.5
15.4
14.7
0.0
0.6
0.1
15.4
Receivables from securities financing
transactions
75.0
71.6
0.0
1.3
2.1
75.0
74.2
64.9
0.0
7.6
1.7
74.2
Cash collateral receivables on derivative
instruments
30.5
30.5
0.0
0.0
0.0
30.5
32.7
32.7
0.0
0.0
0.0
32.7
Loans and advances to customers
397.8
163.1
0.0
43.8
190.1
396.9
379.5
172.0
0.0
34.2
174.6
380.8
Other financial assets measured at amortized
cost
26.2
4.1
9.3
10.7
2.4
26.5
27.2
5.3
9.4
10.9
2.3
28.0
Liabilities
2
Amounts due to banks
13.1
9.1
0.0
4.0
0.0
13.1
11.0
8.5
0.0
2.6
0.0
11.0
Payables from securities financing
transactions
5.5
4.1
0.0
1.5
0.0
5.5
6.3
6.0
0.0
0.3
0.0
6.3
Cash collateral payables on derivative
instruments
31.8
31.8
0.0
0.0
0.0
31.8
37.3
37.3
0.0
0.0
0.0
37.3
Customer deposits
542.0
535.4
0.0
6.6
0.0
542.0
524.6
519.4
0.0
5.3
0.0
524.7
Debt issued measured at amortized cost
139.2
15.8
0.0
125.3
0.0
141.1
139.2
16.4
0.0
125.5
0.0
141.9
Other financial liabilities measured at
amortized cost
3
5.4
5.4
0.0
0.0
0.0
5.4
5.8
5.7
0.0
0.0
0.1
5.8
1 Includes certain financial instruments where the carrying amount is a reasonable
approximation of the fair value due to the instruments’
short-term nature (instruments that are receivable or payable
on demand, or
with a remaining maturity (excluding
the effects of callable
features) of three months or
less).
2 As of 31 December 2021,
USD
0
billion (31 December 2020: USD
0
billion) of Cash and balances
at central banks,
USD
0
billion (31 December 2020: USD
0
billion) of Loans and advances to banks, USD
1
billion (31 December 2020: USD
1
billion) of Receivables from securities financing transactions, USD
175
billion (31 December
2020: USD
163
billion) of Loans and advances to customers, USD
19
billion (31 December 2020: USD
20
billion) of Other financial assets measured at amortized cost, USD
1
billion (31 December 2020: USD
0
billion)
of Amounts due to
banks, USD
3
billion (31 December 2020:
USD
2
billion) of Customer
deposits, USD
84
billion (31 December 2020:
USD
82
billion) of Debt issued
measured at amortized
cost and USD
3
billion
(31 December 2020: USD
3
billion) of Other financial liabilities measured at amortized cost were expected to be recovered or settled after 12 months.
3 Excludes lease liabilities.
The fair
values included in
the table
above have been
calculated
for
disclosure
purposes
only.
The
valuation
techniques
and
assumptions described below relate only
to the fair value
of UBS’s
financial instruments
not measured at
fair value.
Other institutions
may
use different
methods and
assumptions for
their
fair value
estimations,
and
therefore
such
fair
value
disclosures
cannot
necessarily be compared from
one financial institution
to another.
The following principles
were applied when
determining fair
value
estimates for financial instruments not measured at fair value:
–
For
financial
instruments
with
remaining
maturities
greater
than three months, the
fair value was
determined from quoted
market prices, if available.
–
Where quoted market prices were
not available, the fair values
were
estimated
by
discounting
contractual
cash
flows
using
current
market
interest
rates
or
appropriate
yield
curves
for
instruments
with
similar
credit
risk
and
maturity.
These
estimates generally include
adjustments for counterparty
credit
risk or UBS’s own credit.
–
For short-term financial instruments with remaining maturities
of three
months or less,
the carrying amount,
which is net
of
credit
loss
allowances,
is
generally
considered
a
reasonable
estimate of fair value.
Consolidated financial statements | UBS Group AG consolidated financial statements
364
Note 22
Offsetting financial assets and financial liabilities
UBS
enters
into
netting
agreements
with
counterparties
to
manage the credit risks
associated primarily with repurchase
and
reverse repurchase transactions,
securities borrowing
and lending,
over-the-counter
derivatives,
and
exchange-traded
derivatives.
These
netting
agreements
and
similar
arrangements
generally
enable
the
counterparties
to
set
off
liabilities
against
available
assets received
in the ordinary
course of business
and / or
in the
event
that
the
counterparties
to
the
transaction
are
unable
to
fulfill their contractual obligations.
The tables on this page and the next page
provide a summary
of
financial
assets
and
financial
liabilities
subject
to
offsetting,
enforceable master netting
arrangements and
similar agreements,
as well as
financial collateral received
or pledged to
mitigate credit
exposures for these financial instruments.
The
Group
engages
in
a
variety
of
counterparty
credit
risk
mitigation
strategies
in
addition
to
netting
and
collateral
arrangements. Therefore the net amounts presented in the
tables
on this page and the next page do not purport to
represent their
actual credit risk exposure.
Financial assets subject to offsetting, enforceable
master netting arrangements and similar agreements
Assets subject to netting arrangements
Netting recognized on the balance sheet
Netting potential not recognized on
the balance sheet
3
Assets not
subject to netting
arrangements
4
Total assets
As of 31.12.21, USD billion
Gross assets
before netting
Netting with
gross liabilities
2
Net assets
recognized
on the
balance
sheet
Financial
liabilities
Collateral
received
Assets after
consideration
of
netting
potential
Assets
recognized
on the
balance
sheet
Total assets
after
consideration
of netting
potential
Total assets
recognized
on the
balance
sheet
Receivables from securities
financing transactions
67.7
(
13.8
)
53.9
(
2.9
)
(
51.0
)
0.0
21.1
21.1
75.0
Derivative financial instruments
116.0
(
3.6
)
112.4
(
88.9
)
(
18.5
)
5.0
5.7
10.7
118.1
Cash collateral receivables on
derivative instruments
1
29.4
0.0
29.4
(
15.2
)
(
3.3
)
11.0
1.1
12.1
30.5
Financial assets at fair value
not held for trading
93.1
(
87.6
)
5.5
(
1.1
)
(
4.4
)
0.0
54.6
54.6
60.1
of which: reverse
repurchase agreements
93.1
(
87.6
)
5.5
(
1.1
)
(
4.4
)
0.0
0.3
0.3
5.8
Total assets
306.2
(
105.0
)
201.2
(
108.1
)
(
77.2
)
15.9
82.6
98.5
283.7
As of 31.12.20, USD billion
Receivables from securities
financing transactions
70.3
(
13.4
)
57.0
(
1.7
)
(
55.3
)
0.0
17.3
17.3
74.2
Derivative financial instruments
156.9
(
5.0
)
151.9
(
117.2
)
(
27.2
)
7.5
7.7
15.2
159.6
Cash collateral receivables on
derivative instruments
1
31.9
0.0
31.9
(
19.6
)
(
1.5
)
10.8
0.8
11.6
32.7
Financial assets at fair value
not held for trading
85.6
(
79.1
)
6.5
(
0.8
)
(
5.8
)
0.0
73.9
73.9
80.4
of which: reverse
repurchase agreements
85.6
(
79.1
)
6.5
(
0.8
)
(
5.8
)
0.0
0.2
0.2
6.7
Total assets
344.8
(
97.5
)
247.3
(
139.3
)
(
89.8
)
18.3
99.7
117.9
346.9
1 The net
amount of Cash collateral
receivables on derivative
instruments recognized on
the balance sheet includes
certain OTC
derivatives that are
net settled on
a daily basis either
legally or in substance
under
IAS 32 principles and exchange-traded
derivatives that are economically
settled on a daily basis.
2 The logic of
the table results in amounts
presented in the “Netting
with gross liabilities” column corresponding
directly to the amounts presented in the “Netting with gross assets” column in
the liabilities table presented on the following page. Netting in this column for reverse repurchase agreements presented within the lines
“Receivables from securities financing
transactions” and “Financial assets
at fair value not held
for trading” taken together
corresponds to the amounts presented
for repurchase agreements in the
“Payables from
securities financing transactions” and “Other financial
liabilities designated at fair value” lines in the
liabilities table presented on the following
page.
3 For the purpose of this disclosure,
the amounts of financial
instruments and cash collateral
presented have been capped so
as not to exceed the
net amount of financial assets
presented on the balance
sheet; i.e., over-collateralization,
where it exists, is
not reflected in the
table.
4 Includes assets not subject to enforceable netting arrangements and other out-of-scope items.
365
Note 22
Offsetting financial assets and financial liabilities (continued)
Financial liabilities subject to offsetting, enforceable
master netting arrangements and similar
agreements
Liabilities subject to netting arrangements
Netting recognized on the balance sheet
Netting potential not recognized
on the balance sheet
3
Liabilities not
subject
to netting
arrangements
4
Total liabilities
As of 31.12.21, USD billion
Gross
liabilities
before
netting
Netting with
gross assets
2
Net
liabilities
recognized
on the
balance
sheet
Financial
assets
Collateral
pledged
Liabilities
after
consideration of
netting
potential
Liabilities
recognized
on the
balance
sheet
Total
liabilities
after
consideration
of netting
potential
Total
liabilities
recognized
on the
balance
sheet
Payables from securities
financing transactions
16.9
(
12.8
)
4.1
(
1.8
)
(
2.3
)
0.0
1.4
1.4
5.5
Derivative financial instruments
118.4
(
3.6
)
114.9
(
88.9
)
(
18.1
)
7.9
6.4
14.3
121.3
Cash collateral payables on
derivative instruments
1
30.4
0.0
30.4
(
13.1
)
(
3.3
)
14.0
1.4
15.4
31.8
Other financial liabilities
designated at fair value
94.8
(
88.6
)
6.2
(
2.2
)
(
3.8
)
0.2
23.9
24.1
30.1
of which: repurchase agreements
94.6
(
88.6
)
6.0
(
2.2
)
(
3.8
)
0.0
0.4
0.4
6.4
Total liabilities
260.6
(
105.0
)
155.6
(
106.0
)
(
27.5
)
22.1
33.1
55.2
188.7
As of 31.12.20, USD billion
Payables from securities
financing transactions
18.2
(
13.3
)
4.9
(
1.6
)
(
3.3
)
0.0
1.4
1.4
6.3
Derivative financial instruments
157.1
(
5.0
)
152.1
(
117.2
)
(
23.9
)
10.9
9.0
19.9
161.1
Cash collateral payables on
derivative instruments
1
35.6
0.0
35.6
(
19.6
)
(
2.1
)
13.9
1.7
15.7
37.3
Other financial liabilities
designated at fair value
87.0
(
79.2
)
7.8
(
0.8
)
(
6.3
)
0.7
22.6
23.3
30.4
of which: repurchase agreements
86.2
(
79.2
)
7.0
(
0.8
)
(
6.3
)
0.0
0.3
0.3
7.3
Total liabilities
297.8
(
97.5
)
200.3
(
139.2
)
(
35.5
)
25.6
34.8
60.4
235.1
1 The net amount of Cash collateral payables on derivative instruments recognized on the balance sheet includes certain OTC derivatives that are net settled on a daily basis either legally or in substance under IAS 32
principles and exchange-traded derivatives that are economically settled on
a daily basis.
2 The logic of the table results
in amounts presented in the “Netting with
gross assets” column corresponding to the amounts
presented in the
“Netting with gross
liabilities” column in
the assets table
presented on the
previous page.
Netting in this
column for repurchase
agreements presented
within the lines
“Payables from
securities
financing transactions” and “Other financial liabilities designated at fair value”
taken together corresponds to the amounts presented
for reverse repurchase agreements in the “Receivables from securities
financing
transactions” and “Financial assets
at fair value not
held for trading” lines
in the assets table presented
on the previous page.
3 For the purpose
of this disclosure, the
amounts of financial instruments and
cash
collateral presented have been
capped so as not to
exceed the net amount of
financial liabilities presented on the
balance sheet; i.e.,
over-collateralization, where it
exists, is not reflected
in the table.
4 Includes
liabilities not subject to enforceable netting arrangements and other out-of-scope items.
Consolidated financial statements | UBS Group AG consolidated financial statements
366
Note 23
Restricted and transferred financial assets
This Note provides
information about
restricted financial assets
(Note 23a), transfers
of financial
assets (Note 23b
and 23c) and
financial
assets that are received as collateral with the right to resell or repledge these assets (Note 23d).
a) Restricted financial assets
Restricted
financial assets
consist of
assets
pledged as
collateral
against an existing liability or contingent liability and other assets
that are
otherwise explicitly
restricted
such that
they cannot
be
used to secure funding.
Financial
assets
are
mainly
pledged
as
collateral
in
securities
lending
transactions,
in
repurchase
transactions,
against
loans
from
Swiss
mortgage
institutions
and
in
connection
with
the
issuance
of
covered
bonds.
The
Group
generally
enters
into
repurchase
and securities
lending
arrangements
under
standard
market
agreements.
For
securities lending,
the cash
received as
collateral may be more or less than the fair value of the securities
loaned,
depending
on
the
nature
of
the
transaction.
For
repurchase agreements, the fair value of the collateral sold under
an
agreement
to
repurchase
is
generally
in
excess
of
the
cash
borrowed. Pledged mortgage loans serve as collateral for existing
liabilities
against
Swiss
central
mortgage
institutions
and
for
existing
covered
bond
issuances
of
USD
10,843
million
as
of
31 December 2021 (31 December 2020: USD
12,456
million).
Other restricted financial assets include assets protected under
client asset
segregation rules,
assets held
by the
Group’s insurance
entities to back related liabilities to the policy holders, assets held
in certain jurisdictions to
comply with explicit
minimum local asset
maintenance requirements. The carrying
amount of the liabilities
associated with these other
restricted financial assets is
generally
equal to the carrying amount of the assets, with the exception of
assets held to comply with local asset maintenance requirements,
for which the associated liabilities are greater.
Restricted financial assets
USD million
31.12.21
31.12.20
Restricted
financial assets
of which: assets
pledged as
collateral that
may be sold or
repledged by
counterparties
of which:
mortgage loans
1
Restricted
financial assets
of which: assets
pledged as
collateral that
may be sold or
repledged by
counterparties
of which:
mortgage loans
1
Financial assets pledged as collateral
Financial assets at fair value held for trading
63,725
43,397
64,367
47,098
Loans and advances to customers
18,160
16,330
20,361
18,191
Financial assets at fair value not held for trading
961
961
2,140
2,140
Debt securities classified as Other financial assets measured
at amortized
cost
2,234
1,870
2,506
2,506
Financial assets measured at fair value through other comprehensive
income
0
0
149
149
Total financial assets pledged as collateral
2
85,079
89,523
Other restricted financial assets
Loans and advances to banks
3,408
3,730
Financial assets at fair value held for trading
392
741
Cash collateral receivables on derivative instruments
4,747
3,765
Loans and advances to customers
1,237
756
Financial assets at fair value not held for trading
22,765
23,243
Financial assets measured at fair value through other comprehensive
income
894
0
Other
97
110
Total other restricted financial assets
33,540
32,345
Total financial assets pledged and other restricted financial assets
118,619
121,868
1 All related
to mortgage loans
that serve as
collateral for existing
liabilities toward Swiss
central mortgage
institutions and for
existing covered bond
issuances. Of
these pledged mortgage
loans, approximately
USD
2.7
billion as
of 31
December 2021
(31 December
2020: approximately
USD
2.7
billion) could
be withdrawn
or used
for future
liabilities or
covered bond
issuances without
breaching existing
collateral
requirements.
2 Does not
include assets placed
with central banks
related to undrawn
credit lines and
for payment, clearing
and settlement purposes
(31 December 2021:
USD
4.4
billion; 31 December
2020:
USD
1.3
billion).
367
Note 23
Restricted and transferred financial assets (continued)
In addition
to restrictions
on financial
assets,
UBS Group
AG
and
its
subsidiaries
are,
in
certain
cases,
subject
to
regulatory
requirements
that
affect
the
transfer
of
dividends
and
capital
within
the Group,
as
well as
intercompany lending.
Supervisory
authorities
also
may
require
entities
to
measure
capital
and
leverage
ratios on
a
stressed basis,
such
as
the
Federal
Reserve
Board
’s
Comprehensive
Capital
Analysis
and
Review
process,
which
may
limit
the
relevant
subsidiaries’
ability
to
make
distributions of capital based on the results of those tests.
Supervisory
authorities
generally
have
discretion
to
impose
higher
requirements
or
to
otherwise
limit
the
activities
of
subsidiaries.
Non-regulated
subsidiaries
are
generally
not
subject
to
such
requirements
and transfer
restrictions. However,
restrictions
can
also be the result
of different legal, regulatory,
contractual, entity-
or country-specific arrangements and / or requirements.
›
Refer to the “Financial and regulatory key figures
for our
significant regulated subsidiaries and sub-groups” section
of this
report for financial information about significant
regulated
subsidiaries of the Group
b) Transferred financial assets that are not derecognized in their entirety
The table below presents
information for financial
assets that have been
transferred but are
subject to continued recognition
in full,
as well as recognized liabilities associated with those transferred assets.
Transferred financial assets subject to continued recognition in full
USD million
31.12.21
31.12.20
Carrying amount
of transferred
assets
Carrying amount of
associated liabilities
recognized
on balance sheet
Carrying amount
of transferred
assets
Carrying amount of
associated liabilities
recognized
on balance sheet
Financial assets at fair value held for trading that may be sold or repledged
by counterparties
43,397
17,687
47,098
18,874
relating to securities lending and repurchase agreements in
exchange for cash received
17,970
17,687
19,177
18,874
relating to securities lending agreements in exchange for securities
received
24,146
27,595
relating to other financial asset transfers
1,281
326
Financial assets at fair value not held for trading that may be sold or repledged
by
counterparties
961
898
2,140
1,378
Debt securities classified as Other financial assets measured
at amortized cost that may be
sold or repledged by counterparties
1,870
1,725
2,506
1,963
Financial assets measured at fair value through other comprehensive
income that may be sold
or repledged by counterparties
0
0
149
148
Total financial assets transferred
46,227
20,311
51,893
22,363
Transactions
in
which
financial
assets
are
transferred,
but
continue to be recognized
in their entirety on
UBS’s balance sheet
include securities lending
and repurchase agreements
,
as well as
other financial asset
transfers. Repurchase
and securities lending
arrangements are,
for the
most part,
conducted under
standard
market
agreements
and
are
undertaken
with
counterparties
subject to UBS’s normal credit risk control processes.
›
Refer to Note 1a item 2e for more information
about repurchase
and securities lending agreements
As
of
31
December
2021
,
approximately
41
%
of
the
transferred
financial
assets
were
assets
held
for
trading
transferred
in
exchange
for
cash,
in
which
case
the
associated
recognized
liability
represents
the
amount
to
be
repaid
to
counterparties. For securities
lending and repurchase
agreements,
a
haircut
of
between
0
%
and
15
%
is
generally
applied
to
the
transferred assets,
which results
in associated
liabilities having
a
carrying
amount
below
the
carrying
amount
of
the
transferred
assets. The counterparties to the
associated liabilities presented in
the table above have full recourse to UBS.
In securities
lending arrangements
entered into in
exchange for
the receipt
of other
securities as
collateral, neither
the securities
received
nor
the
obligation
to
return
them
are
recognized
on
UBS’s balance
sheet, as
the risks
and rewards
of ownership
are
not
transferred
to
UBS.
In
cases
where
such
financial
assets
received
are
subsequently
sold
or
repledged
in
another
transaction,
this
is
not
considered
to
be
a
transfer
of
financial
assets.
Other
financial
asset
transfers
primarily
include
securities
transferred to
collateralize derivative
transactions, for
which the
carrying
amount
of
associated
liabilities
is
not
provided
in
the
table above,
because those
replacement values are
managed on
a
portfolio
basis
across
counterparties
and
product
types,
and
therefore
there
is
no
direct
relationship
between
the
specific
collateral pledged and the associated liability.
Transferred
financial
assets
that
are
not
subject
to
derecognition in
full but
remain on
the balance
sheet to
the extent
of
the
Group’s
continuing
involvement
were not
material as
of
31 December 2021 and as of 31 December 2020.
Consolidated financial statements | UBS Group AG consolidated financial statements
368
Note 23
Restricted and transferred financial assets (continued)
c) Transferred financial assets that are derecognized in their entirety with continuing involvement
Continuing
involvement
in a
transferred
and fully
derecognized
financial
asset
may
result
from
contractual
provisions
in
the
particular transfer agreement or from
a separate agreement, with
the counterparty or a third party, entered into in connection with
the transfer.
The
fair
value
and
carrying
amount
of
UBS’s
continuing
involvement from
transferred positions as
of
31 December 2021
and
31 December
2020
was
not
material.
Life-to-date
losses
reported
in
prior
periods
primarily
relate
to
legacy
positions
in
securitization
vehicles
which
have been
fully marked
down, with
no
remaining exposure
to loss
.
d) Off-balance sheet assets received
The table below presents assets received from third parties that can
be sold or repledged and that are not recognized on the
balance
sheet, but that are held as collateral, including amounts that have been sold or repledged.
Off-balance sheet assets received
USD million
31.12.21
31.12.20
Fair value of assets received that can be sold or repledged
497,828
500,689
received as collateral under reverse repurchase, securities borrowing
and lending arrangements, derivative and other transactions
1
483,426
487,904
received in unsecured borrowings
14,402
12,785
Thereof sold or repledged
2
367,440
367,258
in connection with financing activities
319,176
315,603
to satisfy commitments under short sale transactions
31,688
33,595
in connection with derivative and other transactions
1
16,575
18,059
1 Includes securities received as initial margin from its clients that UBS is required to remit to central counterparties,
brokers and deposit banks through its exchange-traded derivative
clearing and execution services.
2 Does not include off-balance
sheet securities (31 December 2021:
USD
12.7
billion; 31 December 2020:
USD
18.9
billion) placed with central banks
related to undrawn credit
lines and for payment, clearing
and
settlement purposes for which there are no associated liabilities or contingent liabilities.
369
Note 24
Maturity analysis of financial liabilities
The
residual
contractual
maturities
for
non-derivative
and
non-
trading financial liabilities
as of 31 December 2021
are based on
the earliest date on which UBS could be contractually required to
pay.
The
total
amounts
that
contractually
mature
in
each
time
band are also shown for 31 December 2020.
Derivative positions
and
trading
liabilities,
predominantly
made
up
of
short
sale
transactions, are assigned to the
Due within 1 month
column
,
as
this
provides
a
conservative
reflection
of
the
nature
of
these
trading activities. The
residual contractual
maturities may extend
over significantly longer periods.
Maturity analysis of financial liabilities
31.12.21
USD billion
Due within
1 month
Due between
1 and 3 months
Due between
3 and 12 months
Due between
1 and 5 years
Due after
5 years
Total
Financial liabilities recognized on balance sheet
1
Amounts due to banks
6.7
2.4
3.5
0.6
13.1
Payables from securities financing transactions
3.8
0.3
1.6
0.0
5.7
Cash collateral payables on derivative instruments
31.8
31.8
Customer deposits
530.1
5.2
3.3
3.2
0.4
542.3
Debt issued measured at amortized cost
2
4.0
12.7
41.1
53.5
37.6
148.9
Other financial liabilities measured at amortized cost
4.5
0.1
0.5
1.8
1.6
8.4
of which: lease liabilities
0.1
0.1
0.5
1.8
1.6
4.0
Total financial liabilities measured at amortized cost
580.9
20.8
49.9
59.2
39.5
750.2
Financial liabilities at fair value held for trading
3,4
31.7
31.7
Derivative financial instruments
3,5
121.3
121.3
Brokerage payables designated at fair value
44.0
44.0
Debt issued designated at fair value
6
13.8
11.5
13.5
24.5
18.5
81.9
Other financial liabilities designated at fair value
28.1
0.4
0.5
0.4
1.1
30.5
Total financial liabilities measured at fair value through profit or loss
239.0
11.9
14.0
24.9
19.6
309.4
Total
819.8
32.7
63.9
84.1
59.1
1,059.6
Guarantees, commitments and forward starting transactions
Loan commitments
7
38.3
0.5
0.7
0.0
39.5
Guarantees
21.2
0.0
21.2
Forward starting transactions, reverse repurchase
and securities borrowing agreements
7
1.4
1.4
Total
60.9
0.5
0.7
0.0
0.0
62.1
31.12.20
USD billion
Due within
1 month
Due between
1 and 3 months
Due between
3 and 12 months
Due between
1 and 5 years
Due after
5 years
Total
Financial liabilities recognized on balance sheet
1
Amounts due to banks
6.1
2.4
2.1
0.5
0.0
11.1
Payables from securities financing transactions
5.6
0.4
0.3
0.0
0.0
6.3
Cash collateral payables on derivative instruments
37.3
37.3
Customer deposits
512.8
6.6
3.5
1.8
0.2
524.9
Debt issued measured at amortized cost
2
9.0
8.3
41.9
53.7
35.6
148.5
Other financial liabilities measured at amortized cost
4.5
0.1
0.5
2.0
1.8
8.9
of which: lease liabilities
0.1
0.1
0.5
2.0
1.8
4.5
Total financial liabilities measured at amortized cost
575.3
17.9
48.2
58.0
37.7
737.1
Financial liabilities at fair value held for trading
3,4
33.6
33.6
Derivative financial instruments
3,5
161.1
161.1
Brokerage payables designated at fair value
38.7
38.7
Debt issued designated at fair value
6
21.9
16.8
7.1
9.2
9.5
64.5
Other financial liabilities designated at fair value
27.9
0.6
0.6
0.7
1.1
30.9
Total financial liabilities measured at fair value through profit or loss
283.2
17.4
7.7
9.9
10.6
328.8
Total
858.5
35.3
56.0
67.9
48.3
1,065.9
Guarantees, commitments and forward starting transactions
Loan commitments
7
40.5
0.5
0.4
0.0
41.4
Guarantees
17.5
17.5
Forward starting transactions, reverse repurchase
and securities borrowing agreements
7
3.2
3.2
Total
61.3
0.5
0.4
0.0
0.0
62.2
1 Except for financial liabilities
at fair value held
for trading and derivative
financial instruments (see footnote
3), the amounts presented
generally represent undiscounted cash
flows of future interest and
principal
payments.
2 The time-bucket Due after 5 years includes perpetual loss-absorbing additional tier 1 capital instruments.
3 Carrying amount is fair value. Management believes that this best represents the cash flows
that would have to be paid if these positions had to be settled or
closed out.
4 Contractual maturities of financial liabilities at fair value held for trading are: USD
30.8
billion due within 1 month (31 December 2020:
USD
32.6
billion), USD
0.9
billion due between 1 month and 1 year (31 December 2020: USD
1.0
billion) and USD
0
billion due between 1 and 5 years (31 December 2020: USD
0
billion).
5 Includes USD
34
million
(31 December 2020: USD
32
million) related to fair values of
derivative loan commitments and forward
starting reverse repurchase agreements classified as
derivatives, presented within “Due
within 1 month." The
full contractual committed amount of USD
36.0
billion (31 December 2020: USD
31.3
billion) is presented in Note 10 under notional
amounts.
6 Future interest payments on variable-rate liabilities
are determined
by reference to the
applicable interest rate
prevailing as of
the reporting date.
Future principal payments
that are variable
are determined by
reference to the conditions
existing at the relevant
reporting date.
7
Excludes derivative loan commitments and forward starting reverse repurchase agreements measured at fair value
(see footnote 5).
Consolidated financial statements | UBS Group AG consolidated financial statements
370
Note 25
Interest rate benchmark reform
Background
A market-wide reform of major interest rate benchmarks is being
undertaken
globally,
with
the
Financial
Conduct
Authority
(the
FCA) announcing in
March 2021
that the publication
of London
Interbank Offered Rates (LIBORs) would cease after 31 December
2021 for
all non-US
dollar LIBORs,
as well
as for
one-week and
two-month USD
LIBOR. Publication
of the
remaining USD
LIBOR
tenors will cease immediately after 30 June 2023.
The majority of UBS’s IBOR exposure was linked
to CHF LIBOR
and USD LIBOR. The
alternative reference rate (the
ARR) for CHF
LIBOR is the Swiss Average Rate Overnight (SARON). The ARR for
USD
LIBOR
is
the
Secured
Overnight
Financing
Rate
(SOFR);
in
addition, there are recommended ARRs for GBP LIBOR, JPY LIBOR
and EUR LIBOR.
The
Euro
Interbank Offered
Rate (EURIBOR)
was reformed
in
2019,
with the
reform consisting
of a
change in
the underlying
calculation
method.
Consequently,
contracts
linked
to
EURIBOR
are not considered throughout the rest of this Note.
On 25 January 2021, the IBOR Fallbacks
Supplement and IBOR
Fallbacks
Protocol,
which
amend
the
International
Swaps
and
Derivatives Association (ISDA)
standard definitions
for interest rate
derivatives to incorporate
fallbacks for derivatives
linked to certain
IBORs,
came
into
effect.
From
that
date,
all
newly
cleared
and
non-cleared derivatives
between adhering
parties that
reference
ISDA
standard
definitions
now
include
these
fallbacks.
UBS
adhered to the protocol in November 2020.
UBS’s
focus
throughout
2021
was
on
transitioning
existing
contracts via bi-lateral
and multi-lateral agreements,
by leveraging
industry
solutions
(e.
g.,
the
use
of
fallback
provisions)
and
through
third-party
actions
(those
by
clearing
houses,
agents,
etc.). UBS
has established
a framework
to address
the transition
of
contracts
that
do
not
contain
adequate
fallback
provisions.
Furthermore,
in
line
with
regulatory
guidance
,
UBS
has
implemented
a
framework
to
limit
new
contracts
referencing
IBORs.
Governance over the transition to alternative benchmark rates
UBS
established
a
global
cross-divisional,
cross-functional
governance structure
and change
program
to address
the scale
and complexity of
the transition.
This global program
is sponsored
by
the
Group
CFO
and
led
by
senior
representatives
from
the
business divisions
and UBS’s
control and
support functions.
The
program
includes
governance
and
execution
structures
within
each business division,
together with cross-divisional
teams from
each
control
and
support
function.
During
2021,
progress
was
overseen
centrally
via
a
monthly
operating
committee
and
a
monthly steering
committee, as well
as quarterly
updates to
the
joint Audit and Risk
Committees. A dedicated Group-wide
forum,
with an increased US
regional focus, will oversee
progress of the
remaining USD LIBOR transition.
Risks
A
core
part
of
UBS’s
change
program
is
the
identification,
management
and
monitoring
of
the
risks
associated
with
IBOR
reform and transition. These
risks include,
but are not limited
to,
the following:
–
economic risks to UBS and its
clients, through the repricing of
existing
contracts,
reduced
transparency
and
/
or
liquidity
of
pricing information, market uncertainty or disruption;
–
accounting
risks, where
the transition
affects the
accounting
treatment,
including
hedge
accounting
and
consequential
income statement volatility;
–
valuation risks arising from the variation between benchmarks
that will cease
and ARRs, affecting
the risk profile
of financial
instruments;
–
operational risks
arising from
changes to
UBS’s front-to-back
processes
and
systems
to
accommodate
the
transition,
e.g.,
data sourcing and processing and bulk migration of contracts;
and
–
legal
and
conduct
risks
relating
to
UBS’s
engagement
with
clients
and
market
counterparties
around
new
benchmark
products
and
amendments
required
for
existing
contracts
referencing benchmarks that will cease.
Overall, the effort required to transition is affected by multiple
factors, including
whether negotiations need
to
take place
with
multiple stakeholders
(as is the case for
syndicated loans
or certain
listed
securities),
market
readiness
–
such
as
liquidity
in
ARR
-
equivalent products – and a
client’s technical readiness to handle
ARR
market conventions.
UBS remains
confident that
it
has
the
transparency, oversight and operational preparedness to progress
with the
IBOR transition
consistent
with market
timelines,
given the
significant progress made as
of 31 December 2021.
UBS did
not
have
and does
not expect
changes
to its
risk
management
approach
and strategy
as a result
of interest
rate benchmark
reform.
371
Note 25
Interest rate benchmark reform (continued)
Transition progress
Non-derivative instruments
UBS’s significant non-derivative exposures subject to IBOR reform
primarily
related
to
brokerage
receivable
and
payable
balances,
corporate and
private loans,
and mortgages,
linked to
CHF and
USD
LIBORs.
During
2020,
UBS
transitioned
most
of
its
CHF
LIBOR-linked deposits to SARON.
In that same year, UBS launched
SARON-based mortgages and corporate loans based on all major
ARRs in the
Swiss market, as
well as SOFR-based
mortgages in the
US market.
Throughout
2021,
UBS
transitioned
substantially
all
of
its
private
and
corporate
loans
linked
to
non-USD
IBORs,
with
the
remaining
CHF
LIBOR-linked
contracts
planned
to
transition
on
their first roll date in 2022.
In addition, as
of 31 December 2021
UBS had completed
the
transition
of
IBOR
-
linked
non
-
derivative
financial
assets
and
liabilities
related
to
brokerage
accounts,
except
for
balances
originated in the US, which transitioned
to SOFR in January 2022.
In
March
2021,
following
the FCA
announcement
regarding
the
cessation
timelines
for
IBORs,
UBS
initiated
a
centralized
communication
initiative
for
private
mortgages
linked
to
CHF
LIBOR, with the objective
of transitioning these exposures,
either
through the activation of existing fallbacks
or the amendment of
contractual terms where such
fallbacks do not exist.
During 2021,
mortgages
that
were
linked
to
CHF
LIBOR
were
reduced
to
USD
21
billion
as
of 31 December
2021,
with these
remaining
mortgages automatically
transitioning to
SARON from
their next
coupon roll date.
The
transition
of
US
sec
urities
-
based
lending
to
SOFR
,
amounting
to
USD
37
billion
as of
31 December
2021,
was for
the
most
part
completed
in
January
2022,
with
US
mortgages
linked to USD LIBOR planned
to transition to SOFR
in 2022–2023.
As of
31 December 2021, UBS
had approximately
USD
3
billion
equivalent of
Japanese yen-
and US
dollar-denominated publicly
issued
benchmark
bonds
that, per
current
contractual
terms,
if
not called on their
respective call dates,
would reset based
directly
on
JPY
LIBOR
and
USD
LIBOR.
These
bonds
have
robust
IBOR
fallback language and
the confirmation
of interest rate
calculation
mechanics will
be communicated
as market
standards formalize
and in
advance of
any rate
resets. In
addition, several
US dollar-
and
Swiss
franc-denominated
benchmark
bonds
publicly
issued
by UBS
reference rates
indirectly derived
from IBORs,
if they
are
not
called
on
their
respective
call
dates.
UBS
aims
to
transition
those bonds in advance of their reset dates, with
the transition of
Swiss franc-denominated benchmark
bonds completed in
January
2022. These debt instruments
have not been
included in the
table
on the following page, given their current fixed-rate coupon.
As of
31 December 2021, UBS
had approximately
USD
5
billion
of irrevocable commitments that may
be drawn down in different
currencies with IBOR-linked interest
rates and that
expire after the
relevant benchmark cessation
dates; approximately USD
3
billion
of
these
contracts
had
transitioned
for
all
IBORs,
except
USD
LIBOR
,
and
USD
2
billion
of
these
commitments
retained
a
non
-
USD
IBOR
interest
rate
as
of
31
December
2021
with
transition
dependent
upon
the
actions
of
other
parties.
To
the
extent non-USD IBOR-linked
amounts are requested
under these
contracts,
UBS will
seek to
renegotiate
current
terms or
rely on
legislative solutions.
Derivative instruments
UBS holds derivatives
for trading and
hedging purposes, including
those designated in hedge accounting relationships. A significant
number
of
interest
rate
and cross
-currency
swaps have
floating
legs that
reference various
benchmarks that
are subject
to IBOR
reform.
The majority of derivatives
are transacted with clearing
houses,
in
particular
LCH,
with
the
transition
of
these
non-USD
IBOR-
linked derivatives substantially completed
in December 2021.
UBS
had
also
completed
the
transition
of
all
non-USD
IBOR-linked
exchange
-
traded
derivatives
(ETDs)
through
participation
in
activities
organized
by
respective
exchanges
by
31
December
2021.
For
derivatives
not
transacted
with
clearing
houses
or
exchanges,
UBS
and
a
significant
proportion
of
UBS’s
counterparties have adhered to the ISDA IBOR Fallbacks Protocol,
which builds in
agreed fallbacks. The
majority of these
contracts
had
transitioned as
of 31 December
2021,
with a
small number
of
contracts
transitioned
in
January
2022,
to
ensure
an
orderly
transition
when
converting
high
volumes
of
transactions
at
the
time of cessation.
Consolidated financial statements | UBS Group AG consolidated financial statements
372
Note 25
Interest rate benchmark reform (continued)
Financial instruments yet to transition to alternative benchmarks
The
amounts
included
in
the
table
below
relate
to
financial
instrument
contracts across
UBS’s business
divisions
where
UBS
has material
exposures subject
to IBOR
reform that
have not
yet
transitioned to ARRs, and that:
–
contractually
reference
an
interest
rate
benchmark
that
will
transition to an alternative benchmark; and
–
have
a
contractual
maturity
date
(including
open-ended
contracts) after the agreed cessation dates.
Contracts
where
penalty
terms
reference
IBORs,
or
where
exposure to
an IBOR
is not
the primary
purpose of
the contract,
have not been included,
as these contracts do
not have a material
impact on the transition process.
In line with information provided
to management and external
parties
monitoring
UBS’s
transition
progress,
the
table
below
includes the
following financial
metrics for
instruments external
to the Group that are subject to interest rate benchmark reform:
–
gross
carrying
value
/
exposure
for
non-derivative
financial
instruments;
and
–
total trade count for derivative financial instruments.
The
exposure
s
included
in
the
table
below
represent
the
maximum
IBOR
exposure,
without
regard
for
early
termination
rights,
with
the
actual
exposure
being
dependent
upon
client
preferences and investment decisions.
As of
31 December 2021, UBS
had
made significant progress
in transitioning LIBOR
exposures to ARRs.
The remaining non-USD
LIBOR-linked
exposures
included
in
the
table
below
primarily
relate to derivatives that successfully transitioned in January 2022
and
CHF
LIBOR
mortgages
that
will
automatically
transition
to
SARON on their first roll date in 2022.
31.12.21
LIBOR benchmark rates
Measure
CHF
USD
GBP
EUR
1
JPY
Carrying value of non-derivative financial instruments
Total non-derivative financial assets
USD million
21,616
2
65,234
3
45
4
1
0
Total non-derivative financial liabilities
USD million
27
4
1,985
4
3
4
5
0
Trade count of derivative financial instruments
Total derivative financial instruments
Trade count
829
6
40,500
7
183
6
3,744
6
184
6
Off-balance sheet exposures
Total irrevocable loan commitments
USD million
0
11,863
8
0
0
0
1 Relates primarily to EUR LIBOR positions.
2 Relates primarily to CHF LIBOR mortgages, which will automatically transition to SARON on their first roll date in 2022.
3 Includes USD LIBOR securities-based lending
and brokerage accounts, amounting to USD
37
billion, and USD
5
billion respectively, which for the most part transitioned to SOFR in January 2022, as well as USD
1
billion of loans related to revolving multi-currency
credit lines, where IBOR transition efforts are complete, except for USD LIBOR. The remainder primarily relates to US mortgages and corporate lending.
4 Relates to floating-rate notes that per their contractual terms
can reset to rates linked to
LIBOR, with transition dependent upon the actions of
respective issuers.
5 Relates to contracts that transitioned
in January 2022.
6 Includes predominantly bilateral derivatives,
which
transitioned in January 2022, and an insignificant amount of cleared derivatives, where the respective clearing houses’ organized transition happened in January 2022.
7 Includes approximately
5,000
cross-currency
derivatives, of which approximately
500
have both a non-USD LIBOR leg and a USD LIBOR
leg, where the non-USD leg transitioned in January 2022 before the
next fixing date. The remainder represents cross-currency
swaps with an ARR leg
and a USD IBOR leg.
8 Includes loan commitments that can
be drawn in different currencies
at the client‘s discretion, of
which approximately USD
3
billion have only USD LIBOR
exposure
remaining and approximately USD
2
billion retain a non-USD
LIBOR interest rate as
of 31 December 2021, with
transition dependent upon the
actions of other parties.
The remainder represents loan
commitments
that can be drawn in US dollars only and will transition in 2022–2023.
373
Note 26
Hedge accounting
Derivatives designated in hedge accounting relationships
The
Group
applies
hedge
accounting
to
interest
rate
risk
and
foreign exchange
risk, including
structural foreign
exchange risk
related to net investments in foreign operations.
›
Refer to “Market risk” in the “Risk management
and control”
section of this report for more information about
how risks arise
and how they are managed by the Group
Hedging instruments and hedged risk
Interest
rate
swaps
are
designated
in
fair
value
hedges
or
cash
flow
hedges
of
interest
rate
risk
arising
solely
from
changes
in
benchmark interest rates.
Fair value
changes arising from
such risk
are usually the largest component
of the overall change
in the fair
value of the hedged position in transaction currency.
Cross-currency
swaps are
designated
as
fair
value
hedges
of
foreign
exchange
risk.
Foreign
exchange
forwards
and
foreign
exchange
swaps
are
mainly
designated
as
hedges
of
structural
foreign
exchange
risk
related
to
net
investments
in
foreign
operations.
In
both
cases
the
hedged
risk
arises
solely
from
changes in spot foreign exchange rate.
The notional
of the
designated hedging
instruments matches
the notional
of the
hedged items,
except when
the interest
rate
swaps are
re-designated in
cash flow
hedges, in
which case
the
hedge
ratio
designated
is
determined
based
on
the
swap
sensitivity.
Hedged items and hedge designation
Fair value hedges of interest rate risk related to debt instruments
and loan assets
Fair value hedges of interest
rate risk related to debt
instruments
and loan assets involve
swapping fixed cash flows
associated with
the debt issued,
debt securities held
and, from 2021
onward, loan
assets
(principally
long-term
fixed-rate
mortgage
loans
in
Swiss
francs formerly designated within “Fair
value hedges of portfolio
interest
rate
risk
related
to
loans
designated
under
IAS 39”)
to
floating cash flows by
entering into interest rate swaps
that either
receive
fixed and
pay
floating cash
flows
or
that
pay
fixed
and
receive floating cash flows.
Designations
have
been
made
in
US
dollars,
euros,
Swiss
francs, Australian dollars, Japanese
yen and Singapore dollars.
For
new hedging
instruments and
hedged risk
designations entered
into in 2021 in these
currencies (with the exception of euro),
the
benchmark rate was the relevant alternative reference rate (ARR).
Following the
interbank offered
rate (IBOR)
transition for
swaps
with
LCH
(formerly
the
London
Clearing
House)
in
December
2021,
the
benchmark
hedge
rate
for
Swiss
franc
and
Japanese
yen designations was changed
from an IBOR rate
to the relevant
ARR with
the hedge
relationship continuing
in accordance
with
Interest
Rate
Benchmark
Reform
–
Phase
2
(Amendments
to
IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16)
.
Fair
value
hedges
of
portfolio
interest
rate
risk
related
to
loans
designated under IAS 39
Prior to December 2021, the Group
hedged an open portfolio of
long-term fixed-rate mortgage loans in
Swiss francs using interest
rate swaps that
paid a fixed
rate of interest
and received a
floating
rate
of
interest.
Both
the
hedged
portfolio
and
the
hedging
instruments were adjusted
on a monthly basis
to reflect changes
in
size
and
the
maturity
profile
of
the
hedged
portfolio.
Each
month the
hedge relationship
was discontinued
and a
new one
designated.
Changes in
the portfolio
were
driven by
new loans
being originated or loans being repaid.
Cash flow hedges of forecast transactions
The
Group
hedges forecas
t
cash flows
on
non-trading financial
assets
and
liabilities
that
bear
interest
at
variable
rates
or
are
expected
to
be
refinanced
or
reinvested
in
the
future,
due
to
movements
in
future
market
rates. The
amounts
and
timing of
future cash flows, representing
both principal and interest flows,
are projected on the basis of
contractual terms and other
relevant
factors,
including
estimates
of
prepayments
and
defaults.
The
aggregate
principal
balances
and
interest
cash
flows
across
all
portfolios over time form the
basis for identifying the non-trading
interest rate risk of the Group, which is hedged with interest rate
swaps,
the
maximum
maturity
of
which
is
10
years.
Cash
flow
forecasts
and risk
exposures
are
monitored
and adjusted
on an
ongoing basis, and
consequently additional hedging instruments
are traded and designated, or are terminated resulting
in a hedge
discontinuance.
Hedge
designations
have
been
made
in
the
following
currencies:
US
dollars,
euros,
Swiss
francs,
pounds
sterling
and
Hong
Kong
dollars.
The
cash
flow
hedges
in
US
dollars, Swiss
francs and
pounds sterling
were discontinued
and
replaced with new ARR designations in December 2021.
›
Refer to Note
1b
for more information
Fair value hedges of foreign exchange risk related to issued debt
instruments
Debt
instruments
denominated
in
currencies
other than
the US
dollar
are
designated
in
fair
value
hedges
of
spot
foreign
exchange
risk,
in
addition
to
and
separate
from
the
fair
value
hedges
of
interest
rate
risk.
Cross-currency
swaps
economically
convert debt denominated in currencies
other than the US dollar
to
US
dollars.
This
hedge
accounting
program
started
on
1 January
2020,
with
the
adoption
of
the
hedge
accounting
requirements of IFRS 9,
Financial Instruments,
by UBS.
›
Refer to Note
1b
for more information
Hedges of net investments in foreign operations
The Group applies
hedge accounting for
certain net investments
in
foreign
operations,
which
include
subsidiaries,
branches
and
associates. Upon
maturity of
hedging instruments,
typically two
months,
the
hedge
relationship
is
terminated
and
new
designations
are
made
to
reflect
any
changes
in
the
net
investments in foreign operations.
Consolidated financial statements | UBS Group AG consolidated financial statements
374
Note 26
Hedge accounting (continued)
Economic relationship between hedged item and hedging
instrument
For
hedges
designated
under
IFRS
9,
the economic
relationship
between
the
hedged
item
and
the
hedging
instrument
is
determined based on
a qualitative analysis
of their critical
terms.
In cases where hedge designation takes place after origination of
the
hedging
instrument,
a
quantitative
analysis
of
the
possible
behavior of
the hedging
derivative and
the hedged
item during
their respective terms is also performed.
Prior to
December 2021, for
the fair
value hedge of
portfolio
interest rate risk related to loans designated under IAS 39, hedge
effectiveness was assessed by
comparing changes in the
fair value
of
the hedged
portfolio of
loans
attributable
to
changes
in
the
designated benchmark
interest rate
with the
changes in
the fair
value of the interest rate swaps.
Sources of hedge ineffectiveness
In
hedges
of
interest
rate
risk,
hedge
ineffectiveness
can
arise
from
mismatches
of
critical
terms
and
/
or
the
use
of
different
curves
to
discount
the
hedged
item
and
instrument,
or
from
entering
into
a
hedge
relationship
after
the
trade
date
of
the
hedging derivative
.
In
hedges
of
foreign
exchange
risk
related
to
debt
issued,
hedge
ineffectiveness
can
arise
due
to
the
discounting
of
the
hedging instruments and undesignated risk components and
lack
of such discounting and risk components in the hedged items.
In
hedges
of
net
investments
in
foreign
operations,
ineffectiveness is unlikely unless the hedged
net assets fall below
the designated hedged
amount. The
exceptions are
hedges where
the
hedging
currency
is
not
the
same
as
the
currency
of
the
foreign
operation,
where
the
currency
basis
may
cause
ineffectiveness.
Hedge ineffectiveness from
financial instruments measured
at
fair value through profit
or loss is
recognized in
Other net income.
Derivatives not designated in hedge accounting relationships
Non-hedge accounted derivatives
are mandatorily held
for trading
with
all
fair
value
movements
taken
to
Other
net
income
from
financial instruments measured
at fair value
through profit or
loss
,
even
when
held
as
an
economic
hedge
or
to
facilitate
client
clearing. The
one exception
relates to
forward points
on certain
short-
and
long-duration
foreign
exchange
contracts
acting
as
economic hedges, which are reported in
Net interest income.
All hedges: designated hedging instruments
and hedge ineffectiveness
As of or for the year ended
31.12.21
Carrying amount
USD million
Notional
amount
Derivative
financial
assets
Derivative
financial
liabilities
Changes in
fair value of
hedging
instruments
1
Changes in
fair value of
hedged
items
1
Hedge
ineffectiveness
recognized in the
income statement
Interest rate risk
Fair value hedges
89,525
0
7
(
1,604
)
1,602
(
2
)
Cash flow hedges
79,573
12
1
(
1,185
)
990
(
196
)
Foreign exchange risk
Fair value hedges
2
27,875
87
261
(
2,139
)
2,181
42
Hedges of net investments in foreign operations
13,939
23
105
497
(
497
)
0
As of or for the year ended
31.12.20
Carrying amount
USD million
Notional
amount
Derivative
financial
assets
Derivative
financial
liabilities
Changes in
fair value of
hedging
instruments
1
Changes in
fair value of
hedged
items
1
Hedge
ineffectiveness
recognized in the
income statement
Interest rate risk
Fair value hedges
80,759
12
1,231
(
1,247
)
(
16
)
Cash flow hedges
72,732
18
2,213
(
2,012
)
201
Foreign exchange risk
Fair value hedges
2
21,555
449
7
(
1,735
)
1,715
(
20
)
Hedges of net investments in foreign operations
13,775
3
194
(
937
)
936
(
2
)
1 Amounts used
as the basis
for recognizing hedge
ineffectiveness for the
period.
2 The foreign
currency basis spread
of cross-currency
swaps designated as
hedging derivatives is
excluded from the
hedge
accounting designation and accounted for as a cost of hedging with amounts deferred in Other comprehensive income within Equity.
375
Note 26
Hedge accounting (continued)
Fair value hedges: designated hedged items
USD million
31.12.21
31.12.20
Interest rate
risk
FX risk
Interest rate
risk
FX risk
Debt issued measured at amortized cost
Carrying amount of designated debt issued
74,700
27,875
70,429
21,555
of which: accumulated amount of fair value hedge adjustment
478
2,401
Other financial assets measured at amortized cost – debt securities
Carrying amount of designated debt securities
2,677
3,242
of which: accumulated amount of fair value hedge adjustment
(
7
)
(
38
)
Loans and advances to customers
1
Carrying amount of designated loans
13,835
10,374
of which: accumulated amount of fair value hedge adjustment
2
(
109
)
100
of which: accumulated amount of fair value hedge adjustment subject
to amortization attributable to the portion of the
portfolio that ceased to be part of hedge accounting
2
3
111
1 Prior to 31 December 2021, these amounts were designated in fair value hedges of portfolio interest rate risk under IAS 39.
2 As of 31 December 2021, the amount was presented within Loans and advances to
customers, whereas prior to 1 January 2021 amounts were presented within either Other financial assets
measured at amortized cost or Other financial liabilities measured at amortized cost.
Fair value hedges: profile of the timing of the
nominal amount of the hedging instrument
31.12.21
USD billion
Due within
1 month
Due between
1 and 3 months
Due between
3 and 12 months
Due between
1 and 5 years
Due after
5 years
Total
Interest rate swaps
0
8
10
49
22
90
Cross-currency swaps
1
1
6
13
6
28
31.12.20
USD billion
Due within
1 month
Due between
1 and 3 months
Due between
3 and 12 months
Due between
1 and 5 years
Due after
5 years
Total
Interest rate swaps
1
0
4
9
46
12
70
Cross-currency swaps
0
0
4
16
2
22
1 In accordance with IFRS 7 requirements, the fair value hedges of portfolio interest rate risk
related to loans and advances to customers designated under IAS 39 are not included.
Cash flow hedge reserve on a pre-tax basis
USD million
31.12.21
31.12.20
Amounts related to hedge relationships for which hedge
accounting continues to be applied
26
2,560
Amounts related to hedge relationships for which hedge
accounting is no longer applied
743
296
Total other comprehensive income recognized directly in equity related to cash flow hedges, on a pre-tax basis
769
2,856
Foreign currency translation reserve on a pre-tax basis
USD million
31.12.21
31.12.20
Amounts related to hedge relationships for which hedge
accounting continues to be applied
(
45
)
(
559
)
Amounts related to hedge relationships for which hedge
accounting is no longer applied
262
268
Total other comprehensive income recognized directly in equity related to hedging instruments
designated as net investment hedges, on a pre-tax
basis
217
(
291
)
Consolidated financial statements | UBS Group AG consolidated financial statements
376
Note 26
Hedge accounting (continued)
Interest rate benchmark reform
The Group continues to apply the relief provided
by
Interest Rate
Benchmark
Reform
(amendments
to
IFRS 9,
IAS 39 and
IFRS 7),
published by the IASB in September 2019.
The
interest
rate
benchmarks
subject
to
interest
rate
benchmark
reforms
to
which
the
Group’s
hedge
relationships
were
exposed
were
USD
LIBOR,
CHF
LIBOR,
GBP
LIBOR,
AUD
LIBOR, JPY
LIBOR, HKD
LIBOR, SGD
LIBOR and
EONIA. Interest rate
swaps
designated
in
hedge
relationships
referencing
GBP,
CHF
and JPY LIBOR transitioned to ARRs
in December 2021 when LCH
transitioned
its
contracts.
For
other
currencies,
IBOR
quotations
remain available, but all
new designations will reference
ARR. As
such,
ARR
designations
in
these
currencies
will
replace
IBOR
designations as IBOR contracts mature.
The Group’s hedge
relationships are also
exposed to the Euro
Inter-bank Offered Rate (EURIBOR), which
is expected to continue
to exist as a benchmark rate for the foreseeable future. Thus, the
Group
does
not
consider
its
hedges
involving
the
EURIBOR
benchmark
interest
rate
to
be
directly
affected
by
interest
rate
benchmark reform.
Apart from
EURIBOR hedges,
UBS applied
the relief
to all
its
fair value
hedges of
interest rate
risk and to
those cash
flow hedge
relationships
where
the
hedged
risk
is
LIBOR
or
EONIA.
The
following
table
provides
details
on
the
notional
amount
and
carrying
amount
of
the
hedging
instruments
in
those
hedge
relationships maturing after 31 December 2021, or 30 June 2023
for
USD
LIBOR
hedges,
which
are
the
cessation
dates
of
the
applicable interest rate benchmarks.
Hedges
of
net
investments
in
foreign
operations
are
not
affected by the amendments.
›
Refer to Note
1a item 2j
for more information about the relief
provided by the amendments to IFRS 9, IAS
39 and IFRS 7 related
to interest rate benchmark reform
›
Refer to Note 25 Interest rate benchmark reform
for more
information about the transition progress
Hedging instruments referencing LIBOR
31.12.21
31.12.20
Carrying amount
Carrying amount
USD million
Notional
amount
Derivative
financial
assets
Derivative
financial
liabilities
Notional
amount
Derivative
financial
assets
Derivative
financial
liabilities
Interest rate risk
Fair value hedges
23,367
0
0
37,146
1
(
12
)
Cash flow hedges
10,803
0
0
11,179
0
0
377
Note 27
Post-employment benefit plans
a) Defined benefit plans
UBS
has
established
defined
benefit
plans
for
its
employees
in
various
jurisdiction
s
in
accordance
with
local
regulations
and
practices.
The major plans are located in Switzerland, the UK, the
US
and Germany.
The
level of
benefits
depends on
the specific
plan rules.
Swiss pension plan
The
Swiss
pension
plan
covers
employees
of
UBS
AG
in
Switzerland
and employees
of companies
in Switzerland
having
close
economic
or
financial
ties with
UBS
AG, and
exceeds
the
minimum
benefit
requirements
under
Swiss
pension
law.
The
Swiss plan offers retirement, disability and survivor benefits
and is
governed by a
Pension Foundation
Board. The
responsibilities of
this board are defined by Swiss pension law and the plan rules.
Savings
contributions
to
the
Swiss
plan
are
paid
by
both
employer and employee. Depending on the age of the
employee,
UBS pays
a savings
contribution that
ranges between
6.5
% and
27.5
% of contributory base salary
and between
2.8
% and
9
% of
contributory
variable
compensation.
UBS
also
pays
risk
contributions that
are used
to fund
disability and
survivor benefits.
Employees can
choose the
level of savings
contributions paid
by
them, which vary between
2.5
% and
13.5
% of contributory base
salary
and
between
0
%
and
9
%
of
contributory
variable
compensation,
depending
on
age
and
choice
of
savings
contribution category.
The plan offers to
members at the
normal retirement age
of
65
a choice between
a lifetime pension
and a partial
or full lump
sum
payment.
Participants
can
choose
to
draw
early
retirement
benefits
starting
from
the
age
of
58
,
but
can
also
continue
employment and remain active members
of the plan until the
age
of
70
.
Employees
have
the
opportunity
to
make
additional
purchases of benefits to fund early retirement benefits.
The pension
amount payable
to a
participant is
calculated by
applying
a
conversion
rate
to
the
accumulated
balance
of
the
participant’s
retirement
savings
account
at
the
retirement
date.
The balance is based on credited vested benefits transferred from
previous employers, purchases of benefits, and the
employee and
employer contributions that have
been made to the
participant’s
retirement
savings account,
as well
as the
interest accrued.
The
annual interest rate
credited to participants
is determined by
the
Pension Foundation Board at the end of each year.
Although
the
Swiss
plan
is
based
on
a
defined
contribution
promise under Swiss pension law, it is accounted for as a defined
benefit
plan
under
IFRS,
primarily
because
of
the
obligation
to
accrue
interest
on
the
participants’
retirement
savings
accounts
and the payment of lifetime pension benefits.
An actuarial valuation in accordance with Swiss pension law is
performed
regularly.
Should
an
underfunded
situation
on
this
basis occur, the Pension Foundation Board is required to
take the
necessary measures
to ensure
that full
funding can
be expected
to be
restored within
a maximum
period of
10
years. If
a Swiss
plan
were
to
become
significantly
underfunded
on
a
Swiss
pension
law
basis,
additional
employer
and
employee
contributions could be required.
In this situation, the
risk is shared
between employer and
employees, and the
employer is
not legally
obliged to
cover more than
50
% of
the additional
contributions
required. As of
31 December 2021, the
Swiss plan had
a technical
funding
ratio in
accordance with
Swiss pension
law of
134.8
%
(31 December 2020:
132.6
%).
The investment strategy of the Swiss plan complies with Swiss
pension
law,
including
the
rules
and
regulations
relating
to
diversification of plan assets,
and is derived
from the risk budget
defined by the Pension
Foundation Board on
the basis of
regularly
performed asset and
liability management analyses.
The Pension
Foundation
Board strives
for
a medium
-
and long
-term balance
between assets and liabilities.
As
of
31 December
2021,
the
Swiss
plan
was
in
a
surplus
situation on
an IFRS
measurement basis,
as the
fair value
of the
plan’s
assets
exceeded
the
defined
benefit
obligation
(DBO)
by
USD
6,577
million
(31 December 2020:
a
surplus
of
USD
4,862
million).
However,
a
surplus
is
only
recognized
on
the
balance
sheet to
the extent that
it does not
exceed the
estimated future
economic
benefit,
which
equals
the
difference
between
the
present
value
of
the
estimated
future
net
service
cost
and
the
present value of the estimated
future employer contributions. As
of
both
31 December
2021
and
31 December
2020,
the
estimated
future
economic
benefit
was
zero
and
hence
no
net
defined benefit asset was recognized on the balance sheet.
Changes to the Swiss pension plan in 2019
The
Pension
Foundation
Board
and
UBS
agreed
to
implement
measures that
took effect
from the
start of 2019
to support the
long-term
financial
stability
of
the
Swiss
pension
fund.
The
measures, among
other things, lowered
the conversion rate
and
increased
the
normal
retirement
age
from
64
to
65.
Pensions
already in payment on 1 January 2019 were not affected.
To mitigate the
effects for active
participants, UBS committed
to
pay
an
extraordinary
contribution
of
up
to
CHF
720
million
(USD
790
million at
the
closing exchange
rate
on 31 December
2021)
in
three
installments
in
2020,
2021
and
2022.
Two
installments of USD
235
million and USD
254
million paid in
2020
and 2021 reduced OCI with no effect on the income statement.
The third installment, CHF
193
million (USD
212
million at the
closing exchange rate on 31 December 2021), will
be paid in the
first
quarter
of
2022.
The
regular
employer
contributions
to
be
made to the Swiss plan
in 2022 are estimated at
USD
491
million.
Consolidated financial statements | UBS Group AG consolidated financial statements
378
Note 27
Post-employment benefit plans (continued)
UK pension plan
The UK
plan is
a career
-average revalued
earnings scheme,
and
benefits increase
automatically based
on UK
price inflation.
The
normal retirement
age for
participants in
the UK plan
is
60
. The
plan provides guaranteed lifetime
pension benefits to participants
upon retirement.
The UK
plan has
been closed
to new
entrants
for more than
20 years
and, since 2013,
participants are no
longer
accruing benefits for current or
future service. Instead, employees
participate in the UK defined contribution plan.
The governance
responsibility for the
UK plan lies
jointly with
the Pension
Trustee Board
and UBS.
The employer
contributions
to
the
pension
fund
reflect
agreed-upon
deficit
funding
contributions,
which
are
determined
on
the
basis
of
the
most
recent
actuarial
valuation
using
assumptions
agreed
by
the
Pension Trustee
Board and
UBS. In
the event
of underfunding,
UBS
and the
Pension Trustee
Board must
agree on
a deficit
recovery
plan
within
statutory
deadlines.
In
2021,
UBS
made
no
deficit
funding contributions to the
UK plan. In 2020,
UBS made deficit
funding contributions of USD
46
million.
The
plan
assets
are
invested
in
a
diversified
portfolio
of
financial assets, which
include a longevity
swap with an external
insurance
company.
This
swap
enables
the
UK
pension
plan
to
hedge
the
risk
between
expected
and
actual
longevity,
which
should mitigate volatility in the net defined
benefit asset / liability.
As of 31
December 2021, the
longevity swap had
a negative value
of USD
3
million (31 December 2020: zero).
In 2019,
UBS and
the Pension
Trustee Board
entered into
an
arrangement whereby a collateral
pool was established
to provide
security for the
pension fund. The
value of the
collateral pool as
of 31 December 2021 was USD
337
million (31 December 2020:
USD
347
million)
and
includes
corporate
bonds,
government-
related
debt
instruments
and
other
financial
assets
.
The
arrangement provides the
Pension Trustee Board
dedicated access
to a pool of assets in the event of UBS’s insolvency
or not paying
a required deficit funding contribution.
The
employer
contributions
to
be
made
to
the
UK
defined
benefit
plan
in 2022
are
estimated at
USD
5
million, subject
to
regular funding reviews during the year.
US pension plans
There are two distinct major defined benefit plans in the US,
with
a
normal retirement
age
of
65
. Both
plans
were
closed to
new
entrants
more
than
20
years
ago.
Since
they
closed,
new
employees have participated in a defined contribution plan.
One of the
defined benefit plans
is a contribution-based
plan
in
which
each
participant
accrues
a
percentage
of
salary
in
a
retirement
savings
account.
The
retirement
savings
account
is
credited annually
with interest
based
on a
rate that
is linked
to
the
average
yield
on
one-year
US
government
bonds.
For
the
other defined
benefit plan,
retirement benefits
accrue based
on
the
career-average earnings
of
each
individual
plan
participant.
Former employees with vested benefits have the option to take a
lump sum payment or a lifetime annuity.
As
required
under
applicable
pension
laws,
both
plans
have
fiduciaries
who,
together
with
UBS,
are
responsible
for
the
governance of the plans.
The
plan
assets
of
both
plans
are
invested
in
diversified
portfolio
s
of
financial
assets.
Ea
ch
plan’s
fiduciaries
are
responsible for the
investment decisions with respect
to the plan
assets.
The
employer
contributions
to
be
made
to
the
US
defined
benefit plans in 2022 are estimated at USD
10
million.
German pension plans
There are two
defined benefit plans in
Germany,
which are both
unfunded. The normal retirement age is
65
and benefits are paid
directly
by
UBS. In
the
larger
of
the
two plans
each
participant
accrues
a
percentage
of
salary in
a
retirement
savings
account.
The accumulated account
balance of the
participant is credited
on
an annual basis
with guaranteed
interest at a
rate of
5
%. The
plan
has been closed
to new entrants
and all participants
younger than
the
age
of
55
no
longer
accrue
benefits.
In
the
other
plan,
amounts
are
accrued
annually
based
on
employee
elections
related to variable
compensation. For this plan,
the accumulated
account balance is credited on an annual basis
with a guaranteed
interest rate of
6
% for amounts accrued before 2010, of
4
% for
amounts accrued
from 2010
to 2017
and of
0.9
% for
amounts
accrued
after
2017.
Both
plans
are
subject
to
German
pension
law, whereby the responsibility to
pay pension benefits
when they
are
due
resides
entirely
with
UBS.
A
portion
of
the
pension
payments is directly increased in line with price inflation.
In June
2021, UBS
implemented a
new funded
pension plan
with interest
credited to
participants equal
to actual
investment
returns
with
a
guaranteed
minimum
of
0
%.
The
plan
was
implemented
retrospectively for
new
hires
since
June 2018
and
for all eligible active participants
younger than 55 from July
2021.
Each
participant
accrues
a
percentage
of
salary
in
a
retirement
savings account.
The employer contributions
to be made
to the German
defined
benefit plans in 2022 are estimated at USD
12
million.
Financial information by plan
The
tables
on
the
following
pages
provide
an
analysis
of
the
movement
in the
net asset
/ liability
recognized
on the
balance
sheet for defined benefit plans, as well as an analysis of amounts
recognized in net profit and in
Other comprehensive incom
e.
379
Note 27
Post-employment benefit plans (continued)
Defined benefit plans
USD million
Swiss pension plan
UK pension plan
US and German
pension plans
Total
2021
2020
2021
2020
2021
2020
2021
2020
Defined benefit obligation at the beginning of the year
27,728
24,496
4,162
3,654
1,905
1,820
33,795
29,970
Current service cost
494
447
0
0
6
6
500
453
Interest expense
58
72
58
73
30
45
147
190
Plan participant contributions
266
259
0
0
0
0
266
259
Remeasurements
837
1,279
71
449
(
62
)
105
846
1,832
of which: actuarial (gains) / losses due to changes in demographic
assumptions
51
(
164
)
14
(
14
)
4
(
34
)
69
(
212
)
of which: actuarial (gains) / losses due to changes in financial
assumptions
(
678
)
983
(
3
)
505
(
78
)
134
(
759
)
1,621
of which: experience (gains) / losses
1
1,464
460
59
(
42
)
12
5
1,535
423
Past service cost related to plan amendments
0
0
0
3
4
0
4
3
Curtailments
(
80
)
0
0
0
0
0
(
80
)
0
Benefit payments
(
1,097
)
(
1,153
)
(
148
)
(
148
)
(
112
)
(
108
)
(
1,357
)
(
1,409
)
Other movements
0
(
4
)
0
0
1
0
1
(
4
)
Foreign currency translation
(
809
)
2,333
(
38
)
132
(
33
)
37
(
880
)
2,501
Defined benefit obligation at the end of the year
27,398
27,728
4,105
4,162
1,740
1,905
33,242
33,795
of which: amounts owed to active members
14,333
13,765
150
159
222
245
14,705
14,169
of which: amounts owed to deferred members
0
0
1,593
1,879
669
743
2,262
2,622
of which: amounts owed to retirees
13,065
13,963
2,362
2,124
849
917
16,276
17,004
of which: funded plans
27,398
27,728
4,105
4,162
1,222
1,319
32,724
33,209
of which: unfunded plans
0
0
0
0
518
586
518
586
Fair value of plan assets at the beginning of the year
32,590
28,219
4,149
3,658
1,360
1,299
38,100
33,176
Return on plan assets excluding interest income
2,322
1,818
277
388
40
118
2,639
2,324
Interest income
74
84
58
73
26
38
159
196
Employer contributions
763
729
0
46
16
17
779
792
Plan participant contributions
266
259
0
0
0
0
266
259
Benefit payments
(
1,097
)
(
1,153
)
(
148
)
(
148
)
(
112
)
(
108
)
(
1,357
)
(
1,409
)
Administration expenses, taxes and premiums paid
(
13
)
(
13
)
0
0
(
4
)
(
4
)
(
17
)
(
17
)
Other movements
0
0
0
0
1
0
1
0
Foreign currency translation
(
930
)
2,647
(
39
)
132
0
0
(
969
)
2,779
Fair value of plan assets at the end of the year
33,975
32,590
4,297
4,149
1,329
1,360
39,601
38,100
Surplus / (deficit)
6,577
4,862
192
(
13
)
(
411
)
(
545
)
6,358
4,304
Asset ceiling effect at the beginning of the year
4,862
3,724
0
0
0
0
4,862
3,724
Interest expense on asset ceiling effect
15
12
0
0
0
0
15
12
Asset ceiling effect excluding interest expense and foreign currency
translation on
asset ceiling effect
1,821
814
0
0
0
0
1,821
814
Foreign currency translation
(
121
)
313
0
0
0
0
(
121
)
313
Asset ceiling effect at the end of the year
6,577
4,862
0
0
0
0
6,577
4,862
Net defined benefit asset / (liability) of major plans
0
0
192
(
13
)
(
411
)
(
545
)
(
219
)
(
558
)
Net defined benefit asset / (liability) of remaining plans
(
112
)
(
123
)
Total net defined benefit asset / (liability)
(
331
)
(
680
)
of which: Net defined benefit asset
302
42
of which: Net defined benefit liability
2
(
633
)
(
722
)
1 Experience (gains) /
losses are a component
of actuarial remeasurements of
the defined benefit obligation
and reflect the effects
of differences between
the previous actuarial assumptions
and what has actually
occurred.
2 Refer to Note 19c.
Consolidated financial statements | UBS Group AG consolidated financial statements
380
Note 27
Post-employment benefit plans (continued)
Income statement – expenses related to defined benefit plans
1
USD million
Swiss pension plan
UK pension plan
US and German
pension plans
Total
For the year ended
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
Current service cost
494
447
0
0
6
6
500
453
Interest expense related to defined benefit obligation
58
72
58
73
30
45
147
190
Interest income related to plan assets
(
74
)
(
84
)
(
58
)
(
73
)
(
26
)
(
38
)
(
159
)
(
196
)
Interest expense on asset ceiling effect
15
12
0
0
0
0
15
12
Administration expenses, taxes and premiums paid
13
13
0
0
4
4
17
17
Past service cost related to plan amendments
0
0
0
3
4
0
4
3
Curtailments
(
80
)
0
0
0
0
0
(
80
)
0
Net periodic expenses recognized in net profit for major plans
426
459
0
3
18
18
444
479
Net periodic expenses recognized in net profit for remaining plans
2
25
23
Total net periodic expenses recognized in net profit
470
502
1 Refer to Note 6.
2 Includes differences between actual and estimated performance award accruals.
Other comprehensive income – gains / (losses) on defined benefit plans
USD million
Swiss pension plan
UK pension plan
US and German
pension plans
Total
For the year ended
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
Remeasurement of defined benefit obligation
(
837
)
(
1,279
)
(
71
)
(
449
)
62
(
105
)
(
846
)
(
1,832
)
of which: change in discount rate assumption
870
(
777
)
319
(
504
)
77
(
141
)
1,267
(
1,421
)
of which: change in rate of salary increase assumption
(
3
)
(
230
)
0
0
0
0
(
3
)
(
230
)
of which: change in rate of pension increase assumption
0
0
(
316
)
(
1
)
(
1
)
1
(
318
)
0
of which: change in rate of interest credit on retirement savings
assumption
(
193
)
26
0
0
(
1
)
24
(
194
)
50
of which: change in life expectancy
0
261
9
22
(
3
)
50
5
333
of which: change in other actuarial assumptions
(
47
)
(
99
)
(
23
)
(
8
)
2
(
34
)
(
68
)
(
142
)
of which: experience gains / (losses)
1
(
1,464
)
(
460
)
(
59
)
42
(
12
)
(
5
)
(
1,535
)
(
423
)
Return on plan assets excluding interest income
2,322
1,818
277
388
40
118
2,639
2,324
Asset ceiling effect excluding interest expense and foreign currency
translation
(
1,821
)
(
814
)
0
0
0
0
(
1,821
)
(
814
)
Total gains / (losses) recognized in other comprehensive income for major plans
(
336
)
(
276
)
207
(
61
)
103
14
(
27
)
(
323
)
Total gains / (losses) recognized in other comprehensive income for remaining plans
30
(
4
)
Total gains / (losses) recognized in other comprehensive income
2
2
(
327
)
1 Experience (gains) /
losses are a component
of actuarial remeasurements of
the defined benefit obligation
and reflect the effects
of differences between
the previous actuarial assumptions
and what has actually
occurred.
2 Refer to the “Statement of comprehensive income.”
The table below provides information about the duration of the DBO and the timing for expected benefit payments.
Swiss pension plan
UK pension plan
US and German pension
plans
1
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
Duration of the defined benefit obligation (in years)
15.1
15.7
18.8
19.0
9.5
10.2
Maturity analysis of benefits expected to be paid
USD million
Benefits expected to be paid within 12 months
1,312
1,293
110
114
123
122
Benefits expected to be paid between 1 and 3 years
2,636
2,630
248
232
237
235
Benefits expected to be paid between 3 and 6 years
3,824
3,839
418
406
338
346
Benefits expected to be paid between 6 and 11 years
6,220
6,166
743
744
495
532
Benefits expected to be paid between 11 and 16 years
5,572
5,646
751
758
392
413
Benefits expected to be paid in more than 16 years
18,092
18,884
3,028
3,206
519
541
1 The duration of the defined benefit obligation represents a weighted average across US and
German plans.
381
Note 27
Post-employment benefit plans (continued)
Actuarial assumptions
The actuarial assumptions
used for the
defined benefit plans
are
based on the economic conditions prevailing in the jurisdiction in
which they are offered. Changes
in the defined benefit obligation
are most
sensitive to
changes in
the discount
rate. The
discount
rate is based on the yield of high-quality corporate bonds quoted
in
an
active
market
in
the
currency
of
the
respective
plan.
A
decrease in
the discount
curve increases
the DBO.
UBS regularly
reviews the actuarial assumptions used
in calculating the DBO to
determine their continuing relevance.
›
Refer to Note 1a item 5 for a description
of the accounting policy
for defined benefit plans
The tables below show the significant actuarial assumptions used in calculating the DBO at the end of the year
.
Significant actuarial assumptions
Swiss pension plan
UK pension plan
US and German pension
plans
1
In %
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
Discount rate
0.34
0.10
1.82
1.42
2.10
1.62
Rate of salary increase
2.01
2.00
0.00
0.00
2.35
2.25
Rate of pension increase
0.00
0.00
3.32
2.89
1.80
1.70
Rate of interest credit on retirement savings
1.04
0.60
0.00
0.00
1.18
1.12
1 Represents weighted average assumptions across US and German plans.
Mortality tables and life expectancies for
major plans
Life expectancy at age 65 for a male member currently
aged 65
aged 45
Country
Mortality table
31.12.21
31.12.20
31.12.21
31.12.20
Switzerland
BVG 2020 G with CMI 2019 projections
21.7
21.7
23.3
23.2
UK
S3PA with CMI 2020 projections
1
23.4
23.4
24.5
24.6
USA
Pri-2012 with MP-2021 projection scale
2
21.9
21.8
23.3
23.2
Germany
Dr. K. Heubeck 2018 G
20.5
20.8
23.2
23.6
Life expectancy at age 65 for a female member currently
aged 65
aged 45
Country
Mortality table
31.12.21
31.12.20
31.12.21
31.12.20
Switzerland
BVG 2020 G with CMI 2019 projections
23.4
23.4
25.0
24.9
UK
S3PA with CMI 2020 projections
1
24.9
24.9
26.3
26.3
USA
Pri-2012 with MP-2021 projection scale
2
23.3
23.2
24.7
24.5
Germany
Dr. K. Heubeck 2018 G
23.9
24.3
26.1
26.5
1 In 2020, S3PA with CMI 2019 projections was used.
2 In 2020, Pri-2012 with MP-2020 projection scale was used.
Consolidated financial statements | UBS Group AG consolidated financial statements
382
Note 27
Post-employment benefit plans (continued)
Sensitivity analysis of significant actuarial assumptions
The table below presents a sensitivity analysis for each significant
actuarial
assumption,
showing
how
the
DBO
would
have
been
affected
by
changes
in
the
relevant
actuarial
assumption
that
were reasonably
possible at
the balance
sheet date.
Unforeseen
circumstances may arise, which could
result in variations that are
outside
the
range
of
alternatives
deemed
reasonably
possible.
Caution should be used
in extrapolating the sensitivities
below on
the DBO, as the sensitivities may not be linear.
Sensitivity analysis of significant actuarial
assumptions
1
Increase / (decrease) in defined benefit obligation
Swiss pension plan
UK pension plan
US and German pension plans
USD million
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
Discount rate
Increase by 50 basis points
(
1,695
)
(
1,793
)
(
361
)
(
370
)
(
78
)
(
91
)
Decrease by 50 basis points
1,933
2,048
411
423
84
99
Rate of salary increase
Increase by 50 basis points
109
117
–
2
–
2
0
1
Decrease by 50 basis points
(
104
)
(
111
)
–
2
–
2
0
(
1
)
Rate of pension increase
Increase by 50 basis points
1,333
1,413
334
358
6
8
Decrease by 50 basis points
–
3
–
3
(
306
)
(
316
)
(
6
)
(
7
)
Rate of interest credit on retirement savings
Increase by 50 basis points
224
236
–
4
–
4
8
9
Decrease by 50 basis points
(
224
)
5
(
188
)
–
4
–
4
(
7
)
(
8
)
Life expectancy
Increase in longevity by one additional year
915
1,061
184
182
56
60
1 The sensitivity analyses are based on a change in one assumption while holding all other assumptions constant, so that interdependencies between the assumptions are excluded.
2 As the plan is closed for future
service, a change in assumption is not
applicable.
3 As the assumed rate of pension increase
was
0
% as of 31 December 2021 and as
of 31 December 2020, a downward change
in assumption is not applicable.
4 As the UK plan does not provide interest
credits on retirement savings, a change in
assumption is not applicable.
5 As of 31 December 2021,
19
% of retirement savings were subject to a legal minimum
rate of
1.00
%.
383
Note 27
Post-employment benefit plans (continued)
Fair value of plan assets
The tables
below
provide
information
about
the composition
and fair
value
of plan
assets
of the
Swiss,
UK, US
and German
pension
plans
.
Composition and fair value of plan assets
Swiss pension plan
31.12.21
31.12.20
Fair value
Plan asset
allocation %
Fair value
Plan asset
allocation %
USD million
Quoted
in an active
market
Other
Total
Quoted
in an active
market
Other
Total
Cash and cash equivalents
187
0
187
1
219
0
219
1
Real estate / property
Domestic
0
3,530
3,530
10
0
3,582
3,582
11
Foreign
0
580
580
2
0
331
331
1
Investment funds
Equity
Domestic
843
0
843
2
826
0
826
3
Foreign
6,213
2,652
8,865
26
6,284
1,958
8,242
25
Bonds
1
Domestic, AAA to BBB–
4,446
0
4,446
13
3,721
0
3,721
11
Foreign, AAA to BBB–
5,093
0
5,093
15
6,146
0
6,146
19
Foreign, below BBB–
1,314
0
1,314
4
1,303
0
1,303
4
Other
4,211
3,558
7,769
23
3,363
3,722
7,085
22
Other investments
668
682
1,349
4
663
473
1,136
3
Total fair value of plan assets
22,973
11,002
33,975
100
22,525
10,065
32,590
100
31.12.21
31.12.20
Total fair value of plan assets
33,975
32,590
of which:
2
Bank accounts at UBS
194
231
UBS debt instruments
28
34
UBS shares
25
24
Securities lent to UBS
3
1,079
1,416
Property occupied by UBS
93
96
Derivative financial instruments, counterparty UBS
3
128
149
1 The bond credit ratings
are primarily based on S&P’s
credit ratings. Ratings
AAA to BBB– and below
BBB– represent investment grade
and non-investment grade ratings,
respectively. In cases where
credit ratings
from other rating
agencies were used, these
were converted to
the equivalent rating
in S&P’s rating
classification.
2 Bank accounts at
UBS encompass accounts
in the name of
the Swiss pension
fund. The other
positions disclosed in the table encompass both direct investments in UBS instruments and indirect investments, i.e., those made through funds that the pension fund invests in.
3 Securities lent to UBS and derivative
financial instruments are
presented gross of
any collateral. Securities
lent to UBS
were fully covered
by collateral as
of 31 December
2021 and 31
December 2020. Net
of collateral, derivative
financial instruments
amounted to USD
43
million as of 31 December 2021 (31 December 2020: negative USD
17
million).
Consolidated financial statements | UBS Group AG consolidated financial statements
384
Note 27
Post-employment benefit plans (continued)
Composition and fair value of plan assets
(continued)
UK pension plan
31.12.21
31.12.20
Fair value
Plan asset
allocation %
Fair value
Plan asset
allocation %
USD million
Quoted
in an active
market
Other
Total
Quoted
in an active
market
Other
Total
Cash and cash equivalents
147
0
147
3
195
0
195
5
Bonds
1
Domestic, AAA to BBB–
2,605
0
2,605
61
2,150
0
2,150
52
Foreign, AAA to BBB–
372
0
372
9
53
0
53
1
Foreign, below BBB–
4
0
4
0
0
0
0
0
Investment funds
Equity
Domestic
44
4
47
1
34
3
37
1
Foreign
921
0
921
21
1,077
0
1,077
26
Bonds
1
Domestic, AAA to BBB–
532
147
679
16
919
131
1,050
25
Domestic, below BBB–
12
0
12
0
47
0
47
1
Foreign, AAA to BBB–
179
0
179
4
149
0
149
4
Foreign, below BBB–
115
0
115
3
110
0
110
3
Real estate
Domestic
110
12
122
3
98
16
114
3
Foreign
6
34
40
1
0
37
37
1
Other
(
313
)
0
(
313
)
(
7
)
(
86
)
0
(
86
)
(
2
)
Insurance contracts
0
8
8
0
0
8
8
0
Derivatives
57
(
3
)
54
1
(
3
)
0
(
3
)
0
Asset-backed securities
0
11
11
0
0
6
6
0
Other investments
2
(
717
)
10
(
707
)
(
16
)
(
803
)
9
(
794
)
(
19
)
Total fair value of plan assets
4,074
223
4,297
100
3,940
209
4,149
100
1 The bond credit ratings
are primarily based on S&P’s
credit ratings. Ratings
AAA to BBB– and below
BBB– represent investment grade
and non-investment grade ratings,
respectively. In cases where
credit ratings
from other rating agencies were used, these were converted to the equivalent rating in S&P’s
rating classification.
2 Mainly relates to repurchase arrangements on UK treasury bonds.
385
Note 27
Post-employment benefit plans (continued)
US and German pension plans
31.12.21
31.12.20
Fair value
Plan asset
allocation %
Fair value
Plan asset
allocation %
USD million
Quoted
in an active
market
Other
Total
Quoted
in an active
market
Other
Total
Cash and cash equivalents
11
0
11
1
38
0
38
3
Equity
Domestic
79
0
79
6
0
0
0
0
Foreign
31
0
31
2
0
0
0
0
Bonds
1
Domestic, AAA to BBB–
486
0
486
37
490
0
490
36
Domestic, below BBB–
17
0
17
1
7
0
7
0
Foreign, AAA to BBB–
97
0
97
7
99
0
99
7
Foreign, below BBB–
6
0
6
0
1
0
1
0
Investment funds
Equity
Domestic
3
0
3
0
210
0
210
15
Foreign
56
0
56
4
169
0
169
12
Bonds
1
Domestic, AAA to BBB–
269
0
269
20
195
0
195
14
Domestic, below BBB–
147
0
147
11
34
0
34
2
Foreign, AAA to BBB–
11
0
11
1
19
0
19
1
Foreign, below BBB–
2
0
2
0
3
0
3
0
Real estate
Domestic
0
9
9
1
0
14
14
1
Other
99
0
99
7
79
0
79
6
Insurance contracts
0
1
1
0
0
1
1
0
Other investments
5
0
5
0
0
0
0
0
Total fair value of plan assets
1,319
10
1,329
100
1,345
15
1,360
100
1 The bond credit ratings
are primarily based on S&P’s
credit ratings. Ratings
AAA to BBB– and below
BBB– represent investment grade
and non-investment grade ratings,
respectively. In cases where
credit ratings
from other rating agencies were used, these were converted to the equivalent rating in S&P’s
rating classification.
Consolidated financial statements | UBS Group AG consolidated financial statements
386
Note 27
Post-employment benefit plans (continued)
b) Defined contribution plans
UBS sponsors
a number
of defined
contribution plans,
with the
most significant
plans in
the US
and the
UK. UBS’s
obligation is
limited
to its
contributions made
in accordance
with each
plan,
which
may
include
direct
contributions
and
matching
contributions.
Employer
contributions
to
defined
contribution
plans are recognized as an expense.
Expenses related to defined contribution
plans
For the year ended
USD million
31.12.21
31.12.20
31.12.19
US plan
198
190
173
UK plan
101
88
82
Remaining plans
64
65
71
Total
1
363
343
326
1 Refer to Note 6.
c) Related-party disclosure
UBS is
the principal
provider of
banking services
for the
pension
fund of
UBS in
Switzerland. In
this capacity,
UBS is
engaged to
execute
most
of
the
pension
fund’s
banking
activities.
These
activities
can
include,
but
are
not
limited
to,
trading,
securities
lending and borrowing
and derivative transactions.
The non-Swiss
UBS pension funds
do not
have a similar
banking relationship with
UBS.
Also, UBS leases
certain properties that
are owned by
the Swiss
pension
fund
.
As
of
31
December
202
1
,
the
minimum
commitment
toward
the
Swiss
pension
fund
under
the
related
leases
was
approximately
USD
9
million
(31
December
20
20
:
USD
11
million).
›
Refer to the “Composition and fair value
of plan assets” table in
Note 27a for more information about fair value
of investments
in UBS instruments held by the Swiss
pension fund
The following
amounts have
been received
or paid
by UBS
from
and to the post-employment benefit
plans located in Switzerland,
the UK, the US
and Germany in
respect of these banking
activities
and arrangements.
Related-party disclosure
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Received by UBS
Fees
39
34
34
Paid by UBS
Rent
4
5
4
Dividends, capital repayments and interest
5
10
11
The transaction volumes in UBS shares and UBS debt instruments and the balances of UBS shares held were:
Transaction volumes – UBS shares and UBS debt instruments
For the year ended
31.12.21
31.12.20
Financial instruments bought by pension funds
UBS shares (in thousands of shares)
907
1,758
UBS debt instruments (par values, USD million)
37
28
Financial instruments sold by pension funds or matured
UBS shares (in thousands of shares)
1,688
2,605
UBS debt instruments (par values, USD million)
40
6
UBS shares held by post-employment benefit
plans
31.12.21
31.12.20
Number of shares (in thousands of shares)
14,073
14,854
Fair value (USD million)
252
210
387
Note 28
Employee benefits: variable compensation
a) Plans offered
The
Group
has
several
share-based
and
other
deferred
compensation
plans
that
align
the
interests
of
Group
Executive
Board (GEB) members
and other employees with
the interests of
investors.
Share-based awards are granted in the form of notional shares
and, where
permitted,
carry a dividend
equivalent
that may be
paid
in
notional
shares
or
cash.
Awards
are
settled
by
delivering
UBS
shares
at vesting,
except
in jurisdictions
where
this
is not
permitted
for legal
or tax
reasons.
Deferred compensation awards are
generally forfeitable upon,
among other circumstances,
voluntary termination
of employment
with UBS. These
compensation plans
are
also designed
to
meet
regulatory
requirements
and
include
special
provisions
for
regulated employees.
The most significant
deferred compensation
plans are described
below.
›
Refer to Note 1a
item 5 for a description of the accounting
policy
related to share-based and other deferred compensation
plans
Mandatory deferred compensation plans
The Long-Term Incentive Plan
The
Long-Term
Incentive
Plan
(LTIP)
is
a
mandatory
deferred
share-based
compensation plan
for senior
leaders of
the Group
(i.e., GEB members and selected senior management).
The number of notional
shares delivered at
vesting depends on
two
equally
weighted
performance
metrics
over
a
three
-
year
performance
period:
reported
return
on
common
equity
tier
1
capital and relative
total shareholder return,
which measures the
performance
of
UBS
against
an
index
of
Global
Systemically
Important Banks as determined by the Financial Stability Board.
The final number of shares will vest in three equal installments
in each
of the
three years
following the
performance period
for
GEB
members,
and
cliff
vest
in
the
first
year
following
the
performance period for selected senior management.
The Equity
Ownership
Plan
The
Equity
Ownership
Plan
(EOP)
is
a
deferred
share-based
compensation
plan
for
employees
who
are
subject
to
deferral
requirements but
do not
receive LTIP
awards. Vesting
under the
EOP
generally
occurs
in
equal
installments
two
and
three
years
after
grant,
subject
to
continued
employment
and,
in
certain
cases, achievement of defined performance conditions.
Asset Management employees receive some or all of
their EOP
in
the
form
of
cash-settled
notional
investment
funds.
The
amount
delivered
depends
on
the
value
of
the
underlying
investment funds at the time of vesting.
The Deferred
Contingent
Capital
Plan
The
Deferred
Contingent
Capital
Plan
(DCCP)
is
a
deferred
compensation plan for all
employees who are
subject to deferral
requirements.
Such employees
are awarded
notional
additional
tier
1 (AT1) capital
instruments,
which, at
the discretion
of UBS, can
be
settled as a cash
payment or a perpetual, marketable AT1
capital
instrument. DCCP
awards
generally
vest
in
full
after
five
years,
unless the
award is
written down
following the
occurrence of
a
viability
event (as
defined under
the terms
of an AT1 instrument)
or
if the
Group’s CET1 capital
ratio falls below
a defined
threshold.
Additional performance
conditions
apply
to GEB members.
Interest payments
on DCCP awards
are paid at the
discretion of
UBS.
Where interest
payments
are not
permitted,
such
as for
certain
regulated employees,
the DCCP
award reflects
the fair value
of the
granted non-interest-bearing
award.
Financial advisor variable compensation
In
line
with
market
practice
for
US
wealth
management
businesses, the compensation for US financial advisors in Global
Wealth Management
predominantly includes
production payout
and
deferred
compensation
awards.
Production
payout
is
primarily based
on compensable revenue.
Financial advisors may
also qualify
for deferred
compensation awards,
which generally
vest over
a six-year
period. These
awards are
based on
strategic
performance
measures,
including
production
and
length
of
service
with
UBS.
Production
payout
rates
and
deferred
compensation awards
may be
reduced for,
among other
things,
errors,
negligence or
carelessness, or
failure to
comply with
the
firm’s
rules,
standards,
practices
and
/
or
policies,
and
/
or
applicable laws and regulations.
Financial advisor
compensation also
includes expenses
related
to
compensation
commitments
with
financial
advisors
entered
into
at
the
time
of
recruitment
that
are
subject
to
vesting
requirements.
Share delivery obligations
Share
delivery
obligations
related
to
employee
share-based
compensation awards were
175
million shares as of
31 December
2021
(31 December
2020:
172
million
shares).
Share
delivery
obligations are
calculated on
the basis
of undistributed
notional
share
awards,
taking
applicable
performance
conditions
into
account.
As of 31 December 2021,
UBS held
149
million treasury shares
(31 December
2020:
157
million)
that
were
available
to
satisfy
share delivery obligations.
Consolidated financial statements | UBS Group AG consolidated financial statements
388
Note 28
Employee benefits: variable compensation (continued)
b) Effect on the income statement
Effect
on the
income
statement
for the
financial
year and
future
periods
The table
below
provides
information
about
compensation
expenses
related to
total variable compensation, including financial advisor
variable compensation,
that were
recognized in the
financial year
ended 31 December
2021, as well as expenses
that were deferred
and will be
recognized
in the income
statement
for 2022 and
later.
The majority
of expenses
deferred
to 2022
and later
that are
related
to the
2021
performance
year
pertain
to awards
granted
in February
2022.
The total
unamortized compensation
expense for unvested
share
-
based
awards
granted
up
to
31
December
2021
will
be
recognized
in future periods
over a weighted
average
period of
2.5
years.
Variable compensation including financial advisor variable
compensation
Expenses recognized in 2021
Expenses deferred to 2022 and later
1
USD million
Related to the
2021
performance
year
Related to prior
performance
years
Total
Related to the
2021
performance
year
Related to prior
performance
years
Total
Non-deferred cash
2,383
(
10
)
2,373
0
0
0
Deferred compensation awards
405
412
817
797
624
1,421
of which: Equity Ownership Plan
183
180
363
393
184
577
of which: Deferred Contingent Capital Plan
140
158
297
299
329
628
of which: Long-Term Incentive Plan
54
19
73
50
33
83
of which: Asset Management EOP
29
56
84
56
78
133
Variable compensation – performance awards
2,788
402
3,190
797
624
1,421
Variable compensation – other
2
191
38
229
215
182
397
Total variable compensation excluding financial advisor variable compensation
2,979
440
3,419
1,012
806
1,818
Financial advisor variable compensation
4,134
248
4,382
434
641
1,075
of which: non-deferred cash
3,858
(
6
)
3,853
0
0
0
of which: deferred share-based awards
106
51
157
123
146
269
of which: deferred cash-based awards
170
202
372
311
495
806
Compensation commitments with recruited financial advisors
3
41
438
479
662
1,682
2,344
Total FA variable compensation
4,175
685
4,860
1,097
2,323
3,419
Total variable compensation including FA variable compensation
7,155
1,125
8,280
4
2,109
3,129
5,238
1 Estimate as
of 31 December
2021. Actual
amounts to be
expensed in future
periods may vary,
e.g., due
to forfeiture of
awards.
2 Consists of
replacement payments,
forfeiture credits,
severance payments,
retention plan payments and interest
expense related to the Deferred Contingent
Capital Plan.
3 Reflects expenses related to
compensation commitments with financial advisors entered into
at the time of recruitment
that are subject to
vesting requirements. Amounts
reflected as deferred expenses
represent the maximum
deferred exposure as of
the balance sheet date.
Amounts in the “Related
to the 2021 performance
year”
columns represent commitments entered into
in 2021.
4 Includes USD
651
million in expenses related to share-based
compensation (performance awards: USD
435
million; other variable compensation:
USD
59
million; financial advisor
compensation: USD
157
million). A further
USD
85
million in expenses
related to share-based
compensation was recognized
within other expense
categories included in
Note 6 (salaries:
USD
5
million related to role-based allowances; social security: USD
64
million; other personnel expenses: USD
16
million related to the Equity Plus Plan). Total personnel expense related to share-based equity-settled
compensation excluding social security was USD
641
million.
389
Note 28
Employee benefits: variable compensation (continued)
Variable compensation including financial advisor variable
compensation (continued)
Expenses recognized in 2020
Expenses deferred to 2021 and later
1
USD million
Related to the
2020
performance
year
Related to prior
performance
years
Total
Related to the
2020
performance
year
Related to prior
performance
years
Total
Non-deferred cash
2,167
(
26
)
2,141
0
0
0
Deferred compensation awards
341
727
1,068
756
288
1,044
of which: Equity Ownership Plan
137
327
463
306
69
376
of which: Deferred Contingent Capital Plan
112
351
463
280
196
476
of which: Long-Term Incentive Plan
42
11
54
50
10
61
of which: Asset Management EOP
49
39
88
120
12
132
Variable compensation – performance awards
2,508
701
3,209
756
288
1,044
Variable compensation – other
2
126
94
220
181
192
374
Total variable compensation excluding financial advisor variable compensation
2,634
795
3,429
938
480
1,418
Financial advisor variable compensation
3,356
233
3,589
350
602
952
of which: non-deferred cash
3,154
0
3,154
0
0
0
of which: deferred share-based awards
69
50
119
79
135
214
of which: deferred cash-based awards
133
183
316
271
467
738
Compensation commitments with recruited financial advisors
3
22
480
502
473
1,682
2,155
Total FA variable compensation
3,378
713
4,091
822
2,284
3,106
Total variable compensation including FA variable compensation
6,012
1,508
7,520
4
1,760
2,764
4,524
1 Estimate as of 31
December 2020. Actual amounts to be
expensed in future periods may vary, e.g., due to forfeiture of
awards.
2 Consists of replacement payments, forfeiture credits, severance payments, retention
plan payments and interest expense related
to the Deferred Contingent Capital Plan.
3 Reflects expenses related to compensation
commitments with financial advisors
entered into at the time of
recruitment that
are subject to vesting requirements. Amounts reflected as deferred expenses represent the maximum deferred exposure as of the balance sheet date. Amounts in the “Related to the 2020 performance year” columns
represent commitments entered into
in 2020.
4 Includes USD
686
million in expenses related
to share-based compensation
(performance awards: USD
517
million; other variable compensation:
USD
50
million;
financial advisor compensation:
USD
119
million). A further
USD
100
million in expenses
related to share-based
compensation was recognized
within other expense
categories included in
Note 6 (salaries:
USD
4
million related to
role-based allowances;
social security:
USD
54
million; other
personnel expenses:
USD
42
million related
to the Equity
Plus Plan).
Total personnel
expense related
to share-based
equity-settled
compensation excluding social security was USD
691
million.
Variable compensation including financial advisor variable
compensation (continued)
Expenses recognized in 2019
Expenses deferred to 2020 and later
1
USD million
Related to the
2019
performance
year
Related to prior
performance
years
Total
Related to the
2019
performance
year
Related to prior
performance
years
Total
Non-deferred cash
1,894
(
26
)
1,868
0
0
0
Deferred compensation awards
299
588
887
429
608
1,036
of which: Equity Ownership Plan
122
300
422
205
219
424
of which: Deferred Contingent Capital Plan
113
262
375
173
365
538
of which: Long-Term Incentive Plan
39
0
39
25
0
25
of which: Asset Management EOP
25
26
51
26
23
49
Variable compensation – performance awards
2,193
562
2,755
429
608
1,036
Variable compensation – other
2
159
88
246
117
232
349
Total variable compensation excluding financial advisor variable compensation
2,352
650
3,001
545
840
1,385
Financial advisor variable compensation
3,233
268
3,501
197
710
907
of which: non-deferred cash
3,064
0
3,064
0
0
0
of which: deferred share-based awards
57
48
106
54
130
183
of which: deferred cash-based awards
112
219
331
144
580
724
Compensation commitments with recruited financial advisors
3
32
510
542
350
1,617
1,967
Total FA variable compensation
3,265
778
4,043
548
2,327
2,874
Total variable compensation including FA variable compensation
5,617
1,428
7,045
4
1,093
3,166
4,259
1 Estimate as of 31 December 2019. Actual amounts expensed may vary, e.g.,
due to forfeiture of awards.
2 Consists of replacement payments, forfeiture credits, severance payments,
retention plan payments and
interest expense related to the Deferred Contingent Capital Plan.
3 Reflects expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting
requirements. Amounts reflected as deferred expenses represent
the maximum deferred exposure as of
the balance sheet date. Amounts in the
“Related to the 2019 performance year”
columns represent commitments
entered into in
2019.
4 Includes USD
610
million in expenses related
to share-based compensation (performance
awards: USD
461
million; other variable compensation: USD
43
million; financial advisor compensation:
USD
106
million). A
further USD
61
million in
expenses related
to share-based
compensation was
recognized within
other expense
categories included
in Note
6 (salaries:
USD
10
million related
to role-based
allowances; social security:
USD
25
million; other personnel
expenses: USD
27
million related to
the Equity Plus
Plan). Total personnel
expense related to
share-based equity-settled compensation
excluding social
security was USD
619
million.
Consolidated financial statements | UBS Group AG consolidated financial statements
390
Note 28
Employee benefits: variable compensation (continued)
c) Outstanding share-based compensation awards
Share and performance share awards
Movements in outstanding share-based awards during 2021 and 2020 are provided in the table below.
Movements in outstanding share-based compensation
awards
Number of shares
2021
Weighted average
grant date fair value
(USD)
Number of shares
2020
Weighted average
grant date fair value
(USD)
Outstanding, at the beginning of the year
174,900,395
12
156,064,763
14
Awarded during the year
68,721,549
15
72,250,157
11
Distributed during the year
(
52,137,287
)
13
(
46,899,362
)
15
Forfeited during the year
(
10,906,096
)
13
(
6,515,164
)
13
Outstanding, at the end of the year
180,578,561
13
174,900,395
12
of which: shares vested for accounting purposes
107,828,979
118,260,527
The total carrying amount of the liability related to cash-settled share-based awards as of 31 December 2021 and 31 December 2020
was USD
37
million and USD
36
million, respectively.
d) Valuation
UBS share awards
UBS
measures
compensation
expense
based
on
the
average
market price
of UBS
shares on
the grant
date as
quoted on
the
SIX
Swiss
Exchange,
taking
into
consideration
post-vesting
sale
and
hedge
restrictions,
non-vesting
conditions
and
market
conditions, where
applicable. The
fair value
of the
share awards
subject to
post-vesting sale
and hedge
restrictions is
discounted
on the basis of
the duration of the
post-vesting restriction and is
referenced to
the cost
of purchasing
an at-the-money
European
put option for the term of the transfer restriction. The grant date
fair
value
of
notional
shares
without dividend
entitlements also
includes
a
deduction
for
the
present
value
of
future
expected
dividends to be paid between the grant date and distribution.
391
Note 29
Interests in subsidiaries and other entities
a) Interests in subsidiaries
UBS defines its
significant subsidiaries as
those entities that,
either
individually
or
in
aggregate,
contribute
significantly
to
the
Group’s
financial
position
or
results
of
operations,
based
on
a
number
of
criteria,
including
the
subsidiaries’
equity
and
contribution to the
Group’s total assets
and profit or
loss before
tax,
in
accordance
with
the
requirements
set
by
IFRS
12,
Swiss
regulations
and
the
rules
of
the
US
Securities
and
Exchange
Commission (the SEC).
Individually significant subsidiaries
The
two
tables
below
list
the
Group’s
individually
significant
subsidiaries as
of 31 December
2021. Unless
otherwise stated,
the
subsidiaries
listed
below
have
share
capital
consisting
solely
of
ordinary shares held entirely by the Group, and the proportion of
ownership interest
held is
equal to
the voting
rights held
by the
Group.
The country where the respective registered office is located is
also the
principal place
of business.
UBS AG
operates through
a
global branch network and
a significant proportion of
its business
activity is conducted outside Switzerland, including in
the UK, the
US, Singapore, Hong Kong SAR and other countries.
UBS Europe
SE has
branches and
offices in
a number
of EU
Member States,
including Germany, Italy,
Luxembourg and Spain.
Share capital is
provided in the currency of the legally registered office.
Individually significant subsidiaries
of UBS Group AG as of 31 December 2021
Company
Registered office
Share capital in million
Equity interest accumulated in %
UBS AG
Zurich and Basel, Switzerland
CHF
385.8
100.0
UBS Business Solutions AG
1
Zurich, Switzerland
CHF
1.0
100.0
1 UBS Business Solutions AG holds subsidiaries in China, India, Israel and Poland.
Individually significant subsidiaries
of UBS AG as of 31 December 2021
1
Company
Registered office
Primary business
Share capital in million
Equity interest accumulated in %
UBS Americas Holding LLC
Wilmington, Delaware, USA
Group Functions
USD
4,150.0
2
100.0
UBS Americas Inc.
Wilmington, Delaware, USA
Group Functions
USD
0.0
100.0
UBS Asset Management AG
Zurich, Switzerland
Asset Management
CHF
43.2
100.0
UBS Bank USA
Salt Lake City, Utah, USA
Global Wealth Management
USD
0.0
100.0
UBS Europe SE
Frankfurt, Germany
Global Wealth Management
EUR
446.0
100.0
UBS Financial Services Inc.
Wilmington, Delaware, USA
Global Wealth Management
USD
0.0
100.0
UBS Securities LLC
Wilmington, Delaware, USA
Investment Bank
USD
1,283.1
3
100.0
UBS Switzerland AG
Zurich, Switzerland
Personal & Corporate Banking
CHF
10.0
100.0
1 Includes direct and indirect subsidiaries of UBS AG.
2 Consists of common share capital of USD
1,000
and non-voting preferred share capital of USD
4,150,000,000
.
3 Consists of common share capital of USD
100,000
and non-voting preferred share capital of USD
1,283,000,000
.
Consolidated financial statements | UBS Group AG consolidated financial statements
392
Note 29
Interests in subsidiaries and other entities (continued)
Other subsidiaries
The table below lists other direct and indirect subsidiaries of UBS
AG that are not individually significant but contribute to
the Group’s
total assets and aggregated profit before tax thresholds and are thus disclosed in accordance with requirements
set by the SEC.
Other subsidiaries of UBS AG as of 31
December 2021
Company
Registered office
Primary business
Share capital in million
Equity interest
accumulated in %
UBS Asset Management (Americas) Inc.
Wilmington, Delaware, USA
Asset Management
USD
0.0
100.0
UBS Asset Management (Hong Kong) Limited
Hong Kong SAR, China
Asset Management
HKD
254.0
100.0
UBS Asset Management Life Ltd
London, United Kingdom
Asset Management
GBP
15.0
100.0
UBS Asset Management Switzerland AG
Zurich, Switzerland
Asset Management
CHF
0.5
100.0
UBS Business Solutions US LLC
Wilmington, Delaware, USA
Group Functions
USD
0.0
100.0
UBS Credit Corp.
Wilmington, Delaware, USA
Global Wealth Management
USD
0.0
100.0
UBS (France) S.A.
Paris, France
Global Wealth Management
EUR
133.0
100.0
UBS Fund Management (Luxembourg) S.A.
Luxembourg, Luxembourg
Asset Management
EUR
13.0
100.0
UBS Fund Management (Switzerland) AG
Basel, Switzerland
Asset Management
CHF
1.0
100.0
UBS (Monaco) S.A.
Monte Carlo, Monaco
Global Wealth Management
EUR
49.2
100.0
UBS O‘Connor LLC
Wilmington, Delaware, USA
Asset Management
USD
1.0
100.0
UBS Realty Investors LLC
Boston, Massachusetts, USA
Asset Management
USD
9.0
100.0
UBS Securities Australia Ltd
Sydney, Australia
Investment Bank
AUD
0.3
1
100.0
UBS Securities Hong Kong Limited
Hong Kong SAR, China
Investment Bank
HKD
4,154.2
100.0
UBS Securities Japan Co., Ltd.
Tokyo, Japan
Investment Bank
JPY
34,708.7
100.0
UBS SuMi TRUST Wealth Management Co., Ltd.
Tokyo, Japan
Global Wealth Management
JPY
5,165.0
51.0
1 Includes a nominal amount relating to redeemable preference shares.
Consolidated structured entities
Consolidated structured
entities (SEs)
include certain
investment
funds, securitization
vehicles and client
investment vehicles.
UBS
has no individually significant subsidiaries that are SEs.
In
2021
and
2020,
the
Group
did
not
enter
into
any
contractual
obligation
that
could
require
the
Group
to
provide
financial support
to consolidated SEs.
In addition,
the Group did
not provide support,
financial or otherwise,
to a consolidated
SE
when
the
Group
was
not
contractually
obligated
to
do
so,
nor
does
the
Grou
p
have
an
y
intention
to
do
so
in
the
future.
Furthermore,
the
Group
did
not
provide
support,
financial
or
otherwise, to a
previously unconsolidated SE
that resulted in
the
Group controlling the SE during the reporting period.
393
Note 29
Interests in subsidiaries and other entities (continued)
b) Interests in associates and joint ventures
As of 31 December 2021 and 2020, no associate or joint venture
was
individually
material
to
the
Group.
Also,
there
were
no
significant restrictions on the ability of
associates or joint ventures
to
transfer
funds
to
UBS
Group
AG
or
its
subsidiaries
as
cash
dividends
or
to
repay
loans
or
advances
made.
There
were
no
quoted market
prices for
any associates
or joint
ventures of
the
Group.
Investments in associates and joint ventures
USD million
2021
2020
Carrying amount at the beginning of the year
1,557
1,051
Additions
1
388
Reclassifications
1
(
386
)
0
Share of comprehensive income
150
83
of which: share of net profit
2
105
84
of which: share of other comprehensive income
3
45
(
1
)
Share of changes in retained earnings
1
(
40
)
Dividends received
(
39
)
(
33
)
Foreign currency translation
(
39
)
108
Carrying amount at the end of the year
1,243
1,557
of which: associates
1,200
1,513
of which: SIX Group AG, Zurich
4
1,043
965
of which: Clearstream Fund Centre AG, Zurich
1
399
of which: other associates
157
150
of which: joint ventures
43
44
1 In the second quarter
of 2021, UBS reclassified
its minority investment (
48.8
%) in Clearstream Fund
Centre AG (previously Fondcenter
AG) of USD
386
million to Properties and other
non-current assets held for
sale and sold the investment in the same quarter. Refer to Note 30 for more information.
2 For 2021, consists of USD
79
million from associates and USD
26
million from joint ventures. For 2020, consists of USD
64
million from associates
and USD
19
million from joint
ventures.
3 For 2021,
consists of USD
44
million from associates
and USD
1
million from joint
ventures. For
2020, consists of
negative USD
1
million from
associates.
4 In 2021, UBS AG’s equity interest amounted to
17.31
%. UBS AG is represented on the Board of Directors.
Consolidated financial statements | UBS Group AG consolidated financial statements
394
Note 29
Interests in subsidiaries and other entities (continued)
c) Unconsolidated structured entities
UBS
is
considered
to
sponsor
another
entity
if,
in
addition
to
ongoing
involvement
with
the
entity,
it
had
a
key
role
in
establishing
that
entity
or
in
bringing
together
relevant
counterparties
for a
transaction facilitated
by the
entity.
During
2021
,
the
Group
sponsored
the
creation
of
various
SEs
and
interacted
with
a
number
of
non-sponsored
SEs,
including
securitization
vehicles,
client
vehicles
and
certain
investment
funds,
that
UBS
did
not
consolidate
as
of
31 December
2021
because it did not control them.
Interests in unconsolidated structured entities
The table below
presents the
Group’s interests
in and maximum
exposure
to
loss
from
unconsolidated
SEs,
as
well
as
the
total
assets held
by the
SEs in
which UBS
had an
interest as
of year-
end,
except for
investment funds sponsored
by third
parties, for
which the
carrying amount
of UBS’s
interest as
of year-end
has
been disclosed.
Sponsored
unconsolidated
structured
entities
in
which
UBS
did
not have an interest at year-end
During 2021 and
2020, the Group did
not earn material
income
from sponsored unconsolidated SEs in
which UBS did not have
an
interest at year-end.
During 2021 and 2020,
UBS and third parties did
not transfer
any
assets
into
sponsored
securitization
vehicles
created
in
the
year. UBS and
third parties transferred
assets, alongside deposits
and debt issuances (which
are assets from the
perspective of the
vehicle),
of
USD
1
billion
and
USD
2
billion,
respectively,
into
sponsored client vehicles
created in
2021 (2020: USD
0
billion and
USD
9
billion,
respectively).
For
sponsored
investment
funds,
transfers
arose
during
the
period
as
investors
invested
and
redeemed
positions,
thereby
changing
the
overall
size
of
the
funds, which, when combined with
market movements, resulted
in a total
closing net asset value
of USD
46
billion (31 December
2020: USD
37
billion).
Interests in unconsolidated structured entities
31.12.21
USD million, except where indicated
Securitization
vehicles
Client
vehicles
Investment
funds
Total
Maximum
exposure to loss
1
Financial assets at fair value held for trading
246
162
6,743
7,151
7,151
Derivative financial instruments
5
45
155
205
205
Loans and advances to customers
125
125
125
Financial assets at fair value not held for trading
35
222
257
257
Financial assets measured at fair value through other comprehensive
income
324
4,525
4,849
4,849
Other financial assets measured at amortized cost
0
2
0
1
250
Total assets
610
3
4,732
7,247
12,588
Derivative financial instruments
2
11
281
294
Total liabilities
2
11
281
294
Assets held by the unconsolidated structured entities in which UBS had
an interest
(USD billion)
30
4
81
5
158
6
31.12.20
USD million, except where indicated
Securitization
vehicles
Client
vehicles
Investment
funds
Total
Maximum
exposure to loss
1
Financial assets at fair value held for trading
375
131
7,595
8,101
8,101
Derivative financial instruments
6
49
158
213
211
Loans and advances to customers
179
179
179
Financial assets at fair value not held for trading
35
1
2
172
208
208
Financial assets measured at fair value through other comprehensive
income
6,624
6,624
6,624
Other financial assets measured at amortized cost
0
2
0
250
Total assets
416
3
6,805
8,104
15,326
Derivative financial instruments
3
11
376
390
0
Total liabilities
3
11
376
390
Assets held by the unconsolidated structured entities in which UBS had
an interest
(USD billion)
39
4
136
5
124
6
1 For the purpose of this disclosure, maximum exposure to loss amounts do not consider the risk-reducing effects of collateral or other credit enhancements.
2 Represents the carrying amount of loan commitments.
The maximum exposure to loss for these instruments is equal
to the notional amount.
3 As of 31 December 2021, USD
0.1
billion of the USD
0.6
billion (31 December 2020: USD
0.2
billion of the USD
0.4
billion)
was held in Group Functions – Non-core and Legacy Portfolio.
4 Represents the principal
amount outstanding.
5 Represents the market value of total assets.
6 Represents the net asset value of the investment
funds sponsored by
UBS and the
carrying amount
of UBS’s
interests in the
investment funds not
sponsored by UBS.
In 2021,
UBS updated the
presentation of this
table to remove
its interests in
unconsolidated
structured investment funds and
the corresponding total asset
information, where UBS’s
interest is driven
solely from UBS’s
role as the
fund’s investment
manager and the fees
it receives. This
information is now
separately disclosed in the accompanying text on the following page. Prior-period
information has been aligned with this new presentation.
395
Note 29
Interests in subsidiaries and other entities (continued)
The Group retains or purchases interests in
unconsolidated SEs
in the form of
direct investments, financing, guarantees,
letters of
credit, derivatives,
as well as through management
contracts. The
Group’s
maximum
exposure
to
loss
is
generally
equal
to
the
carrying amount
of the
Group’s interest
in the
SE, with
this subject
to change over time with market movements. Guarantees,
letters
of
credit
and
credit
derivatives
are
an
exception,
with
the
contract’s notional
amount, adjusted
for losses already
incurred,
representing the maximum loss that the Group is exposed to.
The
maximum exposure
to loss
disclosed in
the table
on the
previous
page
does
not
reflect
the
Group’s
risk
management
activities, including effects from
financial instruments that may
be
used to economically
hedge risks inherent
in the unconsolidated
SE
or
risk
-
reducing
effects
of
collateral
or
other
credit
enhancements.
In 2021 and
2020, the
Group did
not provide support,
financial
or
otherwise,
to
an
unconsolidated
SE
when
not
contractually
obligated to do so, nor
does the Group have any
intention to do
so in the future.
In
2021
and
2020,
income
and
expenses
from
interests
in
unconsolidated
SEs
primarily
resulted
from
mark-to-market
movements
recognized
in
Other
net
income
from
financial
instruments
measured at fair
value through profit
of loss
, which
have generally been
hedged with other financial
instruments, as
well
as
fee
and
commission
income
received
from
UBS-
sponsored
funds.
Interests in securitization vehicles
As of 31 December
2021 and
31 December 2020, the
Group held
interests,
both
retained
and
acquired,
in
various
securitization
vehicles that relate
to financing, underwriting, secondary
market
and derivative trading activities.
The numbers
outlined in
the table
on the previous
page may
differ
from
the
securitization
positions
presented
in
the
31
December
2021
Pillar
3
R
eport
,
available
under
“Pillar
3
disclosures”
at
ubs.com/investors
,
for
the
following
reasons:
(i) exclusion
of synthetic
securitizations
transacted
with entities
that
are
not
SEs
and
transactions
in
which
the
Group
did
not
have an interest because it did not absorb any risk
;
(ii) a different
measurement
basis
in certain
cases
(e.g.,
IFRS
carrying
amount
within
the previous
table
compared
with net
exposure
amount
at default for
Pillar 3 disclosures)
;
and (iii) different
classification
of vehicles
viewed as
sponsored by
the Group versus
sponsored
by third parties.
›
Refer to the 31 December 2021 Pillar 3
Report,
available under
“Pillar 3 disclosures” at
ubs.com/investors
,
for more information
Interests in client vehicles
Client
vehicles are
established predominantly
for
clients to
gain
exposure
to specific
assets or
risk exposures.
Such vehicles
may
enter
into
derivative
agreements,
with
UBS
or
a
third
party,
to
align
the
cash
flows
of
the
entity
with
the
investor’s
intended
investment objective,
or to introduce other
desired risk exposures.
As of
31 December 2021 and
31 December 2020,
the Group
retained
interests
in
client
vehicles
sponsored
by
UBS
and
third
parties that
relate to
financing, secondary
market and
derivative
trading activities, and to hedge structured product offerings.
Interests in investment funds
Investment funds have
a collective investment
objective, and are
either passively
managed, so
that any
decision making
does not
have a
substantive effect
on variability,
or are
actively managed
and investors
or their
governing bodies
do not
have substantive
voting or similar rights.
The
Group holds
interests in
a
number
of
investment
funds,
primarily
resulting
from
seed
investments
or
in
order
to
hedge
structured product offerings. In addition to the interests disclosed
in the table on the previous page, the Group manages
the assets
of
various
pooled
investment
funds
and
receives
fees
based,
in
whole
or
part, on
the net
asset
value
of
the
fund and
/
or
the
performance of the fund. The specific fee structure is determined
based on various
market factors and considers
the fund’s nature
and
the
jurisdiction
of
incorporation,
as
well
as
fee
schedules
negotiated with clients. These
fee contracts represent an interest
in
the
fund,
as
they
align
the Group’s
exposure
with
investors,
providing
a
variable
return
based
on
the
performance
of
the
entity. Depending on the structure of
the fund, these fees may
be
collected
directly
from
the
fund
’s
assets
and
/
or
from
the
investors. Any
amounts due are
collected on
a regular
basis and
are
generally
backed
by
the
fund’s
assets.
Therefore
interest
in
such
funds
is
not
represented
by
the
on-balance
sheet
fee
receivable but rather by the
future exposure to variable fees. The
total
assets
of
such
funds
were
USD
370
billion
and
USD
359
billion
as
of
31
December
2021
and
31
December
2020,
respectively,
and
have
been
excluded
from
the
table
on
the
previous page. The Group
did not have any
material exposure to
loss
from
these
interests
as
of
31 December
2021
or
as
of
31 December 2020.
Consolidated financial statements | UBS Group AG consolidated financial statements
396
Note 30
Changes in organization and acquisitions and disposals of subsidiaries and businesses
Strategic partnership with Sumitomo Mitsui Trust Holdings
In
2019,
UBS
entered
into
a
strategic
wealth
management
partnership
in
Japan
with
Sumitomo
Mitsui Trust
Holdings, Inc.
(SuMi
Trust
Holdings).
In
January
2020,
the
first
phase
was
launched, with
operations commencing in
the joint
venture that
was established
to promote
the respective
services. At
the time,
UBS and
SuMi Trust
Holdings also
started offering
each other’s
products and services to their respective clients.
In
the
third
quarter
of
2021,
the
second
phase
of
the
partnership was completed, with the
launch of a new operational
partnership
entity,
UBS
SuMi
TRUST
Wealth
Management
Co.,
Ltd., which is
51
%-owned and controlled by
UBS, requiring UBS
to consolidate
this entity.
The new
entity offers
global securities
and wealth management
capabilities, together with the
custody,
real
estate,
inheritance
and
wealth
transfer
expertise
of
a
Japanese
trust
banking
group.
Upon
completion
of
this
transaction in
the third
quarter of
2021, shareholders’
equity of
the Group increased by USD
155
million, with no effect on profit
or loss.
Disposals of subsidiaries and businesses
Sale of remaining investment in Clearstream Fund Centre AG
In
the
second quarter
of
2021, UBS
sold its
remaining
minority
investment in Clearstream Fund Centre
AG to Deutsche Börse
AG
for
CHF
390
million.
The
transaction
followed
the
sale
of
a
majority
investment
and
successful
transfer
of
control
of
Fondcenter
AG
to
Deutsche
Börse
AG
in
2020,
when
UBS
recognized
a
post-tax gain
on sale
of
USD
631
million
in
Other
income
. The sale of
the remaining
48.8
% investment resulted
in
a post-tax gain of USD
37
million in 2021, which was recognized
in
Other income
, with no
associated net tax
expense. Long-term
commercial
cooperation
arrangements
remain
in
place
for
the
provision
of
services
by
Clearstream
to
UBS,
including
jointly
servicing banks and insurance companies.
Sale of wealth management business in Austria
In
the
third
quarter
of
2021,
UBS
completed
the
sale
of
its
domestic wealth management
business in Austria
to LGT. The sale
resulted
in
a
pre-tax
gain
of
USD
100
million,
which
was
recognized
in
Other
income
,
and
an
associated
tax
expense
of
USD
25
million.
Sale of wealth management business in Spain in 2022
In
October 2021,
UBS signed
an agreement
to sell
its
domestic
wealth
management
business
in
Spain
to
Singular
Bank.
The
agreement
includes
the
transition
of
employees,
client
relationships,
products
and services
of
the
wealth management
business of UBS in Spain. The
transaction is subject to customary
closing conditions and is expected to close in the third quarter of
2022.
As
of
31 December
2021,
the
assets
and
liabilities
of
the
business
were
presented
in
Global
Wealth
Management
as
a
disposal group held for sale within
Other non-financial assets
and
Other non-financial
liabilities
and amounted
to USD
647
million
and
USD
823
million,
respectively.
Upon
the
closing
of
the
transaction, UBS expects
to record a
pre-tax gain of
approximately
USD
0.2
billion.
Sale of UBS Swiss Financial Advisers AG in 2022
In
December
2021,
UBS
signed
an
agreement
to
sell
its
wholly
owned
subsidiary
UBS
Swiss
Financial
Advisers
AG
(SFA)
to
Vontobel.
SFA
is
an
SEC-registered
investment
advisor
and
FINMA-licensed
securities
firm
that
offers
US
clients
tailored
investment
solutions
in
a
Switzerland-based
environment.
The
transaction
is
subject
to
customary
closing
conditions
and
regulatory approvals and is
expected to close in the
third quarter
of 2022.
As
of
31 December
2021,
the
assets
and
liabilities
that
are
subject
to
the
transaction
were
presented
in
Global
Wealth
Management as a disposal group held for sale within
Other non-
financial assets
and
Other non-financial
liabilities
and amounted
to USD
446
million and
USD
475
million, respectively.
Upon the
closing of the
transaction, UBS does not
expect a material
effect
on profit or loss or shareholders’ equity of the Group.
Acquisitions of subsidiaries and businesses in 2022
Acquisition of Wealthfront in 2022
In
January
2022,
UBS
entered
into
an
agreement
to
acquire
Wealthfront,
an
industry-leading
digital
wealth
management
provider,
for
a
cash
consideration
of
USD
1.4
billion.
The
acquisition is aligned with UBS’s growth strategy
in the Americas,
will broaden
our reach
among affluent
investors and
will add
a
new
digital-first
offering
increasing
our
distribution
capabilities.
The
transaction
is
subject
to
customary
closing
conditions,
including
regulatory
approvals,
and
is
expected
to
close
in
the
second
half
of
2022.
Upon
the
closing
of
the
transaction,
Wealthfront
will become
a wholly
owned subsidiary
of UBS
and
UBS expects to
recognize additional goodwill
and other intangible
assets of approximately USD
1.2
billion.
397
Note
31
Related parties
UBS
defines
related
parties
as
associates
(entities
that
are
significantly influenced
by UBS),
joint ventures
(entities in
which
UBS shares control with another party), post-employment benefit
plans
for
UBS
employees,
key
management
personnel,
close
family members
of key management
personnel and entities
that
are,
directly
or
indirectly,
controlled
or
jointly
controlled
by
key
management
personnel
or
their
close
family
members.
Key
management
personnel
is
defined
as
members
of
the Board
of
Directors (BoD) and Group Executive Board (GEB).
a) Remuneration of key management personnel
The
Chairman of
the
BoD
has a
specific
management
employment
contract and
receives
pension
benefits upon
retirement.
Total
remuneration of the Chairman of the BoD and all GEB members is included in the table below.
Remuneration of key management
personnel
USD million, except where indicated
31.12.21
31.12.20
31.12.19
Base salaries and other cash payments
1
31
33
32
Incentive awards – cash
2
17
18
14
Annual incentive award under DCCP
26
27
21
Employer’s contributions to retirement benefit plans
3
3
3
Benefits in kind, fringe benefits (at market value)
1
1
1
Share-based compensation
3
45
47
37
Total
124
129
108
Total (CHF million)
4
113
121
107
1 May include role-based allowances in line
with market practice and regulatory requirements.
2 The cash portion may also include
blocked shares in line with regulatory requirements.
3 Compensation expense
is based on the
share price on grant
date taking into account
performance conditions. Refer
to Note 27 for
more information. For
GEB members, share-based
compensation for 2021, 2020
and 2019 was
entirely
composed of LTIP awards.For
the Chairman of the BoD the share-based compensation for 2021, 2020 and 2019 was
entirely composed of UBS shares.
4 Swiss franc amounts disclosed represent the respective US
dollar amounts translated at the applicable performance award currency exchange rates (2021: USD /
CHF
0.92
; 2020: USD / CHF
0.94
; 2019: USD / CHF
0.99
).
The independent members
of the BoD
do not have
employment
or service contracts
with UBS, and
thus are not
entitled to benefits
upon termination of their
service on the BoD.
Payments to these
individuals for their
services as
external board
members amounted
to
USD
7.5
million
(CHF
6.9
million)
in
2021,
USD
7.0
million
(CHF
6.6
million) in 2020 and USD
7.3
million (CHF
7.3
million) in
2019.
b) Equity holdings of key management personnel
Equity holdings of key management personnel
1
31.12.21
31.12.20
Number of shares held by members of the BoD, GEB and parties closely
linked to them
2
4,597,006
5,288,317
1 No options were held in 2021 and 2020 by non-independent members
of the BoD and any GEB member or any of its related
parties.
2 Excludes shares granted under variable
compensation plans with forfeiture
provisions.
Of
the
share
totals
above,
no
shares
were
held
by
close
family
members of
key management
personnel on
31 December 2021
and 31 December 2020. No shares were
held by entities that are
directly
or
indirectly
controlled
or
jointly
controlled
by
key
management
personnel
or
their
close
family
members
on
31 December 2021 and
31 December 2020. As
of 31 December
2021, no member of the BoD or
GEB was the beneficial owner of
more than 1% of UBS Group AG’s shares.
Consolidated financial statements | UBS Group AG consolidated financial statements
398
Note 31
Related parties (continued)
c) Loans, advances and mortgages to key management personnel
The non-independent members
of the BoD
and GEB members
are
granted
loans,
fixed
advances
and
mortgages
in
the
ordinary
course of business
on substantially the same
terms and conditions
that are available to other employees, including
interest rates and
collateral,
and
neither
involve
more
than
the
normal
risk
of
collectability nor
contain any
other unfavorable
features
for the
firm.
Independent
BoD
members
are
granted
loans
and
mortgages in
the ordinary
course of
business at
general market
conditions.
Movements in the
loan, advances and
mortgage balances are
as follows
.
Loans, advances and mortgages to key management
personnel
1
USD million, except where indicated
2021
2020
Balance at the beginning of the year
38
33
Additions
11
14
Reductions
(
15
)
(
8
)
Balance at the end of the year
2
34
38
Balance at the end of the year (CHF million)
2, 3
31
34
1 All loans are secured loans.
2 There were no unused uncommitted credit facilities as of 31
December 2021 and 31 December 2020.
3 Swiss franc amounts disclosed represent the respective US dollar
amounts
translated at the relevant year-end closing exchange rate.
d) Other related-party transactions with entities controlled by key management personnel
In
2021
and
2020,
UBS
did
not
enter
into
transactions
with
entities
that
are
directly
or
indirectly
controlled
or
jointly
controlled
by
UBS’s
key
management
personnel
or
their
close
family
members
and
as
of
31 December
2021,
31 December
20
20
and
31
December
201
9
,
there
were
no
outstanding
balances related
to such
transactions. Furthermore,
in 2021
and
2020, entities
controlled by
key management
personnel did
not
sell any
goods or
provide any
services to
UBS, and
therefore did
not receive any
fees from UBS.
UBS also did
not provide services
to such entities in 2021 and 2020, and
therefore also received no
fees.
e) Transactions with associates and joint ventures
Loans to and outstanding receivables from associates
and joint ventures
USD million
2021
2020
Carrying amount at the beginning of the year
630
982
Additions
133
527
Reductions
(
497
)
(
1,001
)
Foreign currency translation
(
14
)
123
Carrying amount at the end of the year
251
630
of which: unsecured loans and receivables
243
621
Other transactions with associates and
joint ventures
As of or for the year ended
USD million
31.12.21
31.12.20
Payments to associates and joint ventures for goods and services
received
157
139
Fees received for services provided to associates and joint ventures
104
128
Liabilities to associates and joint ventures
127
91
Commitments and contingent liabilities to associates
and joint ventures
7
9
›
Refer to Note 29 for an overview of investments
in associates and joint ventures
399
Note 32
Invested assets and net new money
The following disclosures provide a bre
akdown of UBS’s invested
assets and a
presentation of their
development, including net
new
money,
as
required
by
the
Swiss
Financial
Market
Supervisory
Authority.
Invested assets
Invested assets
consist of
all client
assets managed
by or
deposited
with
UBS
for
investment
purposes.
Invested
assets
include
managed fund assets, managed institutional assets, discretionary
and
advisory
wealth management
portfolios,
fiduciary
deposits,
time
deposits,
savings
accounts,
and
wealth
management
securities
or
brokerage
accounts.
All
assets
held
for
purely
transactional
purposes
and
custody-only
assets,
including
corporate
client
assets
held
for
cash
management
and
transactional purposes, are excluded
from invested assets, as
the
Group only
administers the
assets and
does not
offer advice
on
how
they
should
be
invested.
Also
excluded
are
non-bankable
assets (e.g.,
art collections)
and deposits
from
third-party
banks
for funding or trading purposes.
Discretionary
assets
are
defined
as
client
assets
that
UBS
decides how to invest. Other invested assets are
those where the
client
ultimately
decides
how
the
assets
are
invested.
When
a
single
product
is
created
in
one
business
division
and
sold
in
another, it is counted in both
the business division managing the
investment
and
the
one
distributing
it.
This
results
in
double
counting
within
UBS
total
invested
assets,
as
both
business
divisions are independently providing a
service to their respective
clients, and both add value and generate revenue.
Net new money
Net new
money in
a reporting
period is
the amount
of invested
assets
entrusted
to
UBS
by
new
and
existing
clients,
less
those
withdrawn
by
existing
clients
and
clients
who
terminated
relationships
with UBS.
Net new
money is
calculated using
the direct
method, under
which
inflows
and
outflows
to
/
from
invested
assets
are
determined at the client level,
based on transactions. Interest and
dividend income from invested
assets are not counted as net new
money inflows. Market and currency movements,
as well as
fees,
commissions
and interest on loans
charged,
are excluded from
net
new
money,
as
are
effects
resulting
from
any
acquisition
or
divestment
of
a
UBS
subsidiary
or
business.
Reclassifications
between invested assets
and custody-only assets as
a
result of
a
change in service level
delivered are generally treated as net
new
money flows.
However, where the change in
service level directly
results
from an
externally
imposed
regulation
or a
strategic
decision
by UBS
to exit
a market
or specific
service
offering,
the one-time
net
effect is
reported as
Other effects
.
The
Investment
Bank
does
not track
invested
assets
and
net
new
money.
However,
when
a
client
is
transferred
from
the
Investment Bank
to another
business division,
this may
produce
net new
money even though
the client assets
were already with
UBS.
Invested
assets and net new money
As of or for the year ended
USD billion
31.12.21
31.12.20
Fund assets managed by UBS
419
397
Discretionary assets
1,705
1,459
Other invested assets
2,472
2,331
Total invested assets
1
4,596
4,187
of which: double counts
356
311
Net new money
1
159
127
1 Includes double counts.
Development of invested assets
USD billion
2021
2020
Total invested assets at the beginning of the year
1
4,187
3,607
Net new money
159
127
Market movements
2
339
359
Foreign currency translation
(
65
)
96
Other effects
(
24
)
(
1
)
of which: acquisitions / (divestments)
(
5
)
0
Total invested assets at the end of the year
1
4,596
4,187
1 Includes double counts.
2 Includes interest and dividend income.
Consolidated financial statements | UBS Group AG consolidated financial statements
400
Note 33
Currency translation rates
The
following table
shows the
rates of
the main
currencies
used to
translate the
financial information
of UBS’s
operations with
a
functional currency other than the US dollar into US dollars.
Closing exchange rate
Average rate
1
As of
For the year ended
31.12.21
31.12.20
31.12.21
31.12.20
31.12.19
1 CHF
1.10
1.13
1.09
1.07
1.01
1 EUR
1.14
1.22
1.18
1.15
1.12
1 GBP
1.35
1.37
1.37
1.29
1.28
100 JPY
0.87
0.97
0.91
0.94
0.92
1 Monthly income statement items of operations with a functional currency other than the US dollar are translated into US dollars using month-end rates. Disclosed average rates for a year represent an average of 12
month-end rates, weighted
according to the income
and expense volumes of all
operations of the Group
with the same functional currency
for each month. Weighted
average rates for individual
business divisions
may deviate from the weighted average rates for the Group.
Note 34
Events after the reporting period
Russia’s invasion of Ukraine
Russia’s
invasion of
Ukraine on
24 February
2022
has triggered
disruptions
and
uncertainties
in
the
markets
and
the
global
economy,
as well as coordinated implementation
of sanctions by
Switzerland, the
United States,
the European
Union, the
United
Kingdom and
others against
Russia and,
certain Russian
entities
and
nationals.
These
events,
together
with
potential
counter-
sanctions
and
other
measures
taken
by
Russia,
impact
UBS’s
businesses.
UBS’s
country
risk
exposure
to
Russia
was
approximately
USD
0.6
billion
across
its
business
divisions
as
of
31 December
2021.
This
exposure
has
been
reduced
since
year-end 2021.
In
addition,
UBS
is
currently
monitoring
settlement
risk
on
certain
open transactions with Russian bank- or non-bank
counterparties
or
Russian
underlyings,
as
market
closures,
the
imposition
of
exchange
controls,
sanctions
or
other
measures
may
limit
our
ability
to
settle
existing
transactions
or
to
realize
on
collateral,
which
may
result
in
unexpected
increases
in
exposures.
UBS’s
balance sheet as of
31 December 2021 also
included net assets
of
USD
51
million held in UBS’s
Russian subsidiary, OOO
UBS Bank.
As of 3 March 2022, UBS also
had approximately USD
0.2
billion
of exposure arising
from reliance on
Russian assets as
collateral on
Lombard
lending and
other secured
financing in
Global
Wealth
Management.
As of 3 March
2022,
UBS identified a small
number of Global
Wealth
Management
clients
subject
to
the
recently
introduced
sanctions with total loans outstanding of under USD
10
million.
UBS continues to closely
monitor related effects on
its financial
statements,
including
estimated
direct
and
indirect
impacts
on
expected credit
loss calculations
and on
fair value
measurement
of assets, liabilities and off-balance
sheet exposures. The situation
continues
to
evolve
and
broader
implications
for
other
counterparties
of
UBS,
including
financial
institutions,
are
not
possible to
assess at
this time;
however, there
were no
material
adverse effects on
UBS’s financial statements
as of 4 March
2022.
›
Refer to “Top and emerging risks” and “Country risk” in the
“Risk management and control” section and
to “Performance in
the financial services industry is affected by
market conditions
and the macroeconomic climate” in the “Risk
factors” section of
this report for more information
401
Note 35
Main differences between IFRS and Swiss GAAP
The
consolidated
financial
statements
of
UBS
Group
AG
are
prepared
in
accordance
with
International
Financial
Reporting
Standards (IFRS). The
Swiss Financial
Market Supervisory Authority
(FINMA) requires financial groups presenting financial statements
under
IFRS
to
provide
a
narrative
explanation
of
the
main
differences
between
IFRS
and
Swiss
g
enerally
accepted
accounting principles (GAAP) (the FINMA Accounting
Ordinance,
FINMA
Circular
2020/1 “Accounting
– banks”
and the
Banking
Ordinance
(the
BO)).
Included
in
this
Note
are
the
significant
differences
in
the
recognition
and
measurement
between
IFRS
and
the
provisions
of
the
BO
and
the
guidelines
of
FINMA
governing
true
and
fair
view
financial
statement
reporting
pursuant to Art. 25 to Art. 42 of the BO.
1. Consolidation
Under IFRS,
all entities
that are
controlled
by the
holding entity
are consolidated. Under
Swiss GAAP,
controlled entities deemed
immaterial to the
Group or held
only temporarily are exempt
from
consolidation,
but
instead
are
recorded
as
participations
accounted
for
under
the
equity
method
of
accounting
or
as
financial
investments
measured
at
the
lower
of
cost
or
market
value.
2. Classification and measurement of financial assets
Under IFRS, debt instruments
are measured at amortized
cost, fair
value through
other comprehensive income
(FVOCI) or fair
value
through
profit
or
loss
(FVTPL),
depending
on
the
nature
of
the
business
model
within
which
the
asset
is
held
and
the
characteristics of
the contractual
cash flows
of the
asset.
Equity
instruments
are
accounted
for
at
FVTPL
by
UBS.
Under
Swiss
GAAP, trading assets and derivatives
are measured at
FVTPL in
line
with IFRS.
However,
non-trading debt
instruments are
generally
measured at amortized
cost, even when
the assets are
managed
on
a
fair value
basis.
In
addition,
the measurement
of
financial
assets in the
form of
securities depends on
the nature of
the asset:
debt instruments not
held to maturity,
i.e., instruments available
for
sale,
and
equity
instruments
with
no
permanent
holding
intent, are classified as
Financial investments
and measured at the
lower
of
(amortized)
cost
or
market
value.
Market
value
adjustments up to the original cost amount and
realized gains or
losses upon disposal
of the investment
are recorded in the
income
statement
as
Other
income
from
ordinary
activities.
Equity
instruments
with
a
permanent
holding
intent
are
classified
as
participations in
Non-consolidated investments in
subsidiaries and
other
participations
and
are
measured
at
cost
less
impairment.
Impairment
losses
are
recorded
in
the
income
statement
as
Impairment
of investments
in non-consolidated
subsidiaries and
other participations.
Reversals of
impairments up
to the
original
cost
amount
and
realized
gains
or
losses
upon
disposal
of
the
investment are
recorded as
Extraordinary income
/
Extraordinary
expenses
.
3. Fair value option applied to financial liabilities
Under IFRS,
UBS applies the
fair value option
to certain financial
liabilities not held for trading.
Instruments for which the fair
value
option
is
applied
are
accounted
for
at
FVTPL.
The
amount
of
change
in
the
fair
value
attributable
to
changes
in
UBS’s
own
credit is presented in
Other comprehensive income
directly within
Retained
earnings
.
The
fair
value
option
is
applied
primarily
to
issued
structured
debt
instruments,
certain
non-structured
debt
instruments,
certain payables
under repurchase
agreements and
cash
collateral
on
securities
lending
agreements,
amounts
due
under unit-linked investment contracts, and brokerage payables.
Under Swiss GAAP, the fair
value option can only be
applied to
structured debt instruments
consisting of
a debt
host contract
and
one
or
more
embedded
derivatives
that
do
not
relate
to
own
equity. Furthermore, unrealized changes
in fair value attributable
to
changes
in
UBS’s
own
credit
are
not
recognized,
whereas
realized own credit is recognized in
Net trading income
.
4. Allowances and provisions for credit losses
Swiss GAAP permit use of IFRS for
accounting for allowances and
provisions for credit losses based on an expected credit loss (ECL)
model. UBS has
chosen to apply
the IFRS 9
ECL approach to
the
substantial
majority
of
exposures
in
scope
of
Swiss
GAAP
ECL
requirements,
including all exposures in scope of ECL under both
Swiss GAAP and IFRS.
In
addition,
for
a
small
population
of
exposures
within
the
scope of Swiss GAAP ECL requirements, which are not subject to
ECL
under
IFRS
due
to
classification
and
measurements
differences,
UBS applies
an alternative
approach.
Where Pillar 1
internal ratings-based (IRB)
models are applied
to measure credit
risk,
ECL
for
such
exposures
is
determined
by
the
regulatory
expected loss
(EL), with
an add-on
for scaling
up to
the residual
maturity of exposures
maturing beyond the next
12 months. For
detailed
information
on
regulatory
EL,
refer
to
the
“
Risk
management
and control”
section
of
this report.
For exposures
where the Pillar 1 standardized approach (SA) is used
to measure
credit
risk,
ECL
is
determined
using
a
portfolio
approach
that
derives
a
conservative probability
of
default
(PD)
and loss
given
default (LGD) for the entire portfolio.
5. Hedge accounting
Under IFRS, when cash flow hedge accounting is applied, the fair
value
gain
or
loss
on
the
effective
portion
of
a
derivative
designated as
a cash
flow hedge
is recognized
initially in
equity
and reclassified to the income statement when certain conditions
are
met.
When
fair
value
hedge
accounting
is
applied,
the
fair
value change of the
hedged item attributable to
the hedged risk
is
reflected
in
the
measurement
of
the
hedged
item
and
is
recognized in the income statement along with
the change in the
fair
value
of
the
hedging
derivative.
Under
Swiss
GAAP,
the
effective
portion
of
the
fair
value
change
of
a
derivative
instrument designated
as a
cash flow
or as
a fair
value hedge
is
deferred on the balance
sheet as
Other assets
or
Other liabilities
.
The carrying amount of the hedged
item designated in fair value
hedges is
not adjusted
for fair
value changes
attributable to
the
hedged risk.
Consolidated financial statements | UBS Group AG consolidated financial statements
402
Note 35
Main differences between IFRS and Swiss GAAP (continued)
6. Goodwill and intangible assets
Under
IFRS,
goodwill acquired
in
a
business combination
is
not
amortized
but tested
annually for
impairment.
Intangible
assets
with
an
indefinite
useful
life
are
also
not
amortized
but
tested
annually
for
impairment.
Under
Swiss
GAAP,
goodwill
and
intangible assets with
indefinite useful lives
are amortized over
a
period not exceeding five years, unless a longer useful life, which
may not exceed
10
years, can
be justified. In
addition, these assets
are tested annually for impairment.
7. Post-employment benefit plans
Swiss GAAP permit the use of IFRS or Swiss accounting
standards
for post-employment benefit
plans, with the
election made on
a
plan-by-plan basis.
UBS
has
elected
to
apply
IFRS
(IAS
19)
for
the
non-Swiss
defined
benefit
plans
in
the
UBS
AG
standalone
financial
statements and
Swiss GAAP
(FER 16)
for the
Swiss pension
plan
in the UBS
AG and the UBS
Switzerland AG standalone
financial
statements. The
requirements of
Swiss GAAP
are better
aligned
with the specific nature
of Swiss pension plans, which
are hybrid
in
that
they
combine
elements
of
defined
contribution
and
defined
benefit
plans,
but
are
treated
as
defined
benefit
plans
under IFRS. Key
differences between Swiss
GAAP and IFRS
include
the treatment
of dynamic
elements, such
as future
salary increases
and future
interest credits
on retirement
savings, which
are not
considered under
the static
method used
in accordance
with Swiss
GAAP.
Also,
the
discount
rate
used
to
determine
the
defined
benefit obligation in accordance with
IFRS is based on the yield
of
high-quality
corporate
bonds
of
the
market
in
the
respective
pension plan country. The
discount rate used in
accordance with
Swiss GAAP (i.e., the technical interest rate) is determined by
the
Pension Foundation
Board based
on the
expected returns of
the
Board’s investment strategy.
For defined benefit plans,
IFRS require the full
defined benefit
obligation net
of the
plan assets
to be
recorded on
the balance
sheet
subject
to
the
asset
ceiling
rules,
with
changes
resulting
from remeasurements recognized
directly in equity.
However, for
non-Swiss
defined
benefit
plans
for
which
IFRS
accounting
is
elected,
changes
due
to
remeasurements
are
recognized
in
the
income statement of UBS AG standalone under Swiss GAAP.
Swiss
GAAP
require
employer
contributions
to
the
pension
fund
to
be
recognized
as
personnel
expenses
in
the
income
statement.
Swiss
GAAP
also
require
an
assessment
of
whether,
based
on
the
pension
fund’s
financial
statements
prepared
in
accordance
with
Swiss
accounting
standards
(FER
26),
an
economic benefit
to, or
obligation of,
the employer
arises from
the
pension
fund that
is recognized
in the
balance sheet
when
conditions are
met. Conditions
for recording
a pension
asset or
liability would
be met
if, for
example, an
employer contribution
reserve is available
or the employer
is required to
contribute to the
reduction of a pension deficit (on an FER 26 basis).
8. Leasing
Under IFRS, a single lease accounting model applies that
requires
UBS to
record a
right-of-use (RoU)
asset and
a corresponding
lease
liability
on
the
balance
sheet
when
UBS
is
a
lessee
in
a
lease
arrangement. The RoU asset and the lease liability are recognized
when UBS
acquires control
of the
physical use
of the
asset. The
lease liability is measured based on the present value of the lease
payments over the lease term, discounted using UBS’s unsecured
borrowing rate. The RoU asset is recorded at an amount equal to
the lease liability
but is adjusted
for rent prepayments,
initial direct
costs,
any
costs
to
refurbish
the
leased
asset
and
/
or
lease
incentives received. The RoU asset is depreciated over the shorter
of the lease term or the useful life of the underlying asset.
Under Swiss GAAP,
leases that
transfer substantially
all the risks
and
rewards,
but
not
necessarily
legal
title
in
the
underlying
assets,
are
classified
as
finance
leases.
All
other
leases
are
classified
as
operating
leases.
Whereas
finance
leases
are
recognized on the balance
sheet and measured in line
with IFRS,
operating
leases are
not recognized
on
the balance
sheet, with
payments recognized as
General and administrative
expenses
on
a straight-line
basis over
the lease term,
which commences with
control
of
the
physical
use
of
the
asset.
Lease
incentives
are
treated
as
a
reduction
of
rental
expense
and
recognized
on
a
consistent basis over the lease term.
9. Netting of derivative assets and liabilities
Under IFRS, derivative assets, derivative liabilities and related cash
collateral
not
settled
to
market
are
reported
on
a
gross
basis
unless
the
restrictive
IFRS
netting
requirements
are
met:
(i)
existence
of
master
netting
agreements
and
related
collateral
arrangements
that are
unconditional and
legally enforceable,
in
both
the
normal
course
of
business
and
the
event
of
default,
bankruptcy
or
insolvency of
UBS and
its
counterparties;
and
(ii)
UBS’s intention
to either
settle on
a net
basis or
to realize the
asset
and
settle
the
liability
simultaneously.
Under
Swiss
GAAP,
derivative
assets,
derivative
liabilities
and
related
cash
collateral
not
settled
to
market
are
generally
reported
on
a
net
basis,
provided the master netting
and the related collateral
agreements
are
legally
enforceable
in
the
event
of
default,
bankruptcy
or
insolvency of UBS’s counterparties.
10. Negative interest
Under IFRS,
negative interest
income arising
on a
financial asset
does not
meet the
definition of
interest
income and,
therefore,
negative
interest
on
financial
assets
and
negative
interest
on
financial
liabilities
are
presented
within
interest
expense
and
interest income, respectively. Under
Swiss GAAP, negative interest
on
financial
assets
is
presented
within
interest
income
and
negative interest on financial liabilities
is presented within interest
expense.
11. Extraordinary income and expense
Certain
non-recurring
and
non-operating
income
and
expense
items,
such
as
realized
gains
or
losses
from
the
disposal
of
participations,
fixed
and
intangible
assets,
a
nd
reversals
of
impairments
of
participations
and
fixed
assets,
are
classified
as
extraordinary
items
under
Swiss
GAAP.
This
distinction
is
not
available under IFRS
.
p
403
UBS AG consolidated financial information
This
section
contains
a
comparison
of
selected
financial
and
capital
information
between
UBS
Group
AG
consolidated
and
UBS AG consolidated. Information for UBS AG consolidated does
not differ materially from UBS Group AG on a consolidated basis.
Comparison between UBS Group AG consolidated and
UBS AG consolidated
The
accounting
policies
applied
under
International
Financial
Reporting Standards
(IFRS) to
both UBS
Group AG
and UBS
AG
consolidated
financial
statements
are
identical.
However,
there
are certain scope and presentation differences as noted below:
–
Assets,
liabilities,
operating
income,
operating
expenses
and
tax
expenses
/
(benefits)
relating
to
UBS
Group
AG
and
its
directly held subsidiaries, including UBS
Business Solutions AG,
are
reflected in
the consolidated
financial statements
of UBS
Group
AG
but
not
of
UBS
AG.
UBS
AG’s
assets,
liabilities,
operating
income
and
operating
expenses
related
to
transactions
with
UBS
Group
AG
and
its
directly
held
subsidiaries,
including
UBS
Business
Solutions
AG
and
other
shared
services
subsidiaries, are
not
subject to
elimination
in
the
UBS
AG
consolidated
financial
statements,
but
are
eliminated
in
the
UBS
Group
AG
consolidated
financial
statements.
–
Differences in net profit between UBS Group AG consolidated
and
UBS
AG
consolidated
mainly
arise
as
UBS
Business
Solutions
AG
and
other
shared
services
subsidiaries
of
UBS
Group
AG
charge
other
legal
entities
within
the
UBS
AG
consolidation scope for
services provided, including
a markup
on
costs
incurred.
In
addition,
and
to
a
lesser
extent,
differences
arise
as
a
result
of
certain
compensation-related
matters, including pensions.
–
The equity of UBS Group AG consolidated was USD 2.6 billion
higher
than
the
equity
of
UBS
AG
consolidated
as
of
31
December
202
1
.
This
difference
was
mainly
driven
by
higher dividends paid by UBS AG to UBS Group AG compared
with
the dividend
distributions of
UBS
Group AG,
as
well as
higher
retained
earnings
in
the
UBS Group
AG
consolidated
financial
statements,
largely
related
to
the
aforementioned
markup charged by
shared services subsidiaries
of UBS Group
AG
to
other
legal
entities
in
the
UBS
AG
scope
of
consolidation.
In
addition,
UBS
Group
is
the
grantor
of
the
majority
of
the
compensation
plans
of
the
Group
and
recognizes share
premium for
equity-settled awards
granted.
These effects were partly offset
by treasury shares acquired as
part of
our share
repurchase programs
and those
held to
hedge
share delivery obligations
associated with
Group compensation
plans, as
well as
additional share
premium recognized
at the
UBS
AG
consolidated
level
related
to
the
establishment
of
UBS Group AG
and
UBS
Business
Solutions
AG,
a
wholly
owned subsidiary of UBS Group AG.
–
The going concern capital of UBS Group AG consolidated was
USD
5
.
1
billion
higher
than
the
going
concern
capital
of
UBS AG
consolidated
as
of
31 December
2021,
reflecting
higher common equity
tier 1 (CET1)
capital of USD 3.7 billion
and higher going
concern loss-absorbing
additional tier 1
(AT1)
capital of USD 1.4 billion
–
The CET1 capital of UBS Group AG consolidated
was USD 3.7
billion
higher
than
that
of
UBS
AG
consolidated
as
of
31 December 2021. The higher
CET1 capital of UBS Group
AG
consolidated
was
primarily
due
to
a
higher
UBS
Group
AG
consolidated
IFRS
equity
of
USD 2.6 billion,
as
described
above, and lower UBS Group AG accruals for future dividends
to
shareholders,
as
well as
a
higher
capital deduction
at
the
UBS
AG
consolidated
level
related
to
deferred
tax
assets
on
temporary differences. The
aforementioned factors were
partly
offset
by
compensation-related
regulatory
capital
accruals
at
the UBS Group AG level.
–
The
going
concern
loss-absorbing
AT1
capital
of
UBS
Group
AG consolidated was
USD 1.4 billion
higher than that
of UBS
AG
consolidated
as
of
31
December 2021,
mainly reflecting
deferred contingent capital plan awards granted at
the Group
level to eligible
employees for the
performance years 2016 to
2020,
partly
offset
by
two
loss-absorbing
AT1
capital
instruments on-lent by UBS Group AG to UBS AG.
Consolidated financial statements | UBS AG consolidated financial statements
404
UBS AG consolidated key figures
As of or for the year ended
USD million, except where indicated
31.12.21
31.12.20
31.12.19
1
Results
Operating income
35,976
32,780
29,307
Operating expenses
27,012
25,081
24,138
Operating profit / (loss) before tax
8,964
7,699
5,169
Net profit / (loss) attributable to shareholders
7,032
6,196
3,965
Profitability and growth
2
Return on equity (%)
12.3
10.9
7.4
Return on tangible equity (%)
13.9
12.4
8.5
Return on common equity tier 1 capital (%)
17.6
16.6
11.3
Return on risk-weighted assets, gross (%)
12.3
11.9
11.2
Return on leverage ratio denominator, gross (%)
3
3.4
3.4
3.2
Cost / income ratio (%)
75.4
74.9
82.1
Net profit growth (%)
13.5
56.3
(3.4)
Resources
Total assets
1,116,145
1,125,327
971,927
Equity attributable to shareholders
58,102
57,754
53,722
Common equity tier 1 capital
4
41,594
38,181
35,233
Risk-weighted assets
4
299,005
286,743
257,831
Common equity tier 1 capital ratio (%)
4
13.9
13.3
13.7
Going concern capital ratio (%)
4
18.5
18.3
18.3
Total loss-absorbing capacity ratio (%)
4
33.3
34.2
33.9
Leverage ratio denominator
3,4
1,067,679
1,036,771
911,228
Common equity tier 1 leverage ratio (%)
3,4
3.90
3.68
3.87
Going concern leverage ratio (%)
3,4
5.2
5.1
5.2
Total loss-absorbing capacity leverage ratio (%)
4
9.3
9.5
9.6
Other
Invested assets (USD billion)
5
4,596
4,187
3,607
Personnel (full-time equivalents)
47,067
47,546
47,005
1 Refer to the “Accounting and financial reporting” and “Consolidated financial
statements” sections of this report for information about the restatement of comparative information, where
applicable.
2 Refer to
the “Targets, aspirations and capital guidance”
section of this report for more information about our performance measurement.
3 Leverage ratio denominators and leverage ratios for year 2020 do not reflect the
effects of the temporary exemption that applied from 25 March 2020 until 1 January 2021 and was granted by FINMA in connection with COVID-19. Refer to the “Regulatory and legal developments” section of our
Annual Report 2020 for more information.
4 Based on the Swiss systemically relevant bank framework
as of 1 January 2020. Refer to the
“Capital, liquidity and funding, and balance sheet” section
of this report
for more
information.
5 Consists of
invested assets
for Global
Wealth Management,
Asset Management
and Personal
& Corporate
Banking. Refer
to “Note
32 Invested
assets and
net new
money” in
the
“Consolidated financial statements” section of this report for more information.
405
Comparison between UBS Group AG consolidated and UBS AG consolidated
As of or for the year ended 31.12.21
As of or for the year ended 31.12.20
USD million, except where indicated
UBS Group AG
consolidated
UBS AG
consolidated
Difference
(absolute)
UBS Group AG
consolidated
UBS AG
consolidated
Difference
(absolute)
Income statement
Operating income
35,542
35,976
(434)
32,390
32,780
(390)
Operating expenses
26,058
27,012
(955)
24,235
25,081
(846)
Operating profit / (loss) before tax
9,484
8,964
520
8,155
7,699
456
of which: Global Wealth Management
4,783
4,706
77
4,019
3,965
54
of which: Personal & Corporate Banking
1,731
1,726
4
1,259
1,261
(2)
of which: Asset Management
1,030
1,023
7
1,455
1,454
1
of which: Investment Bank
2,630
2,592
38
2,482
2,441
41
of which: Group Functions
(689)
(1,083)
394
(1,060)
(1,423)
362
Net profit / (loss)
7,486
7,061
425
6,572
6,211
361
of which: net profit / (loss) attributable to shareholders
7,457
7,032
425
6,557
6,196
361
of which: net profit / (loss) attributable to non-controlling interests
29
29
0
15
15
0
Statement of comprehensive income
Other comprehensive income
(2,367)
(2,235)
(131)
1,740
1,759
(19)
of which: attributable to shareholders
(2,351)
(2,220)
(131)
1,719
1,738
(19)
of which: attributable to non-controlling interests
(16)
(16)
0
21
21
0
Total comprehensive income
5,119
4,826
293
8,312
7,970
342
of which: attributable to shareholders
5,106
4,813
293
8,276
7,934
342
of which: attributable to non-controlling interests
13
13
0
36
36
0
Balance sheet
Total assets
1,117,182
1,116,145
1,037
1,125,765
1,125,327
438
Total liabilities
1,056,180
1,057,702
(1,522)
1,066,000
1,067,254
(1,254)
Total equity
61,002
58,442
2,559
59,765
58,073
1,691
of which: equity attributable to shareholders
60,662
58,102
2,559
59,445
57,754
1,691
of which: equity attributable to non-controlling interests
340
340
0
319
319
0
Capital information
Common equity tier 1 capital
45,281
41,594
3,687
39,890
38,181
1,709
Going concern capital
60,488
55,434
5,054
56,178
52,610
3,567
Risk-weighted assets
302,209
299,005
3,204
289,101
286,743
2,358
Common equity tier 1 capital ratio (%)
15.0
13.9
1.1
13.8
13.3
0.5
Going concern capital ratio (%)
20.0
18.5
1.5
19.4
18.3
1.1
Total loss-absorbing capacity ratio (%)
34.7
33.3
1.3
35.2
34.2
1.0
Leverage ratio denominator
1,068,862
1,067,679
1,183
1,037,150
1,036,771
379
Common equity tier 1 leverage ratio (%)
4.24
3.90
0.34
3.85
3.68
0.16
Going concern leverage ratio (%)
5.7
5.2
0.5
5.4
5.1
0.3
Total loss-absorbing capacity leverage ratio (%)
9.8
9.3
0.5
9.8
9.5
0.3
Consolidated financial statements | UBS AG consolidated financial statements
406
Management’s report on internal control over financial
reporting
Management’s responsibility for internal control over financial
reporting
The
Board
of
Directors
and
management
of
UBS
AG
are
responsible
for
establishing
and
maintaining
adequate
internal
control
over
financial
reporting.
UBS
AG’s
internal control
over
financial
reporting
is
designed
to
provide
reasonable
assurance
regarding
the
preparation
and
fair
presentation
of
published
financial
statements
in
accordance
with
International
Financial
Reporting
Standards
(IFRS)
as
issued
by
the
International
Accounting Standards Board (IASB).
UBS
AG’s
internal
control
over
financial
reporting
includes
those policies and procedures that:
–
pertain
to
the
maintenance
of
records
that,
in
reasonable
detail, accurately and
fairly reflect
transactions and dispositions
of assets;
–
provide reasonable assurance that transactions
are recorded as
necessary
to
permit
preparation
and
fair
presentation
of
financial statements, and that receipts and
expenditures of the
company
are
being
made
only
in
accordance
with
authorizations of UBS AG management; and
–
provide
reasonable
assurance
regarding
prevention
or
timely
detection of unauthorized
acquisition, use or disposition
of the
company’s
assets
that
could
have
a
material
effect
on
the
financial statements.
Because
of
its
inherent
limitations,
internal
control
over
financial reporting may
not prevent
or detect misstatements.
Also,
projections of any
evaluation of effectiveness
to future periods
are
subject to the risk that controls may become inadequate because
of changes
in conditions,
or that the
degree of
compliance with
the policies or procedures may deteriorate.
Management’s assessment of internal control over financial
reporting as of 31 December
2021
UBS AG management has assessed the effectiveness of UBS AG’s
internal control over financial reporting
as of 31 December 2021
based on
the criteria
set forth
by the
Committee of
Sponsoring
Organizations
of
the
Treadway
Commission
(COSO)
in
Internal
Control – Integrated Framework
(2013 Framework). Based
on this
assessment, management believes
that, as of
31 December 2021,
UBS AG’s internal control over financial reporting was effective.
The
effectiveness
of
UBS
AG’s internal
control
over
financial
reporting as
of 31
December 2021
has been
audited by
Ernst &
Young
Ltd,
UBS AG’s
independent
registered public
accounting
firm,
as
stated
in
their
report
appearing
on
page
407
which
expresses an unqualified
opinion on the
effectiveness of UBS
AG’s
internal control over financial reporting as of 31 December 2021.
407
408
409
410
411
412
413
UBS AG consolidated financial statements
Primary financial statements and share information
Audited |
Income statement
For the year ended
USD million
Note
31.12.21
31.12.20
31.12.19
Interest income from financial instruments measured at
amortized cost and fair value through
other comprehensive income
3
8,534
8,816
10,703
Interest expense from financial instruments measured at
amortized cost
3
(
3,366
)
(
4,333
)
(
7,303
)
Net interest income from financial instruments measured
at fair value through profit or loss
3
1,437
1,305
1,015
Net interest income
3
6,605
5,788
4,415
Other net income from financial instruments measured
at fair value through profit or loss
3
5,844
6,930
6,833
Credit loss (expense) / release
20
148
(
695
)
(
78
)
Fee and commission income
4
24,422
20,982
19,156
Fee and commission expense
4
(
1,985
)
(
1,775
)
(
1,696
)
Net fee and commission income
4
22,438
19,207
17,460
Other income
5
941
1,549
677
Total operating income
35,976
32,780
29,307
Personnel expenses
6
15,661
14,686
13,801
General and administrative expenses
7
9,476
8,486
8,586
Depreciation, amortization and impairment of non-financial
assets
12,13
1,875
1,909
1,751
Total operating expenses
27,012
25,081
24,138
Operating profit / (loss) before tax
8,964
7,699
5,169
Tax expense / (benefit)
8
1,903
1,488
1,198
Net profit / (loss)
7,061
6,211
3,971
Net profit / (loss) attributable to non-controlling interests
29
15
6
Net profit / (loss) attributable to shareholders
7,032
6,196
3,965
Consolidated financial statements | UBS AG consolidated financial statements
414
Statement of comprehensive income
For the year ended
USD million
Note
31.12.21
31.12.20
31.12.19
Comprehensive income attributable to shareholders
Net profit / (loss)
7,032
6,196
3,965
Other comprehensive income that may be reclassified to the income
statement
Foreign currency translation
Foreign currency translation movements related to net assets of foreign operations, before tax
(
1,046
)
2,040
199
Effective portion of changes in fair value of hedging instruments
designated as net investment hedges, before tax
492
(
938
)
(
144
)
Foreign currency translation differences on foreign operations reclassified to the
income statement
(
1
)
(
7
)
52
Effective portion of changes in fair value of hedging instruments
designated as net investment hedges reclassified
to
the income statement
10
2
(
14
)
Income tax relating to foreign currency translations, including the effect of
net investment hedges
35
(
67
)
(
1
)
Subtotal foreign currency translation, net of tax
(
510
)
1,030
92
Financial assets measured at fair value through other comprehensive income
11
Net unrealized gains / (losses), before tax
(
203
)
223
189
Net realized gains / (losses) reclassified to the income statement
from equity
(
9
)
(
40
)
(
31
)
Income tax relating to net unrealized gains / (losses)
55
(
48
)
(
41
)
Subtotal financial assets measured at fair value through other comprehensive
income, net of tax
(
157
)
136
117
Cash flow hedges of interest rate risk
26
Effective portion of changes in fair value of derivative instruments designated
as cash flow hedges, before tax
(
992
)
2,012
1,571
Net (gains) / losses reclassified to the income statement from
equity
(
1,073
)
(
770
)
(
175
)
Income tax relating to cash flow hedges
390
(
231
)
(
253
)
Subtotal cash flow hedges, net of tax
(
1,675
)
1
1,011
1,143
Cost of hedging
26
Cost of hedging, before tax
(
32
)
(
13
)
Income tax relating to cost of hedging
6
0
Subtotal cost of hedging, net of tax
(
26
)
(
13
)
Total other comprehensive income that may be reclassified to the income statement, net
of tax
(
2,368
)
2,165
1,351
Other comprehensive income that will not be reclassified to the income
statement
Defined benefit plans
27
Gains / (losses) on defined benefit plans, before tax
133
(
222
)
(
129
)
Income tax relating to defined benefit plans
(
31
)
88
(
41
)
Subtotal defined benefit plans, net of tax
102
(
134
)
(
170
)
Own credit on financial liabilities designated at fair value
21
Gains / (losses) from own credit on financial liabilities designated
at fair value, before tax
46
(
293
)
(
400
)
Income tax relating to own credit on financial liabilities designated
at fair value
0
0
8
Subtotal own credit on financial liabilities designated at
fair value, net of tax
46
(
293
)
(
392
)
Total other comprehensive income that will not be reclassified to the income statement,
net of tax
148
(
427
)
(
562
)
Total other comprehensive income
(
2,220
)
1,738
789
Total comprehensive income attributable to shareholders
4,813
7,934
4,754
Comprehensive income attributable to non-controlling
interests
Net profit / (loss)
29
15
6
Total other comprehensive income that will not be reclassified to the income statement,
net of tax
(
16
)
21
(
4
)
Total comprehensive income attributable to non-controlling interests
13
36
2
Total comprehensive income
Net profit / (loss)
7,061
6,211
3,971
Other comprehensive income
(
2,235
)
1,759
785
of which: other comprehensive income that may be reclassified
to the income statement
(
2,368
)
2,165
1,351
of which: other comprehensive income that will not be reclassified
to the income statement
132
(
406
)
(
566
)
Total comprehensive income
4,826
7,970
4,756
1 Mainly reflects the reclassification of net gains on hedging instruments from OCI to the income statement as the hedged forecast cash flows affected
profit or loss and a decrease in net unrealized gains on US dollar
hedging derivatives resulting from increases in the relevant long-term US dollar interest rates.
415
Balance sheet
USD million
Note
31.12.21
31.12.20
Assets
Cash and balances at central banks
192,817
158,231
Loans and advances to banks
9
15,360
15,344
Receivables from securities financing transactions
9, 22
75,012
74,210
Cash collateral receivables on derivative instruments
9, 22
30,514
32,737
Loans and advances to customers
9
398,693
380,977
Other financial assets measured at amortized cost
9, 14a
26,236
27,219
Total financial assets measured at amortized cost
738,632
688,717
Financial assets at fair value held for trading
21
131,033
125,492
of which: assets pledged as collateral that may be sold or repledged
by counterparties
43,397
47,098
Derivative financial instruments
10, 21, 22
118,145
159,618
Brokerage receivables
21
21,839
24,659
Financial assets at fair value not held for trading
21
59,642
80,038
Total financial assets measured at fair value through profit or loss
330,659
389,808
Financial assets measured at fair value through other comprehensive income
11, 21
8,844
8,258
Investments in associates
29b
1,243
1,557
Property, equipment and software
12
11,712
11,958
Goodwill and intangible assets
13
6,378
6,480
Deferred tax assets
8
8,839
9,174
Other non-financial assets
14b
9,836
9,374
Total assets
1,116,145
1,125,327
Liabilities
Amounts due to banks
15a
13,101
11,050
Payables from securities financing transactions
22
5,533
6,321
Cash collateral payables on derivative instruments
22
31,801
37,313
Customer deposits
15a
544,834
527,929
Funding from UBS Group AG
15b
57,295
53,979
Debt issued measured at amortized cost
17
82,432
85,351
Other financial liabilities measured at amortized cost
19a
9,765
10,421
Total financial liabilities measured at amortized cost
744,762
732,364
Financial liabilities at fair value held for trading
21
31,688
33,595
Derivative financial instruments
10, 21, 22
121,309
161,102
Brokerage payables designated at fair value
21
44,045
38,742
Debt issued designated at fair value
16, 21
71,460
59,868
Other financial liabilities designated at fair value
19b, 21
32,414
31,773
Total financial liabilities measured at fair value through profit or loss
300,916
325,080
Provisions
18a
3,452
2,791
Other non-financial liabilities
19c
8,572
7,018
Total liabilities
1,057,702
1,067,254
Equity
Share capital
338
338
Share premium
24,653
24,580
Retained earnings
27,912
25,251
Other comprehensive income recognized directly in equity, net of tax
5,200
7,585
Equity attributable to shareholders
58,102
57,754
Equity attributable to non-controlling interests
340
319
Total equity
58,442
58,073
Total liabilities and equity
1,116,145
1,125,327
Consolidated financial statements | UBS AG consolidated financial statements
416
Statement of changes in equity
USD million
Share
capital
Share
premium
Retained
earnings
Balance as of 31 December 2018
338
24,655
23,285
Effect of adoption of IFRIC 23
(
11
)
Balance as of 1 January 2019 after the adoption of IFRIC 23
338
24,655
23,274
Premium on shares issued and warrants exercised
0
Tax (expense) / benefit
11
Dividends
(
3,250
)
Translation effects recognized directly in retained earnings
(
9
)
New consolidations / (deconsolidations) and other increases
/ (decreases)
(
7
)
Total comprehensive income for the year
3,403
of which: net profit / (loss)
3,965
of which: OCI, net of tax
(
562
)
Balance as of 31 December 2019
338
24,659
23,419
Premium on shares issued and warrants exercised
(
4
)
2
Tax (expense) / benefit
1
Dividends
(
3,848
)
Translation effects recognized directly in retained earnings
(
49
)
Share of changes in retained earnings of associates and
joint ventures
(
40
)
New consolidations / (deconsolidations) and other increases
/ (decreases)
3
(
76
)
Total comprehensive income for the year
5,769
of which: net profit / (loss)
6,196
of which: OCI, net of tax
(
427
)
Balance as of 31 December 2020
338
24,580
25,251
Premium on shares issued and warrants exercised
(
7
)
2
Tax (expense) / benefit
(
102
)
Dividends
(
4,539
)
Translation effects recognized directly in retained earnings
18
Share of changes in retained earnings of associates and
joint ventures
1
New consolidations / (deconsolidations) and other increases
/ (decreases)
4
182
Total comprehensive income for the year
7,180
of which: net profit / (loss)
7,032
of which: OCI, net of tax
148
Balance as of 31 December 2021
338
24,653
27,912
1 Excludes other comprehensive income related to defined benefit plans and own credit, which is recorded directly in Retained earnings.
2 Includes decreases related to recharges by UBS Group AG for share-based
compensation awards granted to employees of UBS AG or its subsidiaries.
3 Mainly relates to the establishment of a banking partnership with Banco do Brasil. In 2020, UBS AG issued a
49.99
% stake in UBS Brasil
Serviços in exchange
for exclusive access
to Banco do
Brasil’s corporate
clients. Upon
completion of the
transaction in 2020,
equity attributable to
non-controlling interests increased
by USD
115
million, with no
material effect on equity attributable to shareholders.
4 Includes the effects related to the launch of UBS AG’s new operational partnership entity with Sumitomo Mitsui Trust Holdings, Inc. Refer to Note 30 for more
information.
417
Other comprehensive
income recognized
directly in equity,
net of tax
1
of which:
foreign currency
translation
of which:
financial assets
at fair value through
OCI
of which:
cash flow
hedges
of which:
cost of hedging
Total equity
attributable to
shareholders
Non-controlling
interests
Total equity
3,946
3,940
(
103
)
109
52,224
176
52,400
(
11
)
(
11
)
3,946
3,940
(
103
)
109
52,213
176
52,389
0
0
11
11
(
3,250
)
(
8
)
(
3,258
)
9
0
9
0
0
(
7
)
5
(
3
)
1,351
92
117
1,143
4,754
2
4,756
3,965
6
3,971
1,351
92
117
1,143
789
(
4
)
785
5,306
4,032
14
1,260
53,722
174
53,896
(
4
)
(
4
)
1
1
(
3,848
)
(
6
)
(
3,854
)
49
0
49
0
0
(
40
)
(
40
)
65
65
(
12
)
115
103
2,165
1,030
136
1,011
(
13
)
7,934
36
7,970
6,196
15
6,211
2,165
1,030
136
1,011
(
13
)
1,738
21
1,759
7,585
5,126
151
2,321
(
13
)
57,754
319
58,073
(
7
)
(
7
)
(
102
)
(
102
)
(
4,539
)
(
4
)
(
4,542
)
(
18
)
0
(
18
)
0
0
0
1
1
182
12
193
(
2,368
)
(
510
)
(
157
)
(
1,675
)
(
26
)
4,813
13
4,826
7,032
29
7,061
(
2,368
)
(
510
)
(
157
)
(
1,675
)
(
26
)
(
2,220
)
(
16
)
(
2,235
)
5,200
4,617
(
7
)
628
(
39
)
58,102
340
58,442
Consolidated financial statements | UBS AG consolidated financial statements
418
Share information and earnings per share
Ordinary share capital
As
of
31 December
2021,
UBS
AG
had
3,858,408,466
issued
shares
(31 December
2020:
3,858,408,466
shares)
with
a
nominal
value
of
CHF
0.10
each,
leading
to
a
share
capital
of
CHF
385,840,846.60
.
The
shares
were
entirely
held
by
UBS Group AG.
Conditional share capital
As of 31 December 2021, the following
conditional share capital
was available to UBS AG’s Board of Directors (BoD):
–
A
maximum
of
CHF
38,000,000
represented
by
up
to
380,000,000
fully paid registered shares with a
nominal value
of
CHF
0.10
each,
to
be
issued
through
the
voluntary
or
mandatory
exercise
of
conversion
rights
and
/
or
warrants
granted
in
connection
with
the
issuance
of
bonds
or
similar
financial
instruments
on
national
or
international
capital
markets. This conditional
capital
allowance
was approved
at
the Annual General Meeting of UBS
AG on 14 April 2010. The
BoD has not made use of such allowance.
Authorized share capital
UBS
AG
had
no
authorized
capital
available
to
issue
on
31 December 2021.
Earnings per share
In
2015,
UBS
AG
shares
were
delisted
from
the
SIX
Swiss
Exchange and the New York Stock Exchange. As of 31 December
2021, 100% of UBS AG’s issued shares
were held by UBS Group
AG and therefore were not publicly traded. Accordingly, earnings
per share information is not provided for UBS AG.
419
Statement of cash flows
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Cash flow from / (used in) operating activities
Net profit / (loss)
7,061
6,211
3,971
Non-cash items included in net profit and other adjustments:
Depreciation, amortization and impairment of non-financial
assets
1,875
1,909
1,751
Credit loss expense / (release)
(
148
)
695
78
Share of net profits of associates and joint ventures and impairment
related to associates
(
105
)
(
84
)
(
45
)
Deferred tax expense / (benefit)
432
355
460
Net loss / (gain) from investing activities
(
230
)
(
698
)
220
Net loss / (gain) from financing activities
100
3,246
6,506
Other net adjustments
3,790
(
8,061
)
862
Net change in operating assets and liabilities:
Loans and advances to banks and amounts due to banks
2,148
3,586
(
4,336
)
Securities financing transactions
(
2,316
)
9,588
8,678
Cash collateral on derivative instruments
(
3,311
)
(
3,486
)
2,842
Loans and advances to customers
(
26,943
)
(
33,897
)
(
3,205
)
Customer deposits
29,349
52,831
23,399
Financial assets and liabilities at fair value held for trading and derivative financial
instruments
(
10,635
)
11,326
(
18,873
)
Brokerage receivables and payables
8,115
(
5,199
)
(
2,347
)
Financial assets at fair value not held for trading and other financial assets
and liabilities
19,793
392
126
Provisions and other non-financial assets and liabilities
2,617
(
1,213
)
(
537
)
Income taxes paid, net of refunds
(
1,026
)
(
919
)
(
741
)
Net cash flow from / (used in) operating activities
30,563
36,581
18,805
Cash flow from / (used in) investing activities
Purchase of subsidiaries, associates and intangible assets
(
1
)
(
46
)
(
26
)
Disposal of subsidiaries, associates and intangible assets
1
593
674
114
Purchase of property, equipment and software
(
1,581
)
(
1,573
)
(
1,401
)
Disposal of property, equipment and software
295
364
11
Purchase of financial assets measured at fair value through other
comprehensive income
(
5,802
)
(
6,290
)
(
3,424
)
Disposal and redemption of financial assets measured at
fair value through other comprehensive income
5,052
4,530
3,913
Net (purchase) / redemption of debt securities measured
at amortized cost
(
415
)
(
4,166
)
(
562
)
Net cash flow from / (used in) investing activities
(
1,860
)
(
6,506
)
(
1,374
)
Table
continues on the next page.
Consolidated financial statements | UBS AG consolidated financial statements
420
Statement of cash flows (continued)
Table
continued from previous page.
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Cash flow from / (used in) financing activities
Net short-term debt issued / (repaid)
(
3,093
)
23,845
(
17,149
)
Distributions paid on UBS AG shares
(
4,539
)
(
3,848
)
(
3,250
)
Issuance of debt designated at fair value and long-term debt measured
at amortized cost
2
98,619
80,153
65,047
Repayment of debt designated at fair value and long-term debt measured
at amortized cost
2
(
79,799
)
(
87,099
)
(
68,883
)
Net cash flows from other financing activities
(
261
)
(
553
)
(
504
)
Net cash flow from / (used in) financing activities
10,927
12,498
(
24,738
)
Total cash flow
Cash and cash equivalents at the beginning of the year
173,430
119,804
125,853
Net cash flow from / (used in) operating, investing and financing
activities
39,630
42,573
(
7,307
)
Effects of exchange rate differences on cash and cash equivalents
(
5,306
)
11,053
1,258
Cash and cash equivalents at the end of the year
3
207,755
173,430
119,804
of which: cash and balances at central banks
4
192,706
158,088
106,957
of which: loans and advances to banks
13,822
13,928
11,317
of which: money market paper
5
1,227
1,415
1,530
Additional information
Net cash flow from / (used in) operating activities includes:
Interest received in cash
11,170
11,929
15,344
Interest paid in cash
4,802
6,414
10,800
Dividends on equity investments, investment funds and associates
received in cash
6
2,531
1,901
3,145
1 Includes cash proceeds from the sale of UBS AG’s investment in Clearstream Fund Centre AG (previously Fondcenter
AG). UBS AG’s majority stake was
sold in 2020 and the remaining minority investment was sold
in the second quarter of 2021. Refer to
Note 30 for more information. Also includes dividends received
from associates.
2 Includes funding from UBS Group AG measured at
amortized cost (recognized in Funding
from UBS Group AG in the balance sheet)
and measured at fair value (recognized in Other financial
liabilities designated at fair value in the balance
sheet).
3 USD
3,408
million, USD
3,828
million and USD
3,192
million of cash and cash equivalents
(mainly reflected in Loans and advances
to banks) were restricted as of
31 December 2021, 31 December 2020
and 31 December 2019, respectively.
Refer to Note 23 for more
information.
4 Includes only balances with an original maturity of three months or less.
5 Money market paper is included in the balance sheet under Financial assets at fair value held for trading,
Financial assets
measured at fair value through other comprehensive
income, Financial assets at fair value
not held for trading and Other financial
assets measured at amortized cost.
6 Includes dividends received from associates
reported within Net cash flow from / (used in) investing activities.
421
Changes in liabilities arising from financing activities
USD million
Debt issued
measured at
amortized cost
of which:
short-term
1
of which:
long-term
2
Debt issued
designated at fair
value
Over-the-
counter (OTC)
debt
instruments
3
Funding from
UBS Group
AG
4
Total
Balance as of 1 January 2020
62,835
21,837
40,998
66,592
2,022
48,083
179,531
Cash flows
18,722
23,845
(
5,123
)
(
6,423
)
(
6
)
4,606
16,899
Non-cash changes
3,794
984
2,810
(
301
)
44
2,666
6,203
of which: foreign currency translation
3,589
984
2,605
1,760
82
1,395
6,825
of which: fair value changes
(
2,061
)
(
38
)
152
(
1,946
)
of which: hedge accounting and other effects
205
205
1,119
1,324
Balance as of 31 December 2020
85,351
46,666
38,685
59,868
2,060
55,354
202,633
Cash flows
(
550
)
(
3,093
)
2,543
9,075
126
7,076
15,727
Non-cash changes
(
2,369
)
(
475
)
(
1,894
)
2,516
(
58
)
(
2,795
)
(
2,705
)
of which: foreign currency translation
(
1,841
)
(
475
)
(
1,366
)
(
1,611
)
(
65
)
(
1,340
)
(
4,857
)
of which: fair value changes
4,127
7
(
30
)
4,104
of which: hedge accounting and other effects
(
528
)
(
528
)
(
1,425
)
(
1,953
)
Balance as of 31 December 2021
82,432
43,098
39,334
71,460
2,128
59,635
215,655
1 Debt with an original contractual maturity of less than one year.
2 Debt with an original maturity greater than or equal to one year. The classification of debt issued into short-term and long-term does not consider
any early redemption
features.
3 Included in
balance sheet line
Other financial liabilities
designated at fair
value.
4 Includes funding
from UBS Group
AG measured at
amortized cost (refer
to Note 15b)
and
measured at fair value (refer to Note 19b).
Consolidated financial statements | UBS AG consolidated financial statements
422
Notes to the UBS AG consolidated financial statements
Note 1
Summary of material accounting policies
The following table provides an overview of information included in this Note.
423
a)
Significant accounting policies
423
Basis of accounting
423
1)
Consolidation
424
2)
Financial instruments
424
a.
Recognition
424
b.
Classification, measurement and presentation
428
c.
Loan commitments and financial guarantees
428
d.
Interest income and expense
428
e.
Derecognition
428
f.
Fair value of financial instruments
429
g.
Allowances and provisions for expected credit
losses
432
h.
Restructured and modified financial assets
432
i.
Offsetting
433
j.
Hedge accounting
433
3)
Fee and commission income and expenses
434
4)
Share-based and other deferred compensation plans
435
5)
Post-employment benefit plans
435
6)
Income taxes
436
7)
Property,
equipment and software
436
8)
Goodwill
436
9)
Provisions and contingent liabilities
437
10)
Foreign currency translation
437
11)
Net cash settlement contracts
438
b)
Changes in accounting policies, comparability
and other adjustments
438
c)
International Financial Reporting Standards and
Interpretations to be adopted in 2021 and later
and other changes
423
Note 1
Summary of material accounting policies
(continued)
a)
Material accounting policies
This Note describes the
material accounting policies
applied in the
preparation of the
consolidated financial
statements (the
Financial
Statements)
of
UBS
AG
and
its
subsidiaries
(UBS
AG
).
On
24 February 2022,
the Financial
Statements were
authorized for
issue by the Board of Directors.
Basis of accounting
The Financial Statements have been prepared in accordance with
International Financial Reporting
Standards (IFRS), as
issued by the
International
Accounting
Standards
Board
(the
IASB),
and
are
presented in US dollars (USD).
Disclosures
marked
as
audited
in
the
“Risk,
capital,
liquidity
and funding,
and balance
sheet” section
of this
report form
an
integral part of the Financial
Statements. These disclosures relate
to requirements
under IFRS 7,
Financial Instruments:
Disclosures
,
and
IAS
1,
Presentation
of
Financial
Statements
,
and
are
not
repeated in this section.
The
accounting
policies
described
in
this
Note
have
been
applied consistently in all years presented unless otherwise stated
in Note 1b.
Critical accounting estimates and judgments
Preparation of these Financial
Statements under IFRS requires
management
to apply
judgment
and make
estimates
and assumptions
that affect
reported
amounts
of
assets,
liabilities,
income
and
expenses
and
disclosure
of
contingent
assets and
liabilities,
and may
involve
significant
uncertainty
at the
time they are made. Such
estimates and
assumptions
are based on the best
available
information.
UBS
AG
regularly
reassesses
such
estimates
and
assumptions, which
encompass historical experience,
expectations of
the
future and other pertinent factors, to determine their continuing relevance
based on current conditions,
updating them
as necessary. Changes
in those
estimates and
assumptions may have
a
significant effect on
the Financial
Statements.
Furthermore,
actual
results
may differ
significantly
from UBS
AG’s
estimates, which could result in significant
losses to UBS AG, beyond what
was anticipated
or provided
for.
The
following
areas
contain
estimation
uncertainty
or
require
critical
judgment
and
have
a
significant
effect
on
amounts
recognized
in
the
Financial Statements:
–
expected credit loss measurement (refer to item 2g in this Note and to
Note 20);
–
fair value measurement (refer to item 2f in this Note
and to Note 21);
–
income taxes (refer to item 6 in this Note and to Note
8);
–
provisions and contingent liabilities (refer to item 9
in this Note and to
Note 18);
–
post-employment benefit
plans (refer to item
5 in this Note
and to Note
27);
–
goodwill (refer to item 8 in this Note and to Note
13); and
–
consolidation of structured entities (refer to
item 1 in this Note
and to
Note 29).
1) Consolidation
The
Financial
Statements
comprise
the
financial
statements
of
UBS AG
and its
subsidiaries, presented
as a
single economic
entity;
intercompany
transactions
and
balances
have
been
eliminated.
UBS
AG
consolidates
all
entities
that
it
controls,
including
structured entities
(SEs), which is
the case when
it has: (i)
power
over the relevant activities of
the entity;
(ii) exposure to an
entity‘s
variable returns;
and (iii)
the ability
to use
its power
to affect
its
own returns.
Consideration
is
given
to
all
facts
and
circumstances
to
determine whether
UBS AG
has power
over another
entity,
i.e.,
the current ability
to direct the
relevant activities of
an entity when
decisions about those activities need to be made.
Subsidiaries,
including
SEs,
are
consolidated
from
the
date
when control
is gained
and deconsolidated
from the
date when
control ceases.
Control, or
the lack thereof,
is reassessed
if facts
and circumstances indicate that there is a change to one or more
elements required to establish that control is present.
Business combinations are accounted for using the acquisition
method. The amount of any non-controlling
interest is measured
at
the
non-controlling
interest’s
proportionate
share
of
the
acquiree’s identifiable net assets.
›
Refer to Note
29
for more information
Critical accounting estimates and judgments
Each
individual
entity
is
assessed
for
consolidation
in
line
with
the
aforementioned consolidation principles.
The assessment of control
can be
complex
and
requires
the
use
of
significant
judgment,
in
particular
in
determining whether
UBS AG has
power over the
entity. As the nature and
extent
of
UBS
AG’s
involvement
is
unique
for
each
entity,
there
is
no
uniform consolidation
outcome by
entity. Certain entities
within a
class may
be consolidated while
others may
not. When carrying
out the consolidation
assessment, judgment
is exercised
considering all
the relevant
facts and
circumstances, including the
nature and activities
of the investee,
as well as
the substance of voting and similar rights.
›
Refer to Note
29
for more information
Consolidated financial statements | UBS AG consolidated financial statements
424
Note 1
Summary of material accounting policies (continued)
2)
Financial instruments
a. Recognition
UBS AG recognizes financial
instruments when it
becomes a party
to
contractual
provisions
of
an
instrument.
UBS
AG
applies
settlement date accounting to all standard purchases and
sales of
non-derivative financial instruments.
In
transactions
where
UBS
AG
acts
as
a
transferee,
to
the
extent
the
financial
asset
transfer
does
not
qualify
for
derecognition by
the transferor,
UBS AG
does not
recognize the
transferred instrument as its asset.
UBS
AG
also
acts
in
a
fiduciary
capacity,
which
results
in
it
holding
or
placing
assets
on
behalf
of
individuals,
trusts,
retirement benefit plans and
other institutions. Unless these
items
meet
the
definition
of
an
asset
and
the
recognition
criteria
are
satisfied, they are not recognized on UBS AG’s balance sheet and
the related income is excluded from the Financial Statements.
Client
cash balances
associated with
derivatives
clearing and
execution
services
are
not
recognized
on
the
balance
sheet
if,
through
contractual agreement,
regulation
or
practice,
UBS AG
neither obtains benefits from nor controls such cash balances.
b. Classification, measurement and presentation
Financial assets
All financial instruments
are on initial recognition
measured at fair
value
and
classified
as
measured
at
amortized
cost,
fair
value
through
other
comprehensive
income
(FVOCI)
or
fair
value
through
profit
or
loss
(FVTPL)
.
For
financial
instruments
subsequently measured at amortized cost or
FVOCI, the initial fair
value is adjusted for directly attributable transaction costs.
Where the
contractual terms
of a
debt instrument
result in
cash
flows that are
solely payments of
principal and interest
(SPPI) on
the
principal
amount
outstanding,
the
debt
instrument
is
classified
as
measured
at
amortized
cost
if
it
is
held
within
a
business model that has
an objective of
holding financial assets to
collect
contractual
cash flows,
or
at
FVOCI if
it
is held
within a
business
model
with
the
objective
being
achieved
by
both
collecting contractual cash flows and selling financial assets.
All
other
financial
assets
are
measured
at
FVTPL,
including
those
held
for
trading
or
those
managed
on
a
fair
value
basis,
except for derivatives
designated in a
hedge relationship, in
which
case hedge accounting requirements apply (refer
to item 2j in this
Note for more information).
Business model assessment and contractual cash flow
characteristics
UBS AG determines
the nature
of a business
model by
considering
the
way
financial
assets
are
managed
to
achieve
a
particular
business objective.
In assessing whether
contractual cash flows
are SPPI, UBS
AG
considers
whether
the
contractual
terms
of
the
financial
asset
contain
a
term
that
could
change
the
timing
or
amount
of
contractual cash flows arising over the life of the instrument.
Financial liabilities
Financial liabilities measured at amortized cost
Financial liabilities
measured at
amortized cost
include
Debt issued
measured
at
amortized
cost
and
Funding
from UBS
Group AG
,
which
constitute
obligations
of
UBS
AG arising
from
funding it
has received from
UBS Group AG,
which are not
within the UBS
AG scope of consolidation.
The latter includes contingent capital
instruments
issued
to
UBS
Group
AG
cont
ain
ing
contractual
provisions
under which
the principal
amounts would
be written
down or
converted into
equity upon
either a
specified common
equity tier 1 (CET1)
ratio breach or
a determination by
the Swiss
Financial
Market
Supervisory
Authority
(FINMA)
that
a
viability
event
has
occurred.
Such
contractual
provisions
are
not
derivatives,
as
the
underlying
is
deemed
to
be
a
non-financial
variable specific to a party to the contract.
If a debt
were to be written
down or converted into
equity in
a future
period, it
would be
partially or
fully derecognized,
with
the difference between
its carrying amount
and the fair
value of
any equity issued recognized in the income statement.
A gain or loss is recognized in
Other income
when debt issued
is subsequently repurchased
for market-making
or other activities.
A
subsequent
sale
of
own
bonds
in
the
market
is
treated
as
a
reissuance of debt.
Financial liabilities measured at fair value through profit or loss
UBS
AG
designates
certain
issued
debt
instruments
as
financial
liabilities at fair value
through profit or loss, on
the basis that such
financial instruments
include embedded
derivatives and
/ or
are
managed on a fair
value basis (refer to
the table below for
more
information),
in
which
case
bifurcation
of
the
embedded
derivative
component
is
not
required.
Financial
instruments
including
embedded
derivatives
arise
predominantly
from
the
issuance of certain structured debt instruments.
Measurement and presentation
After initial recognition, UBS AG
classifies, measures and presents
its
financial
assets
and
liabilities
in
accordance
with
IFRS
9,
as
described in the table on the following pages.
425
Note 1
Summary of material accounting policies (continued)
Classification, measurement and presentation
of financial assets
Financial assets classification
Significant items included
Measurement and presentation
Measured at
amortized cost
This classification includes:
–
cash and balances at central banks;
–
loans and advances to banks;
–
receivables from securities financing transactions;
–
cash collateral receivables on derivative instruments;
–
residential and commercial mortgages;
–
corporate loans;
–
secured loans, including Lombard loans, and
unsecured loans;
–
loans to financial advisors;
and
–
debt securities held as high-quality liquid
assets
(HQLA).
Measured at amortized cost using the effective interest
method less allowances for expected credit losses
(ECL)
(refer to items 2d and 2g in this Note for more information).
The following items are recognized in the income
statement:
–
interest income, which is accounted for in accordance
with item 2d
in this Note;
–
ECL and reversals;
and
–
foreign exchange (FX) translation gains and losses.
When a financial asset at amortized cost is derecognized,
the gain or loss is recognized in the income statement.
For amounts arising from settlement of certain derivatives,
refer to the next page.
Measured
at FVOCI
Debt instruments
measured at
FVOCI
This classification primarily includes debt securities
and
certain asset-backed securities held as HQLA.
Measured at fair value,
with unrealized gains and losses
reported in
Other comprehensive income,
net of applicable
income taxes, until such investments are derecognized.
Upon derecognition, any accumulated balances in
Other
comprehensive income
are reclassified to the income
statement and reported within
Other income.
The following items, which are determined on the
same
basis as for financial assets measured at amortized
cost,
are
recognized in the income statement:
–
interest income, which is accounted for in accordance
with item 2d
in this Note;
–
ECL and reversals;
and
–
FX translation gains and losses.
Consolidated financial statements | UBS AG consolidated financial statements
426
Note 1
Summary of material accounting policies (continued)
Classification, measurement and presentation
of financial assets
Financial assets classification
Significant items included
Measurement and presentation
Measured at
FVTPL
Held for
trading
Financial assets held for trading include:
–
all derivatives with a positive replacement value,
except
those that are designated and effective hedging
instruments; and
–
other financial assets acquired principally for the
purpose of selling or repurchasing in the near term, or
that are part of a portfolio of identified financial
instruments that are managed together and for
which
there is evidence of a recent actual pattern of short-term
profit taking. Included in this category are debt
instruments (including those in the form of
securities,
money market paper,
and traded corporate and bank
loans) and equity instruments.
Measured at fair value,
with changes recognized in the
income statement.
Derivative assets (including derivatives that
are designated
and effective hedging instruments) are generally
presented as
Derivative financial instruments
, except those
exchange-traded (ETD) and over-the-counter
(OTC)-
cleared derivatives that are legally settled on a daily
basis
or in substance net settled on a daily basis,
which are
presented within
Cash collateral receivables on derivative
instruments.
Changes in fair value, initial transaction costs,
dividends
and gains and losses arising on disposal or redemption
are
recognized in
Other net income from financial
instruments measured at fair value through
profit or loss
,
except interest income on instruments other than
derivatives (refer to item 2d in this Note), interest on
derivatives designated as hedging instruments
in hedges
of interest rate risk and forward points on certain short-
and long-duration FX contracts acting as economic
hedges, which are reported in
Net interest income.
Changes in the fair value of derivatives that
are
designated and effective hedging instruments are
presented either in the income statement or
Other
comprehensive income
, depending on the type of hedge
relationship (refer to item 2j in this Note for more
information).
Mandatorily
measured at
FVTPL – Other
This classification includes financial assets
mandatorily
measured at FVTPL that are not held for trading, as
follows:
–
certain structured loans, certain commercial loans, and
receivables from securities financing transactions are
managed on a fair value basis;
–
loans managed on a fair value basis, including those
hedged with credit derivatives;
–
certain debt securities held as HQLA and
managed on a
fair value basis;
–
certain investment fund holdings and assets
held to
hedge delivery obligations related to cash-settled
employee compensation plans;
–
brokerage receivables, for which contractual cash flows
do not meet the SPPI criterion because the aggregate
balance is accounted for as a single unit of
account,
with interest being calculated on the individual
components;
–
auction rate securities, for which contractual cash
flows
do not meet the SPPI criterion because interest may
be
reset at rates that contain leverage;
–
equity instruments;
and
–
assets held under unit-linked investment contracts.
427
Note 1
Summary of material accounting policies
(continued)
Classification, measurement and presentation
of financial liabilities
Financial liabilities classification
Significant items included
Measurement and presentation
Measured at amortized cost
This classification includes:
–
demand and time deposits;
–
retail savings / deposits;
–
payables
from securities financing transactions;
–
non-structured fixed-rate bonds;
–
subordinated debt;
–
certificates of deposit and covered bonds;
–
obligations against funding from UBS Group AG;
and
–
cash collateral payables on derivative instruments.
Measured at amortized cost using the effective interest
method.
When a financial liability at amortized cost is
derecognized, the gain or loss is recognized in the income
statement.
Measured at
fair value
through
profit or loss
Held for trading
Financial liabilities held for trading include:
–
all derivatives with a negative replacement value
(including certain loan commitments),
except those
that are designated and effective hedging
instruments; and
–
obligations to deliver financial instruments,
such as
debt and equity instruments, that UBS AG has sold
to
third parties but does not own (short positions).
Measurement and presentation of financial liabilities
classified at FVTPL follow the same principles
as for
financial assets classified at FVTPL, except that
the amount
of change in the fair value of a financial liability
designated at FVTPL that is attributable to changes
in UBS
AG’s own credit risk is presented in
Other comprehensive
income
directly within
Retained earnings
and is never
reclassified to the income statement.
Derivative liabilities (including derivatives that
are
designated and effective hedging instruments)
are
generally presented as
Derivative financial instruments
,
except those exchange-traded and OTC-cleared
derivatives that are legally settled on a daily basis
or in
substance net settled on a daily basis, which
are
presented within
Cash collateral payables on derivative
instruments.
Designated at
FVTPL
UBS AG designates
at FVTPL the following financial
liabilities:
–
issued hybrid debt instruments that primarily include
equity-linked, credit-linked and rates-linked bonds
or
notes;
–
issued debt instruments managed on a fair
value
basis;
–
certain payables from securities financing transactions;
–
amounts due under unit-linked investment contracts
the cash flows of which are linked to financial
assets
measured at FVTPL and eliminate an accounting
mismatch;
and
–
brokerage payables, which arise in conjunction with
brokerage receivables and are measured at FVTPL to
achieve measurement consistency.
Consolidated financial statements | UBS AG consolidated financial statements
428
Note 1
Summary of material accounting policies
(continued)
c.
Loan commitments and financial guarantees
Loan
commitments
are
arrangements
to
provide
credit
under
defined terms and
conditions. Irrevocable loan
commitments are
classified
as:
(i)
derivative
loan
commitments
measured
at
fair
value through profit
or loss; (ii) loan
commitments designated at
fair
value
through
profit
or
loss;
or
(iii)
loan
commitments
not
measured at
fair value.
Financial guarantee
contracts are
contracts
that require UBS AG
to make specified
payments to reimburse
the
holder
for
an
incurred
loss
because
a
specified
debtor
fails
to
make
payments
when
due
in
accordance
with
the
terms
of
a
specified debt instrument.
d. Interest income and expense
Interest
income
and
expense
are
recognized
in
the
income
statement
based
on
the
effective
interest
method
.
When
calculating
the
effective
interest
rate
(the
EIR)
for
financial
instruments
(other
than
credit-impaired
financial
instruments),
UBS
AG
estimates
future
cash flows
considering
all
contractual
terms of the instrument,
but not expected credit
losses, with the
EIR applied to the gross
carrying amount of the financial asset or
the
amortized
cost
of
a
financial
liability.
However,
when
a
financial
asset
becomes
credit-impaired
after
initial
recognition,
interest income is
determined by
applying the
EIR to
the amortized
cost
of
the
instrument,
which
represents
the
gross
carrying
amount adjusted for any credit loss allowance.
Upfront
fees,
including
fees
on
loan
commitments
not
measured at fair value where a loan is expected to be issued, and
direct
costs
are
included
within
the
initial
measurement
of
a
financial
instrument
measured
at
amortized
cost
or
FVOCI
and
recognized over the expected
life of the instrument
as part of its
EIR.
Fees related
to loan
commitments where
no loan
is expected
to be issued, as well as loan syndication fees where UBS AG does
not retain a portion
of the syndicated loan
or where UBS AG
does
retain a portion of the syndicated loan at the same effective yield
for comparable risk
as other participants, are
included in
Net fee
and commission income
and either recognized over the
life of the
commitment or when syndication occurs.
›
Refer to item 3 in this Note for more information
Interest
income
on
financial
assets,
excluding
derivatives,
is
included in interest income when positive and in interest expense
when negative.
Similarly, interest
expense on
financial liabilities,
excluding derivatives, is
included in interest
expense,
except when
interest rates are
negative, in which case
it is included in
interest
income.
›
Refer to item 2b
in this Note and Note
3
for more information
e.
Derecognition
Financial assets
UBS AG derecognizes a transferred financial asset, or
a portion of
a financial asset, if the purchaser has received substantially all the
risks and rewards of the asset or
a significant part of the risks
and
rewards
combined
with
a
practical
ability
to
sell
or
pledge
the
asset.
Where
financial
assets
have
been
pledged
as
collateral
or
in
similar
arrangements,
they
are
considered
to
have
been
transferred if the counterparty has received the contractual rights
to the cash flows of
the pledged assets, as may be
evidenced by,
for example,
the counterparty’s
right to
sell or
repledge the
assets.
In transfers where control over the financial asset is retained, UBS
AG continues to
recognize the
asset to
the extent of
its continuing
involvement, determined
by the extent
to which it
is exposed to
changes
in
the
value
of
the
transferred
asset
following
the
transfer.
Certain
OTC
derivative
contracts
and
most
exchange-traded
futures
and
option
contracts
cleared
through
central
clearing
counterparties
and exchanges
are considered
to be
settled on
a
daily basis,
as the
payment or
receipt of
variation margin
on a
daily
basis
represents
legal
or
economic
settlement,
which
results
in
derecognition of the associated derivatives.
›
Refer to Note 22 and Note 23 for more information
Financial liabilities
UBS AG derecognizes
a financial liability
when it is extinguished,
i.e., when
the obligation
specified in
the contract
is discharged,
canceled
or
expires.
When
an
existing
financial
liability
is
exchanged for a
new one from
the same lender
on substantially
different
terms,
or
the
terms
of
an
existing
liability
are
substantially modified, the original
liability is derecognized
and a
new
liability
recognized
with
any
difference
in
the
respective
carrying amounts recognized in the income statement.
f. Fair value of financial instruments
UBS
AG
accounts
for
a
significant
portion
of
its
assets
and
liabilities at fair value. Fair
value is the price on the measurement
date
that would
be received
for the
sale of
an asset
or paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants in the principal market, or in the most advantageous
market in the absence of a principal market.
›
Refer to Note 21 for more information
429
Note 1
Summary of material accounting policies
(continued)
Critical accounting estimates and judgments
The use
of valuation techniques, modeling
assumptions and estimates
of
unobservable market
inputs in
the fair
valuation of
financial instruments
requires
significant judgment and could affect the
amount of gain or loss
recorded
for
a
particular
position.
Valuation
techniques
that
rely
more
heavily on unobservable
inputs and sophisticated
models inherently require
a higher
level of judgment
and may
require adjustment
to reflect
factors
that market
participants would
consider in
estimating fair
value, such
as
close-out costs, which are presented in Note 21d.
UBS
AG
‘
s
governance
framework
over
fair
value
measurement
is
described in
Note 21b,
and UBS
AG provides
a sensitivity
analysis of
the
estimated effects arising from changing significant unobservable inputs in
Level 3 financial instruments
to reasonably possible
alternative assumptions
in Note 21g.
›
Refer to Note 21 for more information
g. Allowances and provisions for expected credit losses
ECL
are
recognized
for
financial
assets
measured
at
amortized
cost,
financial
assets
measured
at
FVOCI,
fee
and
lease
receivables,
financial
guarantees
,
and
loan
commitments
not
measured at
fair value. ECL
are also
recognized on the
undrawn
portion
of
committed
unconditionally
revocable
credit
lines,
which
include
UBS
AG
’s
credit
card
limits
and
master
credit
facilities, as UBS
AG is
exposed to credit
risk because
the borrower
has the ability to
draw down funds
before UBS AG can
take credit
risk mitigation actions.
Recognition of expected credit losses
ECL are recognized on the following basis:
–
Stage 1 instruments: Maximum 12-month
ECL are recognized
from initial recognition,
reflecting the portion
of lifetime cash
shortfalls that would
result if a default
occurs in the 12
months
after
the
reporting
date,
weighted
by
the
risk
of
a
default
occurring.
–
Stage 2
instruments:
Lifetime
ECL
are
recognized
if
a
significant
increase
in
credit
risk
(
an
SICR)
is
observed
subsequent
to
the
instrument’s
initial
recognition,
reflecting
lifetime
cash
shortfalls
that
would
result
from
all
possible
default events over the expected life of a financial instrument,
weighted by
the risk
of a
default occurring.
When an
SICR is
no longer observed, the instrument will move back to stage 1.
–
Stage 3
instruments:
Lifetime
ECL
are
always
recognized
for
credit-impaired
financial
instruments,
as
determined
by
the
occurrence of one or more loss events, by estimating
expected
cash
flows
based
on
a
chosen
recovery
strategy.
Credit
-
impaired
exposures
may
include
positions
for
which
no
allowance has been recognized, for example because they are
expected to be fully recoverable through collateral held.
–
Changes
in
lifetime
ECL
since
initial
recognition
are
also
recognized for
assets that
are purchased
or originated
credit-
impaired (POCI). POCI financial instruments include those that
are purchased
at a
deep discount
or newly
originated with
a
defaulted counterparty; they
remain a separate
category until
derecognition.
All
or
part
of
a
financial
asset
is
written
off
if
it
is
deemed
uncollectible or forgiven.
Write-offs reduce the
principal amount
of a
claim and
are charged
against related
allowances for
credit
losses. Recoveries, in part or in full, of
amounts previously written
off are generally credited to
Credit loss (expense) / release
.
ECL
are
recognized
in
the
income
statement
in
Credit
loss
(expense) / release
. A corresponding ECL allowance is reported as
a decrease in the carrying amount of financial assets measured at
amortized cost on the balance sheet.
For financial assets that are
measured at
FVOCI, the
carrying amount
is not
reduced, but
an
accumulated
amount
is
recognized
in
Other
comprehensive
income
.
For
off-balance
sheet
financial
instruments
and
other
credit lines, provisions for ECL are presented in
Provisions.
Default and credit impairment
UBS
AG
applies
a
single
definition
of
default
for
credit
risk
management
purposes,
regulatory
reporting
and
ECL,
with
a
counterparty
classified
as
defaulted
based
on
quantitative
and
qualitative criteria.
›
Refer to “Credit policies for distressed assets’’ in the ‘’Risk
management and control” section of this report for
more
information
Measurement of expected credit losses
IFRS
9
ECL
reflect
an
unbiased,
probability-weighted
estimate
based
on
loss
expectations
resulting
from
default
events.
The
method
used
to
calculate
ECL
applies
the
following
principal
factors: probability
of default
(PD), loss
given default
(LGD) and
exposure
at default
(EAD). Parameters
are
generally determined
on an
individual financial
asset level. Based
on the materiality
of
the
portfolio,
for
credit
card
exposures
and
personal
account
overdrafts
in
Switzerland,
a
portfolio
approach
is
applied
that
derives an average
PD and LGD
for the entire
portfolio. PDs and
LGDs used in the ECL calculation are point-in-time (PIT)-based for
key portfolios and consider both current conditions and expected
cyclical
changes.
For
material
portfolios,
PDs
and
LGDs
are
determined for
different scenarios,
whereas EAD
projections are
treated as scenario independent.
For the
purpose of
determining the
ECL-relevant parameters,
UBS AG
leverages its
Pillar 1 internal
ratings-based (IRB)
models
that
are
also
used
in
determining
expected
loss
(EL)
and
risk-
weighted assets
under the
Basel III framework
and Pillar 2
stress
loss models.
Adjustments have
been made
to these
models and
IFRS
9-related
models
have
been
developed
that
consider
the
complexity,
structure
and
risk
profile
of
relevant
portfolios
and
take
account
of
the
fact
that
PDs
and
LGDs
used
in
the
ECL
calculation
are
PIT-based,
as
opposed
to
the
corresponding
Basel III through-the-cycle
(TTC) parameters.
All models
that are
relevant for
measuring expected
credit losses
are subject
to UBS
AG’s model validation and oversight processes.
Consolidated financial statements | UBS AG consolidated financial statements
430
Note 1
Summary of material accounting policies (continued)
Probability of default:
PD represents the
probability of a
default
over
a
specified
time
period.
A
12-month
PD
represents
the
probability of
default determined
for the
next 12
months and
a
lifetime
PD
represents
the
probability
of
default
over
the
remaining lifetime of
the instrument.
PIT PDs
are derived from
TTC
PDs and scenario forecasts.
The modeling is region-,
industry- and
client
segment-specific
and
considers
both
macroeconomic
scenario dependencies and client-idiosyncratic information.
Exposure
at
default:
EAD
represents
an
estimate
of
the
exposure to credit risk
at the time of
a potential default
occurring,
considering
expected
repayments,
interest
payments
and
accruals, discounted at
the EIR. Future
drawdowns on facilities
are
considered
through
a
credit
conversion
factor
(a
CCF)
that
is
reflective
of
historical
drawdown
and
default
patterns
and
the
characteristics of the respective portfolios.
Loss given
default:
LGD represents
an estimate
of the loss
at the
time of a potential
default occurring,
taking into
account expected
future cash
flows from
collateral
and other
credit
enhancements,
or
expected
payouts
from
bankruptcy
proceedings
for
unsecured
claims and, where applicable, time to realization of collateral and
the seniority
of claims.
LGD is
commonly
expressed
as a percentage
of EAD.
Estimation of expected credit losses
Number of scenarios and estimation of scenario weights
Determination of probability
-weighted ECL
requires evaluating
a
range
of
diverse
and
relevant
future
economic
conditions,
especially
with
a
view
to
modeling
the
non-linear
effect
of
assumptions about macroeconomic factors on the estimate.
To
accommodate
this
requirement,
UBS
AG
uses
different
economic
scenarios
in
the
ECL
calculation
.
Each
scenario
is
represented
by
a
specific
scenario
narrative,
which
is
relevant
considering the exposure of key portfolios to economic risks, and
for
which
a
set
of
consistent
macroeconomic
variables
is
determined. The estimation
of the appropriate weights
for these
scenarios
is
predominantly
judgement-based.
The
assessment
is
based on a
holistic review of
the prevailing economic
or political
conditions,
which
may
exhibit
different
levels
of
uncertainty.
It
takes
into
account
the
impact
of
changes
in
the
nature
and
severity
of
the underlying
scenario
narratives
and
the
projected
economic variables.
The
determined
weights
constitute
the
probabilities
that
the
respective
set
of
macroeconomic
conditions
will
occur
and
not
that
the
chosen
particular
narratives
with
the
related
macroeconomic variables will materialize.
Macroeconomic and other factors
The
range
of
macroeconomic,
market
and
other
factors
that
is
modeled
as
part
of
the
scenario
determination
is
wide,
and
historical information is
used to support
the identification of
the
key factors.
As the
forecast horizon
increases, the
availability of
information
decreases,
requiring
an
increase
in
judgment.
For
cycle
-
sensitive
PD
a
nd
LGD
determination
purposes,
UBS
AG
projects the relevant economic factors for a period
of three years
before reverting, over
a specified period, to
cycle-neutral PD and
LGD for longer-term projections.
Factors relevant
for ECL
calculation vary
by type
of exposure.
Regional
and
client-segment
characteristics
are
generally
taken
into
account,
with
specific
focus
on
Switzerland
and
the
US,
considering UBS AG’s key ECL-relevant portfolios.
For
UBS
AG,
the
following
forward-looking
macroeconomic
variables represent the most relevant factors for ECL calculation:
–
GDP growth rates, given
their significant effect on
borrowers’
performance;
–
unemployment
rates, given
their significant
effect on
private
clients’ ability to meet contractual obligations;
–
house price indices, given their
significant effect on mortgage
collateral valuations;
–
interest rates,
given their
significant effect
on counterparties’
abilities to service debt;
–
consumer
price
indices,
given
their
overall
relevance
for
companies’
performance,
private
clients’
purchasing
power
and economic stability; and
–
equity indices,
given that
they are
an important
factor in
our
corporate rating tools.
Scenario generation, review process and governance
A
team
of
economists,
who
are
part
of
Group
Risk
Control,
develop
the
forward-looking
macroeconomic
assumptions
with
involvement from a broad range of experts.
The
scenarios, their
weight and
the key
macroeconomic and
other
factors
are
subject
to
a
critical
assessment
by
the
IFRS
9
Scenario Sounding Sessions and ECL Management Forum, which
include senior management from Group Risk and Group Finance.
Important aspects
for the
review include
whether there
may be
particular credit
risk concerns
that may
not be
capable of
being
addressed systematically and
require post-model adjustments
for
stage allocation and ECL allowance.
The
Group
Model
Governance
Committee
,
as
the
highest
authority under UBS
AG’s model governance framework,
ratifies
the decisions taken by the ECL Management Forum.
›
Refer to Note 20 for more information
ECL measurement period
The period for which lifetime ECL are determined is based on the
maximum
contractual
period
that
UBS
AG
is
exposed
to
credit
risk, taking
into account
contractual extension,
termination and
prepayment
options.
For
irrevocable
loan
commitments
and
financial guarantee contracts,
the measurement period
represents
the
maximum
contractual
period
for
which
UBS
AG
has
an
obligation to extend credit.
431
Note 1
Summary of material accounting policies (continued)
Additionally,
some
financial
instruments
include
both
an
on-
demand loan and
a revocable undrawn
commitment, where the
contractual cancellation right
does not limit
UBS AG’s exposure
to
credit risk
to the
contractual notice
period, as
the client
has the
abi
lity
to
draw
down
funds
before
UBS
AG
can
take
risk
-
mitigating actions.
In such
cases UBS
AG is required
to estimate
the period
over which
it is
exposed to
credit risk.
This applies to
UBS
AG
’s
credit
card
limits,
which
do
not
have
a
defined
contractual maturity date, are callable on demand and where the
drawn and undrawn components are managed as
one exposure.
The
exposure
arising
from
UBS
AG’s
credit
card
limits
is
not
significant and is managed at a portfolio level, with credit actions
triggered
when
balances
are
past
due.
An
ECL
measurement
period of seven years
is applied for
credit card limits,
capped at 12
months for
stage 1 balances,
as a
proxy for
the period
that UBS
AG is exposed to credit risk.
Customary
master
credit
agreements
in
the
Swiss
corporate
market
also
include
on-demand
loans
and
revocable
undrawn
commitments.
For
smaller
commercial
facilities,
a
risk-based
monitoring
(RbM)
approach
is
in
place
that
highlights
negative
trends
as
risk
events,
at
an
individual
facility
level,
based
on
a
combination
of
continuously
updated
risk
indicators.
The
risk
events trigger additional
credit reviews by
a risk officer,
enabling
informed credit
decisions to
be taken.
Larger corporate
facilities
are not subject
to RbM, but
are reviewed
at least
annually through
a
formal
credit
review.
UBS
AG
has
assessed
these
credit
risk
management practices and
considers both
the RbM approach
and
formal credit
reviews as
substantive credit
reviews resulting
in a
re-origination
of
the
given
facility.
Following
this,
a
12-month
measurement
period
from
the
reporting
date
is
used
for
both
types of facilities as
an appropriate proxy of
the period over
which
UBS AG is
exposed to credit
risk, with 12
months also used
as a
look-back
period for
assessing SICR,
always from
the respective
reporting date.
Significant increase in credit risk
Financial
instruments
subject
to
ECL
are
monitored
on
an
ongoing
basis.
To
determine
whether
the
recognition
of
a
maximum
12-month
ECL
continues
to
be
appropriate,
an
assessment
is made
as
to
whether
an
SICR
has
occurred
since
initial
recognition
of
the
financial
instrument
,
applying
both
quantitative
and qualitative
factors.
Primarily, UBS
AG assesses
changes in
an instrument’s
risk of
default
on
a
quantitative
basis
by
comparing
the
annualized
forward-looking
and
scenario-weighted
lifetime
PD
of
an
instrument determined at two different dates:
–
at the reporting date; and
–
at inception of the instrument.
If,
based
on
UBS
AG’s
quantitative
modeling,
an
increase
exceeds a set threshold, an SICR is deemed to have occurred and
the
instrument
is
transferred
to
stage 2
with
lifetime
ECL
recognized.
The threshold
applied varies
depending on
the original
credit
quality of the borrower,
with a higher SICR
threshold set for
those
instruments
with
a
low
PD
at
inception.
The
SICR
assessment
based on PD changes
is made at
an individual financial asset
level.
A high-level
overview of
the SICR
trigger, which
is a
multiple of
the
annualized
remaining
lifetime
PIT
PD
expressed
in
rating
downgrades,
is
provided
in
the
“SICR
thresholds”
table
below.
The actual SICR
thresholds applied are
defined on a
more granular
level by interpolating between the values shown in the table.
SICR thresholds
Internal rating at origination
of the instrument
Rating downgrades /
SICR trigger
0–3
3
4–8
2
9–13
1
›
Refer to the “
Risk management and control
” section of this
report for more details about UBS AG’s internal grading system
Irrespective
of
the
SICR
assessment
based
on
default
probabilities, credit
risk is
generally deemed
to have
significantly
increased for an instrument if the contractual payments are more
than
30
days
past
due.
For
certain
less
material
portfolios,
specifically
the
Swiss
credit
card
portfolio,
the
30-day
past
due
criterion
is
used
as
the
primary
indicator
of
an
SICR.
Where
instruments are transferred to stage 2 due
to the 30-day past
due
criterion,
a
minimum
period
of
six
months
is
applied
before
a
transfer
back
to
stage 1
can
be
triggered.
For
instruments
in
Personal &
Corporate Banking
and Global
Wealth Management
Region Switzerland
that are
between 90
and 180
days past
due
but
have
not
been
reclassified
to
stage 3,
a
one-year
period
is
applied before a transfer back to stage 1 can be triggered.
Additionally,
based
on
individual
counterparty-specific
indicators,
external
market
indicators
of
credit
risk
or
general
economic
conditions,
counterparties may
be moved
to a
watch
list, which is used as a
secondary qualitative indicator for an SICR.
Exception management is further applied,
allowing for individual
and collective adjustments
on exposures
sharing the same
credit
risk characteristics
to take
account of
specific situations
that are
not otherwise fully reflected.
In
general,
the
overall
SICR
determination
process
does
not
apply
to
Lombard
loans,
securities
financing
transactions
and
certain other asset-based
lending transactions, because
of the risk
management
practices
adopted,
including
daily
monitoring
processes with strict margining. If margin calls are not satisfied, a
position
is
closed
out
and
classified
as
a
stage 3
position.
In
exceptional
cases,
an
individual
adjustment
and
a
transfer
into
stage 2 may be made to take account of specific facts.
Consolidated financial statements | UBS AG consolidated financial statements
432
Note 1
Summary of material accounting policies
(continued)
Credit risk
officers are
responsible for
the identification
of an
SICR,
which for accounting purposes is in some respects different
from
internal
credit
risk
management processes.
This difference
mainly
arises
because
ECL
accounting
requirements
are
instrument-specific,
such
that
a
borrower
can
have
multiple
exposures
allocated
to
different
stages,
and
maturing
loans
in
stage 2 will
migrate to
stage 1 upon
renewal irrespective
of the
actual
credit
risk
at
that
time.
Under
a
risk-based
approach,
a
holistic counterparty
credit assessment
and the
absolute level
of
risk at any given date
will determine what risk-mitigating actions
may be warranted.
›
Refer to the “
Risk management and control
” section of this
report for more information
Critical accounting estimates and judgments
The calculation of ECL requires management
to apply significant judgment
and make estimates and assumptions
that can result in significant
changes
to the timing and amount of ECL recognized.
Determination of a significant increase in
credit risk
IFRS 9 does not include a definition of what constitutes an SICR, with UBS
AG’s assessment considering
qualitative and quantitative
criteria. An IFRS
9
ECL Management Forum has
been established to review
and challenge the
SICR results.
Scenarios, scenario weights and macroeconomic
variables
ECL reflect an unbiased and probability-weighted amount, which UBS AG
determines
by
evaluating
a
range
of
possible
outcomes.
Management
selects
forward-looking
scenarios
that
include
relevant
macroeconomic
variables
and
management’s
assumptions
around
future
economic
conditions. IFRS
9 Scenario Sounding
Sessions,
in addition
to the IFRS
9 ECL
Management
Forum,
are
in
place
to
derive,
review
and
challenge
the
scenario selection and weights,
and to determine
whether any additional
post-model adjustments are required that may significantly
affect ECL.
ECL measurement period
Lifetime ECL are
generally determined
based upon the
contractual maturity
of the transaction,
which significantly
affects ECL. For credit
card limits and
Swiss callable master
credit facilities, judgment
is required, as UBS
AG must
determine the period over
which it is exposed
to credit risk.
A seven-year
period is
applied for
credit card
limits, capped
at 12
months for
stage 1
positions, and a 12-month period applied for
master credit facilities.
Modeling and post-model adjustments
A number
of complex
models have
been developed
or modified
to calculate
ECL,
with
additional
post-model
adjustments
required
which
may
significantly
affect
ECL.
The
models
are
governed
by
UBS
AG’s
model
validation
controls
and
approved
by
the
Group
Model
Governance
Committee (the GMGC).
The post-model adjustments
are approved by the
ECL Management Forum and endorsed by the
GMGC.
A
sensitivity
analysis
covering
key
macroeconomic
variables
,
scenario
weights and SICR trigger points
on ECL measurement is provided
in Note
20f.
›
Refer to Note 20 for more information
h.
Restructured and modified financial assets
When payment default is expected,
or where default has already
occurred, UBS AG
may grant
concessions to
borrowers in financial
difficulties that
it would not
consider in
the normal course
of its
business, such as
preferential interest rates, extension
of maturity,
modifying
the
schedule
of
repayments,
debt
/
equity
swap,
subordination,
etc. When a concession or forbearance measure is
granted, each case
is considered individually
and the exposure
is
generally classified as
being in default.
Forbearance classification
will
remain
until
the
loan
is
collected
or
written
off,
non-
preferential
conditions
superseding
preferential
conditions
are
granted
or
until
the
counterparty
has
recovered
and
the
preferential conditions no longer exceed UBS AG’s risk tolerance.
Modifications result in an alteration of future contractual cash
flows and can occur
within UBS AG’s normal
risk tolerance or as
part of a
credit restructuring where
a counterparty is
in financial
difficulties. The
restructuring or
modification of
a financial
asset
could lead
to a
substantial change
in the
terms and
conditions,
resulting in the
original financial asset
being derecognized and
a
new
financial
asset
being
recognized.
Where
the
modification
does
not
result
in
a
derecognition,
any
difference
between
the
modified contractual cash
flows discounted at
the original
EIR and
the existing
gross carrying amount
of the
given financial asset
is
recognized in the
income statement as
a modification gain
or loss.
i. Offsetting
UBS AG
presents financial assets
and liabilities
on its
balance sheet
net if (i) it has a legally enforceable right to set
off the recognized
amounts
and
(ii)
it
intends
either
to
settle
on
a
net
basis
or
to
realize
the
asset
and
settle
the
liability
simultaneously.
Netted
positions include, for example, certain derivatives and repurchase
and reverse
repurchase transactions
with various
counterparties,
exchanges and clearing houses.
In assessing whether UBS
AG intends to either
settle on a net
basis, or to realize the asset and settle the liability simultaneously,
emphasis is placed on the effectiveness of operational settlement
mechanics
in
eliminating
substantially
all
credit
and
liquidity
exposure
between
the
counterparties.
This
condition
precludes
offsetting on
the balance
sheet for
substantial amounts
of
UBS
AG’s
financial
assets
and
liabilities,
even
though
they
may
be
subject
to
enforceable
netting
arrangements.
R
epurchase
arrangements and securities financing transactions are presented
net only to the extent that the settlement mechanism
eliminates,
or results
in insignificant,
credit and
liquidity risk,
and processes
the
receivables
and
payables
in
a
single
settlement
process
or
cycle.
›
Refer to Note
22
for more information
433
Note 1
Summary of material accounting policies (continued)
j.
Hedge accounting
UBS AG applies
hedge accounting requirements of IFRS 9, unless
stated otherwise
below, where the criteria for documentation
and
hedge
effectiveness are
met.
If
a
hedge
relationship no
longer
meets
the
criteria
for
hedge
accounting,
hedge
accounting
is
discontinued. Voluntary
discontinuation of
hedge
accounting is
permitted under
IAS 39 but
not under
IFRS 9.
Fair value hedges of interest rate risk related to debt instruments
and loan assets
The fair value change
of the hedged item
attributable
to a hedged
risk is
reflected as
an
adjustment to
the
carrying amount of
the
hedged item, and recognized
in the income statement along with
the change
in the fair
value
of the
hedging
instrument.
Fair value hedges of portfolio interest rate risk related to loans
designated under IAS 39
Prior to discontinuation in December 2021, the fair value change
of the
hedged item
attributable to
a hedged
risk is
reflected within
Other
financial
assets
measured
at
amortized
cost
or
Other
financial liabilities measured
at amortized cost
and recognized in
the income statement
along with the
change in the
fair value of
the hedging instrument.
Fair value hedges of FX risk related to debt instruments
The
fair
value
change
of
the
hedged
item
attributable
to
the
hedged risk
is reflected
in the measurement
of the
hedged item
and recognized
in the
income statement
along with
the change
in the fair value of
the hedging instrument. The foreign
currency
basis
spread
of
cross-currency
swaps
designated
as
hedging
derivatives is excluded from the designation and
accounted for as
a cost of hedging with
amounts deferred in
Other comprehensive
income
within
Equity
. These amounts are released
to the income
statement over the term of the hedged item.
Discontinuation of fair value hedges
Discontinuations
for
reasons
other
than
derecognition
of
the
hedged
item
result
in
an
adjustment to
the
carrying
amount,
which
is
amortized to the income statement over the remaining life of the
hedged
item using
the effective
interest
method.
If the
hedged
item
is derecognized,
the unamortized
fair value adjustment
or deferred
cost of
hedging amount is recognized immediately in the income
statement
as part
of any
derecognition
gain or
loss.
Cash flow hedges of forecast transactions
Fair value gains
or losses associated with
the effective portion
of
derivatives designated as cash
flow hedges for
cash flow repricing
risk are recognized initially in
Other comprehensive income
within
Equity
and
reclassified
to
the
income
statement
in
the
periods
when
the
hedged
forecast
cash
flows
affect
profit
or
loss,
including discontinued
hedges for which
forecast cash
flows are
expected
to
occur.
If
the
forecast
transactions
are
no
longer
expected to
occur,
the deferred
gains or
losses are
immediately
reclassified to the income statement.
Hedges of net investments in foreign operations
Gains or losses on the hedging
instrument
relating to the effective
portion of a hedge are recognized
directly in
Other comprehensive
income
within
Equity,
while
any
gains
or
losses
relating
to
the
ineffective
and / or undesignated
portion (for
example, the
interest
element
of
a
forward
contract)
are
recognized
in
the
income
statement.
Upon
disposal
or
partial
disposal
of the
foreign
operation,
the cumulative
value
of any
such
gains
or losses
recognized
in
Equity
associated
with the
entity
is reclassified
to
Other income
.
Interest Rate Benchmark Reform
UBS
AG
can
continue
hedge
accounting
during
the
period
of
uncertainty before existing interest rate benchmarks are replaced
with alternative
risk-free interest rates.
During this
period, UBS
AG
can
assume
that
the
current
benchmark
rates
will
continue
to
exist,
such
that
forecast
transactions
are
considered
highly
probable
an
d
hedge
relationships
remain,
with
little
or
no
consequential
impact
on
the
financial
statements.
Upon
replacement
of
existing
interest
rate
benchmarks
by
alternative
risk-free interest rates expected in 2021 and beyond, UBS
AG will
apply the requirements of
Amendments to IFRS 9, IAS 39, IFRS 7,
IFRS 4 and IFRS 16 (Interest Rate Benchmark Reform – Phase 2).
›
Refer to Note 1b for more information
3) Fee and commission income and expenses
UBS
AG
earns fee
income
from
the
diverse
range
of
services it
provides to its
clients. Fee income can
be divided into two
broad
categories:
fees
earned
from
services
that
are
provided
over
a
certain
period
of
time,
such
as
management
of
clients’
assets,
custody
services
and
certain
advisory
services;
and
fees
earned
from
point-in-time
services,
such
as
underwriting
fees,
deal-
contingent
merger
and
acquisitions
fees,
and
brokerage
fees
(e.g., securities
and derivatives
execution and
clearing). UBS
AG
recognizes
fees
earned
from
point-in-time-services
when
it
has
fully
provided
the
service
to
the
customer.
Where
the
contract
requires
services to be
provided over
time, income
is recognized
on a systematic basis over the life of the agreement.
Consideration
received
is
allocated
to
the
separately
identifiable performance
obligations in
a contract.
Owing to
the
nature
of
UBS
AG’s
business,
contracts
that
include
multiple
performance obligations are typically those that
are considered to
include
a
series of
similar performance
obligations fulfilled
over
time
with
the
same
pattern
of
transfer
to
the
client,
e.g.,
management
of
client
assets
and
custodial
services.
As
a
consequence,
UBS
AG
is
not
required
to
apply
significant
judgment
in
allocating
the
consideration
received
across
the
various performance obligations.
Consolidated financial statements | UBS AG consolidated financial statements
434
Note 1
Summary of material accounting policies (continued)
Point-in-time
services
are
generally
for
a
fixed
price
or
dependent on
deal size,
e.g., a
fixed number
of basis
points of
trade
size,
where
the
amount
of
revenue
is
known
when
the
performance
obligation
is
met.
Fixed
over-time
fees
are
recognized on
a straight-line
basis over
the performance period.
Custodial
and
asset
management
fees
can
be
variable
through
reference to the size of the customer portfolio. However,
they are
generally
billed
on
a
monthly
or
quarterly
basis
once
the
customer’s portfolio
size is
known or
known with
near certainty
and
therefore
also
recognized
ratably
over
the
performance
period. UBS
AG does
not recognize
performance fees
related to
management
of
clients’
assets
or
fees
related
to
contingencies
beyond UBS AG’s control until such uncertainties are resolved.
UBS AG’s fees are generally earned from short-term contracts.
As
a
result,
UBS
AG
’s
contracts
do
not
include
a
financing
component or
result in
the recognition
of significant
receivables
or prepayment assets. Furthermore, due to the short-term nature
of such contracts,
UBS AG has not
capitalized any material
costs
to obtain or fulfill a contract
or generated any significant contract
assets or liabilities.
UBS AG presents expenses primarily in line with their nature
in
the income statement, differentiating between expenses that are
directly
attributable
to
the
satisfaction
of
specific
performance
obligations associated with the
generation of revenues, which
are
generally
presented
within
Total
operating
income
as
Fee
and
commission
expense
,
and
those
that
are
related
to
personnel,
general and administrative expenses,
which are presented within
Total operating
expenses
. For
derivatives execution
and clearing
services (where UBS AG
acts as an agent),
UBS AG only records
its
specific fees in the income
statement, with fees payable to other
parties
not recognized
as an
expense but
instead directly
offset
against the associated income collected from the given client.
›
Refer to Note 4 for more information, including
the
disaggregation of revenues
4)
Share-based and other deferred compensation plans
UBS AG
recognizes expenses
for deferred
compensation awards
over the
period that
the employee
is required
to provide
service
to
become
entitled
to
the
award.
Where
the
service
period
is
shortened,
for
example
in
the
case
of
employees
affected
by
restructuring programs or
mutually agreed termination
provisions,
recognition
of
such
expense
is
accelerated
to
the
termination
date. Where no
future service is
required, such
as for employees
who are eligible for
retirement or who have
met certain age and
length-of-service criteria, the services are presumed to have been
received
and
compensation
expense
is
recognized
over
the
performance year or, in the case of off-cycle awards, immediately
on the grant date.
Share-based compensation plans
UBS Group
AG is the
grantor of and
maintains the obligation
to
settle
share-based
compensation
plans
that
are
awarded
to
employees of
UBS AG.
As a
consequence, UBS
AG classifies
the
awards
of
UBS
Group
AG
shares
as
equity-settled
share-based
payment transactions. UBS
AG recognizes the
fair value
of awards
granted
to
its
employees
by
reference
to
the
fair
value
of
UBS
Group AG’s
equity instruments on the date of grant, taking into
account
the
terms
and
conditions
inherent
in
the
award,
including, where
relevant, dividend rights,
transfer restrictions in
effect
beyond
the
vesting
date,
market
conditions,
and
non-
vesting conditions.
For equity-settled
awards, fair
value is
not remeasured
unless
the
terms
of
the
award
are
modified
such
that
there
is
an
incremental increase in value. Expenses
are recognized, on a per-
tranche basis, over the service period based
on an estimate of the
number
of
instruments
expected
to
vest
and
are
adjusted
to
reflect the actual outcomes of service or performance conditions.
For
equity-settled
awards,
forfeiture
events
resulting
from
a
breach of
a non-vesting
condition (i.e.,
one that
does not
relate
to
a
service
or
performance
condition)
do
not
result
in
any
adjustment to the share-based compensation expense.
For cash-settled
share-based awards,
fair value
is remeasured
at each reporting
date, so that
the cumulative
expense recognized
equals the cash distributed.
Other deferred compensation plans
Compensation expense for other deferred
compensation plans is
recognized on a
per-tranche or straight-line
basis, depending on
the nature of
the plan. The
amount recognized is
measured based
on the
present
value of
the amount
expected to
be paid
under
the
plan and
is remeasured
at each
reporting
date,
so that
the
cumulative expense
recognized equals
the cash
or the
fair value
of respective financial instruments distributed.
›
Refer to Note
28
for more information
435
Note 1
Summary of material accounting policies (continued)
5)
Post-employment benefit plans
Defined benefit plans
Defined
benefit
plans
specify
an
amount
of
benefit
that
an
employee
will
receive,
which
usually
depends
on
one
or
more
factors,
such
as
age,
years
of
service
and
compensation.
The
defined
benefit
liability
recognized
in
the
balance
sheet
is
the
present value
of the
defined benefit
obligation, measured
using
the projected unit
credit method, less
the fair value of
the plan’s
assets
at
the
balance
sheet
date,
with
changes
resulting
from
remeasurements
recorded
immediately
in
Other
comprehensive
income
.
If
the
fair
value
of
the plan
’s assets
is
higher
than
the
present value of the
defined benefit obligation, the
recognition of
the resulting net asset is limited to the present value of economic
benefits
available
in
the
form
of
refunds
from
the
plan
or
reductions in future
contributions to the plan.
Calculation of the
net
defined
benefit
obligation
or
asset
takes
into
account
the
specific
features
of
each
plan,
including
risk
sharing
between
employee
and
employer,
and
is
calculated
periodically
by
independent qualified actuaries.
Critical accounting estimates and judgments
The net defined benefit liability or asset at the balance sheet date and the
related personnel expense
depend on the
expected future benefits
to be
provided,
determined
using
a
number
of
economic
and
demographic
assumptions.
A
range
of
assumptions
could
be
applied,
and
different
assumptions could
significantly alter
the defined
benefit liability
or asset
and pension expense
recognized. The most
significant assumptions
include
life expectancy, discount rate, expected salary increases, pension increases
and
interest
credits
on
retirement
savings
account
balances.
Sensitivity
analysis for reasonable possible movements in each significant
assumption
for UBS AG‘s post-employment obligations is
provided in Note 27
.
›
Refer to Note 27
for more information
Defined contribution plans
A
defined
contribution
plan
pays
fixed
contributions
into
a
separate entity
from which
post-employment and other
benefits
are paid.
UBS AG
has no
legal or
constructive obligation
to pay
further amounts if the plan does not hold sufficient assets
to pay
employees the benefits relating
to employee service in
the current
and prior periods. Compensation expense
is recognized when the
employees have rendered
services in exchange for
contributions.
This is generally in the year of contribution. Prepaid contributions
are recognized
as an
asset to
the extent that
a cash
refund or
a
reduction in future payments is available.
6)
Income taxes
UBS AG is
subject to
the income
tax laws of
Switzerland and
those
of
the
non-Swiss
jurisdictions
in
which
UBS
AG
has
business
operations.
UBS
AG’s provision
for income
taxes is
composed of
current
and deferred
taxes. Current
income taxes
represent taxes
to be
paid or refunded for the current period or previous periods.
Deferred
taxes
are
recognized
for
temporary
differences
between
the
carrying
amounts
and
tax
bases
of
assets
and
liabilities that will
result in taxable
or deductible amounts
in future
periods and are measured using the applicable tax rates and laws
that have been
enacted or substantively
enacted by the
end of the
reporting period and that
will be in effect when
such differences
are expected to reverse.
Deferred
tax
assets arise
from a
variety
of
sources,
the most
significant being:
(i) tax
losses that
can be
carried forward
to be
used against profits in future years; and (ii) temporary differences
that
will
result
in
deductions
against
profits
in
future
years.
Deferred tax assets
are recognized only to
the extent it
is probable
that sufficient taxable profits will be
available against which these
differences can be
used. When an
entity or tax
group has a
history
of
recent
losses,
deferred
tax
assets
are
only
recognized
to
the
extent there are
sufficient taxable temporary differences
or there
is convincing
other evidence
that sufficient
taxable profit
will be
available against which the unused tax losses can be utilized.
Deferred tax liabilities
are recognized for temporary
differences
between
the
carrying
amounts
of
assets
and
liabilities
in
the
balance sheet
that reflect
the expectation
that certain
items will
give rise to taxable income in future periods.
Deferred and current tax assets and
liabilities are offset
when:
(i) they arise in the
same tax reporting group; (ii)
they relate to the
same tax authority; (iii)
the legal right to
offset exists; and (iv)
they
are intended to be settled net or realized simultaneously.
Current
and
deferred
taxes
are
recognized
as
income
tax
benefit
or
expense in
the income
statement,
except for
current
and deferred taxes recognized in relation to:
(i) the acquisition of
a subsidiary (for which such amounts would
affect the amount of
goodwill arising from the acquisition); (ii) gains
and losses on the
sale of
treasury shares
(for which
the tax
effects are
recognized
directly
in
Equity
);
(iii)
unrealized
gains
or
losses
on
financial
instruments that are classified at
FVOCI; (iv) changes in fair
value
of
derivative
instruments
designated
as
cash
flow
hedges;
(v)
remeasurements
of defined
benefit plans;
or (vi)
certain foreign
currency translations
of foreign
operations. Amounts
relating to
points
(iii)
through
(vi)
above
are
recognized
in
Other
comprehensive income
within
Equity
.
UBS AG reflects the
potential effect of uncertain
tax positions
for
which
acceptance
by
the
relevant
tax
authority
is
not
considered
probable
by
adjusting
current
or
deferred
taxes,
as
applicable, using either the most likely amount or expected value
methods,
depending
on
which
method
is
deemed
a
better
predictor
of
the
basis
on
which
,
and
extent
to
which
,
the
uncertainty will be resolved.
Consolidated financial statements | UBS AG consolidated financial statements
436
Note 1
Summary of material accounting policies (continued)
Critical accounting estimates and judgments
Tax
laws
are
complex,
and
judgment
and
interpretations
about
the
application of such
laws are required
when accounting for
income taxes.
UBS AG
considers the performance
of its
businesses and the
accuracy of
historical forecasts and other factors when evaluating the recoverability of
its
deferred
tax
assets,
including
the
remaining
tax
loss
carry-forward
period, and its
assessment of expected
future taxable profits
in the forecast
period
used
for
recognizing
deferred
tax
assets.
Estimating
future
profitability
and
business
plan
forecasts
is
inherently
subjective
and
is
particularly sensitive to future economic,
market and other conditions.
Forecasts are reviewed
annually, but adjustments
may be made
at other
times, if required. If recent losses have been incurred, convincing evidence
is required to prove there is sufficient future profitability given the
value of
UBS
AG
’s
deferred
tax
assets
may
b
e
affected
,
with
effects
primarily
recognized through the income statement.
In
addition,
judgment
is
required
to
assess
the
expected
value
of
uncertain
tax
positions
and
the
related
probabilities,
including
interpretation of tax laws,
the resolution of any income
tax-related appeals
and litigation.
›
Refer to Note
8
for more information
7) Property, equipment and software
Property,
equipment
and
software
is
measured
at
cost
less
accumulated
dep
reciation
and
impairment
losses
.
Software
development
costs
are
capitalized
only
when
the
costs
can
be
measured reliably and it is
probable that future economic
benefits
will
arise.
Depreciation
of
property,
equipment
and
software
begins
when
they
are
available
for
use
and
is
calculated
on
a
straight line basis over an asset’s estimated useful life.
Property,
equipment
and
software
are
generally
tested
for
impairment
at
the
appropriate
cash
-
generating
unit
level,
alongside goodwill and intangible assets as described in item 8 in
this Note.
An impairment
charge is
recognized for
such assets
if
the
recoverable
amount
is
below
its
carrying
amount
.
The
recoverable amounts of such assets, other than property that has
a market price,
are generally determined
using a replacement
cost
approach
that
reflects
the
amount
that
would
be
currently
required by a market participant to replace the service capacity
of
the
asset.
If
such
assets
are
no
longer
used,
they
are
tested
individually for impairment.
›
Refer to Note
12
for more information
8) Goodwill
Goodwill represents the
excess of
the consideration over the
fair
value
of
identifiable
assets,
liabilities
and
contingent
liabilities
acquired
that
arises
in
a
business combination.
Goodwill is
not
amortized,
but
is
assessed
for
impairment
at
the
end
of
each
reporting period,
or when indicators of impairment exist.
UBS AG
tests
goodwill
for
impairment
annually,
irrespective of
whether
there is any
indication
of impairment.
An impairment charge
is recognized in the income
statement if
the carrying
amount exceeds
the recoverable
amount.
Critical accounting estimates and judgments
UBS
AG‘s
methodology
for
goodwill
impairment
testing
is
based
on
a
model that is most sensitive to the following key assumptions: (i) forecasts
of earnings available to shareholders
in years one to
three; (ii) changes in
the discount rates; and (iii) changes in the
long-term growth rate.
Earnings available
to shareholders
are estimated
on the basis
of forecast
results,
which
are
part
of
the
business
plan
approved
by
the
Board
of
Directors.
The
discount
rates
and
growth
rates
are
determined
using
external information, and
also considering inputs
from both
internal and
external analysts and the view of management.
The
key assumptions
used
to determine
the recoverable
amounts of
each cash-generating unit are tested for sensitivity by applying reasonably
possible changes to those assumptions.
›
Refer to Notes
2
and
13
for more information
9) Provisions and contingent liabilities
Provisions
are
liabilities
of
uncertain
timing
or
amount,
and
are
generally
recognized
in
accordance
with
IAS
37,
Provisions,
Contingent
Liabilities
and
Contingent
Assets
,
when:
(i)
UBS
AG
has a
present obligation
as a
result of
a past
event; (ii)
it is
probable
that
an
outflow
of
resources
will
be
required
to
settle
the
obligation;
and
(iii)
a
reliable
estimate
of
the
amount
of
the
obligation can be made.
The
majority
of
UBS
AG
’s
provisio
ns
relate
to
litigation,
regulatory
and
similar
matters,
restructuring,
and
employee
benefits.
Restructuring
provisions
are
generally
recognized
as
a
consequence of
management agreeing
to materially
change the
scope
of
the
business
or
the
manner
in
which
it
is
conducted,
including
changes
in
management
structures.
Provisions
for
employee
benefits
relate
mainly
to
service
anniversaries
and
sabbatical
leave,
and
are
recognized
in
accordance
with
measurement principles set out in item 4
in this Note. In addition,
UBS AG presents
expected credit loss
allowances within
Provisions
if they relate to a loan commitment, financial
guarantee contract
or a revolving revocable credit line.
IAS 37 provisions are
measured considering the
best estimate
of the
consideration required
to settle
the present
obligation at
the balance sheet date.
When conditions required
to recognize
a provision
are not met,
a
contingent
liability
is
disclosed,
unless
the
likelihood
of
an
outflow
of
resources
is
remote.
Contingent
liabilities
are
also
disclosed for
possible obligations that
arise from past
events the
existence
of
which
will
be
confirmed
only
by
uncertain
future
events not wholly within the control of UBS AG.
437
Note 1
Summary of material accounting policies (continued)
Critical accounting estimates and judgments
Recognition of provisions
often involves significant judgment
in assessing
the
existence
of
an
obligation
that
results
from
past
events
and
in
estimating the
probability, timing and
amount of
any outflows
of resources.
This
is particularly
the case
for litigation,
regulatory and
similar matters,
which, due to their nature,
are subject to many uncertainties,
making their
outcome difficult to predict.
The amount of any provision
recognized is sensitive to the
assumptions
used
and
there
could
be
a
wide
range
of
possible
outcomes
for
any
particular matter.
Management regularly reviews
all the available
information regarding
such
matters,
including
legal
advice,
to
assess
whether
the
recognition
criteria for provisions have been satisfied and to determine the timing and
amount of any potential outflows.
›
Refer to Note
18
for more information
10) Foreign currency translation
Transactions
denominated
in
a
foreign
currency
are
translated
into
the
functional
currency
of
the
reporting
entity
at
the
spot
exchange rate
on the
date of
the transaction.
At the
balance sheet
date, all monetary
assets, including those
at FVOCI, and
monetary
liabilities denominated in foreign currency
are translated into the
functional currency
using the
closing exchange
rate. Translation
differences
are
reported
in
Other
net
income
from
financial
instruments measured at fair value through profit or loss
.
Non-monetary items measured at historical cost are translated
at the exchange rate on the date of the transaction.
Upon consolidation, assets and liabilities of
foreign operations
are translated into US
dollars,
UBS AG’s presentation currency, at
the closing exchange rate on the balance sheet date, and income
and expense
items and
other comprehensive
income are
translated
at the
average rate for the
period. The resulting foreign currency
translation differences are recognized in
Equity
and reclassified to
the income statement
when UBS AG disposes of, partially
or in its
entirety, the foreign
operation and UBS AG no longer controls
the
foreign operation.
Share
capital
issued,
share premium
and treasury
shares held
are
translated
at the historic
average rate,
with the
difference
between
the historic
average rate
and the
spot rate
realized
upon repayment
of
share capital
or
disposal of
treasury shares
reported as
Share
premium.
Cumulative
amounts
recognized
in
Other comprehensive
income
in
respect
of
cash
flow
hedges
and
financial
assets
measured at FVOCI are translated at the closing exchange rate as
of the
balance sheet
dates, with
any translation effects
adjusted
through
Retained earnings
.
›
Refer to Note 33 for more information
11) Net cash settlement contracts
Contracts involving
UBS Group
AG shares
that require
net cash
settlement,
or
provide
the
counterparty
or
UBS
AG
with
a
settlement option
that includes
a choice
of settling
net in
cash,
are classified as derivatives held for trading.
Consolidated financial statements | UBS AG consolidated financial statements
438
Note 1
Summary of material accounting policies (continued)
b)
Changes in accounting policies, comparability and other adjustments
Amendments to IAS 1,
Presentation of Financial Statements
, and
IFRS Practice Statement 2,
Making Materiality Judgements
Effective
from
1 January
2021,
UBS
AG
early
adopted
amendments to IAS 1,
Presentation of Financial
Statements
, and
IFRS Practice Statement 2,
Making Materiality Judgements
, issued
by IASB
in February
2021. The
disclosure of
material accounting
policies
in
Note
1a
has
been
refined
through
adopting
these
amendments.
Amendments to IAS 39, IFRS 9 and IFRS 7 (
Interest Rate
Benchmark Reform – Phase 2
)
On
1 January
2021,
UBS
adopted
Interest
Rate
Benchmark
Reform – Phase
2 (Amendments to
IFRS 9, IAS 39, IFRS 7,
IFRS 4
and IFRS 16)
, addressing a number of issues in financial reporting
areas that arise
when interbank
offered rates (IBORs)
are reformed
or replaced.
The amendments
provide a
practical expedient
that
permits
certain
changes
in
the
contractual
cash
flows
of
debt
instruments
attributable
to
the
replacement
of
IBORs
with
alternative
reference
rates
(ARRs)
to
be
accounted
for
prospectively by
updating a
given instrument’s
effective interest
rate
(EIR),
provided
(i)
the
change
is
necessary
as
a
direct
consequence
of
IBOR
reform
and
(ii)
the
new
basis
for
determining the contractual cash
flows is economically equivalent
to
the
previous
basis.
UBS
AG
has
adopted
the
amendments,
which had no material effect on UBS AG’s financial statements.
T
he
amendments
also
provide
various
hedge
accounting
reliefs, with the following adopted by UBS AG:
–
D
esignate
an
ARR
as
a
non
-
contractually
specified
risk
component, even if it is
not separately identifiable at the
date
when
it
was
designated,
provided
UBS
AG
can
reasonably
expect that it will meet the requirements
within 24 months of
the
first
designation
and
the
risk
component
is
reliably
measurable. As of 31 December 2021, the principal ARRs that
UBS AG has designated as the
hedged risk in fair value hedges
of interest rate
risk related to
debt instruments, mortgages
and
cash
flow
hedges
of
forecast
transactions
were
the
Secured
Overnight
Financing
Rate
(SOFR),
the
Swiss
Average
Rate
Overnight (SARON) and
the Sterling
Overnight Index Average
(SONIA).
–
Amend
hedge
documentation
for
the
fair
value
hedges
of
interest
rate
risk
related
to
debt
instruments
for
which
the
hedged risk changed due
to IBOR reform,
which allowed UBS
AG to continue the hedge relationship in accordance with the
requirements of the phase 2 amendment.
–
The
cash
flow
hedges
of
IBOR forecast
transactions
in
Swiss
francs
and
pounds
sterling
were
discontinued
and
replaced
with
new
ARR
designations in
December
2021. The
amount
accumulated in
the cash
flow hedge
reserve is
deemed to
be
based on the ARR on which the hedged future cash
flows will
be based.
Amounts will
be released
to the
income statement
when the forecast ARR
cash flows affect
the income statement
or are no longer expected to occur.
›
Refer to Note 26 for more information
The
amendments
also
introduced
additional
disclosure
requirements regarding
UBS AG’s management
of the
transition
to
alternative
benchmark
rates,
its
progress
as
at
the
reporting
date
and
the
risks
to
which
it
is
exposed
arising
from
financial
instruments because of the transition.
›
Refer to Note 25 for more information
c)
International Financial Reporting Standards and Interpretations to be adopted in 2022 and later and other changes
IFRS 17,
Insurance Contracts
In May 2017, the IASB issued
IFRS 17,
Insurance Contracts
, which
sets out
the accounting
requirements
for contractual
rights and
obligations
that
arise
from
insurance
contracts
issued
and
reinsurance
contracts
held.
IFRS 17
is
effective
from
1 January
2023. UBS AG is assessing the standard, but
does not expect it to
have a material effect on UBS AG’s financial statements.
439
Note 2a
Segment reporting
UBS
AG’s
businesses
are
organized
globally
into
four
business
divisions:
Global
Wealth
Management,
Personal
&
Corporate
Banking,
Asset Management
and the
Investment Bank.
All four
business divisions
are supported
by Group
Functions and
qualify
as
reportable
segments
for
the
purpose
of
segment
reporting.
Together with Group Functions, the four business divisions reflect
the management structure of UBS AG.
–
Global
Wealth
Management
pr
ovides
financial
services,
advice and solutions to private clients, in particular in the ultra
high
net
worth
and
high
net
worth
segments.
Its
offering
ranges from
investment management
to estate
planning and
corporate
finance
advice,
in
addition
to
specific
wealth
management
products
and
services.
The
business
division
is
managed globally across the regions.
–
Personal & Corporate Banking
serves its private, corporate,
and
institutional
client
s
’
needs
,
from
basic
banking
to
retirement, financing,
investments and
strategic transactions,
in
Switzerland
,
through
its
branch
network
and
digital
channels.
–
Asset
Management
is
a
large-scale
and
diversified
global
asset
manager.
It
offers
investment
capabilities
and
styles
across all major traditional
and alternative asset classes,
as well
as
advisory
support
to
institutions,
wholesale
intermediaries
and wealth management clients globally.
–
The
Investment
Bank
provides
a
range
of
services
to
institutional,
corporate
and
wealth
management
clients
globally,
to
help
them
raise
capital,
grow
their
businesses,
invest and manage risks. Its offering includes advisory services,
facilitating clients raising debt
and equity from the
public and
private
markets
and
capital
markets,
cash
and
derivatives
trading across equities and fixed income,
and financing.
–
Group
Functions
is
made
up
of
the
following
major
areas:
Group
Services
(
which
consists
of
Technology,
Corporate
Services,
Human
Resources
,
Finance,
Legal,
Ris
k
Control,
Compliance,
Regulatory
&
Governance,
Communications
&
Branding and Group
Sustainability and Impact),
Group Treasury
and Non-core and Legacy Portfolio.
Financial
information
about
the
four
business
divisions
and
Group Functions is presented
separately in internal
management
reports
to
the
Executive
Board,
which
is
considered
the
“chief
operating
decision
maker”
pursuant
to
IFRS 8,
Operating
Segments
.
UBS
AG’s
internal
accounting
policies,
which
include
management
accounting
policies
and
service
level
agreements,
determine the revenues and
expenses directly attributable
to each
reportable
segment.
Transactions
between
the
reportable
segments
are
carried
out
at
internally
agreed
rates
and
are
reflected
in
the
operating
results
of
the
reportable
segments.
Revenue-sharing agreements
are used
to allocate
external client
revenues
to
reportable
segments
where
several
reportable
segments
are
involved
in
the
value
creation
chain.
Total
intersegment revenues for UBS
AG are immaterial, as
the majority
of
the revenues
are
allocated across
the segments
by means
of
revenue-sharing
agreements.
Interest
income
earned
from
managing
UBS
AG’s
consolidated
equity
is
allocated
to
the
reportable
segments
based
on
average
attributed
equity
and
currency
composition.
Assets
and
liabilities
of
the
reportable
segments are funded
through and invested
with Group Functions,
and
the
net
interest
margin
is
reflected
in
the
results
of
each
reportable segment.
Segment
assets
are
based
on
a
third-party
view
and
do
not
include intercompany
balances. This
view is
in line
with internal
reporting to
management. If
one operating
segment is
involved
in
an
external
transaction
together
with
another
operating
segment or Group Functions, additional criteria are considered to
determine the segment that will report the associated
assets. This
will
include
a
consideration of
which
segment’s
business needs
are
being
addressed
by
the
transaction
and
which
segment
is
providing the
funding and
/ or
resources. Allocation
of liabilities
follows the same principles.
Non-current
assets disclosed
for segment
reporting
purposes
represent assets that are expected
to be recovered more than
12
months after the reporting date,
excluding financial instruments,
deferred tax assets and post-employment benefits.
Consolidated financial statements | UBS AG consolidated financial statements
440
Note 2a
Segment reporting (continued)
USD million
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
UBS AG
For the year ended 31 December 2021
Net interest income
4,244
2,120
(
15
)
481
(
226
)
6,605
Non-interest income
15,175
2,144
2,632
8,978
294
29,222
Income
19,419
4,264
2,617
9,459
68
35,828
Credit loss (expense) / release
29
86
(
1
)
34
0
148
Total operating income
19,449
4,350
2,616
9,493
68
35,976
Total operating expenses
14,743
2,623
1,593
6,902
1,151
27,012
Operating profit / (loss) before tax
4,706
1,726
1,023
2,592
(
1,083
)
8,964
Tax expense / (benefit)
1,903
Net profit / (loss)
7,061
Additional information
Total assets
395,235
225,425
25,202
346,641
123,641
1,116,145
Additions to non-current assets
56
16
1
30
1,689
1,791
USD million
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
UBS AG
For the year ended 31 December 2020
Net interest income
4,027
2,049
(
17
)
284
(
555
)
5,788
Non-interest income
1
13,107
1,859
2,993
9,224
504
27,686
Income
17,134
3,908
2,975
9,508
(
52
)
33,474
Credit loss (expense) / release
(
88
)
(
257
)
(
2
)
(
305
)
(
42
)
(
695
)
Total operating income
17,046
3,651
2,974
9,203
(
94
)
32,780
Total operating expenses
13,080
2,390
1,520
6,762
1,329
25,081
Operating profit / (loss) before tax
3,965
1,261
1,454
2,441
(
1,423
)
7,699
Tax expense / (benefit)
1,488
Net profit / (loss)
6,211
Additional information
Total assets
367,714
231,710
28,266
369,778
127,858
1,125,327
Additions to non-current assets
5
12
385
150
1,971
2,524
USD million
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
UBS AG
For the year ended 31 December 2019
Net interest income
3,947
1,993
(
25
)
(
669
)
(
831
)
4,415
Non-interest income
12,426
1,745
1,962
7,967
869
24,970
Income
16,373
3,737
1,938
7,298
38
29,385
Credit loss (expense) / release
(
20
)
(
21
)
0
(
30
)
(
7
)
(
78
)
Total operating income
16,353
3,717
1,938
7,268
31
29,307
Total operating expenses
13,018
2,274
1,407
6,515
925
24,138
Operating profit / (loss) before tax
3,335
1,443
531
753
(
893
)
5,169
Tax expense / (benefit)
1,198
Net profit / (loss)
3,971
Additional information
Total assets
309,766
209,512
34,565
316,058
102,028
971,927
Additions to non-current assets
68
10
0
1
4,935
5,014
1 Includes a USD
631
million net gain on the sale of a majority stake in Fondcenter AG
(now Clearstream Fund Centre AG), of which USD
571
million was recognized in Asset Management and USD
60
million was
recognized in Global Wealth Management.
441
Note 2b
Segment reporting by geographic location
The
operating
regions
shown
in
the
table
below
correspond to
the regional management structure of UBS AG. The
allocation of
operating income to these regions
reflects, and is consistent with,
the basis on which
the business is managed and
its performance
is
evaluated.
These
allocations
involve
assumptions
and
judgments
that
management
considers
to
be
reasonable,
and
may
be
refined
to
reflect
changes in
estimates
or
management
structure. The
main principles of
the allocation
methodology are
that
client
revenues
are
attributed
to
the
domicile
of
the
given
client
and
trading
and
portfolio
management
revenues
are
attributed to the country where the
risk is managed. This revenue
attribution
is
consistent
with
the
mandate
of
the
regional
Presidents.
Certain
revenues, such
as
those
related
to Non-core
and Legacy Portfolio in
Group Functions, are managed
at a Group
level. These revenues are included in the
Global
line.
The geographic analysis
of non-current assets
is based on
the
location of the entity in which the given assets are recorded.
For the year ended 31 December 2021
Total operating income
Total non-current assets
USD billion
Share %
USD billion
Share %
Americas
14.5
40
9.0
47
of which: USA
13.5
38
8.5
44
Asia Pacific
6.5
18
1.4
7
Europe, Middle East and Africa (excluding Switzerland)
7.0
19
2.6
13
Switzerland
7.9
22
6.3
33
Global
0.1
0
0.0
0
Total
36.0
100
19.3
100
For the year ended 31 December 2020
Total operating income
Total non-current assets
USD billion
Share %
USD billion
Share %
Americas
13.0
40
9.0
45
of which: USA
11.7
36
8.4
42
Asia Pacific
6.0
18
1.4
7
Europe, Middle East and Africa (excluding Switzerland)
6.5
20
2.7
14
Switzerland
6.9
21
6.9
34
Global
0.5
2
0.0
0
Total
32.8
100
20.0
100
For the year ended 31 December 2019
Total operating income
Total non-current assets
USD billion
Share %
USD billion
Share %
Americas
12.0
41
8.9
46
of which: USA
10.9
37
8.5
44
Asia Pacific
4.7
16
1.3
7
Europe, Middle East and Africa (excluding Switzerland)
5.8
20
2.6
13
Switzerland
6.7
23
6.5
34
Global
0.1
0
0.0
0
Total
29.3
100
19.3
100
Consolidated financial statements | UBS AG consolidated financial statements
442
Income statement notes
Note 3
Net interest
income and other
net income
from financial
instruments
measured at
fair value
through profit
or loss
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Net interest income from financial instruments measured
at fair value through profit or loss
1,437
1,305
1,015
Other net income from financial instruments measured
at fair value through profit or loss
5,844
6,930
6,833
of which: net gains / (losses) from financial liabilities designated
at fair value
1
(
6,457
)
1,625
(
8,748
)
Total net income from financial instruments measured at fair value through profit or loss
7,281
8,235
7,848
Net interest income
Interest income from loans and deposits
2
6,489
6,696
8,026
Interest income from securities financing transactions
3
513
862
2,005
Interest income from other financial instruments measured
at amortized cost
284
335
364
Interest income from debt instruments measured at fair
value through other comprehensive income
115
101
120
Interest income from derivative instruments designated as cash
flow hedges
1,133
822
188
Total interest income from financial instruments measured at amortized cost and fair
value through other comprehensive income
8,534
8,816
10,703
Interest expense on loans and deposits
4
1,655
2,440
4,541
Interest expense on securities financing transactions
5
1,102
870
1,152
Interest expense on debt issued
512
918
1,491
Interest expense on lease liabilities
98
105
118
Total interest expense from financial instruments measured at amortized cost
3,366
4,333
7,303
Total net interest income from financial instruments measured at amortized cost and fair
value through other comprehensive income
5,168
4,483
3,400
Total net interest income from financial instruments measured at fair value through profit or loss
1,437
1,305
1,015
Total net interest income
6,605
5,788
4,415
1 Excludes fair value changes
of hedges related to financial liabilities
designated at fair value and foreign
currency translation effects arising from translating foreign
currency transactions into the respective functional
currency, both of which
are reported within Other net
income from financial instruments measured
at fair value through profit
or loss. 2021 included net
losses of USD
2,068
million (net losses of USD
72
million
and USD
1,830
million in 2020 and 2019, respectively), driven by financial liabilities related to unit-linked investment contracts, which are designated at fair value through profit or loss. This
was offset by net gains
of USD
2,068
million (net gains of USD
72
million and USD
1,830
million in 2020 and 2019, respectively), related to financial assets for unit-linked investment contracts
that are mandatorily measured at fair value
through profit or
loss not
held for
trading.
2 Consists
of interest income
from cash
and balances at
central banks,
loans and
advances to
banks and
customers, and
cash collateral
receivables on
derivative
instruments, as well as negative
interest on amounts due to banks,
customer deposits, and cash collateral
payables on derivative instruments.
3 Includes interest income on receivables
from securities financing
transactions and negative interest, including fees,
on payables from securities financing transactions.
4 Consists of interest expense on amounts
due to banks, cash collateral
payables on derivative instruments,
customer deposits, and funding from UBS Group AG,
as well as negative interest on cash and balances at central banks, loans and advances
to banks, and cash collateral receivables on
derivative instruments.
5
Includes interest expense on payables from securities financing transactions and negative interest, including fees,
on receivables from securities financing transactions.
443
Note 4
Net fee and commission income
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Fee and commission income
Underwriting fees
1,512
1,104
784
M&A and corporate finance fees
1,102
736
774
Brokerage fees
4,383
4,132
3,248
Investment fund fees
5,790
5,289
4,859
Portfolio management and related services
9,762
8,009
7,656
Other
1,874
1,712
1,836
Total fee and commission income
1
24,422
20,982
19,156
of which: recurring
15,410
13,010
12,545
of which: transaction-based
8,743
7,512
6,449
of which: performance-based
269
461
163
Fee and commission expense
Brokerage fees paid
259
274
310
Distribution fees paid
611
589
590
Other
1,115
911
796
Total fee and commission expense
1,985
1,775
1,696
Net fee and commission income
22,438
19,207
17,460
of which: net brokerage fees
4,124
3,858
2,938
1 For the
year ended 31
December 2021, reflects
third-party fee and
commission income of
USD
14,545
million for Global
Wealth Management, USD
1,645
million for Personal
& Corporate Banking,
USD
3,337
million for Asset Management, USD
4,863
million for the Investment Bank and USD
33
million for Group Functions (for the year ended 31
December 2020: USD
12,475
million for Global Wealth Management, USD
1,427
million for Personal & Corporate Banking, USD
3,129
million for Asset Management, USD
3,901
million for the Investment Bank and USD
50
million for Group Functions; for the year ended 31 December 2019:
USD
11,694
million for Global Wealth Management, USD
1,307
million for Personal & Corporate Banking,
USD
2,659
million for Asset Management, USD
3,397
million for the Investment Bank and USD
98
million
for Group Functions).
Note 5
Other income
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Associates, joint ventures and subsidiaries
Net gains / (losses) from acquisitions and disposals of
subsidiaries
1
(
11
)
635
2
(
36
)
Net gains / (losses) from disposals of investments in associates
41
0
4
Share of net profits of associates and joint ventures
105
84
46
Impairments related to associates
0
0
(
1
)
Total
134
719
13
Net gains / (losses) from disposals of financial assets measured
at fair value through other comprehensive income
9
40
31
Income from properties
3
22
25
27
Net gains / (losses) from properties held for sale
100
4
76
5
(
19
)
Income from shared services provided to UBS Group AG or its subsidiaries
451
422
464
Other
224
6
267
7
161
Total other income
941
1,549
677
1 Includes foreign exchange gains
/ (losses) reclassified
from other comprehensive income
related to the disposal
or closure of foreign
operations.
2 Includes a USD
631
million net gain on
the sale of a
majority
stake in Fondcenter AG
(now Clearstream Fund Centre AG).
3 Includes rent received from third parties.
4 Mainly relates to the sale of a
property in Basel.
5 Includes net gains of USD
140
million arising from
sale-and-leaseback transactions, primarily
related to a property in
Geneva, partly offset by
remeasurement losses relating to properties
that were reclassified as held
for sale.
6 Includes a gain of
USD
100
million
from the sale of UBS AG's domestic wealth management business in Austria. Refer to Note 30 for more
information.
7 Includes a USD
215
million gain on the sale of intellectual property rights associated with the
Bloomberg Commodity Index family.
Consolidated financial statements | UBS AG consolidated financial statements
444
Note 6
Personnel expenses
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Salaries
1
5,723
5,535
5,183
Variable compensation – performance awards
2
2,916
2,953
3
2,545
Variable compensation – other
2
196
201
225
Financial advisor compensation
2,4
4,860
4,091
4,043
Contractors
142
138
147
Social security
762
704
3
627
Post-employment benefit plans
5
582
6
597
569
of which: defined benefit plans
280
306
291
of which: defined contribution plans
303
291
278
Other personnel expenses
479
466
3
461
Total personnel expenses
15,661
14,686
13,801
1 Includes role-based allowances.
2 Refer to Note 28 for
more information.
3 During 2020, UBS AG modified the
conditions for continued vesting of certain outstanding deferred
compensation awards for qualifying
employees, resulting in an
expense of approximately USD
270
million, of which USD
240
million is disclosed within Variable
compensation – performance awards,
USD
20
million within Social security and
USD
10
million within
Other personnel
expenses.
4 Financial
advisor compensation
consists of
grid-based
compensation based
directly on
compensable revenues
generated by
financial advisors
and supplemental
compensation calculated on the basis
of financial advisor productivity,
firm tenure, assets and
other variables. It
also includes expenses related
to compensation commitments with financial
advisors entered into at
the time of
recruitment that are
subject to vesting
requirements.
5 Refer to
Note 27 for
more information.
6 Includes curtailment
gains of USD
49
million, which represent
a reduction in
the defined benefit
obligation related to the Swiss pension plan resulting from a decrease in headcount following restructuring activities.
Note 7
General and administrative expenses
1
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Outsourcing costs
426
466
551
IT expenses
490
449
448
Consulting, legal and audit fees
465
566
753
Real estate and logistics costs
530
563
559
Market data services
367
361
364
Marketing and communication
171
162
191
Travel and entertainment
66
77
272
Litigation, regulatory and similar matters
2
910
197
165
Other
6,051
5,646
5,283
of which: shared services costs charged by UBS Group AG or its subsidiaries
5,321
4,939
4,621
of which: UK and German bank levies
3
58
55
41
Total general and administrative expenses
9,476
8,486
8,586
1 In
2021, UBS
AG changed
the presentation
of the
line items
within general
and administrative
expenses. Prior-period
information reflects
the new
presentation structure,
with no
effect on
Total general
and
administrative expenses.
2 Reflects the net increase in
provisions for litigation, regulatory and
similar matters recognized in the
income statement. Refer to Note 18
for more information. Also,
includes recoveries
from third parties of USD
1
million in 2021 (USD
3
million and USD
11
million in 2020 and 2019, respectively).
3 UK bank levy expenses of USD
22
million (USD
38
million for 2020 and USD
30
million for 2019)
included a credit of USD
16
million (USD
27
million for 2020 and USD
31
million for 2019) related to prior years.
445
Note 8 Income taxes
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Tax expense / (benefit)
Swiss
Current
614
417
336
Deferred
26
107
246
Total Swiss
640
524
582
Non-Swiss
Current
857
715
402
Deferred
406
248
214
Total non-Swiss
1,263
963
616
Total income tax expense / (benefit) recognized in the income statement
1,903
1,488
1,198
Income tax recognized in the income statement
Income
tax
expenses
of
USD
1,903
million
were
recognized
for
UBS
AG
in
2021,
representing
an
effective
tax
rate
of
21.2
%.
These included
Swiss tax
expenses of
USD
640
million and
non-
Swiss tax expenses of USD
1,263
million.
The
Swiss
tax
expenses
included
current
tax
expenses
of
USD
614
million related to taxable profits of UBS Switzerland AG
and other Swiss entities.
They also included deferred tax
expenses
of
USD
26
million,
which
reflect
movements
in
temporary
differences.
The non-Swiss
tax expenses
included current
tax expenses
of
USD
857
million
related
to
taxable
profits
earned
by
non-Swiss
subsidiaries
and
branches
,
and
net
deferred
t
ax
expenses
of
USD
406
million.
Expenses
of
USD
740
million,
which
primarily
related to
the amortization
of deferred
tax assets
(DTAs) previously
recognized in relation to
tax losses carried
forward and deductible
temporary differences of UBS Americas Inc.,
were partly offset by
a benefit of USD
334
million in respect of
the remeasurement of
DTAs.
This
benefit
included
upward
revaluation
s
of
DTAs
of
USD
152
million for certain
entities, primarily in
connection with
our business planning process. It also included
USD
113
million in
respect of additional DTA recognition that primarily related to the
contribution of real estate assets by UBS AG to UBS
Americas Inc.
and UBS Financial Services
Inc., which allowed the
full recognition
of DTAs in respect of the associated historic
real estate costs that
were
previously
capitalized
for
US
tax
purposes
under
elections
that
were
made
in
the
fourth
quarter
of
2018.
In
addition,
it
included USD
69
million in respect of an increase in the expected
value of future tax
deductions for deferred
compensation awards,
due to an increase in the Group’s share price during the year.
The pre-tax expense that was recognized in the year in respect
of the increase in litigation provisions for the
French cross-border
matter did not result in any tax benefit.
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Operating profit / (loss) before tax
8,964
7,699
5,169
of which: Swiss
2,983
3,042
2,297
of which: non-Swiss
5,981
4,657
2,872
Income taxes at Swiss tax rate of
18.5
% for 2021,
19.5
% for 2020 and
20.5
% for 2019
1,658
1,501
1,060
Increase / (decrease) resulting from:
Non-Swiss tax rates differing from Swiss tax rate
217
96
72
Tax effects of losses not recognized
124
144
131
Previously unrecognized tax losses now utilized
(
179
)
(
212
)
(
265
)
Non-taxable and lower-taxed income
(
252
)
(
381
)
(
305
)
Non-deductible expenses and additional taxable income
487
373
713
Adjustments related to prior years – current tax
(
38
)
(
66
)
1
Adjustments related to prior years – deferred tax
(
3
)
18
(
6
)
Change in deferred tax recognition
(
341
)
(
383
)
(
293
)
Adjustments to deferred tax balances arising from changes
in tax rates
(
1
)
235
(
9
)
Other items
230
163
99
Income tax expense / (benefit)
1,903
1,488
1,198
Consolidated financial statements | UBS AG consolidated financial statements
446
Note 8
Income taxes (continued)
The components of operating profit before tax, and the differences between income tax expense reflected in the financial statements
and the amounts calculated at the Swiss tax rate, are provided in the table on the previous page and explained below.
Component
Description
Non-Swiss tax rates
differing from Swiss tax
rate
To the extent that UBS AG profits or losses arise outside Switzerland, the applicable local
tax rate may differ from the Swiss
tax rate. This item reflects, for such profits, an adjustment
from the tax expense that would arise at the Swiss
tax rate to the
tax expense that would arise at the applicable local
tax rate. Similarly, it reflects, for such losses, an adjustment from the tax
benefit that would arise at the Swiss tax rate
to the tax benefit that would arise at the applicable
local tax rate.
Tax effects of losses not
recognized
This item relates to tax losses of entities arising in the
year that are not recognized as DTAs and where no tax benefit arises in
relation to those losses. Therefore, the tax benefit calculated
by applying the local tax rate to those losses
as described above
is reversed.
Previously unrecognized
tax losses now utilized
This item relates to taxable profits of the year that are offset by tax losses
of previous years for which no DTAs were previously
recorded. Consequently, no current tax or deferred tax expense arises in relation to those taxable
profits and the tax expense
calculated by applying the local tax rate on
those profits is reversed.
Non-taxable and lower-
taxed income
This item relates to tax deductions for the year in
respect of permanent differences. These include deductions in
respect of
profits that are either not taxable or are taxable at a lower rate
of tax than the local tax rate. They also
include deductions
made for tax purposes, which are not reflected in the
accounts.
Non-deductible expenses
and additional taxable
income
This item relates to additional taxable income for the year
in respect of permanent differences. These include income
that is
recognized for tax purposes by an entity but is not
included in its profit that is reported in the financial
statements, as well as
expenses for the year that are non-deductible (e.g.,
client entertainment costs are not deductible
in certain locations).
Adjustments related to
prior years – current tax
This item relates to adjustments to current tax expense for
prior years (e.g., if the tax payable for a year is
agreed with the tax
authorities in an amount that differs from the amount previously
reflected in the financial statements).
Adjustments related to
prior years – deferred tax
This item relates to adjustments to deferred tax positions
recognized in prior years (e.g., if a tax loss for
a year is fully
recognized and the amount of the tax loss agreed with
the tax authorities is expected to differ from the
amount previously
recognized as DTAs in the accounts).
Change in deferred tax
recognition
This item relates to changes in DTAs, including changes in DTAs previously recognized resulting from reassessments of
expected future taxable profits. It also includes changes
in temporary differences in the year, for which deferred tax is not
recognized.
Adjustments to deferred
tax balances arising from
changes in tax rates
This item relates to remeasurements of DTAs and liabilities recognized due to changes
in tax rates. These have the effect of
changing the future tax saving that is expected from tax
losses or deductible tax differences and therefore the amount
of
DTAs recognized or, alternatively,
changing the tax cost of additional taxable income
from taxable temporary differences and
therefore the deferred tax liability.
Other items
Other items include other differences between profits or losses
at the local tax rate and the actual local tax
expense or
benefit, including movements in provisions for uncertain
positions in relation to the current year and other items.
Income tax recognized directly in equity
A net tax
benefit of USD
455
million was recognized
in
Other comprehensive income
(2020: net expense
of USD
258
million) and a
net tax expense of USD
102
million was recognized in
Share premium
(2020: net benefit of USD
1
million).
447
Note 8
Income taxes (continued)
Deferred tax assets and liabilities
UBS
AG
has
gross
DTAs,
valuation
allowances
and
recognized
DTAs related to tax loss carry-forwards and deductible temporary
differences,
and also
deferred tax
liabilities in
respect of
taxable
temporary differences, as
shown in the
table below. The valuation
allowances reflect DTAs
that were not recognized
because, as of
the last
remeasurement period,
management did not
consider it
probable
that
there
would
be
sufficient
future
taxable
profits
available
to
utilize
the
related
tax
loss
carry
-
forwards
and
deductible temporary differences.
The
recognition of
DTAs is
supported by
forecasts of
taxable
profits
for
the
entities
concerned.
In
addition,
tax
planning
opportunities are
available that
would result
in additional
future
taxable income and these would be utilized, if necessary.
Deferred tax liabilities are recognized in respect of investments
in
subsidiaries,
branches
and
associates,
and
interests
in
joint
arrangements, except to
the extent that UBS
AG can control the
timing
of
the
reversal
of
the
associated
taxable
temporary
difference
and
it
is
probable
that
such
will
not
reverse
in
the
foreseeable
future.
However,
as
of
31
December
202
1
,
this
exception was not
considered to apply
to any taxable
temporary
differences.
USD million
31.12.21
31.12.20
Deferred tax assets
1
Gross
Valuation
allowance
Recognized
Gross
Valuation
allowance
Recognized
Tax loss carry-forwards
13,636
(
9,193
)
4,443
14,108
(
8,715
)
5,393
Temporary differences
5,092
(
696
)
4,396
4,343
(
561
)
3,782
of which: related to real estate costs capitalized for US
tax
purposes
2,272
0
2,272
2,268
0
2,268
of which: related to compensation and benefits
1,200
(
209
)
991
1,112
(
173
)
939
of which: other
1,620
(
487
)
1,133
963
(
388
)
574
Total deferred tax assets
18,728
(
9,889
)
8,839
2
18,450
(
9,276
)
9,174
2
of which: related to the US
8,521
8,780
of which: related to other locations
318
394
Deferred tax liabilities
Cash flow hedges
118
425
Other
179
133
Total deferred tax liabilities
297
558
1 After offset of DTLs, as applicable.
2 As of 31 December 2021, UBS AG recognized DTAs
of USD
77
million (31 December 2020: USD
138
million) in respect of entities that incurred losses in either the current or
preceding year.
In general, US federal tax losses
incurred prior to 31 December
2017 can be
carried forward for
20 years. However,
US federal tax
losses incurred after 31 December 2017 and UK tax losses can be
carried forward indefinitely, although
the utilization of
such losses
is limited to 80% of the entity’s
future year taxable profits for the
US and generally to 25% thereof for
the UK. The amounts of US
tax
loss
carry-forwards
that are
included
in the
table below
are
based
on their
amount for
federal tax
purposes
rather than
for
state and local tax purposes.
Unrecognized tax loss carry-forwards
USD million
31.12.21
31.12.20
Within 1 year
141
146
From 2 to 5 years
1,026
638
From 6 to 10 years
13,283
13,257
From 11 to 20 years
2,093
3,858
No expiry
18,147
17,227
Total
34,690
35,127
of which: related to the US
1
14,870
16,256
of which: related to the UK
14,909
13,848
of which: related to other locations
4,911
5,023
1 Related to UBS AG's US branch.
Consolidated financial statements | UBS AG consolidated financial statements
448
Balance sheet notes
Note 9
Financial assets at amortized cost and other positions in scope of expected credit loss measurement
The
tables
on
the
following
pages
provide
information
about
financial
instruments and
certain credit
lines that
are
subject to
expected credit loss (ECL) requirements
.
UBS AG’s ECL disclosure
segments or “ECL segments” are aggregated portfolios based on
shared
risk
characteristics
and
on
the
same
or
similar
rating
methods
applied.
The
key
segments
are
presented
in
the
table
below.
›
Refer to Note 20 for more information about
expected credit
loss measurement
Segment
Segment description
Description of credit risk sensitivity
Business division / Group Functions
Private clients with
mortgages
Lending to private clients secured by
owner-occupied real estate and
personal account overdrafts of those
clients
Sensitive to the interest rate environment,
unemployment levels, real estate collateral
values
and other regional aspects
–
Personal & Corporate Banking
–
Global Wealth Management
Real estate financing
Rental or income-producing real estate
financing to private and corporate
clients secured by real estate
Sensitive to unemployment levels, the
interest rate environment,
real estate
collateral values
and other regional
aspects
–
Personal & Corporate Banking
–
Global Wealth Management
–
Investment Bank
Large corporate clients
Lending to large corporate and multi-
national clients
Sensitive to GDP developments,
unemployment levels,
seasonality,
business cycles and collateral values
(diverse collateral,
including real estate
and other collateral types)
–
Personal & Corporate Banking
–
Investment Bank
SME clients
Lending to small and medium-sized
corporate clients
Sensitive to GDP developments,
unemployment levels,
the interest rate
environment and, to some extent,
seasonality,
business cycles and collateral
values (diverse collateral,
including real
estate and other collateral types)
–
Personal & Corporate Banking
Lombard
Loans secured by pledges of marketable
securities, guarantees and other forms
of collateral
Sensitive to equity and debt markets
(e.g.,
changes in collateral values)
–
Global Wealth Management
Credit cards
Credit card solutions in Switzerland and
the US
Sensitive to unemployment levels
–
Personal & Corporate Banking
–
Global Wealth Management
Commodity trade
finance
Working capital financing of commodity
traders, generally extended on a self-
liquidating transactional basis
Sensitive primarily to the strength of
individual transaction structures and
collateral values (price volatility of
commodities),
as the primary source for
debt service is directly linked to the
shipments financed
–
Personal & Corporate Banking
Financial intermediaries
and hedge funds
Lending to financial institutions and
pension funds, including exposures to
broker-dealers and clearing houses
Sensitive to GDP development, the
interest rate environment, price and
volatility risks in financial markets, and
regulatory and political risk
–
Personal & Corporate Banking
–
Investment Bank
›
Refer to Note 20f for more details regarding sensitivity
449
Note 9
Financial assets at amortized cost and other positions in scope of expected credit loss measurement (continued)
The
tables below
and on
the following
pages provide
ECL exposure
and ECL
allowance and
provision
information about
financial
instruments and certain non-financial instruments that are subject to ECL.
USD million
31.12.21
Carrying amount
1
ECL allowances
Financial instruments measured at amortized
cost
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Cash and balances at central banks
192,817
192,817
0
0
0
0
0
0
Loans and advances to banks
15,360
15,333
26
1
(
8
)
(
7
)
(
1
)
0
Receivables from securities financing transactions
75,012
75,012
0
0
(
2
)
(
2
)
0
0
Cash collateral receivables on derivative instruments
30,514
30,514
0
0
0
0
0
0
Loans and advances to customers
398,693
381,496
15,620
1,577
(
850
)
(
126
)
(
152
)
(
572
)
of which: Private clients with mortgages
152,479
143,505
8,262
711
(
132
)
(
28
)
(
71
)
(
33
)
of which: Real estate financing
43,945
40,463
3,472
9
(
60
)
(
19
)
(
40
)
0
of which: Large corporate clients
13,990
12,643
1,037
310
(
170
)
(
22
)
(
16
)
(
133
)
of which: SME clients
14,004
12,076
1,492
436
(
259
)
(
19
)
(
15
)
(
225
)
of which: Lombard
149,283
149,255
0
27
(
33
)
(
6
)
0
(
28
)
of which: Credit cards
1,716
1,345
342
29
(
36
)
(
10
)
(
9
)
(
17
)
of which: Commodity trade finance
3,813
3,799
7
7
(
114
)
(
6
)
0
(
108
)
Other financial assets measured at amortized cost
26,236
25,746
302
189
(
109
)
(
27
)
(
7
)
(
76
)
of which: Loans to financial advisors
2,453
2,184
106
163
(
86
)
(
19
)
(
3
)
(
63
)
Total financial assets measured at amortized cost
738,632
720,917
15,948
1,767
(
969
)
(
161
)
(
160
)
(
647
)
Financial assets measured at fair value through other comprehensive income
8,844
8,844
0
0
0
0
0
0
Total on-balance sheet financial assets in scope of ECL requirements
747,477
729,762
15,948
1,767
(
969
)
(
161
)
(
160
)
(
647
)
Total exposure
ECL provisions
Off-balance sheet (in scope of ECL)
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Guarantees
20,972
19,695
1,127
150
(
41
)
(
18
)
(
8
)
(
15
)
of which: Large corporate clients
3,464
2,567
793
104
(
6
)
(
3
)
(
3
)
0
of which: SME clients
1,353
1,143
164
46
(
8
)
(
1
)
(
1
)
(
7
)
of which: Financial intermediaries and hedge funds
9,575
9,491
84
0
(
17
)
(
13
)
(
4
)
0
of which: Lombard
2,454
2,454
0
0
(
1
)
0
0
(
1
)
of which: Commodity trade finance
3,137
3,137
0
0
(
1
)
(
1
)
0
0
Irrevocable loan commitments
39,478
37,097
2,335
46
(
114
)
(
72
)
(
42
)
0
of which: Large corporate clients
23,922
21,811
2,102
9
(
100
)
(
66
)
(
34
)
0
Forward starting reverse repurchase and securities borrowing agreements
1,444
1,444
0
0
0
0
0
0
Committed unconditionally revocable credit lines
42,373
39,802
2,508
63
(
38
)
(
28
)
(
10
)
0
of which: Real estate financing
7,328
7,046
281
0
(
5
)
(
4
)
(
1
)
0
of which: Large corporate clients
5,358
4,599
736
23
(
7
)
(
4
)
(
3
)
0
of which: SME clients
5,160
4,736
389
35
(
15
)
(
11
)
(
3
)
0
of which: Lombard
8,670
8,670
0
0
0
0
0
0
of which: Credit cards
9,466
9,000
462
4
(
6
)
(
5
)
(
2
)
0
of which: Commodity trade finance
117
117
0
0
0
0
0
0
Irrevocable committed prolongation of existing loans
5,611
5,527
36
48
(
3
)
(
3
)
0
0
Total off-balance sheet financial instruments and credit lines
109,878
103,565
6,006
307
(
196
)
(
121
)
(
60
)
(
15
)
Total allowances and provisions
(
1,165
)
(
282
)
(
220
)
(
662
)
1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective
ECL allowances.
Consolidated financial statements | UBS AG consolidated financial statements
450
Note 9
Financial assets at amortized cost and other positions in scope of expected credit loss measurement (continued)
USD million
31.12.20
Carrying amount
1
ECL allowances
Financial instruments measured at amortized
cost
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Cash and balances at central banks
158,231
158,231
0
0
0
0
0
0
Loans and advances to banks
15,344
15,160
184
0
(
16
)
(
9
)
(
5
)
(
1
)
Receivables from securities financing transactions
74,210
74,210
0
0
(
2
)
(
2
)
0
0
Cash collateral receivables on derivative instruments
32,737
32,737
0
0
0
0
0
0
Loans and advances to customers
380,977
358,396
20,341
2,240
(
1,060
)
(
142
)
(
215
)
(
703
)
of which: Private clients with mortgages
148,175
138,769
8,448
959
(
166
)
(
35
)
(
93
)
(
39
)
of which: Real estate financing
43,429
37,568
5,838
23
(
63
)
(
15
)
(
44
)
(
4
)
of which: Large corporate clients
15,161
12,658
2,029
474
(
279
)
(
27
)
(
40
)
(
212
)
of which: SME clients
14,872
11,990
2,254
628
(
310
)
(
19
)
(
23
)
(
268
)
of which: Lombard
133,850
133,795
0
55
(
36
)
(
5
)
0
(
31
)
of which: Credit cards
1,558
1,198
330
30
(
38
)
(
11
)
(
11
)
(
16
)
of which: Commodity trade finance
3,269
3,214
43
12
(
106
)
(
5
)
0
(
101
)
Other financial assets measured at amortized cost
27,219
26,401
348
469
(
133
)
(
34
)
(
9
)
(
90
)
of which: Loans to financial advisors
2,569
1,982
137
450
(
108
)
(
27
)
(
5
)
(
76
)
Total financial assets measured at amortized cost
688,717
665,135
20,873
2,709
(
1,211
)
(
187
)
(
229
)
(
795
)
Financial assets measured at fair value through other comprehensive income
8,258
8,258
0
0
0
0
0
0
Total on-balance sheet financial assets in scope of ECL requirements
696,976
673,394
20,873
2,709
(
1,211
)
(
187
)
(
229
)
(
795
)
Total exposure
ECL provisions
Off-balance sheet (in scope of ECL)
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Guarantees
17,081
14,687
2,225
170
(
63
)
(
14
)
(
15
)
(
34
)
of which: Large corporate clients
3,710
2,048
1,549
113
(
20
)
(
4
)
(
5
)
(
12
)
of which: SME clients
1,310
936
326
48
(
13
)
(
1
)
(
1
)
(
11
)
of which: Financial intermediaries and hedge funds
7,637
7,413
224
0
(
17
)
(
7
)
(
9
)
0
of which: Lombard
641
633
0
8
(
2
)
0
0
(
2
)
of which: Commodity trade finance
1,441
1,416
25
0
(
2
)
(
1
)
0
0
Irrevocable loan commitments
41,372
36,894
4,374
104
(
142
)
(
74
)
(
68
)
0
of which: Large corporate clients
24,209
20,195
3,950
64
(
121
)
(
63
)
(
58
)
0
Forward starting reverse repurchase and securities borrowing agreements
3,247
3,247
0
0
0
0
0
0
Committed unconditionally revocable credit lines
42,077
37,176
4,792
108
(
50
)
(
29
)
(
21
)
0
of which: Real estate financing
6,328
5,811
517
0
(
12
)
(
5
)
(
7
)
0
of which: Large corporate clients
4,909
2,783
2,099
27
(
9
)
(
2
)
(
7
)
0
of which: SME clients
5,827
4,596
1,169
63
(
16
)
(
12
)
(
4
)
0
of which: Lombard
9,671
9,671
0
0
0
(
1
)
0
0
of which: Credit cards
8,661
8,220
430
11
(
8
)
(
6
)
(
2
)
0
of which: Commodity trade finance
242
242
0
0
0
0
0
0
Irrevocable committed prolongation of existing loans
3,282
3,277
5
0
(
2
)
(
2
)
0
0
Total off-balance sheet financial instruments and credit lines
107,059
95,281
11,396
382
(
257
)
(
119
)
(
104
)
(
34
)
Total allowances and provisions
(
1,468
)
(
306
)
(
333
)
(
829
)
1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the
respective ECL allowances.
451
Note 9
Financial assets at amortized cost and other positions in scope of expected credit loss measurement (continued)
Coverage
ratios are
calculated
for
the
core loan
portfolio
by
taking ECL
allowances and
provisions divided
by the
gross carrying
amount of
the exposures.
Core loan
exposure is
defined as
the
sum of
Loans and
advances to
customers
and
Loans to
financial
advisors
.
These ratios are influenced by the following key factors:
–
Lombard loans
are generally
secured with
marketable securities
in
portfolios
that
are,
as
a
rule,
highly
diversified,
with
strict
lending policies
that are
intended to
ensure that
credit risk
is
minimal under most circumstances;
–
mortgage loans to private clients and
real estate financing are
controlled by
conservative eligibility
criteria, including
low loan-
to-value ratios and strong debt service capabilities;
–
the amount of unsecured retail lending (including credit cards)
is insignificant;
–
lending in Switzerland includes government backed
COVID-19
loans;
–
contractual maturities in the loan portfolio, which
are a factor
in the
calculation of
ECLs, are
generally short,
with Lombard
lending
typically having
average contractual
maturities
of
12
months or
less, real
estate lending
generally between
2 years
and 3 years in Switzerland with longer
dated maturities in the
US and
corporate lending
between 1
to 2
years with
related
loan commitments up to 4 years;
and
–
write-offs of
ECL allowances
against the
gross loan
balances
when all or part of a financial asset is deemed
uncollectible or
forgiven, reduces the coverage ratios
.
Coverage ratios for core loan portfolio
31.12.21
Gross carrying amount (USD million)
ECL coverage (bps)
On-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Private clients with mortgages
152,610
143,533
8,333
744
9
2
85
446
Real estate financing
44,004
40,483
3,512
10
14
5
114
231
Large corporate clients
14,161
12,665
1,053
443
120
18
148
2,997
SME clients
14,263
12,095
1,507
661
182
16
103
3,402
Lombard
149,316
149,261
0
55
2
0
0
5,026
Credit cards
1,752
1,355
351
46
204
72
255
3,735
Commodity trade finance
3,927
3,805
7
115
290
15
3
9,388
Other loans and advances to customers
19,510
18,425
1,010
75
23
9
15
3,730
Loans to financial advisors
2,539
2,203
109
226
338
88
303
2,791
Total
1
402,081
383,825
15,882
2,374
23
4
98
2,673
Gross exposure (USD million)
ECL coverage (bps)
Off-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Private clients with mortgages
9,123
8,798
276
49
3
3
9
15
Real estate financing
8,766
8,481
285
0
9
7
88
0
Large corporate clients
32,748
28,981
3,630
136
34
25
110
1
SME clients
8,077
7,276
688
114
38
19
151
585
Lombard
14,438
14,438
0
0
1
0
0
0
Credit cards
9,466
9,000
462
4
7
5
34
0
Commodity trade finance
3,262
3,262
0
0
4
4
0
0
Financial intermediaries and hedge funds
13,747
13,379
369
0
13
10
120
0
Other off-balance sheet commitments
8,806
8,507
296
4
15
6
30
0
Total
2
108,434
102,121
6,006
307
18
12
100
486
1 Includes Loans and
advances to customers
of USD
399,543
million and Loans
to financial advisors
of USD
2,539
million which are presented
on the balance
sheet line Other assets
measured at amortized
cost.
2 Excludes Forward starting reverse repurchase and securities borrowing agreements.
Consolidated financial statements | UBS AG consolidated financial statements
452
Note 9
Financial assets at amortized cost and other positions in scope of expected credit loss measurement (continued)
Coverage ratios for core loan portfolio
31.12.20
Gross carrying amount (USD million)
ECL coverage (bps)
On-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Private clients with mortgages
148,341
138,803
8,540
998
11
2
108
390
Real estate financing
43,492
37,583
5,883
27
15
4
75
1,414
Large corporate clients
15,440
12,684
2,069
686
181
21
192
3,089
SME clients
15,183
12,010
2,277
896
204
16
101
2,991
Lombard
133,886
133,800
0
86
3
0
0
3,592
Credit cards
1,596
1,209
342
46
240
91
333
3,488
Commodity trade finance
3,375
3,219
43
113
315
16
2
8,939
Other loans and advances to customers
20,722
19,229
1,402
91
29
13
25
3,563
Loans to financial advisors
2,677
2,009
142
526
404
135
351
1,446
Total
1
384,714
360,547
20,697
3,470
30
5
106
2,247
Gross exposure (USD million)
ECL coverage (bps)
Off-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Private clients with mortgages
6,285
6,083
198
3
7
6
16
197
Real estate financing
7,056
6,576
481
0
21
9
185
0
Large corporate clients
32,828
25,026
7,598
205
46
27
92
565
SME clients
9,121
7,239
1,734
148
40
19
63
779
Lombard
14,178
14,170
0
8
2
1
0
1,941
Credit cards
8,661
8,220
430
11
9
8
44
0
Commodity trade finance
1,683
1,658
25
0
10
8
15
8,279
Financial intermediaries and hedge funds
7,690
7,270
448
0
26
13
248
166
Other off-balance sheet commitments
16,309
15,792
482
8
12
6
11
12,414
Total
2
103,812
92,034
11,396
382
25
13
91
894
1 Includes Loans and
advances to customers
of USD
382,036
million and Loans
to financial advisors
of USD
2,677
million which are presented
on the balance
sheet line Other assets
measured at amortized
cost.
2 Excludes Forward starting reverse repurchase and securities borrowing agreements.
453
Note 10
Derivative instruments
Overview
Over-the-counter
(OTC)
derivative
contracts
are
usually
traded
under
a
standardized
International
Swaps
and
Derivatives
Association
(ISDA)
master
agreement
between
UBS
AG
and
its
counterparties. Terms
are negotiated directly with counterparties
and the contracts have industry-standard settlement mechanisms
prescribed
by
ISDA.
Other
OTC
derivatives
are
cleared
through
clearing houses, in particular interest rate swaps
with LCH, where
a
settled-to-market method
has
been
generally adopted,
under
which cash collateral exchanged
on a daily basis
is considered to
legally
settle
the
market
value
of
the
derivatives.
Regulators
in
various
jurisdictions
have
begun
a
phased
introduction
of
rules
requiring
the
payment
and
collection
of
initial
and
variation
margins on
certain OTC
derivative contracts,
which may
have a
bearing
on
price
and
other
relevant
terms.
Due
to
challenges
brought
on
by
COVID
-
19
,
the
International
Organization
of
Securities
Commissions
(IOSCO)
has
extended
the
deadline
for
completion of the final phase-in of margin requirements for non-
centrally cleared derivatives,
to 1 September 2022.
Other
derivative
contracts
are
standardized
in
terms
of
their
amounts
and
settlement
dates,
and
are
bought
and
sold
on
regulated
exchanges.
These
are
commonly
referred
to
as
exchange-traded derivatives (ETD) contracts.
Exchanges offer the
benefits of pricing transparency,
standardized daily settlement of
changes in value and, consequently,
reduced credit risk.
Most
of
UBS
AG’s
derivative
transactions
relate
to
sales
and
market-making activity. Sales activities
include the structuring
and
marketing of derivative products to customers to
enable them to
take, transfer, modify or
reduce current or expected
risks. Market-
making aims to
directly support the
facilitation and execution
of
client activity,
and involves
quoting bid
and offer
prices to
other
market participants with
the aim
of generating revenues
based on
spread
and
volume.
UBS
AG
also
uses
various
derivative
instruments for hedging purposes.
›
Refer to Notes 16 and 21 for more information
about derivative
instruments
›
Refer to Note 26 for more information about
derivatives
designated in hedge accounting relationships
Risks of derivative instruments
The derivative financial assets shown on the
balance sheet can be
an important component of UBS AG ’s credit exposure; however,
the
positive
replacement
values
related
to
a
respective
counterparty are rarely an adequate reflection of UBS AG’s credit
exposure in its derivatives business with that
counterparty. This is
generally the case because, on the one hand, replacement values
can increase
over time (potential
future exposure), while,
on the
other hand,
exposure may
be mitigated
by entering
into master
netting
agreements
and
bilateral
collateral
arrangements.
Both
the exposure measures
used internally
by UBS AG
to control credit
risk
and
the
capital
requirements
imposed
by
regulators
reflect
these additional factors.
›
Refer to Note 22 for more information about
derivative financial
assets and liabilities after consideration
of netting potential
allowed under enforceable netting arrangements
›
Refer to the “Risk management and control”
section of this
report for more information about the risks arising
from
derivative instruments
Consolidated financial statements | UBS AG consolidated financial statements
454
Note 10
Derivative instruments (continued)
Derivative instruments
31.12.21
31.12.20
USD billion
Derivative
financial
assets
Notional
amounts
related to
derivative
financial
assets
2,3
Derivative
financial
liabilities
Notional
amounts
related to
derivative
financial
liabilities
2,3
Other
notional
amounts
2,4
Derivative
financial
assets
Notional
amounts
related to
derivative
financial
assets
2,3
Derivative
financial
liabilities
Notional
amounts
related to
derivative
financial
liabilities
2,3
Other
notional
amounts
2,4
Interest rate contracts
33.2
991.2
28.7
943.1
8,675.1
50.9
928.0
43.9
880.4
11,291.5
of which: forward contracts (OTC)
1
0.1
29.4
0.2
28.6
443.6
0.0
19.8
0.4
21.9
2,602.5
of which: swaps (OTC)
26.4
394.3
19.2
344.1
7,549.4
40.8
407.0
30.9
364.8
8,105.2
of which: options (OTC)
6.6
545.2
9.2
553.6
10.1
447.5
12.5
460.5
of which: futures (ETD)
525.0
480.6
of which: options (ETD)
0.0
22.4
0.0
16.8
157.1
0.0
53.6
0.0
33.1
103.3
Credit derivative contracts
1.4
44.7
1.8
46.3
2.4
57.6
2.9
64.8
of which: credit default swaps (OTC)
1.3
39.4
1.6
44.1
2.2
53.6
2.6
62.3
of which: total return swaps (OTC)
0.1
1.3
0.2
1.7
0.1
1.9
0.3
2.5
Foreign exchange contracts
53.3
3,031.0
54.1
2,938.8
1.2
68.7
2,951.2
70.5
2,820.4
1.4
of which: forward contracts (OTC)
23.8
1,009.1
23.8
1,043.2
27.3
779.2
29.0
853.3
of which: swaps (OTC)
24.3
1,606.4
24.9
1,480.3
34.3
1,727.3
34.4
1,567.3
of which: options (OTC)
5.2
412.6
5.3
408.6
7.1
440.9
7.1
394.7
Equity contracts
28.2
456.9
34.9
603.9
80.1
34.8
449.6
41.2
581.3
91.3
of which: swaps (OTC)
4.7
105.7
9.3
154.8
6.4
89.4
9.8
108.4
of which: options (OTC)
4.6
61.4
6.5
102.3
7.0
87.1
10.9
146.2
of which: futures (ETD)
71.2
67.9
of which: options (ETD)
10.2
289.6
9.8
346.3
8.8
10.7
273.1
11.3
326.8
23.5
of which: client-cleared transactions (ETD)
8.6
9.4
10.7
9.1
Commodity contracts
1.6
57.8
1.6
56.4
14.7
2.2
57.8
2.0
49.7
10.1
of which: swaps (OTC)
0.5
19.9
0.8
25.4
0.5
17.7
0.8
18.0
of which: options (OTC)
0.4
14.0
0.2
10.4
1.0
23.5
0.7
17.8
of which: futures (ETD)
13.9
9.3
of which: forward contracts (ETD)
0.0
18.1
0.0
15.2
0.0
8.0
0.0
6.3
of which: client-cleared transactions (ETD)
0.6
0.4
0.5
0.3
Loan commitments
measured at FVTPL (OTC)
0.0
0.8
0.0
8.2
0.0
10.2
Unsettled purchases of non-derivative
financial instruments
5
0.1
13.3
0.2
10.6
0.3
18.3
0.2
10.0
Unsettled sales of non-derivative financial
instruments
5
0.2
18.2
0.1
9.4
0.2
17.2
0.3
12.9
Total derivative instruments,
based on IFRS netting
6
118.1
4,614.0
121.3
4,616.6
8,771.1
159.6
4,479.6
161.1
4,429.7
11,394.4
1 Includes certain forward starting repurchase and reverse repurchase agreements that are classified as measured
at fair value through profit or loss and are recognized within derivative instruments.
2 In cases where
derivative financial instruments
are presented on
a net basis
on the bal
ance sheet, the
respective notional amounts
of the netted
derivative financial
instruments are
still presented on
a gross basis.
3 Notional
amounts of client-cleared ETD and OTC
transactions through central clearing
counterparties are not disclosed, as they
have significantly different risk profile.
4 Other notional amounts relate to derivatives
that are
cleared through either a central counterparty or an exchange. The
fair value of these derivatives is presented on the balance
sheet net of the corresponding cash margin under Cash collateral receivables on
derivative
instruments and Cash collateral
payables on derivative
instruments and was not
material for all periods
presented.
5 Changes in the
fair value of purchased
and sold non-derivative financial
instruments between
trade date and
settlement date are
recognized as derivative
financial instruments.
6 Derivative financial
assets and liabilities
are presented net
on the balance
sheet if UBS
AG has the
unconditional and legally
enforceable right to offset the recognized amounts, both in the normal course of business and in the event of default, bankruptcy or insolvency of the entity and all of the counterparties, and intends either to settle on
a net basis or to realize the asset and settle the liability simultaneously. Refer to Note 22 for more information
on netting arrangements.
On a notional amount basis,
approximately
40
% of OTC interest
rate contracts held as of 31 December 2021 (31 December
2020:
50
%) mature
within one
year,
36
% (31
December 2020:
30
%)
within one to
five years and
25
% (31 December
2020:
20
%) after
five years.
Notional
amounts
of
interest
rate
contracts
cleared
through
either
a
central
counterparty
or
an
exchange
that
are
legally
settled
on
a
daily
basis
are
presented
under
Other
notional
amounts
in
the
table
above
and
are
categorized
into
maturity
buckets
on
the
basis
of
contractual
maturities
of
the
cleared
underlying
derivative
contracts. Other
notional
amounts
related
to interest rate contracts
decreased by USD
2.6
trillion compared
with
31 December
2020,
mainly
reflecting
trade
compressions,
which
included
activity
as
part
of
the
ongoing
transition
to
alternative reference rates, and maturities.
455
Note 11
Financial assets measured at fair value through other comprehensive income
USD million
31.12.21
31.12.20
Financial assets measured at fair value through other comprehensive income
1
Debt instruments
Governments and government agencies
8,522
8,155
of which: USA
7,507
7,727
Banks
322
103
Total financial assets measured at fair value through other comprehensive income
8,844
8,258
Unrealized gains / (losses) recognized in Other comprehensive
income
Unrealized gains, before tax
67
204
Unrealized (losses), before tax
(
80
)
(
4
)
Net unrealized gains / (losses), before tax
(
13
)
200
Net unrealized gains / (losses), after tax
(
7
)
151
1 Refer to Note 21c for more information about product type and fair value hierarchy categorization. Refer
also to Note 9 and Note 20 for more information about expected credit loss measurement.
Note 12
Property, equipment and software
At historical cost less accumulated depreciation
USD million
Owned
properties and
equipment
1
Leased
properties and
equipment
2
Software
Projects in
progress
2021
2020
Historical cost
Balance at the beginning of the year
11,676
4,091
7,111
907
23,785
22,329
Additions
162
1
174
233
1,220
1,789
1,989
Disposals / write-offs
3
(
345
)
(
212
)
(
75
)
0
(
632
)
(
867
)
Reclassifications
4
267
0
703
(
988
)
(
18
)
(
590
)
Foreign currency translation
(
266
)
(
59
)
(
48
)
(
9
)
(
381
)
924
Balance at the end of the year
11,494
3,994
7,924
1,130
24,542
23,785
Accumulated depreciation
Balance at the beginning of the year
7,188
1,019
3,621
0
11,827
10,503
Depreciation
507
474
854
0
1,835
1,779
Impairment
5
8
1
0
0
9
72
Disposals / write-offs
3
(
341
)
(
204
)
(
75
)
0
(
619
)
(
735
)
Reclassifications
4
(
12
)
0
0
0
(
12
)
(
328
)
Foreign currency translation
(
172
)
(
18
)
(
19
)
0
(
210
)
535
Balance at the end of the year
7,178
1,272
4,380
0
12,830
11,827
Net book value
Net book value at the beginning of the year
4,488
3,072
3,490
907
11,958
11,826
Net book value at the end of the year
4,316
2,722
3,544
1,130
6
11,712
11,958
1 Includes leasehold improvements and IT hardware.
2 Represents right-of-use assets recognized by UBS AG as lessee. UBS AG predominantly enters into lease contracts, or contracts that include lease components,
in relation to real estate, including offices, retail branches and sales offices. The
total cash outflow for leases during 2021 was USD
632
million (2020: USD
652
million). Interest expense on lease liabilities is included
within Interest expense from
financial instruments measured at
amortized cost and Lease
liabilities are included within
Other financial liabilities
measured at amortized cost.
Refer to Notes 3
and 19a, respectively.
There were no material gains
or losses arising from sale-and-leaseback
transactions in 2021 (2020: USD
140
million).
3 Includes write-offs of fully
depreciated assets.
4 The total reclassification amount
for the
respective periods represents net reclassifications
to Properties and other
non-current assets held for
sale.
5 Impairment charges recorded in
2021 generally relate to
assets that are no longer
used, for which the
recoverable amount based on a value in use approach was determined to be zero.
6 Consists of USD
1,009
million related to software and USD
121
million related to Owned properties and equipment.
Consolidated financial statements | UBS AG consolidated financial statements
456
Note 13
Goodwill and intangible assets
Introduction
UBS AG performs an impairment test on
its goodwill assets on an
annual basis or when indicators of impairment exist.
UBS AG considers Asset Management,
as it is reported in Note
2a, as a separate cash-generating
unit (a
CGU), as that is
the level
at
which
the
performance
of
investment
(and
the
related
goodwill) is reviewed and assessed by management. Given that a
significant
amount
of
goodwill
in
Global
Wealth
Management
relates
to
the
PaineWebber
acquisition
in
2000,
which
mainly
affected
the
Americas
portion
of
the
business,
this
goodwill
remains
separately
monitored
by
the
Americas
,
despite
the
formation
of
Global
Wealth
Management
in
2018.
Therefore,
goodwill for Global Wealth Management is
separately considered
for
impairment
at
the
level
of
two
CGUs:
Americas;
and
Switzerland
and
International
(consisting
of
EMEA,
Asia
Pacific
and Global).
The
impairment
test
is
performed
for
each
CGU
to
which
goodwill is
allocated by
comparing the
recoverable amount,
based
on
its
value
in
use,
with
the
carrying
amount
of
the
respective
CGU. An impairment charge is recognized if the carrying amount
exceeds the recoverable amount.
As
of
31 December
2021,
total
goodwill
recognized
on
the
balance sheet
was USD
6.1
billion, of which
USD
3.7
billion was
carried
by
the
Global
Wealth
Management
Americas
CGU,
USD
1.2
billion
was
carried
by the
Global
Wealth
Management
Switzerland
and
International
CGU
,
and
USD
1.2
billion
was
carried by
Asset Management.
Based on
the impairment
testing
methodology
described
below,
UBS
AG
concluded
that
the
goodwill
balances
as
of
31 December
2021
allocated
to
these
CGUs are not impaired.
Methodology for goodwill impairment testing
The recoverable amounts are determined using
a discounted cash
flow model, which has
been adapted to use inputs
that consider
features of the banking
business and its regulatory
environment.
The recoverable
amount of
a CGU
is the
sum of
the discounted
earnings attributable to shareholders from the first three forecast
years and the terminal value, adjusted
for the effect of the capital
assumed to
be needed
over the next
three years
and to
support
growth beyond
that period. The
terminal value,
which covers all
periods
beyond
the third
year,
is calculated
on the
basis
of
the
forecast of third
-year profit, the
discount rate and
the long-term
growth rate, as well as the implied perpetual capital growth.
The carrying amount for each CGU is determined by reference
to
UBS’s
equity
attribution
framework.
Within
this
framework,
which
is
described
in
the
“Capital,
liquidity
and
funding,
and
balance sheet” section of this report, UBS attributes equity to the
businesses on the basis of their risk-weighted assets and leverage
ratio denominator (both metrics include
resource allocations from
Group
Functions
to
the
business
divisions),
their
goodwill
and
their
intangible
assets,
as
well
as
attributed
equity
related
to
certain CET1 deduction
items. The framework
is primarily used
for
the purpose of measuring the performance of the
businesses and
includes
certain
management
assumptions.
Attributed
equity
is
equal to the capital a CGU requires to conduct its business and is
currently considered
a reasonable
approximation of
the carrying
amount of
the CGUs.
The attributed
equity methodology
is also
applied in
the business
planning process,
the inputs
from which
are used in calculating the recoverable amounts of the respective
CGU.
›
Refer to the “Capital, liquidity and funding,
and balance sheet”
section of this report for more information about
the equity
attribution framework
Assumptions
Valuation
parameters
used
within
UBS
AG’s
impairment
test
model
are
linked
to
external
market
information,
where
applicable. The model used to determine the recoverable amount
is most
sensitive to changes
in the
forecast earnings available
to
shareholders
in
years
one
to
three,
to
changes
in
the
discount
rates and
to changes
in the
long-term growth
rate. The
applied
long-term
growth
rate is
based on
long-term economic
growth
rates
for
different
regions
worldwide.
Earnings
available
to
shareholders are estimated on the basis of forecast results, which
are part of the business plan approved by the Board of Directors.
The discount
rates are
determined by
applying a
capital asset
pricing model-based approach,
as well as
considering quantitative
and
qualitative
inputs
from
both
internal
and
external
analysts
and
the
view
of
management.
T
hey
also
take
into
account
regional differences in risk-free rates at
the level of the individual
CGUs.
In
line
with
discount
rates,
long-term
growth
rates
are
determined
at
the regional
level
based
on
nominal
or
real GDP
growth rate forecasts.
457
Note 13
Goodwill and intangible assets (continued)
Key assumptions
used to determine
the recoverable
amounts
of eac
h
CGU are
tested
for sensitivity
by applying
a reasonably
possible
change
to
those
assumptions.
Forecast
earnings
available
to
shareholders
were
changed
by
20
%,
the
discount
rates were changed by
1.5
percentage points, and the long-term
growth rates were changed by
0.75
percentage points. Under all
scenarios,
reasonably
possible
changes
in
key
assumptions
did
not
result
in
an
impairment
of
goodwill
or
intangible
assets
reported
by
Global
Wealth
Management
Americas,
Global
Wealth
Management
Switzerland
and
International,
and
Asset
Management.
If
the
estimated
earnings
and
other
assumptions
in
future
periods deviate
from the
current outlook,
the value
of goodwill
attributable
to
Global
Wealth
Management
Americas,
Global
Wealth
Management
Switzerland
and
International,
and
Asset
Management may
become impaired
in the
future, giving
rise to
losses in the income
statement. Recognition of any
impairment of
goodwill
would
reduce IFRS
equity and
net profit.
It
would
not
affect cash flows
and, as goodwill
is required to
be deducted from
capital under
the Basel III capital
framework, no effect
would be
expected on UBS AG’s capital ratios.
Discount and growth rates
Discount rates
Growth rates
In %
31.12.21
31.12.20
31.12.21
31.12.20
Global Wealth Management Americas
9.5
9.5
4.0
5.1
Global Wealth Management Switzerland and International
8.5
8.5
3.1
3.7
Asset Management
8.5
8.5
2.9
3.5
USD million
Goodwill
Intangible
assets
1
2021
2020
Historical cost
Balance at the beginning of the year
6,182
1,683
7,865
7,820
Additions
1
1
147
Disposals
(
3
)
(
3
)
(
158
)
Write-offs
(
41
)
(
41
)
(
35
)
Foreign currency translation
(
53
)
(
30
)
(
83
)
91
Balance at the end of the year
6,126
1,612
7,739
7,865
Accumulated amortization and impairment
Balance at the beginning of the year
1,385
1,385
1,351
Amortization
31
31
55
Impairment / (reversal of impairment)
2
(
1
)
(
1
)
2
Disposals
0
0
Write-offs
(
41
)
(
41
)
(
35
)
Foreign currency translation
(
13
)
(
13
)
11
Balance at the end of the year
1,360
1,360
1,385
Net book value at the end of the year
6,126
252
6,378
6,480
of which: Global Wealth Management Americas
3,720
41
3,760
3,770
of which: Global Wealth Management Switzerland and International
1,204
72
1,276
1,320
of which: Asset Management
1,202
1,202
1,226
of which: Investment Bank
139
139
161
of which: Group Functions
0
4
1 Intangible assets mainly include customer relationships, contractual rights and the fully amortized branch
network intangible asset recognized in connection with the acquisition of PaineWebber
Group, Inc.
2 Impairment charges recorded in 2020 relate to assets for which the recoverable amount was determined considering their value
in use (recoverable amount of the impaired intangible assets: USD
5
million for
2020).
The table below presents estimated aggregated amortization expenses for intangible assets.
USD million
Intangible assets
Estimated aggregated amortization expenses for:
2022
29
2023
27
2024
23
2025
23
2026
23
Thereafter
126
Not amortized due to indefinite useful life
2
Total
252
Consolidated financial statements | UBS AG consolidated financial statements
458
Note 14
Other assets
a) Other financial assets measured at amortized cost
USD million
31.12.21
31.12.20
Debt securities
18,858
18,801
of which: government bills / bonds
9,833
9,789
Loans to financial advisors
2,453
2,569
Fee-
and commission-related receivables
1,966
2,014
Finance lease receivables
1,356
1,447
Settlement and clearing accounts
455
614
Accrued interest income
521
592
Other
627
1,182
Total other financial assets measured at amortized cost
26,236
27,219
b) Other non-financial assets
USD million
31.12.21
31.12.20
Precious metals and other physical commodities
5,258
6,264
Deposits and collateral provided in connection with litigation,
regulatory and similar matters
1
1,526
1,418
Prepaid expenses
717
731
VAT and other tax receivables
591
392
Properties and other non-current assets held for sale
32
246
Assets of disposal groups held for sale
2
1,093
Other
618
323
Total other non-financial assets
9,836
9,374
1 Refer to Note 18 for more information.
2 Refer to Note 30 for more information.
Note 15
Amounts due to banks, customer deposits, and funding from UBS Group AG
a) Amounts due to banks and customer deposits
USD million
31.12.21
31.12.20
Amounts due to banks
13,101
11,050
Customer deposits
544,834
527,929
of which: demand deposits
247,299
237,604
of which: retail savings / deposits
247,224
220,898
of which: time deposits
1
50,312
69,427
Total amounts due to banks and customer deposits
557,935
538,979
1 Includes customer deposits in UBS AG Jersey Branch placed by UBS Switzerland AG on behalf of its clients.
b) Funding from UBS Group AG
USD million
31.12.21
31.12.20
Senior unsecured debt that contributes to total loss-absorbing
capacity (TLAC)
38,984
36,611
Senior unsecured debt other than TLAC
4,471
2,939
High-trigger loss-absorbing additional tier 1 capital instruments
11,414
11,854
Low-trigger loss-absorbing additional tier 1 capital instruments
2,426
2,575
Total
1
57,295
53,979
1 UBS AG has also recognized funding from UBS Group AG that is designated at fair value.
Refer to Note 19b for more information.
459
Note 16
Debt issued designated at fair value
USD million
31.12.21
31.12.20
Issued debt instruments
Equity-linked
1
47,059
41,069
Rates-linked
16,369
11,038
Credit-linked
1,723
1,933
Fixed-rate
2,868
3,604
Commodity-linked
2,911
1,497
Other
529
726
Total debt issued designated at fair value
71,460
59,868
of which: issued by UBS AG with original maturity greater than one
year
2
57,967
46,427
of which: life-to-date own credit (gain) / loss
144
233
1 Includes investment fund unit-linked instruments issued.
2 Based on original contractual maturity without considering any early redemption features. As of 31 December
2021,
100
% of the balance was unsecured
(31 December 2020:
100
%).
As of 31 December
2021 and 31
December 2020, the contractual
redemption amount at maturity
of debt issued designated at
fair
value through profit or
loss was not materially different
from the
carrying amount.
The table below shows the
residual contractual maturity of the
carrying
amount
of
debt
issued
designated
at
fair
value,
split
between
fixed-rate
and
floating-rate
instruments
based
on
the
contractual
terms,
and
does
not
consider
any
early
redemption
features. Interest rate ranges for future interest
payments related
to debt issued designated at fair value have
not been included in
the table below,
as the majority
of the debt
instruments issued are
structured
products
and
therefore
the
future
interest
payments
are
highly
dependent
upon
the
embedded
derivative
and
prevailing market conditions
at the point
in time that
each interest
payment is made.
›
Refer to Note 24 for maturity information
on an undiscounted
cash flow basis
Contractual maturity of carrying amount
USD million
2022
2023
2024
2025
2026
2027–2031
Thereafter
Total
31.12.21
Total
31.12.20
UBS AG
1
Non-subordinated debt
Fixed-rate
4,296
1,658
716
495
226
273
1,732
9,397
9,409
Floating-rate
19,338
15,621
5,067
5,816
3,840
8,364
3,238
61,284
49,528
Subtotal
23,635
17,279
5,783
6,311
4,066
8,637
4,971
70,682
58,937
Other subsidiaries
2
Non-subordinated debt
Fixed-rate
6
0
0
0
0
423
0
429
539
Floating-rate
150
47
145
0
0
0
7
349
392
Subtotal
156
47
145
0
0
423
7
778
931
Total
23,791
17,325
5,929
6,311
4,066
9,060
4,977
71,460
59,868
1 Consists of instruments issued by the legal entity UBS AG.
2 Consists of instruments issued by subsidiaries of UBS AG.
Consolidated financial statements | UBS AG consolidated financial statements
460
Note 17
Debt issued measured at amortized cost
USD million
31.12.21
31.12.20
Certificates of deposit and commercial paper
40,640
41,151
Other short-term debt
2,458
5,515
Short-term debt
1
43,098
46,666
Senior unsecured debt
23,328
18,483
of which: issued by UBS AG with original maturity greater than one
year
2
23,307
18,464
Covered bonds
1,389
2,796
Subordinated debt
5,163
7,744
of which: low-trigger loss-absorbing tier 2 capital instruments
2,596
7,201
of which: non-Basel III-compliant tier 2 capital instruments
547
543
Debt issued through the Swiss central mortgage institutions
9,454
9,660
Other long-term debt
0
3
Long-term debt
3
39,334
38,685
Total debt issued measured at amortized cost
4
82,432
85,351
1 Debt with an original contractual maturity of
less than one year.
2 Based on original contractual maturity without considering
any early redemption features. As
of 31 December 2021,
100
% of the balance was
unsecured (31 December 2020:
100
%).
3 Debt with an original contractual
maturity greater than or equal
to one year.
The classification of debt
issued into short-term and long-term
does not consider any early
redemption features.
4 Net of bifurcated embedded derivatives, the fair value of which was
not material for the periods presented.
UBS
AG
uses
interest
rate
and
foreign
exchange
derivatives
to
manage
the
risks
inherent
in
certain
debt
instruments
held
at
amortized cost. In some cases, UBS AG applies hedge accounting
for interest
rate risk as
discussed in
item 2j in
Note 1a and
Note
26.
As
a
result
of
applying
hedge
accounting,
the
life-to-date
adjustment to the
carrying amount of
debt issued was
an increase
of USD
261
million as
of 31
December 2021
and an
increase of
USD
761
million as
of 31
December 2020,
reflecting changes
in
fair value due to interest rate movements.
Subordinated debt consists of unsecured debt obligations that
are
contractually
subordinated
in
right
of
payment
to
all
other
present and future
non-subordinated obligations of
the respective
issuing
entity.
All
of
the
subo
rdinated
debt
instruments
outstanding as of 31 December 2021 pay a fixed rate of interest.
The table below shows the
residual contractual maturity of
the
carrying
amount
of
debt
issued,
split
between
fixed-rate
and
floating-rate
based
on
the
contractual
terms,
and
does
not
consider any early redemption
features. The effects from interest
rate
swaps,
which
are
used
to
hedge
various
fixed-rate
debt
issuances
by
changing
the
repricing
characteristics
into
those
similar to
floating-rate debt, are
also not considered
in the
table
below.
›
Refer to Note 24 for maturity information
on an undiscounted
cash flow basis
Contractual maturity of carrying amount
USD million
2022
2023
2024
2025
2026
2027–2031
Thereafter
Total
31.12.21
Total
31.12.20
UBS AG
1
Non-subordinated debt
Fixed-rate
38,647
5,578
1,964
349
3,439
1,381
1,213
52,571
52,618
Floating-rate
9,807
2,093
1,922
907
508
0
0
15,238
15,299
Subordinated debt
Fixed-rate
2,020
0
2,596
337
210
0
0
5,163
7,744
Subtotal
50,474
7,671
6,482
1,594
4,158
1,381
1,213
72,972
75,661
Other subsidiaries
2
Non-subordinated debt
Fixed-rate
907
1,007
1,072
1,173
1,045
3,674
582
9,460
9,690
Subtotal
907
1,007
1,072
1,173
1,045
3,674
582
9,460
9,690
Total
51,381
8,679
7,554
2,766
5,203
5,055
1,795
82,432
85,351
1 Consists of debt issued by the legal entity UBS AG.
2 Consists of debt issued by subsidiaries of UBS AG.
461
Note 18
Provisions and contingent liabilities
a) Provisions
The table below presents an overview of total provisions.
USD million
31.12.21
31.12.20
Provisions other than provisions for expected credit losses
3,256
2,534
Provisions for expected credit losses
196
257
Total provisions
3,452
2,791
The following table presents additional information for provisions other than provisions for expected credit losses.
USD million
Litigation,
regulatory and
similar matters
1
Restructuring
Other
3
Total 2021
Balance at the beginning of the year
2,135
67
332
2,534
Increase in provisions recognized in the income statement
986
228
73
1,286
Release of provisions recognized in the income statement
(
74
)
(
25
)
(
29
)
(
128
)
Provisions used in conformity with designated purpose
(
189
)
(
130
)
(
76
)
(
396
)
Capitalized reinstatement costs
0
0
30
30
Foreign currency translation / unwind of discount
(
59
)
(
3
)
(
9
)
(
70
)
Balance at the end of the year
2,798
137
2
321
3,256
1 Consists of provisions for losses resulting from legal, liability and compliance risks.
2 Primarily consists of personnel-related restructuring provisions of USD
90
million as of 31 December 2021 (31 December 2020:
USD
13
million) and provisions
for onerous contracts
of USD
47
million as of
31 December 2021 (31 December 2020: USD
49
million).
3 Mainly includes provisions
related to real
estate, employee benefits
and
operational risks.
Restructuring
provisions
primarily
relate
to
personnel
-
related
provisions and onerous contracts. Personnel-related restructuring
provisions
are
used
within
a
short
period
of
time
but
potential
changes in amount may be
triggered when natural staff
attrition
reduces the
number of
people affected
by a
restructuring event
and therefore the estimated
costs. Onerous contracts
for property
are recognized
when UBS AG
is committed to
pay for non-lease
components,
such
as
utilities,
service
charges,
taxes
and
maintenance, when
a property
is vacated
or not
fully recovered
from sub-tenants.
Information
about
provisions
and
contingent
liabilities
in
respect of
litigation, regulatory
and similar
matters, as
a class, is
included in Note
18b. There are
no material contingent liabilities
associated with the other classes of provisions.
b) Litigation, regulatory and similar matters
UBS operates in a legal and
regulatory environment that exposes
it
to
significant
litigation
and
similar
risks
arising
from
disputes
and regulatory proceedings. As a result, UBS (which for purposes
of
this
Note
may
refer
to
UBS
AG
and/or
one
or
more
of
its
subsidiaries, as applicable)
is involved in various
disputes and legal
proceedings, including
litigation, arbitration,
and regulatory
and
criminal investigations.
Such
matters
are
subject
to
many
uncertainties,
and
the
outcome and the
timing of
resolution are often
difficult to
predict,
particularly in the earlier
stages of a case.
There are also situations
where
UBS
may
enter
into
a
settlement
agreement.
This
may
occur in
order to
avoid the
expense, management
distraction or
reputational implications
of continuing
to contest
liability, even
for
those matters for
which UBS believes
it should be
exonerated. The
uncertainties inherent
in all
such matters
affect the
amount and
timing of any potential outflows for both matters with respect to
which
provisions
have
been
established
and
other
contingent
liabilities. UBS makes provisions for such matters brought against
it when, in
the opinion of management
after seeking legal
advice,
it
is
more
likely
than
not
that
UBS
has
a
present
legal
or
constructive
obligation
as
a
result
of
past
events,
it
is
probable
that an outflow of
resources will be
required, and the
amount can
be reliably estimated. Where these factors
are otherwise satisfied,
a provision may
be established for claims
that have not
yet been
asserted against UBS, but are nevertheless expected to be,
based
on UBS’s
experience with
similar asserted
claims. If
any of
those
conditions is not met, such matters result in contingent liabilities.
If
the
amount
of
an
obligation
cannot
be
reliably
estimated,
a
liability
exists
that
is
not
recognized
even
if
an
outflow
of
resources
is
probable.
Accordingly,
no
provision
is
established
even
if
the
potential
outflow
of
resources
with
respect
to
such
matters could
be significant.
Developments relating
to a
matter
that
occur
after
the
relevant
reporting
period,
but
prior
to
the
issuance
of
financial
statements,
which
affect
management’s
assessment
of
the
provision
for
such
matter
(because,
for
example,
the developments
provide evidence
of
conditions that
existed at
the end
of the
reporting period),
are adjusting
events
after the reporting
period under IAS
10 and must
be recognized
in the financial statements for the reporting period.
Consolidated financial statements | UBS AG consolidated financial statements
462
Note 18
Provisions and contingent liabilities (continued)
Specific litigation,
regulatory and
other matters
are described
below, including
all such
matters that management
considers to
be
material
and
others
that
management
believes
to
be
of
significance
due
to
potential
financial,
reputational
and
other
effects. The amount of
damages claimed, the size
of a transaction
or other information is provided where
available and appropriate
in order to assist
users in considering the magnitude
of potential
exposures.
In
the
case of
certain
matters below,
we state
that we
have
established a
provision, and
for the
other matters,
we make
no
such
statement.
When
we
make
this
statement
and
we
expect
disclosure of the amount of a provision to
prejudice seriously our
position with other
parties in the
matter because it
would reveal
what
UBS
believes
to
be
the
probable
and
reliably
estimable
outflow, we
do not
disclose that
amount. In
some cases
we are
subject
to
confidentiality
obligations
that
preclude
such
disclosure. With respect to the matters for which we do not state
whether we have established
a provision, either: (a)
we have not
established a
provision, in
which case
the matter
is treated
as a
contingent liability
under the
applicable accounting
standard; or
(b) we have
established a provision
but expect disclosure
of that
fact to
prejudice seriously
our position
with other
parties in
the
matter
because
it
would
reveal
the
fact
that
UBS
believes
an
outflow of resources to be probable and reliably estimable.
With respect
to certain
litigation, regulatory
and similar
matters
for which we have established provisions, we
are able to estimate
the expected timing
of outflows. However,
the aggregate amount
of the expected outflows for those matters for which we are able
to estimate
expected timing
is immaterial
relative to
our current
and expected levels of liquidity over the relevant time periods.
The
aggregate
amount
provisioned
for
litigation,
regulatory
and similar matters as a class
is disclosed in the “Provisions” table
in Note
18a above.
It is
not practicable
to provide
an aggregate
estimate
of
liability
for
our
litigation,
regulatory
and
similar
matters as a class of contingent liabilities. Doing so would
require
UBS
to
provide
speculative
legal
assessments
as
to
claims
and
proceedings
that
involve
unique
fact
patterns
or
novel
legal
theories, that have not yet been initiated or are at early
stages of
adjudication,
or
as
to
which
alleged
damages
have
not
been
quantified
by
the
claimants.
Although
UBS
therefore
cannot
provide a numerical estimate of the
future losses that could arise
from litigation,
regulatory and
similar matters,
UBS believes
that
the aggregate
amount of
possible future
losses from
this class
that
are
more than
remote
substantially exceeds
the level
of
current
provisions.
Litigation,
regulatory
and
similar
matters
may
also
result
in
non-monetary
penalties
and
consequences.
A guilty
plea
to,
or
conviction of, a crime could have material consequences for UBS.
Resolution of
regulatory proceedings
may require
UBS to
obtain
waivers
of
regulatory
disqualifications
to
maintain
certain
operations, may entitle regulatory authorities to limit, suspend or
terminate licenses and regulatory authorizations, and may permit
financial
market
utilities
to
limit,
suspend
or
terminate
UBS’s
participation in such
utilities. Failure to
obtain such
waivers, or
any
limitation, suspension or
termination of licenses,
authorizations or
participations, could have material consequences for UBS.
The risk of
loss associated with
litigation, regulatory and
similar
matters
is
a
component
of
operational
risk
for
purposes
of
determining
capital
requirements.
Information
concerning
our
capital requirements
and the
calculation of
operational risk
for this
purpose
is
included
in
the
“Capital,
liquidity
and
funding,
and
balance sheet” section of this report.
Provisions for litigation, regulatory and similar matters
by business division and in Group Functions
1
USD million
Global
Wealth
Manage-
ment
Personal &
Corporate
Banking
Asset
Manage-
ment
Investment
Bank
Group
Functions
Total 2021
Balance at the beginning of the year
861
115
0
227
932
2,135
Increase in provisions recognized in the income statement
754
84
9
107
32
986
Release of provisions recognized in the income statement
(
60
)
(
11
)
0
(
4
)
0
(
74
)
Provisions used in conformity with designated purpose
(
175
)
(
1
)
(
1
)
(
10
)
(
2
)
(
189
)
Foreign currency translation / unwind of discount
(
42
)
(
6
)
0
(
11
)
0
(
59
)
Balance at the end of the year
1,338
181
8
310
962
2,798
1 Provisions, if any,
for the matters described
in items 3 and
4 of this Note are
recorded in Global Wealth
Management, and provisions,
if any, for
the matters described in
item 2 are recorded in
Group Functions.
Provisions, if any, for the matters described in items 1 and 6 of this Note are allocated between Global Wealth Management and Personal & Corporate Banking, and provisions, if any, for the matters described in item
5 are allocated between the Investment Bank and Group Functions.
463
Note 18
Provisions and contingent liabilities (continued)
1. Inquiries regarding cross-border wealth management
businesses
Tax
and
regulatory
authorities
in
a
number
of
countries
have
made
inquiries,
served
requests
for
information
or
examined
employees located
in their
respective jurisdictions
relating to
the
cross-border
wealth management
services provided
by UBS
and
other financial institutions.
It is possible
that the implementation
of
automatic
tax
information
exchange
and
other
measures
relating to
cross-border provision
of financial
services could
give
rise to further inquiries in
the future. UBS has
received disclosure
orders from the Swiss Federal
Tax Administration (FTA) to transfer
information
based
on
requests
for
international
administrative
assistance in tax matters. The
requests concern a number of UBS
account numbers pertaining to
current and former clients and
are
based
on
data
from
2006
and
2008.
UBS
has
taken
steps
to
inform
affected
clients
about
the
administrative
assistance
proceedings
and
their
procedural
rights,
including
the
right
to
appeal. The requests
are based on
data received from the
German
authorities, who seized certain
data related to UBS clients
booked
in
Switzerland
during
their
investigations
and
have
apparently
shared
this
data
with
other
European
countries.
UBS
expects
additional countries to file similar requests.
Since
2013,
UBS
(France)
S.A.,
UBS
AG
and
certain
former
employees
have
been
under
investigation
in
France
for
alleged
complicity
in
unlawful
solicitation
of
clients
on
French
territory,
regarding
the laundering
of proceeds
of tax
fraud, and
banking
and financial solicitation
by unauthorized persons.
In connection
with this
investigation, the investigating
judges ordered
UBS AG
to provide
bail (“
caution
”) of
EUR
1.1
billion and
UBS (France)
S.A.
to post
bail of
EUR
40
million, which
was reduced
on appeal
to
EUR
10
million.
On
20 February
2019,
the
court
of
first
instance
returned
a
verdict finding UBS AG guilty of unlawful
solicitation of clients on
French territory and aggravated laundering of
the proceeds of tax
fraud,
and
UBS
(France)
S.A.
guilty
of
aiding
and
abetting
unlawful solicitation and of laundering the proceeds of tax fraud.
The court
imposed fines aggregating
EUR
3.7
billion on
UBS AG
and
UBS
(France)
S.A.
and
awarded
EUR
800
million
of
civil
damages to the French
state. A trial
in the French Court
of Appeal
took place in
March 2021.
On 13 December
2021, the
Court of
Appeal
found
UBS
AG
guilty
of
unlawful
solicitation
and
aggravated
laundering
of
the
proceeds
of
tax
fraud.
The
court
ordered
a
fine
of
EUR
3.75
million,
the
confiscation
of
EUR
1
billion, and
awarded civil
damages to
the French
state of
EUR
800
million. The
court also
found UBS
(France) SA
guilty of
the aiding and abetting of
unlawful solicitation and ordered it
to
pay a fine of EUR
1.875
million. UBS AG has filed an appeal with
the
French
Supreme
Court
to
preserve
its
rights.
The
appeal
enables UBS AG
to thoroughly assess the
verdict of the
Court of
Appeal
and
to
determine
next
steps
in
the
best
interest
of
its
stakeholders. The fine
and confiscation imposed
by the Court
of
Appeal are
suspended during the
appeal. The civil
damages award
has been
paid to
the French
state (EUR
99
million of
which was
deducted from the bail), subject to the result of UBS’s appeal.
Our balance
sheet at
31 December 2021
reflected provisions
with
respect
to
this
matter
in
an
amount
of
EUR
1.1
billion
(USD
1.252
billion
at
31
December
2021).
The
wide
range
of
possible
outcomes
in
this
case
contributes
to
a
high
degree
of
estimation uncertainty and
the provision reflects
our best estimate
of
possible
financial
implications,
although
actual
penalties and
civil
damages
could
exceed
(or
may
be
less
than)
the
provision
amount.
In 2016,
UBS was
notified by
the Belgian
investigating judge
that it
was under
formal investigation
(“
inculpé
”) regarding
the
allegations of
laundering of
proceeds of
tax fraud,
banking and
financial
solicitation
by
unauthorized
persons,
and
serious
tax
fraud.
In
November
2021,
the
Council
Chamber
approved
a
settlement with the Brussels
Prosecution Office for EUR
49
million
without
recognition
of
guilt
with
regard
to
the
allegations
of
banking
and
financial
solicitation
by
unauthorized
persons
and
serious tax fraud. The allegation of laundering of proceeds of tax
fraud was dismissed.
Our balance
sheet at
31 December
2021 reflected
provisions
with respect to matters described
in this item 1 in
an amount that
UBS believes
to be
appropriate under
the applicable
accounting
standard.
As
in
the
case
of
other
matters
for
which
we
have
established provisions, the
future outflow of resources
in respect
of
such
matters
cannot
be
determined
with
certainty
based
on
currently
available
information
and
accordingly
may
ultimately
prove
to
be
substantially
greater
(or
may
be
less)
than
the
provision that we have recognized.
2. Claims related to sales of residential mortgage-backed
securities and mortgages
From 2002 through
2007, prior to the
crisis in the US
residential
loan market, UBS was
a substantial issuer and
underwriter of US
residential
mortgage-backed
securities
(RMBS)
and
was
a
purchaser and seller of US residential mortgages.
In November 2018,
the DOJ
filed a
civil complaint
in the
District
Court for
the Eastern
District of
New York.
The complaint
seeks
unspecified
civil
monetary
penalties
under
the
Financial
Institutions
Reform,
Recovery
and
Enforcement
Act
of
1989
related
to
UBS’s
issuance,
underwriting
and
sale
of
40
RMBS
transactions
in
2006
and
2007.
UBS
moved
to
dismiss
the
civil
complaint
on
6 February
2019.
On
10 December
2019,
the
district court denied UBS’s motion to dismiss.
Our balance sheet at
31 December 2021 reflected a
provision
with respect to matters described
in this item 2 in
an amount that
UBS believes
to be
appropriate under
the applicable
accounting
standard.
As
in
the
case
of
other
matters
for
which
we
have
established provisions, the
future outflow of resources
in respect
of
this
matter
cannot
be
determined
with
certainty
based
on
currently
available
information
and
accordingly
may
ultimately
prove
to
be
substantially
greater
(or
may
be
less)
than
the
provision that we have recognized.
Consolidated financial statements | UBS AG consolidated financial statements
464
Note 18
Provisions and contingent liabilities (continued)
3. Madoff
In
relation
to
the
Bernard
L.
Madoff
Investment
Securities
LLC
(BMIS) investment
fraud, UBS
AG, UBS
(Luxembourg) S.A.
(now
UBS
Europe
SE,
Luxembourg
branch)
and
certain
other
UBS
subsidiaries
have
been
subject
to
inquiries
by
a
number
of
regulators,
including
the
Swiss
Financial
Market
Supervisory
Authority
(FINMA)
and
the
Luxembourg
Commission
de
Surveillance du Secteur Financier.
Those inquiries concerned
two
third-party funds established
under Luxembourg
law, substantially
all
assets
of
which
were
with
BMIS,
as
well
as
certain
funds
established in
offshore
jurisdictions with
either direct
or indirect
exposure
to
BMIS.
These
funds
faced
severe
losses,
and
the
Luxembourg
funds
are
in
liquidation.
The
documentation
establishing
both
funds
identifies
UBS
entities
in
various
roles,
including
custodian,
administrator,
manager,
distributor
and
promoter,
and
indicates
that
UBS
employees
serve
as
board
members.
In
2009
and
2010,
the
liquidators
of
the
two
Luxembourg
funds
filed
claims
against
UBS
entities,
non-UBS
entities
and
certain individuals, including current
and former UBS employees,
seeking
amounts
totaling
approximately
EUR
2.1
billion,
which
includes
amounts
that
the
funds
may
be
held
liable
to
pay
the
trustee for the liquidation of BMIS (BMIS Trustee).
A
large
number
of
alleged
beneficiaries
have
filed
claims
against UBS
entities (and
non-UBS entities)
for purported
losses
relating
to
the
Madoff
fraud.
The
majority
of
these
cases
have
been filed in
Luxembourg, where decisions
that the claims
in eight
test
cases
were
inadmissible
have
been
affirmed
by
the
Luxembourg
Court
of
Appeal,
and
the
Luxembourg
Supreme
Court has dismissed a further appeal in one of the test cases.
In the
US, the
BMIS Trustee
filed claims
against UBS
entities,
among others, in relation to the two Luxembourg funds and
one
of
the
offshore
funds.
The
total
amount
claimed
against
all
defendants
in
these
actions
was
not
less
than
USD
2
billion.
In
2014, the US Supreme
Court rejected the BMIS
Trustee’s motion
for leave to appeal decisions dismissing
all claims except those for
the
recovery
of
approximately
USD
125
million
of
payments
alleged to
be fraudulent
conveyances and
preference payments.
In 2016, the bankruptcy court dismissed
these claims against the
UBS entities. In February 2019, the Court of Appeals reversed the
dismissal
of
the
BMIS
Trustee’s
remaining
claims,
and
the
US
Supreme Court subsequently denied a
petition seeking review of
the Court
of Appeals’
decision. The
case has
been remanded
to
the Bankruptcy Court for further proceedings.
4. Puerto Rico
Declines since 2013 in the market prices of Puerto Rico municipal
bonds and of
closed-end funds
(funds) that
are sole-managed and
co-managed
by
UBS
Trust
Company
of
Puerto
Rico
and
distributed by UBS
Financial Services Incorporated of
Puerto Rico
(UBS PR)
led to
multiple regulatory
inquiries, which
in 2014
and
2015, led to settlements
with the Office
of the Commissioner of
Financial Institutions
for the
Commonwealth of
Puerto Rico,
the
US Securities
and Exchange
Commission (SEC)
and the
Financial
Industry Regulatory Authority.
Since then,
UBS clients
in Puerto
Rico who
own the
funds or
Puerto Rico municipal bonds and/or
who used their UBS account
assets
as
collateral
for
UBS
non-purpose
loans
filed
customer
complaints and arbitration demands seeking aggregate
damages
of USD
3.4
billion, of
which USD
3.1
billion have
been resolved
through
settlements,
arbitration
or
withdrawal
of
claims
.
Allegations include
fraud, misrepresentation
and unsuitability
of
the funds and of the loans.
A
shareholder
derivative
action
was
filed
in
2014
against
various UBS
entities and
current and
certain former
directors of
the funds, alleging hundreds
of millions of US
dollars in losses in
the funds. In
2021, the
parties reached an
agreement to settle
this
matter for USD
15
million, subject to court approval.
In 2011,
a purported
derivative action
was filed
on behalf
of
the Employee Retirement
System of
the Commonwealth of
Puerto
Rico
(System)
against
over
40
defendants,
including
UBS
PR,
which
was
named
in
connection
with
its
underwriting
and
consulting
services.
Plaintiffs
alleged
that
defendants
violated
their
purported
fiduciary
duties
and
contractual
obligations
in
connection
with the
issuance and
underwriting
of USD
3
billion
of
bonds
by
the
System
in
2008
and
sought
damages
of
over
USD
800
million. In 2016, the court granted the System’s request
to
join
the
action
as
a
plaintiff.
In
2017,
the
court
denied
defendants’ motion to
dismiss the complaint.
In 2020, the
court
denied plaintiffs’ motion for summary judgment.
Beginning in 2015, certain
agencies and public corporations
of
the
Commonwealth
of
Puerto
Rico
(Commonwealth)
defaulted
on certain
interest payments
on Puerto
Rico bonds.
In 2016,
US
federal
legislation
created
an
oversight
board
with
power
to
oversee
Puerto
Rico’s
finances
and
to
restructure
its
debt.
The
oversight
board
has
imposed
a
stay
on
the
exercise
of
certain
creditors’
rights.
In
2017,
the oversight
board placed
certain of
the
bonds
into
a
bankruptcy-like
proceeding
under
the
supervision of a Federal District Judge.
In
May
2019,
the
oversight
board
filed
complaints in
Puerto
Rico federal
district court
bringing claims
against financial,
legal
and
accounting
firms
that
had
participated
in
Puerto
Rico
municipal
bond
offerings,
including
UBS,
seeking
a
return
of
underwriting
and
swap
fees
paid
in
connection
with
those
offerings. UBS
estimates that
it received
approximately USD
125
million in fees in the relevant offerings.
In August
2019, and
February and
November 2020,
four US
insurance companies that insured issues of Puerto Rico municipal
bonds
sued
UBS
and
several
other
underwriters
of
Puerto
Rico
municipal bonds
in three
separate cases.
The actions
collectively
seek
recovery
of
an
aggregate
of
USD
955
million
in
damages
from
the
defendants.
The
plaintiffs
in
these
cases
claim
that
defendants failed to
reasonably investigate financial
statements in
the
offering
materials
for
the
insured
Puerto
Rico
bonds
issued
between 2002 and 2007, which plaintiffs argue they relied
upon
in agreeing to insure the
bonds notwithstanding that they had
no
contractual
relationship
with
the
underwriters.
Defendants’
motions
to
dismiss
were
granted
in
two
of
the
cases;
those
decisions are
being appealed
by the
plaintiffs. In
the third
case,
defendants’
motion
to
dismiss
was
denied,
but
on
appeal
that
ruling was reversed and the motion to dismiss was granted.
465
Note 18
Provisions and contingent liabilities (continued)
Our balance
sheet at
31 December 2021
reflected
provisions
with respect
to matters described
in this
item 4 in
amounts that
UBS believes
to be
appropriate under
the applicable
accounting
standard.
As
in
the
case
of
other
matters
for
which
we
have
established provisions, the future
outflow of resources
in respect
of
such
matters
cannot
be
determined
with
certainty
based
on
currently
available
information
and
accordingly
may
ultimately
prove
to
be
substantially
greater
(or
may
be
less)
than
the
provisions that we have recognized.
5. Foreign exchange, LIBOR and benchmark rates, and other
trading practices
Foreign exchange-related regulatory matters:
Beginning in 2013,
numerous
authorities
commenced
investigations
concerning
possible manipulation of foreign
exchange markets and precious
metals prices. As a
result of these investigations,
UBS entered into
resolutions
with
Swiss,
US
and
United
Kingdom
regulators
and
the
European
Commission.
UBS
was
granted
conditional
immunity by the
Antitrust Division of
the DOJ and
by authorities
in other jurisdictions
in connection with
potential competition law
violations
relating
to
foreign
exchange
and
precious
metals
businesses.
Foreign exchange-related
civil litigation:
Putative class
actions
have
been
filed
since
2013
in
US
federal
courts
and
in
other
jurisdictions against
UBS and
other banks
on behalf
of putative
classes of persons
who engaged in
foreign currency transactions
with
any
of
the
defendant
banks.
UBS
has
resolved
US
federal
court class
actions relating
to foreign
currency transactions
with
the
defendant
banks
and
persons
who
transacted
in
foreign
exchange futures
contracts and options
on such futures
under a
settlement agreement that provides for UBS
to pay an aggregate
of
USD
141
million
and
provide
cooperation
to
the
settlement
classes.
Certain
class
members
have
excluded
themselves
from
that settlement and have
filed individual actions in
US and English
courts against UBS and other banks, alleging violations of US
and
European competition laws and unjust enrichment.
In
2015,
a
putative
class
action
was
filed
in
federal
court
against UBS and numerous other banks on behalf of persons and
businesses in the
US who
directly purchased foreign
currency from
the defendants
and alleged co-conspirators
for their
own end
use.
In March
2017, the
court granted
UBS’s (and
the other
banks’)
motions to dismiss the complaint. The plaintiffs filed an amended
complaint in August
2017. In March
2018, the court
denied the
defendants’ motions to dismiss the amended complaint.
LIBOR
and
other
benchmark
-
related
regulatory
matters:
Numerous
government
agencies
conducted
investigations
regarding potential improper attempts by UBS,
among others, to
manipulate
LIBOR
and
other
benchmark
rates
at
certain
times.
UBS
reached
settlements
or
otherwise
concluded
investigations
relating
to
benchmark
interest
rates
with
the
investigating
authorities. UBS
was granted
conditional leniency
or conditional
immunity
from
authorities
in
certain
jurisdictions,
including
the
Antitrust
Division
of
the
DOJ
and
the
Swiss
Competition
Commission
(WEKO),
in
connection
with
potential
antitrust
or
competition law violations related to certain
rates. However, UBS
has not reached a final settlement with WEKO, as
the Secretariat
of WEKO has asserted
that UBS does
not qualify for full
immunity.
LIBOR and
other benchmark-related
civil litigation:
A number
of
putative
class
actions
and
other
actions
are
pending
in
the
federal courts
in New
York against
UBS and
numerous other
banks
on
behalf
of
parties
who
transacted
in
certain
interest
rate
benchmark-based derivatives. Also
pending in the
US and in
other
jurisdictions are a number of
other actions asserting losses
related
to various products whose
interest rates were linked to
LIBOR and
other benchmarks, including
adjustable rate mortgages,
preferred
and debt securities, bonds
pledged as collateral, loans,
depository
accounts,
investments
and
other
interest-bearing
instruments.
The
complaints
allege
manipulation,
through
various
means, of
certain
benchmark
interest rates,
including USD
LIBOR, Euroyen
TIBOR, Yen
LIBOR, EURIBOR, CHF LIBOR,
GBP LIBOR, SGD
SIBOR
and
SOR
and
Australian
BBSW,
and
seek
unspecified
compensatory and other damages under varying legal theories.
USD LIBOR class and individual actions
in the US:
In 2013 and
2015,
the
district
court
in
the
USD LIBOR
actions
dismissed,
in
whole
or
in
part,
certain
plaintiffs’
antitrust
claims,
federal
racketeering
claims, CEA
claims, and
state common
law claims,
and
again
dismissed
the
antitrust
claims
in
2016
following
an
appeal. In
December 2021,
the Second
Circuit affirmed
the district
court’s dismissal in part and
reversed in part and
remanded to the
district court for further proceedings. The Second
Circuit, among
other things,
held that
there was
personal jurisdiction
over UBS
and other
foreign defendants
based on
allegations that
at least
one alleged
co-conspirator undertook an
overt act in
the United
States. Separately, in
2018, the Second
Circuit reversed in
part the
district
court’s
2015
decision
dismissing
certain
individual
plaintiffs’ claims and certain of
these actions are now
proceeding.
In
2018,
the
district
court
denied
plaintiffs’
motions
for
class
certification
in the
USD class actions
for
claims pending
against
UBS, and plaintiffs sought permission to appeal that ruling to the
Second
Circuit.
In
July
2018,
the
Second
Circuit
denied
the
petition to
appeal of
the class
of USD lenders
and in
November
2018 denied
the petition
of the
USD exchange class.
In January
2019, a putative class action
was filed in the District
Court for the
Southern District
of New
York against
UBS and
numerous other
banks
on
behalf
of
US
residents
who,
since
1 February
2014,
directly
transacted
with
a
defendant
bank
in
USD LIBOR
instruments.
The
complaint
asserts
antitrust
claims.
The
defendants moved to
dismiss the complaint
in August 2019.
On
26 March 2020 the
court granted defendants’ motion to
dismiss
the complaint in
its entirety. Plaintiffs
have appealed the
dismissal.
In
August
2020,
an
individual
action
was
filed
in
the
Northern
District
of
California
against
UBS
and
numerous
other
banks
alleging that the
defendants conspired to
fix the interest
rate used
as
the
basis
for
loans
to
consumers
by
jointly
setting
the
USD LIBOR
rate
and
monopolized
the
market
for
LIBOR-based
consumer
loans
and
credit
cards. Defendants
moved
to
dismiss
the complaint in September 2021.
Consolidated financial statements | UBS AG consolidated financial statements
466
Note 18
Provisions and contingent liabilities (continued)
Other benchmark class actions in the US:
Yen
LIBOR / Euroyen TIBOR –
In 2014, 2015 and 2017, the court
in
one
of
the
Yen
LIBOR
/
Euroyen
TIBOR
lawsuits
dismissed
certain
of
the
plaintiffs’
claims,
including
the
plaintiffs’
federal
antitrust
and
racketeering
claims.
In
August
2020,
the
court
granted defendants’
motion for
judgment on
the pleadings
and
dismissed the lone remaining claim in the action as impermissibly
extraterritorial.
Plaintiffs
have
appealed.
In
2017,
the
court
dismissed
the
other
Yen
LIBOR
/
Euroyen
TIBOR
action
in
its
entirety
on
standing
grounds.
In
April
2020,
the
appeals
court
reversed the dismissal and in August 2020 plaintiffs
in that action
filed
an
amended
complaint
focused
on
Yen
LIBOR.
The
court
granted in part and denied in part defendants’ motion to dismiss
the amended complaint in
September 2021 and plaintiffs and
the
remaining defendants have moved for reconsideration.
CHF LIBOR
– In
2017, the
court dismissed the
CHF LIBOR action
on standing grounds and failure
to state a claim. Plaintiffs
filed an
amended complaint, and the court granted a renewed motion to
dismiss
in
September
2019.
Plaintiffs
appealed.
In
September
2021,
the
Second
Circuit
granted
the
parties’
joint
motion
to
vacate the dismissal and
remand the case for
further proceedings.
EURIBOR
– In 2017,
the court in
the EURIBOR lawsuit
dismissed
the case as
to UBS and
certain other foreign defendants
for lack
of personal jurisdiction. Plaintiffs have appealed.
SIBOR / SOR
– In October
2018, the court
in the SIBOR
/ SOR
action
dismissed
all
but
one
of
plaintiffs’
claims
against
UBS.
Plaintiffs
filed
an
amended
complaint,
and
the
court
granted
a
renewed
motion
to
dismiss
in
July
2019.
Plaintiffs
appealed.
In
March 2021,
the Second
Circuit reversed
the dismissal.
Plaintiffs
filed an amended
complaint in October
2021, which defendants
have moved to dismiss.
BBSW
–
In
November
2018,
the
court
dismissed
the
BBSW
lawsuit as to UBS and certain other
foreign defendants for lack of
personal jurisdiction. Plaintiffs
filed an
amended complaint in
April
2019,
which
UBS
and
other
defendants
moved
to
dismiss.
In
February
2020,
the
court
granted
in
part
and
denied
in
part
defendants’
motions
to
dismiss
the
amended
complaint.
In
August 2020,
UBS and
other BBSW
defendants joined
a motion
for
judgment
on
the pleadings,
which
the
court denied
in May
2021.
GBP
LIBOR
–
The
court
dismissed
the
GBP
LIBOR
action
in
August 2019. Plaintiffs have appealed.
Government bonds:
Putative class actions
have been filed since
2015 in US federal courts against UBS and other banks on behalf
of persons who
participated in markets for US
Treasury securities
since 2007. A consolidated complaint was filed
in 2017 in the US
District Court for the
Southern District of New
York alleging that
the banks colluded with
respect to, and manipulated
prices of, US
Treasury securities
sold at auction
and in the
secondary
market and
asserting
claims
under the
antitrust
laws and
for unjust
enrichment
.
Defendants’ motions
to
dismiss the
consolidated complaint was
granted
in
March
2021.
Plaintiffs filed
an
amended
complaint,
which
defendants moved
to
dismiss in
June
2021.
Similar
class
actions have
been filed
concerning European government bonds
and other government
bonds.
In
May
2021,
the
European
Commission
issued
a
decision
finding that
UBS
and
six other
banks breached
European Union
antitrust
rules
in
2007–2011
relating
to
European
government
bonds. The European
Commission
fined UBS EUR
172
million. UBS
is appealing
the amount
of the fine.
With
respect
to
additional
matters
and
jurisdictions
not
encompassed
by
the
settlements
and
orders
referred
to
above,
our balance
sheet at
31 December 2021
reflected a
provision in
an
amount
that
UBS
believes
to
be
appropriate
under
the
applicable accounting
standard. As
in the
case of
other matters
for which
we have
established provisions,
the future
outflow of
resources in
respect of
such matters
cannot be
determined with
certainty based on
currently available information
and accordingly
may ultimately
prove to
be substantially
greater (or
may be
less)
than the provision that we have recognized.
6. Swiss retrocessions
The Federal Supreme Court of Switzerland
ruled in 2012, in
a test
case
against
UBS,
that
distribution
fees
paid
to
a
firm
for
distributing
third-party
and
intra-group
investment
funds
and
structured products must be
disclosed and surrendered to clients
who have
entered into
a discretionary
mandate agreement
with
the firm, absent
a valid
waiver.
FINMA issued
a supervisory
note
to all Swiss
banks in response to
the Supreme Court decision.
UBS
has met
the FINMA
requirements and
has notified all
potentially
affected clients.
The
Supreme
Court
decision
has
resulted,
and
continues
to
result,
in
a
number
of
client
requests
for
UBS
to
disclose
and
potentially
surrender
retrocessions.
Client
requests
are
assessed
on a case-by-case basis. Considerations taken into account when
assessing these cases
include, among other
things, the existence
of
a
discretionary
mandate
and
whether
or
not
the
client
documentation
contained
a
valid
waiver
with
respect
to
distribution fees.
Our balance sheet at
31 December 2021 reflected a
provision
with respect to matters described
in this item 6 in
an amount that
UBS believes
to be
appropriate under
the applicable
accounting
standard.
The
ultimate
exposure
will
depend
on
client
requests
and the resolution thereof, factors that
are difficult to predict and
assess. Hence, as in the
case of other matters for
which we have
established provisions, the
future outflow of resources
in respect
of
such
matters
cannot
be
determined
with
certainty
based
on
currently
available
information
and
accordingly
may
ultimately
prove
to
be
substantially
greater
(or
may
be
less)
than
the
provision that we have recognized.
467
Note 19
Other liabilities
a) Other financial liabilities measured at amortized cost
USD million
31.12.21
31.12.20
Other accrued expenses
1,642
1,508
Accrued interest expenses
1,134
1,382
Settlement and clearing accounts
1,282
1,181
Lease liabilities
3,438
3,821
Other
2,269
2,530
Total other financial liabilities measured at amortized cost
9,765
10,421
b) Other financial liabilities designated at fair value
USD million
31.12.21
31.12.20
Financial liabilities related to unit-linked investment contracts
21,466
20,975
Securities financing transactions
6,377
7,317
Over-the-counter debt instruments
2,128
2,060
Funding from UBS Group AG
2,340
1,375
Other
103
46
Total other financial liabilities designated at fair value
32,414
31,773
of which: life-to-date own credit (gain) / loss
172
148
c) Other non-financial liabilities
USD million
31.12.21
31.12.20
Compensation-related liabilities
4,795
4,776
of which: financial advisor compensation plans
1,512
1,497
of which: other compensation plans
2,140
2,034
of which: net defined benefit liability
617
711
of which: other compensation-related liabilities
1
526
534
Deferred tax liabilities
297
558
Current tax liabilities
1,365
943
VAT and other tax payables
524
470
Deferred income
225
212
Liabilities of disposal groups held for sale
2
1,298
Other
68
61
Total other non-financial liabilities
8,572
7,018
1 Includes liabilities for payroll taxes and untaken vacation.
2 Refer to Note 30 for more information.
Consolidated financial statements | UBS AG consolidated financial statements
468
Additional information
Note 20
Expected credit loss measurement
a) Expected credit losses in the period
Total
net
credit
loss
releases
were
USD
148
million
in
2021,
reflecting
net
credit
loss
releases
of
USD
123
million
related
to
stage 1 and 2
positions and USD
25
million net credit loss
releases
related to credit-impaired (stage 3) positions.
Stage 1
and
2
net
credit
loss
releases
of
USD
123
million
included
a
USD
68
million
partial
net
release
of
a
post-model
adjustment,
due
to
the
continued
positive
trend
in
macroeconomic
scenario
input
data
during
the
year,
a
USD
45
million
net
release
from
a
number
of
model
and
methodology
changes
and
a
residual
USD
10
million
net
release
from
remeasurements
within
the
loan
book,
derecognized
transactions, partially offset by expenses from new transactions
.
›
Refer to Note 20b
for more information regarding changes to
ECL model, scenarios,
scenario weights and the post-model
adjustment and to Note 20c for more information
regarding the
development of ECL allowances and
provisions
Stage 3 net releases of USD
25
million were recognized across
a number of defaulted
positions with a USD
24
million net release
in Personal & Corporate Banking.
Credit loss (expense) / release
USD million
Global
Wealth
Management
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
Total
For the year ended 31.12.21
Stages 1 and 2
28
62
0
34
0
123
Stage 3
1
24
(
1
)
0
0
25
Total credit loss (expense) / release
29
86
(
1
)
34
0
148
For the year ended 31.12.20
Stages 1 and 2
(
48
)
(
129
)
0
(
88
)
0
(
266
)
Stage 3
(
40
)
(
128
)
(
2
)
(
217
)
(
42
)
(
429
)
Total credit loss (expense) / release
(
88
)
(
257
)
(
2
)
(
305
)
(
42
)
(
695
)
For the year ended 31.12.19
Stages 1 and 2
3
23
0
(
4
)
0
22
Stage 3
(
23
)
(
44
)
0
(
26
)
(
7
)
(
100
)
Total credit loss (expense) / release
(
20
)
(
21
)
0
(
30
)
(
7
)
(
78
)
469
Note 20
Expected credit loss measurement (continued)
b) Changes to ECL models, scenarios, scenario weights and key inputs
Refer to
Note 1a
for information
about the
principles governing
expected credit loss
(ECL) models, scenarios,
scenario weights and
key inputs applied.
Governance
Comprehensive
cross-functional and
cross-divisional
governance
processes
are
in
place
and
are
used
to
discuss
and
approve
scenario
updates
and
weights,
to
assess
whether
significant
increases in credit risk resulted in stage transfers, to
review model
outputs
and
to
reach
conclusions
regarding
post-model
adjustments.
Model changes
During 2021, the model review
and enhancement process led to
adjustments of
the probability
of default
(PD), loss
given default
(LGD)
and
credit
conversion
factor
(CCF)
models,
resulting
in
a
USD
45
million decrease
in ECL
allowances. An
amount of
USD
25
million related
to the
Large corporate
clients
segment in
the
Investment
Bank. The
remainder
related
to
various segments
in
Personal & Corporate Banking and Global Wealth Management.
Scenario and key input updates
During
2021,
the
scenarios
and
related
macroeconomic
factors
were updated
from those
that were
applied at
the end
of 2020
by
taking
into
account
the
prevailing
economic
and
political
conditions
and
uncertainty.
As
the
economic
development
was
more
positive
than
anticipated
following
the
COVID-19-related
downturn,
the
forward
-
looking
scenarios
benefited
from
an
improved forecast starting level.
The projections of
the baseline scenario,
which are aligned
to
the
economic
and
market
assumptions
used
for
UBS
AG
’s
business planning purposes,
are broadly in
line with external
data,
such as
from Bloomberg
Consensus, Oxford
Economics and
the
International
Monetary
Fund
World
Economic
Outlook.
The
economic
performance
during
2021
in
relevant
markets,
especially in the
US and in
Switzerland, highlighted an
accelerated
improvement
after
the
COVID-19-related
shocks.
The
scenario
assumes continued growth in 2022 in
all key markets, albeit at a
slower rate than
seen in 2021,
and unemployment rates
are not
expected to fall noticeably below the current levels. Interest rates
are expected to
remain low in
line with the
central bank policies
pursued in the Eurozone and Switzerland, and any potential rises
in the US would be
limited in the foreseeable
future. House prices
are
expected
to
reflect
the
momentum
and
continue
to
rise,
especially in Switzerland and, to a lesser degree, in the US.
The
narrative
of
the
hypothetical
severe
downside
scenario,
which
is the
Group’s binding
stress
scenario, has
been adapted
and assumes that, while
the immediate risks
from COVID-19 have
decreased,
the
associated
disruptions
and
the
consequences
of
the
unprecedented
monetary
and
fiscal
stimulus
measures
will
remain
critical.
Concerns
regarding
the
sustainability
of
public
debt, following the
marked deterioration of
fiscal positions, lead
to
a
loss
of
confidence
and
market
turbulence,
while
protectionism results
in a
fall in
global trade.
Governments and
central banks have limited
scope to support the economies.
As a
consequence,
the
Eurozone
and
China
suffer
a
hard
landing,
under
this
scenario
which
severely
affects
the
Swiss
export-
oriented
economy,
and
the
US
economy
contracts
as
global
demand
is
significantly
affected.
Given
the
severity
of
the
macroeconomic
impact,
unemployment
rates
rise
to
historical
highs and real estate sectors contract sharply.
With effect
from the
second quarter,
the hypothetical
upside
and mild downside scenarios, which
were viewed as less
plausible
as
of
31
December
2020 and
had
a
probability
weight
of
zero
attached,
were
redesigned
and
reintroduced
in
the
ECL
calculation.
These
two
scenarios
have
become
more
relevant
following
this
update,
as
they
better
reflect
a
more
positive
outlook
with
regard
to
COVID-19
and
market
expectations
regarding a potential change in
central bank policies, respectively.
The
upside
scenario
is
based
on
positive
developments
following
COVID-19 and
strong economic
activity
supported by
pent-up demand in certain
sectors, as well
as the expectation
that
interest rates
will remain
relatively low
in the
near future.
Asset
prices rise significantly, but
a view that currently
observed higher
inflation rates are temporary and spare economic
capacity would
mean that
consumer prices
remain moderate
in the
first year
of
the scenario.
The
mild
downside
scenario
focuses
on
the
implications
of
rising concerns regarding inflationary trends
following a recovery
from
COVID-19.
Higher-than-expected
inflation
data
triggers
a
steepening of
yield curves
across the
globe and
leads to
market
volatility.
Higher
interest
rates
lead
to
a
sell-off
in
assets
and
a
period
of
deleveraging
under
this
scenario.
With
inflation
remaining high, central
banks start hiking
their policy rates
after
a few
quarters, leading
to further
increases in
interest rates
and
impacting corporate
and private
debt sustainability.
A recessionary
period is the consequence.
The table
on the
following page
details the
key assumptions
for the four scenarios applied as of 31 December 2021.
Consolidated financial statements | UBS AG consolidated financial statements
470
Note 20
Expected credit loss measurement (continued)
Scenario weights and post-model adjustments
With the weighting of
four scenarios above 0%
and considering
the generally
more positive
outlook regarding
an abating
effect
on
the
world
economy
from
the
COVID-19
pandemic,
the
distribution of
weights shifted
during 2021.
As of
31 December
2021, 5 percentage points of the weight of the baseline scenario
and 10 percentage
points of
the severe
downside scenario were
redistributed to the upside
scenario (5%) and the mild downside
scenario (10%), as shown in the table below.
Although the scenarios and
weight allocation were
established
in
line
with
the
general
market
sentiment
that
COVID-19
has
passed its peak
and a gradual return
to normal is the
most likely
path,
significant
uncertainties
still
remain.
Models,
which
are
based
on
supportable
statistical
information
from
past
experiences
regarding
interdependencies
of
macroeconomic
factors
and
their
implications
for
credit
risk
portfolios,
cannot
comprehensively reflect extraordinary events, such as a pandemic
or a fundamental change in the world political order. Especially
in
these
uncertain
times,
it
is
in
the
realm
of
possibilities
that
the
generally accepted view that the effects of COVID-19 are abating
may prove to be disappointed by
the emergence of new variants
of
the
virus,
which
may
be
more
harmful
and
may
undermine
current
vaccination
efforts.
Political
events
involving
tensions
between
major
global
forces
may
introduce
unforeseen
challenges, such
as disruptions
in the
global supply
chain and
a
distortion of energy markets. Such events could affect economies
severely and change
the baseline assumptions
significantly. Rather
than
creating multiple
additional
scenarios
to
gauge these
risks
and applying model
parameters that lack
supportable information
and
cannot
be
robustly
validated,
management
continued
to
apply
significant
post
-
model
adjustments.
These
adjustments
were
benchmarked
against
coverage
ratio
levels
as
of
30 June
2021
,
when
a
partial
net
release
of
USD
91
million
was
recognized, corresponding to one third of
the accumulated effect
of
scenario
improvements,
following
comprehensive
expert
assessment and judgment, and
were also deemed appropriate
for
year-end 2021 reporting. The post-model adjustments relating to
COVID-19 amounted to
USD
224
million as of
31 December 2021
(2020: USD
117
million in addition to
overlays of USD
16
million
for
other
aspects,
where
model
results
were
deemed
to
be
uncertain).
ECL scenario
Assigned weights in %
31.12.21
31.12.20
Upside
5.0
0.0
Baseline
55.0
60.0
Mild downside
10.0
0.0
Severe downside
30.0
40.0
Scenario assumptions
One year
Three years cumulative
31.12.21
Upside
Baseline
Mild
downside
Severe
downside
Upside
Baseline
Mild
downside
Severe
downside
Real GDP growth (% change)
United States
9.1
4.4
(
0.1
)
(
5.9
)
17.8
10.1
1.8
(
3.8
)
Eurozone
9.4
3.9
(
0.1
)
(
8.7
)
17.3
7.5
0.9
(
10.3
)
Switzerland
5.5
2.4
(
0.9
)
(
6.6
)
13.1
5.8
(
0.1
)
(
5.7
)
Consumer price index (% change)
United States
3.1
2.2
5.7
(
1.2
)
9.5
6.3
13.0
0.4
Eurozone
2.3
1.4
4.2
(
1.3
)
8.0
4.8
10.4
(
1.7
)
Switzerland
1.8
0.3
3.5
(
1.8
)
6.1
1.7
9.0
(
1.6
)
Unemployment rate (end-of-period level, %)
United States
3.0
3.9
6.1
10.9
3.0
3.5
7.2
10.8
Eurozone
6.2
7.4
8.7
12.9
6.0
7.2
9.1
15.1
Switzerland
2.3
2.5
3.4
5.2
1.6
2.3
4.2
5.9
Fixed income: 10-year government bonds (change in yields, basis points)
USD
50.0
16.5
259.2
(
50.0
)
170.0
41.2
329.2
(
15.0
)
EUR
40.0
11.1
283.8
(
35.0
)
140.0
34.9
349.3
(
25.0
)
CHF
50.0
12.1
245.5
(
70.0
)
150.0
34.4
307.3
(
35.0
)
Equity indices (% change)
S&P 500
12.0
14.1
(
27.0
)
(
50.2
)
35.5
24.7
(
21.8
)
(
40.1
)
EuroStoxx 50
16.0
12.3
(
23.4
)
(
57.6
)
41.6
20.7
(
19.9
)
(
50.4
)
SPI
14.0
12.1
(
22.9
)
(
53.6
)
37.9
19.1
(
19.6
)
(
44.2
)
Swiss real estate (% change)
Single-Family Homes
5.1
4.4
(
4.3
)
(
17.0
)
15.5
7.4
(
8.8
)
(
30.0
)
Other real estate (% change)
United States (S&P / Case-Shiller)
10.0
3.5
(
2.3
)
(
9.5
)
21.7
7.1
(
8.7
)
(
26.3
)
Eurozone (House Price Index)
8.4
5.1
(
4.0
)
(
5.4
)
17.8
9.6
(
7.6
)
(
10.8
)
471
Note 20
Expected credit loss measurement (continued)
Scenario assumptions
One year
Three years cumulative
31.12.20
Baseline
Severe downside
Baseline
Severe downside
Real GDP growth (% change)
United States
2.7
(
5.9
)
9.1
(
3.8
)
Eurozone
2.5
(
8.7
)
9.9
(
10.3
)
Switzerland
3.3
(
6.6
)
9.0
(
5.7
)
Consumer price index (% change)
United States
1.7
(
1.2
)
5.5
0.4
Eurozone
1.4
(
1.3
)
3.9
(
1.7
)
Switzerland
0.3
(
1.8
)
0.9
(
1.6
)
Unemployment rate (end-of-period level, %)
United States
5.5
12.1
4.5
9.9
Eurozone
9.5
14.1
8.0
16.4
Switzerland
3.8
6.1
3.2
6.8
Fixed income: 10-year government bonds (change in yields, basis points)
USD
22.0
(
50.0
)
46.0
(
15.0
)
EUR
4.0
(
35.0
)
21.0
(
25.0
)
CHF
13.0
(
70.0
)
31.0
(
35.0
)
Equity indices (% change)
S&P 500
(
2.9
)
(
50.2
)
(
1.7
)
(
40.1
)
EuroStoxx 50
3.8
(
57.6
)
13.5
(
50.4
)
SPI
(
0.8
)
(
53.6
)
5.8
(
44.2
)
Swiss real estate (% change)
Single-Family Homes
3.4
(
17.0
)
7.1
(
30.0
)
Other real estate (% change)
United States (S&P / Case-Shiller)
2.5
(
15.3
)
9.2
(
28.7
)
Eurozone (House Price Index)
1.1
(
22.9
)
7.2
(
35.4
)
c) Development of ECL allowances and provisions
The ECL
allowances and
provisions recognized
in the
period are
impacted by a variety of factors, such as:
–
origination of new instruments during the period;
–
effect of passage of time as the ECLs on an instrument for the
remaining
lifetime
decrease
(all
other
factors
remaining
the
same);
–
discount
unwind
within ECLs
as
it
is
measured
on
a
present
value basis;
–
derecognition of instruments in the period;
–
change in individual asset quality of instruments;
–
effect
of
updating
forward-looking
scenarios
and
the
respective weights;
–
movements from a
maximum 12-month
ECL to the
recognition
of
lifetime ECLs
(and
vice versa)
following transfers
between
stages 1 and 2;
–
movements
from
stages 1
and
2
to
stage 3
(credit-impaired
status) when
default has
become certain
and PD
increases to
100% (or vice versa);
–
changes in models or updates to model parameters;
–
write-off; and
–
foreign
exchange
translations
for
assets
denominated
in
foreign currencies and other movements.
Consolidated financial statements | UBS AG consolidated financial statements
472
Note 20
Expected credit loss measurement (continued)
The following table explains the changes in
the ECL allowances and provisions for on-
and off-balance sheet financial instruments and
credit lines in
scope of ECL requirements
between the beginning and the
end of the period due
to the factors listed on
the previous
page.
Development of ECL allowances and
provisions
USD million
Total
Stage 1
Stage 2
Stage 3
Balance as of 31 December 2020
(
1,468
)
(
306
)
(
333
)
(
829
)
Net movement from new and derecognized transactions
1
(
59
)
(
72
)
13
0
of which: Private clients with mortgages
(
7
)
(
10
)
3
0
of which: Real estate financing
(
7
)
(
11
)
4
0
of which: Large corporate clients
(
13
)
(
21
)
7
0
of which: SME clients
(
8
)
(
8
)
0
0
of which: Other
(
24
)
(
23
)
(
2
)
0
of which: Financial intermediaries and hedge funds
(
21
)
(
18
)
(
4
)
0
of which: Loans to financial advisors
0
(
1
)
1
0
Remeasurements with stage transfers
2
(
40
)
8
0
(
49
)
of which: Private clients with mortgages
(
9
)
4
(
13
)
0
of which: Real estate financing
(
3
)
1
(
4
)
0
of which: Large corporate clients
2
(
2
)
12
(
8
)
of which: SME clients
(
27
)
5
4
(
36
)
of which: Other
(
3
)
0
2
(
4
)
of which: Financial intermediaries and hedge funds
2
(
1
)
3
0
of which: Loans to financial advisors
0
1
(
1
)
0
Remeasurements without stage transfers
3
203
55
74
74
of which: Private clients with mortgages
33
8
26
(
1
)
of which: Real estate financing
30
13
13
3
of which: Large corporate clients
44
5
21
17
of which: SME clients
53
(
1
)
1
53
of which: Other
44
29
14
2
of which: Financial intermediaries and hedge funds
27
15
12
0
of which: Loans to financial advisors
6
8
1
(
3
)
Model changes
4
45
29
16
0
Movements with profit or loss impact
5
148
19
104
25
Movements without profit or loss impact (write-off, FX and other)
6
154
5
9
141
Balance as of 31 December 2021
(
1,165
)
(
282
)
(
220
)
(
662
)
1 Represents the
increase and decrease
in allowances
and provisions resulting
from financial instruments
(including guarantees
and facilities) that
were newly originated,
purchased or renewed
and from the
final
derecognition of loans or facilities on
their maturity date or earlier.
2 Represents the remeasurement between 12-month and lifetime
ECL due to stage transfers.
3 Represents the change in allowances and provisions
related to
changes in
model inputs
or assumptions,
including changes
in forward
-looking macroeconomic
conditions,
changes in
the exposure
profile,
PD and
LGD changes,
and unwinding
of the
time value.
4 Represents the change in the allowances and provisions related to changes in models and methodologies.
5 Includes ECL movements from new and derecognized transactions, remeasurement changes, model and
methodology changes.
6 Represents the
decrease in
allowances and
provisions resulting
from write-offs
of the ECL
allowance against
the gross carrying
amount when all
or part of
a financial asset
is deemed
uncollectible or forgiven and movements in foreign exchange rates.
In
2021,
ECL
allowances
and
provisions
decreased
by
USD
148
million from net credit loss releases impacting profit or loss:
–
a
USD
59
million
net
increase
from
new
and
derecognized
transactions
that
resulted
from
a
USD
72
million
stage 1
increase
primarily
in
the
corporate
lending
and
real
estate
lending portfolio,
offset by
a USD
13
million net release
from
stage 2
positions,
driven
by
positions
that
were
terminated
before their contractual maturity;
–
a USD
163
million net decrease from book quality movements
that
resulted
from
a
USD
203
million
net
decrease
from
remeasurements
without
stage transfers,
with
approximately
half of
that related to
corporate lending –
another significant
portion related to
real estate related
lending, primarily due
to
the partial release of a
post-model adjustment, partially offset
by USD
40
million from transactions moving
from stages 1 and
2
into
stages 2
and
3,
respectively,
primarily
related
to
SME
clients;
and
–
a USD
45
million net decrease that resulted from a number
of
model changes.
An amount
of USD
25
million related
to the
Large corporate
clients
segment in
the Investment
Bank. The
remainder related to various
segments in Personal &
Corporate
Banking and Global Wealth Management.
In
addition
to
the
movements
im
pacting
profit
or
loss,
allowances decreased by USD
154
million as a result
of USD
137
million
of write
offs and
USD
18
million from
foreign exchange
and other movements, both of which
did not impact the income
statement.
473
Note 20
Expected credit loss measurement (continued)
Development of ECL allowances and
provisions
USD million
Total
Stage 1
Stage 2
Stage 3
Balance as of 31 December 2019
(
1,029
)
(
181
)
(
160
)
(
688
)
Net movement from new and derecognized transactions
1
(
28
)
(
90
)
17
46
of which: Private clients with mortgages
(
2
)
(
3
)
2
0
of which: Real estate financing
(
3
)
(
5
)
2
0
of which: Large corporate clients
(
32
)
(
29
)
(
4
)
0
of which: SME clients
(
16
)
(
14
)
(
3
)
0
of which: Other
26
(
39
)
20
46
of which: Securities financing transactions REIT
32
(
1
)
15
17
of which: Loans to financial advisors
9
(
1
)
9
0
of which: Lombard loans
23
(
6
)
0
29
of which Financial intermediaries
(
20
)
(
15
)
(
5
)
0
Remeasurements with stage transfers
2
(
427
)
45
(
134
)
(
338
)
of which: Private clients with mortgages
(
19
)
(
2
)
(
17
)
0
of which: Real estate financing
(
6
)
3
(
9
)
0
of which: Large corporate clients
(
224
)
34
(
83
)
(
175
)
of which: SME clients
(
43
)
(
1
)
(
11
)
(
31
)
of which: Other
(
134
)
11
(
14
)
(
131
)
of which: Securities financing transactions REIT
(
36
)
0
(
18
)
(
19
)
of which: Loans to financial advisors
(
12
)
7
(
7
)
(
11
)
of which: Lombard loans
(
36
)
0
0
(
36
)
of which Commodity trade finance
(
59
)
0
0
(
59
)
Remeasurements without stage transfers
3
(
271
)
(
88
)
(
47
)
(
136
)
of which: Private clients with mortgages
(
34
)
(
19
)
(
8
)
(
7
)
of which: Real estate financing
(
14
)
(
4
)
(
11
)
1
of which: Large corporate clients
(
149
)
(
53
)
(
17
)
(
79
)
of which: SME clients
(
13
)
0
(
7
)
(
6
)
of which: Other
(
60
)
(
11
)
(
4
)
(
44
)
of which: Loans to financial advisors
(
18
)
(
12
)
(
3
)
(
3
)
of which: Lombard loans
(
3
)
6
0
(
9
)
of which: Credit cards
(
12
)
0
0
(
12
)
Model changes
4
32
21
11
0
Movements with profit or loss impact
5
(
694
)
(
112
)
(
154
)
(
429
)
Movements without profit or loss impact (write-off, FX and other)
6
254
(
14
)
(
19
)
287
Balance as of 31 December 2020
(
1,468
)
(
306
)
(
333
)
(
829
)
1 Represents the
increase and decrease
in allowances
and provisions resulting
from financial
instruments (including guarantees
and facilities) that
were newly originated,
purchased or renewed
and from the
final
derecognition of loans or facilities on
their maturity date or earlier.
2 Represents the remeasurement between 12-month and lifetime
ECL due to stage transfers.
3 Represents the change in allowances and provisions
related to
changes in
model inputs
or assumptions,
including changes
in forward
-looking macroeconomic
conditions,
changes in
the exposure
profile,
PD and
LGD changes,
and unwinding
of the
time value.
4 Represents the change in the allowances and provisions related to changes in models and methodologies.
5 Includes ECL movements from new and derecognized transactions, remeasurement changes, model and
methodology changes.
6 Represents the
decrease in
allowances and
provisions resulting
from write-offs
of the ECL
allowance against
the gross carrying
amount when all
or part of
a financial asset
is deemed
uncollectible or forgiven and movements in foreign exchange rates.
As explained in Note
1a, the assessment of
a significant increase
in
credit
risk
(
SICR
)
considers
a
number
of
qualitative
and
quantitative
factors
to
determine
whether
a
stage
transfer
between
stage 1
and
stage 2
is
required,
although
the
primary
assessment considers changes in PD based
on rating analyses and
economic outlook. Additionally, UBS
AG takes into consideration
counterparties that
have moved
to a
credit watch
list and
those
with payments that are at least 30 days past due.
ECL stage 2 ("significant deterioration
in credit risk”) allowances / provisions as of 31 December
2021 – classification by trigger
USD million
Stage 2
of which:
PD layer
of which:
watch list
of which:
≥30 days
past due
On-and off-balance sheet
(
220
)
(
158
)
(
22
)
(
39
)
of which: Private clients with mortgages
(
71
)
(
54
)
0
(
17
)
of which: Real estate financing
(
43
)
(
38
)
0
(
4
)
of which: Large corporate clients
(
55
)
(
40
)
(
15
)
0
of which: SME clients
(
30
)
(
19
)
(
7
)
(
4
)
of which: Financial intermediaries and hedge funds
(
6
)
(
6
)
0
0
of which: Loans to financial advisors
(
3
)
0
0
(
3
)
of which: Credit cards
(
11
)
0
0
(
11
)
of which: Other
(
1
)
(
1
)
0
0
Consolidated financial statements | UBS AG consolidated financial statements
474
Note 20
Expected credit loss measurement (continued)
d) Maximum exposure to credit risk
The tables below provide
UBS AG’s maximum exposure
to credit
risk for financial instruments subject to ECL requirements and the
respective
collateral
and
other
credit
enhancements
mitigating
credit risk for these classes of financial instruments.
The
maximum
exposure
to
credit
risk
includes
the
carrying
amounts of financial
instruments recognized on
the balance sheet
subject
to
credit
risk
and
the
notional
amounts
for
off-balance
sheet arrangements.
Where information
is available,
collateral is
presented at fair value.
For other collateral, such as
real estate, a
reasonable alternative
value is
used. Credit
enhancements, such
as credit derivative contracts
and guarantees, are included
at their
notional amounts. Both are capped at the maximum
exposure to
credit risk for which
they serve as
security. The “Risk management
and control” section of this
report describes management’s view
of credit risk and
the related exposures,
which can differ
in certain
respects from the requirements of IFRS
.
Maximum exposure to credit risk
31.12.21
Collateral
1,2
Credit enhancements
1
Exposure to
credit risk
after collateral
and credit
enhancements
USD billion
Maximum
exposure to
credit risk
Cash
collateral
received
Collateralized
by securities
Secured by
real estate
Other
collateral
3
Netting
Credit
derivative
contracts
Guarantees
Financial assets measured at
amortized cost on the balance sheet
Cash and balances at central banks
192.8
192.8
Loans and advances to banks
4
15.4
0.1
0.1
15.1
Receivables from securities financing transactions
75.0
0.0
68.0
6.9
0.0
Cash collateral receivables on derivative instruments
5,6
30.5
18.4
12.1
Loans and advances to customers
7
398.7
38.2
128.7
191.3
20.2
4.0
16.4
Other financial assets measured at amortized cost
26.2
0.2
0.1
0.0
1.3
24.7
Total financial assets measured at amortized cost
738.6
38.4
196.9
191.3
28.4
18.4
0.0
4.0
261.1
Financial assets measured at fair value
through other comprehensive income – debt
8.8
8.8
Total maximum exposure to credit risk
reflected on the balance sheet in scope of ECL
747.5
38.4
196.9
191.3
28.4
18.4
0.0
4.0
270.0
Guarantees
8
20.9
1.3
6.5
0.2
2.5
2.3
8.1
Loan commitments
8
39.4
0.5
4.0
2.4
7.3
0.3
1.7
23.1
Forward starting transactions, reverse repurchase
and securities borrowing agreements
1.4
1.4
0.0
Committed unconditionally revocable credit lines
42.3
0.3
9.0
6.2
3.9
0.5
22.5
Total maximum exposure to credit risk not
reflected on the balance sheet, in scope of ECL
104.1
2.2
20.9
8.7
13.7
0.0
0.3
4.5
53.7
31.12.20
Collateral
1,2
Credit enhancements
1
Exposure to
credit risk
after collateral
and credit
enhancements
USD billion
Maximum
exposure to
credit risk
Cash
collateral
received
Collateralized
by securities
Secured by
real estate
Other
collateral
3
Netting
Credit
derivative
contracts
Guarantees
Financial assets measured at
amortized cost on the balance sheet
Cash and balances at central banks
158.2
158.2
Loans and advances to banks
4
15.3
0.1
15.2
Receivables from securities financing transactions
74.2
0.0
67.1
7.0
0.0
Cash collateral receivables on derivative instruments
5,6
32.7
21.1
11.6
Loans and advances to customers
7
381.0
27.0
118.2
194.6
21.7
0.0
4.4
15.1
Other financial assets measured at amortized cost
27.2
0.1
0.2
0.0
1.3
25.5
Total financial assets measured at amortized cost
688.7
27.2
185.7
194.6
30.1
21.1
0.0
4.4
225.6
Financial assets measured at fair value
through other comprehensive income – debt
8.3
8.3
Total maximum exposure to credit risk
reflected on the balance sheet in scope of ECL
697.0
27.2
185.7
194.6
30.1
21.1
0.0
4.4
233.9
Guarantees
8
17.0
0.7
5.0
0.2
1.7
2.5
7.0
Loan commitments
8
41.2
0.0
4.2
2.1
6.8
0.4
2.4
25.3
Forward starting transactions, reverse repurchase
and securities borrowing agreements
3.2
3.2
0.0
Committed unconditionally revocable credit lines
42.0
0.1
10.3
6.2
2.7
0.0
22.7
Total maximum exposure to credit risk not
reflected on the balance sheet, in scope of ECL
103.5
0.8
22.7
8.5
11.2
0.0
0.4
4.9
54.9
1 Of which: USD
1,443
million for 31 December 2021 (31 December 2020: USD
1,983
million) relates to total credit-impaired financial assets measured at amortized cost and USD
130
million for 31 December 2021
(31 December 2020: USD
154
million) to total off-balance sheet
financial instruments and credit lines
for credit-impaired positions.
2 Collateral arrangements generally
incorporate a range of
collateral, including
cash, securities, real
estate and other collateral.
UBS AG applies
a risk-based approach
that generally prioritizes
collateral according to
its liquidity profile.
3 Includes but is not
limited to life insurance
contracts,
inventory, mortgage loans, gold and other commodities.
4 Loans and advances to banks include amounts held with third-party banks on behalf of clients. The credit risk associated with these balances may be borne
by those clients.
5 Included within Cash collateral
receivables on derivative instruments are
margin balances due from exchanges or
clearing houses. Some of
these margin balances reflect amounts transferred
on
behalf
of
clients
who
retain
the
associated
credit
risk.
6 The
amount
shown
in
the
“Netting”
column
represents
the
netting
potential
not
recognized
on
the
balance
sheet.
Refer
to
Note 22
for
more
information.
7 In 2021, the collateral allocation
was updated to reflect
additional cash collateral and
custody accounts that are also
available
as security for certain
on-balance sheet lending. This
resulted in an
increase in loans secured by cash, with an offsetting reduction in loans secured by real estate and loans secured by securities.
8 The amount shown in the “Guarantees” column includes sub-participations.
475
Note 20
Expected credit loss measurement (continued)
e) Financial assets subject to credit risk by rating category
The
table
below
shows
the
credit
quality
and
the
maximum
exposure to credit risk based on the Group’s internal credit rating
system and year-end
stage classification. Under IFRS 9, the credit
risk rating reflects the Group’s assessment of the probability of
default
of
individual
counterparties,
prior
to
substitutions.
The
amounts presented are gross of impairment allowances.
›
Refer to the “Risk management and control”
section of this
report for more details
regarding the Group’s internal grading
system
Financial assets subject to credit risk by rating
category
USD million
31.12.21
Rating category
1
0–1
2–3
4–5
6–8
9–13
Credit-
impaired
(defaulted)
Total gross
carrying
amount
ECL
allowances
Net carrying
amount
(maximum
exposure to
credit risk)
Financial assets measured at amortized cost
Cash and balances at central banks
191,015
1,802
0
0
0
0
192,817
0
192,817
of which: stage 1
191,015
1,802
0
0
0
0
192,817
0
192,817
Loans and advances to banks
407
12,552
1,123
795
490
1
15,368
(
8
)
15,360
of which: stage 1
407
12,552
1,098
795
488
0
15,340
(
7
)
15,333
of which: stage 2
0
0
24
0
2
0
27
(
1
)
26
of which: stage 3
0
0
0
0
0
1
1
0
1
Receivables from securities financing transactions
34,386
11,267
10,483
17,440
1,439
0
75,014
(
2
)
75,012
of which: stage 1
34,386
11,267
10,483
17,440
1,439
0
75,014
(
2
)
75,012
Cash collateral receivables on derivative instruments
7,466
13,476
5,878
3,647
47
0
30,514
0
30,514
of which: stage 1
7,466
13,476
5,878
3,647
47
0
30,514
0
30,514
Loans and advances to customers
5,295
232,663
67,620
70,394
21,423
2,148
399,543
(
850
)
398,693
of which: stage 1
5,295
231,583
65,083
63,298
16,362
0
381,622
(
126
)
381,496
of which: stage 2
0
1,080
2,536
7,096
5,061
0
15,773
(
152
)
15,620
of which: stage 3
0
0
0
0
0
2,148
2,148
(
572
)
1,577
Other financial assets measured at amortized cost
12,564
6,705
321
6,097
394
264
26,346
(
109
)
26,236
of which: stage 1
12,564
6,696
307
5,887
317
0
25,772
(
27
)
25,746
of which: stage 2
0
10
13
209
77
0
309
(
7
)
302
of which: stage 3
0
0
0
0
0
264
264
(
76
)
189
Total financial assets measured at amortized cost
251,133
278,465
85,424
98,372
23,793
2,414
739,601
(
969
)
738,632
On-balance sheet financial instruments
Financial assets measured at FVOCI – debt instruments
3,996
4,771
0
77
0
0
8,844
0
8,844
Total on-balance sheet financial instruments
255,130
283,236
85,424
98,449
23,793
2,414
748,445
(
969
)
747,477
Off-balance sheet positions subject to expected
credit loss by rating category
USD million
31.12.21
Rating category
1
0–1
2–3
4–5
6–8
9–13
Credit-
impaired
(defaulted)
Total off -
balance sheet
exposure
(maximum
exposure to
credit risk)
ECL provisions
Off-balance sheet financial instruments
Guarantees
4,457
7,064
4,535
3,757
1,009
150
20,972
(
41
)
of which: stage 1
4,457
7,037
4,375
3,075
752
0
19,695
(
18
)
of which: stage 2
0
27
160
682
258
0
1,127
(
8
)
of which: stage 3
0
0
0
0
0
150
150
(
15
)
Irrevocable loan commitments
2,797
14,183
7,651
8,298
6,502
46
39,478
(
114
)
of which: stage 1
2,797
13,917
7,416
7,127
5,840
0
37,097
(
72
)
of which: stage 2
0
266
235
1,171
663
0
2,335
(
42
)
of which: stage 3
0
0
0
0
0
46
46
0
Forward starting reverse repurchase and securities borrowing agreements
0
0
55
1,389
0
0
1,444
0
Total off balance sheet financial instruments
7,254
21,247
12,241
13,444
7,512
196
61,894
(
155
)
Credit lines
Committed unconditionally revocable credit lines
2,636
16,811
8,627
10,130
4,107
63
42,373
(
38
)
of which: stage 1
2,636
16,467
8,304
8,724
3,671
0
39,802
(
28
)
of which: stage 2
0
344
323
1,406
436
0
2,508
(
10
)
of which: stage 3
0
0
0
0
0
63
63
0
Irrevocable committed prolongation of existing loans
17
2,438
1,422
1,084
602
48
5,611
(
3
)
of which: stage 1
17
2,438
1,422
1,082
568
0
5,527
(
3
)
of which: stage 2
0
0
0
1
34
0
36
0
of which: stage 3
0
0
0
0
0
48
48
0
Total credit lines
2,653
19,249
10,049
11,214
4,709
111
47,984
(
41
)
1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and
control” section of this report for more information on rating categories.
Consolidated financial statements | UBS AG consolidated financial statements
476
Note 20
Expected credit loss measurement (continued)
Financial assets subject to credit risk by rating
category
USD million
31.12.20
Rating category
1
0–1
2–3
4–5
6–8
9–13
Credit-
impaired
(defaulted)
Total gross
carrying
amount
ECL
allowances
Net carrying
amount
(maximum
exposure to
credit risk)
Financial assets measured at amortized cost
Cash and balances at central banks
156,250
1,981
0
0
0
0
158,231
0
158,231
of which: stage 1
156,250
1,981
0
0
0
0
158,231
0
158,231
Loans and advances to banks
543
12,029
1,344
1,182
260
1
15,360
(
16
)
15,344
of which: stage 1
543
11,974
1,277
1,145
231
0
15,170
(
9
)
15,160
of which: stage 2
0
55
67
37
29
0
189
(
5
)
184
of which: stage 3
0
0
0
0
0
1
1
(
1
)
0
Receivables from securities financing transactions
22,998
16,009
15,367
17,995
1,842
0
74,212
(
2
)
74,210
of which: stage 1
22,998
16,009
15,367
17,995
1,842
0
74,212
(
2
)
74,210
Cash collateral receivables on derivative instruments
8,196
13,477
7,733
3,243
88
0
32,737
0
32,737
of which: stage 1
8,196
13,477
7,733
3,243
88
0
32,737
0
32,737
Loans and advances to customers
5,813
215,755
67,270
69,217
21,038
2,943
382,036
(
1,060
)
380,977
of which: stage 1
5,813
214,418
63,000
59,447
15,860
0
358,538
(
142
)
358,396
of which: stage 2
0
1,338
4,269
9,770
5,178
0
20,556
(
215
)
20,341
of which: stage 3
0
0
0
0
0
2,943
2,943
(
703
)
2,240
Other financial assets measured at amortized cost
15,404
4,043
280
6,585
481
560
27,352
(
133
)
27,219
of which: stage 1
15,404
4,040
269
6,334
389
0
26,435
(
34
)
26,401
of which: stage 2
0
3
11
251
91
0
357
(
9
)
348
of which: stage 3
0
0
0
0
0
560
560
(
90
)
469
Total financial assets measured at amortized cost
209,204
263,295
91,993
98,223
23,709
3,505
689,929
(
1,211
)
688,717
On-balance sheet financial instruments
Financial assets measured at FVOCI – debt instruments
3,212
5,014
0
32
0
0
8,258
0
8,258
Total on-balance sheet financial instruments
212,417
268,309
91,993
98,255
23,709
3,505
698,187
(
1,211
)
696,976
Off-balance sheet positions subject to expected
credit loss by rating category
USD million
31.12.20
Rating category
1
0–1
2–3
4–5
6–8
9–13
Credit-
impaired
(defaulted)
Total off -
balance sheet
exposure
(maximum
exposure to
credit risk)
ECL provisions
Off-balance sheet financial instruments
Guarantees
3,482
4,623
3,522
4,293
991
170
17,081
(
63
)
of which: stage 1
3,482
4,219
2,688
3,558
739
0
14,687
(
14
)
of which: stage 2
0
404
834
736
252
0
2,225
(
15
)
of which: stage 3
0
0
0
0
0
170
170
(
34
)
Irrevocable loan commitments
3,018
14,516
8,583
9,302
5,850
104
41,372
(
142
)
of which: stage 1
3,018
13,589
6,873
8,739
4,676
0
36,894
(
74
)
of which: stage 2
0
927
1,711
563
1,174
0
4,374
(
68
)
of which: stage 3
0
0
0
0
0
104
104
0
Forward starting reverse repurchase and securities borrowing agreements
82
150
0
3,015
0
0
3,247
0
Total off balance sheet financial instruments
6,583
19,289
12,105
16,610
6,840
273
61,700
(
205
)
Credit lines
Committed unconditionally revocable credit lines
574
15,448
5,958
8,488
11,501
108
42,077
(
50
)
of which: stage 1
574
14,883
4,517
6,609
10,593
0
37,176
(
29
)
of which: stage 2
0
565
1,441
1,879
908
0
4,792
(
21
)
of which: stage 3
0
0
0
0
0
108
108
0
Irrevocable committed prolongation of existing loans
14
1,349
931
632
357
0
3,282
(
2
)
of which: stage 1
14
1,349
930
630
355
0
3,277
(
2
)
of which: stage 2
0
1
1
2
1
0
5
0
of which: stage 3
0
0
0
0
0
0
0
0
Total credit lines
588
16,797
6,889
9,119
11,858
109
45,359
(
52
)
1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and
control” section of this report for more information on rating categories.
477
Note 20
Expected credit loss measurement (continued)
f) Sensitivity information
As
outlined
in
Note
1a,
ECL
estimates
involve
significant
uncertainties at the time they are made.
ECL model
The models applied
to determine
point-in-time
PD and LGD rely
on
market
and
statistical
data,
which
has
been
found
to
correlate
well
with
historically
observed
defaults
in
sufficiently
homogeneous
segments.
The
risk
sensitivities
for
each
of
the
ECL reporting
segments to such
factors are
summarized in
Note
9.
Forward-looking scenarios
Depending on the scenario selection
and related macro-economic
assumptions for the
risk factors, the
components of the
relevant
weighted
average
ECL
change.
This
is
particularly
relevant
for
interest rates,
which can
move in
both directions
under a
given
growth assumption
(for example,
low growth
with high
interest
rates
in a
stagflation
scenario,
versus
low growth
and falling
interest
rates
in
a
recession).
Management generally
looks
for
scenario
narratives
that reflect
the key risk
drivers of
a given credit
portfolio.
As forecasting models are complex, due to the combination
of
multiple
factors,
simple
what-if
analyses
involving
a
change
of
individual
parameters
do
not
necessarily
provide
realistic
information
on
the
exposure
of
segments
to
changes
in
the
macroeconomy. Portfolio
-specific analyses based on their key risk
factors would also not be meaningful, as potential compensatory
effects
in
other
segments
would
be
ignored.
The
table
below
indicate
s
some
sensitivities
to
ECL
s
if
a
key
macroeconomic
variable for the forecasting period is amended
across all scenarios
with all other factors remaining unchanged
.
Potential effect on stage 1 and stage 2
positions from changing key parameters as of
31 December 2021
USD million
Baseline
Upside
Mild downside
Severe downside
Weighted average
Change in key parameters
Fixed income: Government bonds (absolute change)
–0.50%
(
1
)
0
(
29
)
(
9
)
(
4
)
+0.50%
1
1
39
11
5
+1.00%
4
2
88
23
14
Unemployment rate (absolute change)
–1.00%
(
2
)
(
2
)
(
30
)
(
48
)
(
13
)
–0.50%
(
1
)
(
1
)
(
17
)
(
27
)
(
7
)
+0.50%
1
1
21
31
8
+1.00%
3
2
47
68
18
Real GDP growth (relative change)
–2.00%
4
2
8
17
10
–1.00%
2
1
4
8
5
+1.00%
(
1
)
0
(
10
)
(
8
)
(
4
)
+2.00%
(
2
)
0
(
14
)
(
16
)
(
7
)
House Price Index (relative change)
–5.00%
6
4
50
73
24
–2.50%
3
2
24
34
12
+2.50%
(
2
)
(
1
)
(
26
)
(
31
)
(
11
)
+5.00%
(
4
)
(
3
)
(
46
)
(
31
)
(
13
)
Equity (S&P500, EuroStoxx, SMI) (relative change)
–10.00%
2
2
5
6
5
–5.00%
1
0
2
3
2
+5.00%
(
1
)
0
(
2
)
(
3
)
(
2
)
+10.00%
(
2
)
0
(
4
)
(
6
)
(
3
)
Consolidated financial statements | UBS AG consolidated financial statements
478
Note 20
Expected credit loss measurement (continued)
Sensitivities can be more meaningfully
assessed in the context
of
coherent
scenarios
with
consistently
developed
macroeconomic factors.
The table on
the previous page
outlines
favorable and
unfavorable effects,
based on
reasonably possible
alternative changes
to the
economic conditions
for stage 1
and
stage 2
positions.
The
ECL
impact
is
calculated
for
material
portfolios and disclosed for each scenario.
The
forecasting
horizon
is
limited
to
three
years,
with
a
model-based
mean
reversion
of
PD
and
LGD
assumed
thereafter.
Changes
to
these
timelines
may
have
an
effect
on
ECLs:
depending
on
the
cycle,
a
longer
or
shorter
forecasting
horizon will lead to different
annualized lifetime
PD and average
LGD estimations.
This is currently
not deemed to be material
for
UBS AG,
as a large
proportion
of loans,
including
mortgages
in
Switzerland,
have
maturities
that
are
within
the
forecasting
horizon.
Scenario weights
ECL
is
sensitive
to
changing
scenario
weights,
in
particular
if
narratives and
parameters are
selected that
are not
close to
the
baseline scenario, highlighting the non-linearity of credit losses.
As shown in the table on the bottom of this page, the ECL for
stage 1 and
stage 2 positions
would have been
USD
387
million
(31 December 2020: USD
442
million) instead of USD
503
million
(31
December
2020:
USD
639
million)
if
ECL
had
been
determined solely on
the baseline scenario.
The weighted average
ECL therefore amounts
to
130
% (31 December 2020:
145
%) of
the
baseline
value.
The
effects
of
weighting
each
of
the
four
scenarios 100% are shown in the table below.
Stage allocation and SICR
The
determination
of
what
constitutes
a
n
SICR
is
based
on
management judgment,
as explained
in Note
1a. Changing
the
SICR trigger
will have
a direct
effect on
ECLs, as
more or
fewer
positions would be subject to lifetime ECLs under any scenario.
The
relevance
of
the
SICR
trigger
on
overall
ECL
is
demonstrated in the table below with the indication that the ECL
allowances and provisions
for stage 1
and stage 2
positions would
have been USD
1,060
million if all
non-impaired positions across
the portfolio had been
measured for lifetime ECLs
irrespective of
their actual SICR
status. This amount
compares to actual
stage 1
and
2
allowances
and
provisions
of
USD
503
million
as
of
31 December 2021.
Potential
effect on
stage 1
and stage
2 positions
from changing
scenario
weights
or moving
to an ECL
lifetime
calculation
as of 31
December
2021
Actual ECL
allowances and
provisions,
including staging
(as per Note 9)
Pro forma ECL allowances and provisions, including staging
and assuming application of 100% scenario weighting
Pro forma ECL
allowances and
provisions,
assuming all
positions being
subject to lifetime
ECL
Scenarios
Weighted average
100% Baseline
100% Upside
100% Mild
downside
100% Severe
downside
Weighted average
USD million, except where indicated
Segmentation
Private clients with mortgages
(
95
)
(
53
)
(
52
)
(
119
)
(
207
)
(
277
)
Real estate financing
(
62
)
(
50
)
(
48
)
(
101
)
(
97
)
(
118
)
Large corporate clients
(
150
)
(
116
)
(
107
)
(
148
)
(
244
)
(
257
)
SME clients
(
65
)
(
56
)
(
55
)
(
71
)
(
91
)
(
117
)
Other segments
(
130
)
(
112
)
(
108
)
(
135
)
(
166
)
(
291
)
Total
(
503
)
(
387
)
(
370
)
(
574
)
(
806
)
(
1,060
)
Maturity profile
The maturity profile is an important driver for changes
in ECL due
to transfers
to stage 2
and from
stage 2 to
stage 1. The
current
maturity profile of most lending books is relatively
short; hence a
movement
to
stage 2
may
have
a
moderate
effect
on
ECLs.
A
significant portion
of our
lending to
SMEs is
documented under
multi-purpose
credit agreements,
which allow
for various
forms
of utilization but are unconditionally
cancelable by UBS AG
at any
time. For drawings
under such agreements
with a fixed
maturity
the respective term is applied for ECL calculations,
or a maximum
of 12 months in stage 1. For unused credit lines and all
drawings
that
have
no
fixed
maturity
(e.g.,
current
accounts),
UBS
AG
generally
applies a
12-month maturity
from
the reporting
date,
given the
credit review
policies, which
require either
continuous
monitoring of
key indicators
and behavioral
patterns for
smaller
positions or an annual formal review for any other
limit. The ECLs
for
these
products
are
sensitive
to
shortening
or
extending
the
maturity assumption.
479
Note 21
Fair value measurement
a) Valuation principles
All
financial
and non-financial
assets
and liabilities
measured
or
disclosed at fair value are categorized into one of three
fair value
hierarchy levels
in accordance
with IFRS.
The fair
value hierarchy
is based on the
transparency of inputs to
the valuation of an
asset
or liability as
of the measurement
date. In certain
cases, the inputs
used to
measure fair
value may fall
within different
levels of
the
fair
value
hierarchy.
For
disclosure
purposes,
the
level
in
the
hierarchy within which an
instrument is classified in its entirety
is
based on the lowest level input
that is significant to the position’s
fair value measurement:
–
Level 1
–
quoted
prices
(unadjusted)
in
active
markets
for
identical assets and liabilities;
–
Level 2 –
valuation techniques
for which
all significant
inputs
are, or are based on, observable market data; or
–
Level 3 – valuation techniques
for which significant inputs are
not based on observable market data.
Fair
values
are
determined
using
quoted
prices
in
active
markets for
identical assets
or liabilities,
where available.
Where
the
market
for
a
financial
instrument
or
non-financial
asset
or
liability
is
not
active,
fair
value
is
established
using
a
valuation
technique, including
pricing models.
Valuation adjustments
may
be made to
allow for additional
factors, including model,
liquidity,
credit and funding
risks, which are
not explicitly captured
within
the
valuation
technique,
but
which
would
nevertheless
be
considered by market participants when establishing
a price. The
limitations
inherent
in
a
particular
valuation
technique
are
considered in the determination
of the classification of
an asset or
liability
within
the
fair
value
hierarchy.
Generally,
the
unit
of
account
for
a
financial
instrument
is
the
individual
instrument,
and UBS applies
valuation adjustments at
an individual instrument
level,
consistent
with
that
unit
of
account.
However,
if
certain
conditions are met, UBS may estimate the fair value
of a portfolio
of
financial
assets
and
liabilities
with
substantially
similar
and
offsetting risk exposures on the basis of the net open risks.
›
Refer to Note 21d for more information
b) Valuation governance
UBS’s fair value measurement and model governance framework
includes numerous controls and other procedural safeguards that
are intended to
maximize the quality of
fair value measurements
reported in the financial statements. New products and valuation
techniques must
be reviewed
and approved
by key
stakeholders
from the risk and finance control functions. Responsibility for the
ongoing measurement of financial and non-financial instruments
at fair value is with the business divisions.
Fair
value
estimates
are
validated
by
the
risk
and
finance
control
functions,
which
are
independent
of
the
business
divisions. Independent
price verification
is performed
by Finance
through benchmarking the business divisions’
fair value estimates
with observable market prices
and other independent sources.
A
governance
framework
and
associated
controls
are
in
place
in
order to monitor
the quality of third
-party pricing sources
where
used.
For
instruments
where
valuation
models
are
used
to
determine
fair
value,
independent
valuation
and
model
control
groups within Finance and Risk
Control evaluate UBS’s models on
a regular basis,
including valuation and
model input parameters,
as well as pricing. As a result of the
valuation controls employed,
valuation
adjustments
may
be
made
to
the
business
divisions’
estimates of fair value to
align with independent market
data and
the relevant accounting standard.
›
Refer to Note 21d for more information
Consolidated financial statements | UBS AG consolidated financial statements
480
Note 21
Fair value measurement (continued)
c) Fair value hierarchy
The table below provides
the fair value hierarchy
classification of
financial and
non-financial assets
and liabilities
measured at
fair
value.
The
narrative
that
follows describes
valuation
techniques
used
in
measuring
their
fair
value
of
different
product
types
(including significant valuation
inputs and assumptions
used), and
the
factors
considered
in
determining
their
classification
within
the fair value hierarchy.
Determination of fair values from quoted market
prices or valuation techniques
1
31.12.21
31.12.20
USD million
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
Financial assets measured at fair value on a recurring basis
Financial assets at fair value held for trading
113,722
15,012
2,299
131,033
107,526
15,630
2,337
125,492
of which:
Equity instruments
97,983
1,090
149
99,222
90,327
1,101
171
91,599
Government bills / bonds
7,135
1,351
10
8,496
9,028
2,207
10
11,245
Investment fund units
7,843
1,364
21
9,229
7,374
1,794
23
9,192
Corporate and municipal bonds
708
7,791
556
9,055
789
8,432
817
10,038
Loans
0
3,099
1,443
4,542
0
1,860
1,134
2,995
Asset-backed securities
53
317
120
489
8
236
181
425
Derivative financial instruments
522
116,482
1,140
118,145
795
157,069
1,754
159,618
of which:
Foreign exchange contracts
255
53,046
7
53,307
319
68,425
5
68,750
Interest rate contracts
0
32,747
494
33,241
0
50,353
537
50,890
Equity / index contracts
0
27,861
384
28,245
0
33,990
853
34,842
Credit derivative contracts
0
1,179
236
1,414
0
2,008
350
2,358
Commodity contracts
0
1,590
16
1,606
0
2,211
6
2,217
Brokerage receivables
0
21,839
0
21,839
0
24,659
0
24,659
Financial assets at fair value not held for trading
2
27,278
28,185
4,180
59,642
40,986
35,110
3,942
80,038
of which:
Financial assets for unit-linked investment contracts
21,110
187
6
21,303
20,628
101
2
20,731
Corporate and municipal bonds
123
13,937
306
14,366
290
16,957
372
17,619
Government bills / bonds
5,624
3,236
0
8,860
19,704
3,593
0
23,297
Loans
0
4,982
892
5,874
0
7,699
862
8,561
Securities financing transactions
0
5,704
100
5,804
0
6,629
122
6,751
Auction rate securities
0
0
1,585
1,585
0
0
1,527
1,527
Investment fund units
338
137
117
591
278
121
105
505
Equity instruments
83
2
681
765
86
0
544
631
Other
0
0
495
495
0
10
408
418
Financial assets measured at fair value through other comprehensive income on
a recurring basis
Financial assets measured at fair value through other comprehensive
income
2
2,704
6,140
0
8,844
1,144
7,114
0
8,258
of which:
Asset-backed securities
0
4,849
0
4,849
0
6,624
0
6,624
Government bills / bonds
2,658
27
0
2,686
1,103
47
0
1,150
Corporate and municipal bonds
45
1,265
0
1,310
40
444
0
485
Non-financial assets measured at fair value on a recurring basis
Precious metals and other physical commodities
5,258
0
0
5,258
6,264
0
0
6,264
Non-financial assets measured at fair value on a non-recurring basis
Other non-financial assets
3
0
0
26
26
0
1
245
246
Total assets measured at fair value
149,484
187,658
7,645
344,787
156,716
239,583
8,278
404,576
481
Note 21
Fair value measurement (continued)
Determination of fair values from quoted market
prices or valuation techniques (continued)
1
31.12.21
31.12.20
USD million
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
Financial liabilities measured at fair value on a recurring basis
Financial liabilities at fair value held for trading
25,413
6,170
105
31,688
26,889
6,652
55
33,595
of which:
Equity instruments
18,328
513
83
18,924
22,519
425
40
22,985
Corporate and municipal bonds
30
4,219
17
4,266
31
4,048
9
4,089
Government bills / bonds
5,883
826
0
6,709
3,642
1,036
0
4,678
Investment fund units
1,172
555
6
1,733
696
1,127
5
1,828
Derivative financial instruments
509
118,558
2,242
121,309
746
156,884
3,471
161,102
of which:
Foreign exchange contracts
258
53,800
21
54,078
316
70,149
61
70,527
Interest rate contracts
0
28,398
278
28,675
0
43,389
527
43,916
Equity / index contracts
0
33,438
1,511
34,949
0
38,870
2,306
41,176
Credit derivative contracts
0
1,412
341
1,753
0
2,403
528
2,931
Commodity contracts
0
1,503
63
1,566
0
2,003
24
2,027
Financial liabilities designated at fair value on a recurring basis
Brokerage payables designated at fair value
0
44,045
0
44,045
0
38,742
0
38,742
Debt issued designated at fair value
2
0
59,606
11,854
71,460
0
50,273
9,595
59,868
Other financial liabilities designated at fair value
2
0
29,258
3,156
32,414
0
29,682
2,091
31,773
of which:
Financial liabilities related to unit-linked investment contracts
0
21,466
0
21,466
0
20,975
0
20,975
Securities financing transactions
0
6,375
2
6,377
0
7,317
0
7,317
Over-the-counter debt instruments
0
1,334
794
2,128
0
1,363
697
2,060
Total liabilities measured at fair value
25,922
257,637
17,357
300,916
27,635
282,233
15,212
325,080
1 Bifurcated embedded derivatives are presented on the same balance sheet lines
as their host contracts and are not included in this table. The fair value of these derivatives was not
material for the periods presented.
2 As of 31 December 2021, USD
16
billion (31 December 2020: USD
20
billion) of Financial assets at fair value not
held for trading, USD
8
billion (31 December 2020: USD
8
billion) of Financial assets measured at
fair value through other
comprehensive income, USD
33
billion (31 December 2020:
USD
15
billion) of Debt issued
designated at fair value
and USD
3
billion (31 December 2020:
USD
3
billion) of Other financial
liabilities designated at fair value are expected to be recovered or settled after 12 months.
3 Other non-financial assets primarily consist of properties and other non-current assets held for sale, which are
measured
at the lower of their net carrying amount or fair value less costs to sell.
Consolidated financial statements | UBS AG consolidated financial statements
482
Note 21
Fair value measurement (continued)
Valuation techniques
UBS uses widely recognized valuation techniques for determining
the fair
value of
financial and
non-financial instruments
that are
not
actively
traded
and
quoted.
The
most
frequently
applied
valuation
techniques include
discounted value
of expected
cash
flows, relative value and option pricing methodologies.
Discounted
value
of
expected
cash
flows
is
a
valuation
technique
that
measures
fair
value
using
estimated
expected
future
cash
flows
from
assets
or
liabilities
and
then
discounts
these
cash
flows
using a
discount
rate
or
discount
margin that
reflects the credit and
/ or funding spreads
required by the market
for instruments with similar risk
and liquidity profiles to produce
a
present
value. When
using such
valuation
techniques, expected
future
cash
flows
are
estimated
using
an
observed
or
implied
market
price
for
the
future
cash
flows
or
by
using
industry-
standard cash flow projection
models. The discount factors
within
the calculation are
generated using industry-standard yield
curve
modeling techniques and models.
Relative value models measure fair
value based on the market
prices
of
equivalent
or
comparable
assets
or
liabilities,
making
adjustments
for
differences
between
the
characteristics
of
the
observed instrument and the instrument being valued.
Option pricing models
incorporate assumptions regarding
the
behavior of future
price movements of
an underlying referenced
asset or assets
to generate a
probability-weighted future expected
payoff for
the option.
The resulting
probability-weighted expected
payoff is
then discounted using
discount factors generated
from
industry-standard
yield
curve
modeling
techniques
and
models.
The
option
pricing
model
may be
implemented
using a
closed-
form analytical
formula or
other mathematical
techniques (e.g.,
binomial tree or Monte Carlo simulation).
Where available,
valuation techniques
use market-observable
assumptions and inputs.
If such data
is not available,
inputs may
be derived
by reference
to similar
assets in
active markets,
from
recent
prices
for
comparable
transactions
or
from
other
observable
market
data.
In
such
cases,
the
inputs
selected
are
based
on
historical
experience
and
practice
for
similar
or
analogous instruments, derivation of input levels based on
similar
products with
observable price
levels,
and knowledge
of current
market conditions and valuation approaches.
For
more
complex instruments,
fair
values may
be
estimated
using
a
combination
of
observed
transaction
prices,
consensus
pricing services and relevant quotes. Consideration
is given to the
nature of
the quotes
(e.g.,
indicative
or firm)
and the
relationship
of
recently
evidenced
market
activity
to
the
prices
provided
by
consensus
pricing
services.
UBS
also
uses
internally
developed
models,
which
are
typically
based
on
valuation
methods
and
techniques
recognized
as standard
within
the industry.
Assumptions
and inputs
used in
valuation
techniques
include
benchmark
interest
rate curves,
credit and funding
spreads used
in estimating
discount
rates, bond
and equity
prices,
equity index
prices,
foreign exchange
rates, levels of market volatility and correlation. Refer to Note 21f
for more
information.
The discount
curves
used by
UBS incorporate
the funding and credit characteristics
of the instruments to which
they are applied.
Financial instruments excluding derivatives: valuation and classification in the fair value hierarchy
Product
Valuation and classification in the fair value hierarchy
Government bills
and bonds
Valuation
–
Generally valued using prices obtained directly
from the market.
–
Instruments not priced directly using active-market data
are valued using discounted cash
flow valuation
techniques that incorporate market data
for similar government instruments.
Fair value hierarchy
–
Generally traded in active markets with prices that can be obtained directly from these markets, resulting
in classification as Level 1,
while the remaining positions are classified
as Level 2 and Level 3.
Corporate and
municipal bonds
Valuation
–
Generally
valued
using
prices
obtained
directly
from
the
market
for
the
security,
or
similar
securities,
adjusted for seniority, maturity and liquidity.
–
When prices
are not
available, instruments are
valued using
discounted cash
flow valuation
techniques
incorporating the credit spread of the
issuer or similar issuers.
–
For convertible bonds
without directly
comparable prices,
issuances may
be priced using
a convertible
bond
model.
Fair value hierarchy
–
Generally classified as Level 1 or Level 2, depending
on the depth of trading activity behind price
sources.
–
Level 3 instruments have no suitable pricing information
available.
Traded loans and
loans measured at
fair value
Valuation
–
Valued directly
using market prices
that reflect recent
transactions or quoted
dealer prices, where
available.
–
Where no
market price
data is
available, loans
are valued
by relative
value benchmarking
using pricing
derived from debt instruments in comparable entities or different products in the same entity, or by using
a credit default
swap valuation technique,
which requires inputs
for credit spreads,
credit recovery rates
and interest
rates. Recently
originated commercial real
estate loans
are measured
using a
securitization
approach based on rating agency guidelines.
Fair value hierarchy
–
Instruments with suitably deep and liquid pricing
information are classified as Level 2.
–
Positions requiring the use of
valuation techniques, or for
which the price sources have
insufficient trading
depth, are classified as Level 3.
483
Note 21
Fair value measurement (continued)
Product
Valuation and classification in the fair value hierarchy
Investment fund
units
Valuation
–
Predominantly exchange-traded, with
readily available quoted prices in liquid markets.
–
Where market prices are not available, fair
value may be measured using net asset values
(NAVs).
Fair value hierarchy
–
Listed units
are classified
as
Level 1, provided
there is
sufficient trading
activity to
justify active-market
classification, while other positions are classified
as Level 2.
–
Positions for which NAVs are not available
are classified as Level 3.
Asset-backed
securities (ABS)
Valuation
–
For liquid securities, the valuation
process will use trade
and price data, updated for movements
in market
levels between the time of trading and the
time of valuation. Less liquid instruments are measured using
discounted expected
cash flows
incorporating price
data for instruments
or indices with
similar risk profiles.
Fair value hierarchy
–
Residential
mortgage
-
backed
securities
,
commercial
mortgage
-
backed
securities
and
other
ABS
are
generally classified as Level 2. However,
if significant inputs are unobservable,
or if market or fundamental
data is not available, they are classified as Level
3.
Auction rate
securities (ARS)
Valuation
–
ARS
are
valued
utilizing
a
discounted
cash
flow
methodology.
The
model
captures
interest
rate
risk
emanating from the note coupon, credit risk attributable to the
underlying closed-end fund investments,
liquidity risk as a function of the level of trading volume in these positions, and extension risk, as ARS are
perpetual instruments that require an assumption
regarding their maturity or issuer redemption
date.
Fair value hierarchy
–
Granular and liquid pricing information is generally not available for
ARS. As a result, these securities are
classified as Level 3.
Equity instruments
Valuation
–
Listed equity instruments are generally valued
using prices obtained directly from the market.
–
Unlisted equity holdings,
including private equity
positions, are initially
marked at their
transaction price
and are
revalued when
reliable evidence of
price movement
becomes available
or when
the position
is
deemed to be impaired.
Fair value hierarchy
–
The majority
of equity
securities are actively
traded on
public stock
exchanges where quoted
prices are
readily and regularly available, resulting in Level
1 classification.
Financial assets for
unit-linked
investment
contracts
Valuation
–
The majority of assets are listed on exchanges
and fair values are determined using quoted
prices.
Fair value hierarchy
–
Most assets are classified as Level 1 if actively traded,
or Level 2 if trading is not active.
–
Instruments for which prices are not readily available
are classified as Level 3.
Securities financing
transactions
Valuation
–
These instruments are valued using discounted expected cash flow techniques. The discount rate applied
is based on funding curves that are relevant
to the collateral eligibility terms.
Fair value hierarchy
–
Collateral funding curves for
these instruments are generally
observable and, as a
result, these positions
are classified as Level 2.
–
Where the collateral
terms are non-standard,
the funding curve
may be considered
unobservable and
these
positions are classified as Level 3.
Brokerage
receivables and
payables
Valuation
–
Fair value is determined based on the value of
the underlying balances.
Fair value hierarchy
–
Due to their on-demand nature, these receivables
and payables are deemed as Level 2.
Amounts due under
unit-linked
investment
contracts
Valuation
–
The
fair
values
of
investment
contract
liabilities
are
determined
by
reference
to
the
fair
value
of
the
corresponding assets.
Fair value hierarchy
–
The liabilities themselves are not actively traded,
but are mainly referenced to instruments
that are actively
traded and are therefore classified as Level 2.
Consolidated financial statements | UBS AG consolidated financial statements
484
Note 21
Fair value measurement (continued)
Derivative instruments: valuation and classification in the
fair value hierarchy
The
curves
used
for
discounting
expected
cash
flows
in
the
valuation
of
collateralized
derivatives
reflect
the
funding
terms
associated
with
the
relevant
collateral
arrangement
for
the
instrument
being
valued.
These
collateral
arrangements
differ
across
counterparties
with
respect
to
the
eligible
currency
and
interest
terms
of
the
collateral.
The
majority
of
collateralized
derivatives are measured using
a discount curve based
on funding
rates
derived
from
overnight
interest
in
the
cheapest
eligible
currency for the respective counterparty collateral agreement.
Uncollateralized
and
partially
collateralized
derivatives
are
discounted
using
the
alternative
reference
rate
(the
ARR)
(or
equivalent) curve for the currency
of the instrument. As described
in
Note
2
1
d
,
the
fair
value
of
uncollateralized
and
partially
collateralized
derivatives
is
then
adjusted
by
credit
valuation
adjustments
(
CVA
s)
,
debit
valuation
adjustments
(
DVA
s)
and
funding valuation adjustments (FVAs), as
applicable, to reflect an
estimation
of
the
effect
of
counterparty
credit
risk,
UBS’s
own
credit risk, and funding costs and benefits.
›
Refer to Note 10 for more information about
derivative
instruments
Derivative product
Valuation and classification in the fair value hierarchy
Interest rate
contracts
Valuation
–
Interest rate swap contracts
are valued by estimating
future interest cash flows
and discounting those
cash
flows using
a rate
that reflects the
appropriate funding rate
for the
position being
measured. The yield
curves used to estimate future index
levels and discount rates are generated using
market-standard yield
curve models using interest rates associated with
current market activity. The key inputs to the
models are
interest rate swap rates, forward rate agreement rates, short-term interest rate futures prices,
basis swap
spreads and inflation swap rates.
–
Interest rate option contracts
are valued using various
market-standard option models, using inputs that
include interest rate yield curves, inflation curves,
volatilities and correlations.
–
When the maturity
of an interest
rate swap or
option contract exceeds
the term for
which standard market
quotes are observable for
a significant input parameter,
the contracts are valued
by extrapolation from the
last observable point using standard assumptions
or by reference to another observable comparable
input
parameter to represent a suitable proxy for that
portion of the term.
Fair value hierarchy
–
The majority of interest rate swaps are classified
as Level 2 as the standard market contracts
that form the
inputs for yield curve models are generally traded
in active and observable markets.
–
Options are generally
treated as Level
2 as the calibration
process enables
the model output
to be validated
to active-market
levels. Models
calibrated in
this way
are then
used to
revalue the
portfolio of
both standard
options and more exotic products.
–
Interest rate swap
or option contracts
are classified as
Level 3 when the
terms
exceed standard market-
observable quotes.
–
Exotic options for
which appropriate volatility
or correlation input
levels cannot be implied
from observable
market data are classified as Level 3.
Credit derivative
contracts
Valuation
–
Credit derivative
contracts are
valued using
industry-standard models
based primarily
on
market credit
spreads, upfront pricing points and implied recovery rates. Where a derivative credit spread is not directly
available, it may be derived from the price of
the reference cash bond.
–
Asset-backed credit
derivatives are
valued using
a valuation
technique similar
to that
of the
underlying
security with an adjustment to reflect
the funding differences between cash
and synthetic form.
Fair value hierarchy
–
Single-entity and
portfolio
credit derivative
contracts are
classified as
Level 2
when credit
spreads and
recovery rates
are determined
from actively
traded observable
market data.
Where the
underlying reference
name(s) are not actively traded
and the correlation cannot be
directly mapped to actively traded tranche
instruments, these contracts are classified
as Level 3.
–
Asset-backed
credit
derivatives
follow
the
characteristics
of
the
underlying
security
and
are
therefore
distributed across Level 2 and Level 3.
485
Note 21
Fair value measurement (continued)
Derivative product
Valuation and classification in the fair value hierarchy
Foreign exchange
contracts
Valuation
–
Open spot foreign exchange (FX)
contracts are valued using the FX spot rate
observed in the market.
–
Forward FX contracts are valued using the FX spot rate adjusted for forward pricing points observed from
standard market-based sources.
–
Over-the-counter (OTC)
FX option
contracts are
valued using
market-standard option valuation
models.
The models used for shorter-dated options (i.e., maturities of
five years or less) tend
to be different than
those used for
longer-dated
options because
the models needed
for longer-dated
OTC FX contracts
require
additional consideration of interest rate and FX
rate interdependency.
–
The valuation for
multi-dimensional FX
options uses a
multi-local volatility model,
which is calibrated
to the
observed FX volatilities for all relevant FX pairs.
Fair value hierarchy
–
The
markets
for
FX
spot
and
FX
forward
pricing
points
are
both
actively
traded
and
observable
and
therefore such FX contracts are generally classified
as Level 2.
–
A significant proportion of
OTC FX option contracts are
classified as Level 2 as
inputs are derived mostly
from standard market contracts traded in
active and observable markets.
–
OTC FX
option contracts
classified as
Level 3 include
multi-dimensional FX
options and
long-dated FX
exotic
option contracts where there is no active market
from which to derive volatility or correlation
inputs.
Equity / index
contracts
Valuation
–
Equity forward
contracts have a
single stock
or index
underlying and are
valued using
market-standard
models. The key inputs to the models are
stock prices, estimated dividend rates and equity funding rates
(which are implied
from prices of
forward contracts
observed in the
market). Estimated cash
flows are then
discounted using market-standard discounted cash flow models using a rate that reflects the appropriate
funding rate for
that portion
of the portfolio.
When no market
data is available
for the instrument
maturity,
they are
valued by
extrapolation of
available data,
use of
historical dividend
data, or
use of
data for
a
related equity.
–
Equity option contracts are valued
using market-standard models that
estimate the equity forward level
as
described
for
equity
forward
contracts
and
incorporate
inputs
for
stock
volatility
and
for
correlation
between
stocks
within
a
basket.
The
probability-weighted
expected
option
payoff
generated
is
then
discounted
using
market-standard
discounted
cash
flow
models
applying
a
rate
that
reflects
the
appropriate funding rate
for that portion of
the portfolio. When
volatility, forward or
correlation inputs are
not
available,
they
are
valued
using
extrapolation
of
available
data,
historical
dividend,
correlation
or
volatility data, or the equivalent data for
a related equity.
Fair value hierarchy
–
As inputs are
derived mostly from standard
market contracts traded in
active and observable markets,
a
significant proportion of equity forward contracts
are classified as Level 2.
–
Equity option positions for which inputs are derived
from standard market contracts traded in active and
observable markets are also classified
as Level 2. Level 3 positions are those
for which volatility, forward or
correlation inputs are not observable.
Commodity
contracts
Valuation
–
Commodity forward
and swap
contracts are
measured using
market-standard models
that use
market
forward levels on standard instruments.
–
Commodity
option
contracts
are
measured
using
market-standard
option
models
that
estimate
the
commodity forward level
as described for
commodity forward and
swap contracts, incorporating
inputs
for the volatility of the underlying
index or commodity. For commodity
options on baskets of commodities
or
bespoke
commodity
indices,
the
valuation
technique
also
incorporates
inputs
for
the
correlation
between different commodities or commodity
indices.
Fair value hierarchy
–
Individual
commodity contracts
are
typically classified
as
Level 2,
because
active
forward and
volatility
market data is available.
Consolidated financial statements | UBS AG consolidated financial statements
486
Note 21
Fair value measurement (continued)
d) Valuation adjustments and other items
The output of a valuation technique is always an estimate of a
fair value that cannot be
measured with complete certainty. As a
result, valuations are adjusted, where appropriate and when such
factors would be considered by market participants in estimating
fair value, to reflect
close-out costs, credit exposure,
model-driven
valuation
uncertainty,
funding
costs
and
benefits,
trading
restrictions and other factors.
The table below summarizes the
valuation adjustment reserves
recognized on the balance sheet. Details about each category are
provided further below.
Valuation adjustment reserves on the balance sheet
As of
Life-to-date gain / (loss), USD million
31.12.21
31.12.20
31.12.19
Deferred day-1 profit or loss reserves
418
269
146
Own credit adjustments on financial liabilities designated at fair value
(
315
)
(
381
)
(
88
)
CVAs, FVAs,
DVAs and other valuation adjustments
(
1,004
)
(
959
)
(
706
)
Deferred day-1 profit or loss reserves
For
new
transactions
where
the
valuation
technique
used
to
measure fair
value requires
significant inputs
that are
not based
on
observable
market
data,
the
financial
instrument
is
initially
recognized
at
the
transaction
price.
The
transaction
price
may
differ
from
the fair
value obtained
using a
valuation technique,
where any such difference is deferred and not initially recognized
in the income statement.
Deferred
day-1
profit
or
loss
is generally
released
into
Other
net
income
from
financial
instruments
measured
at
fair
value
through profit or loss
when pricing of equivalent products or the
underlying
parameters
become
s
observable
or
when
the
transaction is closed out.
The
table
below
summarizes
the
changes
in
deferred
day-1
profit or loss reserves during the respective period.
Deferred day-1 profit or loss reserves
USD million
2021
2020
2019
Reserve balance at the beginning of the year
269
146
255
Profit / (loss) deferred on new transactions
459
362
171
(Profit) / loss recognized in the income statement
(
308
)
(
238
)
(
278
)
Foreign currency translation
(
2
)
0
(
2
)
Reserve balance at the end of the year
418
269
146
Own credit
Own
credit
risk
is
reflected
in
the
valuation
of
UBS’s
fair
value
option liabilities where
this component is considered relevant
for
valuation
purposes
by
UBS’s
counterparties
and
other
market
participants.
Changes in
the fair
value of
financial liabilities
designated at
fair
value
through
profit
or
loss
related
to
own
credit
are
recognized
in
Other
comprehensive
income
directly
within
Retained
earnings,
with
no
reclassification
to
the
income
statement in future periods.
This presentation does not
create or
increase an
accounting mismatch
in the income
statement, as
UBS
does not hedge changes in own credit
.
Own
credit
is
estimated
using
own
credit
adjustment
(OCA)
curves,
which
incorporate
observable
market
data,
including
market-observed
secondary
prices
for
UBS’s
debt,
UBS’s
credit
default swap spreads
and debt curves
of peers. In
the table below,
the
change
in
unrealized
own credit
consists of
changes
in
fair
value that are attributable
to the change in
UBS’s credit spreads,
as well
as the
effect of
changes in
fair values
attributable to
factors
other than credit spreads, such as redemptions, effects from time
decay
and changes
in
interest and
other market
rates.
Realized
own credit is recognized
when an instrument with
an associated
unrealized OCA
is repurchased
prior to
the contractual
maturity
date.
Life-to-date
amounts
reflect
the
cumulative
unrealized
change since initial recognition.
›
Refer to Note 16 for more information about
debt issued
designated at fair value
487
Note 21
Fair value measurement (continued)
Own credit adjustments on financial liabilities
designated at fair value
Included in Other comprehensive income
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Recognized during the period:
Realized gain / (loss)
(
14
)
2
8
Unrealized gain / (loss)
60
(
295
)
(
408
)
Total gain / (loss), before tax
46
(
293
)
(
400
)
As of
USD million
31.12.21
31.12.20
31.12.19
Recognized on the balance sheet as of the end of the period:
Unrealized life-to-date gain / (loss)
(
315
)
(
381
)
(
88
)
Credit valuation adjustments
In order to measure
the fair value of
OTC derivative instruments,
including
funded
derivative
instruments
that
are
classified
as
Financial assets at
fair value
not held for
trading,
CVAs are needed
to
reflect
the
credit
risk
of
the
counterparty
inherent
in
these
instruments. This
amount represents
the estimated
fair value
of
protection required
to hedge the counterparty credit
risk of such
instruments.
A
CVA
is
determined
for
each
counterparty,
considering
all
exposures
with
that
counterparty,
and
is
dependent
on
the
expected
future
value
of
exposures,
default
probabilities
and
recovery
rates,
applicable
collateral
or
netting
arrangements,
break
clauses,
funding
spreads
and
other
contractual factors.
Funding valuation adjustments
FVAs
reflect
the
costs
and
benefits
of
funding
associated
with
uncollateralized and
partially collateralized
derivative receivables
and
payables
and
are
calculated
as
the
valuation
effect
from
moving
the
discounting
of
the
uncollateralized
derivative
cash
flows from the ARR to OCA using the CVA framework, including
the probability of counterparty default.
An FVA is
also applied to
collateralized derivative
assets in
cases where the
collateral cannot
be sold or repledged.
Debit valuation adjustments
A DVA
is estimated to incorporate own
credit in the valuation of
derivatives
where
an
FVA
is
not
already
recognized.
The
DVA
calculation
is
effectively
consistent
with
the
CVA
framework,
being
determined
for
each
counterparty,
considering
all
exposures
with
that
counterparty
and
taking
into
account
collateral
netting
agreements,
expected
future
mark-to-market
movements and UBS’s credit default spreads.
Other valuation adjustments
Instruments that are measured as part of a portfolio of combined
long and short
positions are valued at
mid-market levels to
ensure
consistent
valuation
of
the
long-
and
short-component
risks.
A
liquidity valuation adjustment is
then made to the
overall net long
or
short
exposure
to
move
the
fair
value
to
bid
or
offer
as
appropriate, reflecting current levels of market liquidity.
The bid–
offer spreads used in
the calculation of this valuation adjustment
are obtained from market transactions
and other relevant sources
and are updated periodically.
Uncertainties
associated
with
the
use
of
model-based
valuations
are
incorporated
into
the
measurement
of
fair
value
through
the
use
of
model
reserves.
These
reserves
reflect
the
amounts that UBS estimates should be deducted from
valuations
produced
directly
by
models
to
incorporate
uncertainties
in
the
relevant modeling
assumptions, in
the model
and market
inputs
used,
or
in
the
calibration
of
the
model
output
to
adjust
for
known
model
deficiencies.
In
arriving
at
these
estimates,
UBS
considers a
range of
market practices,
including how
it believes
market
participants
would
assess
these
uncertainties.
Model
reserves are
reassessed periodically
in light
of data
from market
transactions,
consensus
pricing
services
and
other
relevant
sources.
Other items
In the first
half of
2021, UBS
AG incurred
a loss
of USD
861
million
as a
result of
closing out
a significant
portfolio of
swaps with
a
US-based
client
of
its
prime
brokerage
business
and
the
unwinding of
related hedges,
following the
client’s default.
This
loss
is
presented
within
Other
net
income
from
financial
instruments measured at fair value through profit or loss
.
Valuation adjustments on financial instruments
As of
Life-to-date gain / (loss), USD million
31.12.21
31.12.20
Credit valuation adjustments
1
(
44
)
(
66
)
Funding valuation adjustments
(
49
)
(
73
)
Debit valuation adjustments
2
0
Other valuation adjustments
(
913
)
(
820
)
of which: liquidity
(
341
)
(
340
)
of which: model uncertainty
(
571
)
(
479
)
1 Amounts do not include reserves against defaulted counterparties.
Consolidated financial statements | UBS AG consolidated financial statements
488
Note 21
Fair value measurement (continued)
e) Transfers between Level 1 and Level 2
Assets and liabilities transferred
from Level 2 to
Level 1 during 2021
were not material. Assets and
liabilities transferred from Level 1
to Level 2 during 2021 were also not material.
f) Level 3 instruments: valuation techniques and inputs
The
table
below
presents
material
Level 3
assets
and
liabilities,
together
with
the
valuation
techniques
used
to
measure
fair
value,
the
inputs
used
in
a
given
valuation
technique
that
are
considered significant as
of 31 December
2021 and
unobservable,
and a range of values for those unobservable inputs.
The
range
of
values
represents
the
highest-
and lowest-level
inputs
used in
the valuation
techniques. Therefore,
the range
does
not reflect the level of
uncertainty regarding a particular input or
an
assessment
of
the
reasonableness
of
UBS’s
estimates
and
assumptions, but rather the different underlying
characteristics of
the
relevant
assets
and
liabilities
held
by
UBS.
The
ranges
will
therefore vary from period to period and parameter to parameter
based on characteristics
of the instruments
held at each
balance
sheet date. Furthermore,
the ranges of unobservable
inputs may
differ across other financial institutions,
reflecting the diversity of
the products in each firm’s inventory.
Valuation techniques and inputs used in the fair value measurement
of Level 3 assets and liabilities
Fair value
Significant
unobservable
input(s)
1
Range of inputs
Assets
Liabilities
Valuation
technique(s)
31.12.21
31.12.20
USD billion
31.12.21
31.12.20
31.12.21
31.12.20
low
high
weighted
average
2
low
high
weighted
average
2
unit
1
Financial assets and liabilities at fair value held for trading and Financial assets at fair
value not held for trading
Corporate and municipal
bonds
0.9
1.2
0.0
0.0
Relative value to
market comparable
Bond price equivalent
16
143
98
1
143
100
points
Discounted expected
cash flows
Discount margin
434
434
268
268
basis
points
Traded loans, loans
measured at fair value,
loan commitments and
guarantees
2.8
2.4
0.0
0.0
Relative value to
market comparable
Loan price equivalent
0
101
99
0
101
99
points
Discounted expected
cash flows
Credit spread
175
800
436
190
800
398
basis
points
Market comparable
and securitization
model
Credit spread
28
1,544
241
40
1,858
333
basis
points
Auction rate securities
1.6
1.5
Discounted expected
cash flows
Credit spread
115
197
153
100
188
140
basis
points
Investment fund units
3
0.1
0.1
0.0
0.0
Relative value to
market comparable
Net asset value
Equity instruments
3
0.8
0.7
0.1
0.0
Relative value to
market comparable
Price
Debt issued designated at
fair value
4
11.9
9.6
Other financial liabilities
designated at fair value
3.2
2.1
Discounted expected
cash flows
Funding spread
24
175
42
175
basis
points
Derivative financial instruments
Interest rate contracts
0.5
0.5
0.3
0.5
Option model
Volatility of interest
rates
65
81
29
69
basis
points
Credit derivative contracts
0.2
0.3
0.3
0.5
Discounted expected
cash flows
Credit spreads
1
583
1
489
basis
points
Bond price equivalent
2
136
0
100
points
Equity / index contracts
0.4
0.9
1.5
2.3
Option model
Equity dividend yields
0
11
0
13
%
Volatility of equity
stocks, equity and
other indices
4
98
4
100
%
Equity-to-FX
correlation
(
29
)
76
(
34
)
65
%
Equity-to-equity
correlation
(
25
)
100
(
16
)
100
%
1 The ranges of significant
unobservable inputs are represented in
points, percentages and basis
points. Points are a
percentage of par (e.g., 100
points would be 100% of par).
2 Weighted averages are
provided
for most non-derivative financial
instruments and were calculated
by weighting inputs based on
the fair values of the
respective instruments. Weighted
averages are not provided
for inputs related to Other
financial
liabilities designated at
fair value
and Derivative
financial instruments,
as this would
not be meaningful.
3 The
range of
inputs is not
disclosed, as there
is a dispersion
of values
given the diverse
nature of the
investments.
4 Debt issued designated at fair value primarily consists of UBS structured notes, which include variable maturity notes with various equity and foreign exchange underlying risks,
rates-linked and credit-
linked notes, all of which have embedded derivative parameters that are considered to be unobservable.
The equivalent derivative instrument parameters are presented in the respective derivative financial instruments
lines in this table.
489
Note 21
Fair value measurement (continued)
Significant unobservable inputs in Level 3 positions
This section discusses the significant unobservable inputs
used in the valuation of Level 3
instruments and assesses the potential effect
that a change in each
unobservable input in isolation
may have on a
fair value measurement. Relationships
between observable and
unobservable inputs have not been included in the summary below.
Input
Description
Bond price equivalent
–
Where market
prices are
not available
for a
bond, fair
value is
measured by comparison
with observable
pricing data
from
similar instruments. Factors considered when
selecting comparable instruments include credit
quality, maturity and industry of
the issuer. Fair value may be measured either by a direct price comparison or by conversion of
an instrument price into a yield
(either as an outright yield or as a spread to
the relevant benchmark rate).
–
For corporate and municipal bonds,
the range represents the range
of prices from reference issuances
used in determining fair
value. Bonds priced at 0 are distressed to the point that no
recovery is expected, while prices significantly in excess of 100 or
par
relate
to
inflation-linked
or
structured
issuances
that
pay
a
coupon
in
excess
of
the
market
benchmark
as
of
the
measurement date.
–
For credit derivatives, the bond price range
represents the range of prices used for
reference instruments, which are typically
converted to an equivalent yield or credit
spread as part of the valuation process.
Loan price equivalent
–
Where market prices are not available
for a traded loan, fair value is measured
by comparison with observable
pricing data for
similar instruments.
Factors considered
when selecting
comparable instruments include
industry segment, collateral
quality,
maturity and issuer-specific covenants. Fair value may be measured either by a direct price comparison
or by conversion of an
instrument price
into a yield.
The range represents
the range
of prices
derived from
reference issuances
of a similar
credit quality
used to
measure fair
value for
loans classified
as Level 3.
Loans priced
at 0
are distressed
to the
point that
no recovery
is
expected, while a current price of 100 represents
a loan that is expected to be repaid in full.
Credit spread
–
Valuation models for many credit derivatives
require an input for the credit
spread, which is a reflection of the
credit quality of
the associated referenced
underlying. The credit
spread of a
particular security is
quoted in relation
to the yield
on a benchmark
security or reference rate, typically either US Treasury or ARR,
and is generally expressed in terms of basis points. An increase
/
(decrease) in credit
spread will increase
/ (decrease) the
value of credit
protection offered by
credit default swaps
and other
credit derivative
products. The
income statement
effect from
such changes
depends on
the nature
and direction
of the
positions
held. Credit spreads may
be negative where the asset
is more creditworthy than the
benchmark against which the spread
is
calculated. A
wider credit spread
represents decreasing creditworthiness. The
range represents a
diverse set
of underlyings,
with the lower
end of the
range representing
credits of the
highest quality
and the upper
end of the
range representing
greater
levels of credit risk.
Discount margin
–
The discount margin (DM) spread represents the
discount rates applied to present value
cash flows of an asset
to reflect the
market return required for uncertainty in the
estimated cash flows. DM spreads are
a rate or rates applied on top of a floating
index (e.g., Secured Overnight Financing
Rate (SOFR)) to discount expected
cash flows. Generally, a decrease
/ (increase) in the
DM in isolation would result in a higher / (lower)
fair value.
–
The high end
of the
range relates
to securities
that are priced
low within
the market
relative to the
expected cash
flow schedule.
This indicates
that the
market is
pricing an
increased risk
of credit
loss into
the security
that is
greater than
what is
being
captured by the
expected cash
flow generation process.
The low e
nds of
the ranges are
typical of funding
rates on
better-
quality instruments.
Funding spread
–
Structured financing transactions are valued using synthetic funding curves that best represent the assets that are pledged as
collateral for the transactions. They are not representative
of where UBS can fund itself on an unsecured basis, but
provide an
estimate of where UBS can source and deploy secured funding with counterparties for a given type of collateral. The funding
spreads are expressed in terms of basis points,
and if funding spreads widen, this increases the
effect of discounting.
–
A small proportion of structured
debt instruments and non-structured
fixed-rate bonds within financial
liabilities designated at
fair value had an exposure to funding spreads that
was longer in duration than the actively traded
market.
Volatility
–
Volatility measures the variability of future prices
for a particular instrument and is generally
expressed as a percentage, where
a higher number reflects a more volatile instrument, for which future price movements are
more likely to occur. Volatility is a
key input
into option
models, where it
is used
to derive
a probability-based
distribution of
future prices
for the
underlying
instrument. The effect
of volatility on
individual positions within
the portfolio is
driven primarily by
whether the option
contract
is a
long or
short position.
In most
cases, the
fair value
of an
option increases
as a
result of
an increase
in volatility
and is
reduced by
a decrease
in volatility.
Generally,
volatility used
in the
measurement of fair
value is
derived from
active-market
option prices
(referred to
as implied
volatility). A
key feature
of implied
volatility is
the volatility
“smile” or
“skew,” which
represents the effect of pricing options of
different option strikes at different implied volatility
levels.
–
Volatilities of low interest rates tend to be much higher than volatilities of high interest rates. In addition, different currencies
may have significantly different implied volatilities.
Consolidated financial statements | UBS AG consolidated financial statements
490
Note 21
Fair value measurement (continued)
Input
Description
Correlation
–
Correlation measures the interrelationship between the movements of two variables. It is expressed as a percentage between
–100% and
+100%, where
+100% represents
perfectly correlated
variables (meaning
a movement
of one
variable is
associated
with a
movement of the
other variable in
the same direction)
and –100% implies
that the variables
are inversely correlated
(meaning a movement
of one variable
is associated with
a movement of
the other variable
in the opposite
direction). The
effect
of correlation on the measurement of fair value depends on the specific terms of the instruments being valued, reflecting the
range of different payoff features within
such instruments.
–
Equity-to-FX correlation is important for equity options based on
a currency other than the
currency of the underlying stock.
Equity-to-equity correlation is particularly important for complex options that incorporate, in some
manner, different equities
in the projected payoff.
Equity dividend yields
–
The derivation of
a forward price
for an individual
stock or index
is important for
measuring fair value
for forward or
swap
contracts and for measuring fair value using option pricing models. The relationship between the current stock price and
the
forward price is based on a combination of expected future dividend levels and
payment timings, and, to a lesser extent, the
relevant funding rates applicable
to the stock in question.
Dividend yields are generally expressed
as an annualized percentage
of the share price,
with the lowest limit
of 0% representing
a stock that is
not expected to pay
any dividend. The
dividend yield
and timing represent the
most significant parameter in determining
fair value for instruments
that are sensitive to
an equity
forward price.
491
Note 21
Fair value measurement (continued)
g) Level 3 instruments: sensitivity to changes in unobservable input assumptions
The table
below summarizes
those financial
assets and
liabilities
classified
as
Level 3
for
which
a
change
in
one
or
more
of
the
unobservable inputs
to reflect
reasonably possible
favorable and
unfavorable
alternative
assumptions
would
change
fair
value
significantly,
and
the estimated
effect
thereof.
The
table
below
does
not
represent
the
estimated
effect
of
stress
scenarios.
Interdependencies between Level 1, 2 and 3
parameters have not
been
incorporated
in
the
table.
Furthermore,
direct
inter-
relationships between the
Level 3 parameters discussed
below are
not a significant element of the valuation uncertainty.
Sensitivity
data
is
estimated
using
a
number
of
techniques,
including
the
estimation
of
price
dispersion
among
different
market
participants,
variation
in
modeling
approaches
and
reasonably possible
changes to assumptions
used within the
fair
value measurement process. The sensitivity ranges are not always
symmetrical
around
the
fair
values,
as
the
inputs
used
in
valuations are not always precisely in
the middle of the favorable
and unfavorable range.
Sensitivity data
is determined
at a
product or
parameter level
and
then
aggregated
assuming
no
diversification
benefit.
Diversification
would
incorporate
estimated
correlations
across
different sensitivity results and, as such, would result in an overall
sensitivity
that
would
be
less
than
the
sum
of
the
individual
component
sensitivities.
However,
UBS
believes
that
the
diversification benefit is not significant to this analysis.
Sensitivity of fair value measurements to changes
in unobservable input assumptions
1
31.12.21
31.12.20
USD million
Favorable
changes
Unfavorable
changes
Favorable
changes
Unfavorable
changes
Traded loans, loans designated at fair value, loan commitments and guarantees
19
(
13
)
29
(
28
)
Securities financing transactions
41
(
53
)
40
(
52
)
Auction rate securities
66
2
(
66
)
2
105
(
105
)
Asset-backed securities
20
(
20
)
41
(
41
)
Equity instruments
173
(
146
)
129
(
96
)
Interest rate derivative contracts, net
29
(
19
)
11
(
16
)
Credit derivative contracts, net
5
(
8
)
10
(
14
)
Foreign exchange derivative contracts, net
19
(
11
)
20
(
15
)
Equity / index derivative contracts, net
368
(
335
)
318
(
294
)
Other
50
(
73
)
91
(
107
)
Total
790
(
744
)
794
(
768
)
1 Sensitivity of issued and
over-the-counter debt instruments
is reported with the equivalent
derivative or securities financing
instrument.
2 Includes refinements applied in estimating
valuation uncertainty across
various parameters and a change in assumptions regarding the underlying statistical distribution.
Consolidated financial statements | UBS AG consolidated financial statements
492
Note 21
Fair value measurement (continued)
h) Level 3 instruments: movements during the period
The
table below
presents
additional
information about
material
movements in Level 3 assets and
liabilities measured at fair
value
on a recurring basis, excluding any related hedging activity.
Assets
and
liabilities
transferred
into
or
out
of
Level 3
are
presented as
if those
assets or
liabilities had
been transferred
at
the beginning of the year.
Movements of Level 3 instruments
Total gains / losses
included in
comprehensive income
USD billion
Balance
as of
31 December
2019
Net gains /
losses
included in
income
1
of which:
related to
Level 3
instruments
held at the
end of the
reporting
period
Purchases
Sales
Issuances
Settlements
Transfers
into
Level 3
Transfers
out of
Level 3
Foreign
currency
translation
Balance
as of
31 December
2020
Financial assets at fair value held for
trading
1.8
(
0.1
)
(
0.1
)
0.8
(
1.4
)
1.0
0.0
0.3
0.0
0.0
2.3
of which:
Investment fund units
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Corporate and municipal bonds
0.5
0.0
0.0
0.7
(
0.5
)
0.0
0.0
0.1
0.0
0.0
0.8
Loans
0.8
0.0
(
0.1
)
0.0
(
0.7
)
1.0
0.0
0.1
0.0
0.0
1.1
Other
0.4
0.0
0.0
0.1
(
0.3
)
0.0
0.0
0.2
0.0
0.0
0.4
Derivative financial instruments –
assets
1.3
0.3
0.4
0.0
0.0
0.7
(
0.5
)
0.1
(
0.2
)
0.1
1.8
of which:
Interest rate contracts
0.3
0.2
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.5
Equity / index contracts
0.6
0.1
0.1
0.0
0.0
0.6
(
0.3
)
0.0
(
0.1
)
0.0
0.9
Credit derivative contracts
0.4
0.0
0.0
0.0
0.0
0.1
(
0.2
)
0.1
0.0
0.0
0.3
Other
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Financial assets at fair value not held
for trading
4.0
0.0
0.1
0.8
(
0.9
)
0.0
0.0
0.1
0.0
0.0
3.9
of which:
Loans
1.2
0.0
0.0
0.3
(
0.7
)
0.0
0.0
0.0
0.0
0.0
0.9
Auction rate securities
1.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.5
Equity instruments
0.5
0.0
0.0
0.1
(
0.1
)
0.0
0.0
0.0
0.0
0.0
0.5
Other
0.7
0.0
0.0
0.4
(
0.2
)
0.0
0.0
0.0
0.0
0.0
1.0
Derivative financial instruments –
liabilities
2.0
1.3
1.2
0.0
0.0
1.2
(
0.9
)
0.4
(
0.6
)
0.1
3.5
of which:
Interest rate contracts
0.1
0.3
0.3
0.0
0.0
0.3
(
0.2
)
0.2
(
0.2
)
0.0
0.5
Equity / index contracts
1.3
1.0
0.8
0.0
0.0
0.8
(
0.6
)
0.1
(
0.2
)
0.0
2.3
Credit derivative contracts
0.5
0.0
0.0
0.0
0.0
0.1
(
0.1
)
0.1
(
0.2
)
0.0
0.5
Other
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
Debt issued designated at fair value
9.6
0.0
(
0.2
)
0.0
0.0
6.6
(
5.6
)
0.5
(
1.7
)
0.2
9.6
Other financial liabilities designated
at fair value
1.0
0.2
0.2
0.0
0.0
1.4
(
0.6
)
0.0
0.0
0.0
2.1
1 Net gains / losses
included in comprehensive income
are composed of Net interest
income, Other net
income from financial instruments
measured at fair value
through profit or loss
and Other income.
2 Total
Level 3 assets as of 31 December 2021 were USD
7.6
billion (31 December 2020: USD
8.3
billion). Total Level 3 liabilities as of 31 December 2021 were USD
17.4
billion (31 December 2020: USD
15.2
billion).
493
Note 21
Fair value measurement (continued)
Total gains / losses
included in
comprehensive income
Balance
as of
31 December
2020
2
Net gains /
losses
included in
income
1
of which:
related to
Level 3
instruments
held at the
end of the
reporting
period
Purchases
Sales
Issuances
Settlements
Transfers
into
Level 3
Transfers
out of
Level 3
Foreign
currency
translation
Balance
as of
31 December
2021
2
2.3
0.0
(
0.1
)
0.3
(
1.6
)
1.2
0.0
0.3
(
0.3
)
0.0
2.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.8
0.0
0.0
0.2
(
0.4
)
0.0
0.0
0.0
(
0.1
)
0.0
0.6
1.1
0.0
0.0
0.0
(
0.8
)
1.2
0.0
0.0
(
0.2
)
0.0
1.4
0.4
0.0
0.0
0.1
(
0.4
)
0.0
0.0
0.3
0.0
0.0
0.3
1.8
(
0.2
)
(
0.1
)
0.0
0.0
0.5
(
0.7
)
0.1
(
0.3
)
0.0
1.1
0.5
0.1
0.1
0.0
0.0
0.1
(
0.2
)
0.0
(
0.1
)
0.0
0.5
0.9
(
0.1
)
(
0.1
)
0.0
0.0
0.3
(
0.4
)
0.0
(
0.2
)
0.0
0.4
0.3
(
0.1
)
(
0.1
)
0.0
0.0
0.0
(
0.1
)
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.9
0.1
0.1
1.0
(
0.6
)
0.0
0.0
0.1
(
0.3
)
0.0
4.2
0.9
0.0
0.0
0.6
(
0.3
)
0.0
0.0
0.0
(
0.3
)
0.0
0.9
1.5
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.6
0.5
0.1
0.1
0.1
(
0.1
)
0.0
0.0
0.0
0.0
0.0
0.7
1.0
0.0
(
0.1
)
0.3
(
0.2
)
0.0
0.0
0.0
0.0
0.0
1.0
3.5
0.2
0.0
0.0
0.0
0.9
(
1.8
)
0.0
(
0.5
)
0.0
2.2
0.5
(
0.1
)
(
0.1
)
0.0
0.0
0.0
(
0.1
)
0.0
0.0
0.0
0.3
2.3
0.3
0.1
0.0
0.0
0.8
(
1.5
)
0.0
(
0.4
)
0.0
1.5
0.5
(
0.1
)
(
0.1
)
0.0
0.0
0.0
0.0
0.0
(
0.1
)
0.0
0.3
0.1
0.1
0.0
0.0
0.0
0.0
(
0.1
)
0.0
0.0
0.0
0.1
9.6
0.7
0.6
0.0
0.0
7.1
(
4.2
)
0.1
(
1.2
)
(
0.2
)
11.9
2.1
0.0
0.0
0.0
0.0
1.3
(
0.2
)
0.0
0.0
0.0
3.2
Consolidated financial statements | UBS AG consolidated financial statements
494
Note 21
Fair value measurement (continued)
i) Maximum exposure to credit risk for financial instruments measured at fair value
The tables below provide
UBS AG’s maximum exposure
to credit
risk
for
financial
instruments
measured
at
fair
value
and
the
respective
collateral
and
other
credit
enhancements
mitigating
credit risk for these classes of financial instruments.
The
maximum
exposure
to
credit
risk
includes
the
carrying
amounts of financial
instruments recognized on
the balance sheet
subject
to
credit
risk
and
the
notional
amounts
for
off-balance
sheet arrangements.
Where information
is available,
collateral is
presented at fair value.
For other collateral, such as
real estate, a
reasonable alternative
value is
used. Credit
enhancements, such
as credit derivative contracts
and guarantees, are included
at their
notional amounts. Both are capped at the maximum
exposure to
credit risk for which
they serve as
security. The “Risk management
and control” section of this
report describes management’s view
of credit risk and
the related exposures,
which can differ
in certain
respects from the requirements of IFRS.
Maximum exposure to credit risk
31.12.21
Maximum
exposure to
credit risk
Collateral
Credit enhancements
Exposure to
credit risk
after collateral
and credit
enhancements
USD billion
Cash
collateral
received
Collateral-
ized by
securities
Secured by
real estate
Other
collateral
Netting
Credit
derivative
contracts
Guarantees
Financial assets measured at
fair value on the balance sheet
1
Financial assets at fair value
held for trading – debt instruments
2,3
22.6
22.6
Derivative financial instruments
4,5
118.1
4.2
103.2
10.7
Brokerage receivables
21.8
0.0
21.6
0.2
Financial assets at fair value not
held for trading – debt instruments
6
37.0
0.0
11.2
25.7
Total financial assets measured at fair value
199.5
0.0
37.1
0.0
0.0
103.2
0.0
0.0
59.2
Guarantees
7
0.2
0.0
0.2
0.0
31.12.20
Maximum
exposure to
credit risk
Collateral
Credit enhancements
Exposure to
credit risk
after collateral
and credit
enhancements
USD billion
Cash
collateral
received
Collateral-
ized by
securities
Secured by
real estate
Other
collateral
Netting
Credit
derivative
contracts
Guarantees
Financial assets measured at
fair value on the balance sheet
1
Financial assets at fair value
held for trading – debt instruments
2,3
24.7
24.7
Derivative financial instruments
4,5
159.6
6.0
138.4
15.2
Brokerage receivables
24.7
24.4
0.3
Financial assets at fair value not
held for trading – debt instruments
6
58.2
0.0
13.2
45.0
Total financial assets measured at fair value
267.2
0.0
43.6
0.0
0.0
138.4
0.0
0.0
85.2
Guarantees
7
0.5
0.1
0.3
0.0
1 The maximum exposure to loss is generally equal to the carrying amount and subject to change over time with market movements.
2 These positions are generally managed under the market risk framework. For
the purpose of this disclosure, collateral and credit enhancements were
not considered.
3 Does not include investment fund units.
4 Includes USD
0
million (31 December 2020: USD
0
million) fair values of loan
commitments and forward starting reverse repurchase
agreements classified as derivatives. The
full contractual committed amount of forward
starting reverse repurchase agreements (generally highly
collateralized)
of USD
27.8
billion (31 December 2020: USD
21.9
billion) and derivative loan commitments (generally unsecured) of USD
8.2
billion, of which USD
0.8
billion has been sub-participated (31 December 2020: USD
9.4
billion, of which USD
0.8
billion had been sub-participated), is presented in Note 10
under notional amounts.
5 The amount shown in the “Netting” column represents
the netting potential not recognized on the
balance sheet. Refer to Note 22
for more information.
6 Financial assets at fair value
not held for trading collateralized
by securities consisted of structured loans
and reverse repurchase and securities borrowing
agreements.
7 The amount shown in the “Guarantees” column largely relates to sub-participations.
495
Note 21
Fair value measurement (continued)
j) Financial instruments not measured at fair value
The table below provides the estimated fair values of financial instruments not measured at fair value.
Financial instruments not measured at fair value
31.12.21
31.12.20
Carrying
amount
Fair value
Carrying
amount
Fair value
USD billion
Total
Carrying
amount
approximates
fair value
1
Level 1
Level 2
Level 3
Total
Total
Carrying
amount
approximates
fair value
1
Level 1
Level 2
Level 3
Total
Assets
2
Cash and balances at central banks
192.8
192.7
0.1
0.0
0.0
192.8
158.2
158.1
0.1
0.0
0.0
158.2
Loans and advances to banks
15.4
14.6
0.0
0.7
0.0
15.3
15.3
14.6
0.0
0.6
0.1
15.3
Receivables from securities financing
transactions
75.0
71.6
0.0
1.3
2.1
75.0
74.2
64.9
0.0
7.6
1.7
74.2
Cash collateral receivables on derivative
instruments
30.5
30.5
0.0
0.0
0.0
30.5
32.7
32.7
0.0
0.0
0.0
32.7
Loans and advances to customers
398.7
163.7
0.0
43.8
190.4
397.9
381.0
173.1
0.0
34.2
174.9
382.3
Other financial assets measured at amortized
cost
26.2
4.1
9.3
10.7
2.4
26.5
27.2
5.4
9.4
10.9
2.3
28.0
Liabilities
2
Amounts due to banks
13.1
9.1
0.0
4.0
0.0
13.1
11.0
8.5
0.0
2.6
0.0
11.1
Payables from securities financing
transactions
5.5
4.1
0.0
1.5
0.0
5.5
6.3
6.0
0.0
0.2
0.0
6.3
Cash collateral payables on derivative
instruments
31.8
31.8
0.0
0.0
0.0
31.8
37.3
37.3
0.0
0.0
0.0
37.3
Customer deposits
544.8
537.6
0.0
7.3
0.0
544.8
527.9
521.8
0.0
6.2
0.0
528.0
Funding from UBS Group AG
57.3
2.8
0.0
56.0
0.0
58.8
54.0
0.0
0.0
55.6
0.0
55.6
Debt issued measured at amortized cost
82.4
13.0
0.0
69.8
0.0
82.8
85.4
16.4
0.0
70.0
0.0
86.3
Other financial liabilities measured at
amortized cost
3
6.3
6.3
0.0
0.0
0.0
6.3
6.6
6.6
0.0
0.0
0.1
6.7
1 Includes certain financial instruments where the carrying amount is a reasonable
approximation of the fair value due to the instruments’
short-term nature (instruments that are receivable or payable
on demand, or
with a remaining maturity (excluding
the effects of callable
features) of three months or
less).
2 As of 31 December 2021,
USD
0
billion (31 December 2020: USD
0
billion) of Cash and balances
at central banks,
USD
0
billion (31 December 2020: USD
0
billion) of Loans and advances to banks, USD
1
billion (31 December 2020: USD
1
billion) of Receivables from securities financing transactions, USD
175
billion (31 December
2020: USD
163
billion) of Loans and advances to customers, USD
19
billion (31 December 2020: USD
20
billion) of Other financial assets measured at amortized cost, USD
1
billion (31 December 2020: USD
0
billion)
of Amounts due to banks,
USD
4
billion (31 December 2020:
USD
3
billion) of Customer deposits,
USD
53
billion (31 December 2020: USD
49
billion) of Funding from
UBS Group AG,
USD
31
billion (31 December
2020: USD
31
billion) of Debt issued measured at amortized cost and USD
3
billion (31 December 2020: USD
3
billion) of Other financial liabilities measured at amortized cost were expected to be recovered or settled
after 12 months.
3 Excludes lease liabilities.
The fair
values included in
the table
above have been
calculated
for
disclosure
purposes
only.
The
valuation
techniques
and
assumptions described below relate only
to the fair value
of UBS’s
financial instruments
not measured at
fair value.
Other institutions
may
use different
methods and
assumptions for
their
fair value
estimations,
and
therefore
such
fair
value
disclosures
cannot
necessarily be compared from
one financial institution
to another.
The following principles
were applied when
determining fair
value
estimates for financial instruments not measured at fair value:
–
For
financial
instruments
with
remaining
maturities
greater
than three months, the
fair value was
determined from quoted
market prices, if available.
–
Where quoted market prices were
not available, the fair values
were
estimated
by
discounting
contractual
cash
flows
using
current
market
interest
rates
or
appropriate
yield
curves
for
instruments
with
similar
credit
risk
and
maturity.
These
estimates generally include
adjustments for counterparty
credit
risk or UBS’s own credit.
–
For short-term financial instruments with remaining maturities
of three
months or less,
the carrying amount,
which is net
of
credit
loss
allowances,
is
generally
considered
a
reasonable
estimate of fair value.
Consolidated financial statements | UBS AG consolidated financial statements
496
Note 22
Offsetting financial assets and financial liabilities
UBS
AG
enters
into
netting
agreements
with
counterparties
to
manage the credit risks
associated primarily with repurchase
and
reverse repurchase transactions,
securities borrowing
and lending,
over-the-counter
derivatives
and
exchange-traded
derivatives.
These
netting
agreements
and
similar
arrangements
generally
enable
the
counterparties
to
set
off
liabilities
against
available
assets received
in the ordinary
course of business
and / or
in the
event
that
the
counterparties
to
the
transaction
are
unable
to
fulfill their contractual obligations.
The tables on this page and the next page
provide a summary
of
financial
assets
and
financial
liabilities
subject
to
offsetting,
enforceable master netting
arrangements and
similar agreements,
as well as
financial collateral received
or pledged to
mitigate credit
exposures for these financial instruments.
UBS
AG
engages
in
a
variety
of
counterparty
credit
risk
mitigation
strategies
in
addition
to
netting
and
collateral
arrangements. Therefore, the
net amounts presented
in the tables
on this page and the next page do not purport to
represent their
actual credit risk exposure.
Financial assets subject to offsetting, enforceable
master netting arrangements and similar
agreements
Assets subject to netting arrangements
Netting recognized on the balance sheet
Netting potential not recognized on
the balance sheet
3
Assets not
subject to netting
arrangements
4
Total assets
As of 31.12.21, USD billion
Gross assets
before netting
Netting with
gross liabilities
2
Net assets
recognized
on the
balance
sheet
Financial
liabilities
Collateral
received
Assets after
consideration
of
netting
potential
Assets
recognized
on the
balance
sheet
Total assets
after
consideration
of netting
potential
Total assets
recognized
on the
balance
sheet
Receivables from securities
financing transactions
67.7
(
13.8
)
53.9
(
2.9
)
(
51.0
)
0.0
21.1
21.1
75.0
Derivative financial instruments
116.0
(
3.6
)
112.4
(
88.9
)
(
18.5
)
5.0
5.8
10.7
118.1
Cash collateral receivables on
derivative instruments
1
29.4
0.0
29.4
(
15.2
)
(
3.3
)
11.0
1.1
12.1
30.5
Financial assets at fair value
not held for trading
93.1
(
87.6
)
5.5
(
1.1
)
(
4.4
)
0.0
54.1
54.1
59.6
of which: reverse
repurchase agreements
93.1
(
87.6
)
5.5
(
1.1
)
(
4.4
)
0.0
0.3
0.3
5.8
Total assets
306.2
(
105.0
)
201.2
(
108.1
)
(
77.2
)
15.9
82.1
98.1
283.3
As of 31.12.20, USD billion
Receivables from securities
financing transactions
70.3
(
13.4
)
57.0
(
1.7
)
(
55.3
)
0.0
17.3
17.3
74.2
Derivative financial instruments
156.9
(
5.0
)
151.9
(
117.2
)
(
27.2
)
7.5
7.7
15.2
159.6
Cash collateral receivables on
derivative instruments
1
31.9
0.0
31.9
(
19.6
)
(
1.5
)
10.8
0.8
11.6
32.7
Financial assets at fair value
not held for trading
85.6
(
79.1
)
6.5
(
0.8
)
(
5.8
)
0.0
73.5
73.5
80.0
of which: reverse
repurchase agreements
85.6
(
79.1
)
6.5
(
0.8
)
(
5.8
)
0.0
0.2
0.2
6.7
Total assets
344.8
(
97.5
)
247.3
(
139.3
)
(
89.8
)
18.3
99.3
117.6
346.6
1 The net
amount of Cash collateral
receivables on derivative
instruments recognized on
the balance sheet includes
certain OTC
derivatives that are
net settled on
a daily basis either
legally or in substance
under
IAS 32 principles and exchange-traded
derivatives that are economically
settled on a daily basis.
2 The logic of
the table results in amounts
presented in the “Netting
with gross liabilities” column corresponding
directly to the amounts presented in the “Netting with gross assets” column in
the liabilities table presented on the following page. Netting in this column for reverse repurchase agreements presented within the lines
“Receivables from securities financing
transactions” and “Financial assets
at fair value not held
for trading” taken together
corresponds to the amounts presented
for repurchase agreements in the
“Payables from
securities financing transactions” and “Other financial
liabilities designated at fair value” lines in the
liabilities table presented on the following
page.
3 For the purpose of this disclosure,
the amounts of financial
instruments and cash collateral
presented have been capped so
as not to exceed the
net amount of financial assets
presented on the balance
sheet; i.e., over-collateralization,
where it exists, is
not reflected in the
table.
4 Includes assets not subject to enforceable netting arrangements and other out-of-scope items.
497
Note 22
Offsetting financial assets and financial liabilities (continued)
Financial liabilities subject to offsetting, enforceable
master netting arrangements and similar
agreements
Liabilities subject to netting arrangements
Netting recognized on the balance sheet
Netting potential not recognized
on the balance sheet
3
Liabilities not
subject
to netting
arrangements
4
Total liabilities
As of 31.12.21, USD billion
Gross
liabilities
before
netting
Netting with
gross assets
2
Net
liabilities
recognized
on the
balance
sheet
Financial
assets
Collateral
pledged
Liabilities
after
consideration of
netting
potential
Liabilities
recognized
on the
balance
sheet
Total
liabilities
after
consideration
of netting
potential
Total
liabilities
recognized
on the
balance
sheet
Payables from securities
financing transactions
16.9
(
12.8
)
4.1
(
1.8
)
(
2.3
)
0.0
1.4
1.4
5.5
Derivative financial instruments
118.4
(
3.6
)
114.9
(
88.9
)
(
18.1
)
7.9
6.4
14.3
121.3
Cash collateral payables on
derivative instruments
1
30.4
0.0
30.4
(
13.1
)
(
3.3
)
14.0
1.4
15.4
31.8
Other financial liabilities
designated at fair value
94.8
(
88.6
)
6.2
(
2.2
)
(
3.8
)
0.2
26.3
26.5
32.4
of which: repurchase agreements
94.6
(
88.6
)
6.0
(
2.2
)
(
3.8
)
0.0
0.4
0.4
6.4
Total liabilities
260.6
(
105.0
)
155.6
(
106.0
)
(
27.5
)
22.1
35.5
57.6
191.1
As of 31.12.20, USD billion
Payables from securities
financing transactions
18.2
(
13.3
)
4.9
(
1.6
)
(
3.3
)
0.0
1.4
1.4
6.3
Derivative financial instruments
157.1
(
5.0
)
152.1
(
117.2
)
(
23.9
)
10.9
9.0
19.9
161.1
Cash collateral payables on
derivative instruments
1
35.6
0.0
35.6
(
19.6
)
(
2.1
)
13.9
1.7
15.7
37.3
Other financial liabilities
designated at fair value
87.0
(
79.2
)
7.8
(
0.8
)
(
6.3
)
0.7
24.0
24.7
31.8
of which: repurchase agreements
86.2
(
79.2
)
7.0
(
0.8
)
(
6.3
)
0.0
0.3
0.3
7.3
Total liabilities
297.8
(
97.5
)
200.3
(
139.2
)
(
35.5
)
25.6
36.2
61.7
236.5
1 The net amount of Cash collateral payables on derivative instruments recognized on the balance sheet includes certain OTC derivatives that are net settled on a daily basis either legally or in substance under IAS 32
principles and exchange-traded derivatives that are economically settled on
a daily basis.
2 The logic of the table results
in amounts presented in the “Netting with
gross assets” column corresponding to the amounts
presented in the
“Netting with gross
liabilities” column in
the assets table
presented on the
previous page.
Netting in this
column for repurchase
agreements presented
within the lines
“Payables from
securities
financing transactions” and “Other financial liabilities designated at fair value”
taken together corresponds to the amounts presented
for reverse repurchase agreements in the “Receivables from securities
financing
transactions” and “Financial assets
at fair value not
held for trading” lines
in the assets table presented
on the previous page.
3 For the purpose
of this disclosure, the
amounts of financial instruments and
cash
collateral presented have been
capped so as not to
exceed the net amount of
financial liabilities presented on the
balance sheet; i.e.,
over-collateralization, where it
exists, is not reflected
in the table.
4 Includes
liabilities not subject to enforceable netting arrangements and other out-of-scope items.
Consolidated financial statements | UBS AG consolidated financial statements
498
Note 23
Restricted and transferred financial assets
This Note provides
information about
restricted financial assets
(Note 23a), transfers
of financial
assets (Note 23b
and 23c) and
financial
assets that are received as collateral with the right to resell or repledge these assets (Note 23d).
a) Restricted financial assets
Restricted
financial assets
consist of
assets
pledged as
collateral
against an existing liability or contingent liability and other assets
that are
otherwise explicitly
restricted
such that
they cannot
be
used to secure funding.
Financial
assets
are
mainly
pledged
as
collateral
in
securities
lending
transactions,
in
repurchase
transactions,
against
loans
from
Swiss
mortgage
institutions
and
in
connection
with
the
issuance
of
covered
bonds.
UBS
AG
generally
enters
into
repurchase
and securities
lending
arrangements
under
standard
market
agreements.
For
securities lending,
the cash
received
as
collateral may be more or less than the fair value of the securities
loaned,
depending
on
the
nature
of
the
transaction.
For
repurchase agreements, the fair value of the collateral sold under
an
agreement
to
repurchase
is
generally
in
excess
of
the
cash
borrowed. Pledged mortgage loans serve as collateral for existing
liabilities
against
Swiss
central
mortgage
institutions
and
for
existing
covered
bond
issuances
of
USD
10,843
million
as
of
31 December 2021 (31 December 2020: USD
12,456
million).
Other restricted financial assets include assets protected under
client asset segregation
rules, assets held
by UBS AG’s
insurance
entities to back related liabilities to the policy holders, assets held
in certain jurisdictions to
comply with explicit
minimum local asset
maintenance requirements. The carrying
amount of the liabilities
associated with these other
restricted financial assets is
generally
equal to the carrying amount of the assets, with the exception of
assets held to comply with local asset maintenance requirements,
for which the associated liabilities are greater.
Restricted financial assets
USD million
31.12.21
31.12.20
Restricted
financial assets
of which: assets
pledged as
collateral that
may be sold or
repledged by
counterparties
of which:
mortgage loans
1
Restricted
financial assets
of which: assets
pledged as
collateral that
may be sold or
repledged by
counterparties
of which:
mortgage loans
1
Financial assets pledged as collateral
Financial assets at fair value held for trading
63,834
43,397
64,418
47,098
Loans and advances to customers
18,160
16,330
20,361
18,191
Financial assets at fair value not held for trading
961
961
2,140
2,140
Debt securities classified as Other financial assets measured
at amortized
cost
2,234
1,870
2,506
2,506
Financial assets measured at fair value through other comprehensive
income
0
0
149
149
Total financial assets pledged as collateral
2
85,188
89,574
Other restricted financial assets
Loans and advances to banks
3,408
3,730
Financial assets at fair value held for trading
392
741
Cash collateral receivables on derivative instruments
4,747
3,765
Loans and advances to customers
1,237
756
Financial assets at fair value not held for trading
22,328
22,917
Financial assets measured at fair value through other comprehensive
income
894
0
Other
97
110
Total other restricted financial assets
33,104
32,019
Total financial assets pledged and other restricted financial assets
118,292
121,593
1 All related
to mortgage loans
that serve as
collateral for existing
liabilities toward
Swiss central
mortgage institutions
and for existing
covered bond issuances.
Of these pledged
mortgage loans,
approximately
USD
2.7
billion as
of 31
December 2021
(31 December
2020: approximately
USD
2.7
billion) could
be withdrawn
or used
for future
liabilities or
covered bond
issuances without
breaching existing
collateral
requirements.
2 Does not
include assets placed
with central banks
related to undrawn
credit lines
and for payment,
clearing and settlement
purposes (31 December
2021: USD
4.4
billion; 31 December
2020:
USD
1.3
billion).
499
Note 23
Restricted and transferred financial assets (continued)
In addition
to restrictions
on financial
assets, UBS
AG and
its
subsidiaries
are,
in
certain
cases,
subject
to
regulatory
requirements
that
affect
the
transfer
of
dividends
and
capital
within
UBS
AG,
as
well
as
intercompany
lending.
Supervisory
authorities
also
may
require
entities
to
measure
capital
and
leverage
ratios on
a
stressed basis,
such
as
the
Federal
Reserve
Board’s
Comprehensive
Capital
Analysis
and
Review
process,
which
may
limit
the
relevant
subsidiaries’
ability
to
make
distributions of capital based on the results of those tests.
Supervisory
authorities
generally
have
discretion
to
impose
higher
requirements
or
to
otherwise
limit
the
activities
of
subsidiaries.
Non-regulated
subsidiaries
are
generally
not
subject
to
such
requirements
and transfer
restrictions. However,
restrictions
can
also be the result
of different legal, regulatory,
contractual, entity-
or country-specific arrangements and / or requirements.
›
Refer to the “Financial and regulatory key figures
for our
significant regulated subsidiaries and sub-groups” section
of this
report for financial information about significant
regulated
subsidiaries of UBS AG
b) Transferred financial assets that are not derecognized in their entirety
The table below presents
information for financial
assets that have been
transferred but are
subject to continued recognition
in full,
as well as recognized liabilities associated with those transferred assets.
Transferred financial assets subject to continued recognition in full
USD million
31.12.21
31.12.20
Carrying amount
of transferred
assets
Carrying amount of
associated liabilities
recognized
on balance sheet
Carrying amount
of transferred
assets
Carrying amount of
associated liabilities
recognized
on balance sheet
Financial assets at fair value held for trading that may be sold or repledged
by counterparties
43,397
17,687
47,098
18,874
relating to securities lending and repurchase agreements in
exchange for cash received
17,970
17,687
19,177
18,874
relating to securities lending agreements in exchange for securities
received
24,146
27,595
relating to other financial asset transfers
1,281
326
Financial assets at fair value not held for trading that may be sold or repledged
by
counterparties
961
898
2,140
1,378
Debt securities classified as Other financial assets measured
at amortized cost that may be
sold or repledged by counterparties
1,870
1,725
2,506
1,963
Financial assets measured at fair value through other comprehensive
income that may be sold
or repledged by counterparties
0
0
149
148
Total financial assets transferred
46,227
20,311
51,893
22,363
Transactions
in
which
financial
assets
are
transferred,
but
continue to
be recognized
in their entirety
on UBS AG’s
balance
sheet
include
securities
lending
and
repurchase
agreements,
as
well as
other financial
asset transfers.
Repurchase and
securities
lending
arrangements
are,
for
the
most
part,
conducted
under
standard
market
agreements
and
are
undertaken
with
counterparties
subject
to
UBS
AG’s
normal
credit
risk
control
processes.
›
Refer to Note 1a item 2e for more information
about repurchase
and securities lending agreements
As
of
31
December
2021
,
approximately
41
%
of
the
transferred
financial
assets
were
assets
held
for
trading
transferred
in
exchange
for
cash,
in
which
case
the
associated
recognized
liability
represents
the
amount
to
be
repaid
to
counterparties. For securities
lending and repurchase
agreements,
a
haircut
of
between
0
%
and
15
%
is
generally
applied
to
the
transferred assets,
which results
in associated
liabilities having
a
carrying
amount
below
the
carrying
amount
of
the
transferred
assets. The counterparties to the
associated liabilities presented in
the table above have full recourse to UBS AG.
In securities
lending arrangements
entered into in
exchange for
the receipt
of other
securities as
collateral, neither
the securities
received nor the obligation to return them
are recognized on UBS
AG’s balance sheet, as
the risks and rewards
of ownership are not
transferred
to
UBS
AG.
In
cases
where
such
financial
assets
received
are
subsequently
sold
or
repledged
in
another
transaction,
this
is
not
considered
to
be
a
transfer
of
financial
assets.
Other
financial
asset
transfers
primarily
include
securities
transferred to
collateralize derivative
transactions, for
which the
carrying
amount
of
associated
liabilities
is
not
provided
in
the
table above,
because those
replacement values are
managed on
a
portfolio
basis
across
counterparties
and
product
types,
and
therefore
there
is
no
direct
relationship
between
the
specific
collateral pledged and the associated liability.
Transferred
financial
assets
that
are
not
subject
to
derecognition in
full but
remain on
the balance
sheet to
the extent
of
UBS
AG’s
continuing
involvement
were
not
material
as
of
31 December 2021 and as of 31 December 2020.
Consolidated financial statements | UBS AG consolidated financial statements
500
Note 23
Restricted and transferred financial assets (continued)
c) Transferred financial assets that are derecognized in their entirety with continuing involvement
Continuing
involvement
in a
transferred
and fully
derecognized
financial
asset
may
result
from
contractual
provisions
in
the
particular transfer agreement or from
a separate agreement, with
the counterparty or a third party, entered into in connection with
the transfer.
The
fair
value
and
carrying amount
of
UBS
AG’s
continuing
involvement from transferred positions
as of
31 December
2021
and
31
December
2020
was
not
material.
Life-to-date
losses
reported
in
prior
periods
primarily
relate
to
legacy
positions
in
securitization
vehicles
which
have been
fully marked
down, with
no
remaining exposure
to loss.
d) Off-balance sheet assets received
The table below presents assets received from third parties that can
be sold or repledged and that are not recognized on the
balance
sheet, but that are held as collateral, including amounts that have been sold or repledged.
Off-balance sheet assets received
USD million
31.12.21
31.12.20
Fair value of assets received that can be sold or repledged
497,828
500,689
received as collateral under reverse repurchase, securities borrowing
and lending arrangements, derivative and other transactions
1
483,426
487,904
received in unsecured borrowings
14,402
12,785
Thereof sold or repledged
2
367,440
367,258
in connection with financing activities
319,176
315,603
to satisfy commitments under short sale transactions
31,688
33,595
in connection with derivative and other transactions
1
16,575
18,059
1 Includes securities
received as initial
margin from its
clients that UBS
AG is required
to remit to
central counterparties,
brokers and
deposit banks through
its exchange-traded
derivative clearing
and execution
services.
2 Does not include
off-balance sheet securities (31
December 2021: USD
12.7
billion; 31 December 2020:
USD
18.9
billion) placed with
central banks related
to undrawn credit
lines and for payment,
clearing and settlement purposes for which there are no associated liabilities or contingent liabilities.
501
Note 24
Maturity analysis of financial liabilities
The
residual
contractual
maturities
for
non-derivative
and
non-
trading financial liabilities as
of 31 December 2021
are based on
the earliest date
on which UBS
AG could be
contractually required
to pay.
The total amounts that contractually mature in
each time
band are also shown for 31 December 2020.
Derivative positions
and
trading
liabilities,
predominantly
made
up
of
short
sale
transactions, are assigned to the
Due within 1 month
column
,
as
this
provides
a
conservative
reflection
of
the
nature
of
these
trading activities. The
residual contractual
maturities may extend
over significantly longer periods.
Maturity analysis of financial liabilities
31.12.21
USD billion
Due within
1 month
Due between
1 and 3 months
Due between
3 and 12 months
Due between
1 and 5 years
Due after
5 years
Total
Financial liabilities recognized on balance sheet
1
Amounts due to banks
6.7
2.4
3.5
0.6
0.0
13.1
Payables from securities financing transactions
3.8
0.3
1.6
0.0
5.7
Cash collateral payables on derivative instruments
31.8
31.8
Customer deposits
531.0
6.6
3.3
3.9
0.4
545.1
Funding from UBS Group AG
2
0.2
3.3
2.3
28.8
30.6
65.3
Debt issued measured at amortized cost
2
3.8
9.4
38.8
25.1
7.6
84.7
Other financial liabilities measured at amortized cost
5.3
0.1
0.4
1.8
1.5
9.1
of which: lease liabilities
0.1
0.1
0.4
1.8
1.5
3.9
Total financial liabilities measured at amortized cost
582.6
22.1
49.9
60.2
40.1
754.8
Financial liabilities at fair value held for trading
3,4
31.7
31.7
Derivative financial instruments
3,5
121.3
121.3
Brokerage payables designated at fair value
44.0
44.0
Debt issued designated at fair value
6
13.8
11.5
13.5
24.5
12.5
75.9
Other financial liabilities designated at fair value
28.1
0.4
0.5
0.4
7.1
36.5
Total financial liabilities measured at fair value through profit or loss
239.0
11.9
14.0
24.9
19.6
309.4
Total
821.6
34.0
63.9
85.0
59.6
1,064.2
Guarantees, commitments and forward starting transactions
Loan commitments
7
38.3
0.5
0.7
0.0
39.5
Guarantees
21.2
0.0
21.2
Forward starting transactions, reverse repurchase
and securities borrowing agreements
7
1.4
1.4
Total
60.9
0.5
0.7
0.0
0.0
62.1
31.12.20
USD billion
Due within
1 month
Due between
1 and 3 months
Due between
3 and 12 months
Due between
1 and 5 years
Due after
5 years
Total
Financial liabilities recognized on balance sheet
1
Amounts due to banks
6.1
2.4
2.1
0.5
0.0
11.1
Payables from securities financing transactions
5.6
0.4
0.3
0.0
0.0
6.3
Cash collateral payables on derivative instruments
37.3
37.3
Customer deposits
514.0
7.8
3.5
2.8
0.2
528.2
Funding from UBS Group AG
2
0.1
0.3
6.2
29.1
24.8
60.5
Debt issued measured at amortized cost
2
8.8
7.8
38.2
24.5
8.9
88.2
Other financial liabilities measured at amortized cost
5.3
0.1
0.5
2.0
1.8
9.6
of which: lease liabilities
0.1
0.1
0.5
2.0
1.8
4.4
Total financial liabilities measured at amortized cost
577.2
18.9
50.7
58.8
35.8
741.3
Financial liabilities at fair value held for trading
3,4
33.6
33.6
Derivative financial instruments
3,5
161.1
161.1
Brokerage payables designated at fair value
38.7
38.7
Debt issued designated at fair value
6
21.9
16.8
7.1
9.2
6.0
61.0
Other financial liabilities designated at fair value
27.9
0.6
0.6
0.7
4.6
34.3
Total financial liabilities measured at fair value through profit or loss
283.2
17.4
7.7
9.8
10.6
328.8
Total
860.3
36.3
58.4
68.6
46.4
1,070.0
Guarantees, commitments and forward starting transactions
Loan commitments
7
40.5
0.5
0.4
0.0
41.4
Guarantees
17.5
17.5
Forward starting transactions, reverse repurchase
and securities borrowing agreements
7
3.2
3.2
Total
61.3
0.5
0.4
0.0
0.0
62.2
1 Except for financial liabilities at
fair value held for trading
and derivative financial instruments
(see footnote 3), the amounts
presented generally represent undiscounted
cash flows of future interest
and principal
payments.
2 The time-bucket Due after 5 years includes perpetual loss-absorbing additional tier 1 capital instruments.
3 Carrying amount is fair value. Management believes that this best represents the cash flows
that would have to be paid if these positions had to be settled
or closed out.
4 Contractual maturities of financial liabilities at fair value held for trading are: USD
30.8
billion due within 1 month (31 December 2020:
USD
32.6
billion), USD
0.9
billion due between 1 month and 1 year (31 December 2020: USD
1.0
billion) and USD
0
billion due between 1 and 5 years (31 December 2020: USD
0
billion).
5 Includes USD
34
million
(31 December 2020: USD
32
million) related to fair values of derivative
loan commitments and forward starting
reverse repurchase agreements classified as derivatives,
presented within “Due within 1 month." The
full contractual committed amount of USD
36.0
billion (31 December 2020: USD
31.3
billion) is presented in Note 10 under notional amounts.
6 Future interest payments on variable-rate liabilities
are determined
by reference
to the
applicable interest
rate prevailing
as of
the reporting
date. Future
principal payments
that are
variable are
determined by
reference to
the conditions
existing at
the relevant
reporting date.
7 Excludes derivative loan commitments and forward starting reverse repurchase agreements measured at fair value
(see footnote 5).
Consolidated financial statements | UBS AG consolidated financial statements
502
Note 25
Interest rate benchmark reform
Background
A market-wide reform of major interest rate benchmarks is being
undertaken
globally,
with
the
Financial
Conduct
Authority
(the
FCA) announcing in
March 2021
that the publication
of London
Interbank Offered Rates (LIBORs) would cease after 31 December
2021 for
all non-US
dollar LIBORs,
as well
as for
one-week and
two-month USD
LIBOR. Publication
of the
remaining USD
LIBOR
tenors will cease immediately after 30 June 2023.
The
majority
of
UBS
AG’s
IBOR
exposure
was
linked
to
CHF
LIBOR and USD LIBOR.
The alternative reference rate
(the ARR) for
CHF LIBOR is
the Swiss Average
Rate Overnight (SARON).
The ARR
for USD LIBOR is the Secured Overnight Financing Rate (SOFR); in
addition, there are recommended ARRs for GBP LIBOR, JPY LIBOR
and EUR LIBOR.
The
Euro
Interbank Offered
Rate (EURIBOR)
was reformed
in
2019,
with the
reform consisting
of a
change in
the underlying
calculation
method.
Consequently,
contracts
linked
to
EURIBOR
are not considered throughout the rest of this Note.
On 25 January 2021, the IBOR Fallbacks
Supplement and IBOR
Fallbacks
Protocol,
which
amend
the
International
Swaps
and
Derivatives Association (ISDA)
standard definitions
for interest rate
derivatives to incorporate
fallbacks for derivatives
linked to certain
IBORs,
came
into
effect.
From
that
date,
all
newly
cleared
and
non-cleared derivatives
between adhering
parties that
reference
ISDA
standard
definitions
now
include
these
fallbacks.
UBS AG
adhered to the protocol in November 2020.
UBS AG’s focus throughout
2021 was on transitioning
existing
contracts via bi-lateral
and multi-lateral agreements,
by leveraging
industry
solutions
(e.
g.,
the
use
of
fallback
provisions)
and
through
third-party
actions
(those
by
clearing
houses,
agents,
etc
.
).
UBS
AG
h
as
established
a
framework
to
address
the
transition
of
contracts
that
do
not
contain
adequate
fallback
provisions. Furthermore, in line
with regulatory guidance, UBS
AG
has implemented a framework to limit new contracts referencing
IBORs.
Governance over the transition to alternative benchmark rates
UBS
AG
established
a
global
cross
-
divisional,
cross
-
functional
governance structure
and change
program
to address
the scale
and complexity of
the transition.
This global program
is sponsored
by
the
Group
CFO
and
led
by
senior
representatives
from
the
business
divisions and
UBS
AG’s control
and
support functions.
The program includes
governance and
execution structures within
each business division,
together with cross-divisional
teams from
each
control
and
support
function.
During
2021,
progress
was
overseen
centrally
via
a
monthly
operating
committee
and
a
monthly steering
committee, as well
as quarterly
updates to
the
joint Audit and Risk
Committees. A dedicated Group-wide
forum,
with an increased US
regional focus, will oversee
progress of the
remaining USD LIBOR transition.
Risks
A
core
part
of
UBS
AG’s
change
program
is
the
identification,
management
and
monitoring
of
the
risks
associated
with
IBOR
reform and transition. These
risks include,
but are not limited
to,
the following:
–
economic risks to UBS AG
and its clients, through
the repricing
of existing contracts, reduced transparency and
/ or liquidity of
pricing information, market uncertainty or disruption;
–
accounting
risks, where
the transition
affects the
accounting
treatment,
including
hedge
accounting
and
consequential
income statement volatility;
–
valuation risks arising from the variation between benchmarks
that will cease
and ARRs, affecting
the risk profile of
financial
instruments;
–
operational
risks
arising
from
changes
to
UBS
AG’s
front-to-
back
processes
and
systems
to
accommodate
the
transition,
e.g.
,
data
sourcing
and
processing
and
bulk
migration
of
contracts; and
–
legal and conduct risks relating to UBS AG’s engagement with
clients
and
market
counterparties
around
new
benchmark
products
and
amendments
required
for
existing
contracts
referencing benchmarks that will cease.
Overall, the effort required to transition is affected by multiple
factors, including
whether negotiations need
to
take place
with
multiple stakeholders
(as is the case for
syndicated loans
or certain
listed
securities),
market
readiness
–
such
as
liquidity
in
ARR
-
equivalent products – and a
client’s technical readiness to handle
ARR market
conventions.
UBS AG remains
confident
that it
has the
transparency, oversight and operational preparedness to progress
with the
IBOR transition
consistent
with market
timelines,
given the
significant
progress
made as
of 31
December
2021.
UBS AG
did not
have
and does
not expect
changes
to its
risk
management
approach
and strategy
as a result
of interest
rate benchmark
reform.
503
Note 25
Interest rate benchmark reform (continued)
Transition progress
Non-derivative instruments
UBS
AG’s
significant
non-derivative
exposures
subject
to
IBOR
reform
primarily
relate
d
to
brokerage
receivable
and
payable
balances, corporate
and private
loans, and
mortgages, linked
to
CHF and USD LIBORs. During 2020, UBS AG transitioned most of
its CHF
LIBOR-linked deposits
to SARON. In
that same
year,
UBS
AG launched
SARON-based mortgages
and corporate
loans based
on
all
major
ARRs
in
the
Swiss
market,
as
well
as
SOFR-based
mortgages in the US market.
Throughout 2021,
UBS AG
transitioned substantially all
of its
private
and
corporate
loans
linked
to
non-USD
IBORs,
with
the
remaining
CHF
LIBOR-linked
contracts
planned
to
transition
on
their first roll date in 2022.
In addition, as
of 31 December 2021
UBS AG had
completed
the
transition of
IBOR-linked
non-derivative
financial
assets
and
liabilities
related
to
brokerage
accounts,
except
for
balances
originated in the US, which transitioned
to SOFR in January 2022.
In
March
2021,
following
the FCA
announcement
regarding
the cessation
timelines for IBORs,
UBS AG
initiated a
centralized
communication
initiative
for
private
mortgages
linked
to
CHF
LIBOR, with the objective
of transitioning these exposures,
either
through the activation of existing fallbacks
or the amendment of
contractual terms where such
fallbacks do not exist.
During 2021,
mortgages
that
were
linked
to
CHF
LIBOR
were
reduced
to
USD
21
billion
as
of 31 December
2021,
with these
remaining
mortgages automatically
transitioning to
SARON from
their next
coupon roll date.
The
transition
of
US
securities
-
based
lending
to
SOFR
,
amounting
to
USD
37
billion
as of
31 December
2021,
was for
the
most
part
completed
in
January
2022,
with
US
mortgages
linked to USD LIBOR planned
to transition to SOFR
in 2022–2023.
As of
31 December 2021,
UBS AG
had approximately
USD
3
billion
equivalent
of
Japanese
yen-
and
US
dollar-denominated
funding from UBS Group AG that,
per current contractual terms,
if
not
called
on
their
respective
call
dates,
would
reset
based
directly on
JPY LIBOR
and USD
LIBOR. These
bonds have
robust
IBOR
fallback
language
and
the
confirmation
of
interest
rate
calculation mechanics will be communicated as market standards
formalize and
in advance
of any
rate resets.
In addition,
several
US
dollar
-
and
Swiss
franc
-
denominated
contracts
providing
funding
from
UBS
Group
AG
reference
rates
indirectly
derived
from IBORs,
if they
are not
called on
their respective
call dates.
UBS AG aims
to transition these
contracts in advance
of their reset
dates,
with
the
transition
of
Swiss
franc-denominated
funding
completed
in
January
2022.
These
debt
instruments
have
not
been
included
in
the
table
on
the
following
page,
given
their
current fixed-rate coupon.
As of
31 December 2021,
UBS AG
had approximately
USD
5
billion of
irrevocable commitments
that may
be drawn
down in
different currencies with IBOR-linked
interest rates and
that expire
after
the
relevant
benchmark
cessation
dates
;
approximately
USD
3
billion
of
these
contracts
had
transitioned
for
all
IBORs,
except
USD
LIBOR
,
and
USD
2
billion
of
these
commitments
retained a
non-USD IBOR
interest rate
as of
31 December 2021
with transition
dependent upon
the actions
of other
parties. To
the
extent
non-USD
IBOR-linked
amounts
are
requested
under
these contracts, UBS AG will seek to renegotiate current terms or
rely on legislative solutions.
Derivative instruments
UBS
AG
holds
derivatives
for
trading
and
hedging
purposes,
including those
designated in
hedge accounting
relationships. A
significant number of interest rate and cross-currency swaps
have
floating legs
that reference
various benchmarks
that are
subject
to IBOR reform.
The majority of derivatives
are transacted with clearing
houses,
in
particular
LCH,
with
the
transition
of
these
non-USD
IBOR-
linked derivatives substantially completed
in December 2021.
UBS
AG had also completed the transition of all non-USD IBOR-linked
exchange
-
traded
derivatives
(ETDs)
through
participation
in
activities
organized
by
respective
exchanges
by
31
December
2021.
For
derivatives
not
transacted
with
clearing
houses
or
exchanges,
UBS
AG
and
a
significant
proportion
of
UBS
AG’s
counterparties have adhered to the ISDA IBOR Fallbacks Protocol,
which builds in
agreed fallbacks. The
majority of these
contracts
had
transitioned as
of 31 December
2021,
with a
small number
of
contracts
transitioned
in
January
2022,
to
ensure
an
orderly
transition
when
converting
high
volumes
of
transactions
at
the
time of cessation.
Consolidated financial statements | UBS AG consolidated financial statements
504
Note 25
Interest rate benchmark reform (continued)
Financial instruments yet to transition to alternative benchmarks
The
amounts
included
in
the
table
below
relate
to
financial
instrument
contracts
across
UBS
AG’s
business
divisions
where
UBS AG has material exposures subject
to IBOR reform that have
not yet transitioned to ARRs, and that:
–
contractually
reference
an
interest
rate
benchmark
that
will
transition to an alternative benchmark; and
–
have
a
contractual
maturity
date
(including
open-ended
contracts) after the agreed cessation dates.
Contracts
where
penalty
terms
reference
IBOR
s,
or
where
exposure to
an IBOR
is not
the primary
purpose of
the contract,
have not been included,
as these contracts do
not have a material
impact on the transition process.
In line with information provided
to management and external
parties monitoring UBS AG’s
transition progress, the table below
includes the
following financial
metrics for
instruments external
to UBS AG that are subject to interest rate benchmark reform:
–
gross
carrying
value
/
exposure
for
non-derivative
financial
instruments;
and
–
total trade count for derivative financial instruments.
The
exposure
s
included
in
the
table
below
represent
the
maximum
IBOR
exposure,
without
regard
for
early
termination
rights,
with
the
actual
exposure
being
dependent
upon
client
preferences and investment decisions.
As
of
31
December
2021,
UBS
AG
ha
d
made
significant
progress in transitioning LIBOR exposures to ARRs. The remaining
non-USD
LIBOR-linked
exposures
included
in
the
table
below
primarily
relate
t
o
derivatives
that
successfully
transitioned
in
January 2022
and CHF
LIBOR mortgages
that will
automatically
transition to SARON on their first roll date in 2022.
31.12.21
LIBOR benchmark rates
Measure
CHF
USD
GBP
EUR
1
JPY
Carrying value of non-derivative financial instruments
Total non-derivative financial assets
USD million
21,616
2
65,234
3
45
4
1
0
Total non-derivative financial liabilities
USD million
27
4
1,985
4
3
4
5
0
Trade count of derivative financial instruments
Total derivative financial instruments
Trade count
829
6
40,500
7
183
6
3,744
6
184
6
Off-balance sheet exposures
Total irrevocable loan commitments
USD million
0
11,863
8
0
0
0
1 Relates primarily to EUR LIBOR positions.
2 Relates primarily to CHF LIBOR mortgages, which will automatically transition to SARON on their first roll date in 2022.
3 Includes USD LIBOR securities-based lending
and brokerage accounts, amounting to USD
37
billion, and USD
5
billion respectively, which for the most part transitioned to SOFR in January 2022, as well as USD
1
billion of loans related to revolving multi-currency
credit lines, where IBOR transition efforts are complete, except for USD LIBOR. The remainder primarily relates to US mortgages and corporate lending.
4 Relates to floating-rate notes that per their contractual terms
can reset to rates linked to
LIBOR, with transition dependent upon the actions of
respective issuers.
5 Relates to contracts that transitioned
in January 2022.
6 Includes predominantly bilateral derivatives,
which
transitioned in January 2022, and an insignificant amount of cleared derivatives, where the respective clearing houses’ organized transition happened in January 2022.
7 Includes approximately
5,000
cross-currency
derivatives, of which approximately
500
have both a non-USD LIBOR leg and a USD LIBOR
leg, where the non-USD leg transitioned in January 2022 before the
next fixing date. The remainder represents cross-currency
swaps with an ARR leg
and a USD IBOR leg.
8 Includes loan commitments that can
be drawn in different currencies
at the client‘s discretion, of
which approximately USD
3
billion have only USD LIBOR
exposure
remaining and approximately USD
2
billion retain a non-USD
LIBOR interest rate as
of 31 December 2021, with
transition dependent upon the
actions of other parties.
The remainder represents loan
commitments
that can be drawn in US dollars only and will transition in 2022–2023.
505
Note 26 Hedge accounting
Derivatives designated in hedge accounting relationships
UBS AG applies hedge
accounting to interest rate
risk and foreign
exchange risk including structural
foreign exchange risk related
to
net investments in foreign operations.
›
Refer to “Market risk” in the “Risk management
and control”
section of this report for more information about
how risks arise
and how they are managed by UBS AG
Hedging instruments and hedged risk
Interest
rate
swaps
are
designated
in
fair
value
hedges
or
cash
flow
hedges
of
interest
rate
risk
arising
solely
from
changes
in
benchmark interest rates.
Fair value
changes arising from
such risk
are usually the largest
component of the overall
change in the
fair
value of the hedged position in transaction currency.
Cross-currency
swaps are
designated
as
fair
value
hedges
of
foreign
exchange
risk.
Foreign
exchange
forwards
and
foreign
exchange
swaps
are
mainly
designated
as
hedges
of
structural
foreign
exchange
risk
related
to
net
investments
in
foreign
operations.
In
both
cases
the
hedged
risk
arises
solely
from
changes in spot foreign exchange rate.
The notional
of the
designated hedging
instruments matches
the notional
of the
hedged items,
except when
the interest
rate
swaps are
re-designated in
cash flow
hedges, in
which case
the
hedge
ratio
designated
is
determined
based
on
the
swap
sensitivity.
Hedged items and hedge designation
Fair value hedges of interest rate risk related to debt instruments
and loan assets
Fair value hedges of interest
rate risk related to debt
instruments
and loan assets involve
swapping fixed cash flows
associated with
the debt issued,
debt securities held
and, from 2021
onward, loan
assets
(principally
long-term
fixed-rate
mortgage
loans
in
Swiss
francs formerly designated within “Fair
value hedges of portfolio
interest
rate
risk
related
to
loans
designated
under
IAS
39”) to
floating cash flows by
entering into interest rate swaps
that either
receive
fixed and
pay
floating cash
flows
or
that
pay
fixed
and
receive floating cash flows.
Designations
have
been
made
in
US
dollars,
euros,
Swiss
francs, Australian dollars, Japanese
yen and Singapore dollars.
For
new hedging
instruments and
hedged risk
designations entered
into in 2021 in these
currencies (with the exception of euro),
the
benchmark rate was the
relevant
alternative reference rate (ARR).
Following the
interbank offered
rate (IBOR)
transition for
swaps
with
LCH
(formerly
the
London
Clearing
House)
in
December
2021,
the
benchmark
hedge
rate
for
Swiss
franc
and
Japanese
yen designations was changed
from an IBOR rate
to the relevant
ARR with
the hedge
relationship continuing
in accordance
with
Interest Rate Benchmark Reform
– Phase 2 (Amendments to IFRS
9, IAS 39, IFRS 7, IFRS 4 and IFRS 16)
.
Fair
value
hedges
of
portfolio
interest
rate
risk
related
to
loans
designated under IAS 39
Prior
to
December
2021,
UBS AG
hedged an
open
portfolio of
long-term fixed-rate mortgage loans in
Swiss francs using interest
rate swaps that
paid a fixed
rate of interest
and received a
floating
rate
of
interest.
Both
the
hedged
portfolio
and
the
hedging
instruments were adjusted
on a monthly basis
to reflect changes
in
size
and
the
maturity
profile
of
the
hedged
portfolio.
Each
month the
hedge relationship
was discontinued
and a
new one
designated.
Changes in
the portfolio
were
driven by
new loans
being originated or loans being repaid.
Cash flow hedges of forecast transactions
UBS
AG
hedges
forecast
cash
flows
on
non-trading
financial
assets
and
liabilities
that
bear
interest
at
variable
rates
or
are
expected
to
be
refinanced
or
reinvested
in
the
future,
due
to
movements
in
future
market
rates. The
amounts
and
timing of
future cash flows, representing
both principal and interest flows,
are projected on the basis of
contractual terms and other
relevant
factors,
including
estimates
of
prepayments
and
defaults.
The
aggregate
principal
balances
and
interest
cash
flows
across
all
portfolios over time form the
basis for identifying the non-trading
interest
rate risk
of UBS
AG, which
is hedged
with interest
rate
swaps,
the
maximum
maturity
of
which
is
10 years.
Cash
flow
forecasts
and
risk exposures
are
monitored
and adjusted
on an
ongoing basis, and
consequently additional hedging instruments
are traded and designated, or are terminated resulting
in a hedge
discontinuance.
Hedge
designations
have
been
made
in
the
following
currencies
:
US
dollars
,
euros,
Swiss
francs,
pounds
sterling
and
Hong
Kong
dollars.
The
cash
flow
hedges
in
US
dollars, Swiss
francs and
pounds sterling
were discontinued
and
replaced with new ARR designations in December 2021.
Fair value hedges of foreign exchange risk related to issued debt
instruments
Debt
instruments
denominated
in
currencies
other than
the US
dollar
are
designated
in
fair
value
hedges
of
spot
foreign
exchange
risk,
in
addition
to
and
separate
from
the
fair
value
hedges
of
interest
rate
risk.
Cross
currency
swaps economically
convert debt denominated in currencies
other than the US dollar
to
US
dollars
.
This
hedge
accounting
program
started
on
1 January
2020,
with
the
adoption
of
the
hedge
accounting
requirements of IFRS 9,
Financial Instruments,
by UBS AG.
›
Refer to Note
1b
for more information
Hedges of net investments in foreign operations
UBS AG applies
hedge accounting for
certain net investments
in
foreign
operations
,
which
include
subsidiaries,
branches
and
associates. Upon
maturity of
hedging instruments,
typically two
months,
the
hedge
relationship
is
terminated
and
new
designations
are
made
to
reflect
any
changes
in
the
net
investments in foreign operations.
Consolidated financial statements | UBS AG consolidated financial statements
506
Note 26 Hedge accounting (continued)
Economic relationship between hedged item and hedging
instrument
For
hedges
designated
under
IFRS
9,
the economic
relationship
between
the
hedged
item
and
the
hedging
instrument
is
determined based on
a qualitative analysis
of their critical
terms.
In cases where hedge designation takes place after origination of
the
hedging
instrument,
a
quantitative
analysis
of
the
possible
behavior of
the hedging
derivative and
the hedged
item during
their respective terms is also performed.
Prior to
December 2021, for
the fair
value hedge of
portfolio
interest rate risk related to loans designated under IAS 39, hedge
effectiveness was assessed by
comparing changes in the
fair value
of
the hedged
portfolio of
loans
attributable
to
changes
in
the
designated benchmark
interest rate
with the
changes in
the fair
value of the interest rate swaps.
Sources of hedge ineffectiveness
In
hedges
of
interest
rate
risk,
hedge
ineffectiveness
can
arise
from
mismatches
of
critical
terms
and
/
or
the
use
of
different
curves
to
discount
the
hedged
item
and
instrument,
or
from
entering
into
a
hedge
relationship
after
the
trade
date
of
the
hedging derivative
.
In
hedges
of
foreign
exchange
risk
related
to
debt
issued,
hedge
ineffectiveness
can
arise
due
to
the
discounting
of
the
hedging instruments and undesignated risk components and
lack
of such discounting and risk components in the hedged items.
In
hedges
of
net
investments
in
foreign
operations,
ineffectiveness is unlikely unless the hedged
net assets fall below
the designated hedged
amount. The
exceptions are
hedges where
the
hedging
currency
is
not
the
same
as
the
currency
of
the
foreign
operation,
where
the
currency
basis
may
cause
ineffectiveness.
Hedge ineffectiveness from
financial instruments measured
at
fair value through profit
or loss is
recognized in
Other net income.
Derivatives not designated in hedge accounting relationships
Non-hedge accounted derivatives
are mandatorily held
for trading
with
all
fair
value
movements
taken
to
Other
net
income
from
financial instruments measured
at fair value
through profit or
loss
,
even
when
held
as
an
economic
hedge
or
to
facilitate
client
clearing. The
one exception
relates to
forward points
on certain
short-
and
long-duration
foreign
exchange
contracts
acting
as
economic hedges, which are reported in
Net interest income
.
All hedges: designated hedging instruments
and hedge ineffectiveness
As of or for the year ended
31.12.21
USD million
Notional
amount
Carrying amount
Changes in
fair value of
hedging
instruments
1
Changes in
fair value of
hedged
items
1
Hedge
ineffectiveness
recognized in the
income statement
Derivative
financial
assets
Derivative
financial
liabilities
Interest rate risk
Fair value hedges
89,525
0
7
(
1,604
)
1,602
(
2
)
Cash flow hedges
79,573
12
1
(
1,185
)
990
(
196
)
Foreign exchange risk
Fair value hedges
2
27,875
87
261
(
2,139
)
2,181
42
Hedges of net investments in foreign operations
13,761
23
103
492
(
491
)
0
As of or for the year ended
31.12.20
USD million
Notional
amount
Carrying amount
Changes in
fair value of
hedging
instruments
1
Changes in
fair value of
hedged
items
1
Hedge
ineffectiveness
recognized in the
income statement
Derivative
financial
assets
Derivative
financial
liabilities
Interest rate risk
Fair value hedges
80,759
12
1,231
(
1,247
)
(
16
)
Cash flow hedges
72,732
18
2,213
(
2,012
)
201
Foreign exchange risk
Fair value hedges
2
21,555
449
7
(
1,735
)
1,715
(
20
)
Hedges of net investments in foreign operations
13,634
3
193
(
939
)
938
(
2
)
1 Amounts used
as the basis
for recognizing hedge
ineffectiveness for the
period.
2 The
foreign currency basis
spread of cross
-currency swaps designated
as hedging derivatives
is excluded from
the hedge
accounting designation and accounted for as a cost of hedging with amounts deferred in Other comprehensive income within Equity.
507
Note 26 Hedge accounting (continued)
Fair value hedges: designated hedged items
USD million
31.12.21
31.12.20
Interest rate
risk
FX risk
Interest rate
risk
FX risk
Debt issued measured at amortized cost
Carrying amount of designated debt issued
21,653
11,392
24,247
10,889
of which: accumulated amount of fair value hedge adjustment
261
761
Funding from UBS Group AG
Carrying amount of designated debt instruments
53,047
16,483
46,182
10,666
of which: accumulated amount of fair value hedge adjustment
218
1,640
Other financial assets measured at amortized cost – debt securities
Carrying amount of designated debt securities
2,677
3,242
of which: accumulated amount of fair value hedge adjustment
(
7
)
(
38
)
Loans and advances to customers
1
Carrying amount of designated loans
13,835
10,374
of which: accumulated amount of fair value hedge adjustment
2
(
109
)
100
of which: accumulated amount of fair value hedge adjustment subject
to amortization attributable to the
portion of the portfolio that ceased to be part of hedge
accounting
2
3
111
1 Prior to 31 December 2021, these amounts were designated in fair value
hedges of portfolio interest rate risk under IAS 39.
2 As of 31 December 2021, the amount was presented within Loans
and advances to
customers, whereas prior to 1 January 2021 amounts were presented within either Other financial assets
measured at amortized cost or Other financial liabilities measured at amortized cost.
Fair value hedges: profile of the timing of the
nominal amount of the hedging instrument
31.12.21
USD billion
Due within
1 month
Due between
1 and 3 months
Due between
3 and 12 months
Due between
1 and 5 years
Due after
5 years
Total
Interest rate swaps
0
8
10
49
22
90
Cross-currency swaps
1
1
6
13
6
28
31.12.20
USD billion
Due within
1 month
Due between
1 and 3 months
Due between
3 and 12 months
Due between
1 and 5 years
Due after
5 years
Total
Interest rate swaps
1
0
4
9
46
12
70
Cross-currency swaps
0
0
4
16
2
22
1 In accordance with IFRS 7 requirements, the fair value hedges of portfolio interest rate risk
related to loans and advances to customers designated under IAS 39 are not included.
Cash flow hedge reserve on a pre-tax basis
USD million
31.12.21
31.12.20
Amounts related to hedge relationships for which hedge
accounting continues to be applied
26
2,560
Amounts related to hedge relationships for which hedge
accounting is no longer applied
743
296
Total other comprehensive income recognized directly in equity related to cash flow hedges, on a pre-tax basis
769
2,856
Foreign currency translation reserve on a pre-tax basis
USD million
31.12.21
31.12.20
Amounts related to hedge relationships for which hedge
accounting continues to be applied
(61)
(
569
)
Amounts related to hedge relationships for which hedge
accounting is no longer applied
262
268
Total other comprehensive income recognized directly in equity related to hedging instruments
designated as net investment hedges, on a pre-tax
basis
201
(
302
)
Consolidated financial statements | UBS AG consolidated financial statements
508
Note 26 Hedge accounting (continued)
Interest rate benchmark reform
UBS
AG
continues
to
apply
the
relief
provided
by
Interest
Rate
Benchmark
Reform
(amendments
to
IFRS 9,
IAS 39 and
IFRS 7),
published by the IASB in September 2019.
The
interest
rate
benchmarks
subject
to
interest
rate
benchmark
reforms
to
which
the
Group’s
hedge
relationships
were
exposed
were
USD
LIBOR,
CHF
LIBOR,
GBP
LIBOR,
AUD
LIBOR, JPY
LIBOR, HKD
LIBOR, SGD
LIBOR and
EONIA. Interest rate
swaps
designated
in
hedge
relationships
referencing
GBP,
CHF
and JPY LIBOR transitioned to ARRs
in December 2021 when LCH
transitioned
its
contracts.
For
other
currencies,
IBOR
quotations
remain available, but all
new designations will reference
ARR. As
such,
ARR
designations
in
these
currencies
will
replace
IBOR
designations as IBOR contracts mature.
UBS
AG’s
hedge
relationships
are
also
exposed
to
the
Euro
Inter-bank Offered Rate (EURIBOR), which
is expected to continue
to exist as a benchmark rate for the foreseeable future. Thus, the
Group
does
not
consider
its
hedges
involving
the
EURIBOR
benchmark
interest
rate
to
be
directly
affected
by
interest
rate
benchmark reform.
Apart from
EURIBOR hedges,
UBS AG applied
the relief
to all
its fair
value hedges
of interest
rate risk
and to
those cash
flow
hedge relationships where the
hedged risk is
LIBOR or EONIA.
The
following
table
provides
details
on
the
notional
amount
and
carrying
amount
of
the
hedging
instruments
in
those
hedge
relationships maturing after 31 December 2021, or 30 June 2023
for
USD
LIBOR
hedges,
which
are
the
cessation
dates
of
the
applicable interest rate benchmarks.
Hedges
of
net
investments
in
foreign
operations
are
not
affected by the amendments.
›
Refer to Note
1a item 2j
for more information about the relief
provided by the amendments to IFRS 9, IAS
39 and IFRS 7 related
to interest rate benchmark reform
›
Refer to Note 25 Interest rate benchmark reform
for more
information about the transition progress
Hedging instruments referencing LIBOR
31.12.21
31.12.20
Carrying amount
Carrying amount
USD million
Notional
amount
Derivative
financial
assets
Derivative
financial
liabilities
Notional
amount
Derivative
financial
assets
Derivative
financial
liabilities
Interest rate risk
Fair value hedges
23,367
0
0
37,146
1
(
12
)
Cash flow hedges
10,803
0
0
11,179
0
0
509
Note 27
Post-employment benefit plans
a) Defined benefit plans
UBS AG has established defined
benefit plans for its employees in
various
jurisdictions
in
accordance
with
local
r
egulations
and
practices.
The major plans are located in Switzerland, the UK, the
US
and Germany.
The
level of
benefits
depends on
the specific
plan rules.
Swiss pension plan
The
Swiss
pension
plan
covers
employees
of
UBS
AG
in
Switzerland
and employees
of companies
in Switzerland
having
close
economic
or
financial
ties with
UBS
AG, and
exceeds
the
minimum benefit requirements under Swiss pension law.
In 2017,
a significant
number of
employees were
transferred
from UBS
AG to
UBS Business
Solutions AG,
which is
a directly
held
subsidiary
of
UBS
Group
AG.
There
continues
to
be
one
pooled
pension
plan
in
Switzerland
covering
the
employees
of
UBS AG and those transferred to
UBS Business Solutions AG. UBS
AG
and
UBS
Business
Solutions
AG
both
are
legal
sponsors
of
UBS’s Swiss pension
plan. Since
the date of
the employee transfer,
UBS
AG
and
UBS
Business
Solutions
AG
apply
proportionate
defined benefit accounting, i.e., the net pension cost and the net
pension
asset
/
liability
of
the
Swiss
pension
plan
are
allocated
proportionally between
UBS AG
and UBS
Business Solutions
AG
based
on
the
aggregated
net pension
cost and
defined
benefit
obligations related to their employees.
The Swiss
plan offers
retirement, disability
and survivor
benefits
and
is
governed
by
a
Pension
Foundation
Board.
The
responsibilities of this board
are defined by Swiss
pension law and
the plan rules.
Savings
contributions
to
the
Swiss
plan
are
paid
by
both
employer and employee. Depending on the age of the
employee,
UBS AG
pays a
savings contribution
that ranges
between
6.5
%
and
27.5
% of
contributory base
salary and
between
2.8
% and
9
% of contributory variable compensation. UBS AG also pays
risk
contributions that
are used to
fund disability
and survivor
benefits.
Employees can
choose the
level of savings
contributions paid
by
them, which vary between
2.5
% and
13.5
% of contributory base
salary
and
between
0
%
and
9
%
of
contributory
variable
compensation,
depending
on
age
and
choice
of
savings
contribution category.
The plan offers to
members at the
normal retirement age
of
65
a choice between
a lifetime pension
and a partial
or full lump
sum
payment.
Participants
can
choose
to
draw
early
retirement
benefits
starting
from
the
age
of
58
,
but
can
also
continue
employment and remain active members
of the plan until the
age
of
70
.
Employees
have
the
opportunity
to
make
additional
purchases of benefits to fund early retirement benefits.
The pension
amount payable
to a
participant is
calculated by
applying
a
conversion
rate
to
the
accumulated
balance
of
the
participant’s
retirement
savings
account
at
the
retirement
date.
The balance is based on credited vested benefits transferred from
previous employers, purchases of benefits, and the
employee and
employer contributions that have
been made to the
participant’s
retirement
savings account,
as well
as the
interest accrued.
The
annual interest rate
credited to participants
is determined by
the
Pension Foundation Board at the end of each year
.
Although
the
Swiss
plan
is
based
on
a
defined
contribution
promise under Swiss pension law, it is accounted for as a defined
benefit
plan
under
IFRS,
primarily
because
of
the
obligation
to
accrue
interest
on
the
participants’
retirement
savings
accounts
and the payment of lifetime pension benefits.
An actuarial valuation in accordance with Swiss pension law is
performed
regularly.
Should
an
underfunded
situation
on
this
basis occur, the Pension Foundation Board is required to
take the
necessary measures
to ensure
that full
funding can
be expected
to be
restored within
a maximum
period of
10
years. If
a Swiss
plan
were
to
become
significantly
underfunded
on
a
Swiss
pension
law
basis,
additional
employer
and
employee
contributions could be required.
In this situation, the
risk is shared
between employer and
employees, and the
employer is
not legally
obliged to
cover more than
50
% of
the additional
contributions
required. As of
31 December 2021, the
Swiss plan had
a technical
funding
ratio in
accordance with
Swiss pension
law of
134.8
%
(31 December 2020:
132.6
%).
The investment strategy of the Swiss plan complies with Swiss
pension
law,
including
the
rules
and
regulations
relating
to
diversification of plan assets,
and is derived
from the risk budget
defined by the Pension
Foundation Board on
the basis of
regularly
performed asset and
liability management analyses.
The Pension
Foundation
Board strives
for
a medium
-
and long
-term balance
between assets and liabilities.
As
of
31 December
2021,
the
Swiss
plan
was
in
a
surplus
situation on
an IFRS
measurement basis,
as the
fair value
of the
plan’s
assets
exceeded
the
defined
benefit
obligation
(DBO)
by
USD
3,716
million
(31 December 2020:
a
surplus
of
USD
2,739
million).
However,
a
surplus
is
only
recognized
on
the
balance
sheet to
the extent that
it does not
exceed the
estimated future
economic
benefit,
which
equals
the
difference
between
the
present
value
of
the
estimated
future
net
service
cost
and
the
present value of the estimated
future employer contributions. As
of
both
31 December
2021
and
31 December
2020,
the
estimated
future
economic
benefit
was
zero
and
hence
no
net
defined benefit asset was recognized on the balance sheet.
Changes to the Swiss pension plan in 2019
The Pension Foundation Board and UBS AG agreed to implement
measures that
took effect
from the
start of 2019
to support the
long-term
financial
stability
of
the
Swiss
pension
fund.
The
measures, among
other things, lowered
the conversion rate
and
increased
the
normal
retirement
age
from
64
to
65.
Pensions
already in payment on 1 January 2019 were not affected.
To
mitigate
the
effects
for
active
participants
,
UBS
AG
committed to pay an
extraordinary contribution of up
to CHF
450
million
(USD
494
million
at
the
closing
exchange
rate
on
31 December
2021)
in
three
installments
in
2020,
2021
and
2022. Two
installments of
USD
143
million and
USD
152
million
paid in 2020 and
2021 reduced OCI with
no effect on the
income
statement.
The third installment, CHF
116
million (USD
127
million at the
closing exchange rate on 31 December 2021), will
be paid in the
first
quarter
of
2022.
The
regular
employer
contributions
to
be
made to the Swiss plan
in 2022 are estimated at
USD
277
million.
Consolidated financial statements | UBS AG consolidated financial statements
510
Note 27
Post-employment benefit plans (continued)
UK pension plan
The UK
plan is
a career
-average revalued
earnings scheme,
and
benefits increase
automatically based
on UK
price inflation.
The
normal retirement
age for
participants in
the UK plan
is
60
. The
plan provides guaranteed lifetime
pension benefits to participants
upon retirement.
The UK
plan has
been closed
to new
entrants
for more than
20 years
and, since 2013,
participants are no
longer
accruing benefits for current or
future service. Instead, employees
participate in the UK defined contribution plan.
The governance
responsibility for the
UK plan lies
jointly with
the
Pension
Trustee
Board
and
UBS
AG
.
The
employer
contributions
to
the
pension
fund
reflect
agreed-upon
deficit
funding contributions, which
are determined on
the basis of
the
most recent actuarial
valuation using assumptions
agreed by the
Pension Trustee Board and
UBS AG. In the
event of underfunding,
UBS AG
and the
Pension Trustee
Board must
agree on
a deficit
recovery plan within
statutory deadlines. In 2021,
UBS AG made
no deficit funding contributions to the UK plan. In 2020, UBS AG
made deficit funding contributions of USD
46
million.
The
plan
assets
are
invested
in
a
diversified
portfolio
of
financial assets, which
include a longevity
swap with an external
insurance
company.
This
swap
enables
the
UK
pension
plan
to
hedge
the
risk
between
expected
and
actual
longevity,
which
should mitigate volatility in the net defined
benefit asset / liability.
As of 31
December 2021, the
longevity swap had
a negative value
of USD
3
million (31 December 2020: zero).
In 2019,
UBS AG and
the Pension Trustee
Board entered
into
an
arrangement
whereby
a
collateral
pool
was
established
to
provide security for
the pension fund.
The value of
the collateral
pool as of
31 December 2021 was
USD
337
million (31 December
20
20
:
USD
347
million
)
and
includes
corporate
bonds
,
government-related debt
instruments and
other financial
assets.
The
arrangement
provides
the Pension
Trustee
Board
dedicated
access to a pool
of assets in the event
of UBS AG’s insolvency
or
not paying a required deficit funding contribution.
The
employer
contributions
to
be
made
to
the
UK
defined
benefit plan
in 2022
are estimated
at USD
5
million, subject
to
regular funding reviews during the year.
US pension plans
There are two distinct major defined benefit plans in the
US, with
a
normal retirement
age
of
65
. Both
plans
were
closed to
new
entrants
more
than
20
years
ago.
Since
they
closed,
new
employees have participated in a defined contribution plan.
One of the
defined benefit plans
is a contribution-based
plan
in
which
each
participant
accrues
a
percentage
of
salary
in
a
retirement
savings
account.
The
retirement
savings
account
is
credited annually
with interest
based
on a
rate that
is linked
to
the
average
yield
on
one-year
US
government
bonds.
For
the
other defined
benefit plan,
retirement benefits
accrue based
on
the
career-average earnings
of
each
individual
plan
participant.
Former employees with vested benefits have the option to take a
lump sum payment or a lifetime annuity.
As
required
under
applicable
pension
laws,
both
plans
have
fiduciaries
who,
together
with
UBS
AG,
are
responsible
for
the
governance of the plans.
The
plan
assets
of
both
plans
are
invested
in
diversified
portfolio
s
of
finan
cial
assets.
Each
plan’s
fiduciaries
are
responsible for the
investment decisions with respect
to the plan
assets.
The
employer
contributions
to
be
made
to
the
US
defined
benefit plans in 2022 are estimated at USD
10
million.
German pension plans
There are two
defined benefit plans in
Germany,
which are both
unfunded. The normal retirement age is
65
and benefits are paid
directly by UBS AG. In
the larger of
the two plans each
participant
accrues
a
percentage
of
salary in
a
retirement
savings
account.
The accumulated account
balance of the
participant is credited
on
an annual basis
with guaranteed
interest at a
rate of
5
%. The
plan
has been closed
to new entrants
and all participants
younger than
the
age
of
55
no
longer
accrue
benefits.
In
the
other
plan,
amounts
are
accrued
annually
based
on
employee
elections
related to variable
compensation. For this plan,
the accumulated
account balance is credited on an annual basis
with a guaranteed
interest rate of
6
% for amounts accrued before 2010, of
4
% for
amounts accrued
from 2010
to 2017
and of
0.9
% for
amounts
accrued
after
2017.
Both
plans
are
subject
to
German
pension
law, whereby the responsibility to
pay pension benefits
when they
are
due resides
entirely with
UBS AG.
A portion
of the
pension
payments is directly increased in line with price inflation.
In
June
2021,
UBS
AG
implemented
a
new
funded
pension
plan
with
interest
credited
to
participants
equal
to
actual
investment returns with a guaranteed minimum of
0
%. The plan
was implemented
retrospectively for
new hires
since June
2018
and for
all eligible
active participants
younger than
55 from
July
2021.
Each
participant
accrues
a
percentage
of
salary
in
a
retirement savings account.
The employer contributions
to be made
to the German
defined
benefit plans in 2022 are estimated at USD
12
million.
Financial information by plan
The
tables
on
the
following
pages
provide
an
analysis
of
the
movement
in the
net asset
/ liability
recognized
on the
balance
sheet for defined benefit plans, as well as an analysis of amounts
recognized in net profit and in
Other comprehensive incom
e.
511
Note 27
Post-employment benefit plans (continued)
Defined benefit plans
USD million
Swiss pension plan
UK pension plan
US and German
pension plans
Total
2021
2020
2021
2020
2021
2020
2021
2020
Defined benefit obligation at the beginning of the year
15,619
13,809
4,162
3,654
1,905
1,820
21,686
19,283
Current service cost
285
262
0
0
6
6
291
268
Interest expense
33
40
58
73
30
45
122
159
Plan participant contributions
161
159
0
0
0
0
161
159
Remeasurements
490
677
71
449
(
62
)
105
498
1,231
of which: actuarial (gains) / losses due to changes in demographic
assumptions
26
(
53
)
14
(
14
)
4
(
34
)
45
(
101
)
of which: actuarial (gains) / losses due to changes in financial
assumptions
(
385
)
565
(
3
)
505
(
78
)
134
(
466
)
1,204
of which: experience (gains) / losses
1,2
848
165
59
(
42
)
12
5
919
127
Past service cost related to plan amendments
0
0
0
3
4
0
4
3
Curtailments
(
49
)
0
0
0
0
0
(
49
)
0
Benefit payments
(
602
)
(
641
)
(
148
)
(
148
)
(
112
)
(
108
)
(
862
)
(
898
)
Other movements
0
(
4
)
0
0
1
0
1
(
4
)
Foreign currency translation
(
456
)
1,317
(
38
)
132
(
33
)
37
(
527
)
1,486
Defined benefit obligation at the end of the year
15,480
15,619
4,105
4,162
1,740
1,905
21,324
21,686
of which: amounts owed to active members
8,604
8,290
150
159
222
245
8,976
8,694
of which: amounts owed to deferred members
0
0
1,593
1,879
669
743
2,262
2,622
of which: amounts owed to retirees
6,876
7,329
2,362
2,124
849
917
10,086
10,370
of which: funded plans
15,480
15,619
4,105
4,162
1,222
1,319
20,806
21,100
of which: unfunded plans
0
0
0
0
518
586
518
586
Fair value of plan assets at the beginning of the year
18,358
15,908
4,149
3,658
1,360
1,299
23,867
20,864
Return on plan assets excluding interest income
2
1,319
962
277
388
40
118
1,637
1,469
Interest income
42
48
58
73
26
38
127
159
Employer contributions
450
436
0
46
16
17
466
499
Plan participant contributions
161
159
0
0
0
0
161
159
Benefit payments
(
602
)
(
641
)
(
148
)
(
148
)
(
112
)
(
108
)
(
862
)
(
898
)
Administration expenses, taxes and premiums paid
(
8
)
(
8
)
0
0
(
4
)
(
4
)
(
11
)
(
11
)
Other movements
0
0
0
0
1
0
1
0
Foreign currency translation
(
524
)
1,495
(
39
)
132
0
0
(
563
)
1,626
Fair value of plan assets at the end of the year
19,196
18,358
4,297
4,149
1,329
1,360
24,821
23,867
Surplus / (deficit)
3,716
2,739
192
(
13
)
(
411
)
(
545
)
3,497
2,181
Asset ceiling effect at the beginning of the year
2,739
2,099
0
0
0
0
2,739
2,099
Interest expense on asset ceiling effect
8
7
0
0
0
0
8
7
Asset ceiling effect excluding interest expense and foreign currency
translation on
asset ceiling effect
1,037
457
0
0
0
0
1,037
457
Foreign currency translation
(
68
)
176
0
0
0
0
(
68
)
176
Asset ceiling effect at the end of the year
3,716
2,739
0
0
0
0
3,716
2,739
Net defined benefit asset / (liability) of major plans
0
0
192
(
13
)
(
411
)
(
545
)
(
219
)
(
558
)
Net defined benefit asset / (liability) of remaining plans
(
96
)
(
112
)
Total net defined benefit asset / (liability)
(
315
)
(
670
)
of which: Net defined benefit asset
302
42
of which: Net defined benefit liability
3
(
617
)
(
711
)
1 Experience (gains) /
losses are a component
of actuarial remeasurements of
the defined benefit obligation
and reflect the effects
of differences between
the previous actuarial assumptions
and what has actually
occurred.
2 Includes the effect from employees being transferred between UBS AG and UBS Business Solutions during the period.
3 Refer to Note 19c.
Consolidated financial statements | UBS AG consolidated financial statements
512
Note 27
Post-employment benefit plans (continued)
Income statement – expenses related to defined benefit plans
1
USD million
Swiss pension plan
UK pension plan
US and German
pension plans
Total
For the year ended
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
Current service cost
285
262
0
0
6
6
291
268
Interest expense related to defined benefit obligation
33
40
58
73
30
45
122
159
Interest income related to plan assets
(
42
)
(
48
)
(
58
)
(
73
)
(
26
)
(
38
)
(
127
)
(
159
)
Interest expense on asset ceiling effect
8
7
0
0
0
0
8
7
Administration expenses, taxes and premiums paid
8
8
0
0
4
4
11
11
Past service cost related to plan amendments
0
0
0
3
4
0
4
3
Curtailments
(
49
)
0
0
0
0
0
(
49
)
0
Net periodic expenses recognized in net profit for major plans
243
269
0
3
18
18
261
289
Net periodic expenses recognized in net profit for remaining plans
2
19
17
Total net periodic expenses recognized in net profit
280
306
1 Refer to Note 6.
2 Includes differences between actual and estimated performance award accruals.
Other comprehensive income – gains / (losses) on defined benefit plans
USD million
Swiss pension plan
UK pension plan
US and German
pension plans
Total
For the year ended
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
Remeasurement of defined benefit obligation
(
490
)
(
677
)
(
71
)
(
449
)
62
(
105
)
(
498
)
(
1,231
)
of which: change in discount rate assumption
494
(
447
)
319
(
504
)
77
(
141
)
890
(
1,092
)
of which: change in rate of salary increase assumption
(
2
)
(
132
)
0
0
0
0
(
2
)
(
132
)
of which: change in rate of pension increase assumption
0
0
(
316
)
(
1
)
(
1
)
1
(
317
)
0
of which: change in rate of interest credit on retirement savings
assumption
(
110
)
15
0
0
(
1
)
24
(
110
)
39
of which: change in life expectancy
0
84
9
22
(
3
)
50
5
156
of which: change in other actuarial assumptions
(
24
)
(
33
)
(
23
)
(
8
)
2
(
34
)
(
45
)
(
75
)
of which: experience gains / (losses)
1,2
(
848
)
(
165
)
(
59
)
42
(
12
)
(
5
)
(
919
)
(
127
)
Return on plan assets excluding interest income
1,319
962
277
388
40
118
1,637
1,469
Asset ceiling effect excluding interest expense and foreign currency
translation
(
1,037
)
(
457
)
0
0
0
0
(
1,037
)
(
457
)
Total gains / (losses) recognized in other comprehensive income for major plans
(
207
)
(
172
)
207
(
61
)
103
14
102
(
219
)
Total gains / (losses) recognized in other comprehensive income for remaining plans
31
(
3
)
Total gains / (losses) recognized in other comprehensive income
3
133
(
222
)
1 Experience (gains) /
losses are a component
of actuarial remeasurements of
the defined benefit obligation
and reflect the effects
of differences between
the previous actuarial assumptions
and what has actually
occurred.
2 Includes the effect from employees being transferred between UBS AG and UBS Business Solutions during the period.
3 Refer to the “Statement of comprehensive income.”
The table below provides information about the duration of the DBO and the timing for expected benefit payments.
Swiss pension plan
UK pension plan
US and German pension
plans
1
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
Duration of the defined benefit obligation (in years)
15.5
16.2
18.8
19.0
9.5
10.2
Maturity analysis of benefits expected to be paid
USD million
Benefits expected to be paid within 12 months
719
710
110
114
123
122
Benefits expected to be paid between 1 and 3 years
1,440
1,442
248
232
237
235
Benefits expected to be paid between 3 and 6 years
2,097
2,100
418
406
338
346
Benefits expected to be paid between 6 and 11 years
3,467
3,408
743
744
495
532
Benefits expected to be paid between 11 and 16 years
3,156
3,184
751
758
392
413
Benefits expected to be paid in more than 16 years
10,733
11,186
3,028
3,206
519
541
1 The duration of the defined benefit obligation represents a weighted average across US and
German plans.
513
Note 27
Post-employment benefit plans (continued)
Actuarial assumptions
The actuarial assumptions
used for the
defined benefit plans
are
based on the economic conditions prevailing in the jurisdiction in
which they are offered. Changes
in the defined benefit obligation
are most
sensitive to
changes in
the discount
rate. The
discount
rate is based on the yield of high-quality corporate bonds quoted
in
an
active
market
in
the
currency
of
the
respective
plan.
A
decrease
in
the
discount
curve
increases
the
DBO.
UBS
AG
regularly reviews the
actuarial assumptions used
in calculating the
DBO to determine their continuing relevance.
›
Refer to Note 1a item 5 for a description
of the accounting policy
for defined benefit plans
The tables below show the significant actuarial assumptions used in calculating the DBO at the end of the year.
Significant actuarial assumptions
Swiss pension plan
UK pension plan
US and German pension
plans
1
In %
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
Discount rate
0.34
0.10
1.82
1.42
2.10
1.62
Rate of salary increase
2.01
2.00
0.00
0.00
2.35
2.25
Rate of pension increase
0.00
0.00
3.32
2.89
1.80
1.70
Rate of interest credit on retirement savings
1.04
0.60
0.00
0.00
1.18
1.12
1 Represents weighted average assumptions across US and German plans.
Mortality tables and life expectancies for
major plans
Life expectancy at age 65 for a male member currently
aged 65
aged 45
Country
Mortality table
31.12.21
31.12.20
31.12.21
31.12.20
Switzerland
BVG 2020 G with CMI 2019 projections
21.7
21.7
23.3
23.2
UK
S3PA with CMI 2020 projections
1
23.4
23.4
24.5
24.6
USA
Pri-2012 with MP-2021 projection scale
2
21.9
21.8
23.3
23.2
Germany
Dr. K. Heubeck 2018 G
20.5
20.8
23.2
23.6
Life expectancy at age 65 for a female member currently
aged 65
aged 45
Country
Mortality table
31.12.21
31.12.20
31.12.21
31.12.20
Switzerland
BVG 2020 G with CMI 2019 projections
23.4
23.4
25.0
24.9
UK
S3PA with CMI 2020 projections
1
24.9
24.9
26.3
26.3
USA
Pri-2012 with MP-2021 projection scale
2
23.3
23.2
24.7
24.5
Germany
Dr. K. Heubeck 2018 G
23.9
24.3
26.1
26.5
1 In 2020, S3PA with CMI 2019 projections was used.
2 In 2020, Pri-2012 with MP-2020 projection scale was used.
Consolidated financial statements | UBS AG consolidated financial statements
514
Note 27
Post-employment benefit plans (continued)
Sensitivity analysis of significant actuarial assumptions
The table below presents a sensitivity analysis for each significant
actuarial
assumption,
showing
how
the
DBO
would
have
been
affected
by
changes
in
the
relevant
actuarial
assumption
that
were reasonably
possible at
the balance
sheet date.
Unforeseen
circumstances may arise, which could
result in variations that are
outside
the
range
of
alternatives
deemed
reasonably
possible.
Caution should be used
in extrapolating the sensitivities
below on
the DBO, as the sensitivities may not be linear.
Sensitivity analysis of significant actuarial
assumptions
1
Increase / (decrease) in defined benefit obligation
Swiss pension plan
UK pension plan
US and German pension plans
USD million
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
Discount rate
Increase by 50 basis points
(
975
)
(
1,030
)
(
361
)
(
370
)
(
78
)
(
91
)
Decrease by 50 basis points
1,116
1,181
411
423
84
99
Rate of salary increase
Increase by 50 basis points
69
74
–
2
–
2
0
1
Decrease by 50 basis points
(
66
)
(
71
)
–
2
–
2
0
(
1
)
Rate of pension increase
Increase by 50 basis points
749
793
334
358
6
8
Decrease by 50 basis points
–
3
–
3
(
306
)
(
316
)
(
6
)
(
7
)
Rate of interest credit on retirement savings
Increase by 50 basis points
134
142
–
4
–
4
8
9
Decrease by 50 basis points
(
134
)
5
(
113
)
–
4
–
4
(
7
)
(
8
)
Life expectancy
Increase in longevity by one additional year
475
566
184
182
56
60
1 The sensitivity analyses are based on a change in one assumption while holding all other assumptions constant, so that interdependencies between the assumptions are excluded.
2 As the plan is closed for future
service, a change in assumption is not
applicable.
3 As the assumed rate of pension increase
was
0
% as of 31 December 2021 and as
of 31 December 2020, a downward change
in assumption is not applicable.
4 As the UK plan does not provide interest
credits on retirement savings, a change in
assumption is not applicable.
5 As of 31 December 2021,
17
% of retirement savings were subject to a legal minimum
rate of
1.00
%.
515
Note 27
Post-employment benefit plans (continued)
Fair value of plan assets
The tables
below
provide
information
about
the composition
and fair
value
of plan
assets
of the
Swiss,
UK, US
and German
pension
plans.
Composition and fair value of plan assets
Swiss pension plan
31.12.21
31.12.20
Fair value
Plan asset
allocation %
Fair value
Plan asset
allocation %
USD million
Quoted
in an active
market
Other
Total
Quoted
in an active
market
Other
Total
Cash and cash equivalents
106
0
106
1
123
0
123
1
Real estate / property
Domestic
0
1,994
1,994
10
0
2,018
2,018
11
Foreign
0
328
328
2
0
186
186
1
Investment funds
Equity
Domestic
476
0
476
2
465
0
465
3
Foreign
3,510
1,498
5,009
26
3,540
1,103
4,642
25
Bonds
1
Domestic, AAA to BBB–
2,512
0
2,512
13
2,096
0
2,096
11
Foreign, AAA to BBB–
2,877
0
2,877
15
3,462
0
3,462
19
Foreign, below BBB–
742
0
742
4
734
0
734
4
Other
2,379
2,010
4,389
23
1,894
2,097
3,991
22
Other investments
377
385
762
4
373
266
640
3
Total fair value of plan assets
12,980
6,216
19,196
100
12,688
5,670
18,358
100
31.12.21
31.12.20
Total fair value of plan assets
19,196
18,358
of which:
2
Bank accounts at UBS AG
109
130
UBS AG debt instruments
16
19
UBS Group AG shares
14
13
Securities lent to UBS AG
3
608
796
Property occupied by UBS AG
52
54
Derivative financial instruments, counterparty UBS AG
3
72
84
1 The bond credit ratings are
primarily based on S&P’s credit ratings.
Ratings AAA to BBB– and below BBB– represent investment
grade and non-investment grade ratings,
respectively. In cases where credit
ratings
from other rating agencies were used, these were converted to the equivalent rating in S&P’s rating classification.
2 Bank accounts at UBS AG encompass accounts in the name of the Swiss pension fund.
The other
positions disclosed
in the
table encompass
both direct
investments in
UBS AG
instruments and
UBS Group
AG shares
and indirect
investments, i.e.,
those made
through funds
that the
pension fund
invests in.
3 Securities lent to UBS AG and derivative
financial instruments are presented gross of any
collateral. Securities lent to UBS AG
were fully covered by collateral as
of 31 December 2021 and 31 December 2020.
Net
of collateral, derivative financial instruments amounted to USD
24
million as of 31 December 2021 (31 December 2020: negative USD
9
million).
Consolidated financial statements | UBS AG consolidated financial statements
516
Note 27
Post-employment benefit plans (continued)
Composition and fair value of plan assets (continued)
UK pension plan
31.12.21
31.12.20
Fair value
Plan asset
allocation %
Fair value
Plan asset
allocation %
USD million
Quoted
in an active
market
Other
Total
Quoted
in an active
market
Other
Total
Cash and cash equivalents
147
0
147
3
195
0
195
5
Bonds
1
Domestic, AAA to BBB–
2,605
0
2,605
61
2,150
0
2,150
52
Foreign, AAA to BBB–
372
0
372
9
53
0
53
1
Foreign, below BBB–
4
0
4
0
0
0
0
0
Investment funds
Equity
Domestic
44
4
47
1
34
3
37
1
Foreign
921
0
921
21
1,077
0
1,077
26
Bonds
1
Domestic, AAA to BBB–
532
147
679
16
919
131
1,050
25
Domestic, below BBB–
12
0
12
0
47
0
47
1
Foreign, AAA to BBB–
179
0
179
4
149
0
149
4
Foreign, below BBB–
115
0
115
3
110
0
110
3
Real estate
Domestic
110
12
122
3
98
16
114
3
Foreign
6
34
40
1
0
37
37
1
Other
(
313
)
0
(
313
)
(
7
)
(
86
)
0
(
86
)
(
2
)
Insurance contracts
0
8
8
0
0
8
8
0
Derivatives
57
(
3
)
54
1
(
3
)
0
(
3
)
0
Asset-backed securities
0
11
11
0
0
6
6
0
Other investments
2
(
717
)
10
(
707
)
(
16
)
(
803
)
9
(
794
)
(
19
)
Total fair value of plan assets
4,074
223
4,297
100
3,940
209
4,149
100
1 The bond credit ratings are
primarily based on S&P’s credit ratings.
Ratings AAA to BBB– and below BBB– represent
investment grade and non-investment grade
ratings, respectively. In
cases where credit ratings
from other rating agencies were used, these were converted to the equivalent rating in S&P’s
rating classification.
2 Mainly relates to repurchase arrangements on UK treasury bonds.
517
Note 27
Post-employment benefit plans (continued)
Composition and fair value of plan assets (continued)
US and German pension plans
31.12.21
31.12.20
Fair value
Plan asset
allocation %
Fair value
Plan asset
allocation %
USD million
Quoted
in an active
market
Other
Total
Quoted
in an active
market
Other
Total
Cash and cash equivalents
11
0
11
1
38
0
38
3
Equity
Domestic
79
0
79
6
0
0
0
0
Foreign
31
0
31
2
0
0
0
0
Bonds
1
Domestic, AAA to BBB–
486
0
486
37
490
0
490
36
Domestic, below BBB–
17
0
17
1
7
0
7
0
Foreign, AAA to BBB–
97
0
97
7
99
0
99
7
Foreign, below BBB–
6
0
6
0
1
0
1
0
Investment funds
Equity
Domestic
3
0
3
0
210
0
210
15
Foreign
56
0
56
4
169
0
169
12
Bonds
1
Domestic, AAA to BBB–
269
0
269
20
195
0
195
14
Domestic, below BBB–
147
0
147
11
34
0
34
2
Foreign, AAA to BBB–
11
0
11
1
19
0
19
1
Foreign, below BBB–
2
0
2
0
3
0
3
0
Real estate
Domestic
0
9
9
1
0
14
14
1
Other
99
0
99
7
79
0
79
6
Insurance contracts
0
1
1
0
0
1
1
0
Other investments
5
0
5
0
0
0
0
0
Total fair value of plan assets
1,319
10
1,329
100
1,345
15
1,360
100
1 The bond credit ratings are
primarily based on S&P’s credit ratings.
Ratings AAA to BBB– and below BBB– represent
investment grade and non-investment grade
ratings, respectively. In
cases where credit ratings
from other rating agencies were used, these were converted to the equivalent rating in S&P’s
rating classification.
Consolidated financial statements | UBS AG consolidated financial statements
518
Note 27
Post-employment benefit plans (continued)
b) Defined contribution plans
UBS AG
sponsors a
number of
defined contribution
plans, with
the
most
significant
plans
in
the
US
and
the
UK.
UBS
AG’s
obligation is limited to its contributions made in accordance
with
each plan, which
may include direct
contributions and matching
contributions.
Employer
contributions
to
defined
contribution
plans are recognized as an expense.
Expenses related to defined contribution
plans
For the year ended
USD million
31.12.21
31.12.20
31.12.19
US plan
198
190
173
UK plan
41
36
34
Remaining plans
64
65
71
Total
1
303
291
278
1 Refer to Note 6.
c) Related-party disclosure
UBS
AG
is
the
principal
provider
of
banking
services
for
the
pension fund of UBS AG in
Switzerland. In this capacity,
UBS AG
is
engaged
to
execute
most
of
the
pension
fund’s
banking
activities.
These
activities
can
include,
but
are
not
limited
to,
trading,
securities
lending
and
borrowing
and
derivative
transactions. The non-Swiss UBS AG pension funds
do not have a
similar banking relationship with UBS AG.
Also, UBS AG
leases certain properties
that are owned
by the
Swiss
pension
fund.
As
of
31 December
2021,
the
minimum
commitment
toward
the
Swiss
pension
fund
under
the
related
leases
was
approximately
USD
5
million
(31
December
20
20
:
USD
6
million).
›
Refer to the “Composition and fair value
of plan assets” table in
Note 27a for more information about fair value
of investments
in UBS AG and UBS Group AG instruments
held by the Swiss
pension fund
The following amounts have been received or paid by UBS AG
from
and
to
the
post-employment
benefit
plans
located
in
Switzerland,
the
UK,
the
US
and
Germany
in
respect
of
these
banking activities and arrangements.
Related-party disclosure
For the year ended
USD million
31.12.21
31.12.20
31.12.19
Received by UBS AG
Fees
22
19
19
Paid by UBS AG
Rent
2
3
2
Dividends, capital repayments and interest
5
10
10
The transaction volumes in UBS Group AG shares
and UBS AG debt instruments and the
balances of UBS Group AG shares held were:
Transaction volumes – UBS Group AG shares and UBS AG debt instruments
For the year ended
31.12.21
31.12.20
Financial instruments bought by pension funds
UBS Group AG shares (in thousands of shares)
847
1,677
UBS AG debt instruments (par values, USD million)
22
16
Financial instruments sold by pension funds or matured
UBS Group AG shares (in thousands of shares)
1,505
2,556
UBS AG debt instruments (par values, USD million)
22
4
UBS Group AG shares held by post-employment
benefit plans
31.12.21
31.12.20
Number of shares (in thousands of shares)
13,456
14,112
Fair value (USD million)
241
199
519
Note 28
Employee benefits: variable compensation
a) Plans offered
UBS
has
several
share-based
and
other
deferred
compensation
plans
that
align
the
interests
of
Group
Executive
Board
(GEB)
members and other employees with the interests of investors.
Share-based awards are granted in the form of notional shares
and, where
permitted,
carry a dividend
equivalent
that may be
paid
in
notional
shares
or
cash.
Awards
are
settled
by
delivering
UBS
shares
at vesting,
except
in jurisdictions
where
this
is not
permitted
for legal
or tax
reasons.
Deferred compensation awards are
generally forfeitable upon,
among other circumstances,
voluntary termination
of employment
with UBS. These
compensation plans
are
also designed
to
meet
regulatory
requirements
and
include
special
provisions
for
regulated employees.
The most significant
deferred compensation
plans are described
below.
For
the
majority
of
variable
compensation
awards
granted
under such
plans to
employees of
UBS AG,
the grantor
entity is
UBS
Group
AG.
Expenses
associated
with
these
awards
are
charged
by UBS
Group AG
to UBS
AG. For
the purpose
of
this
Note, references to shares refer to UBS Group AG shares.
›
Refer to Note 1a
item 5 for a description of the accounting
policy
related to share-based and other deferred compensation
plans
Mandatory
deferred
compensation
plans
The Long-Term Incentive Plan
The
Long-Term
Incentive
Plan
(LTIP)
is
a
mandatory
deferred
share-based
compensation plan
for senior
leaders of
the Group
(i.e., GEB members and selected senior management).
The number of notional
shares delivered at
vesting depends on
two
equally
weighted
performan
ce
metrics
over
a
three
-
year
performance
period:
reported
return
on
common
equity
tier
1
capital and relative
total shareholder return,
which measures the
performance
of
UBS
against
an
index
of
Global
Systemically
Important Banks as determined by the Financial Stability Board.
The final number of shares will vest in three
equal installments in
each of the three years
following the performance period for
GEB
members, and cliff
vest in the
first year
following the performance
period for selected senior management.
The Equity
Ownership
Plan
The
Equity
Ownership
Plan
(EOP)
is
a
deferred
share-based
compensation
plan
for
employees
who
are
subject
to
deferral
requirements but
do not
receive LTIP
awards. Vesting
under the
EOP
generally
occurs
in
equal
installments
two
and
three
years
after
grant,
subject
to
continued
employment
and,
in
certain
cases, achievement of defined performance conditions.
Asset Management employees receive some or all of
their EOP
in
the
form
of
cash-settled
notional
investment
funds.
The
amount
delivered
depends
on
the
value
of
the
underlying
investment funds at the time of vesting.
The Deferred
Contingent
Capital
Plan
The
Deferred
Contingent
Capital
Plan
(DCCP)
is
a
deferred
compensation plan for all
employees who are
subject to deferral
requirements.
Such employees
are awarded
notional additional
tier
1 (AT1) capital
instruments,
which, at
the discretion
of UBS, can
be
settled as a cash
payment or a perpetual, marketable AT1
capital
instrument. DCCP
awards
generally
vest
in
full
after
five
years,
unless the
award is
written down
following the
occurrence of
a
viability
event (as
defined under
the terms
of an AT1 instrument)
or
if the
Group’s CET1 capital
ratio falls below
a defined
threshold.
Additional performance
conditions
apply to GEB
members.
Interest payments
on DCCP awards
are paid at the
discretion of
UBS.
Where interest
payments
are not
permitted,
such
as for
certain
regulated employees,
the DCCP
award reflects
the fair value
of the
granted non-interest-bearing
award.
Financial advisor variable compensation
In
line
with
market
prac
tice
for
US
wealth
management
businesses, the compensation for US financial advisors in Global
Wealth Management
predominantly includes
production payout
and
deferred
compensation
awards.
Production
payout
is
primarily based
on compensable revenue.
Financial advisors
may
also qualify
for deferred
compensation awards,
which generally
vest over
a six-year
period. These
awards are
based on
strategic
performance
measures,
including
production
and
length
of
service
with
UBS.
Production
payout
rates
and
deferred
compensation awards
may be
reduced for,
among other
things,
errors,
negligence or
carelessness, or
failure to
comply with
the
firm’s
rules,
standards,
practices
and
/
or
policies,
and
/
or
applicable laws and regulations.
Financial advisor
compensation also
includes expenses
related
to
compensation
commitments
with
financial
advisors
entered
into
at
the
time
of
recruitment
that
are
subject
to
vesting
requirements.
Consolidated financial statements | UBS AG consolidated financial statements
520
Note 28
Employee benefits: variable compensation (continued)
b) Effect on the income statement
Effect
on the
income
statement
for the
financial
year and
future
periods
The table
below
provides
information
about
compensation
expenses
related to
total variable compensation, including financial advisor
variable compensation,
that were
recognized in the
financial year
ended 31 December
2021, as well as expenses
that were deferred
and will be
recognized
in the income
statement
for 2022 and
later.
The majority
of expenses
deferred
to 2022
and later
that are
related
to the
2021
performance
year
pertain
to awards
granted
in February
2022.
The total
unamortized compensation
expense for unvested
share
-
based
awards
granted
up
to
31
December
2021
will
be
recognized
in future periods
over a weighted
average
period of
2.5
years.
Variable compensation including financial advisor variable
compensation
Expenses recognized in 2021
Expenses deferred to 2022 and later
1
USD million
Related to the
2021
performance
year
Related to prior
performance
years
Total
Related to the
2021
performance
year
Related to prior
performance
years
Total
Non-deferred cash
2,136
(
8
)
2,128
0
0
0
Deferred compensation awards
389
399
788
767
606
1,373
of which: Equity Ownership Plan
175
174
350
374
180
553
of which: Deferred Contingent Capital Plan
134
151
285
290
318
608
of which: Long-Term Incentive Plan
51
17
69
48
32
79
of which: Asset Management EOP
29
55
84
56
77
133
Variable compensation – performance awards
2,525
391
2,916
767
606
1,373
Variable compensation – other
2
163
33
196
210
178
388
Total variable compensation excluding financial advisor variable compensation
2,688
424
3,112
978
784
1,762
Financial advisor variable compensation
4,134
248
4,382
434
641
1,075
of which: non-deferred cash
3,858
(
6
)
3,853
0
0
0
of which: deferred share-based awards
106
51
157
123
146
269
of which: deferred cash-based awards
170
202
372
311
495
806
Compensation commitments with recruited financial advisors
3
41
438
479
662
1,682
2,344
Total FA variable compensation
4,175
685
4,860
1,097
2,323
3,419
Total variable compensation including FA variable compensation
6,863
1,109
7,973
4
2,074
3,107
5,181
1 Estimate as
of 31 December
2021. Actual
amounts to be
expensed in future
periods may vary,
e.g., due
to forfeiture of
awards.
2 Consists of
replacement payments,
forfeiture credits,
severance payments,
retention plan payments and interest
expense related to the Deferred Contingent
Capital Plan.
3 Reflects expenses related to
compensation commitments with financial advisors entered into
at the time of recruitment
that are subject to
vesting requirements. Amounts
reflected as deferred expenses
represent the maximum
deferred exposure as of
the balance sheet date.
Amounts in the “Related
to the 2021 performance
year”
columns represent commitments entered into
in 2021.
4 Includes USD
631
million in expenses related to share-based
compensation (performance awards: USD
419
million; other variable compensation:
USD
56
million; financial advisor compensation: USD
157
million). A further USD
77
million in expenses related to share-based compensation was recognized within other expense categories included in Note 6 (salaries: USD
5
million related to role-based allowances; social security: USD
59
million; other personnel expenses: USD
13
million related to the Equity Plus Plan).
521
Note 28
Employee benefits: variable compensation (continued)
Variable compensation including financial advisor variable
compensation (continued)
Expenses recognized in 2020
Expenses deferred to 2021 and later
1
USD million
Related to the
2020
performance
year
Related to prior
performance
years
Total
Related to the
2020
performance
year
Related to prior
performance
years
Total
Non-deferred cash
1,948
(
29
)
1,920
0
0
0
Deferred compensation awards
329
704
1,034
734
277
1,011
of which: Equity Ownership Plan
131
315
446
298
67
365
of which: Deferred Contingent Capital Plan
108
339
448
271
189
459
of which: Long-Term Incentive Plan
41
11
52
46
9
55
of which: Asset Management EOP
49
39
88
120
12
132
Variable compensation – performance awards
2,278
675
2,953
734
277
1,011
Variable compensation – other
2
109
92
201
176
189
364
Total variable compensation excluding financial advisor variable compensation
2,387
768
3,155
909
465
1,375
Financial advisor variable compensation
3,356
233
3,589
350
602
952
of which: non-deferred cash
3,154
0
3,154
0
0
0
of which: deferred share-based awards
69
50
119
79
135
214
of which: deferred cash-based awards
133
183
316
271
467
738
Compensation commitments with recruited financial advisors
3
22
480
502
473
1,682
2,155
Total FA variable compensation
3,378
713
4,091
822
2,284
3,106
Total variable compensation including FA variable compensation
5,765
1,481
7,246
4
1,732
2,749
4,481
1 Estimate as of 31
December 2020. Actual amounts to be
expensed in future periods may vary, e.g., due to forfeiture of
awards.
2 Consists of replacement payments, forfeiture credits, severance payments, retention
plan payments and interest expense related
to the Deferred Contingent Capital Plan.
3 Reflects expenses related to compensation
commitments with financial advisors entered
into at the time of recruitment
that
are subject to vesting requirements. Amounts reflected as deferred expenses represent the maximum deferred exposure as of the balance sheet date.
Amounts in the “Related to the 2020 performance year” columns
represent commitments entered into
in 2020.
4 Includes USD
666
million in expenses related
to share-based compensation
(performance awards: USD
498
million; other variable compensation:
USD
49
million;
financial advisor compensation: USD
119
million). A further USD
88
million in expenses related to share-based compensation was recognized within
other expense categories included in Note 6 (salaries: USD
4
million
related to role-based allowances; social security: USD
51
million; other personnel expenses: USD
34
million related to the Equity Plus Plan).
Variable compensation including financial advisor variable
compensation (continued)
Expenses recognized in 2019
Expenses deferred to 2020 and later
1
USD million
Related to the
2019
performance
year
Related to prior
performance
years
Total
Related to the
2019
performance
year
Related to prior
performance
years
Total
Non-deferred cash
1,706
(
24
)
1,682
0
0
0
Deferred compensation awards
287
576
863
413
592
1,005
of which: Equity Ownership Plan
115
294
410
198
213
412
of which: Deferred Contingent Capital Plan
109
256
365
166
356
521
of which: Long-Term Incentive Plan
38
0
38
23
0
23
of which: Asset Management EOP
25
26
51
26
23
49
Variable compensation – performance awards
1,993
553
2,545
413
592
1,005
Variable compensation – other
2
140
85
225
115
228
343
Total variable compensation excluding financial advisor variable compensation
2,133
638
2,770
528
820
1,348
Financial advisor variable compensation
3,233
268
3,501
197
710
907
of which: non-deferred cash
3,064
0
3,064
0
0
0
of which: deferred share-based awards
57
48
106
54
130
183
of which: deferred cash-based awards
112
219
331
144
580
724
Compensation commitments with recruited financial advisors
3
32
510
542
350
1,617
1,967
Total FA variable compensation
3,265
778
4,043
548
2,327
2,874
Total variable compensation including FA variable compensation
5,398
1,416
6,814
4
1,076
3,146
4,222
1 Estimate as of 31 December 2019. Actual amounts expensed may vary, e.g.,
due to forfeiture of awards.
2 Consists of replacement payments, forfeiture credits, severance payments,
retention plan payments and
interest expense related to the Deferred Contingent Capital Plan.
3 Reflects expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting
requirements. Amounts reflected as deferred expenses
represent the maximum deferred exposure
as of the balance sheet
date.
Amounts in the “Related to
the 2019 performance year”
columns represent commitments
entered into in
2019.
4 Includes USD
595
million in expenses related
to share-based compensation (performance
awards: USD
448
million; other variable compensation: USD
42
million; financial advisor compensation:
USD
106
million). A
further USD
54
million in
expenses related
to share-based
compensation was
recognized within
other expense
categories included
in Note
6 (salaries:
USD
10
million related
to role-based
allowances; social security: USD
23
million; other personnel expenses: USD
22
million related to the Equity Plus Plan).
Consolidated financial statements | UBS AG consolidated financial statements
522
Note 28
Employee benefits: variable compensation (continued)
c) Outstanding share-based compensation awards
Share and performance share awards
Movements in outstanding share-based awards under the EOP during 2021 and 2020 are provided in the table below.
The awards presented are granted by UBS AG, but are based on UBS Group AG shares.
Movements in outstanding share-based compensation
awards
Number of shares
2021
Weighted
average grant
date fair
value (USD)
Number of shares
2020
Weighted
average grant
date fair
value (USD)
Outstanding, at the beginning of the year
54,557
13
90,443
14
Awarded during the year
278,756
15
19,229
11
Distributed during the year
(
24,176
)
13
(
55,114
)
14
Forfeited during the year
(
13,215
)
15
0
0
Outstanding, at the end of the year
295,921
15
54,557
13
of which: shares vested for accounting purposes
116,775
53,216
The total carrying amount of the liability related to cash-settled share-based awards as of 31 December 2021 and 31 December 2020
was USD
3
million and USD
1
million, respectively.
d) Valuation
UBS share awards
UBS
measures
compensation
expense
based
on
the
average
market price
of UBS
shares on
the grant
date as
quoted on
the
SIX
Swiss
Exchange,
taking
into
consideration
post-vesting
sale
and
hedge
restrictions,
non-vesting
conditions
and
market
conditions, where
applicable. The
fair value
of the
share awards
subject to
post-vesting sale
and hedge
restrictions is
discounted
on the basis of
the duration of the
post-vesting restriction and is
referenced to
the cost
of purchasing
an at-the-money
European
put option for the term of the transfer restriction. The grant date
fair
value
of
notional
shares
without dividend
entitlements also
includes
a
deduction
for
the
present
value
of
future
expected
dividends to be paid between the grant date and distribution.
523
Note 29
Interests in subsidiaries and other entities
a) Interests in subsidiaries
UBS AG
defines its
significant subsidiaries
as those
entities that,
either individually or in aggregate, contribute significantly to UBS
AG’s
financial
position
or
results
of
operations,
based
on
a
number
of
criteria,
including
the
subsidiaries’
equity
and
contribution to UBS AG’s
total assets and profit
or loss before tax,
in
accordance
with
the
requirements
set
by
IFRS
12,
Swiss
regulations
and
the
rules
of
the
US
Securities
and
Exchange
Commission (the SEC).
Individually significant subsidiaries
The table below lists UBS AG’s individually significant subsidiaries
as of
31 December 2021.
Unless otherwise
stated, the
subsidiaries
listed below have share capital
consisting solely of ordinary
shares
held entirely by UBS
AG, and the
proportion of ownership
interest
held is equal to the voting rights held by UBS AG.
The country where the respective registered office is located is
also the
principal place
of business.
UBS AG
operates through
a
global branch network and
a significant proportion of
its business
activity is conducted outside Switzerland, including in
the UK, the
US, Singapore, Hong Kong SAR and other countries.
UBS Europe
SE has
branches and
offices in
a number
of EU
Member States,
including Germany, Italy,
Luxembourg and Spain.
Share capital is
provided in the currency of the legally registered office.
Individually significant subsidiaries
of UBS AG as of 31 December 2021
1
Company
Registered office
Primary business
Share capital in million
Equity interest accumulated in %
UBS Americas Holding LLC
Wilmington, Delaware, USA
Group Functions
USD
4,150.0
2
100.0
UBS Americas Inc.
Wilmington, Delaware, USA
Group Functions
USD
0.0
100.0
UBS Asset Management AG
Zurich, Switzerland
Asset Management
CHF
43.2
100.0
UBS Bank USA
Salt Lake City, Utah, USA
Global Wealth Management
USD
0.0
100.0
UBS Europe SE
Frankfurt, Germany
Global Wealth Management
EUR
446.0
100.0
UBS Financial Services Inc.
Wilmington, Delaware, USA
Global Wealth Management
USD
0.0
100.0
UBS Securities LLC
Wilmington, Delaware, USA
Investment Bank
USD
1,283.1
3
100.0
UBS Switzerland AG
Zurich, Switzerland
Personal & Corporate Banking
CHF
10.0
100.0
1 Includes direct and indirect subsidiaries of UBS AG.
2 Consists of common share capital of USD
1,000
and non-voting preferred share capital of USD
4,150,000,000
.
3 Consists of common share capital of USD
100,000
and non-voting preferred share capital of USD
1,283,000,000
.
Consolidated financial statements | UBS AG consolidated financial statements
524
Note 29
Interests in subsidiaries and other entities (continued)
Other subsidiaries
The table below lists
other direct and
indirect subsidiaries of
UBS AG that are
not individually significant but
contribute to UBS AG’s
total assets and aggregated profit before tax thresholds and are thus disclosed in accordance with requirements
set by the SEC.
Other subsidiaries of UBS AG as of 31
December 2021
Company
Registered office
Primary business
Share capital in million
Equity interest
accumulated in %
UBS Asset Management (Americas) Inc.
Wilmington, Delaware, USA
Asset Management
USD
0.0
100.0
UBS Asset Management (Hong Kong) Limited
Hong Kong SAR, China
Asset Management
HKD
254.0
100.0
UBS Asset Management Life Ltd
London, United Kingdom
Asset Management
GBP
15.0
100.0
UBS Asset Management Switzerland AG
Zurich, Switzerland
Asset Management
CHF
0.5
100.0
UBS Business Solutions US LLC
Wilmington, Delaware, USA
Group Functions
USD
0.0
100.0
UBS Credit Corp.
Wilmington, Delaware, USA
Global Wealth Management
USD
0.0
100.0
UBS (France) S.A.
Paris, France
Global Wealth Management
EUR
133.0
100.0
UBS Fund Management (Luxembourg) S.A.
Luxembourg, Luxembourg
Asset Management
EUR
13.0
100.0
UBS Fund Management (Switzerland) AG
Basel, Switzerland
Asset Management
CHF
1.0
100.0
UBS (Monaco) S.A.
Monte Carlo, Monaco
Global Wealth Management
EUR
49.2
100.0
UBS O‘Connor LLC
Wilmington, Delaware, USA
Asset Management
USD
1.0
100.0
UBS Realty Investors LLC
Boston, Massachusetts, USA
Asset Management
USD
9.0
100.0
UBS Securities Australia Ltd
Sydney, Australia
Investment Bank
AUD
0.3
1
100.0
UBS Securities Hong Kong Limited
Hong Kong SAR, China
Investment Bank
HKD
4,154.2
100.0
UBS Securities Japan Co., Ltd.
Tokyo, Japan
Investment Bank
JPY
34,708.7
100.0
UBS SuMi TRUST Wealth Management Co., Ltd.
Tokyo, Japan
Global Wealth Management
JPY
5,165.0
51.0
1 Includes a nominal amount relating to redeemable preference shares.
Consolidated structured entities
Consolidated structured
entities (SEs)
include certain
investment
funds, securitization
vehicles and client
investment vehicles.
UBS
AG has no individually significant subsidiaries that are SEs.
In 2021 and 2020, UBS AG
did not enter into any contractual
obligation that could require UBS AG to provide financial support
to consolidated SEs. In addition, UBS AG did
not provide support,
financial
or
otherwise,
to a
consolidated SE
when
UBS AG
was
not contractually obligated
to do so,
nor does UBS
AG have any
intention
to
do
so
in
the
future.
Furthermore,
UBS
AG
did
not
provide
support,
financial
or
otherwise,
to
a
previously
unconsolidated
SE
that
resulted
in
UBS
AG
controlling
the
SE
during the reporting period.
525
Note 29
Interests in subsidiaries and other entities (continued)
b) Interests in associates and joint ventures
As of 31 December 2021 and 2020, no associate or joint venture
was
individually
material
to
UBS
AG
.
Also
,
there
were
no
significant restrictions on the ability of
associates or joint ventures
to transfer
funds to
UBS AG
or its subsidiaries
as cash
dividends
or
to
repay
loans
or
advances
made.
There
were
no
quoted
market prices for any associates or joint ventures of UBS AG.
Investments in associates and joint ventures
USD million
2021
2020
Carrying amount at the beginning of the year
1,557
1,051
Additions
1
388
Reclassifications
1
(
386
)
0
Share of comprehensive income
150
83
of which: share of net profit
2
105
84
of which: share of other comprehensive income
3
45
(
1
)
Share of changes in retained earnings
1
(
40
)
Dividends received
(
39
)
(
33
)
Foreign currency translation
(
39
)
108
Carrying amount at the end of the year
1,243
1,557
of which: associates
1,200
1,513
of which: SIX Group AG, Zurich
4
1,043
965
of which: Clearstream Fund Centre AG, Zurich
1
399
of which: other associates
157
150
of which: joint ventures
43
44
1 In the second quarter
of 2021, UBS reclassified
its minority investment (
48.8
%) in Clearstream Fund
Centre AG (previously Fondcenter
AG) of USD
386
million to Properties and other
non-current assets held for
sale and sold the investment in the same quarter. Refer to Note 30 for more information.
2 For 2021, consists of USD
79
million from associates and USD
26
million from joint ventures. For 2020, consists of USD
64
million from associates
and USD
19
million from joint
ventures.
3 For 2021,
consists of USD
44
million from associates
and USD
1
million from joint
ventures. For
2020, consists of
negative USD
1
million from
associates.
4 In 2021, UBS AG’s equity interest amounted to
17.31
%. UBS AG is represented on the Board of Directors.
Consolidated financial statements | UBS AG consolidated financial statements
526
Note 29
Interests in subsidiaries and other entities (continued)
c) Unconsolidated structured entities
UBS AG is considered
to sponsor another entity
if, in addition to
ongoing
involvement
with
the
entity,
it
had
a
key
role
in
establishing
that
entity
or
in
bringing
together
relevant
counterparties
for a
transaction facilitated
by the
entity.
During
2021
,
U
BS
AG
sponsored
the
creation
of
various
SEs
and
interacted
with
a
number
of
non-sponsored
SEs,
including
securitization
vehicles,
client
vehicles
and
certain
investment
funds, that UBS AG did not consolidate as of 31 December 2021
because it did not control
them.
Interests in unconsolidated structured entities
The
table
below
presents
UBS
AG’s
interests
in
and
maximum
exposure
to
loss
from
unconsolidated
SEs,
as
well
as
the
total
assets held
by the
SEs in
which UBS
had an
interest as
of year-
end,
except for
investment funds sponsored
by third
parties, for
which the
carrying amount
of UBS
AG’s interest
as of
year-end
has been disclosed.
Sponsored
unconsolidated
structured
entities
in
which
UBS
did
not have an interest at year-end
During
2021
and
2020,
UBS
AG
did
not
earn
material
income
from sponsored
unconsolidated SEs
in which
UBS AG
did not
have
an interest at year-end.
During
2021
and
2020,
UBS
AG
and
third
parties
did
not
transfer any
assets into
sponsored securitization
vehicles created
in the year. UBS AG and
third parties transferred assets, alongside
deposits
and
debt
issuances
(which
are
assets
from
the
perspective
of
the
vehicle),
of
USD
1
billion
and
USD
2
billion,
respectively, into sponsored client vehicles created in 2021 (2020:
USD
0
billion
and
USD
9
billion,
respectively).
For
sponsored
investment
funds, transfers
arose during
the period
as investors
invested
and
redeemed
positions,
thereby
changing
the
overall
size
of
the
funds,
which,
when
combined
with
market
movements, resulted in
a total closing net
asset value of
USD
46
billion (31 December 2020: USD
37
billion).
Interests in unconsolidated structured entities
31.12.21
USD million, except where indicated
Securitization
vehicles
Client
vehicles
Investment
funds
Total
Maximum
exposure to loss
1
Financial assets at fair value held for trading
246
162
6,743
7,151
7,151
Derivative financial instruments
5
45
155
205
205
Loans and advances to customers
125
125
125
Financial assets at fair value not held for trading
35
100
135
135
Financial assets measured at fair value through other comprehensive
income
324
4,525
4,849
4,849
Other financial assets measured at amortized cost
0
2
0
1
250
Total assets
610
3
4,732
7,124
12,466
Derivative financial instruments
2
11
281
294
Total liabilities
2
11
281
294
Assets held by the unconsolidated structured entities in which UBS AG had
an
interest (USD billion)
30
4
81
5
103
6
31.12.20
USD million, except where indicated
Securitization
vehicles
Client
vehicles
Investment
funds
Total
Maximum
exposure to loss
1
Financial assets at fair value held for trading
375
131
7,595
8,101
8,101
Derivative financial instruments
6
49
158
213
211
Loans and advances to customers
179
179
179
Financial assets at fair value not held for trading
35
1
2
73
109
109
Financial assets measured at fair value through other comprehensive
income
6,624
6,624
6,624
Other financial assets measured at amortized cost
0
2
0
250
Total assets
416
3
6,805
8,005
15,227
Derivative financial instruments
3
11
376
390
0
Total liabilities
3
11
376
390
Assets held by the unconsolidated structured entities in which UBS AG had
an
interest (USD billion)
39
4
136
5
89
6
1 For the purpose of this disclosure, maximum exposure to loss amounts do not consider the risk-reducing effects of collateral or other credit enhancements.
2 Represents the carrying amount of loan commitments.
The maximum exposure to loss for these instruments is equal
to the notional amount.
3 As of 31 December 2021, USD
0.1
billion of the USD
0.6
billion (31 December 2020: USD
0.2
billion of the USD
0.4
billion)
was held in Group Functions – Non-core and Legacy Portfolio.
4 Represents the principal amount outstanding.
5 Represents the market value of total assets.
6 Represents the net asset value of the investment
funds sponsored by
UBS AG and
the carrying amount
of UBS AG’s
interests in the
investment funds
not sponsored by
UBS AG.
In 2021, UBS
AG updated
the presentation of
this table to
remove its interests
in
unconsolidated structured investment funds and the corresponding total asset information, where UBS AG’s
interest is driven solely from UBS AG’s role as the fund’s
investment manager and the fees it receives. This
information is now separately disclosed in the accompanying text on the following page. Prior-period
information has been aligned with this new presentation.
527
Note 29
Interests in subsidiaries and other entities (continued)
UBS AG retains or purchases interests in unconsolidated SEs in
the form
of direct
investments, financing,
guarantees, letters
of
credit,
derivatives,
as
well
as
through
management
contracts.
UBS AG’s
maximum
exposure
to
loss
is
generally
equal
to
the
carrying amount of UBS
AG’s interest in the SE,
with this subject
to change over time with market movements. Guarantees,
letters
of
credit
and
credit
derivatives
are
an
exception,
with
the
contract’s notional
amount, adjusted
for losses already
incurred,
representing the maximum loss that UBS AG is exposed to.
The
maximum exposure
to loss
disclosed in
the table
on the
previous
page
does
not
reflect
UBS
AG’s
risk
management
activities, including effects from
financial instruments that may
be
used to economically
hedge risks inherent
in the unconsolidated
SE
or
risk-reducing
effects
of
collateral
or
other
credit
enhancements.
In 2021 and
2020, UBS AG
did not provide
support, financial
or
otherwise,
to
an
unconsolidated
SE
when
not
contractually
obligated to do so, nor does UBS AG have any intention to do so
in the future.
In
2021
and
2020,
income
and
expenses
from
interests
in
unconsolidated
SEs
primarily
resulted
from
mark-to-market
movements
recognized
in
Other
net
income
from
financial
instruments
measured at fair
value through profit
of loss
, which
have generally been
hedged with other financial
instruments, as
well
as
fee
and
commission
income
received
from
UBS-
sponsored
funds.
Interests in securitization vehicles
As of
31 December 2021
and 31 December
2020, UBS AG
held
interests,
both
retained
and
acquired,
in
various
securitization
vehicles that relate
to financing, underwriting, secondary
market
and derivative trading activities.
The numbers
outlined in
the table
on the previous
page may
differ
from
the
securitization
positions
presented
in
the
31
December
2021
Pillar
3
R
eport
,
available
under
“Pillar
3
disclosures”
at
ubs.com/investors
,
for
the
following
reasons:
(i) exclusion
of synthetic
securitizations
transacted
with entities
that are not SEs
and transactions
in which UBS
AG did not have
an
interest
because
it
did
not
absorb
any
risk;
(ii)
a
different
measurement
basis
in certain
cases
(e.g.,
IFRS
carrying
amount
within
the previous
table
compared
with net
exposure
amount
at default for
Pillar 3 disclosures)
;
and (iii) different
classification
of vehicles viewed
as sponsored by UBS
AG versus sponsored
by
third parties.
›
Refer to the 31 December 2021 Pillar 3
Report,
available under
“Pillar 3 disclosures” at
ubs.com/investors
,
for more information
Interests in client vehicles
Client
vehicles are
established predominantly
for
clients to
gain
exposure
to specific
assets or
risk exposures.
Such vehicles
may
enter
into
derivative
agreements,
with
UBS
or
a
third
party,
to
align
the
cash
flows
of
the
entity
with
the
investor’s
intended
investment objective,
or to introduce other
desired risk exposures.
As
of
31 December
2021
and
31 December
2020,
UBS
AG
retained
interests
in
client
vehicles
sponsored
by
UBS
and
third
parties that
relate to
financing, secondary
market and
derivative
trading activities, and to hedge structured product offerings.
Interests in investment funds
Investment funds have
a collective investment
objective, and are
either passively
managed, so
that any
decision making
does not
have a
substantive effect
on variability,
or are
actively managed
and investors
or their
governing bodies
do not
have substantive
voting or similar rights.
UBS
AG
holds
interests
in
a
number
of
investment
funds,
primarily
resulting
from
seed
investments
or
in
order
to
hedge
structured product offerings. In addition to the interests disclosed
in the table on the previous page, UBS AG manages the assets of
various pooled
investment funds
and receives
fees based,
in whole
or
part,
on
the
net
asset
value
of
the
fund
and
/
or
the
performance of the fund. The specific fee structure is determined
based on various
market factors and considers
the fund’s nature
and
the
jurisdiction
of
incorporation,
as
well
as
fee
schedules
negotiated with clients. These
fee contracts represent an interest
in
the
fund,
as
they
align
UBS
AG’s
exposure
with
investors,
providing
a
variable
return
based
on
the
performance
of
the
entity. Depending on the structure of
the fund, these fees may
be
collected
directly
from
the
fund
’s
assets
and
/
or
from
the
investors. Any
amounts due are
collected on
a regular
basis and
are
generally
backed
by
the
fund’s
assets.
Therefore
interest
in
such
funds
is
not
represented
by
the
on-balance
sheet
fee
receivable but rather by the
future exposure to variable fees. The
total
assets
of
such
funds
were
USD
425
billion
and
USD
395
billion
as
of
31
December
2021
and
31
De
cember
2020,
respectively,
and
have
been
excluded
from
the
table
on
the
previous page. UBS AG
did not have any
material exposure to loss
from
these
interests
as
of
31
December
2021
or
as
of
31 December 2020.
Consolidated financial statements | UBS AG consolidated financial statements
528
Note 30
Changes in organization and acquisitions and disposals of subsidiaries and businesses
Strategic partnership with Sumitomo Mitsui Trust Holdings
In
2019,
UBS
AG
entered
into
a
strategic
wealth
management
partnership
in
Japan
with
Sumitomo
Mitsui Trust
Holdings, Inc.
(SuMi
Trust
Holdings).
In
January
2020,
the
first
phase
was
launched, with
operations commencing in
the joint
venture that
was established
to promote
the respective
services. At
the time,
UBS
AG
and
SuMi
Trust
Holdings
also
started
offering
each
other’s products and services to their respective clients.
In
the
third
quarter
of
2021,
the
second
phase
of
the
partnership was completed, with the
launch of a new operational
partnership
entity,
UBS
SuMi
TRUST
Wealth
Management
Co.,
Ltd., which
is
51
%-owned and
controlled by
UBS AG,
requiring
UBS
AG
to
consolidate
this
entity.
The
new
entity
offers
global
securities and wealth management capabilities,
together with the
custody, real
estate, inheritance
and wealth
transfer expertise of
a
Japanese
trust
banking
group.
Upon
completion
of
this
transaction in
the third
quarter of
2021, shareholders’
equity of
UBS AG increased by USD
155
million, with no effect on profit or
loss.
Disposals of subsidiaries and businesses
Sale of remaining investment in Clearstream Fund Centre AG
In the second
quarter of 2021,
UBS AG sold
its remaining minority
investment in Clearstream Fund Centre
AG to Deutsche Börse
AG
for
CHF
390
million.
The
transaction
followed
the
sale
of
a
majority
investment
and
successful
transfer
of
control
of
Fondcenter
AG
to
Deutsche
Börse
AG
in
2020,
when
UBS
AG
recognized
a
post-tax gain
on sale
of
USD
631
million
in
Other
income
. The sale of
the remaining
48.8
% investment resulted
in
a post-tax gain of USD
37
million in 2021, which was recognized
in
Other income
, with no
associated net tax
expense. Long-term
commercial
cooperation
arrangements
remain
in
place
for
the
provision
of
services
by
Clearstream
to
UBS,
including
jointly
servicing banks and insurance companies.
Sale of wealth management business in Austria
In
the third
quarter
of 2021,
UBS AG
completed the
sale of
its
domestic wealth management
business in Austria
to LGT. The sale
resulted
in
a
pre-tax
gain
of
USD
100
million,
which
was
recognized
in
Other
income
,
and
an
associated
tax
expense
of
USD
25
million.
Sale of wealth management business in Spain in 2022
In October 2021,
UBS AG signed
an agreement to
sell its
domestic
wealth
management
business
in
Spain
to
Singular
Bank.
The
agreement
includes
the
transition
of
employees,
client
relationships,
products
and services
of
the
wealth management
business
of
UBS
AG
in
Spain.
The
transaction
is
subject
to
customary closing conditions and is expected to close in the third
quarter of 2022.
As
of
31 December
2021,
the
assets
and
liabilities
of
the
business
were
presented
in
Global
Wealth
Management
as
a
disposal group held for sale within
Other non-financial assets
and
Other non-financial
liabilities
and amounted
to USD
647
million
and
USD
823
million,
respectively.
Upon
the
closing
of
the
transaction,
UBS
AG
expects
to
record
a
pre
-
tax
gain
of
approximately USD
0.2
billion.
Sale of UBS Swiss Financial Advisers AG in 2022
In December 2021,
UBS AG signed
an agreement to sell
its wholly
owned
subsidiary
UBS
Swiss
Financial
Advisers
AG
(SFA)
to
Vontobel.
SFA
is
an
SEC-registered
investment
advisor
and
FINMA-licensed
securities
firm
that
offers
US
clients
tailored
investment
solutions
in
a
Switzerland-based
environment.
The
transaction
is
subject
to
customary
closing
conditions
and
regulatory approvals and is
expected to close in the
third quarter
of 2022.
As
of
31 December
2021,
the
assets
and
liabilities
that
are
subject
to
the
transaction
were
presented
in
Global
Wealth
Management as a disposal group held for sale within
Other non-
financial assets
and
Other non-financial
liabilities
and amounted
to USD
446
million and
USD
475
million, respectively.
Upon the
closing
of
the
transaction,
UBS
AG
does
not
expect
a
material
effect on profit or loss or shareholders’ equity.
Acquisitions of subsidiaries and businesses in 2022
Acquisition of Wealthfront in 2022
In January
2022, UBS
AG entered
into an
agreement to
acquire
Wealthfront,
an
industry-leading
digital
wealth
management
provider,
for
a
cash
consideration
of
USD
1.4
billion.
The
acquisition is aligned with UBS’s growth strategy
in the Americas,
will broaden
our reach
among affluent
investors and
will add
a
new
digital-first
offering
increasing
our
distribution
capabilities.
The
transaction
is
subject
to
customary
closing
conditions,
including
regulatory
approvals,
and
is
expected
to
close
in
the
second
half
of
2022.
Upon
the
closing
of
the
transaction,
Wealthfront
will become
a wholly
owned subsidiary
of UBS
AG
and UBS
AG expects
to recognize
additional goodwill
and other
intangible assets of approximately USD
1.2
billion.
529
Note 31
Related parties
UBS
AG
defines
related
parties
as
associates
(entities
that
are
significantly influenced
by UBS),
joint ventures
(entities in
which
UBS shares control with another party), post-employment benefit
plans for
UBS AG
employees, key
management personnel,
close
family members
of key management
personnel and entities
that
are,
directly
or
indirectly,
controlled
or
jointly
controlled
by
key
management
personnel
or
their
close
family
members.
Key
management
personnel
is
defined
as
members
of
the Board
of
Directors (BoD) and Executive Board (EB).
a) Remuneration of key management personnel
The
Chairman of
the
BoD
has a
specific
management
employment
contract and
receives
pension
benefits upon
retirement.
Total
remuneration of the Chairman of the BoD and all EB members is included in the table below.
Remuneration of key management
personnel
USD million, except where indicated
31.12.21
31.12.20
31.12.19
Base salaries and other cash payments
1
30
31
30
Incentive awards – cash
2
17
17
13
Annual incentive award under DCCP
26
26
20
Employer’s contributions to retirement benefit plans
2
2
2
Benefits in kind, fringe benefits (at market value)
1
1
1
Share-based compensation
3
45
45
34
Total
122
122
101
Total (CHF million)
4
112
115
101
1 May include role-based allowances in line with market practice
and regulatory requirements.
2 The cash portion may also include blocked
shares in line with regulatory requirements.
3 Compensation expense
is based on
the share price
on grant date
taking into account
performance conditions.
Refer to Note
27 for more
information. For
EB members, share
-based compensation for
2021, 2020 and
2019 was
entirely
composed of LTIP
awards. For the
Chairman of the BoD, the
share-based compensation for 2021, 2020
and 2019 was entirely composed
of UBS shares.
4 Swiss franc amounts disclosed represent
the respective
US dollar amounts translated at the applicable performance award currency exchange rates (2021: USD
/ CHF
0.92
; 2020: USD / CHF
0.94
; 2019: USD / CHF
0.99
).
The independent members
of the BoD
do not have
employment
or
service
contracts
with
UBS
AG,
and
thus
are
not
entitled
to
benefits upon termination
of their service
on the BoD.
Payments
to these
individuals for their
services as external
board members
amounted to USD
7.5
million (CHF
6.9
million) in 2021, USD
7.0
million
(CHF
6.6
million)
in
2020
and
USD
7.3
million
(CHF
7.3
million) in 2019.
b) Equity holdings of key management personnel
Equity holdings of key management personnel
1
31.12.21
31.12.20
Number of shares held by members of the BoD, EB and parties closely linked to them
2
4,175,515
4,956,640
1 No options were held in 2021 and 2020 by non-independent members
of the BoD and any GEB member or any of its related
parties.
2 Excludes shares granted under variable
compensation plans with forfeiture
provisions.
Of
the
share
totals
above,
no
shares
were
held
by
close
family
members of
key management
personnel on
31 December 2021
and 31 December 2020. No shares were
held by entities that are
directly
or
indirectly
controlled
or
jointly
controlled
by
key
management
personnel
or
their
close
family
members
on
31 December 2021 and
31 December 2020. As
of 31 December
2021,
no member of
the BoD or EB
was the beneficial owner
of
more than 1% of UBS Group AG’s shares.
Consolidated financial statements | UBS AG consolidated financial statements
530
Note 31
Related parties (continued)
c) Loans, advances and mortgages to key management personnel
The non-independent members
of the BoD and
EB members are
granted
loans,
fixed
advances
and
mortgages
in
the
ordinary
course of business
on substantially the same
terms and conditions
that are available to other employees, including
interest rates and
collateral,
and
neither
involve
more
than
the
normal
risk
of
collectability nor
contain any
other unfavorable
features
for the
firm.
Independent
BoD
members
are
granted
loans
and
mortgages in
the ordinary
course of
business at
general market
conditions.
Movements in the
loan, advances and
mortgage balances are
as follows.
Loans, advances and mortgages to key management
personnel
1
USD million, except where indicated
2021
2020
Balance at the beginning of the year
31
23
Additions
11
13
Reductions
(
15
)
(
5
)
Balance at the end of the year
2
28
31
Balance at the end of the year (CHF million)
2, 3
25
28
1 All loans are secured loans.
2 There were no unused uncommitted credit facilities as of 31 December
2021 and 31 December 2020.
3 Swiss franc amounts disclosed represent the respective US dollar amounts
translated at the relevant year-end closing exchange rate.
d) Other related-party transactions with entities controlled by key management personnel
In 2021
and 2020,
UBS AG
did not
enter into
transactions with
entities
that
are
directly
or
indirectly
controlled
or
jointly
controlled by UBS AG’s key management personnel or their close
family
members
and
as
of
31
December
2021
,
31
December
20
20
and
31
December
201
9
,
th
ere
were
no
outstanding
balances related
to such
transactions. Furthermore,
in 2021
and
2020, entities
controlled by
key management
personnel did
not
sell any
goods or
provide any
services to UBS
AG, and
therefore
did
not
receive
any
fees
from
UBS
AG.
UBS
AG
also
did
not
provide services to such entities in 2021 and 2020, and therefore
also received no fees.
531
Note 31
Related parties (continued)
e) Transactions with associates and joint ventures
Loans to and outstanding receivables from associates
and joint ventures
USD million
2021
2020
Carrying amount at the beginning of the year
630
982
Additions
133
527
Reductions
(
497
)
(
1,001
)
Foreign currency translation
(
14
)
123
Carrying amount at the end of the year
251
630
of which: unsecured loans and receivables
243
621
Other transactions with associates and
joint ventures
As of or for the year ended
USD million
31.12.21
31.12.20
Payments to associates and joint ventures for goods and services
received
157
139
Fees received for services provided to associates and joint ventures
104
128
Liabilities to associates and joint ventures
127
91
Commitments and contingent liabilities to associates
and joint ventures
7
9
›
Refer to Note 29 for an overview of investments
in associates and joint ventures
f) Receivables and payables from / to UBS Group AG and other subsidiaries of UBS Group AG
USD million
31.12.21
31.12.20
Receivables
Loans and advances to customers
1,049
1,470
Financial assets at fair value held for trading
187
76
Other financial assets measured at amortized cost
45
38
Payables
Customer deposits
2,828
3,324
Funding from UBS Group AG
57,295
53,979
Other financial liabilities measured at amortized cost
1,887
1,820
Other financial liabilities designated at fair value
1
2,340
1,375
1 Represents funding recognized from UBS Group AG that is designated at fair value. Refer to Note
19b for more information.
Consolidated financial statements | UBS AG consolidated financial statements
532
Note 32
Invested assets and net new money
The
following
disclosures
provide
a
breakdown
of
UBS
AG
’s
invested assets
and a
presentation of their
development, including
net
new
money,
as
required
by
the
Swiss
Financial
Market
Supervisory Authority.
Invested assets
Invested assets
consist of
all client
assets managed
by or
deposited
with
UBS
AG
for
investment
purposes.
Invested
assets
include
managed fund assets, managed institutional assets, discretionary
and
advisory
wealth management
portfolios,
fiduciary
deposits,
time
deposits,
savings
accounts,
and
wealth
management
securities
or
brokerage
accounts.
All
assets
held
for
purely
transactional
purposes
and
custody-only
assets,
including
corporate
client
assets
held
for
cash
management
and
transactional purposes, are excluded
from invested assets, as
the
Group only
administers the
assets and
does not
offer advice
on
how
they
should
be
invested.
Also
excluded
are
non-bankable
assets (e.g.,
art collections)
and deposits
from
third-party
banks
for funding or trading purposes.
Discretionary assets
are
defined as
client assets
that UBS
AG
decides how to invest. Other invested assets are
those where the
client
ultimately
decides
how
the
assets
are
invested.
When
a
single
product
is
created
in
one
business
division
and
sold
in
another, it is counted in both
the business division managing the
investment
and
the
one
distributing
it.
This
results
in
double
counting
within UBS
AG total
invested
assets, as
both business
divisions are independently providing a
service to their respective
clients, and both add value and generate revenue.
Net new money
Net new
money in
a reporting
period is
the amount
of invested
assets entrusted to UBS AG
by new and existing
clients, less those
withdrawn
by
existing
clients
and
clients
who
terminated
relationships
with UBS AG.
Net new
money is
calculated using
the direct
method, under
which
inflows
and
outflows
to
/
from
invested
assets
are
determined at the client level,
based on transactions. Interest and
dividend income from invested
assets are not counted as net new
money inflows. Market and currency movements,
as well as
fees,
commissions
and interest on loans
charged,
are excluded from
net
new
money,
as
are
effects
resulting
from
any
acquisition
or
divestment of
a
UBS
AG
subsidiary or
business. Reclassifications
between invested assets
and custody-only assets as
a
result of
a
change in service level
delivered are generally treated as net
new
money flows.
However, where the change in
service level directly
results
from an
externally
imposed
regulation
or a
strategic
decision
by UBS
AG to
exit a
market
or specific
service
offering,
the one-time
net effect
is reported
as
Other effects
.
The
Investment
Bank
does
not track
invested
assets
and
net
new
money.
However,
when
a
client
is
transferred
from
the
Investment Bank
to another
business division,
this may
produce
net new
money even though
the client assets
were already with
UBS AG.
Invested assets and net new money
As of or for the year ended
USD billion
31.12.21
31.12.20
Fund assets managed by UBS
419
397
Discretionary assets
1,705
1,459
Other invested assets
2,472
2,331
Total invested assets
1
4,596
4,187
of which: double counts
356
311
Net new money
1
159
127
1 Includes double counts.
Development of invested assets
USD billion
2021
2020
Total invested assets at the beginning of the year
1
4,187
3,607
Net new money
159
127
Market movements
2
339
359
Foreign currency translation
(
65
)
96
Other effects
(
24
)
(
1
)
of which: acquisitions / (divestments)
(
5
)
0
Total invested assets at the end of the year
1
4,596
4,187
1 Includes double counts.
2 Includes interest and dividend income.
533
Note 33
Currency translation rates
The following table shows the rates of
the main currencies used to translate
the financial information of UBS AG’s operations with
a
functional currency other than the US dollar into US dollars.
Closing exchange rate
Average rate
1
As of
For the year ended
31.12.21
31.12.20
31.12.21
31.12.20
31.12.19
1 CHF
1.10
1.13
1.09
1.07
1.01
1 EUR
1.14
1.22
1.18
1.15
1.12
1 GBP
1.35
1.37
1.37
1.29
1.28
100 JPY
0.87
0.97
0.91
0.94
0.92
1 Monthly income statement items of operations with a functional currency other than the US dollar are translated into US dollars using month-end rates. Disclosed average rates for a year represent an average of 12
month-end rates, weighted according to the income and expense volumes of all operations of UBS
AG with the same functional currency for each month. Weighted average rates for
individual business divisions may
deviate from the weighted average rates for UBS AG.
Note 34
Events after the reporting period
Russia’s invasion of Ukraine
Russia’s
invasion of
Ukraine on
24 February
2022
has triggered
disruptions
and
uncertainties
in
the
markets
and
the
global
economy,
as well as coordinated implementation
of sanctions by
Switzerland, the
United States,
the European
Union, the
United
Kingdom and
others against
Russia and,
certain Russian
entities
and
nationals.
These
events,
together
with
potential
counter-
sanctions and other
measures taken
by Russia, impact
UBS AG’s
businesses.
UBS
AG’s country
risk exposure
to Russia
was approximately
USD
0.6
billion
across
its
business
divisions
as
of
31 December
2021.
This
exposure
has
been
reduced
since
year-end 2021.
In
addition,
UBS
AG
is
currently
monitoring
settlement
risk
on
certain
open
transactions
with
Russian
bank
-
or
non
-
bank
counterparties
or
Russian
underlyings,
as
market
closures,
the
imposition of exchange
controls, sanctions or
other measures may
limit
our
ability
to
settle
existing
transactions
or
to
realize
on
collateral, which may result in unexpected increases in exposures.
UBS AG’s
balance sheet
as of
31 December 2021
also included
net assets of USD
51
million held in UBS AG’s Russian
subsidiary,
OOO
UBS
Bank.
As
of
3 March
2022,
UBS
AG
also
had
approximately USD
0.2
billion of
exposure arising from
reliance on
Russian assets as
collateral on Lombard
lending and other
secured
financing in Global Wealth Management.
As of 3 March
2022, UBS identified a small
number of Global
Wealth
Management
clients
subject
to
the
recently
introduced
sanctions with total loans outstanding of under USD
10
million.
UBS
AG
continues
to
closely
monitor
related
effects
on
its
financial
statements,
including
estimated
direct
and
indirect
impacts
on
expected
credit
loss
calculations
and
on
fair
value
measurement
of
assets,
liabilities
and
off-balance
sheet
exposures.
The
situation
continues
to
evolve
and
broader
implications
for
other
counterparties
of
UBS
AG,
including
financial
institutions,
are
not
possible
to
assess
at
this
time;
however,
there
were
no
material
adverse
effects
on
UBS
AG’s
financial statements as of 4 March 2022.
›
Refer to “Top and emerging risks” and “Country risk” in the
“Risk management and control” section and
to “Performance in
the financial services industry is affected by
market conditions
and the macroeconomic climate” in the “Risk
factors” section of
this report for more information
Consolidated financial statements | UBS AG consolidated financial statements
534
Note 35
Main differences between IFRS and Swiss GAAP
The consolidated financial statements of UBS AG are
prepared in
accordance
with
International
Financial
Reporting
Standards
(IFRS). The
Swiss Financial Market
Supervisory Authority
(FINMA)
requires
financial
groups
presenting
financial
statements
under
IFRS
to
provide
a
narrative
explanation
of
the
main
differences
between IFRS and Swiss generally accepted accounting principles
(
GAAP
)
(
the
FINMA
Accounting
Ordinance,
FINMA
Circular
2020/1
“Accounting –
banks” and
the
Banking
Ordinance
(the
BO)). Included
in this
Note are
the significant
differences
in the
recognition and measurement between
IFRS and the
provisions of
the BO and the guidelines of FINMA governing true and fair view
financial statement reporting pursuant
to Art. 25 to
Art. 42 of
the
BO.
1. Consolidation
Under IFRS,
all entities
that are
controlled
by the
holding entity
are consolidated. Under
Swiss GAAP,
controlled entities deemed
immaterial to the
Group or held
only temporarily are exempt
from
consolidation,
but
instead
are
recorded
as
participations
accounted
for
under
the
equity
method
of
accounting
or
as
financial
investments
measured
at
the
lower
of
cost
or
market
value.
2. Classification and measurement of financial assets
Under IFRS, debt instruments
are measured at amortized
cost, fair
value through
other comprehensive income
(FVOCI) or fair
value
through
profit
or
loss
(FVTPL),
depending
on
the
nature
of
the
business
model
within
which
the
asset
is
held
and
the
characteristics of
the contractual
cash flows
of the
asset.
Equity
instruments are accounted
for at FVTPL by
UBS AG. Under Swiss
GAAP, trading assets and derivatives
are measured at
FVTPL in
line
with IFRS.
However,
non-trading debt
instruments are
generally
measured at amortized
cost, even when
the assets are
managed
on
a
fair value
basis.
In
addition,
the measurement
of
financial
assets in the
form of
securities depends on
the nature of
the asset:
debt instruments not
held to maturity,
i.e., instruments available
for
sale,
and
equity
instruments
with
no
permanent
holding
intent, are classified as
Financial investments
and measured at the
lower
of
(amortized)
cost
or
market
value.
Market
value
adjustments up to the original cost amount and
realized gains or
losses upon disposal
of the investment
are recorded in the
income
statement
as
Other
income
from
ordinary
activities.
Equity
instruments
with
a
permanent
holding
intent
are
classified
as
participations in
Non-consolidated investments in
subsidiaries and
other
participations
and
are
measured
at
cost
less
impairment.
Impairment
losses
are
recorded
in
the
income
statement
as
Impairment
of investments
in non-consolidated
subsidiaries and
other participations.
Reversals of
impairments up
to the
original
cost
amount
and
realized
gains
or
losses
upon
disposal
of
the
investment are
recorded as
Extraordinary income
/
Extraordinary
expenses
.
3. Fair value option applied to financial liabilities
Under
IFRS,
UBS
AG
applies
the
fair
value
option
to
certain
financial liabilities not held for trading. Instruments for which the
fair
value
option
is
applied
are
accounted
for
at
FVTPL.
The
amount
of
change
in
the
fair
value
attributable
to
changes
in
UBS AG’s own credit
is presented in
Other comprehensive income
directly within
Retained earnings
. The fair value option
is applied
primarily
to
issued
structured
debt
instruments
,
certain
non
-
structured
debt
instruments,
certain
payables
under
repurchase
agreements and cash collateral on securities lending agreements,
amounts
due
under
u
nit
-
linked
investment
contracts,
and
brokerage payables.
Under Swiss GAAP, the fair
value option can only be
applied to
structured debt instruments
consisting of
a debt
host contract
and
one
or
more
embedded
derivatives
that
do
not
relate
to
own
equity. Furthermore, unrealized changes
in fair value attributable
to changes in
UBS AG’s own
credit are not
recognized, whereas
realized own credit is recognized in
Net trading income
.
4. Allowances and provisions for credit losses
Swiss GAAP permit use of IFRS for
accounting for allowances and
provisions for credit losses based on an expected credit loss (ECL)
model. UBS AG
has chosen to
apply the IFRS
9 ECL approach
to
the substantial majority of exposures in scope of Swiss GAAP ECL
requirements,
including all exposures in scope of ECL under both
Swiss GAAP and IFRS.
In
addition,
for
a
small
population
of
exposures
within
the
scope of Swiss GAAP ECL requirements, which are not subject to
ECL
under
IFRS
due
to
classification
and
measurements
differences,
UBS
AG
applies
an
alternative
approach
.
Where
Pillar 1 internal ratings-based (IRB) models are
applied to measure
credit risk, ECL for
such exposures is
determined by the regulatory
expected loss
(EL), with
an add-on
for scaling
up to
the residual
maturity of exposures
maturing beyond the next
12 months. For
detailed
information
on
r
egulatory
EL,
refer
to
the
“
Risk
management
and control”
section
of
this report.
For exposures
where the Pillar 1 standardized approach (SA) is used
to measure
credit
risk,
ECL
is
determined
using
a
portfolio
approach
that
derives
a
conservative probability
of
default
(PD)
and loss
given
default (LGD) for the entire portfolio.
5. Hedge accounting
Under IFRS, when cash flow hedge accounting is applied, the fair
value
gain
or
loss
on
the
effective
portion
of
a
derivative
designated as
a cash
flow hedge
is recognized
initially in
equity
and reclassified to the income statement when certain conditions
are
met.
When
fair
value
hedge
accounting
is
applied,
the
fair
value change of the
hedged item attributable to
the hedged risk
is
reflected
in
the
measurement
of
the
hedged
item
and
is
recognized in the income statement along with
the change in the
fair
value
of
the
hedging
derivative.
Under
Swiss
GAAP,
the
effective
portion
of
the
fair
value
change
of
a
derivative
instrument designated
as a
cash flow
or as
a fair
value hedge
is
deferred on the balance
sheet as
Other assets
or
Other liabilities
.
The carrying amount of the hedged
item designated in fair value
hedges is
not adjusted
for fair
value changes
attributable to
the
hedged risk.
535
Note 35
Main differences between IFRS and Swiss GAAP (continued)
6. Goodwill and intangible assets
Under
IFRS,
goodwill acquired
in
a
business combination
is
not
amortized
but tested
annually for
impairment.
Intangible
assets
with
an
indefinite
useful
life
are
also
not
amortized
but
tested
annually
for
impairment.
Under
Swiss
GAAP,
goodwill
and
intangible assets with
indefinite useful lives
are amortized over
a
period not exceeding five years, unless a longer useful life, which
may not exceed
10
years, can
be justified. In
addition, these assets
are tested annually for impairment.
7. Post-employment benefit plans
Swiss GAAP permit the use of IFRS or Swiss
accounting standards
for post-employment benefit
plans, with the
election made on
a
plan-by-plan basis.
UBS AG
has elected
to apply
IFRS (IAS
19) for
the non-Swiss
defined
benefit
plans
in
the
UBS
AG
standalone
financial
statements and
Swiss GAAP
(FER 16)
for the
Swiss pension
plan
in the UBS
AG and the UBS
Switzerland AG standalone
financial
statements. The
requirements of
Swiss GAAP
are better
aligned
with the specific nature
of Swiss pension plans, which
are hybrid
in
that
they
combine
elements
of
defined
contribution
and
defined
benefit
plans,
but
are
treated
as
defined
benefit
plans
under IFRS. Key
differences between Swiss
GAAP and IFRS
include
the treatment
of dynamic
elements, such
as future
salary increases
and future
interest credits
on retirement
savings, which
are not
considered under
the static
method used
in accordance
with Swiss
GAAP.
Also,
the
discount
rate
used
to
determine
the
defined
benefit obligation in accordance with
IFRS is based on the
yield of
high-quality
corporate
bonds
of
the
market
in
the
respective
pension plan country. The
discount rate used in
accordance with
Swiss GAAP (i.e., the technical interest rate) is determined by
the
Pension Foundation
Board based
on the
expected returns of
the
Board’s investment strategy.
For defined benefit plans,
IFRS require the full
defined benefit
obligation net
of the
plan assets
to be
recorded on
the balance
sheet
subject
to
the
asset
ceiling
rules,
with
changes
resulting
from remeasurements recognized
directly in equity.
However, for
non-Swiss
defined
benefit
plans
for
which
IFRS
accounting
is
elected,
changes
due
to
remeasurements
are
recognized
in
the
income statement of UBS AG standalone under Swiss GAAP.
Swiss
GAAP
require
employer
contributions
to
the
pension
fund
to
be
recognized
as
personnel
expenses
in
the
income
statement.
Swiss
GAAP
also
require
an
assessment
of
whether,
based
on
the
pension
fund’s
financial
statements
prepared
in
accordance
with
Swiss
accounting
standards
(FER
26),
an
economic benefit
to, or
obligation of,
the employer
arises from
the
pension
fund that
is recognized
in the
balance sheet
when
conditions are
met. Conditions
for recording
a pension
asset or
liability would
be met
if, for
example, an
employer contribution
reserve is available
or the employer
is required to
contribute to the
reduction of a pension deficit (on an FER 26 basis).
8. Leasing
Under IFRS, a single lease accounting model applies
that requires
UBS AG to record a right-of-use (RoU) asset and a corresponding
lease liability on
the balance sheet
when UBS AG
is a lessee
in a
lease
arrangement.
The
RoU
asset
and
the
lease
liability
are
recognized when UBS
AG acquires control
of the physical use
of
the
asset.
The
lease
liability
is
measured
based
on
the
present
value of the lease
payments over the
lease term, discounted using
UBS AG’s unsecured borrowing rate.
The RoU asset is recorded at
an
amount
equal
to
the
lease
liability
but
is
adjusted
for
rent
prepayments, initial direct costs, any costs to refurbish the leased
asset
and
/
or
lease
incentives
received.
The
RoU
asset
is
depreciated over the shorter of the lease
term or the useful life of
the underlying asset.
Under Swiss GAAP,
leases that
transfer substantially
all the risks
and
rewards,
but
not
necessarily
legal
title
in
the
underlying
assets,
are
classified
as
finance
leases.
All
other
leases
are
classified
as
operating
leases.
Whereas
finance
leases
are
recognized on the balance
sheet and measured in line
with IFRS,
operating
leases are
not recognized
on
the balance
sheet, with
payments recognized as
General and administrative
expenses
on
a straight-line
basis over
the lease term,
which commences with
control
of
the
physical
use
of
the
asset.
Lease
incentives
are
treated
as
a
reduction
of
rental
expense
and
recognized
on
a
consistent basis over the lease term.
9. Netting of derivative assets and liabilities
Under IFRS, derivative assets, derivative liabilities and related cash
collateral
not
settled
to
market
are
reported
on
a
gross
basis
unless
the
restrictive
IFRS
netting
requirements
are
met:
(i)
existence
of
master
netting
agreements
and
related
collateral
arrangements
that are
unconditional and
legally enforceable,
in
both
the
normal
course
of
business
and
the
event
of
default,
bankruptcy or
insolvency of
UBS AG
and its
counterparties; and
(ii) UBS AG’s intention
to either settle on a net
basis or to realize
the
asset
and
settle
the
liability
simultaneously.
Under
Swiss
GAAP,
derivative
assets
,
derivative
liabilities
and
related
cash
collateral
not
settled
to market
are
generally reported
on a
net
basis,
provided
the
master
netting
and
the
related
collateral
agreements
are
legally
enforceable
in
the
event
of
default,
bankruptcy or insolvency of UBS AG’s counterparties.
10. Negative interest
Under IFRS,
negative interest
income arising
on a
financial asset
does not
meet the
definition of
interest
income and,
therefore,
negative
interest
on
financial
assets
and
negative
interest
on
financial
liabilities
are
presented
within
interest
expense
and
interest income, respectively. Under
Swiss GAAP, negative interest
on
financial
assets
is
presented
within
interest
income
and
negative interest on financial liabilities
is presented within interest
expense.
11. Extraordinary income and expense
Certain
non-recurring
and
non-operating
income
and
expense
items,
such
as
realized
gains
or
losses
from
the
disposal
of
participations,
fixed
and
intangible
assets,
a
nd
reversals
of
impairments
of
participations
and
fixed
assets,
are
classified
as
extraordinary
items
under
Swiss
GAAP.
This
distinction
is
not
available under IFRS
.
p
Consolidated financial statements | UBS AG consolidated financial statements
536
537
Note 36
Supplemental guarantor information required under SEC regulations
Joint liability of UBS Switzerland AG
In
2015,
the
Personal
&
Corporate
Banking
and
Wealth
Management businesses booked in Switzerland
were transferred
from UBS AG to UBS Switzerland AG through an asset transfer in
accordance
with the
Swiss Merger
Act. Under
the terms
of the
asset
transfer
agreement,
UBS
Switzerland
AG
assumed
joint
liability for contractual
obligations of UBS
AG existing
on the asset
transfer date,
including the
full and
unconditional guarantee
of
certain registered debt securities issued by UBS AG.
To reflect this
joint
liability,
UBS
Switzerland
AG
is
presented
in
a
separate
column as a subsidiary co-guarantor.
The
joint
liability
of
UBS
Switzerland
AG
for
contractual
obligations
of UBS
AG decreased
in 2021
by USD
4.4
billion to
USD
5.7
billion
as
of
31
December
2021,
mainly
driven
by
contractual
maturities
and,
to
a
lesser
extent,
early
extinguishments of UBS AG liabilities.
Supplemental guarantor consolidated
income statement
USD million
UBS AG
(standalone)
1
UBS
Switzerland AG
(standalone)
1
Other
subsidiaries
2
Elimination
entries
UBS AG
(consolidated)
For the year ended 31 December 2021
Operating income
Interest income from financial instruments measured at
amortized cost and
fair value through other comprehensive income
3,130
3,652
2,456
(
703
)
8,534
Interest expense from financial instruments measured at
amortized cost
(
2,847
)
(
520
)
(
1,024
)
1,025
(
3,366
)
Net interest income from financial instruments measured
at fair value through
profit or loss
1,229
254
228
(
274
)
1,437
Net interest income
1,512
3,386
1,660
48
6,605
Other net income from financial instruments measured
at fair value through
profit or loss
3,751
807
1,369
(
83
)
5,844
Credit loss (expense) / release
65
98
10
(
24
)
148
Fee and commission income
3,837
5,204
16,151
(
770
)
24,422
Fee and commission expense
(
810
)
(
481
)
(
1,450
)
755
(
1,985
)
Net fee and commission income
3,027
4,723
14,702
(
14
)
22,438
Other income
7,555
221
1,560
(
8,396
)
941
Total operating income
15,910
9,235
19,300
(
8,469
)
35,976
Operating expenses
Personnel expenses
3,401
2,098
10,161
1
15,661
General and administrative expenses
4,255
3,442
4,474
(
2,696
)
9,476
Depreciation, amortization and impairment of non-financial
assets
949
285
755
(
114
)
1,875
Total operating expenses
8,605
5,825
15,390
(
2,809
)
27,012
Operating profit / (loss) before tax
7,305
3,409
3,910
(
5,660
)
8,964
Tax expense / (benefit)
203
622
1,090
(
11
)
1,903
Net profit / (loss)
7,102
2,788
2,820
(
5,649
)
7,061
Net profit / (loss) attributable to non-controlling interests
0
0
29
0
29
Net profit / (loss) attributable to shareholders
7,102
2,788
2,792
(
5,649
)
7,032
1 Amounts presented for UBS
AG standalone and UBS
Switzerland AG standalone represent
IFRS standalone information. Refer
to the UBS AG
standalone and UBS Switzerland
AG standalone financial statements
under “Complementary financial
information” at
ubs.com/investors for
information prepared
in accordance
with Swiss GAAP.
2 The
”Other subsidiaries“ column
includes consolidated information
for the
UBS
Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups,
as well as standalone information for other subsidiaries.
Consolidated financial statements | UBS AG consolidated financial statements
538
Note 36
Supplemental guarantor information required under SEC regulations (continued)
Supplemental guarantor consolidated
statement of comprehensive income
USD million
UBS AG
(standalone)
1
UBS
Switzerland AG
(standalone)
1
Other
subsidiaries
2
Elimination
entries
UBS AG
(consolidated)
For the year ended 31 December 2021
Comprehensive income attributable to shareholders
Net profit / (loss)
7,102
2,788
2,792
(
5,649
)
7,032
Other comprehensive income
Other comprehensive income that may be reclassified to the income
statement
Foreign currency translation, net of tax
(
1
)
(
419
)
(
607
)
517
(
510
)
Financial assets measured at fair value through other comprehensive
income, net of tax
0
(
157
)
0
(
157
)
Cash flow hedges, net of tax
(
1,129
)
(
279
)
(
250
)
(
17
)
(
1,675
)
Cost of hedging, net of tax
(
26
)
(
26
)
Total other comprehensive income that may be reclassified to the
income statement, net of tax
(
1,155
)
(
699
)
(
1,014
)
500
(
2,368
)
Other comprehensive income that will not be reclassified to the
income statement
Defined benefit plans, net of tax
170
(
135
)
67
0
102
Own credit on financial liabilities designated at fair value, net of tax
46
46
Total other comprehensive income that will not be reclassified to the
income statement, net of tax
217
(
135
)
67
0
148
Total other comprehensive income
(
939
)
(
834
)
(
947
)
500
(
2,220
)
Total comprehensive income attributable to shareholders
6,163
1,954
1,845
(
5,149
)
4,813
Total comprehensive income attributable to non-controlling interests
13
13
Total comprehensive income
6,163
1,954
1,858
(
5,149
)
4,826
1 Amounts presented for UBS
AG standalone and UBS
Switzerland AG standalone represent
IFRS standalone information. Refer
to the UBS AG
standalone and UBS Switzerland
AG standalone financial statements
under “Complementary financial
information” at
ubs.com/investors for
information prepared
in accordance
with Swiss
GAAP.
2 The
”Other subsidiaries“ column
includes consolidated information
for the
UBS
Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups,
as well as standalone information for other subsidiaries.
539
Note 36
Supplemental guarantor information required under SEC regulations (continued)
Supplemental guarantor consolidated
balance sheet
USD million
UBS AG
(standalone)
1
UBS
Switzerland AG
(standalone)
1
Other
subsidiaries
2
Elimination
entries
UBS AG
(consolidated)
As of 31 December 2021
Assets
Cash and balances at central banks
53,839
91,031
47,946
192,817
Loans and advances to banks
39,681
7,066
19,858
(
51,245
)
15,360
Receivables from securities financing transactions
50,566
5,438
40,585
(
21,577
)
75,012
Cash collateral receivables on derivative instruments
29,939
779
10,314
(
10,518
)
30,514
Loans and advances to customers
101,458
230,170
93,252
(
26,188
)
398,693
Other financial assets measured at amortized cost
8,902
6,828
12,377
(
1,870
)
26,236
Total financial assets measured at amortized cost
284,385
341,312
224,332
(
111,397
)
738,632
Financial assets at fair value held for trading
116,370
79
16,740
(
2,156
)
131,033
of which: assets pledged as collateral that may be
sold or repledged by counterparties
47,891
0
6,073
(
10,568
)
43,397
Derivative financial instruments
113,426
4,199
35,567
(
35,047
)
118,145
Brokerage receivables
14,563
7,283
(
7
)
21,839
Financial assets at fair value not held for trading
37,532
5,413
33,940
(
17,243
)
59,642
Total financial assets measured at fair value through profit or loss
281,891
9,691
93,531
(
54,454
)
330,659
Financial assets measured at fair value
through other comprehensive income
1,007
7,837
8,844
Investments in subsidiaries and associates
54,204
37
40
(
53,038
)
1,243
Property, equipment and software
6,501
1,456
4,048
(
293
)
11,712
Goodwill and intangible assets
213
6,138
28
6,378
Deferred tax assets
936
7,903
8,839
Other non-financial assets
5,757
2,424
1,656
(
1
)
9,836
Total assets
634,894
354,921
345,484
(
219,154
)
1,116,145
Liabilities
Amounts due to banks
34,691
33,453
50,405
(
105,448
)
13,101
Payables from securities financing transactions
16,711
526
9,910
(
21,615
)
5,533
Cash collateral payables on derivative instruments
30,260
153
11,845
(
10,458
)
31,801
Customer deposits
101,093
286,488
142,967
14,287
544,834
Funding from UBS Group AG
57,295
57,295
Debt issued measured at amortized cost
73,045
9,460
(
73
)
82,432
Other financial liabilities measured at amortized cost
4,477
2,477
5,057
(
2,245
)
9,765
Total financial liabilities measured at amortized cost
317,572
332,556
220,184
(
125,551
)
744,762
Financial liabilities at fair value held for trading
25,711
372
7,652
(
2,046
)
31,688
Derivative financial instruments
116,588
4,053
35,731
(
35,063
)
121,309
Brokerage payables designated at fair value
30,497
13,548
(
1
)
44,045
Debt issued designated at fair value
70,660
785
14
71,460
Other financial liabilities designated at fair value
11,127
24,454
(
3,167
)
32,414
Total financial liabilities measured at fair value through profit or loss
254,584
4,425
82,171
(
40,263
)
300,916
Provisions
2,023
297
1,153
(
21
)
3,452
Other non-financial liabilities
1,799
1,278
5,528
(
33
)
8,572
Total liabilities
575,978
338,556
309,036
(
165,868
)
1,057,702
Equity attributable to shareholders
58,916
16,365
36,108
(
53,287
)
58,102
Equity attributable to non-controlling interests
340
340
Total equity
58,916
16,365
36,448
(
53,287
)
58,442
Total liabilities and equity
634,894
354,921
345,484
(
219,154
)
1,116,145
1 Amounts presented for UBS AG
standalone and UBS Switzerland AG
standalone represent IFRS standalone information.
Refer to the UBS AG
standalone and UBS Switzerland AG standalone
financial statements,
available under “Complementary financial information” at ubs.com/investors, for information prepared
in accordance with Swiss GAAP.
2 The ”Other subsidiaries“ column includes consolidated information for the
UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups,
as well as standalone information for other subsidiaries.
Consolidated financial statements | UBS AG consolidated financial statements
540
Note 36
Supplemental guarantor information required under SEC regulations (continued)
Supplemental guarantor consolidated
statement of cash flows
USD million
UBS AG
1
UBS
Switzerland AG
1
Other
subsidiaries
1
UBS AG
(consolidated)
For the year ended 31 December 2021
Net cash flow from / (used in) operating activities
5,714
2,131
22,718
30,563
Cash flow from / (used in) investing activities
Purchase of subsidiaries, associates and intangible assets
0
(
1
)
0
(
1
)
Disposal of subsidiaries, associates and intangible assets
2
16
0
577
593
Purchase of property, equipment and software
(
656
)
(
276
)
(
650
)
(
1,581
)
Disposal of property, equipment and software
294
0
1
295
Purchase of financial assets measured at fair value through other
comprehensive income
(
1,006
)
0
(
4,795
)
(
5,802
)
Disposal and redemption of financial assets measured at
fair value through other comprehensive
income
189
0
4,863
5,052
Net (purchase) / redemption of debt securities measured
at amortized cost
(
807
)
772
(
380
)
(
415
)
Net cash flow from / (used in) investing activities
(
1,970
)
495
(
385
)
(
1,860
)
Cash flow from / (used in) financing activities
Net short-term debt issued / (repaid)
(
3,073
)
(
21
)
0
(
3,093
)
Distributions paid on UBS AG shares
(
4,539
)
0
0
(
4,539
)
Issuance of debt designated at fair value and long-term debt measured
at amortized cost
3
97,250
1,177
193
98,619
Repayment of debt designated at fair value and long-term debt measured
at amortized cost
3
(
78,385
)
(
1,093
)
(
320
)
(
79,799
)
Net cash flows from other financing activities
(
280
)
0
20
(
261
)
Net activity related to group internal capital transactions and dividends
5,240
(
537
)
(
4,702
)
0
Net cash flow from / (used in) financing activities
16,212
(
475
)
(
4,811
)
10,927
Total cash flow
Cash and cash equivalents at the beginning of the year
39,400
93,342
40,689
173,430
Net cash flow from / (used in) operating, investing and financing
activities
19,957
2,151
17,523
39,630
Effects of exchange rate differences on cash and cash equivalents
(
1,462
)
(
2,693
)
(
1,151
)
(
5,306
)
Cash and cash equivalents at the end of the year
4
57,895
92,799
57,061
207,755
of which: cash and balances at central banks
53,729
91,031
47,946
192,706
of which: loans and advances to banks
3,258
1,588
8,975
13,822
of which: money market paper
5
908
179
139
1,227
1 Cash flows generally represent a
third-party view from a UBS AG
consolidated perspective, except for
Net activity related to group internal
capital transactions and dividends.
2 Includes cash proceeds from the
sale of the minority stake in Clearstream Fund Centre AG and dividends received from associates.
3 Includes funding from UBS Group AG to UBS AG.
4 Balances with an original maturity of three months or less.
USD
3,408
million of cash and cash equivalents were
restricted.
5 Money market paper is included
in the balance sheet under Financial assets
at fair value held for trading,
Financial assets measured at fair value
through other comprehensive income, Financial assets at fair value not held for trading and Other
financial assets measured at amortized cost.
541
Note 36
Supplemental guarantor information required under SEC regulations (continued)
Supplemental guarantor consolidated
income statement
USD million
UBS AG
(standalone)
1
UBS
Switzerland AG
(standalone)
1
Other
subsidiaries
2
Elimination
entries
UBS AG
(consolidated)
For the year ended 31 December 2020
Operating income
Interest income from financial instruments measured at
amortized cost and
fair value through other comprehensive income
3,386
3,636
2,612
(
818
)
8,816
Interest expense from financial instruments measured at
amortized cost
(
3,694
)
(
513
)
(
1,261
)
1,134
(
4,333
)
Net interest income from financial instruments measured
at fair value through
profit or loss
1,103
164
311
(
273
)
1,305
Net interest income
794
3,288
1,662
43
5,788
Other net income from financial instruments measured
at fair value through
profit or loss
4,857
911
1,044
118
6,930
Credit loss (expense) / release
(
352
)
(
286
)
(
56
)
0
(
695
)
Fee and commission income
3,731
4,585
13,651
(
984
)
20,982
Fee and commission expense
(
644
)
(
829
)
(
1,263
)
961
(
1,775
)
Net fee and commission income
3,087
3,756
12,388
(
23
)
19,207
Other income
4,671
233
2,585
(
5,941
)
1,549
Total operating income
13,057
7,902
17,623
(
5,803
)
32,780
Operating expenses
Personnel expenses
3,458
2,017
9,211
0
14,686
General and administrative expenses
3,507
3,313
4,147
(
2,481
)
8,486
Depreciation, amortization and impairment of non-financial
assets
1,013
261
750
(
115
)
1,909
Total operating expenses
7,978
5,591
14,108
(
2,596
)
25,081
Operating profit / (loss) before tax
5,079
2,311
3,515
(
3,207
)
7,699
Tax expense / (benefit)
238
444
912
(
107
)
1,488
Net profit / (loss)
4,840
1,868
2,603
(
3,100
)
6,211
Net profit / (loss) attributable to non-controlling interests
0
0
15
0
15
Net profit / (loss) attributable to shareholders
4,840
1,868
2,588
(
3,100
)
6,196
1 Amounts presented for UBS AG
standalone and UBS Switzerland AG
standalone represent IFRS standalone
information. Refer to the UBS
AG standalone and UBS Switzerland
AG standalone financial statements
under “Complementary financial
information” at ubs.com/investors
for information prepared
in accordance with
Swiss GAAP.
2 The
”Other subsidiaries“
column includes consolidated
information for
the UBS
Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups,
as well as standalone information for other subsidiaries.
Consolidated financial statements | UBS AG consolidated financial statements
542
Note 36
Supplemental guarantor information required under SEC regulations (continued)
Supplemental guarantor consolidated
statement of comprehensive income
USD million
UBS AG
(standalone)
1
UBS
Switzerland AG
(standalone)
1
Other
subsidiaries
2
Elimination
entries
UBS AG
(consolidated)
For the year ended 31 December 2020
Comprehensive income attributable to shareholders
Net profit / (loss)
4,840
1,868
2,588
(
3,100
)
6,196
Other comprehensive income
Other comprehensive income that may be reclassified to the income
statement
Foreign currency translation, net of tax
81
1,228
690
(
969
)
1,030
Financial assets measured at fair value through other comprehensive
income, net of tax
0
0
137
0
136
Cash flow hedges, net of tax
902
26
101
(
18
)
1,011
Cost of hedging, net of tax
(
13
)
(
13
)
Total other comprehensive income that may be reclassified to the
income statement, net of tax
971
1,254
928
(
988
)
2,165
Other comprehensive income that will not be reclassified to the
income statement
Defined benefit plans, net of tax
(
67
)
(
107
)
40
0
(
134
)
Own credit on financial liabilities designated at fair value, net of tax
(
293
)
(
293
)
Total other comprehensive income that will not be reclassified to the
income statement, net of tax
(
360
)
(
107
)
40
0
(
427
)
Total other comprehensive income
611
1,147
968
(
988
)
1,738
Total comprehensive income attributable to shareholders
5,451
3,015
3,556
(
4,088
)
7,934
Total comprehensive income attributable to non-controlling interests
36
36
Total comprehensive income
5,451
3,015
3,592
(
4,088
)
7,970
1 Amounts presented for UBS
AG standalone and UBS
Switzerland AG standalone represent
IFRS standalone information. Refer
to the UBS AG
standalone and UBS Switzerland
AG standalone financial statements
under “Complementary financial
information” at
ubs.com/investors for
information prepared
in accordance
with Swiss GAAP.
2 The
”Other subsidiaries“ column
includes consolidated information
for the
UBS
Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups,
as well as standalone information for other subsidiaries.
543
Note 36
Supplemental guarantor information required under SEC regulations (continued)
Supplemental guarantor consolidated
balance sheet
USD million
UBS AG
(standalone)
1
UBS
Switzerland AG
(standalone)
1
Other
subsidiaries
2
Elimination
entries
UBS AG
(consolidated)
As of 31 December 2020
Assets
Cash and balances at central banks
34,426
91,638
32,167
158,231
Loans and advances to banks
40,171
6,385
19,465
(
50,678
)
15,344
Receivables from securities financing transactions
56,568
4,026
43,350
(
29,735
)
74,210
Cash collateral receivables on derivative instruments
32,771
1,543
10,093
(
11,671
)
32,737
Loans and advances to customers
99,952
228,279
73,513
(
20,767
)
380,977
Other financial assets measured at amortized cost
8,411
8,084
13,368
(
2,644
)
27,219
Total financial assets measured at amortized cost
272,299
339,956
191,957
(
115,495
)
688,717
Financial assets at fair value held for trading
110,812
55
16,260
(
1,634
)
125,492
of which: assets pledged as collateral that
may be sold or repledged by counterparties
54,468
1
6,247
(
13,617
)
47,098
Derivative financial instruments
154,313
6,342
44,005
(
45,041
)
159,618
Brokerage receivables
16,898
7,763
(
2
)
24,659
Financial assets at fair value not held for trading
46,198
13,068
36,444
(
15,672
)
80,038
Total financial assets measured at fair value through profit or loss
328,221
19,464
104,473
(
62,350
)
389,808
Financial assets measured at fair value
through other comprehensive income
187
8,072
8,258
Investments in subsidiaries and associates
53,606
38
439
(
52,526
)
1,557
Property, equipment and software
6,999
1,335
3,975
(
350
)
11,958
Goodwill and intangible assets
217
6,234
28
6,480
Deferred tax assets
840
1
8,334
(
1
)
9,174
Other non-financial assets
6,641
2,063
854
(
183
)
9,374
Total assets
669,010
362,857
324,337
(
230,878
)
1,125,327
Liabilities
Amounts due to banks
41,414
34,096
43,066
(
107,527
)
11,050
Payables from securities financing transactions
17,247
566
18,407
(
29,899
)
6,321
Cash collateral payables on derivative instruments
35,875
561
12,495
(
11,618
)
37,313
Customer deposits
98,441
293,371
112,372
23,745
527,929
Funding from UBS Group AG
53,979
53,979
Debt issued measured at amortized cost
75,658
9,687
3
3
85,351
Other financial liabilities measured at amortized cost
5,285
2,567
5,745
(
3,175
)
10,421
Total financial liabilities measured at amortized cost
327,898
340,848
192,088
(
128,470
)
732,364
Financial liabilities at fair value held for trading
28,800
335
5,989
(
1,529
)
33,595
Derivative financial instruments
156,192
5,593
44,359
(
45,043
)
161,102
Brokerage payables designated at fair value
25,045
13,704
(
7
)
38,742
Debt issued designated at fair value
58,986
935
(
54
)
59,868
Other financial liabilities designated at fair value
11,255
23,445
(
2,927
)
31,773
Total financial liabilities measured at fair value through profit or loss
280,279
5,927
88,433
(
49,559
)
325,080
Provisions
1,293
301
1,197
2,791
Other non-financial liabilities
2,173
987
3,907
(
49
)
7,018
Total liabilities
611,643
348,063
285,625
(
178,078
)
1,067,254
Equity attributable to shareholders
57,367
14,794
38,393
(
52,800
)
57,754
Equity attributable to non-controlling interests
319
319
Total equity
57,367
14,794
38,712
(
52,800
)
58,073
Total liabilities and equity
669,010
362,857
324,337
(
230,878
)
1,125,327
1 Amounts presented for UBS AG
standalone and UBS Switzerland AG
standalone represent IFRS standalone information.
Refer to the UBS AG
standalone and UBS Switzerland AG standalone
financial statements,
available under “Complementary financial information” at ubs.com/investors, for information prepared
in accordance with Swiss GAAP.
2 The ”Other subsidiaries“ column includes consolidated information for the
UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups,
as well as standalone information for other subsidiaries.
Consolidated financial statements | UBS AG consolidated financial statements
544
Note 36
Supplemental guarantor information required under SEC regulations (continued)
Supplemental guarantor consolidated
statement of cash flows
USD million
UBS AG
1
UBS
Switzerland AG
1
Other
subsidiaries
1
UBS AG
(consolidated)
For the year ended 31 December 2020
Net cash flow from / (used in) operating activities
(
14,883
)
24,661
26,804
36,581
Cash flow from / (used in) investing activities
Purchase of subsidiaries, associates and intangible assets
0
(
3
)
(
43
)
(
46
)
Disposal of subsidiaries, associates and intangible assets
2
14
0
660
674
Purchase of property, equipment and software
(
714
)
(
162
)
(
697
)
(
1,573
)
Disposal of property, equipment and software
361
0
3
364
Purchase of financial assets measured at fair value through other
comprehensive income
(
77
)
0
(
6,213
)
(
6,290
)
Disposal and redemption of financial assets measured at
fair value through other comprehensive
income
79
0
4,451
4,530
Net (purchase) / redemption of debt securities measured
at amortized cost
(
3,021
)
132
(
1,277
)
(
4,166
)
Net cash flow from / (used in) investing activities
(
3,357
)
(
33
)
(
3,117
)
(
6,506
)
Cash flow from / (used in) financing activities
Net short-term debt issued / (repaid)
23,828
17
0
23,845
Distributions paid on UBS AG shares
(
3,848
)
0
0
(
3,848
)
Issuance of debt designated at fair value and long-term debt measured
at amortized cost
3
78,867
1,057
229
80,153
Repayment of debt designated at fair value and long-term debt measured
at amortized cost
3
(
86,204
)
(
776
)
(
118
)
(
87,099
)
Net cash flows from other financing activities
(
290
)
0
(
263
)
(
553
)
Net activity related to group internal capital transactions and dividends
2,984
(
1,307
)
(
1,677
)
0
Net cash flow from / (used in) financing activities
15,336
(
1,009
)
(
1,829
)
12,498
Total cash flow
Cash and cash equivalents at the beginning of the year
39,598
62,551
17,655
119,804
Net cash flow from / (used in) operating, investing and financing
activities
(
2,905
)
23,619
21,859
42,573
Effects of exchange rate differences on cash and cash equivalents
2,706
7,171
1,175
11,053
Cash and cash equivalents at the end of the year
4
39,400
93,342
40,689
173,430
of which: cash and balances at central banks
34,283
91,638
32,167
158,088
of which: loans and advances to banks
4,085
1,695
8,148
13,928
of which: money market paper
5
1,032
9
374
1,415
1 Cash flows generally represent
a third-party view from a UBS
AG consolidated perspective,
except for Net activity related
to group internal capital transactions
and dividends.
2 Includes cash proceeds from
the
sale of the majority stake
in Fondcenter AG and
dividends received from associates.
3 Includes funding from UBS Group
AG to UBS AG.
4 Balances with an original maturity of
three months or less. USD
3,828
million of cash and cash equivalents were restricted.
5 Money market paper is included in the balance sheet under Financial assets at fair value held for trading, Financial assets measured at fair value through other
comprehensive income, Financial assets at fair value not held for trading and Other financial assets
measured at amortized cost.
545
Note 36
Supplemental guarantor information required under SEC regulations (continued)
Supplemental guarantor consolidated
income statement
USD million
UBS AG
(standalone)
1
UBS
Switzerland AG
(standalone)
1
Other
subsidiaries
2
Elimination
entries
UBS AG
(consolidated)
For the year ended 31 December 2019
Operating income
Interest income from financial instruments measured at
amortized cost and
fair value through other comprehensive income
4,864
4,048
3,719
(
1,928
)
10,703
Interest expense from financial instruments measured at
amortized cost
(
6,547
)
(
737
)
(
2,317
)
2,298
(
7,303
)
Net interest income from financial instruments measured
at fair value through
profit or loss
1,177
(
228
)
394
(
327
)
1,015
Net interest income
(
506
)
3,083
1,796
42
4,415
Other net income from financial instruments measured
at fair value through
profit or loss
5,116
924
1,114
(
322
)
6,833
Credit loss (expense) / release
(
51
)
7
(
33
)
0
(
78
)
Fee and commission income
3,285
4,342
12,527
(
997
)
19,156
Fee and commission expense
(
674
)
(
819
)
(
1,188
)
986
(
1,696
)
Net fee and commission income
2,610
3
3,523
3
11,338
(
11
)
17,460
Other income
4,899
259
1,960
(
6,442
)
677
Total operating income
12,069
7,796
16,176
(
6,733
)
29,307
Operating expenses
Personnel expenses
3,251
1,936
8,614
0
13,801
General and administrative expenses
3,467
3,181
4,565
(
2,627
)
8,586
Depreciation, amortization and impairment of non-financial
assets
954
221
772
(
196
)
1,751
Total operating expenses
7,672
5,338
13,951
(
2,823
)
24,138
Operating profit / (loss) before tax
4,396
2,458
2,225
(
3,911
)
5,169
Tax expense / (benefit)
175
514
530
(
21
)
1,198
Net profit / (loss)
4,221
1,944
1,695
(
3,890
)
3,971
Net profit / (loss) attributable to non-controlling interests
0
0
6
0
6
Net profit / (loss) attributable to shareholders
4,221
1,944
1,689
(
3,889
)
3,965
1 Amounts presented for UBS
AG standalone and UBS
Switzerland AG standalone represent
IFRS standalone information. Refer
to the UBS AG
standalone and UBS Switzerland
AG standalone financial statements
under “Complementary financial
information” at
ubs.com/investors for
information prepared
in accordance
with Swiss GAAP.
2 The
”Other subsidiaries“ column
includes consolidated
information for
the UBS
Americas Holding LLC,
UBS Europe SE and UBS
Asset Management AG significant
sub-groups, as well
as standalone information for
other subsidiaries.
3 Includes the effects of
the transfer in 2019
of beneficial
ownership of a
portion of
Global Wealth
Management international
business booked
in Switzerland
from UBS Switzerland
AG to
UBS AG.
Refer to “Note
25 Changes
in organization
and other events
affecting
comparability” in the “UBS AG standalone financial statements” section of the UBS AG Standalone financial
statements and regulatory information for the year ended 31 December 2019.
Consolidated financial statements | UBS AG consolidated financial statements
546
Note 36
Supplemental guarantor information required under SEC regulations (continued)
Supplemental guarantor consolidated
statement of comprehensive income
USD million
UBS AG
(standalone)
1
UBS
Switzerland AG
(standalone)
1
Other
subsidiaries
2
Elimination
entries
UBS AG
(consolidated)
For the year ended 31 December 2019
Comprehensive income attributable to shareholders
Net profit / (loss)
4,221
1,944
1,689
(
3,889
)
3,965
Other comprehensive income
Other comprehensive income that may be reclassified to the income
statement
Foreign currency translation, net of tax
5
150
39
(
102
)
92
Financial assets measured at fair value through other
comprehensive income, net of tax
0
0
117
0
117
Cash flow hedges, net of tax
870
140
147
(
15
)
1,143
Total other comprehensive income that may be reclassified to the
income statement, net of tax
875
290
303
(
117
)
1,351
Other comprehensive income that will not be reclassified to the
income statement
Defined benefit plans, net of tax
(
89
)
(
6
)
(
75
)
0
(
170
)
Own credit on financial liabilities designated at fair value, net of tax
(
392
)
(
392
)
Total other comprehensive income that will not be reclassified to
the income statement, net of tax
(
481
)
(
6
)
(
75
)
0
(
562
)
Total other comprehensive income
394
284
228
(
117
)
789
Total comprehensive income attributable to shareholders
4,616
2,228
1,917
(
4,007
)
4,754
Total comprehensive income attributable to non-controlling interests
2
2
Total comprehensive income
4,616
2,228
1,919
(
4,007
)
4,756
1 Amounts presented for UBS AG
standalone and UBS Switzerland AG
standalone represent IFRS standalone information.
Refer to the UBS AG
standalone and UBS Switzerland AG
standalone financial statements
under “Complementary financial information” at ubs.com/investors for information prepared in accordance with Swiss GAAP.
2 The ”Other subsidiaries“ column includes consolidated information for the significant
sub-groups UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG,
as well as standalone information for other subsidiaries.
547
Note 36
Supplemental guarantor information required under SEC regulations (continued)
Supplemental guarantor consolidated
statement of cash flows
USD million
UBS AG
1
UBS
Switzerland AG
1
Other
subsidiaries
1
UBS AG
(consolidated)
For the year ended 31 December 2019
Net cash flow from / (used in) operating activities
17,531
8,882
(
7,608
)
18,805
Purchase of subsidiaries, associates and intangible assets
(
6
)
0
(
20
)
(
26
)
Disposal of subsidiaries, associates and intangible assets
2
100
0
14
114
Purchase of property, equipment and software
(
628
)
(
173
)
(
600
)
(
1,401
)
Disposal of property, equipment and software
10
0
1
11
Purchase of financial assets measured at fair value through other
comprehensive income
(
10
)
0
(
3,414
)
(
3,424
)
Disposal and redemption of financial assets measured at
fair value through other comprehensive
income
10
0
3,904
3,913
Net (purchase) / redemption of debt securities measured
at amortized cost
(
1,045
)
437
45
(
562
)
Net cash flow from / (used in) investing activities
(
1,569
)
264
(
70
)
(
1,374
)
Cash flow from / (used in) financing activities
Net short-term debt issued / (repaid)
(
17,150
)
0
0
(
17,149
)
Distributions paid on UBS AG shares
(
3,250
)
0
0
(
3,250
)
Issuance of debt designated at fair value and long-term debt measured
at amortized cost
3
64,285
621
142
65,047
Repayment of debt designated at fair value and long-term debt measured
at amortized cost
3
(
67,113
)
(
752
)
(
1,017
)
(
68,883
)
Net cash flows from other financing activities
(
262
)
0
(
242
)
(
504
)
Net activity related to group internal capital transactions and dividends
3,569
(
2,055
)
(
1,514
)
0
Net cash flow from / (used in) financing activities
(
19,922
)
(
2,186
)
(
2,630
)
(
24,738
)
Total cash flow
Cash and cash equivalents at the beginning of the year
42,895
54,757
28,201
125,853
Net cash flow from / (used in) operating, investing and financing
activities
(
3,960
)
6,961
(
10,308
)
(
7,307
)
Effects of exchange rate differences on cash and cash equivalents
664
833
(
239
)
1,258
Cash and cash equivalents at the end of the year
4
39,598
62,551
17,655
119,804
of which: cash and balances at central banks
36,275
60,926
9,756
106,957
of which: loans and advances to banks
2,697
1,127
7,493
11,317
of which: money market paper
5
626
498
406
1,530
1 Cash flows generally represent a
third-party view from a UBS AG
consolidated perspective, except for
Net activity related to group internal
capital transactions and dividends.
2 Includes dividends received from
associates.
3 Includes funding from UBS
Group AG to UBS AG.
4 Balances with an original maturity
of three months or less.
USD
3,192
million of cash and cash
equivalents were restricted.
5 Money market
paper is included in the balance sheet under Financial assets at
fair value held for trading, Financial assets measured at fair value through other comprehensive income, Financial assets at
fair value not held for trading
and Other financial assets measured at amortized cost.
p
Significant
regulated
subsidiary and
sub-group
information
6
549
Financial and regulatory key figures for our significant regulated
subsidiaries and sub-groups
UBS AG
(standalone)
UBS Switzerland AG
(standalone)
UBS Europe SE
(consolidated)
UBS Americas Holding
LLC
(consolidated)
All values in million, except where indicated
USD
CHF
EUR
USD
Financial and regulatory requirements
Swiss GAAP
Swiss SRB rules
Swiss GAAP
Swiss SRB rules
IFRS
EU regulatory rules
US GAAP
US Basel III rules
As of or for the year ended
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
31.12.21
31.12.20
Financial information
1
Income statement
Total operating income
16,293
12,951
8,490
7,185
1,123
1,054
14,490
12,675
Total operating expenses
9,712
8,370
5,472
5,590
800
878
11,925
10,842
Operating profit / (loss) before tax
6,581
4,581
3,018
1,595
323
176
2,565
1,833
Net profit / (loss)
6,548
4,539
2,452
1,271
227
163
1,812
975
Balance sheet
Total assets
509,851
509,024
320,656
316,829
46,411
48,591
209,718
172,385
Total liabilities
455,446
456,628
305,919
304,194
42,664
43,896
182,633
144,103
Total equity
54,405
52,396
14,736
12,634
3,747
4,696
27,085
28,283
Capital
2
Common equity tier 1 capital
52,818
50,269
12,609
12,234
2,764
3,703
13,002
14,384
Additional tier 1 capital
13,840
14,430
5,387
5,176
290
290
4,049
3,047
Total going concern capital / Tier 1 capital
66,658
64,699
17,996
17,410
3,054
3,993
17,051
17,431
Tier 2 capital
3,129
7,719
125
736
Total capital
3,054
3,993
17,176
18,166
Total gone concern loss-absorbing capacity
44,250
45,520
10,853
10,824
2,414
3
1,784
3
7,000
4
5,600
4
Total loss-absorbing capacity
110,908
110,219
28,849
28,234
5,468
5,777
24,051
23,031
Risk-weighted assets and leverage ratio
denominator
2
Risk-weighted assets
317,913
305,575
106,399
107,253
12,328
13,175
72,979
63,929
Leverage ratio denominator
5
593,868
595,017
339,788
335,251
46,660
41,376
188,246
154,609
Supplementary leverage ratio denominator
6
212,167
150,019
Capital and leverage ratios (%)
2
Common equity tier 1 capital ratio
5
16.6
16.5
11.9
11.4
22.4
28.1
17.8
22.5
Going concern capital ratio / Tier 1 capital ratio
21.0
21.2
16.9
16.2
24.8
30.3
23.4
27.3
Total capital ratio
24.8
30.3
23.5
28.4
Total loss-absorbing capacity ratio
27.1
26.3
44.4
43.8
33.0
36.0
Tier 1 leverage ratio
6.5
9.7
9.1
11.3
Supplementary tier 1 leverage ratio
8.0
11.6
Going concern leverage ratio
5
11.2
10.9
5.3
5.2
Total loss-absorbing capacity leverage ratio
8.5
8.4
11.7
14.0
12.8
14.9
Gone concern capital coverage ratio
112.0
135.7
Liquidity coverage ratio
2,7
High-quality liquid assets (billion)
89
84
91
92
17
17
32
Net cash outflows (billion)
52
53
64
62
10
11
22
Liquidity coverage ratio (%)
8,9
173
159
143
148
170
151
147
Net stable funding ratio
2,10
Total available stable funding
257,992
225,239
15,358
Total required stable funding
289,195
158,072
8,963
Net stable funding ratio (%)
89
11
142
11
171
Other
Joint and several liability between UBS AG and UBS Switzerland AG
(billion)
12
5
9
1 The financial information
disclosed does not
represent financial statements
under the respective
GAAP / IFRS.
2 Refer to the
31 December 2021 Pillar 3
Report, available under
“Pillar 3 disclosures” at
ubs.com/investors, for
more information.
3 Consists of positions
that meet the conditions
laid down in Art. 72a–b
of the Capital Requirements
Regulation (CRR) II with regard
to contractual, structural
or
legal subordination.
4 Consists of eligible long-term debt
that meets the conditions
specified in 12 CFR 252.162 of the
final TLAC rules. TLAC is the
sum of tier 1 capital
and eligible long-term debt.
5 Leverage
ratio denominators and going concern leverage ratios for UBS AG standalone and UBS Switzerland AG standalone for 31 December 2020 do
not reflect the effects of the temporary exemption that applied from
25 March 2020 until 1 January 2021 and was
granted by FINMA in connection with COVID-19.
Refer to the “Introduction and basis for preparation”
section of the 31 December 2021 Pillar 3 Report.
6 US
regulatory authorities temporarily eased the requirements for the supplementary leverage ratio (the SLR), allowing for the exclusion of US Treasury
securities and deposits at the Federal Reserve Banks from the
SLR denominator through March 2021. This
exclusion resulted in an increase in the
SLR of 170 bps on 31 December 2020.
7 There was no local
disclosure requirement for UBS Americas Holding
LLC as of
31 December 2020.
8 In the fourth quarter
of 2021, the liquidity
coverage ratio (the LCR)
of UBS AG was
173%, remaining above the prudential
requirements communicated by FINMA.
9 In the fourth
quarter of 2021, the LCR of UBS Switzerland AG, which is a Swiss SRB, was 143%, remaining above the prudential
requirement communicated by FINMA in connection with the Swiss Emergency Plan.
10 For
UBS AG standalone and UBS Switzerland
AG standalone, the
local disclosure requirement for
the net stable funding
ratio (the NSFR) came
into force in July
2021. For UBS
Europe SE consolidated, the
local
disclosure requirement for the NSFR came into force in June 2021. For UBS Americas Holding LLC consolidated, the NSFR requirement
became effective as of 1 July 2021 and related disclosures will come into
effect in the second quarter of 2023.
11 In accordance
with
Art. 17h para. 3 and 4
of the Liquidity Ordinance, UBS AG
standalone is required to maintain
a minimum NSFR of at least 80%
without taking
into account excess funding of UBS Switzerland AG and 100% after taking into account such excess
funding.
12 Refer to the “Capital, liquidity and funding, and balance sheet” section of this report for
more
information about the joint and several
liability. Under certain circumstances,
the Swiss Banking Act and FINMA’s
Banking Insolvency Ordinance authorize
FINMA to modify, extinguish
or convert to common
equity liabilities of a bank in connection with a resolution or insolvency of such bank.
Significant regulated subsidiary and sub-group information
550
UBS Group
AG is a
holding company and
conducts substantially
all of its
operations through UBS
AG and subsidiaries
thereof. UBS
Group AG and
UBS AG have contributed
a significant portion of
their
respective
capital
to,
and
provide
substantial
liquidity
to,
such
subsidiaries.
Many
of
these
subsidiaries
are
subject
to
regulations requiring
compliance with minimum
capital, liquidity
and similar requirements. The table
in this section summarizes
the
regulatory capital components and
capital ratios of our
significant
regulated
subsidiaries
and
sub
-
groups
determined
under
the
regulatory
framework of
each subsidiary’s
or sub-group’s
home
jurisdiction.
›
Refer to “Capital and capital ratios of
our significant regulated
subsidiaries” in the “Capital, liquidity and
funding, and balance
sheet” section of this report for more information
›
Refer to “Note 23 Restricted and transferred
financial assets” in
the “Consolidated financial statements”
section of this report for
more information.
Supervisory
authorities
generally
have
discretion
to
impose
higher
requirements
or
to
otherwise
limit
the
activities
of
subsidiaries.
Supervisory
authorities
also
may
require
entities
to
measure capital
and leverage
ratios on
a stressed
basis and
may
limit
the ability
of
an entity
to engage
in new
activities
or take
capital actions based on the results of those tests.
Effective 1 October 2021, UBS
Americas Holding LLC is
subject
to a
stress capital
buffer (an
SCB) of
7.1%, in
addition to
minimum
capital
requirements.
The
SCB
was
determined
by
the
Federal
Reserve
Board
following
the
completion
of
the
Comprehensive
Capital Analysis and Review
(based on Dodd–Frank Act
Stress Test
(DFAST)
results
and
planned
future
dividends).
The
SCB,
which
replaces the static capital
conservation buffer of 2.5%, is
subject
to change on an
annual basis or as otherwise
determined by the
Federal Reserve Board.
Standalone
regulatory
information
for
UBS
AG
and
UBS
Switzerland
AG,
as
well
as
consolidated
regulatory
information
for UBS Europe SE and
UBS Americas Holding LLC, is provided
in
the
31 December
2021
Pillar 3
Report,
available
under
“Pillar 3
disclosures” at
ubs.com/investors
.
Standalone financial statements
for UBS
Group AG,
as well
as
standalone
financial
statements
and
regulatory
information
for
UBS AG
and
UBS Switzerland AG,
are
available under
“Holding
company and significant
regulated
subsidiaries
and sub-groups”
at
ubs.com/investors.
Additional
regulatory
information
7
553
Table of contents
553
UBS Group AG consolidated supplemental
disclosures required under SEC regulations
553
A – Introduction
554
B – Selected financial data
554
Key figures
556
Income statement data
556
Cash dividends received from investments in subsidiaries
557
Balance sheet data
558
C – Information about the company
558
Property,
plant and equipment
559
D – Information required by Subpart 1400 of Regulation
S-K
559
Selected statistical information
559
Average balances and interest rates
561
Analysis of changes in interest income and expense
563
Deposits
563
Uninsured deposits
564
Investments in debt instruments
564
Loans portfolio
564
Allowance for credit loss
565
UBS AG consolidated supplemental disclosures
required under SEC regulations
565
A – Introduction
566
B – Selected financial data
566
Key figures
568
Income statement data
568
Dividends received from investments in subsidiaries and
associates
569
Balance sheet data
570
C – Information about the company
570
Property,
plant and equipment
571
D – Information required by Subpart 1400 of Regulation
S-K
571
Selected statistical information
571
Average balances and interest rates
573
Analysis of changes in interest income and expense
575
Deposits
575
Uninsured deposits
576
Investments in debt instruments
576
Loans portfolio
576
Allowance for credit loss
UBS Group AG consolidated supplemental disclosures required under SEC regulations
554
UBS Group AG consolidated supplemental
disclosures required under SEC regulations
A – Introduction
The
following
pages
contain
supplemental
UBS
Group
AG
disclosures that are required under SEC regulations. In
September
2020,
the
SEC
issued
final
rules
updating
and
codifying
the
disclosure
requirements
for
banking
registrants
set
forth
in
Industry
Guide
3,
Statistical
Disclosure
by
Bank
Holding
Companies. Under the final rules, Industry
Guide 3 was rescinded
and replaced with a new
Subpart 1400 of Regulation S-K, which
has come into effect
for UBS Group AG’s 2021
reporting. Part D
of this section provides the information
required by Subpart 1400
of Regulation S-K
and where applicable, prior-period comparative
information has been revised to align
with the new requirements.
UBS Group AG’s
consolidated financial statements
have been
prepared
in
accordance
with
International
Financial
Reporting
Standards
(IFRS)
as
issued
by
the
International
Accounting
Standards Board (IASB) and are denominated in US dollars (USD),
which is also
the functional currency
of: UBS Group AG;
UBS AG’s
Head
Office;
UBS
AG
London
Branch;
and
UBS’s
US-based
operations.
555
B – Selected financial data
Key figures
As of or for the year ended
USD million, except where indicated
31.12.21
31.12.20
31.12.19
31.12.18
31.12.17
Group results
Operating income
35,542
32,390
28,889
30,213
29,622
Operating expenses
26,058
24,235
23,312
24,222
24,272
Operating profit / (loss) from continuing operations before tax
9,484
8,155
5,577
5,991
5,351
Net profit / (loss) attributable to shareholders
7,457
6,557
4,304
4,516
969
Diluted earnings per share (USD)
1
2.06
1.77
1.14
1.18
0.25
Profitability and growth
2
Return on equity (%)
12.6
11.3
7.9
8.6
1.8
Return on tangible equity (%)
14.1
12.8
9.0
9.8
2.0
Return on common equity tier 1 capital (%)
17.5
17.4
12.4
13.1
3.0
Return on risk-weighted assets, gross (%)
12.0
11.7
11.0
11.8
12.6
Return on leverage ratio denominator, gross (%)
3
3.4
3.4
3.2
3.3
3.3
Cost / income ratio (%)
73.6
73.3
80.5
79.9
81.6
Effective tax rate (%)
21.1
19.4
22.7
24.5
80.5
Net profit growth (%)
13.7
52.3
(4.7)
366.0
(71.1)
Resources
2
Total assets
1,117,182
1,125,765
972,194
958,500
939,279
Equity attributable to shareholders
60,662
59,445
54,501
52,896
52,495
Common equity tier 1 capital
4
45,281
39,890
35,535
34,073
33,516
Risk-weighted assets
4
302,209
289,101
259,208
263,747
243,636
Common equity tier 1 capital ratio (%)
4
15.0
13.8
13.7
12.9
13.8
Going concern capital ratio (%)
4
20.0
19.4
20.0
17.5
17.6
Total loss-absorbing capacity ratio (%)
4
34.7
35.2
34.6
31.7
33.0
Leverage ratio denominator
3,4
1,068,862
1,037,150
911,322
904,595
909,032
Common equity tier 1 leverage ratio (%)
3,4
4.24
3.85
3.90
3.77
3.69
Going concern leverage ratio (%)
3,4
5.7
5.4
5.7
5.1
4.7
Total loss-absorbing capacity leverage ratio (%)
4
9.8
9.8
9.8
9.3
8.8
Net stable funding ratio (%)
5
119.0
119.0
111.0
110.0
105.0
UBS Group AG consolidated supplemental disclosures required under SEC regulations
556
Key figures (continued)
As of or for the year ended
USD million, except where indicated
31.12.21
31.12.20
31.12.19
31.12.18
31.12.17
Other
Invested assets (USD billion)
6
4,596
4,187
3,607
3,101
3,262
Personnel (full-time equivalents)
71,385
71,551
68,601
66,888
61,253
Americas
21,317
21,394
21,036
21,309
20,770
of which: USA
20,537
20,528
20,232
20,495
19,944
Asia Pacific
15,618
15,353
13,956
12,119
8,959
Europe, Middle East and Africa (excluding Switzerland)
14,091
13,899
12,918
12,620
11,097
of which: UK
6,051
6,069
5,704
5,782
5,274
of which: rest of Europe (excluding Switzerland)
7,826
7,652
7,048
6,670
5,662
of which: Middle East and Africa
215
178
166
168
161
Switzerland
20,359
20,904
20,691
20,840
20,427
Market capitalization
7
61,230
50,013
45,661
45,907
68,477
Total book value per share (USD)
7
17.84
16.74
15.07
14.34
14.11
Tangible book value per share (USD)
7
15.97
14.91
13.28
12.54
12.34
Registered ordinary shares (number)
7
3,702,422,995
3,859,055,395
3,859,055,395
3,855,634,749
3,853,096,603
Treasury shares (number)
7
302,815,328
307,477,002
243,021,296
166,467,802
132,301,550
1 Refer to “Share information and earnings
per share” in the “Consolidated financial
statements” section of this report for
more information.
2 Refer to the “Targets,
aspirations and capital guidance” section
of
this report for more information about our
performance targets.
3 Leverage ratio denominators and
leverage ratios for year 2020
do not reflect the effects of the
temporary exemption that applied from
25 March
2020 until 1 January
2021 and was granted
by FINMA in connection with
COVID-19. Refer to the
“Regulatory and legal developments” section
of our Annual Report
2020 for more information.
4 Based on the
Swiss systemically relevant bank
framework as of 1
January 2020. Refer to
the “Capital, liquidity and funding,
and balance sheet” section
of the report for the
respective period for more information.
5 The final
Swiss net stable funding ratio
(NSFR) regulation became effective on
1 July 2021. Prior to
this date, the NSFR
was based on estimated
pro forma reporting. Refer to
the “Capital, liquidity and funding,
and balance
sheet” section of this report for more information.
6 Consists of invested assets for Global Wealth Management,
Asset Management and Personal & Corporate
Banking. Refer to “Note 32 Invested assets
and net
new money” in the “Consolidated financial statements” section of this report for more information.
7 Refer to “UBS shares” in the “Capital, liquidity and funding, and balance sheet” section of this report for more
information.
557
Income statement data
For the year ended
USD million, except where indicated
31.12.21
31.12.20
31.12.19
31.12.18
31.12.17
Net interest income
6,705
5,862
4,501
5,048
6,070
Other net income from financial instruments measured
at fair value through profit or loss
5,850
6,960
6,842
6,960
5,637
Credit loss (expense) / release
148
(694)
(78)
(118)
(131)
Fee and commission income
24,372
20,961
19,110
19,598
19,362
Fee and commission expense
(1,985)
(1,775)
(1,696)
(1,703)
(1,840)
Net fee and commission income
22,387
19,186
17,413
17,895
17,522
Other income
452
1,076
212
428
524
Total operating income
35,542
32,390
28,889
30,213
29,622
Total operating expenses
26,058
24,235
23,312
24,222
24,272
Operating profit / (loss) before tax
9,484
8,155
5,577
5,991
5,351
Tax expense / (benefit)
1,998
1,583
1,267
1,468
4,305
Net profit / (loss)
7,486
6,572
4,310
4,522
1,046
Net profit / (loss) attributable to non-controlling interests
29
15
6
7
77
Net profit / (loss) attributable to shareholders
7,457
6,557
4,304
4,516
969
Cost / income ratio (%)
73.6
73.3
80.5
79.9
81.6
Per share data
Basic earnings per share (USD)
1
2.14
1.83
1.17
1.21
0.26
Diluted earnings per share (USD)
1
2.06
1.77
1.14
1.18
0.25
Ordinary cash dividends declared per share (CHF)
2,3
0.34
0.69
0.70
0.65
Ordinary cash dividends declared per share (USD)
2,3
0.50
0.37
0.73
0.69
0.65
Rates of return (%)
Return on equity attributable to shareholders
12.6
11.3
7.9
8.6
1.8
1 Refer to “Share information and earnings per share” in the “Consolidated financial statements” section of this report for more information.
2 Dividends and / or distributions out of the capital contribution reserve
are normally approved
and paid in
the year subsequent
to the reporting
period. Beginning in
2020, dividends
have been declared
in US dollars.
The Swiss
franc equivalent
amount for the
2021 dividend
will be
determined after the Annual General Meeting using the exchange rate applicable on that date and is therefore not provided in this table.
3 Refer to “Statement of proposed appropriation of total profit and dividend
distribution out of total profit and capital contribution reserve” in the “Standalone financial statements” section of this report for more information.
Cash dividends received from investments in subsidiaries
In 2021,
UBS Group
AG received
cash dividends
of USD 4,672
million (2020:
USD 3,853 million;
2019: USD 3,400
million) from
its
subsidiaries. Dividends
disclosed have
been translated
to US
dollars from
the functional
currency of
the entity
paying the
dividend,
using the closing exchange rate of the month the dividend was received.
UBS Group AG consolidated supplemental disclosures required under SEC regulations
558
Balance sheet data
USD million
31.12.21
31.12.20
31.12.19
31.12.18
31.12.17
Assets
Cash and balances at central banks
192,817
158,231
107,068
108,370
90,045
Loans and advances to banks
15,480
15,444
12,447
16,868
14,094
Receivables from securities financing transactions
75,012
74,210
84,245
95,349
91,951
Cash collateral receivables on derivative instruments
30,514
32,737
23,289
23,602
24,040
Loans and advances to customers
397,761
379,528
326,786
320,352
326,746
Other financial assets measured at amortized cost
26,209
27,194
22,980
22,563
37,815
Total financial assets measured at amortized cost
737,794
687,345
576,815
587,104
584,691
Financial assets at fair value held for trading
130,821
125,397
127,514
104,370
129,407
of which: assets pledged as collateral that may be sold or repledged
by counterparties
43,397
47,098
41,285
32,121
36,277
Derivative financial instruments
118,142
159,617
121,841
126,210
121,285
Brokerage receivables
21,839
24,659
18,007
16,840
Financial assets at fair value not held for trading
60,080
80,364
83,944
82,690
60,457
Total financial assets measured at fair value through profit or loss
330,882
390,037
351,307
330,110
311,148
Financial assets measured at fair value through other comprehensive income
8,844
8,258
6,345
6,667
8,889
Investments in associates
1,243
1,557
1,051
1,099
1,045
Property, equipment and software
12,888
13,109
12,804
9,348
9,057
Goodwill and intangible assets
6,378
6,480
6,469
6,647
6,563
Deferred tax assets
8,876
9,212
9,548
10,116
10,056
Other non-financial assets
10,277
9,768
7,856
7,410
7,830
Total assets
1,117,182
1,125,765
972,194
958,500
939,279
Liabilities
Amounts due to banks
13,101
11,050
6,570
10,962
7,728
Payables from securities financing transactions
5,533
6,321
7,778
10,296
17,485
Cash collateral payables on derivative instruments
31,798
37,312
31,415
28,906
31,029
Customer deposits
542,007
524,605
448,284
419,838
419,577
Debt issued measured at amortized cost
139,155
139,232
110,497
132,271
143,160
Other financial liabilities measured at amortized cost
9,001
9,729
9,712
6,885
37,276
Total financial liabilities measured at amortized cost
740,595
728,250
614,256
609,158
656,255
Financial liabilities at fair value held for trading
31,688
33,595
30,591
28,943
31,251
Derivative financial instruments
121,309
161,102
120,880
125,723
119,137
Brokerage payables designated at fair value
44,045
38,742
37,233
38,420
Debt issued designated at fair value
73,799
61,243
66,809
57,031
50,782
Other financial liabilities designated at fair value
30,074
30,387
35,940
33,594
16,643
Total financial liabilities measured at fair value through profit or loss
300,916
325,069
291,452
283,711
217,813
Provisions
3,518
2,828
2,974
3,494
3,214
Other non-financial liabilities
11,151
9,854
8,837
9,065
9,443
Total liabilities
1,056,180
1,066,000
917,519
905,429
886,725
Equity attributable to shareholders
60,662
59,445
54,501
52,896
52,495
Equity attributable to non-controlling interests
340
319
174
176
59
Total equity
61,002
59,765
54,675
53,071
52,554
Total liabilities and equity
1,117,182
1,125,765
972,194
958,500
939,279
559
C – Information about the company
Property, plant and equipment
As of 31 December 2021, UBS operated about
690 business and
banking locations worldwide, of which approximately
33% were
in Switzerland, 47% in the Americas,
10% in the rest of Europe,
Middle East and
Africa, and 10% in
Asia Pacific. Of the
business
and banking
locations in Switzerland,
30% were
owned directly
by
UBS,
with
the
remainder,
along
with
most
of
UBS’s
offices
outside Switzerland,
being held
under commercial
leases. These
premises are
subject to
continuous maintenance
and upgrading
and
are
considered
suitable
and
adequate
for
current
and
anticipated operations.
UBS Group AG consolidated supplemental disclosures required under SEC regulations
560
D – Information required by Subpart 1400 of Regulation S-K
Selected statistical information
The
following
tables
set
forth
select
statistical
information
regarding
the
Group’s
banking
operations
extracted
from
its
financial
statements.
Unless
otherwise
indicated,
average
balances for
the years
ended 31 December
2021, 31 December
2020 and 31 December
2019 are calculated
from monthly data.
Unless
otherwise
indicated,
the
distinction
between
domestic
(Swiss) and foreign (non-Swiss) is generally based on the booking
location.
Average balances and interest rates
The following table sets forth average interest-earning assets and
average interest
-bearing liabilities,
along with
the average
yield,
for 2021, 2020
and 2019. Refer
to “Note 3
Net interest
income
and other net income from financial instruments measured
at fair
value
through
profit
or
loss”
in
the
“Consolidated
financial
statements”
section
of
this
report
for
more
information
about
interest income and interest expense.
For the year ended
31.12.21
31.12.20
31.12.19
USD million, except where indicated
Average
balance
Interest
income
Average
yield (%)
Average
balance
Interest
income
Average
yield (%)
Average
balance
Interest
income
Average
yield (%)
Assets
Balances at central banks
Domestic
98,804
(105)
(0.1)
90,234
(112)
(0.1)
70,639
(208)
(0.3)
Foreign
71,529
(31)
0.0
51,611
7
0.0
34,017
194
0.6
Loans and advances to banks
Domestic
3,158
40
1.3
2,930
43
1.5
2,574
29
1.1
Foreign
13,074
12
0.1
12,089
31
0.3
12,071
15
0.1
Receivables from securities financing transactions
1
Domestic
9,435
(28)
(0.3)
4,746
8
0.2
7,550
(11)
(0.1)
Foreign
79,297
234
0.3
92,098
551
0.6
99,269
1,654
1.7
Loans and advances to customers
Domestic
228,070
3,211
1.4
210,971
3,014
1.4
189,438
3,280
1.7
Foreign
160,902
2,700
1.7
138,515
3,139
2.3
131,046
3,930
3.0
Financial assets at fair value
1,2
Domestic
10,006
11
0.1
12,455
40
0.3
9,311
72
0.8
Foreign
169,267
1,203
0.7
192,251
1,826
0.9
191,373
3,484
1.8
of which: taxable
169,254
1,203
0.7
192,243
1,826
0.9
191,373
3,484
1.8
of which: non-taxable
12
0
2.4
7
0
4.0
Other interest-earning assets
Domestic
7,477
121
1.6
8,064
136
1.7
7,258
151
2.1
Foreign
47,040
298
0.6
45,442
386
0.8
35,471
637
1.8
Total interest-earning assets
898,059
7,666
0.9
861,406
9,068
1.1
790,017
13,226
1.7
Net interest income on swaps
1,552
1,134
711
Interest income on off-balance sheet securities and other
472
386
429
Interest income and average interest-earning assets
898,059
9,689
3
1.1
861,406
10,588
3
1.2
790,017
14,366
3
1.8
Non-interest-earning assets
4
298,224
310,129
282,668
Total average assets
1,196,284
1,171,535
1,072,685
1 Reverse repurchase agreements are
presented on a gross basis
and therefore, for the
purpose of this disclosure,
do not reflect the
effect of netting permitted under
IFRS.
2 Includes financial assets at
fair value
held for trading, financial assets at fair value not held for trading, financial assets at fair value through other comprehensive income and brokerage
receivables.
3 For the purpose of this disclosure, negative interest
income on assets is presented as a reduction to interest income,
while in the consolidated income statement negative interest income on assets is presented
as interest expense. Refer to Note 3 in the “Consolidated
financial statements” section of this
report for more information.
4 Mainly includes derivative
financial instruments, equity
instruments at fair value
held for trading and
financial assets for unit-linked
investment
contracts.
561
Average balances and interest rates (continued)
For the year ended
31.12.21
31.12.20
31.12.19
USD million, except where indicated
Average
balance
Interest
expense
Average
interest
rate (%)
Average
balance
Interest
expense
Average
interest
rate (%)
Average
balance
Interest
expense
Average
interest
rate (%)
Liabilities and equity
Amount due to banks
Domestic
10,369
(32)
(0.3)
8,097
(9)
(0.1)
6,012
(5)
(0.1)
Foreign
2,897
18
0.6
3,169
26
0.8
2,697
21
0.8
Payables from securities financing transactions
1
Domestic
4,786
1
0.0
3,888
6
0.2
3,238
18
0.6
Foreign
14,161
209
1.5
18,793
174
0.9
17,218
353
2.1
Customer deposits
Domestic
289,096
(290)
(0.1)
263,619
(173)
(0.1)
243,484
(41)
0.0
of which: demand deposits
160,019
(273)
(0.2)
137,599
(166)
(0.1)
123,833
(74)
(0.1)
of which: savings deposits
126,290
4
0.0
121,793
3
0.0
112,810
16
0.0
of which: time deposits
2,786
(20)
(0.7)
4,227
(9)
(0.2)
6,842
18
0.3
Foreign
232,165
107
0.0
214,785
552
0.3
185,097
1,784
1.0
of which: demand deposits
82,226
(31)
0.0
64,957
(6)
0.0
53,981
116
0.2
of which: savings deposits
99,847
81
0.1
71,341
194
0.3
48,629
186
0.4
of which: time deposits
50,092
58
0.1
78,488
363
0.5
82,488
1,482
1.8
Commercial paper
Domestic
292
0
0.0
130
0
(0.3)
105
0
0.0
Foreign
24,461
33
0.1
17,098
120
0.7
19,762
356
1.8
Other short-term debt issued measured at amortized cost
Domestic
13
0
(0.1)
10
0
0.0
8
0
0.0
Foreign
18,473
37
0.2
16,989
147
0.9
9,019
112
1.2
Long-term debt issued measured at amortized cost
Domestic
67,916
1,789
2.6
64,899
1,988
3.1
58,802
2,043
3.5
Foreign
27,820
491
1.8
27,100
581
2.1
34,903
824
2.4
Financial liabilities at fair value (excluding debt issued
designated at fair value)
1,2
Domestic
421
3
0.8
700
2
0.3
902
0
0.0
Foreign
137,268
13
0.0
145,398
324
0.2
143,216
1,834
1.3
Debt issued designated at fair value
Domestic
9,905
48
0.5
4,376
35
0.8
2,337
43
1.8
Foreign
60,388
429
0.7
56,442
801
1.4
63,182
1,450
2.3
Other interest-bearing liabilities
Domestic
2,884
(7)
(0.2)
3,333
(6)
(0.2)
2,384
15
0.6
Foreign
34,943
105
0.3
38,606
191
0.5
32,850
470
1.4
Total interest-bearing liabilities
938,259
2,954
0.3
887,433
4,759
0.5
825,216
9,277
1.1
Swap interest on hedged debt issued and other swaps
(765)
(608)
(63)
Interest expense on off-balance sheet securities and other
795
576
651
Interest expense and average interest-bearing liabilities
938,259
2,985
3
0.3
887,433
4,726
3
0.5
825,216
9,865
3
1.2
Non-interest-bearing liabilities
4
198,130
226,388
193,040
Total liabilities
1,136,389
1,113,820
1,018,256
Total equity
59,895
57,715
54,429
Total average liabilities and equity
1,196,284
1,171,535
1,072,685
Net interest income
6,705
5,862
4,501
Net yield on interest-earning assets
0.7
0.7
0.6
1 Repurchase agreements are presented on a gross basis and therefore, for the purpose of this disclosure, do not reflect the effect of netting permitted under
IFRS.
2 Includes financial liabilities at fair value held for
trading, other financial liabilities designated at fair
value and brokerage payables
designated at fair value.
3 For the purpose of this
disclosure, negative interest expense on liabilities is
presented as a reduction to
interest expense, while in the consolidated income statement negative interest income on liabilities is presented as interest income. Refer to Note 3 in the “Consolidated financial statements” section of this report for
more information.
4 Mainly includes derivative financial instruments, equity instruments at fair value
held for trading and financial liabilities related to unit-linked investment contracts.
The
percentage
of
total
average
interest-earning
assets
attributable to foreign
activities was 60%
for 2021 (2020: 62%;
2019:
64%).
The
percentage
of
total
average
interest-bearing
liabilities
attributable
to
foreign
activities
was
56%
for
2021
(2020:
61%; 2019:
62%). All assets
and liabilities
are translated
into US dollars
at uniform month-end
rates. Interest income
and
expense are translated at monthly average rates.
Average
rates
earned
and
paid
on
assets
and
liabilities
can
change
from period
to period
based
on the
changes in
interest
rates in general, but are also
affected by changes in the currency
mix included in the
assets and liabilities. Tax-exempt
income is not
recorded on a
tax-equivalent basis. For
all three years
presented,
tax-exempt income is considered
to be insignificant
and the effect
from such income is therefore negligible.
UBS Group AG consolidated supplemental disclosures required under SEC regulations
562
Analysis of changes in interest income and expense
The following tables
provide information by
categories of
interest-
earning
assets
and
interest-bearing
liabilities
on
the
changes
in
interest
income
and
expense
due
to
changes
in
volume
and
interest
rates
for
the
year
ended
31 December
2021
compared
with the year ended
31 December 2020, and for
the year ended
31 December 2020 compared with the year ended
31 December
2019.
Volume
and
rate
variances
have
been
calculated
on
movements
in
average
balances
and
changes
in
interest
rates.
Changes
due to
a
combination of
volume
and rates
have been
allocated proportionally.
2021 compared with 2020
2020 compared with 2019
Increase / (decrease)
due to changes in
Increase / (decrease)
due to changes in
USD million
Average
volume
Average
interest rate
Net
change
Average
volume
Average
interest rate
Net
change
Interest income from interest-earning assets
Balances at central banks
Domestic
(9)
16
7
(59)
155
96
Foreign
0
(38)
(38)
106
(293)
(187)
Loans and advances to banks
Domestic
3
(6)
(3)
4
10
14
Foreign
3
(23)
(20)
0
16
16
Receivables from securities financing transactions
Domestic
9
(44)
(35)
3
16
19
Foreign
(77)
(240)
(317)
(122)
(981)
(1,103)
Loans and advances to customers
Domestic
239
(42)
197
366
(632)
(266)
Foreign
515
(954)
(439)
224
(1,015)
(791)
Financial assets at fair value
Domestic
(7)
(22)
(29)
25
(57)
(32)
Foreign
(207)
(416)
(623)
16
(1,674)
(1,658)
of which: taxable
(207)
(416)
(623)
16
(1,674)
(1,658)
of which: non-taxable
0
0
0
0
0
0
Other interest-earning assets
Domestic
(10)
(5)
(15)
17
(32)
(15)
Foreign
13
(101)
(88)
179
(430)
(251)
Interest income
Domestic
225
(103)
122
356
(540)
(184)
Foreign
247
(1,771)
(1,524)
403
(4,377)
(3,974)
Total interest income from interest-earning assets
472
(1,874)
(1,402)
759
(4,917)
(4,158)
Net interest income on swaps
418
423
Interest income on off-balance sheet securities and other
86
(43)
Total interest income
(899)
(3,778)
563
Analysis of changes in interest income and expense (continued)
2021 compared with 2020
2020 compared with 2019
Increase / (decrease)
due to changes in
Increase / (decrease)
due to changes in
USD million
Average
volume
Average
interest rate
Net
change
Average
volume
Average
interest rate
Net
change
Interest expense on interest-bearing liabilities
Amount due to banks
Domestic
(2)
(21)
(23)
(2)
(2)
(4)
Foreign
(2)
(6)
(8)
4
1
5
Payables from securities financing transactions
Domestic
2
(7)
(5)
4
(16)
(12)
Foreign
(42)
76
34
33
(211)
(178)
Customer deposits
Domestic
(19)
(98)
(117)
(22)
(110)
(132)
of which: demand deposits
(22)
(86)
(108)
(14)
(78)
(92)
of which: savings deposits
0
1
1
0
(13)
(13)
of which: time deposits
3
(14)
(11)
(8)
(19)
(27)
Foreign
52
(497)
(445)
297
(1,530)
(1,233)
of which: demand deposits
(2)
(24)
(26)
24
(146)
(122)
of which: savings deposits
78
(192)
(114)
87
(79)
8
of which: time deposits
(24)
(281)
(305)
186
(1,306)
(1,120)
Commercial paper
Domestic
0
0
0
0
0
0
Foreign
52
(138)
(86)
(48)
(189)
(237)
Other short-term debt issued measured at amortized cost
Domestic
0
0
0
0
0
0
Foreign
13
(123)
(110)
133
(98)
35
Long-term debt issued measured at amortized cost
Domestic
94
(293)
(199)
3
(59)
(56)
Foreign
15
(105)
(90)
(187)
(56)
(243)
Financial liabilities at fair value (excluding debt issued designated
at fair value)
Domestic
(1)
2
1
0
2
2
Foreign
(16)
(295)
(311)
28
(1,538)
(1,510)
Debt issued designated at fair value
Domestic
44
(31)
13
37
(44)
(7)
Foreign
55
(427)
(372)
(155)
(494)
(649)
Other interest-bearing liabilities
Domestic
1
(2)
(1)
6
(27)
(21)
Foreign
(18)
(68)
(86)
81
(359)
(278)
Interest expense
Domestic
119
(450)
(331)
26
(257)
(231)
Foreign
109
(1,583)
(1,474)
186
(4,473)
(4,287)
Total interest expense on interest-bearing liabilities
228
(2,033)
(1,805)
212
(4,731)
(4,518)
Swap interest on hedged debt issued and other swaps
(157)
(545)
Interest expense on off-balance sheet securities and other
220
(75)
Total interest expense
(1,742)
(5,139)
UBS Group AG consolidated supplemental disclosures required under SEC regulations
564
Deposits
The following
table analyzes average
deposits and average
rates
on each deposit category
for the years
ended 31 December 2021,
2020
and
2019
.
For
the
purpose
of
this
disclosure,
foreign
deposits
represent
deposits
from
depositors
who
are
based
outside of Switzerland.
Deposits by
foreign depositors in
domestic
offices
were
USD
77,011
million
as
of
31
December
2021
(31 December
2020:
USD 76,167
million;
31 December
2019:
USD 54,251 million).
31.12.21
31.12.20
31.12.19
USD million, except where indicated
Average
deposits
Average
rate (%)
Average
deposits
Average
rate (%)
Average
deposits
Average
rate (%)
Due to banks
Domestic
Demand deposits
927
(0.5)
1,037
(0.4)
925
(0.3)
Time deposits
3,026
0.0
1,775
0.4
44
0.9
Total domestic
3,953
(0.1)
2,812
0.1
969
(0.3)
Foreign
1
Interest-bearing deposits
9,313
(0.1)
8,454
0.1
7,740
0.1
Total due to banks
13,266
(0.1)
11,266
0.1
8,709
0.1
Customer deposits
Domestic
Demand deposits
101,338
(0.2)
90,070
(0.1)
83,835
(0.1)
Savings deposits
114,792
0.0
110,328
0.0
101,845
0.0
Time deposits
8,371
(0.4)
17,610
(0.1)
13,776
0.4
Total domestic
224,502
(0.1)
218,008
(0.1)
199,456
0.0
Foreign
1
Demand deposits
140,906
(0.1)
112,486
0.0
93,979
0.1
Savings deposits
111,345
0.1
82,806
0.2
59,593
0.3
Time deposits
44,507
0.1
65,104
0.5
75,554
1.9
Total foreign
296,758
0.0
260,397
0.2
229,126
0.8
Total customer deposits
521,260
0.0
478,404
0.1
428,582
0.4
1 For the
purpose of this
table, the distinction
between foreign and
domestic deposits is
based on the
domicile of the
depositor,
while foreign and
domestic deposits disclosed
in previous tables
are based on
the
booking location.
Uninsured deposits
From the combined total of Due to banks and Customer deposits
as of 31 December
2021, total
estimated uninsured deposits
were
USD 392
billion
(31 December
2020:
USD 380
billion;
31 December
2019:
USD 318
billion).
Uninsured
deposits
are
deposits that are in excess
of local deposit insurance
or protection
scheme
limits
in
the
key
locations
in
which
UBS
operates,
calculated
based
on
the
respective
local
regulations,
as
well
as
deposits
in
uninsured
accounts.
The
main
deposit
insurance
schemes
applicable
to
UBS
deposits
are
the
Swiss
depositor
protection
scheme
in
Switzerland
(which
protects
applicable
deposits
up
to
a
maximum
of
CHF 100,000
per
client
and
per
bank
or
securities
firm),
the
Compensation
Scheme
of
German
Banks, EdB,
in combination
with the
Deposit Protection
Fund of
the
Association
of
German
Banks
in
Germany
(which
protects
applicable
deposits
up
to
a
maximum
of
EUR 597
million
per
client) and
the Federal
Deposit Insurance
Corporation (the
FDIC)
scheme in the Americas (which protects applicable deposits up
to
a maximum of USD 250,000 per depositor,
per insured bank, for
each account ownership category).
The table below presents the
maturity of estimated uninsured
time deposits as of 31
December 2021. Where a depositor
holds
multiple accounts,
which in aggregate
are in excess
of a deposit
insurance or protection limit, the insured amount is first allocated
to the account with the shortest time to maturity.
USD million
Uninsured time deposits
1
Within 3 months
44,912
3 to 6 months
2,748
6 to 12 months
2,437
Over 12 months
85
Total uninsured time deposits as of 31 December 2021
50,182
1 Amounts are estimated based on the methodologies defined in each local jurisdiction. As of 31 December 2021, there were no
US time deposits subject to the FDIC scheme that were in excess of the FDIC insurance
limit.
565
Investments in debt instruments
The
table
below
presents
the
carrying
amount
and
weighted
average
yield
of
debt
instruments
presented
within
Financial
assets
measured
at
fair
value
through
other
comprehensive
income and Other financial assets measured at amortized cost on
the
balance
sheet
by
contractual maturity
bucket. The
yield
for
each range of
maturities is calculated
by dividing the
annualized
interest
income
by
the
average
balance
of
the
investment
per
contractual maturity bucket. The
maturity information presented
does
not
consider
any
early
redemption
features
and
debt
instruments without fixed maturities are not included.
Within 1 year
1 up to 5 years
5 to 10 years
Over 10 years
Total carrying
amount
USD million, except where indicated
Carrying
amount
Yield (%)
Carrying
amount
Yield (%)
Carrying
amount
Yield (%)
Carrying
amount
Yield (%)
Debt instruments measured at fair value through
other comprehensive income
Asset-backed securities
1,129
1.63
3,720
1.42
4,849
Government bills/bonds
27
1.67
416
2.40
1,998
1.20
244
1.64
2,686
Corporate and other
1,193
1.61
116
2.48
1,310
Subtotal as of 31 December 2021
1,220
533
3,127
3,964
8,844
Debt securities measured at amortized cost
Asset-backed securities
2,418
2.32
2,418
Government bills/bonds
1,693
1.20
5,924
1.85
2,216
2.00
9,833
Corporate and other
1,025
0.77
4,264
0.30
1,318
0.33
6,608
Subtotal as of 31 December 2021
2,718
10,189
3,534
2,418
18,858
Total as of 31 December 2021
3,939
10,721
6,661
6,382
27,702
Loan portfolio
The table below provides the maturity profile of UBS’s core loan portfolio as of 31 December 2021. The contractual maturity is based
on
carrying
amounts
and
includes
the
effect
of
callable
features.
For
loans
due
after
one
year,
a
breakdown
between
fixed
and
adjustable or floating interest rates is also provided.
USD million
31.12.21
Within 1 year
1 - 5 years
5 - 15 years
Over 15 years
Total
of which: over 1 year
Fixed rate
Adjustable or
floating rate
Private clients with mortgages
30,119
66,165
34,226
21,969
152,479
78,826
43,533
Real estate financing
20,010
15,628
8,266
41
43,945
19,057
4,878
Large corporate clients
8,787
4,396
807
1
13,990
3,879
1,325
SME clients
6,772
4,205
3,027
0
14,004
3,817
3,414
Lombard
142,261
6,733
247
42
149,283
6,481
540
Credit cards
1,716
0
0
0
1,716
0
0
Commodity trade finance
3,809
0
4
0
3,813
4
0
Other loans and advances to customers
9,614
7,463
1,357
100
18,532
5,308
3,611
Loans to financial advisors
118
1,196
1,073
66
2,453
2,335
0
Total
223,205
105,785
49,005
22,218
400,214
119,708
57,301
Allowance for credit losses
For the years
ended 31 December
2021, 2020 and
2019, the ratio
of
net
charge-offs
(i.e.,
write-offs
of
expected
credit
loss
allowances
to
gross
carrying
amount
of
the
average
loans
outstanding)
during the
period was
not material
for UBS’s
core
loan portfolio, both on an overall
basis and on an individual loan
category basis. Total
write-offs for 31 December 2021 were
USD
137 million (31
December 2020: USD
356 million, 31
December
2019:
USD
142
million).
Refer
to
the
coverage
ratio
tables
in
“Note 9 Financial assets
at amortized cost and
other positions in
scope of expected
credit loss measurement” in
the "Consolidated
financial
statements"
section
of
this
report
for
the
ratio
of
expected credit loss allowances to total
loans outstanding at each
period end.
UBS AG consolidated supplemental disclosures required under SEC regulations
566
UBS AG consolidated supplemental
disclosures required under SEC regulations
A
–
Introduction
The
following
pages
contain
supplemental
UBS
AG
disclosures
that are required
under SEC regulations. In September 2020,
the
SEC
issued
final
rules
updating
and
codifying
the
disclosure
requirements
for banking
registrants
set forth
in Industry
Guide
3,
Statistical Disclosure
by Bank
Holding
Companies. Under
the
final
rules, Industry
Guide 3
was rescinded
and replaced
with a
new Subpart 1400 of Regulation S-K, which has come into effect
for UBS
AG’s 2021 reporting.
Part D of
this section provides
the
information
required
by
Subpart
1400
of
Regulation
S-K
and
where applicable, prior-period comparative information has been
revised to align with the new requirements.
UBS
AG’s
consolidated
financial
statements
have
been
prepared
in
accordance
with
International
Financial
Reporting
Standards
(IFRS)
as
issued
by
the
International
Accounting
Standards Board (IASB) and are denominated in US dollars (USD),
which is
also the
functional currency
of: UBS
AG’s Head
Office;
UBS AG London Branch; and UBS AG’s US-based operations.
567
B – Selected financial data
Key figures
As of or for the year ended
USD million, except where indicated
31.12.21
31.12.20
31.12.19
31.12.18
31.12.17
Results
Operating income
35,976
32,780
29,307
30,642
30,044
Operating expenses
27,012
25,081
24,138
25,184
24,969
Operating profit / (loss) from continuing operations before tax
8,964
7,699
5,169
5,458
5,076
Net profit / (loss) attributable to shareholders
7,032
6,196
3,965
4,107
758
Profitability and growth
1
Return on equity (%)
12.3
10.9
7.4
7.9
1.4
Return on tangible equity (%)
13.9
12.4
8.5
9.1
1.6
Return on common equity tier 1 capital (%)
17.6
16.6
11.3
11.9
2.3
Return on risk-weighted assets, gross (%)
12.3
11.9
11.2
12.0
12.8
Return on leverage ratio denominator, gross (%)
2
3.4
3.4
3.2
3.4
3.4
Cost / income ratio (%)
75.4
74.9
82.1
81.9
82.7
Net profit growth (%)
13.5
56.3
(3.4)
441.9
(77.4)
Resources
1
Total assets
1,116,145
1,125,327
971,927
958,066
940,020
Equity attributable to shareholders
58,102
57,754
53,722
52,224
51,987
Common equity tier 1 capital
3
41,594
38,181
35,233
34,562
34,100
Risk-weighted assets
3
299,005
286,743
257,831
262,840
242,725
Common equity tier 1 capital ratio (%)
3
13.9
13.3
13.7
13.1
14.0
Going concern capital ratio (%)
3
18.5
18.3
18.3
16.1
15.6
Total loss-absorbing capacity ratio (%)
3
33.3
34.2
33.9
31.3
31.4
Leverage ratio denominator
2,3
1,067,679
1,036,771
911,228
904,455
910,133
Common equity tier 1 leverage ratio (%)
2,3
3.90
3.68
3.87
3.82
3.75
Going concern leverage ratio (%)
2,3
5.2
5.1
5.2
4.7
4.2
Total loss-absorbing capacity leverage ratio (%)
3
9.3
9.5
9.6
9.1
8.4
UBS AG consolidated supplemental disclosures required under SEC regulations
568
Key figures (continued)
As of or for the year ended
USD million, except where indicated
31.12.21
31.12.20
31.12.19
31.12.18
31.12.17
Other
Invested assets (USD billion)
4
4,596
4,187
3,607
3,101
3,262
Personnel (full-time equivalents)
47,067
47,546
47,005
47,643
46,009
Americas
21,317
21,394
21,036
21,309
20,770
of which: USA
20,537
20,528
20,232
20,495
19,944
Asia Pacific
7,993
8,049
7,958
7,987
6,891
Europe, Middle East and Africa (excluding Switzerland)
5,748
5,797
5,546
5,669
5,404
of which: UK
2,611
2,596
2,392
2,508
2,428
of which: rest of Europe (excluding Switzerland)
2,949
3,024
2,988
2,992
2,814
of which: Middle East and Africa
189
177
166
168
161
Switzerland
12,009
12,307
12,465
12,678
12,943
Registered ordinary shares (number)
3,858,408,466
3,858,408,466
3,858,408,466
3,858,408,466
3,858,408,466
Treasury shares (number)
0
0
0
0
0
1 Refer to the “Targets, aspirations
and capital guidance” section of this report for more information
about our performance measurement.
2 Leverage ratio denominators and leverage ratios
for year 2020 do not
reflect the effects of
the temporary exemption
that applied from 25
March 2020 until 1
January 2021 and
was granted by
FINMA in connection with
COVID-19. Refer to
the “Regulatory and legal
developments”
section of our Annual Report 2020 for more information.
3 Based on the Swiss systemically relevant
bank framework as of 1 January 2020.
Refer to the “Capital, liquidity and funding, and
balance sheet” section
of the report for the respective period for more information.
4 Consists of invested assets for Global Wealth Management, Asset Management and Personal
& Corporate Banking. Refer to “Note 32 Invested assets
and net new money” in the “Consolidated financial statements” section of this report for more information.
569
Income statement data
For the year ended
USD million, except where indicated
31.12.21
31.12.20
31.12.19
31.12.18
31.12.17
Net interest income
6,605
5,788
4,415
4,971
6,021
Other net income from financial instruments measured
at fair value through profit or loss
5,844
6,930
6,833
6,953
5,640
Credit loss (expense) / release
148
(695)
(78)
(117)
(131)
Fee and commission income
24,422
20,982
19,156
19,632
19,390
Fee and commission expense
(1,985)
(1,775)
(1,696)
(1,703)
(1,840)
Net fee and commission income
22,438
19,207
17,460
17,930
17,550
Other income
941
1,549
677
905
965
Total operating income
35,976
32,780
29,307
30,642
30,044
Total operating expenses
27,012
25,081
24,138
25,184
24,969
Operating profit / (loss) before tax
8,964
7,699
5,169
5,458
5,076
Tax expense / (benefit)
1,903
1,488
1,198
1,345
4,242
Net profit / (loss)
7,061
6,211
3,971
4,113
834
Net profit / (loss) attributable to preferred noteholders
73
Net profit / (loss) attributable to non-controlling interests
29
15
6
7
4
Net profit / (loss) attributable to shareholders
7,032
6,196
3,965
4,107
758
Cost / income ratio (%)
75.4
74.9
82.1
81.9
82.7
Rates of return (%)
Return on equity attributable to shareholders
12.3
10.9
7.4
7.9
1.4
Dividends received from investments in subsidiaries and associates
In 2021,
UBS AG
received dividends
of USD 6,401
million (2020:
USD 3,214 million;
2019: USD 3,508
million) from
its subsidiaries
and associates. Dividends disclosed have been translated to US dollars from the functional currency of the entity paying the dividend,
using the closing exchange rate of the month the dividend was received.
UBS AG consolidated supplemental disclosures required under SEC regulations
570
Balance sheet data
USD million
31.12.21
31.12.20
31.12.19
31.12.18
31.12.17
Assets
Cash and balances at central banks
192,817
158,231
107,068
108,370
90,045
Loans and advances to banks
15,360
15,344
12,379
16,642
14,047
Receivables from securities financing transactions
75,012
74,210
84,245
95,349
91,951
Cash collateral receivables on derivative instruments
30,514
32,737
23,289
23,603
24,040
Loans and advances to customers
398,693
380,977
327,992
321,482
328,952
Other financial assets measured at amortized cost
26,236
27,219
23,012
22,637
37,890
Total financial assets measured at amortized cost
738,632
688,717
577,985
588,084
586,925
Financial assets at fair value held for trading
131,033
125,492
127,695
104,513
129,509
of which: assets pledged as collateral that may be sold or repledged
by counterparties
43,397
47,098
41,285
32,121
36,277
Derivative financial instruments
118,145
159,618
121,843
126,212
121,286
Brokerage receivables
21,839
24,659
18,007
16,840
Financial assets at fair value not held for trading
59,642
80,038
83,636
82,387
60,070
Total financial assets measured at fair value through profit or loss
330,659
389,808
351,181
329,953
310,865
Financial assets measured at fair value through other comprehensive income
8,844
8,258
6,345
6,667
8,889
Investments in associates
1,243
1,557
1,051
1,099
1,045
Property, equipment and software
11,712
11,958
11,826
8,479
8,191
Goodwill and intangible assets
6,378
6,480
6,469
6,647
6,563
Deferred tax assets
8,839
9,174
9,524
10,077
9,993
Other non-financial assets
9,836
9,374
7,547
7,062
7,548
Total assets
1,116,145
1,125,327
971,927
958,066
940,020
Liabilities
Amounts due to banks
13,101
11,050
6,570
10,962
7,728
Payables from securities financing transactions
5,533
6,321
7,778
10,296
17,485
Cash collateral payables on derivative instruments
31,801
37,313
31,416
28,906
31,029
Customer deposits
544,834
527,929
450,591
421,986
423,058
Funding from UBS Group AG
57,295
53,979
47,866
41,202
35,648
Debt issued measured at amortized cost
82,432
85,351
62,835
91,245
107,458
Other financial liabilities measured at amortized cost
9,765
10,421
10,373
7,576
38,092
Total financial liabilities measured at amortized cost
744,762
732,364
617,429
612,174
660,498
Financial liabilities at fair value held for trading
31,688
33,595
30,591
28,949
31,251
Derivative financial instruments
121,309
161,102
120,880
125,723
119,138
Brokerage payables designated at fair value
44,045
38,742
37,233
38,420
Debt issued designated at fair value
71,460
59,868
66,592
57,031
50,782
Other financial liabilities designated at fair value
32,414
31,773
36,157
33,594
16,643
Total financial liabilities measured at fair value through profit or loss
300,916
325,080
291,452
283,717
217,814
Provisions
3,452
2,791
2,938
3,457
3,164
Other non-financial liabilities
8,572
7,018
6,211
6,318
6,499
Total liabilities
1,057,702
1,067,254
918,031
905,667
887,974
Equity attributable to shareholders
58,102
57,754
53,722
52,224
51,987
Equity attributable to non-controlling interests
340
319
174
176
59
Total equity
58,442
58,073
53,896
52,400
52,046
Total liabilities and equity
1,116,145
1,125,327
971,927
958,066
940,020
571
C – Information about the company
Property, plant and equipment
As of 31
December 2021, UBS AG
operated about 680
business
and banking
locations worldwide,
of which
approximately 33%
were
in
Switzerland,
48%
in
the
Americas,
10%
in
the
rest
of
Europe,
Middle East
and Africa,
and
9% in
Asia Pacific.
Of the
business and banking locations in Switzerland, 30% were owned
directly by UBS
AG, with the remainder,
along with most of
UBS
AG’s
offices
outside
Switzerland,
being
held
under
commercial
leases. These
premises are subject
to continuous
maintenance and
upgrading and are
considered suitable
and adequate for
current
and anticipated operations.
UBS AG consolidated supplemental disclosures required under SEC regulations
572
D – Information required by Subpart 1400 of Regulation S-K
Selected statistical information
The
following
tables
set
forth
select
statistical
information
regarding
UBS
AG’s
banking
operations
extracted
from
its
financial
statements.
Unless
otherwise
indicated,
average
balances for
the years
ended 31 December
2021, 31 December
2020 and 31 December
2019 are calculated
from monthly data.
Unless
otherwise
indicated,
the
distinction
between
domestic
(Swiss) and foreign (non-Swiss) is generally based on the booking
location.
Average balances and interest rates
The following table sets forth average interest-earning assets and
average interest
-bearing liabilities,
along with
the average
yield,
for 2021,
2020 and
2019. Refer
to “Note
3 Net interest income
and other net income from financial instruments measured
at fair
value
through
profit
or
loss”
in
the
“Consolidated
financial
statements”
section
of
this
report
for
more
information
about
interest income and interest expense.
For the year ended
31.12.21
31.12.20
31.12.19
USD million, except where indicated
Average
balance
Interest
income
Average
yield (%)
Average
balance
Interest
income
Average
yield (%)
Average
balance
Interest
income
Average
yield (%)
Assets
Balances at central banks
Domestic
98,804
(105)
(0.1)
90,234
(112)
(0.1)
70,639
(208)
(0.3)
Foreign
71,529
(31)
0.0
51,611
7
0.0
34,017
194
0.6
Loans and advances to banks
Domestic
3,158
40
1.3
2,930
43
1.5
2,574
29
1.1
Foreign
12,961
12
0.1
12,001
31
0.3
11,853
15
0.1
Receivables from securities financing transactions
1
Domestic
9,435
(28)
(0.3)
4,746
8
0.2
7,550
(11)
(0.1)
Foreign
79,297
234
0.3
92,098
551
0.6
99,269
1,654
1.7
Loans and advances to customers
Domestic
229,794
3,214
1.4
212,383
3,020
1.4
190,898
3,300
1.7
Foreign
160,869
2,698
1.7
138,485
3,136
2.3
131,020
3,926
3.0
Financial assets at fair value
1,2
Domestic
10,023
11
0.1
12,459
40
0.3
9,317
72
0.8
Foreign
169,368
1,203
0.7
192,381
1,826
0.9
191,500
3,484
1.8
of which: taxable
169,356
1,202
0.7
192,374
1,826
0.9
191,500
3,484
1.8
of which: non-taxable
12
0
2.4
7
0
4.0
Other interest-earning assets
Domestic
7,477
121
1.6
8,064
136
1.7
7,258
151
2.1
Foreign
47,042
298
0.6
45,443
386
0.8
35,471
637
1.8
Total interest-earning assets
899,757
7,666
0.9
862,835
9,071
1.1
791,366
13,242
1.7
Net interest income on swaps
1,558
1,140
716
Interest income on off-balance sheet securities and other
472
386
429
Interest income and average interest-earning assets
899,757
9,695
3
1.1
862,835
10,597
3
1.2
791,366
14,386
3
1.8
Non-interest-earning assets
4
296,300
308,528
280,815
Total average assets
1,196,057
1,171,363
1,072,181
1 Reverse repurchase agreements are presented
on a gross basis and therefore,
for the purpose of this disclosure,
do not reflect the effect
of netting permitted under IFRS.
2 Includes financial assets at fair
value
held for trading, financial
assets at fair value not held for trading, financial assets at fair value through other comprehensive income and brokerage receivables.
3 For the purpose of this disclosure, negative interest
income on assets is presented as a reduction to interest income, while in the consolidated income statement negative interest income on assets is presented
as interest expense. Refer to Note 3 in the “Consolidated
financial statements” section of this report
for more information.
4 Mainly includes derivative financial
instruments, equity instruments at
fair value held for trading
and financial assets for unit-linked
investment
contracts.
573
Average balances and interest rates (continued)
For the year ended
31.12.21
31.12.20
31.12.19
USD million, except where indicated
Average
balance
Interest
expense
Average
interest
rate (%)
Average
balance
Interest
expense
Average
interest
rate (%)
Average
balance
Interest
expense
Average
interest
rate (%)
Liabilities and equity
Amount due to banks
Domestic
10,369
(32)
(0.3)
8,097
(9)
(0.1)
6,012
(5)
(0.1)
Foreign
2,897
18
0.6
3,169
26
0.8
2,697
21
0.8
Payables from securities financing transactions
1
Domestic
4,786
1
0.0
3,888
6
0.2
3,238
18
0.6
Foreign
14,161
209
1.5
18,793
174
0.9
17,218
353
2.1
Customer deposits
Domestic
293,028
(281)
(0.1)
266,614
(160)
(0.1)
246,066
133
0.1
of which: demand deposits
162,016
(273)
(0.2)
138,949
(164)
(0.1)
125,127
(66)
(0.1)
of which: savings deposits
126,290
4
0.0
121,793
3
0.0
112,810
16
0.0
of which: time deposits
4,721
(12)
(0.3)
5,873
1
0.0
8,130
18
0.2
Foreign
232,165
107
0.0
214,783
551
0.3
185,093
1,784
1.0
of which: demand deposits
82,226
(31)
0.0
64,955
(6)
0.0
53,976
116
0.2
of which: savings deposits
99,847
81
0.1
71,341
194
0.3
48,629
186
0.4
of which: time deposits
50,092
58
0.1
78,488
363
0.5
82,488
1,483
1.8
Funding from UBS Group AG
Domestic
56,008
1,699
3.0
51,005
1,740
3.4
45,487
1,896
4.2
Foreign
0
0
0.0
0
0
0.0
0
0
0.0
Commercial paper
Domestic
292
0
0.0
130
0
0.0
105
0
0.0
Foreign
24,461
33
0.1
17,098
120
0.7
19,762
356
1.8
Other short-term debt issued measured at amortized cost
Domestic
13
0
(0.1)
10
0
0.0
8
0
0.0
Foreign
18,473
37
0.2
16,989
147
0.9
9,019
112
1.2
Long-term debt issued measured at amortized cost
Domestic
12,352
192
1.6
14,054
323
2.3
13,483
336
2.5
Foreign
27,820
491
1.8
27,100
581
2.1
34,903
824
2.4
Financial liabilities at fair value (excluding debt issued
designated at fair value)
1,2
Domestic
421
3
0.8
701
2
0.3
903
0
0.0
Foreign
139,374
81
0.1
146,306
354
0.2
143,246
1,835
1.3
Debt issued designated at fair value
Domestic
7,806
(20)
(0.3)
3,469
6
0.2
2,307
42
1.8
Foreign
60,388
429
0.7
56,442
801
1.4
63,182
1,450
2.3
Other interest-bearing liabilities
Domestic
2,884
(7)
(0.2)
3,333
(6)
(0.2)
2,381
15
0.6
Foreign
34,833
101
0.3
38,516
187
0.5
32,768
465
1.4
Total interest-bearing liabilities
942,531
3,060
0.3
890,498
4,841
0.5
827,878
9,470
1.1
Swap interest on hedged debt instruments and other swaps
(765)
(608)
(149)
Interest expense on off-balance sheet securities and other
797
576
651
Interest expense and average interest-bearing liabilities
942,531
3,091
3
0.3
890,498
4,809
3
0.5
827,878
9,971
3
1.2
Non-interest-bearing liabilities
4
196,273
224,468
191,113
Total liabilities
1,138,804
1,114,966
1,018,991
Total equity
57,254
56,397
53,189
Total average liabilities and equity
1,196,057
1,171,363
1,072,181
Net interest income
6,604
5,788
4,415
Net yield on interest-earning assets
0.7
0.7
0.6
1 Repurchase agreements are presented on a gross basis and therefore, for the purpose of this disclosure, do not reflect the effect of netting permitted under IFRS.
2 Includes financial liabilities at fair value held for
trading, other financial liabilities designated at fair value and brokerage
payables designated at fair value.
3 For the purpose of this disclosure,
negative interest expense on liabilities is presented as a reduction to
interest expense, while in the
consolidated income statement negative interest
income on liabilities is presented
as interest income. Refer
to Note 3 in the “Consolidated
financial statements” section of this
report
for more information.
4 Mainly includes derivative financial instruments, equity instruments at fair value
held for trading and financial liabilities related to unit-linked investment contracts.
The
percentage
of
total
average
interest-earning
assets
attributable to foreign
activities was 60%
for 2021 (2020: 62%;
2019:
64%).
The
percentage
of
total
average
interest-bearing
liabilities
attributable
to
foreign
activities
was
56%
for
2021
(2020:
61%; 2019:
61%). All assets
and liabilities
are translated
into US dollars
at uniform month-end
rates. Interest income
and
expense are translated at monthly average rates.
Average
rates
earned
and
paid
on
assets
and
liabilities
can
change
from period
to period
based
on the
changes in
interest
rates in general, but are also
affected by changes in the currency
mix included in the
assets and liabilities. Tax-exempt
income is not
recorded on a
tax-equivalent basis. For
all three years
presented,
tax-exempt income is considered
to be insignificant
and the effect
from such income is therefore negligible.
UBS AG consolidated supplemental disclosures required under SEC regulations
574
Analysis of changes in interest income and expense
The following tables
provide information by
categories of
interest-
earning
assets
and
interest-bearing
liabilities
on
the
changes
in
interest
income
and
expense
due
to
changes
in
volume
and
interest
rates
for
the
year
ended
31 December
2021
compared
with the year ended
31 December 2020, and for
the year ended
31 December 2020 compared with the year ended
31 December
2019.
Volume
and
rate
variances
have
been
calculated
on
movements
in
average
balances
and
changes
in
interest
rates.
Changes
due to
a
combination of
volume
and rates
have been
allocated proportionally.
2021 compared with 2020
2020 compared with 2019
Increase / (decrease)
due to changes in
Increase / (decrease)
due to changes in
USD million
Average
volume
Average
interest rate
Net
change
Average
volume
Average
interest rate
Net
change
Interest income from interest-earning assets
Balances at central banks
Domestic
(9)
16
7
(59)
155
96
Foreign
0
(38)
(38)
106
(293)
(187)
Loans and advances to banks
Domestic
3
(6)
(3)
4
10
14
Foreign
3
(23)
(20)
0
16
16
Receivables from securities financing transactions
Domestic
9
(44)
(35)
3
16
19
Foreign
(77)
(240)
(317)
(122)
(981)
(1,103)
Loans and advances to customers
Domestic
244
(50)
194
365
(645)
(280)
Foreign
515
(954)
(439)
224
(1,014)
(790)
Financial assets at fair value
Domestic
(7)
(22)
(29)
25
(57)
(32)
Foreign
(207)
(416)
(623)
16
(1,674)
(1,658)
of which: taxable
(207)
(416)
(623)
16
(1,674)
(1,658)
of which: non-taxable
0
0
0
0
0
0
Other interest-earning assets
Domestic
(10)
(5)
(15)
17
(32)
(15)
Foreign
13
(101)
(88)
179
(430)
(251)
Interest income
Domestic
230
(111)
119
355
(553)
(198)
Foreign
247
(1,772)
(1,525)
403
(4,376)
(3,973)
Total interest income from interest-earning assets
477
(1,883)
(1,406)
758
(4,929)
(4,171)
Net interest income on swaps
418
424
Interest income on off-balance sheet securities and other
86
(43)
Total interest income
(902)
(3,789)
575
Analysis of changes in interest income and expense (continued)
2021 compared with 2020
2020 compared with 2019
Increase / (decrease)
due to changes in
Increase / (decrease)
due to changes in
USD million
Average
volume
Average
interest rate
Net
change
Average
volume
Average
interest rate
Net
change
Interest expense on interest-bearing liabilities
Amount due to banks
Domestic
(2)
(21)
(23)
(2)
(3)
(5)
Foreign
(2)
(5)
(7)
4
1
5
Payables from securities financing transactions
Domestic
2
(7)
(5)
4
(16)
(12)
Foreign
(42)
76
34
33
(211)
(178)
Customer deposits
Domestic
(23)
(98)
(121)
(19)
(109)
(128)
of which: demand deposits
(23)
(86)
(109)
(14)
(84)
(98)
of which: savings deposits
0
1
1
0
(13)
(13)
of which: time deposits
0
(13)
(13)
(5)
(12)
(17)
Foreign
52
(497)
(445)
297
(1,530)
(1,233)
of which: demand deposits
0
(26)
(26)
22
(144)
(122)
of which: savings deposits
86
(200)
(114)
91
(83)
8
of which: time deposits
(142)
(163)
(305)
206
(1,326)
(1,120)
Funding from UBS Group AG
Domestic
170
(211)
(41)
(3)
(153)
(156)
Foreign
0
0
0
0
0
0
Commercial paper
Domestic
0
0
0
0
0
0
Foreign
52
(138)
(86)
(48)
(189)
(237)
Other short-term debt issued measured at amortized cost
Domestic
0
0
0
0
0
0
Foreign
13
(123)
(110)
133
(98)
35
Long-term debt issued measured at amortized cost
Domestic
(39)
(92)
(131)
14
(27)
(13)
Foreign
15
(105)
(90)
(187)
(56)
(243)
Financial liabilities at fair value (excluding debt issued designated
at fair value)
Domestic
(1)
2
1
0
2
2
Foreign
(14)
(259)
(273)
40
(1,521)
(1,481)
Debt issued designated at fair value
Domestic
9
(34)
(25)
21
(57)
(36)
Foreign
55
(426)
(371)
(155)
(494)
(649)
Other interest-bearing liabilities
Domestic
1
(2)
(1)
6
(27)
(21)
Foreign
(18)
(68)
(86)
80
(358)
(278)
Interest expense
Domestic
117
(463)
(346)
21
(390)
(369)
Foreign
111
(1,546)
(1,435)
197
(4,456)
(4,259)
Total interest expense on interest-bearing liabilities
228
(2,010)
(1,782)
218
(4,846)
(4,628)
Swap interest on hedged debt instruments and other swaps
(157)
(459)
Interest expense on off-balance sheet securities and other
221
(75)
Total interest expense
(1,718)
(5,162)
UBS AG consolidated supplemental disclosures required under SEC regulations
576
Deposits
The following
table analyzes average
deposits and average
rates
on each deposit category
for the years
ended 31 December 2021,
2020
and
2019
.
For
the
purpose
of
this
disclosure,
foreign
deposits
represent
deposits
from
depositors
who
are
based
outside of Switzerland.
Deposits by
foreign depositors in
domestic
offices
were
USD
77
,
070
million
as
of
31
December
2021
(31 December
2020:
USD 76,200
million;
31 December
2019:
USD 54,262 million).
31.12.21
31.12.20
31.12.19
USD million, except where indicated
Average
deposits
Average
rate (%)
Average
deposits
Average
rate (%)
Average
deposits
Average
rate (%)
Due to banks
Domestic
Demand deposits
927
(0.5)
1,037
(0.4)
925
(0.3)
Time deposits
3,026
0.0
1,775
0.4
44
0.9
Total domestic
3,953
(0.1)
2,812
0.1
969
(0.3)
Foreign
1
Interest-bearing deposits
9,313
(0.1)
8,454
0.1
7,740
0.1
Total due to banks
13,266
(0.1)
11,266
0.1
8,709
0.1
Customer deposits
Domestic
Demand deposits
103,267
(0.2)
91,404
(0.1)
85,115
(0.1)
Savings deposits
114,792
0.0
110,328
0.0
101,845
0.0
Time deposits
10,306
(0.2)
19,256
0.0
15,064
0.3
Total domestic
228,366
(0.1)
220,988
0.0
202,024
0.0
Foreign
1
Demand deposits
140,975
(0.1)
112,499
0.0
93,988
0.1
Savings deposits
111,345
0.1
82,806
0.2
59,593
0.3
Time deposits
44,507
0.1
65,104
0.5
75,554
1.9
Total foreign
296,826
0.0
260,410
0.2
229,135
0.8
Total customer deposits
525,192
0.0
481,398
0.1
431,159
0.4
1 For the
purpose of this
table, the distinction
between foreign and
domestic deposits is
based on the
domicile of the
depositor,
while foreign and
domestic deposits disclosed
in previous tables
are based on
the
booking location.
Uninsured deposits
From the combined total of Due to banks and Customer deposits
as of 31 December
2021, total estimated
uninsured deposits were
USD 395
billion
(31 December
2020:
USD 383
billion;
31 December
2019:
USD 320
billion).
Uninsured
deposits
are
deposits that are in
excess of local deposit
insurance or protection
scheme
limits
in
the
key
locations
in
which
UBS
AG
operates,
calculated
based
on
the
respective
local
regulations,
as
well
as
deposits
in
uninsured
accounts.
The
main
deposit
insurance
schemes applicable
to UBS
AG deposits
are the
Swiss depositor
protection
scheme
in
Switzerland
(which
protects
applicable
deposits
up
to
a
maximum
of
CHF 100,000
per
client
and
per
bank
or
securities
firm),
the
Compensation
Scheme
of
German
Banks, EdB,
in combination
with the
Deposit Protection
Fund of
the
Association
of
German
Banks
in
Germany
(which
protects
applicable
deposits
up
to
a
maximum
of
EUR
597 million
per
client) and
the Federal
Deposit Insurance
Corporation (the
FDIC)
scheme in the Americas (which protects applicable deposits up to
a maximum of USD 250,000 per
depositor, per insured bank, for
each account ownership category).
The table below presents the
maturity of estimated uninsured
time deposits as of 31
December 2021. Where a depositor
holds
multiple accounts,
which in aggregate
are in excess
of a deposit
insurance or protection limit, the insured amount is first allocated
to the account with the shortest time to maturity.
USD million
Uninsured time deposits
1
Within 3 months
46,223
3 to 6 months
2,748
6 to 12 months
2,437
Over 12 months
720
Total uninsured time deposits as of 31 December 2021
52,128
1 Amounts are estimated based on the methodologies defined in each local jurisdiction. As of 31 December 2021, there were no US time deposits subject to the FDIC scheme that
were in excess of the FDIC insurance
limit.
577
Investments in debt instruments
The
table
below
presents
the
carrying
amount
and
weighted
average
yield
of
debt
instruments
presented
within
Financial
assets
measured
at
fair
value
through
other
comprehensive
income and Other financial assets measured at amortized cost on
the
balance
sheet
by
contractual maturity
bucket. The
yield
for
each range of
maturities is calculated
by dividing the
annualized
interest
income
by
the
average
balance
of
the
investment
per
contractual maturity bucket. The
maturity information presented
does
not
consider
any
early
redemption
features
and
debt
instruments without fixed maturities are not included.
Within 1 year
1 up to 5 years
5 to 10 years
Over 10 years
Total
carrying
amount
USD million, except where indicated
Carrying
amount
Yield (%)
Carrying
amount
Yield (%)
Carrying
amount
Yield (%)
Carrying
amount
Yield (%)
Debt instruments measured at fair value
through other comprehensive income
Asset-backed securities
1,129
1.63
3,720
1.42
4,849
Government bills/bonds
27
1.67
416
2.40
1,998
1.20
244
1.64
2,686
Corporate and other
1,193
1.61
116
2.48
1,310
Subtotal as of 31 December 2021
1,220
533
3,127
3,964
8,844
Debt securities measured at amortized cost
Asset-backed securities
2,418
2.32
2,418
Government bills/bonds
1,693
1.20
5,924
1.85
2,216
2.00
9,833
Corporate and other
1,025
0.77
4,264
0.30
1,318
0.33
6,608
Subtotal as of 31 December 2021
2,718
10,189
3,534
2,418
18,858
Total as of 31 December 2021
3,939
10,721
6,661
6,382
27,702
Loan portfolio
The table
below provides
the maturity profile
of UBS
AG’s core
loan portfolio
as of
31 December 2021. The
contractual maturity
is
based on carrying amounts and includes the effect of callable features. For loans due after one year, a breakdown between fixed and
adjustable or floating interest rates is also provided.
USD million
31.12.21
Within 1 year
1 - 5 years
5 - 15 years
Over 15 years
Total
of which: over 1 year
Fixed rate
Adjustable or
floating rate
Private clients with mortgages
30,119
66,165
34,226
21,969
152,479
78,826
43,533
Real estate financing
20,010
15,628
8,266
41
43,945
19,057
4,878
Large corporate clients
8,787
4,396
807
1
13,990
3,879
1,325
SME clients
6,772
4,205
3,027
0
14,004
3,817
3,414
Lombard
142,261
6,733
247
42
149,283
6,481
540
Credit cards
1,716
0
0
0
1,716
0
0
Commodity trade finance
3,809
0
4
0
3,813
4
0
Other loans and advances to customers
10,293
7,679
1,393
100
19,464
5,411
3,760
Loans to financial advisors
118
1,196
1,073
66
2,453
2,335
0
Total
223,884
106,002
49,042
22,218
401,146
119,811
57,450
Allowance for credit losses
For the years
ended 31 December
2021, 2020 and
2019, the ratio
of
net
charge-offs
(i.e.,
write-offs
of
expected
credit
loss
allowances
to
gross
carrying
amount
of
the
average
loans
outstanding)
during
the
period
was
not
material
for
UBS
AG’s
core loan portfolio, both on
an overall basis and on an individual
loan category basis. Total
write-offs for 31 December 2021 were
USD
137
million
(31
December
2020:
USD
356
million,
31
December
2019:
USD
142
million).
Refer
to
the
coverage
ratio
tables
in
“Note
9
Financial
assets
at
amortized
cost
and
other
positions
in
scope of
expected credit
loss measurement”
in
the
"Consolidated financial statements" section of this report for the
ratio of expected credit loss allowances
to total loans outstanding
at each period end.
UBS AG consolidated supplemental disclosures required under SEC regulations
578
579
Appendix
A
Appendix
580
Alternative performance measures
Alternative performance measures
An alternative performance
measure (an
APM) is a
financial measure of
historical or future
financial performance, financial
position
or
cash
flows
other
than
a
financial
measure
defined
or
specified
in
the
applicable
recognized
accounting
standards
or
in
other
applicable regulations. We report
a number of APMs in the discussion of
the financial and operating performance of the Group,
our
business divisions and our Group Functions.
We use APMs to provide a
more complete picture of our
operating performance and to
reflect management’s view of the
fundamental drivers of our
business results. A definition of
each APM, the method
used to calculate
it and the information content are presented in alphabetical order in the table below.
Our APMs may qualify as non-GAAP measures
as defined by US Securities and Exchange Commission (SEC) regulations.
APM label
Calculation
Information content
Active Digital Banking clients in
Corporate & Institutional Clients (%)
– P&C
Calculated as the average number of active
clients for
each month in the relevant period divided by the
average number of total clients. “Clients” refers
to the
number of unique business relationships or legal
entities operated by Corporate & Institutional
Clients,
excluding clients that do not have an account,
mono-
product clients and clients that have defaulted on
loans
or credit facilities. At the end of each month, any client
that has logged on at least once in that
month is
determined to be “active” (a log-in time stamp
is
allocated to all business relationship numbers or
per
legal entity in a digital banking contract).
This measure provides information about the
proportion of active Digital Banking clients in the total
number of UBS clients (within the aforementioned
meaning) which are serviced by Corporate &
Institutional Clients.
Active Digital Banking clients in
Personal Banking (%)
– P&C
Calculated as the average number of active
clients for
each month in the relevant period divided by the
average number of total clients. “Clients” refers
to the
number of unique business relationships operated
by
Personal Banking, excluding persons under the
age of
15, clients who do not have a private account,
clients
domiciled outside Switzerland and clients who have
defaulted on loans or credit facilities. At the
end of
each month, any client that has logged on
at least once
in that month is determined to be “active”
(a log-in
time stamp is allocated to all business relationship
numbers in a digital banking contract).
This measure provides information about the
proportion of active Digital Banking clients in the total
number of UBS clients (within the aforementioned
meaning) who are serviced by Personal Banking.
Business volume for Personal
Banking (CHF and USD)
– P&C
Calculated as the sum of client assets and loans.
This measure provides information about the volume
of client assets and loans.
Client assets (USD and CHF)
– P&C
Calculated as the sum of invested assets
and other
assets held purely for transactional purposes or
custody
only. Net new money is not measured for Personal &
Corporate Banking.
This measure provides information about the volume
of client assets managed by or deposited with
UBS for
investment purposes, including other assets
held
purely for transactional purposes or custody only.
Cost / income ratio (%)
Calculated as operating expenses divided by
operating
income before credit loss expense or release
(annualized as applicable).
This measure provides information about the
efficiency of the business by comparing operating
expenses with gross income.
Fee-generating assets (USD)
– GWM
Calculated as the sum of discretionary and non-
discretionary wealth management portfolios (mandate
volume) and assets where generated revenues are
predominantly of a recurring nature, i.e., mainly
investment and mutual funds, including hedge
funds
and private markets, where we have a distribution
agreement.
This measure provides information about the volume
of invested assets that create a revenue stream,
whether as a result of the nature of the contractual
relationship with clients or through the fee structure
of the asset. An increase in the level of fee-generating
assets results in an increase in the associated revenue
stream.
581
APM label
Calculation
Information content
Fee-generating asset margin (bps)
– GWM
Calculated as revenues from fee-generating assets (a
portion of which is included in recurring fee income
and a portion of which is included in transaction-
based income, annualized as applicable) divided
by
average fee-generating assets for the relevant
mandate fee billing period. For the US, fees have
been billed on daily balances since the fourth
quarter
of 2020 and average fee-generating assets
are
calculated as the average of the monthly
average
balances. Prior to the fourth quarter 2020, billing
was
based on prior quarter-end balances,
and the average
fee-generating
assets were thus the prior quarter-end
balance. For balances outside of the US, billing
is
based on prior month-end balances and average
fee-
generating assets are thus the average of the prior
month-end balances.
This measure provides information about the revenues
from fee-generating assets in relation to their average
volume during the relevant mandate fee billing
period.
Gross margin on invested assets (bps)
– AM
Calculated as operating income before credit loss
expense or release (annualized as applicable) divided
by average invested assets.
This measure provides information about the
operating income before credit loss expense or release
of the business in relation to invested assets.
Impaired loan portfolio as a percentage
of total loan portfolio, gross (%)
– GWM, P&C
Calculated as impaired loan portfolio divided by
total
gross loan portfolio.
This measure provides information about the
proportion of impaired loan portfolio in the total gross
loan portfolio.
Invested assets (USD and CHF)
– GWM, P&C, AM
Calculated as the sum of managed fund
assets,
managed institutional assets, discretionary and
advisory wealth management portfolios, fiduciary
deposits, time deposits, savings accounts,
and wealth
management securities or brokerage accounts.
This measure provides information about the volume
of client assets managed by or deposited with
UBS for
investment purposes.
Loan penetration (%)
– GWM
Calculated as loans divided by invested
assets.
This measure provides information about loan volume
in relation to invested assets.
Mobile Banking log-in share in Personal
Banking (%)
– P&C
Calculated as the number of Mobile Banking
app
log-ins divided by total log-ins via E-Banking
and the
Mobile Banking app in Personal Banking. If
a digital
banking contract is linked to multiple business
relationships, the log-in is attributed to the business
relationship with the most banking products in use.
This measure provides information about the
proportion of Mobile Banking app log-ins in the total
number of log-ins via E-Banking and the Mobile
Banking app in Personal Banking.
Net interest margin (bps)
– P&C
Calculated as net interest income (annualized
as
applicable) divided by average loans.
This measure provides information about the
profitability of the business by calculating the
difference between the price charged for lending and
the cost of funding, relative to loan value.
Net margin on invested assets (bps)
– AM
Calculated as operating profit before tax (annualized
as applicable) divided by average invested
assets.
This measure provides information about the
operating profit before tax of the business in relation
to invested
assets.
Net new business volume for Personal
Banking (CHF and USD)
– P&C
Calculated as the sum of net inflows and outflows
of
client assets and loans during a specific period
(annualized as applicable).
This measure provides information about the business
volume as a result of net new business volume flows
during a specific period.
Net new business volume growth for
Personal Banking (%)
– P&C
Calculated as the sum of net inflows and outflows
of
client assets and loans during a specific period
(annualized as applicable) divided by total business
volume / client assets at the beginning of the
period.
This measure provides information about the growth
of business volume as a result of net new business
volume flows during a specific period.
Net new fee-generating assets (USD)
– GWM
Calculated as the sum of the net amount of
fee-
generating assets inflows and outflows, including
dividend and interest inflows into mandates and
outflows from mandate fees paid by clients, during
a
specific period.
This measure provides information about the
development of fee-generating assets during
a
specific period as a result of net flows and excludes
movements due to market performance and
foreign
exchange translation.
Net new money (USD)
– GWM, AM
Calculated as the sum of the net amount of inflows
and outflows of invested assets (as defined
in UBS
policy) recorded during a specific period.
This measure provides information about the
development of invested assets during a
specific
period as a result of net new money flows and
excludes movements due to market performance,
foreign exchange translation, dividends, interest and
fees.
Net profit growth (%)
Calculated as the change in net profit attributable
to
shareholders from continuing operations between
current and comparison periods divided by net profit
attributable to shareholders from continuing
operations of the comparison period.
This measure provides information about profit
growth in comparison with the prior period.
Appendix
582
APM label
Calculation
Information content
Pre-tax profit growth (%)
Calculated as the change in net profit before tax
attributable to shareholders from continuing
operations between current and comparison periods
divided by net profit before tax attributable to
shareholders from continuing operations of the
comparison period.
This measure provides information about pre-tax
profit growth in comparison with the prior period.
Recurring net fee income
(USD and CHF)
– GWM, P&C
Calculated as the total of fees for services provided
on
an ongoing basis, such as portfolio management
fees,
asset-based investment fund fees and custody
fees,
which are generated on client assets, and
administrative fees for accounts.
This measure provides information about the amount
of recurring net fee income.
Return on attributed equity (%)
Calculated as annualized business division
operating
profit before tax divided by average attributed equity.
This measure provides information about the
profitability of the business divisions in relation to
attributed equity.
Return on
common equity
tier 1
capital (%)
Calculated as annualized net profit attributable to
shareholders divided by average common equity
tier 1
capital.
This measure provides information about the
profitability of the business in relation to common
equity tier 1 capital.
Return on equity (%)
Calculated as annualized net profit attributable to
shareholders divided by average equity attributable
to
shareholders.
This measure provides information about the
profitability of the business in relation to equity.
Return on leverage ratio denominator,
gross (%)
Calculated as annualized operating income
before
credit loss expense or release divided by average
leverage ratio denominator.
This measure provides information about the revenues
of the business in relation to leverage ratio
denominator.
Return on risk-weighted
assets, gross (%)
Calculated as annualized operating income
before
credit loss expense or release divided by average risk-
weighted assets.
This measure provides information about the revenues
of the business in relation to risk-weighted assets.
Return on tangible equity (%)
Calculated as annualized net profit attributable to
shareholders divided by average equity attributable
to
shareholders less average goodwill and intangible
assets.
This measure provides information about the
profitability of the business in relation to tangible
equity.
Secured loan portfolio as a percentage
of total loan portfolio, gross (%)
– P&C
Calculated as secured loan portfolio divided by
total
gross loan portfolio.
This measure provides information about the
proportion of the secured loan portfolio in the total
gross loan portfolio.
Tangible book value per share
(USD and CHF
1
)
Calculated as equity attributable to shareholders less
goodwill and intangible assets divided by the
number
of shares outstanding.
This measure provides information about tangible net
assets on a per-share basis.
Total book value per share
(USD and CHF
1
)
Calculated as equity attributable to shareholders
divided by the number of shares outstanding.
This measure provides information about net assets
on a per-share basis.
Transaction-based income
(USD and CHF)
– GWM, P&C
Calculated as the total of the non-recurring portion
of
net fee and commission income, mainly composed
of
brokerage and transaction-based investment fund
fees, and credit card fees, as well as fees for payment
and foreign exchange transactions, together with
other net income from financial instruments
measured at fair value through profit or loss.
This measure provides information about the amount
of the non-recurring portion of net fee and
commission income.
1
Total book value per share and tangible book value per share in Swiss francs are calculated based
on a translation of equity under our US dollar presentation currency.
583
Abbreviations frequently used in our financial reports
A
ABS
asset
-
backed securities
AG
M
Annual G
eneral
M
eeting
of
shareholders
A
-
IRB
advanced internal ratings
-
based
AIV
alternative investment
vehicle
ALCO
Asset and Liability
Committee
AMA
advanced measurement
approach
AML
anti
-
money laundering
AoA
Articles of Association
APM
alternative pe
rformance
measure
ARR
alternative reference rate
ARS
auction rate securities
ASF
available stable funding
AT1
additional tier 1
AuM
assets under management
B
BCBS
Basel Committee on
Banking Supervision
BIS
Bank for International
Settlements
BoD
Board of Directors
C
CAO
Capital Adequacy
Ordinance
CCAR
Comprehensive Capital
Analysis and Review
CCF
credit conversion factor
CCP
central counterparty
CCR
counterparty credit risk
CCRC
Corporate Culture and
Responsibility Committee
CDS
credit defa
ult swap
CEA
Commodity Exchange Act
CEO
Chief Executive Officer
CET1
common equity tier 1
CFO
Chief Financial Officer
CFTC
US Commodity Futures
Trading Commission
C
GU
c
ash
-
generating unit
CHF
Swiss franc
CIO
Chief Investment Office
CLS
C
ontinuous
Linked
Settlement
C&ORC
Compliance & Operational
Risk Control
CRD IV
EU Capital Requirements
Directive of 2013
CRM
credit risk mitigation (credit
risk) or comprehensive risk
measure (market risk)
CST
combined stress test
CUSIP
Committee on Unif
orm
Security Identification
Procedures
CVA
credit valuation adjustment
D
DBO
defined benefit obligation
DCCP
Deferred Contingent
Capital Plan
DM
discount margin
DOJ
US Department of Justice
DTA
deferred tax asset
DVA
debit valuation adjustment
E
EAD
exposure at default
EB
Executive Board
EC
European Commission
ECB
European Central Bank
ECL
expected credit loss
EGM
Extraordinary General
Meeting of shareholders
EIR
effective interest rate
EL
expected loss
EMEA
Europe, Middle East and
Africa
EOP
Equity Ownership Plan
EPS
earnings per share
ESG
environmental, social and
governance
ETD
exchange
-
traded derivative
s
ETF
exchange
-
traded fund
EU
European Union
EUR
euro
EURIBOR
Euro Interbank Offered Rate
ESR
e
nvironmental and social
risk
EVE
economic va
lue of equity
EY
Ernst & Young Ltd
F
FA
financial advisor
FCA
UK Financial Conduct
Authority
FCT
foreign currency translation
FINMA
Swiss Financial Market
Supervisory Authority
FMIA
Swiss Financial Market
Infrastructure Act
Appendix
584
Abbreviations frequently used in our financial reports (continued)
FSB
Financial Stability Board
F
TA
Swiss Federal Tax
Administration
FVA
funding valuation
adjustment
FVOCI
fair value through other
comprehensive income
FVTPL
fair value through profit or
loss
FX
foreign exchange
G
GAAP
generally accepted
accounting principles
GCRG
Group
Compliance,
Regulatory & Governance
GBP
pound sterling
GDP
gross domestic product
GEB
Group Executive Board
GHG
greenhouse gas
GIA
Group Internal Audit
GMD
Group Managing Director
GRI
Global Reporting Initiative
G
-
SIB
global systemically
important bank
H
Hong Kong
SAR
Hong Kong Special
Administrative Region of
the People’s Republic of
China
HQLA
high-quality liquid assets
I
IAS
International Accounting
Standards
IASB
International Accounting
Standards Board
IBOR
interbank offered rate
IFRIC
International Financial
Reporting Interpretations
Committee
IFRS
International Financial
Reporting Standards
IRB
internal ratings
-
based
IRRBB
interest rate risk in the
banking book
ISDA
International Swaps and
Derivatives Association
ISIN
International Se
curities
Identification Number
K
KRT
Key Risk Taker
L
LAS
liquidity
-
adjusted stress
LCR
liquidity coverage ratio
LGD
loss given default
LIBOR
London Interbank Offered
Rate
LLC
limited liability company
LoD
lines of defense
LRD
leverage ratio
denominator
LTIP
Long
-
Term Incentive Plan
LTV
loan
-
to
-
value
M
M&A
mergers and acquisitions
MiFID II
Markets in Financial
Instruments Directive II
MRT
Material Risk Taker
N
NAV
net asset value
NII
net interest income
NSFR
net stable funding ratio
NYSE
Ne
w York Stock Exchange
O
OCA
own credit adjustment
OCI
other comprehensive
income
ORF
operational risk framework
OTC
over
-
the
-
counter
P
PD
probability of default
PIT
point in time
P&L
profit or loss
POCI
purchased or originated
credit-impaired
PRA
UK Prudential Regulation
Authority
PRV
positive replacement value
R
RBA
role
-
based allowance
RBC
risk
-
based capital
RbM
risk
-
based monitoring
REIT
r
eal estate investment trust
RMBS
residential mortgage
-
backed securities
RniV
risks not
in VaR
RoCET1
return on CET1 capital
RoTE
return on tangible equity
RoU
right
-
of
-
use
rTSR
r
elative total shareholder
return
RWA
risk
-
weighted assets
585
Abbreviations frequently used in our financial reports (continued)
S
SA
standardized approach
SA
-
CCR
standardized approach for
counterparty credit risk
SAR
stock appreciation righ
t
or
Special Administrative
Region
SBC
Swiss Bank Corporation
SDG
Sustainable Development
Goal
SE
structured entity
SEC
US Securities and Exchange
Commission
SEEOP
Senior Executive Equity
Ownership Plan
SFT
securities financing
transaction
SI
sustainable investing
or
sustainable
investments
SIBOR
Singapore Interbank
Offered Rate
SICR
significant increase in credit
risk
SIX
SIX Swiss Exchange
SME
small and medium
-
sized
entities
SMF
Senior Management
Function
SNB
Swiss National Bank
SOR
Singapore Swap Offer Rate
SPPI
solely payments of principal
and interest
SRB
systemically relevant bank
SRM
specific risk measure
SVaR
stressed value
-
at
-
risk
T
TBTF
too big to fail
TCFD
Task
Force on Climate
-
related Financial Disclosures
TIBOR
Tokyo
Inte
rbank Offered
Rate
TLAC
total loss
-
absorbing capacity
U
UoM
units of measure
USD
US dollar
V
VaR
value
-
at
-
risk
VAT
value added tax
This is a
general list of
the abbreviations
frequently used
in our financial
reporting. Not all
of the listed
abbreviations may
appear in
this particular report.
Appendix
586
Information sources
Reporting publications
Annual publications
Annual Report (SAP No. 80531):
Published in English, this single-
volume
report
provides
descriptions of:
our
Group strategy
and
performance;
the
strategy
and
performance
of
the
business
divisions
and
Group
Functions;
risk,
capital
and
funding,
and
balance
sheet
management;
corporate
governance,
corporate
responsibility
and
our
compensation
framework,
including
information about
compensation for
the Board
of Directors
and
the Group
Executive Board
members; and
financial information,
including the financial statements.
Geschäftsbericht
(SAP
No.
80531):
This
publication
provides
a
translation
into
German
of
selected
sections
of
our
Annual
Report.
Annual
Review
(SAP
No.
80530):
This
booklet
contains
key
information about our strategy and
performance, with a focus
on
corporate responsibility at UBS.
It is published in
English, German,
French and Italian.
Compensation Report (SAP No. 82307):
This report discusses our
compensation
framework
and
provides
information
about
compensation for the Board of Directors and
the Group Executive
Board members. It is available in English and German.
Quarterly publications
The quarterly financial report provides
an update on our strategy
and
performance
for
the
respective
quarter.
It
is
available
in
English.
How to order publications
The annual and quarterly publications are available in .pdf format
at
ubs.com/investors
, under “Financial information,” and printed
copies
can
be
requested
from
UBS
free
of
charge.
For
annual
publications,
refer
to
the
“Investor
services”
section
at
ubs.com/investors.
Alternatively, they
can be ordered
by quoting
the SAP number and the language preference,
where applicable,
from UBS AG,
F4UK–AUL, P.O. Box, CH-8098 Zurich, Switzerland.
Other information
Website
The
“Investor
Relations”
website
at
ubs.com/investors
provides
the
following
information
about
UBS:
news
releases;
financial
information, including results-related filings
with the US
Securities
and
Exchange
Commission
(the
SEC);
information
for
shareholders, including UBS
share price charts,
as well as
data and
dividend
information,
and
for
bondholders;
the
UBS
corporate
calendar;
and
presentations
by
management
for
investors
and
financial analysts.
Information is
available online
in English,
with
some information also available in German.
Results presentations
Our
quarterly
results
presentations
are
webcast
live.
Playbacks
of
most
presentations
can
be
download
ed
from
ubs.com/presentations
.
Messaging
service
Email alerts to news
about UBS can be subscribed
for under “UBS
News
Alert”
at
ubs.com/global/en/investor-relations/contact/
investor-services.html
.
Messages
are
sent
in
English,
German,
French or
Italian, with an
option to
select theme preferences
for
such alerts.
Form 20-F
and other
submissions to
the US
Securities and
Exchange Commission
We file periodic reports and submit other
information about UBS
to the
US Securities
and Exchange
Commission (the
SEC). Principal
among
these
filings
is
the
annual
report
on
Form
20-F,
filed
pursuant to the US Securities Exchange Act of 1934. The filing of
Form
20-F
is
structured
as
a
wrap-around
document.
Most
sections of the filing can
be satisfied by referring to the
combined
UBS Group
AG and
UBS AG
annual report.
However,
there is
a
small amount
of additional
information in
Form 20-F
that is
not
presented elsewhere and is particularly targeted at
readers in the
US. Readers are encouraged to refer
to this additional disclosure.
Any document that we file with the SEC is available on the SEC’s
website:
sec.gov
.
Refer
to
ubs.com/investors
for
more
information.
587
Cautionary Statement Regarding Forward-Looking Statements |
This report contains statements that constitute “forward-looking statements,” including
but not limited to management’s outlook for
UBS’s financial performance,
statements relating to the anticipated effect of
transactions and strategic initiatives
on UBS’s
business and future
development and goals
or intentions to
achieve climate, sustainability
and other social
objectives. While these
forward-looking
statements represent
UBS’s judgments,
expectations and
objectives concerning the
matters described,
a number
of risks,
uncertainties and
other important
factors could cause
actual developments
and results
to differ materially
from UBS’s expectations.
Russia’s invasion of
Ukraine has led
to heightened volatility
across global markets
and to
the coordinated
implementation of sanctions
on Russia, Russian
entities and nationals.
Russia’s invasion of
Ukraine
already has
caused significant population displacement, and as the conflict continues, the disruption will likely increase. The scale
of the conflict and the speed and extent
of sanctions, as well as the uncertainty as to how the situation will develop, may have significant adverse effects to the market and
macroeconomic conditions,
including in ways that cannot be anticipated. This creates significantly greater uncertainty about forward-looking statements. The COVID-19 pandemic and the
measures taken to manage it
have had and may
also continue to have
a significant adverse effect on
global and regional economic
activity, including disruptions
to global supply chains,
inflationary pressures, and labor
market displacements. Factors
that may affect our
performance and ability
to achieve our plans,
outlook
and other objectives also
include, but are not limited
to: (i) the degree to
which UBS is successful
in the ongoing execution
of its strategic plans,
including its cost
reduction and efficiency initiatives
and its ability to
manage its levels of
risk-weighted assets (RWA) and
leverage ratio denominator
(LRD), liquidity coverage
ratio
and other financial resources,
including changes in RWA assets
and liabilities arising from higher
market volatility; (ii) the degree
to which UBS is successful
in
implementing changes to its businesses
to meet changing market, regulatory
and other conditions; (iii) the continuing
low or negative interest rate environment
in Switzerland
and other
jurisdictions; (iv) developments
in the
macroeconomic climate and
in the
markets in
which UBS
operates or
to which
it is
exposed,
including movements in securities
prices or liquidity, credit spreads, and currency exchange
rates, and the effects of economic
conditions, market developments,
and increasing geopolitical tensions, and changes to national trade policies on the
financial position or creditworthiness of UBS’s clients and counterparties, as
well as on client sentiment and levels of activity; (v) changes in the availability
of capital and funding, including any changes in UBS’s credit spreads and ratings,
as well as availability and cost of funding to meet requirements for debt eligible for total loss-absorbing capacity (TLAC); (vi) changes in central bank policies or
the implementation
of financial legislation and regulation in Switzerland,
the US, the UK, the European Union and other financial
centers that have imposed, or
resulted in, or may do
so in the future, more
stringent or entity-specific
capital, TLAC, leverage
ratio, net stable
funding ratio, liquidity
and funding requirements,
heightened operational resilience requirements, incremental tax requirements, additional levies, limitations
on permitted activities, constraints on remuneration,
constraints on transfers of capital and liquidity and sharing of operational costs
across the Group or other measures, and the effect these will or would have on
UBS’s business activities;
(vii) UBS’s ability
to successfully implement resolvability
and related
regulatory requirements and
the potential need
to make further
changes to the
legal structure or
booking model of
UBS Group in
response to legal
and regulatory requirements,
or other external
developments; (viii) UBS’s
ability to maintain
and improve its
systems and controls
for complying with
sanctions and for
the detection and
prevention of money
laundering to meet
evolving
regulatory
requirements
and
expectations, in
particular
in
current
geopolitical
turmoil;
(ix)
the
uncertainty
arising
from
domestic stresses
in
certain
major
economies; (x)
changes in
UBS’s competitive position,
including whether differences
in regulatory
capital and
other requirements
among the
major financial
centers adversely affect UBS’s ability
to compete in certain lines
of business; (xi) changes in
the standards of conduct applicable
to our businesses that
may result
from new regulations or new enforcement of existing standards, including measures to impose
new and enhanced duties when interacting with customers
and
in the
execution and
handling of
customer transactions;
(xii) the
liability to
which UBS
may be
exposed, or
possible constraints
or sanctions
that regulatory
authorities might
impose on
UBS, due
to litigation,
contractual claims
and regulatory
investigations, including the
potential for
disqualification from
certain
businesses, potentially large fines or monetary penalties, or the loss of licenses or privileges
as a result of regulatory or other governmental sanctions, as well as
the effect that litigation, regulatory
and similar matters have
on the operational risk
component of our RWA, as
well as the amount
of capital available for
return
to shareholders; (xiii) the effects on UBS’s cross-border banking business of sanctions, tax or regulatory developments and of possible changes in UBS’s policies
and practices relating to this business;
(xiv) UBS’s ability to retain and
attract the employees necessary
to generate revenues and to manage,
support and control
its businesses,
which may
be affected
by competitive
factors; (xv) changes
in accounting
or tax
standards or
policies, and
determinations or
interpretations
affecting the recognition of gain or loss,
the valuation of goodwill, the
recognition of deferred tax assets and
other matters; (xvi) UBS’s ability
to implement new
technologies and business methods, including digital services and technologies, and ability to successfully compete with both
existing and new financial service
providers, some of which may not be
regulated to the same extent; (xvii) limitations on
the effectiveness of UBS’s internal processes for risk management, risk
control, measurement and modeling, and
of financial models generally; (xviii)
the occurrence of operational
failures, such as
fraud, misconduct, unauthorized
trading, financial crime,
cyberattacks, data leakage and
systems failures,
the risk
of which is
increased with cyberattack
threats from
nation states and
while
COVID-19 control measures
require large portions
of the staff of
both UBS and
its service providers
to work remotely;
(xix) restrictions on the
ability of UBS
Group
AG to make payments or distributions,
including due to restrictions on the
ability of its subsidiaries to make
loans or distributions, directly or indirectly, or, in the
case of financial difficulties, due to the exercise by FINMA or the regulators of UBS’s operations in other countries of their broad statutory powers in relation to
protective measures, restructuring
and liquidation proceedings;
(xx) the degree to
which changes in
regulation, capital or
legal structure, financial results
or other
factors may affect
UBS’s ability to
maintain its stated
capital return
objective; (xxi)
uncertainty over
the scope
of actions that
may be required
by UBS, governments
and
others
to
achieve
goals
relating
to
climate,
environmental and
social
matters, as
well
as
the
evolving
nature
of
underlying science
and
industry and
governmental standards; and (xxii) the effect that
these or other factors or unanticipated events may have
on our reputation and the additional
consequences
that this may have on
our business and performance.
The sequence in which the
factors above are presented is
not indicative of their
likelihood of occurrence or
the potential magnitude
of their consequences.
Our business and
financial performance could
be affected by
other factors identified
in our past
and future filings
and reports, including those filed with the SEC. More
detailed information about those factors is set forth in documents furnished by UBS and
filings made by
UBS with the
SEC, including
UBS’s Annual Report
on Form 20-F
for the year
ended 31 December
2021. UBS is
not under any
obligation to
(and expressly disclaims
any obligation to) update or alter its forward-looking
statements, whether as a result of new information,
future events, or otherwise.
Rounding |
Numbers presented throughout this report may not add up
precisely to the totals provided in the tables and text.
Percentages and percent changes
disclosed in text and tables are
calculated on the basis of unrounded
figures. Absolute changes between reporting periods disclosed
in the text, which can be
derived from numbers presented in related tables, are calculated on
a rounded basis.
Tables |
Within tables, blank fields generally indicate non-applicability or that presentation of any content would not be meaningful, or that information is not
available as of the relevant date or for the relevant period. Zero values generally indicate that the respective figure is zero on an actual or rounded basis.
Values
that are zero on a rounded basis can be either negative
or positive on an actual basis.
UBS Group AG
P.O.
Box
CH-8098 Zurich
ubs.com